data_2jty_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jty _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.29 -34.92 16.56 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 126.587 1.955 . . . . 0.0 111.189 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.8 m -125.76 146.51 49.74 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 127.376 2.27 . . . . 0.0 107.649 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.93 1.81 55.31 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -163.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.307 13.7 p 49.54 113.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 129.81 3.244 . . . . 0.0 114.275 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -53.0 141.78 21.41 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.423 1.089 . . . . 0.0 110.736 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.08 -39.12 55.31 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.768 1.227 . . . . 0.0 109.643 171.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.19 13.84 1.84 Allowed Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.799 -1.0 . . . . 0.0 114.522 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 t -144.63 -36.69 0.31 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.665 1.586 . . . . 0.0 111.515 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.08 -49.87 80.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.424 0 CA-C-N 119.698 1.135 . . . . 0.0 109.095 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -121.94 75.52 1.22 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -171.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -105.68 138.21 42.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.388 -169.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 m -106.87 99.93 9.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.5 t -86.33 101.22 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -92.12 98.42 11.53 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -174.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.5 mt -75.94 -7.28 54.2 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.304 2.242 . . . . 0.0 109.883 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.54 -172.64 27.3 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 124.108 0.861 . . . . 0.0 111.734 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -77.67 142.39 38.85 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.943 0.878 . . . . 0.0 110.915 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.7 t -124.01 150.77 28.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 125.538 1.535 . . . . 0.0 108.095 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.92 137.66 32.98 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.0 p -60.39 -21.79 62.59 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 122.931 0.492 . . . . 0.0 112.253 171.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.47 -48.78 47.48 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-O 122.439 1.114 . . . . 0.0 111.312 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.2 m -79.19 5.87 11.1 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.221 1.008 . . . . 0.0 113.448 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.7 mt -142.65 72.08 1.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.696 1.998 . . . . 0.0 107.114 -170.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.72 -7.19 1.68 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -171.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -145.51 162.82 36.49 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.651 1.18 . . . . 0.0 108.056 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -62.65 117.84 6.82 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 173.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.441 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 106.6 -10.33 41.84 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-O 118.305 -1.275 . . . . 0.0 112.471 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.34 147.69 52.0 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.809 1.305 . . . . 0.0 109.432 171.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.1 p -143.72 155.62 44.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.528 0.68 . . . . 0.0 111.736 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.4 p -66.7 -177.69 0.62 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.388 0.675 . . . . 0.0 110.56 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -59.56 -22.32 61.56 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 119.56 -1.962 . . . . 0.0 113.397 171.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 74.07 164.83 0.28 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 127.335 2.254 . . . . 0.0 110.782 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.2 t -149.2 142.63 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.17 125.3 8.3 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -115.6 158.52 22.56 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 170.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.428 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 2.7 m-20 -131.14 173.9 10.57 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.085 0.857 . . . . 0.0 110.808 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.9 mm -121.57 109.84 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.602 1.161 . . . . 0.0 107.935 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.36 109.38 17.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.539 1.936 . . . . 0.0 109.5 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.66 106.61 17.22 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 127.218 2.207 . . . . 0.0 108.507 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -87.05 158.55 19.19 Favored 'General case' 0 CA--C 1.523 -0.085 0 C-N-CA 124.539 1.135 . . . . 0.0 110.667 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 32.98 57.75 0.45 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.269 2.628 . . . . 0.0 113.145 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.9 m -64.36 142.3 58.47 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 125.705 1.602 . . . . 0.0 110.602 168.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -120.32 132.48 55.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 127.305 2.242 . . . . 0.0 108.73 171.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.7 p -92.74 -9.43 40.67 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -67.32 -47.66 69.86 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.036 0.834 . . . . 0.0 109.871 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 p -65.14 -49.1 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.237 -177.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.67 114.04 2.6 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.44 1.896 . . . . 0.0 108.294 -170.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.8 m -76.75 -2.24 32.09 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.711 169.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -137.6 164.69 28.16 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.986 1.721 . . . . 0.0 112.03 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.96 140.35 26.84 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.64 166.09 13.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.537 1.935 . . . . 0.0 106.292 163.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 t -125.71 157.89 34.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.57 167.64 19.67 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 164.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -130.82 155.86 45.98 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.549 1.54 . . . . 0.0 109.94 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 tp -150.79 134.04 16.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.909 0.484 . . . . 0.0 111.192 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.6 172.67 42.53 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.124 0.869 . . . . 0.0 111.325 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 m -55.39 125.79 22.35 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.494 1.117 . . . . 0.0 108.347 171.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.55 139.83 44.02 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.424 1.011 . . . . 0.0 108.666 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.1 tt -57.06 -39.39 66.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.032 0.533 . . . . 0.0 111.112 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -160.59 177.75 10.2 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.672 1.589 . . . . 0.0 108.025 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.93 -37.77 79.1 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.396 0.678 . . . . 0.0 111.549 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.06 5.26 55.01 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.622 0.63 . . . . 0.0 111.966 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -146.91 50.47 1.11 Allowed 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.146 -1.208 . . . . 0.0 110.1 -171.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.5 p -67.03 -8.87 33.37 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.355 1.462 . . . . 0.0 111.749 171.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -81.77 -11.92 58.79 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 167.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.8 t -125.83 136.3 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 121.308 1.867 . . . . 0.0 109.964 -161.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.85 156.01 30.66 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 118.923 0.783 . . . . 0.0 111.737 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.58 19.3 10.02 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.485 1.514 . . . . 0.0 113.866 -171.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.3 mt 55.19 -156.87 0.23 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.943 0.897 . . . . 0.0 109.902 -165.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.239 0.536 0 C-N-CA 125.733 1.613 . . . . 0.0 108.659 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.447 -0.617 0 CA-C-O 122.501 1.143 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.19 153.97 24.61 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.611 -0.681 . . . . 0.0 109.292 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.0 p -115.85 164.69 14.03 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.906 0.882 . . . . 0.0 109.194 170.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 57.05 20.82 5.76 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.928 1.691 . . . . 0.0 111.889 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -138.4 152.04 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.46 177.94 28.22 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.408 HG23 ' CD2' ' A' ' 177' ' ' PHE . 0.7 OUTLIER -90.48 155.05 3.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.392 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -126.45 167.52 15.47 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 120.744 -1.223 . . . . 0.0 110.558 158.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.12 130.59 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 127.428 2.291 . . . . 0.0 105.33 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.0 mt -122.19 140.81 52.14 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -62.68 171.55 2.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 122.216 1.008 . . . . 0.0 110.252 164.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -53.22 -25.82 15.45 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.462 1.505 . . . . 0.0 113.966 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.1 p -75.13 -23.76 57.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 119.677 1.126 . . . . 0.0 108.974 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.72 6.44 40.61 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.504 2.002 . . . . 0.0 112.708 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.52 131.33 34.39 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.247 1.524 . . . . 0.0 109.31 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.88 120.0 14.96 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.903 1.281 . . . . 0.0 111.701 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.0 mt -78.76 157.42 28.49 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.341 0.656 . . . . 0.0 109.756 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 m -100.69 144.97 29.03 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.426 1.09 . . . . 0.0 109.545 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.5 mt -89.22 70.79 8.29 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.454 1.102 . . . . 0.0 108.743 -173.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.55 -9.84 11.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.301 0.64 . . . . 0.0 112.316 174.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.02 -9.56 31.39 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.743 -1.032 . . . . 0.0 112.871 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.33 -8.34 5.82 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.087 1.355 . . . . 0.0 113.083 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.0 m -67.16 91.48 0.23 Allowed 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 168.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -64.89 164.2 12.96 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.795 0.838 . . . . 0.0 109.609 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 57.9 p -133.58 -175.93 3.98 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.662 1.185 . . . . 0.0 110.888 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -32.36 112.89 0.12 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 128.105 2.562 . . . . 0.0 112.431 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -73.26 108.58 6.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 88.4 m -81.95 113.3 19.76 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 167.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 93.8 m -57.95 121.0 9.52 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 160.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 99.0 mt -77.16 -170.06 1.57 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.393 1.477 . . . . 0.0 109.694 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.64 161.46 42.64 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 127.167 2.187 . . . . 0.0 107.593 168.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -64.49 140.19 58.84 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 170.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.25 -111.22 4.12 Favored Glycine 0 N--CA 1.467 0.704 0 CA-C-O 118.148 -1.362 . . . . 0.0 111.54 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 m -125.33 139.88 53.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.322 2.061 . . . . 0.0 110.488 -171.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -142.32 151.97 42.48 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 124.313 1.045 . . . . 0.0 109.959 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.428 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 97.1 m -132.72 124.22 27.74 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.017 0.527 . . . . 0.0 109.902 170.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.0 116.02 64.12 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 166.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.98 155.99 34.15 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.895 1.73 . . . . 0.0 110.51 166.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -139.1 172.69 12.47 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 127.743 2.417 . . . . 0.0 108.263 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.99 155.97 34.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 162.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -137.6 149.35 46.57 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.705 1.202 . . . . 0.0 108.014 171.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -161.04 153.68 20.73 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -70.02 133.32 47.11 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.441 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 60.8 t80 -113.11 124.82 53.47 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.384 1.474 . . . . 0.0 107.85 176.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.43 141.65 29.81 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 170.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.4 p -105.48 11.19 32.83 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.862 0.465 . . . . 0.0 111.258 172.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.22 -153.8 23.63 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.54 93.65 0.05 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.94 1.696 . . . . 0.0 109.893 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.82 170.01 13.43 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 122.976 0.511 . . . . 0.0 111.443 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.8 p -136.49 159.19 71.51 Favored Pre-proline 0 N--CA 1.467 0.386 0 C-N-CA 123.441 0.696 . . . . 0.0 110.528 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -75.12 177.08 9.08 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.63 1.554 . . . . 0.0 110.434 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.01 -95.84 0.17 Allowed Glycine 0 CA--C 1.522 0.494 0 O-C-N 121.606 -0.684 . . . . 0.0 111.695 168.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.03 157.36 45.43 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.884 1.674 . . . . 0.0 107.189 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -146.51 66.41 1.18 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.592 0.71 . . . . 0.0 110.612 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -108.45 150.95 26.71 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.28 163.03 40.27 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.616 1.566 . . . . 0.0 109.161 170.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -138.95 96.35 3.11 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.27 167.66 20.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.492 166.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.2 p -106.88 164.84 11.78 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 147.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -122.35 157.38 31.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 168.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -117.49 166.66 12.1 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.609 1.564 . . . . 0.0 108.595 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 8.5 t -127.86 106.65 15.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.454 HE21 ' NE2' ' A' ' 159' ' ' GLN . 40.8 tt0 -88.1 92.64 9.22 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 167.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -63.42 153.97 33.57 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 163.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.454 ' NE2' HE21 ' A' ' 157' ' ' GLN . 11.9 pt20 -160.84 170.46 20.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.208 0.603 . . . . 0.0 110.662 168.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 CA-C-O 118.251 -1.305 . . . . 0.0 111.784 177.672 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.632 0 CA-C-O 120.472 0.177 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 87.2 m -142.61 108.49 5.16 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.59 1.956 . . . . 0.0 107.647 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 15.5 m -97.0 94.04 6.95 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.789 0.836 . . . . 0.0 110.15 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -85.32 168.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 124.121 0.968 . . . . 0.0 110.018 168.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -63.62 174.97 1.18 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.056 0.542 . . . . 0.0 109.688 160.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -144.64 -34.17 0.08 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-O 117.817 -1.546 . . . . 0.0 114.416 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 147.58 -176.8 26.25 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 119.412 1.606 . . . . 0.0 112.67 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.1 m -101.34 140.05 36.16 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.291 1.836 . . . . 0.0 108.908 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.56 96.48 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -83.42 88.49 6.98 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.408 ' CD2' HG23 ' A' ' 101' ' ' VAL . 58.8 m-85 -66.19 113.06 4.26 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 170.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -120.42 161.6 20.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 135.88 -174.19 21.49 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -170.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -161.51 172.14 16.92 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -168.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 39.2 t -124.93 133.45 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.4 m -112.61 148.19 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 C-N-CA 127.113 2.165 . . . . 0.0 108.365 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.77 31.23 0.09 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.686 2.395 . . . . 0.0 112.429 -170.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 127.856 2.463 . . . . 0.0 110.028 -165.488 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.278 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.7 -18.04 61.05 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -172.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.0 m -133.77 160.04 38.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.15 109.45 19.91 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.621 1.568 . . . . 0.0 107.867 161.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -50.15 125.86 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 152.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.68 151.77 40.93 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.713 0.688 . . . . 0.0 109.698 174.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.75 -29.26 53.3 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 120.952 -1.092 . . . . 0.0 112.396 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.38 -50.48 66.36 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 123.91 0.767 . . . . 0.0 111.26 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.0 m -72.03 -27.05 62.45 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.899 0.88 . . . . 0.0 111.286 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.1 t -60.74 -25.87 36.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.368 1.067 . . . . 0.0 113.035 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -145.48 30.63 1.11 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.691 1.196 . . . . 0.0 111.488 -166.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -77.87 133.27 38.17 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 120.828 -1.17 . . . . 0.0 108.663 -162.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.4 m -100.88 103.05 14.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.3 t -82.8 95.72 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -176.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -77.82 95.51 4.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -71.43 -12.31 61.34 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.983 1.313 . . . . 0.0 111.162 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.18 -177.89 31.37 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.325 0.964 . . . . 0.0 112.431 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -67.84 121.01 15.09 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.206 1.403 . . . . 0.0 109.748 168.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.5 t -99.82 149.26 5.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 126.063 1.745 . . . . 0.0 106.961 171.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -82.93 133.85 35.1 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.9 p -58.77 -19.37 40.14 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.817 0.847 . . . . 0.0 111.048 170.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.91 -50.09 61.77 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 120.746 -1.221 . . . . 0.0 109.336 170.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.4 m -73.12 -2.31 20.95 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.5 mt -141.23 79.19 1.68 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.403 1.481 . . . . 0.0 107.366 -171.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.31 -0.27 1.27 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -148.69 159.42 44.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -62.21 118.17 7.04 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.11 6.55 66.66 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 126.347 1.927 . . . . 0.0 112.885 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.84 149.02 23.48 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 148.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.37 153.57 42.1 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -178.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.9 p -70.3 171.78 9.34 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.366 -0.834 . . . . 0.0 109.065 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -47.5 -66.78 0.35 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -173.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 154.19 136.71 0.0 OUTLIER 'General case' 0 C--O 1.233 0.224 0 C-N-CA 128.199 2.6 . . . . 0.0 106.74 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.6 t -137.7 138.38 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 173.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.64 127.4 9.21 Favored Glycine 0 CA--C 1.516 0.148 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -132.47 87.95 2.48 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 123.307 1.527 . . . . 0.0 109.263 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -81.13 160.77 24.33 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 120.626 -1.297 . . . . 0.0 111.487 -173.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 mm -112.03 108.71 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 175.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -76.31 110.82 11.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.69 1.996 . . . . 0.0 109.113 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.56 108.6 18.16 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.474 1.51 . . . . 0.0 107.173 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.0 168.46 10.94 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.489 1.116 . . . . 0.0 109.832 171.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t70 51.46 36.26 16.3 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.828 2.451 . . . . 0.0 116.76 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.9 m -69.89 85.62 0.5 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.626 1.97 . . . . 0.0 114.736 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -72.98 111.8 8.42 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.454 -0.778 . . . . 0.0 112.375 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.6 p -62.5 -12.86 24.8 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.374 1.07 . . . . 0.0 112.234 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -66.37 -38.35 87.36 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.359 0.981 . . . . 0.0 110.272 173.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.55 -58.15 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.37 143.83 19.19 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.186 1.394 . . . . 0.0 107.743 -172.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.2 p -88.19 -12.79 42.84 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.66 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -140.82 156.15 46.21 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 127.125 2.17 . . . . 0.0 107.797 -166.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.56 85.94 1.2 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -173.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.11 173.52 11.2 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 123.642 0.777 . . . . 0.0 109.293 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -148.14 107.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -170.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.71 163.8 13.21 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 124.037 0.935 . . . . 0.0 108.922 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.448 ' CE2' HG23 ' A' ' 103' ' ' ILE . 6.7 m-85 -135.36 148.61 49.47 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.758 0.823 . . . . 0.0 109.652 -168.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 tp -146.91 132.71 18.97 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.122 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.27 175.53 39.55 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 172.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.5 m -60.2 134.04 56.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.67 1.188 . . . . 0.0 108.79 172.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.81 132.06 35.18 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.207 1.003 . . . . 0.0 109.003 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.7 tt -60.5 -34.26 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 122.83 0.452 . . . . 0.0 110.609 -178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -153.25 164.74 37.55 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 126.382 1.873 . . . . 0.0 109.623 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.72 -31.04 46.62 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.113 2.565 . . . . 0.0 115.061 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.97 -40.18 6.28 Favored Glycine 0 CA--C 1.518 0.274 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 174.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.411 ' CE1' ' HB ' ' A' ' 140' ' ' THR . 47.9 m80 -86.71 43.59 1.09 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.435 1.494 . . . . 0.0 110.51 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.6 p -63.81 -12.88 39.64 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.816 1.646 . . . . 0.0 112.232 173.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -82.13 -9.44 59.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.517 -0.739 . . . . 0.0 112.629 171.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 t -127.98 137.24 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 119.726 1.148 . . . . 0.0 109.855 -165.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.95 149.17 29.48 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.306 1.442 . . . . 0.0 110.743 -168.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.71 14.02 22.54 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -162.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.8 mt 51.54 -169.21 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.509 1.124 . . . . 0.0 110.41 -162.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 . . . . . 0 CA--C 1.514 -0.418 0 C-N-CA 126.364 1.866 . . . . 0.0 108.292 -177.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.443 -0.784 0 CA-C-O 122.35 1.071 . . . . 0.0 108.345 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.42 145.25 33.41 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.008 -1.451 . . . . 0.0 107.562 162.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 p -118.24 160.87 20.84 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 124.628 1.171 . . . . 0.0 109.156 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 59.83 27.04 16.3 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.511 0.725 . . . . 0.0 110.635 -173.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.0 p -143.74 145.45 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 121.215 -0.928 . . . . 0.0 108.667 170.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.88 174.12 23.74 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.414 HG11 ' CG ' ' A' ' 177' ' ' PHE . 99.3 t -86.45 147.2 5.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -129.99 140.81 50.83 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.333 1.053 . . . . 0.0 108.575 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.448 HG23 ' CE2' ' A' ' 73' ' ' PHE . 5.3 mp -108.3 134.99 48.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.8 mt -134.11 132.77 40.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.959 1.704 . . . . 0.0 107.673 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -73.11 -170.85 0.81 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.724 1.147 . . . . 0.0 112.046 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -48.63 -37.15 17.47 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.757 1.623 . . . . 0.0 111.854 167.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 p -77.83 -5.84 52.17 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.512 1.925 . . . . 0.0 112.484 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 57.25 25.12 53.8 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.755 1.169 . . . . 0.0 112.975 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.27 138.78 32.74 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.71 154.21 40.81 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.231 0.469 . . . . 0.0 111.704 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.3 mt -127.22 119.92 27.51 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.238 1.015 . . . . 0.0 110.487 -167.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.9 m -74.11 156.93 36.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.822 0.849 . . . . 0.0 111.578 -171.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.7 mt -99.3 71.57 1.8 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.889 1.676 . . . . 0.0 108.151 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -120.71 -20.94 6.85 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.317 0.647 . . . . 0.0 111.016 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.35 -22.53 8.49 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.488 1.518 . . . . 0.0 113.092 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.55 -40.78 9.68 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 119.091 1.446 . . . . 0.0 110.638 168.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 38.3 m -55.96 99.74 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.71 2.004 . . . . 0.0 110.595 -174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -71.11 173.71 7.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.183 1.393 . . . . 0.0 111.396 -173.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 59.7 p -115.51 -160.74 0.76 Allowed 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.593 1.157 . . . . 0.0 111.834 -170.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.7 147.37 53.5 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.596 0.758 . . . . 0.0 109.027 172.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -89.71 141.41 28.64 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 120.659 -1.275 . . . . 0.0 107.983 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.1 m -121.29 110.31 15.98 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 128.537 2.735 . . . . 0.0 104.163 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.5 m -68.53 117.05 9.78 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.169 1.387 . . . . 0.0 107.808 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.9 mt -64.69 173.69 2.11 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.999 1.72 . . . . 0.0 111.369 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.479 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 0.7 OUTLIER -132.39 159.12 40.18 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 127.676 2.39 . . . . 0.0 107.058 156.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -58.31 129.58 42.7 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.02 -140.55 15.67 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -172.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.5 m -107.51 142.7 36.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.886 1.343 . . . . 0.0 109.826 -172.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.479 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 12.8 m-80 -143.18 173.53 11.5 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 127.923 2.489 . . . . 0.0 108.532 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 129' ' ' ASN . 86.3 m -157.15 141.25 16.27 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.357 -1.465 . . . . 0.0 109.955 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.27 116.04 65.78 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.593 1.557 . . . . 0.0 107.361 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -86.25 78.27 2.18 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 124.121 3.214 . . . . 0.0 112.171 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -66.22 162.72 19.34 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.393 -0.817 . . . . 0.0 111.216 171.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -115.42 141.26 48.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.345 154.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -101.55 145.32 29.18 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 126.299 1.839 . . . . 0.0 108.462 160.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -149.61 152.56 35.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 159.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -70.03 151.23 45.78 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 163.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -129.16 116.11 18.71 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.921 2.488 . . . . 0.0 106.626 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.73 146.72 29.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.411 ' HB ' ' CE1' ' A' ' 82' ' ' HIS . 29.3 p -114.27 7.0 16.35 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.095 0.958 . . . . 0.0 112.068 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 168.79 -150.41 15.78 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.5 94.59 0.03 OUTLIER 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.621 1.169 . . . . 0.0 108.756 170.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.42 128.98 34.03 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.221 1.008 . . . . 0.0 108.734 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.3 p -90.84 171.58 8.04 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.151 1.38 . . . . 0.0 109.855 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -88.13 172.92 5.05 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.172 1.915 . . . . 0.0 110.371 166.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.96 -95.23 0.14 Allowed Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -144.1 155.7 44.06 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 127.718 2.407 . . . . 0.0 107.574 174.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -143.44 92.14 2.33 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.548 1.166 . . . . 0.0 108.238 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -126.15 145.32 50.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.32 153.18 34.31 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.535 1.534 . . . . 0.0 107.41 169.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.43 98.14 4.6 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.87 1.268 . . . . 0.0 110.521 176.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.81 163.49 23.41 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.665 171.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.2 p -99.8 161.98 13.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 147.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -122.96 153.62 39.5 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 162.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -113.71 168.21 9.97 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.534 1.934 . . . . 0.0 107.954 172.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.4 t -121.67 134.73 64.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.447 HE21 ' NE2' ' A' ' 159' ' ' GLN . 28.0 tt0 -122.09 87.55 2.77 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -57.11 149.69 18.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.188 166.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.447 ' NE2' HE21 ' A' ' 157' ' ' GLN . 4.6 pt20 -165.6 164.11 19.24 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.408 1.483 . . . . 0.0 109.59 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.529 0 CA-C-O 117.855 -1.525 . . . . 0.0 113.419 173.853 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.444 0 CA-C-O 121.169 0.509 . . . . 0.0 111.853 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.0 m -134.23 95.58 3.44 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.113 1.765 . . . . 0.0 107.366 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.2 m -76.93 133.59 39.18 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 168.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 13.1 m -149.06 171.44 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 127.013 2.125 . . . . 0.0 109.097 -175.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -68.11 170.67 8.09 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.416 1.007 . . . . 0.0 109.682 172.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -135.89 -52.21 0.07 OUTLIER Glycine 0 CA--C 1.522 0.524 0 C-N-CA 124.341 0.972 . . . . 0.0 111.063 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 161.08 -162.14 33.44 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 118.043 0.922 . . . . 0.0 111.352 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.7 m -127.15 112.95 15.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.988 2.115 . . . . 0.0 107.247 -166.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 7.7 t -105.16 106.72 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -96.75 87.76 4.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -169.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.414 ' CG ' HG11 ' A' ' 101' ' ' VAL . 73.5 m-85 -68.37 113.07 5.62 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -120.07 166.33 13.54 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.035 -1.041 . . . . 0.0 108.261 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 143.82 -161.57 27.78 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -170.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -165.82 172.44 11.67 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.59 135.47 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 166.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.481 ' C ' ' H ' ' A' ' 184' ' ' ALA . 3.3 m -117.84 151.65 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 127.637 2.375 . . . . 0.0 107.677 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -74.03 24.59 0.08 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.781 1.632 . . . . 0.0 113.5 -169.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.246 0.91 0 C-N-CA 131.402 3.881 . . . . 0.0 112.565 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.747 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.48 -20.65 64.78 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -160.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.3 m -123.22 160.57 26.29 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 127.895 2.478 . . . . 0.0 107.792 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.8 -20.27 27.82 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -167.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.261 8.6 t 54.81 124.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 130.143 3.377 . . . . 0.0 111.509 -163.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -77.65 164.63 25.14 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.138 1.775 . . . . 0.0 110.676 -174.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.04 -39.98 60.41 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.623 -1.298 . . . . 0.0 110.598 164.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.38 2.71 36.1 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.962 1.744 . . . . 0.0 113.979 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 63.4 p -141.73 -9.85 0.92 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 119.886 1.843 . . . . 0.0 113.488 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.0 p -72.09 -65.42 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 119.15 0.886 . . . . 0.0 110.612 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -126.32 46.08 2.52 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.202 -0.936 . . . . 0.0 108.499 -160.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -82.91 144.47 30.02 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.543 1.137 . . . . 0.0 109.81 -163.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.71 154.52 27.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 164.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.9 t -131.28 96.97 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 165.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.85 94.87 3.96 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 mt -68.46 -10.08 53.01 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.555 1.942 . . . . 0.0 110.224 172.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.5 -177.9 32.55 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 124.945 1.26 . . . . 0.0 111.304 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -69.35 138.68 53.92 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 122.067 -0.666 . . . . 0.0 109.373 167.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -121.01 147.64 24.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 125.582 1.553 . . . . 0.0 106.926 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -83.39 131.93 35.02 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.0 p -59.1 -23.03 61.74 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 118.904 0.775 . . . . 0.0 110.397 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.89 -27.45 66.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.064 1.346 . . . . 0.0 112.134 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.3 m -80.21 -15.4 57.09 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.035 -0.984 . . . . 0.0 113.076 173.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.1 mt -134.11 75.86 1.62 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.708 2.003 . . . . 0.0 109.336 -164.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.91 -4.05 7.0 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -167.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -152.7 163.38 39.78 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 124.425 1.09 . . . . 0.0 109.284 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -64.83 127.34 31.15 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.39 -1.19 75.97 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-O 118.511 -1.161 . . . . 0.0 111.762 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.59 146.29 54.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 119.807 1.803 . . . . 0.0 109.769 168.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.8 p -138.09 151.29 47.67 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.112 0.414 . . . . 0.0 110.744 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.7 p -75.57 -169.91 1.14 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -45.11 -92.38 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.98 75.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 129.607 3.163 . . . . 0.0 107.259 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 p -73.66 148.57 8.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 169.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.85 155.72 19.83 Favored Glycine 0 CA--C 1.51 -0.262 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -147.71 1.59 0.69 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -171.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 36.92 -169.95 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 130.963 3.705 . . . . 0.0 114.281 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 mm -133.29 106.36 9.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 159.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -65.99 113.38 4.39 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 171.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.86 149.13 23.23 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -148.69 153.43 38.23 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.1 2.16 . . . . 0.0 108.609 -165.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 30.18 54.25 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 129.263 3.025 . . . . 0.0 114.825 -169.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.8 m -69.64 138.34 52.96 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.328 2.251 . . . . 0.0 111.3 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -113.96 119.76 38.33 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.147 1.379 . . . . 0.0 109.294 166.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.5 p -71.81 -17.66 62.14 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -59.65 -44.89 93.37 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 124.101 0.96 . . . . 0.0 109.939 175.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.4 t -61.42 -61.59 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.04 120.42 4.56 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.395 1.478 . . . . 0.0 109.061 -174.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.9 m -76.24 -6.94 53.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.864 0.865 . . . . 0.0 111.135 169.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -130.72 159.02 38.51 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 120.155 -1.591 . . . . 0.0 110.368 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.75 159.56 41.98 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 160.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.55 167.83 18.72 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.804 2.042 . . . . 0.0 106.258 161.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.0 t -119.95 148.82 22.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.64 159.45 26.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -133.49 155.53 49.4 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.901 1.68 . . . . 0.0 108.548 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.4 tp -141.46 161.55 37.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.787 0.435 . . . . 0.0 110.095 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -178.16 179.82 48.38 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 173.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.3 m -64.9 135.83 56.16 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 164.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.17 141.83 41.74 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.079 0.854 . . . . 0.0 109.322 171.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.6 tt -60.77 -36.12 69.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 122.998 0.519 . . . . 0.0 111.036 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -160.87 171.2 19.18 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.207 1.803 . . . . 0.0 107.343 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.1 -28.14 68.59 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.753 0.821 . . . . 0.0 111.341 165.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.64 -19.13 72.74 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 119.109 -0.829 . . . . 0.0 112.224 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -147.2 57.93 1.15 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.15 1.475 . . . . 0.0 110.619 -164.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.3 p -63.09 -14.74 52.06 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 128.297 2.639 . . . . 0.0 113.313 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -84.96 -3.26 58.68 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 170.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.2 t -123.21 138.37 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 119.897 1.226 . . . . 0.0 109.446 -170.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.08 150.04 37.34 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.641 1.176 . . . . 0.0 110.787 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.19 14.99 20.32 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -167.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.9 mt 54.36 -161.27 0.14 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.482 1.113 . . . . 0.0 111.665 -167.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 . . . . . 0 C--O 1.235 0.303 0 C-N-CA 125.311 1.444 . . . . 0.0 110.869 -178.493 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.44 -0.94 0 CA-C-O 122.622 1.201 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.23 120.57 8.9 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 159.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.4 p -85.26 166.45 16.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 57.58 24.54 10.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.576 1.151 . . . . 0.0 111.499 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.36 154.5 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 119.304 0.956 . . . . 0.0 109.655 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.33 -179.06 27.62 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 125.644 1.592 . . . . 0.0 110.322 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.447 HG13 ' CG ' ' A' ' 177' ' ' PHE . 73.5 t -91.89 152.93 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -132.1 167.97 18.79 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.218 -0.926 . . . . 0.0 110.247 161.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.23 142.67 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 127.506 2.322 . . . . 0.0 105.559 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.1 mt -129.33 146.41 51.22 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 126.282 1.833 . . . . 0.0 107.53 176.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.96 -72.25 0.14 Allowed 'General case' 0 C--O 1.221 -0.431 0 O-C-N 124.309 1.005 . . . . 0.0 111.873 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.427 ' C ' ' H ' ' A' ' 108' ' ' GLY . 15.8 ptt180 -167.84 -35.23 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.044 1.338 . . . . 0.0 111.553 172.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 t -66.77 11.1 0.1 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.622 2.369 . . . . 0.0 111.063 167.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 106' ' ' ARG . . . 61.99 12.31 35.73 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.239 1.4 . . . . 0.0 114.68 -171.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.71 110.76 1.6 Allowed 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.246 1.419 . . . . 0.0 108.781 175.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.03 118.57 8.03 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.902 1.281 . . . . 0.0 109.572 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 mt -79.16 155.93 28.46 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 m -86.67 170.36 11.87 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 169.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.8 85.96 2.41 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 171.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -111.32 -17.05 13.24 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 165.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.89 -0.06 73.47 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.342 0.972 . . . . 0.0 112.512 -168.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -128.35 -32.84 2.18 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.525 1.53 . . . . 0.0 111.419 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.2 m -57.26 112.07 1.27 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.133 0.973 . . . . 0.0 108.566 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -79.39 146.78 32.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.9 p -74.69 -150.46 0.03 OUTLIER 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.503 1.121 . . . . 0.0 109.869 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.35 156.85 38.65 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 120.995 -1.066 . . . . 0.0 109.107 163.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -76.94 157.42 31.31 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 122.666 1.222 . . . . 0.0 108.274 166.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.9 m -133.57 122.75 23.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 164.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.1 m -65.49 120.92 13.74 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 167.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.3 mt -78.94 -168.24 1.39 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.171 2.188 . . . . 0.0 107.915 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.413 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 5.7 p-10 -153.63 160.06 42.29 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.782 0.833 . . . . 0.0 108.941 164.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -65.56 107.68 1.79 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 127.22 -102.45 0.61 Allowed Glycine 0 C--O 1.225 -0.414 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 -172.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 m -137.36 147.64 45.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.444 1.122 . . . . 0.0 109.204 -167.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 0.4 OUTLIER -168.45 161.05 11.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.552 1.541 . . . . 0.0 107.117 -175.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 96.8 m -149.54 151.48 33.95 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -175.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.5 mt -115.53 121.68 34.14 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.28 67.26 7.56 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.232 2.621 . . . . 0.0 113.206 -168.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -65.92 145.07 56.36 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -114.67 148.66 37.9 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.922 168.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -123.39 156.1 36.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 166.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.7 ptt-85 -157.37 167.92 28.86 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 169.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -80.16 147.77 31.19 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 167.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -116.42 117.91 31.23 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 127.053 2.141 . . . . 0.0 106.103 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.01 139.74 30.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 53.6 p -102.09 13.68 34.04 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.646 1.179 . . . . 0.0 110.277 172.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.73 -154.21 24.9 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 107.756 -2.138 . . . . 0.0 107.756 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.71 95.66 0.9 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.477 1.111 . . . . 0.0 109.555 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.72 121.4 10.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.624 0.769 . . . . 0.0 109.179 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 63.8 p -74.78 161.82 76.12 Favored Pre-proline 0 C--O 1.235 0.323 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -68.71 173.49 9.93 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 120.861 1.041 . . . . 0.0 110.412 159.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.03 -109.95 0.42 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 173.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -138.94 152.93 48.11 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 128.064 2.546 . . . . 0.0 105.904 174.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.31 75.78 1.45 Allowed 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.934 1.243 . . . . 0.0 111.553 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -118.1 157.47 26.81 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.97 164.96 36.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.488 1.515 . . . . 0.0 108.607 172.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -131.59 113.0 13.1 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -91.12 169.8 10.55 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.416 1.087 . . . . 0.0 109.79 170.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.3 p -115.41 156.22 25.98 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 152.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -120.52 152.41 38.09 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -122.36 169.7 10.68 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.861 1.664 . . . . 0.0 108.37 170.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.1 t -126.09 132.18 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -107.78 89.77 3.1 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 166.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -62.04 145.35 53.41 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 163.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -164.36 169.77 16.96 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.678 0.791 . . . . 0.0 111.287 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.284 0 N-CA-C 107.696 -2.162 . . . . 0.0 107.696 -173.091 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 120.739 0.304 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 60.6 m -150.29 103.11 3.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.639 1.976 . . . . 0.0 107.141 -173.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.2 m -101.48 109.22 21.0 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 125.595 1.558 . . . . 0.0 109.616 -170.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.6 m -137.29 149.52 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.955 1.302 . . . . 0.0 109.708 -160.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.97 163.03 20.67 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.244 0.929 . . . . 0.0 111.906 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -121.94 -80.87 0.57 Allowed Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -174.29 -153.9 10.35 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -165.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.0 m -128.31 105.97 8.7 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.277 1.831 . . . . 0.0 110.327 -161.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.8 t -94.08 106.9 18.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -90.17 101.08 13.8 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -175.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.447 ' CG ' HG13 ' A' ' 101' ' ' VAL . 70.5 m-85 -82.55 121.5 26.87 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -126.74 159.4 33.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.6 -163.68 27.87 Favored Glycine 0 CA--C 1.518 0.269 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -166.26 166.24 16.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 81.8 t -113.86 125.46 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 172.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.9 m -106.27 152.32 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 126.265 1.826 . . . . 0.0 108.823 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -75.13 24.78 0.1 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -169.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 C-N-CA 129.103 2.961 . . . . 0.0 111.839 -175.127 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.599 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 43.67 -50.63 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.28 1 C-N-CA 134.45 5.1 . . . . 0.0 115.48 -167.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 m -104.51 174.24 5.96 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.262 2.225 . . . . 0.0 110.977 172.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.6 102.82 12.04 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 127.634 2.374 . . . . 0.0 108.065 172.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.05 130.85 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -67.41 153.75 42.96 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.12 -32.31 61.95 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.908 -1.12 . . . . 0.0 110.486 165.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.84 4.65 4.1 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 118.606 -1.108 . . . . 0.0 114.705 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.3 m -143.38 -19.57 0.62 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 120.609 2.204 . . . . 0.0 114.535 175.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.57 -39.72 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 119.384 0.993 . . . . 0.0 111.292 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -136.23 67.1 1.47 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -167.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.89 140.15 44.18 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.577 -164.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.2 m -109.89 100.19 9.2 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.25 102.22 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -84.77 93.15 8.4 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -69.57 -16.44 63.41 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.903 1.681 . . . . 0.0 109.059 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.84 -168.63 43.56 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.434 1.016 . . . . 0.0 111.15 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -73.63 152.27 40.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.358 1.063 . . . . 0.0 109.798 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.46 147.25 28.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 125.208 1.403 . . . . 0.0 108.109 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -82.68 131.37 35.21 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -57.12 -27.59 61.95 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 122.74 0.416 . . . . 0.0 111.266 170.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.71 -35.3 65.95 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.535 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.2 m -77.14 -1.53 29.75 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.5 mt -143.71 74.08 1.42 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.726 1.61 . . . . 0.0 108.043 -163.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.22 -6.47 4.85 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -170.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -151.94 163.81 38.47 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 126.292 1.837 . . . . 0.0 107.408 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -61.43 136.21 57.95 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 122.071 0.939 . . . . 0.0 108.735 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.458 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 82.93 -3.58 83.39 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-O 118.095 -1.391 . . . . 0.0 111.27 175.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.17 151.29 19.41 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.478 1.139 . . . . 0.0 109.46 158.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 p -143.37 154.44 43.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.577 0.703 . . . . 0.0 109.702 -174.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.5 t -65.27 175.84 1.55 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 166.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -38.38 -81.52 0.01 OUTLIER 'General case' 0 C--N 1.339 0.12 0 C-N-CA 127.622 2.369 . . . . 0.0 110.375 167.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.57 158.48 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 129.733 3.213 . . . . 0.0 106.146 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.7 t -145.03 152.06 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 168.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.47 144.13 16.6 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 106.339 -2.704 . . . . 0.0 106.339 167.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -141.01 157.72 44.93 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -141.53 168.81 18.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 119.886 1.221 . . . . 0.0 113.241 -172.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 mm -111.41 92.63 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.32 118.68 13.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.884 1.673 . . . . 0.0 108.011 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.4 mt -118.8 132.18 56.12 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.829 1.251 . . . . 0.0 109.947 -175.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -116.49 164.68 14.21 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.365 1.466 . . . . 0.0 108.863 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.3 t0 53.66 31.72 13.23 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.742 2.017 . . . . 0.0 113.384 163.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.7 t -75.05 153.58 38.34 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.467 -1.396 . . . . 0.0 113.096 -170.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -126.38 125.9 42.99 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.978 1.311 . . . . 0.0 110.742 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 p -73.75 -17.1 61.15 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.059 0.543 . . . . 0.0 110.955 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -58.87 -45.75 89.43 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.899 1.28 . . . . 0.0 110.001 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.1 t -72.57 -46.11 56.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -175.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -165.85 130.91 2.38 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.162 1.385 . . . . 0.0 109.253 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 m -73.83 -23.19 59.61 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -120.79 166.09 14.23 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 126.154 1.782 . . . . 0.0 110.205 -173.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.83 151.64 51.55 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 157.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.77 170.79 10.68 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 144.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.36 159.74 41.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -172.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.55 167.07 23.04 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -125.33 154.9 41.1 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.642 0.777 . . . . 0.0 109.101 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.2 tp -150.01 124.26 9.51 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.918 0.887 . . . . 0.0 108.998 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.15 -178.98 42.75 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.674 1.131 . . . . 0.0 110.824 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m -70.37 133.68 47.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.399 1.48 . . . . 0.0 110.174 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.84 141.13 47.98 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 121.296 -0.878 . . . . 0.0 111.156 169.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 tt -63.01 -37.58 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 123.554 0.742 . . . . 0.0 110.961 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -159.83 165.78 31.63 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.752 2.021 . . . . 0.0 107.279 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.22 69.5 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 125.536 1.534 . . . . 0.0 112.318 169.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.54 -3.38 90.1 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-O 118.691 -1.061 . . . . 0.0 113.277 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -145.78 50.09 1.2 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.211 1.506 . . . . 0.0 109.614 -172.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.0 p -64.51 -17.41 63.87 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.978 1.311 . . . . 0.0 114.38 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -75.75 -25.78 56.82 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.92 173.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.27 137.84 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.396 1.478 . . . . 0.0 110.23 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.82 146.19 32.39 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.221 1.008 . . . . 0.0 111.79 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.36 18.17 6.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.353 1.861 . . . . 0.0 114.226 -167.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 73.4 mt 51.48 -156.12 0.14 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.797 1.239 . . . . 0.0 110.762 -169.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 . . . . . 0 CA--C 1.537 0.446 0 C-N-CA 128.622 2.769 . . . . 0.0 107.827 177.971 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 121.173 0.511 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.96 142.33 3.56 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.144 1.378 . . . . 0.0 111.079 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.8 p -94.93 163.42 13.33 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 169.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 56.07 23.75 7.16 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.451 1.501 . . . . 0.0 112.425 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -144.23 155.02 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.19 -168.06 14.04 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.5 t -101.42 136.94 30.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 169.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -115.12 158.73 21.78 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 164.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.7 mp -133.48 123.57 46.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.512 1.925 . . . . 0.0 106.768 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.9 mt -114.41 153.47 29.83 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -85.76 -107.82 0.05 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.438 0.563 . . . . 0.0 110.325 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.79 -45.78 4.69 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 129.618 3.167 . . . . 0.0 109.528 168.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.8 p -78.38 -0.17 28.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.052 0.541 . . . . 0.0 112.078 -166.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.77 14.15 57.68 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.055 1.312 . . . . 0.0 112.684 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.7 142.35 55.05 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 159.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.82 135.64 37.28 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 74.3 mt -105.82 120.51 41.9 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.653 -0.655 . . . . 0.0 110.702 -157.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.6 m -73.31 160.1 32.37 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.858 0.837 . . . . 0.0 110.725 -173.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.1 mt -109.38 40.64 1.81 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.243 1.417 . . . . 0.0 111.794 -160.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -106.76 0.28 24.03 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.32 -0.863 . . . . 0.0 112.593 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.26 -17.77 31.64 Favored Glycine 0 CA--C 1.519 0.335 0 O-C-N 120.423 -1.423 . . . . 0.0 114.196 166.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -115.1 -6.7 12.49 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.313 1.056 . . . . 0.0 112.899 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.2 m -68.94 99.4 1.06 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 168.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -61.19 130.09 44.53 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.484 171.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.8 m -83.55 -158.31 0.29 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 127.19 2.196 . . . . 0.0 109.962 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.45 129.62 38.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.973 0.892 . . . . 0.0 108.942 -170.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -84.57 115.17 22.47 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -166.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m -96.66 110.14 22.64 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.0 m -61.83 130.34 45.26 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 163.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 51.5 mt -96.33 -149.26 0.31 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 126.184 1.794 . . . . 0.0 108.255 -170.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -150.34 173.79 13.6 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.616 1.566 . . . . 0.0 107.974 164.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.57 115.24 12.72 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 159.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 119.0 -150.46 17.94 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.631 1.11 . . . . 0.0 111.631 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.6 m -75.27 135.27 40.95 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.326 1.45 . . . . 0.0 110.766 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.62 168.97 25.76 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.528 1.531 . . . . 0.0 108.514 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 95.0 m -152.24 149.81 29.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.556 0.742 . . . . 0.0 109.291 -176.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.75 106.97 57.06 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.479 1.112 . . . . 0.0 108.356 163.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.65 117.37 3.66 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 124.319 3.346 . . . . 0.0 111.552 171.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -93.08 170.43 9.66 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.037 1.735 . . . . 0.0 110.849 168.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -134.71 113.83 12.07 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.917 2.087 . . . . 0.0 107.287 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -104.34 133.88 48.5 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 128.553 2.741 . . . . 0.0 109.239 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 -145.15 143.36 30.31 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 170.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -70.46 116.46 10.81 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 162.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.458 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 3.0 t80 -101.62 130.54 47.97 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.71 144.84 26.92 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 30.3 p -98.7 7.0 46.6 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.273 1.029 . . . . 0.0 112.158 167.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 160.26 -152.64 23.46 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.89 89.3 0.05 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.892 1.277 . . . . 0.0 111.329 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.04 141.64 49.29 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.934 0.893 . . . . 0.0 110.999 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.5 p -112.36 152.99 44.95 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 119.161 -0.447 . . . . 0.0 110.241 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -76.86 162.4 32.36 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.402 1.401 . . . . 0.0 110.081 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 156.42 -133.08 3.51 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.903 1.239 . . . . 0.0 110.397 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.11 152.13 18.99 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.29 1.045 . . . . 0.0 108.234 169.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -136.96 82.28 1.93 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.664 0.745 . . . . 0.0 109.133 168.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -121.06 152.12 39.01 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -145.32 175.55 10.22 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -138.78 115.21 10.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 171.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -108.63 156.64 19.31 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 167.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 p -99.4 158.91 15.4 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 149.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -117.91 147.93 42.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 165.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -120.19 167.7 11.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.278 1.431 . . . . 0.0 107.645 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.94 106.38 3.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -169.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -95.14 87.94 5.04 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.148 1.379 . . . . 0.0 108.995 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -68.58 149.11 49.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.655 1.182 . . . . 0.0 110.704 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -172.82 174.9 3.48 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.135 1.774 . . . . 0.0 109.092 -173.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.171 0 N-CA-C 107.835 -2.106 . . . . 0.0 107.835 -177.777 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.818 0 CA-C-O 121.215 0.531 . . . . 0.0 109.972 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 21.2 m -135.78 101.94 4.92 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.1 m -79.11 104.82 10.0 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 162.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.14 156.76 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.44 161.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -65.25 129.04 38.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 153.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -85.29 -61.47 1.73 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 166.93 -157.53 30.05 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 89.8 m -116.89 135.75 53.48 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.952 1.701 . . . . 0.0 109.29 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.7 t -114.35 107.67 23.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 122.306 1.05 . . . . 0.0 108.344 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -88.36 91.31 8.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -71.2 115.2 10.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -123.27 159.49 28.64 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 124.369 1.068 . . . . 0.0 109.149 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 145.95 -166.2 27.98 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 106.491 -2.644 . . . . 0.0 106.491 -173.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.56 176.23 10.62 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.3 130.15 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 171.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.472 ' C ' ' H ' ' A' ' 184' ' ' ALA . 4.2 m -105.66 152.29 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 127.393 2.277 . . . . 0.0 108.536 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.21 24.9 0.08 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.837 1.255 . . . . 0.0 114.065 -170.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.257 1.463 1 C-N-CA 133.424 4.689 . . . . 0.0 113.374 -176.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.089 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.96 -39.22 0.81 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 128.168 2.587 . . . . 0.0 112.93 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.3 m -111.34 142.42 43.6 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.04 -8.96 13.44 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -168.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.2 t 45.95 102.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.29 0 C-N-CA 130.233 3.413 . . . . 0.0 109.265 -162.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -58.97 154.02 16.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.761 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.26 -31.16 65.28 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.812 0.733 . . . . 0.0 110.823 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.55 -11.9 60.61 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.987 -0.896 . . . . 0.0 114.249 176.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.6 m -105.86 -36.49 6.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.864 1.332 . . . . 0.0 109.921 172.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.3 t -52.02 -39.69 26.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 123.878 0.871 . . . . 0.0 110.127 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.93 77.21 1.59 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.959 0.885 . . . . 0.0 110.909 -173.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.25 138.28 49.17 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.907 -170.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.4 m -115.13 84.56 2.1 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.407 2.283 . . . . 0.0 110.026 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.4 t -67.93 112.43 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -87.37 97.29 10.72 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.2 mt -70.97 -3.18 18.09 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.722 2.009 . . . . 0.0 109.003 172.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.73 -176.63 35.67 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 124.541 1.067 . . . . 0.0 111.979 169.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -68.67 148.98 49.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.471 0.653 . . . . 0.0 109.569 164.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.7 t -136.16 144.97 31.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 125.536 1.534 . . . . 0.0 107.356 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.08 133.69 34.63 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.4 p -57.62 -25.02 59.49 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.004 0.522 . . . . 0.0 110.663 173.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.45 69.92 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.865 1.266 . . . . 0.0 112.65 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.8 m -76.37 -11.0 59.82 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 173.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.1 mt -139.12 74.37 1.47 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.92 2.088 . . . . 0.0 109.209 -157.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.22 10.65 4.15 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.177 -0.952 . . . . 0.0 112.901 -169.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -154.91 158.41 39.25 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 124.885 1.274 . . . . 0.0 108.824 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -61.29 132.39 53.44 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 166.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.73 5.68 87.87 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-O 118.194 -1.337 . . . . 0.0 112.464 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.65 153.36 36.27 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.652 1.726 . . . . 0.0 109.27 163.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.8 p -141.45 155.43 45.86 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.9 t -68.39 178.05 2.13 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.345 1.058 . . . . 0.0 109.039 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.8 m -44.71 -86.14 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.915 2.486 . . . . 0.0 113.155 171.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 157.69 134.85 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 127.416 2.286 . . . . 0.0 107.239 -171.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.36 104.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -177.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.92 135.14 30.08 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 112.746 -2.025 . . . . 0.0 109.16 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -143.96 80.64 1.66 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -77.79 141.56 39.16 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.284 -0.885 . . . . 0.0 110.027 -177.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.0 mm -81.09 102.62 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -65.34 101.71 0.6 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.4 mt -91.19 161.0 15.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 161.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -131.49 160.37 35.39 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 167.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 t70 45.21 54.51 7.11 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 127.109 2.164 . . . . 0.0 113.418 175.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.7 m -68.62 103.35 1.69 Allowed 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.848 -0.532 . . . . 0.0 110.361 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -66.04 149.46 50.22 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 161.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 p -110.13 -15.84 13.92 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.049 0.94 . . . . 0.0 112.724 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -60.24 -46.65 89.05 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 122.361 1.077 . . . . 0.0 109.297 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 p -60.2 -52.75 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 125.69 1.596 . . . . 0.0 108.55 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -167.24 135.73 2.62 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.37 1.468 . . . . 0.0 108.363 171.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.0 m -77.87 -12.49 59.98 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.32 -0.848 . . . . 0.0 113.074 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -117.3 152.38 35.01 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 120.232 1.378 . . . . 0.0 109.841 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.91 138.9 51.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 169.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.66 -176.68 3.52 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 123.266 1.508 . . . . 0.0 107.367 150.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 0.5 OUTLIER -153.49 160.3 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 131.678 3.991 . . . . 0.0 103.773 -162.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.85 171.57 13.89 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 165.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -129.72 152.41 49.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.4 tp -152.87 126.8 8.99 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.83 169.8 42.69 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.3 m -60.27 128.11 35.1 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.075 0.95 . . . . 0.0 110.669 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.99 135.99 46.59 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.76 -0.587 . . . . 0.0 110.431 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.2 tt -60.6 -33.66 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.783 0.833 . . . . 0.0 110.333 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -160.0 168.14 26.31 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 164.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.63 -31.85 66.66 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.942 1.297 . . . . 0.0 111.351 166.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.0 -10.92 60.03 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 120.588 -1.32 . . . . 0.0 112.531 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -148.33 50.63 1.02 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.154 1.781 . . . . 0.0 111.206 -165.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.3 p -68.22 -12.6 61.24 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.964 -1.085 . . . . 0.0 112.121 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -80.94 1.49 30.81 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.469 -0.769 . . . . 0.0 111.233 172.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.1 t -136.45 138.91 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 120.939 -1.1 . . . . 0.0 110.893 -169.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.75 148.11 24.88 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 125.63 1.572 . . . . 0.0 111.51 -168.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.14 14.26 12.94 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.735 1.614 . . . . 0.0 115.305 -163.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.1 mt 52.08 -164.88 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.3 1.04 . . . . 0.0 110.643 -166.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.553 1.541 . . . . 0.0 108.49 177.258 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 120.014 -0.041 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.31 168.31 3.56 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.315 1.446 . . . . 0.0 109.692 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.9 p -116.43 167.57 10.93 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.492 1.117 . . . . 0.0 109.039 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 53.36 27.25 6.06 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.695 1.598 . . . . 0.0 111.881 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.84 151.14 13.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 CA-C-N 120.265 1.393 . . . . 0.0 110.827 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.11 174.45 31.1 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 124.969 1.271 . . . . 0.0 111.317 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.7 t -86.48 126.75 40.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -95.64 153.07 17.91 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 120.121 1.328 . . . . 0.0 108.358 158.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.59 138.45 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 169.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.9 mt -133.49 138.99 46.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -65.8 178.45 1.05 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.295 1.045 . . . . 0.0 110.347 170.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -53.88 -13.31 0.71 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.807 1.243 . . . . 0.0 114.287 172.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.7 p -102.36 -11.63 18.51 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.636 1.107 . . . . 0.0 110.902 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.82 11.04 74.67 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.941 1.257 . . . . 0.0 113.467 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.85 60.04 5.69 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.77 1.228 . . . . 0.0 111.513 -174.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 23.47 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 128.827 2.851 . . . . 0.0 113.834 153.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.7 mt -78.08 168.0 20.56 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.228 -169.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -109.19 164.21 12.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -172.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.7 mt -113.29 52.59 0.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.325 1.05 . . . . 0.0 108.323 -175.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -104.32 -23.31 13.23 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.588 1.155 . . . . 0.0 111.742 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 67.62 21.76 72.99 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 118.634 0.652 . . . . 0.0 113.261 -174.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -161.51 34.52 0.13 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.179 1.792 . . . . 0.0 110.392 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 26.9 m -128.92 91.81 3.28 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.078 -2.194 . . . . 0.0 105.078 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -62.35 152.91 32.64 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.097 0.475 . . . . 0.0 110.632 -170.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.9 m -126.3 104.07 8.0 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.546 0.739 . . . . 0.0 109.63 -163.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 49.98 -177.73 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.588 1.955 . . . . 0.0 112.018 -168.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -117.48 172.99 6.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 119.632 -1.918 . . . . 0.0 108.167 154.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m -151.02 116.06 5.28 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 165.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.1 m -67.62 137.87 55.96 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.9 mt -108.88 -178.85 3.7 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 129.038 2.935 . . . . 0.0 110.085 -170.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.406 ' ND2' HD22 ' A' ' 129' ' ' ASN . 0.9 OUTLIER -143.45 156.98 44.8 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.009 1.724 . . . . 0.0 109.121 167.352 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -60.78 85.8 0.01 OUTLIER 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.943 2.097 . . . . 0.0 110.644 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.57 -169.57 25.1 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.758 0.694 . . . . 0.0 111.804 -161.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.7 m -96.8 125.48 41.28 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 120.574 -1.545 . . . . 0.0 111.822 -158.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.406 HD22 ' ND2' ' A' ' 125' ' ' ASN . 4.5 m-80 -139.92 157.79 45.13 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 129.097 2.959 . . . . 0.0 109.686 -171.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 61.2 m -131.53 150.09 52.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.049 1.339 . . . . 0.0 110.003 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 17.1 mt -106.11 118.47 54.9 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -71.15 148.52 56.31 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.236 1.957 . . . . 0.0 112.039 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -148.39 165.37 31.3 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 127.459 2.304 . . . . 0.0 109.003 170.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -128.46 140.83 51.62 Favored 'General case' 0 CA--C 1.523 -0.082 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 162.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.12 165.9 10.89 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 161.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -166.34 152.38 8.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 169.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -69.06 151.48 46.39 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 166.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -126.51 133.79 51.07 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.493 1.917 . . . . 0.0 106.509 172.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -101.2 148.32 25.23 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.49 0.716 . . . . 0.0 110.55 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 66.7 p -109.96 12.34 23.77 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.576 1.15 . . . . 0.0 111.089 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.97 -154.44 24.85 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.88 89.24 0.16 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.356 1.062 . . . . 0.0 110.721 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.62 119.95 9.65 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.405 1.882 . . . . 0.0 109.599 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.3 p -83.17 161.78 56.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 123.847 0.859 . . . . 0.0 109.449 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -75.02 173.4 14.58 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 119.777 0.956 . . . . 0.0 109.633 165.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.26 -111.75 0.49 Allowed Glycine 0 C--O 1.229 -0.215 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 172.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.84 168.19 14.19 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.063 1.745 . . . . 0.0 106.828 166.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.14 89.39 1.95 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -125.29 140.79 52.52 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 178.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -147.71 170.06 18.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.535 1.061 . . . . 0.0 109.563 171.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -142.08 115.25 8.83 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.175 1.39 . . . . 0.0 108.648 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -130.25 167.74 17.97 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.677 1.591 . . . . 0.0 110.332 172.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 76.9 p -121.05 145.59 47.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -100.35 135.98 40.94 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 170.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.473 ' HZ2' ' ND2' ' A' ' 171' ' ' ASN . 23.9 mmtt -81.55 169.26 17.3 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 157.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.575 HG22 ' CE2' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -113.64 152.13 15.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 127.998 2.519 . . . . 0.0 105.342 163.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -143.96 87.68 1.92 Allowed 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.596 1.558 . . . . 0.0 107.493 164.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.575 ' CE2' HG22 ' A' ' 156' ' ' VAL . 83.0 m-85 -60.79 163.22 5.85 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.494 166.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -161.85 162.76 29.47 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.765 1.226 . . . . 0.0 111.316 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.443 0 CA-C-O 117.464 -1.742 . . . . 0.0 116.048 171.021 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.093 0 CA-C-O 121.619 0.723 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 56.6 m -142.1 84.34 1.87 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.1 m -77.11 116.0 17.38 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.009 1.323 . . . . 0.0 108.336 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 28.2 m -134.84 162.15 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 125.697 1.599 . . . . 0.0 110.166 -175.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.473 ' ND2' ' HZ2' ' A' ' 155' ' ' LYS . 9.9 m-80 -75.68 159.49 31.08 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.91 -1.119 . . . . 0.0 109.332 169.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -129.73 -67.35 0.11 Allowed Glycine 0 CA--C 1.52 0.374 0 CA-C-O 119.475 -0.625 . . . . 0.0 111.655 -163.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 175.85 175.42 43.23 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 117.412 0.606 . . . . 0.0 111.64 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 54.0 m -104.06 138.46 40.55 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.058 1.343 . . . . 0.0 109.214 -174.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.79 92.95 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -73.13 85.01 1.34 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.325 1.85 . . . . 0.0 108.234 174.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -67.45 125.16 25.26 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -131.17 163.38 27.84 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.454 1.102 . . . . 0.0 109.895 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 140.77 -162.71 26.64 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 -172.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -165.06 170.08 15.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.55 125.51 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 167.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.429 ' C ' ' H ' ' A' ' 184' ' ' ALA . 3.8 m -103.68 151.83 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 126.506 1.923 . . . . 0.0 108.424 173.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.39 25.05 0.08 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.685 1.594 . . . . 0.0 113.567 -169.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.247 0.963 0 C-N-CA 129.209 3.004 . . . . 0.0 110.756 -168.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.765 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.55 -22.2 61.36 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 123.973 0.796 . . . . 0.0 112.982 -167.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.4 m -118.84 156.23 29.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.087 1.355 . . . . 0.0 107.364 171.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.33 171.64 14.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.477 0.656 . . . . 0.0 109.779 156.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.63 150.26 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 168.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 26' ' ' GLY . 23.2 t0 -87.22 18.0 3.97 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -171.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 69.99 -34.75 0.3 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 130.177 3.391 . . . . 0.0 110.305 -166.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 24' ' ' ASP . . . -69.61 -18.32 73.73 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-O 119.057 -0.857 . . . . 0.0 113.966 -172.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -108.24 -7.08 16.06 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.35 1.06 . . . . 0.0 111.209 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.93 -32.18 26.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 C-N-CA 125.22 1.408 . . . . 0.0 111.338 -170.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -148.8 73.09 1.21 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 -172.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.1 142.35 38.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -171.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.5 m -112.59 100.1 8.47 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 172.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.35 102.15 2.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -79.53 100.54 7.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.6 mt -64.77 -19.01 65.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.635 1.974 . . . . 0.0 110.399 169.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.12 -178.15 41.31 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 125.244 1.402 . . . . 0.0 111.662 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -66.13 154.47 39.59 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.7 t -140.21 143.07 30.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 124.49 1.116 . . . . 0.0 108.514 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -76.19 133.68 40.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 p -58.73 -23.09 59.18 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.167 0.987 . . . . 0.0 110.627 174.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.46 74.57 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.158 -0.964 . . . . 0.0 111.041 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.2 m -69.74 -10.69 59.32 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.9 mt -140.55 79.44 1.7 Allowed 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 120.071 1.305 . . . . 0.0 107.547 -162.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.01 1.47 0.98 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.22 152.16 37.89 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.429 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 50.9 tt0 -61.33 125.39 23.59 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.412 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 101.46 -10.66 57.94 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 118.014 -1.437 . . . . 0.0 112.976 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.05 155.18 20.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.972 1.886 . . . . 0.0 110.227 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.8 p -136.44 161.63 35.29 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.425 0.557 . . . . 0.0 110.814 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.2 p -73.58 -163.31 0.16 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.458 0.703 . . . . 0.0 111.356 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.4 m -46.11 -31.68 2.49 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 126.979 2.111 . . . . 0.0 114.655 166.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 63.51 167.05 0.14 Allowed 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 126.359 2.287 . . . . 0.0 110.055 -166.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -162.05 143.35 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 C-N-CA 126.119 1.768 . . . . 0.0 106.276 -167.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.57 121.52 5.39 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 107.228 -2.349 . . . . 0.0 107.228 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -121.17 134.58 55.22 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -115.04 131.66 56.85 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -167.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.8 mm -89.89 108.8 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -77.61 118.46 20.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 mt -122.31 121.4 36.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -91.91 162.43 14.42 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.358 1.063 . . . . 0.0 110.068 -172.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.0 t0 47.33 42.52 13.98 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.889 1.675 . . . . 0.0 112.276 167.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.3 m -63.74 136.49 57.5 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.511 0.724 . . . . 0.0 109.292 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -121.47 103.78 9.18 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.837 0.855 . . . . 0.0 110.739 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.517 ' HG1' ' ND2' ' A' ' 126' ' ' ASN . 44.9 p -63.98 -19.91 65.5 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.957 0.903 . . . . 0.0 112.037 -174.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -61.89 -37.52 84.89 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.318 1.447 . . . . 0.0 110.577 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.5 t -78.3 -57.91 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.1 125.27 3.96 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -166.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 m -71.4 -14.76 62.27 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 118.566 -0.731 . . . . 0.0 111.93 169.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -132.42 162.8 30.23 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 120.019 1.281 . . . . 0.0 111.689 -173.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.08 136.06 45.66 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 154.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.8 169.14 11.88 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 147.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.0 t -120.59 163.19 18.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 165.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.62 163.11 33.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.872 2.069 . . . . 0.0 107.526 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -133.74 152.18 51.81 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.091 1.756 . . . . 0.0 109.729 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.7 tp -152.31 131.07 12.4 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 122.805 0.442 . . . . 0.0 110.847 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.21 -172.12 34.82 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.15 163.96 1.43 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.061 1.744 . . . . 0.0 110.373 171.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.53 130.47 53.56 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 125.753 1.621 . . . . 0.0 109.143 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.6 tt -60.62 -46.77 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 O-C-N 123.413 0.446 . . . . 0.0 110.526 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.1 164.86 32.59 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.75 -15.84 63.83 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.21 -0.24 74.17 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.888 1.232 . . . . 0.0 112.386 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -143.45 41.21 1.47 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.963 1.705 . . . . 0.0 109.691 -167.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.2 p -61.11 -19.85 61.95 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.199 -0.938 . . . . 0.0 112.324 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -75.51 -7.22 53.61 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.855 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.7 t -124.7 130.43 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.711 1.141 . . . . 0.0 108.702 -168.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mt -74.71 151.33 39.23 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.812 1.245 . . . . 0.0 111.133 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.06 19.91 10.96 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.147 2.179 . . . . 0.0 114.093 -163.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.7 mt 53.44 -163.85 0.1 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.983 1.313 . . . . 0.0 110.872 -164.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 CA--C 1.514 -0.414 0 C-N-CA 124.441 1.096 . . . . 0.0 110.485 -178.376 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.446 -0.659 0 CA-C-O 122.109 0.957 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.08 168.77 2.32 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.396 157.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.9 p -126.85 170.38 12.28 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 127.263 2.225 . . . . 0.0 108.645 171.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 53.51 29.54 9.21 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 127.472 2.309 . . . . 0.0 111.329 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.1 p -148.44 151.14 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 124.126 0.971 . . . . 0.0 108.565 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.72 -176.21 21.12 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.54 138.8 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -115.58 159.89 20.69 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.524 1.056 . . . . 0.0 110.411 171.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.38 137.38 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 170.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.69 151.84 50.59 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.718 -177.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -66.6 179.22 1.08 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.042 0.925 . . . . 0.0 111.975 160.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -44.22 -33.92 1.71 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 129.191 2.996 . . . . 0.0 114.966 168.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.4 p -87.83 -7.14 57.66 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.183 1.356 . . . . 0.0 110.846 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.38 22.34 78.77 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.798 1.666 . . . . 0.0 112.419 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.8 34.13 0.49 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -165.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 33.08 94.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 129.051 2.941 . . . . 0.0 114.978 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.73 136.31 56.09 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.82 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.9 m -68.61 167.7 14.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 166.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.9 mt -119.73 70.58 0.86 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -168.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -113.82 -11.77 12.82 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.862 0.865 . . . . 0.0 111.816 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.65 -12.38 4.81 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.082 -1.011 . . . . 0.0 113.894 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -133.45 -10.67 2.83 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.945 1.298 . . . . 0.0 112.942 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.4 t -61.22 123.52 17.97 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 164.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -84.57 157.88 21.09 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.2 t -104.11 174.37 5.9 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.438 1.495 . . . . 0.0 109.073 173.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.31 13.98 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.525 1 C-N-CA 134.708 5.203 . . . . 0.0 120.765 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 44.69 -179.63 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 130.314 3.445 . . . . 0.0 113.458 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 m -158.43 137.66 11.59 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 157.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.0 m -77.82 110.86 13.07 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 175.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.4 mt -72.44 -174.11 1.28 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.413 2.285 . . . . 0.0 108.221 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -151.45 176.17 11.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.6 1.96 . . . . 0.0 108.723 169.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.517 ' ND2' ' HG1' ' A' ' 63' ' ' THR . 2.6 m120 -68.16 101.32 1.15 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 137.77 -170.36 23.75 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.788 1.185 . . . . 0.0 110.698 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 51.4 m -76.74 129.19 35.97 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.087 -1.243 . . . . 0.0 110.0 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -123.41 166.35 15.5 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.289 1.436 . . . . 0.0 109.333 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.0 m -154.71 147.44 24.34 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.037 0.923 . . . . 0.0 109.666 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.2 mt -130.33 111.31 16.64 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 -171.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.67 100.16 0.86 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.918 3.079 . . . . 0.0 110.367 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.86 166.62 20.74 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 171.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -117.32 155.84 28.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 168.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.53 163.55 34.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.673 1.989 . . . . 0.0 107.835 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -175.41 156.06 1.93 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.467 1.907 . . . . 0.0 107.626 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -71.83 147.22 47.4 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 156.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.412 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 31.1 t80 -123.55 121.0 34.51 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.423 1.889 . . . . 0.0 106.893 176.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.88 141.31 32.32 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.429 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 46.4 p -100.41 11.07 40.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.463 0.705 . . . . 0.0 111.599 169.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 158.59 -148.22 17.03 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.82 82.37 0.2 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.15 1.78 . . . . 0.0 110.214 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.31 157.51 28.92 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.247 1.019 . . . . 0.0 111.342 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.1 p -123.79 153.95 67.07 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 124.592 1.157 . . . . 0.0 109.964 -176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.86 163.41 26.06 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.434 1.422 . . . . 0.0 111.018 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.23 -116.51 0.72 Allowed Glycine 0 N--CA 1.469 0.877 0 C-N-CA 124.442 1.02 . . . . 0.0 111.045 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -119.89 145.36 46.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.164 0.982 . . . . 0.0 109.668 167.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -134.45 86.16 2.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -120.48 146.72 45.98 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -149.0 175.16 11.54 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -152.48 152.95 32.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 173.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.13 175.34 9.66 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.836 2.455 . . . . 0.0 107.881 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.9 p -116.54 153.52 32.04 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 155.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -112.54 151.54 29.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -131.28 157.62 42.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.3 t -122.85 133.81 67.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -169.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -120.84 85.13 2.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -67.92 128.85 38.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.983 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -153.64 176.67 11.81 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 124.801 1.24 . . . . 0.0 111.452 -174.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.279 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -173.832 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 122.405 1.098 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 10.1 m -79.48 99.48 7.26 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 164.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.9 m -78.16 129.64 35.38 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 165.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.18 151.84 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.713 1.605 . . . . 0.0 109.722 -176.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -61.48 139.59 58.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.7 -56.73 0.56 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 166.42 -171.35 41.38 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -175.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.5 m -103.15 138.4 40.02 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.75 1.22 . . . . 0.0 109.657 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.1 t -119.72 103.07 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -82.67 141.99 32.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 171.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -121.16 113.74 20.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -124.75 156.39 37.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 118.582 0.628 . . . . 0.0 110.677 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 148.59 -162.6 28.89 Favored Glycine 0 N--CA 1.437 -1.279 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 -167.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.25 177.22 3.66 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 -173.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.4 t -125.87 135.98 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.409 ' C ' ' H ' ' A' ' 184' ' ' ALA . 14.8 m -118.86 149.97 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 C-N-CA 127.59 2.356 . . . . 0.0 108.492 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -74.99 34.18 0.1 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.248 1.006 0 C-N-CA 130.269 3.428 . . . . 0.0 112.765 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.11 -37.44 46.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 116.671 -1.633 . . . . 0.0 111.913 172.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.1 m -121.48 164.86 16.48 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 125.104 1.503 . . . . 0.0 112.128 -167.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.43 -12.81 25.3 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.974 1.31 . . . . 0.0 113.866 -170.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.8 t 50.06 109.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 130.191 3.396 . . . . 0.0 112.127 -174.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.06 151.68 39.23 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.001 -1.062 . . . . 0.0 109.525 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.82 -33.72 17.54 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.353 1.461 . . . . 0.0 111.189 166.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.35 -6.03 1.98 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.442 1.496 . . . . 0.0 114.537 171.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.5 p -132.69 -34.93 1.13 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.847 1.824 . . . . 0.0 112.342 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.0 p -62.13 -55.23 25.42 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 123.396 0.679 . . . . 0.0 111.282 -170.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.446 ' CG ' ' HE2' ' A' ' 176' ' ' HIS . 10.0 t70 -132.04 67.8 1.51 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -165.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -105.72 140.3 38.98 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.902 -1.499 . . . . 0.0 108.295 -161.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.1 m -110.32 94.59 5.09 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.6 t -77.65 104.32 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -86.68 107.79 18.36 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 mt -85.37 -3.39 58.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.8 1.24 . . . . 0.0 110.029 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.5 -178.34 23.76 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 125.241 1.4 . . . . 0.0 112.298 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -65.74 151.51 46.42 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.088 0.555 . . . . 0.0 109.877 162.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.46 152.95 34.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 C-N-CA 125.919 1.688 . . . . 0.0 107.578 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -83.2 134.92 34.94 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.1 p -59.31 -21.94 60.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.82 0.448 . . . . 0.0 111.735 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.1 -31.44 70.04 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.684 -1.26 . . . . 0.0 112.229 171.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -74.05 -9.58 58.77 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.854 0.861 . . . . 0.0 111.449 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.6 mt -143.35 76.56 1.53 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.176 1.39 . . . . 0.0 107.715 -159.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.93 -1.27 2.21 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -171.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -151.14 161.29 43.0 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 35.6 tt0 -64.08 126.76 28.73 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.27 2.53 79.99 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.995 -0.891 . . . . 0.0 113.166 -174.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.45 159.55 34.01 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.642 1.721 . . . . 0.0 109.779 161.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.0 p -149.67 162.81 39.49 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.301 0.64 . . . . 0.0 110.203 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.5 p -73.85 174.8 7.98 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.646 -0.659 . . . . 0.0 110.339 168.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -55.13 -17.27 3.92 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 83.0 160.62 0.13 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 129.765 3.226 . . . . 0.0 112.121 173.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.1 t -143.26 140.53 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.85 130.0 10.09 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 107.152 -2.379 . . . . 0.0 107.152 169.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -136.49 130.19 32.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.422 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 2.8 m-20 -109.64 165.48 11.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -169.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.9 mm -116.74 99.33 8.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -68.36 95.84 0.63 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.902 1.681 . . . . 0.0 110.281 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.45 158.31 19.62 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 122.473 1.13 . . . . 0.0 109.123 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -163.39 155.59 17.87 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 126.794 2.037 . . . . 0.0 107.547 -169.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 45.55 59.2 3.74 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 127.91 2.484 . . . . 0.0 111.079 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.8 m -108.77 107.81 18.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.389 2.275 . . . . 0.0 111.15 -168.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -79.4 158.45 27.37 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.679 1.127 . . . . 0.0 111.121 172.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.4 p -100.52 -18.04 16.83 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.226 1.41 . . . . 0.0 113.554 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -64.77 -46.85 80.39 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.403 1.081 . . . . 0.0 109.063 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -57.96 -53.05 50.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 114.184 -1.371 . . . . 0.0 107.442 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.19 142.26 21.34 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 166.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -93.75 11.39 29.31 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.394 172.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HE3' ' OE1' ' A' ' 159' ' ' GLN . 7.7 mtmt -148.48 163.34 37.47 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.036 1.334 . . . . 0.0 108.724 168.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.84 177.08 9.85 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 123.764 0.665 . . . . 0.0 109.486 157.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.54 178.37 8.18 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 128.696 2.798 . . . . 0.0 107.726 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.6 t -143.85 100.96 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.435 1.894 . . . . 0.0 106.929 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.63 152.52 28.46 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 118.341 -0.838 . . . . 0.0 109.267 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -112.75 158.66 19.81 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 118.814 0.733 . . . . 0.0 110.328 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.9 tp -144.5 153.45 41.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.747 1.619 . . . . 0.0 108.002 175.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.0 170.69 33.92 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 m -64.45 131.44 47.14 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.191 1.397 . . . . 0.0 109.334 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.94 135.65 43.25 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.613 1.097 . . . . 0.0 110.366 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.7 tt -63.19 -35.29 71.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.229 0.611 . . . . 0.0 111.076 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -159.57 166.53 30.58 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.392 1.477 . . . . 0.0 108.755 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.44 -19.86 57.82 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 127.654 2.382 . . . . 0.0 114.612 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.2 -20.23 43.01 Favored Glycine 0 CA--C 1.524 0.629 0 O-C-N 120.838 -1.164 . . . . 0.0 112.149 171.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -125.02 53.76 1.48 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.634 1.573 . . . . 0.0 108.18 -170.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.9 p -63.58 -15.56 58.45 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 127.303 2.241 . . . . 0.0 111.99 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -97.04 2.84 51.89 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.717 2.007 . . . . 0.0 113.073 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 t -128.35 141.13 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 120.157 1.344 . . . . 0.0 109.392 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.41 146.11 30.45 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.271 -169.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.95 14.52 10.32 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.629 1.572 . . . . 0.0 114.509 -166.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.5 mt 51.51 -154.3 0.17 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.328 1.051 . . . . 0.0 110.556 -167.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 . . . . . 0 N--CA 1.45 -0.435 0 O-C-N 121.504 -0.747 . . . . 0.0 110.729 179.218 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.937 0 CA-C-O 122.224 1.011 . . . . 0.0 112.884 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.79 125.73 14.06 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 148.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.1 p -90.3 172.6 8.66 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 56.6 28.62 14.26 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.993 1.717 . . . . 0.0 111.361 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.28 151.29 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.858 0.863 . . . . 0.0 109.485 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.6 175.18 29.73 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 124.382 0.991 . . . . 0.0 110.815 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.2 t -85.11 126.54 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -98.87 144.61 27.88 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 164.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.6 mp -118.41 146.95 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 169.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 mt -141.52 151.42 43.26 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.201 1.4 . . . . 0.0 107.643 -172.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -59.25 -75.08 0.06 Allowed 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.118 0.485 . . . . 0.0 111.073 170.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.1 ptt-85 -176.0 -24.57 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 128.055 2.542 . . . . 0.0 109.415 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.4 p -80.58 -28.17 37.24 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.107 1.363 . . . . 0.0 108.588 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.6 7.06 9.13 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.016 1.77 . . . . 0.0 112.591 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.88 104.87 2.17 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 120.146 1.973 . . . . 0.0 108.402 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.95 100.78 0.22 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.166 0.986 . . . . 0.0 109.279 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.34 132.48 52.76 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.888 0.875 . . . . 0.0 109.251 -170.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 49.3 m -74.63 148.34 40.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.32 0.581 . . . . 0.0 109.789 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.7 mt -92.35 81.55 4.93 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -127.61 -24.42 3.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.6 1.96 . . . . 0.0 111.324 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.84 7.78 71.1 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.14 1.353 . . . . 0.0 113.548 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -140.17 -29.17 0.71 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.785 1.292 . . . . 0.0 112.482 170.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.4 m -53.81 115.09 1.81 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.633 1.173 . . . . 0.0 108.846 173.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -71.52 179.64 2.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.309 1.052 . . . . 0.0 112.384 -164.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.8 p -134.27 126.22 29.34 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.938 1.695 . . . . 0.0 107.791 167.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.6 m 23.2 85.25 0.01 OUTLIER 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.757 2.023 . . . . 0.0 114.083 147.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -61.61 144.95 53.61 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.128 -162.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.9 m -113.71 114.21 26.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 86.0 m -53.74 110.58 0.6 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 154.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.0 mt -72.84 176.9 5.23 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 170.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.12 162.22 30.38 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 121.621 -0.675 . . . . 0.0 109.993 171.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.37 132.18 47.54 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 94.7 -118.54 5.85 Favored Glycine 0 C--O 1.223 -0.58 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.9 m -118.54 144.47 46.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.455 1.102 . . . . 0.0 109.706 -164.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.417 ' C ' ' HG1' ' A' ' 130' ' ' THR . 0.0 OUTLIER -160.63 171.5 18.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.127 1.371 . . . . 0.0 109.309 -173.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.422 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 97.1 m -154.32 163.78 39.62 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 119.527 -1.983 . . . . 0.0 108.637 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -122.05 121.0 28.14 Favored Pre-proline 0 N--CA 1.446 -0.638 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 168.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -70.62 135.64 28.86 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 N-CA-C 108.026 -1.567 . . . . 0.0 108.026 160.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -120.54 170.78 9.08 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.802 0.841 . . . . 0.0 108.75 163.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.77 143.33 50.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 168.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -115.74 164.5 14.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.694 1.197 . . . . 0.0 107.915 162.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -164.77 152.33 11.53 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 167.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -69.5 142.09 53.79 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 165.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -121.74 122.01 38.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.18 141.79 29.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.403 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 65.4 p -101.43 7.35 42.59 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.271 1.028 . . . . 0.0 111.302 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.81 -151.97 21.3 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.17 91.98 0.08 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.069 1.348 . . . . 0.0 109.658 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.34 144.46 34.19 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.529 0.732 . . . . 0.0 110.897 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.2 p -110.56 165.58 12.4 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.014 0.925 . . . . 0.0 110.019 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.9 174.48 12.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.166 1.911 . . . . 0.0 111.17 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.96 -85.55 0.14 Allowed Glycine 0 C--N 1.336 0.555 0 O-C-N 121.36 -0.838 . . . . 0.0 113.819 167.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -147.11 162.9 37.91 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.311 2.244 . . . . 0.0 105.771 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -151.74 68.42 0.89 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 119.443 1.02 . . . . 0.0 110.133 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -114.73 150.37 35.4 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.08 169.95 20.58 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 169.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -132.93 120.53 21.57 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 174.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -120.44 159.64 24.72 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.933 1.693 . . . . 0.0 108.95 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.0 p -124.54 141.33 52.17 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 162.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -104.36 155.94 18.34 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 168.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -119.5 131.03 55.49 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 171.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.21 137.98 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 171.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -128.8 90.15 3.0 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 171.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -62.23 161.52 11.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 166.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.45 ' OE1' ' HE3' ' A' ' 68' ' ' LYS . 8.2 mt-30 -103.35 -142.99 0.36 Allowed 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 125.027 1.331 . . . . 0.0 108.044 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.468 1 C-N-CA 113.642 -4.123 . . . . 0.0 118.419 126.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.655 0 CA-C-O 121.083 0.468 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.3 m -137.92 92.8 2.7 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.566 1.546 . . . . 0.0 108.04 -173.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.51 126.15 28.4 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 167.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.38 140.58 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.624 1.17 . . . . 0.0 109.328 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -58.96 143.13 49.07 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -114.68 -87.77 1.51 Allowed Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -144.58 -144.35 4.16 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 126.711 2.101 . . . . 0.0 112.137 -167.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 96.5 m -138.18 149.42 45.83 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.333 2.253 . . . . 0.0 108.2 166.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.7 t -115.73 119.15 61.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 163.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . 0.446 ' HE2' ' CG ' ' A' ' 29' ' ' ASP . 45.4 m-70 -96.97 94.51 7.23 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -72.35 119.5 16.64 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -124.95 160.27 29.29 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 138.15 -169.91 24.03 Favored Glycine 0 C--N 1.321 -0.292 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -171.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -162.66 177.05 9.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -167.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 41.3 t -126.69 131.06 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 167.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.3 m -101.9 155.9 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 127.354 2.262 . . . . 0.0 108.227 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.13 37.79 0.16 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.421 1.088 . . . . 0.0 113.494 -172.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 C-N-CA 127.844 2.457 . . . . 0.0 110.371 -167.189 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.177 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -30.78 -52.8 0.18 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 126.58 1.952 . . . . 0.0 111.452 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 1.8 m -103.73 143.3 32.98 Favored 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 124.684 1.24 . . . . 0.0 108.774 166.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.97 172.26 1.83 Allowed 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 124.621 1.201 . . . . 0.0 109.918 164.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.8 137.55 55.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -71.37 158.2 36.74 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.779 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.03 -32.56 69.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.176 0.99 . . . . 0.0 111.869 172.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.65 3.36 60.22 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.435 -1.203 . . . . 0.0 113.901 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.8 t -128.39 -40.92 1.58 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.355 1.462 . . . . 0.0 109.087 -169.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.0 p -56.57 -41.46 73.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 123.992 0.917 . . . . 0.0 111.06 171.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.43 ' CG ' ' HE2' ' A' ' 176' ' ' HIS . 5.1 t70 -131.4 69.02 1.48 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.074 0.94 . . . . 0.0 109.503 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -103.02 129.48 49.81 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.545 -171.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.45 99.34 10.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 172.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.2 t -85.17 115.21 26.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -90.04 108.35 19.67 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.68 -16.52 62.25 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.566 0.747 . . . . 0.0 109.801 173.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.48 -175.53 52.98 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -71.27 156.81 39.09 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.497 0.719 . . . . 0.0 109.484 171.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.3 t -141.63 146.57 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.5 1.92 . . . . 0.0 107.026 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.11 137.54 37.54 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.8 p -59.87 -20.85 59.5 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.254 0.622 . . . . 0.0 111.337 173.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.48 -39.43 87.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.245 1.018 . . . . 0.0 111.883 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.4 m -67.66 -9.27 41.82 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mt -142.05 60.93 1.46 Allowed 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 125.882 1.673 . . . . 0.0 110.412 -162.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.64 -3.8 7.19 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -166.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.504 HE21 ' HB3' ' A' ' 47' ' ' ALA . 2.7 pm0 -153.45 160.26 42.54 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.516 1.526 . . . . 0.0 107.19 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -61.52 135.09 57.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.98 0.895 . . . . 0.0 109.131 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.91 -7.88 64.87 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-O 117.088 -1.951 . . . . 0.0 112.982 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.504 ' HB3' HE21 ' A' ' 44' ' ' GLN . . . -58.8 155.93 12.11 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 120.239 2.019 . . . . 0.0 110.51 165.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.3 p -146.74 150.51 35.49 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.688 0.756 . . . . 0.0 110.382 -171.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.5 t -59.54 164.57 3.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 163.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 m -46.35 -81.17 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.335 1.054 . . . . 0.0 112.772 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 173.32 143.49 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.53 1.932 . . . . 0.0 106.839 -172.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 t -141.29 130.46 24.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 170.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.55 126.53 8.93 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -131.55 78.01 1.8 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 123.707 1.718 . . . . 0.0 109.539 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.16 153.51 43.04 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.362 -173.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.9 mm -94.3 104.08 15.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.39 112.92 2.63 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.886 -1.154 . . . . 0.0 107.886 167.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.87 167.0 11.52 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 161.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -137.92 169.7 17.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.401 1.481 . . . . 0.0 107.485 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 43.47 54.02 5.46 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 128.287 2.635 . . . . 0.0 114.712 164.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 2.0 t -81.12 168.71 18.28 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -137.73 141.62 40.99 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.804 2.442 . . . . 0.0 106.446 172.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.1 p -95.72 -12.63 25.14 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.372 1.069 . . . . 0.0 113.138 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -60.71 -49.36 77.82 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.919 1.288 . . . . 0.0 109.475 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 p -59.64 -58.92 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 113.692 -1.595 . . . . 0.0 107.378 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.4 132.02 9.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.38 1.872 . . . . 0.0 107.38 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.49 -18.53 61.1 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.838 170.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -129.2 157.4 41.94 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 119.605 1.093 . . . . 0.0 110.856 -164.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.94 145.73 46.47 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 124.974 1.31 . . . . 0.0 107.74 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.5 164.95 23.7 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 124.509 1.124 . . . . 0.0 108.534 157.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -153.77 92.07 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 -169.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.04 165.77 24.38 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.966 0.907 . . . . 0.0 109.405 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -130.22 163.42 26.75 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.16 1.384 . . . . 0.0 109.136 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 tp -154.42 133.55 12.47 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.122 1.369 . . . . 0.0 109.217 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.31 177.07 42.56 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.7 m -73.77 130.7 40.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.105 0.962 . . . . 0.0 109.946 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.02 136.88 48.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 118.949 0.795 . . . . 0.0 111.3 176.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.5 tt -62.24 -42.04 93.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.758 0.823 . . . . 0.0 110.946 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -152.64 164.83 36.93 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.59 1.556 . . . . 0.0 106.924 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.15 82.6 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 126.22 1.808 . . . . 0.0 110.955 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.87 -4.83 78.12 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 119.541 -0.588 . . . . 0.0 112.476 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -143.02 41.84 1.53 Allowed 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.884 1.342 . . . . 0.0 110.53 -167.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 p -62.99 -13.38 34.34 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.209 2.204 . . . . 0.0 115.023 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -81.37 -13.48 58.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.761 0.315 . . . . 0.0 111.329 171.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.0 t -115.31 133.01 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 O-C-N 120.36 -1.462 . . . . 0.0 108.624 -166.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.08 148.11 38.16 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.649 1.18 . . . . 0.0 110.014 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.77 14.89 12.3 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.301 1.84 . . . . 0.0 113.955 -164.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.4 mt 52.76 -155.35 0.19 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.125 0.97 . . . . 0.0 109.565 -163.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 C--O 1.234 0.283 0 C-N-CA 122.707 0.403 . . . . 0.0 110.856 -178.643 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.213 0.53 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.82 144.85 56.98 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.954 2.101 . . . . 0.0 110.044 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 p -90.96 165.93 13.3 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 56.55 20.85 5.19 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 127.286 2.234 . . . . 0.0 113.517 175.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -142.79 149.76 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 119.209 0.913 . . . . 0.0 108.844 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.94 174.99 24.81 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 124.864 1.221 . . . . 0.0 110.603 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.4 t -84.36 149.3 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -136.69 143.97 43.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.56 1.544 . . . . 0.0 106.935 175.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.35 137.29 57.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.9 mt -133.44 129.13 36.85 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.767 1.627 . . . . 0.0 107.061 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -55.45 -60.7 3.05 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -171.62 -45.31 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.294 2.238 . . . . 0.0 108.408 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.293 0.5 OUTLIER -82.05 18.65 1.3 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.427 1.891 . . . . 0.0 109.94 -177.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.8 10.94 48.02 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 120.252 -1.53 . . . . 0.0 112.105 -169.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.79 111.42 8.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.554 1.677 . . . . 0.0 107.484 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.78 138.86 58.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.11 0.564 . . . . 0.0 109.801 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 73.0 mt -108.33 110.25 21.78 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.418 0.687 . . . . 0.0 110.398 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -53.25 139.16 30.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.699 1.6 . . . . 0.0 110.6 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.6 mt -89.41 59.39 4.79 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 127.903 2.481 . . . . 0.0 108.015 -173.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.69 -31.98 10.53 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.314 0.578 . . . . 0.0 111.257 -174.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.74 -36.85 3.95 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-O 117.522 -1.71 . . . . 0.0 114.086 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.55 -16.56 13.63 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.91 1.355 . . . . 0.0 112.222 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.1 m -73.02 95.74 2.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -70.24 173.19 7.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.363 2.265 . . . . 0.0 110.786 -174.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.0 p -112.88 -170.36 1.66 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.302 1.441 . . . . 0.0 111.814 -172.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.43 142.59 1.53 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.579 1.552 . . . . 0.0 111.594 164.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -80.67 134.39 35.86 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.623 0.725 . . . . 0.0 109.156 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.9 m -113.93 113.26 24.59 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 167.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.7 m -61.44 143.5 55.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.9 mt -115.41 179.48 3.95 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.301 2.24 . . . . 0.0 109.105 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -134.03 167.87 19.84 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.347 1.459 . . . . 0.0 108.21 172.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -72.28 104.11 3.6 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.07 -149.9 18.26 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -173.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.95 138.36 31.48 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.269 1.028 . . . . 0.0 111.248 -165.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.78 169.0 24.57 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.449 1.9 . . . . 0.0 110.915 -174.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.6 m -151.99 150.39 29.94 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.534 1.134 . . . . 0.0 109.641 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.27 119.31 55.51 Favored Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 124.58 1.152 . . . . 0.0 108.784 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -81.54 83.69 2.09 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 124.011 3.141 . . . . 0.0 112.782 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -74.52 160.9 30.31 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.269 -0.894 . . . . 0.0 112.572 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -116.95 147.65 42.08 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 155.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -122.82 161.63 23.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.833 1.653 . . . . 0.0 107.121 160.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -157.61 160.16 37.79 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -76.76 148.83 36.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 163.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -124.19 127.23 47.43 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.254 1.422 . . . . 0.0 107.376 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.77 144.26 25.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.482 0.713 . . . . 0.0 109.639 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.8 p -104.35 8.33 35.87 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 123.617 0.767 . . . . 0.0 111.653 171.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 162.96 -150.35 19.17 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 107.944 -2.062 . . . . 0.0 107.944 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.8 89.74 0.27 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.582 1.153 . . . . 0.0 110.699 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.53 141.7 46.88 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.512 0.725 . . . . 0.0 109.672 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.6 p -92.72 160.6 33.95 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -75.96 157.84 38.61 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 121.126 1.218 . . . . 0.0 109.464 160.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.67 176.23 18.49 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.357 1.456 . . . . 0.0 109.685 -168.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.16 157.67 34.85 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.526 -0.984 . . . . 0.0 108.732 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -144.75 81.63 1.66 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.719 0.771 . . . . 0.0 110.174 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -124.77 152.1 44.27 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -173.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -156.11 175.34 14.1 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.702 1.201 . . . . 0.0 109.523 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -156.47 84.69 0.98 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.936 0.874 . . . . 0.0 110.642 -175.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.31 169.89 16.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.934 173.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.3 p -117.61 163.12 16.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.86 155.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -120.37 159.55 24.83 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.534 1.134 . . . . 0.0 109.91 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -129.1 125.27 36.83 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 167.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.31 143.32 15.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 163.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -137.26 82.24 1.92 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -67.51 154.03 42.35 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.744 -0.646 . . . . 0.0 109.687 176.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -158.32 176.12 12.87 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.498 1.119 . . . . 0.0 112.795 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.483 0 C-N-CA 125.095 1.331 . . . . 0.0 111.644 177.873 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.707 0 CA-C-O 122.051 0.929 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.1 m -145.1 90.69 2.06 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.119 0.967 . . . . 0.0 109.341 -168.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.3 m -92.95 96.58 10.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.1 0.952 . . . . 0.0 110.678 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.53 135.12 51.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 125.767 1.627 . . . . 0.0 110.292 -174.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -55.78 107.67 0.37 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.452 1.101 . . . . 0.0 108.907 168.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -74.95 -58.05 4.19 Favored Glycine 0 CA--C 1.523 0.578 0 O-C-N 120.587 -1.321 . . . . 0.0 110.931 -168.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 169.33 -161.47 35.0 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -171.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.6 m -122.43 133.93 54.61 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 127.588 2.355 . . . . 0.0 107.008 -176.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.49 109.65 28.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . 0.43 ' HE2' ' CG ' ' A' ' 29' ' ' ASP . 20.2 m-70 -88.07 96.75 10.64 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -76.63 133.03 39.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -137.73 162.1 34.8 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 121.537 -0.727 . . . . 0.0 111.325 175.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 146.92 -155.87 26.75 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -169.97 175.28 5.18 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -168.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 32.0 t -128.22 136.99 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 184' ' ' ALA . 16.3 m -118.72 147.49 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 C-N-CA 126.495 1.918 . . . . 0.0 109.496 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.35 25.31 0.1 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -167.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 128.54 2.736 . . . . 0.0 111.326 -167.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.12 -16.32 63.09 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.795 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.7 m -129.68 157.08 43.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.695 1.198 . . . . 0.0 107.829 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.25 107.14 15.59 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 161.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.12 118.58 2.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 121.104 -0.997 . . . . 0.0 108.859 167.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -70.97 163.88 26.62 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.737 -0.602 . . . . 0.0 111.135 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.27 -12.9 61.35 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.99 -1.069 . . . . 0.0 113.209 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.63 -1.65 90.04 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 121.233 -0.917 . . . . 0.0 112.787 167.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.4 t -121.82 -31.1 4.01 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.758 1.279 . . . . 0.0 110.765 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.1 p -63.75 -24.32 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 O-C-N 121.11 -0.994 . . . . 0.0 113.3 -175.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -157.01 53.67 0.51 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.664 0.786 . . . . 0.0 110.365 -162.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -99.49 143.37 29.81 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 120.543 -1.348 . . . . 0.0 110.404 -169.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.9 m -113.79 95.32 5.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 t -73.15 136.45 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -114.26 118.78 34.91 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.501 1.143 . . . . 0.0 108.464 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -85.94 -21.2 28.02 Favored 'General case' 0 N--CA 1.44 -0.974 1 C-N-CA 131.9 4.08 . . . . 0.0 108.422 177.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.45 -172.58 34.79 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 124.658 1.123 . . . . 0.0 111.144 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -67.57 112.77 4.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.806 0.842 . . . . 0.0 108.827 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.19 153.23 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 125.258 1.423 . . . . 0.0 107.691 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -86.32 136.34 33.18 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.3 p -60.66 -27.25 67.68 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 169.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.08 3.24 2.19 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.975 1.71 . . . . 0.0 113.789 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 m -121.45 7.0 10.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.866 1.267 . . . . 0.0 112.203 164.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 mt -142.26 71.79 1.36 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.397 1.879 . . . . 0.0 109.15 -171.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.55 4.46 3.37 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.813 -1.18 . . . . 0.0 113.901 -171.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -153.69 158.57 41.23 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 19.1 tt0 -61.42 136.42 58.03 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 172.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.411 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 86.42 -5.79 83.67 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 118.371 -1.238 . . . . 0.0 112.965 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.12 156.48 24.92 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.376 1.588 . . . . 0.0 109.892 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.2 p -146.29 155.44 42.65 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.309 0.959 . . . . 0.0 111.834 -176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -69.33 178.62 2.31 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.831 -0.543 . . . . 0.0 110.142 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.84 -21.27 4.02 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 81.62 129.57 0.05 OUTLIER 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 128.744 2.817 . . . . 0.0 112.572 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 m -133.56 129.2 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-O 122.932 1.349 . . . . 0.0 109.74 -158.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.19 149.96 39.91 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 171.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -154.09 154.57 33.86 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 162.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.462 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 4.6 m-20 -135.44 166.47 23.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.93 0.786 . . . . 0.0 109.854 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.2 mm -108.7 97.24 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 125.52 1.528 . . . . 0.0 107.281 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.65 132.56 51.48 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 170.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.6 mt -137.79 110.76 7.73 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.867 1.667 . . . . 0.0 107.72 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -86.01 150.63 24.34 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.978 1.311 . . . . 0.0 108.85 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 t70 36.96 70.73 0.16 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.231 2.613 . . . . 0.0 114.734 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.3 m -84.71 86.57 7.31 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 128.357 2.663 . . . . 0.0 112.267 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.82 103.76 0.96 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.505 1.922 . . . . 0.0 111.147 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -60.24 -19.79 56.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.365 1.066 . . . . 0.0 112.415 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -61.3 -36.63 80.64 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.769 1.228 . . . . 0.0 111.932 175.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.0 t -70.67 -49.59 50.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -165.3 127.59 2.11 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -171.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -68.3 -12.27 60.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 117.454 -1.26 . . . . 0.0 111.695 169.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.413 ' HA ' ' CD2' ' A' ' 124' ' ' LEU . 30.3 mtmt -136.33 157.61 46.39 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 120.844 1.657 . . . . 0.0 113.94 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.07 123.26 20.48 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.806 2.042 . . . . 0.0 108.329 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.75 -177.61 3.83 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 149.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.33 146.5 19.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 -165.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.23 168.18 13.3 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 120.273 1.397 . . . . 0.0 107.871 166.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -128.89 158.83 37.67 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.114 1.766 . . . . 0.0 108.969 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 22.1 tp -147.17 150.9 35.84 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.462 1.905 . . . . 0.0 107.949 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.29 -162.69 19.63 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 119.138 0.881 . . . . 0.0 112.531 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.7 m -105.88 121.28 43.74 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.101 1.761 . . . . 0.0 106.782 163.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.06 140.14 50.62 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.4 tt -60.27 -35.69 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.257 0.623 . . . . 0.0 110.356 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -165.47 165.86 18.8 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.743 1.617 . . . . 0.0 108.684 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.24 -35.1 62.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 127.576 2.351 . . . . 0.0 113.419 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.37 -8.54 66.4 Favored Glycine 0 CA--C 1.531 1.058 0 O-C-N 120.955 -1.091 . . . . 0.0 112.801 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -147.11 47.7 1.14 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.115 1.366 . . . . 0.0 109.899 -160.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.3 p -67.69 -8.82 38.19 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.554 1.542 . . . . 0.0 112.625 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -98.32 3.3 48.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.865 1.266 . . . . 0.0 112.704 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 t -120.3 131.78 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.763 1.165 . . . . 0.0 108.954 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.3 mt -71.76 153.88 41.69 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.392 1.077 . . . . 0.0 111.749 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.04 15.0 14.24 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 128.198 2.599 . . . . 0.0 114.08 -171.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.9 mt 54.65 -150.54 0.4 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.462 1.105 . . . . 0.0 109.204 -158.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 . . . . . 0 C--O 1.236 0.351 0 C-N-CA 126.035 1.734 . . . . 0.0 107.282 177.303 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.445 -0.699 0 CA-C-O 121.923 0.868 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.56 145.33 5.01 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 160.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.5 p -115.94 142.54 46.65 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.935 1.294 . . . . 0.0 109.796 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 77.3 28.78 0.59 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.908 1.683 . . . . 0.0 113.18 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -143.79 167.15 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 125.009 1.323 . . . . 0.0 109.645 169.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -168.78 173.85 43.37 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -171.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.6 t -91.82 136.98 23.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -118.86 161.26 20.45 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.088 1.755 . . . . 0.0 108.17 169.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.7 mt -144.09 122.52 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 127.78 2.432 . . . . 0.0 105.296 -169.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mt -124.72 153.26 42.64 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -74.54 -102.99 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.316 1.047 . . . . 0.0 110.919 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -148.32 -26.39 0.33 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 128.566 2.746 . . . . 0.0 110.341 -170.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.258 13.3 t -78.7 -4.71 50.54 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 167.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.57 20.04 79.78 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 118.543 -1.143 . . . . 0.0 110.864 -177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.93 127.41 33.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 170.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.9 132.95 43.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.7 mt -102.35 108.37 19.69 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.509 0.724 . . . . 0.0 109.176 -166.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.3 m -65.67 152.01 45.19 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.013 0.435 . . . . 0.0 110.957 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.5 mt -109.14 73.1 0.84 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.861 1.664 . . . . 0.0 109.726 -160.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -120.25 0.49 10.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.651 1.18 . . . . 0.0 113.094 171.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.28 13.77 83.25 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.009 -0.884 . . . . 0.0 112.862 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -149.43 -17.43 0.28 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.77 1.285 . . . . 0.0 114.178 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.7 m -70.96 97.64 1.47 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 120.453 1.479 . . . . 0.0 107.629 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -76.5 130.54 38.09 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.17 0.988 . . . . 0.0 109.696 -168.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.4 m -72.64 -171.54 0.84 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.981 2.513 . . . . 0.0 111.367 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.37 148.44 6.71 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.803 -0.56 . . . . 0.0 111.037 167.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -85.65 166.64 16.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 123.662 1.696 . . . . 0.0 110.154 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.7 m -130.06 138.6 50.82 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 153.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.4 m -86.85 135.48 33.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 164.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.413 ' CD2' ' HA ' ' A' ' 68' ' ' LYS . 2.5 mm? -95.08 172.35 8.18 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 126.102 1.761 . . . . 0.0 109.104 -168.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -132.33 158.87 40.78 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 158.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -64.45 100.14 0.34 Allowed 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 125.615 1.822 . . . . 0.0 106.265 170.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.26 -167.86 25.32 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 107.802 -2.119 . . . . 0.0 107.802 -160.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 98.2 m -106.65 136.65 46.09 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.402 -1.058 . . . . 0.0 108.85 -166.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -135.71 170.46 15.94 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.835 1.654 . . . . 0.0 108.895 -169.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.462 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 3.7 m -146.32 142.84 28.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.972 0.909 . . . . 0.0 108.999 172.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.65 116.44 65.39 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 161.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.5 159.61 28.86 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.54 2.16 . . . . 0.0 110.86 170.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -141.31 172.62 12.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.326 1.85 . . . . 0.0 109.697 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.44 99.83 4.48 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.596 1.558 . . . . 0.0 107.0 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.64 146.23 28.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.076 -1.015 . . . . 0.0 108.728 174.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -152.77 160.27 43.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -69.44 153.02 44.18 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 117.35 -1.74 . . . . 0.0 108.813 166.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.411 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 11.0 t80 -128.05 125.84 40.1 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.584 1.954 . . . . 0.0 108.324 173.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.32 145.62 27.42 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.778 0.831 . . . . 0.0 110.356 174.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.422 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 41.3 p -105.62 10.64 32.9 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.372 1.069 . . . . 0.0 112.235 175.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.08 -150.63 19.24 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.26 98.09 0.3 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.71 164.15 1.6 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.444 1.116 . . . . 0.0 109.348 171.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.6 p -120.26 162.14 35.35 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 164.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -74.24 168.38 24.93 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 N-CA-C 109.667 -0.936 . . . . 0.0 109.667 164.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.24 178.96 16.17 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.315 1.436 . . . . 0.0 111.364 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.88 150.61 44.53 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 121.467 -1.019 . . . . 0.0 109.582 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.97 93.64 2.36 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -125.48 150.23 47.54 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 172.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.31 164.49 36.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 120.484 1.493 . . . . 0.0 108.204 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.21 140.52 27.96 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -173.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.08 172.96 11.95 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 128.291 2.637 . . . . 0.0 110.633 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 37.5 p -127.84 159.56 34.48 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 159.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -124.41 154.69 40.03 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.368 1.067 . . . . 0.0 109.453 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -114.75 173.59 6.4 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.091 1.756 . . . . 0.0 109.087 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.0 t -127.95 128.97 69.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 127.443 2.297 . . . . 0.0 105.386 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.618 HE21 ' NE2' ' A' ' 159' ' ' GLN . 32.0 tt0 -112.96 86.86 2.46 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 173.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -68.39 150.83 47.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.652 172.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.618 ' NE2' HE21 ' A' ' 157' ' ' GLN . 6.0 pt20 -168.93 165.5 11.49 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.199 1.4 . . . . 0.0 109.35 -175.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.707 0 CA-C-O 117.751 -1.583 . . . . 0.0 114.795 -179.359 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 98.7 m -135.5 107.19 6.97 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 173.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.6 m -102.76 112.52 25.35 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.775 0.83 . . . . 0.0 108.947 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.16 156.43 40.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 126.144 1.778 . . . . 0.0 109.9 -172.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -66.97 132.48 48.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.17 -40.74 3.19 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 118.646 -1.086 . . . . 0.0 111.727 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 158.29 -176.02 35.34 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 118.882 1.341 . . . . 0.0 112.334 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.9 m -91.06 144.36 25.73 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.779 1.232 . . . . 0.0 108.25 172.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.0 t -123.95 136.76 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 168.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -120.52 145.74 47.0 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -131.03 126.53 36.14 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -130.87 159.05 38.53 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.08 0.855 . . . . 0.0 109.93 -172.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 159.98 -160.92 32.02 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -164.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -172.66 173.02 4.05 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 128.556 2.743 . . . . 0.0 104.411 174.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.84 144.0 31.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 165.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.442 ' C ' ' H ' ' A' ' 184' ' ' ALA . 14.7 m -127.25 150.56 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.936 2.094 . . . . 0.0 107.568 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -74.51 36.08 0.1 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.785 1.634 . . . . 0.0 112.634 -173.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.252 1.227 0 C-N-CA 129.131 2.972 . . . . 0.0 112.726 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 118.001 -1.0 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 41.35 -55.21 0.0 OUTLIER 'General case' 0 C--N 1.34 0.166 1 C-N-CA 135.425 5.49 . . . . 0.0 115.794 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 58' ' ' LEU . 1.6 m -87.81 -166.99 1.74 Allowed 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.952 1.301 . . . . 0.0 109.982 166.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.25 -6.79 11.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.131 1.372 . . . . 0.0 113.922 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.26 3.7 t 50.87 120.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 129.535 3.134 . . . . 0.0 113.06 -165.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.37 153.28 41.54 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.526 1.13 . . . . 0.0 109.343 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.28 -25.5 67.67 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.101 -1.0 . . . . 0.0 111.035 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.96 5.29 1.3 Allowed Glycine 0 CA--C 1.534 1.261 0 CA-C-O 117.001 -2.0 . . . . 0.0 113.789 167.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.5 t -149.85 7.36 0.63 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 120.279 2.04 . . . . 0.0 113.986 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.4 p -92.14 -40.48 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 121.269 1.849 . . . . 0.0 112.81 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.7 47.95 1.64 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -170.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -85.87 145.44 27.18 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.824 -159.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 m -117.72 98.95 6.63 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.676 1.19 . . . . 0.0 108.794 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.17 104.57 5.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -77.93 109.67 12.18 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 170.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 mt -87.33 -6.75 58.38 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.714 2.006 . . . . 0.0 109.799 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.83 -171.68 37.92 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 121.925 0.736 . . . . 0.0 112.464 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -84.41 134.95 34.45 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.396 1.478 . . . . 0.0 109.448 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 t -125.94 142.0 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 124.231 1.012 . . . . 0.0 109.008 -173.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.37 120.6 21.84 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 125.682 1.593 . . . . 0.0 107.733 -177.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 p -48.52 -29.76 4.52 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.036 1.334 . . . . 0.0 111.471 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.34 -35.01 77.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.823 0.849 . . . . 0.0 111.691 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.1 m -72.26 -7.09 47.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.251 1.02 . . . . 0.0 113.123 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.3 mt -136.88 78.75 1.72 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 128.61 2.764 . . . . 0.0 108.585 -170.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.04 3.91 3.2 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.584 -1.322 . . . . 0.0 112.227 -175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -149.66 155.77 40.78 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 124.758 1.223 . . . . 0.0 108.247 -175.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 31.7 tt0 -62.25 129.7 41.96 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.427 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 90.14 -4.46 82.92 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.011 -1.438 . . . . 0.0 113.233 -176.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.45 157.5 31.87 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 119.371 1.586 . . . . 0.0 110.933 172.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.2 p -148.42 161.09 42.28 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -173.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.3 p -73.08 -171.45 0.9 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.268 0.627 . . . . 0.0 110.706 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 m -54.11 -24.45 17.71 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 170.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.98 150.4 0.07 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.27 1.428 . . . . 0.0 112.399 -170.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -151.42 153.49 9.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 126.841 2.057 . . . . 0.0 105.716 -165.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.01 162.28 21.04 Favored Glycine 0 CA--C 1.526 0.721 0 O-C-N 121.02 -1.05 . . . . 0.0 110.549 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -160.63 63.02 0.31 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 124.562 2.125 . . . . 0.0 109.566 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -55.12 139.47 41.58 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 112.424 -2.171 . . . . 0.0 111.467 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 mm -84.28 105.45 13.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -76.85 104.61 7.44 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.428 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 57.5 mt -84.5 -175.09 5.63 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 167.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -173.36 144.35 1.16 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 126.237 1.815 . . . . 0.0 109.914 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.0 t0 48.67 63.62 2.03 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.957 2.103 . . . . 0.0 113.117 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.451 ' HB2' HD22 ' A' ' 129' ' ' ASN . 0.8 OUTLIER -86.32 115.6 23.96 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 121.692 -0.63 . . . . 0.0 111.774 -177.167 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.11 108.33 7.77 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 161.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.5 p -62.09 -7.94 4.72 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.427 0.691 . . . . 0.0 112.838 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -79.14 -31.15 43.97 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.207 1.403 . . . . 0.0 112.234 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.87 -35.0 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -170.39 138.53 1.57 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.88 2.472 . . . . 0.0 105.072 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -78.89 -6.83 57.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 116.774 -1.584 . . . . 0.0 110.774 163.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.4 ' HA ' HD13 ' A' ' 124' ' ' LEU . 47.2 mtmt -141.56 161.51 37.74 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 122.605 2.457 . . . . 0.0 115.624 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.31 115.02 15.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.71 175.9 7.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 152.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -156.38 128.97 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 101.718 -3.438 . . . . 0.0 101.718 -160.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.54 169.98 8.65 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.509 1.524 . . . . 0.0 107.623 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -131.2 154.27 48.59 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.902 0.774 . . . . 0.0 110.496 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.347 0.1 OUTLIER -145.51 171.33 14.82 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 168.151 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.84 177.06 30.59 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.405 1.479 . . . . 0.0 110.056 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.2 m -67.0 141.33 57.62 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.288 1.044 . . . . 0.0 109.542 174.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.0 134.2 33.87 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 119.366 0.985 . . . . 0.0 110.874 174.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.3 tt -62.79 -33.93 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 122.898 0.479 . . . . 0.0 111.002 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -153.16 166.55 32.16 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.946 1.298 . . . . 0.0 108.724 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.66 -34.53 78.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.549 167.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.17 5.45 76.65 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.258 0.932 . . . . 0.0 112.874 174.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -148.45 48.44 1.03 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.124 1.962 . . . . 0.0 110.01 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.1 p -71.12 -7.81 49.17 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.68 -1.263 . . . . 0.0 113.809 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -84.91 -6.37 59.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.44 -0.788 . . . . 0.0 111.812 169.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 t -118.97 134.23 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.073 0 CA-C-N 119.665 1.12 . . . . 0.0 108.837 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.25 148.72 32.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.92 1.288 . . . . 0.0 110.234 -169.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.44 20.06 5.61 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.248 1.419 . . . . 0.0 113.958 -167.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.6 mt 55.16 -157.32 0.23 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.287 1.035 . . . . 0.0 109.969 -168.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 CA--C 1.515 -0.374 0 C-N-CA 125.057 1.343 . . . . 0.0 109.042 176.44 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 122.9 1.333 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.02 159.98 10.69 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.0 148.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.99 167.2 11.97 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.672 1.189 . . . . 0.0 108.702 168.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 62.26 3.63 1.07 Allowed 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 125.945 1.698 . . . . 0.0 113.105 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -125.91 150.48 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 121.373 1.897 . . . . 0.0 108.764 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.36 177.7 25.47 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 125.025 1.297 . . . . 0.0 110.736 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.8 t -92.14 122.34 43.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -91.17 158.55 16.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.819 1.19 . . . . 0.0 109.521 163.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.84 136.84 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 165.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mt -133.04 142.33 48.73 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.109 1.363 . . . . 0.0 108.025 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.3 p30 -68.64 -179.86 1.52 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.93 1.347 . . . . 0.0 111.175 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.8 ptt85 -58.46 -7.08 0.8 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.809 1.644 . . . . 0.0 114.589 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.356 10.9 t -116.03 8.26 14.51 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 120.433 1.469 . . . . 0.0 110.985 177.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.11 7.84 84.7 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 120.598 -1.314 . . . . 0.0 112.53 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.96 126.07 30.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.564 1.182 . . . . 0.0 108.328 172.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.11 130.44 35.55 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.164 0.985 . . . . 0.0 111.349 -172.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.62 151.47 21.57 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 123.92 0.763 . . . . 0.0 111.464 -164.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.2 m -75.64 154.63 36.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 123.553 0.533 . . . . 0.0 110.688 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.6 mt -97.68 64.03 1.76 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.171 1.388 . . . . 0.0 108.427 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.27 -11.12 9.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.267 0.627 . . . . 0.0 111.644 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.64 13.2 82.77 Favored Glycine 0 CA--C 1.524 0.594 0 O-C-N 120.577 -1.327 . . . . 0.0 113.858 170.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.68 -40.66 0.26 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.365 1.466 . . . . 0.0 110.034 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.2 m -53.91 96.27 0.01 OUTLIER 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.188 1.795 . . . . 0.0 109.461 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -86.03 138.06 32.24 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.231 0.612 . . . . 0.0 109.431 -164.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.55 -175.99 1.8 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.087 2.155 . . . . 0.0 109.171 174.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 t -52.85 143.2 17.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.37 0.605 . . . . 0.0 110.19 169.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -88.33 176.04 7.38 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 123.198 1.475 . . . . 0.0 108.966 167.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.3 m -144.82 163.29 34.52 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 128.205 2.602 . . . . 0.0 105.103 169.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.9 m -100.23 142.95 31.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 122.416 1.103 . . . . 0.0 110.24 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -101.91 167.68 9.9 Favored 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 129.571 3.149 . . . . 0.0 108.0 -168.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.455 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 0.8 OUTLIER -152.26 156.2 39.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.796 -173.544 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -73.98 91.57 2.04 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 125.285 1.616 . . . . 0.0 107.107 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 147.22 -123.58 1.78 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 107.691 -2.164 . . . . 0.0 107.691 -164.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.4 m -143.5 139.24 29.73 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.619 1.167 . . . . 0.0 109.075 -172.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.455 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 1.2 p30 -147.74 162.32 39.44 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 127.594 2.358 . . . . 0.0 108.702 -170.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.1 m -144.73 137.97 26.89 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -170.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.91 122.54 61.82 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.63 145.07 68.67 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.952 1.768 . . . . 0.0 110.564 173.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -142.32 157.3 44.96 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 124.777 1.231 . . . . 0.0 110.24 166.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -131.81 113.75 13.88 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -101.29 167.56 10.11 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.752 1.221 . . . . 0.0 109.227 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -168.05 153.83 7.16 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 127.225 2.21 . . . . 0.0 106.444 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -66.76 144.11 56.52 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 160.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.427 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 16.5 t80 -123.35 133.12 54.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 126.074 1.75 . . . . 0.0 106.827 174.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -104.39 143.48 32.95 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.967 1.307 . . . . 0.0 109.89 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.41 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 46.9 p -103.08 4.66 37.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.683 1.593 . . . . 0.0 111.529 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.51 -141.45 6.87 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.08 93.61 0.3 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.479 1.112 . . . . 0.0 110.332 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.27 147.6 46.26 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.301 -0.874 . . . . 0.0 110.108 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 35.0 p -120.71 153.38 56.79 Favored Pre-proline 0 CA--C 1.537 0.442 0 C-N-CA 125.153 1.381 . . . . 0.0 109.028 -175.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -74.69 166.92 28.28 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.02 1.813 . . . . 0.0 112.663 173.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.77 -85.39 0.11 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.098 166.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -142.62 163.06 33.85 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.66 1.984 . . . . 0.0 106.623 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -151.46 77.33 1.24 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.075 0.852 . . . . 0.0 109.674 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -117.59 155.97 28.92 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.48 173.44 16.67 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.356 1.063 . . . . 0.0 109.004 171.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -150.31 146.46 26.77 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.775 1.23 . . . . 0.0 108.153 169.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -161.48 169.79 21.18 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 127.802 2.441 . . . . 0.0 108.771 -165.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.53 141.68 46.77 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 116.996 -1.882 . . . . 0.0 107.57 -172.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -103.68 152.21 22.07 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -134.2 114.02 12.63 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.1 t -77.4 125.61 37.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -111.52 90.81 3.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -62.52 148.51 45.65 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.885 1.274 . . . . 0.0 110.344 173.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -165.93 169.66 14.54 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.697 1.199 . . . . 0.0 110.635 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.412 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -170.419 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 54.7 m -137.32 92.84 2.75 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.869 1.267 . . . . 0.0 109.313 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.1 m -72.05 133.7 45.42 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.68 165.81 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 127.747 2.419 . . . . 0.0 108.554 173.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -59.45 143.78 48.89 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 164.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -101.34 -64.44 0.77 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 169.16 168.76 31.64 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -174.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 89.9 m -90.22 118.89 30.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.772 1.286 . . . . 0.0 107.987 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.1 t -88.09 106.76 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 166.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -79.28 144.38 34.35 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 164.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -126.45 121.1 31.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -127.68 156.01 43.03 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.816 0.734 . . . . 0.0 109.475 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.02 -158.66 27.48 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -163.69 167.34 21.21 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.603 -0.94 . . . . 0.0 108.999 -173.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 73.7 t -113.15 126.01 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 167.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.2 m -106.28 150.27 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 126.705 2.002 . . . . 0.0 108.436 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -74.9 39.56 0.14 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.246 1.418 . . . . 0.0 113.1 -176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.304 0 C-N-CA 127.634 2.374 . . . . 0.0 111.934 -179.773 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.0 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.49 -18.14 6.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.027 1.331 . . . . 0.0 112.753 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -134.35 147.49 50.54 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.132 2.173 . . . . 0.0 107.235 176.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.05 -14.12 44.19 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 118.257 2.688 . . . . 0.0 118.257 -155.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.3 t 49.46 104.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 127.645 2.378 . . . . 0.0 111.342 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.46 159.02 10.97 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.39 -0.819 . . . . 0.0 113.096 -169.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.91 -42.07 88.77 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.541 -0.725 . . . . 0.0 109.94 171.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.39 27.52 2.44 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.737 -1.035 . . . . 0.0 112.682 171.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -138.94 -33.07 0.66 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.286 1.543 . . . . 0.0 111.402 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.34 -35.66 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 119.791 1.178 . . . . 0.0 111.122 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -139.92 69.56 1.36 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -170.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -110.52 146.45 35.99 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.863 0.865 . . . . 0.0 111.414 -169.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -112.18 121.33 44.63 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.309 1.043 . . . . 0.0 109.904 173.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.6 t -87.39 113.41 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 169.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -88.22 96.18 10.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 172.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.4 mt -76.81 -8.16 56.8 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 126.009 1.724 . . . . 0.0 110.221 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.23 -171.26 32.75 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 121.829 0.683 . . . . 0.0 112.231 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -90.99 126.91 36.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.505 1.922 . . . . 0.0 110.491 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.0 t -117.64 137.73 50.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 123.4 0.68 . . . . 0.0 109.772 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -66.56 124.18 22.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.874 2.07 . . . . 0.0 106.53 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.9 p -55.25 -30.02 59.24 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 123.787 0.679 . . . . 0.0 110.37 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.89 -36.06 76.16 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.368 1.467 . . . . 0.0 111.524 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.0 m -80.16 2.37 24.47 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 123.521 0.728 . . . . 0.0 112.797 176.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.4 mt -131.83 32.08 4.13 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.37 1.868 . . . . 0.0 110.922 -170.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.49 5.24 13.37 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -150.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -154.69 155.96 35.55 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.405 1.882 . . . . 0.0 106.725 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.401 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 36.4 tt0 -64.23 116.84 6.39 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.33 -11.51 36.55 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 117.847 -1.529 . . . . 0.0 112.752 -177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.27 156.88 33.03 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.432 1.616 . . . . 0.0 110.253 172.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.6 p -144.88 157.34 44.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.41 0.624 . . . . 0.0 112.179 -174.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -73.58 -168.19 0.53 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 122.008 -0.433 . . . . 0.0 110.091 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -43.55 -99.57 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.719 2.007 . . . . 0.0 114.281 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.37 73.57 0.0 OUTLIER 'General case' 0 C--O 1.236 0.393 0 C-N-CA 131.002 3.721 . . . . 0.0 107.427 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.9 p -69.55 148.32 11.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 170.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.03 127.2 7.97 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 107.145 -2.382 . . . . 0.0 107.145 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -135.41 89.91 2.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 123.215 1.483 . . . . 0.0 109.624 -170.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -84.11 165.86 18.13 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 120.892 -1.13 . . . . 0.0 112.69 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.0 mm -102.3 99.01 7.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -71.8 126.32 29.42 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -109.25 171.84 7.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 11.5 p30 -153.81 175.05 13.77 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.253 0.933 . . . . 0.0 111.504 165.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.6 t70 32.12 48.75 0.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 129.821 3.248 . . . . 0.0 115.974 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 4.6 t -69.69 167.46 16.99 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -171.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -133.76 114.49 13.47 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.872 1.669 . . . . 0.0 112.253 168.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.9 p -56.16 -29.68 61.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.698 1.599 . . . . 0.0 113.575 172.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -62.32 -42.47 99.4 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 123.117 0.567 . . . . 0.0 110.323 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.2 t -65.24 -52.68 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 175.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.413 ' CB ' ' HB3' ' A' ' 158' ' ' TYR . . . -165.49 127.04 1.98 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.192 0.52 . . . . 0.0 111.674 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.4 m -77.37 -8.58 57.92 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.55 1.54 . . . . 0.0 112.163 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -130.03 152.65 49.25 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 121.377 1.899 . . . . 0.0 110.371 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.02 144.36 49.88 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 165.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.94 172.01 9.27 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 122.076 0.941 . . . . 0.0 109.617 156.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.261 0.5 OUTLIER -143.22 144.23 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 113.633 -1.621 . . . . 0.0 106.693 -174.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.41 162.39 30.28 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.313 2.645 . . . . 0.0 107.045 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -137.15 152.6 50.13 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.711 0.804 . . . . 0.0 110.328 -172.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.1 tp -151.6 124.68 8.68 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 122.082 -0.386 . . . . 0.0 110.609 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.26 165.87 33.97 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -54.08 128.7 31.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.313 1.445 . . . . 0.0 109.944 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.71 134.97 41.85 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.823 1.192 . . . . 0.0 110.371 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.2 tt -60.38 -37.39 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 122.72 0.408 . . . . 0.0 110.81 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -157.27 168.62 26.86 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.182 1.793 . . . . 0.0 109.046 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.33 -39.95 67.54 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.759 1.624 . . . . 0.0 112.641 171.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.28 7.44 80.69 Favored Glycine 0 CA--C 1.526 0.752 0 O-C-N 121.433 -0.792 . . . . 0.0 112.884 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -142.76 42.4 1.58 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.456 1.102 . . . . 0.0 109.481 -175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.5 p -67.95 -11.68 59.26 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.958 1.303 . . . . 0.0 112.84 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -77.69 -2.08 34.29 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.631 -0.668 . . . . 0.0 112.19 168.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.41 137.09 48.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 O-C-N 120.44 -1.412 . . . . 0.0 110.894 -166.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.77 150.9 29.05 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.469 1.508 . . . . 0.0 111.405 -171.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.73 18.33 11.84 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.675 1.99 . . . . 0.0 114.192 -167.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.4 mt 53.71 -159.9 0.14 Allowed 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.587 1.155 . . . . 0.0 110.621 -169.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.237 0.432 0 C-N-CA 124.453 1.101 . . . . 0.0 109.309 176.092 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.644 0.259 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.78 148.74 48.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 168.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.34 164.93 12.09 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.88 0.872 . . . . 0.0 108.762 166.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 69.96 -7.88 0.88 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 128.725 2.81 . . . . 0.0 115.11 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.7 p -126.99 152.19 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 121.417 1.917 . . . . 0.0 107.949 -171.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -146.31 170.64 27.37 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 126.11 1.814 . . . . 0.0 111.82 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.2 t -83.56 120.44 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -100.65 154.19 18.8 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.714 1.597 . . . . 0.0 108.3 164.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.09 143.97 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 170.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 mt -139.58 138.98 36.68 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.044 1.738 . . . . 0.0 108.042 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -66.22 173.62 3.06 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 122.219 1.009 . . . . 0.0 111.959 167.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -55.32 -13.18 1.26 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.194 1.398 . . . . 0.0 113.667 175.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 p -105.08 -9.09 18.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.929 1.292 . . . . 0.0 110.874 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.81 10.21 65.21 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.712 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.06 117.13 13.3 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 119.061 1.431 . . . . 0.0 107.938 169.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.68 131.15 40.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.661 0.784 . . . . 0.0 110.122 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.0 mt -103.34 117.27 34.1 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.589 1.156 . . . . 0.0 110.745 -158.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.0 m -67.39 143.23 56.42 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.77 0.795 . . . . 0.0 110.539 -170.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.9 mt -93.6 74.78 4.38 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.196 1.398 . . . . 0.0 107.307 -171.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.46 -18.31 11.01 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.327 1.051 . . . . 0.0 110.683 170.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.67 -28.27 4.96 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-O 118.16 -1.356 . . . . 0.0 112.751 176.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -82.62 -45.08 15.0 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.407 1.604 . . . . 0.0 110.505 166.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.2 m -51.25 97.33 0.01 OUTLIER 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.839 2.055 . . . . 0.0 111.586 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.66 169.38 4.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.81 2.044 . . . . 0.0 111.112 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 75.5 p -135.75 -161.59 1.17 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.611 0.765 . . . . 0.0 111.35 173.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -42.82 122.53 2.4 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 129.73 3.212 . . . . 0.0 111.69 -175.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -89.01 106.23 18.3 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.942 0.877 . . . . 0.0 108.701 -173.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.7 m -70.34 117.88 12.44 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 162.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.2 m -64.0 141.77 58.65 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 155.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.98 -170.44 2.14 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.052 0.941 . . . . 0.0 109.785 176.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -148.87 167.56 25.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.818 2.047 . . . . 0.0 107.071 178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -64.41 128.36 35.43 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 120.29 -159.57 15.13 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 22.0 m -83.13 136.01 34.61 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.669 1.188 . . . . 0.0 111.648 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.48 177.98 9.76 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.369 1.468 . . . . 0.0 108.325 -176.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.6 m -155.01 144.48 21.27 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.33 -0.856 . . . . 0.0 109.734 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.05 114.53 65.72 Favored Pre-proline 0 C--O 1.237 0.446 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 162.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.01 151.39 50.08 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.192 1.928 . . . . 0.0 110.475 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -141.17 167.03 23.16 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.716 2.006 . . . . 0.0 108.303 171.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.24 154.29 33.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 122.722 1.248 . . . . 0.0 110.071 161.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -132.83 147.3 52.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 127.517 2.327 . . . . 0.0 106.398 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -163.89 151.95 12.97 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 170.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -66.18 135.84 55.08 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 170.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -111.28 127.8 55.74 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.978 1.711 . . . . 0.0 108.482 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.26 142.47 27.72 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.424 1.09 . . . . 0.0 111.242 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.401 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 17.6 p -110.82 9.21 22.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.273 1.429 . . . . 0.0 112.135 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.5 -152.47 22.2 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.38 95.92 0.22 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.116 1.366 . . . . 0.0 110.891 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -53.82 151.98 5.91 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.621 0.724 . . . . 0.0 110.497 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 73.1 p -105.5 154.02 39.39 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 162.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -71.48 174.73 10.46 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.115 1.21 . . . . 0.0 109.284 166.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.79 -93.67 0.14 Allowed Glycine 0 C--O 1.225 -0.441 0 O-C-N 121.855 -0.528 . . . . 0.0 112.838 171.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -146.65 161.95 39.47 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.38 1.872 . . . . 0.0 106.394 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -151.35 73.37 1.09 Allowed 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 121.776 -0.577 . . . . 0.0 110.52 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -117.64 151.65 36.78 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.9 179.25 9.37 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -156.35 145.94 20.87 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -146.38 169.41 18.92 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.81 2.044 . . . . 0.0 106.992 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.7 p -106.98 163.66 12.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 156.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -117.72 155.87 29.23 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 164.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 38.5 mttm -125.61 137.9 53.91 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 168.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.526 ' CG2' ' CE2' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -87.18 150.75 3.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 175.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -142.12 84.16 1.86 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.539 1.536 . . . . 0.0 108.918 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.526 ' CE2' ' CG2' ' A' ' 156' ' ' VAL . 59.0 m-85 -63.7 156.16 27.82 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.988 1.315 . . . . 0.0 112.805 169.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -174.82 174.83 2.5 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.721 2.009 . . . . 0.0 108.567 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.319 0 O-C-N 120.852 -1.155 . . . . 0.0 111.359 177.405 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.941 0 CA-C-O 121.282 0.563 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 52.9 m -96.81 89.3 4.85 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.65 1.98 . . . . 0.0 106.458 171.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.3 m -82.02 120.4 25.22 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 175.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 30.2 m -128.14 145.72 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 118.645 0.657 . . . . 0.0 111.209 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -77.88 105.44 9.07 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -79.75 -68.49 1.48 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 124.035 0.826 . . . . 0.0 111.936 -164.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -178.14 -172.62 42.76 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 117.503 0.651 . . . . 0.0 111.847 -173.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.3 m -89.22 145.38 25.44 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.782 1.633 . . . . 0.0 108.971 174.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.6 119.95 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 156.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -88.94 134.48 33.95 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -114.17 113.09 24.2 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -117.31 157.47 26.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 147.29 -165.42 28.64 Favored Glycine 0 C--O 1.239 0.411 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -176.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -161.56 171.73 17.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.9 t -122.15 132.84 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 173.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 184' ' ' ALA . 8.2 m -117.91 149.69 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 127.608 2.363 . . . . 0.0 107.972 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -76.23 34.23 0.13 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -170.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 N--CA 1.438 -1.035 0 C-N-CA 131.231 3.812 . . . . 0.0 112.802 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.221 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.97 1.83 51.46 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 117.672 -1.156 . . . . 0.0 113.799 -173.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.25 164.18 30.94 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.554 1.542 . . . . 0.0 107.68 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.67 -24.29 21.65 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.757 0.823 . . . . 0.0 113.002 -168.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t 58.58 131.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 128.07 2.548 . . . . 0.0 112.172 -173.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -78.44 156.13 29.55 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.033 -1.042 . . . . 0.0 111.895 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.48 -31.95 64.52 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.611 -0.681 . . . . 0.0 110.682 166.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.54 -2.12 73.7 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 117.559 -1.69 . . . . 0.0 114.293 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.4 p -125.21 -30.02 3.22 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 121.018 2.409 . . . . 0.0 111.809 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.94 -38.9 78.48 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 124.822 1.249 . . . . 0.0 113.789 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -132.6 46.69 2.6 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.085 0.954 . . . . 0.0 109.726 -168.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -93.13 132.19 37.5 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.283 -0.885 . . . . 0.0 110.478 -159.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 m -113.98 86.8 2.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.737 1.215 . . . . 0.0 108.652 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.75 99.91 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 127.047 2.139 . . . . 0.0 108.02 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -84.48 102.97 13.23 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -170.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mt -76.79 -7.61 55.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.713 1.205 . . . . 0.0 111.004 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.82 -173.53 26.77 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.529 1.061 . . . . 0.0 112.327 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -68.97 153.88 43.03 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.954 0.902 . . . . 0.0 109.479 170.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.4 t -139.7 148.14 23.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 C-N-CA 125.067 1.347 . . . . 0.0 108.611 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -81.18 134.44 35.63 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 121.508 -0.745 . . . . 0.0 109.053 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.1 p -60.64 -24.06 65.24 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.556 0.742 . . . . 0.0 110.899 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.43 -46.41 66.37 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.35 0.66 . . . . 0.0 110.454 170.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 t -71.9 -2.38 17.76 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.962 177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.3 mt -142.93 64.86 1.35 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 120.546 1.521 . . . . 0.0 108.854 -170.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.94 0.22 5.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -167.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -158.32 159.62 36.11 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.395 1.478 . . . . 0.0 108.404 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 39.1 tt0 -65.33 118.15 8.92 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 106.77 -12.97 42.14 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-O 118.422 -1.21 . . . . 0.0 112.112 -174.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.71 142.26 57.34 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.899 1.35 . . . . 0.0 109.44 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 p -136.66 159.44 41.81 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.094 0.861 . . . . 0.0 111.052 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.5 p -74.5 -175.07 2.25 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.778 0.799 . . . . 0.0 112.216 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.7 m -56.08 -24.04 37.62 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.803 2.041 . . . . 0.0 114.417 171.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.1 158.95 0.18 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 129.336 3.054 . . . . 0.0 112.582 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.3 t -145.56 140.48 22.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -171.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.67 141.26 15.45 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 170.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -136.88 149.55 47.72 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 171.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.37 117.52 8.36 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.056 -1.027 . . . . 0.0 108.619 -167.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 mm -77.88 101.11 3.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -163.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -65.36 121.44 14.84 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 mp -125.8 107.17 10.26 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.598 1.959 . . . . 0.0 106.914 -172.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -101.87 157.42 16.86 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -171.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 48.6 t0 50.87 50.58 18.77 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 123.189 1.471 . . . . 0.0 111.847 167.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.7 m -73.29 151.29 41.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.967 1.707 . . . . 0.0 110.365 174.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -136.47 107.53 6.74 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.616 1.166 . . . . 0.0 110.683 -174.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.1 p -60.29 -18.48 49.64 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.434 1.494 . . . . 0.0 112.886 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -60.44 -38.24 83.49 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.35 1.46 . . . . 0.0 111.171 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.03 -55.89 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.35 144.38 18.4 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.689 1.195 . . . . 0.0 108.438 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.21 -15.04 42.16 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.978 -0.534 . . . . 0.0 111.839 169.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -135.44 160.94 36.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.28 0.945 . . . . 0.0 110.584 -167.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.61 153.88 38.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 159.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.469 ' HB3' ' H ' ' A' ' 119' ' ' SER . . . -132.18 173.44 11.24 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.916 1.686 . . . . 0.0 107.301 162.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 133' ' ' PHE . 61.0 t -135.87 123.55 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 118.804 0.729 . . . . 0.0 109.415 -171.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.55 0.46 26.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -160.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.407 ' CD1' HG21 ' A' ' 103' ' ' ILE . 48.5 m-85 37.29 -177.84 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.702 1 C-N-CA 131.963 4.105 . . . . 0.0 112.504 -166.298 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.8 tp -168.07 126.92 1.22 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 164.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.73 173.43 42.72 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -68.74 129.34 39.65 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.258 1.423 . . . . 0.0 109.516 -172.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.35 131.53 34.19 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.581 1.152 . . . . 0.0 113.156 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.4 tt -65.54 -32.27 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.132 0.973 . . . . 0.0 112.018 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -152.87 165.27 35.97 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.694 0.797 . . . . 0.0 109.07 166.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.74 -43.5 47.88 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.707 2.003 . . . . 0.0 112.477 165.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.18 0.83 88.37 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.265 0.936 . . . . 0.0 112.524 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -142.03 40.62 1.65 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.207 1.504 . . . . 0.0 109.886 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.8 p -64.26 -15.84 60.89 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 124.825 1.25 . . . . 0.0 113.788 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -73.43 -12.02 60.66 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.433 174.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.9 t -133.15 143.82 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 123.088 1.423 . . . . 0.0 108.394 -164.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 88' ' ' LEU . 1.5 mm? -80.55 136.47 36.28 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 112.682 -2.054 . . . . 0.0 110.717 -159.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.9 14.22 0.12 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 124.742 1.217 . . . . 0.0 113.242 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.494 ' H ' ' C ' ' A' ' 86' ' ' LEU . 89.0 mt 48.11 -147.91 0.22 Allowed 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.535 1.934 . . . . 0.0 108.484 -171.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 . . . . . 0 N--CA 1.449 -0.487 0 C-N-CA 124.941 1.297 . . . . 0.0 108.518 177.35 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 122.281 1.038 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.05 144.15 57.15 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.575 -0.703 . . . . 0.0 109.218 164.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.0 p -91.91 168.69 11.24 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.691 1.196 . . . . 0.0 109.003 166.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 55.85 18.78 3.15 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.115 1.766 . . . . 0.0 113.865 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.4 p -146.34 142.92 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 121.132 -0.98 . . . . 0.0 108.508 175.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.32 165.28 27.49 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 175.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.81 150.06 9.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -125.55 147.01 49.42 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 129.019 2.928 . . . . 0.0 105.917 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.407 HG21 ' CD1' ' A' ' 73' ' ' PHE . 1.9 mp -118.99 141.83 36.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.41 149.08 46.66 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.72 1.608 . . . . 0.0 107.015 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.07 -172.21 1.03 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.348 1.07 . . . . 0.0 112.342 174.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -47.51 -48.31 27.38 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 127.567 2.347 . . . . 0.0 110.115 170.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.5 p -81.3 -14.37 57.43 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.072 -168.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.91 22.7 44.67 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 126.386 1.946 . . . . 0.0 111.567 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.54 133.46 40.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 162.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.44 151.99 42.76 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.6 mt -117.14 151.64 36.41 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.039 1.336 . . . . 0.0 109.257 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.1 m -78.67 163.97 25.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 167.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.69 68.67 1.1 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 101.466 -3.531 . . . . 0.0 101.466 174.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.06 -7.34 19.24 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.983 0.897 . . . . 0.0 111.641 -175.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 66.87 31.36 77.96 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -158.91 -64.01 0.08 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.027 1.731 . . . . 0.0 106.879 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.7 m -49.65 99.95 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.205 2.202 . . . . 0.0 112.131 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -72.39 171.79 11.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.588 1.155 . . . . 0.0 111.003 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.469 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 39.6 p -131.81 -146.95 0.3 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.993 1.717 . . . . 0.0 110.776 -169.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.9 t -58.37 124.64 20.23 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.446 1.021 . . . . 0.0 108.938 172.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -85.36 110.5 19.16 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 122.035 0.921 . . . . 0.0 108.559 170.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.7 m -79.35 121.83 25.61 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 161.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.1 m -66.36 111.06 3.33 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 160.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.0 mt -73.66 -179.4 3.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.604 1.962 . . . . 0.0 108.973 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.27 165.8 33.76 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.443 1.097 . . . . 0.0 109.538 173.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -59.39 138.14 57.75 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 171.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.15 -139.7 15.36 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -172.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.1 m -111.51 146.34 37.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 118.44 1.12 . . . . 0.0 111.37 -164.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.435 ' C ' ' HG1' ' A' ' 130' ' ' THR . 18.9 m-80 -144.97 174.35 11.1 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 128.423 2.689 . . . . 0.0 108.606 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.435 ' HG1' ' C ' ' A' ' 129' ' ' ASN . 91.4 m -157.01 148.19 21.99 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 170.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.5 mt -110.05 112.63 57.58 Favored Pre-proline 0 C--O 1.237 0.418 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.8 137.17 19.69 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.276 1.984 . . . . 0.0 110.184 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.455 ' CZ ' ' HB ' ' A' ' 71' ' ' VAL . 76.1 m-85 -127.4 172.59 10.52 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 127.007 2.123 . . . . 0.0 107.74 171.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -128.88 143.72 50.97 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 167.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -126.85 139.08 53.35 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.92 2.088 . . . . 0.0 108.063 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -160.26 159.91 32.0 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 175.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -73.61 126.28 29.93 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 171.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.466 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 23.7 t80 -111.55 120.81 43.36 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.948 2.099 . . . . 0.0 106.877 172.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.28 137.8 33.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 175.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 64.1 p -97.18 6.92 47.64 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.15 0.98 . . . . 0.0 111.283 171.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.69 -155.81 27.24 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.05 91.79 0.5 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.204 1.002 . . . . 0.0 111.172 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.97 158.52 4.83 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.673 0.789 . . . . 0.0 111.469 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 42.3 p -115.82 158.35 42.36 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 170.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -80.95 164.56 20.04 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.916 1.744 . . . . 0.0 111.681 170.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.6 -84.87 0.11 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.953 0.787 . . . . 0.0 114.277 171.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -153.11 143.56 22.56 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 128.917 2.887 . . . . 0.0 106.365 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -137.95 84.16 2.02 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.989 0.813 . . . . 0.0 109.931 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -126.84 154.38 44.43 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -156.27 -178.22 7.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.766 0.712 . . . . 0.0 110.975 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -151.34 110.18 3.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 122.63 1.205 . . . . 0.0 109.672 172.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.14 163.99 12.02 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 169.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.1 p -109.02 152.68 24.65 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 160.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -102.59 117.08 33.9 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 170.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -92.69 154.68 18.19 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 167.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.8 t -119.13 126.72 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.587 HE21 ' NE2' ' A' ' 159' ' ' GLN . 35.7 tt0 -103.59 89.54 3.38 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 170.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -69.79 139.59 53.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.327 169.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.587 ' NE2' HE21 ' A' ' 157' ' ' GLN . 9.6 pt20 -155.0 170.62 21.33 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.686 0.795 . . . . 0.0 111.288 176.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.552 0 C-N-CA 125.966 1.746 . . . . 0.0 110.728 178.268 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.779 0 CA-C-O 123.667 1.699 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 95.5 m -76.2 99.06 4.6 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 113.024 -1.898 . . . . 0.0 107.879 170.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 93.6 m -66.08 138.37 57.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 158.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.05 137.27 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 124.927 1.291 . . . . 0.0 107.859 169.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -57.22 121.55 10.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 161.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -88.77 -86.88 1.23 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -146.78 -177.13 21.12 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.665 1.603 . . . . 0.0 110.449 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 27.4 m -93.88 144.58 25.31 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.152 1.381 . . . . 0.0 110.254 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.3 t -123.39 124.56 70.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 169.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -110.97 99.48 8.36 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.002 1.321 . . . . 0.0 107.609 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -79.33 107.13 11.87 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -112.66 157.78 20.82 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.792 1.637 . . . . 0.0 106.815 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.04 -162.91 27.8 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -174.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -165.67 174.37 9.85 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -166.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 82.3 t -129.73 138.13 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 170.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 184' ' ' ALA . 17.2 m -119.96 151.13 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 C-N-CA 128.663 2.785 . . . . 0.0 108.777 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.72 26.07 0.09 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -168.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 130.969 3.708 . . . . 0.0 111.279 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.128 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.406 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -49.65 -28.72 6.23 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.671 1.588 . . . . 0.0 114.012 -170.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.1 m -126.64 153.65 45.07 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 171.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.31 6.86 35.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.514 1.526 . . . . 0.0 114.851 -167.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.28 9.8 p 36.17 100.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 130.686 3.595 . . . . 0.0 113.245 -174.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -59.49 162.16 5.18 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.117 0.967 . . . . 0.0 111.922 -162.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.28 -28.69 43.53 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.234 1.413 . . . . 0.0 111.411 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.97 8.49 66.43 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.899 1.237 . . . . 0.0 114.444 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.0 m -142.6 -23.8 0.65 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.683 1.741 . . . . 0.0 113.634 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.0 p -55.01 -33.96 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 120.529 1.513 . . . . 0.0 111.091 165.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -137.89 105.06 5.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -131.22 132.84 44.94 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.345 1.058 . . . . 0.0 108.97 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.4 m -118.64 89.72 3.19 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.2 t -72.78 124.01 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -88.51 101.06 13.56 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.4 mt -69.8 -14.72 62.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 165.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.89 -172.21 46.74 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -92.28 142.37 27.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.8 t -128.98 143.65 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 125.499 1.52 . . . . 0.0 108.406 -172.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.69 130.58 38.92 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.3 p -56.22 -24.17 40.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.01 0.924 . . . . 0.0 110.791 172.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.62 -23.99 67.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.34 1.056 . . . . 0.0 112.892 174.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.5 m -89.77 2.96 54.24 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.581 -1.324 . . . . 0.0 113.406 169.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.4 mt -142.17 68.93 1.32 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.959 1.303 . . . . 0.0 108.413 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.84 -5.19 7.5 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -168.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -155.09 164.51 38.76 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 125.158 1.383 . . . . 0.0 108.072 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -62.18 133.62 55.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.67 -10.97 73.41 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-O 118.62 -1.1 . . . . 0.0 111.96 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.45 148.18 42.68 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 119.176 1.488 . . . . 0.0 110.018 168.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.7 p -137.39 153.8 50.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 122.053 0.93 . . . . 0.0 110.251 -178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.2 t -55.35 160.34 2.33 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.59 160.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 m -44.81 -28.58 0.66 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.64 2.376 . . . . 0.0 114.587 169.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 85.03 149.17 0.07 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 129.281 3.033 . . . . 0.0 110.383 174.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.03 156.92 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 C-N-CA 128.634 2.774 . . . . 0.0 106.178 -163.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.3 151.41 17.25 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -158.11 142.2 15.8 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -126.62 147.75 49.87 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.511 1.05 . . . . 0.0 109.801 -174.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.4 mm -89.95 108.76 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.466 1.107 . . . . 0.0 108.038 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -69.21 115.03 8.02 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.732 0.813 . . . . 0.0 109.981 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.0 mt -116.86 101.96 8.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.145 1.378 . . . . 0.0 107.681 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -94.3 158.53 15.54 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.918 2.087 . . . . 0.0 110.324 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.4 t70 34.46 63.07 0.46 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 128.107 2.563 . . . . 0.0 114.052 -167.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 49.4 m -76.06 91.93 3.14 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.611 0.764 . . . . 0.0 111.461 177.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -64.35 124.33 21.48 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 167.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 p -81.88 -24.42 35.73 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.905 -1.122 . . . . 0.0 113.499 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -63.0 -40.32 97.4 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.361 0.982 . . . . 0.0 110.356 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -66.51 -45.28 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.094 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -164.07 127.75 2.62 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.107 1.363 . . . . 0.0 107.715 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -81.2 6.78 12.95 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 116.837 -1.554 . . . . 0.0 112.508 169.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HE3' ' HG3' ' A' ' 159' ' ' GLN . 49.1 mtmt -147.36 157.71 43.69 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 121.504 1.956 . . . . 0.0 114.354 172.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.21 133.43 51.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.479 1.911 . . . . 0.0 108.224 168.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.34 173.1 6.47 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 154.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.96 166.27 29.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.28 167.67 21.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -134.97 149.11 50.16 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -173.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 tp -146.44 124.79 12.3 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.89 0.376 . . . . 0.0 110.157 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.54 177.89 39.98 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.1 m -63.74 129.6 40.79 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.658 1.983 . . . . 0.0 110.124 -171.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.83 130.52 39.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.885 0.766 . . . . 0.0 110.073 173.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.6 tt -60.24 -40.32 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.839 0.856 . . . . 0.0 110.619 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -151.94 171.44 17.79 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 174.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.33 -35.36 75.84 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.013 0.925 . . . . 0.0 112.639 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.19 -0.07 89.47 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 123.661 0.648 . . . . 0.0 112.162 173.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -129.04 39.99 3.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.097 1.759 . . . . 0.0 109.28 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.9 p -66.66 -8.83 30.29 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.017 1.327 . . . . 0.0 113.018 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -87.93 -0.5 57.07 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.334 1.454 . . . . 0.0 113.024 167.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 36.1 t -129.08 139.54 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 120.739 1.609 . . . . 0.0 108.984 -177.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.43 143.05 27.12 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.752 -167.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.31 15.48 3.58 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.334 1.854 . . . . 0.0 114.764 -165.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.0 mt 52.83 -169.17 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.059 0.944 . . . . 0.0 110.016 -168.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 124.905 1.282 . . . . 0.0 108.276 177.728 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.4 m . . . . . 0 C--O 1.236 0.391 0 CA-C-O 121.05 0.452 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.44 164.82 4.08 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.086 1.354 . . . . 0.0 110.058 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.9 p -120.65 166.81 13.16 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.622 1.169 . . . . 0.0 109.508 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.4 m-20 55.22 25.59 7.49 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.072 1.349 . . . . 0.0 111.191 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.83 150.77 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 119.373 0.988 . . . . 0.0 109.122 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.35 174.83 34.14 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -81.71 144.19 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -126.35 155.42 42.08 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.558 1.143 . . . . 0.0 108.95 165.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 mp -131.82 141.6 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.951 2.1 . . . . 0.0 107.011 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mt -140.69 146.49 37.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.896 1.278 . . . . 0.0 107.827 -173.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.36 176.23 4.13 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.683 1.23 . . . . 0.0 111.915 166.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -45.71 -30.17 1.5 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.731 2.812 . . . . 0.0 115.271 171.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 50.9 p -88.64 -31.57 18.48 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 120.724 1.602 . . . . 0.0 110.98 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.47 10.39 11.69 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.413 1.482 . . . . 0.0 113.622 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.9 131.18 44.04 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.188 1.494 . . . . 0.0 109.286 174.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.38 116.28 10.53 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.211 1.404 . . . . 0.0 109.778 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.1 mt -83.32 109.85 17.62 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.709 0.803 . . . . 0.0 109.011 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.4 m -57.86 151.94 16.98 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.077 0.465 . . . . 0.0 109.808 171.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.3 mt -102.84 76.06 1.46 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.024 2.129 . . . . 0.0 108.099 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -113.0 -19.58 11.85 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.646 1.178 . . . . 0.0 111.589 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.04 -22.49 0.76 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 126.579 2.038 . . . . 0.0 113.222 -175.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.23 -68.51 0.7 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 117.303 -1.332 . . . . 0.0 108.363 162.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.0 m -37.18 98.38 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.213 2.205 . . . . 0.0 111.745 -167.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -74.87 159.42 31.91 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.963 1.705 . . . . 0.0 110.175 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.9 p -107.85 175.51 5.46 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.423 1.489 . . . . 0.0 112.349 -175.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.6 m -39.88 110.95 0.16 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.728 2.011 . . . . 0.0 112.748 167.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -63.38 164.59 8.88 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.663 1.221 . . . . 0.0 110.48 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 86.1 m -140.15 137.23 34.26 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 165.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 100.0 m -82.95 141.24 32.29 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.194 0.998 . . . . 0.0 108.654 173.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.552 ' H ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -113.37 173.35 6.44 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 127.821 2.448 . . . . 0.0 107.773 -175.562 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.524 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 27.1 p30 -138.05 166.5 23.94 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 127.008 2.123 . . . . 0.0 109.02 176.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.59 115.16 2.85 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 123.967 0.792 . . . . 0.0 109.297 172.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.41 ' C ' ' HG1' ' A' ' 128' ' ' THR . . . 129.9 -104.37 0.62 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 174.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.41 ' HG1' ' C ' ' A' ' 127' ' ' GLY . 86.5 m -146.19 129.25 16.51 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.11 -1.818 . . . . 0.0 110.148 -169.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.524 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 56.0 m-80 -135.07 169.03 18.06 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 126.818 2.047 . . . . 0.0 109.396 -171.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.9 m -158.22 112.09 2.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -172.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.4 mt -76.74 121.35 84.66 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -75.32 146.91 32.08 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.636 1.557 . . . . 0.0 111.194 169.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -132.04 172.74 11.98 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.473 1.909 . . . . 0.0 107.629 168.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.36 151.75 45.68 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 162.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -130.54 162.73 28.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 165.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -157.2 166.13 34.06 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -82.63 138.57 34.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 156.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -117.21 128.05 54.71 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.643 1.977 . . . . 0.0 106.156 174.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.42 146.87 24.99 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.671 0.788 . . . . 0.0 109.883 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.5 p -113.24 18.07 18.15 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.682 1.593 . . . . 0.0 111.164 172.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 163.03 -157.55 29.66 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.08 92.29 0.17 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.376 1.088 . . . . 0.0 109.833 174.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.41 128.78 35.89 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.214 1.005 . . . . 0.0 109.267 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.2 p -76.42 159.64 79.31 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 118.924 -1.11 . . . . 0.0 109.0 166.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -69.5 171.88 13.39 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 N-CA-C 110.061 -0.784 . . . . 0.0 110.061 158.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.02 178.99 17.4 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 125.769 1.652 . . . . 0.0 109.574 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.3 146.31 51.39 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.66 74.23 1.47 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -113.88 156.42 23.98 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.47 167.62 28.18 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.812 1.245 . . . . 0.0 108.027 173.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -137.84 136.62 37.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.78 169.37 17.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.436 1.494 . . . . 0.0 108.522 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.42 152.25 41.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 165.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -117.67 158.19 25.12 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -118.98 168.66 10.59 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 169.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.9 t -133.4 123.88 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -120.37 85.21 2.35 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.577 1.18 . . . . 0.0 108.856 -172.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.406 ' CE1' ' HB2' ' A' ' 20' ' ' ALA . 92.0 m-85 -72.59 157.42 37.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.894 -1.503 . . . . 0.0 112.847 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.425 ' HG3' ' HE3' ' A' ' 68' ' ' LYS . 3.4 pt20 -174.33 170.02 3.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.243 1.817 . . . . 0.0 110.01 -174.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.69 0 O-C-N 120.895 -1.128 . . . . 0.0 113.214 171.991 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 86.5 m -99.99 104.51 16.12 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.708 1.203 . . . . 0.0 109.206 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.2 m -94.57 93.17 7.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.427 1.891 . . . . 0.0 109.329 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.2 m -94.16 155.01 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 124.036 0.935 . . . . 0.0 110.166 173.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.98 144.88 52.18 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 161.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -103.71 -75.69 1.07 Allowed Glycine 0 C--N 1.332 0.352 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -177.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -175.62 -173.16 41.1 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -167.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.1 m -99.1 128.04 45.16 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.809 1.243 . . . . 0.0 109.53 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 19.9 t -104.98 105.34 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -82.49 143.27 31.23 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 168.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -122.76 126.39 47.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -134.75 152.23 51.6 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 118.185 0.448 . . . . 0.0 111.182 -171.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 139.94 -161.57 26.32 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.88 169.12 16.95 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -166.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 87.3 t -116.51 130.77 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' A' ' 184' ' ' ALA . 15.4 m -113.18 147.22 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 C-N-CA 125.895 1.678 . . . . 0.0 109.804 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.82 30.8 0.09 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -171.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.251 1.155 0 C-N-CA 131.436 3.895 . . . . 0.0 115.959 166.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.311 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.408 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -56.33 -43.6 79.18 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.5 m -108.92 175.19 5.55 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.536 1.535 . . . . 0.0 108.576 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.76 -16.06 15.04 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -167.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 t 54.88 114.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 128.343 2.657 . . . . 0.0 111.836 -173.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -59.17 154.38 16.21 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.2 1.4 . . . . 0.0 111.678 169.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.89 -27.3 68.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.732 1.213 . . . . 0.0 112.397 174.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.402 ' H ' ' CG ' ' A' ' 24' ' ' ASP . . . -81.1 9.98 50.84 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.406 1.003 . . . . 0.0 112.997 172.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.2 t -129.46 -40.41 1.43 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.356 1.862 . . . . 0.0 108.546 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.16 -34.13 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 123.696 0.798 . . . . 0.0 111.067 173.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -150.52 75.52 1.22 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.491 0.662 . . . . 0.0 109.565 -167.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.52 145.7 35.86 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.702 -0.624 . . . . 0.0 109.496 -173.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.9 m -112.58 95.3 5.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.94 111.8 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -84.54 103.46 13.69 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.2 mt -83.82 -4.99 59.1 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.045 1.338 . . . . 0.0 109.988 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.79 177.7 36.05 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 122.014 0.785 . . . . 0.0 112.522 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -75.83 139.6 41.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 167.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -125.77 143.42 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.129 0.971 . . . . 0.0 109.509 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -74.39 131.19 40.88 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 p -56.49 -23.3 38.46 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 123.304 0.642 . . . . 0.0 111.569 173.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.51 -48.67 71.62 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.488 1.115 . . . . 0.0 110.71 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.0 m -74.36 5.92 4.14 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.4 mt -142.92 59.39 1.42 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.354 1.862 . . . . 0.0 107.72 -168.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.57 6.41 3.5 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -165.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.607 HE21 ' HB3' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -153.35 168.32 26.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.794 1.638 . . . . 0.0 107.161 170.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -63.09 136.56 57.86 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 167.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.42 3.37 86.03 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-O 118.936 -0.924 . . . . 0.0 112.123 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.607 ' HB3' HE21 ' A' ' 44' ' ' GLN . . . -65.53 145.32 56.24 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.766 1.283 . . . . 0.0 109.045 162.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -142.24 152.44 43.07 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.563 0.697 . . . . 0.0 110.377 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.4 p -69.82 -179.2 1.74 Allowed 'General case' 0 CA--C 1.555 1.141 0 O-C-N 121.518 -0.739 . . . . 0.0 109.097 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.43 -28.93 32.64 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -169.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 95.58 110.75 0.02 OUTLIER 'General case' 0 C--N 1.343 0.301 0 C-N-CA 130.703 3.601 . . . . 0.0 109.522 -168.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -100.77 147.55 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.23 112.73 2.87 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -116.13 179.01 4.11 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.891 0.877 . . . . 0.0 109.142 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -158.66 172.44 18.27 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.193 -0.942 . . . . 0.0 110.659 176.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.3 mm -121.76 103.71 13.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -65.96 132.35 48.4 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 172.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 mp -129.24 119.9 24.81 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.245 2.218 . . . . 0.0 107.663 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -120.99 167.73 12.27 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.147 2.179 . . . . 0.0 111.178 -171.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.2 t70 25.31 57.0 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.28 2.632 . . . . 0.0 114.385 -165.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 91.2 m -73.74 121.73 21.26 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.551 2.34 . . . . 0.0 109.425 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -92.52 140.06 29.95 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 167.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.1 p -88.92 -13.79 38.24 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.907 1.685 . . . . 0.0 114.503 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -60.92 -51.33 69.74 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.112 0.958 . . . . 0.0 109.009 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.426 ' H ' HG12 ' A' ' 65' ' ' VAL . 2.1 p -58.26 -48.72 84.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 124.809 1.244 . . . . 0.0 108.126 -175.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -167.8 127.17 1.31 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.41 1.884 . . . . 0.0 107.28 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.3 m -88.34 1.67 54.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.599 0.76 . . . . 0.0 110.821 169.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -127.68 160.79 30.57 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 121.107 1.776 . . . . 0.0 110.802 172.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.83 132.58 25.67 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.108 0.963 . . . . 0.0 109.385 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.35 170.38 9.41 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 122.384 1.088 . . . . 0.0 109.266 167.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.9 t -138.81 147.75 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 127.007 2.123 . . . . 0.0 105.453 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.53 159.33 36.65 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -123.61 157.31 34.03 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.613 1.565 . . . . 0.0 109.165 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.7 tp -152.59 142.14 21.77 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.715 0.806 . . . . 0.0 108.897 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.37 171.14 43.87 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -175.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 m -58.04 124.88 20.83 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.758 1.279 . . . . 0.0 110.261 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.56 136.6 44.02 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 119.533 1.061 . . . . 0.0 110.34 173.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.5 tt -61.0 -54.22 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 O-C-N 123.786 0.679 . . . . 0.0 110.686 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -134.12 161.7 34.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 176.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.8 -33.61 74.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.07 -0.394 . . . . 0.0 111.146 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.66 1.72 76.6 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 121.614 -0.679 . . . . 0.0 113.721 175.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -140.37 43.8 1.88 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.902 1.681 . . . . 0.0 109.86 -173.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 p -66.26 -3.89 6.71 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 128.233 2.613 . . . . 0.0 112.503 169.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -93.52 9.16 37.84 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.774 1.23 . . . . 0.0 112.183 167.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.7 t -138.37 143.6 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 120.892 -1.13 . . . . 0.0 110.939 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.4 mt -78.62 151.91 32.05 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 119.305 0.957 . . . . 0.0 112.071 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.58 18.73 5.98 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 127.444 2.297 . . . . 0.0 114.017 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.5 mt 51.74 -156.5 0.14 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.045 0.938 . . . . 0.0 110.806 -167.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 . . . . . 0 N--CA 1.447 -0.592 0 C-N-CA 125.417 1.487 . . . . 0.0 108.516 174.605 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 CA--C 1.536 0.43 0 CA-C-O 121.294 0.568 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.86 132.96 46.84 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 164.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.7 p -87.37 166.81 14.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 170.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 59.8 18.73 7.6 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.294 1.838 . . . . 0.0 112.507 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -141.46 156.35 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -165.58 170.16 40.31 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -169.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.21 138.66 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 119.283 1.542 . . . . 0.0 108.671 -175.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -105.32 156.46 18.14 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.317 0.962 . . . . 0.0 109.955 163.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -117.73 141.62 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 158.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.7 mt -125.29 137.63 54.08 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.15 2.18 . . . . 0.0 105.385 175.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -63.29 166.67 6.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.72 1.248 . . . . 0.0 110.298 166.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.0 ptt85 -59.26 -26.01 64.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.085 1.354 . . . . 0.0 112.806 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.63 -12.93 60.9 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.967 0.803 . . . . 0.0 109.635 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.69 3.59 68.5 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 126.612 2.053 . . . . 0.0 112.738 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.05 159.61 31.52 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.398 1.599 . . . . 0.0 109.202 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.58 158.11 16.16 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.58 0.352 . . . . 0.0 110.207 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.6 mt -114.72 138.25 50.94 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 -172.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -75.22 157.19 34.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 170.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.7 mt -110.32 76.43 0.98 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.86 -14.97 10.07 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.289 0.635 . . . . 0.0 111.588 172.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.28 -2.82 81.66 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 117.055 -1.97 . . . . 0.0 113.946 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -139.66 -15.6 1.04 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.467 1.634 . . . . 0.0 112.851 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 49.6 m -59.54 111.7 1.51 Allowed 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 164.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.4 168.18 9.35 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.96 0.904 . . . . 0.0 110.082 173.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.6 p -120.01 -38.18 2.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -175.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.68 121.28 0.09 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.428 1.891 . . . . 0.0 109.41 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -67.62 140.29 56.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.7 m -130.96 117.39 19.15 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 55.0 m -56.92 137.73 54.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 171.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 45.4 mt -90.96 -163.59 1.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.195 0.998 . . . . 0.0 109.174 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -154.63 166.58 32.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.878 2.071 . . . . 0.0 108.149 167.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -66.45 91.01 0.16 Allowed 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.274 1.83 . . . . 0.0 109.621 170.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.12 -107.93 0.64 Allowed Glycine 0 C--O 1.224 -0.517 0 CA-C-O 119.04 -0.867 . . . . 0.0 112.424 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.64 136.75 54.74 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 119.219 1.509 . . . . 0.0 110.614 -172.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -137.58 168.98 18.57 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 127.159 2.184 . . . . 0.0 108.529 -176.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 97.6 m -149.41 145.12 26.79 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 168.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.41 107.77 59.68 Favored Pre-proline 0 N--CA 1.447 -0.582 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 169.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.35 156.23 65.02 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 N-CA-C 109.117 -1.147 . . . . 0.0 109.117 171.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -139.72 166.29 25.0 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.827 1.651 . . . . 0.0 107.184 170.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -117.48 137.64 52.4 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 167.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -128.87 149.86 50.58 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.59 -175.4 5.37 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.944 -0.472 . . . . 0.0 110.443 170.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -89.65 140.81 29.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 161.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -102.85 147.28 27.09 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.134 1.774 . . . . 0.0 106.321 164.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.11 144.55 41.31 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 166.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 75.0 p -102.51 12.4 36.51 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.192 0.997 . . . . 0.0 110.974 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 162.99 -145.49 10.65 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 176.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.04 87.11 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.897 1.679 . . . . 0.0 111.591 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.27 130.13 45.45 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.321 -0.862 . . . . 0.0 109.334 173.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 49.1 p -83.39 161.42 56.92 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 168.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -70.28 174.2 10.31 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.653 1.569 . . . . 0.0 110.079 163.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.26 -93.51 0.14 Allowed Glycine 0 C--N 1.333 0.365 0 O-C-N 120.965 -1.084 . . . . 0.0 111.536 172.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -149.53 163.3 38.21 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 175.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -146.02 86.05 1.7 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -125.63 153.43 43.78 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -162.93 165.73 24.73 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.682 1.193 . . . . 0.0 107.986 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -137.67 134.93 36.01 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -126.56 165.47 19.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.918 1.687 . . . . 0.0 109.484 174.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 41.4 p -119.67 124.86 47.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -93.8 149.66 21.05 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -121.35 163.45 18.64 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.256 1.422 . . . . 0.0 107.757 171.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.52 109.13 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.248 -2.131 . . . . 0.0 105.248 -164.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -111.01 80.32 1.29 Allowed 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.316 1.446 . . . . 0.0 108.935 -167.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -71.6 161.72 30.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.802 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -175.26 171.53 2.91 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.352 1.061 . . . . 0.0 111.251 -174.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.376 0 C-N-CA 124.496 1.046 . . . . 0.0 111.591 176.64 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.776 0 CA-C-O 120.735 0.302 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 98.2 m -151.84 97.16 2.32 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.399 1.479 . . . . 0.0 107.866 -170.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.6 m -89.08 117.08 27.82 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.023 1.729 . . . . 0.0 109.768 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.93 159.27 26.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.755 1.622 . . . . 0.0 110.744 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -76.32 111.96 12.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.71 -67.59 1.82 Allowed Glycine 0 C--N 1.334 0.423 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.99 -160.98 34.73 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -171.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 37.5 m -107.05 128.35 54.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.448 1.099 . . . . 0.0 108.504 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 19.6 t -104.5 105.75 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 166.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -78.85 143.49 35.92 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 170.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -122.32 122.88 40.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -128.61 168.78 15.25 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.687 1.195 . . . . 0.0 109.699 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 138.88 -161.78 25.88 Favored Glycine 0 N--CA 1.443 -0.9 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -162.07 170.36 19.34 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.08 129.89 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 168.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.4 m -115.38 147.98 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 C-N-CA 127.166 2.186 . . . . 0.0 107.844 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.78 41.9 0.22 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.358 1.463 . . . . 0.0 113.356 -174.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.276 0 C-N-CA 129.627 3.171 . . . . 0.0 113.605 175.206 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 48.7 -69.02 0.0 OUTLIER 'General case' 0 C--N 1.34 0.182 1 C-N-CA 133.453 4.701 . . . . 0.0 112.099 -171.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 29.1 m -83.19 -176.23 6.22 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.972 2.109 . . . . 0.0 111.229 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.31 16.14 10.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.925 2.09 . . . . 0.0 113.27 -171.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t 24.62 102.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 130.164 3.385 . . . . 0.0 113.137 172.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -55.32 157.59 3.59 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.63 1.172 . . . . 0.0 112.221 -171.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.22 -23.08 62.0 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.927 -1.108 . . . . 0.0 111.553 169.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.15 -18.49 73.07 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 117.872 -1.516 . . . . 0.0 113.671 172.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.2 p -118.43 -17.76 9.33 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.254 2.027 . . . . 0.0 111.919 -176.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.01 -27.77 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 O-C-N 120.876 -1.14 . . . . 0.0 112.771 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -167.3 82.3 0.21 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 -167.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.58 129.72 56.27 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -173.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -77.57 142.24 39.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 156.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.5 t -117.66 99.94 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 162.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -82.43 101.24 10.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.18 -17.3 59.6 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.767 0.827 . . . . 0.0 109.747 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.55 -165.21 18.78 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 121.716 0.62 . . . . 0.0 113.041 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -66.92 153.81 42.61 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.306 1.443 . . . . 0.0 111.53 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.5 t -137.13 147.95 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 125.414 1.485 . . . . 0.0 108.628 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.41 127.98 32.97 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 p -59.15 -25.1 63.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.227 0.537 . . . . 0.0 111.806 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.31 -27.87 66.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.497 -0.752 . . . . 0.0 111.204 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.5 t -84.52 0.89 48.15 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.245 1.418 . . . . 0.0 112.802 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.1 mt -143.84 82.69 1.73 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.62 1.568 . . . . 0.0 107.826 -170.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.04 0.05 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.408 -1.433 . . . . 0.0 113.485 -174.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -148.22 157.25 43.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 33.0 tt0 -63.37 121.83 14.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.51 -4.57 61.97 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.282 1.42 . . . . 0.0 113.523 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.22 154.24 24.01 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 119.24 1.52 . . . . 0.0 109.499 168.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.5 p -144.06 156.23 44.29 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.251 0.478 . . . . 0.0 110.678 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.7 p -72.55 -174.67 1.43 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.6 m -50.54 -40.18 51.11 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 117.101 -1.428 . . . . 0.0 113.806 171.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 95.18 170.92 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 C-N-CA 131.694 3.998 . . . . 0.0 109.815 -166.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.6 t -145.0 139.1 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 167.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.27 69.48 0.22 Allowed Glycine 0 CA--C 1.51 -0.246 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -69.0 161.0 29.9 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -133.67 175.84 9.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.739 1.616 . . . . 0.0 109.518 169.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.3 mm -109.81 112.29 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -68.55 112.42 5.34 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.301 0.64 . . . . 0.0 109.861 172.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.92 135.91 49.33 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 125.006 1.323 . . . . 0.0 108.272 168.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -136.95 167.65 21.08 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.378 1.471 . . . . 0.0 110.362 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 46.07 30.74 0.99 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.965 2.106 . . . . 0.0 113.353 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 96.3 m -62.83 162.48 10.97 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 127.031 2.132 . . . . 0.0 111.388 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -151.42 120.24 6.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.797 1.639 . . . . 0.0 106.898 -167.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.9 p -79.4 -18.45 52.26 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 120.898 -1.126 . . . . 0.0 112.22 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -60.35 -46.97 88.06 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.472 0.709 . . . . 0.0 109.725 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.2 p -73.12 -45.78 52.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.212 1.005 . . . . 0.0 109.637 -175.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -161.82 124.17 2.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.145 1.378 . . . . 0.0 108.099 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 m -66.85 -11.75 56.73 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.893 170.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -149.46 163.1 38.72 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 120.846 1.657 . . . . 0.0 114.116 -169.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.89 126.51 39.89 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.713 2.005 . . . . 0.0 106.836 166.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.55 172.96 8.15 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 142.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.88 151.09 21.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 103.182 -2.896 . . . . 0.0 103.182 -171.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.76 149.45 46.44 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -114.24 157.88 22.13 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.856 0.862 . . . . 0.0 110.757 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.9 tp -150.47 140.93 22.44 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.952 1.301 . . . . 0.0 108.934 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.16 -169.0 34.39 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 123.929 0.776 . . . . 0.0 112.381 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 m -81.5 130.87 35.21 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.205 1.802 . . . . 0.0 109.605 166.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.97 140.07 40.32 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 119.553 1.07 . . . . 0.0 111.028 172.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.3 tt -64.04 -44.62 97.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 122.689 0.396 . . . . 0.0 111.503 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.43 164.46 34.91 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.836 1.254 . . . . 0.0 108.636 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.85 -27.22 66.47 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.888 1.275 . . . . 0.0 113.114 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.77 -2.94 88.45 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.798 0.713 . . . . 0.0 112.582 175.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -143.34 47.3 1.5 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.772 1.629 . . . . 0.0 109.133 -169.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.5 p -61.89 -15.61 44.03 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.15 0.98 . . . . 0.0 112.943 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.628 ' ND2' ' HG1' ' A' ' 112' ' ' THR . 2.0 m-20 -94.48 -12.76 27.05 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 124.709 1.203 . . . . 0.0 109.762 -173.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.09 130.81 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.857 1.263 . . . . 0.0 107.653 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mt -72.2 150.01 44.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.85 1.26 . . . . 0.0 110.291 -174.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.74 14.05 16.44 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.983 1.713 . . . . 0.0 114.351 -164.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.1 mt 48.74 -152.48 0.12 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.216 1.007 . . . . 0.0 110.199 -162.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--O 1.241 0.623 0 C-N-CA 125.507 1.523 . . . . 0.0 110.374 -178.005 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 CA--C 1.538 0.511 0 CA-C-O 122.513 1.149 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.78 128.9 39.5 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.036 1.334 . . . . 0.0 109.177 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.5 p -87.5 170.27 11.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.893 0.77 . . . . 0.0 110.03 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 49.6 32.78 5.23 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.938 1.695 . . . . 0.0 111.943 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 p -154.68 151.02 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.4 172.77 34.83 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.2 t -84.61 133.74 28.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -104.48 153.54 21.01 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 157.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.0 mp -116.72 128.91 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 103.747 -2.686 . . . . 0.0 103.747 164.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 mt -125.96 143.11 51.22 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 5.7 p-10 -66.66 -178.33 0.7 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.475 1.11 . . . . 0.0 112.659 173.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -44.37 -31.67 1.12 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 128.605 2.762 . . . . 0.0 114.856 169.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.6 p -95.09 -4.65 45.92 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.884 1.274 . . . . 0.0 112.125 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.48 22.23 78.76 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 121.162 -0.961 . . . . 0.0 112.933 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -82.69 144.31 30.33 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.923 1.861 . . . . 0.0 109.081 168.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.87 129.05 37.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.756 0.822 . . . . 0.0 111.106 -176.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 51.9 mt -89.45 168.68 12.0 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.001 0.52 . . . . 0.0 110.396 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.628 ' HG1' ' ND2' ' A' ' 84' ' ' ASN . 9.5 m -122.32 140.63 52.43 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.995 1.318 . . . . 0.0 107.764 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.7 mt -93.69 52.03 1.64 Allowed 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.513 1.125 . . . . 0.0 109.895 -160.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.33 -29.34 19.22 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.238 1.015 . . . . 0.0 111.495 -174.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.99 -30.43 3.59 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 124.564 1.078 . . . . 0.0 113.697 -172.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.05 -58.04 3.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 116.989 -1.481 . . . . 0.0 109.383 166.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.2 m -40.66 103.97 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.315 1.446 . . . . 0.0 111.956 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -63.32 160.77 15.24 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.068 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.3 p -118.43 173.08 7.03 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.857 1.263 . . . . 0.0 109.383 168.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 17.2 m -25.2 116.46 0.05 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.051 2.14 . . . . 0.0 113.402 166.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -72.33 167.4 20.54 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 122.318 1.056 . . . . 0.0 109.174 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.1 m -132.57 157.11 45.55 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 160.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.4 m -107.04 133.81 51.11 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 123.517 1.627 . . . . 0.0 107.961 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.99 175.77 6.51 Favored 'General case' 0 N--CA 1.428 -1.561 0 C-N-CA 129.179 2.991 . . . . 0.0 108.904 -164.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.428 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 7.3 p30 -145.68 165.48 28.63 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.411 1.484 . . . . 0.0 107.971 172.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -61.09 122.59 15.37 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 169.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.21 -119.27 6.11 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.263 0.935 . . . . 0.0 111.208 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 m -117.58 125.87 51.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 119.232 1.516 . . . . 0.0 110.436 -167.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.428 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -133.22 176.02 8.88 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 125.051 1.34 . . . . 0.0 109.948 175.734 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.0 m -145.28 137.32 25.64 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.261 -0.899 . . . . 0.0 110.586 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.8 mt -102.63 108.88 59.46 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 169.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -86.59 159.5 9.31 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.607 2.205 . . . . 0.0 110.648 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -146.43 177.17 9.24 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.1 1.76 . . . . 0.0 109.438 -172.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.09 115.34 8.88 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.393 0.997 . . . . 0.0 111.09 153.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.24 164.88 18.8 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 121.45 -0.781 . . . . 0.0 109.535 167.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -157.24 160.63 38.84 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.011 1.325 . . . . 0.0 107.506 171.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -79.77 132.11 36.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 160.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -116.33 123.02 46.59 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.503 1.921 . . . . 0.0 106.054 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.06 143.44 31.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.165 0.586 . . . . 0.0 109.82 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.411 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 12.3 p -106.19 11.17 31.54 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.765 0.826 . . . . 0.0 112.173 170.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 160.84 -149.25 18.21 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.06 86.78 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.956 1.303 . . . . 0.0 110.01 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.67 155.96 39.71 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.282 0.633 . . . . 0.0 109.871 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.4 p -118.83 161.52 35.71 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.757 0.708 . . . . 0.0 109.896 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -75.39 176.89 9.36 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.681 1.587 . . . . 0.0 110.629 171.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.43 -97.95 0.17 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 164.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.94 163.19 31.29 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 129.947 3.299 . . . . 0.0 105.456 168.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -150.19 77.22 1.3 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.673 0.67 . . . . 0.0 109.816 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -119.81 150.35 40.57 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -174.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.73 164.08 38.45 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.454 1.102 . . . . 0.0 108.193 171.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -134.68 98.28 4.01 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.97 177.81 8.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.39 0.614 . . . . 0.0 110.376 168.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.5 p -122.16 162.44 21.32 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 150.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CE1' ' HA3' ' A' ' 172' ' ' GLY . 44.4 p90 -115.98 150.86 36.51 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.912 0.863 . . . . 0.0 109.763 158.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -107.37 167.04 10.2 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.042 1.737 . . . . 0.0 106.659 161.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.88 146.71 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 171.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -128.1 85.12 2.31 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -66.54 147.98 52.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.143 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -161.44 176.91 10.61 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 124.76 1.224 . . . . 0.0 110.752 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.407 0 C-N-CA 125.056 1.312 . . . . 0.0 111.339 175.605 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.4 m -130.91 99.41 4.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.6 131.74 42.85 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 167.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.7 m -148.55 140.65 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 124.405 1.082 . . . . 0.0 109.742 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -66.87 126.27 28.54 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 166.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' ' 154' ' ' PHE . . . -93.41 -75.96 1.32 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -160.29 -175.48 31.33 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 123.72 0.306 . . . . 0.0 113.232 -176.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 25.6 m -103.6 142.82 33.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.401 1.48 . . . . 0.0 109.007 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.4 t -125.57 101.56 8.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -88.35 95.6 10.26 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -75.14 102.21 4.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 175.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -114.24 156.94 23.4 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 -175.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 143.75 -163.37 27.63 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -171.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -161.44 170.15 20.54 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -164.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 48.3 t -126.4 140.51 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 167.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.442 ' C ' ' H ' ' A' ' 184' ' ' ALA . 16.9 m -122.06 150.37 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 127.058 2.143 . . . . 0.0 109.046 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.65 24.59 0.09 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -169.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.25 1.107 1 C-N-CA 132.993 4.517 . . . . 0.0 113.719 171.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.909 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.28 -38.87 63.48 Favored 'General case' 0 C--O 1.225 -0.211 0 O-C-N 123.986 0.803 . . . . 0.0 112.206 -165.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.5 m -110.22 159.3 17.51 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.798 1.239 . . . . 0.0 107.779 165.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.81 -9.3 52.26 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -164.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.5 t 44.95 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 129.038 2.935 . . . . 0.0 110.744 -167.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -62.91 160.57 14.49 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.289 -170.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.7 -21.2 39.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.953 1.301 . . . . 0.0 112.15 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.53 -12.9 67.53 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.564 1.078 . . . . 0.0 112.755 173.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 t -127.09 -21.67 3.91 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.834 1.654 . . . . 0.0 110.792 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.9 -26.13 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 125.25 1.42 . . . . 0.0 113.007 -173.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -150.7 94.5 2.1 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -132.61 148.31 52.36 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.343 0.657 . . . . 0.0 109.485 -175.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.2 m -124.32 100.4 6.67 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.634 1.973 . . . . 0.0 108.041 -174.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.5 t -74.53 111.28 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -88.55 101.41 13.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 mt -76.46 -16.39 59.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.033 1.733 . . . . 0.0 109.7 170.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.39 -166.55 25.49 Favored Glycine 0 C--N 1.343 0.935 0 C-N-CA 124.796 1.189 . . . . 0.0 112.765 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -68.68 147.63 51.58 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.98 0.912 . . . . 0.0 109.64 173.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 t -135.88 143.41 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 124.353 1.061 . . . . 0.0 108.949 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -73.29 127.67 33.3 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.3 p -58.01 -21.94 47.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.211 0.529 . . . . 0.0 111.485 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.38 -43.3 75.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.165 -0.96 . . . . 0.0 110.675 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.6 m -72.49 -2.11 18.39 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.4 mt -144.0 66.28 1.29 Allowed 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.488 1.915 . . . . 0.0 109.017 -161.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.97 -9.07 6.0 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -167.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -152.52 163.09 40.26 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.391 1.476 . . . . 0.0 107.928 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -62.77 129.97 42.84 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.24 -10.68 63.58 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.842 1.211 . . . . 0.0 112.734 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.83 106.2 2.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.35 1.06 . . . . 0.0 111.458 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.8 p -101.18 150.6 22.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.44 -0.788 . . . . 0.0 110.812 -176.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.1 p -67.56 172.45 5.09 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 166.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.7 m -24.64 -98.9 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 130.257 3.423 . . . . 0.0 114.517 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 154.72 118.24 0.0 OUTLIER 'General case' 0 C--O 1.233 0.191 0 C-N-CA 129.746 3.218 . . . . 0.0 105.356 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.58 130.96 65.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -176.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.08 139.5 14.58 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -138.48 158.77 43.62 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 168.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -148.94 130.08 14.51 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 120.347 -1.471 . . . . 0.0 110.396 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.7 mm -83.54 115.61 26.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 125.002 1.321 . . . . 0.0 107.459 -167.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -76.63 108.95 9.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.988 0.915 . . . . 0.0 109.826 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.7 mp -111.71 97.13 6.5 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 125.414 1.485 . . . . 0.0 108.294 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -95.83 160.32 14.53 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.161 1.784 . . . . 0.0 112.227 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.3 t70 40.49 49.7 2.68 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.275 2.63 . . . . 0.0 114.007 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 57.5 m -65.66 122.16 16.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 127.701 2.4 . . . . 0.0 111.05 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -111.17 112.6 24.51 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.582 1.153 . . . . 0.0 110.161 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.9 p -70.84 -24.68 62.57 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.146 2.178 . . . . 0.0 113.738 -165.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -61.47 -48.2 82.19 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 128.543 2.737 . . . . 0.0 112.44 168.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.1 t -64.88 -39.13 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -176.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -168.63 146.06 3.91 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.117 -176.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.25 -11.42 35.34 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 118.795 -0.621 . . . . 0.0 111.67 170.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -134.04 164.8 26.5 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 125.46 1.504 . . . . 0.0 109.942 -173.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.79 144.06 37.18 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 163.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.79 167.88 9.83 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.98 1.712 . . . . 0.0 107.429 158.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.7 t -124.8 150.97 29.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 169.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.25 155.21 37.62 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 161.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.441 ' CE1' HG23 ' A' ' 103' ' ' ILE . 60.0 m-85 -114.04 154.85 26.98 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 tp -142.11 125.97 17.11 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 125.373 1.469 . . . . 0.0 107.365 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.85 162.91 36.34 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.3 m -63.08 129.47 40.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.003 0.901 . . . . 0.0 109.107 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.69 141.31 46.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.071 0.462 . . . . 0.0 110.245 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.3 tt -60.77 -37.51 76.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 123.931 0.892 . . . . 0.0 110.382 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -158.24 165.56 34.55 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.45 -35.4 72.06 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.856 1.262 . . . . 0.0 111.254 169.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.79 -3.68 64.29 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 121.276 -0.89 . . . . 0.0 112.381 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -147.78 48.54 1.08 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.959 1.704 . . . . 0.0 108.788 -164.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.3 p -58.75 -18.4 31.4 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.598 1.959 . . . . 0.0 112.414 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -95.07 -1.79 51.44 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 117.928 -1.034 . . . . 0.0 113.076 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.3 t -115.58 130.59 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 120.329 1.422 . . . . 0.0 109.807 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.8 mt -72.2 151.47 42.89 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.209 1.004 . . . . 0.0 111.393 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.72 17.41 10.39 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.999 1.719 . . . . 0.0 113.656 -168.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 63.8 mt 52.34 -154.17 0.2 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.606 1.562 . . . . 0.0 109.406 -168.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--O 1.234 0.255 0 CA-C-N 118.725 0.693 . . . . 0.0 110.158 -179.245 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.8 m . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.07 139.07 57.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.389 1.476 . . . . 0.0 107.57 164.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 p -90.36 170.4 10.28 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.761 0.709 . . . . 0.0 109.594 173.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 58.73 19.92 7.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 126.536 1.934 . . . . 0.0 112.71 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.7 p -143.49 151.38 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -153.5 177.67 30.92 Favored Glycine 0 C--O 1.225 -0.408 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 m -96.03 142.87 13.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 CA-C-N 120.018 1.909 . . . . 0.0 109.056 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -110.15 156.61 20.37 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 120.257 1.39 . . . . 0.0 109.328 161.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.441 HG23 ' CE1' ' A' ' 73' ' ' PHE . 4.6 mp -114.02 142.97 24.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 126.995 2.118 . . . . 0.0 105.562 159.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.3 mt -131.77 156.0 46.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.235 1.814 . . . . 0.0 106.674 170.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.552 ' CG ' ' H ' ' A' ' 106' ' ' ARG . 3.5 t70 -72.34 -105.35 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 165.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.552 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 19.7 ptt180 -151.21 -9.79 0.23 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.744 1.618 . . . . 0.0 112.432 178.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.5 p -83.12 7.54 15.66 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.646 1.578 . . . . 0.0 109.344 172.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.45 8.1 30.1 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.441 1.496 . . . . 0.0 113.484 -166.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.31 114.65 3.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 119.476 1.638 . . . . 0.0 107.377 170.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.08 127.44 41.15 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.47 ' HG ' ' HG ' ' A' ' 119' ' ' SER . 0.3 OUTLIER -104.43 131.62 51.59 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.826 0.704 . . . . 0.0 110.623 -162.134 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.8 m -65.18 153.96 39.41 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.616 0.366 . . . . 0.0 110.611 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.81 49.92 0.8 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.393 1.477 . . . . 0.0 110.226 -171.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.59 -28.86 20.42 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.564 -1.335 . . . . 0.0 111.091 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.44 2.03 56.63 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 126.523 2.011 . . . . 0.0 113.641 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.78 -31.69 1.95 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 117.583 -1.198 . . . . 0.0 111.35 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.1 m -54.67 104.35 0.11 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.713 1.142 . . . . 0.0 110.131 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -87.26 149.95 24.22 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.886 -173.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.47 ' HG ' ' HG ' ' A' ' 111' ' ' LEU . 0.9 OUTLIER -77.6 -160.73 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.896 1.278 . . . . 0.0 111.789 -174.556 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 m -50.76 156.49 0.94 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.519 0.727 . . . . 0.0 111.778 147.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -102.4 152.93 20.53 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.393 1.877 . . . . 0.0 108.313 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.8 m -132.03 118.25 19.44 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.449 1.499 . . . . 0.0 107.851 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.5 m -59.15 123.76 17.71 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 166.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 73.3 mt -91.2 -174.69 4.04 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 128.805 2.842 . . . . 0.0 109.59 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -163.04 172.94 14.22 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.522 1.929 . . . . 0.0 108.537 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -59.57 107.38 0.58 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.974 1.709 . . . . 0.0 109.748 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.1 -124.25 3.19 Favored Glycine 0 N--CA 1.474 1.226 0 CA-C-N 120.417 1.462 . . . . 0.0 112.8 169.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 99.2 m -122.75 125.31 45.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 120.535 2.168 . . . . 0.0 109.091 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -133.29 177.72 7.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.474 1.91 . . . . 0.0 109.706 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.57 162.18 40.71 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -166.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 17.6 mt -139.92 112.29 7.5 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.64 153.08 43.46 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.971 1.781 . . . . 0.0 109.431 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -136.41 161.3 36.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.894 1.677 . . . . 0.0 107.605 170.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -127.18 97.27 4.87 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -175.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.12 157.23 25.41 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.406 1.482 . . . . 0.0 110.578 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -159.14 169.83 23.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.079 1.352 . . . . 0.0 111.306 162.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -82.78 146.05 29.18 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 152.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -123.83 116.53 23.11 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.97 2.108 . . . . 0.0 106.914 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.54 141.15 36.92 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 171.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.2 p -105.67 17.13 24.28 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.895 0.878 . . . . 0.0 110.375 171.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 161.64 -155.98 27.36 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.06 91.34 0.15 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.995 1.718 . . . . 0.0 110.043 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.12 152.72 32.11 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 55.0 p -104.38 161.06 23.99 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -72.87 170.9 18.56 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 N-CA-C 109.215 -1.11 . . . . 0.0 109.215 160.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.06 -95.46 0.15 Allowed Glycine 0 C--O 1.226 -0.348 0 O-C-N 121.35 -0.844 . . . . 0.0 112.114 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -151.12 161.18 43.21 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.175 1.79 . . . . 0.0 106.743 173.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.11 81.23 1.54 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -118.92 139.53 51.49 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.5 157.24 42.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -130.34 121.88 26.84 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -101.15 163.57 12.22 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 162.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.3 p -103.8 156.15 18.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 151.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -115.84 157.8 23.89 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.49 0.716 . . . . 0.0 109.604 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -126.31 162.7 24.88 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 126.946 2.098 . . . . 0.0 107.768 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.8 t -128.55 123.34 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 -175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -111.78 85.56 2.16 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -64.7 146.84 54.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.283 170.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -164.47 168.21 18.66 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 121.838 0.827 . . . . 0.0 112.44 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 105.894 -2.883 . . . . 0.0 105.894 -176.928 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.682 0 CA-C-O 120.834 0.349 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 90.9 m -103.58 91.89 4.22 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.414 1.486 . . . . 0.0 107.939 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.2 m -79.02 101.97 8.1 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 171.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -104.84 169.2 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 126.111 1.765 . . . . 0.0 108.791 170.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.33 173.63 4.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.437 0.637 . . . . 0.0 111.094 169.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -127.16 -72.09 0.18 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 174.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.68 -167.23 39.88 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -167.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.1 m -96.9 137.5 35.89 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.048 0.939 . . . . 0.0 108.745 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.7 t -117.96 105.49 18.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 163.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -78.11 141.74 38.56 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 171.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -123.56 101.15 7.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.27 2.228 . . . . 0.0 105.174 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -115.06 155.99 25.99 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.89 0.876 . . . . 0.0 109.265 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.64 -166.71 27.28 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -167.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -167.09 175.22 7.66 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -169.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 24.3 t -128.86 138.0 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 174.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.433 ' C ' ' H ' ' A' ' 184' ' ' ALA . 11.0 m -124.69 151.43 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 C-N-CA 127.255 2.222 . . . . 0.0 107.75 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -74.89 30.88 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -171.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.249 1.049 0 C-N-CA 131.074 3.75 . . . . 0.0 114.017 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.4 -40.21 25.1 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.87 1.268 . . . . 0.0 112.377 -175.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.436 ' SG ' ' HB3' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -112.79 160.71 17.71 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.755 1.622 . . . . 0.0 109.579 178.404 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.92 -21.62 31.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.334 -167.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 t 56.51 107.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 128.633 2.773 . . . . 0.0 110.272 -165.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -65.7 163.14 17.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.66 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.26 -29.6 33.76 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.242 1.017 . . . . 0.0 111.356 167.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.43 4.61 3.65 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.673 1.13 . . . . 0.0 114.784 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.8 t -147.6 -34.13 0.25 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.188 1.494 . . . . 0.0 110.351 -167.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.4 -36.84 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 O-C-N 120.738 -1.226 . . . . 0.0 111.371 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -151.24 97.38 2.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.96 0.886 . . . . 0.0 109.081 -172.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -131.33 133.83 45.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 123.376 1.56 . . . . 0.0 110.179 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.8 m -108.75 88.96 2.85 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -174.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.56 105.11 7.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -171.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -80.89 115.14 20.23 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 mt -79.89 -7.44 58.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.974 0.91 . . . . 0.0 110.732 175.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.19 -178.47 51.42 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.647 1.117 . . . . 0.0 110.703 -177.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -79.05 146.82 33.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 165.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.58 145.58 35.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 124.395 1.078 . . . . 0.0 108.637 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -77.63 132.44 38.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.3 p -59.04 -22.81 61.31 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 122.489 0.316 . . . . 0.0 110.7 168.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.14 -9.64 41.95 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.91 -1.119 . . . . 0.0 113.274 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.0 m -101.36 -2.38 31.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.456 1.103 . . . . 0.0 113.28 168.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.4 mt -142.56 83.22 1.81 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 126.845 2.058 . . . . 0.0 106.815 -166.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.69 6.98 1.45 Allowed 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.289 -0.882 . . . . 0.0 112.274 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -154.48 160.15 41.42 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.701 1.2 . . . . 0.0 107.886 -174.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -64.09 136.42 57.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 121.528 -0.732 . . . . 0.0 109.796 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.31 -4.17 56.09 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-O 117.51 -1.717 . . . . 0.0 112.344 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.71 143.78 45.69 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 120.562 2.181 . . . . 0.0 108.113 170.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.8 p -140.75 154.68 46.4 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -176.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.5 p -73.41 -178.49 3.03 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.2 m -28.55 -91.03 0.0 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.622 2.769 . . . . 0.0 114.735 173.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.41 111.02 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 130.495 3.518 . . . . 0.0 104.356 -176.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.02 136.08 43.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 173.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.33 88.77 0.43 Allowed Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 -173.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -83.22 -179.55 7.44 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -148.53 162.97 38.58 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 120.189 -1.569 . . . . 0.0 109.997 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.1 mm -99.62 103.81 15.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -69.49 124.47 23.99 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 174.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.436 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 6.5 mp -117.5 165.46 13.51 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.729 1.612 . . . . 0.0 108.789 174.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -176.03 153.26 1.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.313 1.445 . . . . 0.0 109.219 -165.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 47.12 37.47 5.4 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.542 2.337 . . . . 0.0 114.501 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.3 119.42 12.13 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.407 1.483 . . . . 0.0 110.35 177.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -90.53 142.57 27.61 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 163.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.3 p -91.19 -14.02 31.8 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.664 1.575 . . . . 0.0 114.308 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -70.64 -43.49 69.1 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.739 0.781 . . . . 0.0 110.222 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 65' ' ' VAL . 2.8 p -60.27 -49.71 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.86 130.37 3.19 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 125.955 1.702 . . . . 0.0 108.081 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -82.29 -8.05 59.63 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.018 0.927 . . . . 0.0 111.695 174.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -131.24 167.04 19.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.921 1.689 . . . . 0.0 110.111 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.03 129.1 22.01 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 162.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.4 176.91 5.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 145.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.03 160.5 15.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 101.648 -3.464 . . . . 0.0 101.648 -168.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.25 167.9 21.71 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 120.354 -1.466 . . . . 0.0 107.458 168.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -126.39 153.51 44.86 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 tp -142.13 142.72 32.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.11 170.07 42.85 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 m -57.19 125.76 24.18 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.954 1.701 . . . . 0.0 109.374 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.43 137.52 46.51 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.687 1.13 . . . . 0.0 109.866 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.1 tt -59.2 -49.21 84.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 124.405 1.082 . . . . 0.0 110.7 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -147.78 166.72 26.67 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.09 -34.41 76.24 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.961 1.304 . . . . 0.0 112.231 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.9 -12.69 84.17 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 119.514 -0.603 . . . . 0.0 112.347 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -125.79 48.86 2.01 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.266 1.427 . . . . 0.0 110.153 -173.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.4 p -63.89 -11.96 32.53 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 126.776 2.03 . . . . 0.0 114.041 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -86.25 -4.05 59.09 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.15 -0.968 . . . . 0.0 111.074 171.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.7 t -124.47 132.7 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 119.832 1.196 . . . . 0.0 109.258 -168.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.34 148.25 35.72 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.47 1.508 . . . . 0.0 110.473 -172.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.53 17.33 8.83 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.395 1.478 . . . . 0.0 114.27 -166.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.579 ' CD1' ' HG ' ' A' ' 95' ' ' SER . 26.0 mt 51.27 -153.02 0.19 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.261 0.624 . . . . 0.0 109.811 -166.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 N--CA 1.45 -0.462 0 C-N-CA 125.073 1.349 . . . . 0.0 109.238 177.689 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.579 ' HG ' ' CD1' ' A' ' 88' ' ' LEU . 6.5 t . . . . . 0 N--CA 1.44 -0.931 0 CA-C-O 124.343 2.021 . . . . 0.0 111.901 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.06 156.75 14.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 112.277 -2.238 . . . . 0.0 107.891 151.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.44 163.8 28.55 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.495 1.518 . . . . 0.0 108.471 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 59.03 15.65 4.16 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.298 1.439 . . . . 0.0 111.214 -170.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.14 152.71 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 120.207 1.367 . . . . 0.0 109.025 -176.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.27 176.11 28.16 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 125.396 1.474 . . . . 0.0 110.306 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.409 HG13 ' CG ' ' A' ' 177' ' ' PHE . 92.9 t -86.4 142.51 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 172.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.478 HE22 ' HB1' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -120.64 157.87 28.62 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.659 1.184 . . . . 0.0 108.544 163.009 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.7 mp -134.72 138.68 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 C-N-CA 129.082 2.953 . . . . 0.0 104.783 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.07 147.28 46.01 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -178.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.84 -175.26 0.53 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.263 0.938 . . . . 0.0 110.405 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -52.16 -18.14 1.37 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 171.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 t -81.41 -13.65 58.04 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.51 -0.744 . . . . 0.0 109.363 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.15 13.26 52.98 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.557 2.027 . . . . 0.0 113.501 -167.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.05 127.59 33.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 168.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.478 ' HB1' HE22 ' A' ' 102' ' ' GLN . . . -62.04 129.05 39.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.328 1.451 . . . . 0.0 111.482 -177.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.0 mt -100.76 160.44 14.36 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 124.086 0.866 . . . . 0.0 110.54 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.0 m -96.13 153.16 17.94 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.995 0.918 . . . . 0.0 108.567 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.4 mt -107.19 64.26 0.64 Allowed 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 123.593 0.757 . . . . 0.0 109.542 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -111.06 -12.61 14.17 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.616 0.766 . . . . 0.0 111.799 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.82 -27.02 1.38 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 125.179 1.371 . . . . 0.0 112.739 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.02 -69.7 0.57 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 117.862 -1.066 . . . . 0.0 109.266 164.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.7 m -39.6 99.09 0.02 OUTLIER 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.804 2.041 . . . . 0.0 112.128 -169.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -70.16 155.96 39.9 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.207 1.403 . . . . 0.0 109.81 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.8 p -109.98 -138.94 0.38 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.043 0.937 . . . . 0.0 112.181 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.51 135.44 48.6 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -78.53 163.17 25.77 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.737 0.779 . . . . 0.0 108.969 167.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.0 m -145.61 118.75 8.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 174.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.1 m -70.32 113.64 7.68 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 171.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.2 mt -80.29 177.78 8.73 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.048 2.139 . . . . 0.0 107.868 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -143.36 164.9 29.0 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.62 -0.675 . . . . 0.0 109.846 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -63.72 104.99 0.73 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.919 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 122.99 -109.49 1.38 Allowed Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.586 1.565 . . . . 0.0 111.681 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 94.3 m -126.55 131.25 51.6 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 120.769 -1.43 . . . . 0.0 111.587 -164.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.06 174.41 12.78 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.649 1.979 . . . . 0.0 108.249 -172.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.0 m -151.23 157.45 42.62 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 10.5 mt -118.33 110.7 39.01 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 170.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -67.36 154.25 74.5 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 121.709 1.606 . . . . 0.0 109.996 172.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -136.12 166.77 22.62 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.595 1.558 . . . . 0.0 108.496 173.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -120.02 152.17 37.9 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 164.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.88 166.84 20.71 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 162.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -164.25 158.29 18.75 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 170.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -71.32 153.89 42.02 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 159.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -134.01 112.89 11.58 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.226 2.21 . . . . 0.0 105.931 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.08 150.68 30.22 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.123 0.963 . . . . 0.0 109.184 170.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 68.1 p -115.61 8.04 14.96 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 125.958 1.703 . . . . 0.0 110.601 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.58 -154.28 24.33 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.05 87.0 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.002 1.321 . . . . 0.0 112.064 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.07 137.45 56.41 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.243 1.417 . . . . 0.0 111.495 -170.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 31.1 p -99.97 160.8 26.25 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 118.26 0.482 . . . . 0.0 110.613 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -72.36 178.78 5.71 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.446 1.43 . . . . 0.0 110.743 166.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.01 -93.59 0.14 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.593 1.092 . . . . 0.0 112.213 158.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.24 159.12 42.71 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 127.559 2.343 . . . . 0.0 105.06 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.33 71.78 1.13 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 120.015 1.279 . . . . 0.0 110.767 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -115.47 154.79 28.65 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -176.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.0 152.63 26.85 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.749 0.82 . . . . 0.0 109.715 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -120.74 121.32 37.98 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -120.79 175.69 5.9 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.009 2.124 . . . . 0.0 109.819 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.7 p -127.61 152.11 48.06 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 159.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -105.09 156.1 18.38 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 164.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -113.49 171.98 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.797 1.239 . . . . 0.0 107.943 168.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.6 t -129.34 129.05 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -120.9 89.37 3.12 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -67.58 146.62 53.71 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 125.115 1.366 . . . . 0.0 110.716 173.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -155.87 171.71 19.6 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 126.702 2.001 . . . . 0.0 110.556 166.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.424 0 O-C-N 120.847 -1.158 . . . . 0.0 111.432 166.669 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 34.4 m -150.06 100.18 2.9 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 120.399 -1.438 . . . . 0.0 108.235 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.54 109.51 15.12 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.799 2.04 . . . . 0.0 109.763 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.36 157.69 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.018 1.327 . . . . 0.0 109.974 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.0 157.39 36.24 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.339 -0.851 . . . . 0.0 109.949 174.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.59 -59.93 0.46 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 172.52 176.5 41.28 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -168.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.9 m -97.45 128.35 44.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.255 1.422 . . . . 0.0 110.197 177.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.43 115.2 49.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -106.4 90.34 3.32 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -172.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.409 ' CG ' HG13 ' A' ' 101' ' ' VAL . 75.2 m-85 -67.34 118.77 11.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 175.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -123.69 160.45 27.19 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 138.41 -165.21 25.55 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -163.47 168.85 19.66 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -167.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.08 136.76 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 167.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.463 ' C ' ' H ' ' A' ' 184' ' ' ALA . 6.1 m -115.8 152.36 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 C-N-CA 126.963 2.105 . . . . 0.0 108.329 177.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -75.11 31.42 0.1 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -172.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 N--CA 1.442 -0.837 1 C-N-CA 131.711 4.004 . . . . 0.0 112.096 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.581 0 N-CA-C 102.471 -3.159 . . . . 0.0 102.471 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.72 -13.42 61.72 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.204 -0.998 . . . . 0.0 112.808 -173.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.5 m -130.91 151.06 51.75 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.014 1.726 . . . . 0.0 107.799 -175.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.89 -10.26 59.32 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -173.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 t 55.21 140.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 129.036 2.934 . . . . 0.0 112.121 -160.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.62 163.99 13.33 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.182 -0.949 . . . . 0.0 112.711 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.75 78.3 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.501 1.121 . . . . 0.0 111.392 -173.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.91 28.0 2.22 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.38 0.991 . . . . 0.0 112.006 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.7 t -139.68 -55.6 0.56 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.0 1.32 . . . . 0.0 108.554 -174.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.4 p -50.87 -36.09 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.844 1.258 . . . . 0.0 112.873 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -143.41 101.36 3.78 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 104.87 -2.271 . . . . 0.0 104.87 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -130.9 138.48 49.81 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.055 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 93.3 m -106.96 98.66 8.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 172.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.8 t -77.67 115.89 20.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -89.66 127.67 35.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 mt -100.99 -3.63 29.04 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.375 1.87 . . . . 0.0 109.57 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.01 179.77 37.26 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.49 1.043 . . . . 0.0 112.345 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -76.01 116.57 16.84 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.777 1.631 . . . . 0.0 109.889 170.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.5 t -103.0 140.67 20.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 122.776 1.274 . . . . 0.0 109.245 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.422 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 7.4 mmt180 -71.76 126.58 30.08 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 125.466 1.506 . . . . 0.0 107.003 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 p -50.92 -31.57 18.0 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.321 1.448 . . . . 0.0 111.073 166.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.29 -16.58 60.76 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 t -92.72 0.28 57.39 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.064 1.346 . . . . 0.0 112.062 172.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.9 mt -145.9 67.65 1.2 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.881 1.672 . . . . 0.0 106.653 -162.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.63 -6.27 4.12 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -163.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -147.85 157.56 43.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.855 1.662 . . . . 0.0 106.848 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -63.33 134.62 56.1 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 170.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.71 -7.09 77.37 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 118.822 -0.988 . . . . 0.0 112.322 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.35 152.42 43.87 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.475 1.138 . . . . 0.0 109.604 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.9 p -138.08 158.57 44.05 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.858 0.837 . . . . 0.0 111.237 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.6 p -72.05 -175.86 1.59 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.438 0.695 . . . . 0.0 111.484 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 p -40.38 -47.45 2.56 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 126.635 1.974 . . . . 0.0 113.607 160.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 83.74 162.78 0.12 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 129.047 2.939 . . . . 0.0 108.914 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -144.9 133.23 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.87 104.23 3.14 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 106.111 -2.796 . . . . 0.0 106.111 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -104.69 156.74 17.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 168.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.97 151.87 50.38 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 120.515 -1.366 . . . . 0.0 109.701 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.2 mm -99.78 115.01 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.63 136.33 38.16 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -173.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.6 mt -123.52 160.26 27.37 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.444 1.498 . . . . 0.0 107.955 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -149.59 151.35 33.67 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.448 1.499 . . . . 0.0 111.077 -164.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.6 t70 38.74 44.11 0.78 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.453 2.701 . . . . 0.0 113.524 -171.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.8 m -72.53 97.14 2.05 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.781 1.632 . . . . 0.0 113.909 -164.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -71.92 104.93 3.65 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.166 0.986 . . . . 0.0 111.126 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.1 p -68.67 -11.88 60.7 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -175.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -66.49 -48.21 70.57 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.707 0.685 . . . . 0.0 109.159 173.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -58.02 -41.76 81.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 124.204 1.001 . . . . 0.0 109.081 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -167.04 138.24 3.2 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.767 1.627 . . . . 0.0 108.345 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.1 m -96.46 12.58 30.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.927 1.291 . . . . 0.0 113.059 169.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -148.04 167.1 25.81 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 121.309 1.868 . . . . 0.0 113.326 158.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.21 93.6 2.46 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.189 2.196 . . . . 0.0 112.088 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.34 152.22 24.23 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 119.031 -2.293 . . . . 0.0 108.734 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 t -120.44 123.81 71.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.99 165.49 14.53 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 165.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -127.66 160.34 31.93 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.543 163.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.285 0.0 OUTLIER -139.15 160.25 40.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.228 168.077 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.84 163.78 32.91 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 m -58.17 125.93 25.31 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 164.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.05 140.49 43.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 119.374 0.988 . . . . 0.0 109.091 174.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.4 tt -60.53 -48.46 88.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 123.35 0.66 . . . . 0.0 110.557 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.73 162.6 35.09 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.98 -24.98 67.92 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.678 0.791 . . . . 0.0 112.306 166.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.77 4.91 83.98 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 119.003 -0.887 . . . . 0.0 112.727 173.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -149.39 57.06 1.0 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.163 1.385 . . . . 0.0 109.126 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.3 p -64.61 -20.09 66.07 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.103 1.361 . . . . 0.0 113.101 -173.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -102.6 3.56 37.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -172.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.1 t -116.18 136.21 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 124.916 1.287 . . . . 0.0 108.366 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.07 151.87 26.85 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 125.229 1.412 . . . . 0.0 110.63 -172.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.53 15.38 19.92 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -164.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt 56.3 -167.8 0.11 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.438 1.095 . . . . 0.0 110.589 -163.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 . . . . . 0 C--O 1.236 0.348 0 O-C-N 120.922 -1.111 . . . . 0.0 110.645 -174.135 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 120.746 0.308 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.81 148.59 38.68 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 163.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.7 p -90.68 165.81 13.5 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 159.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 54.46 31.02 13.9 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 127.274 2.23 . . . . 0.0 113.142 170.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.18 153.39 10.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 O-C-N 121.085 -1.009 . . . . 0.0 109.156 175.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.31 174.16 29.78 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 124.465 1.031 . . . . 0.0 110.66 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.92 151.91 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -128.79 163.43 25.22 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.144 0.884 . . . . 0.0 109.094 153.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.01 141.81 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 128.19 2.596 . . . . 0.0 104.12 171.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mt -141.26 135.62 30.82 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.792 2.437 . . . . 0.0 105.455 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.64 -174.4 2.1 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.731 1.15 . . . . 0.0 108.376 169.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.1 ptt85 -58.33 -20.11 40.62 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.6 p -68.42 -10.63 56.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 124.298 1.039 . . . . 0.0 112.001 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.48 6.31 34.04 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 119.256 0.935 . . . . 0.0 112.291 -168.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.94 126.19 33.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.965 1.382 . . . . 0.0 107.314 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.83 151.08 42.18 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.865 0.364 . . . . 0.0 110.718 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.49 145.69 30.55 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.1 m -70.32 157.35 37.9 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.5 mt -104.91 63.71 0.71 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.615 1.566 . . . . 0.0 108.548 -172.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.1 -1.41 6.46 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.669 1.188 . . . . 0.0 113.064 -171.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.32 -1.77 87.47 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.259 -1.301 . . . . 0.0 112.121 170.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -139.82 -28.01 0.76 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.852 1.326 . . . . 0.0 114.3 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.5 m -53.3 146.89 11.18 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.046 1.738 . . . . 0.0 110.638 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -116.73 141.74 47.82 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.015 -1.053 . . . . 0.0 109.065 -166.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.25 79.0 p -86.74 -124.78 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 123.3 0.64 . . . . 0.0 111.295 -170.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.52 21.7 6.03 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.183 1.393 . . . . 0.0 113.828 -169.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 56.91 171.66 0.04 OUTLIER 'General case' 0 N--CA 1.42 -1.931 1 C-N-CA 131.786 4.034 . . . . 0.0 114.307 173.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 m -149.9 134.42 17.48 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 158.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.8 m -88.58 126.28 35.2 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 169.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.651 ' H ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -86.76 179.86 6.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.211 -168.491 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.436 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -156.82 138.93 14.54 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 -171.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -57.48 94.65 0.02 OUTLIER 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.318 1.847 . . . . 0.0 108.567 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.56 -137.86 6.65 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -159.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.5 m -125.2 146.0 49.71 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.854 2.061 . . . . 0.0 107.197 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 0.8 OUTLIER -160.44 154.46 22.98 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.553 1.141 . . . . 0.0 108.811 -179.057 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 29.7 m -144.87 141.41 29.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.179 -165.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.2 mt -104.97 107.48 58.86 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 126.653 1.981 . . . . 0.0 106.149 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -85.65 103.1 0.74 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.502 2.801 . . . . 0.0 112.316 -175.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -81.27 174.66 11.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 122.897 1.332 . . . . 0.0 111.457 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -127.79 126.7 42.23 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 162.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -101.02 138.81 37.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 163.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -150.31 134.96 17.45 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -60.01 143.82 50.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -118.95 115.22 23.9 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.94 142.3 35.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 63.4 p -109.94 23.76 13.94 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.002 1.321 . . . . 0.0 110.095 176.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 148.78 -153.99 25.56 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 107.85 -2.1 . . . . 0.0 107.85 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.38 91.21 0.54 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.704 1.201 . . . . 0.0 109.497 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.43 124.96 21.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.767 0.827 . . . . 0.0 109.306 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.4 p -85.63 154.54 59.02 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -71.95 160.28 48.09 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 120.932 1.088 . . . . 0.0 110.449 169.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.72 -148.72 15.87 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -170.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -91.0 152.49 20.66 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 118.913 1.356 . . . . 0.0 109.036 163.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -136.24 66.14 1.5 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.424 0.69 . . . . 0.0 109.675 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -104.53 151.79 23.17 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 178.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.26 166.48 30.81 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.427 1.091 . . . . 0.0 108.101 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -148.72 140.73 23.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.054 0.93 . . . . 0.0 111.231 174.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.61 156.61 46.6 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.532 2.333 . . . . 0.0 109.283 -171.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 64.5 p -91.33 163.45 14.21 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 117.422 -1.711 . . . . 0.0 108.27 152.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -127.9 153.4 46.7 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 158.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -119.54 175.41 5.86 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.817 0.847 . . . . 0.0 110.541 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 4.4 t -138.4 99.62 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -84.25 100.04 10.95 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.595 1.958 . . . . 0.0 107.825 171.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -73.52 139.46 45.69 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.398 1.094 . . . . 0.0 113.546 167.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -133.98 160.31 38.1 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 129.484 3.114 . . . . 0.0 111.041 -168.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.254 0 CA-C-O 119.089 -0.84 . . . . 0.0 111.047 -177.683 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.722 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 19.6 m -138.4 81.65 1.86 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.238 0.615 . . . . 0.0 109.455 -165.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.1 m -83.06 95.3 8.01 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.156 1.382 . . . . 0.0 109.972 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.8 m -81.72 167.18 2.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 158.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -72.89 154.99 40.34 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.542 -0.723 . . . . 0.0 109.292 164.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.19 -25.57 2.94 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 124.128 0.87 . . . . 0.0 112.944 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 146.26 -163.51 28.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 117.784 0.792 . . . . 0.0 111.647 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.9 m -116.24 136.48 52.97 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 40.2 t -112.56 115.63 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 166.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -97.07 113.13 24.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -87.1 119.48 27.37 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -116.06 166.66 11.75 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 135.5 -173.13 21.88 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 106.264 -2.735 . . . . 0.0 106.264 -171.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.67 170.51 18.34 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -171.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.3 t -120.82 130.1 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 175.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 15.3 m -115.79 146.62 19.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 126.81 2.044 . . . . 0.0 109.046 -177.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.94 27.4 0.09 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -172.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.248 1.024 0 C-N-CA 128.269 2.628 . . . . 0.0 113.793 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.609 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.24 -26.93 31.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 118.411 -0.804 . . . . 0.0 113.016 -169.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.41 153.91 48.26 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.794 1.638 . . . . 0.0 110.063 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.7 93.96 6.27 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.997 2.519 . . . . 0.0 109.526 166.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.4 p -48.46 106.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 125.39 1.476 . . . . 0.0 109.313 158.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -69.23 166.24 18.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.355 1.462 . . . . 0.0 113.008 -161.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.32 -32.31 66.57 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.253 1.021 . . . . 0.0 112.253 171.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.88 7.97 47.08 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.617 1.103 . . . . 0.0 112.882 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.15 -44.67 1.58 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.993 1.717 . . . . 0.0 109.606 -170.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.38 -28.0 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 127.352 2.261 . . . . 0.0 113.693 -168.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -149.39 61.69 1.03 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.613 1.165 . . . . 0.0 108.007 -169.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -104.97 137.5 42.62 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.272 0.629 . . . . 0.0 109.85 -168.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.9 m -108.32 92.84 4.23 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.08 1.352 . . . . 0.0 108.045 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.2 t -78.7 108.34 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 126.328 1.851 . . . . 0.0 107.125 -171.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -91.61 122.82 34.52 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -98.91 -1.02 41.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 122.844 0.457 . . . . 0.0 110.412 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.6 -177.84 33.02 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 126.423 1.963 . . . . 0.0 111.273 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -70.29 138.1 51.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 122.187 -0.596 . . . . 0.0 109.628 158.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.8 t -128.41 146.41 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 124.372 1.069 . . . . 0.0 109.501 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -75.82 127.07 32.24 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 125.832 1.653 . . . . 0.0 107.34 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 p -55.57 -29.03 58.3 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.204 0.602 . . . . 0.0 111.008 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.03 -39.86 72.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.453 1.101 . . . . 0.0 111.577 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 62.1 m -74.23 -0.8 18.04 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.0 mt -134.28 31.52 3.48 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 125.226 1.41 . . . . 0.0 111.827 -160.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.49 13.92 13.58 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -150.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.57 HE21 ' HB2' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -149.61 162.71 39.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 171.011 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -60.32 121.22 11.47 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 164.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.95 -8.58 57.79 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 118.812 -0.993 . . . . 0.0 113.691 -173.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.57 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -67.79 154.52 41.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.835 1.818 . . . . 0.0 110.644 174.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.5 p -147.97 157.25 43.42 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.884 0.766 . . . . 0.0 112.17 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.0 p -72.1 175.17 6.21 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.949 -1.094 . . . . 0.0 111.241 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.0 m -47.63 -27.46 1.89 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.611 1.964 . . . . 0.0 114.591 172.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 81.37 145.93 0.08 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 129.479 3.112 . . . . 0.0 111.06 167.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 m -141.8 130.65 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 C-N-CA 124.113 0.965 . . . . 0.0 109.415 -152.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.25 121.31 6.79 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -174.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -130.82 102.56 6.13 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 118.313 1.056 . . . . 0.0 108.279 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.95 150.83 20.02 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.063 -1.023 . . . . 0.0 111.242 -170.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.0 mm -94.66 98.1 7.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -65.84 126.87 29.84 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.2 mp -133.68 123.06 24.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 129.742 3.217 . . . . 0.0 106.589 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -118.04 154.39 32.11 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.509 1.049 . . . . 0.0 113.434 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 t70 65.92 37.41 5.46 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.094 1.758 . . . . 0.0 114.104 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 97.9 m -68.97 104.36 2.07 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.012 1.325 . . . . 0.0 108.798 -174.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -81.87 137.17 35.28 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.174 0.99 . . . . 0.0 109.593 174.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.5 p -83.0 -17.87 41.86 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -65.44 -42.63 92.2 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.319 1.048 . . . . 0.0 110.364 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.402 ' H ' HG12 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -68.02 -54.56 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 125.87 1.668 . . . . 0.0 106.705 -176.103 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.21 158.46 43.94 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.9 m -115.2 3.6 14.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.745 0.702 . . . . 0.0 111.804 168.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -128.87 149.39 50.79 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.277 1.431 . . . . 0.0 109.28 171.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.63 153.13 33.82 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.412 1.085 . . . . 0.0 108.457 165.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.89 -178.18 5.14 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.825 1.65 . . . . 0.0 106.779 157.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -153.78 141.02 12.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 -164.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.23 152.65 51.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 119.957 1.253 . . . . 0.0 108.678 175.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -114.55 153.61 29.75 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.438 0.695 . . . . 0.0 110.081 -175.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 tp -148.3 143.07 26.67 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.614 1.166 . . . . 0.0 107.996 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.81 173.35 35.05 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 108.104 -1.998 . . . . 0.0 108.104 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 m -59.88 121.88 12.85 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.513 1.125 . . . . 0.0 110.359 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.8 138.44 52.69 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.425 0.557 . . . . 0.0 110.413 172.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.0 tt -64.35 -31.12 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.576 0.75 . . . . 0.0 110.937 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -160.71 168.64 24.43 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.639 1.576 . . . . 0.0 107.441 165.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.36 -36.24 66.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.629 1.172 . . . . 0.0 111.311 166.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.29 -2.91 64.07 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 120.792 -1.193 . . . . 0.0 112.998 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -149.93 55.47 0.94 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.298 1.439 . . . . 0.0 109.716 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.6 p -69.43 -6.84 32.88 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.44 1.096 . . . . 0.0 111.886 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -85.89 3.54 41.37 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.931 1.293 . . . . 0.0 112.655 170.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.65 143.04 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.934 1.243 . . . . 0.0 111.63 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.02 151.26 28.5 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.954 1.301 . . . . 0.0 111.237 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.12 14.72 10.13 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 127.477 2.311 . . . . 0.0 114.059 -169.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 71.5 mt 55.26 -157.65 0.22 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.167 1.387 . . . . 0.0 111.227 -166.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 . . . . . 0 CA--C 1.539 0.546 0 C-N-CA 128.732 2.813 . . . . 0.0 107.748 178.086 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.831 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.98 131.55 45.0 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.484 1.114 . . . . 0.0 109.697 174.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.4 p -85.39 169.42 13.7 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 58.5 14.65 3.11 Favored 'General case' 0 C--N 1.335 -0.04 0 C-N-CA 126.247 1.819 . . . . 0.0 112.712 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.26 156.68 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 119.927 1.24 . . . . 0.0 107.819 -174.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -165.14 168.16 39.12 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -168.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.9 t -90.56 112.66 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -82.06 153.84 25.93 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.363 0.983 . . . . 0.0 108.52 160.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 mp -125.54 136.33 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 166.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.0 mt -136.54 143.93 43.96 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.645 1.178 . . . . 0.0 107.838 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 106' ' ' ARG . 24.5 p-10 -54.06 -74.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.278 1.431 . . . . 0.0 113.204 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.497 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 37.0 ptt85 179.61 -47.45 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 127.781 2.432 . . . . 0.0 107.994 -163.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 p -68.04 -29.12 68.02 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.169 0.895 . . . . 0.0 109.784 172.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.76 9.96 27.59 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.815 1.198 . . . . 0.0 111.176 -169.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.69 110.67 0.93 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 163.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.89 125.88 33.01 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.75 150.22 23.06 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -167.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -82.31 146.61 29.33 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.344 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.6 mt -88.16 61.87 6.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.844 0.858 . . . . 0.0 108.87 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.26 -15.16 14.55 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.063 1.345 . . . . 0.0 112.27 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.18 -7.38 60.51 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 125.872 1.701 . . . . 0.0 114.476 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.46 -6.36 5.84 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.158 1.479 . . . . 0.0 112.877 172.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.9 m -65.15 94.41 0.15 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.692 1.133 . . . . 0.0 108.623 171.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -67.51 131.65 46.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.786 1.235 . . . . 0.0 109.14 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.8 p -72.19 168.29 18.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.135 0.493 . . . . 0.0 110.906 170.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.2 m -26.37 113.85 0.05 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.527 2.331 . . . . 0.0 112.569 155.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -66.45 155.11 38.44 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 122.248 1.023 . . . . 0.0 108.74 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 98.6 m -127.12 112.99 15.81 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 169.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.7 m -58.06 126.25 26.63 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 167.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.8 mt -98.73 -177.88 3.8 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 124.745 1.218 . . . . 0.0 108.679 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -147.53 169.69 19.03 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.805 1.642 . . . . 0.0 108.327 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -65.22 104.49 0.93 Allowed 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.852 0.72 . . . . 0.0 109.551 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.08 -160.8 26.8 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 124.643 1.116 . . . . 0.0 111.3 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 93.3 m -90.53 134.08 34.62 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.31 -1.112 . . . . 0.0 108.828 -179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -146.2 154.56 41.89 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.152 1.381 . . . . 0.0 110.418 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.1 m -137.49 144.23 42.12 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.928 0.871 . . . . 0.0 109.987 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.9 mt -104.72 118.35 56.62 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -65.14 157.02 59.65 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.349 1.366 . . . . 0.0 108.646 171.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -136.52 157.14 47.47 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 153.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -119.76 94.67 4.48 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.11 156.2 28.4 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 167.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -161.93 153.76 18.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 166.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -63.73 130.5 44.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 163.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -103.19 151.52 22.53 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 163.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -115.67 137.79 51.73 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.593 0.757 . . . . 0.0 109.736 173.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 69.5 p -96.86 14.06 26.57 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.976 0.91 . . . . 0.0 111.034 170.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 169.5 -153.89 22.68 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.49 93.08 0.47 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.259 1.024 . . . . 0.0 110.157 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.06 119.07 5.3 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 44.3 p -76.65 163.62 64.67 Favored Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 165.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -74.73 172.71 15.71 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.118 1.212 . . . . 0.0 111.007 168.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.69 179.72 16.29 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 124.756 1.169 . . . . 0.0 111.283 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.9 140.67 58.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -132.9 73.34 1.52 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -115.5 158.7 22.2 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.97 160.48 37.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.69 0.677 . . . . 0.0 109.413 175.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -133.38 116.21 15.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.34 1.067 . . . . 0.0 110.233 -170.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.01 164.69 19.62 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.416 1.486 . . . . 0.0 111.22 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.9 p -119.21 157.08 28.7 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 155.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -115.91 146.68 41.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.522 1.129 . . . . 0.0 109.195 167.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -104.57 171.28 7.42 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.041 1.737 . . . . 0.0 108.316 168.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.4 t -129.2 128.21 66.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -130.52 84.48 2.2 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.478 1.111 . . . . 0.0 109.54 -172.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -70.12 151.98 44.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.562 -1.199 . . . . 0.0 112.242 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -161.64 174.3 13.51 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.42 1.488 . . . . 0.0 111.849 169.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.271 0 C-N-CA 125.405 1.479 . . . . 0.0 110.136 174.492 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 40.4 m -122.14 90.75 3.36 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -176.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.5 m -82.37 120.53 25.55 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.6 m -130.47 158.32 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.812 1.645 . . . . 0.0 109.415 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -79.28 143.02 35.64 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.097 -1.002 . . . . 0.0 108.984 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -105.21 -73.0 0.88 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -175.75 -174.21 42.12 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.884 0.342 . . . . 0.0 113.01 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.4 m -100.87 141.8 33.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.912 2.085 . . . . 0.0 108.635 -177.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.65 104.42 12.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -96.14 96.98 9.19 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 -176.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -73.19 127.09 31.63 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 176.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -128.68 156.57 43.25 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.552 0.741 . . . . 0.0 111.636 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 142.37 -160.07 27.22 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -163.72 169.2 18.76 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.833 0.853 . . . . 0.0 108.97 -175.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 75.3 t -116.79 124.51 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 171.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.411 ' C ' ' H ' ' A' ' 184' ' ' ALA . 6.3 m -103.58 153.33 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 127.026 2.13 . . . . 0.0 108.782 174.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.04 25.67 0.09 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -168.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.25 1.121 1 C-N-CA 132.117 4.167 . . . . 0.0 114.544 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.41 -28.65 30.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.286 1.034 . . . . 0.0 113.745 -170.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.9 m -131.19 151.93 50.98 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.502 1.921 . . . . 0.0 108.071 -171.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.32 -10.56 51.93 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -169.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.323 14.2 p 45.9 97.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 129.36 3.064 . . . . 0.0 112.911 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -50.58 141.08 13.08 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.575 1.95 . . . . 0.0 110.719 -172.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.632 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . . . -59.5 -9.94 2.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.295 1.838 . . . . 0.0 111.945 -176.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.64 -7.41 88.16 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.115 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.8 p -124.13 -33.05 3.15 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.692 1.746 . . . . 0.0 112.18 -164.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.632 ' CG2' ' HA ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -52.48 -78.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 127.84 2.456 . . . . 0.0 109.924 166.138 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.507 ' CG ' ' HE2' ' A' ' 176' ' ' HIS . 10.5 t70 -95.53 83.1 3.73 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -114.15 142.53 46.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.286 1.041 . . . . 0.0 108.92 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.5 m -105.06 88.77 2.95 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.6 t -69.39 98.51 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 174.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -72.42 103.09 3.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.3 mt -70.58 -15.59 62.77 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.899 0.88 . . . . 0.0 109.329 169.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.83 -175.93 49.55 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 124.599 1.095 . . . . 0.0 112.138 170.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.49 143.6 56.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 162.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.8 t -133.59 148.83 30.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 124.96 1.304 . . . . 0.0 107.674 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 28.2 mtm105 -79.14 132.87 36.7 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.4 p -55.14 -24.25 25.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.609 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.25 -48.44 68.23 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.649 0.779 . . . . 0.0 110.141 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.54 3.61 5.96 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.0 mt -146.22 66.18 1.19 Allowed 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.679 1.592 . . . . 0.0 107.446 -166.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.13 -2.25 3.19 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -170.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -146.92 151.79 37.61 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.998 1.319 . . . . 0.0 107.751 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -64.38 120.77 12.87 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.2 1.45 61.04 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-O 117.364 -1.798 . . . . 0.0 112.481 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.53 163.54 18.42 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 120.055 1.928 . . . . 0.0 110.122 169.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.1 p -146.74 155.12 42.15 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 122.014 -0.429 . . . . 0.0 110.472 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 84.8 p -68.22 178.64 1.83 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 164.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.0 p -30.89 -92.59 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 129.697 3.199 . . . . 0.0 114.633 173.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 154.11 113.22 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 131.284 3.834 . . . . 0.0 105.46 -172.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.28 105.25 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -173.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.21 154.71 44.87 Favored Glycine 0 C--N 1.311 -0.843 0 CA-C-N 112.45 -2.159 . . . . 0.0 110.721 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -152.58 176.6 11.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.242 1.817 . . . . 0.0 107.172 171.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.405 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 11.8 p-10 -143.0 163.18 33.49 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 120.885 -1.134 . . . . 0.0 110.6 177.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.9 mm -117.79 108.06 23.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -81.22 103.72 11.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.806 0.842 . . . . 0.0 109.312 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.9 mp -99.23 93.03 5.73 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -84.48 167.6 16.24 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.202 1.401 . . . . 0.0 109.094 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.32 31.06 17.89 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.162 0.985 . . . . 0.0 110.853 173.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 80.3 m -69.3 148.24 50.01 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.982 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -120.23 152.42 37.76 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 163.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 p -94.58 -20.84 19.26 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.62 -43.62 84.23 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.96 0.886 . . . . 0.0 110.555 -177.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.415 ' H ' HG13 ' A' ' 65' ' ' VAL . 1.9 p -56.2 -52.92 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.647 1.579 . . . . 0.0 108.027 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.63 133.61 4.91 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 128.083 2.553 . . . . 0.0 104.773 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.3 m -87.81 -5.13 58.77 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.846 0.748 . . . . 0.0 111.805 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -128.3 164.29 22.93 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.089 1.356 . . . . 0.0 109.853 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.63 160.72 34.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 164.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.65 168.28 20.18 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 158.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.3 t -122.15 142.77 37.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.84 162.26 19.42 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 169.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -134.99 149.11 50.14 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.077 0.951 . . . . 0.0 109.191 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 tp -143.67 151.53 40.21 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.2 169.69 36.62 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.3 m -66.28 126.84 30.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.246 1.023 . . . . 0.0 109.157 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.14 137.06 50.75 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.996 -0.44 . . . . 0.0 110.637 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.0 tt -59.78 -40.25 82.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 123.354 0.662 . . . . 0.0 110.285 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -152.09 167.9 26.99 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 127.13 2.172 . . . . 0.0 107.765 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.28 -40.08 95.24 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.564 1.546 . . . . 0.0 112.117 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.98 3.9 48.96 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.268 -0.74 . . . . 0.0 112.234 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -142.89 41.1 1.54 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.053 1.426 . . . . 0.0 110.67 -172.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.3 p -67.68 -6.31 20.01 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.875 -1.141 . . . . 0.0 113.317 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.78 -16.39 59.48 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.612 -1.305 . . . . 0.0 111.811 166.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.48 129.61 74.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 120.478 -1.389 . . . . 0.0 108.62 -160.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 mt -77.15 149.83 35.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.87 0.759 . . . . 0.0 111.504 -172.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.42 22.0 3.12 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.829 1.652 . . . . 0.0 113.494 -173.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.6 mt 49.7 -146.44 0.38 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.827 0.851 . . . . 0.0 109.067 -170.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 . . . . . 0 N--CA 1.451 -0.375 0 C-N-CA 126.042 1.737 . . . . 0.0 108.067 176.577 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 59.4 m . . . . . 0 N--CA 1.45 -0.431 0 CA-C-O 123.098 1.428 . . . . 0.0 114.504 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.77 113.66 3.16 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 125.281 1.432 . . . . 0.0 107.933 170.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.28 165.61 24.25 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.66 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 55.31 24.15 6.24 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.261 1.425 . . . . 0.0 113.162 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.2 p -145.0 151.6 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.24 175.43 27.54 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 173.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.405 HG21 ' CD2' ' A' ' 177' ' ' PHE . 1.2 m -86.71 155.44 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 118.653 1.227 . . . . 0.0 108.384 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -124.52 147.01 48.66 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 170.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.8 mp -117.02 135.82 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 169.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 9.9 mt -126.41 159.48 33.17 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 128.408 2.683 . . . . 0.0 107.109 174.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' A' ' 106' ' ' ARG . 34.8 p30 -73.11 -106.37 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 123.956 0.785 . . . . 0.0 109.437 171.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.435 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 15.3 ptm180 -149.26 3.81 0.6 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.895 2.078 . . . . 0.0 110.624 -169.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.4 p -123.64 7.31 8.84 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.115 1.366 . . . . 0.0 109.493 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.09 1.89 90.19 Favored Glycine 0 C--N 1.342 0.861 0 C-N-CA 127.22 2.343 . . . . 0.0 114.27 -172.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.13 122.77 20.07 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 119.468 1.634 . . . . 0.0 107.917 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -87.29 147.4 25.54 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.034 0.533 . . . . 0.0 110.419 176.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.8 138.85 46.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.707 -173.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 m -69.62 147.31 50.85 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.73 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.9 mt -79.86 69.54 6.22 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.612 1.565 . . . . 0.0 108.303 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.51 -13.87 13.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.51 0.724 . . . . 0.0 111.242 174.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.419 ' O ' ' HE3' ' A' ' 155' ' ' LYS . . . 75.09 -9.03 13.27 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 120.626 -1.296 . . . . 0.0 113.278 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.54 -12.91 7.17 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.145 1.378 . . . . 0.0 111.272 174.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 92.3 m -76.77 90.91 3.46 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -72.71 172.84 9.96 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.322 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.3 p -120.7 -176.12 3.18 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.668 1.587 . . . . 0.0 110.036 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -33.46 111.52 0.11 Allowed 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 126.082 1.753 . . . . 0.0 111.328 169.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.99 155.8 38.7 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.5 m -151.72 114.95 4.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.7 m -58.52 133.2 55.6 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.528 1.931 . . . . 0.0 108.344 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.5 mt -86.57 178.54 7.04 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.302 1.441 . . . . 0.0 108.831 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.432 ' ND2' HD22 ' A' ' 129' ' ' ASN . 0.5 OUTLIER -135.45 170.3 16.16 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.62 1.968 . . . . 0.0 107.067 156.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.73 128.2 35.0 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 166.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.09 -168.24 22.09 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -171.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 90.6 m -83.33 139.91 32.76 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 120.776 -1.426 . . . . 0.0 111.806 -166.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.432 HD22 ' ND2' ' A' ' 125' ' ' ASN . 26.3 m-80 -139.34 168.22 20.32 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 128.678 2.791 . . . . 0.0 109.37 -173.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.405 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 85.0 m -155.47 158.9 39.29 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 120.347 -1.47 . . . . 0.0 110.369 176.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.4 mt -131.93 112.79 14.83 Favored Pre-proline 0 C--O 1.24 0.603 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.72 150.0 38.94 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.598 1.532 . . . . 0.0 108.348 170.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -128.4 165.74 20.05 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.534 1.934 . . . . 0.0 108.59 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -133.26 113.28 12.46 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 121.453 -0.78 . . . . 0.0 108.909 172.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -94.83 170.36 9.5 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.819 0.819 . . . . 0.0 109.263 173.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -160.68 179.55 8.46 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.036 1.334 . . . . 0.0 108.909 167.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -91.45 149.41 21.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 153.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -122.5 124.84 44.5 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.835 2.054 . . . . 0.0 106.365 173.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.92 145.73 25.35 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 54.1 p -108.58 10.36 27.13 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 125.525 1.53 . . . . 0.0 111.168 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 161.65 -151.69 21.94 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.38 91.44 0.26 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.548 1.939 . . . . 0.0 109.935 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.19 157.06 20.18 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.022 0.439 . . . . 0.0 110.942 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 77.0 p -112.06 158.16 37.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 170.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -78.65 162.01 27.48 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.025 1.817 . . . . 0.0 110.636 165.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.39 -76.12 0.18 Allowed Glycine 0 N--CA 1.462 0.373 0 O-C-N 121.391 -0.818 . . . . 0.0 113.922 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -158.93 155.42 27.63 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.339 1.856 . . . . 0.0 106.874 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.98 91.04 1.74 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -125.73 135.44 52.07 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -146.19 167.19 24.07 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 165.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.49 111.05 6.78 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 167.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.82 169.87 17.56 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 162.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.8 p -116.2 151.98 34.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 153.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -114.71 132.12 56.53 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.201 0.601 . . . . 0.0 109.502 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 115' ' ' GLY . 29.2 mtmt -97.28 171.2 8.58 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.97 0.908 . . . . 0.0 109.199 167.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.1 t -133.1 118.63 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 -172.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -105.55 83.64 1.97 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -62.2 150.78 37.93 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.775 0.83 . . . . 0.0 108.936 168.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -167.94 169.84 11.04 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 123.289 0.636 . . . . 0.0 110.779 -174.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 177.474 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.629 0 CA-C-O 121.067 0.46 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.6 m -133.14 119.47 19.98 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.343 2.257 . . . . 0.0 106.799 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 m -114.52 123.9 50.54 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.469 1.108 . . . . 0.0 109.152 -169.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.2 m -143.49 150.91 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 123.975 0.91 . . . . 0.0 110.988 -168.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.07 132.25 48.1 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.627 1.571 . . . . 0.0 109.274 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -101.36 -78.54 1.34 Allowed Glycine 0 CA--C 1.519 0.344 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -173.95 -170.54 37.44 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.905 0.764 . . . . 0.0 111.772 -170.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 28.3 m -114.15 120.83 41.84 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.736 1.614 . . . . 0.0 110.989 -170.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.5 t -104.94 96.9 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' HIS . . . . . 0.507 ' HE2' ' CG ' ' A' ' 29' ' ' ASP . 42.6 m-70 -80.81 94.82 6.51 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.405 ' CD2' HG21 ' A' ' 101' ' ' VAL . 58.9 m-85 -76.91 85.49 3.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -93.86 165.7 12.55 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.623 0.769 . . . . 0.0 109.518 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 147.7 -161.96 28.62 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -170.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -170.25 174.77 5.18 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 75.4 t -123.19 138.28 53.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 171.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 6.8 m -116.61 149.22 18.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 126.008 1.723 . . . . 0.0 109.08 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.77 33.08 0.14 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -171.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 C-N-CA 128.454 2.702 . . . . 0.0 112.019 175.217 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 118.343 -0.837 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -42.51 -42.78 3.44 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.001 1.32 . . . . 0.0 113.17 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.3 m 47.69 65.41 1.29 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.467 1.507 . . . . 0.0 110.538 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.5 t -146.12 168.51 20.78 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.577 0.751 . . . . 0.0 109.09 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.7 t 70.21 147.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 127.423 2.289 . . . . 0.0 111.157 173.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -71.94 -45.09 62.39 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.256 -173.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 143.05 84.84 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 107.219 -2.353 . . . . 0.0 107.219 -175.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.77 165.82 10.42 Favored Glycine 0 N--CA 1.44 -1.079 0 N-CA-C 106.42 -2.672 . . . . 0.0 106.42 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.41 91.83 5.14 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 172.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 t 45.43 71.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.812 1.245 . . . . 0.0 110.426 157.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -85.5 50.97 2.06 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.304 -0.873 . . . . 0.0 109.214 -168.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -156.66 118.05 3.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -135.38 54.73 1.91 Allowed 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.419 1.088 . . . . 0.0 109.911 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.87 -47.23 76.82 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -129.94 -154.6 0.64 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.832 1.253 . . . . 0.0 109.671 -164.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.59 70.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 127.574 2.349 . . . . 0.0 110.706 172.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -76.11 58.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 120.446 -1.409 . . . . 0.0 110.559 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -129.89 95.6 4.0 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.848 1.259 . . . . 0.0 109.978 170.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.74 114.71 13.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.29 -34.92 16.56 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 126.587 1.955 . . . . 0.0 111.189 -173.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.8 m -125.76 146.51 49.74 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 127.376 2.27 . . . . 0.0 107.649 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.93 1.81 55.31 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -163.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.307 13.7 p 49.54 113.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 129.81 3.244 . . . . 0.0 114.275 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -53.0 141.78 21.41 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.423 1.089 . . . . 0.0 110.736 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.08 -39.12 55.31 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.768 1.227 . . . . 0.0 109.643 171.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.19 13.84 1.84 Allowed Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.799 -1.0 . . . . 0.0 114.522 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 t -144.63 -36.69 0.31 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.665 1.586 . . . . 0.0 111.515 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.08 -49.87 80.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.424 0 CA-C-N 119.698 1.135 . . . . 0.0 109.095 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -121.94 75.52 1.22 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -171.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -105.68 138.21 42.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.388 -169.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 m -106.87 99.93 9.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.5 t -86.33 101.22 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -92.12 98.42 11.53 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -174.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.5 mt -75.94 -7.28 54.2 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.304 2.242 . . . . 0.0 109.883 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.54 -172.64 27.3 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 124.108 0.861 . . . . 0.0 111.734 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -77.67 142.39 38.85 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.943 0.878 . . . . 0.0 110.915 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.7 t -124.01 150.77 28.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 125.538 1.535 . . . . 0.0 108.095 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.92 137.66 32.98 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.0 p -60.39 -21.79 62.59 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 122.931 0.492 . . . . 0.0 112.253 171.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.47 -48.78 47.48 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-O 122.439 1.114 . . . . 0.0 111.312 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.2 m -79.19 5.87 11.1 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.221 1.008 . . . . 0.0 113.448 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.7 mt -142.65 72.08 1.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.696 1.998 . . . . 0.0 107.114 -170.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.72 -7.19 1.68 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -171.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -145.51 162.82 36.49 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.651 1.18 . . . . 0.0 108.056 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -62.65 117.84 6.82 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 173.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.441 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 106.6 -10.33 41.84 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-O 118.305 -1.275 . . . . 0.0 112.471 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.34 147.69 52.0 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.809 1.305 . . . . 0.0 109.432 171.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.1 p -143.72 155.62 44.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.528 0.68 . . . . 0.0 111.736 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.4 p -66.7 -177.69 0.62 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.388 0.675 . . . . 0.0 110.56 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -59.56 -22.32 61.56 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 119.56 -1.962 . . . . 0.0 113.397 171.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 74.07 164.83 0.28 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 127.335 2.254 . . . . 0.0 110.782 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.2 t -149.2 142.63 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.17 125.3 8.3 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -115.6 158.52 22.56 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 170.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.428 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 2.7 m-20 -131.14 173.9 10.57 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.085 0.857 . . . . 0.0 110.808 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.9 mm -121.57 109.84 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.602 1.161 . . . . 0.0 107.935 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.36 109.38 17.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.539 1.936 . . . . 0.0 109.5 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.66 106.61 17.22 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 127.218 2.207 . . . . 0.0 108.507 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -87.05 158.55 19.19 Favored 'General case' 0 CA--C 1.523 -0.085 0 C-N-CA 124.539 1.135 . . . . 0.0 110.667 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 32.98 57.75 0.45 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.269 2.628 . . . . 0.0 113.145 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.9 m -64.36 142.3 58.47 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 125.705 1.602 . . . . 0.0 110.602 168.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -120.32 132.48 55.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 127.305 2.242 . . . . 0.0 108.73 171.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.7 p -92.74 -9.43 40.67 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -67.32 -47.66 69.86 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.036 0.834 . . . . 0.0 109.871 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 p -65.14 -49.1 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.237 -177.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.67 114.04 2.6 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.44 1.896 . . . . 0.0 108.294 -170.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.8 m -76.75 -2.24 32.09 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.711 169.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -137.6 164.69 28.16 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.986 1.721 . . . . 0.0 112.03 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.96 140.35 26.84 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.64 166.09 13.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.537 1.935 . . . . 0.0 106.292 163.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 t -125.71 157.89 34.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.57 167.64 19.67 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 164.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -130.82 155.86 45.98 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.549 1.54 . . . . 0.0 109.94 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 tp -150.79 134.04 16.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.909 0.484 . . . . 0.0 111.192 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.6 172.67 42.53 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.124 0.869 . . . . 0.0 111.325 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 m -55.39 125.79 22.35 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.494 1.117 . . . . 0.0 108.347 171.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.55 139.83 44.02 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.424 1.011 . . . . 0.0 108.666 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.1 tt -57.06 -39.39 66.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.032 0.533 . . . . 0.0 111.112 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -160.59 177.75 10.2 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.672 1.589 . . . . 0.0 108.025 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.93 -37.77 79.1 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.396 0.678 . . . . 0.0 111.549 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.06 5.26 55.01 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.622 0.63 . . . . 0.0 111.966 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -146.91 50.47 1.11 Allowed 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.146 -1.208 . . . . 0.0 110.1 -171.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.5 p -67.03 -8.87 33.37 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.355 1.462 . . . . 0.0 111.749 171.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -81.77 -11.92 58.79 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 167.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.8 t -125.83 136.3 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 121.308 1.867 . . . . 0.0 109.964 -161.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.85 156.01 30.66 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 118.923 0.783 . . . . 0.0 111.737 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.58 19.3 10.02 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.485 1.514 . . . . 0.0 113.866 -171.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.3 mt 55.19 -156.87 0.23 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.943 0.897 . . . . 0.0 109.902 -165.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -152.14 -176.94 5.88 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.733 1.613 . . . . 0.0 108.659 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t 67.58 -143.99 0.13 Allowed 'General case' 0 C--N 1.339 0.136 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 93' ' ' ALA . 19.7 m -46.15 86.07 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.916 2.086 . . . . 0.0 112.297 169.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.5 7.77 0.21 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.258 1.023 . . . . 0.0 112.946 161.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 91' ' ' SER . . . -133.35 18.1 4.01 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 126.079 1.752 . . . . 0.0 110.516 175.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -153.95 -26.56 0.04 OUTLIER Glycine 0 CA--C 1.531 1.047 0 CA-C-N 119.444 1.02 . . . . 0.0 113.961 -176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.7 m -60.43 175.06 0.48 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 122.501 1.143 . . . . 0.0 109.536 162.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.19 153.97 24.61 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.611 -0.681 . . . . 0.0 109.292 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.0 p -115.85 164.69 14.03 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.906 0.882 . . . . 0.0 109.194 170.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 57.05 20.82 5.76 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.928 1.691 . . . . 0.0 111.889 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -138.4 152.04 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.46 177.94 28.22 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.408 HG23 ' CD2' ' A' ' 177' ' ' PHE . 0.7 OUTLIER -90.48 155.05 3.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.392 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -126.45 167.52 15.47 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 120.744 -1.223 . . . . 0.0 110.558 158.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.12 130.59 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 127.428 2.291 . . . . 0.0 105.33 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.0 mt -122.19 140.81 52.14 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -62.68 171.55 2.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 122.216 1.008 . . . . 0.0 110.252 164.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -53.22 -25.82 15.45 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.462 1.505 . . . . 0.0 113.966 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.1 p -75.13 -23.76 57.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 119.677 1.126 . . . . 0.0 108.974 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.72 6.44 40.61 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.504 2.002 . . . . 0.0 112.708 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.52 131.33 34.39 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.247 1.524 . . . . 0.0 109.31 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.88 120.0 14.96 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.903 1.281 . . . . 0.0 111.701 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.0 mt -78.76 157.42 28.49 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.341 0.656 . . . . 0.0 109.756 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 m -100.69 144.97 29.03 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.426 1.09 . . . . 0.0 109.545 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.5 mt -89.22 70.79 8.29 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.454 1.102 . . . . 0.0 108.743 -173.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.55 -9.84 11.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.301 0.64 . . . . 0.0 112.316 174.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.02 -9.56 31.39 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.743 -1.032 . . . . 0.0 112.871 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.33 -8.34 5.82 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.087 1.355 . . . . 0.0 113.083 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.0 m -67.16 91.48 0.23 Allowed 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 168.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -64.89 164.2 12.96 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.795 0.838 . . . . 0.0 109.609 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 57.9 p -133.58 -175.93 3.98 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.662 1.185 . . . . 0.0 110.888 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -32.36 112.89 0.12 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 128.105 2.562 . . . . 0.0 112.431 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -73.26 108.58 6.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 88.4 m -81.95 113.3 19.76 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 167.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 93.8 m -57.95 121.0 9.52 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 160.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 99.0 mt -77.16 -170.06 1.57 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.393 1.477 . . . . 0.0 109.694 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.64 161.46 42.64 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 127.167 2.187 . . . . 0.0 107.593 168.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -64.49 140.19 58.84 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 170.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.25 -111.22 4.12 Favored Glycine 0 N--CA 1.467 0.704 0 CA-C-O 118.148 -1.362 . . . . 0.0 111.54 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 m -125.33 139.88 53.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.322 2.061 . . . . 0.0 110.488 -171.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -142.32 151.97 42.48 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 124.313 1.045 . . . . 0.0 109.959 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.428 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 97.1 m -132.72 124.22 27.74 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.017 0.527 . . . . 0.0 109.902 170.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.0 116.02 64.12 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 166.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.98 155.99 34.15 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.895 1.73 . . . . 0.0 110.51 166.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -139.1 172.69 12.47 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 127.743 2.417 . . . . 0.0 108.263 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.99 155.97 34.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 162.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -137.6 149.35 46.57 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.705 1.202 . . . . 0.0 108.014 171.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -161.04 153.68 20.73 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -70.02 133.32 47.11 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.441 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 60.8 t80 -113.11 124.82 53.47 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.384 1.474 . . . . 0.0 107.85 176.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.43 141.65 29.81 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 170.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.4 p -105.48 11.19 32.83 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.862 0.465 . . . . 0.0 111.258 172.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.22 -153.8 23.63 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.54 93.65 0.05 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.94 1.696 . . . . 0.0 109.893 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.82 170.01 13.43 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 122.976 0.511 . . . . 0.0 111.443 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.8 p -136.49 159.19 71.51 Favored Pre-proline 0 N--CA 1.467 0.386 0 C-N-CA 123.441 0.696 . . . . 0.0 110.528 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -75.12 177.08 9.08 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.63 1.554 . . . . 0.0 110.434 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.01 -95.84 0.17 Allowed Glycine 0 CA--C 1.522 0.494 0 O-C-N 121.606 -0.684 . . . . 0.0 111.695 168.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.03 157.36 45.43 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.884 1.674 . . . . 0.0 107.189 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -146.51 66.41 1.18 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.592 0.71 . . . . 0.0 110.612 -176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -108.45 150.95 26.71 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.28 163.03 40.27 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.616 1.566 . . . . 0.0 109.161 170.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -138.95 96.35 3.11 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.27 167.66 20.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.492 166.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.2 p -106.88 164.84 11.78 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 147.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -122.35 157.38 31.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 168.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -117.49 166.66 12.1 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.609 1.564 . . . . 0.0 108.595 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 8.5 t -127.86 106.65 15.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.454 HE21 ' NE2' ' A' ' 159' ' ' GLN . 40.8 tt0 -88.1 92.64 9.22 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 167.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -63.42 153.97 33.57 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 163.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.454 ' NE2' HE21 ' A' ' 157' ' ' GLN . 11.9 pt20 -160.84 170.46 20.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.208 0.603 . . . . 0.0 110.662 168.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.59 50.95 2.07 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-O 118.251 -1.305 . . . . 0.0 111.784 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -109.27 -1.57 31.35 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 117.847 0.824 . . . . 0.0 114.232 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.65 171.12 12.84 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.776 1.655 . . . . 0.0 110.872 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.79 -51.47 4.04 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.517 1.532 . . . . 0.0 112.146 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 151.35 -25.22 0.97 Allowed Glycine 0 C--N 1.334 0.428 0 CA-C-N 118.496 1.148 . . . . 0.0 114.718 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -124.34 -83.16 0.56 Allowed Glycine 0 C--N 1.329 0.174 0 N-CA-C 107.2 -2.36 . . . . 0.0 107.2 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 46.71 98.99 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 129.513 3.125 . . . . 0.0 113.156 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -130.06 153.71 48.18 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.154 1.382 . . . . 0.0 110.946 -170.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 87.2 m -142.61 108.49 5.16 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.59 1.956 . . . . 0.0 107.647 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 15.5 m -97.0 94.04 6.95 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.789 0.836 . . . . 0.0 110.15 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -85.32 168.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 124.121 0.968 . . . . 0.0 110.018 168.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -63.62 174.97 1.18 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.056 0.542 . . . . 0.0 109.688 160.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -144.64 -34.17 0.08 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-O 117.817 -1.546 . . . . 0.0 114.416 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 147.58 -176.8 26.25 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 119.412 1.606 . . . . 0.0 112.67 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.1 m -101.34 140.05 36.16 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.291 1.836 . . . . 0.0 108.908 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.56 96.48 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -83.42 88.49 6.98 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.408 ' CD2' HG23 ' A' ' 101' ' ' VAL . 58.8 m-85 -66.19 113.06 4.26 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 170.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -120.42 161.6 20.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 135.88 -174.19 21.49 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -170.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -161.51 172.14 16.92 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -168.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 39.2 t -124.93 133.45 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.4 m -112.61 148.19 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 C-N-CA 127.113 2.165 . . . . 0.0 108.365 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.77 31.23 0.09 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.686 2.395 . . . . 0.0 112.429 -170.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 127.856 2.463 . . . . 0.0 110.028 -165.488 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.63 87.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.822 0.737 . . . . 0.0 112.229 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . 0.383 13.5 t 46.95 -157.54 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.428 1.491 . . . . 0.0 109.991 -162.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.1 p 24.24 82.74 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.687 2.395 . . . . 0.0 115.367 159.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.8 p -155.79 121.31 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 119.429 1.013 . . . . 0.0 108.586 170.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 24.52 84.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 130.416 3.487 . . . . 0.0 113.337 173.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.87 -102.46 1.33 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 106.109 -2.796 . . . . 0.0 106.109 -162.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.07 60.99 0.22 Allowed Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 117.185 -1.897 . . . . 0.0 110.173 176.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.256 1.7 t 45.54 100.37 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 128.766 2.826 . . . . 0.0 111.977 -173.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.256 1.3 m 54.56 21.08 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.257 1.423 . . . . 0.0 113.789 166.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.8 p80 40.73 61.99 1.51 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.969 2.108 . . . . 0.0 113.194 -162.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -142.58 87.99 2.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 104.81 -2.292 . . . . 0.0 104.81 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -133.49 98.05 4.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.63 8.07 0.06 OUTLIER Glycine 0 CA--C 1.529 0.912 0 C-N-CA 123.282 0.467 . . . . 0.0 113.651 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -140.62 -153.65 0.47 Allowed 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.8 p -56.13 -39.97 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 119.6 1.091 . . . . 0.0 110.129 159.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m 37.18 49.59 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 126.981 2.112 . . . . 0.0 111.685 -171.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -139.25 144.0 38.23 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 160.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -173.34 137.77 0.68 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 128.766 2.827 . . . . 0.0 104.375 159.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.7 -18.04 61.05 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -172.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.0 m -133.77 160.04 38.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.15 109.45 19.91 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.621 1.568 . . . . 0.0 107.867 161.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -50.15 125.86 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 152.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.68 151.77 40.93 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.713 0.688 . . . . 0.0 109.698 174.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.75 -29.26 53.3 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 120.952 -1.092 . . . . 0.0 112.396 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.38 -50.48 66.36 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 123.91 0.767 . . . . 0.0 111.26 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.0 m -72.03 -27.05 62.45 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.899 0.88 . . . . 0.0 111.286 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.1 t -60.74 -25.87 36.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.368 1.067 . . . . 0.0 113.035 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -145.48 30.63 1.11 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.691 1.196 . . . . 0.0 111.488 -166.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -77.87 133.27 38.17 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 120.828 -1.17 . . . . 0.0 108.663 -162.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.4 m -100.88 103.05 14.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.3 t -82.8 95.72 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -176.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -77.82 95.51 4.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -71.43 -12.31 61.34 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.983 1.313 . . . . 0.0 111.162 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.18 -177.89 31.37 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.325 0.964 . . . . 0.0 112.431 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -67.84 121.01 15.09 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.206 1.403 . . . . 0.0 109.748 168.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.5 t -99.82 149.26 5.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 126.063 1.745 . . . . 0.0 106.961 171.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -82.93 133.85 35.1 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.9 p -58.77 -19.37 40.14 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.817 0.847 . . . . 0.0 111.048 170.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.91 -50.09 61.77 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 120.746 -1.221 . . . . 0.0 109.336 170.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.4 m -73.12 -2.31 20.95 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.5 mt -141.23 79.19 1.68 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.403 1.481 . . . . 0.0 107.366 -171.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.31 -0.27 1.27 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -148.69 159.42 44.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -62.21 118.17 7.04 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.11 6.55 66.66 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 126.347 1.927 . . . . 0.0 112.885 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.84 149.02 23.48 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 148.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.37 153.57 42.1 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -178.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.9 p -70.3 171.78 9.34 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.366 -0.834 . . . . 0.0 109.065 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -47.5 -66.78 0.35 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -173.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 154.19 136.71 0.0 OUTLIER 'General case' 0 C--O 1.233 0.224 0 C-N-CA 128.199 2.6 . . . . 0.0 106.74 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.6 t -137.7 138.38 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 173.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.64 127.4 9.21 Favored Glycine 0 CA--C 1.516 0.148 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -132.47 87.95 2.48 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 123.307 1.527 . . . . 0.0 109.263 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -81.13 160.77 24.33 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 120.626 -1.297 . . . . 0.0 111.487 -173.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 mm -112.03 108.71 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 175.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -76.31 110.82 11.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.69 1.996 . . . . 0.0 109.113 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.56 108.6 18.16 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.474 1.51 . . . . 0.0 107.173 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.0 168.46 10.94 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.489 1.116 . . . . 0.0 109.832 171.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t70 51.46 36.26 16.3 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.828 2.451 . . . . 0.0 116.76 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.9 m -69.89 85.62 0.5 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.626 1.97 . . . . 0.0 114.736 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -72.98 111.8 8.42 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.454 -0.778 . . . . 0.0 112.375 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.6 p -62.5 -12.86 24.8 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.374 1.07 . . . . 0.0 112.234 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -66.37 -38.35 87.36 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.359 0.981 . . . . 0.0 110.272 173.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.55 -58.15 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.37 143.83 19.19 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.186 1.394 . . . . 0.0 107.743 -172.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.2 p -88.19 -12.79 42.84 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.66 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -140.82 156.15 46.21 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 127.125 2.17 . . . . 0.0 107.797 -166.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.56 85.94 1.2 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -173.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.11 173.52 11.2 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 123.642 0.777 . . . . 0.0 109.293 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -148.14 107.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -170.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.71 163.8 13.21 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 124.037 0.935 . . . . 0.0 108.922 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.448 ' CE2' HG23 ' A' ' 103' ' ' ILE . 6.7 m-85 -135.36 148.61 49.47 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.758 0.823 . . . . 0.0 109.652 -168.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 tp -146.91 132.71 18.97 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.122 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.27 175.53 39.55 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 172.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.5 m -60.2 134.04 56.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.67 1.188 . . . . 0.0 108.79 172.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.81 132.06 35.18 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.207 1.003 . . . . 0.0 109.003 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.7 tt -60.5 -34.26 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 122.83 0.452 . . . . 0.0 110.609 -178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -153.25 164.74 37.55 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 126.382 1.873 . . . . 0.0 109.623 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.72 -31.04 46.62 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.113 2.565 . . . . 0.0 115.061 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.97 -40.18 6.28 Favored Glycine 0 CA--C 1.518 0.274 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 174.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.411 ' CE1' ' HB ' ' A' ' 140' ' ' THR . 47.9 m80 -86.71 43.59 1.09 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.435 1.494 . . . . 0.0 110.51 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.6 p -63.81 -12.88 39.64 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.816 1.646 . . . . 0.0 112.232 173.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -82.13 -9.44 59.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.517 -0.739 . . . . 0.0 112.629 171.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 t -127.98 137.24 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 119.726 1.148 . . . . 0.0 109.855 -165.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.95 149.17 29.48 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.306 1.442 . . . . 0.0 110.743 -168.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.71 14.02 22.54 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -162.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.8 mt 51.54 -169.21 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.509 1.124 . . . . 0.0 110.41 -162.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -140.32 174.8 10.16 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 126.364 1.866 . . . . 0.0 108.292 -177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.2 p 59.66 -170.06 0.14 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.747 1.219 . . . . 0.0 110.277 172.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.9 m 24.76 71.48 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.716 2.406 . . . . 0.0 114.853 158.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -45.96 -34.63 4.1 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.486 1.114 . . . . 0.0 113.198 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.43 16.92 4.02 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.923 1.289 . . . . 0.0 111.494 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.91 -27.26 4.66 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.792 1.187 . . . . 0.0 110.894 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.5 m -61.04 162.61 6.9 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.35 1.071 . . . . 0.0 108.345 161.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.42 145.25 33.41 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.008 -1.451 . . . . 0.0 107.562 162.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 p -118.24 160.87 20.84 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 124.628 1.171 . . . . 0.0 109.156 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 59.83 27.04 16.3 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.511 0.725 . . . . 0.0 110.635 -173.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.0 p -143.74 145.45 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 121.215 -0.928 . . . . 0.0 108.667 170.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.88 174.12 23.74 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.414 HG11 ' CG ' ' A' ' 177' ' ' PHE . 99.3 t -86.45 147.2 5.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -129.99 140.81 50.83 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.333 1.053 . . . . 0.0 108.575 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.448 HG23 ' CE2' ' A' ' 73' ' ' PHE . 5.3 mp -108.3 134.99 48.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.8 mt -134.11 132.77 40.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.959 1.704 . . . . 0.0 107.673 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -73.11 -170.85 0.81 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.724 1.147 . . . . 0.0 112.046 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -48.63 -37.15 17.47 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.757 1.623 . . . . 0.0 111.854 167.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 p -77.83 -5.84 52.17 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.512 1.925 . . . . 0.0 112.484 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 57.25 25.12 53.8 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.755 1.169 . . . . 0.0 112.975 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.27 138.78 32.74 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.71 154.21 40.81 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.231 0.469 . . . . 0.0 111.704 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.3 mt -127.22 119.92 27.51 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.238 1.015 . . . . 0.0 110.487 -167.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.9 m -74.11 156.93 36.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.822 0.849 . . . . 0.0 111.578 -171.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.7 mt -99.3 71.57 1.8 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.889 1.676 . . . . 0.0 108.151 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -120.71 -20.94 6.85 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.317 0.647 . . . . 0.0 111.016 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.35 -22.53 8.49 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.488 1.518 . . . . 0.0 113.092 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.55 -40.78 9.68 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 119.091 1.446 . . . . 0.0 110.638 168.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 38.3 m -55.96 99.74 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.71 2.004 . . . . 0.0 110.595 -174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -71.11 173.71 7.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.183 1.393 . . . . 0.0 111.396 -173.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 59.7 p -115.51 -160.74 0.76 Allowed 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.593 1.157 . . . . 0.0 111.834 -170.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.7 147.37 53.5 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.596 0.758 . . . . 0.0 109.027 172.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -89.71 141.41 28.64 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 120.659 -1.275 . . . . 0.0 107.983 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.1 m -121.29 110.31 15.98 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 128.537 2.735 . . . . 0.0 104.163 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.5 m -68.53 117.05 9.78 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.169 1.387 . . . . 0.0 107.808 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.9 mt -64.69 173.69 2.11 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.999 1.72 . . . . 0.0 111.369 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.479 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 0.7 OUTLIER -132.39 159.12 40.18 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 127.676 2.39 . . . . 0.0 107.058 156.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -58.31 129.58 42.7 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.02 -140.55 15.67 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -172.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.5 m -107.51 142.7 36.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.886 1.343 . . . . 0.0 109.826 -172.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.479 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 12.8 m-80 -143.18 173.53 11.5 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 127.923 2.489 . . . . 0.0 108.532 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 129' ' ' ASN . 86.3 m -157.15 141.25 16.27 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.357 -1.465 . . . . 0.0 109.955 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.27 116.04 65.78 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.593 1.557 . . . . 0.0 107.361 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -86.25 78.27 2.18 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 124.121 3.214 . . . . 0.0 112.171 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -66.22 162.72 19.34 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.393 -0.817 . . . . 0.0 111.216 171.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -115.42 141.26 48.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.345 154.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -101.55 145.32 29.18 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 126.299 1.839 . . . . 0.0 108.462 160.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -149.61 152.56 35.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 159.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -70.03 151.23 45.78 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 163.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -129.16 116.11 18.71 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.921 2.488 . . . . 0.0 106.626 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.73 146.72 29.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.411 ' HB ' ' CE1' ' A' ' 82' ' ' HIS . 29.3 p -114.27 7.0 16.35 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.095 0.958 . . . . 0.0 112.068 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 168.79 -150.41 15.78 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.5 94.59 0.03 OUTLIER 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.621 1.169 . . . . 0.0 108.756 170.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.42 128.98 34.03 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.221 1.008 . . . . 0.0 108.734 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.3 p -90.84 171.58 8.04 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.151 1.38 . . . . 0.0 109.855 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -88.13 172.92 5.05 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.172 1.915 . . . . 0.0 110.371 166.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.96 -95.23 0.14 Allowed Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -144.1 155.7 44.06 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 127.718 2.407 . . . . 0.0 107.574 174.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -143.44 92.14 2.33 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.548 1.166 . . . . 0.0 108.238 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -126.15 145.32 50.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.32 153.18 34.31 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.535 1.534 . . . . 0.0 107.41 169.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.43 98.14 4.6 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.87 1.268 . . . . 0.0 110.521 176.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.81 163.49 23.41 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.665 171.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.2 p -99.8 161.98 13.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 147.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -122.96 153.62 39.5 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 162.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -113.71 168.21 9.97 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.534 1.934 . . . . 0.0 107.954 172.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.4 t -121.67 134.73 64.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.447 HE21 ' NE2' ' A' ' 159' ' ' GLN . 28.0 tt0 -122.09 87.55 2.77 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -57.11 149.69 18.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.188 166.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.447 ' NE2' HE21 ' A' ' 157' ' ' GLN . 4.6 pt20 -165.6 164.11 19.24 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.408 1.483 . . . . 0.0 109.59 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 136.66 -8.69 3.97 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 117.855 -1.525 . . . . 0.0 113.419 173.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -64.37 -70.35 1.1 Allowed Glycine 0 C--N 1.335 0.49 0 CA-C-N 119.521 1.661 . . . . 0.0 109.934 175.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.45 -9.67 83.13 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-O 118.182 -1.344 . . . . 0.0 113.508 -171.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.01 -74.31 2.2 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-N 118.841 1.321 . . . . 0.0 110.744 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -55.54 -77.35 0.16 Allowed Glycine 0 CA--C 1.521 0.429 0 C-N-CA 125.949 1.738 . . . . 0.0 111.813 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.61 83.94 0.23 Allowed Glycine 0 CA--C 1.519 0.327 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -172.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -156.83 123.04 4.91 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -154.02 168.8 25.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.289 1.036 . . . . 0.0 111.853 -172.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.0 m -134.23 95.58 3.44 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.113 1.765 . . . . 0.0 107.366 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.2 m -76.93 133.59 39.18 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 168.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 13.1 m -149.06 171.44 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 127.013 2.125 . . . . 0.0 109.097 -175.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -68.11 170.67 8.09 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.416 1.007 . . . . 0.0 109.682 172.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -135.89 -52.21 0.07 OUTLIER Glycine 0 CA--C 1.522 0.524 0 C-N-CA 124.341 0.972 . . . . 0.0 111.063 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 161.08 -162.14 33.44 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 118.043 0.922 . . . . 0.0 111.352 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.7 m -127.15 112.95 15.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.988 2.115 . . . . 0.0 107.247 -166.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 7.7 t -105.16 106.72 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -96.75 87.76 4.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -169.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.414 ' CG ' HG11 ' A' ' 101' ' ' VAL . 73.5 m-85 -68.37 113.07 5.62 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -120.07 166.33 13.54 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.035 -1.041 . . . . 0.0 108.261 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 143.82 -161.57 27.78 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -170.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -165.82 172.44 11.67 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.59 135.47 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 166.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.481 ' C ' ' H ' ' A' ' 184' ' ' ALA . 3.3 m -117.84 151.65 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 127.637 2.375 . . . . 0.0 107.677 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -74.03 24.59 0.08 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.781 1.632 . . . . 0.0 113.5 -169.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.246 0.91 0 C-N-CA 131.402 3.881 . . . . 0.0 112.565 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 116.704 -1.617 . . . . 0.0 107.272 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.37 50.12 15.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.37 1.468 . . . . 0.0 110.945 -173.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.7 t -69.46 152.88 44.33 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 169.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.7 t -64.77 165.07 11.07 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 158.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.58 101.2 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -60.3 -49.92 75.7 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.264 0.626 . . . . 0.0 110.216 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.33 171.32 36.53 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 127.357 2.408 . . . . 0.0 107.249 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.08 9.52 31.88 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.383 -0.676 . . . . 0.0 112.296 -175.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.299 0.4 OUTLIER -146.22 70.32 1.22 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 172.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.271 12.9 p 32.92 62.71 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 128.623 2.769 . . . . 0.0 115.752 175.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -66.87 -11.67 56.57 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -169.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 67.36 56.31 0.62 Allowed 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 126.672 1.989 . . . . 0.0 106.771 171.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.9 67.89 9.16 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -170.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.03 36.25 1.77 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -167.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' C ' ' H ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER 71.2 163.49 0.26 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.91 1.284 . . . . 0.0 109.21 -163.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . 0.371 11.7 p 54.82 -28.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 1 C-N-CA 133.447 4.699 . . . . 0.0 114.965 -175.863 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.424 ' H ' ' C ' ' A' ' 15' ' ' GLU 0.259 4.6 m 38.3 33.44 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.288 1 C-N-CA 132.106 4.162 . . . . 0.0 112.708 178.928 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -146.61 94.42 2.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.427 1.891 . . . . 0.0 106.018 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.81 111.61 7.76 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 161.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.48 -20.65 64.78 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -160.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.3 m -123.22 160.57 26.29 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 127.895 2.478 . . . . 0.0 107.792 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.8 -20.27 27.82 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -167.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.261 8.6 t 54.81 124.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 130.143 3.377 . . . . 0.0 111.509 -163.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -77.65 164.63 25.14 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.138 1.775 . . . . 0.0 110.676 -174.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.04 -39.98 60.41 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.623 -1.298 . . . . 0.0 110.598 164.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.38 2.71 36.1 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.962 1.744 . . . . 0.0 113.979 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 63.4 p -141.73 -9.85 0.92 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 119.886 1.843 . . . . 0.0 113.488 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.0 p -72.09 -65.42 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 119.15 0.886 . . . . 0.0 110.612 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -126.32 46.08 2.52 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.202 -0.936 . . . . 0.0 108.499 -160.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -82.91 144.47 30.02 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.543 1.137 . . . . 0.0 109.81 -163.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.71 154.52 27.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 164.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.9 t -131.28 96.97 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 165.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.85 94.87 3.96 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 mt -68.46 -10.08 53.01 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.555 1.942 . . . . 0.0 110.224 172.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.5 -177.9 32.55 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 124.945 1.26 . . . . 0.0 111.304 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -69.35 138.68 53.92 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 122.067 -0.666 . . . . 0.0 109.373 167.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -121.01 147.64 24.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 125.582 1.553 . . . . 0.0 106.926 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -83.39 131.93 35.02 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.0 p -59.1 -23.03 61.74 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 118.904 0.775 . . . . 0.0 110.397 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.89 -27.45 66.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.064 1.346 . . . . 0.0 112.134 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.3 m -80.21 -15.4 57.09 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.035 -0.984 . . . . 0.0 113.076 173.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.1 mt -134.11 75.86 1.62 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.708 2.003 . . . . 0.0 109.336 -164.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.91 -4.05 7.0 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -167.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -152.7 163.38 39.78 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 124.425 1.09 . . . . 0.0 109.284 -175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -64.83 127.34 31.15 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.39 -1.19 75.97 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-O 118.511 -1.161 . . . . 0.0 111.762 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.59 146.29 54.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 119.807 1.803 . . . . 0.0 109.769 168.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.8 p -138.09 151.29 47.67 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.112 0.414 . . . . 0.0 110.744 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.7 p -75.57 -169.91 1.14 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -45.11 -92.38 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.98 75.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 129.607 3.163 . . . . 0.0 107.259 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 p -73.66 148.57 8.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 169.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.85 155.72 19.83 Favored Glycine 0 CA--C 1.51 -0.262 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -147.71 1.59 0.69 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -171.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 36.92 -169.95 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 130.963 3.705 . . . . 0.0 114.281 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 mm -133.29 106.36 9.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 159.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -65.99 113.38 4.39 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 171.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.86 149.13 23.23 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -148.69 153.43 38.23 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.1 2.16 . . . . 0.0 108.609 -165.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 30.18 54.25 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 129.263 3.025 . . . . 0.0 114.825 -169.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.8 m -69.64 138.34 52.96 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.328 2.251 . . . . 0.0 111.3 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -113.96 119.76 38.33 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.147 1.379 . . . . 0.0 109.294 166.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.5 p -71.81 -17.66 62.14 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -59.65 -44.89 93.37 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 124.101 0.96 . . . . 0.0 109.939 175.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.4 t -61.42 -61.59 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.04 120.42 4.56 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.395 1.478 . . . . 0.0 109.061 -174.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.9 m -76.24 -6.94 53.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.864 0.865 . . . . 0.0 111.135 169.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -130.72 159.02 38.51 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 120.155 -1.591 . . . . 0.0 110.368 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.75 159.56 41.98 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 160.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.55 167.83 18.72 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.804 2.042 . . . . 0.0 106.258 161.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.0 t -119.95 148.82 22.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.64 159.45 26.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -133.49 155.53 49.4 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.901 1.68 . . . . 0.0 108.548 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.4 tp -141.46 161.55 37.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.787 0.435 . . . . 0.0 110.095 173.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -178.16 179.82 48.38 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 173.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.3 m -64.9 135.83 56.16 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 164.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.17 141.83 41.74 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.079 0.854 . . . . 0.0 109.322 171.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.6 tt -60.77 -36.12 69.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 122.998 0.519 . . . . 0.0 111.036 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -160.87 171.2 19.18 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.207 1.803 . . . . 0.0 107.343 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.1 -28.14 68.59 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.753 0.821 . . . . 0.0 111.341 165.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.64 -19.13 72.74 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 119.109 -0.829 . . . . 0.0 112.224 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -147.2 57.93 1.15 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.15 1.475 . . . . 0.0 110.619 -164.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.3 p -63.09 -14.74 52.06 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 128.297 2.639 . . . . 0.0 113.313 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -84.96 -3.26 58.68 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 170.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.2 t -123.21 138.37 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 119.897 1.226 . . . . 0.0 109.446 -170.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.08 150.04 37.34 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.641 1.176 . . . . 0.0 110.787 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.19 14.99 20.32 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -167.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.9 mt 54.36 -161.27 0.14 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.482 1.113 . . . . 0.0 111.665 -167.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -148.87 162.36 40.0 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.311 1.444 . . . . 0.0 110.869 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.4 p 49.55 -158.78 0.07 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.186 1.795 . . . . 0.0 111.099 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.4 m 24.98 75.5 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 129.172 2.989 . . . . 0.0 111.901 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.35 -30.48 12.26 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.309 1.844 . . . . 0.0 114.088 -169.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.61 17.29 3.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.227 1.411 . . . . 0.0 110.164 174.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.99 -16.27 8.01 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 125.474 1.511 . . . . 0.0 111.751 -171.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 m -62.13 172.23 1.5 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.622 1.201 . . . . 0.0 109.205 164.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.23 120.57 8.9 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 159.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.4 p -85.26 166.45 16.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 57.58 24.54 10.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.576 1.151 . . . . 0.0 111.499 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.36 154.5 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 119.304 0.956 . . . . 0.0 109.655 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.33 -179.06 27.62 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 125.644 1.592 . . . . 0.0 110.322 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.447 HG13 ' CG ' ' A' ' 177' ' ' PHE . 73.5 t -91.89 152.93 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -132.1 167.97 18.79 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.218 -0.926 . . . . 0.0 110.247 161.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.23 142.67 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 127.506 2.322 . . . . 0.0 105.559 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.1 mt -129.33 146.41 51.22 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 126.282 1.833 . . . . 0.0 107.53 176.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.96 -72.25 0.14 Allowed 'General case' 0 C--O 1.221 -0.431 0 O-C-N 124.309 1.005 . . . . 0.0 111.873 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.427 ' C ' ' H ' ' A' ' 108' ' ' GLY . 15.8 ptt180 -167.84 -35.23 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.044 1.338 . . . . 0.0 111.553 172.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 t -66.77 11.1 0.1 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.622 2.369 . . . . 0.0 111.063 167.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 106' ' ' ARG . . . 61.99 12.31 35.73 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.239 1.4 . . . . 0.0 114.68 -171.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.71 110.76 1.6 Allowed 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.246 1.419 . . . . 0.0 108.781 175.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.03 118.57 8.03 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.902 1.281 . . . . 0.0 109.572 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 mt -79.16 155.93 28.46 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 m -86.67 170.36 11.87 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 169.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.8 85.96 2.41 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 171.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -111.32 -17.05 13.24 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 165.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.89 -0.06 73.47 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.342 0.972 . . . . 0.0 112.512 -168.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -128.35 -32.84 2.18 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.525 1.53 . . . . 0.0 111.419 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.2 m -57.26 112.07 1.27 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.133 0.973 . . . . 0.0 108.566 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -79.39 146.78 32.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.9 p -74.69 -150.46 0.03 OUTLIER 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.503 1.121 . . . . 0.0 109.869 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.35 156.85 38.65 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 120.995 -1.066 . . . . 0.0 109.107 163.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -76.94 157.42 31.31 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 122.666 1.222 . . . . 0.0 108.274 166.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.9 m -133.57 122.75 23.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 164.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.1 m -65.49 120.92 13.74 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 167.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.3 mt -78.94 -168.24 1.39 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.171 2.188 . . . . 0.0 107.915 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.413 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 5.7 p-10 -153.63 160.06 42.29 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.782 0.833 . . . . 0.0 108.941 164.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -65.56 107.68 1.79 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 127.22 -102.45 0.61 Allowed Glycine 0 C--O 1.225 -0.414 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 -172.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 m -137.36 147.64 45.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.444 1.122 . . . . 0.0 109.204 -167.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 0.4 OUTLIER -168.45 161.05 11.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.552 1.541 . . . . 0.0 107.117 -175.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 96.8 m -149.54 151.48 33.95 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -175.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.5 mt -115.53 121.68 34.14 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.28 67.26 7.56 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.232 2.621 . . . . 0.0 113.206 -168.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -65.92 145.07 56.36 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -114.67 148.66 37.9 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.922 168.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -123.39 156.1 36.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 166.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 5.7 ptt-85 -157.37 167.92 28.86 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 169.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -80.16 147.77 31.19 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 167.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -116.42 117.91 31.23 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 127.053 2.141 . . . . 0.0 106.103 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.01 139.74 30.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 53.6 p -102.09 13.68 34.04 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.646 1.179 . . . . 0.0 110.277 172.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.73 -154.21 24.9 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 107.756 -2.138 . . . . 0.0 107.756 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.71 95.66 0.9 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.477 1.111 . . . . 0.0 109.555 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.72 121.4 10.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.624 0.769 . . . . 0.0 109.179 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 63.8 p -74.78 161.82 76.12 Favored Pre-proline 0 C--O 1.235 0.323 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -68.71 173.49 9.93 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 120.861 1.041 . . . . 0.0 110.412 159.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.03 -109.95 0.42 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 173.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -138.94 152.93 48.11 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 128.064 2.546 . . . . 0.0 105.904 174.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.31 75.78 1.45 Allowed 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.934 1.243 . . . . 0.0 111.553 -175.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -118.1 157.47 26.81 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.97 164.96 36.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.488 1.515 . . . . 0.0 108.607 172.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -131.59 113.0 13.1 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -91.12 169.8 10.55 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.416 1.087 . . . . 0.0 109.79 170.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.3 p -115.41 156.22 25.98 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 152.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -120.52 152.41 38.09 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -122.36 169.7 10.68 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.861 1.664 . . . . 0.0 108.37 170.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.1 t -126.09 132.18 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -107.78 89.77 3.1 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 166.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -62.04 145.35 53.41 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 163.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -164.36 169.77 16.96 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.678 0.791 . . . . 0.0 111.287 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 135.44 -89.72 0.23 Allowed Glycine 0 C--O 1.237 0.284 0 N-CA-C 107.696 -2.162 . . . . 0.0 107.696 -173.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 55.54 -108.36 1.02 Allowed Glycine 0 CA--C 1.522 0.482 0 C-N-CA 126.55 2.024 . . . . 0.0 110.057 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.74 -110.19 0.14 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -153.23 20.95 0.74 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-O 119.238 -0.757 . . . . 0.0 111.495 -173.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 178.48 105.7 0.19 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 119.207 1.503 . . . . 0.0 109.557 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.41 73.62 1.0 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -148.16 120.59 8.47 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 160.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -151.73 160.73 43.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 124.384 1.052 . . . . 0.0 110.511 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 60.6 m -150.29 103.11 3.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.639 1.976 . . . . 0.0 107.141 -173.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.2 m -101.48 109.22 21.0 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 125.595 1.558 . . . . 0.0 109.616 -170.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.6 m -137.29 149.52 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.955 1.302 . . . . 0.0 109.708 -160.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.97 163.03 20.67 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.244 0.929 . . . . 0.0 111.906 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -121.94 -80.87 0.57 Allowed Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -174.29 -153.9 10.35 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -165.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.0 m -128.31 105.97 8.7 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.277 1.831 . . . . 0.0 110.327 -161.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.8 t -94.08 106.9 18.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -90.17 101.08 13.8 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -175.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.447 ' CG ' HG13 ' A' ' 101' ' ' VAL . 70.5 m-85 -82.55 121.5 26.87 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -126.74 159.4 33.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.6 -163.68 27.87 Favored Glycine 0 CA--C 1.518 0.269 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -166.26 166.24 16.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 81.8 t -113.86 125.46 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 172.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.9 m -106.27 152.32 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 126.265 1.826 . . . . 0.0 108.823 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -75.13 24.78 0.1 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -169.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 C-N-CA 129.103 2.961 . . . . 0.0 111.839 -175.127 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.88 -178.35 7.0 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.748 1.619 . . . . 0.0 107.673 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.1 t -140.08 152.78 46.43 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.487 -0.758 . . . . 0.0 109.031 166.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -134.31 20.15 3.69 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.364 1.865 . . . . 0.0 107.585 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.9 144.16 11.0 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 C-N-CA 125.419 1.487 . . . . 0.0 109.347 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -147.22 159.66 43.38 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.34 -143.65 14.57 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 -172.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -85.2 -89.55 0.87 Allowed Glycine 0 C--N 1.331 0.29 0 N-CA-C 105.04 -3.224 . . . . 0.0 105.04 161.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -136.72 117.22 13.78 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 157.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.3 p 23.36 99.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.284 1.833 . . . . 0.0 111.425 147.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -81.05 -123.89 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -146.61 25.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.113 -0.992 . . . . 0.0 112.409 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.6 mttt 32.61 -94.78 0.01 OUTLIER 'General case' 0 C--O 1.238 0.448 0 C-N-CA 127.434 2.294 . . . . 0.0 111.611 -170.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -157.58 50.2 0.43 Allowed Glycine 0 N--CA 1.444 -0.833 0 CA-C-O 117.729 -1.595 . . . . 0.0 110.897 170.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 95.88 167.14 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 129.452 3.101 . . . . 0.0 110.793 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.455 ' C ' ' H ' ' A' ' 18' ' ' ASN . 29.0 t 23.79 71.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.55 0 C-N-CA 130.405 3.482 . . . . 0.0 110.294 -177.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.9 t -76.03 34.95 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 128.451 2.7 . . . . 0.0 110.616 -172.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.455 ' H ' ' C ' ' A' ' 16' ' ' VAL . 68.0 m-80 -146.51 112.05 5.56 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 128.096 2.558 . . . . 0.0 105.213 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.01 29.15 1.68 Allowed 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 122.986 0.514 . . . . 0.0 110.531 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 43.67 -50.63 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.28 1 C-N-CA 134.45 5.1 . . . . 0.0 115.48 -167.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 m -104.51 174.24 5.96 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.262 2.225 . . . . 0.0 110.977 172.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.6 102.82 12.04 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 127.634 2.374 . . . . 0.0 108.065 172.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.05 130.85 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -67.41 153.75 42.96 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.12 -32.31 61.95 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.908 -1.12 . . . . 0.0 110.486 165.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.84 4.65 4.1 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 118.606 -1.108 . . . . 0.0 114.705 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.3 m -143.38 -19.57 0.62 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 120.609 2.204 . . . . 0.0 114.535 175.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.4 p -60.57 -39.72 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 119.384 0.993 . . . . 0.0 111.292 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -136.23 67.1 1.47 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -167.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.89 140.15 44.18 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.577 -164.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.2 m -109.89 100.19 9.2 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.25 102.22 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -84.77 93.15 8.4 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -69.57 -16.44 63.41 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.903 1.681 . . . . 0.0 109.059 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.84 -168.63 43.56 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.434 1.016 . . . . 0.0 111.15 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -73.63 152.27 40.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.358 1.063 . . . . 0.0 109.798 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.46 147.25 28.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 125.208 1.403 . . . . 0.0 108.109 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -82.68 131.37 35.21 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -57.12 -27.59 61.95 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 122.74 0.416 . . . . 0.0 111.266 170.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.71 -35.3 65.95 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.535 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.2 m -77.14 -1.53 29.75 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.5 mt -143.71 74.08 1.42 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.726 1.61 . . . . 0.0 108.043 -163.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.22 -6.47 4.85 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -170.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -151.94 163.81 38.47 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 126.292 1.837 . . . . 0.0 107.408 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -61.43 136.21 57.95 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 122.071 0.939 . . . . 0.0 108.735 177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.458 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 82.93 -3.58 83.39 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-O 118.095 -1.391 . . . . 0.0 111.27 175.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.17 151.29 19.41 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.478 1.139 . . . . 0.0 109.46 158.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 p -143.37 154.44 43.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.577 0.703 . . . . 0.0 109.702 -174.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.5 t -65.27 175.84 1.55 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 166.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -38.38 -81.52 0.01 OUTLIER 'General case' 0 C--N 1.339 0.12 0 C-N-CA 127.622 2.369 . . . . 0.0 110.375 167.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.57 158.48 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 129.733 3.213 . . . . 0.0 106.146 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.7 t -145.03 152.06 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 168.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.47 144.13 16.6 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 106.339 -2.704 . . . . 0.0 106.339 167.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -141.01 157.72 44.93 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -141.53 168.81 18.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 119.886 1.221 . . . . 0.0 113.241 -172.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 mm -111.41 92.63 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.32 118.68 13.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.884 1.673 . . . . 0.0 108.011 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.4 mt -118.8 132.18 56.12 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.829 1.251 . . . . 0.0 109.947 -175.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -116.49 164.68 14.21 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.365 1.466 . . . . 0.0 108.863 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.3 t0 53.66 31.72 13.23 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.742 2.017 . . . . 0.0 113.384 163.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.7 t -75.05 153.58 38.34 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.467 -1.396 . . . . 0.0 113.096 -170.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -126.38 125.9 42.99 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.978 1.311 . . . . 0.0 110.742 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 p -73.75 -17.1 61.15 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.059 0.543 . . . . 0.0 110.955 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -58.87 -45.75 89.43 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.899 1.28 . . . . 0.0 110.001 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.1 t -72.57 -46.11 56.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -175.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -165.85 130.91 2.38 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.162 1.385 . . . . 0.0 109.253 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 m -73.83 -23.19 59.61 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -120.79 166.09 14.23 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 126.154 1.782 . . . . 0.0 110.205 -173.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.83 151.64 51.55 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 157.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.77 170.79 10.68 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 144.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.36 159.74 41.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -172.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.55 167.07 23.04 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -125.33 154.9 41.1 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.642 0.777 . . . . 0.0 109.101 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.2 tp -150.01 124.26 9.51 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.918 0.887 . . . . 0.0 108.998 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.15 -178.98 42.75 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.674 1.131 . . . . 0.0 110.824 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m -70.37 133.68 47.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.399 1.48 . . . . 0.0 110.174 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.84 141.13 47.98 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 121.296 -0.878 . . . . 0.0 111.156 169.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 tt -63.01 -37.58 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 123.554 0.742 . . . . 0.0 110.961 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -159.83 165.78 31.63 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.752 2.021 . . . . 0.0 107.279 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.22 69.5 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 125.536 1.534 . . . . 0.0 112.318 169.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.54 -3.38 90.1 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-O 118.691 -1.061 . . . . 0.0 113.277 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -145.78 50.09 1.2 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.211 1.506 . . . . 0.0 109.614 -172.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.0 p -64.51 -17.41 63.87 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.978 1.311 . . . . 0.0 114.38 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -75.75 -25.78 56.82 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.92 173.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.27 137.84 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.396 1.478 . . . . 0.0 110.23 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.82 146.19 32.39 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.221 1.008 . . . . 0.0 111.79 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.36 18.17 6.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.353 1.861 . . . . 0.0 114.226 -167.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 73.4 mt 51.48 -156.12 0.14 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.797 1.239 . . . . 0.0 110.762 -169.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.38 -173.44 4.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.622 2.769 . . . . 0.0 107.827 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.8 t 76.26 158.37 0.2 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.553 1.941 . . . . 0.0 112.548 163.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.1 t 46.46 27.39 0.61 Allowed 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 127.958 2.503 . . . . 0.0 114.429 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 61.78 -50.87 0.14 Allowed 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 128.48 2.712 . . . . 0.0 114.327 -163.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -151.37 11.27 0.61 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.778 1.231 . . . . 0.0 110.675 -170.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.57 -12.9 52.85 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 126.264 1.888 . . . . 0.0 114.311 -161.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 p -51.71 162.74 0.37 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 121.768 -0.842 . . . . 0.0 110.784 162.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.96 142.33 3.56 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.144 1.378 . . . . 0.0 111.079 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.8 p -94.93 163.42 13.33 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 169.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 56.07 23.75 7.16 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.451 1.501 . . . . 0.0 112.425 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -144.23 155.02 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.19 -168.06 14.04 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.5 t -101.42 136.94 30.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 169.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -115.12 158.73 21.78 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 164.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.7 mp -133.48 123.57 46.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.512 1.925 . . . . 0.0 106.768 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.9 mt -114.41 153.47 29.83 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 174.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -85.76 -107.82 0.05 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.438 0.563 . . . . 0.0 110.325 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.79 -45.78 4.69 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 129.618 3.167 . . . . 0.0 109.528 168.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.8 p -78.38 -0.17 28.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.052 0.541 . . . . 0.0 112.078 -166.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.77 14.15 57.68 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.055 1.312 . . . . 0.0 112.684 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.7 142.35 55.05 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 159.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.82 135.64 37.28 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 74.3 mt -105.82 120.51 41.9 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.653 -0.655 . . . . 0.0 110.702 -157.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.6 m -73.31 160.1 32.37 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.858 0.837 . . . . 0.0 110.725 -173.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.1 mt -109.38 40.64 1.81 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.243 1.417 . . . . 0.0 111.794 -160.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -106.76 0.28 24.03 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.32 -0.863 . . . . 0.0 112.593 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.26 -17.77 31.64 Favored Glycine 0 CA--C 1.519 0.335 0 O-C-N 120.423 -1.423 . . . . 0.0 114.196 166.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -115.1 -6.7 12.49 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.313 1.056 . . . . 0.0 112.899 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.2 m -68.94 99.4 1.06 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 168.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -61.19 130.09 44.53 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.484 171.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.8 m -83.55 -158.31 0.29 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 127.19 2.196 . . . . 0.0 109.962 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.45 129.62 38.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.973 0.892 . . . . 0.0 108.942 -170.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -84.57 115.17 22.47 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -166.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m -96.66 110.14 22.64 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.0 m -61.83 130.34 45.26 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 163.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 51.5 mt -96.33 -149.26 0.31 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 126.184 1.794 . . . . 0.0 108.255 -170.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -150.34 173.79 13.6 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.616 1.566 . . . . 0.0 107.974 164.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.57 115.24 12.72 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 159.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 119.0 -150.46 17.94 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.631 1.11 . . . . 0.0 111.631 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.6 m -75.27 135.27 40.95 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.326 1.45 . . . . 0.0 110.766 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.62 168.97 25.76 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.528 1.531 . . . . 0.0 108.514 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 95.0 m -152.24 149.81 29.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.556 0.742 . . . . 0.0 109.291 -176.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.75 106.97 57.06 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.479 1.112 . . . . 0.0 108.356 163.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.65 117.37 3.66 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 124.319 3.346 . . . . 0.0 111.552 171.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -93.08 170.43 9.66 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.037 1.735 . . . . 0.0 110.849 168.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -134.71 113.83 12.07 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.917 2.087 . . . . 0.0 107.287 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -104.34 133.88 48.5 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 128.553 2.741 . . . . 0.0 109.239 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.1 ptt-85 -145.15 143.36 30.31 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 170.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -70.46 116.46 10.81 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 162.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.458 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 3.0 t80 -101.62 130.54 47.97 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.71 144.84 26.92 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 30.3 p -98.7 7.0 46.6 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.273 1.029 . . . . 0.0 112.158 167.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 160.26 -152.64 23.46 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.89 89.3 0.05 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.892 1.277 . . . . 0.0 111.329 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.04 141.64 49.29 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.934 0.893 . . . . 0.0 110.999 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.5 p -112.36 152.99 44.95 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 119.161 -0.447 . . . . 0.0 110.241 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -76.86 162.4 32.36 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.402 1.401 . . . . 0.0 110.081 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 156.42 -133.08 3.51 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.903 1.239 . . . . 0.0 110.397 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.11 152.13 18.99 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.29 1.045 . . . . 0.0 108.234 169.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -136.96 82.28 1.93 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.664 0.745 . . . . 0.0 109.133 168.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -121.06 152.12 39.01 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -145.32 175.55 10.22 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -138.78 115.21 10.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 171.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -108.63 156.64 19.31 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 167.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 p -99.4 158.91 15.4 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 149.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -117.91 147.93 42.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 165.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -120.19 167.7 11.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.278 1.431 . . . . 0.0 107.645 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.94 106.38 3.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -169.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -95.14 87.94 5.04 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.148 1.379 . . . . 0.0 108.995 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -68.58 149.11 49.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.655 1.182 . . . . 0.0 110.704 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -172.82 174.9 3.48 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.135 1.774 . . . . 0.0 109.092 -173.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 145.8 -80.95 0.22 Allowed Glycine 0 CA--C 1.517 0.171 0 N-CA-C 107.835 -2.106 . . . . 0.0 107.835 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -71.06 165.97 52.78 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 123.71 0.671 . . . . 0.0 111.684 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 129.64 162.78 10.96 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 125.996 1.76 . . . . 0.0 110.46 174.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -57.24 -41.16 92.73 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 118.934 -0.926 . . . . 0.0 113.336 -172.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 167.76 25.48 0.02 OUTLIER Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.269 0.937 . . . . 0.0 112.038 -172.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 157.17 96.6 0.12 Allowed Glycine 0 C--N 1.335 0.498 0 N-CA-C 106.483 -2.647 . . . . 0.0 106.483 -166.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -168.17 128.73 1.32 Allowed 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 125.093 1.357 . . . . 0.0 110.1 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -157.72 170.47 22.3 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 123.746 0.654 . . . . 0.0 109.972 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 21.2 m -135.78 101.94 4.92 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.1 m -79.11 104.82 10.0 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 162.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.14 156.76 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.44 161.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -65.25 129.04 38.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 153.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -85.29 -61.47 1.73 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 166.93 -157.53 30.05 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 89.8 m -116.89 135.75 53.48 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.952 1.701 . . . . 0.0 109.29 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.7 t -114.35 107.67 23.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 122.306 1.05 . . . . 0.0 108.344 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -88.36 91.31 8.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -71.2 115.2 10.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -123.27 159.49 28.64 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 124.369 1.068 . . . . 0.0 109.149 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 145.95 -166.2 27.98 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 106.491 -2.644 . . . . 0.0 106.491 -173.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.56 176.23 10.62 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.3 130.15 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 171.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.472 ' C ' ' H ' ' A' ' 184' ' ' ALA . 4.2 m -105.66 152.29 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 127.393 2.277 . . . . 0.0 108.536 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.21 24.9 0.08 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.837 1.255 . . . . 0.0 114.065 -170.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.257 1.463 1 C-N-CA 133.424 4.689 . . . . 0.0 113.374 -176.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 117.303 -1.332 . . . . 0.0 107.533 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.62 73.0 0.18 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.708 1.603 . . . . 0.0 112.433 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.3 p -136.37 -47.99 0.64 Allowed 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.048 0.939 . . . . 0.0 109.192 172.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.6 m 63.35 21.59 12.88 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.612 1.165 . . . . 0.0 110.594 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 p -144.35 160.68 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.504 1.521 . . . . 0.0 107.696 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -52.52 117.17 2.68 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.459 1.904 . . . . 0.0 109.141 174.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 63.54 -103.62 0.71 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -172.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.4 179.45 40.93 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 126.097 1.808 . . . . 0.0 108.808 -175.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.252 0.4 OUTLIER -87.98 85.42 6.98 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 124.014 1.864 . . . . 0.0 106.575 -164.213 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 t 48.49 60.64 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 126.442 1.897 . . . . 0.0 110.968 157.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.475 ' CD2' ' H ' ' A' ' 11' ' ' HIS . 1.8 p80 -82.41 34.72 0.43 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.086 1.354 . . . . 0.0 112.84 -154.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -130.63 56.37 1.78 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.44 1.096 . . . . 0.0 108.656 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -105.27 79.95 1.54 Allowed 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 171.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.98 7.33 1.42 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 119.136 -0.813 . . . . 0.0 111.98 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -152.81 -171.43 3.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 118.913 1.356 . . . . 0.0 108.066 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.0 t -53.18 -37.81 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 126.249 1.82 . . . . 0.0 111.765 -172.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 m 40.91 34.55 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 128.149 2.58 . . . . 0.0 116.202 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -120.61 103.19 8.95 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.24 1.016 . . . . 0.0 109.058 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -109.92 118.18 35.77 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 167.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -39.96 -39.22 0.81 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 128.168 2.587 . . . . 0.0 112.93 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.3 m -111.34 142.42 43.6 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.04 -8.96 13.44 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -168.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.2 t 45.95 102.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.29 0 C-N-CA 130.233 3.413 . . . . 0.0 109.265 -162.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -58.97 154.02 16.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.761 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.26 -31.16 65.28 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.812 0.733 . . . . 0.0 110.823 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.55 -11.9 60.61 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.987 -0.896 . . . . 0.0 114.249 176.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.6 m -105.86 -36.49 6.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.864 1.332 . . . . 0.0 109.921 172.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.3 t -52.02 -39.69 26.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 123.878 0.871 . . . . 0.0 110.127 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.93 77.21 1.59 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.959 0.885 . . . . 0.0 110.909 -173.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.25 138.28 49.17 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.907 -170.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.4 m -115.13 84.56 2.1 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.407 2.283 . . . . 0.0 110.026 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.4 t -67.93 112.43 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -87.37 97.29 10.72 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.2 mt -70.97 -3.18 18.09 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.722 2.009 . . . . 0.0 109.003 172.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.73 -176.63 35.67 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 124.541 1.067 . . . . 0.0 111.979 169.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -68.67 148.98 49.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.471 0.653 . . . . 0.0 109.569 164.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.7 t -136.16 144.97 31.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 125.536 1.534 . . . . 0.0 107.356 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.08 133.69 34.63 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.4 p -57.62 -25.02 59.49 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.004 0.522 . . . . 0.0 110.663 173.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.45 69.92 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.865 1.266 . . . . 0.0 112.65 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.8 m -76.37 -11.0 59.82 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 173.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.1 mt -139.12 74.37 1.47 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.92 2.088 . . . . 0.0 109.209 -157.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.22 10.65 4.15 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.177 -0.952 . . . . 0.0 112.901 -169.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -154.91 158.41 39.25 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 124.885 1.274 . . . . 0.0 108.824 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -61.29 132.39 53.44 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 166.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.73 5.68 87.87 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-O 118.194 -1.337 . . . . 0.0 112.464 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.65 153.36 36.27 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.652 1.726 . . . . 0.0 109.27 163.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.8 p -141.45 155.43 45.86 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.9 t -68.39 178.05 2.13 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.345 1.058 . . . . 0.0 109.039 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.8 m -44.71 -86.14 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.915 2.486 . . . . 0.0 113.155 171.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 157.69 134.85 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 127.416 2.286 . . . . 0.0 107.239 -171.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.36 104.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -177.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.92 135.14 30.08 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 112.746 -2.025 . . . . 0.0 109.16 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -143.96 80.64 1.66 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -77.79 141.56 39.16 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.284 -0.885 . . . . 0.0 110.027 -177.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.0 mm -81.09 102.62 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -65.34 101.71 0.6 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.4 mt -91.19 161.0 15.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 161.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -131.49 160.37 35.39 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 167.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 t70 45.21 54.51 7.11 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 127.109 2.164 . . . . 0.0 113.418 175.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.7 m -68.62 103.35 1.69 Allowed 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.848 -0.532 . . . . 0.0 110.361 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -66.04 149.46 50.22 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 161.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 p -110.13 -15.84 13.92 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.049 0.94 . . . . 0.0 112.724 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -60.24 -46.65 89.05 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 122.361 1.077 . . . . 0.0 109.297 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.9 p -60.2 -52.75 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 125.69 1.596 . . . . 0.0 108.55 177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -167.24 135.73 2.62 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.37 1.468 . . . . 0.0 108.363 171.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.0 m -77.87 -12.49 59.98 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.32 -0.848 . . . . 0.0 113.074 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -117.3 152.38 35.01 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 120.232 1.378 . . . . 0.0 109.841 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.91 138.9 51.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 169.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.66 -176.68 3.52 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 123.266 1.508 . . . . 0.0 107.367 150.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 156' ' ' VAL . 0.5 OUTLIER -153.49 160.3 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 131.678 3.991 . . . . 0.0 103.773 -162.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.85 171.57 13.89 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 165.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -129.72 152.41 49.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.4 tp -152.87 126.8 8.99 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.83 169.8 42.69 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.3 m -60.27 128.11 35.1 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.075 0.95 . . . . 0.0 110.669 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.99 135.99 46.59 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.76 -0.587 . . . . 0.0 110.431 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.2 tt -60.6 -33.66 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.783 0.833 . . . . 0.0 110.333 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -160.0 168.14 26.31 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 164.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.63 -31.85 66.66 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.942 1.297 . . . . 0.0 111.351 166.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.0 -10.92 60.03 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 120.588 -1.32 . . . . 0.0 112.531 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -148.33 50.63 1.02 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.154 1.781 . . . . 0.0 111.206 -165.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.3 p -68.22 -12.6 61.24 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.964 -1.085 . . . . 0.0 112.121 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -80.94 1.49 30.81 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.469 -0.769 . . . . 0.0 111.233 172.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.1 t -136.45 138.91 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 120.939 -1.1 . . . . 0.0 110.893 -169.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.75 148.11 24.88 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 125.63 1.572 . . . . 0.0 111.51 -168.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.14 14.26 12.94 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.735 1.614 . . . . 0.0 115.305 -163.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.1 mt 52.08 -164.88 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.3 1.04 . . . . 0.0 110.643 -166.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -139.87 177.23 8.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.553 1.541 . . . . 0.0 108.49 177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.6 m -54.1 142.93 23.81 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.249 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 m -177.45 86.52 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.426 2.69 . . . . 0.0 106.832 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 37.44 -74.72 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 129.949 3.3 . . . . 0.0 113.853 -168.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.66 14.3 1.35 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.72 1.208 . . . . 0.0 112.647 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.63 41.4 50.87 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 121.1 -1.0 . . . . 0.0 111.768 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.2 m 63.07 -170.51 0.18 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.837 1.655 . . . . 0.0 111.078 -169.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.31 168.31 3.56 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.315 1.446 . . . . 0.0 109.692 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.9 p -116.43 167.57 10.93 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.492 1.117 . . . . 0.0 109.039 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 53.36 27.25 6.06 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.695 1.598 . . . . 0.0 111.881 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.84 151.14 13.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 CA-C-N 120.265 1.393 . . . . 0.0 110.827 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.11 174.45 31.1 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 124.969 1.271 . . . . 0.0 111.317 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.7 t -86.48 126.75 40.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -95.64 153.07 17.91 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 120.121 1.328 . . . . 0.0 108.358 158.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.59 138.45 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 169.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.9 mt -133.49 138.99 46.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -65.8 178.45 1.05 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.295 1.045 . . . . 0.0 110.347 170.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -53.88 -13.31 0.71 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.807 1.243 . . . . 0.0 114.287 172.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.7 p -102.36 -11.63 18.51 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.636 1.107 . . . . 0.0 110.902 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.82 11.04 74.67 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.941 1.257 . . . . 0.0 113.467 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.85 60.04 5.69 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.77 1.228 . . . . 0.0 111.513 -174.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 23.47 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 128.827 2.851 . . . . 0.0 113.834 153.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 87.7 mt -78.08 168.0 20.56 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.228 -169.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -109.19 164.21 12.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -172.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.7 mt -113.29 52.59 0.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.325 1.05 . . . . 0.0 108.323 -175.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -104.32 -23.31 13.23 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.588 1.155 . . . . 0.0 111.742 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 67.62 21.76 72.99 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 118.634 0.652 . . . . 0.0 113.261 -174.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -161.51 34.52 0.13 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.179 1.792 . . . . 0.0 110.392 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 26.9 m -128.92 91.81 3.28 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.078 -2.194 . . . . 0.0 105.078 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -62.35 152.91 32.64 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.097 0.475 . . . . 0.0 110.632 -170.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.9 m -126.3 104.07 8.0 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.546 0.739 . . . . 0.0 109.63 -163.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 49.98 -177.73 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.588 1.955 . . . . 0.0 112.018 -168.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -117.48 172.99 6.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 119.632 -1.918 . . . . 0.0 108.167 154.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m -151.02 116.06 5.28 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 165.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.1 m -67.62 137.87 55.96 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.9 mt -108.88 -178.85 3.7 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 129.038 2.935 . . . . 0.0 110.085 -170.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.406 ' ND2' HD22 ' A' ' 129' ' ' ASN . 0.9 OUTLIER -143.45 156.98 44.8 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.009 1.724 . . . . 0.0 109.121 167.352 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -60.78 85.8 0.01 OUTLIER 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.943 2.097 . . . . 0.0 110.644 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.57 -169.57 25.1 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.758 0.694 . . . . 0.0 111.804 -161.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.7 m -96.8 125.48 41.28 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 120.574 -1.545 . . . . 0.0 111.822 -158.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.406 HD22 ' ND2' ' A' ' 125' ' ' ASN . 4.5 m-80 -139.92 157.79 45.13 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 129.097 2.959 . . . . 0.0 109.686 -171.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 61.2 m -131.53 150.09 52.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.049 1.339 . . . . 0.0 110.003 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 17.1 mt -106.11 118.47 54.9 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -71.15 148.52 56.31 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.236 1.957 . . . . 0.0 112.039 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -148.39 165.37 31.3 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 127.459 2.304 . . . . 0.0 109.003 170.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -128.46 140.83 51.62 Favored 'General case' 0 CA--C 1.523 -0.082 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 162.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.12 165.9 10.89 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 161.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -166.34 152.38 8.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 169.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -69.06 151.48 46.39 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 166.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -126.51 133.79 51.07 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.493 1.917 . . . . 0.0 106.509 172.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -101.2 148.32 25.23 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.49 0.716 . . . . 0.0 110.55 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 66.7 p -109.96 12.34 23.77 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.576 1.15 . . . . 0.0 111.089 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.97 -154.44 24.85 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.88 89.24 0.16 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.356 1.062 . . . . 0.0 110.721 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.62 119.95 9.65 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.405 1.882 . . . . 0.0 109.599 -176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.3 p -83.17 161.78 56.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 123.847 0.859 . . . . 0.0 109.449 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -75.02 173.4 14.58 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 119.777 0.956 . . . . 0.0 109.633 165.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.26 -111.75 0.49 Allowed Glycine 0 C--O 1.229 -0.215 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 172.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.84 168.19 14.19 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.063 1.745 . . . . 0.0 106.828 166.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.14 89.39 1.95 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -125.29 140.79 52.52 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 178.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -147.71 170.06 18.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.535 1.061 . . . . 0.0 109.563 171.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -142.08 115.25 8.83 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.175 1.39 . . . . 0.0 108.648 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -130.25 167.74 17.97 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.677 1.591 . . . . 0.0 110.332 172.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 76.9 p -121.05 145.59 47.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -100.35 135.98 40.94 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 170.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.473 ' HZ2' ' ND2' ' A' ' 171' ' ' ASN . 23.9 mmtt -81.55 169.26 17.3 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 157.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.575 HG22 ' CE2' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -113.64 152.13 15.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 127.998 2.519 . . . . 0.0 105.342 163.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -143.96 87.68 1.92 Allowed 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.596 1.558 . . . . 0.0 107.493 164.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.575 ' CE2' HG22 ' A' ' 156' ' ' VAL . 83.0 m-85 -60.79 163.22 5.85 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.494 166.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -161.85 162.76 29.47 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.765 1.226 . . . . 0.0 111.316 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 148.33 -15.95 1.3 Allowed Glycine 0 CA--C 1.521 0.443 0 CA-C-O 117.464 -1.742 . . . . 0.0 116.048 171.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -64.78 -83.17 0.09 OUTLIER Glycine 0 C--N 1.336 0.563 0 CA-C-N 120.31 2.055 . . . . 0.0 110.959 -174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.463 ' H ' ' CB ' ' A' ' 166' ' ' ALA . . . -47.98 -55.73 9.71 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-O 118.502 -1.166 . . . . 0.0 111.563 166.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.97 39.65 5.12 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.063 0.932 . . . . 0.0 111.028 -172.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 178.9 -55.5 0.09 OUTLIER Glycine 0 C--N 1.334 0.442 0 O-C-N 121.672 -0.899 . . . . 0.0 111.616 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -121.32 33.88 4.18 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.275 1.417 . . . . 0.0 111.007 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.463 ' CB ' ' H ' ' A' ' 162' ' ' GLY . . . -128.91 100.37 5.65 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 123.99 0.916 . . . . 0.0 110.277 -177.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -148.91 167.76 24.86 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 125.413 1.485 . . . . 0.0 110.522 -174.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 56.6 m -142.1 84.34 1.87 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.1 m -77.11 116.0 17.38 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.009 1.323 . . . . 0.0 108.336 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 28.2 m -134.84 162.15 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 125.697 1.599 . . . . 0.0 110.166 -175.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.473 ' ND2' ' HZ2' ' A' ' 155' ' ' LYS . 9.9 m-80 -75.68 159.49 31.08 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.91 -1.119 . . . . 0.0 109.332 169.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -129.73 -67.35 0.11 Allowed Glycine 0 CA--C 1.52 0.374 0 CA-C-O 119.475 -0.625 . . . . 0.0 111.655 -163.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 175.85 175.42 43.23 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 117.412 0.606 . . . . 0.0 111.64 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 54.0 m -104.06 138.46 40.55 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.058 1.343 . . . . 0.0 109.214 -174.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.79 92.95 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -73.13 85.01 1.34 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.325 1.85 . . . . 0.0 108.234 174.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -67.45 125.16 25.26 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -131.17 163.38 27.84 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.454 1.102 . . . . 0.0 109.895 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 140.77 -162.71 26.64 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 -172.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -165.06 170.08 15.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.55 125.51 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 167.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.429 ' C ' ' H ' ' A' ' 184' ' ' ALA . 3.8 m -103.68 151.83 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 126.506 1.923 . . . . 0.0 108.424 173.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.39 25.05 0.08 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.685 1.594 . . . . 0.0 113.567 -169.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.247 0.963 0 C-N-CA 129.209 3.004 . . . . 0.0 110.756 -168.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.725 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.62 127.13 28.73 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 168.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.9 m -165.7 163.19 19.08 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.673 1.989 . . . . 0.0 106.227 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 56.49 -115.22 0.89 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.88 173.5 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.519 1.528 . . . . 0.0 109.537 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -60.11 -35.44 75.24 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.063 1.345 . . . . 0.0 112.582 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.51 -89.93 2.13 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.57 -103.16 2.3 Favored Glycine 0 CA--C 1.503 -0.703 0 N-CA-C 105.859 -2.896 . . . . 0.0 105.859 166.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 t -114.44 83.39 1.88 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 168.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 p 41.14 76.45 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 122.85 1.31 . . . . 0.0 112.035 157.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.545 ' CD2' ' H ' ' A' ' 11' ' ' HIS . 17.4 p80 -74.51 40.39 0.13 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.555 1.142 . . . . 0.0 111.551 -172.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -80.18 -6.8 58.4 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 120.527 -1.358 . . . . 0.0 111.497 -171.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? 58.3 32.64 22.31 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.033 2.533 . . . . 0.0 112.309 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.17 -16.35 80.7 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.404 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.82 -164.39 1.83 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.403 2.281 . . . . 0.0 108.565 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.3 t -57.39 -27.55 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 126.482 1.913 . . . . 0.0 112.199 -175.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 t 44.46 56.9 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 126.69 1.996 . . . . 0.0 112.358 -170.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -144.54 101.77 3.72 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.49 1.138 . . . . 0.0 109.688 155.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.89 115.42 10.56 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.55 -22.2 61.36 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 123.973 0.796 . . . . 0.0 112.982 -167.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.4 m -118.84 156.23 29.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.087 1.355 . . . . 0.0 107.364 171.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.33 171.64 14.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.477 0.656 . . . . 0.0 109.779 156.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.63 150.26 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 168.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 26' ' ' GLY . 23.2 t0 -87.22 18.0 3.97 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -171.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 69.99 -34.75 0.3 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 130.177 3.391 . . . . 0.0 110.305 -166.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 24' ' ' ASP . . . -69.61 -18.32 73.73 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-O 119.057 -0.857 . . . . 0.0 113.966 -172.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -108.24 -7.08 16.06 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.35 1.06 . . . . 0.0 111.209 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.93 -32.18 26.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 C-N-CA 125.22 1.408 . . . . 0.0 111.338 -170.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -148.8 73.09 1.21 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 -172.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.1 142.35 38.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -171.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.5 m -112.59 100.1 8.47 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 172.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.35 102.15 2.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -79.53 100.54 7.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.6 mt -64.77 -19.01 65.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.635 1.974 . . . . 0.0 110.399 169.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.12 -178.15 41.31 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 125.244 1.402 . . . . 0.0 111.662 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -66.13 154.47 39.59 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.7 t -140.21 143.07 30.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 124.49 1.116 . . . . 0.0 108.514 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -76.19 133.68 40.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 p -58.73 -23.09 59.18 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.167 0.987 . . . . 0.0 110.627 174.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.46 74.57 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.158 -0.964 . . . . 0.0 111.041 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.2 m -69.74 -10.69 59.32 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.9 mt -140.55 79.44 1.7 Allowed 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 120.071 1.305 . . . . 0.0 107.547 -162.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.01 1.47 0.98 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.22 152.16 37.89 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.429 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 50.9 tt0 -61.33 125.39 23.59 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.412 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 101.46 -10.66 57.94 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 118.014 -1.437 . . . . 0.0 112.976 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.05 155.18 20.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.972 1.886 . . . . 0.0 110.227 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.8 p -136.44 161.63 35.29 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.425 0.557 . . . . 0.0 110.814 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.2 p -73.58 -163.31 0.16 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.458 0.703 . . . . 0.0 111.356 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.4 m -46.11 -31.68 2.49 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 126.979 2.111 . . . . 0.0 114.655 166.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 63.51 167.05 0.14 Allowed 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 126.359 2.287 . . . . 0.0 110.055 -166.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -162.05 143.35 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 C-N-CA 126.119 1.768 . . . . 0.0 106.276 -167.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.57 121.52 5.39 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 107.228 -2.349 . . . . 0.0 107.228 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -121.17 134.58 55.22 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -115.04 131.66 56.85 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -167.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.8 mm -89.89 108.8 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -77.61 118.46 20.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 mt -122.31 121.4 36.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -91.91 162.43 14.42 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.358 1.063 . . . . 0.0 110.068 -172.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.0 t0 47.33 42.52 13.98 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.889 1.675 . . . . 0.0 112.276 167.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.3 m -63.74 136.49 57.5 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.511 0.724 . . . . 0.0 109.292 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -121.47 103.78 9.18 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.837 0.855 . . . . 0.0 110.739 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.517 ' HG1' ' ND2' ' A' ' 126' ' ' ASN . 44.9 p -63.98 -19.91 65.5 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.957 0.903 . . . . 0.0 112.037 -174.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -61.89 -37.52 84.89 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.318 1.447 . . . . 0.0 110.577 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.5 t -78.3 -57.91 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.1 125.27 3.96 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -166.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 m -71.4 -14.76 62.27 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 118.566 -0.731 . . . . 0.0 111.93 169.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -132.42 162.8 30.23 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 120.019 1.281 . . . . 0.0 111.689 -173.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.08 136.06 45.66 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 154.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.8 169.14 11.88 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 147.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.0 t -120.59 163.19 18.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 165.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.62 163.11 33.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.872 2.069 . . . . 0.0 107.526 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -133.74 152.18 51.81 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.091 1.756 . . . . 0.0 109.729 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.7 tp -152.31 131.07 12.4 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 122.805 0.442 . . . . 0.0 110.847 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.21 -172.12 34.82 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.15 163.96 1.43 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.061 1.744 . . . . 0.0 110.373 171.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.53 130.47 53.56 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 125.753 1.621 . . . . 0.0 109.143 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.6 tt -60.62 -46.77 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 O-C-N 123.413 0.446 . . . . 0.0 110.526 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.1 164.86 32.59 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.75 -15.84 63.83 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.21 -0.24 74.17 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.888 1.232 . . . . 0.0 112.386 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -143.45 41.21 1.47 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.963 1.705 . . . . 0.0 109.691 -167.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.2 p -61.11 -19.85 61.95 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.199 -0.938 . . . . 0.0 112.324 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -75.51 -7.22 53.61 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.855 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.7 t -124.7 130.43 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.711 1.141 . . . . 0.0 108.702 -168.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mt -74.71 151.33 39.23 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.812 1.245 . . . . 0.0 111.133 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.06 19.91 10.96 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.147 2.179 . . . . 0.0 114.093 -163.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.7 mt 53.44 -163.85 0.1 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.983 1.313 . . . . 0.0 110.872 -164.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -148.05 164.08 34.93 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.441 1.096 . . . . 0.0 110.485 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.8 m 53.73 -166.96 0.07 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.912 1.285 . . . . 0.0 110.262 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m 24.42 70.3 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 128.546 2.739 . . . . 0.0 114.906 158.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -38.82 -39.4 0.51 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.122 1.769 . . . . 0.0 113.229 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.09 29.58 3.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.602 1.161 . . . . 0.0 111.478 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.54 -21.03 6.28 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 166.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 m -64.94 173.81 2.18 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.417 -1.049 . . . . 0.0 110.079 162.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.08 168.77 2.32 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.396 157.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.9 p -126.85 170.38 12.28 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 127.263 2.225 . . . . 0.0 108.645 171.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 53.51 29.54 9.21 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 127.472 2.309 . . . . 0.0 111.329 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.1 p -148.44 151.14 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 124.126 0.971 . . . . 0.0 108.565 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.72 -176.21 21.12 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.4 t -102.54 138.8 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -115.58 159.89 20.69 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.524 1.056 . . . . 0.0 110.411 171.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.38 137.38 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 170.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.69 151.84 50.59 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.718 -177.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -66.6 179.22 1.08 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.042 0.925 . . . . 0.0 111.975 160.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -44.22 -33.92 1.71 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 129.191 2.996 . . . . 0.0 114.966 168.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.4 p -87.83 -7.14 57.66 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.183 1.356 . . . . 0.0 110.846 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.38 22.34 78.77 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.798 1.666 . . . . 0.0 112.419 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.8 34.13 0.49 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -165.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 33.08 94.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 129.051 2.941 . . . . 0.0 114.978 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.73 136.31 56.09 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.82 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 16.9 m -68.61 167.7 14.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 166.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 66.9 mt -119.73 70.58 0.86 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -168.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -113.82 -11.77 12.82 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.862 0.865 . . . . 0.0 111.816 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.65 -12.38 4.81 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.082 -1.011 . . . . 0.0 113.894 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -133.45 -10.67 2.83 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.945 1.298 . . . . 0.0 112.942 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.4 t -61.22 123.52 17.97 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 164.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -84.57 157.88 21.09 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.2 t -104.11 174.37 5.9 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.438 1.495 . . . . 0.0 109.073 173.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.31 13.98 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.525 1 C-N-CA 134.708 5.203 . . . . 0.0 120.765 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 44.69 -179.63 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 130.314 3.445 . . . . 0.0 113.458 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 m -158.43 137.66 11.59 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 157.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.0 m -77.82 110.86 13.07 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 175.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.4 mt -72.44 -174.11 1.28 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.413 2.285 . . . . 0.0 108.221 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -151.45 176.17 11.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.6 1.96 . . . . 0.0 108.723 169.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.517 ' ND2' ' HG1' ' A' ' 63' ' ' THR . 2.6 m120 -68.16 101.32 1.15 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 137.77 -170.36 23.75 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.788 1.185 . . . . 0.0 110.698 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 51.4 m -76.74 129.19 35.97 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.087 -1.243 . . . . 0.0 110.0 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -123.41 166.35 15.5 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.289 1.436 . . . . 0.0 109.333 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.0 m -154.71 147.44 24.34 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.037 0.923 . . . . 0.0 109.666 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.2 mt -130.33 111.31 16.64 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 -171.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.67 100.16 0.86 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.918 3.079 . . . . 0.0 110.367 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.86 166.62 20.74 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 171.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -117.32 155.84 28.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 168.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.53 163.55 34.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.673 1.989 . . . . 0.0 107.835 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -175.41 156.06 1.93 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.467 1.907 . . . . 0.0 107.626 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -71.83 147.22 47.4 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 156.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.412 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 31.1 t80 -123.55 121.0 34.51 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.423 1.889 . . . . 0.0 106.893 176.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.88 141.31 32.32 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.429 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 46.4 p -100.41 11.07 40.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.463 0.705 . . . . 0.0 111.599 169.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 158.59 -148.22 17.03 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.82 82.37 0.2 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.15 1.78 . . . . 0.0 110.214 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.31 157.51 28.92 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.247 1.019 . . . . 0.0 111.342 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.1 p -123.79 153.95 67.07 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 124.592 1.157 . . . . 0.0 109.964 -176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.86 163.41 26.06 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.434 1.422 . . . . 0.0 111.018 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.23 -116.51 0.72 Allowed Glycine 0 N--CA 1.469 0.877 0 C-N-CA 124.442 1.02 . . . . 0.0 111.045 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -119.89 145.36 46.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.164 0.982 . . . . 0.0 109.668 167.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -134.45 86.16 2.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -120.48 146.72 45.98 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -149.0 175.16 11.54 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -152.48 152.95 32.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 173.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.13 175.34 9.66 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.836 2.455 . . . . 0.0 107.881 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.9 p -116.54 153.52 32.04 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 155.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -112.54 151.54 29.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -131.28 157.62 42.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 9.3 t -122.85 133.81 67.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -169.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -120.84 85.13 2.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -67.92 128.85 38.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.983 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -153.64 176.67 11.81 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 124.801 1.24 . . . . 0.0 111.452 -174.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 129.16 -50.58 0.88 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -173.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -68.77 173.53 34.17 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 173.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.9 169.12 41.4 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 69.54 4.88 47.76 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 119.518 -0.601 . . . . 0.0 112.215 -169.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 149.95 87.62 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -172.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 100.23 74.68 1.12 Allowed Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -123.91 115.0 20.58 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 69.4 75.3 0.23 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 126.756 2.022 . . . . 0.0 112.119 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 10.1 m -79.48 99.48 7.26 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 164.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.9 m -78.16 129.64 35.38 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 165.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.18 151.84 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.713 1.605 . . . . 0.0 109.722 -176.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -61.48 139.59 58.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.7 -56.73 0.56 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 166.42 -171.35 41.38 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -175.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.5 m -103.15 138.4 40.02 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.75 1.22 . . . . 0.0 109.657 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.1 t -119.72 103.07 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -82.67 141.99 32.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 171.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -121.16 113.74 20.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -124.75 156.39 37.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 118.582 0.628 . . . . 0.0 110.677 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 148.59 -162.6 28.89 Favored Glycine 0 N--CA 1.437 -1.279 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 -167.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.25 177.22 3.66 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 -173.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.4 t -125.87 135.98 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.409 ' C ' ' H ' ' A' ' 184' ' ' ALA . 14.8 m -118.86 149.97 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 C-N-CA 127.59 2.356 . . . . 0.0 108.492 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -74.99 34.18 0.1 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.248 1.006 0 C-N-CA 130.269 3.428 . . . . 0.0 112.765 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.36 142.26 22.09 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 156.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.6 m -132.57 152.77 51.5 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.039 1.336 . . . . 0.0 108.795 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.4 t -143.56 150.81 39.4 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 159.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 p -173.36 160.95 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 128.412 2.685 . . . . 0.0 105.541 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -120.05 158.05 27.63 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.564 1.146 . . . . 0.0 110.712 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.44 -39.98 2.17 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.254 1.883 . . . . 0.0 112.638 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.36 -97.96 0.11 Allowed Glycine 0 C--N 1.334 0.425 0 N-CA-C 105.694 -2.962 . . . . 0.0 105.694 169.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.4 t -145.86 113.54 6.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 160.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.291 4.3 p 22.74 85.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.087 1.355 . . . . 0.0 112.112 145.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -53.93 -78.46 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.676 0.79 . . . . 0.0 111.321 -155.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 176.69 71.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 130.553 3.541 . . . . 0.0 101.678 165.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -85.74 -103.7 0.06 Allowed 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.13 -13.76 65.4 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 123.614 0.626 . . . . 0.0 113.781 163.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -142.89 -158.46 0.87 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.97 2.108 . . . . 0.0 106.412 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.0 t -55.92 -20.08 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.773 1.229 . . . . 0.0 111.391 167.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 56.4 45.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.726 1.211 . . . . 0.0 110.238 -166.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -152.21 99.95 2.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 162.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.13 133.85 52.67 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 165.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.11 -37.44 46.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 116.671 -1.633 . . . . 0.0 111.913 172.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.1 m -121.48 164.86 16.48 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 125.104 1.503 . . . . 0.0 112.128 -167.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.43 -12.81 25.3 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.974 1.31 . . . . 0.0 113.866 -170.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.8 t 50.06 109.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 130.191 3.396 . . . . 0.0 112.127 -174.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.06 151.68 39.23 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.001 -1.062 . . . . 0.0 109.525 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.82 -33.72 17.54 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.353 1.461 . . . . 0.0 111.189 166.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.35 -6.03 1.98 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.442 1.496 . . . . 0.0 114.537 171.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.5 p -132.69 -34.93 1.13 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.847 1.824 . . . . 0.0 112.342 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.0 p -62.13 -55.23 25.42 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 123.396 0.679 . . . . 0.0 111.282 -170.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.446 ' CG ' ' HE2' ' A' ' 176' ' ' HIS . 10.0 t70 -132.04 67.8 1.51 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -165.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -105.72 140.3 38.98 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.902 -1.499 . . . . 0.0 108.295 -161.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.1 m -110.32 94.59 5.09 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.6 t -77.65 104.32 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -86.68 107.79 18.36 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 mt -85.37 -3.39 58.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.8 1.24 . . . . 0.0 110.029 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.5 -178.34 23.76 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 125.241 1.4 . . . . 0.0 112.298 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -65.74 151.51 46.42 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.088 0.555 . . . . 0.0 109.877 162.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.46 152.95 34.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 C-N-CA 125.919 1.688 . . . . 0.0 107.578 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -83.2 134.92 34.94 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.1 p -59.31 -21.94 60.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.82 0.448 . . . . 0.0 111.735 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.1 -31.44 70.04 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.684 -1.26 . . . . 0.0 112.229 171.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -74.05 -9.58 58.77 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.854 0.861 . . . . 0.0 111.449 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.6 mt -143.35 76.56 1.53 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.176 1.39 . . . . 0.0 107.715 -159.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.93 -1.27 2.21 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -171.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -151.14 161.29 43.0 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 35.6 tt0 -64.08 126.76 28.73 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.27 2.53 79.99 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.995 -0.891 . . . . 0.0 113.166 -174.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.45 159.55 34.01 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.642 1.721 . . . . 0.0 109.779 161.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.0 p -149.67 162.81 39.49 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.301 0.64 . . . . 0.0 110.203 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.5 p -73.85 174.8 7.98 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.646 -0.659 . . . . 0.0 110.339 168.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -55.13 -17.27 3.92 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 83.0 160.62 0.13 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 129.765 3.226 . . . . 0.0 112.121 173.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.1 t -143.26 140.53 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.85 130.0 10.09 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 107.152 -2.379 . . . . 0.0 107.152 169.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -136.49 130.19 32.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.422 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 2.8 m-20 -109.64 165.48 11.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -169.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.9 mm -116.74 99.33 8.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -68.36 95.84 0.63 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.902 1.681 . . . . 0.0 110.281 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.45 158.31 19.62 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 122.473 1.13 . . . . 0.0 109.123 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -163.39 155.59 17.87 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 126.794 2.037 . . . . 0.0 107.547 -169.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 45.55 59.2 3.74 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 127.91 2.484 . . . . 0.0 111.079 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.8 m -108.77 107.81 18.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.389 2.275 . . . . 0.0 111.15 -168.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -79.4 158.45 27.37 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.679 1.127 . . . . 0.0 111.121 172.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.4 p -100.52 -18.04 16.83 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.226 1.41 . . . . 0.0 113.554 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -64.77 -46.85 80.39 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.403 1.081 . . . . 0.0 109.063 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -57.96 -53.05 50.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 114.184 -1.371 . . . . 0.0 107.442 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.19 142.26 21.34 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 166.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -93.75 11.39 29.31 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.394 172.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HE3' ' OE1' ' A' ' 159' ' ' GLN . 7.7 mtmt -148.48 163.34 37.47 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.036 1.334 . . . . 0.0 108.724 168.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.84 177.08 9.85 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 123.764 0.665 . . . . 0.0 109.486 157.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.54 178.37 8.18 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 128.696 2.798 . . . . 0.0 107.726 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.6 t -143.85 100.96 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.435 1.894 . . . . 0.0 106.929 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.63 152.52 28.46 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 118.341 -0.838 . . . . 0.0 109.267 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -112.75 158.66 19.81 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 118.814 0.733 . . . . 0.0 110.328 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.9 tp -144.5 153.45 41.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.747 1.619 . . . . 0.0 108.002 175.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.0 170.69 33.92 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 m -64.45 131.44 47.14 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.191 1.397 . . . . 0.0 109.334 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.94 135.65 43.25 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.613 1.097 . . . . 0.0 110.366 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.7 tt -63.19 -35.29 71.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.229 0.611 . . . . 0.0 111.076 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -159.57 166.53 30.58 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.392 1.477 . . . . 0.0 108.755 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.44 -19.86 57.82 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 127.654 2.382 . . . . 0.0 114.612 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.2 -20.23 43.01 Favored Glycine 0 CA--C 1.524 0.629 0 O-C-N 120.838 -1.164 . . . . 0.0 112.149 171.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -125.02 53.76 1.48 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.634 1.573 . . . . 0.0 108.18 -170.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.9 p -63.58 -15.56 58.45 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 127.303 2.241 . . . . 0.0 111.99 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -97.04 2.84 51.89 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.717 2.007 . . . . 0.0 113.073 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 t -128.35 141.13 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 120.157 1.344 . . . . 0.0 109.392 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.41 146.11 30.45 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.271 -169.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.95 14.52 10.32 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.629 1.572 . . . . 0.0 114.509 -166.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.5 mt 51.51 -154.3 0.17 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.328 1.051 . . . . 0.0 110.556 -167.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -145.34 94.67 2.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.504 -0.747 . . . . 0.0 110.729 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.7 m 51.58 -148.59 0.37 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.084 170.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.7 m 141.43 65.05 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 121.342 1.883 . . . . 0.0 108.844 141.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.62 -77.7 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.566 1.947 . . . . 0.0 111.46 -171.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.79 27.16 1.19 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.078 1.751 . . . . 0.0 112.727 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.06 36.93 86.8 Favored Glycine 0 C--N 1.334 0.417 0 O-C-N 121.739 -0.601 . . . . 0.0 113.458 163.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.83 -173.13 0.08 Allowed 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 126.458 1.903 . . . . 0.0 112.884 -171.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.79 125.73 14.06 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 148.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.1 p -90.3 172.6 8.66 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 56.6 28.62 14.26 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.993 1.717 . . . . 0.0 111.361 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.28 151.29 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.858 0.863 . . . . 0.0 109.485 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.6 175.18 29.73 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 124.382 0.991 . . . . 0.0 110.815 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.2 t -85.11 126.54 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -98.87 144.61 27.88 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 164.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.6 mp -118.41 146.95 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 169.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 mt -141.52 151.42 43.26 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.201 1.4 . . . . 0.0 107.643 -172.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -59.25 -75.08 0.06 Allowed 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.118 0.485 . . . . 0.0 111.073 170.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.1 ptt-85 -176.0 -24.57 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 128.055 2.542 . . . . 0.0 109.415 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.4 p -80.58 -28.17 37.24 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.107 1.363 . . . . 0.0 108.588 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.6 7.06 9.13 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.016 1.77 . . . . 0.0 112.591 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.88 104.87 2.17 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 120.146 1.973 . . . . 0.0 108.402 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.95 100.78 0.22 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.166 0.986 . . . . 0.0 109.279 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.34 132.48 52.76 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.888 0.875 . . . . 0.0 109.251 -170.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 49.3 m -74.63 148.34 40.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.32 0.581 . . . . 0.0 109.789 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.7 mt -92.35 81.55 4.93 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -127.61 -24.42 3.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.6 1.96 . . . . 0.0 111.324 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.84 7.78 71.1 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.14 1.353 . . . . 0.0 113.548 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -140.17 -29.17 0.71 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.785 1.292 . . . . 0.0 112.482 170.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.4 m -53.81 115.09 1.81 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.633 1.173 . . . . 0.0 108.846 173.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -71.52 179.64 2.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.309 1.052 . . . . 0.0 112.384 -164.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.8 p -134.27 126.22 29.34 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.938 1.695 . . . . 0.0 107.791 167.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.6 m 23.2 85.25 0.01 OUTLIER 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.757 2.023 . . . . 0.0 114.083 147.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -61.61 144.95 53.61 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.128 -162.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.9 m -113.71 114.21 26.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 86.0 m -53.74 110.58 0.6 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 154.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.0 mt -72.84 176.9 5.23 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 170.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.12 162.22 30.38 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 121.621 -0.675 . . . . 0.0 109.993 171.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.37 132.18 47.54 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 94.7 -118.54 5.85 Favored Glycine 0 C--O 1.223 -0.58 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.9 m -118.54 144.47 46.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.455 1.102 . . . . 0.0 109.706 -164.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.417 ' C ' ' HG1' ' A' ' 130' ' ' THR . 0.0 OUTLIER -160.63 171.5 18.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.127 1.371 . . . . 0.0 109.309 -173.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.422 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 97.1 m -154.32 163.78 39.62 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 119.527 -1.983 . . . . 0.0 108.637 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -122.05 121.0 28.14 Favored Pre-proline 0 N--CA 1.446 -0.638 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 168.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -70.62 135.64 28.86 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 N-CA-C 108.026 -1.567 . . . . 0.0 108.026 160.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -120.54 170.78 9.08 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.802 0.841 . . . . 0.0 108.75 163.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.77 143.33 50.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 168.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -115.74 164.5 14.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.694 1.197 . . . . 0.0 107.915 162.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -164.77 152.33 11.53 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 167.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -69.5 142.09 53.79 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 165.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -121.74 122.01 38.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.18 141.79 29.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.403 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 65.4 p -101.43 7.35 42.59 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.271 1.028 . . . . 0.0 111.302 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.81 -151.97 21.3 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.17 91.98 0.08 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.069 1.348 . . . . 0.0 109.658 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.34 144.46 34.19 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.529 0.732 . . . . 0.0 110.897 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.2 p -110.56 165.58 12.4 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.014 0.925 . . . . 0.0 110.019 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.9 174.48 12.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.166 1.911 . . . . 0.0 111.17 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.96 -85.55 0.14 Allowed Glycine 0 C--N 1.336 0.555 0 O-C-N 121.36 -0.838 . . . . 0.0 113.819 167.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -147.11 162.9 37.91 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.311 2.244 . . . . 0.0 105.771 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -151.74 68.42 0.89 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 119.443 1.02 . . . . 0.0 110.133 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -114.73 150.37 35.4 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.08 169.95 20.58 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 169.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -132.93 120.53 21.57 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 174.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -120.44 159.64 24.72 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.933 1.693 . . . . 0.0 108.95 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.0 p -124.54 141.33 52.17 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 162.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -104.36 155.94 18.34 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 168.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -119.5 131.03 55.49 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 171.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.21 137.98 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 171.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -128.8 90.15 3.0 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 171.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -62.23 161.52 11.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 166.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.45 ' OE1' ' HE3' ' A' ' 68' ' ' LYS . 8.2 mt-30 -103.35 -142.99 0.36 Allowed 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 125.027 1.331 . . . . 0.0 108.044 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -131.9 9.85 5.44 Favored Glycine 0 N--CA 1.434 -1.468 1 C-N-CA 113.642 -4.123 . . . . 0.0 118.419 126.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.423 ' HA2' ' HE2' ' A' ' 68' ' ' LYS . . . 86.41 13.03 68.84 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 120.996 2.398 . . . . 0.0 111.852 -176.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -84.04 -168.06 43.28 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 150.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.25 76.46 0.39 Allowed Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.36 101.24 0.6 Allowed Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 142.32 9.42 0.57 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 124.525 1.059 . . . . 0.0 113.701 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -155.51 123.44 5.73 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.966 0.907 . . . . 0.0 109.544 174.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -164.67 153.85 13.14 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.265 1.826 . . . . 0.0 110.848 173.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.3 m -137.92 92.8 2.7 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.566 1.546 . . . . 0.0 108.04 -173.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.51 126.15 28.4 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 167.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.38 140.58 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.624 1.17 . . . . 0.0 109.328 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -58.96 143.13 49.07 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -114.68 -87.77 1.51 Allowed Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -144.58 -144.35 4.16 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 126.711 2.101 . . . . 0.0 112.137 -167.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 96.5 m -138.18 149.42 45.83 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.333 2.253 . . . . 0.0 108.2 166.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.7 t -115.73 119.15 61.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 163.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . 0.446 ' HE2' ' CG ' ' A' ' 29' ' ' ASP . 45.4 m-70 -96.97 94.51 7.23 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -72.35 119.5 16.64 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -124.95 160.27 29.29 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 138.15 -169.91 24.03 Favored Glycine 0 C--N 1.321 -0.292 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -171.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -162.66 177.05 9.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -167.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 41.3 t -126.69 131.06 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 167.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.3 m -101.9 155.9 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 127.354 2.262 . . . . 0.0 108.227 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.13 37.79 0.16 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.421 1.088 . . . . 0.0 113.494 -172.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 C-N-CA 127.844 2.457 . . . . 0.0 110.371 -167.189 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.55 151.77 39.41 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.325 1.421 . . . . 0.0 110.357 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -136.82 -25.57 1.09 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -166.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.254 3.6 t 37.06 -158.71 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 128.876 2.87 . . . . 0.0 116.16 164.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 p -82.96 79.31 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 126.395 1.878 . . . . 0.0 108.324 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -75.92 82.83 2.83 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.046 -1.034 . . . . 0.0 109.148 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.71 -98.8 0.13 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.155 -0.803 . . . . 0.0 112.728 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.26 -40.72 1.68 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.412 1.482 . . . . 0.0 110.003 -171.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.55 84.39 1.8 Allowed 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 157.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.25 10.2 p 24.31 68.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 128.577 2.751 . . . . 0.0 113.249 164.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -74.65 -38.43 62.49 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.937 -175.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 t80 85.3 -2.36 0.85 Allowed 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 128.771 2.828 . . . . 0.0 113.085 165.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt 47.0 104.43 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.125 0 CA-C-O 124.378 2.037 . . . . 0.0 109.355 -140.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -56.84 78.3 0.01 OUTLIER Glycine 0 C--N 1.306 -1.096 0 C-N-CA 126.937 2.208 . . . . 0.0 111.987 166.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.3 0.0 OUTLIER 72.25 168.04 0.31 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.466 2.306 . . . . 0.0 110.222 -177.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . 0.431 2.1 p 53.17 -42.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.511 1 C-N-CA 133.01 4.524 . . . . 0.0 113.336 -164.852 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 t 41.85 31.14 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 128.513 2.725 . . . . 0.0 115.394 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -134.86 107.5 7.41 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 -176.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.3 110.83 21.5 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 171.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -30.78 -52.8 0.18 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 126.58 1.952 . . . . 0.0 111.452 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 1.8 m -103.73 143.3 32.98 Favored 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 124.684 1.24 . . . . 0.0 108.774 166.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.97 172.26 1.83 Allowed 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 124.621 1.201 . . . . 0.0 109.918 164.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.8 137.55 55.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -71.37 158.2 36.74 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.779 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.03 -32.56 69.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.176 0.99 . . . . 0.0 111.869 172.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.65 3.36 60.22 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.435 -1.203 . . . . 0.0 113.901 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.8 t -128.39 -40.92 1.58 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.355 1.462 . . . . 0.0 109.087 -169.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.0 p -56.57 -41.46 73.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 123.992 0.917 . . . . 0.0 111.06 171.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.43 ' CG ' ' HE2' ' A' ' 176' ' ' HIS . 5.1 t70 -131.4 69.02 1.48 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.074 0.94 . . . . 0.0 109.503 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -103.02 129.48 49.81 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.545 -171.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.45 99.34 10.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 172.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.2 t -85.17 115.21 26.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -90.04 108.35 19.67 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.68 -16.52 62.25 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.566 0.747 . . . . 0.0 109.801 173.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.48 -175.53 52.98 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -71.27 156.81 39.09 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.497 0.719 . . . . 0.0 109.484 171.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.3 t -141.63 146.57 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.5 1.92 . . . . 0.0 107.026 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.11 137.54 37.54 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.8 p -59.87 -20.85 59.5 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.254 0.622 . . . . 0.0 111.337 173.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.48 -39.43 87.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.245 1.018 . . . . 0.0 111.883 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.4 m -67.66 -9.27 41.82 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mt -142.05 60.93 1.46 Allowed 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 125.882 1.673 . . . . 0.0 110.412 -162.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.64 -3.8 7.19 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -166.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.504 HE21 ' HB3' ' A' ' 47' ' ' ALA . 2.7 pm0 -153.45 160.26 42.54 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.516 1.526 . . . . 0.0 107.19 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -61.52 135.09 57.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.98 0.895 . . . . 0.0 109.131 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.91 -7.88 64.87 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-O 117.088 -1.951 . . . . 0.0 112.982 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.504 ' HB3' HE21 ' A' ' 44' ' ' GLN . . . -58.8 155.93 12.11 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 120.239 2.019 . . . . 0.0 110.51 165.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.3 p -146.74 150.51 35.49 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.688 0.756 . . . . 0.0 110.382 -171.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.5 t -59.54 164.57 3.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 163.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 m -46.35 -81.17 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.335 1.054 . . . . 0.0 112.772 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 173.32 143.49 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.53 1.932 . . . . 0.0 106.839 -172.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 t -141.29 130.46 24.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 170.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.55 126.53 8.93 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -131.55 78.01 1.8 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 123.707 1.718 . . . . 0.0 109.539 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.16 153.51 43.04 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.362 -173.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.9 mm -94.3 104.08 15.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.39 112.92 2.63 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.886 -1.154 . . . . 0.0 107.886 167.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.87 167.0 11.52 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 161.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -137.92 169.7 17.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.401 1.481 . . . . 0.0 107.485 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 43.47 54.02 5.46 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 128.287 2.635 . . . . 0.0 114.712 164.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 2.0 t -81.12 168.71 18.28 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -137.73 141.62 40.99 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.804 2.442 . . . . 0.0 106.446 172.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.1 p -95.72 -12.63 25.14 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.372 1.069 . . . . 0.0 113.138 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -60.71 -49.36 77.82 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.919 1.288 . . . . 0.0 109.475 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 p -59.64 -58.92 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 113.692 -1.595 . . . . 0.0 107.378 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.4 132.02 9.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.38 1.872 . . . . 0.0 107.38 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.49 -18.53 61.1 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.838 170.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -129.2 157.4 41.94 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 119.605 1.093 . . . . 0.0 110.856 -164.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.94 145.73 46.47 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 124.974 1.31 . . . . 0.0 107.74 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.5 164.95 23.7 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 124.509 1.124 . . . . 0.0 108.534 157.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -153.77 92.07 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 -169.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.04 165.77 24.38 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.966 0.907 . . . . 0.0 109.405 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -130.22 163.42 26.75 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.16 1.384 . . . . 0.0 109.136 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 tp -154.42 133.55 12.47 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.122 1.369 . . . . 0.0 109.217 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.31 177.07 42.56 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.7 m -73.77 130.7 40.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.105 0.962 . . . . 0.0 109.946 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.02 136.88 48.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 118.949 0.795 . . . . 0.0 111.3 176.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.5 tt -62.24 -42.04 93.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.758 0.823 . . . . 0.0 110.946 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -152.64 164.83 36.93 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.59 1.556 . . . . 0.0 106.924 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.15 82.6 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 126.22 1.808 . . . . 0.0 110.955 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.87 -4.83 78.12 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 119.541 -0.588 . . . . 0.0 112.476 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -143.02 41.84 1.53 Allowed 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.884 1.342 . . . . 0.0 110.53 -167.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 p -62.99 -13.38 34.34 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.209 2.204 . . . . 0.0 115.023 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -81.37 -13.48 58.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.761 0.315 . . . . 0.0 111.329 171.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.0 t -115.31 133.01 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 O-C-N 120.36 -1.462 . . . . 0.0 108.624 -166.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.08 148.11 38.16 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.649 1.18 . . . . 0.0 110.014 -174.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.77 14.89 12.3 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.301 1.84 . . . . 0.0 113.955 -164.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.4 mt 52.76 -155.35 0.19 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.125 0.97 . . . . 0.0 109.565 -163.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -127.82 -165.58 1.5 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.707 0.403 . . . . 0.0 110.856 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -53.78 -178.14 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.654 1.981 . . . . 0.0 111.778 171.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.48 ' HB3' ' HA3' ' A' ' 94' ' ' GLY . 0.7 OUTLIER 66.77 79.52 0.23 Allowed 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 125.97 1.708 . . . . 0.0 107.23 -149.442 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.85 -44.76 29.49 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.5 2.32 . . . . 0.0 112.011 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.73 -4.13 12.19 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.022 0.929 . . . . 0.0 111.455 175.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 91' ' ' SER . . . -74.31 -50.76 9.49 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.7 m -68.75 150.91 47.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.239 173.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.82 144.85 56.98 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.954 2.101 . . . . 0.0 110.044 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.8 p -90.96 165.93 13.3 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 56.55 20.85 5.19 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 127.286 2.234 . . . . 0.0 113.517 175.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -142.79 149.76 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 119.209 0.913 . . . . 0.0 108.844 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.94 174.99 24.81 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 124.864 1.221 . . . . 0.0 110.603 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.4 t -84.36 149.3 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -136.69 143.97 43.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.56 1.544 . . . . 0.0 106.935 175.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.35 137.29 57.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.9 mt -133.44 129.13 36.85 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.767 1.627 . . . . 0.0 107.061 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.0 p30 -55.45 -60.7 3.05 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -171.62 -45.31 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.294 2.238 . . . . 0.0 108.408 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.293 0.5 OUTLIER -82.05 18.65 1.3 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.427 1.891 . . . . 0.0 109.94 -177.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.8 10.94 48.02 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 120.252 -1.53 . . . . 0.0 112.105 -169.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.79 111.42 8.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.554 1.677 . . . . 0.0 107.484 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.78 138.86 58.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.11 0.564 . . . . 0.0 109.801 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 73.0 mt -108.33 110.25 21.78 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.418 0.687 . . . . 0.0 110.398 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -53.25 139.16 30.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.699 1.6 . . . . 0.0 110.6 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.6 mt -89.41 59.39 4.79 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 127.903 2.481 . . . . 0.0 108.015 -173.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.69 -31.98 10.53 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.314 0.578 . . . . 0.0 111.257 -174.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.74 -36.85 3.95 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-O 117.522 -1.71 . . . . 0.0 114.086 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.55 -16.56 13.63 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.91 1.355 . . . . 0.0 112.222 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.1 m -73.02 95.74 2.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -70.24 173.19 7.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.363 2.265 . . . . 0.0 110.786 -174.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.0 p -112.88 -170.36 1.66 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.302 1.441 . . . . 0.0 111.814 -172.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -44.43 142.59 1.53 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.579 1.552 . . . . 0.0 111.594 164.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -80.67 134.39 35.86 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.623 0.725 . . . . 0.0 109.156 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.9 m -113.93 113.26 24.59 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 167.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.7 m -61.44 143.5 55.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.9 mt -115.41 179.48 3.95 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.301 2.24 . . . . 0.0 109.105 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -134.03 167.87 19.84 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.347 1.459 . . . . 0.0 108.21 172.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -72.28 104.11 3.6 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.07 -149.9 18.26 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -173.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.95 138.36 31.48 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.269 1.028 . . . . 0.0 111.248 -165.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.78 169.0 24.57 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.449 1.9 . . . . 0.0 110.915 -174.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.6 m -151.99 150.39 29.94 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.534 1.134 . . . . 0.0 109.641 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.27 119.31 55.51 Favored Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 124.58 1.152 . . . . 0.0 108.784 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -81.54 83.69 2.09 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 124.011 3.141 . . . . 0.0 112.782 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -74.52 160.9 30.31 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.269 -0.894 . . . . 0.0 112.572 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -116.95 147.65 42.08 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 155.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -122.82 161.63 23.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.833 1.653 . . . . 0.0 107.121 160.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -157.61 160.16 37.79 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -76.76 148.83 36.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 163.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -124.19 127.23 47.43 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.254 1.422 . . . . 0.0 107.376 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.77 144.26 25.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.482 0.713 . . . . 0.0 109.639 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 24.8 p -104.35 8.33 35.87 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 123.617 0.767 . . . . 0.0 111.653 171.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 162.96 -150.35 19.17 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 107.944 -2.062 . . . . 0.0 107.944 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.8 89.74 0.27 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.582 1.153 . . . . 0.0 110.699 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.53 141.7 46.88 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.512 0.725 . . . . 0.0 109.672 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.6 p -92.72 160.6 33.95 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -75.96 157.84 38.61 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 121.126 1.218 . . . . 0.0 109.464 160.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.67 176.23 18.49 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.357 1.456 . . . . 0.0 109.685 -168.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.16 157.67 34.85 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.526 -0.984 . . . . 0.0 108.732 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -144.75 81.63 1.66 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.719 0.771 . . . . 0.0 110.174 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -124.77 152.1 44.27 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -173.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -156.11 175.34 14.1 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.702 1.201 . . . . 0.0 109.523 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -156.47 84.69 0.98 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.936 0.874 . . . . 0.0 110.642 -175.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.31 169.89 16.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.934 173.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.3 p -117.61 163.12 16.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.86 155.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -120.37 159.55 24.83 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.534 1.134 . . . . 0.0 109.91 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -129.1 125.27 36.83 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 167.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.31 143.32 15.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 163.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -137.26 82.24 1.92 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -67.51 154.03 42.35 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.744 -0.646 . . . . 0.0 109.687 176.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -158.32 176.12 12.87 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.498 1.119 . . . . 0.0 112.795 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 141.35 -32.53 2.07 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.095 1.331 . . . . 0.0 111.644 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -90.44 -141.69 9.28 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.439 1.971 . . . . 0.0 110.167 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 151.38 -13.98 0.82 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.963 1.268 . . . . 0.0 111.809 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -80.05 79.43 1.71 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 149.54 -100.5 0.21 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -87.84 -46.28 4.87 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 76.76 119.33 0.05 Allowed 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 127.753 2.421 . . . . 0.0 110.541 -168.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 59.61 175.6 0.08 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.512 2.325 . . . . 0.0 112.538 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.1 m -145.1 90.69 2.06 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.119 0.967 . . . . 0.0 109.341 -168.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.3 m -92.95 96.58 10.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.1 0.952 . . . . 0.0 110.678 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.53 135.12 51.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 125.767 1.627 . . . . 0.0 110.292 -174.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -55.78 107.67 0.37 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.452 1.101 . . . . 0.0 108.907 168.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -74.95 -58.05 4.19 Favored Glycine 0 CA--C 1.523 0.578 0 O-C-N 120.587 -1.321 . . . . 0.0 110.931 -168.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 169.33 -161.47 35.0 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -171.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.6 m -122.43 133.93 54.61 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 127.588 2.355 . . . . 0.0 107.008 -176.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.49 109.65 28.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . 0.43 ' HE2' ' CG ' ' A' ' 29' ' ' ASP . 20.2 m-70 -88.07 96.75 10.64 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -76.63 133.03 39.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -137.73 162.1 34.8 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 121.537 -0.727 . . . . 0.0 111.325 175.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 146.92 -155.87 26.75 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -169.97 175.28 5.18 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -168.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 32.0 t -128.22 136.99 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 184' ' ' ALA . 16.3 m -118.72 147.49 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 C-N-CA 126.495 1.918 . . . . 0.0 109.496 178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.35 25.31 0.1 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -167.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 128.54 2.736 . . . . 0.0 111.326 -167.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.35 106.06 4.12 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -155.53 121.83 5.19 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -173.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.0 m -153.68 101.67 2.49 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 173.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -66.06 134.38 29.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 162.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -63.48 92.8 0.07 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.285 1.434 . . . . 0.0 107.965 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.4 -87.78 0.71 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.6 -111.48 0.29 Allowed Glycine 0 C--N 1.336 0.541 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.55 96.83 4.22 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.263 11.4 p 41.98 48.8 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 127.33 2.252 . . . . 0.0 115.366 160.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -89.85 68.37 7.4 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.164 -1.585 . . . . 0.0 110.663 -164.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -144.98 -2.92 0.79 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -77.27 22.63 0.22 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -164.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.79 36.93 3.18 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -150.98 -171.71 4.01 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 171.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 p -55.23 -29.61 23.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.896 1.278 . . . . 0.0 112.478 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.1 t 25.71 63.67 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 126.923 2.089 . . . . 0.0 112.458 -172.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -136.77 105.86 5.98 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 170.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.71 139.11 53.81 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.12 -16.32 63.09 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.795 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.7 m -129.68 157.08 43.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.695 1.198 . . . . 0.0 107.829 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.25 107.14 15.59 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 161.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.12 118.58 2.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 121.104 -0.997 . . . . 0.0 108.859 167.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -70.97 163.88 26.62 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.737 -0.602 . . . . 0.0 111.135 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.27 -12.9 61.35 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.99 -1.069 . . . . 0.0 113.209 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.63 -1.65 90.04 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 121.233 -0.917 . . . . 0.0 112.787 167.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.4 t -121.82 -31.1 4.01 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.758 1.279 . . . . 0.0 110.765 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.1 p -63.75 -24.32 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 O-C-N 121.11 -0.994 . . . . 0.0 113.3 -175.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -157.01 53.67 0.51 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.664 0.786 . . . . 0.0 110.365 -162.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -99.49 143.37 29.81 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 120.543 -1.348 . . . . 0.0 110.404 -169.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.9 m -113.79 95.32 5.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 t -73.15 136.45 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -114.26 118.78 34.91 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.501 1.143 . . . . 0.0 108.464 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -85.94 -21.2 28.02 Favored 'General case' 0 N--CA 1.44 -0.974 1 C-N-CA 131.9 4.08 . . . . 0.0 108.422 177.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.45 -172.58 34.79 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 124.658 1.123 . . . . 0.0 111.144 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -67.57 112.77 4.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.806 0.842 . . . . 0.0 108.827 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.19 153.23 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 125.258 1.423 . . . . 0.0 107.691 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -86.32 136.34 33.18 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.3 p -60.66 -27.25 67.68 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 169.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.08 3.24 2.19 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.975 1.71 . . . . 0.0 113.789 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 m -121.45 7.0 10.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.866 1.267 . . . . 0.0 112.203 164.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 mt -142.26 71.79 1.36 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.397 1.879 . . . . 0.0 109.15 -171.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.55 4.46 3.37 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.813 -1.18 . . . . 0.0 113.901 -171.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -153.69 158.57 41.23 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.422 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 19.1 tt0 -61.42 136.42 58.03 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 172.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.411 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 86.42 -5.79 83.67 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 118.371 -1.238 . . . . 0.0 112.965 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.12 156.48 24.92 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.376 1.588 . . . . 0.0 109.892 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.2 p -146.29 155.44 42.65 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.309 0.959 . . . . 0.0 111.834 -176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -69.33 178.62 2.31 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.831 -0.543 . . . . 0.0 110.142 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.84 -21.27 4.02 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 81.62 129.57 0.05 OUTLIER 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 128.744 2.817 . . . . 0.0 112.572 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 m -133.56 129.2 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-O 122.932 1.349 . . . . 0.0 109.74 -158.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.19 149.96 39.91 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 171.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -154.09 154.57 33.86 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 162.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.462 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 4.6 m-20 -135.44 166.47 23.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.93 0.786 . . . . 0.0 109.854 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.2 mm -108.7 97.24 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 125.52 1.528 . . . . 0.0 107.281 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.65 132.56 51.48 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 170.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.6 mt -137.79 110.76 7.73 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.867 1.667 . . . . 0.0 107.72 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -86.01 150.63 24.34 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.978 1.311 . . . . 0.0 108.85 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 t70 36.96 70.73 0.16 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.231 2.613 . . . . 0.0 114.734 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.3 m -84.71 86.57 7.31 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 128.357 2.663 . . . . 0.0 112.267 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.82 103.76 0.96 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.505 1.922 . . . . 0.0 111.147 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -60.24 -19.79 56.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.365 1.066 . . . . 0.0 112.415 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -61.3 -36.63 80.64 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.769 1.228 . . . . 0.0 111.932 175.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.0 t -70.67 -49.59 50.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -165.3 127.59 2.11 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -171.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -68.3 -12.27 60.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 117.454 -1.26 . . . . 0.0 111.695 169.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.413 ' HA ' ' CD2' ' A' ' 124' ' ' LEU . 30.3 mtmt -136.33 157.61 46.39 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 120.844 1.657 . . . . 0.0 113.94 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.07 123.26 20.48 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.806 2.042 . . . . 0.0 108.329 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.75 -177.61 3.83 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 149.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.33 146.5 19.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 -165.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.23 168.18 13.3 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 120.273 1.397 . . . . 0.0 107.871 166.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -128.89 158.83 37.67 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.114 1.766 . . . . 0.0 108.969 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 22.1 tp -147.17 150.9 35.84 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.462 1.905 . . . . 0.0 107.949 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.29 -162.69 19.63 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 119.138 0.881 . . . . 0.0 112.531 -175.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.7 m -105.88 121.28 43.74 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.101 1.761 . . . . 0.0 106.782 163.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.06 140.14 50.62 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.4 tt -60.27 -35.69 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.257 0.623 . . . . 0.0 110.356 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -165.47 165.86 18.8 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.743 1.617 . . . . 0.0 108.684 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.24 -35.1 62.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 127.576 2.351 . . . . 0.0 113.419 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.37 -8.54 66.4 Favored Glycine 0 CA--C 1.531 1.058 0 O-C-N 120.955 -1.091 . . . . 0.0 112.801 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -147.11 47.7 1.14 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.115 1.366 . . . . 0.0 109.899 -160.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.3 p -67.69 -8.82 38.19 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.554 1.542 . . . . 0.0 112.625 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -98.32 3.3 48.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.865 1.266 . . . . 0.0 112.704 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 t -120.3 131.78 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.763 1.165 . . . . 0.0 108.954 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.3 mt -71.76 153.88 41.69 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.392 1.077 . . . . 0.0 111.749 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.04 15.0 14.24 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 128.198 2.599 . . . . 0.0 114.08 -171.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.9 mt 54.65 -150.54 0.4 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.462 1.105 . . . . 0.0 109.204 -158.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -152.72 158.48 42.39 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.035 1.734 . . . . 0.0 107.282 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.4 m 55.78 -173.84 0.06 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.576 1.15 . . . . 0.0 113.04 171.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.429 ' HB3' ' HA3' ' A' ' 94' ' ' GLY . 15.0 m 25.03 79.25 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 129.805 3.242 . . . . 0.0 112.498 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.3 -28.31 27.53 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.36 1.464 . . . . 0.0 114.09 -168.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.3 2.06 5.14 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.958 1.303 . . . . 0.0 111.423 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 91' ' ' SER . . . -89.03 -41.68 5.83 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 126.089 1.804 . . . . 0.0 109.798 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 m -56.76 158.06 4.99 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.923 0.868 . . . . 0.0 109.363 171.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.56 145.33 5.01 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 160.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.5 p -115.94 142.54 46.65 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.935 1.294 . . . . 0.0 109.796 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 77.3 28.78 0.59 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.908 1.683 . . . . 0.0 113.18 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -143.79 167.15 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 125.009 1.323 . . . . 0.0 109.645 169.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -168.78 173.85 43.37 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -171.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.6 t -91.82 136.98 23.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -118.86 161.26 20.45 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.088 1.755 . . . . 0.0 108.17 169.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.7 mt -144.09 122.52 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 127.78 2.432 . . . . 0.0 105.296 -169.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mt -124.72 153.26 42.64 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -74.54 -102.99 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.316 1.047 . . . . 0.0 110.919 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -148.32 -26.39 0.33 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 128.566 2.746 . . . . 0.0 110.341 -170.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.258 13.3 t -78.7 -4.71 50.54 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 167.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.57 20.04 79.78 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 118.543 -1.143 . . . . 0.0 110.864 -177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.93 127.41 33.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 170.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.9 132.95 43.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.7 mt -102.35 108.37 19.69 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.509 0.724 . . . . 0.0 109.176 -166.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.3 m -65.67 152.01 45.19 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.013 0.435 . . . . 0.0 110.957 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.5 mt -109.14 73.1 0.84 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.861 1.664 . . . . 0.0 109.726 -160.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -120.25 0.49 10.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.651 1.18 . . . . 0.0 113.094 171.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.28 13.77 83.25 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.009 -0.884 . . . . 0.0 112.862 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -149.43 -17.43 0.28 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.77 1.285 . . . . 0.0 114.178 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.7 m -70.96 97.64 1.47 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 120.453 1.479 . . . . 0.0 107.629 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -76.5 130.54 38.09 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.17 0.988 . . . . 0.0 109.696 -168.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.4 m -72.64 -171.54 0.84 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.981 2.513 . . . . 0.0 111.367 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.37 148.44 6.71 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.803 -0.56 . . . . 0.0 111.037 167.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -85.65 166.64 16.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 123.662 1.696 . . . . 0.0 110.154 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.7 m -130.06 138.6 50.82 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 153.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.4 m -86.85 135.48 33.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 164.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.413 ' CD2' ' HA ' ' A' ' 68' ' ' LYS . 2.5 mm? -95.08 172.35 8.18 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 126.102 1.761 . . . . 0.0 109.104 -168.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -132.33 158.87 40.78 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 158.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -64.45 100.14 0.34 Allowed 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 125.615 1.822 . . . . 0.0 106.265 170.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.26 -167.86 25.32 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 107.802 -2.119 . . . . 0.0 107.802 -160.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 98.2 m -106.65 136.65 46.09 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.402 -1.058 . . . . 0.0 108.85 -166.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -135.71 170.46 15.94 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.835 1.654 . . . . 0.0 108.895 -169.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.462 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 3.7 m -146.32 142.84 28.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.972 0.909 . . . . 0.0 108.999 172.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.65 116.44 65.39 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 161.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.5 159.61 28.86 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.54 2.16 . . . . 0.0 110.86 170.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -141.31 172.62 12.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.326 1.85 . . . . 0.0 109.697 178.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.44 99.83 4.48 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.596 1.558 . . . . 0.0 107.0 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.64 146.23 28.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.076 -1.015 . . . . 0.0 108.728 174.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -152.77 160.27 43.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -69.44 153.02 44.18 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 117.35 -1.74 . . . . 0.0 108.813 166.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.411 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 11.0 t80 -128.05 125.84 40.1 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.584 1.954 . . . . 0.0 108.324 173.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.32 145.62 27.42 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.778 0.831 . . . . 0.0 110.356 174.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.422 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 41.3 p -105.62 10.64 32.9 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.372 1.069 . . . . 0.0 112.235 175.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.08 -150.63 19.24 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.26 98.09 0.3 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.71 164.15 1.6 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.444 1.116 . . . . 0.0 109.348 171.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.6 p -120.26 162.14 35.35 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 164.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -74.24 168.38 24.93 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 N-CA-C 109.667 -0.936 . . . . 0.0 109.667 164.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.24 178.96 16.17 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.315 1.436 . . . . 0.0 111.364 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.88 150.61 44.53 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 121.467 -1.019 . . . . 0.0 109.582 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -145.97 93.64 2.36 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -125.48 150.23 47.54 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 172.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.31 164.49 36.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 120.484 1.493 . . . . 0.0 108.204 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.21 140.52 27.96 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -173.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.08 172.96 11.95 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 128.291 2.637 . . . . 0.0 110.633 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 37.5 p -127.84 159.56 34.48 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 159.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -124.41 154.69 40.03 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.368 1.067 . . . . 0.0 109.453 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -114.75 173.59 6.4 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.091 1.756 . . . . 0.0 109.087 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.0 t -127.95 128.97 69.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 127.443 2.297 . . . . 0.0 105.386 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.618 HE21 ' NE2' ' A' ' 159' ' ' GLN . 32.0 tt0 -112.96 86.86 2.46 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 173.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -68.39 150.83 47.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.652 172.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.618 ' NE2' HE21 ' A' ' 157' ' ' GLN . 6.0 pt20 -168.93 165.5 11.49 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.199 1.4 . . . . 0.0 109.35 -175.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 130.64 1.83 5.01 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 117.751 -1.583 . . . . 0.0 114.795 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -82.99 -81.04 0.97 Allowed Glycine 0 C--N 1.333 0.392 0 CA-C-N 119.687 1.744 . . . . 0.0 109.779 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 148.48 103.08 0.3 Allowed Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.36 21.79 0.29 Allowed Glycine 0 CA--C 1.526 0.748 0 CA-C-O 118.936 -0.924 . . . . 0.0 113.437 175.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 56.92 58.19 15.85 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 124.4 1.0 . . . . 0.0 111.186 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.08 74.93 1.26 Allowed Glycine 0 C--N 1.333 0.382 0 N-CA-C 107.085 -2.406 . . . . 0.0 107.085 -164.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -146.54 101.83 3.51 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.885 0.874 . . . . 0.0 108.974 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -116.72 -175.94 2.87 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.987 2.115 . . . . 0.0 108.551 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 98.7 m -135.5 107.19 6.97 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 173.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.6 m -102.76 112.52 25.35 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.775 0.83 . . . . 0.0 108.947 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.16 156.43 40.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 126.144 1.778 . . . . 0.0 109.9 -172.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -66.97 132.48 48.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.17 -40.74 3.19 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 118.646 -1.086 . . . . 0.0 111.727 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 158.29 -176.02 35.34 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 118.882 1.341 . . . . 0.0 112.334 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.9 m -91.06 144.36 25.73 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.779 1.232 . . . . 0.0 108.25 172.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.0 t -123.95 136.76 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 168.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -120.52 145.74 47.0 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -131.03 126.53 36.14 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -130.87 159.05 38.53 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.08 0.855 . . . . 0.0 109.93 -172.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 159.98 -160.92 32.02 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -164.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -172.66 173.02 4.05 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 128.556 2.743 . . . . 0.0 104.411 174.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.84 144.0 31.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 165.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.442 ' C ' ' H ' ' A' ' 184' ' ' ALA . 14.7 m -127.25 150.56 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.936 2.094 . . . . 0.0 107.568 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -74.51 36.08 0.1 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.785 1.634 . . . . 0.0 112.634 -173.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.252 1.227 0 C-N-CA 129.131 2.972 . . . . 0.0 112.726 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.277 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.24 -74.96 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.3 m 69.73 101.9 0.06 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.659 1.984 . . . . 0.0 110.955 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.3 p -140.95 162.97 34.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.089 1.356 . . . . 0.0 108.331 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.9 t 82.12 91.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 127.509 2.324 . . . . 0.0 107.617 -174.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.28 -170.55 3.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.049 0.539 . . . . 0.0 110.391 172.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.0 -113.12 3.62 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 118.6 0.636 . . . . 0.0 112.733 168.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.49 -95.97 1.0 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -164.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -125.59 104.59 8.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 104.06 -2.57 . . . . 0.0 104.06 150.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.8 p 28.33 78.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 129.437 3.095 . . . . 0.0 112.525 161.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -75.69 -80.03 0.09 Allowed 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.72 -0.612 . . . . 0.0 110.916 -167.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 153.53 -16.87 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 130.679 3.591 . . . . 0.0 110.725 168.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -149.51 -35.76 0.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.893 1.277 . . . . 0.0 111.47 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.5 34.24 7.54 Favored Glycine 0 CA--C 1.517 0.196 0 CA-C-O 118.145 -1.364 . . . . 0.0 113.734 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.535 ' C ' ' H ' ' A' ' 17' ' ' VAL 0.257 0.7 OUTLIER 72.61 159.51 0.22 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.685 1.243 . . . . 0.0 109.87 175.399 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.2 t 54.44 -17.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 130.834 3.654 . . . . 0.0 114.493 -165.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.535 ' H ' ' C ' ' A' ' 15' ' ' GLU 0.279 3.9 m 43.36 33.99 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 130.95 3.7 . . . . 0.0 113.325 -177.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -149.79 93.57 2.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -146.74 31.73 0.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.35 1.06 . . . . 0.0 112.261 -174.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 41.35 -55.21 0.0 OUTLIER 'General case' 0 C--N 1.34 0.166 1 C-N-CA 135.425 5.49 . . . . 0.0 115.794 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 58' ' ' LEU . 1.6 m -87.81 -166.99 1.74 Allowed 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.952 1.301 . . . . 0.0 109.982 166.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.25 -6.79 11.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.131 1.372 . . . . 0.0 113.922 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.26 3.7 t 50.87 120.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 129.535 3.134 . . . . 0.0 113.06 -165.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.37 153.28 41.54 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.526 1.13 . . . . 0.0 109.343 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.28 -25.5 67.67 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.101 -1.0 . . . . 0.0 111.035 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.96 5.29 1.3 Allowed Glycine 0 CA--C 1.534 1.261 0 CA-C-O 117.001 -2.0 . . . . 0.0 113.789 167.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.5 t -149.85 7.36 0.63 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 120.279 2.04 . . . . 0.0 113.986 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.4 p -92.14 -40.48 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 121.269 1.849 . . . . 0.0 112.81 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.7 47.95 1.64 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -170.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -85.87 145.44 27.18 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.824 -159.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 m -117.72 98.95 6.63 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.676 1.19 . . . . 0.0 108.794 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.17 104.57 5.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -77.93 109.67 12.18 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 170.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 mt -87.33 -6.75 58.38 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.714 2.006 . . . . 0.0 109.799 176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.83 -171.68 37.92 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 121.925 0.736 . . . . 0.0 112.464 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -84.41 134.95 34.45 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.396 1.478 . . . . 0.0 109.448 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 t -125.94 142.0 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 124.231 1.012 . . . . 0.0 109.008 -173.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.37 120.6 21.84 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 125.682 1.593 . . . . 0.0 107.733 -177.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 p -48.52 -29.76 4.52 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.036 1.334 . . . . 0.0 111.471 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.34 -35.01 77.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.823 0.849 . . . . 0.0 111.691 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.1 m -72.26 -7.09 47.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.251 1.02 . . . . 0.0 113.123 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.3 mt -136.88 78.75 1.72 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 128.61 2.764 . . . . 0.0 108.585 -170.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.04 3.91 3.2 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.584 -1.322 . . . . 0.0 112.227 -175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -149.66 155.77 40.78 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 124.758 1.223 . . . . 0.0 108.247 -175.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 31.7 tt0 -62.25 129.7 41.96 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.427 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 90.14 -4.46 82.92 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.011 -1.438 . . . . 0.0 113.233 -176.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.45 157.5 31.87 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 119.371 1.586 . . . . 0.0 110.933 172.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.2 p -148.42 161.09 42.28 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -173.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.3 p -73.08 -171.45 0.9 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.268 0.627 . . . . 0.0 110.706 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 m -54.11 -24.45 17.71 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 170.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.98 150.4 0.07 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.27 1.428 . . . . 0.0 112.399 -170.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -151.42 153.49 9.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 126.841 2.057 . . . . 0.0 105.716 -165.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.01 162.28 21.04 Favored Glycine 0 CA--C 1.526 0.721 0 O-C-N 121.02 -1.05 . . . . 0.0 110.549 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -160.63 63.02 0.31 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 124.562 2.125 . . . . 0.0 109.566 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -55.12 139.47 41.58 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 112.424 -2.171 . . . . 0.0 111.467 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 mm -84.28 105.45 13.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -76.85 104.61 7.44 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.428 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 57.5 mt -84.5 -175.09 5.63 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 167.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -173.36 144.35 1.16 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 126.237 1.815 . . . . 0.0 109.914 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.0 t0 48.67 63.62 2.03 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.957 2.103 . . . . 0.0 113.117 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.451 ' HB2' HD22 ' A' ' 129' ' ' ASN . 0.8 OUTLIER -86.32 115.6 23.96 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 121.692 -0.63 . . . . 0.0 111.774 -177.167 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.11 108.33 7.77 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 161.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.5 p -62.09 -7.94 4.72 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.427 0.691 . . . . 0.0 112.838 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -79.14 -31.15 43.97 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.207 1.403 . . . . 0.0 112.234 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.87 -35.0 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -170.39 138.53 1.57 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.88 2.472 . . . . 0.0 105.072 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -78.89 -6.83 57.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 116.774 -1.584 . . . . 0.0 110.774 163.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.4 ' HA ' HD13 ' A' ' 124' ' ' LEU . 47.2 mtmt -141.56 161.51 37.74 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 122.605 2.457 . . . . 0.0 115.624 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.31 115.02 15.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.71 175.9 7.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 152.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -156.38 128.97 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 101.718 -3.438 . . . . 0.0 101.718 -160.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -114.54 169.98 8.65 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.509 1.524 . . . . 0.0 107.623 173.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -131.2 154.27 48.59 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.902 0.774 . . . . 0.0 110.496 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.347 0.1 OUTLIER -145.51 171.33 14.82 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 168.151 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.84 177.06 30.59 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.405 1.479 . . . . 0.0 110.056 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.2 m -67.0 141.33 57.62 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.288 1.044 . . . . 0.0 109.542 174.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.0 134.2 33.87 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 119.366 0.985 . . . . 0.0 110.874 174.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.3 tt -62.79 -33.93 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 122.898 0.479 . . . . 0.0 111.002 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -153.16 166.55 32.16 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.946 1.298 . . . . 0.0 108.724 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.66 -34.53 78.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.549 167.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.17 5.45 76.65 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.258 0.932 . . . . 0.0 112.874 174.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -148.45 48.44 1.03 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.124 1.962 . . . . 0.0 110.01 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.1 p -71.12 -7.81 49.17 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.68 -1.263 . . . . 0.0 113.809 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -84.91 -6.37 59.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.44 -0.788 . . . . 0.0 111.812 169.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 t -118.97 134.23 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.073 0 CA-C-N 119.665 1.12 . . . . 0.0 108.837 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.25 148.72 32.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.92 1.288 . . . . 0.0 110.234 -169.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.44 20.06 5.61 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.248 1.419 . . . . 0.0 113.958 -167.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.6 mt 55.16 -157.32 0.23 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.287 1.035 . . . . 0.0 109.969 -168.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -143.21 174.8 10.39 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.057 1.343 . . . . 0.0 109.042 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.7 m -51.09 131.29 27.27 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.54 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.4 m -148.58 161.66 41.24 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 128.044 2.538 . . . . 0.0 107.359 164.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.13 -48.31 74.06 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.187 0.595 . . . . 0.0 111.5 -169.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.62 8.81 1.28 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.44 0.696 . . . . 0.0 112.509 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 63.42 35.21 91.75 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 124.141 0.877 . . . . 0.0 111.291 -170.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.6 m 57.95 -167.77 0.13 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.155 1.382 . . . . 0.0 111.959 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.02 159.98 10.69 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.0 148.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.99 167.2 11.97 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.672 1.189 . . . . 0.0 108.702 168.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 62.26 3.63 1.07 Allowed 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 125.945 1.698 . . . . 0.0 113.105 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -125.91 150.48 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 121.373 1.897 . . . . 0.0 108.764 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.36 177.7 25.47 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 125.025 1.297 . . . . 0.0 110.736 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.8 t -92.14 122.34 43.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -91.17 158.55 16.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.819 1.19 . . . . 0.0 109.521 163.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.84 136.84 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 165.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mt -133.04 142.33 48.73 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.109 1.363 . . . . 0.0 108.025 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.3 p30 -68.64 -179.86 1.52 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.93 1.347 . . . . 0.0 111.175 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.8 ptt85 -58.46 -7.08 0.8 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.809 1.644 . . . . 0.0 114.589 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.356 10.9 t -116.03 8.26 14.51 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 120.433 1.469 . . . . 0.0 110.985 177.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.11 7.84 84.7 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 120.598 -1.314 . . . . 0.0 112.53 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.96 126.07 30.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.564 1.182 . . . . 0.0 108.328 172.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.11 130.44 35.55 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.164 0.985 . . . . 0.0 111.349 -172.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.62 151.47 21.57 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 123.92 0.763 . . . . 0.0 111.464 -164.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.2 m -75.64 154.63 36.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 123.553 0.533 . . . . 0.0 110.688 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.6 mt -97.68 64.03 1.76 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.171 1.388 . . . . 0.0 108.427 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.27 -11.12 9.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.267 0.627 . . . . 0.0 111.644 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.64 13.2 82.77 Favored Glycine 0 CA--C 1.524 0.594 0 O-C-N 120.577 -1.327 . . . . 0.0 113.858 170.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.68 -40.66 0.26 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.365 1.466 . . . . 0.0 110.034 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.2 m -53.91 96.27 0.01 OUTLIER 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.188 1.795 . . . . 0.0 109.461 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -86.03 138.06 32.24 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.231 0.612 . . . . 0.0 109.431 -164.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.55 -175.99 1.8 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.087 2.155 . . . . 0.0 109.171 174.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 t -52.85 143.2 17.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.37 0.605 . . . . 0.0 110.19 169.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -88.33 176.04 7.38 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 123.198 1.475 . . . . 0.0 108.966 167.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.3 m -144.82 163.29 34.52 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 128.205 2.602 . . . . 0.0 105.103 169.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.9 m -100.23 142.95 31.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 122.416 1.103 . . . . 0.0 110.24 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -101.91 167.68 9.9 Favored 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 129.571 3.149 . . . . 0.0 108.0 -168.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.455 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 0.8 OUTLIER -152.26 156.2 39.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.796 -173.544 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -73.98 91.57 2.04 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 125.285 1.616 . . . . 0.0 107.107 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 147.22 -123.58 1.78 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 107.691 -2.164 . . . . 0.0 107.691 -164.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.4 m -143.5 139.24 29.73 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.619 1.167 . . . . 0.0 109.075 -172.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.455 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 1.2 p30 -147.74 162.32 39.44 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 127.594 2.358 . . . . 0.0 108.702 -170.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.1 m -144.73 137.97 26.89 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -170.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.91 122.54 61.82 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.63 145.07 68.67 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.952 1.768 . . . . 0.0 110.564 173.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -142.32 157.3 44.96 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 124.777 1.231 . . . . 0.0 110.24 166.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -131.81 113.75 13.88 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -101.29 167.56 10.11 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.752 1.221 . . . . 0.0 109.227 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -168.05 153.83 7.16 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 127.225 2.21 . . . . 0.0 106.444 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -66.76 144.11 56.52 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 160.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.427 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 16.5 t80 -123.35 133.12 54.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 126.074 1.75 . . . . 0.0 106.827 174.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -104.39 143.48 32.95 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.967 1.307 . . . . 0.0 109.89 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.41 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 46.9 p -103.08 4.66 37.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.683 1.593 . . . . 0.0 111.529 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.51 -141.45 6.87 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.08 93.61 0.3 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.479 1.112 . . . . 0.0 110.332 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.27 147.6 46.26 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.301 -0.874 . . . . 0.0 110.108 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 35.0 p -120.71 153.38 56.79 Favored Pre-proline 0 CA--C 1.537 0.442 0 C-N-CA 125.153 1.381 . . . . 0.0 109.028 -175.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -74.69 166.92 28.28 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.02 1.813 . . . . 0.0 112.663 173.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.77 -85.39 0.11 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.098 166.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -142.62 163.06 33.85 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.66 1.984 . . . . 0.0 106.623 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -151.46 77.33 1.24 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.075 0.852 . . . . 0.0 109.674 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -117.59 155.97 28.92 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.48 173.44 16.67 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.356 1.063 . . . . 0.0 109.004 171.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -150.31 146.46 26.77 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.775 1.23 . . . . 0.0 108.153 169.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -161.48 169.79 21.18 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 127.802 2.441 . . . . 0.0 108.771 -165.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.53 141.68 46.77 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 116.996 -1.882 . . . . 0.0 107.57 -172.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -103.68 152.21 22.07 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -134.2 114.02 12.63 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.1 t -77.4 125.61 37.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -111.52 90.81 3.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -62.52 148.51 45.65 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.885 1.274 . . . . 0.0 110.344 173.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -165.93 169.66 14.54 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.697 1.199 . . . . 0.0 110.635 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 139.31 -73.16 0.41 Allowed Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -170.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -76.79 87.59 0.95 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 124.782 1.182 . . . . 0.0 110.329 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -162.33 175.59 38.77 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 118.185 0.992 . . . . 0.0 112.149 -176.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -131.24 27.13 3.84 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.777 1.18 . . . . 0.0 111.313 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 107.08 11.52 25.81 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 117.986 -1.452 . . . . 0.0 113.699 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -156.57 22.6 0.49 Allowed Glycine 0 CA--C 1.528 0.877 0 CA-C-N 120.486 2.143 . . . . 0.0 112.793 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -129.91 119.77 23.79 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.857 1.263 . . . . 0.0 109.973 -173.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -152.33 175.29 12.83 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 129.359 3.064 . . . . 0.0 108.139 171.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 54.7 m -137.32 92.84 2.75 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.869 1.267 . . . . 0.0 109.313 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.1 m -72.05 133.7 45.42 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.68 165.81 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 127.747 2.419 . . . . 0.0 108.554 173.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -59.45 143.78 48.89 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 164.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -101.34 -64.44 0.77 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 169.16 168.76 31.64 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -174.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 89.9 m -90.22 118.89 30.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.772 1.286 . . . . 0.0 107.987 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.1 t -88.09 106.76 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 166.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -79.28 144.38 34.35 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 164.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -126.45 121.1 31.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -127.68 156.01 43.03 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.816 0.734 . . . . 0.0 109.475 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.02 -158.66 27.48 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -163.69 167.34 21.21 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.603 -0.94 . . . . 0.0 108.999 -173.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 73.7 t -113.15 126.01 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 167.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.2 m -106.28 150.27 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 126.705 2.002 . . . . 0.0 108.436 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -74.9 39.56 0.14 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.246 1.418 . . . . 0.0 113.1 -176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.304 0 C-N-CA 127.634 2.374 . . . . 0.0 111.934 -179.773 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.12 125.28 20.97 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.458 0.703 . . . . 0.0 109.501 -175.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.6 t -124.52 8.2 8.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.242 1.417 . . . . 0.0 111.023 -171.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 m 92.91 147.09 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 129.146 2.978 . . . . 0.0 109.19 165.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.366 7.3 p 44.04 -86.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 129.539 3.136 . . . . 0.0 113.875 -171.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 143.57 -88.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 131.178 3.791 . . . . 0.0 107.961 160.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.7 -61.82 3.67 Favored Glycine 0 C--N 1.336 0.543 0 O-C-N 121.907 -0.496 . . . . 0.0 113.177 -165.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.98 -178.27 15.88 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 106.779 -2.528 . . . . 0.0 106.779 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.264 1.3 t -102.39 84.18 2.42 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 -169.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.448 HG21 ' H ' ' A' ' 11' ' ' HIS 0.294 10.1 p 48.32 -139.94 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.055 1.742 . . . . 0.0 108.108 176.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.448 ' H ' HG21 ' A' ' 10' ' ' VAL . 73.5 m-70 -135.99 57.83 1.77 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-N 120.868 1.667 . . . . 0.0 109.423 161.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.38 101.29 3.97 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -128.26 -114.14 0.26 Allowed 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 103.408 -2.812 . . . . 0.0 103.408 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.94 -72.4 0.64 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 106.885 -2.486 . . . . 0.0 106.885 167.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' A' ' 17' ' ' VAL . 3.2 pt-20 -168.86 162.91 11.58 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 166.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . 0.356 3.2 p 56.38 -29.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 131.286 3.834 . . . . 0.0 114.415 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.434 ' H ' ' C ' ' A' ' 15' ' ' GLU . 3.6 t 44.44 37.55 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.866 2.066 . . . . 0.0 111.519 166.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -141.38 93.54 2.59 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.072 171.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.5 134.07 34.06 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 150.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.49 -18.14 6.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.027 1.331 . . . . 0.0 112.753 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -134.35 147.49 50.54 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.132 2.173 . . . . 0.0 107.235 176.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.05 -14.12 44.19 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 118.257 2.688 . . . . 0.0 118.257 -155.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.3 t 49.46 104.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 127.645 2.378 . . . . 0.0 111.342 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.46 159.02 10.97 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.39 -0.819 . . . . 0.0 113.096 -169.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.91 -42.07 88.77 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.541 -0.725 . . . . 0.0 109.94 171.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.39 27.52 2.44 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.737 -1.035 . . . . 0.0 112.682 171.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -138.94 -33.07 0.66 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.286 1.543 . . . . 0.0 111.402 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.34 -35.66 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 119.791 1.178 . . . . 0.0 111.122 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -139.92 69.56 1.36 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -170.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -110.52 146.45 35.99 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.863 0.865 . . . . 0.0 111.414 -169.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -112.18 121.33 44.63 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.309 1.043 . . . . 0.0 109.904 173.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.6 t -87.39 113.41 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 169.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -88.22 96.18 10.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 172.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.4 mt -76.81 -8.16 56.8 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 126.009 1.724 . . . . 0.0 110.221 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.23 -171.26 32.75 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 121.829 0.683 . . . . 0.0 112.231 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -90.99 126.91 36.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.505 1.922 . . . . 0.0 110.491 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.0 t -117.64 137.73 50.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 123.4 0.68 . . . . 0.0 109.772 -172.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -66.56 124.18 22.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.874 2.07 . . . . 0.0 106.53 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.9 p -55.25 -30.02 59.24 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 123.787 0.679 . . . . 0.0 110.37 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.89 -36.06 76.16 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.368 1.467 . . . . 0.0 111.524 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.0 m -80.16 2.37 24.47 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 123.521 0.728 . . . . 0.0 112.797 176.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.4 mt -131.83 32.08 4.13 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.37 1.868 . . . . 0.0 110.922 -170.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.49 5.24 13.37 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -150.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -154.69 155.96 35.55 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.405 1.882 . . . . 0.0 106.725 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.401 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 36.4 tt0 -64.23 116.84 6.39 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.33 -11.51 36.55 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 117.847 -1.529 . . . . 0.0 112.752 -177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.27 156.88 33.03 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.432 1.616 . . . . 0.0 110.253 172.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.6 p -144.88 157.34 44.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.41 0.624 . . . . 0.0 112.179 -174.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -73.58 -168.19 0.53 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 122.008 -0.433 . . . . 0.0 110.091 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -43.55 -99.57 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.719 2.007 . . . . 0.0 114.281 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.37 73.57 0.0 OUTLIER 'General case' 0 C--O 1.236 0.393 0 C-N-CA 131.002 3.721 . . . . 0.0 107.427 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.9 p -69.55 148.32 11.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 170.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.03 127.2 7.97 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 107.145 -2.382 . . . . 0.0 107.145 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -135.41 89.91 2.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 123.215 1.483 . . . . 0.0 109.624 -170.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -84.11 165.86 18.13 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 120.892 -1.13 . . . . 0.0 112.69 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.0 mm -102.3 99.01 7.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -71.8 126.32 29.42 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -109.25 171.84 7.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 174.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 11.5 p30 -153.81 175.05 13.77 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.253 0.933 . . . . 0.0 111.504 165.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.6 t70 32.12 48.75 0.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 129.821 3.248 . . . . 0.0 115.974 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 4.6 t -69.69 167.46 16.99 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -171.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -133.76 114.49 13.47 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.872 1.669 . . . . 0.0 112.253 168.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.9 p -56.16 -29.68 61.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.698 1.599 . . . . 0.0 113.575 172.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -62.32 -42.47 99.4 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 123.117 0.567 . . . . 0.0 110.323 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.2 t -65.24 -52.68 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 175.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.413 ' CB ' ' HB3' ' A' ' 158' ' ' TYR . . . -165.49 127.04 1.98 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.192 0.52 . . . . 0.0 111.674 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.4 m -77.37 -8.58 57.92 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.55 1.54 . . . . 0.0 112.163 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -130.03 152.65 49.25 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 121.377 1.899 . . . . 0.0 110.371 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.02 144.36 49.88 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 165.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.94 172.01 9.27 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 122.076 0.941 . . . . 0.0 109.617 156.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.261 0.5 OUTLIER -143.22 144.23 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 113.633 -1.621 . . . . 0.0 106.693 -174.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.41 162.39 30.28 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.313 2.645 . . . . 0.0 107.045 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -137.15 152.6 50.13 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.711 0.804 . . . . 0.0 110.328 -172.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.1 tp -151.6 124.68 8.68 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 122.082 -0.386 . . . . 0.0 110.609 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.26 165.87 33.97 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -54.08 128.7 31.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.313 1.445 . . . . 0.0 109.944 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.71 134.97 41.85 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.823 1.192 . . . . 0.0 110.371 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.2 tt -60.38 -37.39 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 122.72 0.408 . . . . 0.0 110.81 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -157.27 168.62 26.86 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.182 1.793 . . . . 0.0 109.046 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.33 -39.95 67.54 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.759 1.624 . . . . 0.0 112.641 171.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.28 7.44 80.69 Favored Glycine 0 CA--C 1.526 0.752 0 O-C-N 121.433 -0.792 . . . . 0.0 112.884 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -142.76 42.4 1.58 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.456 1.102 . . . . 0.0 109.481 -175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.5 p -67.95 -11.68 59.26 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.958 1.303 . . . . 0.0 112.84 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -77.69 -2.08 34.29 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.631 -0.668 . . . . 0.0 112.19 168.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.41 137.09 48.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 O-C-N 120.44 -1.412 . . . . 0.0 110.894 -166.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.77 150.9 29.05 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.469 1.508 . . . . 0.0 111.405 -171.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.73 18.33 11.84 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.675 1.99 . . . . 0.0 114.192 -167.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.4 mt 53.71 -159.9 0.14 Allowed 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.587 1.155 . . . . 0.0 110.621 -169.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -141.82 170.32 15.94 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.453 1.101 . . . . 0.0 109.309 176.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.1 m -45.88 147.94 0.89 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.342 1.457 . . . . 0.0 112.074 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 t -160.79 161.83 32.15 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.156 1.382 . . . . 0.0 107.358 168.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.21 -23.81 65.88 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -176.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.19 12.44 14.43 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.37 1.468 . . . . 0.0 110.712 176.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.41 26.48 65.66 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.523 1.059 . . . . 0.0 114.459 173.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.7 m 56.87 -170.83 0.09 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.959 0.904 . . . . 0.0 110.682 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.78 148.74 48.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 168.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.34 164.93 12.09 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.88 0.872 . . . . 0.0 108.762 166.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 69.96 -7.88 0.88 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 128.725 2.81 . . . . 0.0 115.11 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.7 p -126.99 152.19 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 121.417 1.917 . . . . 0.0 107.949 -171.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -146.31 170.64 27.37 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 126.11 1.814 . . . . 0.0 111.82 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 94.2 t -83.56 120.44 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -100.65 154.19 18.8 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.714 1.597 . . . . 0.0 108.3 164.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.09 143.97 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 170.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 mt -139.58 138.98 36.68 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.044 1.738 . . . . 0.0 108.042 -168.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.0 p30 -66.22 173.62 3.06 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 122.219 1.009 . . . . 0.0 111.959 167.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -55.32 -13.18 1.26 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.194 1.398 . . . . 0.0 113.667 175.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 p -105.08 -9.09 18.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.929 1.292 . . . . 0.0 110.874 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.81 10.21 65.21 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.712 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.06 117.13 13.3 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 119.061 1.431 . . . . 0.0 107.938 169.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.68 131.15 40.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.661 0.784 . . . . 0.0 110.122 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.0 mt -103.34 117.27 34.1 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.589 1.156 . . . . 0.0 110.745 -158.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.0 m -67.39 143.23 56.42 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.77 0.795 . . . . 0.0 110.539 -170.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.9 mt -93.6 74.78 4.38 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.196 1.398 . . . . 0.0 107.307 -171.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.46 -18.31 11.01 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.327 1.051 . . . . 0.0 110.683 170.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.67 -28.27 4.96 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-O 118.16 -1.356 . . . . 0.0 112.751 176.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -82.62 -45.08 15.0 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.407 1.604 . . . . 0.0 110.505 166.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.2 m -51.25 97.33 0.01 OUTLIER 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.839 2.055 . . . . 0.0 111.586 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.66 169.38 4.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.81 2.044 . . . . 0.0 111.112 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 75.5 p -135.75 -161.59 1.17 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.611 0.765 . . . . 0.0 111.35 173.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -42.82 122.53 2.4 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 129.73 3.212 . . . . 0.0 111.69 -175.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -89.01 106.23 18.3 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.942 0.877 . . . . 0.0 108.701 -173.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.7 m -70.34 117.88 12.44 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 162.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.2 m -64.0 141.77 58.65 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 155.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.98 -170.44 2.14 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.052 0.941 . . . . 0.0 109.785 176.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -148.87 167.56 25.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.818 2.047 . . . . 0.0 107.071 178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -64.41 128.36 35.43 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 120.29 -159.57 15.13 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 22.0 m -83.13 136.01 34.61 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.669 1.188 . . . . 0.0 111.648 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.48 177.98 9.76 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.369 1.468 . . . . 0.0 108.325 -176.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.6 m -155.01 144.48 21.27 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.33 -0.856 . . . . 0.0 109.734 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.4 mp -100.05 114.53 65.72 Favored Pre-proline 0 C--O 1.237 0.446 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 162.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.01 151.39 50.08 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.192 1.928 . . . . 0.0 110.475 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -141.17 167.03 23.16 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.716 2.006 . . . . 0.0 108.303 171.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.24 154.29 33.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 122.722 1.248 . . . . 0.0 110.071 161.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -132.83 147.3 52.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 127.517 2.327 . . . . 0.0 106.398 175.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -163.89 151.95 12.97 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 170.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -66.18 135.84 55.08 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 170.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -111.28 127.8 55.74 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.978 1.711 . . . . 0.0 108.482 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.26 142.47 27.72 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.424 1.09 . . . . 0.0 111.242 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.401 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 17.6 p -110.82 9.21 22.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.273 1.429 . . . . 0.0 112.135 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.5 -152.47 22.2 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.38 95.92 0.22 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.116 1.366 . . . . 0.0 110.891 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -53.82 151.98 5.91 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.621 0.724 . . . . 0.0 110.497 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 73.1 p -105.5 154.02 39.39 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 162.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -71.48 174.73 10.46 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.115 1.21 . . . . 0.0 109.284 166.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.79 -93.67 0.14 Allowed Glycine 0 C--O 1.225 -0.441 0 O-C-N 121.855 -0.528 . . . . 0.0 112.838 171.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -146.65 161.95 39.47 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.38 1.872 . . . . 0.0 106.394 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -151.35 73.37 1.09 Allowed 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 121.776 -0.577 . . . . 0.0 110.52 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -117.64 151.65 36.78 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.9 179.25 9.37 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -156.35 145.94 20.87 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -146.38 169.41 18.92 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.81 2.044 . . . . 0.0 106.992 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.7 p -106.98 163.66 12.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 156.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -117.72 155.87 29.23 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 164.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 38.5 mttm -125.61 137.9 53.91 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 168.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.526 ' CG2' ' CE2' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -87.18 150.75 3.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 175.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -142.12 84.16 1.86 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.539 1.536 . . . . 0.0 108.918 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.526 ' CE2' ' CG2' ' A' ' 156' ' ' VAL . 59.0 m-85 -63.7 156.16 27.82 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.988 1.315 . . . . 0.0 112.805 169.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -174.82 174.83 2.5 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.721 2.009 . . . . 0.0 108.567 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 139.99 -48.01 0.86 Allowed Glycine 0 N--CA 1.461 0.319 0 O-C-N 120.852 -1.155 . . . . 0.0 111.359 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -77.83 -15.04 81.72 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 170.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -73.75 88.07 0.64 Allowed Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 166.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -61.07 -4.76 4.9 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.286 -1.285 . . . . 0.0 113.747 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -107.27 -75.54 0.94 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 107.004 -2.439 . . . . 0.0 107.004 159.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.74 -61.24 0.04 OUTLIER Glycine 0 C--O 1.228 -0.222 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 24.85 93.65 0.01 OUTLIER 'General case' 0 C--O 1.235 0.301 0 C-N-CA 129.511 3.124 . . . . 0.0 113.39 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -117.47 146.88 43.21 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.237 -161.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 52.9 m -96.81 89.3 4.85 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.65 1.98 . . . . 0.0 106.458 171.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.3 m -82.02 120.4 25.22 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 175.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 30.2 m -128.14 145.72 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 118.645 0.657 . . . . 0.0 111.209 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -77.88 105.44 9.07 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -79.75 -68.49 1.48 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 124.035 0.826 . . . . 0.0 111.936 -164.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -178.14 -172.62 42.76 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 117.503 0.651 . . . . 0.0 111.847 -173.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.3 m -89.22 145.38 25.44 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.782 1.633 . . . . 0.0 108.971 174.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.6 119.95 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 156.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -88.94 134.48 33.95 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -114.17 113.09 24.2 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -117.31 157.47 26.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 147.29 -165.42 28.64 Favored Glycine 0 C--O 1.239 0.411 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -176.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -161.56 171.73 17.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.9 t -122.15 132.84 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 173.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 184' ' ' ALA . 8.2 m -117.91 149.69 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 127.608 2.363 . . . . 0.0 107.972 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -76.23 34.23 0.13 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -170.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 N--CA 1.438 -1.035 0 C-N-CA 131.231 3.812 . . . . 0.0 112.802 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.38 -53.47 0.89 Allowed 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 123.906 0.754 . . . . 0.0 110.735 -165.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.8 t 50.35 -169.43 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.773 2.029 . . . . 0.0 112.092 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.82 0.88 1.64 Allowed 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.418 -0.801 . . . . 0.0 110.562 163.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.91 114.13 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 120.459 -1.401 . . . . 0.0 108.277 -174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -54.45 -40.79 68.73 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.29 167.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.26 133.87 1.59 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.955 1.264 . . . . 0.0 110.042 162.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.26 -93.19 0.11 Allowed Glycine 0 C--N 1.335 0.497 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 165.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -148.36 107.02 3.79 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 153.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.272 10.5 p 22.68 74.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 126.946 2.098 . . . . 0.0 114.687 153.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -82.51 45.23 0.95 Allowed 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.892 -1.13 . . . . 0.0 112.901 -168.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -159.31 51.34 0.36 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.208 1.003 . . . . 0.0 109.834 -161.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -133.54 87.79 2.42 Favored 'General case' 0 C--N 1.334 -0.086 0 C-N-CA 124.319 1.048 . . . . 0.0 108.695 -176.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.64 5.32 0.23 Allowed Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.602 -0.554 . . . . 0.0 114.093 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -146.56 -157.83 0.85 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.3 p -58.85 -44.35 90.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.488 1.04 . . . . 0.0 110.752 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 t 44.36 59.11 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 127.151 2.18 . . . . 0.0 111.281 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -149.41 105.95 3.53 Favored 'General case' 0 C--O 1.228 -0.079 0 O-C-N 121.97 -0.456 . . . . 0.0 109.813 169.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -126.44 141.5 51.86 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 166.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.97 1.83 51.46 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 117.672 -1.156 . . . . 0.0 113.799 -173.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.25 164.18 30.94 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.554 1.542 . . . . 0.0 107.68 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.67 -24.29 21.65 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.757 0.823 . . . . 0.0 113.002 -168.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t 58.58 131.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 128.07 2.548 . . . . 0.0 112.172 -173.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -78.44 156.13 29.55 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.033 -1.042 . . . . 0.0 111.895 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.48 -31.95 64.52 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.611 -0.681 . . . . 0.0 110.682 166.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.54 -2.12 73.7 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 117.559 -1.69 . . . . 0.0 114.293 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.4 p -125.21 -30.02 3.22 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 121.018 2.409 . . . . 0.0 111.809 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.94 -38.9 78.48 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 124.822 1.249 . . . . 0.0 113.789 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -132.6 46.69 2.6 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.085 0.954 . . . . 0.0 109.726 -168.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -93.13 132.19 37.5 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.283 -0.885 . . . . 0.0 110.478 -159.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 15.3 m -113.98 86.8 2.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.737 1.215 . . . . 0.0 108.652 -175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.75 99.91 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 127.047 2.139 . . . . 0.0 108.02 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -84.48 102.97 13.23 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -170.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mt -76.79 -7.61 55.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.713 1.205 . . . . 0.0 111.004 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.82 -173.53 26.77 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.529 1.061 . . . . 0.0 112.327 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -68.97 153.88 43.03 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.954 0.902 . . . . 0.0 109.479 170.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.4 t -139.7 148.14 23.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 C-N-CA 125.067 1.347 . . . . 0.0 108.611 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -81.18 134.44 35.63 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 121.508 -0.745 . . . . 0.0 109.053 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.1 p -60.64 -24.06 65.24 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.556 0.742 . . . . 0.0 110.899 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.43 -46.41 66.37 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.35 0.66 . . . . 0.0 110.454 170.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 t -71.9 -2.38 17.76 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.962 177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.3 mt -142.93 64.86 1.35 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 120.546 1.521 . . . . 0.0 108.854 -170.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.94 0.22 5.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -167.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -158.32 159.62 36.11 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.395 1.478 . . . . 0.0 108.404 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 39.1 tt0 -65.33 118.15 8.92 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 106.77 -12.97 42.14 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-O 118.422 -1.21 . . . . 0.0 112.112 -174.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.71 142.26 57.34 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.899 1.35 . . . . 0.0 109.44 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 p -136.66 159.44 41.81 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.094 0.861 . . . . 0.0 111.052 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.5 p -74.5 -175.07 2.25 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.778 0.799 . . . . 0.0 112.216 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.7 m -56.08 -24.04 37.62 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.803 2.041 . . . . 0.0 114.417 171.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.1 158.95 0.18 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 129.336 3.054 . . . . 0.0 112.582 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.3 t -145.56 140.48 22.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -171.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.67 141.26 15.45 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 170.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -136.88 149.55 47.72 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 171.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.37 117.52 8.36 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.056 -1.027 . . . . 0.0 108.619 -167.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 mm -77.88 101.11 3.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -163.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -65.36 121.44 14.84 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 mp -125.8 107.17 10.26 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.598 1.959 . . . . 0.0 106.914 -172.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -101.87 157.42 16.86 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -171.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 48.6 t0 50.87 50.58 18.77 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 123.189 1.471 . . . . 0.0 111.847 167.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.7 m -73.29 151.29 41.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.967 1.707 . . . . 0.0 110.365 174.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -136.47 107.53 6.74 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.616 1.166 . . . . 0.0 110.683 -174.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.1 p -60.29 -18.48 49.64 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.434 1.494 . . . . 0.0 112.886 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -60.44 -38.24 83.49 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.35 1.46 . . . . 0.0 111.171 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.03 -55.89 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.35 144.38 18.4 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.689 1.195 . . . . 0.0 108.438 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.21 -15.04 42.16 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.978 -0.534 . . . . 0.0 111.839 169.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -135.44 160.94 36.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.28 0.945 . . . . 0.0 110.584 -167.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.61 153.88 38.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 159.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.469 ' HB3' ' H ' ' A' ' 119' ' ' SER . . . -132.18 173.44 11.24 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.916 1.686 . . . . 0.0 107.301 162.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.455 ' HB ' ' CZ ' ' A' ' 133' ' ' PHE . 61.0 t -135.87 123.55 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 118.804 0.729 . . . . 0.0 109.415 -171.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.55 0.46 26.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -160.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.407 ' CD1' HG21 ' A' ' 103' ' ' ILE . 48.5 m-85 37.29 -177.84 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.702 1 C-N-CA 131.963 4.105 . . . . 0.0 112.504 -166.298 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.8 tp -168.07 126.92 1.22 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 164.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.73 173.43 42.72 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -68.74 129.34 39.65 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.258 1.423 . . . . 0.0 109.516 -172.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.35 131.53 34.19 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.581 1.152 . . . . 0.0 113.156 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.4 tt -65.54 -32.27 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.132 0.973 . . . . 0.0 112.018 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -152.87 165.27 35.97 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.694 0.797 . . . . 0.0 109.07 166.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.74 -43.5 47.88 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.707 2.003 . . . . 0.0 112.477 165.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.18 0.83 88.37 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.265 0.936 . . . . 0.0 112.524 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -142.03 40.62 1.65 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.207 1.504 . . . . 0.0 109.886 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.8 p -64.26 -15.84 60.89 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 124.825 1.25 . . . . 0.0 113.788 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -73.43 -12.02 60.66 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.433 174.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.9 t -133.15 143.82 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 123.088 1.423 . . . . 0.0 108.394 -164.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 88' ' ' LEU . 1.5 mm? -80.55 136.47 36.28 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 112.682 -2.054 . . . . 0.0 110.717 -159.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.9 14.22 0.12 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 124.742 1.217 . . . . 0.0 113.242 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.494 ' H ' ' C ' ' A' ' 86' ' ' LEU . 89.0 mt 48.11 -147.91 0.22 Allowed 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.535 1.934 . . . . 0.0 108.484 -171.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -143.29 -177.87 5.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.941 1.297 . . . . 0.0 108.518 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.1 m -58.81 148.08 31.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.311 1.444 . . . . 0.0 110.818 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.6 m -164.69 176.2 9.05 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.295 1.838 . . . . 0.0 107.85 169.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.43 -18.31 65.28 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -167.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.56 16.8 12.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.151 0.98 . . . . 0.0 111.344 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.34 29.68 68.01 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.177 0.894 . . . . 0.0 113.072 -173.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.8 m 62.38 -176.73 0.14 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.913 1.285 . . . . 0.0 112.031 -174.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.05 144.15 57.15 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.575 -0.703 . . . . 0.0 109.218 164.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.0 p -91.91 168.69 11.24 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.691 1.196 . . . . 0.0 109.003 166.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 55.85 18.78 3.15 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.115 1.766 . . . . 0.0 113.865 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.4 p -146.34 142.92 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 121.132 -0.98 . . . . 0.0 108.508 175.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.32 165.28 27.49 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 175.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.81 150.06 9.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -125.55 147.01 49.42 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 129.019 2.928 . . . . 0.0 105.917 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.407 HG21 ' CD1' ' A' ' 73' ' ' PHE . 1.9 mp -118.99 141.83 36.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.41 149.08 46.66 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.72 1.608 . . . . 0.0 107.015 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.07 -172.21 1.03 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.348 1.07 . . . . 0.0 112.342 174.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -47.51 -48.31 27.38 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 127.567 2.347 . . . . 0.0 110.115 170.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.5 p -81.3 -14.37 57.43 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.072 -168.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.91 22.7 44.67 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 126.386 1.946 . . . . 0.0 111.567 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.54 133.46 40.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 162.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.44 151.99 42.76 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.6 mt -117.14 151.64 36.41 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.039 1.336 . . . . 0.0 109.257 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.1 m -78.67 163.97 25.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 167.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.69 68.67 1.1 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 101.466 -3.531 . . . . 0.0 101.466 174.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.06 -7.34 19.24 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.983 0.897 . . . . 0.0 111.641 -175.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 66.87 31.36 77.96 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -158.91 -64.01 0.08 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.027 1.731 . . . . 0.0 106.879 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.7 m -49.65 99.95 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.205 2.202 . . . . 0.0 112.131 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -72.39 171.79 11.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.588 1.155 . . . . 0.0 111.003 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.469 ' H ' ' HB3' ' A' ' 70' ' ' ALA . 39.6 p -131.81 -146.95 0.3 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.993 1.717 . . . . 0.0 110.776 -169.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.9 t -58.37 124.64 20.23 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.446 1.021 . . . . 0.0 108.938 172.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -85.36 110.5 19.16 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 122.035 0.921 . . . . 0.0 108.559 170.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.7 m -79.35 121.83 25.61 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 161.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.1 m -66.36 111.06 3.33 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 160.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.0 mt -73.66 -179.4 3.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.604 1.962 . . . . 0.0 108.973 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.27 165.8 33.76 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.443 1.097 . . . . 0.0 109.538 173.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -59.39 138.14 57.75 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 171.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.15 -139.7 15.36 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -172.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.1 m -111.51 146.34 37.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 118.44 1.12 . . . . 0.0 111.37 -164.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.435 ' C ' ' HG1' ' A' ' 130' ' ' THR . 18.9 m-80 -144.97 174.35 11.1 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 128.423 2.689 . . . . 0.0 108.606 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.435 ' HG1' ' C ' ' A' ' 129' ' ' ASN . 91.4 m -157.01 148.19 21.99 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 170.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.5 mt -110.05 112.63 57.58 Favored Pre-proline 0 C--O 1.237 0.418 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.8 137.17 19.69 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.276 1.984 . . . . 0.0 110.184 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.455 ' CZ ' ' HB ' ' A' ' 71' ' ' VAL . 76.1 m-85 -127.4 172.59 10.52 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 127.007 2.123 . . . . 0.0 107.74 171.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -128.88 143.72 50.97 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 167.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -126.85 139.08 53.35 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.92 2.088 . . . . 0.0 108.063 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -160.26 159.91 32.0 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 175.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -73.61 126.28 29.93 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 171.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.466 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 23.7 t80 -111.55 120.81 43.36 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.948 2.099 . . . . 0.0 106.877 172.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.28 137.8 33.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 175.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 64.1 p -97.18 6.92 47.64 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.15 0.98 . . . . 0.0 111.283 171.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.69 -155.81 27.24 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.05 91.79 0.5 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.204 1.002 . . . . 0.0 111.172 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.97 158.52 4.83 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.673 0.789 . . . . 0.0 111.469 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 42.3 p -115.82 158.35 42.36 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 170.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -80.95 164.56 20.04 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.916 1.744 . . . . 0.0 111.681 170.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.6 -84.87 0.11 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.953 0.787 . . . . 0.0 114.277 171.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -153.11 143.56 22.56 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 128.917 2.887 . . . . 0.0 106.365 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -137.95 84.16 2.02 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.989 0.813 . . . . 0.0 109.931 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -126.84 154.38 44.43 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -156.27 -178.22 7.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.766 0.712 . . . . 0.0 110.975 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -151.34 110.18 3.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 122.63 1.205 . . . . 0.0 109.672 172.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.14 163.99 12.02 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 169.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.1 p -109.02 152.68 24.65 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 160.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -102.59 117.08 33.9 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 170.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -92.69 154.68 18.19 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 167.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 14.8 t -119.13 126.72 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.587 HE21 ' NE2' ' A' ' 159' ' ' GLN . 35.7 tt0 -103.59 89.54 3.38 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 170.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -69.79 139.59 53.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.327 169.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.587 ' NE2' HE21 ' A' ' 157' ' ' GLN . 9.6 pt20 -155.0 170.62 21.33 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.686 0.795 . . . . 0.0 111.288 176.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 137.16 -46.6 1.0 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 125.966 1.746 . . . . 0.0 110.728 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -67.35 175.95 24.21 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.097 0.856 . . . . 0.0 112.42 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -136.68 -153.35 6.46 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 125.638 1.589 . . . . 0.0 111.14 -173.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 70.5 -100.27 0.8 Allowed Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 -167.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -137.15 31.42 2.54 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-O 119.09 -0.839 . . . . 0.0 114.764 -148.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.1 -92.75 0.2 Allowed Glycine 0 CA--C 1.521 0.456 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 166.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 70.49 122.59 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 128.826 2.851 . . . . 0.0 111.235 -171.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 61.4 75.31 0.41 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.408 1.883 . . . . 0.0 111.038 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 95.5 m -76.2 99.06 4.6 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 113.024 -1.898 . . . . 0.0 107.879 170.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 93.6 m -66.08 138.37 57.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 158.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.05 137.27 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 124.927 1.291 . . . . 0.0 107.859 169.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -57.22 121.55 10.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 161.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -88.77 -86.88 1.23 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -146.78 -177.13 21.12 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.665 1.603 . . . . 0.0 110.449 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 27.4 m -93.88 144.58 25.31 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.152 1.381 . . . . 0.0 110.254 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.3 t -123.39 124.56 70.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 169.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -110.97 99.48 8.36 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.002 1.321 . . . . 0.0 107.609 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -79.33 107.13 11.87 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -112.66 157.78 20.82 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.792 1.637 . . . . 0.0 106.815 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.04 -162.91 27.8 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -174.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -165.67 174.37 9.85 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -166.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 82.3 t -129.73 138.13 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 170.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 184' ' ' ALA . 17.2 m -119.96 151.13 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 C-N-CA 128.663 2.785 . . . . 0.0 108.777 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.72 26.07 0.09 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -168.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 130.969 3.708 . . . . 0.0 111.279 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.023 -0.037 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.94 -48.39 30.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.784 0.434 . . . . 0.0 110.521 170.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.8 m 67.41 -66.72 0.19 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.153 1.781 . . . . 0.0 111.613 -172.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 m 60.66 170.7 0.09 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.936 2.094 . . . . 0.0 110.751 -176.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.9 t -78.79 52.07 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 O-C-N 119.949 -1.719 . . . . 0.0 107.739 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.46 46.58 0.75 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.705 1.602 . . . . 0.0 110.632 -169.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.49 -7.25 0.23 Allowed Glycine 0 CA--C 1.526 0.729 0 O-C-N 120.854 -1.154 . . . . 0.0 114.143 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.4 -72.78 0.59 Allowed Glycine 0 CA--C 1.503 -0.669 0 N-CA-C 106.111 -2.796 . . . . 0.0 106.111 163.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.6 t -125.01 90.94 3.33 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.0 p 46.9 56.54 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.323 1.449 . . . . 0.0 112.404 161.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -34.95 -58.75 0.51 Allowed 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 126.792 2.037 . . . . 0.0 116.148 -166.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 153.87 52.33 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 130.69 3.596 . . . . 0.0 108.693 169.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -129.38 105.08 7.87 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 173.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -128.68 -13.58 2.49 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 118.796 -1.002 . . . . 0.0 112.313 177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -130.58 -156.96 0.79 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-N 118.815 1.307 . . . . 0.0 108.961 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.1 t -49.22 -49.87 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 126.752 2.021 . . . . 0.0 110.278 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m 38.95 40.82 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 127.921 2.489 . . . . 0.0 113.652 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -136.33 98.17 3.77 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 125.39 1.476 . . . . 0.0 107.827 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -131.39 109.67 10.5 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.986 -1.071 . . . . 0.0 108.915 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.406 ' HB2' ' CE1' ' A' ' 158' ' ' TYR . . . -49.65 -28.72 6.23 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.671 1.588 . . . . 0.0 114.012 -170.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.1 m -126.64 153.65 45.07 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 171.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.31 6.86 35.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.514 1.526 . . . . 0.0 114.851 -167.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.28 9.8 p 36.17 100.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 130.686 3.595 . . . . 0.0 113.245 -174.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -59.49 162.16 5.18 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.117 0.967 . . . . 0.0 111.922 -162.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.28 -28.69 43.53 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.234 1.413 . . . . 0.0 111.411 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.97 8.49 66.43 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.899 1.237 . . . . 0.0 114.444 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.0 m -142.6 -23.8 0.65 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.683 1.741 . . . . 0.0 113.634 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.0 p -55.01 -33.96 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 120.529 1.513 . . . . 0.0 111.091 165.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -137.89 105.06 5.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -131.22 132.84 44.94 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.345 1.058 . . . . 0.0 108.97 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.4 m -118.64 89.72 3.19 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.2 t -72.78 124.01 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -88.51 101.06 13.56 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.4 mt -69.8 -14.72 62.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 165.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.89 -172.21 46.74 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -92.28 142.37 27.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.8 t -128.98 143.65 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 125.499 1.52 . . . . 0.0 108.406 -172.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.69 130.58 38.92 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.3 p -56.22 -24.17 40.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.01 0.924 . . . . 0.0 110.791 172.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.62 -23.99 67.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.34 1.056 . . . . 0.0 112.892 174.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.5 m -89.77 2.96 54.24 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.581 -1.324 . . . . 0.0 113.406 169.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.4 mt -142.17 68.93 1.32 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.959 1.303 . . . . 0.0 108.413 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.84 -5.19 7.5 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -168.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -155.09 164.51 38.76 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 125.158 1.383 . . . . 0.0 108.072 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -62.18 133.62 55.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.67 -10.97 73.41 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-O 118.62 -1.1 . . . . 0.0 111.96 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.45 148.18 42.68 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 119.176 1.488 . . . . 0.0 110.018 168.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.7 p -137.39 153.8 50.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 122.053 0.93 . . . . 0.0 110.251 -178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.2 t -55.35 160.34 2.33 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.59 160.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 m -44.81 -28.58 0.66 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.64 2.376 . . . . 0.0 114.587 169.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 85.03 149.17 0.07 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 129.281 3.033 . . . . 0.0 110.383 174.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.03 156.92 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 C-N-CA 128.634 2.774 . . . . 0.0 106.178 -163.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.3 151.41 17.25 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -158.11 142.2 15.8 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -126.62 147.75 49.87 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.511 1.05 . . . . 0.0 109.801 -174.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.4 mm -89.95 108.76 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.466 1.107 . . . . 0.0 108.038 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -69.21 115.03 8.02 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.732 0.813 . . . . 0.0 109.981 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.0 mt -116.86 101.96 8.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.145 1.378 . . . . 0.0 107.681 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -94.3 158.53 15.54 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.918 2.087 . . . . 0.0 110.324 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.4 t70 34.46 63.07 0.46 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 128.107 2.563 . . . . 0.0 114.052 -167.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 49.4 m -76.06 91.93 3.14 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.611 0.764 . . . . 0.0 111.461 177.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -64.35 124.33 21.48 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 167.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 p -81.88 -24.42 35.73 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.905 -1.122 . . . . 0.0 113.499 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -63.0 -40.32 97.4 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.361 0.982 . . . . 0.0 110.356 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 p -66.51 -45.28 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.094 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -164.07 127.75 2.62 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.107 1.363 . . . . 0.0 107.715 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -81.2 6.78 12.95 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 116.837 -1.554 . . . . 0.0 112.508 169.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HE3' ' HG3' ' A' ' 159' ' ' GLN . 49.1 mtmt -147.36 157.71 43.69 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 121.504 1.956 . . . . 0.0 114.354 172.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.21 133.43 51.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.479 1.911 . . . . 0.0 108.224 168.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.34 173.1 6.47 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 154.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.96 166.27 29.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.28 167.67 21.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -134.97 149.11 50.16 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -173.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 tp -146.44 124.79 12.3 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.89 0.376 . . . . 0.0 110.157 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.54 177.89 39.98 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.1 m -63.74 129.6 40.79 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.658 1.983 . . . . 0.0 110.124 -171.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.83 130.52 39.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.885 0.766 . . . . 0.0 110.073 173.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.6 tt -60.24 -40.32 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.839 0.856 . . . . 0.0 110.619 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -151.94 171.44 17.79 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 174.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.33 -35.36 75.84 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.013 0.925 . . . . 0.0 112.639 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.19 -0.07 89.47 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 123.661 0.648 . . . . 0.0 112.162 173.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -129.04 39.99 3.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.097 1.759 . . . . 0.0 109.28 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.9 p -66.66 -8.83 30.29 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.017 1.327 . . . . 0.0 113.018 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -87.93 -0.5 57.07 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.334 1.454 . . . . 0.0 113.024 167.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 36.1 t -129.08 139.54 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 120.739 1.609 . . . . 0.0 108.984 -177.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.43 143.05 27.12 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.752 -167.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -84.31 15.48 3.58 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.334 1.854 . . . . 0.0 114.764 -165.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.0 mt 52.83 -169.17 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.059 0.944 . . . . 0.0 110.016 -168.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -131.39 176.73 8.05 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.905 1.282 . . . . 0.0 108.276 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.6 t -63.68 150.96 43.14 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 123.339 1.542 . . . . 0.0 111.077 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.47 ' HB2' ' H ' ' A' ' 95' ' ' SER . 71.9 m -151.55 177.09 10.68 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 128.42 2.688 . . . . 0.0 106.356 170.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.14 -50.97 63.44 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.036 0.534 . . . . 0.0 111.773 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.44 21.26 13.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.426 0.691 . . . . 0.0 110.755 175.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.98 22.43 71.59 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-O 118.325 -1.264 . . . . 0.0 114.95 171.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.47 ' H ' ' HB2' ' A' ' 91' ' ' SER . 44.4 m 65.46 173.47 0.22 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.997 2.119 . . . . 0.0 112.067 -175.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.44 164.82 4.08 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.086 1.354 . . . . 0.0 110.058 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.9 p -120.65 166.81 13.16 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.622 1.169 . . . . 0.0 109.508 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.4 m-20 55.22 25.59 7.49 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.072 1.349 . . . . 0.0 111.191 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.83 150.77 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 119.373 0.988 . . . . 0.0 109.122 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.35 174.83 34.14 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -81.71 144.19 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -126.35 155.42 42.08 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.558 1.143 . . . . 0.0 108.95 165.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 mp -131.82 141.6 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.951 2.1 . . . . 0.0 107.011 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mt -140.69 146.49 37.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.896 1.278 . . . . 0.0 107.827 -173.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.36 176.23 4.13 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.683 1.23 . . . . 0.0 111.915 166.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -45.71 -30.17 1.5 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.731 2.812 . . . . 0.0 115.271 171.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 50.9 p -88.64 -31.57 18.48 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 120.724 1.602 . . . . 0.0 110.98 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.47 10.39 11.69 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.413 1.482 . . . . 0.0 113.622 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.9 131.18 44.04 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.188 1.494 . . . . 0.0 109.286 174.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.38 116.28 10.53 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.211 1.404 . . . . 0.0 109.778 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.1 mt -83.32 109.85 17.62 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.709 0.803 . . . . 0.0 109.011 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.4 m -57.86 151.94 16.98 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.077 0.465 . . . . 0.0 109.808 171.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.3 mt -102.84 76.06 1.46 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.024 2.129 . . . . 0.0 108.099 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -113.0 -19.58 11.85 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.646 1.178 . . . . 0.0 111.589 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.04 -22.49 0.76 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 126.579 2.038 . . . . 0.0 113.222 -175.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.23 -68.51 0.7 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 117.303 -1.332 . . . . 0.0 108.363 162.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.0 m -37.18 98.38 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.213 2.205 . . . . 0.0 111.745 -167.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -74.87 159.42 31.91 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.963 1.705 . . . . 0.0 110.175 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.9 p -107.85 175.51 5.46 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.423 1.489 . . . . 0.0 112.349 -175.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.6 m -39.88 110.95 0.16 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.728 2.011 . . . . 0.0 112.748 167.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -63.38 164.59 8.88 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.663 1.221 . . . . 0.0 110.48 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 86.1 m -140.15 137.23 34.26 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 165.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 100.0 m -82.95 141.24 32.29 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.194 0.998 . . . . 0.0 108.654 173.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.552 ' H ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -113.37 173.35 6.44 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 127.821 2.448 . . . . 0.0 107.773 -175.562 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.524 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 27.1 p30 -138.05 166.5 23.94 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 127.008 2.123 . . . . 0.0 109.02 176.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.59 115.16 2.85 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 123.967 0.792 . . . . 0.0 109.297 172.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.41 ' C ' ' HG1' ' A' ' 128' ' ' THR . . . 129.9 -104.37 0.62 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 174.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.41 ' HG1' ' C ' ' A' ' 127' ' ' GLY . 86.5 m -146.19 129.25 16.51 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.11 -1.818 . . . . 0.0 110.148 -169.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.524 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 56.0 m-80 -135.07 169.03 18.06 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 126.818 2.047 . . . . 0.0 109.396 -171.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.9 m -158.22 112.09 2.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -172.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.4 mt -76.74 121.35 84.66 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -75.32 146.91 32.08 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.636 1.557 . . . . 0.0 111.194 169.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -132.04 172.74 11.98 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.473 1.909 . . . . 0.0 107.629 168.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.36 151.75 45.68 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 162.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -130.54 162.73 28.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 165.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -157.2 166.13 34.06 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -82.63 138.57 34.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 156.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -117.21 128.05 54.71 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.643 1.977 . . . . 0.0 106.156 174.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.42 146.87 24.99 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.671 0.788 . . . . 0.0 109.883 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.5 p -113.24 18.07 18.15 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.682 1.593 . . . . 0.0 111.164 172.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 163.03 -157.55 29.66 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.08 92.29 0.17 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.376 1.088 . . . . 0.0 109.833 174.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.41 128.78 35.89 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.214 1.005 . . . . 0.0 109.267 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.2 p -76.42 159.64 79.31 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 118.924 -1.11 . . . . 0.0 109.0 166.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -69.5 171.88 13.39 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 N-CA-C 110.061 -0.784 . . . . 0.0 110.061 158.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.02 178.99 17.4 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 125.769 1.652 . . . . 0.0 109.574 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.3 146.31 51.39 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -138.66 74.23 1.47 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -113.88 156.42 23.98 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.47 167.62 28.18 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.812 1.245 . . . . 0.0 108.027 173.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -137.84 136.62 37.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.78 169.37 17.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.436 1.494 . . . . 0.0 108.522 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.42 152.25 41.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 165.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -117.67 158.19 25.12 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -118.98 168.66 10.59 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 169.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.9 t -133.4 123.88 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -120.37 85.21 2.35 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.577 1.18 . . . . 0.0 108.856 -172.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.406 ' CE1' ' HB2' ' A' ' 20' ' ' ALA . 92.0 m-85 -72.59 157.42 37.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.894 -1.503 . . . . 0.0 112.847 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.425 ' HG3' ' HE3' ' A' ' 68' ' ' LYS . 3.4 pt20 -174.33 170.02 3.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.243 1.817 . . . . 0.0 110.01 -174.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 143.02 -23.61 2.26 Favored Glycine 0 N--CA 1.466 0.69 0 O-C-N 120.895 -1.128 . . . . 0.0 113.214 171.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -65.83 -22.78 70.47 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 70.48 -108.35 2.45 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 107.975 -2.05 . . . . 0.0 107.975 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.18 -77.29 2.05 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.91 81.54 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.52 81.87 0.38 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 176.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -151.73 128.56 10.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.242 1.417 . . . . 0.0 107.639 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -153.24 137.31 16.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.491 1.516 . . . . 0.0 108.512 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 86.5 m -99.99 104.51 16.12 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.708 1.203 . . . . 0.0 109.206 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.2 m -94.57 93.17 7.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.427 1.891 . . . . 0.0 109.329 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.2 m -94.16 155.01 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 124.036 0.935 . . . . 0.0 110.166 173.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.98 144.88 52.18 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 161.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -103.71 -75.69 1.07 Allowed Glycine 0 C--N 1.332 0.352 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -177.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -175.62 -173.16 41.1 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -167.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.1 m -99.1 128.04 45.16 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.809 1.243 . . . . 0.0 109.53 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 19.9 t -104.98 105.34 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -82.49 143.27 31.23 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 168.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -122.76 126.39 47.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -134.75 152.23 51.6 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 118.185 0.448 . . . . 0.0 111.182 -171.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 139.94 -161.57 26.32 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.88 169.12 16.95 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -166.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 87.3 t -116.51 130.77 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' A' ' 184' ' ' ALA . 15.4 m -113.18 147.22 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 C-N-CA 125.895 1.678 . . . . 0.0 109.804 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.82 30.8 0.09 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -171.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.251 1.155 0 C-N-CA 131.436 3.895 . . . . 0.0 115.959 166.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.49 -79.45 0.13 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.778 1.172 . . . . 0.0 108.269 176.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 74.45 159.15 0.22 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.014 2.126 . . . . 0.0 109.351 -172.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.7 t -154.15 160.32 41.85 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 165.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -171.59 168.79 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.708 2.003 . . . . 0.0 106.608 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -66.93 85.51 0.12 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 122.335 1.064 . . . . 0.0 110.247 174.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.7 -53.35 3.64 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 120.391 -1.443 . . . . 0.0 112.343 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.84 -173.39 44.12 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 172.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t -92.7 95.72 9.74 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 146.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.3 t 56.03 61.28 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 122.195 0.998 . . . . 0.0 113.555 146.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -54.23 -49.46 69.42 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -158.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 153.95 71.07 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.176 1 C-N-CA 132.017 4.127 . . . . 0.0 104.943 176.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -71.16 -97.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.95 7.69 9.01 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.834 1.683 . . . . 0.0 115.957 156.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -176.65 -158.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.305 2.242 . . . . 0.0 105.072 -160.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.68 -11.42 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 O-C-N 120.679 -1.263 . . . . 0.0 112.262 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 t 56.39 40.63 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.353 1.061 . . . . 0.0 111.964 -176.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -154.67 94.56 1.69 Allowed 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 121.23 -0.919 . . . . 0.0 108.971 168.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.35 128.12 47.68 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 159.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.408 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -56.33 -43.6 79.18 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.5 m -108.92 175.19 5.55 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.536 1.535 . . . . 0.0 108.576 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.76 -16.06 15.04 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -167.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 t 54.88 114.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 128.343 2.657 . . . . 0.0 111.836 -173.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -59.17 154.38 16.21 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.2 1.4 . . . . 0.0 111.678 169.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.89 -27.3 68.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.732 1.213 . . . . 0.0 112.397 174.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.402 ' H ' ' CG ' ' A' ' 24' ' ' ASP . . . -81.1 9.98 50.84 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.406 1.003 . . . . 0.0 112.997 172.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.2 t -129.46 -40.41 1.43 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.356 1.862 . . . . 0.0 108.546 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.1 p -58.16 -34.13 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 123.696 0.798 . . . . 0.0 111.067 173.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -150.52 75.52 1.22 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.491 0.662 . . . . 0.0 109.565 -167.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.52 145.7 35.86 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.702 -0.624 . . . . 0.0 109.496 -173.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.9 m -112.58 95.3 5.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.94 111.8 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -84.54 103.46 13.69 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.2 mt -83.82 -4.99 59.1 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.045 1.338 . . . . 0.0 109.988 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.79 177.7 36.05 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 122.014 0.785 . . . . 0.0 112.522 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -75.83 139.6 41.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 167.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -125.77 143.42 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.129 0.971 . . . . 0.0 109.509 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.6 mmt180 -74.39 131.19 40.88 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 p -56.49 -23.3 38.46 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 123.304 0.642 . . . . 0.0 111.569 173.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.51 -48.67 71.62 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.488 1.115 . . . . 0.0 110.71 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.0 m -74.36 5.92 4.14 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.4 mt -142.92 59.39 1.42 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.354 1.862 . . . . 0.0 107.72 -168.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.57 6.41 3.5 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -165.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.607 HE21 ' HB3' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -153.35 168.32 26.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.794 1.638 . . . . 0.0 107.161 170.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -63.09 136.56 57.86 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 167.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.42 3.37 86.03 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-O 118.936 -0.924 . . . . 0.0 112.123 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.607 ' HB3' HE21 ' A' ' 44' ' ' GLN . . . -65.53 145.32 56.24 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.766 1.283 . . . . 0.0 109.045 162.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -142.24 152.44 43.07 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.563 0.697 . . . . 0.0 110.377 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.4 p -69.82 -179.2 1.74 Allowed 'General case' 0 CA--C 1.555 1.141 0 O-C-N 121.518 -0.739 . . . . 0.0 109.097 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.43 -28.93 32.64 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -169.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 95.58 110.75 0.02 OUTLIER 'General case' 0 C--N 1.343 0.301 0 C-N-CA 130.703 3.601 . . . . 0.0 109.522 -168.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -100.77 147.55 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.23 112.73 2.87 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -116.13 179.01 4.11 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.891 0.877 . . . . 0.0 109.142 177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -158.66 172.44 18.27 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.193 -0.942 . . . . 0.0 110.659 176.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.3 mm -121.76 103.71 13.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -65.96 132.35 48.4 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 172.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 mp -129.24 119.9 24.81 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.245 2.218 . . . . 0.0 107.663 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -120.99 167.73 12.27 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.147 2.179 . . . . 0.0 111.178 -171.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.2 t70 25.31 57.0 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.28 2.632 . . . . 0.0 114.385 -165.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 91.2 m -73.74 121.73 21.26 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.551 2.34 . . . . 0.0 109.425 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -92.52 140.06 29.95 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 167.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.1 p -88.92 -13.79 38.24 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.907 1.685 . . . . 0.0 114.503 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -60.92 -51.33 69.74 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.112 0.958 . . . . 0.0 109.009 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.426 ' H ' HG12 ' A' ' 65' ' ' VAL . 2.1 p -58.26 -48.72 84.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 124.809 1.244 . . . . 0.0 108.126 -175.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -167.8 127.17 1.31 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.41 1.884 . . . . 0.0 107.28 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.3 m -88.34 1.67 54.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.599 0.76 . . . . 0.0 110.821 169.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -127.68 160.79 30.57 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 121.107 1.776 . . . . 0.0 110.802 172.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.83 132.58 25.67 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.108 0.963 . . . . 0.0 109.385 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.35 170.38 9.41 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 122.384 1.088 . . . . 0.0 109.266 167.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.9 t -138.81 147.75 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 127.007 2.123 . . . . 0.0 105.453 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.53 159.33 36.65 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -123.61 157.31 34.03 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.613 1.565 . . . . 0.0 109.165 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.7 tp -152.59 142.14 21.77 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.715 0.806 . . . . 0.0 108.897 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.37 171.14 43.87 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -175.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 m -58.04 124.88 20.83 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.758 1.279 . . . . 0.0 110.261 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.56 136.6 44.02 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 119.533 1.061 . . . . 0.0 110.34 173.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.5 tt -61.0 -54.22 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 O-C-N 123.786 0.679 . . . . 0.0 110.686 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -134.12 161.7 34.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 176.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.8 -33.61 74.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.07 -0.394 . . . . 0.0 111.146 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.66 1.72 76.6 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 121.614 -0.679 . . . . 0.0 113.721 175.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -140.37 43.8 1.88 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.902 1.681 . . . . 0.0 109.86 -173.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 p -66.26 -3.89 6.71 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 128.233 2.613 . . . . 0.0 112.503 169.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -93.52 9.16 37.84 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.774 1.23 . . . . 0.0 112.183 167.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.7 t -138.37 143.6 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 120.892 -1.13 . . . . 0.0 110.939 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.4 mt -78.62 151.91 32.05 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 119.305 0.957 . . . . 0.0 112.071 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.58 18.73 5.98 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 127.444 2.297 . . . . 0.0 114.017 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 62.5 mt 51.74 -156.5 0.14 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.045 0.938 . . . . 0.0 110.806 -167.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -143.44 -179.47 6.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.417 1.487 . . . . 0.0 108.516 174.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.2 m -60.31 156.82 14.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.27 1.828 . . . . 0.0 113.195 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.489 ' HB2' ' H ' ' A' ' 95' ' ' SER . 51.0 m -158.85 175.11 14.0 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 128.318 2.647 . . . . 0.0 107.494 168.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.78 -54.32 24.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.508 0.723 . . . . 0.0 111.741 168.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.5 -0.26 49.44 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.46 37.41 94.41 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 121.102 -0.999 . . . . 0.0 113.015 -167.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.489 ' H ' ' HB2' ' A' ' 91' ' ' SER . 13.9 m 66.16 -168.64 0.2 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.822 1.649 . . . . 0.0 111.758 168.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.86 132.96 46.84 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 164.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.7 p -87.37 166.81 14.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 170.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 59.8 18.73 7.6 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.294 1.838 . . . . 0.0 112.507 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -141.46 156.35 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -165.58 170.16 40.31 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -169.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.21 138.66 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 119.283 1.542 . . . . 0.0 108.671 -175.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -105.32 156.46 18.14 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.317 0.962 . . . . 0.0 109.955 163.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -117.73 141.62 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 158.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.7 mt -125.29 137.63 54.08 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.15 2.18 . . . . 0.0 105.385 175.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -63.29 166.67 6.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.72 1.248 . . . . 0.0 110.298 166.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.0 ptt85 -59.26 -26.01 64.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.085 1.354 . . . . 0.0 112.806 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.63 -12.93 60.9 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.967 0.803 . . . . 0.0 109.635 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.69 3.59 68.5 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 126.612 2.053 . . . . 0.0 112.738 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.05 159.61 31.52 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.398 1.599 . . . . 0.0 109.202 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.58 158.11 16.16 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.58 0.352 . . . . 0.0 110.207 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.6 mt -114.72 138.25 50.94 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 -172.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -75.22 157.19 34.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 170.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.7 mt -110.32 76.43 0.98 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.86 -14.97 10.07 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.289 0.635 . . . . 0.0 111.588 172.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.28 -2.82 81.66 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 117.055 -1.97 . . . . 0.0 113.946 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -139.66 -15.6 1.04 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.467 1.634 . . . . 0.0 112.851 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 49.6 m -59.54 111.7 1.51 Allowed 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 164.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.4 168.18 9.35 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.96 0.904 . . . . 0.0 110.082 173.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.6 p -120.01 -38.18 2.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -175.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.68 121.28 0.09 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.428 1.891 . . . . 0.0 109.41 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -67.62 140.29 56.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.7 m -130.96 117.39 19.15 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 55.0 m -56.92 137.73 54.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 171.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 45.4 mt -90.96 -163.59 1.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.195 0.998 . . . . 0.0 109.174 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -154.63 166.58 32.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.878 2.071 . . . . 0.0 108.149 167.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -66.45 91.01 0.16 Allowed 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.274 1.83 . . . . 0.0 109.621 170.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.12 -107.93 0.64 Allowed Glycine 0 C--O 1.224 -0.517 0 CA-C-O 119.04 -0.867 . . . . 0.0 112.424 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.64 136.75 54.74 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 119.219 1.509 . . . . 0.0 110.614 -172.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -137.58 168.98 18.57 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 127.159 2.184 . . . . 0.0 108.529 -176.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 97.6 m -149.41 145.12 26.79 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 168.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.41 107.77 59.68 Favored Pre-proline 0 N--CA 1.447 -0.582 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 169.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.35 156.23 65.02 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 N-CA-C 109.117 -1.147 . . . . 0.0 109.117 171.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -139.72 166.29 25.0 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.827 1.651 . . . . 0.0 107.184 170.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -117.48 137.64 52.4 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 167.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -128.87 149.86 50.58 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.59 -175.4 5.37 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.944 -0.472 . . . . 0.0 110.443 170.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -89.65 140.81 29.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 161.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -102.85 147.28 27.09 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.134 1.774 . . . . 0.0 106.321 164.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.11 144.55 41.31 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 166.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 75.0 p -102.51 12.4 36.51 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.192 0.997 . . . . 0.0 110.974 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 162.99 -145.49 10.65 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 176.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.04 87.11 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.897 1.679 . . . . 0.0 111.591 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.27 130.13 45.45 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.321 -0.862 . . . . 0.0 109.334 173.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 49.1 p -83.39 161.42 56.92 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 168.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -70.28 174.2 10.31 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.653 1.569 . . . . 0.0 110.079 163.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.26 -93.51 0.14 Allowed Glycine 0 C--N 1.333 0.365 0 O-C-N 120.965 -1.084 . . . . 0.0 111.536 172.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -149.53 163.3 38.21 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 175.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -146.02 86.05 1.7 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -125.63 153.43 43.78 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -162.93 165.73 24.73 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.682 1.193 . . . . 0.0 107.986 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -137.67 134.93 36.01 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -126.56 165.47 19.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.918 1.687 . . . . 0.0 109.484 174.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 41.4 p -119.67 124.86 47.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -93.8 149.66 21.05 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -121.35 163.45 18.64 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.256 1.422 . . . . 0.0 107.757 171.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.52 109.13 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.248 -2.131 . . . . 0.0 105.248 -164.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -111.01 80.32 1.29 Allowed 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.316 1.446 . . . . 0.0 108.935 -167.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -71.6 161.72 30.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.802 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -175.26 171.53 2.91 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.352 1.061 . . . . 0.0 111.251 -174.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 141.61 -46.65 0.88 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 124.496 1.046 . . . . 0.0 111.591 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -72.45 70.16 1.1 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 126.139 1.828 . . . . 0.0 113.416 -171.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 163.45 4.18 0.04 OUTLIER Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.344 1.926 . . . . 0.0 113.182 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.65 -63.01 4.06 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 119.846 1.823 . . . . 0.0 110.796 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.41 70.57 0.22 Allowed Glycine 0 CA--C 1.521 0.421 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 163.67 58.02 0.02 OUTLIER Glycine 0 C--N 1.332 0.315 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -171.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -173.09 129.31 0.47 Allowed 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 126.269 1.827 . . . . 0.0 107.62 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -161.49 165.1 29.16 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 125.357 1.661 . . . . 0.0 110.498 171.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 98.2 m -151.84 97.16 2.32 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.399 1.479 . . . . 0.0 107.866 -170.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.6 m -89.08 117.08 27.82 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.023 1.729 . . . . 0.0 109.768 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.93 159.27 26.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.755 1.622 . . . . 0.0 110.744 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -76.32 111.96 12.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.71 -67.59 1.82 Allowed Glycine 0 C--N 1.334 0.423 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.99 -160.98 34.73 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -171.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 37.5 m -107.05 128.35 54.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.448 1.099 . . . . 0.0 108.504 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 19.6 t -104.5 105.75 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 166.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -78.85 143.49 35.92 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 170.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -122.32 122.88 40.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -128.61 168.78 15.25 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.687 1.195 . . . . 0.0 109.699 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 138.88 -161.78 25.88 Favored Glycine 0 N--CA 1.443 -0.9 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -162.07 170.36 19.34 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.08 129.89 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 168.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.4 m -115.38 147.98 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 C-N-CA 127.166 2.186 . . . . 0.0 107.844 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.78 41.9 0.22 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.358 1.463 . . . . 0.0 113.356 -174.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.276 0 C-N-CA 129.627 3.171 . . . . 0.0 113.605 175.206 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.92 159.11 43.14 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.102 1.361 . . . . 0.0 107.976 166.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.48 161.64 40.9 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.805 1.242 . . . . 0.0 108.024 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.9 t -151.9 113.16 4.3 Favored 'General case' 0 N--CA 1.457 -0.113 0 O-C-N 120.919 -1.113 . . . . 0.0 109.703 172.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -147.58 154.59 11.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 165.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -64.41 -50.78 66.29 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 122.272 -0.267 . . . . 0.0 110.771 -165.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.81 37.81 3.31 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.115 0.864 . . . . 0.0 111.595 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.13 41.49 0.2 Allowed Glycine 0 C--N 1.338 0.662 0 CA-C-N 118.49 1.145 . . . . 0.0 111.468 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -163.14 13.22 0.06 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.889 1.276 . . . . 0.0 109.173 174.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 12' ' ' PHE . 35.0 m -71.28 35.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 130.345 3.458 . . . . 0.0 111.696 -169.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.3 m170 31.8 -21.04 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.02 1 C-N-CA 137.484 6.314 . . . . 0.0 117.576 -146.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.447 ' H ' ' C ' ' A' ' 10' ' ' VAL . 41.8 m-85 -103.8 1.14 31.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 128.191 2.597 . . . . 0.0 112.067 -166.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.8 mttt 68.03 -27.92 0.14 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 128.478 2.711 . . . . 0.0 116.101 -172.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.1 -16.76 1.96 Allowed Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.33 1.919 . . . . 0.0 115.774 170.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.492 ' HG3' ' H ' ' A' ' 17' ' ' VAL . 13.3 pt-20 -80.11 -153.28 0.08 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 129.686 3.195 . . . . 0.0 110.928 -173.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.6 p -46.79 -26.54 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 126.717 2.007 . . . . 0.0 113.587 167.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.492 ' H ' ' HG3' ' A' ' 15' ' ' GLU . 27.6 m 41.81 33.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 130.704 3.602 . . . . 0.0 113.802 -174.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -160.5 104.99 1.43 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.935 2.094 . . . . 0.0 106.861 171.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.45 36.55 1.49 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 128.553 2.741 . . . . 0.0 108.438 175.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 48.7 -69.02 0.0 OUTLIER 'General case' 0 C--N 1.34 0.182 1 C-N-CA 133.453 4.701 . . . . 0.0 112.099 -171.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 29.1 m -83.19 -176.23 6.22 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.972 2.109 . . . . 0.0 111.229 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.31 16.14 10.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.925 2.09 . . . . 0.0 113.27 -171.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t 24.62 102.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 130.164 3.385 . . . . 0.0 113.137 172.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -55.32 157.59 3.59 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.63 1.172 . . . . 0.0 112.221 -171.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.22 -23.08 62.0 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.927 -1.108 . . . . 0.0 111.553 169.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.15 -18.49 73.07 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 117.872 -1.516 . . . . 0.0 113.671 172.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.2 p -118.43 -17.76 9.33 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.254 2.027 . . . . 0.0 111.919 -176.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.01 -27.77 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 O-C-N 120.876 -1.14 . . . . 0.0 112.771 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -167.3 82.3 0.21 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 -167.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.58 129.72 56.27 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -173.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -77.57 142.24 39.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 156.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.5 t -117.66 99.94 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 162.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -82.43 101.24 10.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.18 -17.3 59.6 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.767 0.827 . . . . 0.0 109.747 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.55 -165.21 18.78 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 121.716 0.62 . . . . 0.0 113.041 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -66.92 153.81 42.61 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.306 1.443 . . . . 0.0 111.53 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.5 t -137.13 147.95 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 125.414 1.485 . . . . 0.0 108.628 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.41 127.98 32.97 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 p -59.15 -25.1 63.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.227 0.537 . . . . 0.0 111.806 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.31 -27.87 66.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.497 -0.752 . . . . 0.0 111.204 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.5 t -84.52 0.89 48.15 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.245 1.418 . . . . 0.0 112.802 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.1 mt -143.84 82.69 1.73 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.62 1.568 . . . . 0.0 107.826 -170.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.04 0.05 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.408 -1.433 . . . . 0.0 113.485 -174.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -148.22 157.25 43.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 33.0 tt0 -63.37 121.83 14.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.51 -4.57 61.97 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.282 1.42 . . . . 0.0 113.523 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.22 154.24 24.01 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 119.24 1.52 . . . . 0.0 109.499 168.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.5 p -144.06 156.23 44.29 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.251 0.478 . . . . 0.0 110.678 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.7 p -72.55 -174.67 1.43 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.6 m -50.54 -40.18 51.11 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 117.101 -1.428 . . . . 0.0 113.806 171.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 95.18 170.92 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 C-N-CA 131.694 3.998 . . . . 0.0 109.815 -166.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.6 t -145.0 139.1 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 167.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.27 69.48 0.22 Allowed Glycine 0 CA--C 1.51 -0.246 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -69.0 161.0 29.9 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -133.67 175.84 9.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.739 1.616 . . . . 0.0 109.518 169.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.3 mm -109.81 112.29 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -68.55 112.42 5.34 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.301 0.64 . . . . 0.0 109.861 172.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.92 135.91 49.33 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 125.006 1.323 . . . . 0.0 108.272 168.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -136.95 167.65 21.08 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.378 1.471 . . . . 0.0 110.362 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 46.07 30.74 0.99 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.965 2.106 . . . . 0.0 113.353 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 96.3 m -62.83 162.48 10.97 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 127.031 2.132 . . . . 0.0 111.388 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -151.42 120.24 6.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.797 1.639 . . . . 0.0 106.898 -167.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.9 p -79.4 -18.45 52.26 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 120.898 -1.126 . . . . 0.0 112.22 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -60.35 -46.97 88.06 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.472 0.709 . . . . 0.0 109.725 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.2 p -73.12 -45.78 52.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.212 1.005 . . . . 0.0 109.637 -175.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -161.82 124.17 2.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.145 1.378 . . . . 0.0 108.099 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 m -66.85 -11.75 56.73 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.893 170.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -149.46 163.1 38.72 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 120.846 1.657 . . . . 0.0 114.116 -169.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.89 126.51 39.89 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.713 2.005 . . . . 0.0 106.836 166.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.55 172.96 8.15 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 142.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.88 151.09 21.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 103.182 -2.896 . . . . 0.0 103.182 -171.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.76 149.45 46.44 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -114.24 157.88 22.13 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.856 0.862 . . . . 0.0 110.757 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.9 tp -150.47 140.93 22.44 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.952 1.301 . . . . 0.0 108.934 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.16 -169.0 34.39 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 123.929 0.776 . . . . 0.0 112.381 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 m -81.5 130.87 35.21 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.205 1.802 . . . . 0.0 109.605 166.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.97 140.07 40.32 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 119.553 1.07 . . . . 0.0 111.028 172.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.3 tt -64.04 -44.62 97.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 122.689 0.396 . . . . 0.0 111.503 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.43 164.46 34.91 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.836 1.254 . . . . 0.0 108.636 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.85 -27.22 66.47 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.888 1.275 . . . . 0.0 113.114 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.77 -2.94 88.45 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.798 0.713 . . . . 0.0 112.582 175.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -143.34 47.3 1.5 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.772 1.629 . . . . 0.0 109.133 -169.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.5 p -61.89 -15.61 44.03 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.15 0.98 . . . . 0.0 112.943 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.628 ' ND2' ' HG1' ' A' ' 112' ' ' THR . 2.0 m-20 -94.48 -12.76 27.05 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 124.709 1.203 . . . . 0.0 109.762 -173.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.09 130.81 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.857 1.263 . . . . 0.0 107.653 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mt -72.2 150.01 44.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.85 1.26 . . . . 0.0 110.291 -174.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.74 14.05 16.44 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.983 1.713 . . . . 0.0 114.351 -164.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.1 mt 48.74 -152.48 0.12 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.216 1.007 . . . . 0.0 110.199 -162.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -148.04 179.34 7.81 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.507 1.523 . . . . 0.0 110.374 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.6 m -51.97 145.78 9.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.911 1.684 . . . . 0.0 112.404 170.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.6 m -164.16 174.05 11.7 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.625 2.77 . . . . 0.0 105.876 172.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.69 -38.81 56.71 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -176.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.87 35.06 4.77 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.561 1.544 . . . . 0.0 109.775 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.64 32.13 83.19 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 166.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 62.6 m 66.02 176.88 0.22 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.715 2.406 . . . . 0.0 112.536 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.78 128.9 39.5 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.036 1.334 . . . . 0.0 109.177 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.5 p -87.5 170.27 11.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.893 0.77 . . . . 0.0 110.03 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 49.6 32.78 5.23 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.938 1.695 . . . . 0.0 111.943 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 p -154.68 151.02 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.4 172.77 34.83 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.2 t -84.61 133.74 28.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -104.48 153.54 21.01 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 157.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.0 mp -116.72 128.91 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 103.747 -2.686 . . . . 0.0 103.747 164.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 mt -125.96 143.11 51.22 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 5.7 p-10 -66.66 -178.33 0.7 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.475 1.11 . . . . 0.0 112.659 173.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -44.37 -31.67 1.12 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 128.605 2.762 . . . . 0.0 114.856 169.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.6 p -95.09 -4.65 45.92 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.884 1.274 . . . . 0.0 112.125 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.48 22.23 78.76 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 121.162 -0.961 . . . . 0.0 112.933 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -82.69 144.31 30.33 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.923 1.861 . . . . 0.0 109.081 168.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.87 129.05 37.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.756 0.822 . . . . 0.0 111.106 -176.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 51.9 mt -89.45 168.68 12.0 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.001 0.52 . . . . 0.0 110.396 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.628 ' HG1' ' ND2' ' A' ' 84' ' ' ASN . 9.5 m -122.32 140.63 52.43 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.995 1.318 . . . . 0.0 107.764 -177.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.7 mt -93.69 52.03 1.64 Allowed 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.513 1.125 . . . . 0.0 109.895 -160.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.33 -29.34 19.22 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.238 1.015 . . . . 0.0 111.495 -174.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.99 -30.43 3.59 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 124.564 1.078 . . . . 0.0 113.697 -172.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.05 -58.04 3.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 116.989 -1.481 . . . . 0.0 109.383 166.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.2 m -40.66 103.97 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.315 1.446 . . . . 0.0 111.956 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -63.32 160.77 15.24 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.068 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.3 p -118.43 173.08 7.03 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.857 1.263 . . . . 0.0 109.383 168.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 17.2 m -25.2 116.46 0.05 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.051 2.14 . . . . 0.0 113.402 166.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -72.33 167.4 20.54 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 122.318 1.056 . . . . 0.0 109.174 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.1 m -132.57 157.11 45.55 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 160.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.4 m -107.04 133.81 51.11 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 123.517 1.627 . . . . 0.0 107.961 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.99 175.77 6.51 Favored 'General case' 0 N--CA 1.428 -1.561 0 C-N-CA 129.179 2.991 . . . . 0.0 108.904 -164.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.428 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 7.3 p30 -145.68 165.48 28.63 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.411 1.484 . . . . 0.0 107.971 172.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -61.09 122.59 15.37 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 169.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.21 -119.27 6.11 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.263 0.935 . . . . 0.0 111.208 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 m -117.58 125.87 51.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 119.232 1.516 . . . . 0.0 110.436 -167.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.428 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -133.22 176.02 8.88 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 125.051 1.34 . . . . 0.0 109.948 175.734 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.0 m -145.28 137.32 25.64 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.261 -0.899 . . . . 0.0 110.586 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.8 mt -102.63 108.88 59.46 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 169.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -86.59 159.5 9.31 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.607 2.205 . . . . 0.0 110.648 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -146.43 177.17 9.24 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.1 1.76 . . . . 0.0 109.438 -172.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.09 115.34 8.88 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.393 0.997 . . . . 0.0 111.09 153.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.24 164.88 18.8 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 121.45 -0.781 . . . . 0.0 109.535 167.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -157.24 160.63 38.84 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.011 1.325 . . . . 0.0 107.506 171.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -79.77 132.11 36.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 160.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -116.33 123.02 46.59 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.503 1.921 . . . . 0.0 106.054 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.06 143.44 31.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.165 0.586 . . . . 0.0 109.82 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.411 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 12.3 p -106.19 11.17 31.54 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.765 0.826 . . . . 0.0 112.173 170.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 160.84 -149.25 18.21 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.06 86.78 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.956 1.303 . . . . 0.0 110.01 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.67 155.96 39.71 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.282 0.633 . . . . 0.0 109.871 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.4 p -118.83 161.52 35.71 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.757 0.708 . . . . 0.0 109.896 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -75.39 176.89 9.36 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.681 1.587 . . . . 0.0 110.629 171.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.43 -97.95 0.17 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 164.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.94 163.19 31.29 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 129.947 3.299 . . . . 0.0 105.456 168.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -150.19 77.22 1.3 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.673 0.67 . . . . 0.0 109.816 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -119.81 150.35 40.57 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -174.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.73 164.08 38.45 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.454 1.102 . . . . 0.0 108.193 171.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -134.68 98.28 4.01 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.97 177.81 8.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.39 0.614 . . . . 0.0 110.376 168.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.5 p -122.16 162.44 21.32 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 150.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CE1' ' HA3' ' A' ' 172' ' ' GLY . 44.4 p90 -115.98 150.86 36.51 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.912 0.863 . . . . 0.0 109.763 158.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -107.37 167.04 10.2 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.042 1.737 . . . . 0.0 106.659 161.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.88 146.71 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 171.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -128.1 85.12 2.31 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -66.54 147.98 52.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.143 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -161.44 176.91 10.61 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 124.76 1.224 . . . . 0.0 110.752 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 142.96 -32.51 1.9 Allowed Glycine 0 CA--C 1.521 0.407 0 C-N-CA 125.056 1.312 . . . . 0.0 111.339 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.67 84.98 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 118.219 1.01 . . . . 0.0 112.458 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 79.27 -81.66 1.42 Allowed Glycine 0 C--N 1.337 0.606 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 174.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 60.33 -87.38 0.03 OUTLIER Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.88 1.705 . . . . 0.0 111.559 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -145.4 22.6 1.87 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.581 1.562 . . . . 0.0 111.651 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 103.59 80.49 1.44 Allowed Glycine 0 C--N 1.336 0.548 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 -165.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.79 119.92 17.69 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.109 1.764 . . . . 0.0 107.253 -173.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -149.29 172.57 14.66 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 127.219 2.208 . . . . 0.0 109.343 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.4 m -130.91 99.41 4.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.6 131.74 42.85 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 167.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.7 m -148.55 140.65 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 124.405 1.082 . . . . 0.0 109.742 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -66.87 126.27 28.54 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 166.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' ' 154' ' ' PHE . . . -93.41 -75.96 1.32 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -160.29 -175.48 31.33 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 123.72 0.306 . . . . 0.0 113.232 -176.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 25.6 m -103.6 142.82 33.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.401 1.48 . . . . 0.0 109.007 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.4 t -125.57 101.56 8.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -88.35 95.6 10.26 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -75.14 102.21 4.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 175.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -114.24 156.94 23.4 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 -175.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 143.75 -163.37 27.63 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -171.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -161.44 170.15 20.54 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -164.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 48.3 t -126.4 140.51 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 167.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.442 ' C ' ' H ' ' A' ' 184' ' ' ALA . 16.9 m -122.06 150.37 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 127.058 2.143 . . . . 0.0 109.046 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.65 24.59 0.09 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -169.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.25 1.107 1 C-N-CA 132.993 4.517 . . . . 0.0 113.719 171.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.44 -77.93 0.42 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 171.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.0 m 65.27 172.75 0.21 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.975 1.71 . . . . 0.0 111.285 -176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.9 p -135.58 127.4 29.32 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.912 2.085 . . . . 0.0 106.37 -170.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.9 p -146.4 172.02 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -55.69 103.35 0.09 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.745 1.618 . . . . 0.0 111.422 -167.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.57 -88.55 1.59 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.33 173.76 23.66 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -174.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 t -96.6 14.32 25.19 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.022 0.529 . . . . 0.0 112.196 -164.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 74.01 156.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 127.945 2.498 . . . . 0.0 110.43 -155.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -85.35 36.45 0.64 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.78 1.232 . . . . 0.0 110.723 -165.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -159.02 16.88 0.18 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.912 2.085 . . . . 0.0 110.522 -161.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 69.82 -36.32 0.34 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 127.599 2.36 . . . . 0.0 114.877 -175.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.07 27.61 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.884 0 CA-C-O 117.141 -1.921 . . . . 0.0 114.203 -167.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.347 2.2 pt-20 97.77 -157.79 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 130.141 3.376 . . . . 0.0 112.147 173.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 p -41.53 -39.57 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 126.841 2.056 . . . . 0.0 113.283 -176.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.258 22.1 m 33.26 34.52 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 130.051 3.34 . . . . 0.0 117.83 176.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -116.87 100.29 7.68 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.978 0.894 . . . . 0.0 109.667 169.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -129.01 110.79 12.36 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 -173.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.28 -38.87 63.48 Favored 'General case' 0 C--O 1.225 -0.211 0 O-C-N 123.986 0.803 . . . . 0.0 112.206 -165.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.5 m -110.22 159.3 17.51 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.798 1.239 . . . . 0.0 107.779 165.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.81 -9.3 52.26 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -164.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.5 t 44.95 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 129.038 2.935 . . . . 0.0 110.744 -167.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -62.91 160.57 14.49 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.289 -170.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.7 -21.2 39.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.953 1.301 . . . . 0.0 112.15 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.53 -12.9 67.53 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.564 1.078 . . . . 0.0 112.755 173.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 t -127.09 -21.67 3.91 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.834 1.654 . . . . 0.0 110.792 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.9 -26.13 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 125.25 1.42 . . . . 0.0 113.007 -173.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -150.7 94.5 2.1 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -132.61 148.31 52.36 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.343 0.657 . . . . 0.0 109.485 -175.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.2 m -124.32 100.4 6.67 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.634 1.973 . . . . 0.0 108.041 -174.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.5 t -74.53 111.28 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -88.55 101.41 13.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 mt -76.46 -16.39 59.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.033 1.733 . . . . 0.0 109.7 170.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.39 -166.55 25.49 Favored Glycine 0 C--N 1.343 0.935 0 C-N-CA 124.796 1.189 . . . . 0.0 112.765 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -68.68 147.63 51.58 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.98 0.912 . . . . 0.0 109.64 173.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 t -135.88 143.41 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 124.353 1.061 . . . . 0.0 108.949 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -73.29 127.67 33.3 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.3 p -58.01 -21.94 47.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.211 0.529 . . . . 0.0 111.485 172.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.38 -43.3 75.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.165 -0.96 . . . . 0.0 110.675 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.6 m -72.49 -2.11 18.39 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.4 mt -144.0 66.28 1.29 Allowed 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.488 1.915 . . . . 0.0 109.017 -161.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.97 -9.07 6.0 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -167.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -152.52 163.09 40.26 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.391 1.476 . . . . 0.0 107.928 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -62.77 129.97 42.84 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.24 -10.68 63.58 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.842 1.211 . . . . 0.0 112.734 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.83 106.2 2.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.35 1.06 . . . . 0.0 111.458 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.8 p -101.18 150.6 22.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.44 -0.788 . . . . 0.0 110.812 -176.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.1 p -67.56 172.45 5.09 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 166.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.7 m -24.64 -98.9 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 130.257 3.423 . . . . 0.0 114.517 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 154.72 118.24 0.0 OUTLIER 'General case' 0 C--O 1.233 0.191 0 C-N-CA 129.746 3.218 . . . . 0.0 105.356 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.58 130.96 65.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -176.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.08 139.5 14.58 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -138.48 158.77 43.62 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 168.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -148.94 130.08 14.51 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 120.347 -1.471 . . . . 0.0 110.396 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.7 mm -83.54 115.61 26.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 125.002 1.321 . . . . 0.0 107.459 -167.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -76.63 108.95 9.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.988 0.915 . . . . 0.0 109.826 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.7 mp -111.71 97.13 6.5 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 125.414 1.485 . . . . 0.0 108.294 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -95.83 160.32 14.53 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.161 1.784 . . . . 0.0 112.227 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.3 t70 40.49 49.7 2.68 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.275 2.63 . . . . 0.0 114.007 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 57.5 m -65.66 122.16 16.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 127.701 2.4 . . . . 0.0 111.05 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -111.17 112.6 24.51 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.582 1.153 . . . . 0.0 110.161 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.9 p -70.84 -24.68 62.57 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.146 2.178 . . . . 0.0 113.738 -165.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -61.47 -48.2 82.19 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 128.543 2.737 . . . . 0.0 112.44 168.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.1 t -64.88 -39.13 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -176.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -168.63 146.06 3.91 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.117 -176.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.25 -11.42 35.34 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 118.795 -0.621 . . . . 0.0 111.67 170.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -134.04 164.8 26.5 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 125.46 1.504 . . . . 0.0 109.942 -173.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.79 144.06 37.18 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 163.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.79 167.88 9.83 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.98 1.712 . . . . 0.0 107.429 158.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.7 t -124.8 150.97 29.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 169.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.25 155.21 37.62 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 161.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.441 ' CE1' HG23 ' A' ' 103' ' ' ILE . 60.0 m-85 -114.04 154.85 26.98 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.7 tp -142.11 125.97 17.11 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 125.373 1.469 . . . . 0.0 107.365 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.85 162.91 36.34 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.3 m -63.08 129.47 40.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.003 0.901 . . . . 0.0 109.107 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.69 141.31 46.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.071 0.462 . . . . 0.0 110.245 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.3 tt -60.77 -37.51 76.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 123.931 0.892 . . . . 0.0 110.382 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -158.24 165.56 34.55 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.45 -35.4 72.06 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.856 1.262 . . . . 0.0 111.254 169.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.79 -3.68 64.29 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 121.276 -0.89 . . . . 0.0 112.381 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -147.78 48.54 1.08 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.959 1.704 . . . . 0.0 108.788 -164.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.3 p -58.75 -18.4 31.4 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.598 1.959 . . . . 0.0 112.414 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -95.07 -1.79 51.44 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 117.928 -1.034 . . . . 0.0 113.076 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.3 t -115.58 130.59 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 120.329 1.422 . . . . 0.0 109.807 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.8 mt -72.2 151.47 42.89 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.209 1.004 . . . . 0.0 111.393 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.72 17.41 10.39 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.999 1.719 . . . . 0.0 113.656 -168.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 63.8 mt 52.34 -154.17 0.2 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.606 1.562 . . . . 0.0 109.406 -168.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -145.09 -172.43 3.85 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.725 0.693 . . . . 0.0 110.158 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.4 m -56.08 154.74 7.27 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.794 0.807 . . . . 0.0 111.75 170.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.493 ' HB2' ' H ' ' A' ' 95' ' ' SER . 1.4 m -162.12 178.8 8.46 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.635 1.974 . . . . 0.0 106.556 167.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -45.15 -58.88 2.93 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.857 0.863 . . . . 0.0 109.271 169.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -101.41 16.41 25.69 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.786 0.834 . . . . 0.0 113.01 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.96 48.22 73.72 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.634 -0.666 . . . . 0.0 111.998 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.493 ' H ' ' HB2' ' A' ' 91' ' ' SER . 45.8 m 62.45 177.78 0.14 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.484 2.314 . . . . 0.0 113.343 175.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.07 139.07 57.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.389 1.476 . . . . 0.0 107.57 164.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 p -90.36 170.4 10.28 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.761 0.709 . . . . 0.0 109.594 173.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 58.73 19.92 7.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 126.536 1.934 . . . . 0.0 112.71 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.7 p -143.49 151.38 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -153.5 177.67 30.92 Favored Glycine 0 C--O 1.225 -0.408 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 m -96.03 142.87 13.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 CA-C-N 120.018 1.909 . . . . 0.0 109.056 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -110.15 156.61 20.37 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 120.257 1.39 . . . . 0.0 109.328 161.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.441 HG23 ' CE1' ' A' ' 73' ' ' PHE . 4.6 mp -114.02 142.97 24.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 126.995 2.118 . . . . 0.0 105.562 159.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.3 mt -131.77 156.0 46.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.235 1.814 . . . . 0.0 106.674 170.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.552 ' CG ' ' H ' ' A' ' 106' ' ' ARG . 3.5 t70 -72.34 -105.35 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 165.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.552 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 19.7 ptt180 -151.21 -9.79 0.23 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.744 1.618 . . . . 0.0 112.432 178.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.5 p -83.12 7.54 15.66 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.646 1.578 . . . . 0.0 109.344 172.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.45 8.1 30.1 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.441 1.496 . . . . 0.0 113.484 -166.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.31 114.65 3.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 119.476 1.638 . . . . 0.0 107.377 170.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.08 127.44 41.15 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.47 ' HG ' ' HG ' ' A' ' 119' ' ' SER . 0.3 OUTLIER -104.43 131.62 51.59 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.826 0.704 . . . . 0.0 110.623 -162.134 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.8 m -65.18 153.96 39.41 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.616 0.366 . . . . 0.0 110.611 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.81 49.92 0.8 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.393 1.477 . . . . 0.0 110.226 -171.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.59 -28.86 20.42 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.564 -1.335 . . . . 0.0 111.091 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.44 2.03 56.63 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 126.523 2.011 . . . . 0.0 113.641 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.78 -31.69 1.95 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 117.583 -1.198 . . . . 0.0 111.35 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.1 m -54.67 104.35 0.11 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.713 1.142 . . . . 0.0 110.131 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -87.26 149.95 24.22 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.886 -173.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.47 ' HG ' ' HG ' ' A' ' 111' ' ' LEU . 0.9 OUTLIER -77.6 -160.73 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.896 1.278 . . . . 0.0 111.789 -174.556 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 m -50.76 156.49 0.94 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.519 0.727 . . . . 0.0 111.778 147.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -102.4 152.93 20.53 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.393 1.877 . . . . 0.0 108.313 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.8 m -132.03 118.25 19.44 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.449 1.499 . . . . 0.0 107.851 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.5 m -59.15 123.76 17.71 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 166.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 73.3 mt -91.2 -174.69 4.04 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 128.805 2.842 . . . . 0.0 109.59 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -163.04 172.94 14.22 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.522 1.929 . . . . 0.0 108.537 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -59.57 107.38 0.58 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.974 1.709 . . . . 0.0 109.748 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.1 -124.25 3.19 Favored Glycine 0 N--CA 1.474 1.226 0 CA-C-N 120.417 1.462 . . . . 0.0 112.8 169.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 99.2 m -122.75 125.31 45.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 120.535 2.168 . . . . 0.0 109.091 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -133.29 177.72 7.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.474 1.91 . . . . 0.0 109.706 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.57 162.18 40.71 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -166.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 17.6 mt -139.92 112.29 7.5 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.64 153.08 43.46 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.971 1.781 . . . . 0.0 109.431 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -136.41 161.3 36.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.894 1.677 . . . . 0.0 107.605 170.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -127.18 97.27 4.87 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -175.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.12 157.23 25.41 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.406 1.482 . . . . 0.0 110.578 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -159.14 169.83 23.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.079 1.352 . . . . 0.0 111.306 162.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -82.78 146.05 29.18 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 152.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -123.83 116.53 23.11 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.97 2.108 . . . . 0.0 106.914 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.54 141.15 36.92 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 171.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.2 p -105.67 17.13 24.28 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.895 0.878 . . . . 0.0 110.375 171.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 161.64 -155.98 27.36 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.06 91.34 0.15 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.995 1.718 . . . . 0.0 110.043 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.12 152.72 32.11 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 55.0 p -104.38 161.06 23.99 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -72.87 170.9 18.56 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 N-CA-C 109.215 -1.11 . . . . 0.0 109.215 160.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.06 -95.46 0.15 Allowed Glycine 0 C--O 1.226 -0.348 0 O-C-N 121.35 -0.844 . . . . 0.0 112.114 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -151.12 161.18 43.21 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.175 1.79 . . . . 0.0 106.743 173.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.11 81.23 1.54 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -118.92 139.53 51.49 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.5 157.24 42.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -130.34 121.88 26.84 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -101.15 163.57 12.22 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 162.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.3 p -103.8 156.15 18.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 151.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -115.84 157.8 23.89 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.49 0.716 . . . . 0.0 109.604 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -126.31 162.7 24.88 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 126.946 2.098 . . . . 0.0 107.768 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.8 t -128.55 123.34 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 -175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -111.78 85.56 2.16 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -64.7 146.84 54.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.283 170.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -164.47 168.21 18.66 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 121.838 0.827 . . . . 0.0 112.44 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 154.28 -86.02 0.14 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 105.894 -2.883 . . . . 0.0 105.894 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -24.71 -59.18 0.06 OUTLIER Glycine 0 CA--C 1.523 0.544 0 C-N-CA 129.891 3.615 . . . . 0.0 116.87 -172.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -71.47 -22.47 78.61 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 119.487 1.644 . . . . 0.0 112.772 -171.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.62 49.53 3.61 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 118.262 1.031 . . . . 0.0 111.604 167.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 86.85 116.47 1.04 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -172.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.34 32.22 9.79 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 123.664 0.65 . . . . 0.0 111.939 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -155.88 124.48 5.94 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -155.8 148.2 23.75 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 123.588 0.555 . . . . 0.0 110.491 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 90.9 m -103.58 91.89 4.22 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.414 1.486 . . . . 0.0 107.939 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.2 m -79.02 101.97 8.1 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 171.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -104.84 169.2 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 126.111 1.765 . . . . 0.0 108.791 170.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.33 173.63 4.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.437 0.637 . . . . 0.0 111.094 169.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -127.16 -72.09 0.18 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 174.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.68 -167.23 39.88 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -167.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.1 m -96.9 137.5 35.89 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.048 0.939 . . . . 0.0 108.745 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.7 t -117.96 105.49 18.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 163.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -78.11 141.74 38.56 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 171.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -123.56 101.15 7.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.27 2.228 . . . . 0.0 105.174 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -115.06 155.99 25.99 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.89 0.876 . . . . 0.0 109.265 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.64 -166.71 27.28 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -167.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -167.09 175.22 7.66 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -169.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 24.3 t -128.86 138.0 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 174.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.433 ' C ' ' H ' ' A' ' 184' ' ' ALA . 11.0 m -124.69 151.43 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 C-N-CA 127.255 2.222 . . . . 0.0 107.75 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -74.89 30.88 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -171.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.249 1.049 0 C-N-CA 131.074 3.75 . . . . 0.0 114.017 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.925 0 CA-C-O 117.92 -1.038 . . . . 0.0 108.74 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.46 169.43 23.93 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.761 1.619 . . . . 0.0 110.7 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.5 t -114.72 46.97 1.31 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.356 1.074 . . . . 0.0 109.483 178.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -148.53 175.11 11.44 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.681 1.193 . . . . 0.0 108.218 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -49.72 -33.27 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.842 2.057 . . . . 0.0 111.41 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 t30 64.11 -60.22 0.19 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 129.095 2.958 . . . . 0.0 112.769 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.37 106.59 0.23 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 106.013 -2.835 . . . . 0.0 106.013 176.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.61 -65.46 0.01 OUTLIER Glycine 0 CA--C 1.505 -0.574 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -172.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 t -63.94 3.81 0.36 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.839 2.056 . . . . 0.0 115.326 -171.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.9 p 174.97 -24.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 131.427 3.891 . . . . 0.0 111.008 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 77.33 39.49 0.19 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.565 2.346 . . . . 0.0 112.048 178.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -136.78 132.08 34.25 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 169.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -136.79 -102.48 0.2 Allowed 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 167.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.15 -3.35 33.34 Favored Glycine 0 N--CA 1.46 0.292 0 C-N-CA 125.702 1.62 . . . . 0.0 112.623 170.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -166.84 -163.4 0.55 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.947 1.699 . . . . 0.0 106.424 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.9 p -46.07 -31.82 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 127.203 2.201 . . . . 0.0 113.469 167.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m 26.15 56.47 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 127.64 2.376 . . . . 0.0 115.348 -171.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -140.33 97.41 3.22 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -140.24 119.33 12.75 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.4 -40.21 25.1 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.87 1.268 . . . . 0.0 112.377 -175.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.436 ' SG ' ' HB3' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -112.79 160.71 17.71 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.755 1.622 . . . . 0.0 109.579 178.404 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.92 -21.62 31.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.334 -167.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 t 56.51 107.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 128.633 2.773 . . . . 0.0 110.272 -165.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -65.7 163.14 17.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.66 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.26 -29.6 33.76 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.242 1.017 . . . . 0.0 111.356 167.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.43 4.61 3.65 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.673 1.13 . . . . 0.0 114.784 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.8 t -147.6 -34.13 0.25 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.188 1.494 . . . . 0.0 110.351 -167.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.4 -36.84 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 O-C-N 120.738 -1.226 . . . . 0.0 111.371 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -151.24 97.38 2.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.96 0.886 . . . . 0.0 109.081 -172.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -131.33 133.83 45.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 123.376 1.56 . . . . 0.0 110.179 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.8 m -108.75 88.96 2.85 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -174.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.56 105.11 7.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -171.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -80.89 115.14 20.23 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 mt -79.89 -7.44 58.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.974 0.91 . . . . 0.0 110.732 175.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.19 -178.47 51.42 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.647 1.117 . . . . 0.0 110.703 -177.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -79.05 146.82 33.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 165.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.58 145.58 35.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 124.395 1.078 . . . . 0.0 108.637 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -77.63 132.44 38.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.3 p -59.04 -22.81 61.31 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 122.489 0.316 . . . . 0.0 110.7 168.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.14 -9.64 41.95 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.91 -1.119 . . . . 0.0 113.274 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.0 m -101.36 -2.38 31.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.456 1.103 . . . . 0.0 113.28 168.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.4 mt -142.56 83.22 1.81 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 126.845 2.058 . . . . 0.0 106.815 -166.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.69 6.98 1.45 Allowed 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.289 -0.882 . . . . 0.0 112.274 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -154.48 160.15 41.42 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.701 1.2 . . . . 0.0 107.886 -174.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -64.09 136.42 57.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 121.528 -0.732 . . . . 0.0 109.796 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.31 -4.17 56.09 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-O 117.51 -1.717 . . . . 0.0 112.344 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.71 143.78 45.69 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 120.562 2.181 . . . . 0.0 108.113 170.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.8 p -140.75 154.68 46.4 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -176.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.5 p -73.41 -178.49 3.03 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.2 m -28.55 -91.03 0.0 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.622 2.769 . . . . 0.0 114.735 173.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.41 111.02 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 130.495 3.518 . . . . 0.0 104.356 -176.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.02 136.08 43.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 173.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.33 88.77 0.43 Allowed Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 -173.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -83.22 -179.55 7.44 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -148.53 162.97 38.58 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 120.189 -1.569 . . . . 0.0 109.997 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.1 mm -99.62 103.81 15.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -69.49 124.47 23.99 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 174.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.436 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 6.5 mp -117.5 165.46 13.51 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.729 1.612 . . . . 0.0 108.789 174.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -176.03 153.26 1.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.313 1.445 . . . . 0.0 109.219 -165.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 47.12 37.47 5.4 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.542 2.337 . . . . 0.0 114.501 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.3 119.42 12.13 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.407 1.483 . . . . 0.0 110.35 177.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -90.53 142.57 27.61 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 163.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.3 p -91.19 -14.02 31.8 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.664 1.575 . . . . 0.0 114.308 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -70.64 -43.49 69.1 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.739 0.781 . . . . 0.0 110.222 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 65' ' ' VAL . 2.8 p -60.27 -49.71 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.86 130.37 3.19 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 125.955 1.702 . . . . 0.0 108.081 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -82.29 -8.05 59.63 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.018 0.927 . . . . 0.0 111.695 174.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -131.24 167.04 19.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.921 1.689 . . . . 0.0 110.111 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.03 129.1 22.01 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 162.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.4 176.91 5.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 145.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.03 160.5 15.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 101.648 -3.464 . . . . 0.0 101.648 -168.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.25 167.9 21.71 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 120.354 -1.466 . . . . 0.0 107.458 168.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -126.39 153.51 44.86 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 tp -142.13 142.72 32.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.11 170.07 42.85 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.0 m -57.19 125.76 24.18 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.954 1.701 . . . . 0.0 109.374 177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.43 137.52 46.51 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.687 1.13 . . . . 0.0 109.866 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.1 tt -59.2 -49.21 84.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 124.405 1.082 . . . . 0.0 110.7 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -147.78 166.72 26.67 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.09 -34.41 76.24 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.961 1.304 . . . . 0.0 112.231 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.9 -12.69 84.17 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 119.514 -0.603 . . . . 0.0 112.347 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -125.79 48.86 2.01 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.266 1.427 . . . . 0.0 110.153 -173.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.4 p -63.89 -11.96 32.53 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 126.776 2.03 . . . . 0.0 114.041 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -86.25 -4.05 59.09 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.15 -0.968 . . . . 0.0 111.074 171.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.7 t -124.47 132.7 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 119.832 1.196 . . . . 0.0 109.258 -168.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.34 148.25 35.72 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.47 1.508 . . . . 0.0 110.473 -172.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.53 17.33 8.83 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.395 1.478 . . . . 0.0 114.27 -166.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.579 ' CD1' ' HG ' ' A' ' 95' ' ' SER . 26.0 mt 51.27 -153.02 0.19 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.261 0.624 . . . . 0.0 109.811 -166.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -146.94 171.59 15.0 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.073 1.349 . . . . 0.0 109.238 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.9 m -48.57 140.02 8.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.062 1.745 . . . . 0.0 111.01 174.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.61 168.79 25.95 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.985 1.314 . . . . 0.0 108.406 176.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.99 -48.95 78.49 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.002 0.921 . . . . 0.0 111.471 -174.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.53 11.48 7.01 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.411 0.684 . . . . 0.0 112.4 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 54.83 50.61 57.6 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 125.578 1.561 . . . . 0.0 111.344 -166.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.579 ' HG ' ' CD1' ' A' ' 88' ' ' LEU . 6.5 t 58.11 -176.64 0.07 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 128.77 2.828 . . . . 0.0 111.901 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.06 156.75 14.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 112.277 -2.238 . . . . 0.0 107.891 151.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.44 163.8 28.55 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.495 1.518 . . . . 0.0 108.471 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 59.03 15.65 4.16 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.298 1.439 . . . . 0.0 111.214 -170.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.14 152.71 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 120.207 1.367 . . . . 0.0 109.025 -176.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.27 176.11 28.16 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 125.396 1.474 . . . . 0.0 110.306 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.409 HG13 ' CG ' ' A' ' 177' ' ' PHE . 92.9 t -86.4 142.51 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 172.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.478 HE22 ' HB1' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -120.64 157.87 28.62 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.659 1.184 . . . . 0.0 108.544 163.009 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.7 mp -134.72 138.68 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 C-N-CA 129.082 2.953 . . . . 0.0 104.783 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.07 147.28 46.01 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -178.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.84 -175.26 0.53 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.263 0.938 . . . . 0.0 110.405 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -52.16 -18.14 1.37 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 171.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 t -81.41 -13.65 58.04 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.51 -0.744 . . . . 0.0 109.363 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.15 13.26 52.98 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.557 2.027 . . . . 0.0 113.501 -167.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.05 127.59 33.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 168.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.478 ' HB1' HE22 ' A' ' 102' ' ' GLN . . . -62.04 129.05 39.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.328 1.451 . . . . 0.0 111.482 -177.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.0 mt -100.76 160.44 14.36 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 124.086 0.866 . . . . 0.0 110.54 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.0 m -96.13 153.16 17.94 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.995 0.918 . . . . 0.0 108.567 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.4 mt -107.19 64.26 0.64 Allowed 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 123.593 0.757 . . . . 0.0 109.542 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -111.06 -12.61 14.17 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.616 0.766 . . . . 0.0 111.799 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.82 -27.02 1.38 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 125.179 1.371 . . . . 0.0 112.739 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.02 -69.7 0.57 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 117.862 -1.066 . . . . 0.0 109.266 164.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.7 m -39.6 99.09 0.02 OUTLIER 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.804 2.041 . . . . 0.0 112.128 -169.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -70.16 155.96 39.9 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.207 1.403 . . . . 0.0 109.81 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.8 p -109.98 -138.94 0.38 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.043 0.937 . . . . 0.0 112.181 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.51 135.44 48.6 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -78.53 163.17 25.77 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.737 0.779 . . . . 0.0 108.969 167.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.0 m -145.61 118.75 8.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 174.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.1 m -70.32 113.64 7.68 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 171.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.2 mt -80.29 177.78 8.73 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.048 2.139 . . . . 0.0 107.868 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -143.36 164.9 29.0 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.62 -0.675 . . . . 0.0 109.846 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -63.72 104.99 0.73 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.919 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 122.99 -109.49 1.38 Allowed Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.586 1.565 . . . . 0.0 111.681 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 94.3 m -126.55 131.25 51.6 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 120.769 -1.43 . . . . 0.0 111.587 -164.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.06 174.41 12.78 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.649 1.979 . . . . 0.0 108.249 -172.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.0 m -151.23 157.45 42.62 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 10.5 mt -118.33 110.7 39.01 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 170.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -67.36 154.25 74.5 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 121.709 1.606 . . . . 0.0 109.996 172.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -136.12 166.77 22.62 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.595 1.558 . . . . 0.0 108.496 173.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -120.02 152.17 37.9 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 164.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.88 166.84 20.71 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 162.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -164.25 158.29 18.75 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 170.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -71.32 153.89 42.02 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 159.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -134.01 112.89 11.58 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.226 2.21 . . . . 0.0 105.931 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.08 150.68 30.22 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.123 0.963 . . . . 0.0 109.184 170.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 68.1 p -115.61 8.04 14.96 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 125.958 1.703 . . . . 0.0 110.601 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.58 -154.28 24.33 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.05 87.0 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.002 1.321 . . . . 0.0 112.064 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.07 137.45 56.41 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.243 1.417 . . . . 0.0 111.495 -170.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 31.1 p -99.97 160.8 26.25 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 118.26 0.482 . . . . 0.0 110.613 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -72.36 178.78 5.71 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.446 1.43 . . . . 0.0 110.743 166.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.01 -93.59 0.14 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.593 1.092 . . . . 0.0 112.213 158.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.24 159.12 42.71 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 127.559 2.343 . . . . 0.0 105.06 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.33 71.78 1.13 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 120.015 1.279 . . . . 0.0 110.767 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -115.47 154.79 28.65 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -176.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.0 152.63 26.85 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.749 0.82 . . . . 0.0 109.715 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -120.74 121.32 37.98 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -120.79 175.69 5.9 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.009 2.124 . . . . 0.0 109.819 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.7 p -127.61 152.11 48.06 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 159.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -105.09 156.1 18.38 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 164.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -113.49 171.98 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.797 1.239 . . . . 0.0 107.943 168.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.6 t -129.34 129.05 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -120.9 89.37 3.12 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -67.58 146.62 53.71 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 125.115 1.366 . . . . 0.0 110.716 173.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -155.87 171.71 19.6 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 126.702 2.001 . . . . 0.0 110.556 166.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 157.89 -60.29 0.33 Allowed Glycine 0 N--CA 1.45 -0.424 0 O-C-N 120.847 -1.158 . . . . 0.0 111.432 166.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -53.71 -34.67 50.88 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 123.828 0.728 . . . . 0.0 113.289 -173.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -128.23 43.95 1.28 Allowed Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.923 1.249 . . . . 0.0 109.996 171.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -53.02 -16.15 4.02 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 118.47 1.135 . . . . 0.0 115.256 -170.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -61.55 -19.96 58.58 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 118.962 1.381 . . . . 0.0 114.52 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 168.94 53.45 0.03 OUTLIER Glycine 0 CA--C 1.525 0.718 0 CA-C-N 119.547 1.673 . . . . 0.0 111.094 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -154.62 121.84 5.64 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.673 1.189 . . . . 0.0 109.05 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -142.79 -173.94 4.03 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.41 1.484 . . . . 0.0 110.229 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 34.4 m -150.06 100.18 2.9 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 120.399 -1.438 . . . . 0.0 108.235 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.54 109.51 15.12 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.799 2.04 . . . . 0.0 109.763 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.36 157.69 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.018 1.327 . . . . 0.0 109.974 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.0 157.39 36.24 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.339 -0.851 . . . . 0.0 109.949 174.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.59 -59.93 0.46 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 172.52 176.5 41.28 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -168.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.9 m -97.45 128.35 44.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.255 1.422 . . . . 0.0 110.197 177.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.43 115.2 49.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -106.4 90.34 3.32 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -172.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.409 ' CG ' HG13 ' A' ' 101' ' ' VAL . 75.2 m-85 -67.34 118.77 11.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 175.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -123.69 160.45 27.19 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 138.41 -165.21 25.55 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -163.47 168.85 19.66 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -167.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.08 136.76 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 167.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.463 ' C ' ' H ' ' A' ' 184' ' ' ALA . 6.1 m -115.8 152.36 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 C-N-CA 126.963 2.105 . . . . 0.0 108.329 177.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -75.11 31.42 0.1 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -172.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 N--CA 1.442 -0.837 1 C-N-CA 131.711 4.004 . . . . 0.0 112.096 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.51 147.6 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.124 1.37 . . . . 0.0 110.473 -145.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.8 t 171.43 -56.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.807 2.443 . . . . 0.0 107.026 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 m 72.32 115.17 0.05 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.276 2.23 . . . . 0.0 110.217 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -164.16 162.42 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.024 1.33 . . . . 0.0 107.587 -174.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -84.19 -1.36 54.97 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.143 0.883 . . . . 0.0 111.846 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.11 -76.16 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -174.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.04 -86.62 0.15 Allowed Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 172.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t -141.66 6.74 1.86 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -160.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 p 95.86 -178.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 130.761 3.625 . . . . 0.0 108.307 -155.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -125.65 -135.42 0.26 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 162.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.32 41.32 0.72 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 120.509 1.504 . . . . 0.0 110.032 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -81.81 84.51 6.85 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.49 -0.756 . . . . 0.0 110.97 -160.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.52 4.95 0.28 Allowed Glycine 0 CA--C 1.525 0.705 0 C-N-CA 123.156 0.407 . . . . 0.0 113.367 166.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.97 -159.45 0.96 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.818 0.847 . . . . 0.0 111.211 -165.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.2 t -44.73 -43.04 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 127.243 2.217 . . . . 0.0 111.831 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.9 t 37.13 49.62 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 127.438 2.295 . . . . 0.0 110.263 -173.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -148.92 94.44 2.25 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 172.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -132.46 132.46 42.76 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 102.471 -3.159 . . . . 0.0 102.471 157.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.72 -13.42 61.72 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.204 -0.998 . . . . 0.0 112.808 -173.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.5 m -130.91 151.06 51.75 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.014 1.726 . . . . 0.0 107.799 -175.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.89 -10.26 59.32 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -173.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 t 55.21 140.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 129.036 2.934 . . . . 0.0 112.121 -160.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.62 163.99 13.33 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.182 -0.949 . . . . 0.0 112.711 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.75 78.3 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.501 1.121 . . . . 0.0 111.392 -173.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.91 28.0 2.22 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.38 0.991 . . . . 0.0 112.006 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.7 t -139.68 -55.6 0.56 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.0 1.32 . . . . 0.0 108.554 -174.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.4 p -50.87 -36.09 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.844 1.258 . . . . 0.0 112.873 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -143.41 101.36 3.78 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 104.87 -2.271 . . . . 0.0 104.87 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -130.9 138.48 49.81 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.055 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 93.3 m -106.96 98.66 8.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 172.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.8 t -77.67 115.89 20.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -89.66 127.67 35.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 mt -100.99 -3.63 29.04 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.375 1.87 . . . . 0.0 109.57 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.01 179.77 37.26 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.49 1.043 . . . . 0.0 112.345 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -76.01 116.57 16.84 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.777 1.631 . . . . 0.0 109.889 170.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.5 t -103.0 140.67 20.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 122.776 1.274 . . . . 0.0 109.245 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.422 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 7.4 mmt180 -71.76 126.58 30.08 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 125.466 1.506 . . . . 0.0 107.003 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 p -50.92 -31.57 18.0 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.321 1.448 . . . . 0.0 111.073 166.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.29 -16.58 60.76 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 t -92.72 0.28 57.39 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.064 1.346 . . . . 0.0 112.062 172.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.9 mt -145.9 67.65 1.2 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.881 1.672 . . . . 0.0 106.653 -162.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.63 -6.27 4.12 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -163.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -147.85 157.56 43.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.855 1.662 . . . . 0.0 106.848 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -63.33 134.62 56.1 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 170.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.71 -7.09 77.37 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 118.822 -0.988 . . . . 0.0 112.322 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.35 152.42 43.87 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.475 1.138 . . . . 0.0 109.604 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.9 p -138.08 158.57 44.05 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.858 0.837 . . . . 0.0 111.237 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.6 p -72.05 -175.86 1.59 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.438 0.695 . . . . 0.0 111.484 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 p -40.38 -47.45 2.56 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 126.635 1.974 . . . . 0.0 113.607 160.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 83.74 162.78 0.12 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 129.047 2.939 . . . . 0.0 108.914 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -144.9 133.23 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.87 104.23 3.14 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 106.111 -2.796 . . . . 0.0 106.111 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -104.69 156.74 17.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 168.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.97 151.87 50.38 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 120.515 -1.366 . . . . 0.0 109.701 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.2 mm -99.78 115.01 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.63 136.33 38.16 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -173.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.6 mt -123.52 160.26 27.37 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.444 1.498 . . . . 0.0 107.955 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -149.59 151.35 33.67 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.448 1.499 . . . . 0.0 111.077 -164.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.6 t70 38.74 44.11 0.78 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.453 2.701 . . . . 0.0 113.524 -171.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.8 m -72.53 97.14 2.05 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.781 1.632 . . . . 0.0 113.909 -164.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -71.92 104.93 3.65 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.166 0.986 . . . . 0.0 111.126 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.1 p -68.67 -11.88 60.7 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -175.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -66.49 -48.21 70.57 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.707 0.685 . . . . 0.0 109.159 173.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -58.02 -41.76 81.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 124.204 1.001 . . . . 0.0 109.081 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -167.04 138.24 3.2 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.767 1.627 . . . . 0.0 108.345 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.1 m -96.46 12.58 30.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.927 1.291 . . . . 0.0 113.059 169.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 28.1 mtmt -148.04 167.1 25.81 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 121.309 1.868 . . . . 0.0 113.326 158.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.21 93.6 2.46 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.189 2.196 . . . . 0.0 112.088 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.34 152.22 24.23 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 119.031 -2.293 . . . . 0.0 108.734 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 t -120.44 123.81 71.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.99 165.49 14.53 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 165.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -127.66 160.34 31.93 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.543 163.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.285 0.0 OUTLIER -139.15 160.25 40.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.228 168.077 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.84 163.78 32.91 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.6 m -58.17 125.93 25.31 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 164.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.05 140.49 43.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 119.374 0.988 . . . . 0.0 109.091 174.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.4 tt -60.53 -48.46 88.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 123.35 0.66 . . . . 0.0 110.557 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.73 162.6 35.09 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.98 -24.98 67.92 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.678 0.791 . . . . 0.0 112.306 166.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.77 4.91 83.98 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 119.003 -0.887 . . . . 0.0 112.727 173.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -149.39 57.06 1.0 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.163 1.385 . . . . 0.0 109.126 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.3 p -64.61 -20.09 66.07 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.103 1.361 . . . . 0.0 113.101 -173.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -102.6 3.56 37.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -172.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.1 t -116.18 136.21 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 124.916 1.287 . . . . 0.0 108.366 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.07 151.87 26.85 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 125.229 1.412 . . . . 0.0 110.63 -172.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -95.53 15.38 19.92 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -164.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt 56.3 -167.8 0.11 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.438 1.095 . . . . 0.0 110.589 -163.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -149.65 167.79 25.4 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 120.922 -1.111 . . . . 0.0 110.645 -174.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.1 t 55.72 -154.59 0.3 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.3 p 24.45 68.24 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.257 2.623 . . . . 0.0 115.891 162.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.79 -26.23 5.41 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.874 1.67 . . . . 0.0 114.5 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.33 30.43 1.39 Allowed 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 123.308 0.38 . . . . 0.0 110.169 168.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.66 -19.71 5.24 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.687 1.137 . . . . 0.0 112.451 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.1 m -63.93 173.76 1.73 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.146 0.978 . . . . 0.0 110.42 169.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.81 148.59 38.68 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 163.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.7 p -90.68 165.81 13.5 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 159.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 54.46 31.02 13.9 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 127.274 2.23 . . . . 0.0 113.142 170.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.18 153.39 10.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 O-C-N 121.085 -1.009 . . . . 0.0 109.156 175.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.31 174.16 29.78 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 124.465 1.031 . . . . 0.0 110.66 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.2 t -83.92 151.91 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 173.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -128.79 163.43 25.22 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.144 0.884 . . . . 0.0 109.094 153.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.6 mp -121.01 141.81 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 128.19 2.596 . . . . 0.0 104.12 171.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mt -141.26 135.62 30.82 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.792 2.437 . . . . 0.0 105.455 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.64 -174.4 2.1 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.731 1.15 . . . . 0.0 108.376 169.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.1 ptt85 -58.33 -20.11 40.62 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.6 p -68.42 -10.63 56.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 124.298 1.039 . . . . 0.0 112.001 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.48 6.31 34.04 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 119.256 0.935 . . . . 0.0 112.291 -168.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.94 126.19 33.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.965 1.382 . . . . 0.0 107.314 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.83 151.08 42.18 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.865 0.364 . . . . 0.0 110.718 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.49 145.69 30.55 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.1 m -70.32 157.35 37.9 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.5 mt -104.91 63.71 0.71 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.615 1.566 . . . . 0.0 108.548 -172.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.1 -1.41 6.46 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.669 1.188 . . . . 0.0 113.064 -171.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.32 -1.77 87.47 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.259 -1.301 . . . . 0.0 112.121 170.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -139.82 -28.01 0.76 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.852 1.326 . . . . 0.0 114.3 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.5 m -53.3 146.89 11.18 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.046 1.738 . . . . 0.0 110.638 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -116.73 141.74 47.82 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.015 -1.053 . . . . 0.0 109.065 -166.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.25 79.0 p -86.74 -124.78 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 123.3 0.64 . . . . 0.0 111.295 -170.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.52 21.7 6.03 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.183 1.393 . . . . 0.0 113.828 -169.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 56.91 171.66 0.04 OUTLIER 'General case' 0 N--CA 1.42 -1.931 1 C-N-CA 131.786 4.034 . . . . 0.0 114.307 173.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 m -149.9 134.42 17.48 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 158.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.8 m -88.58 126.28 35.2 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 169.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.651 ' H ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -86.76 179.86 6.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.211 -168.491 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.436 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -156.82 138.93 14.54 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 -171.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -57.48 94.65 0.02 OUTLIER 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.318 1.847 . . . . 0.0 108.567 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.56 -137.86 6.65 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -159.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.5 m -125.2 146.0 49.71 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.854 2.061 . . . . 0.0 107.197 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 0.8 OUTLIER -160.44 154.46 22.98 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.553 1.141 . . . . 0.0 108.811 -179.057 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 29.7 m -144.87 141.41 29.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.179 -165.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.2 mt -104.97 107.48 58.86 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 126.653 1.981 . . . . 0.0 106.149 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -85.65 103.1 0.74 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.502 2.801 . . . . 0.0 112.316 -175.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -81.27 174.66 11.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 122.897 1.332 . . . . 0.0 111.457 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -127.79 126.7 42.23 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 162.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -101.02 138.81 37.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 163.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -150.31 134.96 17.45 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -60.01 143.82 50.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -118.95 115.22 23.9 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.94 142.3 35.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 63.4 p -109.94 23.76 13.94 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.002 1.321 . . . . 0.0 110.095 176.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 148.78 -153.99 25.56 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 107.85 -2.1 . . . . 0.0 107.85 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.38 91.21 0.54 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.704 1.201 . . . . 0.0 109.497 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.43 124.96 21.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.767 0.827 . . . . 0.0 109.306 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.4 p -85.63 154.54 59.02 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -71.95 160.28 48.09 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 120.932 1.088 . . . . 0.0 110.449 169.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.72 -148.72 15.87 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -170.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -91.0 152.49 20.66 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 118.913 1.356 . . . . 0.0 109.036 163.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -136.24 66.14 1.5 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.424 0.69 . . . . 0.0 109.675 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -104.53 151.79 23.17 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 178.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.26 166.48 30.81 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.427 1.091 . . . . 0.0 108.101 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -148.72 140.73 23.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.054 0.93 . . . . 0.0 111.231 174.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.61 156.61 46.6 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.532 2.333 . . . . 0.0 109.283 -171.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 64.5 p -91.33 163.45 14.21 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 117.422 -1.711 . . . . 0.0 108.27 152.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -127.9 153.4 46.7 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 158.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -119.54 175.41 5.86 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.817 0.847 . . . . 0.0 110.541 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 4.4 t -138.4 99.62 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -84.25 100.04 10.95 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.595 1.958 . . . . 0.0 107.825 171.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -73.52 139.46 45.69 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.398 1.094 . . . . 0.0 113.546 167.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -133.98 160.31 38.1 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 129.484 3.114 . . . . 0.0 111.041 -168.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 99.26 -44.01 1.75 Allowed Glycine 0 C--N 1.321 -0.254 0 CA-C-O 119.089 -0.84 . . . . 0.0 111.047 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -87.07 66.33 3.56 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 -172.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.71 -45.1 0.43 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -160.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.13 52.63 4.8 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.17 -58.17 5.01 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 124.37 0.986 . . . . 0.0 111.603 170.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.93 4.49 9.96 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.815 1.198 . . . . 0.0 114.458 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -141.73 139.79 32.96 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 127.887 2.475 . . . . 0.0 104.753 171.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -146.45 167.75 22.87 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.53 1.132 . . . . 0.0 109.38 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 19.6 m -138.4 81.65 1.86 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.238 0.615 . . . . 0.0 109.455 -165.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.1 m -83.06 95.3 8.01 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.156 1.382 . . . . 0.0 109.972 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.8 m -81.72 167.18 2.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 158.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -72.89 154.99 40.34 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.542 -0.723 . . . . 0.0 109.292 164.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.19 -25.57 2.94 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 124.128 0.87 . . . . 0.0 112.944 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 146.26 -163.51 28.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 117.784 0.792 . . . . 0.0 111.647 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.9 m -116.24 136.48 52.97 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 40.2 t -112.56 115.63 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 166.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -97.07 113.13 24.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -87.1 119.48 27.37 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -116.06 166.66 11.75 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 135.5 -173.13 21.88 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 106.264 -2.735 . . . . 0.0 106.264 -171.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.67 170.51 18.34 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -171.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.3 t -120.82 130.1 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 175.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 15.3 m -115.79 146.62 19.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 126.81 2.044 . . . . 0.0 109.046 -177.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.94 27.4 0.09 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -172.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.248 1.024 0 C-N-CA 128.269 2.628 . . . . 0.0 113.793 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.38 56.48 7.41 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.11 0.957 . . . . 0.0 109.0 -156.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.4 p -142.49 151.48 41.73 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.651 1.58 . . . . 0.0 107.078 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -58.57 155.74 11.86 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.223 1.409 . . . . 0.0 110.746 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.51 166.89 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 170.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -151.78 177.69 10.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.685 1.594 . . . . 0.0 107.065 171.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.28 18.94 56.5 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 119.292 -0.727 . . . . 0.0 113.375 170.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.33 178.45 45.17 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 108.841 -1.703 . . . . 0.0 108.841 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -76.98 9.49 2.92 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.236 1.014 . . . . 0.0 111.722 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 95.8 -172.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 131.175 3.79 . . . . 0.0 106.47 -149.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -157.25 113.16 2.89 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 173.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -98.28 -134.35 0.25 Allowed 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 127.453 2.301 . . . . 0.0 106.115 170.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.496 ' CG ' ' H ' ' A' ' 14' ' ' GLY . 3.7 ptpt -169.36 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 128.551 2.74 . . . . 0.0 105.984 175.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.496 ' H ' ' CG ' ' A' ' 13' ' ' LYS . . . 137.08 -37.99 1.79 Allowed Glycine 0 C--N 1.319 -0.404 0 C-N-CA 126.747 2.118 . . . . 0.0 109.974 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -130.81 -169.85 2.24 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 125.172 1.389 . . . . 0.0 108.549 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.9 p -50.94 -31.38 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 126.236 1.814 . . . . 0.0 113.286 -172.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m 36.11 34.68 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 127.916 2.487 . . . . 0.0 115.886 -177.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -131.96 94.74 3.54 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -175.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.58 108.64 4.76 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.24 -26.93 31.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 118.411 -0.804 . . . . 0.0 113.016 -169.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.41 153.91 48.26 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.794 1.638 . . . . 0.0 110.063 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.7 93.96 6.27 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.997 2.519 . . . . 0.0 109.526 166.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.4 p -48.46 106.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 125.39 1.476 . . . . 0.0 109.313 158.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -69.23 166.24 18.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.355 1.462 . . . . 0.0 113.008 -161.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.32 -32.31 66.57 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.253 1.021 . . . . 0.0 112.253 171.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.88 7.97 47.08 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.617 1.103 . . . . 0.0 112.882 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.15 -44.67 1.58 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.993 1.717 . . . . 0.0 109.606 -170.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.38 -28.0 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 127.352 2.261 . . . . 0.0 113.693 -168.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -149.39 61.69 1.03 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.613 1.165 . . . . 0.0 108.007 -169.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -104.97 137.5 42.62 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.272 0.629 . . . . 0.0 109.85 -168.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.9 m -108.32 92.84 4.23 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.08 1.352 . . . . 0.0 108.045 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.2 t -78.7 108.34 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 126.328 1.851 . . . . 0.0 107.125 -171.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -91.61 122.82 34.52 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -98.91 -1.02 41.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 122.844 0.457 . . . . 0.0 110.412 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.6 -177.84 33.02 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 126.423 1.963 . . . . 0.0 111.273 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -70.29 138.1 51.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 122.187 -0.596 . . . . 0.0 109.628 158.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.8 t -128.41 146.41 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 124.372 1.069 . . . . 0.0 109.501 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -75.82 127.07 32.24 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 125.832 1.653 . . . . 0.0 107.34 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 p -55.57 -29.03 58.3 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.204 0.602 . . . . 0.0 111.008 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.03 -39.86 72.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.453 1.101 . . . . 0.0 111.577 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 62.1 m -74.23 -0.8 18.04 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.0 mt -134.28 31.52 3.48 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 125.226 1.41 . . . . 0.0 111.827 -160.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.49 13.92 13.58 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -150.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.57 HE21 ' HB2' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -149.61 162.71 39.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 171.011 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -60.32 121.22 11.47 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 164.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.95 -8.58 57.79 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 118.812 -0.993 . . . . 0.0 113.691 -173.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.57 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -67.79 154.52 41.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.835 1.818 . . . . 0.0 110.644 174.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.5 p -147.97 157.25 43.42 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.884 0.766 . . . . 0.0 112.17 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.0 p -72.1 175.17 6.21 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.949 -1.094 . . . . 0.0 111.241 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.0 m -47.63 -27.46 1.89 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.611 1.964 . . . . 0.0 114.591 172.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 81.37 145.93 0.08 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 129.479 3.112 . . . . 0.0 111.06 167.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 m -141.8 130.65 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 C-N-CA 124.113 0.965 . . . . 0.0 109.415 -152.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.25 121.31 6.79 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -174.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -130.82 102.56 6.13 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 118.313 1.056 . . . . 0.0 108.279 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.95 150.83 20.02 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.063 -1.023 . . . . 0.0 111.242 -170.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.0 mm -94.66 98.1 7.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -65.84 126.87 29.84 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.2 mp -133.68 123.06 24.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 129.742 3.217 . . . . 0.0 106.589 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -118.04 154.39 32.11 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.509 1.049 . . . . 0.0 113.434 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 t70 65.92 37.41 5.46 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.094 1.758 . . . . 0.0 114.104 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 97.9 m -68.97 104.36 2.07 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.012 1.325 . . . . 0.0 108.798 -174.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -81.87 137.17 35.28 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.174 0.99 . . . . 0.0 109.593 174.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.5 p -83.0 -17.87 41.86 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -65.44 -42.63 92.2 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.319 1.048 . . . . 0.0 110.364 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.402 ' H ' HG12 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -68.02 -54.56 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 125.87 1.668 . . . . 0.0 106.705 -176.103 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.21 158.46 43.94 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.9 m -115.2 3.6 14.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.745 0.702 . . . . 0.0 111.804 168.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -128.87 149.39 50.79 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.277 1.431 . . . . 0.0 109.28 171.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.63 153.13 33.82 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.412 1.085 . . . . 0.0 108.457 165.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.89 -178.18 5.14 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.825 1.65 . . . . 0.0 106.779 157.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -153.78 141.02 12.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 -164.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.23 152.65 51.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 119.957 1.253 . . . . 0.0 108.678 175.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -114.55 153.61 29.75 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.438 0.695 . . . . 0.0 110.081 -175.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 tp -148.3 143.07 26.67 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.614 1.166 . . . . 0.0 107.996 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.81 173.35 35.05 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 108.104 -1.998 . . . . 0.0 108.104 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 m -59.88 121.88 12.85 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.513 1.125 . . . . 0.0 110.359 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.8 138.44 52.69 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.425 0.557 . . . . 0.0 110.413 172.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.0 tt -64.35 -31.12 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.576 0.75 . . . . 0.0 110.937 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -160.71 168.64 24.43 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.639 1.576 . . . . 0.0 107.441 165.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.36 -36.24 66.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.629 1.172 . . . . 0.0 111.311 166.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.29 -2.91 64.07 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 120.792 -1.193 . . . . 0.0 112.998 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -149.93 55.47 0.94 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.298 1.439 . . . . 0.0 109.716 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.6 p -69.43 -6.84 32.88 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.44 1.096 . . . . 0.0 111.886 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -85.89 3.54 41.37 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.931 1.293 . . . . 0.0 112.655 170.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.65 143.04 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.934 1.243 . . . . 0.0 111.63 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.02 151.26 28.5 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.954 1.301 . . . . 0.0 111.237 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.12 14.72 10.13 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 127.477 2.311 . . . . 0.0 114.059 -169.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 71.5 mt 55.26 -157.65 0.22 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.167 1.387 . . . . 0.0 111.227 -166.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -165.24 -178.34 5.0 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.732 2.813 . . . . 0.0 107.748 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.6 t 71.73 160.34 0.22 Allowed 'General case' 0 C--O 1.227 -0.096 0 C-N-CA 128.735 2.814 . . . . 0.0 112.017 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.496 ' HB3' ' HA3' ' A' ' 94' ' ' GLY . 0.6 OUTLIER 41.53 35.5 0.47 Allowed 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 127.485 2.314 . . . . 0.0 113.291 -166.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.2 -70.35 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.067 1.747 . . . . 0.0 112.924 -150.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.11 20.91 2.1 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.723 1.609 . . . . 0.0 111.132 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 91' ' ' SER . . . -71.29 -14.23 74.07 Favored Glycine 0 N--CA 1.467 0.703 0 O-C-N 121.226 -0.921 . . . . 0.0 112.567 176.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -31.6 161.31 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.383 1.873 . . . . 0.0 114.158 151.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.98 131.55 45.0 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.484 1.114 . . . . 0.0 109.697 174.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.4 p -85.39 169.42 13.7 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 58.5 14.65 3.11 Favored 'General case' 0 C--N 1.335 -0.04 0 C-N-CA 126.247 1.819 . . . . 0.0 112.712 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.26 156.68 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 119.927 1.24 . . . . 0.0 107.819 -174.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -165.14 168.16 39.12 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -168.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.9 t -90.56 112.66 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -82.06 153.84 25.93 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.363 0.983 . . . . 0.0 108.52 160.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 mp -125.54 136.33 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 166.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.0 mt -136.54 143.93 43.96 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.645 1.178 . . . . 0.0 107.838 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.497 ' CG ' ' H ' ' A' ' 106' ' ' ARG . 24.5 p-10 -54.06 -74.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.278 1.431 . . . . 0.0 113.204 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.497 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 37.0 ptt85 179.61 -47.45 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 127.781 2.432 . . . . 0.0 107.994 -163.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 p -68.04 -29.12 68.02 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.169 0.895 . . . . 0.0 109.784 172.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.76 9.96 27.59 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.815 1.198 . . . . 0.0 111.176 -169.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.69 110.67 0.93 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 163.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.89 125.88 33.01 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.75 150.22 23.06 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -167.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -82.31 146.61 29.33 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.344 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.6 mt -88.16 61.87 6.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.844 0.858 . . . . 0.0 108.87 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.26 -15.16 14.55 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.063 1.345 . . . . 0.0 112.27 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.18 -7.38 60.51 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 125.872 1.701 . . . . 0.0 114.476 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.46 -6.36 5.84 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.158 1.479 . . . . 0.0 112.877 172.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.9 m -65.15 94.41 0.15 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.692 1.133 . . . . 0.0 108.623 171.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -67.51 131.65 46.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.786 1.235 . . . . 0.0 109.14 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.8 p -72.19 168.29 18.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.135 0.493 . . . . 0.0 110.906 170.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.2 m -26.37 113.85 0.05 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.527 2.331 . . . . 0.0 112.569 155.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -66.45 155.11 38.44 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 122.248 1.023 . . . . 0.0 108.74 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 98.6 m -127.12 112.99 15.81 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 169.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.7 m -58.06 126.25 26.63 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 167.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 80.8 mt -98.73 -177.88 3.8 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 124.745 1.218 . . . . 0.0 108.679 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -147.53 169.69 19.03 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.805 1.642 . . . . 0.0 108.327 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -65.22 104.49 0.93 Allowed 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.852 0.72 . . . . 0.0 109.551 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.08 -160.8 26.8 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 124.643 1.116 . . . . 0.0 111.3 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 93.3 m -90.53 134.08 34.62 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.31 -1.112 . . . . 0.0 108.828 -179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -146.2 154.56 41.89 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.152 1.381 . . . . 0.0 110.418 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.1 m -137.49 144.23 42.12 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.928 0.871 . . . . 0.0 109.987 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.9 mt -104.72 118.35 56.62 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -65.14 157.02 59.65 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.349 1.366 . . . . 0.0 108.646 171.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -136.52 157.14 47.47 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 153.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -119.76 94.67 4.48 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.11 156.2 28.4 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 167.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -161.93 153.76 18.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 166.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -63.73 130.5 44.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 163.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -103.19 151.52 22.53 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 163.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -115.67 137.79 51.73 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.593 0.757 . . . . 0.0 109.736 173.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 69.5 p -96.86 14.06 26.57 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.976 0.91 . . . . 0.0 111.034 170.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 169.5 -153.89 22.68 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.49 93.08 0.47 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.259 1.024 . . . . 0.0 110.157 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.06 119.07 5.3 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 44.3 p -76.65 163.62 64.67 Favored Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 165.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -74.73 172.71 15.71 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.118 1.212 . . . . 0.0 111.007 168.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.69 179.72 16.29 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 124.756 1.169 . . . . 0.0 111.283 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.9 140.67 58.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -132.9 73.34 1.52 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -115.5 158.7 22.2 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.97 160.48 37.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.69 0.677 . . . . 0.0 109.413 175.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -133.38 116.21 15.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.34 1.067 . . . . 0.0 110.233 -170.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.01 164.69 19.62 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.416 1.486 . . . . 0.0 111.22 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.9 p -119.21 157.08 28.7 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 155.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -115.91 146.68 41.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.522 1.129 . . . . 0.0 109.195 167.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -104.57 171.28 7.42 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.041 1.737 . . . . 0.0 108.316 168.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.4 t -129.2 128.21 66.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -130.52 84.48 2.2 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.478 1.111 . . . . 0.0 109.54 -172.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -70.12 151.98 44.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.562 -1.199 . . . . 0.0 112.242 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -161.64 174.3 13.51 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.42 1.488 . . . . 0.0 111.849 169.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 148.03 -33.81 1.24 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 125.405 1.479 . . . . 0.0 110.136 174.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -94.89 99.16 2.39 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 166.39 165.52 23.9 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 118.223 1.011 . . . . 0.0 111.11 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -73.97 -22.41 78.01 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 124.468 1.032 . . . . 0.0 110.609 171.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 128.5 120.85 2.32 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 168.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 109.2 58.4 0.53 Allowed Glycine 0 CA--C 1.517 0.215 0 N-CA-C 106.815 -2.514 . . . . 0.0 106.815 -173.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -172.42 108.8 0.21 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.59 1.556 . . . . 0.0 107.975 -162.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -153.89 164.91 37.62 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.025 0.93 . . . . 0.0 109.106 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 40.4 m -122.14 90.75 3.36 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -176.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.5 m -82.37 120.53 25.55 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.6 m -130.47 158.32 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.812 1.645 . . . . 0.0 109.415 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -79.28 143.02 35.64 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.097 -1.002 . . . . 0.0 108.984 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -105.21 -73.0 0.88 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -175.75 -174.21 42.12 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.884 0.342 . . . . 0.0 113.01 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.4 m -100.87 141.8 33.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.912 2.085 . . . . 0.0 108.635 -177.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.65 104.42 12.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -96.14 96.98 9.19 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 -176.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -73.19 127.09 31.63 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 176.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -128.68 156.57 43.25 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.552 0.741 . . . . 0.0 111.636 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 142.37 -160.07 27.22 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -163.72 169.2 18.76 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.833 0.853 . . . . 0.0 108.97 -175.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 75.3 t -116.79 124.51 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 171.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.411 ' C ' ' H ' ' A' ' 184' ' ' ALA . 6.3 m -103.58 153.33 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 127.026 2.13 . . . . 0.0 108.782 174.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.04 25.67 0.09 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -168.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.25 1.121 1 C-N-CA 132.117 4.167 . . . . 0.0 114.544 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.6 136.33 5.29 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.6 p -145.23 86.25 1.76 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.799 0.84 . . . . 0.0 109.363 -165.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.1 p -135.83 178.68 6.86 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.97 -1.081 . . . . 0.0 110.911 -174.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -53.77 148.73 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 126.272 1.829 . . . . 0.0 112.249 175.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -85.06 158.56 20.41 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.376 -0.828 . . . . 0.0 110.456 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 61.3 77.91 0.18 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 173.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.13 5.0 1.42 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-O 118.691 -1.061 . . . . 0.0 113.534 173.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -172.1 2.76 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 120.871 2.335 . . . . 0.0 111.151 -169.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.9 t -55.78 -32.99 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 C-N-CA 127.921 2.489 . . . . 0.0 109.987 -173.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -163.87 19.49 0.07 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 147.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -85.29 -0.19 53.94 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.823 -1.173 . . . . 0.0 111.651 -156.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 mttm 45.04 49.59 9.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.828 1.651 . . . . 0.0 112.913 -172.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.51 -3.94 50.09 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.411 170.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -172.87 -164.57 0.26 Allowed 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.251 1.42 . . . . 0.0 109.707 -167.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.1 t -49.12 -35.96 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 128.814 2.846 . . . . 0.0 113.187 172.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 t 35.27 54.76 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 127.027 2.131 . . . . 0.0 112.371 -169.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -152.23 96.11 2.14 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 171.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -129.49 118.01 21.41 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 163.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.41 -28.65 30.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.286 1.034 . . . . 0.0 113.745 -170.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.9 m -131.19 151.93 50.98 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.502 1.921 . . . . 0.0 108.071 -171.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.32 -10.56 51.93 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -169.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.323 14.2 p 45.9 97.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 129.36 3.064 . . . . 0.0 112.911 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -50.58 141.08 13.08 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.575 1.95 . . . . 0.0 110.719 -172.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.632 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . . . -59.5 -9.94 2.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.295 1.838 . . . . 0.0 111.945 -176.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.64 -7.41 88.16 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.115 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.8 p -124.13 -33.05 3.15 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.692 1.746 . . . . 0.0 112.18 -164.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.632 ' CG2' ' HA ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -52.48 -78.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 127.84 2.456 . . . . 0.0 109.924 166.138 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.507 ' CG ' ' HE2' ' A' ' 176' ' ' HIS . 10.5 t70 -95.53 83.1 3.73 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -114.15 142.53 46.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.286 1.041 . . . . 0.0 108.92 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.5 m -105.06 88.77 2.95 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.6 t -69.39 98.51 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 174.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -72.42 103.09 3.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.3 mt -70.58 -15.59 62.77 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.899 0.88 . . . . 0.0 109.329 169.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.83 -175.93 49.55 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 124.599 1.095 . . . . 0.0 112.138 170.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.49 143.6 56.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 162.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.8 t -133.59 148.83 30.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 124.96 1.304 . . . . 0.0 107.674 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 28.2 mtm105 -79.14 132.87 36.7 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.4 p -55.14 -24.25 25.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.609 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.25 -48.44 68.23 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.649 0.779 . . . . 0.0 110.141 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.54 3.61 5.96 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.0 mt -146.22 66.18 1.19 Allowed 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.679 1.592 . . . . 0.0 107.446 -166.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.13 -2.25 3.19 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -170.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -146.92 151.79 37.61 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.998 1.319 . . . . 0.0 107.751 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -64.38 120.77 12.87 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.2 1.45 61.04 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-O 117.364 -1.798 . . . . 0.0 112.481 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.53 163.54 18.42 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 120.055 1.928 . . . . 0.0 110.122 169.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.1 p -146.74 155.12 42.15 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 122.014 -0.429 . . . . 0.0 110.472 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 84.8 p -68.22 178.64 1.83 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 164.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.0 p -30.89 -92.59 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 129.697 3.199 . . . . 0.0 114.633 173.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 154.11 113.22 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 131.284 3.834 . . . . 0.0 105.46 -172.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.28 105.25 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -173.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.21 154.71 44.87 Favored Glycine 0 C--N 1.311 -0.843 0 CA-C-N 112.45 -2.159 . . . . 0.0 110.721 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -152.58 176.6 11.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.242 1.817 . . . . 0.0 107.172 171.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.405 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 11.8 p-10 -143.0 163.18 33.49 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 120.885 -1.134 . . . . 0.0 110.6 177.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.9 mm -117.79 108.06 23.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -81.22 103.72 11.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.806 0.842 . . . . 0.0 109.312 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.9 mp -99.23 93.03 5.73 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -84.48 167.6 16.24 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.202 1.401 . . . . 0.0 109.094 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.32 31.06 17.89 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.162 0.985 . . . . 0.0 110.853 173.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 80.3 m -69.3 148.24 50.01 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.982 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -120.23 152.42 37.76 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 163.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 p -94.58 -20.84 19.26 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.62 -43.62 84.23 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.96 0.886 . . . . 0.0 110.555 -177.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.415 ' H ' HG13 ' A' ' 65' ' ' VAL . 1.9 p -56.2 -52.92 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.647 1.579 . . . . 0.0 108.027 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.63 133.61 4.91 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 128.083 2.553 . . . . 0.0 104.773 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.3 m -87.81 -5.13 58.77 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.846 0.748 . . . . 0.0 111.805 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -128.3 164.29 22.93 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.089 1.356 . . . . 0.0 109.853 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.63 160.72 34.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 164.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.65 168.28 20.18 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 158.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.3 t -122.15 142.77 37.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.84 162.26 19.42 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 169.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -134.99 149.11 50.14 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.077 0.951 . . . . 0.0 109.191 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 tp -143.67 151.53 40.21 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.2 169.69 36.62 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.3 m -66.28 126.84 30.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.246 1.023 . . . . 0.0 109.157 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.14 137.06 50.75 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.996 -0.44 . . . . 0.0 110.637 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.0 tt -59.78 -40.25 82.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 123.354 0.662 . . . . 0.0 110.285 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -152.09 167.9 26.99 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 127.13 2.172 . . . . 0.0 107.765 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.28 -40.08 95.24 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.564 1.546 . . . . 0.0 112.117 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.98 3.9 48.96 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.268 -0.74 . . . . 0.0 112.234 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -142.89 41.1 1.54 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.053 1.426 . . . . 0.0 110.67 -172.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.3 p -67.68 -6.31 20.01 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.875 -1.141 . . . . 0.0 113.317 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.78 -16.39 59.48 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.612 -1.305 . . . . 0.0 111.811 166.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.48 129.61 74.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 120.478 -1.389 . . . . 0.0 108.62 -160.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 mt -77.15 149.83 35.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.87 0.759 . . . . 0.0 111.504 -172.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.42 22.0 3.12 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.829 1.652 . . . . 0.0 113.494 -173.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.6 mt 49.7 -146.44 0.38 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.827 0.851 . . . . 0.0 109.067 -170.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -153.41 177.79 10.51 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 126.042 1.737 . . . . 0.0 108.067 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.82 160.76 9.0 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.557 1.17 . . . . 0.0 112.561 176.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.7 m -169.06 158.77 8.74 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 128.938 2.895 . . . . 0.0 106.98 176.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.14 91.63 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.871 0.869 . . . . 0.0 111.509 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.53 12.76 4.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.833 1.253 . . . . 0.0 112.972 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 61.59 14.69 43.93 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.681 0.658 . . . . 0.0 114.294 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 59.4 m 52.74 175.04 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.281 2.233 . . . . 0.0 114.504 -171.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.77 113.66 3.16 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 125.281 1.432 . . . . 0.0 107.933 170.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.28 165.61 24.25 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.66 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 55.31 24.15 6.24 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.261 1.425 . . . . 0.0 113.162 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.2 p -145.0 151.6 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.24 175.43 27.54 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 173.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.405 HG21 ' CD2' ' A' ' 177' ' ' PHE . 1.2 m -86.71 155.44 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 118.653 1.227 . . . . 0.0 108.384 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -124.52 147.01 48.66 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 170.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.8 mp -117.02 135.82 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 169.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 9.9 mt -126.41 159.48 33.17 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 128.408 2.683 . . . . 0.0 107.109 174.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' A' ' 106' ' ' ARG . 34.8 p30 -73.11 -106.37 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 123.956 0.785 . . . . 0.0 109.437 171.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.435 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 15.3 ptm180 -149.26 3.81 0.6 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.895 2.078 . . . . 0.0 110.624 -169.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.4 p -123.64 7.31 8.84 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.115 1.366 . . . . 0.0 109.493 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.09 1.89 90.19 Favored Glycine 0 C--N 1.342 0.861 0 C-N-CA 127.22 2.343 . . . . 0.0 114.27 -172.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.13 122.77 20.07 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 119.468 1.634 . . . . 0.0 107.917 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -87.29 147.4 25.54 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.034 0.533 . . . . 0.0 110.419 176.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.8 138.85 46.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.707 -173.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 m -69.62 147.31 50.85 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.73 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.9 mt -79.86 69.54 6.22 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.612 1.565 . . . . 0.0 108.303 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.51 -13.87 13.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.51 0.724 . . . . 0.0 111.242 174.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.419 ' O ' ' HE3' ' A' ' 155' ' ' LYS . . . 75.09 -9.03 13.27 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 120.626 -1.296 . . . . 0.0 113.278 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.54 -12.91 7.17 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.145 1.378 . . . . 0.0 111.272 174.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 92.3 m -76.77 90.91 3.46 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -72.71 172.84 9.96 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.322 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.3 p -120.7 -176.12 3.18 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.668 1.587 . . . . 0.0 110.036 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -33.46 111.52 0.11 Allowed 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 126.082 1.753 . . . . 0.0 111.328 169.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.99 155.8 38.7 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.5 m -151.72 114.95 4.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.7 m -58.52 133.2 55.6 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.528 1.931 . . . . 0.0 108.344 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.5 mt -86.57 178.54 7.04 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.302 1.441 . . . . 0.0 108.831 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.432 ' ND2' HD22 ' A' ' 129' ' ' ASN . 0.5 OUTLIER -135.45 170.3 16.16 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.62 1.968 . . . . 0.0 107.067 156.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.73 128.2 35.0 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 166.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 99.09 -168.24 22.09 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -171.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 90.6 m -83.33 139.91 32.76 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 120.776 -1.426 . . . . 0.0 111.806 -166.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.432 HD22 ' ND2' ' A' ' 125' ' ' ASN . 26.3 m-80 -139.34 168.22 20.32 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 128.678 2.791 . . . . 0.0 109.37 -173.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.405 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 85.0 m -155.47 158.9 39.29 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 120.347 -1.47 . . . . 0.0 110.369 176.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.4 mt -131.93 112.79 14.83 Favored Pre-proline 0 C--O 1.24 0.603 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.72 150.0 38.94 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.598 1.532 . . . . 0.0 108.348 170.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -128.4 165.74 20.05 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.534 1.934 . . . . 0.0 108.59 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -133.26 113.28 12.46 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 121.453 -0.78 . . . . 0.0 108.909 172.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -94.83 170.36 9.5 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.819 0.819 . . . . 0.0 109.263 173.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -160.68 179.55 8.46 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.036 1.334 . . . . 0.0 108.909 167.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -91.45 149.41 21.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 153.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -122.5 124.84 44.5 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.835 2.054 . . . . 0.0 106.365 173.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.92 145.73 25.35 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 54.1 p -108.58 10.36 27.13 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 125.525 1.53 . . . . 0.0 111.168 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 161.65 -151.69 21.94 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.38 91.44 0.26 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.548 1.939 . . . . 0.0 109.935 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.19 157.06 20.18 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.022 0.439 . . . . 0.0 110.942 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 77.0 p -112.06 158.16 37.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 170.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -78.65 162.01 27.48 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.025 1.817 . . . . 0.0 110.636 165.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.39 -76.12 0.18 Allowed Glycine 0 N--CA 1.462 0.373 0 O-C-N 121.391 -0.818 . . . . 0.0 113.922 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -158.93 155.42 27.63 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.339 1.856 . . . . 0.0 106.874 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.98 91.04 1.74 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -125.73 135.44 52.07 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -146.19 167.19 24.07 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 165.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.49 111.05 6.78 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 167.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.82 169.87 17.56 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 162.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.8 p -116.2 151.98 34.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 153.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -114.71 132.12 56.53 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.201 0.601 . . . . 0.0 109.502 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 115' ' ' GLY . 29.2 mtmt -97.28 171.2 8.58 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.97 0.908 . . . . 0.0 109.199 167.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.1 t -133.1 118.63 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 -172.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -105.55 83.64 1.97 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -62.2 150.78 37.93 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.775 0.83 . . . . 0.0 108.936 168.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -167.94 169.84 11.04 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 123.289 0.636 . . . . 0.0 110.779 -174.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 151.22 -79.74 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -24.43 -75.32 0.01 OUTLIER Glycine 0 CA--C 1.527 0.809 0 C-N-CA 129.515 3.436 . . . . 0.0 115.045 -168.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -68.83 157.43 53.28 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 122.48 1.044 . . . . 0.0 113.041 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -91.6 57.53 3.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 125.563 1.554 . . . . 0.0 110.437 -167.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.45 85.52 1.81 Allowed Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 115.69 58.16 0.34 Allowed Glycine 0 C--N 1.329 0.173 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 167.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -146.54 111.82 5.47 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.863 1.265 . . . . 0.0 108.961 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -154.81 160.05 41.01 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.893 0.877 . . . . 0.0 110.903 -177.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.6 m -133.14 119.47 19.98 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.343 2.257 . . . . 0.0 106.799 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 m -114.52 123.9 50.54 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.469 1.108 . . . . 0.0 109.152 -169.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.2 m -143.49 150.91 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 123.975 0.91 . . . . 0.0 110.988 -168.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.07 132.25 48.1 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.627 1.571 . . . . 0.0 109.274 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -101.36 -78.54 1.34 Allowed Glycine 0 CA--C 1.519 0.344 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -173.95 -170.54 37.44 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.905 0.764 . . . . 0.0 111.772 -170.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 28.3 m -114.15 120.83 41.84 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.736 1.614 . . . . 0.0 110.989 -170.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.5 t -104.94 96.9 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' HIS . . . . . 0.507 ' HE2' ' CG ' ' A' ' 29' ' ' ASP . 42.6 m-70 -80.81 94.82 6.51 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -177.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.405 ' CD2' HG21 ' A' ' 101' ' ' VAL . 58.9 m-85 -76.91 85.49 3.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -93.86 165.7 12.55 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.623 0.769 . . . . 0.0 109.518 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 147.7 -161.96 28.62 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -170.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -170.25 174.77 5.18 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 75.4 t -123.19 138.28 53.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 171.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 6.8 m -116.61 149.22 18.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 126.008 1.723 . . . . 0.0 109.08 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.77 33.08 0.14 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -171.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 C-N-CA 128.454 2.702 . . . . 0.0 112.019 175.217 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.479 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -49.29 -34.92 16.56 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 126.587 1.955 . . . . 0.0 111.189 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.8 m -125.76 146.51 49.74 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 127.376 2.27 . . . . 0.0 107.649 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.93 1.81 55.31 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -163.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.307 13.7 p 49.54 113.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 129.81 3.244 . . . . 0.0 114.275 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -53.0 141.78 21.41 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.423 1.089 . . . . 0.0 110.736 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.493 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -51.08 -39.12 55.31 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.768 1.227 . . . . 0.0 109.643 171.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.19 13.84 1.84 Allowed Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.799 -1.0 . . . . 0.0 114.522 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 t -144.63 -36.69 0.31 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.665 1.586 . . . . 0.0 111.515 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 25' ' ' ALA . 10.6 p -58.08 -49.87 80.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.424 0 CA-C-N 119.698 1.135 . . . . 0.0 109.095 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -121.94 75.52 1.22 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -171.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -105.68 138.21 42.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.388 -169.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 m -106.87 99.93 9.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.5 t -86.33 101.22 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -92.12 98.42 11.53 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -174.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.5 mt -75.94 -7.28 54.2 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.304 2.242 . . . . 0.0 109.883 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.54 -172.64 27.3 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 124.108 0.861 . . . . 0.0 111.734 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -77.67 142.39 38.85 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.943 0.878 . . . . 0.0 110.915 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.7 t -124.01 150.77 28.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 125.538 1.535 . . . . 0.0 108.095 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.92 137.66 32.98 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.0 p -60.39 -21.79 62.59 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 122.931 0.492 . . . . 0.0 112.253 171.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.47 -48.78 47.48 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-O 122.439 1.114 . . . . 0.0 111.312 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.2 m -79.19 5.87 11.1 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.221 1.008 . . . . 0.0 113.448 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.567 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 13.7 mt -142.65 72.08 1.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.696 1.998 . . . . 0.0 107.114 -170.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.72 -7.19 1.68 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -171.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -145.51 162.82 36.49 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.651 1.18 . . . . 0.0 108.056 174.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -62.65 117.84 6.82 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 173.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.444 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 106.6 -10.33 41.84 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-O 118.305 -1.275 . . . . 0.0 112.471 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.34 147.69 52.0 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.809 1.305 . . . . 0.0 109.432 171.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.1 p -143.72 155.62 44.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.528 0.68 . . . . 0.0 111.736 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.4 p -66.7 -177.69 0.62 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.388 0.675 . . . . 0.0 110.56 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -59.56 -22.32 61.56 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 119.56 -1.962 . . . . 0.0 113.397 171.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 74.07 164.83 0.28 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 127.335 2.254 . . . . 0.0 110.782 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.2 t -149.2 142.63 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.17 125.3 8.3 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -115.6 158.52 22.56 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 170.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.512 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 2.7 m-20 -131.14 173.9 10.57 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.085 0.857 . . . . 0.0 110.808 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.9 mm -121.57 109.84 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.602 1.161 . . . . 0.0 107.935 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.36 109.38 17.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.539 1.936 . . . . 0.0 109.5 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.66 106.61 17.22 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 127.218 2.207 . . . . 0.0 108.507 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -87.05 158.55 19.19 Favored 'General case' 0 CA--C 1.523 -0.085 0 C-N-CA 124.539 1.135 . . . . 0.0 110.667 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 32.98 57.75 0.45 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.269 2.628 . . . . 0.0 113.145 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.9 m -64.36 142.3 58.47 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 125.705 1.602 . . . . 0.0 110.602 168.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -120.32 132.48 55.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 127.305 2.242 . . . . 0.0 108.73 171.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.7 p -92.74 -9.43 40.67 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -67.32 -47.66 69.86 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.036 0.834 . . . . 0.0 109.871 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.479 HG11 ' HA ' ' A' ' 20' ' ' ALA . 3.6 p -65.14 -49.1 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.237 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.67 114.04 2.6 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.44 1.896 . . . . 0.0 108.294 -170.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.8 m -76.75 -2.24 32.09 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.711 169.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -137.6 164.69 28.16 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.986 1.721 . . . . 0.0 112.03 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.96 140.35 26.84 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.64 166.09 13.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.537 1.935 . . . . 0.0 106.292 163.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 t -125.71 157.89 34.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.57 167.64 19.67 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 164.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -130.82 155.86 45.98 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.549 1.54 . . . . 0.0 109.94 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 tp -150.79 134.04 16.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.909 0.484 . . . . 0.0 111.192 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.6 172.67 42.53 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.124 0.869 . . . . 0.0 111.325 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 2.3 m -55.39 125.79 22.35 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.494 1.117 . . . . 0.0 108.347 171.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.55 139.83 44.02 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.424 1.011 . . . . 0.0 108.666 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.1 tt -57.06 -39.39 66.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.032 0.533 . . . . 0.0 111.112 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -160.59 177.75 10.2 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.672 1.589 . . . . 0.0 108.025 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.93 -37.77 79.1 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.396 0.678 . . . . 0.0 111.549 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.06 5.26 55.01 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.622 0.63 . . . . 0.0 111.966 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -146.91 50.47 1.11 Allowed 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.146 -1.208 . . . . 0.0 110.1 -171.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.5 p -67.03 -8.87 33.37 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.355 1.462 . . . . 0.0 111.749 171.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -81.77 -11.92 58.79 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 167.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.8 t -125.83 136.3 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 121.308 1.867 . . . . 0.0 109.964 -161.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.85 156.01 30.66 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 118.923 0.783 . . . . 0.0 111.737 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.435 ' HB3' ' HB ' ' A' ' 76' ' ' THR . . . -94.58 19.3 10.02 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.485 1.514 . . . . 0.0 113.866 -171.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.3 mt 55.19 -156.87 0.23 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.943 0.897 . . . . 0.0 109.902 -165.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.239 0.536 0 C-N-CA 125.733 1.613 . . . . 0.0 108.659 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.447 -0.617 0 CA-C-O 122.501 1.143 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.19 153.97 24.61 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.611 -0.681 . . . . 0.0 109.292 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.0 p -115.85 164.69 14.03 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.906 0.882 . . . . 0.0 109.194 170.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 57.05 20.82 5.76 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.928 1.691 . . . . 0.0 111.889 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -138.4 152.04 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.46 177.94 28.22 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.427 HG21 ' CD2' ' A' ' 177' ' ' PHE . 0.7 OUTLIER -90.48 155.05 3.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.392 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -126.45 167.52 15.47 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 120.744 -1.223 . . . . 0.0 110.558 158.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.12 130.59 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 127.428 2.291 . . . . 0.0 105.33 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.0 mt -122.19 140.81 52.14 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -62.68 171.55 2.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 122.216 1.008 . . . . 0.0 110.252 164.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -53.22 -25.82 15.45 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.462 1.505 . . . . 0.0 113.966 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.1 p -75.13 -23.76 57.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 119.677 1.126 . . . . 0.0 108.974 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.72 6.44 40.61 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.504 2.002 . . . . 0.0 112.708 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.52 131.33 34.39 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.247 1.524 . . . . 0.0 109.31 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.88 120.0 14.96 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.903 1.281 . . . . 0.0 111.701 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.0 mt -78.76 157.42 28.49 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.341 0.656 . . . . 0.0 109.756 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 m -100.69 144.97 29.03 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.426 1.09 . . . . 0.0 109.545 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.5 mt -89.22 70.79 8.29 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.454 1.102 . . . . 0.0 108.743 -173.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.55 -9.84 11.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.301 0.64 . . . . 0.0 112.316 174.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.02 -9.56 31.39 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.743 -1.032 . . . . 0.0 112.871 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.33 -8.34 5.82 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.087 1.355 . . . . 0.0 113.083 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.0 m -67.16 91.48 0.23 Allowed 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 168.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -64.89 164.2 12.96 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.795 0.838 . . . . 0.0 109.609 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 57.9 p -133.58 -175.93 3.98 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.662 1.185 . . . . 0.0 110.888 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -32.36 112.89 0.12 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 128.105 2.562 . . . . 0.0 112.431 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -73.26 108.58 6.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 88.4 m -81.95 113.3 19.76 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 167.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 93.8 m -57.95 121.0 9.52 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 160.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 99.0 mt -77.16 -170.06 1.57 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.393 1.477 . . . . 0.0 109.694 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.433 ' H ' HD21 ' A' ' 129' ' ' ASN . 0.6 OUTLIER -151.64 161.46 42.64 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 127.167 2.187 . . . . 0.0 107.593 168.651 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -64.49 140.19 58.84 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 170.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.25 -111.22 4.12 Favored Glycine 0 N--CA 1.467 0.704 0 CA-C-O 118.148 -1.362 . . . . 0.0 111.54 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 m -125.33 139.88 53.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.322 2.061 . . . . 0.0 110.488 -171.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.433 HD21 ' H ' ' A' ' 125' ' ' ASN . 12.1 m-80 -142.32 151.97 42.48 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 124.313 1.045 . . . . 0.0 109.959 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.512 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 97.1 m -132.72 124.22 27.74 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.017 0.527 . . . . 0.0 109.902 170.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.0 116.02 64.12 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 166.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.98 155.99 34.15 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.895 1.73 . . . . 0.0 110.51 166.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -139.1 172.69 12.47 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 127.743 2.417 . . . . 0.0 108.263 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.99 155.97 34.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 162.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -137.6 149.35 46.57 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.705 1.202 . . . . 0.0 108.014 171.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -161.04 153.68 20.73 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.404 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 77.3 m-85 -70.02 133.32 47.11 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 174.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.444 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 60.8 t80 -113.11 124.82 53.47 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.384 1.474 . . . . 0.0 107.85 176.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.43 141.65 29.81 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 170.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.4 p -105.48 11.19 32.83 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.862 0.465 . . . . 0.0 111.258 172.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.22 -153.8 23.63 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.54 93.65 0.05 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.94 1.696 . . . . 0.0 109.893 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -70.82 170.01 13.43 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 122.976 0.511 . . . . 0.0 111.443 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.8 p -136.49 159.19 71.51 Favored Pre-proline 0 N--CA 1.467 0.386 0 C-N-CA 123.441 0.696 . . . . 0.0 110.528 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -75.12 177.08 9.08 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.63 1.554 . . . . 0.0 110.434 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.01 -95.84 0.17 Allowed Glycine 0 CA--C 1.522 0.494 0 O-C-N 121.606 -0.684 . . . . 0.0 111.695 168.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.03 157.36 45.43 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.884 1.674 . . . . 0.0 107.189 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.404 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -146.51 66.41 1.18 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.592 0.71 . . . . 0.0 110.612 -176.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -108.45 150.95 26.71 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.28 163.03 40.27 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.616 1.566 . . . . 0.0 109.161 170.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -138.95 96.35 3.11 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.27 167.66 20.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.492 166.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.2 p -106.88 164.84 11.78 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 147.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -122.35 157.38 31.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 168.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -117.49 166.66 12.1 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.609 1.564 . . . . 0.0 108.595 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 8.5 t -127.86 106.65 15.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -88.1 92.64 9.22 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 167.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 73.5 m-85 -63.42 153.97 33.57 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 163.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -160.84 170.46 20.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.208 0.603 . . . . 0.0 110.662 168.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 CA-C-O 118.251 -1.305 . . . . 0.0 111.784 177.672 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.632 0 CA-C-O 120.472 0.177 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 87.2 m -142.61 108.49 5.16 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.59 1.956 . . . . 0.0 107.647 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 15.5 m -97.0 94.04 6.95 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.789 0.836 . . . . 0.0 110.15 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -85.32 168.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 124.121 0.968 . . . . 0.0 110.018 168.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -63.62 174.97 1.18 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.056 0.542 . . . . 0.0 109.688 160.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -144.64 -34.17 0.08 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-O 117.817 -1.546 . . . . 0.0 114.416 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 147.58 -176.8 26.25 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 119.412 1.606 . . . . 0.0 112.67 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.1 m -101.34 140.05 36.16 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.291 1.836 . . . . 0.0 108.908 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.56 96.48 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -83.42 88.49 6.98 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.427 ' CD2' HG21 ' A' ' 101' ' ' VAL . 58.8 m-85 -66.19 113.06 4.26 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 170.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -120.42 161.6 20.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 135.88 -174.19 21.49 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -170.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -161.51 172.14 16.92 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -168.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 39.2 t -124.93 133.45 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.4 m -112.61 148.19 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 C-N-CA 127.113 2.165 . . . . 0.0 108.365 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.77 31.23 0.09 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.686 2.395 . . . . 0.0 112.429 -170.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 127.856 2.463 . . . . 0.0 110.028 -165.488 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.547 ' HB1' ' CE2' ' A' ' 158' ' ' TYR . . . . . . . . 0 C--O 1.234 0.278 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.7 -18.04 61.05 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -172.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.0 m -133.77 160.04 38.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.15 109.45 19.91 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.621 1.568 . . . . 0.0 107.867 161.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -50.15 125.86 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 152.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.68 151.77 40.93 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.713 0.688 . . . . 0.0 109.698 174.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.75 -29.26 53.3 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 120.952 -1.092 . . . . 0.0 112.396 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.38 -50.48 66.36 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 123.91 0.767 . . . . 0.0 111.26 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.0 m -72.03 -27.05 62.45 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.899 0.88 . . . . 0.0 111.286 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.1 t -60.74 -25.87 36.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.368 1.067 . . . . 0.0 113.035 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -145.48 30.63 1.11 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.691 1.196 . . . . 0.0 111.488 -166.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -77.87 133.27 38.17 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 120.828 -1.17 . . . . 0.0 108.663 -162.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 176' ' ' HIS . 4.4 m -100.88 103.05 14.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.3 t -82.8 95.72 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -176.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -77.82 95.51 4.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -71.43 -12.31 61.34 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.983 1.313 . . . . 0.0 111.162 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.18 -177.89 31.37 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.325 0.964 . . . . 0.0 112.431 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -67.84 121.01 15.09 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.206 1.403 . . . . 0.0 109.748 168.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.5 t -99.82 149.26 5.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 126.063 1.745 . . . . 0.0 106.961 171.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -82.93 133.85 35.1 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.9 p -58.77 -19.37 40.14 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.817 0.847 . . . . 0.0 111.048 170.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.91 -50.09 61.77 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 120.746 -1.221 . . . . 0.0 109.336 170.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.437 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 66.4 m -73.12 -2.31 20.95 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.554 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 13.5 mt -141.23 79.19 1.68 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.403 1.481 . . . . 0.0 107.366 -171.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.31 -0.27 1.27 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.44 ' OE1' ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -148.69 159.42 44.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 177.162 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.439 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 35.6 tt0 -62.21 118.17 7.04 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.11 6.55 66.66 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 126.347 1.927 . . . . 0.0 112.885 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.44 ' HB2' ' OE1' ' A' ' 44' ' ' GLN . . . -57.84 149.02 23.48 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 148.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.37 153.57 42.1 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -178.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.9 p -70.3 171.78 9.34 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.366 -0.834 . . . . 0.0 109.065 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -47.5 -66.78 0.35 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -173.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 154.19 136.71 0.0 OUTLIER 'General case' 0 C--O 1.233 0.224 0 C-N-CA 128.199 2.6 . . . . 0.0 106.74 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.6 t -137.7 138.38 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 173.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.64 127.4 9.21 Favored Glycine 0 CA--C 1.516 0.148 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -132.47 87.95 2.48 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 123.307 1.527 . . . . 0.0 109.263 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.513 ' HB2' HG22 ' A' ' 130' ' ' THR . 6.7 p30 -81.13 160.77 24.33 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 120.626 -1.297 . . . . 0.0 111.487 -173.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 130' ' ' THR . 4.2 mm -112.03 108.71 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 175.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -76.31 110.82 11.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.69 1.996 . . . . 0.0 109.113 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.56 108.6 18.16 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.474 1.51 . . . . 0.0 107.173 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.0 168.46 10.94 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.489 1.116 . . . . 0.0 109.832 171.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t70 51.46 36.26 16.3 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.828 2.451 . . . . 0.0 116.76 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.9 m -69.89 85.62 0.5 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.626 1.97 . . . . 0.0 114.736 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -72.98 111.8 8.42 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.454 -0.778 . . . . 0.0 112.375 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.6 p -62.5 -12.86 24.8 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.374 1.07 . . . . 0.0 112.234 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -66.37 -38.35 87.36 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.359 0.981 . . . . 0.0 110.272 173.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.55 -58.15 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.37 143.83 19.19 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.186 1.394 . . . . 0.0 107.743 -172.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.2 p -88.19 -12.79 42.84 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.66 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -140.82 156.15 46.21 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 127.125 2.17 . . . . 0.0 107.797 -166.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.56 85.94 1.2 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -173.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.11 173.52 11.2 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 123.642 0.777 . . . . 0.0 109.293 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.405 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -148.14 107.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -170.438 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.71 163.8 13.21 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 124.037 0.935 . . . . 0.0 108.922 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CE2' HG21 ' A' ' 103' ' ' ILE . 6.7 m-85 -135.36 148.61 49.47 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.758 0.823 . . . . 0.0 109.652 -168.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.426 HD13 ' C ' ' A' ' 114' ' ' ASP . 13.2 tp -146.91 132.71 18.97 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.122 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.27 175.53 39.55 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 172.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.5 m -60.2 134.04 56.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.67 1.188 . . . . 0.0 108.79 172.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.81 132.06 35.18 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.207 1.003 . . . . 0.0 109.003 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.7 tt -60.5 -34.26 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 122.83 0.452 . . . . 0.0 110.609 -178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -153.25 164.74 37.55 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 126.382 1.873 . . . . 0.0 109.623 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.72 -31.04 46.62 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.113 2.565 . . . . 0.0 115.061 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.97 -40.18 6.28 Favored Glycine 0 CA--C 1.518 0.274 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 174.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -86.71 43.59 1.09 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.435 1.494 . . . . 0.0 110.51 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.6 p -63.81 -12.88 39.64 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.816 1.646 . . . . 0.0 112.232 173.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -82.13 -9.44 59.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.517 -0.739 . . . . 0.0 112.629 171.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 t -127.98 137.24 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 119.726 1.148 . . . . 0.0 109.855 -165.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.95 149.17 29.48 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.306 1.442 . . . . 0.0 110.743 -168.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.71 14.02 22.54 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -162.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.8 mt 51.54 -169.21 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.509 1.124 . . . . 0.0 110.41 -162.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 . . . . . 0 CA--C 1.514 -0.418 0 C-N-CA 126.364 1.866 . . . . 0.0 108.292 -177.997 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.443 -0.784 0 CA-C-O 122.35 1.071 . . . . 0.0 108.345 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.42 145.25 33.41 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.008 -1.451 . . . . 0.0 107.562 162.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 p -118.24 160.87 20.84 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 124.628 1.171 . . . . 0.0 109.156 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 59.83 27.04 16.3 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.511 0.725 . . . . 0.0 110.635 -173.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.404 HG21 HD13 ' A' ' 42' ' ' LEU . 2.0 p -143.74 145.45 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 121.215 -0.928 . . . . 0.0 108.667 170.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.88 174.12 23.74 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.411 HG11 ' CG ' ' A' ' 177' ' ' PHE . 99.3 t -86.45 147.2 5.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -129.99 140.81 50.83 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.333 1.053 . . . . 0.0 108.575 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.504 HG22 HD12 ' A' ' 111' ' ' LEU . 5.3 mp -108.3 134.99 48.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 110' ' ' ALA . 9.8 mt -134.11 132.77 40.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.959 1.704 . . . . 0.0 107.673 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.424 ' CB ' ' HB2' ' A' ' 120' ' ' SER . 1.5 t70 -73.11 -170.85 0.81 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.724 1.147 . . . . 0.0 112.046 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -48.63 -37.15 17.47 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.757 1.623 . . . . 0.0 111.854 167.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 p -77.83 -5.84 52.17 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.512 1.925 . . . . 0.0 112.484 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 57.25 25.12 53.8 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.755 1.169 . . . . 0.0 112.975 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.27 138.78 32.74 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.423 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -72.71 154.21 40.81 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.231 0.469 . . . . 0.0 111.704 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.504 HD12 HG22 ' A' ' 103' ' ' ILE . 90.3 mt -127.22 119.92 27.51 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.238 1.015 . . . . 0.0 110.487 -167.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.9 m -74.11 156.93 36.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.822 0.849 . . . . 0.0 111.578 -171.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.7 mt -99.3 71.57 1.8 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.889 1.676 . . . . 0.0 108.151 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.426 ' C ' HD13 ' A' ' 74' ' ' LEU . 79.2 m-20 -120.71 -20.94 6.85 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.317 0.647 . . . . 0.0 111.016 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.35 -22.53 8.49 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.488 1.518 . . . . 0.0 113.092 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.55 -40.78 9.68 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 119.091 1.446 . . . . 0.0 110.638 168.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 38.3 m -55.96 99.74 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.71 2.004 . . . . 0.0 110.595 -174.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -71.11 173.71 7.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.183 1.393 . . . . 0.0 111.396 -173.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 59.7 p -115.51 -160.74 0.76 Allowed 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.593 1.157 . . . . 0.0 111.834 -170.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.424 ' HB2' ' CB ' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -65.7 147.37 53.5 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.596 0.758 . . . . 0.0 109.027 172.103 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -89.71 141.41 28.64 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 120.659 -1.275 . . . . 0.0 107.983 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.1 m -121.29 110.31 15.98 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 128.537 2.735 . . . . 0.0 104.163 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.5 m -68.53 117.05 9.78 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.169 1.387 . . . . 0.0 107.808 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.9 mt -64.69 173.69 2.11 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.999 1.72 . . . . 0.0 111.369 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.39 159.12 40.18 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 127.676 2.39 . . . . 0.0 107.058 156.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -58.31 129.58 42.7 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.02 -140.55 15.67 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -172.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.5 m -107.51 142.7 36.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.886 1.343 . . . . 0.0 109.826 -172.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -143.18 173.53 11.5 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 127.923 2.489 . . . . 0.0 108.532 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 55' ' ' ASN . 86.3 m -157.15 141.25 16.27 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.357 -1.465 . . . . 0.0 109.955 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.27 116.04 65.78 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.593 1.557 . . . . 0.0 107.361 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -86.25 78.27 2.18 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 124.121 3.214 . . . . 0.0 112.171 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.405 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 97.5 m-85 -66.22 162.72 19.34 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.393 -0.817 . . . . 0.0 111.216 171.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -115.42 141.26 48.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.345 154.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -101.55 145.32 29.18 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 126.299 1.839 . . . . 0.0 108.462 160.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -149.61 152.56 35.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 159.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.417 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 69.9 m-85 -70.03 151.23 45.78 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 163.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -129.16 116.11 18.71 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.921 2.488 . . . . 0.0 106.626 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.73 146.72 29.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.439 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 29.3 p -114.27 7.0 16.35 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.095 0.958 . . . . 0.0 112.068 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 168.79 -150.41 15.78 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.5 94.59 0.03 OUTLIER 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.621 1.169 . . . . 0.0 108.756 170.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -79.42 128.98 34.03 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.221 1.008 . . . . 0.0 108.734 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.3 p -90.84 171.58 8.04 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.151 1.38 . . . . 0.0 109.855 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -88.13 172.92 5.05 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.172 1.915 . . . . 0.0 110.371 166.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.96 -95.23 0.14 Allowed Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -144.1 155.7 44.06 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 127.718 2.407 . . . . 0.0 107.574 174.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.417 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -143.44 92.14 2.33 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.548 1.166 . . . . 0.0 108.238 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -126.15 145.32 50.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.32 153.18 34.31 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.535 1.534 . . . . 0.0 107.41 169.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.43 98.14 4.6 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.87 1.268 . . . . 0.0 110.521 176.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.81 163.49 23.41 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.665 171.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.2 p -99.8 161.98 13.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 147.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -122.96 153.62 39.5 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 162.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -113.71 168.21 9.97 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.534 1.934 . . . . 0.0 107.954 172.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.494 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 18.4 t -121.67 134.73 64.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -122.09 87.55 2.77 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.547 ' CE2' ' HB1' ' A' ' 19' ' ' ALA . 84.4 m-85 -57.11 149.69 18.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.188 166.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -165.6 164.11 19.24 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.408 1.483 . . . . 0.0 109.59 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.529 0 CA-C-O 117.855 -1.525 . . . . 0.0 113.419 173.853 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.444 0 CA-C-O 121.169 0.509 . . . . 0.0 111.853 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.0 m -134.23 95.58 3.44 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.113 1.765 . . . . 0.0 107.366 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.2 m -76.93 133.59 39.18 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 168.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 13.1 m -149.06 171.44 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 127.013 2.125 . . . . 0.0 109.097 -175.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -68.11 170.67 8.09 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.416 1.007 . . . . 0.0 109.682 172.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -135.89 -52.21 0.07 OUTLIER Glycine 0 CA--C 1.522 0.524 0 C-N-CA 124.341 0.972 . . . . 0.0 111.063 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 161.08 -162.14 33.44 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 118.043 0.922 . . . . 0.0 111.352 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.7 m -127.15 112.95 15.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.988 2.115 . . . . 0.0 107.247 -166.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 7.7 t -105.16 106.72 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' HIS . . . . . 0.432 ' HB2' HG23 ' A' ' 31' ' ' THR . 28.9 m-70 -96.75 87.76 4.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -169.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.411 ' CG ' HG11 ' A' ' 101' ' ' VAL . 73.5 m-85 -68.37 113.07 5.62 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -120.07 166.33 13.54 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.035 -1.041 . . . . 0.0 108.261 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 143.82 -161.57 27.78 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -170.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -165.82 172.44 11.67 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.59 135.47 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 166.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' A' ' 184' ' ' ALA . 3.3 m -117.84 151.65 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 127.637 2.375 . . . . 0.0 107.677 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -74.03 24.59 0.08 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.781 1.632 . . . . 0.0 113.5 -169.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.246 0.91 0 C-N-CA 131.402 3.881 . . . . 0.0 112.565 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.747 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.48 -20.65 64.78 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -160.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.3 m -123.22 160.57 26.29 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 127.895 2.478 . . . . 0.0 107.792 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.8 -20.27 27.82 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -167.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.261 8.6 t 54.81 124.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 130.143 3.377 . . . . 0.0 111.509 -163.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -77.65 164.63 25.14 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.138 1.775 . . . . 0.0 110.676 -174.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.04 -39.98 60.41 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.623 -1.298 . . . . 0.0 110.598 164.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.38 2.71 36.1 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.962 1.744 . . . . 0.0 113.979 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 63.4 p -141.73 -9.85 0.92 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 119.886 1.843 . . . . 0.0 113.488 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.0 p -72.09 -65.42 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 119.15 0.886 . . . . 0.0 110.612 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -126.32 46.08 2.52 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.202 -0.936 . . . . 0.0 108.499 -160.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -82.91 144.47 30.02 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.543 1.137 . . . . 0.0 109.81 -163.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.71 154.52 27.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 164.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.9 t -131.28 96.97 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 165.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.85 94.87 3.96 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.831 HD23 ' CG1' ' A' ' 52' ' ' VAL . 2.1 mt -68.46 -10.08 53.01 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.555 1.942 . . . . 0.0 110.224 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.5 -177.9 32.55 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 124.945 1.26 . . . . 0.0 111.304 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -69.35 138.68 53.92 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 122.067 -0.666 . . . . 0.0 109.373 167.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -121.01 147.64 24.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 125.582 1.553 . . . . 0.0 106.926 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -83.39 131.93 35.02 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.0 p -59.1 -23.03 61.74 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 118.904 0.775 . . . . 0.0 110.397 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.89 -27.45 66.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.064 1.346 . . . . 0.0 112.134 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.3 m -80.21 -15.4 57.09 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.035 -0.984 . . . . 0.0 113.076 173.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.458 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . 29.1 mt -134.11 75.86 1.62 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.708 2.003 . . . . 0.0 109.336 -164.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.91 -4.05 7.0 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -167.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.402 ' OE1' ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -152.7 163.38 39.78 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 124.425 1.09 . . . . 0.0 109.284 -175.072 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -64.83 127.34 31.15 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.39 -1.19 75.97 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-O 118.511 -1.161 . . . . 0.0 111.762 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -64.59 146.29 54.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 119.807 1.803 . . . . 0.0 109.769 168.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.8 p -138.09 151.29 47.67 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.112 0.414 . . . . 0.0 110.744 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.7 p -75.57 -169.91 1.14 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -45.11 -92.38 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.98 75.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 129.607 3.163 . . . . 0.0 107.259 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.831 ' CG1' HD23 ' A' ' 34' ' ' LEU . 1.6 p -73.66 148.57 8.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 169.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.85 155.72 19.83 Favored Glycine 0 CA--C 1.51 -0.262 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -147.71 1.59 0.69 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -171.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.42 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 2.8 m-20 36.92 -169.95 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 130.963 3.705 . . . . 0.0 114.281 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 mm -133.29 106.36 9.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 159.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -65.99 113.38 4.39 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 171.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.86 149.13 23.23 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -148.69 153.43 38.23 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.1 2.16 . . . . 0.0 108.609 -165.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 30.18 54.25 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 129.263 3.025 . . . . 0.0 114.825 -169.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.8 m -69.64 138.34 52.96 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.328 2.251 . . . . 0.0 111.3 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -113.96 119.76 38.33 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.147 1.379 . . . . 0.0 109.294 166.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.5 p -71.81 -17.66 62.14 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -59.65 -44.89 93.37 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 124.101 0.96 . . . . 0.0 109.939 175.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.4 t -61.42 -61.59 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.04 120.42 4.56 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.395 1.478 . . . . 0.0 109.061 -174.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.9 m -76.24 -6.94 53.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.864 0.865 . . . . 0.0 111.135 169.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -130.72 159.02 38.51 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 120.155 -1.591 . . . . 0.0 110.368 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.75 159.56 41.98 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 160.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.55 167.83 18.72 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.804 2.042 . . . . 0.0 106.258 161.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.0 t -119.95 148.82 22.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.64 159.45 26.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.427 ' CE1' HG21 ' A' ' 103' ' ' ILE . 20.7 m-85 -133.49 155.53 49.4 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.901 1.68 . . . . 0.0 108.548 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.404 HD13 ' C ' ' A' ' 114' ' ' ASP . 7.4 tp -141.46 161.55 37.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.787 0.435 . . . . 0.0 110.095 173.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.424 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -178.16 179.82 48.38 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 173.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 3.3 m -64.9 135.83 56.16 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 164.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.17 141.83 41.74 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.079 0.854 . . . . 0.0 109.322 171.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.6 tt -60.77 -36.12 69.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 122.998 0.519 . . . . 0.0 111.036 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -160.87 171.2 19.18 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.207 1.803 . . . . 0.0 107.343 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.1 -28.14 68.59 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.753 0.821 . . . . 0.0 111.341 165.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.64 -19.13 72.74 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 119.109 -0.829 . . . . 0.0 112.224 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -147.2 57.93 1.15 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.15 1.475 . . . . 0.0 110.619 -164.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.3 p -63.09 -14.74 52.06 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 128.297 2.639 . . . . 0.0 113.313 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -84.96 -3.26 58.68 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 170.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.2 t -123.21 138.37 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 119.897 1.226 . . . . 0.0 109.446 -170.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.424 HD21 ' HA3' ' A' ' 75' ' ' GLY . 0.9 OUTLIER -76.08 150.04 37.34 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.641 1.176 . . . . 0.0 110.787 -178.485 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB3' ' HB ' ' A' ' 76' ' ' THR . . . -95.19 14.99 20.32 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -167.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.9 mt 54.36 -161.27 0.14 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.482 1.113 . . . . 0.0 111.665 -167.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 . . . . . 0 C--O 1.235 0.303 0 C-N-CA 125.311 1.444 . . . . 0.0 110.869 -178.493 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.44 -0.94 0 CA-C-O 122.622 1.201 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.23 120.57 8.9 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 159.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.4 p -85.26 166.45 16.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 57.58 24.54 10.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.576 1.151 . . . . 0.0 111.499 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.413 HG21 HD13 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -148.36 154.5 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 119.304 0.956 . . . . 0.0 109.655 -178.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.33 -179.06 27.62 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 125.644 1.592 . . . . 0.0 110.322 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.45 HG11 ' CG ' ' A' ' 177' ' ' PHE . 73.5 t -91.89 152.93 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.404 HE22 ' HB1' ' A' ' 110' ' ' ALA . 1.7 mt-30 -132.1 167.97 18.79 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.218 -0.926 . . . . 0.0 110.247 161.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.427 HG21 ' CE1' ' A' ' 73' ' ' PHE . 4.8 mp -128.23 142.67 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 127.506 2.322 . . . . 0.0 105.559 174.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 110' ' ' ALA . 35.1 mt -129.33 146.41 51.22 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 126.282 1.833 . . . . 0.0 107.53 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.96 -72.25 0.14 Allowed 'General case' 0 C--O 1.221 -0.431 0 O-C-N 124.309 1.005 . . . . 0.0 111.873 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 108' ' ' GLY . 15.8 ptt180 -167.84 -35.23 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.044 1.338 . . . . 0.0 111.553 172.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.443 ' H ' HG22 ' A' ' 107' ' ' THR . 1.7 t -66.77 11.1 0.1 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.622 2.369 . . . . 0.0 111.063 167.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.426 ' HA2' HD13 ' A' ' 104' ' ' LEU . . . 61.99 12.31 35.73 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.239 1.4 . . . . 0.0 114.68 -171.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.71 110.76 1.6 Allowed 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.246 1.419 . . . . 0.0 108.781 175.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.54 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -63.03 118.57 8.03 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.902 1.281 . . . . 0.0 109.572 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 mt -79.16 155.93 28.46 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 m -86.67 170.36 11.87 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 169.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.8 85.96 2.41 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 171.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.404 ' C ' HD13 ' A' ' 74' ' ' LEU . 8.2 t70 -111.32 -17.05 13.24 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 165.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.89 -0.06 73.47 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.342 0.972 . . . . 0.0 112.512 -168.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -128.35 -32.84 2.18 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.525 1.53 . . . . 0.0 111.419 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.2 m -57.26 112.07 1.27 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.133 0.973 . . . . 0.0 108.566 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -79.39 146.78 32.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.9 p -74.69 -150.46 0.03 OUTLIER 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.503 1.121 . . . . 0.0 109.869 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.35 156.85 38.65 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 120.995 -1.066 . . . . 0.0 109.107 163.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -76.94 157.42 31.31 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 122.666 1.222 . . . . 0.0 108.274 166.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.9 m -133.57 122.75 23.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 164.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.1 m -65.49 120.92 13.74 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 167.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.509 HD22 ' ND2' ' A' ' 129' ' ' ASN . 31.3 mt -78.94 -168.24 1.39 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.171 2.188 . . . . 0.0 107.915 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -153.63 160.06 42.29 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.782 0.833 . . . . 0.0 108.941 164.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -65.56 107.68 1.79 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 127.22 -102.45 0.61 Allowed Glycine 0 C--O 1.225 -0.414 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 -172.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 m -137.36 147.64 45.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.444 1.122 . . . . 0.0 109.204 -167.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.509 ' ND2' HD22 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -168.45 161.05 11.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.552 1.541 . . . . 0.0 107.117 -175.285 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.42 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 96.8 m -149.54 151.48 33.95 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -175.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.5 mt -115.53 121.68 34.14 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.28 67.26 7.56 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.232 2.621 . . . . 0.0 113.206 -168.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -65.92 145.07 56.36 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -114.67 148.66 37.9 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.922 168.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -123.39 156.1 36.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 166.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.508 ' NH1' HD21 ' A' ' 104' ' ' LEU . 5.7 ptt-85 -157.37 167.92 28.86 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 169.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.469 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 96.2 m-85 -80.16 147.77 31.19 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 167.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -116.42 117.91 31.23 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 127.053 2.141 . . . . 0.0 106.103 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -87.01 139.74 30.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 53.6 p -102.09 13.68 34.04 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.646 1.179 . . . . 0.0 110.277 172.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.73 -154.21 24.9 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 107.756 -2.138 . . . . 0.0 107.756 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.71 95.66 0.9 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.477 1.111 . . . . 0.0 109.555 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.72 121.4 10.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.624 0.769 . . . . 0.0 109.179 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 63.8 p -74.78 161.82 76.12 Favored Pre-proline 0 C--O 1.235 0.323 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -68.71 173.49 9.93 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 120.861 1.041 . . . . 0.0 110.412 159.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.03 -109.95 0.42 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 173.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -138.94 152.93 48.11 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 128.064 2.546 . . . . 0.0 105.904 174.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.469 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -145.31 75.78 1.45 Allowed 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.934 1.243 . . . . 0.0 111.553 -175.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -118.1 157.47 26.81 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.97 164.96 36.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.488 1.515 . . . . 0.0 108.607 172.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -131.59 113.0 13.1 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -91.12 169.8 10.55 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.416 1.087 . . . . 0.0 109.79 170.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.3 p -115.41 156.22 25.98 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 152.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -120.52 152.41 38.09 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -122.36 169.7 10.68 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.861 1.664 . . . . 0.0 108.37 170.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.562 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 61.1 t -126.09 132.18 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -107.78 89.77 3.1 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 166.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.562 ' CZ ' HG11 ' A' ' 156' ' ' VAL . 85.5 m-85 -62.04 145.35 53.41 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 163.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -164.36 169.77 16.96 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.678 0.791 . . . . 0.0 111.287 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.284 0 N-CA-C 107.696 -2.162 . . . . 0.0 107.696 -173.091 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 120.739 0.304 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 60.6 m -150.29 103.11 3.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.639 1.976 . . . . 0.0 107.141 -173.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.2 m -101.48 109.22 21.0 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 125.595 1.558 . . . . 0.0 109.616 -170.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.6 m -137.29 149.52 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.955 1.302 . . . . 0.0 109.708 -160.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.97 163.03 20.67 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.244 0.929 . . . . 0.0 111.906 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -121.94 -80.87 0.57 Allowed Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -174.29 -153.9 10.35 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -165.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.0 m -128.31 105.97 8.7 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.277 1.831 . . . . 0.0 110.327 -161.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.421 HG21 ' CE2' ' A' ' 73' ' ' PHE . 3.8 t -94.08 106.9 18.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -90.17 101.08 13.8 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -175.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.45 ' CG ' HG11 ' A' ' 101' ' ' VAL . 70.5 m-85 -82.55 121.5 26.87 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -126.74 159.4 33.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.6 -163.68 27.87 Favored Glycine 0 CA--C 1.518 0.269 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -166.26 166.24 16.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 81.8 t -113.86 125.46 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 172.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.9 m -106.27 152.32 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 126.265 1.826 . . . . 0.0 108.823 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -75.13 24.78 0.1 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -169.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 C-N-CA 129.103 2.961 . . . . 0.0 111.839 -175.127 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.415 ' HB2' HG11 ' A' ' 170' ' ' VAL . . . . . . . . 0 C--O 1.218 -0.599 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 43.67 -50.63 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.28 1 C-N-CA 134.45 5.1 . . . . 0.0 115.48 -167.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 1.6 m -104.51 174.24 5.96 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.262 2.225 . . . . 0.0 110.977 172.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.6 102.82 12.04 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 127.634 2.374 . . . . 0.0 108.065 172.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.05 130.85 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -67.41 153.75 42.96 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -55.12 -32.31 61.95 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.908 -1.12 . . . . 0.0 110.486 165.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.84 4.65 4.1 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 118.606 -1.108 . . . . 0.0 114.705 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.3 m -143.38 -19.57 0.62 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 120.609 2.204 . . . . 0.0 114.535 175.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 25' ' ' ALA . 8.4 p -60.57 -39.72 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 119.384 0.993 . . . . 0.0 111.292 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -136.23 67.1 1.47 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -167.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.89 140.15 44.18 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.577 -164.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.2 m -109.89 100.19 9.2 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.25 102.22 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -84.77 93.15 8.4 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -69.57 -16.44 63.41 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.903 1.681 . . . . 0.0 109.059 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.84 -168.63 43.56 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.434 1.016 . . . . 0.0 111.15 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -73.63 152.27 40.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.358 1.063 . . . . 0.0 109.798 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.46 147.25 28.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 125.208 1.403 . . . . 0.0 108.109 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -82.68 131.37 35.21 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -57.12 -27.59 61.95 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 122.74 0.416 . . . . 0.0 111.266 170.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.71 -35.3 65.95 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.535 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.2 m -77.14 -1.53 29.75 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.5 mt -143.71 74.08 1.42 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.726 1.61 . . . . 0.0 108.043 -163.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.22 -6.47 4.85 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -170.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.94 163.81 38.47 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 126.292 1.837 . . . . 0.0 107.408 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.401 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 16.2 tt0 -61.43 136.21 57.95 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 122.071 0.939 . . . . 0.0 108.735 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.471 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 82.93 -3.58 83.39 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-O 118.095 -1.391 . . . . 0.0 111.27 175.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.17 151.29 19.41 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.478 1.139 . . . . 0.0 109.46 158.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 p -143.37 154.44 43.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.577 0.703 . . . . 0.0 109.702 -174.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.5 t -65.27 175.84 1.55 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 166.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -38.38 -81.52 0.01 OUTLIER 'General case' 0 C--N 1.339 0.12 0 C-N-CA 127.622 2.369 . . . . 0.0 110.375 167.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.57 158.48 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 129.733 3.213 . . . . 0.0 106.146 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.7 t -145.03 152.06 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 168.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.47 144.13 16.6 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 106.339 -2.704 . . . . 0.0 106.339 167.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -141.01 157.72 44.93 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -141.53 168.81 18.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 119.886 1.221 . . . . 0.0 113.241 -172.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 mm -111.41 92.63 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.32 118.68 13.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.884 1.673 . . . . 0.0 108.011 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.4 mt -118.8 132.18 56.12 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.829 1.251 . . . . 0.0 109.947 -175.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -116.49 164.68 14.21 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.365 1.466 . . . . 0.0 108.863 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.3 t0 53.66 31.72 13.23 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.742 2.017 . . . . 0.0 113.384 163.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 2.7 t -75.05 153.58 38.34 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.467 -1.396 . . . . 0.0 113.096 -170.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.639 ' HB3' HG23 ' A' ' 65' ' ' VAL . 14.2 t0 -126.38 125.9 42.99 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.978 1.311 . . . . 0.0 110.742 176.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 p -73.75 -17.1 61.15 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.059 0.543 . . . . 0.0 110.955 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -58.87 -45.75 89.43 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.899 1.28 . . . . 0.0 110.001 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.639 HG23 ' HB3' ' A' ' 62' ' ' ASP . 4.1 t -72.57 -46.11 56.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -175.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -165.85 130.91 2.38 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.162 1.385 . . . . 0.0 109.253 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 m -73.83 -23.19 59.61 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -120.79 166.09 14.23 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 126.154 1.782 . . . . 0.0 110.205 -173.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.83 151.64 51.55 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 157.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.77 170.79 10.68 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 144.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.408 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -134.36 159.74 41.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -172.33 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.55 167.07 23.04 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -125.33 154.9 41.1 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.642 0.777 . . . . 0.0 109.101 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.2 tp -150.01 124.26 9.51 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.918 0.887 . . . . 0.0 108.998 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.15 -178.98 42.75 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.674 1.131 . . . . 0.0 110.824 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m -70.37 133.68 47.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.399 1.48 . . . . 0.0 110.174 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.84 141.13 47.98 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 121.296 -0.878 . . . . 0.0 111.156 169.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 tt -63.01 -37.58 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 123.554 0.742 . . . . 0.0 110.961 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -159.83 165.78 31.63 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.752 2.021 . . . . 0.0 107.279 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.22 69.5 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 125.536 1.534 . . . . 0.0 112.318 169.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.54 -3.38 90.1 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-O 118.691 -1.061 . . . . 0.0 113.277 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -145.78 50.09 1.2 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.211 1.506 . . . . 0.0 109.614 -172.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.0 p -64.51 -17.41 63.87 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.978 1.311 . . . . 0.0 114.38 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -75.75 -25.78 56.82 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.92 173.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.27 137.84 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.396 1.478 . . . . 0.0 110.23 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.82 146.19 32.39 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.221 1.008 . . . . 0.0 111.79 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.36 18.17 6.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.353 1.861 . . . . 0.0 114.226 -167.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 73.4 mt 51.48 -156.12 0.14 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.797 1.239 . . . . 0.0 110.762 -169.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 . . . . . 0 CA--C 1.537 0.446 0 C-N-CA 128.622 2.769 . . . . 0.0 107.827 177.971 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 121.173 0.511 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.96 142.33 3.56 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.144 1.378 . . . . 0.0 111.079 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.8 p -94.93 163.42 13.33 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 169.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 56.07 23.75 7.16 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.451 1.501 . . . . 0.0 112.425 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -144.23 155.02 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.19 -168.06 14.04 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.483 HG11 ' CG ' ' A' ' 177' ' ' PHE . 95.5 t -101.42 136.94 30.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 169.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -115.12 158.73 21.78 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 164.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.495 HG22 HD12 ' A' ' 111' ' ' LEU . 2.7 mp -133.48 123.57 46.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.512 1.925 . . . . 0.0 106.768 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 110' ' ' ALA . 10.9 mt -114.41 153.47 29.83 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 174.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.419 ' CB ' ' HB2' ' A' ' 120' ' ' SER . 7.9 t70 -85.76 -107.82 0.05 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.438 0.563 . . . . 0.0 110.325 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.79 -45.78 4.69 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 129.618 3.167 . . . . 0.0 109.528 168.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.8 p -78.38 -0.17 28.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.052 0.541 . . . . 0.0 112.078 -166.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.77 14.15 57.68 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.055 1.312 . . . . 0.0 112.684 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.7 142.35 55.05 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 159.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.559 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -95.82 135.64 37.28 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.495 HD12 HG22 ' A' ' 103' ' ' ILE . 74.3 mt -105.82 120.51 41.9 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.653 -0.655 . . . . 0.0 110.702 -157.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.6 m -73.31 160.1 32.37 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.858 0.837 . . . . 0.0 110.725 -173.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.1 mt -109.38 40.64 1.81 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.243 1.417 . . . . 0.0 111.794 -160.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -106.76 0.28 24.03 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.32 -0.863 . . . . 0.0 112.593 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.26 -17.77 31.64 Favored Glycine 0 CA--C 1.519 0.335 0 O-C-N 120.423 -1.423 . . . . 0.0 114.196 166.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -115.1 -6.7 12.49 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.313 1.056 . . . . 0.0 112.899 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.2 m -68.94 99.4 1.06 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 168.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -61.19 130.09 44.53 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.484 171.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.8 m -83.55 -158.31 0.29 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 127.19 2.196 . . . . 0.0 109.962 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.419 ' HB2' ' CB ' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -73.45 129.62 38.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.973 0.892 . . . . 0.0 108.942 -170.262 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -84.57 115.17 22.47 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -166.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m -96.66 110.14 22.64 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.0 m -61.83 130.34 45.26 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 163.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 51.5 mt -96.33 -149.26 0.31 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 126.184 1.794 . . . . 0.0 108.255 -170.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -150.34 173.79 13.6 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.616 1.566 . . . . 0.0 107.974 164.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.57 115.24 12.72 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 159.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 119.0 -150.46 17.94 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.631 1.11 . . . . 0.0 111.631 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.6 m -75.27 135.27 40.95 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.326 1.45 . . . . 0.0 110.766 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.62 168.97 25.76 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.528 1.531 . . . . 0.0 108.514 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 95.0 m -152.24 149.81 29.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.556 0.742 . . . . 0.0 109.291 -176.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.75 106.97 57.06 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.479 1.112 . . . . 0.0 108.356 163.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.65 117.37 3.66 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 124.319 3.346 . . . . 0.0 111.552 171.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.408 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 91.2 m-85 -93.08 170.43 9.66 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.037 1.735 . . . . 0.0 110.849 168.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -134.71 113.83 12.07 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.917 2.087 . . . . 0.0 107.287 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -104.34 133.88 48.5 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 128.553 2.741 . . . . 0.0 109.239 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 136' ' ' ARG . 10.1 ptt-85 -145.15 143.36 30.31 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 170.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.437 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 71.6 m-85 -70.46 116.46 10.81 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 162.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.471 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 3.0 t80 -101.62 130.54 47.97 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.71 144.84 26.92 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.401 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 30.3 p -98.7 7.0 46.6 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.273 1.029 . . . . 0.0 112.158 167.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 160.26 -152.64 23.46 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.89 89.3 0.05 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.892 1.277 . . . . 0.0 111.329 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.04 141.64 49.29 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.934 0.893 . . . . 0.0 110.999 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.5 p -112.36 152.99 44.95 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 119.161 -0.447 . . . . 0.0 110.241 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -76.86 162.4 32.36 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.402 1.401 . . . . 0.0 110.081 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 156.42 -133.08 3.51 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.903 1.239 . . . . 0.0 110.397 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.11 152.13 18.99 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.29 1.045 . . . . 0.0 108.234 169.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.437 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -136.96 82.28 1.93 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.664 0.745 . . . . 0.0 109.133 168.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -121.06 152.12 39.01 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -145.32 175.55 10.22 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -138.78 115.21 10.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 171.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -108.63 156.64 19.31 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 167.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 p -99.4 158.91 15.4 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 149.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -117.91 147.93 42.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 165.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -120.19 167.7 11.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.278 1.431 . . . . 0.0 107.645 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.94 106.38 3.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -169.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -95.14 87.94 5.04 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.148 1.379 . . . . 0.0 108.995 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -68.58 149.11 49.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.655 1.182 . . . . 0.0 110.704 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -172.82 174.9 3.48 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.135 1.774 . . . . 0.0 109.092 -173.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.171 0 N-CA-C 107.835 -2.106 . . . . 0.0 107.835 -177.777 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.818 0 CA-C-O 121.215 0.531 . . . . 0.0 109.972 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 21.2 m -135.78 101.94 4.92 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.1 m -79.11 104.82 10.0 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 162.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -90.14 156.76 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.44 161.074 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -65.25 129.04 38.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 153.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -85.29 -61.47 1.73 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 166.93 -157.53 30.05 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 89.8 m -116.89 135.75 53.48 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.952 1.701 . . . . 0.0 109.29 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.7 t -114.35 107.67 23.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 122.306 1.05 . . . . 0.0 108.344 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -88.36 91.31 8.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.483 ' CG ' HG11 ' A' ' 101' ' ' VAL . 73.0 m-85 -71.2 115.2 10.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -123.27 159.49 28.64 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 124.369 1.068 . . . . 0.0 109.149 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 145.95 -166.2 27.98 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 106.491 -2.644 . . . . 0.0 106.491 -173.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.56 176.23 10.62 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.3 130.15 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 171.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.405 ' C ' ' H ' ' A' ' 184' ' ' ALA . 4.2 m -105.66 152.29 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 127.393 2.277 . . . . 0.0 108.536 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.21 24.9 0.08 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.837 1.255 . . . . 0.0 114.065 -170.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.257 1.463 1 C-N-CA 133.424 4.689 . . . . 0.0 113.374 -176.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.413 ' HA ' ' HE2' ' A' ' 158' ' ' TYR . . . . . . . . 0 N--CA 1.457 -0.089 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.432 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -39.96 -39.22 0.81 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 128.168 2.587 . . . . 0.0 112.93 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.3 m -111.34 142.42 43.6 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.04 -8.96 13.44 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -168.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.2 t 45.95 102.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.29 0 C-N-CA 130.233 3.413 . . . . 0.0 109.265 -162.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -58.97 154.02 16.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.761 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.26 -31.16 65.28 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.812 0.733 . . . . 0.0 110.823 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.55 -11.9 60.61 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.987 -0.896 . . . . 0.0 114.249 176.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.6 m -105.86 -36.49 6.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.864 1.332 . . . . 0.0 109.921 172.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.3 t -52.02 -39.69 26.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 123.878 0.871 . . . . 0.0 110.127 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.93 77.21 1.59 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.959 0.885 . . . . 0.0 110.909 -173.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.25 138.28 49.17 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.907 -170.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.4 m -115.13 84.56 2.1 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.407 2.283 . . . . 0.0 110.026 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.4 t -67.93 112.43 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -87.37 97.29 10.72 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.44 HD23 HG11 ' A' ' 52' ' ' VAL . 6.2 mt -70.97 -3.18 18.09 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.722 2.009 . . . . 0.0 109.003 172.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.73 -176.63 35.67 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 124.541 1.067 . . . . 0.0 111.979 169.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -68.67 148.98 49.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.471 0.653 . . . . 0.0 109.569 164.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.7 t -136.16 144.97 31.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 125.536 1.534 . . . . 0.0 107.356 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.08 133.69 34.63 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.4 p -57.62 -25.02 59.49 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.004 0.522 . . . . 0.0 110.663 173.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.45 69.92 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.865 1.266 . . . . 0.0 112.65 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.8 m -76.37 -11.0 59.82 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 173.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.46 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . 37.1 mt -139.12 74.37 1.47 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.92 2.088 . . . . 0.0 109.209 -157.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.22 10.65 4.15 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.177 -0.952 . . . . 0.0 112.901 -169.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.466 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 4.8 pm0 -154.91 158.41 39.25 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 124.885 1.274 . . . . 0.0 108.824 -174.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -61.29 132.39 53.44 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 166.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.73 5.68 87.87 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-O 118.194 -1.337 . . . . 0.0 112.464 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -63.65 153.36 36.27 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.652 1.726 . . . . 0.0 109.27 163.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.8 p -141.45 155.43 45.86 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.9 t -68.39 178.05 2.13 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.345 1.058 . . . . 0.0 109.039 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.8 m -44.71 -86.14 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.915 2.486 . . . . 0.0 113.155 171.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 157.69 134.85 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 127.416 2.286 . . . . 0.0 107.239 -171.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.44 HG11 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -146.36 104.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -177.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.92 135.14 30.08 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 112.746 -2.025 . . . . 0.0 109.16 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -143.96 80.64 1.66 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.442 ' HB2' HG22 ' A' ' 130' ' ' THR . 27.7 p30 -77.79 141.56 39.16 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.284 -0.885 . . . . 0.0 110.027 -177.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 130' ' ' THR . 7.0 mm -81.09 102.62 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 -174.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -65.34 101.71 0.6 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.4 mt -91.19 161.0 15.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 161.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.47 ' HA ' HG23 ' A' ' 128' ' ' THR . 86.3 m-20 -131.49 160.37 35.39 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 167.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 t70 45.21 54.51 7.11 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 127.109 2.164 . . . . 0.0 113.418 175.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.7 m -68.62 103.35 1.69 Allowed 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.848 -0.532 . . . . 0.0 110.361 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -66.04 149.46 50.22 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 161.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 p -110.13 -15.84 13.92 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.049 0.94 . . . . 0.0 112.724 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -60.24 -46.65 89.05 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 122.361 1.077 . . . . 0.0 109.297 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 66' ' ' ALA . 5.9 p -60.2 -52.75 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 125.69 1.596 . . . . 0.0 108.55 177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 158' ' ' TYR . . . -167.24 135.73 2.62 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.37 1.468 . . . . 0.0 108.363 171.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.0 m -77.87 -12.49 59.98 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.32 -0.848 . . . . 0.0 113.074 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -117.3 152.38 35.01 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 120.232 1.378 . . . . 0.0 109.841 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.91 138.9 51.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 169.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.66 -176.68 3.52 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 123.266 1.508 . . . . 0.0 107.367 150.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.415 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -153.49 160.3 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 131.678 3.991 . . . . 0.0 103.773 -162.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.85 171.57 13.89 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 165.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.413 ' CD1' HG21 ' A' ' 103' ' ' ILE . 23.0 m-85 -129.72 152.41 49.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.458 HD22 ' HA3' ' A' ' 115' ' ' GLY . 14.4 tp -152.87 126.8 8.99 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -176.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.83 169.8 42.69 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.3 m -60.27 128.11 35.1 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.075 0.95 . . . . 0.0 110.669 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.99 135.99 46.59 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.76 -0.587 . . . . 0.0 110.431 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.2 tt -60.6 -33.66 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.783 0.833 . . . . 0.0 110.333 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -160.0 168.14 26.31 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 164.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.63 -31.85 66.66 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.942 1.297 . . . . 0.0 111.351 166.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.0 -10.92 60.03 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 120.588 -1.32 . . . . 0.0 112.531 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -148.33 50.63 1.02 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.154 1.781 . . . . 0.0 111.206 -165.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.3 p -68.22 -12.6 61.24 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.964 -1.085 . . . . 0.0 112.121 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -80.94 1.49 30.81 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.469 -0.769 . . . . 0.0 111.233 172.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.1 t -136.45 138.91 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 120.939 -1.1 . . . . 0.0 110.893 -169.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -87.75 148.11 24.88 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 125.63 1.572 . . . . 0.0 111.51 -168.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.14 14.26 12.94 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.735 1.614 . . . . 0.0 115.305 -163.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.534 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 58.1 mt 52.08 -164.88 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.3 1.04 . . . . 0.0 110.643 -166.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.553 1.541 . . . . 0.0 108.49 177.258 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 120.014 -0.041 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.31 168.31 3.56 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.315 1.446 . . . . 0.0 109.692 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.9 p -116.43 167.57 10.93 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.492 1.117 . . . . 0.0 109.039 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 53.36 27.25 6.06 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.695 1.598 . . . . 0.0 111.881 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.84 151.14 13.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 CA-C-N 120.265 1.393 . . . . 0.0 110.827 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.11 174.45 31.1 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 124.969 1.271 . . . . 0.0 111.317 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.412 HG11 ' CD2' ' A' ' 177' ' ' PHE . 97.7 t -86.48 126.75 40.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 176.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -95.64 153.07 17.91 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 120.121 1.328 . . . . 0.0 108.358 158.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.601 HG22 HD12 ' A' ' 111' ' ' LEU . 2.6 mp -122.59 138.45 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 169.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 110' ' ' ALA . 12.9 mt -133.49 138.99 46.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -65.8 178.45 1.05 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.295 1.045 . . . . 0.0 110.347 170.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -53.88 -13.31 0.71 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.807 1.243 . . . . 0.0 114.287 172.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.7 p -102.36 -11.63 18.51 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.636 1.107 . . . . 0.0 110.902 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.82 11.04 74.67 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.941 1.257 . . . . 0.0 113.467 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.85 60.04 5.69 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.77 1.228 . . . . 0.0 111.513 -174.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.435 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . 23.47 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 128.827 2.851 . . . . 0.0 113.834 153.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.601 HD12 HG22 ' A' ' 103' ' ' ILE . 87.7 mt -78.08 168.0 20.56 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.228 -169.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -109.19 164.21 12.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -172.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.7 mt -113.29 52.59 0.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.325 1.05 . . . . 0.0 108.323 -175.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -104.32 -23.31 13.23 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.588 1.155 . . . . 0.0 111.742 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.458 ' HA3' HD22 ' A' ' 74' ' ' LEU . . . 67.62 21.76 72.99 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 118.634 0.652 . . . . 0.0 113.261 -174.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -161.51 34.52 0.13 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.179 1.792 . . . . 0.0 110.392 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 26.9 m -128.92 91.81 3.28 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.078 -2.194 . . . . 0.0 105.078 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -62.35 152.91 32.64 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.097 0.475 . . . . 0.0 110.632 -170.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.9 m -126.3 104.07 8.0 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.546 0.739 . . . . 0.0 109.63 -163.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 49.98 -177.73 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.588 1.955 . . . . 0.0 112.018 -168.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -117.48 172.99 6.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 119.632 -1.918 . . . . 0.0 108.167 154.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m -151.02 116.06 5.28 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 165.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.1 m -67.62 137.87 55.96 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.9 mt -108.88 -178.85 3.7 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 129.038 2.935 . . . . 0.0 110.085 -170.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.45 156.98 44.8 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.009 1.724 . . . . 0.0 109.121 167.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -60.78 85.8 0.01 OUTLIER 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.943 2.097 . . . . 0.0 110.644 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.57 -169.57 25.1 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.758 0.694 . . . . 0.0 111.804 -161.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 59' ' ' ASN . 28.7 m -96.8 125.48 41.28 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 120.574 -1.545 . . . . 0.0 111.822 -158.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -139.92 157.79 45.13 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 129.097 2.959 . . . . 0.0 109.686 -171.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 56' ' ' ILE . 61.2 m -131.53 150.09 52.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.049 1.339 . . . . 0.0 110.003 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 17.1 mt -106.11 118.47 54.9 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -71.15 148.52 56.31 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.236 1.957 . . . . 0.0 112.039 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.415 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 71.1 m-85 -148.39 165.37 31.3 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 127.459 2.304 . . . . 0.0 109.003 170.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -128.46 140.83 51.62 Favored 'General case' 0 CA--C 1.523 -0.082 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 162.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.12 165.9 10.89 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 161.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -166.34 152.38 8.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 169.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.502 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 86.7 m-85 -69.06 151.48 46.39 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 166.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -126.51 133.79 51.07 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.493 1.917 . . . . 0.0 106.509 172.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -101.2 148.32 25.23 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.49 0.716 . . . . 0.0 110.55 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 66.7 p -109.96 12.34 23.77 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.576 1.15 . . . . 0.0 111.089 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.97 -154.44 24.85 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.88 89.24 0.16 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.356 1.062 . . . . 0.0 110.721 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -61.62 119.95 9.65 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.405 1.882 . . . . 0.0 109.599 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.3 p -83.17 161.78 56.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 123.847 0.859 . . . . 0.0 109.449 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -75.02 173.4 14.58 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 119.777 0.956 . . . . 0.0 109.633 165.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.26 -111.75 0.49 Allowed Glycine 0 C--O 1.229 -0.215 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 172.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.84 168.19 14.19 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.063 1.745 . . . . 0.0 106.828 166.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.502 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -145.14 89.39 1.95 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 173.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -125.29 140.79 52.52 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 178.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.534 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -147.71 170.06 18.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.535 1.061 . . . . 0.0 109.563 171.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -142.08 115.25 8.83 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.175 1.39 . . . . 0.0 108.648 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.633 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -130.25 167.74 17.97 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.677 1.591 . . . . 0.0 110.332 172.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 76.9 p -121.05 145.59 47.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -100.35 135.98 40.94 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 170.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -81.55 169.26 17.3 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 157.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.866 HG13 HG23 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -113.64 152.13 15.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 127.998 2.519 . . . . 0.0 105.342 163.641 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -143.96 87.68 1.92 Allowed 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.596 1.558 . . . . 0.0 107.493 164.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.802 ' CE2' HG21 ' A' ' 156' ' ' VAL . 83.0 m-85 -60.79 163.22 5.85 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.494 166.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.522 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 2.0 pt20 -161.85 162.76 29.47 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.765 1.226 . . . . 0.0 111.316 172.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.443 0 CA-C-O 117.464 -1.742 . . . . 0.0 116.048 171.021 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.093 0 CA-C-O 121.619 0.723 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 56.6 m -142.1 84.34 1.87 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.1 m -77.11 116.0 17.38 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.009 1.323 . . . . 0.0 108.336 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.866 HG23 HG13 ' A' ' 156' ' ' VAL . 28.2 m -134.84 162.15 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 125.697 1.599 . . . . 0.0 110.166 -175.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -75.68 159.49 31.08 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.91 -1.119 . . . . 0.0 109.332 169.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -129.73 -67.35 0.11 Allowed Glycine 0 CA--C 1.52 0.374 0 CA-C-O 119.475 -0.625 . . . . 0.0 111.655 -163.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 175.85 175.42 43.23 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 117.412 0.606 . . . . 0.0 111.64 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 54.0 m -104.06 138.46 40.55 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.058 1.343 . . . . 0.0 109.214 -174.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.79 92.95 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -73.13 85.01 1.34 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.325 1.85 . . . . 0.0 108.234 174.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.412 ' CD2' HG11 ' A' ' 101' ' ' VAL . 57.6 m-85 -67.45 125.16 25.26 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -131.17 163.38 27.84 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.454 1.102 . . . . 0.0 109.895 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 140.77 -162.71 26.64 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 -172.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -165.06 170.08 15.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.55 125.51 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 167.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.8 m -103.68 151.83 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 126.506 1.923 . . . . 0.0 108.424 173.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.39 25.05 0.08 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.685 1.594 . . . . 0.0 113.567 -169.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 C-N-CA 129.209 3.004 . . . . 0.0 110.756 -168.955 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.765 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.55 -22.2 61.36 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 123.973 0.796 . . . . 0.0 112.982 -167.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.4 m -118.84 156.23 29.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.087 1.355 . . . . 0.0 107.364 171.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.33 171.64 14.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.477 0.656 . . . . 0.0 109.779 156.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.63 150.26 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 168.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -87.22 18.0 3.97 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -171.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 69.99 -34.75 0.3 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 130.177 3.391 . . . . 0.0 110.305 -166.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.61 -18.32 73.73 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-O 119.057 -0.857 . . . . 0.0 113.966 -172.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -108.24 -7.08 16.06 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.35 1.06 . . . . 0.0 111.209 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.93 -32.18 26.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 C-N-CA 125.22 1.408 . . . . 0.0 111.338 -170.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -148.8 73.09 1.21 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 -172.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.1 142.35 38.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -171.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.42 HG23 ' HB2' ' A' ' 176' ' ' HIS . 22.5 m -112.59 100.1 8.47 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 172.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.35 102.15 2.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -79.53 100.54 7.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.768 HD23 HG11 ' A' ' 52' ' ' VAL . 14.6 mt -64.77 -19.01 65.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.635 1.974 . . . . 0.0 110.399 169.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.12 -178.15 41.31 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 125.244 1.402 . . . . 0.0 111.662 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -66.13 154.47 39.59 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.7 t -140.21 143.07 30.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 124.49 1.116 . . . . 0.0 108.514 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -76.19 133.68 40.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 p -58.73 -23.09 59.18 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.167 0.987 . . . . 0.0 110.627 174.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.46 74.57 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.158 -0.964 . . . . 0.0 111.041 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.418 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 67.2 m -69.74 -10.69 59.32 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 172.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.605 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 17.9 mt -140.55 79.44 1.7 Allowed 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 120.071 1.305 . . . . 0.0 107.547 -162.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.01 1.47 0.98 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -147.22 152.16 37.89 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 50.9 tt0 -61.33 125.39 23.59 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.419 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 101.46 -10.66 57.94 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 118.014 -1.437 . . . . 0.0 112.976 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -61.05 155.18 20.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.972 1.886 . . . . 0.0 110.227 177.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.8 p -136.44 161.63 35.29 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.425 0.557 . . . . 0.0 110.814 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.2 p -73.58 -163.31 0.16 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.458 0.703 . . . . 0.0 111.356 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.4 m -46.11 -31.68 2.49 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 126.979 2.111 . . . . 0.0 114.655 166.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 63.51 167.05 0.14 Allowed 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 126.359 2.287 . . . . 0.0 110.055 -166.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.768 HG11 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -162.05 143.35 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 C-N-CA 126.119 1.768 . . . . 0.0 106.276 -167.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.57 121.52 5.39 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 107.228 -2.349 . . . . 0.0 107.228 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -121.17 134.58 55.22 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -115.04 131.66 56.85 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -167.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.8 mm -89.89 108.8 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -77.61 118.46 20.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 mt -122.31 121.4 36.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -91.91 162.43 14.42 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.358 1.063 . . . . 0.0 110.068 -172.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.0 t0 47.33 42.52 13.98 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.889 1.675 . . . . 0.0 112.276 167.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.3 m -63.74 136.49 57.5 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.511 0.724 . . . . 0.0 109.292 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -121.47 103.78 9.18 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.837 0.855 . . . . 0.0 110.739 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.9 p -63.98 -19.91 65.5 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.957 0.903 . . . . 0.0 112.037 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -61.89 -37.52 84.89 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.318 1.447 . . . . 0.0 110.577 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.5 t -78.3 -57.91 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.1 125.27 3.96 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -166.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 m -71.4 -14.76 62.27 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 118.566 -0.731 . . . . 0.0 111.93 169.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -132.42 162.8 30.23 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 120.019 1.281 . . . . 0.0 111.689 -173.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.08 136.06 45.66 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 154.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.8 169.14 11.88 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 147.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.0 t -120.59 163.19 18.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 165.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.62 163.11 33.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.872 2.069 . . . . 0.0 107.526 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -133.74 152.18 51.81 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.091 1.756 . . . . 0.0 109.729 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.7 tp -152.31 131.07 12.4 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 122.805 0.442 . . . . 0.0 110.847 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.21 -172.12 34.82 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.15 163.96 1.43 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.061 1.744 . . . . 0.0 110.373 171.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.53 130.47 53.56 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 125.753 1.621 . . . . 0.0 109.143 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.6 tt -60.62 -46.77 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 O-C-N 123.413 0.446 . . . . 0.0 110.526 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.1 164.86 32.59 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.75 -15.84 63.83 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.21 -0.24 74.17 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.888 1.232 . . . . 0.0 112.386 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -143.45 41.21 1.47 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.963 1.705 . . . . 0.0 109.691 -167.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.2 p -61.11 -19.85 61.95 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.199 -0.938 . . . . 0.0 112.324 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -75.51 -7.22 53.61 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.855 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.7 t -124.7 130.43 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.711 1.141 . . . . 0.0 108.702 -168.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mt -74.71 151.33 39.23 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.812 1.245 . . . . 0.0 111.133 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.06 19.91 10.96 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.147 2.179 . . . . 0.0 114.093 -163.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.7 mt 53.44 -163.85 0.1 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.983 1.313 . . . . 0.0 110.872 -164.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 CA--C 1.514 -0.414 0 C-N-CA 124.441 1.096 . . . . 0.0 110.485 -178.376 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.446 -0.659 0 CA-C-O 122.109 0.957 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.08 168.77 2.32 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.396 157.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.9 p -126.85 170.38 12.28 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 127.263 2.225 . . . . 0.0 108.645 171.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 53.51 29.54 9.21 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 127.472 2.309 . . . . 0.0 111.329 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.1 p -148.44 151.14 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 124.126 0.971 . . . . 0.0 108.565 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.72 -176.21 21.12 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.413 HG11 ' CG ' ' A' ' 177' ' ' PHE . 46.4 t -102.54 138.8 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -115.58 159.89 20.69 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.524 1.056 . . . . 0.0 110.411 171.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.38 137.38 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 170.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -135.69 151.84 50.59 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.718 -177.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 4.1 p-10 -66.6 179.22 1.08 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.042 0.925 . . . . 0.0 111.975 160.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -44.22 -33.92 1.71 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 129.191 2.996 . . . . 0.0 114.966 168.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.4 p -87.83 -7.14 57.66 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.183 1.356 . . . . 0.0 110.846 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.38 22.34 78.77 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.798 1.666 . . . . 0.0 112.419 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.8 34.13 0.49 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -165.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.437 ' HA ' HD13 ' A' ' 104' ' ' LEU . . . 33.08 94.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 129.051 2.941 . . . . 0.0 114.978 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.73 136.31 56.09 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.82 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 113' ' ' LEU . 16.9 m -68.61 167.7 14.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 166.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.457 ' H ' HG22 ' A' ' 112' ' ' THR . 66.9 mt -119.73 70.58 0.86 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -168.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -113.82 -11.77 12.82 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.862 0.865 . . . . 0.0 111.816 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.65 -12.38 4.81 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.082 -1.011 . . . . 0.0 113.894 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -133.45 -10.67 2.83 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.945 1.298 . . . . 0.0 112.942 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.4 t -61.22 123.52 17.97 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 164.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -84.57 157.88 21.09 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.2 t -104.11 174.37 5.9 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.438 1.495 . . . . 0.0 109.073 173.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.444 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 0.5 OUTLIER -45.31 13.98 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.525 1 C-N-CA 134.708 5.203 . . . . 0.0 120.765 179.756 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 44.69 -179.63 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 130.314 3.445 . . . . 0.0 113.458 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 m -158.43 137.66 11.59 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 157.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.0 m -77.82 110.86 13.07 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 175.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.4 mt -72.44 -174.11 1.28 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.413 2.285 . . . . 0.0 108.221 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -151.45 176.17 11.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.6 1.96 . . . . 0.0 108.723 169.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -68.16 101.32 1.15 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 137.77 -170.36 23.75 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.788 1.185 . . . . 0.0 110.698 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 51.4 m -76.74 129.19 35.97 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.087 -1.243 . . . . 0.0 110.0 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -123.41 166.35 15.5 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.289 1.436 . . . . 0.0 109.333 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.0 m -154.71 147.44 24.34 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.037 0.923 . . . . 0.0 109.666 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.2 mt -130.33 111.31 16.64 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 -171.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.67 100.16 0.86 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.918 3.079 . . . . 0.0 110.367 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.86 166.62 20.74 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 171.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -117.32 155.84 28.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 168.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.53 163.55 34.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.673 1.989 . . . . 0.0 107.835 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -175.41 156.06 1.93 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.467 1.907 . . . . 0.0 107.626 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.413 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 85.5 m-85 -71.83 147.22 47.4 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 156.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.419 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 31.1 t80 -123.55 121.0 34.51 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.423 1.889 . . . . 0.0 106.893 176.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -82.88 141.31 32.32 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 46.4 p -100.41 11.07 40.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.463 0.705 . . . . 0.0 111.599 169.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 158.59 -148.22 17.03 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.82 82.37 0.2 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.15 1.78 . . . . 0.0 110.214 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -65.31 157.51 28.92 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.247 1.019 . . . . 0.0 111.342 -177.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.1 p -123.79 153.95 67.07 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 124.592 1.157 . . . . 0.0 109.964 -176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.86 163.41 26.06 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.434 1.422 . . . . 0.0 111.018 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.23 -116.51 0.72 Allowed Glycine 0 N--CA 1.469 0.877 0 C-N-CA 124.442 1.02 . . . . 0.0 111.045 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -119.89 145.36 46.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.164 0.982 . . . . 0.0 109.668 167.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -134.45 86.16 2.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -120.48 146.72 45.98 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -149.0 175.16 11.54 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -152.48 152.95 32.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 173.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.13 175.34 9.66 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.836 2.455 . . . . 0.0 107.881 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.9 p -116.54 153.52 32.04 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 155.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -112.54 151.54 29.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -131.28 157.62 42.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.429 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 9.3 t -122.85 133.81 67.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -169.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -120.84 85.13 2.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.429 ' CZ ' HG11 ' A' ' 156' ' ' VAL . 94.7 m-85 -67.92 128.85 38.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.983 175.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -153.64 176.67 11.81 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 124.801 1.24 . . . . 0.0 111.452 -174.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.279 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -173.832 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 122.405 1.098 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 10.1 m -79.48 99.48 7.26 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 164.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.9 m -78.16 129.64 35.38 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 165.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.18 151.84 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.713 1.605 . . . . 0.0 109.722 -176.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -61.48 139.59 58.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.7 -56.73 0.56 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 166.42 -171.35 41.38 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -175.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.5 m -103.15 138.4 40.02 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.75 1.22 . . . . 0.0 109.657 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.1 t -119.72 103.07 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' HIS . . . . . 0.42 ' HB2' HG23 ' A' ' 31' ' ' THR . 20.0 m-70 -82.67 141.99 32.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 171.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.413 ' CG ' HG11 ' A' ' 101' ' ' VAL . 86.3 m-85 -121.16 113.74 20.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -124.75 156.39 37.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 118.582 0.628 . . . . 0.0 110.677 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 148.59 -162.6 28.89 Favored Glycine 0 N--CA 1.437 -1.279 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 -167.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.25 177.22 3.66 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 -173.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.4 t -125.87 135.98 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.8 m -118.86 149.97 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 C-N-CA 127.59 2.356 . . . . 0.0 108.492 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -74.99 34.18 0.1 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 C-N-CA 130.269 3.428 . . . . 0.0 112.765 173.033 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.536 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -51.11 -37.44 46.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 116.671 -1.633 . . . . 0.0 111.913 172.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.1 m -121.48 164.86 16.48 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 125.104 1.503 . . . . 0.0 112.128 -167.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.43 -12.81 25.3 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.974 1.31 . . . . 0.0 113.866 -170.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.453 HG13 ' OG ' ' A' ' 27' ' ' SER . 70.8 t 50.06 109.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 130.191 3.396 . . . . 0.0 112.127 -174.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.06 151.68 39.23 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.001 -1.062 . . . . 0.0 109.525 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.593 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -49.82 -33.72 17.54 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.353 1.461 . . . . 0.0 111.189 166.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.35 -6.03 1.98 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.442 1.496 . . . . 0.0 114.537 171.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.453 ' OG ' HG13 ' A' ' 23' ' ' VAL . 96.5 p -132.69 -34.93 1.13 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.847 1.824 . . . . 0.0 112.342 -177.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 25' ' ' ALA . 8.0 p -62.13 -55.23 25.42 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 123.396 0.679 . . . . 0.0 111.282 -170.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -132.04 67.8 1.51 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -165.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -105.72 140.3 38.98 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.902 -1.499 . . . . 0.0 108.295 -161.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.1 m -110.32 94.59 5.09 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.6 t -77.65 104.32 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -86.68 107.79 18.36 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 mt -85.37 -3.39 58.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.8 1.24 . . . . 0.0 110.029 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.5 -178.34 23.76 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 125.241 1.4 . . . . 0.0 112.298 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -65.74 151.51 46.42 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.088 0.555 . . . . 0.0 109.877 162.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.46 152.95 34.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 C-N-CA 125.919 1.688 . . . . 0.0 107.578 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -83.2 134.92 34.94 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.1 p -59.31 -21.94 60.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.82 0.448 . . . . 0.0 111.735 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.1 -31.44 70.04 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.684 -1.26 . . . . 0.0 112.229 171.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -74.05 -9.58 58.77 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.854 0.861 . . . . 0.0 111.449 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.542 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 18.6 mt -143.35 76.56 1.53 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.176 1.39 . . . . 0.0 107.715 -159.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.93 -1.27 2.21 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -171.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 2.7 pm0 -151.14 161.29 43.0 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 35.6 tt0 -64.08 126.76 28.73 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.27 2.53 79.99 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.995 -0.891 . . . . 0.0 113.166 -174.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.57 ' HB2' ' NE2' ' A' ' 44' ' ' GLN . . . -70.45 159.55 34.01 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.642 1.721 . . . . 0.0 109.779 161.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.0 p -149.67 162.81 39.49 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.301 0.64 . . . . 0.0 110.203 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.5 p -73.85 174.8 7.98 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.646 -0.659 . . . . 0.0 110.339 168.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -55.13 -17.27 3.92 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 83.0 160.62 0.13 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 129.765 3.226 . . . . 0.0 112.121 173.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.1 t -143.26 140.53 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.85 130.0 10.09 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 107.152 -2.379 . . . . 0.0 107.152 169.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -136.49 130.19 32.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.468 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 2.8 m-20 -109.64 165.48 11.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -169.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.9 mm -116.74 99.33 8.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -68.36 95.84 0.63 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.902 1.681 . . . . 0.0 110.281 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.45 158.31 19.62 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 122.473 1.13 . . . . 0.0 109.123 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -163.39 155.59 17.87 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 126.794 2.037 . . . . 0.0 107.547 -169.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 45.55 59.2 3.74 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 127.91 2.484 . . . . 0.0 111.079 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.8 m -108.77 107.81 18.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.389 2.275 . . . . 0.0 111.15 -168.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -79.4 158.45 27.37 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.679 1.127 . . . . 0.0 111.121 172.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.4 p -100.52 -18.04 16.83 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.226 1.41 . . . . 0.0 113.554 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -64.77 -46.85 80.39 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.403 1.081 . . . . 0.0 109.063 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 20' ' ' ALA . 2.4 p -57.96 -53.05 50.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 114.184 -1.371 . . . . 0.0 107.442 -175.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.431 ' HA ' ' HA2' ' A' ' 160' ' ' GLY . . . -153.19 142.26 21.34 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 166.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -93.75 11.39 29.31 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.394 172.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.469 ' HE3' ' OE1' ' A' ' 159' ' ' GLN . 7.7 mtmt -148.48 163.34 37.47 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.036 1.334 . . . . 0.0 108.724 168.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.84 177.08 9.85 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 123.764 0.665 . . . . 0.0 109.486 157.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.54 178.37 8.18 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 128.696 2.798 . . . . 0.0 107.726 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.6 t -143.85 100.96 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.435 1.894 . . . . 0.0 106.929 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.63 152.52 28.46 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 118.341 -0.838 . . . . 0.0 109.267 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -112.75 158.66 19.81 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 118.814 0.733 . . . . 0.0 110.328 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.9 tp -144.5 153.45 41.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.747 1.619 . . . . 0.0 108.002 175.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.0 170.69 33.92 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 m -64.45 131.44 47.14 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.191 1.397 . . . . 0.0 109.334 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.94 135.65 43.25 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.613 1.097 . . . . 0.0 110.366 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.7 tt -63.19 -35.29 71.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.229 0.611 . . . . 0.0 111.076 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -159.57 166.53 30.58 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.392 1.477 . . . . 0.0 108.755 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.44 -19.86 57.82 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 127.654 2.382 . . . . 0.0 114.612 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.2 -20.23 43.01 Favored Glycine 0 CA--C 1.524 0.629 0 O-C-N 120.838 -1.164 . . . . 0.0 112.149 171.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -125.02 53.76 1.48 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.634 1.573 . . . . 0.0 108.18 -170.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.9 p -63.58 -15.56 58.45 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 127.303 2.241 . . . . 0.0 111.99 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -97.04 2.84 51.89 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.717 2.007 . . . . 0.0 113.073 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 t -128.35 141.13 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 120.157 1.344 . . . . 0.0 109.392 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -81.41 146.11 30.45 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.271 -169.751 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.55 ' H ' HD23 ' A' ' 86' ' ' LEU . . . -88.95 14.52 10.32 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.629 1.572 . . . . 0.0 114.509 -166.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.5 mt 51.51 -154.3 0.17 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.328 1.051 . . . . 0.0 110.556 -167.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 . . . . . 0 N--CA 1.45 -0.435 0 O-C-N 121.504 -0.747 . . . . 0.0 110.729 179.218 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.937 0 CA-C-O 122.224 1.011 . . . . 0.0 112.884 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.79 125.73 14.06 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 148.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.1 p -90.3 172.6 8.66 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 56.6 28.62 14.26 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.993 1.717 . . . . 0.0 111.361 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.28 151.29 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.858 0.863 . . . . 0.0 109.485 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.6 175.18 29.73 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 124.382 0.991 . . . . 0.0 110.815 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.2 t -85.11 126.54 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -98.87 144.61 27.88 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 164.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.6 mp -118.41 146.95 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 169.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 mt -141.52 151.42 43.26 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.201 1.4 . . . . 0.0 107.643 -172.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -59.25 -75.08 0.06 Allowed 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.118 0.485 . . . . 0.0 111.073 170.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.1 ptt-85 -176.0 -24.57 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 128.055 2.542 . . . . 0.0 109.415 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.4 p -80.58 -28.17 37.24 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.107 1.363 . . . . 0.0 108.588 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.6 7.06 9.13 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.016 1.77 . . . . 0.0 112.591 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.88 104.87 2.17 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 120.146 1.973 . . . . 0.0 108.402 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.95 100.78 0.22 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.166 0.986 . . . . 0.0 109.279 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.34 132.48 52.76 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.888 0.875 . . . . 0.0 109.251 -170.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 49.3 m -74.63 148.34 40.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.32 0.581 . . . . 0.0 109.789 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.7 mt -92.35 81.55 4.93 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -127.61 -24.42 3.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.6 1.96 . . . . 0.0 111.324 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.84 7.78 71.1 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.14 1.353 . . . . 0.0 113.548 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -140.17 -29.17 0.71 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.785 1.292 . . . . 0.0 112.482 170.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.4 m -53.81 115.09 1.81 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.633 1.173 . . . . 0.0 108.846 173.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -71.52 179.64 2.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.309 1.052 . . . . 0.0 112.384 -164.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.8 p -134.27 126.22 29.34 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.938 1.695 . . . . 0.0 107.791 167.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.6 m 23.2 85.25 0.01 OUTLIER 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.757 2.023 . . . . 0.0 114.083 147.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -61.61 144.95 53.61 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.128 -162.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.9 m -113.71 114.21 26.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 86.0 m -53.74 110.58 0.6 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 154.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.0 mt -72.84 176.9 5.23 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 170.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.12 162.22 30.38 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 121.621 -0.675 . . . . 0.0 109.993 171.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.37 132.18 47.54 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 94.7 -118.54 5.85 Favored Glycine 0 C--O 1.223 -0.58 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.9 m -118.54 144.47 46.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.455 1.102 . . . . 0.0 109.706 -164.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.63 171.5 18.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.127 1.371 . . . . 0.0 109.309 -173.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.468 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 97.1 m -154.32 163.78 39.62 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 119.527 -1.983 . . . . 0.0 108.637 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -122.05 121.0 28.14 Favored Pre-proline 0 N--CA 1.446 -0.638 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 168.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -70.62 135.64 28.86 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 N-CA-C 108.026 -1.567 . . . . 0.0 108.026 160.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -120.54 170.78 9.08 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.802 0.841 . . . . 0.0 108.75 163.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.77 143.33 50.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 168.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -115.74 164.5 14.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.694 1.197 . . . . 0.0 107.915 162.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -164.77 152.33 11.53 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 167.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.451 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 70.4 m-85 -69.5 142.09 53.79 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 165.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -121.74 122.01 38.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -86.18 141.79 29.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.46 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 65.4 p -101.43 7.35 42.59 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.271 1.028 . . . . 0.0 111.302 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.81 -151.97 21.3 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.17 91.98 0.08 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.069 1.348 . . . . 0.0 109.658 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -79.34 144.46 34.19 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.529 0.732 . . . . 0.0 110.897 -174.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.2 p -110.56 165.58 12.4 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.014 0.925 . . . . 0.0 110.019 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.9 174.48 12.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.166 1.911 . . . . 0.0 111.17 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.96 -85.55 0.14 Allowed Glycine 0 C--N 1.336 0.555 0 O-C-N 121.36 -0.838 . . . . 0.0 113.819 167.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -147.11 162.9 37.91 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.311 2.244 . . . . 0.0 105.771 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -151.74 68.42 0.89 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 119.443 1.02 . . . . 0.0 110.133 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -114.73 150.37 35.4 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.08 169.95 20.58 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 169.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -132.93 120.53 21.57 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 174.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -120.44 159.64 24.72 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.933 1.693 . . . . 0.0 108.95 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.0 p -124.54 141.33 52.17 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 162.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -104.36 155.94 18.34 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 168.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -119.5 131.03 55.49 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 171.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 156' ' ' VAL . 0.2 OUTLIER -66.21 137.98 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 171.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -128.8 90.15 3.0 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 171.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.536 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 84.6 m-85 -62.23 161.52 11.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 166.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.469 ' OE1' ' HE3' ' A' ' 68' ' ' LYS . 8.2 mt-30 -103.35 -142.99 0.36 Allowed 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 125.027 1.331 . . . . 0.0 108.044 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 66' ' ' ALA . . . . . . . . 0 N--CA 1.434 -1.468 1 C-N-CA 113.642 -4.123 . . . . 0.0 118.419 126.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.655 0 CA-C-O 121.083 0.468 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.3 m -137.92 92.8 2.7 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.566 1.546 . . . . 0.0 108.04 -173.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.51 126.15 28.4 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 167.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.38 140.58 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.624 1.17 . . . . 0.0 109.328 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -58.96 143.13 49.07 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -114.68 -87.77 1.51 Allowed Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -144.58 -144.35 4.16 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 126.711 2.101 . . . . 0.0 112.137 -167.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 96.5 m -138.18 149.42 45.83 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.333 2.253 . . . . 0.0 108.2 166.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.7 t -115.73 119.15 61.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 163.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -96.97 94.51 7.23 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -72.35 119.5 16.64 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -124.95 160.27 29.29 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 138.15 -169.91 24.03 Favored Glycine 0 C--N 1.321 -0.292 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -171.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -162.66 177.05 9.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -167.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 41.3 t -126.69 131.06 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 167.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.3 m -101.9 155.9 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 127.354 2.262 . . . . 0.0 108.227 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.13 37.79 0.16 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.421 1.088 . . . . 0.0 113.494 -172.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 C-N-CA 127.844 2.457 . . . . 0.0 110.371 -167.189 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.177 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.414 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -30.78 -52.8 0.18 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 126.58 1.952 . . . . 0.0 111.452 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 1.8 m -103.73 143.3 32.98 Favored 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 124.684 1.24 . . . . 0.0 108.774 166.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.97 172.26 1.83 Allowed 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 124.621 1.201 . . . . 0.0 109.918 164.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.8 137.55 55.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -71.37 158.2 36.74 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.779 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -59.03 -32.56 69.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.176 0.99 . . . . 0.0 111.869 172.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.65 3.36 60.22 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.435 -1.203 . . . . 0.0 113.901 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.8 t -128.39 -40.92 1.58 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.355 1.462 . . . . 0.0 109.087 -169.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 25' ' ' ALA . 9.0 p -56.57 -41.46 73.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 123.992 0.917 . . . . 0.0 111.06 171.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -131.4 69.02 1.48 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.074 0.94 . . . . 0.0 109.503 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -103.02 129.48 49.81 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.545 -171.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.621 HG23 ' HB2' ' A' ' 176' ' ' HIS . 0.3 OUTLIER -97.45 99.34 10.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 172.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.2 t -85.17 115.21 26.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -90.04 108.35 19.67 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.68 -16.52 62.25 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.566 0.747 . . . . 0.0 109.801 173.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.48 -175.53 52.98 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -71.27 156.81 39.09 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.497 0.719 . . . . 0.0 109.484 171.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.3 t -141.63 146.57 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.5 1.92 . . . . 0.0 107.026 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.11 137.54 37.54 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.8 p -59.87 -20.85 59.5 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.254 0.622 . . . . 0.0 111.337 173.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.48 -39.43 87.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.245 1.018 . . . . 0.0 111.883 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.4 m -67.66 -9.27 41.82 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mt -142.05 60.93 1.46 Allowed 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 125.882 1.673 . . . . 0.0 110.412 -162.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.64 -3.8 7.19 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -166.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -153.45 160.26 42.54 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.516 1.526 . . . . 0.0 107.19 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.408 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 36.3 tt0 -61.52 135.09 57.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.98 0.895 . . . . 0.0 109.131 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.91 -7.88 64.87 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-O 117.088 -1.951 . . . . 0.0 112.982 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.8 155.93 12.11 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 120.239 2.019 . . . . 0.0 110.51 165.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.3 p -146.74 150.51 35.49 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.688 0.756 . . . . 0.0 110.382 -171.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.5 t -59.54 164.57 3.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 163.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 m -46.35 -81.17 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.335 1.054 . . . . 0.0 112.772 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 173.32 143.49 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.53 1.932 . . . . 0.0 106.839 -172.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 t -141.29 130.46 24.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 170.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.55 126.53 8.93 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.549 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 8.3 p90 -131.55 78.01 1.8 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 123.707 1.718 . . . . 0.0 109.539 -177.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.443 ' HB2' HG22 ' A' ' 130' ' ' THR . 22.2 p30 -70.16 153.51 43.04 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.362 -173.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.9 mm -94.3 104.08 15.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.39 112.92 2.63 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.886 -1.154 . . . . 0.0 107.886 167.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.87 167.0 11.52 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 161.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -137.92 169.7 17.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.401 1.481 . . . . 0.0 107.485 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 43.47 54.02 5.46 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 128.287 2.635 . . . . 0.0 114.712 164.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 2.0 t -81.12 168.71 18.28 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -137.73 141.62 40.99 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.804 2.442 . . . . 0.0 106.446 172.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.1 p -95.72 -12.63 25.14 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.372 1.069 . . . . 0.0 113.138 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -60.71 -49.36 77.82 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.919 1.288 . . . . 0.0 109.475 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.414 HG11 ' HA ' ' A' ' 20' ' ' ALA . 3.0 p -59.64 -58.92 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 113.692 -1.595 . . . . 0.0 107.378 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.4 132.02 9.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.38 1.872 . . . . 0.0 107.38 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.49 -18.53 61.1 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.838 170.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -129.2 157.4 41.94 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 119.605 1.093 . . . . 0.0 110.856 -164.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.94 145.73 46.47 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 124.974 1.31 . . . . 0.0 107.74 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.5 164.95 23.7 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 124.509 1.124 . . . . 0.0 108.534 157.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.415 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -153.77 92.07 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 -169.385 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.04 165.77 24.38 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.966 0.907 . . . . 0.0 109.405 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -130.22 163.42 26.75 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.16 1.384 . . . . 0.0 109.136 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 tp -154.42 133.55 12.47 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.122 1.369 . . . . 0.0 109.217 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.31 177.07 42.56 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.7 m -73.77 130.7 40.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.105 0.962 . . . . 0.0 109.946 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.02 136.88 48.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 118.949 0.795 . . . . 0.0 111.3 176.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.5 tt -62.24 -42.04 93.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.758 0.823 . . . . 0.0 110.946 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -152.64 164.83 36.93 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.59 1.556 . . . . 0.0 106.924 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.15 82.6 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 126.22 1.808 . . . . 0.0 110.955 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.87 -4.83 78.12 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 119.541 -0.588 . . . . 0.0 112.476 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -143.02 41.84 1.53 Allowed 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.884 1.342 . . . . 0.0 110.53 -167.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 p -62.99 -13.38 34.34 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.209 2.204 . . . . 0.0 115.023 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -81.37 -13.48 58.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.761 0.315 . . . . 0.0 111.329 171.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.0 t -115.31 133.01 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 O-C-N 120.36 -1.462 . . . . 0.0 108.624 -166.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -76.08 148.11 38.16 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.649 1.18 . . . . 0.0 110.014 -174.739 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.77 14.89 12.3 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.301 1.84 . . . . 0.0 113.955 -164.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.4 mt 52.76 -155.35 0.19 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.125 0.97 . . . . 0.0 109.565 -163.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 C--O 1.234 0.283 0 C-N-CA 122.707 0.403 . . . . 0.0 110.856 -178.643 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.213 0.53 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.82 144.85 56.98 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.954 2.101 . . . . 0.0 110.044 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.401 ' H ' ' HG1' ' A' ' 144' ' ' THR . 3.8 p -90.96 165.93 13.3 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 56.55 20.85 5.19 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 127.286 2.234 . . . . 0.0 113.517 175.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -142.79 149.76 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 119.209 0.913 . . . . 0.0 108.844 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.94 174.99 24.81 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 124.864 1.221 . . . . 0.0 110.603 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.432 HG11 ' CD2' ' A' ' 177' ' ' PHE . 53.4 t -84.36 149.3 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -136.69 143.97 43.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.56 1.544 . . . . 0.0 106.935 175.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.35 137.29 57.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.9 mt -133.44 129.13 36.85 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.767 1.627 . . . . 0.0 107.061 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 12.0 p30 -55.45 -60.7 3.05 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -175.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -171.62 -45.31 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.294 2.238 . . . . 0.0 108.408 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.293 0.5 OUTLIER -82.05 18.65 1.3 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.427 1.891 . . . . 0.0 109.94 -177.341 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.8 10.94 48.02 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 120.252 -1.53 . . . . 0.0 112.105 -169.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.79 111.42 8.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.554 1.677 . . . . 0.0 107.484 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.78 138.86 58.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.11 0.564 . . . . 0.0 109.801 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 73.0 mt -108.33 110.25 21.78 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.418 0.687 . . . . 0.0 110.398 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -53.25 139.16 30.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.699 1.6 . . . . 0.0 110.6 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.6 mt -89.41 59.39 4.79 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 127.903 2.481 . . . . 0.0 108.015 -173.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.69 -31.98 10.53 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.314 0.578 . . . . 0.0 111.257 -174.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.74 -36.85 3.95 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-O 117.522 -1.71 . . . . 0.0 114.086 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.55 -16.56 13.63 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.91 1.355 . . . . 0.0 112.222 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.1 m -73.02 95.74 2.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -70.24 173.19 7.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.363 2.265 . . . . 0.0 110.786 -174.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.0 p -112.88 -170.36 1.66 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.302 1.441 . . . . 0.0 111.814 -172.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -44.43 142.59 1.53 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.579 1.552 . . . . 0.0 111.594 164.123 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -80.67 134.39 35.86 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.623 0.725 . . . . 0.0 109.156 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.9 m -113.93 113.26 24.59 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 167.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.7 m -61.44 143.5 55.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.9 mt -115.41 179.48 3.95 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.301 2.24 . . . . 0.0 109.105 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -134.03 167.87 19.84 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.347 1.459 . . . . 0.0 108.21 172.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -72.28 104.11 3.6 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.07 -149.9 18.26 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -173.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.95 138.36 31.48 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.269 1.028 . . . . 0.0 111.248 -165.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.78 169.0 24.57 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.449 1.9 . . . . 0.0 110.915 -174.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.6 m -151.99 150.39 29.94 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.534 1.134 . . . . 0.0 109.641 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.27 119.31 55.51 Favored Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 124.58 1.152 . . . . 0.0 108.784 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -81.54 83.69 2.09 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 124.011 3.141 . . . . 0.0 112.782 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.415 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 76.3 m-85 -74.52 160.9 30.31 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.269 -0.894 . . . . 0.0 112.572 173.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -116.95 147.65 42.08 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 155.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.549 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -122.82 161.63 23.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.833 1.653 . . . . 0.0 107.121 160.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -157.61 160.16 37.79 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.421 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 97.4 m-85 -76.76 148.83 36.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 163.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -124.19 127.23 47.43 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.254 1.422 . . . . 0.0 107.376 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.77 144.26 25.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.482 0.713 . . . . 0.0 109.639 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.408 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 24.8 p -104.35 8.33 35.87 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 123.617 0.767 . . . . 0.0 111.653 171.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 162.96 -150.35 19.17 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 107.944 -2.062 . . . . 0.0 107.944 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.8 89.74 0.27 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.582 1.153 . . . . 0.0 110.699 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.53 141.7 46.88 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.512 0.725 . . . . 0.0 109.672 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.401 ' HG1' ' H ' ' A' ' 97' ' ' THR . 69.6 p -92.72 160.6 33.95 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -75.96 157.84 38.61 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 121.126 1.218 . . . . 0.0 109.464 160.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.67 176.23 18.49 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.357 1.456 . . . . 0.0 109.685 -168.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.16 157.67 34.85 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.526 -0.984 . . . . 0.0 108.732 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.421 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -144.75 81.63 1.66 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.719 0.771 . . . . 0.0 110.174 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -124.77 152.1 44.27 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -173.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -156.11 175.34 14.1 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.702 1.201 . . . . 0.0 109.523 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -156.47 84.69 0.98 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.936 0.874 . . . . 0.0 110.642 -175.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.448 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -81.31 169.89 16.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.934 173.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.3 p -117.61 163.12 16.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.86 155.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.406 ' CD2' ' HA3' ' A' ' 172' ' ' GLY . 38.9 p90 -120.37 159.55 24.83 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.534 1.134 . . . . 0.0 109.91 173.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -129.1 125.27 36.83 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 167.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.31 143.32 15.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 163.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -137.26 82.24 1.92 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -67.51 154.03 42.35 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.744 -0.646 . . . . 0.0 109.687 176.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -158.32 176.12 12.87 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.498 1.119 . . . . 0.0 112.795 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.483 0 C-N-CA 125.095 1.331 . . . . 0.0 111.644 177.873 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.707 0 CA-C-O 122.051 0.929 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.1 m -145.1 90.69 2.06 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.119 0.967 . . . . 0.0 109.341 -168.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.3 m -92.95 96.58 10.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.1 0.952 . . . . 0.0 110.678 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.53 135.12 51.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 125.767 1.627 . . . . 0.0 110.292 -174.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -55.78 107.67 0.37 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.452 1.101 . . . . 0.0 108.907 168.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.406 ' HA3' ' CD2' ' A' ' 154' ' ' PHE . . . -74.95 -58.05 4.19 Favored Glycine 0 CA--C 1.523 0.578 0 O-C-N 120.587 -1.321 . . . . 0.0 110.931 -168.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 169.33 -161.47 35.0 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -171.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.6 m -122.43 133.93 54.61 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 127.588 2.355 . . . . 0.0 107.008 -176.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.49 109.65 28.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' HIS . . . . . 0.621 ' HB2' HG23 ' A' ' 31' ' ' THR . 20.2 m-70 -88.07 96.75 10.64 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.432 ' CD2' HG11 ' A' ' 101' ' ' VAL . 77.9 m-85 -76.63 133.03 39.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -137.73 162.1 34.8 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 121.537 -0.727 . . . . 0.0 111.325 175.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 146.92 -155.87 26.75 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -169.97 175.28 5.18 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -168.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 32.0 t -128.22 136.99 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 16.3 m -118.72 147.49 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 C-N-CA 126.495 1.918 . . . . 0.0 109.496 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.35 25.31 0.1 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -167.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 128.54 2.736 . . . . 0.0 111.326 -167.63 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.401 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . . . -70.12 -16.32 63.09 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.795 -177.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.7 m -129.68 157.08 43.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.695 1.198 . . . . 0.0 107.829 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.25 107.14 15.59 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 161.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.12 118.58 2.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 121.104 -0.997 . . . . 0.0 108.859 167.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -70.97 163.88 26.62 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.737 -0.602 . . . . 0.0 111.135 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -72.27 -12.9 61.35 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.99 -1.069 . . . . 0.0 113.209 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.63 -1.65 90.04 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 121.233 -0.917 . . . . 0.0 112.787 167.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.4 t -121.82 -31.1 4.01 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.758 1.279 . . . . 0.0 110.765 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 25' ' ' ALA . 4.1 p -63.75 -24.32 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 O-C-N 121.11 -0.994 . . . . 0.0 113.3 -175.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -157.01 53.67 0.51 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.664 0.786 . . . . 0.0 110.365 -162.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -99.49 143.37 29.81 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 120.543 -1.348 . . . . 0.0 110.404 -169.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 176' ' ' HIS . 4.9 m -113.79 95.32 5.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 t -73.15 136.45 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -114.26 118.78 34.91 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.501 1.143 . . . . 0.0 108.464 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 34' ' ' LEU . 1.3 mm? -85.94 -21.2 28.02 Favored 'General case' 0 N--CA 1.44 -0.974 1 C-N-CA 131.9 4.08 . . . . 0.0 108.422 177.582 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.45 -172.58 34.79 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 124.658 1.123 . . . . 0.0 111.144 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -67.57 112.77 4.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.806 0.842 . . . . 0.0 108.827 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.19 153.23 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 125.258 1.423 . . . . 0.0 107.691 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 5.8 mmt180 -86.32 136.34 33.18 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.3 p -60.66 -27.25 67.68 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 169.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.08 3.24 2.19 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.975 1.71 . . . . 0.0 113.789 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 m -121.45 7.0 10.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.866 1.267 . . . . 0.0 112.203 164.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.569 HD13 HG21 ' A' ' 99' ' ' VAL . 29.6 mt -142.26 71.79 1.36 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.397 1.879 . . . . 0.0 109.15 -171.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.55 4.46 3.37 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.813 -1.18 . . . . 0.0 113.901 -171.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.533 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 4.1 pm0 -153.69 158.57 41.23 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 19.1 tt0 -61.42 136.42 58.03 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 172.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.417 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 86.42 -5.79 83.67 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 118.371 -1.238 . . . . 0.0 112.965 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -63.12 156.48 24.92 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.376 1.588 . . . . 0.0 109.892 169.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.2 p -146.29 155.44 42.65 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.309 0.959 . . . . 0.0 111.834 -176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 137' ' ' TYR . 60.6 p -69.33 178.62 2.31 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.831 -0.543 . . . . 0.0 110.142 175.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.84 -21.27 4.02 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 81.62 129.57 0.05 OUTLIER 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 128.744 2.817 . . . . 0.0 112.572 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 m -133.56 129.2 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-O 122.932 1.349 . . . . 0.0 109.74 -158.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.19 149.96 39.91 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 171.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 2.2 p90 -154.09 154.57 33.86 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 162.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.545 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 4.6 m-20 -135.44 166.47 23.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.93 0.786 . . . . 0.0 109.854 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.2 mm -108.7 97.24 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 125.52 1.528 . . . . 0.0 107.281 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.65 132.56 51.48 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 170.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.6 mt -137.79 110.76 7.73 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.867 1.667 . . . . 0.0 107.72 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -86.01 150.63 24.34 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.978 1.311 . . . . 0.0 108.85 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 t70 36.96 70.73 0.16 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.231 2.613 . . . . 0.0 114.734 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.552 ' SG ' HD12 ' A' ' 124' ' ' LEU . 58.3 m -84.71 86.57 7.31 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 128.357 2.663 . . . . 0.0 112.267 -175.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.82 103.76 0.96 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.505 1.922 . . . . 0.0 111.147 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -60.24 -19.79 56.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.365 1.066 . . . . 0.0 112.415 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -61.3 -36.63 80.64 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.769 1.228 . . . . 0.0 111.932 175.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 20' ' ' ALA . 14.0 t -70.67 -49.59 50.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 177.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.41 ' HB1' ' H ' ' A' ' 159' ' ' GLN . . . -165.3 127.59 2.11 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -171.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -68.3 -12.27 60.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 117.454 -1.26 . . . . 0.0 111.695 169.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HA ' HD23 ' A' ' 124' ' ' LEU . 30.3 mtmt -136.33 157.61 46.39 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 120.844 1.657 . . . . 0.0 113.94 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.07 123.26 20.48 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.806 2.042 . . . . 0.0 108.329 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.75 -177.61 3.83 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 149.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.422 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -145.33 146.5 19.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 -165.228 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.23 168.18 13.3 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 120.273 1.397 . . . . 0.0 107.871 166.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -128.89 158.83 37.67 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.114 1.766 . . . . 0.0 108.969 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 22.1 tp -147.17 150.9 35.84 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.462 1.905 . . . . 0.0 107.949 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.467 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -167.29 -162.69 19.63 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 119.138 0.881 . . . . 0.0 112.531 -175.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.7 m -105.88 121.28 43.74 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.101 1.761 . . . . 0.0 106.782 163.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.06 140.14 50.62 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.4 tt -60.27 -35.69 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.257 0.623 . . . . 0.0 110.356 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -165.47 165.86 18.8 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.743 1.617 . . . . 0.0 108.684 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.24 -35.1 62.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 127.576 2.351 . . . . 0.0 113.419 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.37 -8.54 66.4 Favored Glycine 0 CA--C 1.531 1.058 0 O-C-N 120.955 -1.091 . . . . 0.0 112.801 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -147.11 47.7 1.14 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.115 1.366 . . . . 0.0 109.899 -160.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.3 p -67.69 -8.82 38.19 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.554 1.542 . . . . 0.0 112.625 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -98.32 3.3 48.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.865 1.266 . . . . 0.0 112.704 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 t -120.3 131.78 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.763 1.165 . . . . 0.0 108.954 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.68 HD13 ' HB1' ' A' ' 150' ' ' ALA . 8.3 mt -71.76 153.88 41.69 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.392 1.077 . . . . 0.0 111.749 175.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.04 15.0 14.24 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 128.198 2.599 . . . . 0.0 114.08 -171.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 53.9 mt 54.65 -150.54 0.4 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.462 1.105 . . . . 0.0 109.204 -158.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 . . . . . 0 C--O 1.236 0.351 0 C-N-CA 126.035 1.734 . . . . 0.0 107.282 177.303 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.445 -0.699 0 CA-C-O 121.923 0.868 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.56 145.33 5.01 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 160.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.5 p -115.94 142.54 46.65 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.935 1.294 . . . . 0.0 109.796 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 77.3 28.78 0.59 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.908 1.683 . . . . 0.0 113.18 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.569 HG21 HD13 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -143.79 167.15 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 125.009 1.323 . . . . 0.0 109.645 169.027 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -168.78 173.85 43.37 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -171.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.496 HG11 ' CG ' ' A' ' 177' ' ' PHE . 8.6 t -91.82 136.98 23.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 177.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.438 HE22 ' HB1' ' A' ' 110' ' ' ALA . 2.3 mm-40 -118.86 161.26 20.45 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.088 1.755 . . . . 0.0 108.17 169.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.483 HG22 HD12 ' A' ' 111' ' ' LEU . 8.7 mt -144.09 122.52 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 127.78 2.432 . . . . 0.0 105.296 -169.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 110' ' ' ALA . 5.4 mt -124.72 153.26 42.64 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -74.54 -102.99 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.316 1.047 . . . . 0.0 110.919 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -148.32 -26.39 0.33 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 128.566 2.746 . . . . 0.0 110.341 -170.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.258 13.3 t -78.7 -4.71 50.54 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 167.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.57 20.04 79.78 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 118.543 -1.143 . . . . 0.0 110.864 -177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.93 127.41 33.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 170.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.612 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -73.9 132.95 43.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 103' ' ' ILE . 79.7 mt -102.35 108.37 19.69 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.509 0.724 . . . . 0.0 109.176 -166.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.3 m -65.67 152.01 45.19 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.013 0.435 . . . . 0.0 110.957 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.5 mt -109.14 73.1 0.84 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.861 1.664 . . . . 0.0 109.726 -160.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -120.25 0.49 10.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.651 1.18 . . . . 0.0 113.094 171.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.28 13.77 83.25 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.009 -0.884 . . . . 0.0 112.862 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -149.43 -17.43 0.28 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.77 1.285 . . . . 0.0 114.178 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.7 m -70.96 97.64 1.47 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 120.453 1.479 . . . . 0.0 107.629 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -76.5 130.54 38.09 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.17 0.988 . . . . 0.0 109.696 -168.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.4 m -72.64 -171.54 0.84 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.981 2.513 . . . . 0.0 111.367 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.37 148.44 6.71 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.803 -0.56 . . . . 0.0 111.037 167.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -85.65 166.64 16.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 123.662 1.696 . . . . 0.0 110.154 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.7 m -130.06 138.6 50.82 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 153.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.4 m -86.85 135.48 33.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 164.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.552 HD12 ' SG ' ' A' ' 61' ' ' CYS . 2.5 mm? -95.08 172.35 8.18 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 126.102 1.761 . . . . 0.0 109.104 -168.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -132.33 158.87 40.78 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 158.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -64.45 100.14 0.34 Allowed 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 125.615 1.822 . . . . 0.0 106.265 170.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.26 -167.86 25.32 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 107.802 -2.119 . . . . 0.0 107.802 -160.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 98.2 m -106.65 136.65 46.09 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.402 -1.058 . . . . 0.0 108.85 -166.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -135.71 170.46 15.94 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.835 1.654 . . . . 0.0 108.895 -169.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.545 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 3.7 m -146.32 142.84 28.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.972 0.909 . . . . 0.0 108.999 172.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.65 116.44 65.39 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 161.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.5 159.61 28.86 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.54 2.16 . . . . 0.0 110.86 170.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.422 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 62.2 m-85 -141.31 172.62 12.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.326 1.85 . . . . 0.0 109.697 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -134.44 99.83 4.48 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.596 1.558 . . . . 0.0 107.0 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.505 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -102.64 146.23 28.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.076 -1.015 . . . . 0.0 108.728 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -152.77 160.27 43.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.422 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 7.7 m-30 -69.44 153.02 44.18 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 117.35 -1.74 . . . . 0.0 108.813 166.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.417 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 11.0 t80 -128.05 125.84 40.1 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.584 1.954 . . . . 0.0 108.324 173.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -85.32 145.62 27.42 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.778 0.831 . . . . 0.0 110.356 174.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.488 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 41.3 p -105.62 10.64 32.9 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.372 1.069 . . . . 0.0 112.235 175.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.08 -150.63 19.24 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.26 98.09 0.3 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.71 164.15 1.6 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.444 1.116 . . . . 0.0 109.348 171.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.6 p -120.26 162.14 35.35 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 164.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -74.24 168.38 24.93 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 N-CA-C 109.667 -0.936 . . . . 0.0 109.667 164.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.24 178.96 16.17 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.315 1.436 . . . . 0.0 111.364 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.88 150.61 44.53 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 121.467 -1.019 . . . . 0.0 109.582 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.404 ' HB1' ' CE2' ' A' ' 137' ' ' TYR . . . -145.97 93.64 2.36 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -125.48 150.23 47.54 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 172.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.68 ' HB1' HD13 ' A' ' 86' ' ' LEU . . . -151.31 164.49 36.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 120.484 1.493 . . . . 0.0 108.204 175.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.21 140.52 27.96 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -173.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.08 172.96 11.95 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 128.291 2.637 . . . . 0.0 110.633 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 37.5 p -127.84 159.56 34.48 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 159.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -124.41 154.69 40.03 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.368 1.067 . . . . 0.0 109.453 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -114.75 173.59 6.4 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.091 1.756 . . . . 0.0 109.087 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.467 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 3.0 t -127.95 128.97 69.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 127.443 2.297 . . . . 0.0 105.386 175.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -112.96 86.86 2.46 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 173.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.467 ' CZ ' HG11 ' A' ' 156' ' ' VAL . 90.3 m-85 -68.39 150.83 47.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.652 172.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.41 ' H ' ' HB1' ' A' ' 66' ' ' ALA . 7.0 pt20 -168.93 165.5 11.49 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.199 1.4 . . . . 0.0 109.35 -175.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.707 0 CA-C-O 117.751 -1.583 . . . . 0.0 114.795 -179.359 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 98.7 m -135.5 107.19 6.97 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 173.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.6 m -102.76 112.52 25.35 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.775 0.83 . . . . 0.0 108.947 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.16 156.43 40.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 126.144 1.778 . . . . 0.0 109.9 -172.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -66.97 132.48 48.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.17 -40.74 3.19 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 118.646 -1.086 . . . . 0.0 111.727 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 158.29 -176.02 35.34 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 118.882 1.341 . . . . 0.0 112.334 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.9 m -91.06 144.36 25.73 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.779 1.232 . . . . 0.0 108.25 172.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.0 t -123.95 136.76 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 168.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' HIS . . . . . 0.622 ' HB2' HG23 ' A' ' 31' ' ' THR . 23.8 m-70 -120.52 145.74 47.0 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.496 ' CG ' HG11 ' A' ' 101' ' ' VAL . 97.7 m-85 -131.03 126.53 36.14 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -130.87 159.05 38.53 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.08 0.855 . . . . 0.0 109.93 -172.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 159.98 -160.92 32.02 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -164.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -172.66 173.02 4.05 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 128.556 2.743 . . . . 0.0 104.411 174.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.84 144.0 31.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 165.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.7 m -127.25 150.56 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.936 2.094 . . . . 0.0 107.568 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -74.51 36.08 0.1 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.785 1.634 . . . . 0.0 112.634 -173.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.252 1.227 0 C-N-CA 129.131 2.972 . . . . 0.0 112.726 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 118.001 -1.0 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 41.35 -55.21 0.0 OUTLIER 'General case' 0 C--N 1.34 0.166 1 C-N-CA 135.425 5.49 . . . . 0.0 115.794 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 58' ' ' LEU . 1.6 m -87.81 -166.99 1.74 Allowed 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.952 1.301 . . . . 0.0 109.982 166.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.25 -6.79 11.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.131 1.372 . . . . 0.0 113.922 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.26 3.7 t 50.87 120.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 129.535 3.134 . . . . 0.0 113.06 -165.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.37 153.28 41.54 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.526 1.13 . . . . 0.0 109.343 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -65.28 -25.5 67.67 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.101 -1.0 . . . . 0.0 111.035 173.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.96 5.29 1.3 Allowed Glycine 0 CA--C 1.534 1.261 0 CA-C-O 117.001 -2.0 . . . . 0.0 113.789 167.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.5 t -149.85 7.36 0.63 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 120.279 2.04 . . . . 0.0 113.986 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 25' ' ' ALA . 8.4 p -92.14 -40.48 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 121.269 1.849 . . . . 0.0 112.81 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.7 47.95 1.64 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -170.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -85.87 145.44 27.18 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.824 -159.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 m -117.72 98.95 6.63 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.676 1.19 . . . . 0.0 108.794 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.17 104.57 5.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -77.93 109.67 12.18 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 170.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.762 HD23 HG11 ' A' ' 52' ' ' VAL . 3.7 mt -87.33 -6.75 58.38 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.714 2.006 . . . . 0.0 109.799 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.83 -171.68 37.92 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 121.925 0.736 . . . . 0.0 112.464 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -84.41 134.95 34.45 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.396 1.478 . . . . 0.0 109.448 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 t -125.94 142.0 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 124.231 1.012 . . . . 0.0 109.008 -173.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.37 120.6 21.84 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 125.682 1.593 . . . . 0.0 107.733 -177.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 p -48.52 -29.76 4.52 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.036 1.334 . . . . 0.0 111.471 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.34 -35.01 77.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.823 0.849 . . . . 0.0 111.691 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.1 m -72.26 -7.09 47.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.251 1.02 . . . . 0.0 113.123 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.551 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 21.3 mt -136.88 78.75 1.72 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 128.61 2.764 . . . . 0.0 108.585 -170.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.04 3.91 3.2 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.584 -1.322 . . . . 0.0 112.227 -175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.429 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 6.8 pm0 -149.66 155.77 40.78 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 124.758 1.223 . . . . 0.0 108.247 -175.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 31.7 tt0 -62.25 129.7 41.96 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 90.14 -4.46 82.92 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.011 -1.438 . . . . 0.0 113.233 -176.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -66.45 157.5 31.87 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 119.371 1.586 . . . . 0.0 110.933 172.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.2 p -148.42 161.09 42.28 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -173.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.3 p -73.08 -171.45 0.9 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.268 0.627 . . . . 0.0 110.706 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 m -54.11 -24.45 17.71 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 170.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.98 150.4 0.07 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.27 1.428 . . . . 0.0 112.399 -170.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.762 HG11 HD23 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.42 153.49 9.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 126.841 2.057 . . . . 0.0 105.716 -165.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.01 162.28 21.04 Favored Glycine 0 CA--C 1.526 0.721 0 O-C-N 121.02 -1.05 . . . . 0.0 110.549 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 1.2 p90 -160.63 63.02 0.31 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 124.562 2.125 . . . . 0.0 109.566 177.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.563 HD22 HG21 ' A' ' 130' ' ' THR . 9.5 p-10 -55.12 139.47 41.58 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 112.424 -2.171 . . . . 0.0 111.467 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 mm -84.28 105.45 13.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -76.85 104.61 7.44 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.538 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 57.5 mt -84.5 -175.09 5.63 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 167.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -173.36 144.35 1.16 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 126.237 1.815 . . . . 0.0 109.914 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.0 t0 48.67 63.62 2.03 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.957 2.103 . . . . 0.0 113.117 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.32 115.6 23.96 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 121.692 -0.63 . . . . 0.0 111.774 -177.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.564 ' HB3' HG23 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -75.11 108.33 7.77 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 161.417 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.5 p -62.09 -7.94 4.72 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.427 0.691 . . . . 0.0 112.838 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -79.14 -31.15 43.97 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.207 1.403 . . . . 0.0 112.234 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 62' ' ' ASP . 2.2 t -72.87 -35.0 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -170.39 138.53 1.57 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.88 2.472 . . . . 0.0 105.072 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -78.89 -6.83 57.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 116.774 -1.584 . . . . 0.0 110.774 163.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -141.56 161.51 37.74 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 122.605 2.457 . . . . 0.0 115.624 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.31 115.02 15.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.71 175.9 7.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 152.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.405 HG21 ' CZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -156.38 128.97 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 101.718 -3.438 . . . . 0.0 101.718 -160.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 154' ' ' PHE . . . -114.54 169.98 8.65 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.509 1.524 . . . . 0.0 107.623 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.52 ' CD1' HG21 ' A' ' 103' ' ' ILE . 21.4 m-85 -131.2 154.27 48.59 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.902 0.774 . . . . 0.0 110.496 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.624 ' O ' ' HB1' ' A' ' 152' ' ' ALA 0.347 0.1 OUTLIER -145.51 171.33 14.82 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 168.151 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.84 177.06 30.59 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.405 1.479 . . . . 0.0 110.056 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.2 m -67.0 141.33 57.62 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.288 1.044 . . . . 0.0 109.542 174.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.0 134.2 33.87 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 119.366 0.985 . . . . 0.0 110.874 174.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.3 tt -62.79 -33.93 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 122.898 0.479 . . . . 0.0 111.002 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -153.16 166.55 32.16 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.946 1.298 . . . . 0.0 108.724 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.66 -34.53 78.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.549 167.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.17 5.45 76.65 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.258 0.932 . . . . 0.0 112.874 174.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -148.45 48.44 1.03 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.124 1.962 . . . . 0.0 110.01 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.1 p -71.12 -7.81 49.17 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.68 -1.263 . . . . 0.0 113.809 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -84.91 -6.37 59.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.44 -0.788 . . . . 0.0 111.812 169.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 t -118.97 134.23 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.073 0 CA-C-N 119.665 1.12 . . . . 0.0 108.837 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.883 HD11 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -79.25 148.72 32.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.92 1.288 . . . . 0.0 110.234 -169.516 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.44 20.06 5.61 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.248 1.419 . . . . 0.0 113.958 -167.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.6 mt 55.16 -157.32 0.23 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.287 1.035 . . . . 0.0 109.969 -168.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 CA--C 1.515 -0.374 0 C-N-CA 125.057 1.343 . . . . 0.0 109.042 176.44 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 122.9 1.333 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.02 159.98 10.69 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.0 148.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.99 167.2 11.97 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.672 1.189 . . . . 0.0 108.702 168.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 62.26 3.63 1.07 Allowed 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 125.945 1.698 . . . . 0.0 113.105 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.452 HG21 HD13 ' A' ' 42' ' ' LEU . 1.6 p -125.91 150.48 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 121.373 1.897 . . . . 0.0 108.764 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.36 177.7 25.47 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 125.025 1.297 . . . . 0.0 110.736 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.534 HG11 ' CG ' ' A' ' 177' ' ' PHE . 90.8 t -92.14 122.34 43.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -91.17 158.55 16.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.819 1.19 . . . . 0.0 109.521 163.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.581 HG22 HD23 ' A' ' 111' ' ' LEU . 3.1 mp -127.84 136.84 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 165.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.443 ' CD2' ' HB2' ' A' ' 110' ' ' ALA . 5.1 mt -133.04 142.33 48.73 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.109 1.363 . . . . 0.0 108.025 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.3 p30 -68.64 -179.86 1.52 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.93 1.347 . . . . 0.0 111.175 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.8 ptt85 -58.46 -7.08 0.8 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.809 1.644 . . . . 0.0 114.589 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.356 10.9 t -116.03 8.26 14.51 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 120.433 1.469 . . . . 0.0 110.985 177.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.11 7.84 84.7 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 120.598 -1.314 . . . . 0.0 112.53 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.96 126.07 30.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.564 1.182 . . . . 0.0 108.328 172.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.443 ' HB2' ' CD2' ' A' ' 104' ' ' LEU . . . -89.11 130.44 35.55 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.164 0.985 . . . . 0.0 111.349 -172.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.581 HD23 HG22 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -100.62 151.47 21.57 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 123.92 0.763 . . . . 0.0 111.464 -164.1 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.2 m -75.64 154.63 36.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 123.553 0.533 . . . . 0.0 110.688 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.6 mt -97.68 64.03 1.76 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.171 1.388 . . . . 0.0 108.427 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.27 -11.12 9.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.267 0.627 . . . . 0.0 111.644 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.406 ' HA3' HD13 ' A' ' 74' ' ' LEU . . . 79.64 13.2 82.77 Favored Glycine 0 CA--C 1.524 0.594 0 O-C-N 120.577 -1.327 . . . . 0.0 113.858 170.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.68 -40.66 0.26 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.365 1.466 . . . . 0.0 110.034 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.2 m -53.91 96.27 0.01 OUTLIER 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.188 1.795 . . . . 0.0 109.461 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -86.03 138.06 32.24 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.231 0.612 . . . . 0.0 109.431 -164.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.55 -175.99 1.8 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.087 2.155 . . . . 0.0 109.171 174.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 t -52.85 143.2 17.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.37 0.605 . . . . 0.0 110.19 169.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -88.33 176.04 7.38 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 123.198 1.475 . . . . 0.0 108.966 167.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.3 m -144.82 163.29 34.52 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 128.205 2.602 . . . . 0.0 105.103 169.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.9 m -100.23 142.95 31.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 122.416 1.103 . . . . 0.0 110.24 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.91 167.68 9.9 Favored 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 129.571 3.149 . . . . 0.0 108.0 -168.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.26 156.2 39.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.796 -173.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -73.98 91.57 2.04 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 125.285 1.616 . . . . 0.0 107.107 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 147.22 -123.58 1.78 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 107.691 -2.164 . . . . 0.0 107.691 -164.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.4 m -143.5 139.24 29.73 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.619 1.167 . . . . 0.0 109.075 -172.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.74 162.32 39.44 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 127.594 2.358 . . . . 0.0 108.702 -170.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.563 HG21 HD22 ' A' ' 55' ' ' ASN . 4.1 m -144.73 137.97 26.89 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -170.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.91 122.54 61.82 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.63 145.07 68.67 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.952 1.768 . . . . 0.0 110.564 173.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.405 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 58.4 m-85 -142.32 157.3 44.96 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 124.777 1.231 . . . . 0.0 110.24 166.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -131.81 113.75 13.88 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.57 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -101.29 167.56 10.11 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.752 1.221 . . . . 0.0 109.227 171.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -168.05 153.83 7.16 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 127.225 2.21 . . . . 0.0 106.444 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.458 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 82.1 m-85 -66.76 144.11 56.52 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 160.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.429 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 16.5 t80 -123.35 133.12 54.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 126.074 1.75 . . . . 0.0 106.827 174.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -104.39 143.48 32.95 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.967 1.307 . . . . 0.0 109.89 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 46.9 p -103.08 4.66 37.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.683 1.593 . . . . 0.0 111.529 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.51 -141.45 6.87 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.08 93.61 0.3 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.479 1.112 . . . . 0.0 110.332 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -72.27 147.6 46.26 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.301 -0.874 . . . . 0.0 110.108 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 35.0 p -120.71 153.38 56.79 Favored Pre-proline 0 CA--C 1.537 0.442 0 C-N-CA 125.153 1.381 . . . . 0.0 109.028 -175.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -74.69 166.92 28.28 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.02 1.813 . . . . 0.0 112.663 173.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.77 -85.39 0.11 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.098 166.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -142.62 163.06 33.85 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.66 1.984 . . . . 0.0 106.623 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.458 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -151.46 77.33 1.24 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.075 0.852 . . . . 0.0 109.674 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -117.59 155.97 28.92 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.48 173.44 16.67 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.356 1.063 . . . . 0.0 109.004 171.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -150.31 146.46 26.77 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.775 1.23 . . . . 0.0 108.153 169.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.883 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -161.48 169.79 21.18 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 127.802 2.441 . . . . 0.0 108.771 -165.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.53 141.68 46.77 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 116.996 -1.882 . . . . 0.0 107.57 -172.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 72' ' ' ALA . 14.1 p90 -103.68 152.21 22.07 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -134.2 114.02 12.63 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.44 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 13.1 t -77.4 125.61 37.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -176.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -111.52 90.81 3.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.44 ' CZ ' HG11 ' A' ' 156' ' ' VAL . 70.5 m-85 -62.52 148.51 45.65 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.885 1.274 . . . . 0.0 110.344 173.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -165.93 169.66 14.54 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.697 1.199 . . . . 0.0 110.635 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.412 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -170.419 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 54.7 m -137.32 92.84 2.75 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.869 1.267 . . . . 0.0 109.313 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.1 m -72.05 133.7 45.42 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.68 165.81 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 127.747 2.419 . . . . 0.0 108.554 173.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -59.45 143.78 48.89 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 164.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -101.34 -64.44 0.77 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 169.16 168.76 31.64 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -174.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 89.9 m -90.22 118.89 30.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.772 1.286 . . . . 0.0 107.987 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.1 t -88.09 106.76 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 166.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -79.28 144.38 34.35 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 164.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.534 ' CG ' HG11 ' A' ' 101' ' ' VAL . 96.3 m-85 -126.45 121.1 31.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -127.68 156.01 43.03 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.816 0.734 . . . . 0.0 109.475 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.02 -158.66 27.48 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -163.69 167.34 21.21 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.603 -0.94 . . . . 0.0 108.999 -173.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 73.7 t -113.15 126.01 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 167.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.2 m -106.28 150.27 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 126.705 2.002 . . . . 0.0 108.436 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -74.9 39.56 0.14 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.246 1.418 . . . . 0.0 113.1 -176.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.304 0 C-N-CA 127.634 2.374 . . . . 0.0 111.934 -179.773 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.494 ' HB1' ' HE2' ' A' ' 158' ' ' TYR . . . . . . . . 0 N--CA 1.439 -1.0 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.49 -18.14 6.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.027 1.331 . . . . 0.0 112.753 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -134.35 147.49 50.54 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.132 2.173 . . . . 0.0 107.235 176.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.05 -14.12 44.19 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 118.257 2.688 . . . . 0.0 118.257 -155.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.3 t 49.46 104.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 127.645 2.378 . . . . 0.0 111.342 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.46 159.02 10.97 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.39 -0.819 . . . . 0.0 113.096 -169.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.91 -42.07 88.77 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.541 -0.725 . . . . 0.0 109.94 171.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.39 27.52 2.44 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.737 -1.035 . . . . 0.0 112.682 171.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -138.94 -33.07 0.66 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.286 1.543 . . . . 0.0 111.402 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.34 -35.66 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 119.791 1.178 . . . . 0.0 111.122 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -139.92 69.56 1.36 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -170.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -110.52 146.45 35.99 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.863 0.865 . . . . 0.0 111.414 -169.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -112.18 121.33 44.63 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.309 1.043 . . . . 0.0 109.904 173.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.6 t -87.39 113.41 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 169.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -88.22 96.18 10.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 172.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.782 HD23 HG11 ' A' ' 52' ' ' VAL . 9.4 mt -76.81 -8.16 56.8 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 126.009 1.724 . . . . 0.0 110.221 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.23 -171.26 32.75 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 121.829 0.683 . . . . 0.0 112.231 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -90.99 126.91 36.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.505 1.922 . . . . 0.0 110.491 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.406 HG21 ' HD2' ' A' ' 137' ' ' TYR . 21.0 t -117.64 137.73 50.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 123.4 0.68 . . . . 0.0 109.772 -172.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 4.6 mmt180 -66.56 124.18 22.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.874 2.07 . . . . 0.0 106.53 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.9 p -55.25 -30.02 59.24 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 123.787 0.679 . . . . 0.0 110.37 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.89 -36.06 76.16 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.368 1.467 . . . . 0.0 111.524 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.447 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 70.0 m -80.16 2.37 24.47 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 123.521 0.728 . . . . 0.0 112.797 176.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.4 mt -131.83 32.08 4.13 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.37 1.868 . . . . 0.0 110.922 -170.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.49 5.24 13.37 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -150.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.537 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 4.2 pm0 -154.69 155.96 35.55 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.405 1.882 . . . . 0.0 106.725 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 36.4 tt0 -64.23 116.84 6.39 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.33 -11.51 36.55 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 117.847 -1.529 . . . . 0.0 112.752 -177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.537 ' HB2' ' NE2' ' A' ' 44' ' ' GLN . . . -66.27 156.88 33.03 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.432 1.616 . . . . 0.0 110.253 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.6 p -144.88 157.34 44.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.41 0.624 . . . . 0.0 112.179 -174.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -73.58 -168.19 0.53 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 122.008 -0.433 . . . . 0.0 110.091 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -43.55 -99.57 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.719 2.007 . . . . 0.0 114.281 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.37 73.57 0.0 OUTLIER 'General case' 0 C--O 1.236 0.393 0 C-N-CA 131.002 3.721 . . . . 0.0 107.427 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.782 HG11 HD23 ' A' ' 34' ' ' LEU . 3.9 p -69.55 148.32 11.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 170.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.03 127.2 7.97 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 107.145 -2.382 . . . . 0.0 107.145 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 135' ' ' ALA . 5.1 p90 -135.41 89.91 2.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 123.215 1.483 . . . . 0.0 109.624 -170.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -84.11 165.86 18.13 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 120.892 -1.13 . . . . 0.0 112.69 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.0 mm -102.3 99.01 7.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -71.8 126.32 29.42 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.435 HD11 HD11 ' A' ' 131' ' ' ILE . 95.9 mt -109.25 171.84 7.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 174.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 11.5 p30 -153.81 175.05 13.77 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.253 0.933 . . . . 0.0 111.504 165.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.6 t70 32.12 48.75 0.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 129.821 3.248 . . . . 0.0 115.974 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 4.6 t -69.69 167.46 16.99 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -171.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.501 ' HB3' HG23 ' A' ' 65' ' ' VAL . 32.1 t0 -133.76 114.49 13.47 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.872 1.669 . . . . 0.0 112.253 168.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.9 p -56.16 -29.68 61.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.698 1.599 . . . . 0.0 113.575 172.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -62.32 -42.47 99.4 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 123.117 0.567 . . . . 0.0 110.323 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.501 HG23 ' HB3' ' A' ' 62' ' ' ASP . 15.2 t -65.24 -52.68 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 175.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.433 ' CB ' ' HB3' ' A' ' 158' ' ' TYR . . . -165.49 127.04 1.98 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.192 0.52 . . . . 0.0 111.674 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.4 m -77.37 -8.58 57.92 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.55 1.54 . . . . 0.0 112.163 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -130.03 152.65 49.25 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 121.377 1.899 . . . . 0.0 110.371 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.02 144.36 49.88 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 165.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.94 172.01 9.27 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 122.076 0.941 . . . . 0.0 109.617 156.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.261 0.5 OUTLIER -143.22 144.23 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 113.633 -1.621 . . . . 0.0 106.693 -174.585 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.41 162.39 30.28 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.313 2.645 . . . . 0.0 107.045 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -137.15 152.6 50.13 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.711 0.804 . . . . 0.0 110.328 -172.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 74' ' ' LEU . 19.1 tp -151.6 124.68 8.68 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 122.082 -0.386 . . . . 0.0 110.609 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.26 165.87 33.97 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -54.08 128.7 31.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.313 1.445 . . . . 0.0 109.944 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.71 134.97 41.85 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.823 1.192 . . . . 0.0 110.371 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.2 tt -60.38 -37.39 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 122.72 0.408 . . . . 0.0 110.81 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -157.27 168.62 26.86 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.182 1.793 . . . . 0.0 109.046 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.33 -39.95 67.54 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.759 1.624 . . . . 0.0 112.641 171.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.28 7.44 80.69 Favored Glycine 0 CA--C 1.526 0.752 0 O-C-N 121.433 -0.792 . . . . 0.0 112.884 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -142.76 42.4 1.58 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.456 1.102 . . . . 0.0 109.481 -175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.5 p -67.95 -11.68 59.26 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.958 1.303 . . . . 0.0 112.84 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -77.69 -2.08 34.29 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.631 -0.668 . . . . 0.0 112.19 168.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.41 137.09 48.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 O-C-N 120.44 -1.412 . . . . 0.0 110.894 -166.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.77 150.9 29.05 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.469 1.508 . . . . 0.0 111.405 -171.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.73 18.33 11.84 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.675 1.99 . . . . 0.0 114.192 -167.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 79.4 mt 53.71 -159.9 0.14 Allowed 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.587 1.155 . . . . 0.0 110.621 -169.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.237 0.432 0 C-N-CA 124.453 1.101 . . . . 0.0 109.309 176.092 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.644 0.259 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.78 148.74 48.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 168.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.34 164.93 12.09 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.88 0.872 . . . . 0.0 108.762 166.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 69.96 -7.88 0.88 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 128.725 2.81 . . . . 0.0 115.11 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.7 p -126.99 152.19 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 121.417 1.917 . . . . 0.0 107.949 -171.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -146.31 170.64 27.37 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 126.11 1.814 . . . . 0.0 111.82 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.437 HG11 ' CG ' ' A' ' 177' ' ' PHE . 94.2 t -83.56 120.44 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -100.65 154.19 18.8 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.714 1.597 . . . . 0.0 108.3 164.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.09 143.97 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 170.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 110' ' ' ALA . 15.4 mt -139.58 138.98 36.68 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.044 1.738 . . . . 0.0 108.042 -168.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.542 ' HB2' ' HB3' ' A' ' 120' ' ' SER . 29.0 p30 -66.22 173.62 3.06 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 122.219 1.009 . . . . 0.0 111.959 167.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -55.32 -13.18 1.26 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.194 1.398 . . . . 0.0 113.667 175.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 p -105.08 -9.09 18.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.929 1.292 . . . . 0.0 110.874 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.81 10.21 65.21 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.712 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.06 117.13 13.3 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 119.061 1.431 . . . . 0.0 107.938 169.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.456 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -74.68 131.15 40.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.661 0.784 . . . . 0.0 110.122 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.0 mt -103.34 117.27 34.1 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.589 1.156 . . . . 0.0 110.745 -158.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.0 m -67.39 143.23 56.42 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.77 0.795 . . . . 0.0 110.539 -170.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.9 mt -93.6 74.78 4.38 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.196 1.398 . . . . 0.0 107.307 -171.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.46 -18.31 11.01 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.327 1.051 . . . . 0.0 110.683 170.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.67 -28.27 4.96 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-O 118.16 -1.356 . . . . 0.0 112.751 176.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -82.62 -45.08 15.0 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.407 1.604 . . . . 0.0 110.505 166.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.2 m -51.25 97.33 0.01 OUTLIER 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.839 2.055 . . . . 0.0 111.586 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.66 169.38 4.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.81 2.044 . . . . 0.0 111.112 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 75.5 p -135.75 -161.59 1.17 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.611 0.765 . . . . 0.0 111.35 173.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 0.9 OUTLIER -42.82 122.53 2.4 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 129.73 3.212 . . . . 0.0 111.69 -175.016 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -89.01 106.23 18.3 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.942 0.877 . . . . 0.0 108.701 -173.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.7 m -70.34 117.88 12.44 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 162.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.2 m -64.0 141.77 58.65 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 155.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.98 -170.44 2.14 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.052 0.941 . . . . 0.0 109.785 176.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -148.87 167.56 25.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.818 2.047 . . . . 0.0 107.071 178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -64.41 128.36 35.43 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 120.29 -159.57 15.13 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 22.0 m -83.13 136.01 34.61 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.669 1.188 . . . . 0.0 111.648 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.48 177.98 9.76 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.369 1.468 . . . . 0.0 108.325 -176.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.6 m -155.01 144.48 21.27 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.33 -0.856 . . . . 0.0 109.734 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.435 HD11 HD11 ' A' ' 58' ' ' LEU . 2.4 mp -100.05 114.53 65.72 Favored Pre-proline 0 C--O 1.237 0.446 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 162.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.01 151.39 50.08 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.192 1.928 . . . . 0.0 110.475 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -141.17 167.03 23.16 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.716 2.006 . . . . 0.0 108.303 171.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.24 154.29 33.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 122.722 1.248 . . . . 0.0 110.071 161.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.507 ' HB2' ' CD1' ' A' ' 54' ' ' PHE . . . -132.83 147.3 52.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 127.517 2.327 . . . . 0.0 106.398 175.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -163.89 151.95 12.97 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 170.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.473 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 76.0 m-85 -66.18 135.84 55.08 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 170.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -111.28 127.8 55.74 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.978 1.711 . . . . 0.0 108.482 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.26 142.47 27.72 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.424 1.09 . . . . 0.0 111.242 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 17.6 p -110.82 9.21 22.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.273 1.429 . . . . 0.0 112.135 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.5 -152.47 22.2 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.38 95.92 0.22 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.116 1.366 . . . . 0.0 110.891 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -53.82 151.98 5.91 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.621 0.724 . . . . 0.0 110.497 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 73.1 p -105.5 154.02 39.39 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 162.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -71.48 174.73 10.46 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.115 1.21 . . . . 0.0 109.284 166.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.79 -93.67 0.14 Allowed Glycine 0 C--O 1.225 -0.441 0 O-C-N 121.855 -0.528 . . . . 0.0 112.838 171.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -146.65 161.95 39.47 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.38 1.872 . . . . 0.0 106.394 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.473 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -151.35 73.37 1.09 Allowed 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 121.776 -0.577 . . . . 0.0 110.52 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -117.64 151.65 36.78 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -157.9 179.25 9.37 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -156.35 145.94 20.87 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -146.38 169.41 18.92 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.81 2.044 . . . . 0.0 106.992 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.7 p -106.98 163.66 12.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 156.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -117.72 155.87 29.23 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 164.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 38.5 mttm -125.61 137.9 53.91 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 168.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.903 HG13 HG23 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -87.18 150.75 3.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 175.169 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -142.12 84.16 1.86 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.539 1.536 . . . . 0.0 108.918 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.752 ' CE2' HG21 ' A' ' 156' ' ' VAL . 59.0 m-85 -63.7 156.16 27.82 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.988 1.315 . . . . 0.0 112.805 169.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -174.82 174.83 2.5 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.721 2.009 . . . . 0.0 108.567 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.319 0 O-C-N 120.852 -1.155 . . . . 0.0 111.359 177.405 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.941 0 CA-C-O 121.282 0.563 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 52.9 m -96.81 89.3 4.85 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.65 1.98 . . . . 0.0 106.458 171.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.3 m -82.02 120.4 25.22 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 175.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.903 HG23 HG13 ' A' ' 156' ' ' VAL . 30.2 m -128.14 145.72 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 118.645 0.657 . . . . 0.0 111.209 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -77.88 105.44 9.07 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -79.75 -68.49 1.48 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 124.035 0.826 . . . . 0.0 111.936 -164.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -178.14 -172.62 42.76 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 117.503 0.651 . . . . 0.0 111.847 -173.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.4 HG21 ' CE1' ' A' ' 176' ' ' HIS . 8.3 m -89.22 145.38 25.44 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.782 1.633 . . . . 0.0 108.971 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.6 119.95 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 156.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' HIS . . . . . 0.4 ' CE1' HG21 ' A' ' 174' ' ' THR . 88.1 m-70 -88.94 134.48 33.95 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 172.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.437 ' CG ' HG11 ' A' ' 101' ' ' VAL . 90.3 m-85 -114.17 113.09 24.2 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -117.31 157.47 26.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 147.29 -165.42 28.64 Favored Glycine 0 C--O 1.239 0.411 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -176.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -161.56 171.73 17.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.9 t -122.15 132.84 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 173.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.2 m -117.91 149.69 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 127.608 2.363 . . . . 0.0 107.972 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -76.23 34.23 0.13 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -170.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 N--CA 1.438 -1.035 0 C-N-CA 131.231 3.812 . . . . 0.0 112.802 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.221 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.507 ' HB3' ' CD1' ' A' ' 158' ' ' TYR . . . -86.97 1.83 51.46 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 117.672 -1.156 . . . . 0.0 113.799 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.25 164.18 30.94 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.554 1.542 . . . . 0.0 107.68 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.67 -24.29 21.65 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.757 0.823 . . . . 0.0 113.002 -168.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t 58.58 131.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 128.07 2.548 . . . . 0.0 112.172 -173.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -78.44 156.13 29.55 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.033 -1.042 . . . . 0.0 111.895 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.48 -31.95 64.52 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.611 -0.681 . . . . 0.0 110.682 166.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.54 -2.12 73.7 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 117.559 -1.69 . . . . 0.0 114.293 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.4 p -125.21 -30.02 3.22 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 121.018 2.409 . . . . 0.0 111.809 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.94 -38.9 78.48 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 124.822 1.249 . . . . 0.0 113.789 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -132.6 46.69 2.6 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.085 0.954 . . . . 0.0 109.726 -168.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -93.13 132.19 37.5 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.283 -0.885 . . . . 0.0 110.478 -159.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.4 HG23 ' HB2' ' A' ' 176' ' ' HIS . 15.3 m -113.98 86.8 2.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.737 1.215 . . . . 0.0 108.652 -175.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.75 99.91 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 127.047 2.139 . . . . 0.0 108.02 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -84.48 102.97 13.23 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -170.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mt -76.79 -7.61 55.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.713 1.205 . . . . 0.0 111.004 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.82 -173.53 26.77 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.529 1.061 . . . . 0.0 112.327 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -68.97 153.88 43.03 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.954 0.902 . . . . 0.0 109.479 170.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.4 t -139.7 148.14 23.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 C-N-CA 125.067 1.347 . . . . 0.0 108.611 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -81.18 134.44 35.63 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 121.508 -0.745 . . . . 0.0 109.053 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.1 p -60.64 -24.06 65.24 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.556 0.742 . . . . 0.0 110.899 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.43 -46.41 66.37 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.35 0.66 . . . . 0.0 110.454 170.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 t -71.9 -2.38 17.76 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.962 177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 17.3 mt -142.93 64.86 1.35 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 120.546 1.521 . . . . 0.0 108.854 -170.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.94 0.22 5.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -167.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.442 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 3.1 pm0 -158.32 159.62 36.11 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.395 1.478 . . . . 0.0 108.404 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 39.1 tt0 -65.33 118.15 8.92 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 106.77 -12.97 42.14 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-O 118.422 -1.21 . . . . 0.0 112.112 -174.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -61.71 142.26 57.34 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.899 1.35 . . . . 0.0 109.44 173.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 p -136.66 159.44 41.81 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.094 0.861 . . . . 0.0 111.052 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.5 p -74.5 -175.07 2.25 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.778 0.799 . . . . 0.0 112.216 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.7 m -56.08 -24.04 37.62 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.803 2.041 . . . . 0.0 114.417 171.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.1 158.95 0.18 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 129.336 3.054 . . . . 0.0 112.582 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.3 t -145.56 140.48 22.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -171.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.67 141.26 15.45 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 170.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 2.8 p90 -136.88 149.55 47.72 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 171.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.448 ' HB2' HG22 ' A' ' 130' ' ' THR . 8.3 p30 -145.37 117.52 8.36 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.056 -1.027 . . . . 0.0 108.619 -167.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 mm -77.88 101.11 3.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -163.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -65.36 121.44 14.84 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 mp -125.8 107.17 10.26 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.598 1.959 . . . . 0.0 106.914 -172.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -101.87 157.42 16.86 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -171.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 48.6 t0 50.87 50.58 18.77 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 123.189 1.471 . . . . 0.0 111.847 167.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.7 m -73.29 151.29 41.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.967 1.707 . . . . 0.0 110.365 174.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -136.47 107.53 6.74 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.616 1.166 . . . . 0.0 110.683 -174.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.1 p -60.29 -18.48 49.64 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.434 1.494 . . . . 0.0 112.886 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -60.44 -38.24 83.49 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.35 1.46 . . . . 0.0 111.171 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.03 -55.89 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.35 144.38 18.4 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.689 1.195 . . . . 0.0 108.438 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.21 -15.04 42.16 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.978 -0.534 . . . . 0.0 111.839 169.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -135.44 160.94 36.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.28 0.945 . . . . 0.0 110.584 -167.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.61 153.88 38.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 159.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.528 ' HB1' ' H ' ' A' ' 119' ' ' SER . . . -132.18 173.44 11.24 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.916 1.686 . . . . 0.0 107.301 162.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.446 ' HB ' ' CZ ' ' A' ' 133' ' ' PHE . 61.0 t -135.87 123.55 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 118.804 0.729 . . . . 0.0 109.415 -171.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.55 0.46 26.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -160.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.409 ' CD1' HG21 ' A' ' 103' ' ' ILE . 48.5 m-85 37.29 -177.84 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.702 1 C-N-CA 131.963 4.105 . . . . 0.0 112.504 -166.298 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.526 HD22 ' HA3' ' A' ' 115' ' ' GLY . 7.8 tp -168.07 126.92 1.22 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 164.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.73 173.43 42.72 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -68.74 129.34 39.65 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.258 1.423 . . . . 0.0 109.516 -172.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -86.35 131.53 34.19 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.581 1.152 . . . . 0.0 113.156 -176.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.4 tt -65.54 -32.27 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.132 0.973 . . . . 0.0 112.018 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -152.87 165.27 35.97 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.694 0.797 . . . . 0.0 109.07 166.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.74 -43.5 47.88 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.707 2.003 . . . . 0.0 112.477 165.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.18 0.83 88.37 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.265 0.936 . . . . 0.0 112.524 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -142.03 40.62 1.65 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.207 1.504 . . . . 0.0 109.886 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.429 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 21.8 p -64.26 -15.84 60.89 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 124.825 1.25 . . . . 0.0 113.788 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -73.43 -12.02 60.66 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.433 174.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.9 t -133.15 143.82 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 123.088 1.423 . . . . 0.0 108.394 -164.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.936 HD23 HG22 ' A' ' 101' ' ' VAL . 1.5 mm? -80.55 136.47 36.28 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 112.682 -2.054 . . . . 0.0 110.717 -159.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.9 14.22 0.12 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 124.742 1.217 . . . . 0.0 113.242 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 86' ' ' LEU . 89.0 mt 48.11 -147.91 0.22 Allowed 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.535 1.934 . . . . 0.0 108.484 -171.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 . . . . . 0 N--CA 1.449 -0.487 0 C-N-CA 124.941 1.297 . . . . 0.0 108.518 177.35 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 122.281 1.038 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.05 144.15 57.15 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.575 -0.703 . . . . 0.0 109.218 164.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.0 p -91.91 168.69 11.24 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.691 1.196 . . . . 0.0 109.003 166.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 55.85 18.78 3.15 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.115 1.766 . . . . 0.0 113.865 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.4 p -146.34 142.92 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 121.132 -0.98 . . . . 0.0 108.508 175.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.32 165.28 27.49 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 175.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.936 HG22 HD23 ' A' ' 86' ' ' LEU . 0.9 OUTLIER -70.81 150.06 9.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.622 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -125.55 147.01 49.42 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 129.019 2.928 . . . . 0.0 105.917 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.492 HD11 ' CE2' ' A' ' 177' ' ' PHE . 1.9 mp -118.99 141.83 36.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.41 149.08 46.66 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.72 1.608 . . . . 0.0 107.015 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.07 -172.21 1.03 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.348 1.07 . . . . 0.0 112.342 174.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -47.51 -48.31 27.38 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 127.567 2.347 . . . . 0.0 110.115 170.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.5 p -81.3 -14.37 57.43 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.072 -168.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.91 22.7 44.67 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 126.386 1.946 . . . . 0.0 111.567 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.54 133.46 40.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 162.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.44 151.99 42.76 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.6 mt -117.14 151.64 36.41 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.039 1.336 . . . . 0.0 109.257 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.1 m -78.67 163.97 25.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 167.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.489 HD22 HD13 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -124.69 68.67 1.1 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 101.466 -3.531 . . . . 0.0 101.466 174.448 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.06 -7.34 19.24 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.983 0.897 . . . . 0.0 111.641 -175.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.526 ' HA3' HD22 ' A' ' 74' ' ' LEU . . . 66.87 31.36 77.96 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -158.91 -64.01 0.08 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.027 1.731 . . . . 0.0 106.879 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.7 m -49.65 99.95 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.205 2.202 . . . . 0.0 112.131 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -72.39 171.79 11.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.588 1.155 . . . . 0.0 111.003 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.528 ' H ' ' HB1' ' A' ' 70' ' ' ALA . 39.6 p -131.81 -146.95 0.3 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.993 1.717 . . . . 0.0 110.776 -169.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.9 t -58.37 124.64 20.23 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.446 1.021 . . . . 0.0 108.938 172.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -85.36 110.5 19.16 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 122.035 0.921 . . . . 0.0 108.559 170.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.7 m -79.35 121.83 25.61 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 161.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.1 m -66.36 111.06 3.33 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 160.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.0 mt -73.66 -179.4 3.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.604 1.962 . . . . 0.0 108.973 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.27 165.8 33.76 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.443 1.097 . . . . 0.0 109.538 173.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -59.39 138.14 57.75 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 171.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.15 -139.7 15.36 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -172.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.1 m -111.51 146.34 37.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 118.44 1.12 . . . . 0.0 111.37 -164.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -144.97 174.35 11.1 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 128.423 2.689 . . . . 0.0 108.606 -176.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 55' ' ' ASN . 91.4 m -157.01 148.19 21.99 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 170.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.5 mt -110.05 112.63 57.58 Favored Pre-proline 0 C--O 1.237 0.418 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.8 137.17 19.69 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.276 1.984 . . . . 0.0 110.184 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.446 ' CZ ' ' HB ' ' A' ' 71' ' ' VAL . 76.1 m-85 -127.4 172.59 10.52 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 127.007 2.123 . . . . 0.0 107.74 171.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -128.88 143.72 50.97 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 167.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.579 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -126.85 139.08 53.35 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.92 2.088 . . . . 0.0 108.063 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -160.26 159.91 32.0 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 175.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.426 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 74.4 m-85 -73.61 126.28 29.93 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 171.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.47 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 23.7 t80 -111.55 120.81 43.36 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.948 2.099 . . . . 0.0 106.877 172.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -83.28 137.8 33.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 175.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.496 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 64.1 p -97.18 6.92 47.64 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.15 0.98 . . . . 0.0 111.283 171.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.69 -155.81 27.24 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.05 91.79 0.5 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.204 1.002 . . . . 0.0 111.172 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -56.97 158.52 4.83 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.673 0.789 . . . . 0.0 111.469 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 42.3 p -115.82 158.35 42.36 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 170.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -80.95 164.56 20.04 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.916 1.744 . . . . 0.0 111.681 170.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.6 -84.87 0.11 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.953 0.787 . . . . 0.0 114.277 171.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -153.11 143.56 22.56 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 128.917 2.887 . . . . 0.0 106.365 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.426 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -137.95 84.16 2.02 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.989 0.813 . . . . 0.0 109.931 -177.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -126.84 154.38 44.43 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.45 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -156.27 -178.22 7.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.766 0.712 . . . . 0.0 110.975 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -151.34 110.18 3.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 122.63 1.205 . . . . 0.0 109.672 172.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.14 163.99 12.02 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 169.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.1 p -109.02 152.68 24.65 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 160.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -102.59 117.08 33.9 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 170.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.427 ' HE3' ' HA3' ' A' ' 115' ' ' GLY . 19.7 mttt -92.69 154.68 18.19 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 167.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.446 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 14.8 t -119.13 126.72 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -103.59 89.54 3.38 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.507 ' CD1' ' HB3' ' A' ' 20' ' ' ALA . 96.5 m-85 -69.79 139.59 53.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.327 169.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -155.0 170.62 21.33 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.686 0.795 . . . . 0.0 111.288 176.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.552 0 C-N-CA 125.966 1.746 . . . . 0.0 110.728 178.268 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.779 0 CA-C-O 123.667 1.699 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 95.5 m -76.2 99.06 4.6 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 113.024 -1.898 . . . . 0.0 107.879 170.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 93.6 m -66.08 138.37 57.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 158.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.05 137.27 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 124.927 1.291 . . . . 0.0 107.859 169.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -57.22 121.55 10.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 161.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -88.77 -86.88 1.23 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -146.78 -177.13 21.12 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.665 1.603 . . . . 0.0 110.449 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 27.4 m -93.88 144.58 25.31 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.152 1.381 . . . . 0.0 110.254 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.3 t -123.39 124.56 70.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 169.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' HIS . . . . . 0.4 ' HB2' HG23 ' A' ' 31' ' ' THR . 32.7 m-70 -110.97 99.48 8.36 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.002 1.321 . . . . 0.0 107.609 -174.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.492 ' CE2' HD11 ' A' ' 103' ' ' ILE . 53.9 m-85 -79.33 107.13 11.87 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 175.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -112.66 157.78 20.82 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.792 1.637 . . . . 0.0 106.815 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.04 -162.91 27.8 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -174.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -165.67 174.37 9.85 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -166.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 82.3 t -129.73 138.13 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 170.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 17.2 m -119.96 151.13 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 C-N-CA 128.663 2.785 . . . . 0.0 108.777 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.72 26.07 0.09 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -168.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 130.969 3.708 . . . . 0.0 111.279 177.631 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.128 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -49.65 -28.72 6.23 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.671 1.588 . . . . 0.0 114.012 -170.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.1 m -126.64 153.65 45.07 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 171.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.31 6.86 35.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.514 1.526 . . . . 0.0 114.851 -167.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.28 9.8 p 36.17 100.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 130.686 3.595 . . . . 0.0 113.245 -174.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -59.49 162.16 5.18 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.117 0.967 . . . . 0.0 111.922 -162.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.28 -28.69 43.53 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.234 1.413 . . . . 0.0 111.411 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.97 8.49 66.43 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.899 1.237 . . . . 0.0 114.444 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.0 m -142.6 -23.8 0.65 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.683 1.741 . . . . 0.0 113.634 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.0 p -55.01 -33.96 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 120.529 1.513 . . . . 0.0 111.091 165.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -137.89 105.06 5.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -131.22 132.84 44.94 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.345 1.058 . . . . 0.0 108.97 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.4 m -118.64 89.72 3.19 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.2 t -72.78 124.01 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -88.51 101.06 13.56 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.4 mt -69.8 -14.72 62.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 165.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.89 -172.21 46.74 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -92.28 142.37 27.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.8 t -128.98 143.65 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 125.499 1.52 . . . . 0.0 108.406 -172.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 0.8 OUTLIER -75.69 130.58 38.92 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -179.123 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.3 p -56.22 -24.17 40.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.01 0.924 . . . . 0.0 110.791 172.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.62 -23.99 67.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.34 1.056 . . . . 0.0 112.892 174.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.5 m -89.77 2.96 54.24 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.581 -1.324 . . . . 0.0 113.406 169.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.4 mt -142.17 68.93 1.32 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.959 1.303 . . . . 0.0 108.413 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.84 -5.19 7.5 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -168.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -155.09 164.51 38.76 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 125.158 1.383 . . . . 0.0 108.072 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -62.18 133.62 55.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.67 -10.97 73.41 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-O 118.62 -1.1 . . . . 0.0 111.96 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.45 148.18 42.68 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 119.176 1.488 . . . . 0.0 110.018 168.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.7 p -137.39 153.8 50.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 122.053 0.93 . . . . 0.0 110.251 -178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.2 t -55.35 160.34 2.33 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.59 160.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 m -44.81 -28.58 0.66 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.64 2.376 . . . . 0.0 114.587 169.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 85.03 149.17 0.07 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 129.281 3.033 . . . . 0.0 110.383 174.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.03 156.92 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 C-N-CA 128.634 2.774 . . . . 0.0 106.178 -163.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.3 151.41 17.25 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -158.11 142.2 15.8 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.725 ' HB3' HG22 ' A' ' 130' ' ' THR . 3.7 m-20 -126.62 147.75 49.87 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.511 1.05 . . . . 0.0 109.801 -174.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.4 mm -89.95 108.76 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.466 1.107 . . . . 0.0 108.038 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -69.21 115.03 8.02 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.732 0.813 . . . . 0.0 109.981 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.0 mt -116.86 101.96 8.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.145 1.378 . . . . 0.0 107.681 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -94.3 158.53 15.54 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.918 2.087 . . . . 0.0 110.324 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.4 t70 34.46 63.07 0.46 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 128.107 2.563 . . . . 0.0 114.052 -167.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 49.4 m -76.06 91.93 3.14 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.611 0.764 . . . . 0.0 111.461 177.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -64.35 124.33 21.48 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 167.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 p -81.88 -24.42 35.73 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.905 -1.122 . . . . 0.0 113.499 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -63.0 -40.32 97.4 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.361 0.982 . . . . 0.0 110.356 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.468 HG11 ' HA ' ' A' ' 20' ' ' ALA . 2.4 p -66.51 -45.28 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.094 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -164.07 127.75 2.62 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.107 1.363 . . . . 0.0 107.715 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -81.2 6.78 12.95 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 116.837 -1.554 . . . . 0.0 112.508 169.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.505 ' CA ' HD21 ' A' ' 124' ' ' LEU . 49.1 mtmt -147.36 157.71 43.69 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 121.504 1.956 . . . . 0.0 114.354 172.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.21 133.43 51.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.479 1.911 . . . . 0.0 108.224 168.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.34 173.1 6.47 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 154.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.96 166.27 29.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.28 167.67 21.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -134.97 149.11 50.16 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -173.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 tp -146.44 124.79 12.3 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.89 0.376 . . . . 0.0 110.157 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.54 177.89 39.98 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 2.1 m -63.74 129.6 40.79 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.658 1.983 . . . . 0.0 110.124 -171.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.83 130.52 39.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.885 0.766 . . . . 0.0 110.073 173.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.6 tt -60.24 -40.32 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.839 0.856 . . . . 0.0 110.619 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -151.94 171.44 17.79 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 174.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.33 -35.36 75.84 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.013 0.925 . . . . 0.0 112.639 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.19 -0.07 89.47 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 123.661 0.648 . . . . 0.0 112.162 173.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -129.04 39.99 3.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.097 1.759 . . . . 0.0 109.28 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.9 p -66.66 -8.83 30.29 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.017 1.327 . . . . 0.0 113.018 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -87.93 -0.5 57.07 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.334 1.454 . . . . 0.0 113.024 167.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 36.1 t -129.08 139.54 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 120.739 1.609 . . . . 0.0 108.984 -177.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.454 HD23 ' H ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -89.43 143.05 27.12 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.752 -167.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.454 ' H ' HD23 ' A' ' 86' ' ' LEU . . . -84.31 15.48 3.58 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.334 1.854 . . . . 0.0 114.764 -165.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.0 mt 52.83 -169.17 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.059 0.944 . . . . 0.0 110.016 -168.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 124.905 1.282 . . . . 0.0 108.276 177.728 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.4 m . . . . . 0 C--O 1.236 0.391 0 CA-C-O 121.05 0.452 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.44 164.82 4.08 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.086 1.354 . . . . 0.0 110.058 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.9 p -120.65 166.81 13.16 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.622 1.169 . . . . 0.0 109.508 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.4 m-20 55.22 25.59 7.49 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.072 1.349 . . . . 0.0 111.191 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.83 150.77 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 119.373 0.988 . . . . 0.0 109.122 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.35 174.83 34.14 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -81.71 144.19 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -126.35 155.42 42.08 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.558 1.143 . . . . 0.0 108.95 165.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 mp -131.82 141.6 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.951 2.1 . . . . 0.0 107.011 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.691 HD23 ' HA ' ' A' ' 110' ' ' ALA . 5.1 mt -140.69 146.49 37.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.896 1.278 . . . . 0.0 107.827 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.56 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 4.2 p-10 -70.36 176.23 4.13 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.683 1.23 . . . . 0.0 111.915 166.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -45.71 -30.17 1.5 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.731 2.812 . . . . 0.0 115.271 171.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 50.9 p -88.64 -31.57 18.48 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 120.724 1.602 . . . . 0.0 110.98 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.409 ' O ' HD22 ' A' ' 104' ' ' LEU . . . 115.47 10.39 11.69 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.413 1.482 . . . . 0.0 113.622 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.9 131.18 44.04 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.188 1.494 . . . . 0.0 109.286 174.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.691 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -70.38 116.28 10.53 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.211 1.404 . . . . 0.0 109.778 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.1 mt -83.32 109.85 17.62 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.709 0.803 . . . . 0.0 109.011 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.4 m -57.86 151.94 16.98 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.077 0.465 . . . . 0.0 109.808 171.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.3 mt -102.84 76.06 1.46 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.024 2.129 . . . . 0.0 108.099 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -113.0 -19.58 11.85 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.646 1.178 . . . . 0.0 111.589 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.04 -22.49 0.76 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 126.579 2.038 . . . . 0.0 113.222 -175.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.23 -68.51 0.7 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 117.303 -1.332 . . . . 0.0 108.363 162.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.0 m -37.18 98.38 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.213 2.205 . . . . 0.0 111.745 -167.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -74.87 159.42 31.91 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.963 1.705 . . . . 0.0 110.175 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.9 p -107.85 175.51 5.46 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.423 1.489 . . . . 0.0 112.349 -175.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 5.6 m -39.88 110.95 0.16 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.728 2.011 . . . . 0.0 112.748 167.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -63.38 164.59 8.88 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.663 1.221 . . . . 0.0 110.48 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 86.1 m -140.15 137.23 34.26 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 165.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 100.0 m -82.95 141.24 32.29 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.194 0.998 . . . . 0.0 108.654 173.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.678 ' H ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -113.37 173.35 6.44 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 127.821 2.448 . . . . 0.0 107.773 -175.562 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -138.05 166.5 23.94 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 127.008 2.123 . . . . 0.0 109.02 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -58.59 115.16 2.85 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 123.967 0.792 . . . . 0.0 109.297 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 129.9 -104.37 0.62 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 174.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 86.5 m -146.19 129.25 16.51 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.11 -1.818 . . . . 0.0 110.148 -169.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -135.07 169.03 18.06 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 126.818 2.047 . . . . 0.0 109.396 -171.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 55' ' ' ASN . 1.9 m -158.22 112.09 2.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -172.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.4 mt -76.74 121.35 84.66 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -75.32 146.91 32.08 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.636 1.557 . . . . 0.0 111.194 169.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -132.04 172.74 11.98 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.473 1.909 . . . . 0.0 107.629 168.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.36 151.75 45.68 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 162.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -130.54 162.73 28.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 165.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -157.2 166.13 34.06 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.411 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 85.2 m-85 -82.63 138.57 34.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 156.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -117.21 128.05 54.71 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.643 1.977 . . . . 0.0 106.156 174.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.42 146.87 24.99 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.671 0.788 . . . . 0.0 109.883 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.5 p -113.24 18.07 18.15 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.682 1.593 . . . . 0.0 111.164 172.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 163.03 -157.55 29.66 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.08 92.29 0.17 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.376 1.088 . . . . 0.0 109.833 174.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.41 128.78 35.89 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.214 1.005 . . . . 0.0 109.267 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.2 p -76.42 159.64 79.31 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 118.924 -1.11 . . . . 0.0 109.0 166.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -69.5 171.88 13.39 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 N-CA-C 110.061 -0.784 . . . . 0.0 110.061 158.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.02 178.99 17.4 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 125.769 1.652 . . . . 0.0 109.574 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.3 146.31 51.39 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.411 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -138.66 74.23 1.47 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -113.88 156.42 23.98 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.47 167.62 28.18 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.812 1.245 . . . . 0.0 108.027 173.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -137.84 136.62 37.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.78 169.37 17.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.436 1.494 . . . . 0.0 108.522 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.42 152.25 41.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 165.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -117.67 158.19 25.12 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -118.98 168.66 10.59 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 169.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.9 t -133.4 123.88 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -120.37 85.21 2.35 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.577 1.18 . . . . 0.0 108.856 -172.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.472 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 92.0 m-85 -72.59 157.42 37.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.894 -1.503 . . . . 0.0 112.847 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.426 ' HG3' ' HE3' ' A' ' 68' ' ' LYS . 3.4 pt20 -174.33 170.02 3.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.243 1.817 . . . . 0.0 110.01 -174.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.69 0 O-C-N 120.895 -1.128 . . . . 0.0 113.214 171.991 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 86.5 m -99.99 104.51 16.12 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.708 1.203 . . . . 0.0 109.206 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.2 m -94.57 93.17 7.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.427 1.891 . . . . 0.0 109.329 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.2 m -94.16 155.01 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 124.036 0.935 . . . . 0.0 110.166 173.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.98 144.88 52.18 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 161.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -103.71 -75.69 1.07 Allowed Glycine 0 C--N 1.332 0.352 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -177.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -175.62 -173.16 41.1 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -167.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.1 m -99.1 128.04 45.16 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.809 1.243 . . . . 0.0 109.53 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 19.9 t -104.98 105.34 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -82.49 143.27 31.23 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 168.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -122.76 126.39 47.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -134.75 152.23 51.6 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 118.185 0.448 . . . . 0.0 111.182 -171.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 139.94 -161.57 26.32 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.88 169.12 16.95 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -166.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 87.3 t -116.51 130.77 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.18 147.22 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 C-N-CA 125.895 1.678 . . . . 0.0 109.804 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.82 30.8 0.09 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -171.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.251 1.155 0 C-N-CA 131.436 3.895 . . . . 0.0 115.959 166.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.311 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.665 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -56.33 -43.6 79.18 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.5 m -108.92 175.19 5.55 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.536 1.535 . . . . 0.0 108.576 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.76 -16.06 15.04 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -167.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 t 54.88 114.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 128.343 2.657 . . . . 0.0 111.836 -173.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.17 154.38 16.21 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.2 1.4 . . . . 0.0 111.678 169.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -60.89 -27.3 68.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.732 1.213 . . . . 0.0 112.397 174.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.1 9.98 50.84 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.406 1.003 . . . . 0.0 112.997 172.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.2 t -129.46 -40.41 1.43 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.356 1.862 . . . . 0.0 108.546 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 25' ' ' ALA . 5.1 p -58.16 -34.13 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 123.696 0.798 . . . . 0.0 111.067 173.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -150.52 75.52 1.22 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.491 0.662 . . . . 0.0 109.565 -167.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.52 145.7 35.86 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.702 -0.624 . . . . 0.0 109.496 -173.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.9 m -112.58 95.3 5.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.94 111.8 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -84.54 103.46 13.69 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.4 HD23 HG21 ' A' ' 52' ' ' VAL . 13.2 mt -83.82 -4.99 59.1 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.045 1.338 . . . . 0.0 109.988 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.79 177.7 36.05 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 122.014 0.785 . . . . 0.0 112.522 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -75.83 139.6 41.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 167.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -125.77 143.42 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.129 0.971 . . . . 0.0 109.509 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.433 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 7.6 mmt180 -74.39 131.19 40.88 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 p -56.49 -23.3 38.46 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 123.304 0.642 . . . . 0.0 111.569 173.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.51 -48.67 71.62 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.488 1.115 . . . . 0.0 110.71 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.416 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 45.0 m -74.36 5.92 4.14 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.4 mt -142.92 59.39 1.42 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.354 1.862 . . . . 0.0 107.72 -168.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.57 6.41 3.5 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -165.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.418 ' OE1' ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -153.35 168.32 26.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.794 1.638 . . . . 0.0 107.161 170.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -63.09 136.56 57.86 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 167.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.42 3.37 86.03 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-O 118.936 -0.924 . . . . 0.0 112.123 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -65.53 145.32 56.24 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.766 1.283 . . . . 0.0 109.045 162.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -142.24 152.44 43.07 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.563 0.697 . . . . 0.0 110.377 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.4 p -69.82 -179.2 1.74 Allowed 'General case' 0 CA--C 1.555 1.141 0 O-C-N 121.518 -0.739 . . . . 0.0 109.097 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.43 -28.93 32.64 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -169.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 95.58 110.75 0.02 OUTLIER 'General case' 0 C--N 1.343 0.301 0 C-N-CA 130.703 3.601 . . . . 0.0 109.522 -168.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.4 HG21 HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -100.77 147.55 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.623 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.23 112.73 2.87 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.655 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 7.9 p90 -116.13 179.01 4.11 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.891 0.877 . . . . 0.0 109.142 177.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -158.66 172.44 18.27 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.193 -0.942 . . . . 0.0 110.659 176.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.3 mm -121.76 103.71 13.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -65.96 132.35 48.4 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 172.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 mp -129.24 119.9 24.81 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.245 2.218 . . . . 0.0 107.663 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -120.99 167.73 12.27 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.147 2.179 . . . . 0.0 111.178 -171.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.2 t70 25.31 57.0 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.28 2.632 . . . . 0.0 114.385 -165.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 91.2 m -73.74 121.73 21.26 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.551 2.34 . . . . 0.0 109.425 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -92.52 140.06 29.95 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 167.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.1 p -88.92 -13.79 38.24 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.907 1.685 . . . . 0.0 114.503 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -60.92 -51.33 69.74 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.112 0.958 . . . . 0.0 109.009 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.665 HG11 ' HA ' ' A' ' 20' ' ' ALA . 2.1 p -58.26 -48.72 84.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 124.809 1.244 . . . . 0.0 108.126 -175.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HB1' ' H ' ' A' ' 159' ' ' GLN . . . -167.8 127.17 1.31 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.41 1.884 . . . . 0.0 107.28 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.3 m -88.34 1.67 54.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.599 0.76 . . . . 0.0 110.821 169.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -127.68 160.79 30.57 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 121.107 1.776 . . . . 0.0 110.802 172.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.83 132.58 25.67 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.108 0.963 . . . . 0.0 109.385 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.35 170.38 9.41 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 122.384 1.088 . . . . 0.0 109.266 167.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.9 t -138.81 147.75 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 127.007 2.123 . . . . 0.0 105.453 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.53 159.33 36.65 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -123.61 157.31 34.03 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.613 1.565 . . . . 0.0 109.165 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.7 tp -152.59 142.14 21.77 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.715 0.806 . . . . 0.0 108.897 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.661 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -177.37 171.14 43.87 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -175.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 m -58.04 124.88 20.83 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.758 1.279 . . . . 0.0 110.261 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.56 136.6 44.02 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 119.533 1.061 . . . . 0.0 110.34 173.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.5 tt -61.0 -54.22 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 O-C-N 123.786 0.679 . . . . 0.0 110.686 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -134.12 161.7 34.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 176.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.8 -33.61 74.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.07 -0.394 . . . . 0.0 111.146 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.66 1.72 76.6 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 121.614 -0.679 . . . . 0.0 113.721 175.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -140.37 43.8 1.88 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.902 1.681 . . . . 0.0 109.86 -173.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 p -66.26 -3.89 6.71 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 128.233 2.613 . . . . 0.0 112.503 169.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -93.52 9.16 37.84 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.774 1.23 . . . . 0.0 112.183 167.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.7 t -138.37 143.6 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 120.892 -1.13 . . . . 0.0 110.939 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.683 HD13 ' HB1' ' A' ' 150' ' ' ALA . 6.4 mt -78.62 151.91 32.05 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 119.305 0.957 . . . . 0.0 112.071 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.58 18.73 5.98 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 127.444 2.297 . . . . 0.0 114.017 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.633 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 62.5 mt 51.74 -156.5 0.14 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.045 0.938 . . . . 0.0 110.806 -167.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 . . . . . 0 N--CA 1.447 -0.592 0 C-N-CA 125.417 1.487 . . . . 0.0 108.516 174.605 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 CA--C 1.536 0.43 0 CA-C-O 121.294 0.568 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.86 132.96 46.84 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 164.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.7 p -87.37 166.81 14.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 170.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 59.8 18.73 7.6 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.294 1.838 . . . . 0.0 112.507 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -141.46 156.35 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -165.58 170.16 40.31 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -169.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.21 138.66 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 119.283 1.542 . . . . 0.0 108.671 -175.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -105.32 156.46 18.14 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.317 0.962 . . . . 0.0 109.955 163.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -117.73 141.62 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 158.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 110' ' ' ALA . 50.7 mt -125.29 137.63 54.08 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.15 2.18 . . . . 0.0 105.385 175.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -63.29 166.67 6.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.72 1.248 . . . . 0.0 110.298 166.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.0 ptt85 -59.26 -26.01 64.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.085 1.354 . . . . 0.0 112.806 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.63 -12.93 60.9 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.967 0.803 . . . . 0.0 109.635 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.69 3.59 68.5 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 126.612 2.053 . . . . 0.0 112.738 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.05 159.61 31.52 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.398 1.599 . . . . 0.0 109.202 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.47 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -92.58 158.11 16.16 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.58 0.352 . . . . 0.0 110.207 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.6 mt -114.72 138.25 50.94 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 -172.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -75.22 157.19 34.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 170.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.7 mt -110.32 76.43 0.98 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.86 -14.97 10.07 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.289 0.635 . . . . 0.0 111.588 172.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.28 -2.82 81.66 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 117.055 -1.97 . . . . 0.0 113.946 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -139.66 -15.6 1.04 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.467 1.634 . . . . 0.0 112.851 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 49.6 m -59.54 111.7 1.51 Allowed 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 164.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.4 168.18 9.35 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.96 0.904 . . . . 0.0 110.082 173.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.6 p -120.01 -38.18 2.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -175.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.68 121.28 0.09 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.428 1.891 . . . . 0.0 109.41 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -67.62 140.29 56.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.7 m -130.96 117.39 19.15 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 55.0 m -56.92 137.73 54.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 171.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 45.4 mt -90.96 -163.59 1.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.195 0.998 . . . . 0.0 109.174 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -154.63 166.58 32.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.878 2.071 . . . . 0.0 108.149 167.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -66.45 91.01 0.16 Allowed 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.274 1.83 . . . . 0.0 109.621 170.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.12 -107.93 0.64 Allowed Glycine 0 C--O 1.224 -0.517 0 CA-C-O 119.04 -0.867 . . . . 0.0 112.424 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.64 136.75 54.74 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 119.219 1.509 . . . . 0.0 110.614 -172.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -137.58 168.98 18.57 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 127.159 2.184 . . . . 0.0 108.529 -176.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 97.6 m -149.41 145.12 26.79 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 168.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.41 107.77 59.68 Favored Pre-proline 0 N--CA 1.447 -0.582 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 169.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.35 156.23 65.02 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 N-CA-C 109.117 -1.147 . . . . 0.0 109.117 171.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -139.72 166.29 25.0 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.827 1.651 . . . . 0.0 107.184 170.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -117.48 137.64 52.4 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 167.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.655 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -128.87 149.86 50.58 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.59 -175.4 5.37 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.944 -0.472 . . . . 0.0 110.443 170.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.468 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 72.4 m-85 -89.65 140.81 29.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 161.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -102.85 147.28 27.09 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.134 1.774 . . . . 0.0 106.321 164.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -112.11 144.55 41.31 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 166.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 75.0 p -102.51 12.4 36.51 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.192 0.997 . . . . 0.0 110.974 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 162.99 -145.49 10.65 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 176.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.04 87.11 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.897 1.679 . . . . 0.0 111.591 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.27 130.13 45.45 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.321 -0.862 . . . . 0.0 109.334 173.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 49.1 p -83.39 161.42 56.92 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 168.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -70.28 174.2 10.31 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.653 1.569 . . . . 0.0 110.079 163.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.26 -93.51 0.14 Allowed Glycine 0 C--N 1.333 0.365 0 O-C-N 120.965 -1.084 . . . . 0.0 111.536 172.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -149.53 163.3 38.21 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 175.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -146.02 86.05 1.7 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -125.63 153.43 43.78 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.683 ' HB1' HD13 ' A' ' 86' ' ' LEU . . . -162.93 165.73 24.73 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.682 1.193 . . . . 0.0 107.986 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -137.67 134.93 36.01 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -126.56 165.47 19.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.918 1.687 . . . . 0.0 109.484 174.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 41.4 p -119.67 124.86 47.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -93.8 149.66 21.05 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HG2' ' HA ' ' A' ' 171' ' ' ASN . 3.2 mtmp? -121.35 163.45 18.64 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.256 1.422 . . . . 0.0 107.757 171.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.52 109.13 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.248 -2.131 . . . . 0.0 105.248 -164.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -111.01 80.32 1.29 Allowed 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.316 1.446 . . . . 0.0 108.935 -167.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -71.6 161.72 30.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.802 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.421 ' H ' ' HB1' ' A' ' 66' ' ' ALA . 10.1 pt20 -175.26 171.53 2.91 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.352 1.061 . . . . 0.0 111.251 -174.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.376 0 C-N-CA 124.496 1.046 . . . . 0.0 111.591 176.64 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.776 0 CA-C-O 120.735 0.302 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 98.2 m -151.84 97.16 2.32 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.399 1.479 . . . . 0.0 107.866 -170.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.6 m -89.08 117.08 27.82 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.023 1.729 . . . . 0.0 109.768 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.93 159.27 26.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.755 1.622 . . . . 0.0 110.744 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.409 ' HA ' ' HG2' ' A' ' 155' ' ' LYS . 25.9 m120 -76.32 111.96 12.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.71 -67.59 1.82 Allowed Glycine 0 C--N 1.334 0.423 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.99 -160.98 34.73 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -171.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 37.5 m -107.05 128.35 54.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.448 1.099 . . . . 0.0 108.504 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 19.6 t -104.5 105.75 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 166.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -78.85 143.49 35.92 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 170.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -122.32 122.88 40.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -128.61 168.78 15.25 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.687 1.195 . . . . 0.0 109.699 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 138.88 -161.78 25.88 Favored Glycine 0 N--CA 1.443 -0.9 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -162.07 170.36 19.34 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.08 129.89 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 168.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.4 m -115.38 147.98 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 C-N-CA 127.166 2.186 . . . . 0.0 107.844 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -75.78 41.9 0.22 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.358 1.463 . . . . 0.0 113.356 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.253 1.276 0 C-N-CA 129.627 3.171 . . . . 0.0 113.605 175.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.56 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . 48.7 -69.02 0.0 OUTLIER 'General case' 0 C--N 1.34 0.182 1 C-N-CA 133.453 4.701 . . . . 0.0 112.099 -171.679 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 29.1 m -83.19 -176.23 6.22 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.972 2.109 . . . . 0.0 111.229 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.31 16.14 10.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.925 2.09 . . . . 0.0 113.27 -171.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t 24.62 102.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 130.164 3.385 . . . . 0.0 113.137 172.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -55.32 157.59 3.59 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.63 1.172 . . . . 0.0 112.221 -171.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.22 -23.08 62.0 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.927 -1.108 . . . . 0.0 111.553 169.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.15 -18.49 73.07 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 117.872 -1.516 . . . . 0.0 113.671 172.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.2 p -118.43 -17.76 9.33 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.254 2.027 . . . . 0.0 111.919 -176.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.01 -27.77 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 O-C-N 120.876 -1.14 . . . . 0.0 112.771 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -167.3 82.3 0.21 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 -167.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.58 129.72 56.27 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -173.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -77.57 142.24 39.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 156.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.5 t -117.66 99.94 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 162.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -82.43 101.24 10.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.18 -17.3 59.6 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.767 0.827 . . . . 0.0 109.747 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.55 -165.21 18.78 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 121.716 0.62 . . . . 0.0 113.041 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -66.92 153.81 42.61 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.306 1.443 . . . . 0.0 111.53 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.5 t -137.13 147.95 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 125.414 1.485 . . . . 0.0 108.628 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.41 127.98 32.97 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 p -59.15 -25.1 63.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.227 0.537 . . . . 0.0 111.806 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.31 -27.87 66.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.497 -0.752 . . . . 0.0 111.204 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.5 t -84.52 0.89 48.15 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.245 1.418 . . . . 0.0 112.802 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.434 HD13 HG21 ' A' ' 99' ' ' VAL . 11.1 mt -143.84 82.69 1.73 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.62 1.568 . . . . 0.0 107.826 -170.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.04 0.05 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.408 -1.433 . . . . 0.0 113.485 -174.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.494 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 4.0 pm0 -148.22 157.25 43.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.472 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 33.0 tt0 -63.37 121.83 14.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.51 -4.57 61.97 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.282 1.42 . . . . 0.0 113.523 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB2' ' NE2' ' A' ' 44' ' ' GLN . . . -61.22 154.24 24.01 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 119.24 1.52 . . . . 0.0 109.499 168.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.5 p -144.06 156.23 44.29 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.251 0.478 . . . . 0.0 110.678 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.7 p -72.55 -174.67 1.43 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.6 m -50.54 -40.18 51.11 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 117.101 -1.428 . . . . 0.0 113.806 171.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 95.18 170.92 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 C-N-CA 131.694 3.998 . . . . 0.0 109.815 -166.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.6 t -145.0 139.1 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 167.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.27 69.48 0.22 Allowed Glycine 0 CA--C 1.51 -0.246 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.52 ' HE1' ' HB2' ' A' ' 135' ' ' ALA . 29.4 p90 -69.0 161.0 29.9 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -133.67 175.84 9.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.739 1.616 . . . . 0.0 109.518 169.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.3 mm -109.81 112.29 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -68.55 112.42 5.34 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.301 0.64 . . . . 0.0 109.861 172.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.92 135.91 49.33 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 125.006 1.323 . . . . 0.0 108.272 168.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -136.95 167.65 21.08 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.378 1.471 . . . . 0.0 110.362 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 46.07 30.74 0.99 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.965 2.106 . . . . 0.0 113.353 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 96.3 m -62.83 162.48 10.97 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 127.031 2.132 . . . . 0.0 111.388 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -151.42 120.24 6.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.797 1.639 . . . . 0.0 106.898 -167.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.9 p -79.4 -18.45 52.26 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 120.898 -1.126 . . . . 0.0 112.22 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -60.35 -46.97 88.06 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.472 0.709 . . . . 0.0 109.725 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 20' ' ' ALA . 6.2 p -73.12 -45.78 52.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.212 1.005 . . . . 0.0 109.637 -175.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -161.82 124.17 2.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.145 1.378 . . . . 0.0 108.099 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 m -66.85 -11.75 56.73 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.893 170.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -149.46 163.1 38.72 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 120.846 1.657 . . . . 0.0 114.116 -169.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.89 126.51 39.89 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.713 2.005 . . . . 0.0 106.836 166.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.55 172.96 8.15 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 142.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.453 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.4 OUTLIER -139.88 151.09 21.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 103.182 -2.896 . . . . 0.0 103.182 -171.247 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.76 149.45 46.44 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.427 ' CD1' HG21 ' A' ' 103' ' ' ILE . 17.6 m-85 -114.24 157.88 22.13 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.856 0.862 . . . . 0.0 110.757 177.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.408 HD22 ' HA3' ' A' ' 115' ' ' GLY . 13.9 tp -150.47 140.93 22.44 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.952 1.301 . . . . 0.0 108.934 -176.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.16 -169.0 34.39 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 123.929 0.776 . . . . 0.0 112.381 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 m -81.5 130.87 35.21 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.205 1.802 . . . . 0.0 109.605 166.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -76.97 140.07 40.32 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 119.553 1.07 . . . . 0.0 111.028 172.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.3 tt -64.04 -44.62 97.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 122.689 0.396 . . . . 0.0 111.503 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.43 164.46 34.91 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.836 1.254 . . . . 0.0 108.636 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.85 -27.22 66.47 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.888 1.275 . . . . 0.0 113.114 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.77 -2.94 88.45 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.798 0.713 . . . . 0.0 112.582 175.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -143.34 47.3 1.5 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.772 1.629 . . . . 0.0 109.133 -169.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.474 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 25.5 p -61.89 -15.61 44.03 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.15 0.98 . . . . 0.0 112.943 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -94.48 -12.76 27.05 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 124.709 1.203 . . . . 0.0 109.762 -173.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.09 130.81 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.857 1.263 . . . . 0.0 107.653 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mt -72.2 150.01 44.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.85 1.26 . . . . 0.0 110.291 -174.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.74 14.05 16.44 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.983 1.713 . . . . 0.0 114.351 -164.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 51.1 mt 48.74 -152.48 0.12 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.216 1.007 . . . . 0.0 110.199 -162.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--O 1.241 0.623 0 C-N-CA 125.507 1.523 . . . . 0.0 110.374 -178.005 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 CA--C 1.538 0.511 0 CA-C-O 122.513 1.149 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.78 128.9 39.5 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.036 1.334 . . . . 0.0 109.177 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.5 p -87.5 170.27 11.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.893 0.77 . . . . 0.0 110.03 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 49.6 32.78 5.23 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.938 1.695 . . . . 0.0 111.943 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.434 HG21 HD13 ' A' ' 42' ' ' LEU . 3.1 p -154.68 151.02 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.4 172.77 34.83 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.434 HG11 ' CD2' ' A' ' 177' ' ' PHE . 79.2 t -84.61 133.74 28.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -104.48 153.54 21.01 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 157.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.427 HG21 ' CD1' ' A' ' 73' ' ' PHE . 4.0 mp -116.72 128.91 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 103.747 -2.686 . . . . 0.0 103.747 164.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 mt -125.96 143.11 51.22 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.566 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 5.7 p-10 -66.66 -178.33 0.7 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.475 1.11 . . . . 0.0 112.659 173.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.429 ' HG3' HG23 ' A' ' 107' ' ' THR . 9.4 ptm180 -44.37 -31.67 1.12 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 128.605 2.762 . . . . 0.0 114.856 169.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.429 HG23 ' HG3' ' A' ' 106' ' ' ARG . 28.6 p -95.09 -4.65 45.92 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.884 1.274 . . . . 0.0 112.125 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.48 22.23 78.76 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 121.162 -0.961 . . . . 0.0 112.933 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -82.69 144.31 30.33 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.923 1.861 . . . . 0.0 109.081 168.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.87 129.05 37.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.756 0.822 . . . . 0.0 111.106 -176.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.426 HD12 HG22 ' A' ' 103' ' ' ILE . 51.9 mt -89.45 168.68 12.0 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.001 0.52 . . . . 0.0 110.396 176.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 m -122.32 140.63 52.43 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.995 1.318 . . . . 0.0 107.764 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.7 mt -93.69 52.03 1.64 Allowed 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.513 1.125 . . . . 0.0 109.895 -160.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.33 -29.34 19.22 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.238 1.015 . . . . 0.0 111.495 -174.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.408 ' HA3' HD22 ' A' ' 74' ' ' LEU . . . 83.99 -30.43 3.59 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 124.564 1.078 . . . . 0.0 113.697 -172.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.05 -58.04 3.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 116.989 -1.481 . . . . 0.0 109.383 166.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.2 m -40.66 103.97 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.315 1.446 . . . . 0.0 111.956 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -63.32 160.77 15.24 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.068 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.3 p -118.43 173.08 7.03 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.857 1.263 . . . . 0.0 109.383 168.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 17.2 m -25.2 116.46 0.05 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.051 2.14 . . . . 0.0 113.402 166.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -72.33 167.4 20.54 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 122.318 1.056 . . . . 0.0 109.174 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.1 m -132.57 157.11 45.55 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 160.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.4 m -107.04 133.81 51.11 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 123.517 1.627 . . . . 0.0 107.961 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.99 175.77 6.51 Favored 'General case' 0 N--CA 1.428 -1.561 0 C-N-CA 129.179 2.991 . . . . 0.0 108.904 -164.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.479 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 7.3 p30 -145.68 165.48 28.63 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.411 1.484 . . . . 0.0 107.971 172.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -61.09 122.59 15.37 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 169.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.21 -119.27 6.11 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.263 0.935 . . . . 0.0 111.208 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 m -117.58 125.87 51.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 119.232 1.516 . . . . 0.0 110.436 -167.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.479 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -133.22 176.02 8.88 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 125.051 1.34 . . . . 0.0 109.948 175.734 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.0 m -145.28 137.32 25.64 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.261 -0.899 . . . . 0.0 110.586 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.8 mt -102.63 108.88 59.46 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 169.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -86.59 159.5 9.31 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.607 2.205 . . . . 0.0 110.648 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.453 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 40.9 m-85 -146.43 177.17 9.24 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.1 1.76 . . . . 0.0 109.438 -172.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.09 115.34 8.88 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.393 0.997 . . . . 0.0 111.09 153.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.52 ' HB2' ' HE1' ' A' ' 54' ' ' PHE . . . -84.24 164.88 18.8 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 121.45 -0.781 . . . . 0.0 109.535 167.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -157.24 160.63 38.84 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.011 1.325 . . . . 0.0 107.506 171.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -79.77 132.11 36.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 160.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -116.33 123.02 46.59 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.503 1.921 . . . . 0.0 106.054 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -82.06 143.44 31.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.165 0.586 . . . . 0.0 109.82 176.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.472 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 12.3 p -106.19 11.17 31.54 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.765 0.826 . . . . 0.0 112.173 170.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 160.84 -149.25 18.21 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.06 86.78 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.956 1.303 . . . . 0.0 110.01 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.67 155.96 39.71 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.282 0.633 . . . . 0.0 109.871 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.4 p -118.83 161.52 35.71 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.757 0.708 . . . . 0.0 109.896 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -75.39 176.89 9.36 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.681 1.587 . . . . 0.0 110.629 171.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.43 -97.95 0.17 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 164.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.94 163.19 31.29 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 129.947 3.299 . . . . 0.0 105.456 168.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -150.19 77.22 1.3 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.673 0.67 . . . . 0.0 109.816 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -119.81 150.35 40.57 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -174.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -152.73 164.08 38.45 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.454 1.102 . . . . 0.0 108.193 171.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -134.68 98.28 4.01 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.97 177.81 8.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.39 0.614 . . . . 0.0 110.376 168.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.5 p -122.16 162.44 21.32 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 150.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.428 ' CE1' ' HA3' ' A' ' 172' ' ' GLY . 44.4 p90 -115.98 150.86 36.51 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.912 0.863 . . . . 0.0 109.763 158.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -107.37 167.04 10.2 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.042 1.737 . . . . 0.0 106.659 161.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.88 146.71 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 171.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -128.1 85.12 2.31 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -66.54 147.98 52.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.143 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -161.44 176.91 10.61 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 124.76 1.224 . . . . 0.0 110.752 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.407 0 C-N-CA 125.056 1.312 . . . . 0.0 111.339 175.605 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.4 m -130.91 99.41 4.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.6 131.74 42.85 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 167.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.7 m -148.55 140.65 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 124.405 1.082 . . . . 0.0 109.742 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -66.87 126.27 28.54 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 166.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 154' ' ' PHE . . . -93.41 -75.96 1.32 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -160.29 -175.48 31.33 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 123.72 0.306 . . . . 0.0 113.232 -176.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 25.6 m -103.6 142.82 33.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.401 1.48 . . . . 0.0 109.007 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.4 t -125.57 101.56 8.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -88.35 95.6 10.26 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.434 ' CD2' HG11 ' A' ' 101' ' ' VAL . 71.4 m-85 -75.14 102.21 4.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 175.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -114.24 156.94 23.4 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 -175.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 143.75 -163.37 27.63 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -171.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -161.44 170.15 20.54 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -164.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 48.3 t -126.4 140.51 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 167.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 16.9 m -122.06 150.37 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 127.058 2.143 . . . . 0.0 109.046 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.65 24.59 0.09 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -169.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 1 C-N-CA 132.993 4.517 . . . . 0.0 113.719 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.909 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.474 ' HB3' ' CD1' ' A' ' 158' ' ' TYR . . . -53.28 -38.87 63.48 Favored 'General case' 0 C--O 1.225 -0.211 0 O-C-N 123.986 0.803 . . . . 0.0 112.206 -165.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.4 ' SG ' HD13 ' A' ' 124' ' ' LEU . 3.5 m -110.22 159.3 17.51 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.798 1.239 . . . . 0.0 107.779 165.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.81 -9.3 52.26 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -164.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.5 t 44.95 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 129.038 2.935 . . . . 0.0 110.744 -167.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -62.91 160.57 14.49 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.289 -170.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.7 -21.2 39.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.953 1.301 . . . . 0.0 112.15 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.53 -12.9 67.53 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.564 1.078 . . . . 0.0 112.755 173.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 t -127.09 -21.67 3.91 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.834 1.654 . . . . 0.0 110.792 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.9 -26.13 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 125.25 1.42 . . . . 0.0 113.007 -173.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -150.7 94.5 2.1 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -132.61 148.31 52.36 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.343 0.657 . . . . 0.0 109.485 -175.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.2 m -124.32 100.4 6.67 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.634 1.973 . . . . 0.0 108.041 -174.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.5 t -74.53 111.28 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -88.55 101.41 13.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.63 HD23 HG11 ' A' ' 52' ' ' VAL . 1.2 mt -76.46 -16.39 59.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.033 1.733 . . . . 0.0 109.7 170.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.39 -166.55 25.49 Favored Glycine 0 C--N 1.343 0.935 0 C-N-CA 124.796 1.189 . . . . 0.0 112.765 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -68.68 147.63 51.58 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.98 0.912 . . . . 0.0 109.64 173.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 t -135.88 143.41 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 124.353 1.061 . . . . 0.0 108.949 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 3.8 mmt85 -73.29 127.67 33.3 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 182' ' ' VAL . 33.3 p -58.01 -21.94 47.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.211 0.529 . . . . 0.0 111.485 172.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.38 -43.3 75.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.165 -0.96 . . . . 0.0 110.675 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.6 m -72.49 -2.11 18.39 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.4 mt -144.0 66.28 1.29 Allowed 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.488 1.915 . . . . 0.0 109.017 -161.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.97 -9.07 6.0 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -167.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.52 163.09 40.26 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.391 1.476 . . . . 0.0 107.928 -178.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -62.77 129.97 42.84 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.24 -10.68 63.58 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.842 1.211 . . . . 0.0 112.734 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.83 106.2 2.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.35 1.06 . . . . 0.0 111.458 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.415 HG21 ' CZ ' ' A' ' 136' ' ' ARG . 11.8 p -101.18 150.6 22.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.44 -0.788 . . . . 0.0 110.812 -176.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.1 p -67.56 172.45 5.09 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 166.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.7 m -24.64 -98.9 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 130.257 3.423 . . . . 0.0 114.517 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 154.72 118.24 0.0 OUTLIER 'General case' 0 C--O 1.233 0.191 0 C-N-CA 129.746 3.218 . . . . 0.0 105.356 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.63 HG11 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -130.58 130.96 65.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -176.17 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.08 139.5 14.58 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -138.48 158.77 43.62 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 168.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -148.94 130.08 14.51 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 120.347 -1.471 . . . . 0.0 110.396 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.7 mm -83.54 115.61 26.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 125.002 1.321 . . . . 0.0 107.459 -167.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -76.63 108.95 9.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.988 0.915 . . . . 0.0 109.826 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.7 mp -111.71 97.13 6.5 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 125.414 1.485 . . . . 0.0 108.294 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -95.83 160.32 14.53 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.161 1.784 . . . . 0.0 112.227 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.3 t70 40.49 49.7 2.68 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.275 2.63 . . . . 0.0 114.007 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 57.5 m -65.66 122.16 16.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 127.701 2.4 . . . . 0.0 111.05 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.425 ' HB3' HG23 ' A' ' 65' ' ' VAL . 5.9 t0 -111.17 112.6 24.51 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.582 1.153 . . . . 0.0 110.161 -173.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.9 p -70.84 -24.68 62.57 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.146 2.178 . . . . 0.0 113.738 -165.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -61.47 -48.2 82.19 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 128.543 2.737 . . . . 0.0 112.44 168.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 62' ' ' ASP . 40.1 t -64.88 -39.13 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -176.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -168.63 146.06 3.91 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.117 -176.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.25 -11.42 35.34 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 118.795 -0.621 . . . . 0.0 111.67 170.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -134.04 164.8 26.5 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 125.46 1.504 . . . . 0.0 109.942 -173.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.79 144.06 37.18 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 163.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.79 167.88 9.83 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.98 1.712 . . . . 0.0 107.429 158.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.7 t -124.8 150.97 29.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 169.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.25 155.21 37.62 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 161.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.623 ' CE1' HG21 ' A' ' 103' ' ' ILE . 60.0 m-85 -114.04 154.85 26.98 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.406 HD13 ' C ' ' A' ' 114' ' ' ASP . 9.7 tp -142.11 125.97 17.11 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 125.373 1.469 . . . . 0.0 107.365 177.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.679 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -165.85 162.91 36.34 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.3 m -63.08 129.47 40.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.003 0.901 . . . . 0.0 109.107 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.69 141.31 46.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.071 0.462 . . . . 0.0 110.245 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.3 tt -60.77 -37.51 76.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 123.931 0.892 . . . . 0.0 110.382 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -158.24 165.56 34.55 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.45 -35.4 72.06 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.856 1.262 . . . . 0.0 111.254 169.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.79 -3.68 64.29 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 121.276 -0.89 . . . . 0.0 112.381 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -147.78 48.54 1.08 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.959 1.704 . . . . 0.0 108.788 -164.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.3 p -58.75 -18.4 31.4 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.598 1.959 . . . . 0.0 112.414 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.558 ' H ' HD21 ' A' ' 84' ' ' ASN . 0.6 OUTLIER -95.07 -1.79 51.44 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 117.928 -1.034 . . . . 0.0 113.076 175.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.3 t -115.58 130.59 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 120.329 1.422 . . . . 0.0 109.807 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.679 HD21 ' HA3' ' A' ' 75' ' ' GLY . 4.8 mt -72.2 151.47 42.89 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.209 1.004 . . . . 0.0 111.393 -175.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.72 17.41 10.39 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.999 1.719 . . . . 0.0 113.656 -168.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.644 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 63.8 mt 52.34 -154.17 0.2 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.606 1.562 . . . . 0.0 109.406 -168.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 . . . . . 0 C--O 1.234 0.255 0 CA-C-N 118.725 0.693 . . . . 0.0 110.158 -179.245 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.8 m . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.07 139.07 57.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.389 1.476 . . . . 0.0 107.57 164.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 p -90.36 170.4 10.28 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.761 0.709 . . . . 0.0 109.594 173.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 58.73 19.92 7.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 126.536 1.934 . . . . 0.0 112.71 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.7 p -143.49 151.38 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -153.5 177.67 30.92 Favored Glycine 0 C--O 1.225 -0.408 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 m -96.03 142.87 13.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 CA-C-N 120.018 1.909 . . . . 0.0 109.056 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -110.15 156.61 20.37 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 120.257 1.39 . . . . 0.0 109.328 161.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.623 HG21 ' CE1' ' A' ' 73' ' ' PHE . 4.6 mp -114.02 142.97 24.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 126.995 2.118 . . . . 0.0 105.562 159.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 110' ' ' ALA . 8.3 mt -131.77 156.0 46.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.235 1.814 . . . . 0.0 106.674 170.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 106' ' ' ARG . 3.5 t70 -72.34 -105.35 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 165.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.402 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 19.7 ptt180 -151.21 -9.79 0.23 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.744 1.618 . . . . 0.0 112.432 178.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.5 p -83.12 7.54 15.66 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.646 1.578 . . . . 0.0 109.344 172.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.45 8.1 30.1 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.441 1.496 . . . . 0.0 113.484 -166.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.31 114.65 3.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 119.476 1.638 . . . . 0.0 107.377 170.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.499 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -95.08 127.44 41.15 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.43 131.62 51.59 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.826 0.704 . . . . 0.0 110.623 -162.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.8 m -65.18 153.96 39.41 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.616 0.366 . . . . 0.0 110.611 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.81 49.92 0.8 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.393 1.477 . . . . 0.0 110.226 -171.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.406 ' C ' HD13 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -88.59 -28.86 20.42 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.564 -1.335 . . . . 0.0 111.091 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.44 2.03 56.63 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 126.523 2.011 . . . . 0.0 113.641 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.78 -31.69 1.95 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 117.583 -1.198 . . . . 0.0 111.35 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.1 m -54.67 104.35 0.11 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.713 1.142 . . . . 0.0 110.131 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -87.26 149.95 24.22 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.886 -173.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.6 -160.73 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.896 1.278 . . . . 0.0 111.789 -174.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 m -50.76 156.49 0.94 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.519 0.727 . . . . 0.0 111.778 147.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -102.4 152.93 20.53 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.393 1.877 . . . . 0.0 108.313 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.8 m -132.03 118.25 19.44 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.449 1.499 . . . . 0.0 107.851 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.5 m -59.15 123.76 17.71 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 166.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.4 HD13 ' SG ' ' A' ' 21' ' ' CYS . 73.3 mt -91.2 -174.69 4.04 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 128.805 2.842 . . . . 0.0 109.59 176.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -163.04 172.94 14.22 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.522 1.929 . . . . 0.0 108.537 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -59.57 107.38 0.58 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.974 1.709 . . . . 0.0 109.748 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.1 -124.25 3.19 Favored Glycine 0 N--CA 1.474 1.226 0 CA-C-N 120.417 1.462 . . . . 0.0 112.8 169.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 99.2 m -122.75 125.31 45.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 120.535 2.168 . . . . 0.0 109.091 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -133.29 177.72 7.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.474 1.91 . . . . 0.0 109.706 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.57 162.18 40.71 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -166.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 17.6 mt -139.92 112.29 7.5 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.64 153.08 43.46 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.971 1.781 . . . . 0.0 109.431 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -136.41 161.3 36.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.894 1.677 . . . . 0.0 107.605 170.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -127.18 97.27 4.87 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -175.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.12 157.23 25.41 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.406 1.482 . . . . 0.0 110.578 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.415 ' CZ ' HG21 ' A' ' 48' ' ' THR . 24.9 ptt180 -159.14 169.83 23.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.079 1.352 . . . . 0.0 111.306 162.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.433 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 76.0 m-85 -82.78 146.05 29.18 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 152.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -123.83 116.53 23.11 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.97 2.108 . . . . 0.0 106.914 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.54 141.15 36.92 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 171.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.2 p -105.67 17.13 24.28 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.895 0.878 . . . . 0.0 110.375 171.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 161.64 -155.98 27.36 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.06 91.34 0.15 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.995 1.718 . . . . 0.0 110.043 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.12 152.72 32.11 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 55.0 p -104.38 161.06 23.99 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -72.87 170.9 18.56 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 N-CA-C 109.215 -1.11 . . . . 0.0 109.215 160.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.06 -95.46 0.15 Allowed Glycine 0 C--O 1.226 -0.348 0 O-C-N 121.35 -0.844 . . . . 0.0 112.114 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -151.12 161.18 43.21 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.175 1.79 . . . . 0.0 106.743 173.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.433 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -147.11 81.23 1.54 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -118.92 139.53 51.49 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.644 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -151.5 157.24 42.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -130.34 121.88 26.84 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -101.15 163.57 12.22 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 162.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.3 p -103.8 156.15 18.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 151.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -115.84 157.8 23.89 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.49 0.716 . . . . 0.0 109.604 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -126.31 162.7 24.88 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 126.946 2.098 . . . . 0.0 107.768 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.411 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 10.8 t -128.55 123.34 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 -175.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -111.78 85.56 2.16 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 20' ' ' ALA . 85.8 m-85 -64.7 146.84 54.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.283 170.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -164.47 168.21 18.66 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 121.838 0.827 . . . . 0.0 112.44 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 105.894 -2.883 . . . . 0.0 105.894 -176.928 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.682 0 CA-C-O 120.834 0.349 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 90.9 m -103.58 91.89 4.22 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.414 1.486 . . . . 0.0 107.939 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.2 m -79.02 101.97 8.1 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 171.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -104.84 169.2 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 126.111 1.765 . . . . 0.0 108.791 170.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.33 173.63 4.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.437 0.637 . . . . 0.0 111.094 169.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -127.16 -72.09 0.18 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 174.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.68 -167.23 39.88 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -167.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.1 m -96.9 137.5 35.89 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.048 0.939 . . . . 0.0 108.745 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.7 t -117.96 105.49 18.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 163.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -78.11 141.74 38.56 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 171.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -123.56 101.15 7.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.27 2.228 . . . . 0.0 105.174 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -115.06 155.99 25.99 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.89 0.876 . . . . 0.0 109.265 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.64 -166.71 27.28 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -167.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -167.09 175.22 7.66 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -169.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 24.3 t -128.86 138.0 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 174.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 39' ' ' THR . 11.0 m -124.69 151.43 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 C-N-CA 127.255 2.222 . . . . 0.0 107.75 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -74.89 30.88 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -171.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.249 1.049 0 C-N-CA 131.074 3.75 . . . . 0.0 114.017 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.554 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -48.4 -40.21 25.1 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.87 1.268 . . . . 0.0 112.377 -175.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -112.79 160.71 17.71 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.755 1.622 . . . . 0.0 109.579 178.404 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.92 -21.62 31.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.334 -167.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 t 56.51 107.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 128.633 2.773 . . . . 0.0 110.272 -165.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -65.7 163.14 17.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.66 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.552 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -53.26 -29.6 33.76 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.242 1.017 . . . . 0.0 111.356 167.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.43 4.61 3.65 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.673 1.13 . . . . 0.0 114.784 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.8 t -147.6 -34.13 0.25 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.188 1.494 . . . . 0.0 110.351 -167.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 25' ' ' ALA . 8.1 p -60.4 -36.84 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 O-C-N 120.738 -1.226 . . . . 0.0 111.371 174.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -151.24 97.38 2.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.96 0.886 . . . . 0.0 109.081 -172.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -131.33 133.83 45.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 123.376 1.56 . . . . 0.0 110.179 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.8 m -108.75 88.96 2.85 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -174.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.56 105.11 7.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -171.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -80.89 115.14 20.23 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.674 HD23 HG11 ' A' ' 52' ' ' VAL . 1.2 mt -79.89 -7.44 58.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.974 0.91 . . . . 0.0 110.732 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.19 -178.47 51.42 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.647 1.117 . . . . 0.0 110.703 -177.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -79.05 146.82 33.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 165.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.58 145.58 35.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 124.395 1.078 . . . . 0.0 108.637 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -77.63 132.44 38.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.3 p -59.04 -22.81 61.31 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 122.489 0.316 . . . . 0.0 110.7 168.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.14 -9.64 41.95 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.91 -1.119 . . . . 0.0 113.274 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.0 m -101.36 -2.38 31.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.456 1.103 . . . . 0.0 113.28 168.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.594 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 17.4 mt -142.56 83.22 1.81 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 126.845 2.058 . . . . 0.0 106.815 -166.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.69 6.98 1.45 Allowed 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.289 -0.882 . . . . 0.0 112.274 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.464 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 6.5 pm0 -154.48 160.15 41.42 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.701 1.2 . . . . 0.0 107.886 -174.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -64.09 136.42 57.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 121.528 -0.732 . . . . 0.0 109.796 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.31 -4.17 56.09 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-O 117.51 -1.717 . . . . 0.0 112.344 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.464 ' HB2' ' NE2' ' A' ' 44' ' ' GLN . . . -58.71 143.78 45.69 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 120.562 2.181 . . . . 0.0 108.113 170.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.8 p -140.75 154.68 46.4 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -176.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.5 p -73.41 -178.49 3.03 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.2 m -28.55 -91.03 0.0 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.622 2.769 . . . . 0.0 114.735 173.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.41 111.02 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 130.495 3.518 . . . . 0.0 104.356 -176.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.674 HG11 HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -107.02 136.08 43.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 173.374 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.33 88.77 0.43 Allowed Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 -173.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -83.22 -179.55 7.44 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -148.53 162.97 38.58 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 120.189 -1.569 . . . . 0.0 109.997 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.1 mm -99.62 103.81 15.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -69.49 124.47 23.99 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 174.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.4 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 6.5 mp -117.5 165.46 13.51 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.729 1.612 . . . . 0.0 108.789 174.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -176.03 153.26 1.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.313 1.445 . . . . 0.0 109.219 -165.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 47.12 37.47 5.4 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.542 2.337 . . . . 0.0 114.501 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.534 ' SG ' HD13 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -67.3 119.42 12.13 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.407 1.483 . . . . 0.0 110.35 177.403 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -90.53 142.57 27.61 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 163.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.3 p -91.19 -14.02 31.8 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.664 1.575 . . . . 0.0 114.308 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -70.64 -43.49 69.1 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.739 0.781 . . . . 0.0 110.222 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 20' ' ' ALA . 2.8 p -60.27 -49.71 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.86 130.37 3.19 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 125.955 1.702 . . . . 0.0 108.081 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -82.29 -8.05 59.63 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.018 0.927 . . . . 0.0 111.695 174.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -131.24 167.04 19.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.921 1.689 . . . . 0.0 110.111 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.56 ' HB2' HD11 ' A' ' 124' ' ' LEU . . . -141.03 129.1 22.01 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 162.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.4 176.91 5.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 145.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.424 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.4 OUTLIER -144.03 160.5 15.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 101.648 -3.464 . . . . 0.0 101.648 -168.418 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.25 167.9 21.71 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 120.354 -1.466 . . . . 0.0 107.458 168.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -126.39 153.51 44.86 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 tp -142.13 142.72 32.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.11 170.07 42.85 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 2.0 m -57.19 125.76 24.18 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.954 1.701 . . . . 0.0 109.374 177.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.43 137.52 46.51 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.687 1.13 . . . . 0.0 109.866 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.1 tt -59.2 -49.21 84.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 124.405 1.082 . . . . 0.0 110.7 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -147.78 166.72 26.67 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.09 -34.41 76.24 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.961 1.304 . . . . 0.0 112.231 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.9 -12.69 84.17 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 119.514 -0.603 . . . . 0.0 112.347 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -125.79 48.86 2.01 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.266 1.427 . . . . 0.0 110.153 -173.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.4 p -63.89 -11.96 32.53 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 126.776 2.03 . . . . 0.0 114.041 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.25 -4.05 59.09 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.15 -0.968 . . . . 0.0 111.074 171.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.7 t -124.47 132.7 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 119.832 1.196 . . . . 0.0 109.258 -168.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.34 148.25 35.72 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.47 1.508 . . . . 0.0 110.473 -172.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 76' ' ' THR . . . -91.53 17.33 8.83 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.395 1.478 . . . . 0.0 114.27 -166.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.402 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 26.0 mt 51.27 -153.02 0.19 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.261 0.624 . . . . 0.0 109.811 -166.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 . . . . . 0 N--CA 1.45 -0.462 0 C-N-CA 125.073 1.349 . . . . 0.0 109.238 177.689 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.44 -0.931 0 CA-C-O 124.343 2.021 . . . . 0.0 111.901 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.06 156.75 14.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 112.277 -2.238 . . . . 0.0 107.891 151.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.44 163.8 28.55 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.495 1.518 . . . . 0.0 108.471 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 59.03 15.65 4.16 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.298 1.439 . . . . 0.0 111.214 -170.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.14 152.71 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 120.207 1.367 . . . . 0.0 109.025 -176.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.27 176.11 28.16 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 125.396 1.474 . . . . 0.0 110.306 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.406 HG11 ' CG ' ' A' ' 177' ' ' PHE . 92.9 t -86.4 142.51 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 172.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.64 157.87 28.62 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.659 1.184 . . . . 0.0 108.544 163.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.7 mp -134.72 138.68 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 C-N-CA 129.082 2.953 . . . . 0.0 104.783 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.07 147.28 46.01 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -178.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.473 ' CG ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -67.84 -175.26 0.53 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.263 0.938 . . . . 0.0 110.405 175.278 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -52.16 -18.14 1.37 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 171.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 t -81.41 -13.65 58.04 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.51 -0.744 . . . . 0.0 109.363 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.15 13.26 52.98 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.557 2.027 . . . . 0.0 113.501 -167.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.05 127.59 33.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 168.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.04 129.05 39.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.328 1.451 . . . . 0.0 111.482 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.0 mt -100.76 160.44 14.36 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 124.086 0.866 . . . . 0.0 110.54 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.0 m -96.13 153.16 17.94 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.995 0.918 . . . . 0.0 108.567 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.4 mt -107.19 64.26 0.64 Allowed 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 123.593 0.757 . . . . 0.0 109.542 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -111.06 -12.61 14.17 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.616 0.766 . . . . 0.0 111.799 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.82 -27.02 1.38 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 125.179 1.371 . . . . 0.0 112.739 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.02 -69.7 0.57 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 117.862 -1.066 . . . . 0.0 109.266 164.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.7 m -39.6 99.09 0.02 OUTLIER 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.804 2.041 . . . . 0.0 112.128 -169.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -70.16 155.96 39.9 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.207 1.403 . . . . 0.0 109.81 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.8 p -109.98 -138.94 0.38 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.043 0.937 . . . . 0.0 112.181 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' CG ' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -70.51 135.44 48.6 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.177 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -78.53 163.17 25.77 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.737 0.779 . . . . 0.0 108.969 167.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.0 m -145.61 118.75 8.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 174.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.1 m -70.32 113.64 7.68 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 171.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 69' ' ' ALA . 31.2 mt -80.29 177.78 8.73 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.048 2.139 . . . . 0.0 107.868 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -143.36 164.9 29.0 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.62 -0.675 . . . . 0.0 109.846 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -63.72 104.99 0.73 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.919 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 122.99 -109.49 1.38 Allowed Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.586 1.565 . . . . 0.0 111.681 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 94.3 m -126.55 131.25 51.6 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 120.769 -1.43 . . . . 0.0 111.587 -164.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.06 174.41 12.78 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.649 1.979 . . . . 0.0 108.249 -172.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.0 m -151.23 157.45 42.62 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 10.5 mt -118.33 110.7 39.01 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 170.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -67.36 154.25 74.5 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 121.709 1.606 . . . . 0.0 109.996 172.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.424 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 25.8 m-85 -136.12 166.77 22.62 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.595 1.558 . . . . 0.0 108.496 173.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -120.02 152.17 37.9 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 164.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.88 166.84 20.71 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 162.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -164.25 158.29 18.75 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 170.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.451 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 84.3 m-85 -71.32 153.89 42.02 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 159.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -134.01 112.89 11.58 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.226 2.21 . . . . 0.0 105.931 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -80.08 150.68 30.22 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.123 0.963 . . . . 0.0 109.184 170.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 68.1 p -115.61 8.04 14.96 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 125.958 1.703 . . . . 0.0 110.601 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.58 -154.28 24.33 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.05 87.0 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.002 1.321 . . . . 0.0 112.064 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -67.07 137.45 56.41 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.243 1.417 . . . . 0.0 111.495 -170.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 31.1 p -99.97 160.8 26.25 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 118.26 0.482 . . . . 0.0 110.613 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -72.36 178.78 5.71 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.446 1.43 . . . . 0.0 110.743 166.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.01 -93.59 0.14 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.593 1.092 . . . . 0.0 112.213 158.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.24 159.12 42.71 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 127.559 2.343 . . . . 0.0 105.06 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -149.33 71.78 1.13 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 120.015 1.279 . . . . 0.0 110.767 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -115.47 154.79 28.65 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -176.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -157.0 152.63 26.85 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.749 0.82 . . . . 0.0 109.715 175.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -120.74 121.32 37.98 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -120.79 175.69 5.9 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.009 2.124 . . . . 0.0 109.819 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.7 p -127.61 152.11 48.06 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 159.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -105.09 156.1 18.38 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 164.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -113.49 171.98 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.797 1.239 . . . . 0.0 107.943 168.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.461 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 15.6 t -129.34 129.05 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -120.9 89.37 3.12 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.543 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 67.0 m-85 -67.58 146.62 53.71 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 125.115 1.366 . . . . 0.0 110.716 173.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -155.87 171.71 19.6 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 126.702 2.001 . . . . 0.0 110.556 166.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.424 0 O-C-N 120.847 -1.158 . . . . 0.0 111.432 166.669 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 34.4 m -150.06 100.18 2.9 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 120.399 -1.438 . . . . 0.0 108.235 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.54 109.51 15.12 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.799 2.04 . . . . 0.0 109.763 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.36 157.69 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.018 1.327 . . . . 0.0 109.974 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.0 157.39 36.24 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.339 -0.851 . . . . 0.0 109.949 174.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.59 -59.93 0.46 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 172.52 176.5 41.28 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -168.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.9 m -97.45 128.35 44.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.255 1.422 . . . . 0.0 110.197 177.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.43 115.2 49.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -106.4 90.34 3.32 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -172.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.406 ' CG ' HG11 ' A' ' 101' ' ' VAL . 75.2 m-85 -67.34 118.77 11.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 175.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -123.69 160.45 27.19 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 138.41 -165.21 25.55 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -163.47 168.85 19.66 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -167.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.08 136.76 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 167.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 184' ' ' ALA . 6.1 m -115.8 152.36 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 C-N-CA 126.963 2.105 . . . . 0.0 108.329 177.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -75.11 31.42 0.1 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -172.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 N--CA 1.442 -0.837 1 C-N-CA 131.711 4.004 . . . . 0.0 112.096 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.485 ' HB2' HG21 ' A' ' 170' ' ' VAL . . . . . . . . 0 N--CA 1.447 -0.581 0 N-CA-C 102.471 -3.159 . . . . 0.0 102.471 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.72 -13.42 61.72 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.204 -0.998 . . . . 0.0 112.808 -173.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.5 m -130.91 151.06 51.75 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.014 1.726 . . . . 0.0 107.799 -175.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.89 -10.26 59.32 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -173.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 t 55.21 140.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 129.036 2.934 . . . . 0.0 112.121 -160.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.62 163.99 13.33 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.182 -0.949 . . . . 0.0 112.711 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.75 78.3 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.501 1.121 . . . . 0.0 111.392 -173.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.91 28.0 2.22 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.38 0.991 . . . . 0.0 112.006 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.7 t -139.68 -55.6 0.56 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.0 1.32 . . . . 0.0 108.554 -174.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.4 p -50.87 -36.09 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.844 1.258 . . . . 0.0 112.873 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -143.41 101.36 3.78 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 104.87 -2.271 . . . . 0.0 104.87 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -130.9 138.48 49.81 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.055 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 176' ' ' HIS . 93.3 m -106.96 98.66 8.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 172.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.8 t -77.67 115.89 20.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -89.66 127.67 35.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 mt -100.99 -3.63 29.04 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.375 1.87 . . . . 0.0 109.57 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.01 179.77 37.26 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.49 1.043 . . . . 0.0 112.345 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -76.01 116.57 16.84 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.777 1.631 . . . . 0.0 109.889 170.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.5 t -103.0 140.67 20.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 122.776 1.274 . . . . 0.0 109.245 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 7.4 mmt180 -71.76 126.58 30.08 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 125.466 1.506 . . . . 0.0 107.003 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 p -50.92 -31.57 18.0 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.321 1.448 . . . . 0.0 111.073 166.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.29 -16.58 60.76 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 t -92.72 0.28 57.39 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.064 1.346 . . . . 0.0 112.062 172.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.9 mt -145.9 67.65 1.2 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.881 1.672 . . . . 0.0 106.653 -162.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.63 -6.27 4.12 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -163.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.413 ' OE1' ' HB2' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -147.85 157.56 43.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.855 1.662 . . . . 0.0 106.848 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 16.4 tt0 -63.33 134.62 56.1 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 170.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.71 -7.09 77.37 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 118.822 -0.988 . . . . 0.0 112.322 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -65.35 152.42 43.87 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.475 1.138 . . . . 0.0 109.604 172.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.9 p -138.08 158.57 44.05 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.858 0.837 . . . . 0.0 111.237 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.6 p -72.05 -175.86 1.59 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.438 0.695 . . . . 0.0 111.484 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 p -40.38 -47.45 2.56 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 126.635 1.974 . . . . 0.0 113.607 160.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 83.74 162.78 0.12 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 129.047 2.939 . . . . 0.0 108.914 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -144.9 133.23 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.87 104.23 3.14 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 106.111 -2.796 . . . . 0.0 106.111 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -104.69 156.74 17.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 168.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.466 ' HB2' HG22 ' A' ' 130' ' ' THR . 0.1 OUTLIER -135.97 151.87 50.38 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 120.515 -1.366 . . . . 0.0 109.701 -177.255 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.2 mm -99.78 115.01 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.63 136.33 38.16 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -173.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.6 mt -123.52 160.26 27.37 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.444 1.498 . . . . 0.0 107.955 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -149.59 151.35 33.67 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.448 1.499 . . . . 0.0 111.077 -164.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.6 t70 38.74 44.11 0.78 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.453 2.701 . . . . 0.0 113.524 -171.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.8 m -72.53 97.14 2.05 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.781 1.632 . . . . 0.0 113.909 -164.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -71.92 104.93 3.65 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.166 0.986 . . . . 0.0 111.126 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.1 p -68.67 -11.88 60.7 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -175.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -66.49 -48.21 70.57 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.707 0.685 . . . . 0.0 109.159 173.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -58.02 -41.76 81.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 124.204 1.001 . . . . 0.0 109.081 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 159' ' ' GLN . . . -167.04 138.24 3.2 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.767 1.627 . . . . 0.0 108.345 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.1 m -96.46 12.58 30.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.927 1.291 . . . . 0.0 113.059 169.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.56 ' CA ' HD21 ' A' ' 124' ' ' LEU . 28.1 mtmt -148.04 167.1 25.81 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 121.309 1.868 . . . . 0.0 113.326 158.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.21 93.6 2.46 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.189 2.196 . . . . 0.0 112.088 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.34 152.22 24.23 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 119.031 -2.293 . . . . 0.0 108.734 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 t -120.44 123.81 71.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.99 165.49 14.53 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 165.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.547 ' CE1' HG21 ' A' ' 103' ' ' ILE . 27.0 m-85 -127.66 160.34 31.93 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.543 163.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.728 HD22 ' OG1' ' A' ' 153' ' ' THR 0.285 0.0 OUTLIER -139.15 160.25 40.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.228 168.077 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.84 163.78 32.91 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 4.6 m -58.17 125.93 25.31 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 164.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.05 140.49 43.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 119.374 0.988 . . . . 0.0 109.091 174.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.4 tt -60.53 -48.46 88.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 123.35 0.66 . . . . 0.0 110.557 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.73 162.6 35.09 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.98 -24.98 67.92 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.678 0.791 . . . . 0.0 112.306 166.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.77 4.91 83.98 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 119.003 -0.887 . . . . 0.0 112.727 173.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -149.39 57.06 1.0 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.163 1.385 . . . . 0.0 109.126 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.3 p -64.61 -20.09 66.07 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.103 1.361 . . . . 0.0 113.101 -173.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -102.6 3.56 37.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -172.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.1 t -116.18 136.21 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 124.916 1.287 . . . . 0.0 108.366 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.07 151.87 26.85 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 125.229 1.412 . . . . 0.0 110.63 -172.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.427 ' HB3' ' HB ' ' A' ' 76' ' ' THR . . . -95.53 15.38 19.92 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -164.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt 56.3 -167.8 0.11 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.438 1.095 . . . . 0.0 110.589 -163.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 . . . . . 0 C--O 1.236 0.348 0 O-C-N 120.922 -1.111 . . . . 0.0 110.645 -174.135 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 120.746 0.308 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.81 148.59 38.68 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 163.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.7 p -90.68 165.81 13.5 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 159.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 54.46 31.02 13.9 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 127.274 2.23 . . . . 0.0 113.142 170.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.18 153.39 10.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 O-C-N 121.085 -1.009 . . . . 0.0 109.156 175.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.31 174.16 29.78 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 124.465 1.031 . . . . 0.0 110.66 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.406 HG11 ' CD2' ' A' ' 177' ' ' PHE . 44.2 t -83.92 151.91 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 173.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -128.79 163.43 25.22 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.144 0.884 . . . . 0.0 109.094 153.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.549 HG22 HD23 ' A' ' 111' ' ' LEU . 4.6 mp -121.01 141.81 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 128.19 2.596 . . . . 0.0 104.12 171.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mt -141.26 135.62 30.82 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.792 2.437 . . . . 0.0 105.455 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.64 -174.4 2.1 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.731 1.15 . . . . 0.0 108.376 169.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.1 ptt85 -58.33 -20.11 40.62 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.6 p -68.42 -10.63 56.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 124.298 1.039 . . . . 0.0 112.001 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.48 6.31 34.04 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 119.256 0.935 . . . . 0.0 112.291 -168.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.94 126.19 33.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.965 1.382 . . . . 0.0 107.314 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.83 151.08 42.18 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.865 0.364 . . . . 0.0 110.718 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.549 HD23 HG22 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -105.49 145.69 30.55 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.381 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.451 ' H ' HG21 ' A' ' 117' ' ' THR . 4.1 m -70.32 157.35 37.9 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.5 mt -104.91 63.71 0.71 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.615 1.566 . . . . 0.0 108.548 -172.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.1 -1.41 6.46 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.669 1.188 . . . . 0.0 113.064 -171.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.434 ' N ' ' HB2' ' A' ' 74' ' ' LEU . . . 86.32 -1.77 87.47 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.259 -1.301 . . . . 0.0 112.121 170.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -139.82 -28.01 0.76 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.852 1.326 . . . . 0.0 114.3 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.451 HG21 ' H ' ' A' ' 112' ' ' THR . 51.5 m -53.3 146.89 11.18 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.046 1.738 . . . . 0.0 110.638 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -116.73 141.74 47.82 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.015 -1.053 . . . . 0.0 109.065 -166.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.25 79.0 p -86.74 -124.78 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 123.3 0.64 . . . . 0.0 111.295 -170.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.52 21.7 6.03 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.183 1.393 . . . . 0.0 113.828 -169.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 56.91 171.66 0.04 OUTLIER 'General case' 0 N--CA 1.42 -1.931 1 C-N-CA 131.786 4.034 . . . . 0.0 114.307 173.368 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 m -149.9 134.42 17.48 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 158.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.8 m -88.58 126.28 35.2 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 169.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.788 ' H ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -86.76 179.86 6.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.211 -168.491 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.82 138.93 14.54 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 -171.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -57.48 94.65 0.02 OUTLIER 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.318 1.847 . . . . 0.0 108.567 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.56 -137.86 6.65 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -159.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.5 m -125.2 146.0 49.71 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.854 2.061 . . . . 0.0 107.197 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.44 154.46 22.98 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.553 1.141 . . . . 0.0 108.811 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.466 HG22 ' HB2' ' A' ' 55' ' ' ASN . 29.7 m -144.87 141.41 29.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.179 -165.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.2 mt -104.97 107.48 58.86 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 126.653 1.981 . . . . 0.0 106.149 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -85.65 103.1 0.74 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.502 2.801 . . . . 0.0 112.316 -175.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -81.27 174.66 11.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 122.897 1.332 . . . . 0.0 111.457 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -127.79 126.7 42.23 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 162.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -101.02 138.81 37.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 163.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -150.31 134.96 17.45 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -60.01 143.82 50.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -118.95 115.22 23.9 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -79.94 142.3 35.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.423 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 63.4 p -109.94 23.76 13.94 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.002 1.321 . . . . 0.0 110.095 176.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 148.78 -153.99 25.56 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 107.85 -2.1 . . . . 0.0 107.85 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.38 91.21 0.54 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.704 1.201 . . . . 0.0 109.497 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.43 124.96 21.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.767 0.827 . . . . 0.0 109.306 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.4 p -85.63 154.54 59.02 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -71.95 160.28 48.09 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 120.932 1.088 . . . . 0.0 110.449 169.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.72 -148.72 15.87 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -170.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -91.0 152.49 20.66 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 118.913 1.356 . . . . 0.0 109.036 163.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -136.24 66.14 1.5 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.424 0.69 . . . . 0.0 109.675 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -104.53 151.79 23.17 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 178.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.26 166.48 30.81 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.427 1.091 . . . . 0.0 108.101 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -148.72 140.73 23.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.054 0.93 . . . . 0.0 111.231 174.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.61 156.61 46.6 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.532 2.333 . . . . 0.0 109.283 -171.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.728 ' OG1' HD22 ' A' ' 74' ' ' LEU . 64.5 p -91.33 163.45 14.21 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 117.422 -1.711 . . . . 0.0 108.27 152.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.509 ' CD1' HG23 ' A' ' 175' ' ' VAL . 23.0 p90 -127.9 153.4 46.7 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 158.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -119.54 175.41 5.86 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.817 0.847 . . . . 0.0 110.541 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 4.4 t -138.4 99.62 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -84.25 100.04 10.95 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.595 1.958 . . . . 0.0 107.825 171.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.412 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 87.1 m-85 -73.52 139.46 45.69 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.398 1.094 . . . . 0.0 113.546 167.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.438 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 3.5 mt-30 -133.98 160.31 38.1 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 129.484 3.114 . . . . 0.0 111.041 -168.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.254 0 CA-C-O 119.089 -0.84 . . . . 0.0 111.047 -177.683 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.722 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 19.6 m -138.4 81.65 1.86 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.238 0.615 . . . . 0.0 109.455 -165.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.1 m -83.06 95.3 8.01 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.156 1.382 . . . . 0.0 109.972 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.485 HG21 ' HB2' ' A' ' 19' ' ' ALA . 1.8 m -81.72 167.18 2.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 158.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -72.89 154.99 40.34 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.542 -0.723 . . . . 0.0 109.292 164.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.19 -25.57 2.94 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 124.128 0.87 . . . . 0.0 112.944 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 146.26 -163.51 28.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 117.784 0.792 . . . . 0.0 111.647 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.9 m -116.24 136.48 52.97 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.509 HG23 ' CD1' ' A' ' 154' ' ' PHE . 40.2 t -112.56 115.63 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 166.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 31' ' ' THR . 10.3 m-70 -97.07 113.13 24.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 175.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.406 ' CD2' HG11 ' A' ' 101' ' ' VAL . 81.7 m-85 -87.1 119.48 27.37 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 176.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -116.06 166.66 11.75 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 135.5 -173.13 21.88 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 106.264 -2.735 . . . . 0.0 106.264 -171.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.67 170.51 18.34 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -171.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.3 t -120.82 130.1 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 175.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 15.3 m -115.79 146.62 19.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 126.81 2.044 . . . . 0.0 109.046 -177.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -74.94 27.4 0.09 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -172.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.248 1.024 0 C-N-CA 128.269 2.628 . . . . 0.0 113.793 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.609 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.24 -26.93 31.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 118.411 -0.804 . . . . 0.0 113.016 -169.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.402 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -130.41 153.91 48.26 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.794 1.638 . . . . 0.0 110.063 -179.474 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.7 93.96 6.27 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.997 2.519 . . . . 0.0 109.526 166.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.4 p -48.46 106.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 125.39 1.476 . . . . 0.0 109.313 158.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -69.23 166.24 18.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.355 1.462 . . . . 0.0 113.008 -161.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.32 -32.31 66.57 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.253 1.021 . . . . 0.0 112.253 171.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.88 7.97 47.08 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.617 1.103 . . . . 0.0 112.882 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.15 -44.67 1.58 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.993 1.717 . . . . 0.0 109.606 -170.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.38 -28.0 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 127.352 2.261 . . . . 0.0 113.693 -168.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -149.39 61.69 1.03 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.613 1.165 . . . . 0.0 108.007 -169.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -104.97 137.5 42.62 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.272 0.629 . . . . 0.0 109.85 -168.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.9 m -108.32 92.84 4.23 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.08 1.352 . . . . 0.0 108.045 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.2 t -78.7 108.34 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 126.328 1.851 . . . . 0.0 107.125 -171.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -91.61 122.82 34.52 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -98.91 -1.02 41.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 122.844 0.457 . . . . 0.0 110.412 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.6 -177.84 33.02 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 126.423 1.963 . . . . 0.0 111.273 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -70.29 138.1 51.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 122.187 -0.596 . . . . 0.0 109.628 158.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.8 t -128.41 146.41 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 124.372 1.069 . . . . 0.0 109.501 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 9.4 mmt180 -75.82 127.07 32.24 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 125.832 1.653 . . . . 0.0 107.34 -176.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 p -55.57 -29.03 58.3 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.204 0.602 . . . . 0.0 111.008 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.03 -39.86 72.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.453 1.101 . . . . 0.0 111.577 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 62.1 m -74.23 -0.8 18.04 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.0 mt -134.28 31.52 3.48 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 125.226 1.41 . . . . 0.0 111.827 -160.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.49 13.92 13.58 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -150.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -149.61 162.71 39.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 171.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -60.32 121.22 11.47 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 164.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.95 -8.58 57.79 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 118.812 -0.993 . . . . 0.0 113.691 -173.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -67.79 154.52 41.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.835 1.818 . . . . 0.0 110.644 174.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.5 p -147.97 157.25 43.42 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.884 0.766 . . . . 0.0 112.17 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.0 p -72.1 175.17 6.21 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.949 -1.094 . . . . 0.0 111.241 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.0 m -47.63 -27.46 1.89 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.611 1.964 . . . . 0.0 114.591 172.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 81.37 145.93 0.08 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 129.479 3.112 . . . . 0.0 111.06 167.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 m -141.8 130.65 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 C-N-CA 124.113 0.965 . . . . 0.0 109.415 -152.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.25 121.31 6.79 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -174.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 10.1 p90 -130.82 102.56 6.13 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 118.313 1.056 . . . . 0.0 108.279 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.453 ' HB2' HG22 ' A' ' 130' ' ' THR . 27.1 p30 -93.95 150.83 20.02 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.063 -1.023 . . . . 0.0 111.242 -170.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.0 mm -94.66 98.1 7.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -65.84 126.87 29.84 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' A' ' 21' ' ' CYS . 2.2 mp -133.68 123.06 24.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 129.742 3.217 . . . . 0.0 106.589 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -118.04 154.39 32.11 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.509 1.049 . . . . 0.0 113.434 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 t70 65.92 37.41 5.46 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.094 1.758 . . . . 0.0 114.104 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 97.9 m -68.97 104.36 2.07 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.012 1.325 . . . . 0.0 108.798 -174.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -81.87 137.17 35.28 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.174 0.99 . . . . 0.0 109.593 174.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.5 p -83.0 -17.87 41.86 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -65.44 -42.63 92.2 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.319 1.048 . . . . 0.0 110.364 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.411 HG12 ' H ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -68.02 -54.56 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 125.87 1.668 . . . . 0.0 106.705 -176.103 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.21 158.46 43.94 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.9 m -115.2 3.6 14.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.745 0.702 . . . . 0.0 111.804 168.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -128.87 149.39 50.79 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.277 1.431 . . . . 0.0 109.28 171.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 124' ' ' LEU . . . -117.63 153.13 33.82 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.412 1.085 . . . . 0.0 108.457 165.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.89 -178.18 5.14 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.825 1.65 . . . . 0.0 106.779 157.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -153.78 141.02 12.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 -164.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.23 152.65 51.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 119.957 1.253 . . . . 0.0 108.678 175.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -114.55 153.61 29.75 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.438 0.695 . . . . 0.0 110.081 -175.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 tp -148.3 143.07 26.67 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.614 1.166 . . . . 0.0 107.996 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.81 173.35 35.05 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 108.104 -1.998 . . . . 0.0 108.104 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 m -59.88 121.88 12.85 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.513 1.125 . . . . 0.0 110.359 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.8 138.44 52.69 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.425 0.557 . . . . 0.0 110.413 172.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.0 tt -64.35 -31.12 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.576 0.75 . . . . 0.0 110.937 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -160.71 168.64 24.43 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.639 1.576 . . . . 0.0 107.441 165.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.36 -36.24 66.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.629 1.172 . . . . 0.0 111.311 166.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.29 -2.91 64.07 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 120.792 -1.193 . . . . 0.0 112.998 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -149.93 55.47 0.94 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.298 1.439 . . . . 0.0 109.716 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.6 p -69.43 -6.84 32.88 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.44 1.096 . . . . 0.0 111.886 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -85.89 3.54 41.37 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.931 1.293 . . . . 0.0 112.655 170.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.65 143.04 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.934 1.243 . . . . 0.0 111.63 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.02 151.26 28.5 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.954 1.301 . . . . 0.0 111.237 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.12 14.72 10.13 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 127.477 2.311 . . . . 0.0 114.059 -169.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 71.5 mt 55.26 -157.65 0.22 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.167 1.387 . . . . 0.0 111.227 -166.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 . . . . . 0 CA--C 1.539 0.546 0 C-N-CA 128.732 2.813 . . . . 0.0 107.748 178.086 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.831 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.98 131.55 45.0 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.484 1.114 . . . . 0.0 109.697 174.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.4 p -85.39 169.42 13.7 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 58.5 14.65 3.11 Favored 'General case' 0 C--N 1.335 -0.04 0 C-N-CA 126.247 1.819 . . . . 0.0 112.712 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.26 156.68 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 119.927 1.24 . . . . 0.0 107.819 -174.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -165.14 168.16 39.12 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -168.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.674 HG11 ' CD2' ' A' ' 177' ' ' PHE . 9.9 t -90.56 112.66 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -82.06 153.84 25.93 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.363 0.983 . . . . 0.0 108.52 160.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 mp -125.54 136.33 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 166.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 110' ' ' ALA . 9.0 mt -136.54 143.93 43.96 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.645 1.178 . . . . 0.0 107.838 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.521 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 24.5 p-10 -54.06 -74.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.278 1.431 . . . . 0.0 113.204 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.0 ptt85 179.61 -47.45 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 127.781 2.432 . . . . 0.0 107.994 -163.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 p -68.04 -29.12 68.02 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.169 0.895 . . . . 0.0 109.784 172.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.76 9.96 27.59 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.815 1.198 . . . . 0.0 111.176 -169.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.69 110.67 0.93 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 163.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.463 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -84.89 125.88 33.01 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.589 HD22 ' H ' ' A' ' 111' ' ' LEU . 0.4 OUTLIER -88.75 150.22 23.06 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -167.237 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -82.31 146.61 29.33 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.344 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.6 mt -88.16 61.87 6.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.844 0.858 . . . . 0.0 108.87 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.26 -15.16 14.55 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.063 1.345 . . . . 0.0 112.27 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.18 -7.38 60.51 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 125.872 1.701 . . . . 0.0 114.476 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.46 -6.36 5.84 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.158 1.479 . . . . 0.0 112.877 172.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.9 m -65.15 94.41 0.15 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.692 1.133 . . . . 0.0 108.623 171.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -67.51 131.65 46.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.786 1.235 . . . . 0.0 109.14 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.8 p -72.19 168.29 18.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.135 0.493 . . . . 0.0 110.906 170.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 14.2 m -26.37 113.85 0.05 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.527 2.331 . . . . 0.0 112.569 155.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -66.45 155.11 38.44 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 122.248 1.023 . . . . 0.0 108.74 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 98.6 m -127.12 112.99 15.81 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 169.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.7 m -58.06 126.25 26.63 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 167.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 69' ' ' ALA . 80.8 mt -98.73 -177.88 3.8 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 124.745 1.218 . . . . 0.0 108.679 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -147.53 169.69 19.03 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.805 1.642 . . . . 0.0 108.327 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -65.22 104.49 0.93 Allowed 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.852 0.72 . . . . 0.0 109.551 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.08 -160.8 26.8 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 124.643 1.116 . . . . 0.0 111.3 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 93.3 m -90.53 134.08 34.62 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.31 -1.112 . . . . 0.0 108.828 -179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -146.2 154.56 41.89 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.152 1.381 . . . . 0.0 110.418 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 55' ' ' ASN . 6.1 m -137.49 144.23 42.12 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.928 0.871 . . . . 0.0 109.987 -174.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.9 mt -104.72 118.35 56.62 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -65.14 157.02 59.65 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.349 1.366 . . . . 0.0 108.646 171.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -136.52 157.14 47.47 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 153.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -119.76 94.67 4.48 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.581 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -79.11 156.2 28.4 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 167.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -161.93 153.76 18.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 166.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.422 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 60.7 m-85 -63.73 130.5 44.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 163.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -103.19 151.52 22.53 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 163.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -115.67 137.79 51.73 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.593 0.757 . . . . 0.0 109.736 173.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 69.5 p -96.86 14.06 26.57 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.976 0.91 . . . . 0.0 111.034 170.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 169.5 -153.89 22.68 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.49 93.08 0.47 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.259 1.024 . . . . 0.0 110.157 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.06 119.07 5.3 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 44.3 p -76.65 163.62 64.67 Favored Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 165.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -74.73 172.71 15.71 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.118 1.212 . . . . 0.0 111.007 168.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.69 179.72 16.29 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 124.756 1.169 . . . . 0.0 111.283 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.9 140.67 58.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.422 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -132.9 73.34 1.52 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -115.5 158.7 22.2 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -157.97 160.48 37.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.69 0.677 . . . . 0.0 109.413 175.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -133.38 116.21 15.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.34 1.067 . . . . 0.0 110.233 -170.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.01 164.69 19.62 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.416 1.486 . . . . 0.0 111.22 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.9 p -119.21 157.08 28.7 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 155.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -115.91 146.68 41.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.522 1.129 . . . . 0.0 109.195 167.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -104.57 171.28 7.42 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.041 1.737 . . . . 0.0 108.316 168.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.4 t -129.2 128.21 66.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -130.52 84.48 2.2 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.478 1.111 . . . . 0.0 109.54 -172.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -70.12 151.98 44.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.562 -1.199 . . . . 0.0 112.242 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -161.64 174.3 13.51 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.42 1.488 . . . . 0.0 111.849 169.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.271 0 C-N-CA 125.405 1.479 . . . . 0.0 110.136 174.492 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 40.4 m -122.14 90.75 3.36 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -176.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.5 m -82.37 120.53 25.55 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.6 m -130.47 158.32 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.812 1.645 . . . . 0.0 109.415 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -79.28 143.02 35.64 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.097 -1.002 . . . . 0.0 108.984 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -105.21 -73.0 0.88 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -175.75 -174.21 42.12 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.884 0.342 . . . . 0.0 113.01 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.4 m -100.87 141.8 33.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.912 2.085 . . . . 0.0 108.635 -177.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.65 104.42 12.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -96.14 96.98 9.19 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 -176.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.674 ' CD2' HG11 ' A' ' 101' ' ' VAL . 79.9 m-85 -73.19 127.09 31.63 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 176.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -128.68 156.57 43.25 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.552 0.741 . . . . 0.0 111.636 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 142.37 -160.07 27.22 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -163.72 169.2 18.76 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.833 0.853 . . . . 0.0 108.97 -175.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 75.3 t -116.79 124.51 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 171.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 6.3 m -103.58 153.33 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 127.026 2.13 . . . . 0.0 108.782 174.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.04 25.67 0.09 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -168.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.25 1.121 1 C-N-CA 132.117 4.167 . . . . 0.0 114.544 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.41 -28.65 30.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.286 1.034 . . . . 0.0 113.745 -170.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.9 m -131.19 151.93 50.98 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.502 1.921 . . . . 0.0 108.071 -171.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.32 -10.56 51.93 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -169.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.323 14.2 p 45.9 97.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 129.36 3.064 . . . . 0.0 112.911 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -50.58 141.08 13.08 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.575 1.95 . . . . 0.0 110.719 -172.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.665 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . . . -59.5 -9.94 2.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.295 1.838 . . . . 0.0 111.945 -176.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.64 -7.41 88.16 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.115 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.8 p -124.13 -33.05 3.15 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.692 1.746 . . . . 0.0 112.18 -164.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.665 ' CG2' ' HA ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -52.48 -78.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 127.84 2.456 . . . . 0.0 109.924 166.138 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.486 ' H ' HG23 ' A' ' 28' ' ' VAL . 10.5 t70 -95.53 83.1 3.73 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -114.15 142.53 46.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.286 1.041 . . . . 0.0 108.92 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.5 m -105.06 88.77 2.95 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.6 t -69.39 98.51 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 174.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -72.42 103.09 3.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.3 mt -70.58 -15.59 62.77 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.899 0.88 . . . . 0.0 109.329 169.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.83 -175.93 49.55 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 124.599 1.095 . . . . 0.0 112.138 170.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.49 143.6 56.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 162.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.8 t -133.59 148.83 30.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 124.96 1.304 . . . . 0.0 107.674 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 28.2 mtm105 -79.14 132.87 36.7 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 182' ' ' VAL . 20.4 p -55.14 -24.25 25.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.609 173.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.25 -48.44 68.23 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.649 0.779 . . . . 0.0 110.141 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.54 3.61 5.96 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.0 mt -146.22 66.18 1.19 Allowed 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.679 1.592 . . . . 0.0 107.446 -166.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.13 -2.25 3.19 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -170.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.467 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 7.0 pm0 -146.92 151.79 37.61 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.998 1.319 . . . . 0.0 107.751 -176.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.441 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 47.5 tt0 -64.38 120.77 12.87 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.2 1.45 61.04 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-O 117.364 -1.798 . . . . 0.0 112.481 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.626 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -66.53 163.54 18.42 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 120.055 1.928 . . . . 0.0 110.122 169.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.1 p -146.74 155.12 42.15 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 122.014 -0.429 . . . . 0.0 110.472 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 84.8 p -68.22 178.64 1.83 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 164.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.0 p -30.89 -92.59 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 129.697 3.199 . . . . 0.0 114.633 173.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 154.11 113.22 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 131.284 3.834 . . . . 0.0 105.46 -172.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.28 105.25 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -173.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.21 154.71 44.87 Favored Glycine 0 C--N 1.311 -0.843 0 CA-C-N 112.45 -2.159 . . . . 0.0 110.721 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -152.58 176.6 11.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.242 1.817 . . . . 0.0 107.172 171.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.431 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 0.5 OUTLIER -143.0 163.18 33.49 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 120.885 -1.134 . . . . 0.0 110.6 177.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.9 mm -117.79 108.06 23.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -81.22 103.72 11.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.806 0.842 . . . . 0.0 109.312 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.9 mp -99.23 93.03 5.73 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -84.48 167.6 16.24 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.202 1.401 . . . . 0.0 109.094 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.32 31.06 17.89 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.162 0.985 . . . . 0.0 110.853 173.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 80.3 m -69.3 148.24 50.01 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.982 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -120.23 152.42 37.76 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 163.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 p -94.58 -20.84 19.26 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.62 -43.62 84.23 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.96 0.886 . . . . 0.0 110.555 -177.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.9 p -56.2 -52.92 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.647 1.579 . . . . 0.0 108.027 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.63 133.61 4.91 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 128.083 2.553 . . . . 0.0 104.773 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.3 m -87.81 -5.13 58.77 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.846 0.748 . . . . 0.0 111.805 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -128.3 164.29 22.93 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.089 1.356 . . . . 0.0 109.853 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.63 160.72 34.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 164.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.65 168.28 20.18 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 158.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.3 t -122.15 142.77 37.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.84 162.26 19.42 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 169.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -134.99 149.11 50.14 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.077 0.951 . . . . 0.0 109.191 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 tp -143.67 151.53 40.21 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.632 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . 174.2 169.69 36.62 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.3 m -66.28 126.84 30.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.246 1.023 . . . . 0.0 109.157 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.14 137.06 50.75 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.996 -0.44 . . . . 0.0 110.637 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.0 tt -59.78 -40.25 82.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 123.354 0.662 . . . . 0.0 110.285 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -152.09 167.9 26.99 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 127.13 2.172 . . . . 0.0 107.765 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.28 -40.08 95.24 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.564 1.546 . . . . 0.0 112.117 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.98 3.9 48.96 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.268 -0.74 . . . . 0.0 112.234 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -142.89 41.1 1.54 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.053 1.426 . . . . 0.0 110.67 -172.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.3 p -67.68 -6.31 20.01 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.875 -1.141 . . . . 0.0 113.317 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.78 -16.39 59.48 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.612 -1.305 . . . . 0.0 111.811 166.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.48 129.61 74.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 120.478 -1.389 . . . . 0.0 108.62 -160.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.632 HD21 ' HA3' ' A' ' 75' ' ' GLY . 3.8 mt -77.15 149.83 35.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.87 0.759 . . . . 0.0 111.504 -172.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.42 22.0 3.12 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.829 1.652 . . . . 0.0 113.494 -173.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.636 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 53.6 mt 49.7 -146.44 0.38 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.827 0.851 . . . . 0.0 109.067 -170.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 . . . . . 0 N--CA 1.451 -0.375 0 C-N-CA 126.042 1.737 . . . . 0.0 108.067 176.577 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 59.4 m . . . . . 0 N--CA 1.45 -0.431 0 CA-C-O 123.098 1.428 . . . . 0.0 114.504 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.77 113.66 3.16 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 125.281 1.432 . . . . 0.0 107.933 170.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.28 165.61 24.25 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.66 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 55.31 24.15 6.24 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.261 1.425 . . . . 0.0 113.162 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.2 p -145.0 151.6 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.24 175.43 27.54 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 173.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 177' ' ' PHE . 1.2 m -86.71 155.44 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 118.653 1.227 . . . . 0.0 108.384 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -124.52 147.01 48.66 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 170.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.511 HG22 HD23 ' A' ' 111' ' ' LEU . 3.8 mp -117.02 135.82 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 169.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 9.9 mt -126.41 159.48 33.17 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 128.408 2.683 . . . . 0.0 107.109 174.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -73.11 -106.37 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 123.956 0.785 . . . . 0.0 109.437 171.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -149.26 3.81 0.6 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.895 2.078 . . . . 0.0 110.624 -169.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.4 p -123.64 7.31 8.84 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.115 1.366 . . . . 0.0 109.493 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.09 1.89 90.19 Favored Glycine 0 C--N 1.342 0.861 0 C-N-CA 127.22 2.343 . . . . 0.0 114.27 -172.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.13 122.77 20.07 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 119.468 1.634 . . . . 0.0 107.917 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -87.29 147.4 25.54 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.034 0.533 . . . . 0.0 110.419 176.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.511 HD23 HG22 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -110.8 138.85 46.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.707 -173.283 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 m -69.62 147.31 50.85 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.73 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.9 mt -79.86 69.54 6.22 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.612 1.565 . . . . 0.0 108.303 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.51 -13.87 13.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.51 0.724 . . . . 0.0 111.242 174.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.437 ' O ' ' HE3' ' A' ' 155' ' ' LYS . . . 75.09 -9.03 13.27 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 120.626 -1.296 . . . . 0.0 113.278 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.54 -12.91 7.17 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.145 1.378 . . . . 0.0 111.272 174.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 92.3 m -76.77 90.91 3.46 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -72.71 172.84 9.96 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.322 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.3 p -120.7 -176.12 3.18 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.668 1.587 . . . . 0.0 110.036 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -33.46 111.52 0.11 Allowed 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 126.082 1.753 . . . . 0.0 111.328 169.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.99 155.8 38.7 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.5 m -151.72 114.95 4.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.7 m -58.52 133.2 55.6 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.528 1.931 . . . . 0.0 108.344 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.5 mt -86.57 178.54 7.04 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.302 1.441 . . . . 0.0 108.831 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.45 170.3 16.16 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.62 1.968 . . . . 0.0 107.067 156.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.73 128.2 35.0 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 166.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 61' ' ' CYS . . . 99.09 -168.24 22.09 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -171.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 90.6 m -83.33 139.91 32.76 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 120.776 -1.426 . . . . 0.0 111.806 -166.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -139.34 168.22 20.32 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 128.678 2.791 . . . . 0.0 109.37 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 85.0 m -155.47 158.9 39.29 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 120.347 -1.47 . . . . 0.0 110.369 176.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.4 mt -131.93 112.79 14.83 Favored Pre-proline 0 C--O 1.24 0.603 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.72 150.0 38.94 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.598 1.532 . . . . 0.0 108.348 170.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -128.4 165.74 20.05 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.534 1.934 . . . . 0.0 108.59 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -133.26 113.28 12.46 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 121.453 -0.78 . . . . 0.0 108.909 172.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -94.83 170.36 9.5 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.819 0.819 . . . . 0.0 109.263 173.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -160.68 179.55 8.46 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.036 1.334 . . . . 0.0 108.909 167.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -91.45 149.41 21.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 153.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -122.5 124.84 44.5 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.835 2.054 . . . . 0.0 106.365 173.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.626 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -88.92 145.73 25.35 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.441 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 54.1 p -108.58 10.36 27.13 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 125.525 1.53 . . . . 0.0 111.168 176.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 161.65 -151.69 21.94 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.38 91.44 0.26 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.548 1.939 . . . . 0.0 109.935 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.19 157.06 20.18 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.022 0.439 . . . . 0.0 110.942 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 77.0 p -112.06 158.16 37.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 170.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -78.65 162.01 27.48 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.025 1.817 . . . . 0.0 110.636 165.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.39 -76.12 0.18 Allowed Glycine 0 N--CA 1.462 0.373 0 O-C-N 121.391 -0.818 . . . . 0.0 113.922 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -158.93 155.42 27.63 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.339 1.856 . . . . 0.0 106.874 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.98 91.04 1.74 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -125.73 135.44 52.07 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -146.19 167.19 24.07 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 165.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.49 111.05 6.78 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 167.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.82 169.87 17.56 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 162.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.8 p -116.2 151.98 34.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 153.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -114.71 132.12 56.53 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.201 0.601 . . . . 0.0 109.502 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.437 ' HE3' ' O ' ' A' ' 115' ' ' GLY . 29.2 mtmt -97.28 171.2 8.58 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.97 0.908 . . . . 0.0 109.199 167.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.1 t -133.1 118.63 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 -172.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -105.55 83.64 1.97 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -62.2 150.78 37.93 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.775 0.83 . . . . 0.0 108.936 168.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -167.94 169.84 11.04 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 123.289 0.636 . . . . 0.0 110.779 -174.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 177.474 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.629 0 CA-C-O 121.067 0.46 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.6 m -133.14 119.47 19.98 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.343 2.257 . . . . 0.0 106.799 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 m -114.52 123.9 50.54 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.469 1.108 . . . . 0.0 109.152 -169.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.2 m -143.49 150.91 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 123.975 0.91 . . . . 0.0 110.988 -168.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.07 132.25 48.1 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.627 1.571 . . . . 0.0 109.274 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -101.36 -78.54 1.34 Allowed Glycine 0 CA--C 1.519 0.344 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -173.95 -170.54 37.44 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.905 0.764 . . . . 0.0 111.772 -170.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 28.3 m -114.15 120.83 41.84 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.736 1.614 . . . . 0.0 110.989 -170.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.5 t -104.94 96.9 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -80.81 94.82 6.51 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.421 ' CD2' HG21 ' A' ' 101' ' ' VAL . 58.9 m-85 -76.91 85.49 3.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -93.86 165.7 12.55 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.623 0.769 . . . . 0.0 109.518 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 147.7 -161.96 28.62 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -170.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -170.25 174.77 5.18 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 75.4 t -123.19 138.28 53.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 171.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 39' ' ' THR . 6.8 m -116.61 149.22 18.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 126.008 1.723 . . . . 0.0 109.08 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -76.77 33.08 0.14 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -171.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 C-N-CA 128.454 2.702 . . . . 0.0 112.019 175.217 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 118.343 -0.837 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -42.51 -42.78 3.44 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.001 1.32 . . . . 0.0 113.17 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.3 m 47.69 65.41 1.29 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.467 1.507 . . . . 0.0 110.538 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.5 t -146.12 168.51 20.78 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.577 0.751 . . . . 0.0 109.09 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.7 t 70.21 147.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 127.423 2.289 . . . . 0.0 111.157 173.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -71.94 -45.09 62.39 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.256 -173.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 143.05 84.84 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 107.219 -2.353 . . . . 0.0 107.219 -175.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.77 165.82 10.42 Favored Glycine 0 N--CA 1.44 -1.079 0 N-CA-C 106.42 -2.672 . . . . 0.0 106.42 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.41 91.83 5.14 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 172.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 t 45.43 71.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.812 1.245 . . . . 0.0 110.426 157.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -85.5 50.97 2.06 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.304 -0.873 . . . . 0.0 109.214 -168.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -156.66 118.05 3.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -135.38 54.73 1.91 Allowed 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.419 1.088 . . . . 0.0 109.911 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.87 -47.23 76.82 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -129.94 -154.6 0.64 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.832 1.253 . . . . 0.0 109.671 -164.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.59 70.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 127.574 2.349 . . . . 0.0 110.706 172.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -76.11 58.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 120.446 -1.409 . . . . 0.0 110.559 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -129.89 95.6 4.0 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.848 1.259 . . . . 0.0 109.978 170.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.74 114.71 13.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.479 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -49.29 -34.92 16.56 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 126.587 1.955 . . . . 0.0 111.189 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.8 m -125.76 146.51 49.74 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 127.376 2.27 . . . . 0.0 107.649 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.93 1.81 55.31 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -163.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.307 13.7 p 49.54 113.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 129.81 3.244 . . . . 0.0 114.275 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -53.0 141.78 21.41 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.423 1.089 . . . . 0.0 110.736 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.493 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -51.08 -39.12 55.31 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.768 1.227 . . . . 0.0 109.643 171.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.19 13.84 1.84 Allowed Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.799 -1.0 . . . . 0.0 114.522 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 t -144.63 -36.69 0.31 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.665 1.586 . . . . 0.0 111.515 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 25' ' ' ALA . 10.6 p -58.08 -49.87 80.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.424 0 CA-C-N 119.698 1.135 . . . . 0.0 109.095 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -121.94 75.52 1.22 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -171.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -105.68 138.21 42.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.388 -169.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 m -106.87 99.93 9.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.5 t -86.33 101.22 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -92.12 98.42 11.53 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -174.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.5 mt -75.94 -7.28 54.2 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.304 2.242 . . . . 0.0 109.883 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.54 -172.64 27.3 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 124.108 0.861 . . . . 0.0 111.734 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -77.67 142.39 38.85 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.943 0.878 . . . . 0.0 110.915 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.7 t -124.01 150.77 28.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 125.538 1.535 . . . . 0.0 108.095 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.92 137.66 32.98 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.0 p -60.39 -21.79 62.59 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 122.931 0.492 . . . . 0.0 112.253 171.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.47 -48.78 47.48 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-O 122.439 1.114 . . . . 0.0 111.312 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.2 m -79.19 5.87 11.1 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.221 1.008 . . . . 0.0 113.448 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.567 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 13.7 mt -142.65 72.08 1.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.696 1.998 . . . . 0.0 107.114 -170.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.72 -7.19 1.68 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -171.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -145.51 162.82 36.49 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.651 1.18 . . . . 0.0 108.056 174.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -62.65 117.84 6.82 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 173.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.444 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 106.6 -10.33 41.84 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-O 118.305 -1.275 . . . . 0.0 112.471 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.34 147.69 52.0 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.809 1.305 . . . . 0.0 109.432 171.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.1 p -143.72 155.62 44.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.528 0.68 . . . . 0.0 111.736 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.4 p -66.7 -177.69 0.62 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.388 0.675 . . . . 0.0 110.56 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -59.56 -22.32 61.56 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 119.56 -1.962 . . . . 0.0 113.397 171.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 74.07 164.83 0.28 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 127.335 2.254 . . . . 0.0 110.782 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.2 t -149.2 142.63 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.17 125.3 8.3 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -115.6 158.52 22.56 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 170.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.512 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 2.7 m-20 -131.14 173.9 10.57 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.085 0.857 . . . . 0.0 110.808 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.9 mm -121.57 109.84 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.602 1.161 . . . . 0.0 107.935 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.36 109.38 17.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.539 1.936 . . . . 0.0 109.5 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.66 106.61 17.22 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 127.218 2.207 . . . . 0.0 108.507 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -87.05 158.55 19.19 Favored 'General case' 0 CA--C 1.523 -0.085 0 C-N-CA 124.539 1.135 . . . . 0.0 110.667 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 32.98 57.75 0.45 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.269 2.628 . . . . 0.0 113.145 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.9 m -64.36 142.3 58.47 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 125.705 1.602 . . . . 0.0 110.602 168.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -120.32 132.48 55.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 127.305 2.242 . . . . 0.0 108.73 171.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.7 p -92.74 -9.43 40.67 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -67.32 -47.66 69.86 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.036 0.834 . . . . 0.0 109.871 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.479 HG11 ' HA ' ' A' ' 20' ' ' ALA . 3.6 p -65.14 -49.1 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.237 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.67 114.04 2.6 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.44 1.896 . . . . 0.0 108.294 -170.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.8 m -76.75 -2.24 32.09 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.711 169.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -137.6 164.69 28.16 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.986 1.721 . . . . 0.0 112.03 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.96 140.35 26.84 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.64 166.09 13.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.537 1.935 . . . . 0.0 106.292 163.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 t -125.71 157.89 34.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.57 167.64 19.67 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 164.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -130.82 155.86 45.98 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.549 1.54 . . . . 0.0 109.94 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 tp -150.79 134.04 16.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.909 0.484 . . . . 0.0 111.192 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.6 172.67 42.53 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.124 0.869 . . . . 0.0 111.325 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 2.3 m -55.39 125.79 22.35 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.494 1.117 . . . . 0.0 108.347 171.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.55 139.83 44.02 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.424 1.011 . . . . 0.0 108.666 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.1 tt -57.06 -39.39 66.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.032 0.533 . . . . 0.0 111.112 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -160.59 177.75 10.2 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.672 1.589 . . . . 0.0 108.025 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.93 -37.77 79.1 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.396 0.678 . . . . 0.0 111.549 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.06 5.26 55.01 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.622 0.63 . . . . 0.0 111.966 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -146.91 50.47 1.11 Allowed 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.146 -1.208 . . . . 0.0 110.1 -171.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.5 p -67.03 -8.87 33.37 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.355 1.462 . . . . 0.0 111.749 171.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -81.77 -11.92 58.79 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 167.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.8 t -125.83 136.3 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 121.308 1.867 . . . . 0.0 109.964 -161.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.85 156.01 30.66 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 118.923 0.783 . . . . 0.0 111.737 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.435 ' HB3' ' HB ' ' A' ' 76' ' ' THR . . . -94.58 19.3 10.02 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.485 1.514 . . . . 0.0 113.866 -171.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.3 mt 55.19 -156.87 0.23 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.943 0.897 . . . . 0.0 109.902 -165.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -152.14 -176.94 5.88 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.733 1.613 . . . . 0.0 108.659 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t 67.58 -143.99 0.13 Allowed 'General case' 0 C--N 1.339 0.136 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.7 m -46.15 86.07 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.916 2.086 . . . . 0.0 112.297 169.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.5 7.77 0.21 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.258 1.023 . . . . 0.0 112.946 161.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.35 18.1 4.01 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 126.079 1.752 . . . . 0.0 110.516 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -153.95 -26.56 0.04 OUTLIER Glycine 0 CA--C 1.531 1.047 0 CA-C-N 119.444 1.02 . . . . 0.0 113.961 -176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.7 m -60.43 175.06 0.48 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 122.501 1.143 . . . . 0.0 109.536 162.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.19 153.97 24.61 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.611 -0.681 . . . . 0.0 109.292 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.0 p -115.85 164.69 14.03 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.906 0.882 . . . . 0.0 109.194 170.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 57.05 20.82 5.76 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.928 1.691 . . . . 0.0 111.889 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -138.4 152.04 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.46 177.94 28.22 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.427 HG21 ' CD2' ' A' ' 177' ' ' PHE . 0.7 OUTLIER -90.48 155.05 3.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.392 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -126.45 167.52 15.47 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 120.744 -1.223 . . . . 0.0 110.558 158.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.12 130.59 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 127.428 2.291 . . . . 0.0 105.33 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.0 mt -122.19 140.81 52.14 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -62.68 171.55 2.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 122.216 1.008 . . . . 0.0 110.252 164.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -53.22 -25.82 15.45 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.462 1.505 . . . . 0.0 113.966 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.1 p -75.13 -23.76 57.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 119.677 1.126 . . . . 0.0 108.974 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.72 6.44 40.61 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.504 2.002 . . . . 0.0 112.708 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.52 131.33 34.39 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.247 1.524 . . . . 0.0 109.31 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.88 120.0 14.96 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.903 1.281 . . . . 0.0 111.701 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.0 mt -78.76 157.42 28.49 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.341 0.656 . . . . 0.0 109.756 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 m -100.69 144.97 29.03 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.426 1.09 . . . . 0.0 109.545 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.5 mt -89.22 70.79 8.29 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.454 1.102 . . . . 0.0 108.743 -173.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.55 -9.84 11.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.301 0.64 . . . . 0.0 112.316 174.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.02 -9.56 31.39 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.743 -1.032 . . . . 0.0 112.871 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.33 -8.34 5.82 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.087 1.355 . . . . 0.0 113.083 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.0 m -67.16 91.48 0.23 Allowed 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 168.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -64.89 164.2 12.96 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.795 0.838 . . . . 0.0 109.609 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 57.9 p -133.58 -175.93 3.98 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.662 1.185 . . . . 0.0 110.888 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -32.36 112.89 0.12 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 128.105 2.562 . . . . 0.0 112.431 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -73.26 108.58 6.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 88.4 m -81.95 113.3 19.76 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 167.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 93.8 m -57.95 121.0 9.52 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 160.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 99.0 mt -77.16 -170.06 1.57 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.393 1.477 . . . . 0.0 109.694 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.433 ' H ' HD21 ' A' ' 129' ' ' ASN . 0.6 OUTLIER -151.64 161.46 42.64 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 127.167 2.187 . . . . 0.0 107.593 168.651 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -64.49 140.19 58.84 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 170.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.25 -111.22 4.12 Favored Glycine 0 N--CA 1.467 0.704 0 CA-C-O 118.148 -1.362 . . . . 0.0 111.54 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 m -125.33 139.88 53.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.322 2.061 . . . . 0.0 110.488 -171.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.433 HD21 ' H ' ' A' ' 125' ' ' ASN . 12.1 m-80 -142.32 151.97 42.48 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 124.313 1.045 . . . . 0.0 109.959 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.512 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 97.1 m -132.72 124.22 27.74 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.017 0.527 . . . . 0.0 109.902 170.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.0 116.02 64.12 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 166.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.98 155.99 34.15 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.895 1.73 . . . . 0.0 110.51 166.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -139.1 172.69 12.47 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 127.743 2.417 . . . . 0.0 108.263 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.99 155.97 34.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 162.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -137.6 149.35 46.57 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.705 1.202 . . . . 0.0 108.014 171.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -161.04 153.68 20.73 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.404 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 77.3 m-85 -70.02 133.32 47.11 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 174.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.444 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 60.8 t80 -113.11 124.82 53.47 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.384 1.474 . . . . 0.0 107.85 176.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.43 141.65 29.81 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 170.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.4 p -105.48 11.19 32.83 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.862 0.465 . . . . 0.0 111.258 172.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.22 -153.8 23.63 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.54 93.65 0.05 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.94 1.696 . . . . 0.0 109.893 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -70.82 170.01 13.43 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 122.976 0.511 . . . . 0.0 111.443 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.8 p -136.49 159.19 71.51 Favored Pre-proline 0 N--CA 1.467 0.386 0 C-N-CA 123.441 0.696 . . . . 0.0 110.528 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -75.12 177.08 9.08 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.63 1.554 . . . . 0.0 110.434 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.01 -95.84 0.17 Allowed Glycine 0 CA--C 1.522 0.494 0 O-C-N 121.606 -0.684 . . . . 0.0 111.695 168.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.03 157.36 45.43 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.884 1.674 . . . . 0.0 107.189 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.404 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -146.51 66.41 1.18 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.592 0.71 . . . . 0.0 110.612 -176.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -108.45 150.95 26.71 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.28 163.03 40.27 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.616 1.566 . . . . 0.0 109.161 170.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -138.95 96.35 3.11 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.27 167.66 20.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.492 166.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.2 p -106.88 164.84 11.78 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 147.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -122.35 157.38 31.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 168.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -117.49 166.66 12.1 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.609 1.564 . . . . 0.0 108.595 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 8.5 t -127.86 106.65 15.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -88.1 92.64 9.22 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 167.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 73.5 m-85 -63.42 153.97 33.57 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 163.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -160.84 170.46 20.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.208 0.603 . . . . 0.0 110.662 168.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.59 50.95 2.07 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-O 118.251 -1.305 . . . . 0.0 111.784 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -109.27 -1.57 31.35 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 117.847 0.824 . . . . 0.0 114.232 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.65 171.12 12.84 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.776 1.655 . . . . 0.0 110.872 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.79 -51.47 4.04 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.517 1.532 . . . . 0.0 112.146 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 151.35 -25.22 0.97 Allowed Glycine 0 C--N 1.334 0.428 0 CA-C-N 118.496 1.148 . . . . 0.0 114.718 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -124.34 -83.16 0.56 Allowed Glycine 0 C--N 1.329 0.174 0 N-CA-C 107.2 -2.36 . . . . 0.0 107.2 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 46.71 98.99 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 129.513 3.125 . . . . 0.0 113.156 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -130.06 153.71 48.18 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.154 1.382 . . . . 0.0 110.946 -170.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 87.2 m -142.61 108.49 5.16 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.59 1.956 . . . . 0.0 107.647 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 15.5 m -97.0 94.04 6.95 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.789 0.836 . . . . 0.0 110.15 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -85.32 168.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 124.121 0.968 . . . . 0.0 110.018 168.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -63.62 174.97 1.18 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.056 0.542 . . . . 0.0 109.688 160.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -144.64 -34.17 0.08 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-O 117.817 -1.546 . . . . 0.0 114.416 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 147.58 -176.8 26.25 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 119.412 1.606 . . . . 0.0 112.67 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.1 m -101.34 140.05 36.16 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.291 1.836 . . . . 0.0 108.908 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.56 96.48 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -83.42 88.49 6.98 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.427 ' CD2' HG21 ' A' ' 101' ' ' VAL . 58.8 m-85 -66.19 113.06 4.26 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 170.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -120.42 161.6 20.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 135.88 -174.19 21.49 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -170.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -161.51 172.14 16.92 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -168.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 39.2 t -124.93 133.45 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.4 m -112.61 148.19 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 C-N-CA 127.113 2.165 . . . . 0.0 108.365 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.77 31.23 0.09 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.686 2.395 . . . . 0.0 112.429 -170.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 127.856 2.463 . . . . 0.0 110.028 -165.488 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.63 87.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.822 0.737 . . . . 0.0 112.229 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . 0.383 13.5 t 46.95 -157.54 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.428 1.491 . . . . 0.0 109.991 -162.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.1 p 24.24 82.74 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.687 2.395 . . . . 0.0 115.367 159.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.8 p -155.79 121.31 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 119.429 1.013 . . . . 0.0 108.586 170.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 24.52 84.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 130.416 3.487 . . . . 0.0 113.337 173.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.87 -102.46 1.33 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 106.109 -2.796 . . . . 0.0 106.109 -162.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.07 60.99 0.22 Allowed Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 117.185 -1.897 . . . . 0.0 110.173 176.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.256 1.7 t 45.54 100.37 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 128.766 2.826 . . . . 0.0 111.977 -173.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.256 1.3 m 54.56 21.08 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.257 1.423 . . . . 0.0 113.789 166.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.8 p80 40.73 61.99 1.51 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.969 2.108 . . . . 0.0 113.194 -162.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -142.58 87.99 2.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 104.81 -2.292 . . . . 0.0 104.81 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -133.49 98.05 4.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.63 8.07 0.06 OUTLIER Glycine 0 CA--C 1.529 0.912 0 C-N-CA 123.282 0.467 . . . . 0.0 113.651 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -140.62 -153.65 0.47 Allowed 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.498 HG11 HG12 ' A' ' 170' ' ' VAL . 9.8 p -56.13 -39.97 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 119.6 1.091 . . . . 0.0 110.129 159.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m 37.18 49.59 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 126.981 2.112 . . . . 0.0 111.685 -171.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -139.25 144.0 38.23 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 160.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.547 ' HB1' ' CE2' ' A' ' 158' ' ' TYR . . . -173.34 137.77 0.68 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 128.766 2.827 . . . . 0.0 104.375 159.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.7 -18.04 61.05 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -172.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.0 m -133.77 160.04 38.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.15 109.45 19.91 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.621 1.568 . . . . 0.0 107.867 161.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -50.15 125.86 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 152.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.68 151.77 40.93 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.713 0.688 . . . . 0.0 109.698 174.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.75 -29.26 53.3 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 120.952 -1.092 . . . . 0.0 112.396 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.38 -50.48 66.36 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 123.91 0.767 . . . . 0.0 111.26 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.0 m -72.03 -27.05 62.45 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.899 0.88 . . . . 0.0 111.286 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.1 t -60.74 -25.87 36.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.368 1.067 . . . . 0.0 113.035 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -145.48 30.63 1.11 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.691 1.196 . . . . 0.0 111.488 -166.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -77.87 133.27 38.17 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 120.828 -1.17 . . . . 0.0 108.663 -162.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 176' ' ' HIS . 4.4 m -100.88 103.05 14.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.3 t -82.8 95.72 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -176.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -77.82 95.51 4.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -71.43 -12.31 61.34 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.983 1.313 . . . . 0.0 111.162 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.18 -177.89 31.37 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.325 0.964 . . . . 0.0 112.431 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -67.84 121.01 15.09 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.206 1.403 . . . . 0.0 109.748 168.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.5 t -99.82 149.26 5.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 126.063 1.745 . . . . 0.0 106.961 171.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -82.93 133.85 35.1 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.9 p -58.77 -19.37 40.14 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.817 0.847 . . . . 0.0 111.048 170.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.91 -50.09 61.77 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 120.746 -1.221 . . . . 0.0 109.336 170.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.437 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 66.4 m -73.12 -2.31 20.95 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.554 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 13.5 mt -141.23 79.19 1.68 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.403 1.481 . . . . 0.0 107.366 -171.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.31 -0.27 1.27 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.44 ' OE1' ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -148.69 159.42 44.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 177.162 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.439 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 35.6 tt0 -62.21 118.17 7.04 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.11 6.55 66.66 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 126.347 1.927 . . . . 0.0 112.885 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.44 ' HB2' ' OE1' ' A' ' 44' ' ' GLN . . . -57.84 149.02 23.48 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 148.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.37 153.57 42.1 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -178.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.9 p -70.3 171.78 9.34 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.366 -0.834 . . . . 0.0 109.065 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -47.5 -66.78 0.35 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -173.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 154.19 136.71 0.0 OUTLIER 'General case' 0 C--O 1.233 0.224 0 C-N-CA 128.199 2.6 . . . . 0.0 106.74 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.6 t -137.7 138.38 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 173.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.64 127.4 9.21 Favored Glycine 0 CA--C 1.516 0.148 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -132.47 87.95 2.48 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 123.307 1.527 . . . . 0.0 109.263 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.513 ' HB2' HG22 ' A' ' 130' ' ' THR . 6.7 p30 -81.13 160.77 24.33 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 120.626 -1.297 . . . . 0.0 111.487 -173.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 130' ' ' THR . 4.2 mm -112.03 108.71 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 175.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -76.31 110.82 11.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.69 1.996 . . . . 0.0 109.113 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.56 108.6 18.16 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.474 1.51 . . . . 0.0 107.173 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.0 168.46 10.94 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.489 1.116 . . . . 0.0 109.832 171.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t70 51.46 36.26 16.3 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.828 2.451 . . . . 0.0 116.76 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.9 m -69.89 85.62 0.5 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.626 1.97 . . . . 0.0 114.736 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -72.98 111.8 8.42 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.454 -0.778 . . . . 0.0 112.375 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.6 p -62.5 -12.86 24.8 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.374 1.07 . . . . 0.0 112.234 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -66.37 -38.35 87.36 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.359 0.981 . . . . 0.0 110.272 173.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.55 -58.15 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.37 143.83 19.19 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.186 1.394 . . . . 0.0 107.743 -172.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.2 p -88.19 -12.79 42.84 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.66 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -140.82 156.15 46.21 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 127.125 2.17 . . . . 0.0 107.797 -166.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.56 85.94 1.2 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -173.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.11 173.52 11.2 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 123.642 0.777 . . . . 0.0 109.293 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.405 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -148.14 107.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -170.438 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.71 163.8 13.21 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 124.037 0.935 . . . . 0.0 108.922 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CE2' HG21 ' A' ' 103' ' ' ILE . 6.7 m-85 -135.36 148.61 49.47 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.758 0.823 . . . . 0.0 109.652 -168.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.426 HD13 ' C ' ' A' ' 114' ' ' ASP . 13.2 tp -146.91 132.71 18.97 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.122 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.27 175.53 39.55 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 172.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.5 m -60.2 134.04 56.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.67 1.188 . . . . 0.0 108.79 172.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.81 132.06 35.18 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.207 1.003 . . . . 0.0 109.003 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.7 tt -60.5 -34.26 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 122.83 0.452 . . . . 0.0 110.609 -178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -153.25 164.74 37.55 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 126.382 1.873 . . . . 0.0 109.623 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.72 -31.04 46.62 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.113 2.565 . . . . 0.0 115.061 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.97 -40.18 6.28 Favored Glycine 0 CA--C 1.518 0.274 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 174.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -86.71 43.59 1.09 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.435 1.494 . . . . 0.0 110.51 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.6 p -63.81 -12.88 39.64 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.816 1.646 . . . . 0.0 112.232 173.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -82.13 -9.44 59.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.517 -0.739 . . . . 0.0 112.629 171.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 t -127.98 137.24 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 119.726 1.148 . . . . 0.0 109.855 -165.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.95 149.17 29.48 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.306 1.442 . . . . 0.0 110.743 -168.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.71 14.02 22.54 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -162.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.8 mt 51.54 -169.21 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.509 1.124 . . . . 0.0 110.41 -162.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -140.32 174.8 10.16 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 126.364 1.866 . . . . 0.0 108.292 -177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.2 p 59.66 -170.06 0.14 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.747 1.219 . . . . 0.0 110.277 172.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.9 m 24.76 71.48 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.716 2.406 . . . . 0.0 114.853 158.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -45.96 -34.63 4.1 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.486 1.114 . . . . 0.0 113.198 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.43 16.92 4.02 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.923 1.289 . . . . 0.0 111.494 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.91 -27.26 4.66 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.792 1.187 . . . . 0.0 110.894 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.5 m -61.04 162.61 6.9 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.35 1.071 . . . . 0.0 108.345 161.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.42 145.25 33.41 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.008 -1.451 . . . . 0.0 107.562 162.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 p -118.24 160.87 20.84 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 124.628 1.171 . . . . 0.0 109.156 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 59.83 27.04 16.3 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.511 0.725 . . . . 0.0 110.635 -173.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.404 HG21 HD13 ' A' ' 42' ' ' LEU . 2.0 p -143.74 145.45 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 121.215 -0.928 . . . . 0.0 108.667 170.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.88 174.12 23.74 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.411 HG11 ' CG ' ' A' ' 177' ' ' PHE . 99.3 t -86.45 147.2 5.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -129.99 140.81 50.83 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.333 1.053 . . . . 0.0 108.575 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.504 HG22 HD12 ' A' ' 111' ' ' LEU . 5.3 mp -108.3 134.99 48.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 110' ' ' ALA . 9.8 mt -134.11 132.77 40.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.959 1.704 . . . . 0.0 107.673 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.424 ' CB ' ' HB2' ' A' ' 120' ' ' SER . 1.5 t70 -73.11 -170.85 0.81 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.724 1.147 . . . . 0.0 112.046 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -48.63 -37.15 17.47 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.757 1.623 . . . . 0.0 111.854 167.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 p -77.83 -5.84 52.17 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.512 1.925 . . . . 0.0 112.484 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 57.25 25.12 53.8 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.755 1.169 . . . . 0.0 112.975 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.27 138.78 32.74 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.423 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -72.71 154.21 40.81 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.231 0.469 . . . . 0.0 111.704 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.504 HD12 HG22 ' A' ' 103' ' ' ILE . 90.3 mt -127.22 119.92 27.51 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.238 1.015 . . . . 0.0 110.487 -167.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.9 m -74.11 156.93 36.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.822 0.849 . . . . 0.0 111.578 -171.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.7 mt -99.3 71.57 1.8 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.889 1.676 . . . . 0.0 108.151 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.426 ' C ' HD13 ' A' ' 74' ' ' LEU . 79.2 m-20 -120.71 -20.94 6.85 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.317 0.647 . . . . 0.0 111.016 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.35 -22.53 8.49 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.488 1.518 . . . . 0.0 113.092 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.55 -40.78 9.68 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 119.091 1.446 . . . . 0.0 110.638 168.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 38.3 m -55.96 99.74 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.71 2.004 . . . . 0.0 110.595 -174.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -71.11 173.71 7.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.183 1.393 . . . . 0.0 111.396 -173.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 59.7 p -115.51 -160.74 0.76 Allowed 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.593 1.157 . . . . 0.0 111.834 -170.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.424 ' HB2' ' CB ' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -65.7 147.37 53.5 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.596 0.758 . . . . 0.0 109.027 172.103 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -89.71 141.41 28.64 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 120.659 -1.275 . . . . 0.0 107.983 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.1 m -121.29 110.31 15.98 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 128.537 2.735 . . . . 0.0 104.163 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.5 m -68.53 117.05 9.78 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.169 1.387 . . . . 0.0 107.808 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.9 mt -64.69 173.69 2.11 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.999 1.72 . . . . 0.0 111.369 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.39 159.12 40.18 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 127.676 2.39 . . . . 0.0 107.058 156.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -58.31 129.58 42.7 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.02 -140.55 15.67 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -172.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.5 m -107.51 142.7 36.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.886 1.343 . . . . 0.0 109.826 -172.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -143.18 173.53 11.5 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 127.923 2.489 . . . . 0.0 108.532 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 55' ' ' ASN . 86.3 m -157.15 141.25 16.27 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.357 -1.465 . . . . 0.0 109.955 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.27 116.04 65.78 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.593 1.557 . . . . 0.0 107.361 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -86.25 78.27 2.18 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 124.121 3.214 . . . . 0.0 112.171 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.405 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 97.5 m-85 -66.22 162.72 19.34 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.393 -0.817 . . . . 0.0 111.216 171.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -115.42 141.26 48.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.345 154.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -101.55 145.32 29.18 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 126.299 1.839 . . . . 0.0 108.462 160.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -149.61 152.56 35.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 159.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.417 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 69.9 m-85 -70.03 151.23 45.78 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 163.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -129.16 116.11 18.71 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.921 2.488 . . . . 0.0 106.626 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.73 146.72 29.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.439 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 29.3 p -114.27 7.0 16.35 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.095 0.958 . . . . 0.0 112.068 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 168.79 -150.41 15.78 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.5 94.59 0.03 OUTLIER 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.621 1.169 . . . . 0.0 108.756 170.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -79.42 128.98 34.03 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.221 1.008 . . . . 0.0 108.734 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.3 p -90.84 171.58 8.04 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.151 1.38 . . . . 0.0 109.855 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -88.13 172.92 5.05 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.172 1.915 . . . . 0.0 110.371 166.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.96 -95.23 0.14 Allowed Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -144.1 155.7 44.06 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 127.718 2.407 . . . . 0.0 107.574 174.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.417 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -143.44 92.14 2.33 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.548 1.166 . . . . 0.0 108.238 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -126.15 145.32 50.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.32 153.18 34.31 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.535 1.534 . . . . 0.0 107.41 169.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.43 98.14 4.6 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.87 1.268 . . . . 0.0 110.521 176.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.81 163.49 23.41 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.665 171.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.2 p -99.8 161.98 13.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 147.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -122.96 153.62 39.5 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 162.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -113.71 168.21 9.97 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.534 1.934 . . . . 0.0 107.954 172.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.494 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 18.4 t -121.67 134.73 64.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -122.09 87.55 2.77 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.547 ' CE2' ' HB1' ' A' ' 19' ' ' ALA . 84.4 m-85 -57.11 149.69 18.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.188 166.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -165.6 164.11 19.24 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.408 1.483 . . . . 0.0 109.59 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 136.66 -8.69 3.97 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 117.855 -1.525 . . . . 0.0 113.419 173.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -64.37 -70.35 1.1 Allowed Glycine 0 C--N 1.335 0.49 0 CA-C-N 119.521 1.661 . . . . 0.0 109.934 175.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.45 -9.67 83.13 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-O 118.182 -1.344 . . . . 0.0 113.508 -171.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.01 -74.31 2.2 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-N 118.841 1.321 . . . . 0.0 110.744 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -55.54 -77.35 0.16 Allowed Glycine 0 CA--C 1.521 0.429 0 C-N-CA 125.949 1.738 . . . . 0.0 111.813 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.61 83.94 0.23 Allowed Glycine 0 CA--C 1.519 0.327 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -172.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -156.83 123.04 4.91 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -154.02 168.8 25.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.289 1.036 . . . . 0.0 111.853 -172.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.0 m -134.23 95.58 3.44 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.113 1.765 . . . . 0.0 107.366 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.2 m -76.93 133.59 39.18 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 168.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.498 HG12 HG11 ' A' ' 16' ' ' VAL . 13.1 m -149.06 171.44 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 127.013 2.125 . . . . 0.0 109.097 -175.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -68.11 170.67 8.09 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.416 1.007 . . . . 0.0 109.682 172.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -135.89 -52.21 0.07 OUTLIER Glycine 0 CA--C 1.522 0.524 0 C-N-CA 124.341 0.972 . . . . 0.0 111.063 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 161.08 -162.14 33.44 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 118.043 0.922 . . . . 0.0 111.352 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.7 m -127.15 112.95 15.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.988 2.115 . . . . 0.0 107.247 -166.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 7.7 t -105.16 106.72 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' HIS . . . . . 0.432 ' HB2' HG23 ' A' ' 31' ' ' THR . 28.9 m-70 -96.75 87.76 4.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -169.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.411 ' CG ' HG11 ' A' ' 101' ' ' VAL . 73.5 m-85 -68.37 113.07 5.62 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -120.07 166.33 13.54 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.035 -1.041 . . . . 0.0 108.261 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 143.82 -161.57 27.78 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -170.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -165.82 172.44 11.67 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.59 135.47 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 166.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' A' ' 184' ' ' ALA . 3.3 m -117.84 151.65 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 127.637 2.375 . . . . 0.0 107.677 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -74.03 24.59 0.08 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.781 1.632 . . . . 0.0 113.5 -169.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.246 0.91 0 C-N-CA 131.402 3.881 . . . . 0.0 112.565 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 116.704 -1.617 . . . . 0.0 107.272 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.37 50.12 15.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.37 1.468 . . . . 0.0 110.945 -173.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.7 t -69.46 152.88 44.33 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 169.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.7 t -64.77 165.07 11.07 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 158.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.58 101.2 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -60.3 -49.92 75.7 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.264 0.626 . . . . 0.0 110.216 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.33 171.32 36.53 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 127.357 2.408 . . . . 0.0 107.249 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.08 9.52 31.88 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.383 -0.676 . . . . 0.0 112.296 -175.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.299 0.4 OUTLIER -146.22 70.32 1.22 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 172.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.271 12.9 p 32.92 62.71 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 128.623 2.769 . . . . 0.0 115.752 175.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -66.87 -11.67 56.57 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -169.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 67.36 56.31 0.62 Allowed 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 126.672 1.989 . . . . 0.0 106.771 171.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.9 67.89 9.16 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -170.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.03 36.25 1.77 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -167.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER 71.2 163.49 0.26 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.91 1.284 . . . . 0.0 109.21 -163.622 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.647 HG11 HG12 ' A' ' 170' ' ' VAL 0.371 11.7 p 54.82 -28.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 1 C-N-CA 133.447 4.699 . . . . 0.0 114.965 -175.863 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 15' ' ' GLU 0.259 4.6 m 38.3 33.44 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.288 1 C-N-CA 132.106 4.162 . . . . 0.0 112.708 178.928 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -146.61 94.42 2.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.427 1.891 . . . . 0.0 106.018 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.81 111.61 7.76 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 161.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.48 -20.65 64.78 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -160.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.3 m -123.22 160.57 26.29 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 127.895 2.478 . . . . 0.0 107.792 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.8 -20.27 27.82 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -167.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.261 8.6 t 54.81 124.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 130.143 3.377 . . . . 0.0 111.509 -163.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -77.65 164.63 25.14 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.138 1.775 . . . . 0.0 110.676 -174.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.04 -39.98 60.41 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.623 -1.298 . . . . 0.0 110.598 164.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.38 2.71 36.1 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.962 1.744 . . . . 0.0 113.979 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 63.4 p -141.73 -9.85 0.92 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 119.886 1.843 . . . . 0.0 113.488 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.0 p -72.09 -65.42 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 119.15 0.886 . . . . 0.0 110.612 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -126.32 46.08 2.52 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.202 -0.936 . . . . 0.0 108.499 -160.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -82.91 144.47 30.02 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.543 1.137 . . . . 0.0 109.81 -163.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.71 154.52 27.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 164.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.9 t -131.28 96.97 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 165.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.85 94.87 3.96 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.831 HD23 ' CG1' ' A' ' 52' ' ' VAL . 2.1 mt -68.46 -10.08 53.01 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.555 1.942 . . . . 0.0 110.224 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.5 -177.9 32.55 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 124.945 1.26 . . . . 0.0 111.304 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -69.35 138.68 53.92 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 122.067 -0.666 . . . . 0.0 109.373 167.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -121.01 147.64 24.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 125.582 1.553 . . . . 0.0 106.926 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -83.39 131.93 35.02 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.0 p -59.1 -23.03 61.74 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 118.904 0.775 . . . . 0.0 110.397 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.89 -27.45 66.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.064 1.346 . . . . 0.0 112.134 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.3 m -80.21 -15.4 57.09 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.035 -0.984 . . . . 0.0 113.076 173.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.458 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . 29.1 mt -134.11 75.86 1.62 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.708 2.003 . . . . 0.0 109.336 -164.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.91 -4.05 7.0 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -167.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.402 ' OE1' ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -152.7 163.38 39.78 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 124.425 1.09 . . . . 0.0 109.284 -175.072 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -64.83 127.34 31.15 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.39 -1.19 75.97 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-O 118.511 -1.161 . . . . 0.0 111.762 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -64.59 146.29 54.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 119.807 1.803 . . . . 0.0 109.769 168.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.8 p -138.09 151.29 47.67 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.112 0.414 . . . . 0.0 110.744 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.7 p -75.57 -169.91 1.14 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -45.11 -92.38 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.98 75.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 129.607 3.163 . . . . 0.0 107.259 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.831 ' CG1' HD23 ' A' ' 34' ' ' LEU . 1.6 p -73.66 148.57 8.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 169.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.85 155.72 19.83 Favored Glycine 0 CA--C 1.51 -0.262 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -147.71 1.59 0.69 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -171.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.42 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 2.8 m-20 36.92 -169.95 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 130.963 3.705 . . . . 0.0 114.281 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 mm -133.29 106.36 9.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 159.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -65.99 113.38 4.39 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 171.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.86 149.13 23.23 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -148.69 153.43 38.23 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.1 2.16 . . . . 0.0 108.609 -165.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 30.18 54.25 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 129.263 3.025 . . . . 0.0 114.825 -169.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.8 m -69.64 138.34 52.96 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.328 2.251 . . . . 0.0 111.3 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -113.96 119.76 38.33 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.147 1.379 . . . . 0.0 109.294 166.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.5 p -71.81 -17.66 62.14 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -59.65 -44.89 93.37 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 124.101 0.96 . . . . 0.0 109.939 175.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.4 t -61.42 -61.59 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.04 120.42 4.56 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.395 1.478 . . . . 0.0 109.061 -174.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.9 m -76.24 -6.94 53.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.864 0.865 . . . . 0.0 111.135 169.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -130.72 159.02 38.51 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 120.155 -1.591 . . . . 0.0 110.368 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.75 159.56 41.98 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 160.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.55 167.83 18.72 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.804 2.042 . . . . 0.0 106.258 161.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.0 t -119.95 148.82 22.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.64 159.45 26.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.427 ' CE1' HG21 ' A' ' 103' ' ' ILE . 20.7 m-85 -133.49 155.53 49.4 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.901 1.68 . . . . 0.0 108.548 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.404 HD13 ' C ' ' A' ' 114' ' ' ASP . 7.4 tp -141.46 161.55 37.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.787 0.435 . . . . 0.0 110.095 173.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.424 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -178.16 179.82 48.38 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 173.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 3.3 m -64.9 135.83 56.16 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 164.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.17 141.83 41.74 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.079 0.854 . . . . 0.0 109.322 171.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.6 tt -60.77 -36.12 69.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 122.998 0.519 . . . . 0.0 111.036 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -160.87 171.2 19.18 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.207 1.803 . . . . 0.0 107.343 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.1 -28.14 68.59 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.753 0.821 . . . . 0.0 111.341 165.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.64 -19.13 72.74 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 119.109 -0.829 . . . . 0.0 112.224 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -147.2 57.93 1.15 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.15 1.475 . . . . 0.0 110.619 -164.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.3 p -63.09 -14.74 52.06 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 128.297 2.639 . . . . 0.0 113.313 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -84.96 -3.26 58.68 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 170.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.2 t -123.21 138.37 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 119.897 1.226 . . . . 0.0 109.446 -170.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.424 HD21 ' HA3' ' A' ' 75' ' ' GLY . 0.9 OUTLIER -76.08 150.04 37.34 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.641 1.176 . . . . 0.0 110.787 -178.485 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB3' ' HB ' ' A' ' 76' ' ' THR . . . -95.19 14.99 20.32 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -167.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.9 mt 54.36 -161.27 0.14 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.482 1.113 . . . . 0.0 111.665 -167.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -148.87 162.36 40.0 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.311 1.444 . . . . 0.0 110.869 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.4 p 49.55 -158.78 0.07 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.186 1.795 . . . . 0.0 111.099 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.4 m 24.98 75.5 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 129.172 2.989 . . . . 0.0 111.901 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.35 -30.48 12.26 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.309 1.844 . . . . 0.0 114.088 -169.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.61 17.29 3.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.227 1.411 . . . . 0.0 110.164 174.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.99 -16.27 8.01 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 125.474 1.511 . . . . 0.0 111.751 -171.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 m -62.13 172.23 1.5 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.622 1.201 . . . . 0.0 109.205 164.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.23 120.57 8.9 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 159.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.4 p -85.26 166.45 16.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 57.58 24.54 10.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.576 1.151 . . . . 0.0 111.499 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.413 HG21 HD13 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -148.36 154.5 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 119.304 0.956 . . . . 0.0 109.655 -178.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.33 -179.06 27.62 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 125.644 1.592 . . . . 0.0 110.322 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.45 HG11 ' CG ' ' A' ' 177' ' ' PHE . 73.5 t -91.89 152.93 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.404 HE22 ' HB1' ' A' ' 110' ' ' ALA . 1.7 mt-30 -132.1 167.97 18.79 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.218 -0.926 . . . . 0.0 110.247 161.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.427 HG21 ' CE1' ' A' ' 73' ' ' PHE . 4.8 mp -128.23 142.67 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 127.506 2.322 . . . . 0.0 105.559 174.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 110' ' ' ALA . 35.1 mt -129.33 146.41 51.22 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 126.282 1.833 . . . . 0.0 107.53 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.96 -72.25 0.14 Allowed 'General case' 0 C--O 1.221 -0.431 0 O-C-N 124.309 1.005 . . . . 0.0 111.873 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 108' ' ' GLY . 15.8 ptt180 -167.84 -35.23 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.044 1.338 . . . . 0.0 111.553 172.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.443 ' H ' HG22 ' A' ' 107' ' ' THR . 1.7 t -66.77 11.1 0.1 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.622 2.369 . . . . 0.0 111.063 167.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.426 ' HA2' HD13 ' A' ' 104' ' ' LEU . . . 61.99 12.31 35.73 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.239 1.4 . . . . 0.0 114.68 -171.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.71 110.76 1.6 Allowed 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.246 1.419 . . . . 0.0 108.781 175.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.54 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -63.03 118.57 8.03 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.902 1.281 . . . . 0.0 109.572 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 mt -79.16 155.93 28.46 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 m -86.67 170.36 11.87 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 169.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.8 85.96 2.41 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 171.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.404 ' C ' HD13 ' A' ' 74' ' ' LEU . 8.2 t70 -111.32 -17.05 13.24 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 165.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.89 -0.06 73.47 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.342 0.972 . . . . 0.0 112.512 -168.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -128.35 -32.84 2.18 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.525 1.53 . . . . 0.0 111.419 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.2 m -57.26 112.07 1.27 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.133 0.973 . . . . 0.0 108.566 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -79.39 146.78 32.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.9 p -74.69 -150.46 0.03 OUTLIER 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.503 1.121 . . . . 0.0 109.869 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.35 156.85 38.65 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 120.995 -1.066 . . . . 0.0 109.107 163.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -76.94 157.42 31.31 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 122.666 1.222 . . . . 0.0 108.274 166.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.9 m -133.57 122.75 23.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 164.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.1 m -65.49 120.92 13.74 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 167.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.509 HD22 ' ND2' ' A' ' 129' ' ' ASN . 31.3 mt -78.94 -168.24 1.39 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.171 2.188 . . . . 0.0 107.915 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -153.63 160.06 42.29 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.782 0.833 . . . . 0.0 108.941 164.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -65.56 107.68 1.79 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 127.22 -102.45 0.61 Allowed Glycine 0 C--O 1.225 -0.414 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 -172.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 m -137.36 147.64 45.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.444 1.122 . . . . 0.0 109.204 -167.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.509 ' ND2' HD22 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -168.45 161.05 11.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.552 1.541 . . . . 0.0 107.117 -175.285 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.42 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 96.8 m -149.54 151.48 33.95 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -175.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.5 mt -115.53 121.68 34.14 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.28 67.26 7.56 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.232 2.621 . . . . 0.0 113.206 -168.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -65.92 145.07 56.36 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -114.67 148.66 37.9 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.922 168.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -123.39 156.1 36.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 166.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.508 ' NH1' HD21 ' A' ' 104' ' ' LEU . 5.7 ptt-85 -157.37 167.92 28.86 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 169.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.469 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 96.2 m-85 -80.16 147.77 31.19 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 167.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -116.42 117.91 31.23 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 127.053 2.141 . . . . 0.0 106.103 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -87.01 139.74 30.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 53.6 p -102.09 13.68 34.04 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.646 1.179 . . . . 0.0 110.277 172.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.73 -154.21 24.9 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 107.756 -2.138 . . . . 0.0 107.756 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.71 95.66 0.9 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.477 1.111 . . . . 0.0 109.555 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.72 121.4 10.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.624 0.769 . . . . 0.0 109.179 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 63.8 p -74.78 161.82 76.12 Favored Pre-proline 0 C--O 1.235 0.323 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -68.71 173.49 9.93 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 120.861 1.041 . . . . 0.0 110.412 159.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.03 -109.95 0.42 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 173.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -138.94 152.93 48.11 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 128.064 2.546 . . . . 0.0 105.904 174.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.469 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -145.31 75.78 1.45 Allowed 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.934 1.243 . . . . 0.0 111.553 -175.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -118.1 157.47 26.81 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.97 164.96 36.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.488 1.515 . . . . 0.0 108.607 172.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -131.59 113.0 13.1 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -91.12 169.8 10.55 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.416 1.087 . . . . 0.0 109.79 170.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.3 p -115.41 156.22 25.98 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 152.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -120.52 152.41 38.09 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -122.36 169.7 10.68 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.861 1.664 . . . . 0.0 108.37 170.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.562 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 61.1 t -126.09 132.18 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -107.78 89.77 3.1 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 166.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.562 ' CZ ' HG11 ' A' ' 156' ' ' VAL . 85.5 m-85 -62.04 145.35 53.41 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 163.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -164.36 169.77 16.96 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.678 0.791 . . . . 0.0 111.287 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 135.44 -89.72 0.23 Allowed Glycine 0 C--O 1.237 0.284 0 N-CA-C 107.696 -2.162 . . . . 0.0 107.696 -173.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 55.54 -108.36 1.02 Allowed Glycine 0 CA--C 1.522 0.482 0 C-N-CA 126.55 2.024 . . . . 0.0 110.057 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.74 -110.19 0.14 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -153.23 20.95 0.74 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-O 119.238 -0.757 . . . . 0.0 111.495 -173.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 178.48 105.7 0.19 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 119.207 1.503 . . . . 0.0 109.557 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.41 73.62 1.0 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -148.16 120.59 8.47 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 160.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -151.73 160.73 43.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 124.384 1.052 . . . . 0.0 110.511 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 60.6 m -150.29 103.11 3.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.639 1.976 . . . . 0.0 107.141 -173.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.2 m -101.48 109.22 21.0 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 125.595 1.558 . . . . 0.0 109.616 -170.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.647 HG12 HG11 ' A' ' 16' ' ' VAL . 19.6 m -137.29 149.52 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.955 1.302 . . . . 0.0 109.708 -160.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.97 163.03 20.67 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.244 0.929 . . . . 0.0 111.906 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -121.94 -80.87 0.57 Allowed Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -174.29 -153.9 10.35 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -165.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.0 m -128.31 105.97 8.7 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.277 1.831 . . . . 0.0 110.327 -161.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.421 HG21 ' CE2' ' A' ' 73' ' ' PHE . 3.8 t -94.08 106.9 18.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -90.17 101.08 13.8 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -175.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.45 ' CG ' HG11 ' A' ' 101' ' ' VAL . 70.5 m-85 -82.55 121.5 26.87 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -126.74 159.4 33.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.6 -163.68 27.87 Favored Glycine 0 CA--C 1.518 0.269 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -166.26 166.24 16.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 81.8 t -113.86 125.46 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 172.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.9 m -106.27 152.32 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 126.265 1.826 . . . . 0.0 108.823 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -75.13 24.78 0.1 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -169.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 C-N-CA 129.103 2.961 . . . . 0.0 111.839 -175.127 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.88 -178.35 7.0 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.748 1.619 . . . . 0.0 107.673 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.1 t -140.08 152.78 46.43 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.487 -0.758 . . . . 0.0 109.031 166.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -134.31 20.15 3.69 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.364 1.865 . . . . 0.0 107.585 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.9 144.16 11.0 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 C-N-CA 125.419 1.487 . . . . 0.0 109.347 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -147.22 159.66 43.38 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.34 -143.65 14.57 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 -172.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -85.2 -89.55 0.87 Allowed Glycine 0 C--N 1.331 0.29 0 N-CA-C 105.04 -3.224 . . . . 0.0 105.04 161.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -136.72 117.22 13.78 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 157.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.3 p 23.36 99.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.284 1.833 . . . . 0.0 111.425 147.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -81.05 -123.89 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -146.61 25.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.113 -0.992 . . . . 0.0 112.409 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.6 mttt 32.61 -94.78 0.01 OUTLIER 'General case' 0 C--O 1.238 0.448 0 C-N-CA 127.434 2.294 . . . . 0.0 111.611 -170.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -157.58 50.2 0.43 Allowed Glycine 0 N--CA 1.444 -0.833 0 CA-C-O 117.729 -1.595 . . . . 0.0 110.897 170.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 95.88 167.14 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 129.452 3.101 . . . . 0.0 110.793 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.424 ' C ' ' H ' ' A' ' 18' ' ' ASN . 29.0 t 23.79 71.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.55 0 C-N-CA 130.405 3.482 . . . . 0.0 110.294 -177.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.9 t -76.03 34.95 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 128.451 2.7 . . . . 0.0 110.616 -172.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.424 ' H ' ' C ' ' A' ' 16' ' ' VAL . 68.0 m-80 -146.51 112.05 5.56 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 128.096 2.558 . . . . 0.0 105.213 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' HB2' HG11 ' A' ' 170' ' ' VAL . . . -142.01 29.15 1.68 Allowed 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 122.986 0.514 . . . . 0.0 110.531 177.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 43.67 -50.63 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.28 1 C-N-CA 134.45 5.1 . . . . 0.0 115.48 -167.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 1.6 m -104.51 174.24 5.96 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.262 2.225 . . . . 0.0 110.977 172.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.6 102.82 12.04 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 127.634 2.374 . . . . 0.0 108.065 172.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.05 130.85 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -67.41 153.75 42.96 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -55.12 -32.31 61.95 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.908 -1.12 . . . . 0.0 110.486 165.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.84 4.65 4.1 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 118.606 -1.108 . . . . 0.0 114.705 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.3 m -143.38 -19.57 0.62 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 120.609 2.204 . . . . 0.0 114.535 175.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 25' ' ' ALA . 8.4 p -60.57 -39.72 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 119.384 0.993 . . . . 0.0 111.292 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -136.23 67.1 1.47 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -167.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.89 140.15 44.18 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.577 -164.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.2 m -109.89 100.19 9.2 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.25 102.22 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -84.77 93.15 8.4 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -69.57 -16.44 63.41 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.903 1.681 . . . . 0.0 109.059 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.84 -168.63 43.56 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.434 1.016 . . . . 0.0 111.15 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -73.63 152.27 40.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.358 1.063 . . . . 0.0 109.798 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.46 147.25 28.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 125.208 1.403 . . . . 0.0 108.109 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -82.68 131.37 35.21 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -57.12 -27.59 61.95 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 122.74 0.416 . . . . 0.0 111.266 170.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.71 -35.3 65.95 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.535 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.2 m -77.14 -1.53 29.75 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.5 mt -143.71 74.08 1.42 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.726 1.61 . . . . 0.0 108.043 -163.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.22 -6.47 4.85 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -170.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.94 163.81 38.47 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 126.292 1.837 . . . . 0.0 107.408 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.401 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 16.2 tt0 -61.43 136.21 57.95 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 122.071 0.939 . . . . 0.0 108.735 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.471 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 82.93 -3.58 83.39 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-O 118.095 -1.391 . . . . 0.0 111.27 175.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.17 151.29 19.41 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.478 1.139 . . . . 0.0 109.46 158.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 p -143.37 154.44 43.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.577 0.703 . . . . 0.0 109.702 -174.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.5 t -65.27 175.84 1.55 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 166.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -38.38 -81.52 0.01 OUTLIER 'General case' 0 C--N 1.339 0.12 0 C-N-CA 127.622 2.369 . . . . 0.0 110.375 167.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.57 158.48 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 129.733 3.213 . . . . 0.0 106.146 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.7 t -145.03 152.06 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 168.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.47 144.13 16.6 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 106.339 -2.704 . . . . 0.0 106.339 167.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -141.01 157.72 44.93 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -141.53 168.81 18.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 119.886 1.221 . . . . 0.0 113.241 -172.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 mm -111.41 92.63 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.32 118.68 13.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.884 1.673 . . . . 0.0 108.011 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.4 mt -118.8 132.18 56.12 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.829 1.251 . . . . 0.0 109.947 -175.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -116.49 164.68 14.21 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.365 1.466 . . . . 0.0 108.863 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.3 t0 53.66 31.72 13.23 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.742 2.017 . . . . 0.0 113.384 163.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 2.7 t -75.05 153.58 38.34 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.467 -1.396 . . . . 0.0 113.096 -170.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.639 ' HB3' HG23 ' A' ' 65' ' ' VAL . 14.2 t0 -126.38 125.9 42.99 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.978 1.311 . . . . 0.0 110.742 176.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 p -73.75 -17.1 61.15 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.059 0.543 . . . . 0.0 110.955 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -58.87 -45.75 89.43 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.899 1.28 . . . . 0.0 110.001 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.639 HG23 ' HB3' ' A' ' 62' ' ' ASP . 4.1 t -72.57 -46.11 56.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -175.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -165.85 130.91 2.38 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.162 1.385 . . . . 0.0 109.253 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 m -73.83 -23.19 59.61 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -120.79 166.09 14.23 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 126.154 1.782 . . . . 0.0 110.205 -173.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.83 151.64 51.55 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 157.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.77 170.79 10.68 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 144.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.408 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -134.36 159.74 41.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -172.33 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.55 167.07 23.04 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -125.33 154.9 41.1 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.642 0.777 . . . . 0.0 109.101 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.2 tp -150.01 124.26 9.51 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.918 0.887 . . . . 0.0 108.998 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.15 -178.98 42.75 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.674 1.131 . . . . 0.0 110.824 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m -70.37 133.68 47.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.399 1.48 . . . . 0.0 110.174 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.84 141.13 47.98 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 121.296 -0.878 . . . . 0.0 111.156 169.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 tt -63.01 -37.58 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 123.554 0.742 . . . . 0.0 110.961 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -159.83 165.78 31.63 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.752 2.021 . . . . 0.0 107.279 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.22 69.5 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 125.536 1.534 . . . . 0.0 112.318 169.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.54 -3.38 90.1 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-O 118.691 -1.061 . . . . 0.0 113.277 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -145.78 50.09 1.2 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.211 1.506 . . . . 0.0 109.614 -172.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.0 p -64.51 -17.41 63.87 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.978 1.311 . . . . 0.0 114.38 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -75.75 -25.78 56.82 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.92 173.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.27 137.84 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.396 1.478 . . . . 0.0 110.23 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.82 146.19 32.39 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.221 1.008 . . . . 0.0 111.79 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.36 18.17 6.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.353 1.861 . . . . 0.0 114.226 -167.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 73.4 mt 51.48 -156.12 0.14 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.797 1.239 . . . . 0.0 110.762 -169.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.38 -173.44 4.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.622 2.769 . . . . 0.0 107.827 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.8 t 76.26 158.37 0.2 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.553 1.941 . . . . 0.0 112.548 163.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.408 ' HB3' ' HA3' ' A' ' 94' ' ' GLY . 6.1 t 46.46 27.39 0.61 Allowed 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 127.958 2.503 . . . . 0.0 114.429 -175.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 61.78 -50.87 0.14 Allowed 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 128.48 2.712 . . . . 0.0 114.327 -163.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -151.37 11.27 0.61 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.778 1.231 . . . . 0.0 110.675 -170.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.408 ' HA3' ' HB3' ' A' ' 91' ' ' SER . . . -95.57 -12.9 52.85 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 126.264 1.888 . . . . 0.0 114.311 -161.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 p -51.71 162.74 0.37 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 121.768 -0.842 . . . . 0.0 110.784 162.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.96 142.33 3.56 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.144 1.378 . . . . 0.0 111.079 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.8 p -94.93 163.42 13.33 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 169.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 56.07 23.75 7.16 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.451 1.501 . . . . 0.0 112.425 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -144.23 155.02 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.19 -168.06 14.04 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.483 HG11 ' CG ' ' A' ' 177' ' ' PHE . 95.5 t -101.42 136.94 30.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 169.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -115.12 158.73 21.78 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 164.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.495 HG22 HD12 ' A' ' 111' ' ' LEU . 2.7 mp -133.48 123.57 46.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.512 1.925 . . . . 0.0 106.768 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 110' ' ' ALA . 10.9 mt -114.41 153.47 29.83 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 174.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.419 ' CB ' ' HB2' ' A' ' 120' ' ' SER . 7.9 t70 -85.76 -107.82 0.05 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.438 0.563 . . . . 0.0 110.325 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.79 -45.78 4.69 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 129.618 3.167 . . . . 0.0 109.528 168.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.8 p -78.38 -0.17 28.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.052 0.541 . . . . 0.0 112.078 -166.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.77 14.15 57.68 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.055 1.312 . . . . 0.0 112.684 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.7 142.35 55.05 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 159.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.559 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -95.82 135.64 37.28 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.495 HD12 HG22 ' A' ' 103' ' ' ILE . 74.3 mt -105.82 120.51 41.9 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.653 -0.655 . . . . 0.0 110.702 -157.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.6 m -73.31 160.1 32.37 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.858 0.837 . . . . 0.0 110.725 -173.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.1 mt -109.38 40.64 1.81 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.243 1.417 . . . . 0.0 111.794 -160.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -106.76 0.28 24.03 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.32 -0.863 . . . . 0.0 112.593 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.26 -17.77 31.64 Favored Glycine 0 CA--C 1.519 0.335 0 O-C-N 120.423 -1.423 . . . . 0.0 114.196 166.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -115.1 -6.7 12.49 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.313 1.056 . . . . 0.0 112.899 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.2 m -68.94 99.4 1.06 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 168.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -61.19 130.09 44.53 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.484 171.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.8 m -83.55 -158.31 0.29 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 127.19 2.196 . . . . 0.0 109.962 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.419 ' HB2' ' CB ' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -73.45 129.62 38.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.973 0.892 . . . . 0.0 108.942 -170.262 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -84.57 115.17 22.47 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -166.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m -96.66 110.14 22.64 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.0 m -61.83 130.34 45.26 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 163.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 51.5 mt -96.33 -149.26 0.31 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 126.184 1.794 . . . . 0.0 108.255 -170.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -150.34 173.79 13.6 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.616 1.566 . . . . 0.0 107.974 164.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.57 115.24 12.72 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 159.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 119.0 -150.46 17.94 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.631 1.11 . . . . 0.0 111.631 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.6 m -75.27 135.27 40.95 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.326 1.45 . . . . 0.0 110.766 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.62 168.97 25.76 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.528 1.531 . . . . 0.0 108.514 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 95.0 m -152.24 149.81 29.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.556 0.742 . . . . 0.0 109.291 -176.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.75 106.97 57.06 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.479 1.112 . . . . 0.0 108.356 163.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.65 117.37 3.66 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 124.319 3.346 . . . . 0.0 111.552 171.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.408 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 91.2 m-85 -93.08 170.43 9.66 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.037 1.735 . . . . 0.0 110.849 168.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -134.71 113.83 12.07 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.917 2.087 . . . . 0.0 107.287 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -104.34 133.88 48.5 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 128.553 2.741 . . . . 0.0 109.239 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 136' ' ' ARG . 10.1 ptt-85 -145.15 143.36 30.31 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 170.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.437 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 71.6 m-85 -70.46 116.46 10.81 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 162.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.471 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 3.0 t80 -101.62 130.54 47.97 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.71 144.84 26.92 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.401 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 30.3 p -98.7 7.0 46.6 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.273 1.029 . . . . 0.0 112.158 167.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 160.26 -152.64 23.46 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.89 89.3 0.05 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.892 1.277 . . . . 0.0 111.329 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.04 141.64 49.29 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.934 0.893 . . . . 0.0 110.999 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.5 p -112.36 152.99 44.95 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 119.161 -0.447 . . . . 0.0 110.241 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -76.86 162.4 32.36 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.402 1.401 . . . . 0.0 110.081 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 156.42 -133.08 3.51 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.903 1.239 . . . . 0.0 110.397 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.11 152.13 18.99 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.29 1.045 . . . . 0.0 108.234 169.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.437 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -136.96 82.28 1.93 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.664 0.745 . . . . 0.0 109.133 168.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -121.06 152.12 39.01 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -145.32 175.55 10.22 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -138.78 115.21 10.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 171.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -108.63 156.64 19.31 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 167.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 p -99.4 158.91 15.4 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 149.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -117.91 147.93 42.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 165.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -120.19 167.7 11.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.278 1.431 . . . . 0.0 107.645 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.94 106.38 3.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -169.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -95.14 87.94 5.04 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.148 1.379 . . . . 0.0 108.995 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -68.58 149.11 49.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.655 1.182 . . . . 0.0 110.704 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -172.82 174.9 3.48 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.135 1.774 . . . . 0.0 109.092 -173.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 145.8 -80.95 0.22 Allowed Glycine 0 CA--C 1.517 0.171 0 N-CA-C 107.835 -2.106 . . . . 0.0 107.835 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -71.06 165.97 52.78 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 123.71 0.671 . . . . 0.0 111.684 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 129.64 162.78 10.96 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 125.996 1.76 . . . . 0.0 110.46 174.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -57.24 -41.16 92.73 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 118.934 -0.926 . . . . 0.0 113.336 -172.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 167.76 25.48 0.02 OUTLIER Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.269 0.937 . . . . 0.0 112.038 -172.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 157.17 96.6 0.12 Allowed Glycine 0 C--N 1.335 0.498 0 N-CA-C 106.483 -2.647 . . . . 0.0 106.483 -166.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -168.17 128.73 1.32 Allowed 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 125.093 1.357 . . . . 0.0 110.1 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -157.72 170.47 22.3 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 123.746 0.654 . . . . 0.0 109.972 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 21.2 m -135.78 101.94 4.92 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.1 m -79.11 104.82 10.0 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 162.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -90.14 156.76 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.44 161.074 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -65.25 129.04 38.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 153.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -85.29 -61.47 1.73 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 166.93 -157.53 30.05 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 89.8 m -116.89 135.75 53.48 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.952 1.701 . . . . 0.0 109.29 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.7 t -114.35 107.67 23.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 122.306 1.05 . . . . 0.0 108.344 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -88.36 91.31 8.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.483 ' CG ' HG11 ' A' ' 101' ' ' VAL . 73.0 m-85 -71.2 115.2 10.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -123.27 159.49 28.64 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 124.369 1.068 . . . . 0.0 109.149 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 145.95 -166.2 27.98 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 106.491 -2.644 . . . . 0.0 106.491 -173.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.56 176.23 10.62 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.3 130.15 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 171.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.405 ' C ' ' H ' ' A' ' 184' ' ' ALA . 4.2 m -105.66 152.29 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 127.393 2.277 . . . . 0.0 108.536 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.21 24.9 0.08 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.837 1.255 . . . . 0.0 114.065 -170.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.257 1.463 1 C-N-CA 133.424 4.689 . . . . 0.0 113.374 -176.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 117.303 -1.332 . . . . 0.0 107.533 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.62 73.0 0.18 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.708 1.603 . . . . 0.0 112.433 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.3 p -136.37 -47.99 0.64 Allowed 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.048 0.939 . . . . 0.0 109.192 172.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.6 m 63.35 21.59 12.88 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.612 1.165 . . . . 0.0 110.594 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 p -144.35 160.68 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.504 1.521 . . . . 0.0 107.696 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -52.52 117.17 2.68 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.459 1.904 . . . . 0.0 109.141 174.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 63.54 -103.62 0.71 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -172.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.4 179.45 40.93 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 126.097 1.808 . . . . 0.0 108.808 -175.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.252 0.4 OUTLIER -87.98 85.42 6.98 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 124.014 1.864 . . . . 0.0 106.575 -164.213 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 t 48.49 60.64 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 126.442 1.897 . . . . 0.0 110.968 157.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -82.41 34.72 0.43 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.086 1.354 . . . . 0.0 112.84 -154.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -130.63 56.37 1.78 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.44 1.096 . . . . 0.0 108.656 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -105.27 79.95 1.54 Allowed 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 171.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.98 7.33 1.42 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 119.136 -0.813 . . . . 0.0 111.98 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -152.81 -171.43 3.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 118.913 1.356 . . . . 0.0 108.066 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.0 t -53.18 -37.81 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 126.249 1.82 . . . . 0.0 111.765 -172.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 m 40.91 34.55 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 128.149 2.58 . . . . 0.0 116.202 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.465 ' O ' HG11 ' A' ' 170' ' ' VAL . 49.9 m-20 -120.61 103.19 8.95 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.24 1.016 . . . . 0.0 109.058 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.413 ' HA ' ' HE2' ' A' ' 158' ' ' TYR . . . -109.92 118.18 35.77 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 167.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.432 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -39.96 -39.22 0.81 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 128.168 2.587 . . . . 0.0 112.93 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.3 m -111.34 142.42 43.6 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.04 -8.96 13.44 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -168.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.2 t 45.95 102.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.29 0 C-N-CA 130.233 3.413 . . . . 0.0 109.265 -162.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -58.97 154.02 16.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.761 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.26 -31.16 65.28 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.812 0.733 . . . . 0.0 110.823 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.55 -11.9 60.61 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.987 -0.896 . . . . 0.0 114.249 176.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.6 m -105.86 -36.49 6.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.864 1.332 . . . . 0.0 109.921 172.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.3 t -52.02 -39.69 26.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 123.878 0.871 . . . . 0.0 110.127 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.93 77.21 1.59 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.959 0.885 . . . . 0.0 110.909 -173.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.25 138.28 49.17 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.907 -170.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.4 m -115.13 84.56 2.1 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.407 2.283 . . . . 0.0 110.026 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.4 t -67.93 112.43 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -87.37 97.29 10.72 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.44 HD23 HG11 ' A' ' 52' ' ' VAL . 6.2 mt -70.97 -3.18 18.09 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.722 2.009 . . . . 0.0 109.003 172.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.73 -176.63 35.67 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 124.541 1.067 . . . . 0.0 111.979 169.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -68.67 148.98 49.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.471 0.653 . . . . 0.0 109.569 164.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.7 t -136.16 144.97 31.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 125.536 1.534 . . . . 0.0 107.356 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.08 133.69 34.63 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.4 p -57.62 -25.02 59.49 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.004 0.522 . . . . 0.0 110.663 173.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.45 69.92 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.865 1.266 . . . . 0.0 112.65 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.8 m -76.37 -11.0 59.82 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 173.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.46 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . 37.1 mt -139.12 74.37 1.47 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.92 2.088 . . . . 0.0 109.209 -157.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.22 10.65 4.15 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.177 -0.952 . . . . 0.0 112.901 -169.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.466 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 4.8 pm0 -154.91 158.41 39.25 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 124.885 1.274 . . . . 0.0 108.824 -174.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -61.29 132.39 53.44 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 166.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.73 5.68 87.87 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-O 118.194 -1.337 . . . . 0.0 112.464 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -63.65 153.36 36.27 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.652 1.726 . . . . 0.0 109.27 163.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.8 p -141.45 155.43 45.86 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.9 t -68.39 178.05 2.13 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.345 1.058 . . . . 0.0 109.039 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.8 m -44.71 -86.14 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.915 2.486 . . . . 0.0 113.155 171.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 157.69 134.85 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 127.416 2.286 . . . . 0.0 107.239 -171.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.44 HG11 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -146.36 104.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -177.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.92 135.14 30.08 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 112.746 -2.025 . . . . 0.0 109.16 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -143.96 80.64 1.66 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.442 ' HB2' HG22 ' A' ' 130' ' ' THR . 27.7 p30 -77.79 141.56 39.16 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.284 -0.885 . . . . 0.0 110.027 -177.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 130' ' ' THR . 7.0 mm -81.09 102.62 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 -174.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -65.34 101.71 0.6 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.4 mt -91.19 161.0 15.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 161.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.47 ' HA ' HG23 ' A' ' 128' ' ' THR . 86.3 m-20 -131.49 160.37 35.39 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 167.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 t70 45.21 54.51 7.11 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 127.109 2.164 . . . . 0.0 113.418 175.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.7 m -68.62 103.35 1.69 Allowed 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.848 -0.532 . . . . 0.0 110.361 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -66.04 149.46 50.22 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 161.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 p -110.13 -15.84 13.92 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.049 0.94 . . . . 0.0 112.724 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -60.24 -46.65 89.05 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 122.361 1.077 . . . . 0.0 109.297 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 66' ' ' ALA . 5.9 p -60.2 -52.75 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 125.69 1.596 . . . . 0.0 108.55 177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 158' ' ' TYR . . . -167.24 135.73 2.62 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.37 1.468 . . . . 0.0 108.363 171.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.0 m -77.87 -12.49 59.98 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.32 -0.848 . . . . 0.0 113.074 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -117.3 152.38 35.01 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 120.232 1.378 . . . . 0.0 109.841 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.91 138.9 51.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 169.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.66 -176.68 3.52 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 123.266 1.508 . . . . 0.0 107.367 150.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.415 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -153.49 160.3 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 131.678 3.991 . . . . 0.0 103.773 -162.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.85 171.57 13.89 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 165.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.413 ' CD1' HG21 ' A' ' 103' ' ' ILE . 23.0 m-85 -129.72 152.41 49.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.458 HD22 ' HA3' ' A' ' 115' ' ' GLY . 14.4 tp -152.87 126.8 8.99 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -176.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.83 169.8 42.69 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.3 m -60.27 128.11 35.1 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.075 0.95 . . . . 0.0 110.669 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.99 135.99 46.59 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.76 -0.587 . . . . 0.0 110.431 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.2 tt -60.6 -33.66 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.783 0.833 . . . . 0.0 110.333 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -160.0 168.14 26.31 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 164.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.63 -31.85 66.66 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.942 1.297 . . . . 0.0 111.351 166.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.0 -10.92 60.03 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 120.588 -1.32 . . . . 0.0 112.531 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -148.33 50.63 1.02 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.154 1.781 . . . . 0.0 111.206 -165.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.3 p -68.22 -12.6 61.24 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.964 -1.085 . . . . 0.0 112.121 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -80.94 1.49 30.81 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.469 -0.769 . . . . 0.0 111.233 172.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.1 t -136.45 138.91 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 120.939 -1.1 . . . . 0.0 110.893 -169.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -87.75 148.11 24.88 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 125.63 1.572 . . . . 0.0 111.51 -168.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.14 14.26 12.94 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.735 1.614 . . . . 0.0 115.305 -163.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.534 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 58.1 mt 52.08 -164.88 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.3 1.04 . . . . 0.0 110.643 -166.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -139.87 177.23 8.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.553 1.541 . . . . 0.0 108.49 177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.6 m -54.1 142.93 23.81 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.249 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 m -177.45 86.52 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.426 2.69 . . . . 0.0 106.832 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 37.44 -74.72 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 129.949 3.3 . . . . 0.0 113.853 -168.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.66 14.3 1.35 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.72 1.208 . . . . 0.0 112.647 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.63 41.4 50.87 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 121.1 -1.0 . . . . 0.0 111.768 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.2 m 63.07 -170.51 0.18 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.837 1.655 . . . . 0.0 111.078 -169.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.31 168.31 3.56 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.315 1.446 . . . . 0.0 109.692 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.9 p -116.43 167.57 10.93 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.492 1.117 . . . . 0.0 109.039 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 53.36 27.25 6.06 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.695 1.598 . . . . 0.0 111.881 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.84 151.14 13.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 CA-C-N 120.265 1.393 . . . . 0.0 110.827 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.11 174.45 31.1 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 124.969 1.271 . . . . 0.0 111.317 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.412 HG11 ' CD2' ' A' ' 177' ' ' PHE . 97.7 t -86.48 126.75 40.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 176.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -95.64 153.07 17.91 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 120.121 1.328 . . . . 0.0 108.358 158.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.601 HG22 HD12 ' A' ' 111' ' ' LEU . 2.6 mp -122.59 138.45 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 169.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 110' ' ' ALA . 12.9 mt -133.49 138.99 46.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -65.8 178.45 1.05 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.295 1.045 . . . . 0.0 110.347 170.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -53.88 -13.31 0.71 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.807 1.243 . . . . 0.0 114.287 172.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.7 p -102.36 -11.63 18.51 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.636 1.107 . . . . 0.0 110.902 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.82 11.04 74.67 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.941 1.257 . . . . 0.0 113.467 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.85 60.04 5.69 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.77 1.228 . . . . 0.0 111.513 -174.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.435 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . 23.47 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 128.827 2.851 . . . . 0.0 113.834 153.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.601 HD12 HG22 ' A' ' 103' ' ' ILE . 87.7 mt -78.08 168.0 20.56 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.228 -169.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -109.19 164.21 12.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -172.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.7 mt -113.29 52.59 0.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.325 1.05 . . . . 0.0 108.323 -175.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -104.32 -23.31 13.23 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.588 1.155 . . . . 0.0 111.742 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.458 ' HA3' HD22 ' A' ' 74' ' ' LEU . . . 67.62 21.76 72.99 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 118.634 0.652 . . . . 0.0 113.261 -174.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -161.51 34.52 0.13 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.179 1.792 . . . . 0.0 110.392 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 26.9 m -128.92 91.81 3.28 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.078 -2.194 . . . . 0.0 105.078 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -62.35 152.91 32.64 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.097 0.475 . . . . 0.0 110.632 -170.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.9 m -126.3 104.07 8.0 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.546 0.739 . . . . 0.0 109.63 -163.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 49.98 -177.73 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.588 1.955 . . . . 0.0 112.018 -168.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -117.48 172.99 6.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 119.632 -1.918 . . . . 0.0 108.167 154.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m -151.02 116.06 5.28 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 165.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.1 m -67.62 137.87 55.96 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.9 mt -108.88 -178.85 3.7 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 129.038 2.935 . . . . 0.0 110.085 -170.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.45 156.98 44.8 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.009 1.724 . . . . 0.0 109.121 167.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -60.78 85.8 0.01 OUTLIER 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.943 2.097 . . . . 0.0 110.644 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.57 -169.57 25.1 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.758 0.694 . . . . 0.0 111.804 -161.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 59' ' ' ASN . 28.7 m -96.8 125.48 41.28 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 120.574 -1.545 . . . . 0.0 111.822 -158.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -139.92 157.79 45.13 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 129.097 2.959 . . . . 0.0 109.686 -171.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 56' ' ' ILE . 61.2 m -131.53 150.09 52.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.049 1.339 . . . . 0.0 110.003 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 17.1 mt -106.11 118.47 54.9 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -71.15 148.52 56.31 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.236 1.957 . . . . 0.0 112.039 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.415 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 71.1 m-85 -148.39 165.37 31.3 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 127.459 2.304 . . . . 0.0 109.003 170.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -128.46 140.83 51.62 Favored 'General case' 0 CA--C 1.523 -0.082 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 162.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.12 165.9 10.89 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 161.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -166.34 152.38 8.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 169.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.502 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 86.7 m-85 -69.06 151.48 46.39 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 166.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -126.51 133.79 51.07 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.493 1.917 . . . . 0.0 106.509 172.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -101.2 148.32 25.23 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.49 0.716 . . . . 0.0 110.55 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 66.7 p -109.96 12.34 23.77 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.576 1.15 . . . . 0.0 111.089 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.97 -154.44 24.85 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.88 89.24 0.16 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.356 1.062 . . . . 0.0 110.721 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -61.62 119.95 9.65 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.405 1.882 . . . . 0.0 109.599 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.3 p -83.17 161.78 56.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 123.847 0.859 . . . . 0.0 109.449 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -75.02 173.4 14.58 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 119.777 0.956 . . . . 0.0 109.633 165.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.26 -111.75 0.49 Allowed Glycine 0 C--O 1.229 -0.215 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 172.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.84 168.19 14.19 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.063 1.745 . . . . 0.0 106.828 166.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.502 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -145.14 89.39 1.95 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 173.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -125.29 140.79 52.52 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 178.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.534 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -147.71 170.06 18.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.535 1.061 . . . . 0.0 109.563 171.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -142.08 115.25 8.83 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.175 1.39 . . . . 0.0 108.648 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.633 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -130.25 167.74 17.97 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.677 1.591 . . . . 0.0 110.332 172.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 76.9 p -121.05 145.59 47.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -100.35 135.98 40.94 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 170.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -81.55 169.26 17.3 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 157.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.866 HG13 HG23 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -113.64 152.13 15.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 127.998 2.519 . . . . 0.0 105.342 163.641 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -143.96 87.68 1.92 Allowed 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.596 1.558 . . . . 0.0 107.493 164.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.802 ' CE2' HG21 ' A' ' 156' ' ' VAL . 83.0 m-85 -60.79 163.22 5.85 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.494 166.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.522 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 2.0 pt20 -161.85 162.76 29.47 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.765 1.226 . . . . 0.0 111.316 172.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 148.33 -15.95 1.3 Allowed Glycine 0 CA--C 1.521 0.443 0 CA-C-O 117.464 -1.742 . . . . 0.0 116.048 171.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -64.78 -83.17 0.09 OUTLIER Glycine 0 C--N 1.336 0.563 0 CA-C-N 120.31 2.055 . . . . 0.0 110.959 -174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.468 ' H ' ' CB ' ' A' ' 166' ' ' ALA . . . -47.98 -55.73 9.71 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-O 118.502 -1.166 . . . . 0.0 111.563 166.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.97 39.65 5.12 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.063 0.932 . . . . 0.0 111.028 -172.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 178.9 -55.5 0.09 OUTLIER Glycine 0 C--N 1.334 0.442 0 O-C-N 121.672 -0.899 . . . . 0.0 111.616 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -121.32 33.88 4.18 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.275 1.417 . . . . 0.0 111.007 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.468 ' CB ' ' H ' ' A' ' 162' ' ' GLY . . . -128.91 100.37 5.65 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 123.99 0.916 . . . . 0.0 110.277 -177.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -148.91 167.76 24.86 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 125.413 1.485 . . . . 0.0 110.522 -174.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 56.6 m -142.1 84.34 1.87 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.1 m -77.11 116.0 17.38 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.009 1.323 . . . . 0.0 108.336 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.866 HG23 HG13 ' A' ' 156' ' ' VAL . 28.2 m -134.84 162.15 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 125.697 1.599 . . . . 0.0 110.166 -175.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -75.68 159.49 31.08 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.91 -1.119 . . . . 0.0 109.332 169.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -129.73 -67.35 0.11 Allowed Glycine 0 CA--C 1.52 0.374 0 CA-C-O 119.475 -0.625 . . . . 0.0 111.655 -163.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 175.85 175.42 43.23 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 117.412 0.606 . . . . 0.0 111.64 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 54.0 m -104.06 138.46 40.55 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.058 1.343 . . . . 0.0 109.214 -174.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.79 92.95 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -73.13 85.01 1.34 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.325 1.85 . . . . 0.0 108.234 174.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.412 ' CD2' HG11 ' A' ' 101' ' ' VAL . 57.6 m-85 -67.45 125.16 25.26 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -131.17 163.38 27.84 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.454 1.102 . . . . 0.0 109.895 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 140.77 -162.71 26.64 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 -172.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -165.06 170.08 15.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.55 125.51 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 167.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.8 m -103.68 151.83 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 126.506 1.923 . . . . 0.0 108.424 173.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.39 25.05 0.08 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.685 1.594 . . . . 0.0 113.567 -169.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 C-N-CA 129.209 3.004 . . . . 0.0 110.756 -168.955 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.725 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.62 127.13 28.73 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 168.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.9 m -165.7 163.19 19.08 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.673 1.989 . . . . 0.0 106.227 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 56.49 -115.22 0.89 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.88 173.5 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.519 1.528 . . . . 0.0 109.537 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -60.11 -35.44 75.24 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.063 1.345 . . . . 0.0 112.582 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.51 -89.93 2.13 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.57 -103.16 2.3 Favored Glycine 0 CA--C 1.503 -0.703 0 N-CA-C 105.859 -2.896 . . . . 0.0 105.859 166.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 t -114.44 83.39 1.88 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 168.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 p 41.14 76.45 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 122.85 1.31 . . . . 0.0 112.035 157.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 26.7 p-80 -74.51 40.39 0.13 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.555 1.142 . . . . 0.0 111.551 -172.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -80.18 -6.8 58.4 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 120.527 -1.358 . . . . 0.0 111.497 -171.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? 58.3 32.64 22.31 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.033 2.533 . . . . 0.0 112.309 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.17 -16.35 80.7 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.404 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.82 -164.39 1.83 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.403 2.281 . . . . 0.0 108.565 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.3 t -57.39 -27.55 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 126.482 1.913 . . . . 0.0 112.199 -175.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 t 44.46 56.9 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 126.69 1.996 . . . . 0.0 112.358 -170.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -144.54 101.77 3.72 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.49 1.138 . . . . 0.0 109.688 155.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.89 115.42 10.56 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.55 -22.2 61.36 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 123.973 0.796 . . . . 0.0 112.982 -167.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.4 m -118.84 156.23 29.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.087 1.355 . . . . 0.0 107.364 171.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.33 171.64 14.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.477 0.656 . . . . 0.0 109.779 156.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.63 150.26 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 168.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -87.22 18.0 3.97 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -171.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 69.99 -34.75 0.3 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 130.177 3.391 . . . . 0.0 110.305 -166.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.61 -18.32 73.73 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-O 119.057 -0.857 . . . . 0.0 113.966 -172.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -108.24 -7.08 16.06 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.35 1.06 . . . . 0.0 111.209 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.93 -32.18 26.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 C-N-CA 125.22 1.408 . . . . 0.0 111.338 -170.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -148.8 73.09 1.21 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 -172.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.1 142.35 38.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -171.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.42 HG23 ' HB2' ' A' ' 176' ' ' HIS . 22.5 m -112.59 100.1 8.47 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 172.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.35 102.15 2.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -79.53 100.54 7.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.768 HD23 HG11 ' A' ' 52' ' ' VAL . 14.6 mt -64.77 -19.01 65.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.635 1.974 . . . . 0.0 110.399 169.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.12 -178.15 41.31 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 125.244 1.402 . . . . 0.0 111.662 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -66.13 154.47 39.59 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.7 t -140.21 143.07 30.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 124.49 1.116 . . . . 0.0 108.514 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -76.19 133.68 40.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 p -58.73 -23.09 59.18 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.167 0.987 . . . . 0.0 110.627 174.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.46 74.57 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.158 -0.964 . . . . 0.0 111.041 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.418 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 67.2 m -69.74 -10.69 59.32 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 172.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.605 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 17.9 mt -140.55 79.44 1.7 Allowed 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 120.071 1.305 . . . . 0.0 107.547 -162.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.01 1.47 0.98 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -147.22 152.16 37.89 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 50.9 tt0 -61.33 125.39 23.59 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.419 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 101.46 -10.66 57.94 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 118.014 -1.437 . . . . 0.0 112.976 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -61.05 155.18 20.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.972 1.886 . . . . 0.0 110.227 177.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.8 p -136.44 161.63 35.29 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.425 0.557 . . . . 0.0 110.814 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.2 p -73.58 -163.31 0.16 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.458 0.703 . . . . 0.0 111.356 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.4 m -46.11 -31.68 2.49 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 126.979 2.111 . . . . 0.0 114.655 166.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 63.51 167.05 0.14 Allowed 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 126.359 2.287 . . . . 0.0 110.055 -166.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.768 HG11 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -162.05 143.35 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 C-N-CA 126.119 1.768 . . . . 0.0 106.276 -167.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.57 121.52 5.39 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 107.228 -2.349 . . . . 0.0 107.228 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -121.17 134.58 55.22 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -115.04 131.66 56.85 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -167.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.8 mm -89.89 108.8 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -77.61 118.46 20.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 mt -122.31 121.4 36.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -91.91 162.43 14.42 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.358 1.063 . . . . 0.0 110.068 -172.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.0 t0 47.33 42.52 13.98 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.889 1.675 . . . . 0.0 112.276 167.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.3 m -63.74 136.49 57.5 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.511 0.724 . . . . 0.0 109.292 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -121.47 103.78 9.18 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.837 0.855 . . . . 0.0 110.739 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.9 p -63.98 -19.91 65.5 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.957 0.903 . . . . 0.0 112.037 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -61.89 -37.52 84.89 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.318 1.447 . . . . 0.0 110.577 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.5 t -78.3 -57.91 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.1 125.27 3.96 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -166.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 m -71.4 -14.76 62.27 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 118.566 -0.731 . . . . 0.0 111.93 169.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -132.42 162.8 30.23 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 120.019 1.281 . . . . 0.0 111.689 -173.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.08 136.06 45.66 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 154.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.8 169.14 11.88 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 147.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.0 t -120.59 163.19 18.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 165.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.62 163.11 33.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.872 2.069 . . . . 0.0 107.526 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -133.74 152.18 51.81 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.091 1.756 . . . . 0.0 109.729 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.7 tp -152.31 131.07 12.4 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 122.805 0.442 . . . . 0.0 110.847 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.21 -172.12 34.82 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.15 163.96 1.43 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.061 1.744 . . . . 0.0 110.373 171.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.53 130.47 53.56 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 125.753 1.621 . . . . 0.0 109.143 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.6 tt -60.62 -46.77 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 O-C-N 123.413 0.446 . . . . 0.0 110.526 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.1 164.86 32.59 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.75 -15.84 63.83 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.21 -0.24 74.17 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.888 1.232 . . . . 0.0 112.386 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -143.45 41.21 1.47 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.963 1.705 . . . . 0.0 109.691 -167.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.2 p -61.11 -19.85 61.95 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.199 -0.938 . . . . 0.0 112.324 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -75.51 -7.22 53.61 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.855 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.7 t -124.7 130.43 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.711 1.141 . . . . 0.0 108.702 -168.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mt -74.71 151.33 39.23 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.812 1.245 . . . . 0.0 111.133 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.06 19.91 10.96 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.147 2.179 . . . . 0.0 114.093 -163.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.7 mt 53.44 -163.85 0.1 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.983 1.313 . . . . 0.0 110.872 -164.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -148.05 164.08 34.93 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.441 1.096 . . . . 0.0 110.485 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.8 m 53.73 -166.96 0.07 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.912 1.285 . . . . 0.0 110.262 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m 24.42 70.3 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 128.546 2.739 . . . . 0.0 114.906 158.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -38.82 -39.4 0.51 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.122 1.769 . . . . 0.0 113.229 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.09 29.58 3.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.602 1.161 . . . . 0.0 111.478 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.54 -21.03 6.28 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 166.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 m -64.94 173.81 2.18 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.417 -1.049 . . . . 0.0 110.079 162.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.08 168.77 2.32 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.396 157.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.9 p -126.85 170.38 12.28 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 127.263 2.225 . . . . 0.0 108.645 171.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 53.51 29.54 9.21 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 127.472 2.309 . . . . 0.0 111.329 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.1 p -148.44 151.14 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 124.126 0.971 . . . . 0.0 108.565 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.72 -176.21 21.12 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.413 HG11 ' CG ' ' A' ' 177' ' ' PHE . 46.4 t -102.54 138.8 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -115.58 159.89 20.69 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.524 1.056 . . . . 0.0 110.411 171.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.38 137.38 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 170.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -135.69 151.84 50.59 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.718 -177.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 4.1 p-10 -66.6 179.22 1.08 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.042 0.925 . . . . 0.0 111.975 160.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -44.22 -33.92 1.71 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 129.191 2.996 . . . . 0.0 114.966 168.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.4 p -87.83 -7.14 57.66 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.183 1.356 . . . . 0.0 110.846 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.38 22.34 78.77 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.798 1.666 . . . . 0.0 112.419 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.8 34.13 0.49 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -165.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.437 ' HA ' HD13 ' A' ' 104' ' ' LEU . . . 33.08 94.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 129.051 2.941 . . . . 0.0 114.978 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.73 136.31 56.09 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.82 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 113' ' ' LEU . 16.9 m -68.61 167.7 14.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 166.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.457 ' H ' HG22 ' A' ' 112' ' ' THR . 66.9 mt -119.73 70.58 0.86 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -168.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -113.82 -11.77 12.82 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.862 0.865 . . . . 0.0 111.816 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.65 -12.38 4.81 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.082 -1.011 . . . . 0.0 113.894 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -133.45 -10.67 2.83 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.945 1.298 . . . . 0.0 112.942 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.4 t -61.22 123.52 17.97 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 164.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -84.57 157.88 21.09 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.2 t -104.11 174.37 5.9 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.438 1.495 . . . . 0.0 109.073 173.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.444 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 0.5 OUTLIER -45.31 13.98 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.525 1 C-N-CA 134.708 5.203 . . . . 0.0 120.765 179.756 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 44.69 -179.63 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 130.314 3.445 . . . . 0.0 113.458 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 m -158.43 137.66 11.59 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 157.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.0 m -77.82 110.86 13.07 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 175.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.4 mt -72.44 -174.11 1.28 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.413 2.285 . . . . 0.0 108.221 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -151.45 176.17 11.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.6 1.96 . . . . 0.0 108.723 169.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -68.16 101.32 1.15 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 137.77 -170.36 23.75 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.788 1.185 . . . . 0.0 110.698 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 51.4 m -76.74 129.19 35.97 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.087 -1.243 . . . . 0.0 110.0 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -123.41 166.35 15.5 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.289 1.436 . . . . 0.0 109.333 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.0 m -154.71 147.44 24.34 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.037 0.923 . . . . 0.0 109.666 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.2 mt -130.33 111.31 16.64 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 -171.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.67 100.16 0.86 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.918 3.079 . . . . 0.0 110.367 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.86 166.62 20.74 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 171.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -117.32 155.84 28.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 168.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.53 163.55 34.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.673 1.989 . . . . 0.0 107.835 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -175.41 156.06 1.93 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.467 1.907 . . . . 0.0 107.626 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.413 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 85.5 m-85 -71.83 147.22 47.4 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 156.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.419 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 31.1 t80 -123.55 121.0 34.51 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.423 1.889 . . . . 0.0 106.893 176.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -82.88 141.31 32.32 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 46.4 p -100.41 11.07 40.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.463 0.705 . . . . 0.0 111.599 169.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 158.59 -148.22 17.03 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.82 82.37 0.2 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.15 1.78 . . . . 0.0 110.214 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -65.31 157.51 28.92 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.247 1.019 . . . . 0.0 111.342 -177.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.1 p -123.79 153.95 67.07 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 124.592 1.157 . . . . 0.0 109.964 -176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.86 163.41 26.06 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.434 1.422 . . . . 0.0 111.018 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.23 -116.51 0.72 Allowed Glycine 0 N--CA 1.469 0.877 0 C-N-CA 124.442 1.02 . . . . 0.0 111.045 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -119.89 145.36 46.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.164 0.982 . . . . 0.0 109.668 167.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -134.45 86.16 2.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -120.48 146.72 45.98 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -149.0 175.16 11.54 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -152.48 152.95 32.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 173.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.13 175.34 9.66 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.836 2.455 . . . . 0.0 107.881 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.9 p -116.54 153.52 32.04 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 155.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -112.54 151.54 29.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -131.28 157.62 42.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.429 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 9.3 t -122.85 133.81 67.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -169.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -120.84 85.13 2.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.429 ' CZ ' HG11 ' A' ' 156' ' ' VAL . 94.7 m-85 -67.92 128.85 38.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.983 175.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -153.64 176.67 11.81 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 124.801 1.24 . . . . 0.0 111.452 -174.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 129.16 -50.58 0.88 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -173.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -68.77 173.53 34.17 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 173.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.9 169.12 41.4 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 69.54 4.88 47.76 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 119.518 -0.601 . . . . 0.0 112.215 -169.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 149.95 87.62 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -172.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 100.23 74.68 1.12 Allowed Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -123.91 115.0 20.58 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 69.4 75.3 0.23 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 126.756 2.022 . . . . 0.0 112.119 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 10.1 m -79.48 99.48 7.26 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 164.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.9 m -78.16 129.64 35.38 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 165.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.18 151.84 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.713 1.605 . . . . 0.0 109.722 -176.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -61.48 139.59 58.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.7 -56.73 0.56 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 166.42 -171.35 41.38 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -175.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.5 m -103.15 138.4 40.02 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.75 1.22 . . . . 0.0 109.657 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.1 t -119.72 103.07 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' HIS . . . . . 0.42 ' HB2' HG23 ' A' ' 31' ' ' THR . 20.0 m-70 -82.67 141.99 32.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 171.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.413 ' CG ' HG11 ' A' ' 101' ' ' VAL . 86.3 m-85 -121.16 113.74 20.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -124.75 156.39 37.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 118.582 0.628 . . . . 0.0 110.677 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 148.59 -162.6 28.89 Favored Glycine 0 N--CA 1.437 -1.279 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 -167.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.25 177.22 3.66 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 -173.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.4 t -125.87 135.98 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.8 m -118.86 149.97 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 C-N-CA 127.59 2.356 . . . . 0.0 108.492 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -74.99 34.18 0.1 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 C-N-CA 130.269 3.428 . . . . 0.0 112.765 173.033 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.36 142.26 22.09 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 156.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.6 m -132.57 152.77 51.5 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.039 1.336 . . . . 0.0 108.795 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.4 t -143.56 150.81 39.4 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 159.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 p -173.36 160.95 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 128.412 2.685 . . . . 0.0 105.541 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -120.05 158.05 27.63 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.564 1.146 . . . . 0.0 110.712 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.44 -39.98 2.17 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.254 1.883 . . . . 0.0 112.638 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.36 -97.96 0.11 Allowed Glycine 0 C--N 1.334 0.425 0 N-CA-C 105.694 -2.962 . . . . 0.0 105.694 169.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.4 t -145.86 113.54 6.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 160.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.291 4.3 p 22.74 85.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.087 1.355 . . . . 0.0 112.112 145.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -53.93 -78.46 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.676 0.79 . . . . 0.0 111.321 -155.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 176.69 71.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 130.553 3.541 . . . . 0.0 101.678 165.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -85.74 -103.7 0.06 Allowed 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -173.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.13 -13.76 65.4 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 123.614 0.626 . . . . 0.0 113.781 163.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -142.89 -158.46 0.87 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.97 2.108 . . . . 0.0 106.412 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.0 t -55.92 -20.08 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.773 1.229 . . . . 0.0 111.391 167.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 56.4 45.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.726 1.211 . . . . 0.0 110.238 -166.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -152.21 99.95 2.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 162.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.13 133.85 52.67 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 165.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.536 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -51.11 -37.44 46.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 116.671 -1.633 . . . . 0.0 111.913 172.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.1 m -121.48 164.86 16.48 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 125.104 1.503 . . . . 0.0 112.128 -167.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.43 -12.81 25.3 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.974 1.31 . . . . 0.0 113.866 -170.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.453 HG13 ' OG ' ' A' ' 27' ' ' SER . 70.8 t 50.06 109.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 130.191 3.396 . . . . 0.0 112.127 -174.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.06 151.68 39.23 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.001 -1.062 . . . . 0.0 109.525 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.593 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -49.82 -33.72 17.54 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.353 1.461 . . . . 0.0 111.189 166.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.35 -6.03 1.98 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.442 1.496 . . . . 0.0 114.537 171.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.453 ' OG ' HG13 ' A' ' 23' ' ' VAL . 96.5 p -132.69 -34.93 1.13 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.847 1.824 . . . . 0.0 112.342 -177.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 25' ' ' ALA . 8.0 p -62.13 -55.23 25.42 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 123.396 0.679 . . . . 0.0 111.282 -170.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -132.04 67.8 1.51 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -165.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -105.72 140.3 38.98 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.902 -1.499 . . . . 0.0 108.295 -161.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.1 m -110.32 94.59 5.09 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.6 t -77.65 104.32 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -86.68 107.79 18.36 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 mt -85.37 -3.39 58.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.8 1.24 . . . . 0.0 110.029 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.5 -178.34 23.76 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 125.241 1.4 . . . . 0.0 112.298 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -65.74 151.51 46.42 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.088 0.555 . . . . 0.0 109.877 162.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.46 152.95 34.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 C-N-CA 125.919 1.688 . . . . 0.0 107.578 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -83.2 134.92 34.94 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.1 p -59.31 -21.94 60.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.82 0.448 . . . . 0.0 111.735 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.1 -31.44 70.04 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.684 -1.26 . . . . 0.0 112.229 171.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -74.05 -9.58 58.77 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.854 0.861 . . . . 0.0 111.449 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.542 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 18.6 mt -143.35 76.56 1.53 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.176 1.39 . . . . 0.0 107.715 -159.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.93 -1.27 2.21 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -171.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 2.7 pm0 -151.14 161.29 43.0 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 35.6 tt0 -64.08 126.76 28.73 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.27 2.53 79.99 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.995 -0.891 . . . . 0.0 113.166 -174.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.57 ' HB2' ' NE2' ' A' ' 44' ' ' GLN . . . -70.45 159.55 34.01 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.642 1.721 . . . . 0.0 109.779 161.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.0 p -149.67 162.81 39.49 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.301 0.64 . . . . 0.0 110.203 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.5 p -73.85 174.8 7.98 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.646 -0.659 . . . . 0.0 110.339 168.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -55.13 -17.27 3.92 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 83.0 160.62 0.13 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 129.765 3.226 . . . . 0.0 112.121 173.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.1 t -143.26 140.53 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.85 130.0 10.09 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 107.152 -2.379 . . . . 0.0 107.152 169.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -136.49 130.19 32.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.468 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 2.8 m-20 -109.64 165.48 11.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -169.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.9 mm -116.74 99.33 8.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -68.36 95.84 0.63 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.902 1.681 . . . . 0.0 110.281 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.45 158.31 19.62 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 122.473 1.13 . . . . 0.0 109.123 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -163.39 155.59 17.87 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 126.794 2.037 . . . . 0.0 107.547 -169.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 45.55 59.2 3.74 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 127.91 2.484 . . . . 0.0 111.079 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.8 m -108.77 107.81 18.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.389 2.275 . . . . 0.0 111.15 -168.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -79.4 158.45 27.37 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.679 1.127 . . . . 0.0 111.121 172.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.4 p -100.52 -18.04 16.83 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.226 1.41 . . . . 0.0 113.554 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -64.77 -46.85 80.39 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.403 1.081 . . . . 0.0 109.063 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 20' ' ' ALA . 2.4 p -57.96 -53.05 50.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 114.184 -1.371 . . . . 0.0 107.442 -175.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.431 ' HA ' ' HA2' ' A' ' 160' ' ' GLY . . . -153.19 142.26 21.34 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 166.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -93.75 11.39 29.31 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.394 172.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.469 ' HE3' ' OE1' ' A' ' 159' ' ' GLN . 7.7 mtmt -148.48 163.34 37.47 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.036 1.334 . . . . 0.0 108.724 168.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.84 177.08 9.85 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 123.764 0.665 . . . . 0.0 109.486 157.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.54 178.37 8.18 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 128.696 2.798 . . . . 0.0 107.726 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.6 t -143.85 100.96 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.435 1.894 . . . . 0.0 106.929 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.63 152.52 28.46 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 118.341 -0.838 . . . . 0.0 109.267 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -112.75 158.66 19.81 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 118.814 0.733 . . . . 0.0 110.328 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.9 tp -144.5 153.45 41.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.747 1.619 . . . . 0.0 108.002 175.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.0 170.69 33.92 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 m -64.45 131.44 47.14 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.191 1.397 . . . . 0.0 109.334 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.94 135.65 43.25 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.613 1.097 . . . . 0.0 110.366 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.7 tt -63.19 -35.29 71.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.229 0.611 . . . . 0.0 111.076 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -159.57 166.53 30.58 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.392 1.477 . . . . 0.0 108.755 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.44 -19.86 57.82 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 127.654 2.382 . . . . 0.0 114.612 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.2 -20.23 43.01 Favored Glycine 0 CA--C 1.524 0.629 0 O-C-N 120.838 -1.164 . . . . 0.0 112.149 171.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -125.02 53.76 1.48 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.634 1.573 . . . . 0.0 108.18 -170.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.9 p -63.58 -15.56 58.45 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 127.303 2.241 . . . . 0.0 111.99 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -97.04 2.84 51.89 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.717 2.007 . . . . 0.0 113.073 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 t -128.35 141.13 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 120.157 1.344 . . . . 0.0 109.392 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -81.41 146.11 30.45 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.271 -169.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.55 ' H ' HD23 ' A' ' 86' ' ' LEU . . . -88.95 14.52 10.32 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.629 1.572 . . . . 0.0 114.509 -166.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.5 mt 51.51 -154.3 0.17 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.328 1.051 . . . . 0.0 110.556 -167.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -145.34 94.67 2.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.504 -0.747 . . . . 0.0 110.729 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.7 m 51.58 -148.59 0.37 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.084 170.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.7 m 141.43 65.05 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 121.342 1.883 . . . . 0.0 108.844 141.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.62 -77.7 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.566 1.947 . . . . 0.0 111.46 -171.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.79 27.16 1.19 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.078 1.751 . . . . 0.0 112.727 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.06 36.93 86.8 Favored Glycine 0 C--N 1.334 0.417 0 O-C-N 121.739 -0.601 . . . . 0.0 113.458 163.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.83 -173.13 0.08 Allowed 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 126.458 1.903 . . . . 0.0 112.884 -171.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.79 125.73 14.06 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 148.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.1 p -90.3 172.6 8.66 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 56.6 28.62 14.26 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.993 1.717 . . . . 0.0 111.361 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.28 151.29 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.858 0.863 . . . . 0.0 109.485 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.6 175.18 29.73 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 124.382 0.991 . . . . 0.0 110.815 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.2 t -85.11 126.54 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -98.87 144.61 27.88 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 164.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.6 mp -118.41 146.95 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 169.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 mt -141.52 151.42 43.26 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.201 1.4 . . . . 0.0 107.643 -172.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -59.25 -75.08 0.06 Allowed 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.118 0.485 . . . . 0.0 111.073 170.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.1 ptt-85 -176.0 -24.57 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 128.055 2.542 . . . . 0.0 109.415 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.4 p -80.58 -28.17 37.24 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.107 1.363 . . . . 0.0 108.588 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.6 7.06 9.13 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.016 1.77 . . . . 0.0 112.591 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.88 104.87 2.17 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 120.146 1.973 . . . . 0.0 108.402 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.95 100.78 0.22 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.166 0.986 . . . . 0.0 109.279 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.34 132.48 52.76 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.888 0.875 . . . . 0.0 109.251 -170.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 49.3 m -74.63 148.34 40.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.32 0.581 . . . . 0.0 109.789 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.7 mt -92.35 81.55 4.93 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -127.61 -24.42 3.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.6 1.96 . . . . 0.0 111.324 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.84 7.78 71.1 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.14 1.353 . . . . 0.0 113.548 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -140.17 -29.17 0.71 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.785 1.292 . . . . 0.0 112.482 170.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.4 m -53.81 115.09 1.81 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.633 1.173 . . . . 0.0 108.846 173.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -71.52 179.64 2.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.309 1.052 . . . . 0.0 112.384 -164.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.8 p -134.27 126.22 29.34 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.938 1.695 . . . . 0.0 107.791 167.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.6 m 23.2 85.25 0.01 OUTLIER 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.757 2.023 . . . . 0.0 114.083 147.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -61.61 144.95 53.61 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.128 -162.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.9 m -113.71 114.21 26.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 86.0 m -53.74 110.58 0.6 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 154.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.0 mt -72.84 176.9 5.23 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 170.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.12 162.22 30.38 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 121.621 -0.675 . . . . 0.0 109.993 171.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.37 132.18 47.54 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 94.7 -118.54 5.85 Favored Glycine 0 C--O 1.223 -0.58 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.9 m -118.54 144.47 46.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.455 1.102 . . . . 0.0 109.706 -164.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.63 171.5 18.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.127 1.371 . . . . 0.0 109.309 -173.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.468 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 97.1 m -154.32 163.78 39.62 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 119.527 -1.983 . . . . 0.0 108.637 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -122.05 121.0 28.14 Favored Pre-proline 0 N--CA 1.446 -0.638 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 168.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -70.62 135.64 28.86 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 N-CA-C 108.026 -1.567 . . . . 0.0 108.026 160.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -120.54 170.78 9.08 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.802 0.841 . . . . 0.0 108.75 163.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.77 143.33 50.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 168.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -115.74 164.5 14.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.694 1.197 . . . . 0.0 107.915 162.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -164.77 152.33 11.53 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 167.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.451 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 70.4 m-85 -69.5 142.09 53.79 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 165.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -121.74 122.01 38.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -86.18 141.79 29.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.46 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 65.4 p -101.43 7.35 42.59 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.271 1.028 . . . . 0.0 111.302 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.81 -151.97 21.3 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.17 91.98 0.08 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.069 1.348 . . . . 0.0 109.658 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -79.34 144.46 34.19 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.529 0.732 . . . . 0.0 110.897 -174.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.2 p -110.56 165.58 12.4 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.014 0.925 . . . . 0.0 110.019 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.9 174.48 12.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.166 1.911 . . . . 0.0 111.17 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.96 -85.55 0.14 Allowed Glycine 0 C--N 1.336 0.555 0 O-C-N 121.36 -0.838 . . . . 0.0 113.819 167.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -147.11 162.9 37.91 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.311 2.244 . . . . 0.0 105.771 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -151.74 68.42 0.89 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 119.443 1.02 . . . . 0.0 110.133 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -114.73 150.37 35.4 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.08 169.95 20.58 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 169.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -132.93 120.53 21.57 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 174.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -120.44 159.64 24.72 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.933 1.693 . . . . 0.0 108.95 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.0 p -124.54 141.33 52.17 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 162.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -104.36 155.94 18.34 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 168.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -119.5 131.03 55.49 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 171.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 156' ' ' VAL . 0.2 OUTLIER -66.21 137.98 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 171.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -128.8 90.15 3.0 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 171.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.536 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 84.6 m-85 -62.23 161.52 11.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 166.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.469 ' OE1' ' HE3' ' A' ' 68' ' ' LYS . 8.2 mt-30 -103.35 -142.99 0.36 Allowed 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 125.027 1.331 . . . . 0.0 108.044 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 66' ' ' ALA . . . -131.9 9.85 5.44 Favored Glycine 0 N--CA 1.434 -1.468 1 C-N-CA 113.642 -4.123 . . . . 0.0 118.419 126.655 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.439 ' HA2' ' HE2' ' A' ' 68' ' ' LYS . . . 86.41 13.03 68.84 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 120.996 2.398 . . . . 0.0 111.852 -176.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -84.04 -168.06 43.28 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 150.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.25 76.46 0.39 Allowed Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.36 101.24 0.6 Allowed Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 142.32 9.42 0.57 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 124.525 1.059 . . . . 0.0 113.701 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -155.51 123.44 5.73 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.966 0.907 . . . . 0.0 109.544 174.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -164.67 153.85 13.14 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.265 1.826 . . . . 0.0 110.848 173.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.3 m -137.92 92.8 2.7 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.566 1.546 . . . . 0.0 108.04 -173.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.51 126.15 28.4 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 167.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.38 140.58 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.624 1.17 . . . . 0.0 109.328 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -58.96 143.13 49.07 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -114.68 -87.77 1.51 Allowed Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -144.58 -144.35 4.16 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 126.711 2.101 . . . . 0.0 112.137 -167.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 96.5 m -138.18 149.42 45.83 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.333 2.253 . . . . 0.0 108.2 166.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.7 t -115.73 119.15 61.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 163.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -96.97 94.51 7.23 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -72.35 119.5 16.64 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -124.95 160.27 29.29 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 138.15 -169.91 24.03 Favored Glycine 0 C--N 1.321 -0.292 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -171.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -162.66 177.05 9.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -167.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 41.3 t -126.69 131.06 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 167.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.3 m -101.9 155.9 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 127.354 2.262 . . . . 0.0 108.227 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.13 37.79 0.16 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.421 1.088 . . . . 0.0 113.494 -172.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 C-N-CA 127.844 2.457 . . . . 0.0 110.371 -167.189 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.55 151.77 39.41 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.325 1.421 . . . . 0.0 110.357 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -136.82 -25.57 1.09 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -166.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.254 3.6 t 37.06 -158.71 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 128.876 2.87 . . . . 0.0 116.16 164.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 p -82.96 79.31 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 126.395 1.878 . . . . 0.0 108.324 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -75.92 82.83 2.83 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.046 -1.034 . . . . 0.0 109.148 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.71 -98.8 0.13 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.155 -0.803 . . . . 0.0 112.728 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.26 -40.72 1.68 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.412 1.482 . . . . 0.0 110.003 -171.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.55 84.39 1.8 Allowed 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 157.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.25 10.2 p 24.31 68.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 128.577 2.751 . . . . 0.0 113.249 164.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -74.65 -38.43 62.49 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.937 -175.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 t80 85.3 -2.36 0.85 Allowed 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 128.771 2.828 . . . . 0.0 113.085 165.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt 47.0 104.43 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.125 0 CA-C-O 124.378 2.037 . . . . 0.0 109.355 -140.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -56.84 78.3 0.01 OUTLIER Glycine 0 C--N 1.306 -1.096 0 C-N-CA 126.937 2.208 . . . . 0.0 111.987 166.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.3 0.0 OUTLIER 72.25 168.04 0.31 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.466 2.306 . . . . 0.0 110.222 -177.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . 0.431 2.1 p 53.17 -42.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.511 1 C-N-CA 133.01 4.524 . . . . 0.0 113.336 -164.852 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 t 41.85 31.14 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 128.513 2.725 . . . . 0.0 115.394 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -134.86 107.5 7.41 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 -176.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.3 110.83 21.5 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 171.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.414 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -30.78 -52.8 0.18 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 126.58 1.952 . . . . 0.0 111.452 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 1.8 m -103.73 143.3 32.98 Favored 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 124.684 1.24 . . . . 0.0 108.774 166.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.97 172.26 1.83 Allowed 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 124.621 1.201 . . . . 0.0 109.918 164.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.8 137.55 55.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -71.37 158.2 36.74 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.779 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -59.03 -32.56 69.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.176 0.99 . . . . 0.0 111.869 172.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.65 3.36 60.22 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.435 -1.203 . . . . 0.0 113.901 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.8 t -128.39 -40.92 1.58 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.355 1.462 . . . . 0.0 109.087 -169.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 25' ' ' ALA . 9.0 p -56.57 -41.46 73.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 123.992 0.917 . . . . 0.0 111.06 171.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -131.4 69.02 1.48 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.074 0.94 . . . . 0.0 109.503 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -103.02 129.48 49.81 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.545 -171.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.621 HG23 ' HB2' ' A' ' 176' ' ' HIS . 0.3 OUTLIER -97.45 99.34 10.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 172.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.2 t -85.17 115.21 26.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -90.04 108.35 19.67 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.68 -16.52 62.25 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.566 0.747 . . . . 0.0 109.801 173.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.48 -175.53 52.98 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -71.27 156.81 39.09 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.497 0.719 . . . . 0.0 109.484 171.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.3 t -141.63 146.57 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.5 1.92 . . . . 0.0 107.026 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.11 137.54 37.54 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.8 p -59.87 -20.85 59.5 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.254 0.622 . . . . 0.0 111.337 173.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.48 -39.43 87.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.245 1.018 . . . . 0.0 111.883 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.4 m -67.66 -9.27 41.82 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mt -142.05 60.93 1.46 Allowed 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 125.882 1.673 . . . . 0.0 110.412 -162.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.64 -3.8 7.19 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -166.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -153.45 160.26 42.54 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.516 1.526 . . . . 0.0 107.19 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.408 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 36.3 tt0 -61.52 135.09 57.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.98 0.895 . . . . 0.0 109.131 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.91 -7.88 64.87 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-O 117.088 -1.951 . . . . 0.0 112.982 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -58.8 155.93 12.11 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 120.239 2.019 . . . . 0.0 110.51 165.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.3 p -146.74 150.51 35.49 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.688 0.756 . . . . 0.0 110.382 -171.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.5 t -59.54 164.57 3.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 163.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 m -46.35 -81.17 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.335 1.054 . . . . 0.0 112.772 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 173.32 143.49 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.53 1.932 . . . . 0.0 106.839 -172.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 t -141.29 130.46 24.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 170.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.55 126.53 8.93 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.549 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 8.3 p90 -131.55 78.01 1.8 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 123.707 1.718 . . . . 0.0 109.539 -177.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.443 ' HB2' HG22 ' A' ' 130' ' ' THR . 22.2 p30 -70.16 153.51 43.04 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.362 -173.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.9 mm -94.3 104.08 15.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.39 112.92 2.63 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.886 -1.154 . . . . 0.0 107.886 167.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.87 167.0 11.52 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 161.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -137.92 169.7 17.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.401 1.481 . . . . 0.0 107.485 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 43.47 54.02 5.46 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 128.287 2.635 . . . . 0.0 114.712 164.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 2.0 t -81.12 168.71 18.28 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -137.73 141.62 40.99 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.804 2.442 . . . . 0.0 106.446 172.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.1 p -95.72 -12.63 25.14 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.372 1.069 . . . . 0.0 113.138 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -60.71 -49.36 77.82 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.919 1.288 . . . . 0.0 109.475 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.414 HG11 ' HA ' ' A' ' 20' ' ' ALA . 3.0 p -59.64 -58.92 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 113.692 -1.595 . . . . 0.0 107.378 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.4 132.02 9.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.38 1.872 . . . . 0.0 107.38 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.49 -18.53 61.1 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.838 170.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -129.2 157.4 41.94 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 119.605 1.093 . . . . 0.0 110.856 -164.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.94 145.73 46.47 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 124.974 1.31 . . . . 0.0 107.74 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.5 164.95 23.7 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 124.509 1.124 . . . . 0.0 108.534 157.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.415 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -153.77 92.07 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 -169.385 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.04 165.77 24.38 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.966 0.907 . . . . 0.0 109.405 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -130.22 163.42 26.75 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.16 1.384 . . . . 0.0 109.136 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 tp -154.42 133.55 12.47 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.122 1.369 . . . . 0.0 109.217 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.31 177.07 42.56 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.7 m -73.77 130.7 40.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.105 0.962 . . . . 0.0 109.946 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.02 136.88 48.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 118.949 0.795 . . . . 0.0 111.3 176.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.5 tt -62.24 -42.04 93.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.758 0.823 . . . . 0.0 110.946 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -152.64 164.83 36.93 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.59 1.556 . . . . 0.0 106.924 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.15 82.6 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 126.22 1.808 . . . . 0.0 110.955 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.87 -4.83 78.12 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 119.541 -0.588 . . . . 0.0 112.476 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -143.02 41.84 1.53 Allowed 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.884 1.342 . . . . 0.0 110.53 -167.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 p -62.99 -13.38 34.34 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.209 2.204 . . . . 0.0 115.023 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -81.37 -13.48 58.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.761 0.315 . . . . 0.0 111.329 171.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.0 t -115.31 133.01 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 O-C-N 120.36 -1.462 . . . . 0.0 108.624 -166.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -76.08 148.11 38.16 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.649 1.18 . . . . 0.0 110.014 -174.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.77 14.89 12.3 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.301 1.84 . . . . 0.0 113.955 -164.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.4 mt 52.76 -155.35 0.19 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.125 0.97 . . . . 0.0 109.565 -163.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -127.82 -165.58 1.5 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.707 0.403 . . . . 0.0 110.856 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -53.78 -178.14 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.654 1.981 . . . . 0.0 111.778 171.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.513 ' HB3' ' HA3' ' A' ' 94' ' ' GLY . 0.7 OUTLIER 66.77 79.52 0.23 Allowed 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 125.97 1.708 . . . . 0.0 107.23 -149.442 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.85 -44.76 29.49 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.5 2.32 . . . . 0.0 112.011 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.73 -4.13 12.19 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.022 0.929 . . . . 0.0 111.455 175.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 91' ' ' SER . . . -74.31 -50.76 9.49 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.7 m -68.75 150.91 47.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.239 173.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.82 144.85 56.98 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.954 2.101 . . . . 0.0 110.044 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.401 ' H ' ' HG1' ' A' ' 144' ' ' THR . 3.8 p -90.96 165.93 13.3 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 56.55 20.85 5.19 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 127.286 2.234 . . . . 0.0 113.517 175.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -142.79 149.76 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 119.209 0.913 . . . . 0.0 108.844 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.94 174.99 24.81 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 124.864 1.221 . . . . 0.0 110.603 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.432 HG11 ' CD2' ' A' ' 177' ' ' PHE . 53.4 t -84.36 149.3 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -136.69 143.97 43.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.56 1.544 . . . . 0.0 106.935 175.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.35 137.29 57.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.9 mt -133.44 129.13 36.85 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.767 1.627 . . . . 0.0 107.061 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 12.0 p30 -55.45 -60.7 3.05 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -175.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -171.62 -45.31 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.294 2.238 . . . . 0.0 108.408 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.293 0.5 OUTLIER -82.05 18.65 1.3 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.427 1.891 . . . . 0.0 109.94 -177.341 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.8 10.94 48.02 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 120.252 -1.53 . . . . 0.0 112.105 -169.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.79 111.42 8.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.554 1.677 . . . . 0.0 107.484 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.78 138.86 58.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.11 0.564 . . . . 0.0 109.801 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 73.0 mt -108.33 110.25 21.78 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.418 0.687 . . . . 0.0 110.398 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -53.25 139.16 30.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.699 1.6 . . . . 0.0 110.6 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.6 mt -89.41 59.39 4.79 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 127.903 2.481 . . . . 0.0 108.015 -173.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.69 -31.98 10.53 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.314 0.578 . . . . 0.0 111.257 -174.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.74 -36.85 3.95 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-O 117.522 -1.71 . . . . 0.0 114.086 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.55 -16.56 13.63 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.91 1.355 . . . . 0.0 112.222 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.1 m -73.02 95.74 2.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -70.24 173.19 7.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.363 2.265 . . . . 0.0 110.786 -174.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.0 p -112.88 -170.36 1.66 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.302 1.441 . . . . 0.0 111.814 -172.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -44.43 142.59 1.53 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.579 1.552 . . . . 0.0 111.594 164.123 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -80.67 134.39 35.86 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.623 0.725 . . . . 0.0 109.156 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.9 m -113.93 113.26 24.59 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 167.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.7 m -61.44 143.5 55.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.9 mt -115.41 179.48 3.95 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.301 2.24 . . . . 0.0 109.105 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -134.03 167.87 19.84 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.347 1.459 . . . . 0.0 108.21 172.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -72.28 104.11 3.6 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.07 -149.9 18.26 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -173.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.95 138.36 31.48 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.269 1.028 . . . . 0.0 111.248 -165.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.78 169.0 24.57 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.449 1.9 . . . . 0.0 110.915 -174.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.6 m -151.99 150.39 29.94 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.534 1.134 . . . . 0.0 109.641 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.27 119.31 55.51 Favored Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 124.58 1.152 . . . . 0.0 108.784 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -81.54 83.69 2.09 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 124.011 3.141 . . . . 0.0 112.782 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.415 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 76.3 m-85 -74.52 160.9 30.31 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.269 -0.894 . . . . 0.0 112.572 173.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -116.95 147.65 42.08 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 155.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.549 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -122.82 161.63 23.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.833 1.653 . . . . 0.0 107.121 160.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -157.61 160.16 37.79 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.421 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 97.4 m-85 -76.76 148.83 36.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 163.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -124.19 127.23 47.43 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.254 1.422 . . . . 0.0 107.376 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.77 144.26 25.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.482 0.713 . . . . 0.0 109.639 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.408 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 24.8 p -104.35 8.33 35.87 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 123.617 0.767 . . . . 0.0 111.653 171.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 162.96 -150.35 19.17 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 107.944 -2.062 . . . . 0.0 107.944 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.8 89.74 0.27 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.582 1.153 . . . . 0.0 110.699 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.53 141.7 46.88 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.512 0.725 . . . . 0.0 109.672 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.401 ' HG1' ' H ' ' A' ' 97' ' ' THR . 69.6 p -92.72 160.6 33.95 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -75.96 157.84 38.61 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 121.126 1.218 . . . . 0.0 109.464 160.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.67 176.23 18.49 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.357 1.456 . . . . 0.0 109.685 -168.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.16 157.67 34.85 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.526 -0.984 . . . . 0.0 108.732 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.421 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -144.75 81.63 1.66 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.719 0.771 . . . . 0.0 110.174 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -124.77 152.1 44.27 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -173.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -156.11 175.34 14.1 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.702 1.201 . . . . 0.0 109.523 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -156.47 84.69 0.98 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.936 0.874 . . . . 0.0 110.642 -175.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.448 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -81.31 169.89 16.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.934 173.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.3 p -117.61 163.12 16.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.86 155.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.406 ' CD2' ' HA3' ' A' ' 172' ' ' GLY . 38.9 p90 -120.37 159.55 24.83 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.534 1.134 . . . . 0.0 109.91 173.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -129.1 125.27 36.83 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 167.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.31 143.32 15.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 163.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -137.26 82.24 1.92 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -67.51 154.03 42.35 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.744 -0.646 . . . . 0.0 109.687 176.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -158.32 176.12 12.87 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.498 1.119 . . . . 0.0 112.795 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 141.35 -32.53 2.07 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.095 1.331 . . . . 0.0 111.644 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -90.44 -141.69 9.28 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.439 1.971 . . . . 0.0 110.167 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 151.38 -13.98 0.82 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.963 1.268 . . . . 0.0 111.809 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -80.05 79.43 1.71 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 149.54 -100.5 0.21 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -87.84 -46.28 4.87 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 76.76 119.33 0.05 Allowed 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 127.753 2.421 . . . . 0.0 110.541 -168.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 59.61 175.6 0.08 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.512 2.325 . . . . 0.0 112.538 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.1 m -145.1 90.69 2.06 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.119 0.967 . . . . 0.0 109.341 -168.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.3 m -92.95 96.58 10.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.1 0.952 . . . . 0.0 110.678 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.53 135.12 51.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 125.767 1.627 . . . . 0.0 110.292 -174.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -55.78 107.67 0.37 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.452 1.101 . . . . 0.0 108.907 168.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.406 ' HA3' ' CD2' ' A' ' 154' ' ' PHE . . . -74.95 -58.05 4.19 Favored Glycine 0 CA--C 1.523 0.578 0 O-C-N 120.587 -1.321 . . . . 0.0 110.931 -168.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 169.33 -161.47 35.0 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -171.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.6 m -122.43 133.93 54.61 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 127.588 2.355 . . . . 0.0 107.008 -176.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.49 109.65 28.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' HIS . . . . . 0.621 ' HB2' HG23 ' A' ' 31' ' ' THR . 20.2 m-70 -88.07 96.75 10.64 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.432 ' CD2' HG11 ' A' ' 101' ' ' VAL . 77.9 m-85 -76.63 133.03 39.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -137.73 162.1 34.8 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 121.537 -0.727 . . . . 0.0 111.325 175.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 146.92 -155.87 26.75 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -169.97 175.28 5.18 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -168.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 32.0 t -128.22 136.99 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 16.3 m -118.72 147.49 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 C-N-CA 126.495 1.918 . . . . 0.0 109.496 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.35 25.31 0.1 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -167.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 128.54 2.736 . . . . 0.0 111.326 -167.63 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.35 106.06 4.12 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -155.53 121.83 5.19 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -173.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.0 m -153.68 101.67 2.49 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 173.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -66.06 134.38 29.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 162.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -63.48 92.8 0.07 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.285 1.434 . . . . 0.0 107.965 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.4 -87.78 0.71 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.6 -111.48 0.29 Allowed Glycine 0 C--N 1.336 0.541 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.55 96.83 4.22 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.263 11.4 p 41.98 48.8 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 127.33 2.252 . . . . 0.0 115.366 160.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -89.85 68.37 7.4 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.164 -1.585 . . . . 0.0 110.663 -164.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -144.98 -2.92 0.79 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -77.27 22.63 0.22 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -164.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.79 36.93 3.18 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -150.98 -171.71 4.01 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 171.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 p -55.23 -29.61 23.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.896 1.278 . . . . 0.0 112.478 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.1 t 25.71 63.67 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 126.923 2.089 . . . . 0.0 112.458 -172.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -136.77 105.86 5.98 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 170.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.71 139.11 53.81 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.401 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . . . -70.12 -16.32 63.09 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.795 -177.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.7 m -129.68 157.08 43.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.695 1.198 . . . . 0.0 107.829 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.25 107.14 15.59 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 161.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.12 118.58 2.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 121.104 -0.997 . . . . 0.0 108.859 167.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -70.97 163.88 26.62 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.737 -0.602 . . . . 0.0 111.135 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -72.27 -12.9 61.35 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.99 -1.069 . . . . 0.0 113.209 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.63 -1.65 90.04 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 121.233 -0.917 . . . . 0.0 112.787 167.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.4 t -121.82 -31.1 4.01 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.758 1.279 . . . . 0.0 110.765 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 25' ' ' ALA . 4.1 p -63.75 -24.32 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 O-C-N 121.11 -0.994 . . . . 0.0 113.3 -175.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -157.01 53.67 0.51 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.664 0.786 . . . . 0.0 110.365 -162.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -99.49 143.37 29.81 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 120.543 -1.348 . . . . 0.0 110.404 -169.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 176' ' ' HIS . 4.9 m -113.79 95.32 5.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 t -73.15 136.45 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -114.26 118.78 34.91 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.501 1.143 . . . . 0.0 108.464 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 34' ' ' LEU . 1.3 mm? -85.94 -21.2 28.02 Favored 'General case' 0 N--CA 1.44 -0.974 1 C-N-CA 131.9 4.08 . . . . 0.0 108.422 177.582 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.45 -172.58 34.79 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 124.658 1.123 . . . . 0.0 111.144 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -67.57 112.77 4.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.806 0.842 . . . . 0.0 108.827 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.19 153.23 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 125.258 1.423 . . . . 0.0 107.691 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 5.8 mmt180 -86.32 136.34 33.18 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.3 p -60.66 -27.25 67.68 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 169.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.08 3.24 2.19 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.975 1.71 . . . . 0.0 113.789 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 m -121.45 7.0 10.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.866 1.267 . . . . 0.0 112.203 164.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.569 HD13 HG21 ' A' ' 99' ' ' VAL . 29.6 mt -142.26 71.79 1.36 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.397 1.879 . . . . 0.0 109.15 -171.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.55 4.46 3.37 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.813 -1.18 . . . . 0.0 113.901 -171.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.533 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 4.1 pm0 -153.69 158.57 41.23 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 19.1 tt0 -61.42 136.42 58.03 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 172.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.417 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 86.42 -5.79 83.67 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 118.371 -1.238 . . . . 0.0 112.965 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -63.12 156.48 24.92 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.376 1.588 . . . . 0.0 109.892 169.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.2 p -146.29 155.44 42.65 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.309 0.959 . . . . 0.0 111.834 -176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 137' ' ' TYR . 60.6 p -69.33 178.62 2.31 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.831 -0.543 . . . . 0.0 110.142 175.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.84 -21.27 4.02 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 81.62 129.57 0.05 OUTLIER 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 128.744 2.817 . . . . 0.0 112.572 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 m -133.56 129.2 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-O 122.932 1.349 . . . . 0.0 109.74 -158.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.19 149.96 39.91 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 171.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 2.2 p90 -154.09 154.57 33.86 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 162.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.545 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 4.6 m-20 -135.44 166.47 23.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.93 0.786 . . . . 0.0 109.854 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.2 mm -108.7 97.24 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 125.52 1.528 . . . . 0.0 107.281 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.65 132.56 51.48 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 170.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.6 mt -137.79 110.76 7.73 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.867 1.667 . . . . 0.0 107.72 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -86.01 150.63 24.34 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.978 1.311 . . . . 0.0 108.85 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 t70 36.96 70.73 0.16 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.231 2.613 . . . . 0.0 114.734 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.552 ' SG ' HD12 ' A' ' 124' ' ' LEU . 58.3 m -84.71 86.57 7.31 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 128.357 2.663 . . . . 0.0 112.267 -175.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.82 103.76 0.96 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.505 1.922 . . . . 0.0 111.147 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -60.24 -19.79 56.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.365 1.066 . . . . 0.0 112.415 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -61.3 -36.63 80.64 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.769 1.228 . . . . 0.0 111.932 175.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 20' ' ' ALA . 14.0 t -70.67 -49.59 50.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 177.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.41 ' HB1' ' H ' ' A' ' 159' ' ' GLN . . . -165.3 127.59 2.11 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -171.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -68.3 -12.27 60.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 117.454 -1.26 . . . . 0.0 111.695 169.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HA ' HD23 ' A' ' 124' ' ' LEU . 30.3 mtmt -136.33 157.61 46.39 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 120.844 1.657 . . . . 0.0 113.94 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.07 123.26 20.48 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.806 2.042 . . . . 0.0 108.329 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.75 -177.61 3.83 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 149.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.422 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -145.33 146.5 19.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 -165.228 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.23 168.18 13.3 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 120.273 1.397 . . . . 0.0 107.871 166.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -128.89 158.83 37.67 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.114 1.766 . . . . 0.0 108.969 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 22.1 tp -147.17 150.9 35.84 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.462 1.905 . . . . 0.0 107.949 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.467 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -167.29 -162.69 19.63 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 119.138 0.881 . . . . 0.0 112.531 -175.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.7 m -105.88 121.28 43.74 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.101 1.761 . . . . 0.0 106.782 163.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.06 140.14 50.62 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.4 tt -60.27 -35.69 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.257 0.623 . . . . 0.0 110.356 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -165.47 165.86 18.8 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.743 1.617 . . . . 0.0 108.684 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.24 -35.1 62.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 127.576 2.351 . . . . 0.0 113.419 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.37 -8.54 66.4 Favored Glycine 0 CA--C 1.531 1.058 0 O-C-N 120.955 -1.091 . . . . 0.0 112.801 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -147.11 47.7 1.14 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.115 1.366 . . . . 0.0 109.899 -160.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.3 p -67.69 -8.82 38.19 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.554 1.542 . . . . 0.0 112.625 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -98.32 3.3 48.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.865 1.266 . . . . 0.0 112.704 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 t -120.3 131.78 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.763 1.165 . . . . 0.0 108.954 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.68 HD13 ' HB1' ' A' ' 150' ' ' ALA . 8.3 mt -71.76 153.88 41.69 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.392 1.077 . . . . 0.0 111.749 175.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.04 15.0 14.24 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 128.198 2.599 . . . . 0.0 114.08 -171.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 53.9 mt 54.65 -150.54 0.4 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.462 1.105 . . . . 0.0 109.204 -158.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -152.72 158.48 42.39 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.035 1.734 . . . . 0.0 107.282 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.4 m 55.78 -173.84 0.06 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.576 1.15 . . . . 0.0 113.04 171.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.434 ' HB3' ' HA3' ' A' ' 94' ' ' GLY . 15.0 m 25.03 79.25 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 129.805 3.242 . . . . 0.0 112.498 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.3 -28.31 27.53 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.36 1.464 . . . . 0.0 114.09 -168.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.3 2.06 5.14 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.958 1.303 . . . . 0.0 111.423 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 91' ' ' SER . . . -89.03 -41.68 5.83 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 126.089 1.804 . . . . 0.0 109.798 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 m -56.76 158.06 4.99 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.923 0.868 . . . . 0.0 109.363 171.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.56 145.33 5.01 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 160.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.5 p -115.94 142.54 46.65 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.935 1.294 . . . . 0.0 109.796 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 77.3 28.78 0.59 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.908 1.683 . . . . 0.0 113.18 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.569 HG21 HD13 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -143.79 167.15 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 125.009 1.323 . . . . 0.0 109.645 169.027 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -168.78 173.85 43.37 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -171.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.496 HG11 ' CG ' ' A' ' 177' ' ' PHE . 8.6 t -91.82 136.98 23.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 177.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.438 HE22 ' HB1' ' A' ' 110' ' ' ALA . 2.3 mm-40 -118.86 161.26 20.45 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.088 1.755 . . . . 0.0 108.17 169.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.483 HG22 HD12 ' A' ' 111' ' ' LEU . 8.7 mt -144.09 122.52 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 127.78 2.432 . . . . 0.0 105.296 -169.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 110' ' ' ALA . 5.4 mt -124.72 153.26 42.64 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -74.54 -102.99 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.316 1.047 . . . . 0.0 110.919 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -148.32 -26.39 0.33 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 128.566 2.746 . . . . 0.0 110.341 -170.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.258 13.3 t -78.7 -4.71 50.54 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 167.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.57 20.04 79.78 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 118.543 -1.143 . . . . 0.0 110.864 -177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.93 127.41 33.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 170.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.612 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -73.9 132.95 43.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 103' ' ' ILE . 79.7 mt -102.35 108.37 19.69 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.509 0.724 . . . . 0.0 109.176 -166.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.3 m -65.67 152.01 45.19 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.013 0.435 . . . . 0.0 110.957 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.5 mt -109.14 73.1 0.84 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.861 1.664 . . . . 0.0 109.726 -160.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -120.25 0.49 10.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.651 1.18 . . . . 0.0 113.094 171.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.28 13.77 83.25 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.009 -0.884 . . . . 0.0 112.862 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -149.43 -17.43 0.28 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.77 1.285 . . . . 0.0 114.178 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.7 m -70.96 97.64 1.47 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 120.453 1.479 . . . . 0.0 107.629 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -76.5 130.54 38.09 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.17 0.988 . . . . 0.0 109.696 -168.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.4 m -72.64 -171.54 0.84 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.981 2.513 . . . . 0.0 111.367 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.37 148.44 6.71 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.803 -0.56 . . . . 0.0 111.037 167.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -85.65 166.64 16.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 123.662 1.696 . . . . 0.0 110.154 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.7 m -130.06 138.6 50.82 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 153.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.4 m -86.85 135.48 33.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 164.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.552 HD12 ' SG ' ' A' ' 61' ' ' CYS . 2.5 mm? -95.08 172.35 8.18 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 126.102 1.761 . . . . 0.0 109.104 -168.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -132.33 158.87 40.78 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 158.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -64.45 100.14 0.34 Allowed 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 125.615 1.822 . . . . 0.0 106.265 170.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.26 -167.86 25.32 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 107.802 -2.119 . . . . 0.0 107.802 -160.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 98.2 m -106.65 136.65 46.09 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.402 -1.058 . . . . 0.0 108.85 -166.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -135.71 170.46 15.94 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.835 1.654 . . . . 0.0 108.895 -169.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.545 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 3.7 m -146.32 142.84 28.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.972 0.909 . . . . 0.0 108.999 172.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.65 116.44 65.39 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 161.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.5 159.61 28.86 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.54 2.16 . . . . 0.0 110.86 170.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.422 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 62.2 m-85 -141.31 172.62 12.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.326 1.85 . . . . 0.0 109.697 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -134.44 99.83 4.48 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.596 1.558 . . . . 0.0 107.0 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.505 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -102.64 146.23 28.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.076 -1.015 . . . . 0.0 108.728 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -152.77 160.27 43.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.422 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 7.7 m-30 -69.44 153.02 44.18 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 117.35 -1.74 . . . . 0.0 108.813 166.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.417 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 11.0 t80 -128.05 125.84 40.1 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.584 1.954 . . . . 0.0 108.324 173.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -85.32 145.62 27.42 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.778 0.831 . . . . 0.0 110.356 174.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.488 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 41.3 p -105.62 10.64 32.9 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.372 1.069 . . . . 0.0 112.235 175.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.08 -150.63 19.24 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.26 98.09 0.3 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.71 164.15 1.6 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.444 1.116 . . . . 0.0 109.348 171.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.6 p -120.26 162.14 35.35 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 164.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -74.24 168.38 24.93 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 N-CA-C 109.667 -0.936 . . . . 0.0 109.667 164.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.24 178.96 16.17 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.315 1.436 . . . . 0.0 111.364 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.88 150.61 44.53 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 121.467 -1.019 . . . . 0.0 109.582 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.404 ' HB1' ' CE2' ' A' ' 137' ' ' TYR . . . -145.97 93.64 2.36 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -125.48 150.23 47.54 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 172.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.68 ' HB1' HD13 ' A' ' 86' ' ' LEU . . . -151.31 164.49 36.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 120.484 1.493 . . . . 0.0 108.204 175.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.21 140.52 27.96 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -173.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.08 172.96 11.95 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 128.291 2.637 . . . . 0.0 110.633 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 37.5 p -127.84 159.56 34.48 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 159.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -124.41 154.69 40.03 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.368 1.067 . . . . 0.0 109.453 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -114.75 173.59 6.4 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.091 1.756 . . . . 0.0 109.087 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.467 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 3.0 t -127.95 128.97 69.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 127.443 2.297 . . . . 0.0 105.386 175.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -112.96 86.86 2.46 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 173.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.467 ' CZ ' HG11 ' A' ' 156' ' ' VAL . 90.3 m-85 -68.39 150.83 47.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.652 172.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.41 ' H ' ' HB1' ' A' ' 66' ' ' ALA . 7.0 pt20 -168.93 165.5 11.49 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.199 1.4 . . . . 0.0 109.35 -175.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 130.64 1.83 5.01 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 117.751 -1.583 . . . . 0.0 114.795 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -82.99 -81.04 0.97 Allowed Glycine 0 C--N 1.333 0.392 0 CA-C-N 119.687 1.744 . . . . 0.0 109.779 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 148.48 103.08 0.3 Allowed Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.36 21.79 0.29 Allowed Glycine 0 CA--C 1.526 0.748 0 CA-C-O 118.936 -0.924 . . . . 0.0 113.437 175.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 56.92 58.19 15.85 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 124.4 1.0 . . . . 0.0 111.186 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.08 74.93 1.26 Allowed Glycine 0 C--N 1.333 0.382 0 N-CA-C 107.085 -2.406 . . . . 0.0 107.085 -164.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -146.54 101.83 3.51 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.885 0.874 . . . . 0.0 108.974 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -116.72 -175.94 2.87 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.987 2.115 . . . . 0.0 108.551 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 98.7 m -135.5 107.19 6.97 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 173.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.6 m -102.76 112.52 25.35 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.775 0.83 . . . . 0.0 108.947 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.16 156.43 40.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 126.144 1.778 . . . . 0.0 109.9 -172.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -66.97 132.48 48.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.17 -40.74 3.19 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 118.646 -1.086 . . . . 0.0 111.727 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 158.29 -176.02 35.34 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 118.882 1.341 . . . . 0.0 112.334 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.9 m -91.06 144.36 25.73 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.779 1.232 . . . . 0.0 108.25 172.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.0 t -123.95 136.76 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 168.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' HIS . . . . . 0.622 ' HB2' HG23 ' A' ' 31' ' ' THR . 23.8 m-70 -120.52 145.74 47.0 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.496 ' CG ' HG11 ' A' ' 101' ' ' VAL . 97.7 m-85 -131.03 126.53 36.14 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -130.87 159.05 38.53 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.08 0.855 . . . . 0.0 109.93 -172.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 159.98 -160.92 32.02 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -164.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -172.66 173.02 4.05 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 128.556 2.743 . . . . 0.0 104.411 174.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.84 144.0 31.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 165.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.7 m -127.25 150.56 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.936 2.094 . . . . 0.0 107.568 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -74.51 36.08 0.1 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.785 1.634 . . . . 0.0 112.634 -173.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.252 1.227 0 C-N-CA 129.131 2.972 . . . . 0.0 112.726 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.277 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.24 -74.96 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.436 ' CG2' ' H ' ' A' ' 25' ' ' ALA . 45.3 m 69.73 101.9 0.06 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.659 1.984 . . . . 0.0 110.955 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.3 p -140.95 162.97 34.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.089 1.356 . . . . 0.0 108.331 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.9 t 82.12 91.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 127.509 2.324 . . . . 0.0 107.617 -174.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.28 -170.55 3.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.049 0.539 . . . . 0.0 110.391 172.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.0 -113.12 3.62 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 118.6 0.636 . . . . 0.0 112.733 168.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.49 -95.97 1.0 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -164.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -125.59 104.59 8.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 104.06 -2.57 . . . . 0.0 104.06 150.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.8 p 28.33 78.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 129.437 3.095 . . . . 0.0 112.525 161.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -75.69 -80.03 0.09 Allowed 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.72 -0.612 . . . . 0.0 110.916 -167.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 153.53 -16.87 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 130.679 3.591 . . . . 0.0 110.725 168.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -149.51 -35.76 0.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.893 1.277 . . . . 0.0 111.47 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.5 34.24 7.54 Favored Glycine 0 CA--C 1.517 0.196 0 CA-C-O 118.145 -1.364 . . . . 0.0 113.734 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 17' ' ' VAL 0.257 0.7 OUTLIER 72.61 159.51 0.22 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.685 1.243 . . . . 0.0 109.87 175.399 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.2 t 54.44 -17.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 130.834 3.654 . . . . 0.0 114.493 -165.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 15' ' ' GLU 0.279 3.9 m 43.36 33.99 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 130.95 3.7 . . . . 0.0 113.325 -177.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -149.79 93.57 2.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -146.74 31.73 0.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.35 1.06 . . . . 0.0 112.261 -174.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 41.35 -55.21 0.0 OUTLIER 'General case' 0 C--N 1.34 0.166 1 C-N-CA 135.425 5.49 . . . . 0.0 115.794 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 58' ' ' LEU . 1.6 m -87.81 -166.99 1.74 Allowed 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.952 1.301 . . . . 0.0 109.982 166.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.25 -6.79 11.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.131 1.372 . . . . 0.0 113.922 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.26 3.7 t 50.87 120.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 129.535 3.134 . . . . 0.0 113.06 -165.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.37 153.28 41.54 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.526 1.13 . . . . 0.0 109.343 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -65.28 -25.5 67.67 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.101 -1.0 . . . . 0.0 111.035 173.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.96 5.29 1.3 Allowed Glycine 0 CA--C 1.534 1.261 0 CA-C-O 117.001 -2.0 . . . . 0.0 113.789 167.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.5 t -149.85 7.36 0.63 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 120.279 2.04 . . . . 0.0 113.986 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 25' ' ' ALA . 8.4 p -92.14 -40.48 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 121.269 1.849 . . . . 0.0 112.81 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.7 47.95 1.64 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -170.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -85.87 145.44 27.18 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.824 -159.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 m -117.72 98.95 6.63 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.676 1.19 . . . . 0.0 108.794 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.17 104.57 5.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -77.93 109.67 12.18 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 170.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.762 HD23 HG11 ' A' ' 52' ' ' VAL . 3.7 mt -87.33 -6.75 58.38 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.714 2.006 . . . . 0.0 109.799 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.83 -171.68 37.92 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 121.925 0.736 . . . . 0.0 112.464 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -84.41 134.95 34.45 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.396 1.478 . . . . 0.0 109.448 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 t -125.94 142.0 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 124.231 1.012 . . . . 0.0 109.008 -173.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.37 120.6 21.84 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 125.682 1.593 . . . . 0.0 107.733 -177.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 p -48.52 -29.76 4.52 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.036 1.334 . . . . 0.0 111.471 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.34 -35.01 77.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.823 0.849 . . . . 0.0 111.691 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.1 m -72.26 -7.09 47.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.251 1.02 . . . . 0.0 113.123 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.551 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 21.3 mt -136.88 78.75 1.72 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 128.61 2.764 . . . . 0.0 108.585 -170.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.04 3.91 3.2 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.584 -1.322 . . . . 0.0 112.227 -175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.429 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 6.8 pm0 -149.66 155.77 40.78 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 124.758 1.223 . . . . 0.0 108.247 -175.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 31.7 tt0 -62.25 129.7 41.96 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 90.14 -4.46 82.92 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.011 -1.438 . . . . 0.0 113.233 -176.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -66.45 157.5 31.87 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 119.371 1.586 . . . . 0.0 110.933 172.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.2 p -148.42 161.09 42.28 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -173.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.3 p -73.08 -171.45 0.9 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.268 0.627 . . . . 0.0 110.706 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 m -54.11 -24.45 17.71 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 170.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.98 150.4 0.07 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.27 1.428 . . . . 0.0 112.399 -170.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.762 HG11 HD23 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.42 153.49 9.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 126.841 2.057 . . . . 0.0 105.716 -165.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.01 162.28 21.04 Favored Glycine 0 CA--C 1.526 0.721 0 O-C-N 121.02 -1.05 . . . . 0.0 110.549 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 1.2 p90 -160.63 63.02 0.31 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 124.562 2.125 . . . . 0.0 109.566 177.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.563 HD22 HG21 ' A' ' 130' ' ' THR . 9.5 p-10 -55.12 139.47 41.58 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 112.424 -2.171 . . . . 0.0 111.467 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 mm -84.28 105.45 13.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -76.85 104.61 7.44 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.538 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 57.5 mt -84.5 -175.09 5.63 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 167.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -173.36 144.35 1.16 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 126.237 1.815 . . . . 0.0 109.914 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.0 t0 48.67 63.62 2.03 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.957 2.103 . . . . 0.0 113.117 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.32 115.6 23.96 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 121.692 -0.63 . . . . 0.0 111.774 -177.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.564 ' HB3' HG23 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -75.11 108.33 7.77 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 161.417 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.5 p -62.09 -7.94 4.72 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.427 0.691 . . . . 0.0 112.838 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -79.14 -31.15 43.97 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.207 1.403 . . . . 0.0 112.234 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 62' ' ' ASP . 2.2 t -72.87 -35.0 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -170.39 138.53 1.57 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.88 2.472 . . . . 0.0 105.072 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -78.89 -6.83 57.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 116.774 -1.584 . . . . 0.0 110.774 163.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -141.56 161.51 37.74 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 122.605 2.457 . . . . 0.0 115.624 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.31 115.02 15.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.71 175.9 7.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 152.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.405 HG21 ' CZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -156.38 128.97 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 101.718 -3.438 . . . . 0.0 101.718 -160.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 154' ' ' PHE . . . -114.54 169.98 8.65 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.509 1.524 . . . . 0.0 107.623 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.52 ' CD1' HG21 ' A' ' 103' ' ' ILE . 21.4 m-85 -131.2 154.27 48.59 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.902 0.774 . . . . 0.0 110.496 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.624 ' O ' ' HB1' ' A' ' 152' ' ' ALA 0.347 0.1 OUTLIER -145.51 171.33 14.82 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 168.151 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.84 177.06 30.59 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.405 1.479 . . . . 0.0 110.056 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.2 m -67.0 141.33 57.62 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.288 1.044 . . . . 0.0 109.542 174.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.0 134.2 33.87 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 119.366 0.985 . . . . 0.0 110.874 174.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.3 tt -62.79 -33.93 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 122.898 0.479 . . . . 0.0 111.002 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -153.16 166.55 32.16 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.946 1.298 . . . . 0.0 108.724 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.66 -34.53 78.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.549 167.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.17 5.45 76.65 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.258 0.932 . . . . 0.0 112.874 174.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -148.45 48.44 1.03 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.124 1.962 . . . . 0.0 110.01 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.1 p -71.12 -7.81 49.17 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.68 -1.263 . . . . 0.0 113.809 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -84.91 -6.37 59.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.44 -0.788 . . . . 0.0 111.812 169.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 t -118.97 134.23 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.073 0 CA-C-N 119.665 1.12 . . . . 0.0 108.837 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.883 HD11 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -79.25 148.72 32.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.92 1.288 . . . . 0.0 110.234 -169.516 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.44 20.06 5.61 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.248 1.419 . . . . 0.0 113.958 -167.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.6 mt 55.16 -157.32 0.23 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.287 1.035 . . . . 0.0 109.969 -168.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -143.21 174.8 10.39 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.057 1.343 . . . . 0.0 109.042 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.7 m -51.09 131.29 27.27 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.54 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.4 m -148.58 161.66 41.24 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 128.044 2.538 . . . . 0.0 107.359 164.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.13 -48.31 74.06 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.187 0.595 . . . . 0.0 111.5 -169.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.62 8.81 1.28 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.44 0.696 . . . . 0.0 112.509 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 63.42 35.21 91.75 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 124.141 0.877 . . . . 0.0 111.291 -170.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.6 m 57.95 -167.77 0.13 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.155 1.382 . . . . 0.0 111.959 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.02 159.98 10.69 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.0 148.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.99 167.2 11.97 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.672 1.189 . . . . 0.0 108.702 168.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 62.26 3.63 1.07 Allowed 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 125.945 1.698 . . . . 0.0 113.105 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.452 HG21 HD13 ' A' ' 42' ' ' LEU . 1.6 p -125.91 150.48 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 121.373 1.897 . . . . 0.0 108.764 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.36 177.7 25.47 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 125.025 1.297 . . . . 0.0 110.736 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.534 HG11 ' CG ' ' A' ' 177' ' ' PHE . 90.8 t -92.14 122.34 43.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -91.17 158.55 16.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.819 1.19 . . . . 0.0 109.521 163.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.581 HG22 HD23 ' A' ' 111' ' ' LEU . 3.1 mp -127.84 136.84 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 165.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.443 ' CD2' ' HB2' ' A' ' 110' ' ' ALA . 5.1 mt -133.04 142.33 48.73 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.109 1.363 . . . . 0.0 108.025 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.3 p30 -68.64 -179.86 1.52 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.93 1.347 . . . . 0.0 111.175 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.8 ptt85 -58.46 -7.08 0.8 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.809 1.644 . . . . 0.0 114.589 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.356 10.9 t -116.03 8.26 14.51 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 120.433 1.469 . . . . 0.0 110.985 177.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.11 7.84 84.7 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 120.598 -1.314 . . . . 0.0 112.53 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.96 126.07 30.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.564 1.182 . . . . 0.0 108.328 172.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.443 ' HB2' ' CD2' ' A' ' 104' ' ' LEU . . . -89.11 130.44 35.55 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.164 0.985 . . . . 0.0 111.349 -172.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.581 HD23 HG22 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -100.62 151.47 21.57 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 123.92 0.763 . . . . 0.0 111.464 -164.1 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.2 m -75.64 154.63 36.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 123.553 0.533 . . . . 0.0 110.688 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.6 mt -97.68 64.03 1.76 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.171 1.388 . . . . 0.0 108.427 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.27 -11.12 9.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.267 0.627 . . . . 0.0 111.644 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.406 ' HA3' HD13 ' A' ' 74' ' ' LEU . . . 79.64 13.2 82.77 Favored Glycine 0 CA--C 1.524 0.594 0 O-C-N 120.577 -1.327 . . . . 0.0 113.858 170.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.68 -40.66 0.26 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.365 1.466 . . . . 0.0 110.034 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.2 m -53.91 96.27 0.01 OUTLIER 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.188 1.795 . . . . 0.0 109.461 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -86.03 138.06 32.24 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.231 0.612 . . . . 0.0 109.431 -164.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.55 -175.99 1.8 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.087 2.155 . . . . 0.0 109.171 174.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 t -52.85 143.2 17.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.37 0.605 . . . . 0.0 110.19 169.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -88.33 176.04 7.38 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 123.198 1.475 . . . . 0.0 108.966 167.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.3 m -144.82 163.29 34.52 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 128.205 2.602 . . . . 0.0 105.103 169.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.9 m -100.23 142.95 31.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 122.416 1.103 . . . . 0.0 110.24 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.91 167.68 9.9 Favored 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 129.571 3.149 . . . . 0.0 108.0 -168.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.26 156.2 39.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.796 -173.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -73.98 91.57 2.04 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 125.285 1.616 . . . . 0.0 107.107 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 147.22 -123.58 1.78 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 107.691 -2.164 . . . . 0.0 107.691 -164.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.4 m -143.5 139.24 29.73 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.619 1.167 . . . . 0.0 109.075 -172.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.74 162.32 39.44 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 127.594 2.358 . . . . 0.0 108.702 -170.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.563 HG21 HD22 ' A' ' 55' ' ' ASN . 4.1 m -144.73 137.97 26.89 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -170.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.91 122.54 61.82 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.63 145.07 68.67 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.952 1.768 . . . . 0.0 110.564 173.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.405 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 58.4 m-85 -142.32 157.3 44.96 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 124.777 1.231 . . . . 0.0 110.24 166.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -131.81 113.75 13.88 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.57 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -101.29 167.56 10.11 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.752 1.221 . . . . 0.0 109.227 171.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -168.05 153.83 7.16 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 127.225 2.21 . . . . 0.0 106.444 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.458 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 82.1 m-85 -66.76 144.11 56.52 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 160.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.429 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 16.5 t80 -123.35 133.12 54.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 126.074 1.75 . . . . 0.0 106.827 174.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -104.39 143.48 32.95 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.967 1.307 . . . . 0.0 109.89 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 46.9 p -103.08 4.66 37.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.683 1.593 . . . . 0.0 111.529 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.51 -141.45 6.87 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.08 93.61 0.3 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.479 1.112 . . . . 0.0 110.332 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -72.27 147.6 46.26 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.301 -0.874 . . . . 0.0 110.108 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 35.0 p -120.71 153.38 56.79 Favored Pre-proline 0 CA--C 1.537 0.442 0 C-N-CA 125.153 1.381 . . . . 0.0 109.028 -175.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -74.69 166.92 28.28 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.02 1.813 . . . . 0.0 112.663 173.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.77 -85.39 0.11 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.098 166.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -142.62 163.06 33.85 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.66 1.984 . . . . 0.0 106.623 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.458 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -151.46 77.33 1.24 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.075 0.852 . . . . 0.0 109.674 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -117.59 155.97 28.92 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.48 173.44 16.67 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.356 1.063 . . . . 0.0 109.004 171.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -150.31 146.46 26.77 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.775 1.23 . . . . 0.0 108.153 169.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.883 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -161.48 169.79 21.18 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 127.802 2.441 . . . . 0.0 108.771 -165.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.53 141.68 46.77 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 116.996 -1.882 . . . . 0.0 107.57 -172.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 72' ' ' ALA . 14.1 p90 -103.68 152.21 22.07 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -134.2 114.02 12.63 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.44 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 13.1 t -77.4 125.61 37.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -176.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -111.52 90.81 3.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.44 ' CZ ' HG11 ' A' ' 156' ' ' VAL . 70.5 m-85 -62.52 148.51 45.65 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.885 1.274 . . . . 0.0 110.344 173.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -165.93 169.66 14.54 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.697 1.199 . . . . 0.0 110.635 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 139.31 -73.16 0.41 Allowed Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -170.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -76.79 87.59 0.95 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 124.782 1.182 . . . . 0.0 110.329 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -162.33 175.59 38.77 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 118.185 0.992 . . . . 0.0 112.149 -176.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -131.24 27.13 3.84 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.777 1.18 . . . . 0.0 111.313 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 107.08 11.52 25.81 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 117.986 -1.452 . . . . 0.0 113.699 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -156.57 22.6 0.49 Allowed Glycine 0 CA--C 1.528 0.877 0 CA-C-N 120.486 2.143 . . . . 0.0 112.793 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -129.91 119.77 23.79 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.857 1.263 . . . . 0.0 109.973 -173.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -152.33 175.29 12.83 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 129.359 3.064 . . . . 0.0 108.139 171.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 54.7 m -137.32 92.84 2.75 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.869 1.267 . . . . 0.0 109.313 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.1 m -72.05 133.7 45.42 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.68 165.81 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 127.747 2.419 . . . . 0.0 108.554 173.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -59.45 143.78 48.89 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 164.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -101.34 -64.44 0.77 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 169.16 168.76 31.64 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -174.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 89.9 m -90.22 118.89 30.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.772 1.286 . . . . 0.0 107.987 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.1 t -88.09 106.76 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 166.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -79.28 144.38 34.35 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 164.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.534 ' CG ' HG11 ' A' ' 101' ' ' VAL . 96.3 m-85 -126.45 121.1 31.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -127.68 156.01 43.03 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.816 0.734 . . . . 0.0 109.475 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.02 -158.66 27.48 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -163.69 167.34 21.21 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.603 -0.94 . . . . 0.0 108.999 -173.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 73.7 t -113.15 126.01 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 167.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.2 m -106.28 150.27 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 126.705 2.002 . . . . 0.0 108.436 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -74.9 39.56 0.14 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.246 1.418 . . . . 0.0 113.1 -176.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.304 0 C-N-CA 127.634 2.374 . . . . 0.0 111.934 -179.773 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.12 125.28 20.97 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.458 0.703 . . . . 0.0 109.501 -175.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.6 t -124.52 8.2 8.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.242 1.417 . . . . 0.0 111.023 -171.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 m 92.91 147.09 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 129.146 2.978 . . . . 0.0 109.19 165.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.606 HG13 ' H ' ' A' ' 6' ' ' ASN 0.366 7.3 p 44.04 -86.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 129.539 3.136 . . . . 0.0 113.875 -171.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.606 ' H ' HG13 ' A' ' 5' ' ' VAL . 78.6 m-20 143.57 -88.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 131.178 3.791 . . . . 0.0 107.961 160.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.7 -61.82 3.67 Favored Glycine 0 C--N 1.336 0.543 0 O-C-N 121.907 -0.496 . . . . 0.0 113.177 -165.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.98 -178.27 15.88 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 106.779 -2.528 . . . . 0.0 106.779 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.264 1.3 t -102.39 84.18 2.42 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 -169.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.608 HG22 ' H ' ' A' ' 11' ' ' HIS 0.294 10.1 p 48.32 -139.94 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.055 1.742 . . . . 0.0 108.108 176.729 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.608 ' H ' HG22 ' A' ' 10' ' ' VAL . 73.5 m-70 -135.99 57.83 1.77 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-N 120.868 1.667 . . . . 0.0 109.423 161.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.38 101.29 3.97 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -128.26 -114.14 0.26 Allowed 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 103.408 -2.812 . . . . 0.0 103.408 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.94 -72.4 0.64 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 106.885 -2.486 . . . . 0.0 106.885 167.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -168.86 162.91 11.58 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 166.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.721 HG13 HG12 ' A' ' 170' ' ' VAL 0.356 3.2 p 56.38 -29.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 131.286 3.834 . . . . 0.0 114.415 -178.104 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t 44.44 37.55 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.866 2.066 . . . . 0.0 111.519 166.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.621 ' O ' HG11 ' A' ' 170' ' ' VAL . 53.9 m-20 -141.38 93.54 2.59 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.072 171.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.494 ' HB1' ' HE2' ' A' ' 158' ' ' TYR . . . -85.5 134.07 34.06 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 150.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.49 -18.14 6.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.027 1.331 . . . . 0.0 112.753 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -134.35 147.49 50.54 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.132 2.173 . . . . 0.0 107.235 176.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.05 -14.12 44.19 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 118.257 2.688 . . . . 0.0 118.257 -155.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.3 t 49.46 104.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 127.645 2.378 . . . . 0.0 111.342 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.46 159.02 10.97 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.39 -0.819 . . . . 0.0 113.096 -169.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.91 -42.07 88.77 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.541 -0.725 . . . . 0.0 109.94 171.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.39 27.52 2.44 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.737 -1.035 . . . . 0.0 112.682 171.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -138.94 -33.07 0.66 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.286 1.543 . . . . 0.0 111.402 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.34 -35.66 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 119.791 1.178 . . . . 0.0 111.122 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -139.92 69.56 1.36 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -170.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -110.52 146.45 35.99 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.863 0.865 . . . . 0.0 111.414 -169.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -112.18 121.33 44.63 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.309 1.043 . . . . 0.0 109.904 173.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.6 t -87.39 113.41 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 169.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -88.22 96.18 10.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 172.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.782 HD23 HG11 ' A' ' 52' ' ' VAL . 9.4 mt -76.81 -8.16 56.8 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 126.009 1.724 . . . . 0.0 110.221 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.23 -171.26 32.75 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 121.829 0.683 . . . . 0.0 112.231 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -90.99 126.91 36.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.505 1.922 . . . . 0.0 110.491 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG21 ' HD2' ' A' ' 137' ' ' TYR . 21.0 t -117.64 137.73 50.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 123.4 0.68 . . . . 0.0 109.772 -172.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 4.6 mmt180 -66.56 124.18 22.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.874 2.07 . . . . 0.0 106.53 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.9 p -55.25 -30.02 59.24 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 123.787 0.679 . . . . 0.0 110.37 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.89 -36.06 76.16 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.368 1.467 . . . . 0.0 111.524 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.447 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 70.0 m -80.16 2.37 24.47 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 123.521 0.728 . . . . 0.0 112.797 176.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.4 mt -131.83 32.08 4.13 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.37 1.868 . . . . 0.0 110.922 -170.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.49 5.24 13.37 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -150.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.537 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 4.2 pm0 -154.69 155.96 35.55 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.405 1.882 . . . . 0.0 106.725 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 36.4 tt0 -64.23 116.84 6.39 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.33 -11.51 36.55 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 117.847 -1.529 . . . . 0.0 112.752 -177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.537 ' HB2' ' NE2' ' A' ' 44' ' ' GLN . . . -66.27 156.88 33.03 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.432 1.616 . . . . 0.0 110.253 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.6 p -144.88 157.34 44.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.41 0.624 . . . . 0.0 112.179 -174.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -73.58 -168.19 0.53 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 122.008 -0.433 . . . . 0.0 110.091 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -43.55 -99.57 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.719 2.007 . . . . 0.0 114.281 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.37 73.57 0.0 OUTLIER 'General case' 0 C--O 1.236 0.393 0 C-N-CA 131.002 3.721 . . . . 0.0 107.427 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.782 HG11 HD23 ' A' ' 34' ' ' LEU . 3.9 p -69.55 148.32 11.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 170.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.03 127.2 7.97 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 107.145 -2.382 . . . . 0.0 107.145 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 135' ' ' ALA . 5.1 p90 -135.41 89.91 2.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 123.215 1.483 . . . . 0.0 109.624 -170.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -84.11 165.86 18.13 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 120.892 -1.13 . . . . 0.0 112.69 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.0 mm -102.3 99.01 7.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -71.8 126.32 29.42 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.435 HD11 HD11 ' A' ' 131' ' ' ILE . 95.9 mt -109.25 171.84 7.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 174.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 11.5 p30 -153.81 175.05 13.77 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.253 0.933 . . . . 0.0 111.504 165.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.6 t70 32.12 48.75 0.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 129.821 3.248 . . . . 0.0 115.974 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 4.6 t -69.69 167.46 16.99 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -171.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.501 ' HB3' HG23 ' A' ' 65' ' ' VAL . 32.1 t0 -133.76 114.49 13.47 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.872 1.669 . . . . 0.0 112.253 168.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.9 p -56.16 -29.68 61.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.698 1.599 . . . . 0.0 113.575 172.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -62.32 -42.47 99.4 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 123.117 0.567 . . . . 0.0 110.323 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.501 HG23 ' HB3' ' A' ' 62' ' ' ASP . 15.2 t -65.24 -52.68 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 175.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.433 ' CB ' ' HB3' ' A' ' 158' ' ' TYR . . . -165.49 127.04 1.98 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.192 0.52 . . . . 0.0 111.674 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.4 m -77.37 -8.58 57.92 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.55 1.54 . . . . 0.0 112.163 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -130.03 152.65 49.25 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 121.377 1.899 . . . . 0.0 110.371 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.02 144.36 49.88 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 165.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.94 172.01 9.27 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 122.076 0.941 . . . . 0.0 109.617 156.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.261 0.5 OUTLIER -143.22 144.23 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 113.633 -1.621 . . . . 0.0 106.693 -174.585 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.41 162.39 30.28 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.313 2.645 . . . . 0.0 107.045 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -137.15 152.6 50.13 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.711 0.804 . . . . 0.0 110.328 -172.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 74' ' ' LEU . 19.1 tp -151.6 124.68 8.68 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 122.082 -0.386 . . . . 0.0 110.609 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.26 165.87 33.97 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -54.08 128.7 31.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.313 1.445 . . . . 0.0 109.944 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.71 134.97 41.85 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.823 1.192 . . . . 0.0 110.371 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.2 tt -60.38 -37.39 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 122.72 0.408 . . . . 0.0 110.81 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -157.27 168.62 26.86 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.182 1.793 . . . . 0.0 109.046 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.33 -39.95 67.54 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.759 1.624 . . . . 0.0 112.641 171.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.28 7.44 80.69 Favored Glycine 0 CA--C 1.526 0.752 0 O-C-N 121.433 -0.792 . . . . 0.0 112.884 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -142.76 42.4 1.58 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.456 1.102 . . . . 0.0 109.481 -175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.5 p -67.95 -11.68 59.26 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.958 1.303 . . . . 0.0 112.84 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -77.69 -2.08 34.29 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.631 -0.668 . . . . 0.0 112.19 168.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.41 137.09 48.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 O-C-N 120.44 -1.412 . . . . 0.0 110.894 -166.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.77 150.9 29.05 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.469 1.508 . . . . 0.0 111.405 -171.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.73 18.33 11.84 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.675 1.99 . . . . 0.0 114.192 -167.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 79.4 mt 53.71 -159.9 0.14 Allowed 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.587 1.155 . . . . 0.0 110.621 -169.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -141.82 170.32 15.94 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.453 1.101 . . . . 0.0 109.309 176.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.1 m -45.88 147.94 0.89 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.342 1.457 . . . . 0.0 112.074 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 t -160.79 161.83 32.15 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.156 1.382 . . . . 0.0 107.358 168.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.21 -23.81 65.88 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -176.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.19 12.44 14.43 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.37 1.468 . . . . 0.0 110.712 176.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.41 26.48 65.66 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.523 1.059 . . . . 0.0 114.459 173.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.7 m 56.87 -170.83 0.09 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.959 0.904 . . . . 0.0 110.682 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.78 148.74 48.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 168.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.34 164.93 12.09 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.88 0.872 . . . . 0.0 108.762 166.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 69.96 -7.88 0.88 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 128.725 2.81 . . . . 0.0 115.11 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.7 p -126.99 152.19 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 121.417 1.917 . . . . 0.0 107.949 -171.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -146.31 170.64 27.37 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 126.11 1.814 . . . . 0.0 111.82 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.437 HG11 ' CG ' ' A' ' 177' ' ' PHE . 94.2 t -83.56 120.44 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -100.65 154.19 18.8 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.714 1.597 . . . . 0.0 108.3 164.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.09 143.97 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 170.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 110' ' ' ALA . 15.4 mt -139.58 138.98 36.68 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.044 1.738 . . . . 0.0 108.042 -168.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.542 ' HB2' ' HB3' ' A' ' 120' ' ' SER . 29.0 p30 -66.22 173.62 3.06 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 122.219 1.009 . . . . 0.0 111.959 167.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -55.32 -13.18 1.26 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.194 1.398 . . . . 0.0 113.667 175.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 p -105.08 -9.09 18.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.929 1.292 . . . . 0.0 110.874 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.81 10.21 65.21 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.712 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.06 117.13 13.3 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 119.061 1.431 . . . . 0.0 107.938 169.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.456 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -74.68 131.15 40.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.661 0.784 . . . . 0.0 110.122 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.0 mt -103.34 117.27 34.1 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.589 1.156 . . . . 0.0 110.745 -158.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.0 m -67.39 143.23 56.42 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.77 0.795 . . . . 0.0 110.539 -170.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.9 mt -93.6 74.78 4.38 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.196 1.398 . . . . 0.0 107.307 -171.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.46 -18.31 11.01 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.327 1.051 . . . . 0.0 110.683 170.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.67 -28.27 4.96 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-O 118.16 -1.356 . . . . 0.0 112.751 176.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -82.62 -45.08 15.0 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.407 1.604 . . . . 0.0 110.505 166.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.2 m -51.25 97.33 0.01 OUTLIER 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.839 2.055 . . . . 0.0 111.586 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.66 169.38 4.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.81 2.044 . . . . 0.0 111.112 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 75.5 p -135.75 -161.59 1.17 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.611 0.765 . . . . 0.0 111.35 173.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 0.9 OUTLIER -42.82 122.53 2.4 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 129.73 3.212 . . . . 0.0 111.69 -175.016 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -89.01 106.23 18.3 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.942 0.877 . . . . 0.0 108.701 -173.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.7 m -70.34 117.88 12.44 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 162.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.2 m -64.0 141.77 58.65 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 155.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.98 -170.44 2.14 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.052 0.941 . . . . 0.0 109.785 176.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -148.87 167.56 25.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.818 2.047 . . . . 0.0 107.071 178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -64.41 128.36 35.43 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 120.29 -159.57 15.13 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 22.0 m -83.13 136.01 34.61 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.669 1.188 . . . . 0.0 111.648 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.48 177.98 9.76 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.369 1.468 . . . . 0.0 108.325 -176.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.6 m -155.01 144.48 21.27 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.33 -0.856 . . . . 0.0 109.734 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.435 HD11 HD11 ' A' ' 58' ' ' LEU . 2.4 mp -100.05 114.53 65.72 Favored Pre-proline 0 C--O 1.237 0.446 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 162.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.01 151.39 50.08 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.192 1.928 . . . . 0.0 110.475 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -141.17 167.03 23.16 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.716 2.006 . . . . 0.0 108.303 171.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.24 154.29 33.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 122.722 1.248 . . . . 0.0 110.071 161.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.507 ' HB2' ' CD1' ' A' ' 54' ' ' PHE . . . -132.83 147.3 52.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 127.517 2.327 . . . . 0.0 106.398 175.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -163.89 151.95 12.97 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 170.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.473 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 76.0 m-85 -66.18 135.84 55.08 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 170.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -111.28 127.8 55.74 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.978 1.711 . . . . 0.0 108.482 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.26 142.47 27.72 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.424 1.09 . . . . 0.0 111.242 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 17.6 p -110.82 9.21 22.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.273 1.429 . . . . 0.0 112.135 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.5 -152.47 22.2 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.38 95.92 0.22 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.116 1.366 . . . . 0.0 110.891 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -53.82 151.98 5.91 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.621 0.724 . . . . 0.0 110.497 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 73.1 p -105.5 154.02 39.39 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 162.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -71.48 174.73 10.46 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.115 1.21 . . . . 0.0 109.284 166.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.79 -93.67 0.14 Allowed Glycine 0 C--O 1.225 -0.441 0 O-C-N 121.855 -0.528 . . . . 0.0 112.838 171.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -146.65 161.95 39.47 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.38 1.872 . . . . 0.0 106.394 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.473 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -151.35 73.37 1.09 Allowed 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 121.776 -0.577 . . . . 0.0 110.52 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -117.64 151.65 36.78 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -157.9 179.25 9.37 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -156.35 145.94 20.87 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -146.38 169.41 18.92 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.81 2.044 . . . . 0.0 106.992 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.7 p -106.98 163.66 12.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 156.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -117.72 155.87 29.23 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 164.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 38.5 mttm -125.61 137.9 53.91 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 168.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.903 HG13 HG23 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -87.18 150.75 3.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 175.169 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -142.12 84.16 1.86 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.539 1.536 . . . . 0.0 108.918 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.752 ' CE2' HG21 ' A' ' 156' ' ' VAL . 59.0 m-85 -63.7 156.16 27.82 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.988 1.315 . . . . 0.0 112.805 169.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -174.82 174.83 2.5 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.721 2.009 . . . . 0.0 108.567 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 139.99 -48.01 0.86 Allowed Glycine 0 N--CA 1.461 0.319 0 O-C-N 120.852 -1.155 . . . . 0.0 111.359 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -77.83 -15.04 81.72 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 170.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -73.75 88.07 0.64 Allowed Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 166.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -61.07 -4.76 4.9 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.286 -1.285 . . . . 0.0 113.747 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -107.27 -75.54 0.94 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 107.004 -2.439 . . . . 0.0 107.004 159.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.74 -61.24 0.04 OUTLIER Glycine 0 C--O 1.228 -0.222 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 24.85 93.65 0.01 OUTLIER 'General case' 0 C--O 1.235 0.301 0 C-N-CA 129.511 3.124 . . . . 0.0 113.39 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -117.47 146.88 43.21 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.237 -161.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 52.9 m -96.81 89.3 4.85 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.65 1.98 . . . . 0.0 106.458 171.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.3 m -82.02 120.4 25.22 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 175.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.903 HG23 HG13 ' A' ' 156' ' ' VAL . 30.2 m -128.14 145.72 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 118.645 0.657 . . . . 0.0 111.209 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -77.88 105.44 9.07 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -79.75 -68.49 1.48 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 124.035 0.826 . . . . 0.0 111.936 -164.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -178.14 -172.62 42.76 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 117.503 0.651 . . . . 0.0 111.847 -173.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.4 HG21 ' CE1' ' A' ' 176' ' ' HIS . 8.3 m -89.22 145.38 25.44 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.782 1.633 . . . . 0.0 108.971 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.6 119.95 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 156.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' HIS . . . . . 0.4 ' CE1' HG21 ' A' ' 174' ' ' THR . 88.1 m-70 -88.94 134.48 33.95 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 172.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.437 ' CG ' HG11 ' A' ' 101' ' ' VAL . 90.3 m-85 -114.17 113.09 24.2 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -117.31 157.47 26.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 147.29 -165.42 28.64 Favored Glycine 0 C--O 1.239 0.411 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -176.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -161.56 171.73 17.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.9 t -122.15 132.84 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 173.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.2 m -117.91 149.69 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 127.608 2.363 . . . . 0.0 107.972 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -76.23 34.23 0.13 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -170.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 N--CA 1.438 -1.035 0 C-N-CA 131.231 3.812 . . . . 0.0 112.802 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.38 -53.47 0.89 Allowed 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 123.906 0.754 . . . . 0.0 110.735 -165.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.8 t 50.35 -169.43 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.773 2.029 . . . . 0.0 112.092 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.82 0.88 1.64 Allowed 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.418 -0.801 . . . . 0.0 110.562 163.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.91 114.13 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 120.459 -1.401 . . . . 0.0 108.277 -174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -54.45 -40.79 68.73 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.29 167.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.26 133.87 1.59 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.955 1.264 . . . . 0.0 110.042 162.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.26 -93.19 0.11 Allowed Glycine 0 C--N 1.335 0.497 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 165.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -148.36 107.02 3.79 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 153.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.272 10.5 p 22.68 74.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 126.946 2.098 . . . . 0.0 114.687 153.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -82.51 45.23 0.95 Allowed 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.892 -1.13 . . . . 0.0 112.901 -168.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -159.31 51.34 0.36 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.208 1.003 . . . . 0.0 109.834 -161.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -133.54 87.79 2.42 Favored 'General case' 0 C--N 1.334 -0.086 0 C-N-CA 124.319 1.048 . . . . 0.0 108.695 -176.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.64 5.32 0.23 Allowed Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.602 -0.554 . . . . 0.0 114.093 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -146.56 -157.83 0.85 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 16' ' ' VAL . 1.3 p -58.85 -44.35 90.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.488 1.04 . . . . 0.0 110.752 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 t 44.36 59.11 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 127.151 2.18 . . . . 0.0 111.281 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -149.41 105.95 3.53 Favored 'General case' 0 C--O 1.228 -0.079 0 O-C-N 121.97 -0.456 . . . . 0.0 109.813 169.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -126.44 141.5 51.86 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 166.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.507 ' HB3' ' CD1' ' A' ' 158' ' ' TYR . . . -86.97 1.83 51.46 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 117.672 -1.156 . . . . 0.0 113.799 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.25 164.18 30.94 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.554 1.542 . . . . 0.0 107.68 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.67 -24.29 21.65 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.757 0.823 . . . . 0.0 113.002 -168.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t 58.58 131.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 128.07 2.548 . . . . 0.0 112.172 -173.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -78.44 156.13 29.55 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.033 -1.042 . . . . 0.0 111.895 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.48 -31.95 64.52 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.611 -0.681 . . . . 0.0 110.682 166.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.54 -2.12 73.7 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 117.559 -1.69 . . . . 0.0 114.293 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.4 p -125.21 -30.02 3.22 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 121.018 2.409 . . . . 0.0 111.809 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.94 -38.9 78.48 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 124.822 1.249 . . . . 0.0 113.789 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -132.6 46.69 2.6 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.085 0.954 . . . . 0.0 109.726 -168.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -93.13 132.19 37.5 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.283 -0.885 . . . . 0.0 110.478 -159.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.4 HG23 ' HB2' ' A' ' 176' ' ' HIS . 15.3 m -113.98 86.8 2.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.737 1.215 . . . . 0.0 108.652 -175.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.75 99.91 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 127.047 2.139 . . . . 0.0 108.02 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -84.48 102.97 13.23 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -170.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mt -76.79 -7.61 55.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.713 1.205 . . . . 0.0 111.004 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.82 -173.53 26.77 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.529 1.061 . . . . 0.0 112.327 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -68.97 153.88 43.03 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.954 0.902 . . . . 0.0 109.479 170.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.4 t -139.7 148.14 23.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 C-N-CA 125.067 1.347 . . . . 0.0 108.611 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -81.18 134.44 35.63 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 121.508 -0.745 . . . . 0.0 109.053 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.1 p -60.64 -24.06 65.24 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.556 0.742 . . . . 0.0 110.899 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.43 -46.41 66.37 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.35 0.66 . . . . 0.0 110.454 170.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 t -71.9 -2.38 17.76 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.962 177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 17.3 mt -142.93 64.86 1.35 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 120.546 1.521 . . . . 0.0 108.854 -170.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.94 0.22 5.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -167.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.442 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 3.1 pm0 -158.32 159.62 36.11 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.395 1.478 . . . . 0.0 108.404 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 39.1 tt0 -65.33 118.15 8.92 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 106.77 -12.97 42.14 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-O 118.422 -1.21 . . . . 0.0 112.112 -174.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -61.71 142.26 57.34 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.899 1.35 . . . . 0.0 109.44 173.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 p -136.66 159.44 41.81 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.094 0.861 . . . . 0.0 111.052 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.5 p -74.5 -175.07 2.25 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.778 0.799 . . . . 0.0 112.216 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.7 m -56.08 -24.04 37.62 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.803 2.041 . . . . 0.0 114.417 171.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.1 158.95 0.18 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 129.336 3.054 . . . . 0.0 112.582 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.3 t -145.56 140.48 22.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -171.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.67 141.26 15.45 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 170.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 2.8 p90 -136.88 149.55 47.72 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 171.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.448 ' HB2' HG22 ' A' ' 130' ' ' THR . 8.3 p30 -145.37 117.52 8.36 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.056 -1.027 . . . . 0.0 108.619 -167.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 mm -77.88 101.11 3.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -163.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -65.36 121.44 14.84 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 mp -125.8 107.17 10.26 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.598 1.959 . . . . 0.0 106.914 -172.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -101.87 157.42 16.86 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -171.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 48.6 t0 50.87 50.58 18.77 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 123.189 1.471 . . . . 0.0 111.847 167.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.7 m -73.29 151.29 41.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.967 1.707 . . . . 0.0 110.365 174.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -136.47 107.53 6.74 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.616 1.166 . . . . 0.0 110.683 -174.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.1 p -60.29 -18.48 49.64 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.434 1.494 . . . . 0.0 112.886 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -60.44 -38.24 83.49 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.35 1.46 . . . . 0.0 111.171 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.03 -55.89 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.35 144.38 18.4 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.689 1.195 . . . . 0.0 108.438 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.21 -15.04 42.16 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.978 -0.534 . . . . 0.0 111.839 169.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -135.44 160.94 36.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.28 0.945 . . . . 0.0 110.584 -167.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.61 153.88 38.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 159.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.528 ' HB1' ' H ' ' A' ' 119' ' ' SER . . . -132.18 173.44 11.24 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.916 1.686 . . . . 0.0 107.301 162.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.446 ' HB ' ' CZ ' ' A' ' 133' ' ' PHE . 61.0 t -135.87 123.55 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 118.804 0.729 . . . . 0.0 109.415 -171.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.55 0.46 26.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -160.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.409 ' CD1' HG21 ' A' ' 103' ' ' ILE . 48.5 m-85 37.29 -177.84 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.702 1 C-N-CA 131.963 4.105 . . . . 0.0 112.504 -166.298 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.526 HD22 ' HA3' ' A' ' 115' ' ' GLY . 7.8 tp -168.07 126.92 1.22 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 164.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.73 173.43 42.72 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -68.74 129.34 39.65 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.258 1.423 . . . . 0.0 109.516 -172.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -86.35 131.53 34.19 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.581 1.152 . . . . 0.0 113.156 -176.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.4 tt -65.54 -32.27 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.132 0.973 . . . . 0.0 112.018 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -152.87 165.27 35.97 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.694 0.797 . . . . 0.0 109.07 166.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.74 -43.5 47.88 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.707 2.003 . . . . 0.0 112.477 165.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.18 0.83 88.37 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.265 0.936 . . . . 0.0 112.524 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -142.03 40.62 1.65 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.207 1.504 . . . . 0.0 109.886 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.429 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 21.8 p -64.26 -15.84 60.89 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 124.825 1.25 . . . . 0.0 113.788 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -73.43 -12.02 60.66 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.433 174.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.9 t -133.15 143.82 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 123.088 1.423 . . . . 0.0 108.394 -164.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.936 HD23 HG22 ' A' ' 101' ' ' VAL . 1.5 mm? -80.55 136.47 36.28 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 112.682 -2.054 . . . . 0.0 110.717 -159.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.9 14.22 0.12 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 124.742 1.217 . . . . 0.0 113.242 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 86' ' ' LEU . 89.0 mt 48.11 -147.91 0.22 Allowed 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.535 1.934 . . . . 0.0 108.484 -171.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -143.29 -177.87 5.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.941 1.297 . . . . 0.0 108.518 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.1 m -58.81 148.08 31.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.311 1.444 . . . . 0.0 110.818 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.6 m -164.69 176.2 9.05 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.295 1.838 . . . . 0.0 107.85 169.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.43 -18.31 65.28 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -167.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.56 16.8 12.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.151 0.98 . . . . 0.0 111.344 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.34 29.68 68.01 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.177 0.894 . . . . 0.0 113.072 -173.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.8 m 62.38 -176.73 0.14 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.913 1.285 . . . . 0.0 112.031 -174.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.05 144.15 57.15 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.575 -0.703 . . . . 0.0 109.218 164.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.0 p -91.91 168.69 11.24 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.691 1.196 . . . . 0.0 109.003 166.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 55.85 18.78 3.15 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.115 1.766 . . . . 0.0 113.865 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.4 p -146.34 142.92 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 121.132 -0.98 . . . . 0.0 108.508 175.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.32 165.28 27.49 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 175.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.936 HG22 HD23 ' A' ' 86' ' ' LEU . 0.9 OUTLIER -70.81 150.06 9.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.622 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -125.55 147.01 49.42 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 129.019 2.928 . . . . 0.0 105.917 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.492 HD11 ' CE2' ' A' ' 177' ' ' PHE . 1.9 mp -118.99 141.83 36.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.41 149.08 46.66 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.72 1.608 . . . . 0.0 107.015 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.07 -172.21 1.03 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.348 1.07 . . . . 0.0 112.342 174.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -47.51 -48.31 27.38 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 127.567 2.347 . . . . 0.0 110.115 170.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.5 p -81.3 -14.37 57.43 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.072 -168.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.91 22.7 44.67 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 126.386 1.946 . . . . 0.0 111.567 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.54 133.46 40.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 162.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.44 151.99 42.76 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.6 mt -117.14 151.64 36.41 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.039 1.336 . . . . 0.0 109.257 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.1 m -78.67 163.97 25.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 167.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.489 HD22 HD13 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -124.69 68.67 1.1 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 101.466 -3.531 . . . . 0.0 101.466 174.448 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.06 -7.34 19.24 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.983 0.897 . . . . 0.0 111.641 -175.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.526 ' HA3' HD22 ' A' ' 74' ' ' LEU . . . 66.87 31.36 77.96 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -158.91 -64.01 0.08 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.027 1.731 . . . . 0.0 106.879 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.7 m -49.65 99.95 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.205 2.202 . . . . 0.0 112.131 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -72.39 171.79 11.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.588 1.155 . . . . 0.0 111.003 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.528 ' H ' ' HB1' ' A' ' 70' ' ' ALA . 39.6 p -131.81 -146.95 0.3 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.993 1.717 . . . . 0.0 110.776 -169.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.9 t -58.37 124.64 20.23 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.446 1.021 . . . . 0.0 108.938 172.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -85.36 110.5 19.16 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 122.035 0.921 . . . . 0.0 108.559 170.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.7 m -79.35 121.83 25.61 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 161.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.1 m -66.36 111.06 3.33 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 160.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.0 mt -73.66 -179.4 3.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.604 1.962 . . . . 0.0 108.973 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.27 165.8 33.76 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.443 1.097 . . . . 0.0 109.538 173.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -59.39 138.14 57.75 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 171.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.15 -139.7 15.36 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -172.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.1 m -111.51 146.34 37.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 118.44 1.12 . . . . 0.0 111.37 -164.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -144.97 174.35 11.1 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 128.423 2.689 . . . . 0.0 108.606 -176.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 55' ' ' ASN . 91.4 m -157.01 148.19 21.99 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 170.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.5 mt -110.05 112.63 57.58 Favored Pre-proline 0 C--O 1.237 0.418 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.8 137.17 19.69 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.276 1.984 . . . . 0.0 110.184 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.446 ' CZ ' ' HB ' ' A' ' 71' ' ' VAL . 76.1 m-85 -127.4 172.59 10.52 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 127.007 2.123 . . . . 0.0 107.74 171.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -128.88 143.72 50.97 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 167.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.579 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -126.85 139.08 53.35 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.92 2.088 . . . . 0.0 108.063 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -160.26 159.91 32.0 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 175.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.426 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 74.4 m-85 -73.61 126.28 29.93 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 171.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.47 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 23.7 t80 -111.55 120.81 43.36 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.948 2.099 . . . . 0.0 106.877 172.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -83.28 137.8 33.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 175.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.496 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 64.1 p -97.18 6.92 47.64 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.15 0.98 . . . . 0.0 111.283 171.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.69 -155.81 27.24 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.05 91.79 0.5 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.204 1.002 . . . . 0.0 111.172 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -56.97 158.52 4.83 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.673 0.789 . . . . 0.0 111.469 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 42.3 p -115.82 158.35 42.36 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 170.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -80.95 164.56 20.04 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.916 1.744 . . . . 0.0 111.681 170.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.6 -84.87 0.11 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.953 0.787 . . . . 0.0 114.277 171.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -153.11 143.56 22.56 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 128.917 2.887 . . . . 0.0 106.365 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.426 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -137.95 84.16 2.02 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.989 0.813 . . . . 0.0 109.931 -177.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -126.84 154.38 44.43 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.45 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -156.27 -178.22 7.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.766 0.712 . . . . 0.0 110.975 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -151.34 110.18 3.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 122.63 1.205 . . . . 0.0 109.672 172.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.14 163.99 12.02 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 169.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.1 p -109.02 152.68 24.65 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 160.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -102.59 117.08 33.9 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 170.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.427 ' HE3' ' HA3' ' A' ' 115' ' ' GLY . 19.7 mttt -92.69 154.68 18.19 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 167.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.446 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 14.8 t -119.13 126.72 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -103.59 89.54 3.38 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 170.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.507 ' CD1' ' HB3' ' A' ' 20' ' ' ALA . 96.5 m-85 -69.79 139.59 53.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.327 169.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -155.0 170.62 21.33 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.686 0.795 . . . . 0.0 111.288 176.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 137.16 -46.6 1.0 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 125.966 1.746 . . . . 0.0 110.728 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -67.35 175.95 24.21 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.097 0.856 . . . . 0.0 112.42 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -136.68 -153.35 6.46 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 125.638 1.589 . . . . 0.0 111.14 -173.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 70.5 -100.27 0.8 Allowed Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 -167.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -137.15 31.42 2.54 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-O 119.09 -0.839 . . . . 0.0 114.764 -148.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.1 -92.75 0.2 Allowed Glycine 0 CA--C 1.521 0.456 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 166.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 70.49 122.59 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 128.826 2.851 . . . . 0.0 111.235 -171.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 61.4 75.31 0.41 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.408 1.883 . . . . 0.0 111.038 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 95.5 m -76.2 99.06 4.6 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 113.024 -1.898 . . . . 0.0 107.879 170.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 93.6 m -66.08 138.37 57.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 158.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.05 137.27 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 124.927 1.291 . . . . 0.0 107.859 169.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -57.22 121.55 10.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 161.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -88.77 -86.88 1.23 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -146.78 -177.13 21.12 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.665 1.603 . . . . 0.0 110.449 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 27.4 m -93.88 144.58 25.31 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.152 1.381 . . . . 0.0 110.254 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.3 t -123.39 124.56 70.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 169.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' HIS . . . . . 0.4 ' HB2' HG23 ' A' ' 31' ' ' THR . 32.7 m-70 -110.97 99.48 8.36 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.002 1.321 . . . . 0.0 107.609 -174.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.492 ' CE2' HD11 ' A' ' 103' ' ' ILE . 53.9 m-85 -79.33 107.13 11.87 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 175.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -112.66 157.78 20.82 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.792 1.637 . . . . 0.0 106.815 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.04 -162.91 27.8 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -174.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -165.67 174.37 9.85 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -166.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 82.3 t -129.73 138.13 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 170.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 17.2 m -119.96 151.13 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 C-N-CA 128.663 2.785 . . . . 0.0 108.777 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.72 26.07 0.09 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -168.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 130.969 3.708 . . . . 0.0 111.279 177.631 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.023 -0.037 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.94 -48.39 30.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.784 0.434 . . . . 0.0 110.521 170.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.8 m 67.41 -66.72 0.19 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.153 1.781 . . . . 0.0 111.613 -172.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 m 60.66 170.7 0.09 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.936 2.094 . . . . 0.0 110.751 -176.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.9 t -78.79 52.07 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 O-C-N 119.949 -1.719 . . . . 0.0 107.739 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.46 46.58 0.75 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.705 1.602 . . . . 0.0 110.632 -169.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.49 -7.25 0.23 Allowed Glycine 0 CA--C 1.526 0.729 0 O-C-N 120.854 -1.154 . . . . 0.0 114.143 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.4 -72.78 0.59 Allowed Glycine 0 CA--C 1.503 -0.669 0 N-CA-C 106.111 -2.796 . . . . 0.0 106.111 163.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.6 t -125.01 90.94 3.33 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.0 p 46.9 56.54 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.323 1.449 . . . . 0.0 112.404 161.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -34.95 -58.75 0.51 Allowed 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 126.792 2.037 . . . . 0.0 116.148 -166.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 153.87 52.33 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 130.69 3.596 . . . . 0.0 108.693 169.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -129.38 105.08 7.87 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 173.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -128.68 -13.58 2.49 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 118.796 -1.002 . . . . 0.0 112.313 177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -130.58 -156.96 0.79 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-N 118.815 1.307 . . . . 0.0 108.961 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.1 t -49.22 -49.87 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 126.752 2.021 . . . . 0.0 110.278 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m 38.95 40.82 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 127.921 2.489 . . . . 0.0 113.652 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -136.33 98.17 3.77 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 125.39 1.476 . . . . 0.0 107.827 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -131.39 109.67 10.5 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.986 -1.071 . . . . 0.0 108.915 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -49.65 -28.72 6.23 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.671 1.588 . . . . 0.0 114.012 -170.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.1 m -126.64 153.65 45.07 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 171.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.31 6.86 35.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.514 1.526 . . . . 0.0 114.851 -167.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.28 9.8 p 36.17 100.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 130.686 3.595 . . . . 0.0 113.245 -174.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -59.49 162.16 5.18 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.117 0.967 . . . . 0.0 111.922 -162.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.28 -28.69 43.53 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.234 1.413 . . . . 0.0 111.411 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.97 8.49 66.43 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.899 1.237 . . . . 0.0 114.444 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.0 m -142.6 -23.8 0.65 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.683 1.741 . . . . 0.0 113.634 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.0 p -55.01 -33.96 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 120.529 1.513 . . . . 0.0 111.091 165.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -137.89 105.06 5.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -131.22 132.84 44.94 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.345 1.058 . . . . 0.0 108.97 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.4 m -118.64 89.72 3.19 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.2 t -72.78 124.01 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -88.51 101.06 13.56 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.4 mt -69.8 -14.72 62.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 165.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.89 -172.21 46.74 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -92.28 142.37 27.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.8 t -128.98 143.65 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 125.499 1.52 . . . . 0.0 108.406 -172.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 0.8 OUTLIER -75.69 130.58 38.92 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -179.123 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.3 p -56.22 -24.17 40.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.01 0.924 . . . . 0.0 110.791 172.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.62 -23.99 67.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.34 1.056 . . . . 0.0 112.892 174.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.5 m -89.77 2.96 54.24 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.581 -1.324 . . . . 0.0 113.406 169.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.4 mt -142.17 68.93 1.32 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.959 1.303 . . . . 0.0 108.413 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.84 -5.19 7.5 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -168.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -155.09 164.51 38.76 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 125.158 1.383 . . . . 0.0 108.072 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -62.18 133.62 55.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.67 -10.97 73.41 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-O 118.62 -1.1 . . . . 0.0 111.96 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.45 148.18 42.68 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 119.176 1.488 . . . . 0.0 110.018 168.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.7 p -137.39 153.8 50.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 122.053 0.93 . . . . 0.0 110.251 -178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.2 t -55.35 160.34 2.33 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.59 160.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 m -44.81 -28.58 0.66 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.64 2.376 . . . . 0.0 114.587 169.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 85.03 149.17 0.07 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 129.281 3.033 . . . . 0.0 110.383 174.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.03 156.92 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 C-N-CA 128.634 2.774 . . . . 0.0 106.178 -163.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.3 151.41 17.25 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -158.11 142.2 15.8 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.725 ' HB3' HG22 ' A' ' 130' ' ' THR . 3.7 m-20 -126.62 147.75 49.87 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.511 1.05 . . . . 0.0 109.801 -174.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.4 mm -89.95 108.76 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.466 1.107 . . . . 0.0 108.038 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -69.21 115.03 8.02 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.732 0.813 . . . . 0.0 109.981 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.0 mt -116.86 101.96 8.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.145 1.378 . . . . 0.0 107.681 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -94.3 158.53 15.54 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.918 2.087 . . . . 0.0 110.324 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.4 t70 34.46 63.07 0.46 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 128.107 2.563 . . . . 0.0 114.052 -167.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 49.4 m -76.06 91.93 3.14 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.611 0.764 . . . . 0.0 111.461 177.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -64.35 124.33 21.48 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 167.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 p -81.88 -24.42 35.73 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.905 -1.122 . . . . 0.0 113.499 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -63.0 -40.32 97.4 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.361 0.982 . . . . 0.0 110.356 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.468 HG11 ' HA ' ' A' ' 20' ' ' ALA . 2.4 p -66.51 -45.28 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.094 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -164.07 127.75 2.62 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.107 1.363 . . . . 0.0 107.715 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -81.2 6.78 12.95 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 116.837 -1.554 . . . . 0.0 112.508 169.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.505 ' CA ' HD21 ' A' ' 124' ' ' LEU . 49.1 mtmt -147.36 157.71 43.69 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 121.504 1.956 . . . . 0.0 114.354 172.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.21 133.43 51.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.479 1.911 . . . . 0.0 108.224 168.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.34 173.1 6.47 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 154.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.96 166.27 29.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.28 167.67 21.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -134.97 149.11 50.16 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -173.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 tp -146.44 124.79 12.3 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.89 0.376 . . . . 0.0 110.157 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.54 177.89 39.98 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 2.1 m -63.74 129.6 40.79 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.658 1.983 . . . . 0.0 110.124 -171.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.83 130.52 39.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.885 0.766 . . . . 0.0 110.073 173.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.6 tt -60.24 -40.32 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.839 0.856 . . . . 0.0 110.619 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -151.94 171.44 17.79 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 174.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.33 -35.36 75.84 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.013 0.925 . . . . 0.0 112.639 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.19 -0.07 89.47 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 123.661 0.648 . . . . 0.0 112.162 173.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -129.04 39.99 3.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.097 1.759 . . . . 0.0 109.28 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.9 p -66.66 -8.83 30.29 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.017 1.327 . . . . 0.0 113.018 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -87.93 -0.5 57.07 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.334 1.454 . . . . 0.0 113.024 167.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 36.1 t -129.08 139.54 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 120.739 1.609 . . . . 0.0 108.984 -177.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.454 HD23 ' H ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -89.43 143.05 27.12 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.752 -167.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.454 ' H ' HD23 ' A' ' 86' ' ' LEU . . . -84.31 15.48 3.58 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.334 1.854 . . . . 0.0 114.764 -165.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.0 mt 52.83 -169.17 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.059 0.944 . . . . 0.0 110.016 -168.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -131.39 176.73 8.05 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.905 1.282 . . . . 0.0 108.276 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.6 t -63.68 150.96 43.14 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 123.339 1.542 . . . . 0.0 111.077 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.449 ' HB2' ' H ' ' A' ' 95' ' ' SER . 71.9 m -151.55 177.09 10.68 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 128.42 2.688 . . . . 0.0 106.356 170.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.14 -50.97 63.44 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.036 0.534 . . . . 0.0 111.773 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.44 21.26 13.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.426 0.691 . . . . 0.0 110.755 175.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.98 22.43 71.59 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-O 118.325 -1.264 . . . . 0.0 114.95 171.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.449 ' H ' ' HB2' ' A' ' 91' ' ' SER . 44.4 m 65.46 173.47 0.22 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.997 2.119 . . . . 0.0 112.067 -175.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.44 164.82 4.08 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.086 1.354 . . . . 0.0 110.058 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.9 p -120.65 166.81 13.16 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.622 1.169 . . . . 0.0 109.508 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.4 m-20 55.22 25.59 7.49 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.072 1.349 . . . . 0.0 111.191 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.83 150.77 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 119.373 0.988 . . . . 0.0 109.122 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.35 174.83 34.14 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -81.71 144.19 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -126.35 155.42 42.08 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.558 1.143 . . . . 0.0 108.95 165.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 mp -131.82 141.6 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.951 2.1 . . . . 0.0 107.011 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.691 HD23 ' HA ' ' A' ' 110' ' ' ALA . 5.1 mt -140.69 146.49 37.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.896 1.278 . . . . 0.0 107.827 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.56 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 4.2 p-10 -70.36 176.23 4.13 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.683 1.23 . . . . 0.0 111.915 166.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -45.71 -30.17 1.5 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.731 2.812 . . . . 0.0 115.271 171.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 50.9 p -88.64 -31.57 18.48 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 120.724 1.602 . . . . 0.0 110.98 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.409 ' O ' HD22 ' A' ' 104' ' ' LEU . . . 115.47 10.39 11.69 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.413 1.482 . . . . 0.0 113.622 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.9 131.18 44.04 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.188 1.494 . . . . 0.0 109.286 174.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.691 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -70.38 116.28 10.53 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.211 1.404 . . . . 0.0 109.778 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.1 mt -83.32 109.85 17.62 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.709 0.803 . . . . 0.0 109.011 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.4 m -57.86 151.94 16.98 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.077 0.465 . . . . 0.0 109.808 171.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.3 mt -102.84 76.06 1.46 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.024 2.129 . . . . 0.0 108.099 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -113.0 -19.58 11.85 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.646 1.178 . . . . 0.0 111.589 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.04 -22.49 0.76 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 126.579 2.038 . . . . 0.0 113.222 -175.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.23 -68.51 0.7 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 117.303 -1.332 . . . . 0.0 108.363 162.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.0 m -37.18 98.38 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.213 2.205 . . . . 0.0 111.745 -167.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -74.87 159.42 31.91 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.963 1.705 . . . . 0.0 110.175 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.9 p -107.85 175.51 5.46 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.423 1.489 . . . . 0.0 112.349 -175.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 5.6 m -39.88 110.95 0.16 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.728 2.011 . . . . 0.0 112.748 167.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -63.38 164.59 8.88 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.663 1.221 . . . . 0.0 110.48 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 86.1 m -140.15 137.23 34.26 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 165.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 100.0 m -82.95 141.24 32.29 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.194 0.998 . . . . 0.0 108.654 173.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.678 ' H ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -113.37 173.35 6.44 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 127.821 2.448 . . . . 0.0 107.773 -175.562 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -138.05 166.5 23.94 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 127.008 2.123 . . . . 0.0 109.02 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -58.59 115.16 2.85 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 123.967 0.792 . . . . 0.0 109.297 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 129.9 -104.37 0.62 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 174.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 86.5 m -146.19 129.25 16.51 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.11 -1.818 . . . . 0.0 110.148 -169.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -135.07 169.03 18.06 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 126.818 2.047 . . . . 0.0 109.396 -171.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 55' ' ' ASN . 1.9 m -158.22 112.09 2.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -172.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.4 mt -76.74 121.35 84.66 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -75.32 146.91 32.08 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.636 1.557 . . . . 0.0 111.194 169.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -132.04 172.74 11.98 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.473 1.909 . . . . 0.0 107.629 168.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.36 151.75 45.68 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 162.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -130.54 162.73 28.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 165.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -157.2 166.13 34.06 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.411 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 85.2 m-85 -82.63 138.57 34.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 156.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -117.21 128.05 54.71 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.643 1.977 . . . . 0.0 106.156 174.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.42 146.87 24.99 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.671 0.788 . . . . 0.0 109.883 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.5 p -113.24 18.07 18.15 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.682 1.593 . . . . 0.0 111.164 172.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 163.03 -157.55 29.66 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.08 92.29 0.17 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.376 1.088 . . . . 0.0 109.833 174.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.41 128.78 35.89 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.214 1.005 . . . . 0.0 109.267 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.2 p -76.42 159.64 79.31 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 118.924 -1.11 . . . . 0.0 109.0 166.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -69.5 171.88 13.39 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 N-CA-C 110.061 -0.784 . . . . 0.0 110.061 158.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.02 178.99 17.4 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 125.769 1.652 . . . . 0.0 109.574 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.3 146.31 51.39 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.411 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -138.66 74.23 1.47 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -113.88 156.42 23.98 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.47 167.62 28.18 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.812 1.245 . . . . 0.0 108.027 173.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -137.84 136.62 37.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.78 169.37 17.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.436 1.494 . . . . 0.0 108.522 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.42 152.25 41.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 165.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -117.67 158.19 25.12 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -118.98 168.66 10.59 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 169.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.9 t -133.4 123.88 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -120.37 85.21 2.35 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.577 1.18 . . . . 0.0 108.856 -172.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.472 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 92.0 m-85 -72.59 157.42 37.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.894 -1.503 . . . . 0.0 112.847 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.426 ' HG3' ' HE3' ' A' ' 68' ' ' LYS . 3.4 pt20 -174.33 170.02 3.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.243 1.817 . . . . 0.0 110.01 -174.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 143.02 -23.61 2.26 Favored Glycine 0 N--CA 1.466 0.69 0 O-C-N 120.895 -1.128 . . . . 0.0 113.214 171.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -65.83 -22.78 70.47 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 70.48 -108.35 2.45 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 107.975 -2.05 . . . . 0.0 107.975 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.18 -77.29 2.05 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.91 81.54 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.52 81.87 0.38 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 176.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -151.73 128.56 10.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.242 1.417 . . . . 0.0 107.639 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -153.24 137.31 16.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.491 1.516 . . . . 0.0 108.512 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 86.5 m -99.99 104.51 16.12 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.708 1.203 . . . . 0.0 109.206 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.2 m -94.57 93.17 7.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.427 1.891 . . . . 0.0 109.329 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.2 m -94.16 155.01 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 124.036 0.935 . . . . 0.0 110.166 173.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.98 144.88 52.18 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 161.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -103.71 -75.69 1.07 Allowed Glycine 0 C--N 1.332 0.352 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -177.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -175.62 -173.16 41.1 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -167.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.1 m -99.1 128.04 45.16 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.809 1.243 . . . . 0.0 109.53 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 19.9 t -104.98 105.34 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -82.49 143.27 31.23 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 168.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -122.76 126.39 47.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -134.75 152.23 51.6 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 118.185 0.448 . . . . 0.0 111.182 -171.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 139.94 -161.57 26.32 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.88 169.12 16.95 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -166.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 87.3 t -116.51 130.77 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.18 147.22 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 C-N-CA 125.895 1.678 . . . . 0.0 109.804 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.82 30.8 0.09 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -171.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.251 1.155 0 C-N-CA 131.436 3.895 . . . . 0.0 115.959 166.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.49 -79.45 0.13 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.778 1.172 . . . . 0.0 108.269 176.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 74.45 159.15 0.22 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.014 2.126 . . . . 0.0 109.351 -172.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.7 t -154.15 160.32 41.85 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 165.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -171.59 168.79 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.708 2.003 . . . . 0.0 106.608 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -66.93 85.51 0.12 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 122.335 1.064 . . . . 0.0 110.247 174.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.7 -53.35 3.64 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 120.391 -1.443 . . . . 0.0 112.343 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.84 -173.39 44.12 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 172.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t -92.7 95.72 9.74 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 146.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.3 t 56.03 61.28 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 122.195 0.998 . . . . 0.0 113.555 146.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -54.23 -49.46 69.42 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -158.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 153.95 71.07 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.176 1 C-N-CA 132.017 4.127 . . . . 0.0 104.943 176.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -71.16 -97.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.95 7.69 9.01 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.834 1.683 . . . . 0.0 115.957 156.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -176.65 -158.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.305 2.242 . . . . 0.0 105.072 -160.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.68 -11.42 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 O-C-N 120.679 -1.263 . . . . 0.0 112.262 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 t 56.39 40.63 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.353 1.061 . . . . 0.0 111.964 -176.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -154.67 94.56 1.69 Allowed 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 121.23 -0.919 . . . . 0.0 108.971 168.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.35 128.12 47.68 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 159.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.665 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -56.33 -43.6 79.18 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.5 m -108.92 175.19 5.55 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.536 1.535 . . . . 0.0 108.576 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.76 -16.06 15.04 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -167.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 t 54.88 114.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 128.343 2.657 . . . . 0.0 111.836 -173.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.17 154.38 16.21 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.2 1.4 . . . . 0.0 111.678 169.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -60.89 -27.3 68.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.732 1.213 . . . . 0.0 112.397 174.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.1 9.98 50.84 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.406 1.003 . . . . 0.0 112.997 172.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.2 t -129.46 -40.41 1.43 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.356 1.862 . . . . 0.0 108.546 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 25' ' ' ALA . 5.1 p -58.16 -34.13 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 123.696 0.798 . . . . 0.0 111.067 173.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -150.52 75.52 1.22 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.491 0.662 . . . . 0.0 109.565 -167.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.52 145.7 35.86 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.702 -0.624 . . . . 0.0 109.496 -173.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.9 m -112.58 95.3 5.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.94 111.8 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -84.54 103.46 13.69 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.4 HD23 HG21 ' A' ' 52' ' ' VAL . 13.2 mt -83.82 -4.99 59.1 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.045 1.338 . . . . 0.0 109.988 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.79 177.7 36.05 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 122.014 0.785 . . . . 0.0 112.522 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -75.83 139.6 41.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 167.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -125.77 143.42 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.129 0.971 . . . . 0.0 109.509 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.433 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 7.6 mmt180 -74.39 131.19 40.88 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 p -56.49 -23.3 38.46 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 123.304 0.642 . . . . 0.0 111.569 173.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.51 -48.67 71.62 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.488 1.115 . . . . 0.0 110.71 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.416 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 45.0 m -74.36 5.92 4.14 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.4 mt -142.92 59.39 1.42 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.354 1.862 . . . . 0.0 107.72 -168.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.57 6.41 3.5 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -165.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.418 ' OE1' ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -153.35 168.32 26.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.794 1.638 . . . . 0.0 107.161 170.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -63.09 136.56 57.86 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 167.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.42 3.37 86.03 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-O 118.936 -0.924 . . . . 0.0 112.123 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -65.53 145.32 56.24 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.766 1.283 . . . . 0.0 109.045 162.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -142.24 152.44 43.07 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.563 0.697 . . . . 0.0 110.377 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.4 p -69.82 -179.2 1.74 Allowed 'General case' 0 CA--C 1.555 1.141 0 O-C-N 121.518 -0.739 . . . . 0.0 109.097 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.43 -28.93 32.64 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -169.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 95.58 110.75 0.02 OUTLIER 'General case' 0 C--N 1.343 0.301 0 C-N-CA 130.703 3.601 . . . . 0.0 109.522 -168.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.4 HG21 HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -100.77 147.55 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.623 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.23 112.73 2.87 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.655 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 7.9 p90 -116.13 179.01 4.11 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.891 0.877 . . . . 0.0 109.142 177.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -158.66 172.44 18.27 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.193 -0.942 . . . . 0.0 110.659 176.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.3 mm -121.76 103.71 13.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -65.96 132.35 48.4 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 172.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 mp -129.24 119.9 24.81 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.245 2.218 . . . . 0.0 107.663 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -120.99 167.73 12.27 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.147 2.179 . . . . 0.0 111.178 -171.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.2 t70 25.31 57.0 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.28 2.632 . . . . 0.0 114.385 -165.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 91.2 m -73.74 121.73 21.26 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.551 2.34 . . . . 0.0 109.425 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -92.52 140.06 29.95 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 167.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.1 p -88.92 -13.79 38.24 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.907 1.685 . . . . 0.0 114.503 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -60.92 -51.33 69.74 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.112 0.958 . . . . 0.0 109.009 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.665 HG11 ' HA ' ' A' ' 20' ' ' ALA . 2.1 p -58.26 -48.72 84.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 124.809 1.244 . . . . 0.0 108.126 -175.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HB1' ' H ' ' A' ' 159' ' ' GLN . . . -167.8 127.17 1.31 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.41 1.884 . . . . 0.0 107.28 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.3 m -88.34 1.67 54.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.599 0.76 . . . . 0.0 110.821 169.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -127.68 160.79 30.57 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 121.107 1.776 . . . . 0.0 110.802 172.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.83 132.58 25.67 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.108 0.963 . . . . 0.0 109.385 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.35 170.38 9.41 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 122.384 1.088 . . . . 0.0 109.266 167.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.9 t -138.81 147.75 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 127.007 2.123 . . . . 0.0 105.453 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.53 159.33 36.65 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -123.61 157.31 34.03 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.613 1.565 . . . . 0.0 109.165 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.7 tp -152.59 142.14 21.77 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.715 0.806 . . . . 0.0 108.897 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.661 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -177.37 171.14 43.87 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -175.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 m -58.04 124.88 20.83 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.758 1.279 . . . . 0.0 110.261 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.56 136.6 44.02 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 119.533 1.061 . . . . 0.0 110.34 173.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.5 tt -61.0 -54.22 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 O-C-N 123.786 0.679 . . . . 0.0 110.686 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -134.12 161.7 34.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 176.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.8 -33.61 74.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.07 -0.394 . . . . 0.0 111.146 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.66 1.72 76.6 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 121.614 -0.679 . . . . 0.0 113.721 175.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -140.37 43.8 1.88 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.902 1.681 . . . . 0.0 109.86 -173.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 p -66.26 -3.89 6.71 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 128.233 2.613 . . . . 0.0 112.503 169.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -93.52 9.16 37.84 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.774 1.23 . . . . 0.0 112.183 167.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.7 t -138.37 143.6 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 120.892 -1.13 . . . . 0.0 110.939 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.683 HD13 ' HB1' ' A' ' 150' ' ' ALA . 6.4 mt -78.62 151.91 32.05 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 119.305 0.957 . . . . 0.0 112.071 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.58 18.73 5.98 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 127.444 2.297 . . . . 0.0 114.017 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.633 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 62.5 mt 51.74 -156.5 0.14 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.045 0.938 . . . . 0.0 110.806 -167.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -143.44 -179.47 6.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.417 1.487 . . . . 0.0 108.516 174.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.2 m -60.31 156.82 14.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.27 1.828 . . . . 0.0 113.195 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.418 ' HB2' ' H ' ' A' ' 95' ' ' SER . 51.0 m -158.85 175.11 14.0 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 128.318 2.647 . . . . 0.0 107.494 168.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.78 -54.32 24.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.508 0.723 . . . . 0.0 111.741 168.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.5 -0.26 49.44 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.46 37.41 94.41 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 121.102 -0.999 . . . . 0.0 113.015 -167.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.418 ' H ' ' HB2' ' A' ' 91' ' ' SER . 13.9 m 66.16 -168.64 0.2 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.822 1.649 . . . . 0.0 111.758 168.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.86 132.96 46.84 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 164.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.7 p -87.37 166.81 14.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 170.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 59.8 18.73 7.6 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.294 1.838 . . . . 0.0 112.507 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -141.46 156.35 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -165.58 170.16 40.31 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -169.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.21 138.66 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 119.283 1.542 . . . . 0.0 108.671 -175.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -105.32 156.46 18.14 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.317 0.962 . . . . 0.0 109.955 163.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -117.73 141.62 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 158.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 110' ' ' ALA . 50.7 mt -125.29 137.63 54.08 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.15 2.18 . . . . 0.0 105.385 175.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -63.29 166.67 6.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.72 1.248 . . . . 0.0 110.298 166.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.0 ptt85 -59.26 -26.01 64.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.085 1.354 . . . . 0.0 112.806 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.63 -12.93 60.9 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.967 0.803 . . . . 0.0 109.635 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.69 3.59 68.5 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 126.612 2.053 . . . . 0.0 112.738 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.05 159.61 31.52 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.398 1.599 . . . . 0.0 109.202 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.47 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -92.58 158.11 16.16 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.58 0.352 . . . . 0.0 110.207 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.6 mt -114.72 138.25 50.94 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 -172.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -75.22 157.19 34.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 170.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.7 mt -110.32 76.43 0.98 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.86 -14.97 10.07 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.289 0.635 . . . . 0.0 111.588 172.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.28 -2.82 81.66 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 117.055 -1.97 . . . . 0.0 113.946 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -139.66 -15.6 1.04 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.467 1.634 . . . . 0.0 112.851 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 49.6 m -59.54 111.7 1.51 Allowed 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 164.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.4 168.18 9.35 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.96 0.904 . . . . 0.0 110.082 173.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.6 p -120.01 -38.18 2.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -175.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.68 121.28 0.09 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.428 1.891 . . . . 0.0 109.41 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -67.62 140.29 56.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.7 m -130.96 117.39 19.15 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 55.0 m -56.92 137.73 54.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 171.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 45.4 mt -90.96 -163.59 1.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.195 0.998 . . . . 0.0 109.174 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -154.63 166.58 32.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.878 2.071 . . . . 0.0 108.149 167.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -66.45 91.01 0.16 Allowed 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.274 1.83 . . . . 0.0 109.621 170.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.12 -107.93 0.64 Allowed Glycine 0 C--O 1.224 -0.517 0 CA-C-O 119.04 -0.867 . . . . 0.0 112.424 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.64 136.75 54.74 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 119.219 1.509 . . . . 0.0 110.614 -172.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -137.58 168.98 18.57 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 127.159 2.184 . . . . 0.0 108.529 -176.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 97.6 m -149.41 145.12 26.79 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 168.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.41 107.77 59.68 Favored Pre-proline 0 N--CA 1.447 -0.582 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 169.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.35 156.23 65.02 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 N-CA-C 109.117 -1.147 . . . . 0.0 109.117 171.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -139.72 166.29 25.0 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.827 1.651 . . . . 0.0 107.184 170.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -117.48 137.64 52.4 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 167.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.655 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -128.87 149.86 50.58 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.59 -175.4 5.37 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.944 -0.472 . . . . 0.0 110.443 170.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.468 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 72.4 m-85 -89.65 140.81 29.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 161.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -102.85 147.28 27.09 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.134 1.774 . . . . 0.0 106.321 164.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -112.11 144.55 41.31 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 166.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 75.0 p -102.51 12.4 36.51 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.192 0.997 . . . . 0.0 110.974 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 162.99 -145.49 10.65 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 176.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.04 87.11 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.897 1.679 . . . . 0.0 111.591 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.27 130.13 45.45 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.321 -0.862 . . . . 0.0 109.334 173.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 49.1 p -83.39 161.42 56.92 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 168.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -70.28 174.2 10.31 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.653 1.569 . . . . 0.0 110.079 163.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.26 -93.51 0.14 Allowed Glycine 0 C--N 1.333 0.365 0 O-C-N 120.965 -1.084 . . . . 0.0 111.536 172.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -149.53 163.3 38.21 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 175.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -146.02 86.05 1.7 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -125.63 153.43 43.78 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.683 ' HB1' HD13 ' A' ' 86' ' ' LEU . . . -162.93 165.73 24.73 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.682 1.193 . . . . 0.0 107.986 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -137.67 134.93 36.01 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -126.56 165.47 19.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.918 1.687 . . . . 0.0 109.484 174.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 41.4 p -119.67 124.86 47.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -93.8 149.66 21.05 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HG2' ' HA ' ' A' ' 171' ' ' ASN . 3.2 mtmp? -121.35 163.45 18.64 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.256 1.422 . . . . 0.0 107.757 171.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.52 109.13 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.248 -2.131 . . . . 0.0 105.248 -164.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -111.01 80.32 1.29 Allowed 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.316 1.446 . . . . 0.0 108.935 -167.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -71.6 161.72 30.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.802 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.421 ' H ' ' HB1' ' A' ' 66' ' ' ALA . 10.1 pt20 -175.26 171.53 2.91 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.352 1.061 . . . . 0.0 111.251 -174.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 141.61 -46.65 0.88 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 124.496 1.046 . . . . 0.0 111.591 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -72.45 70.16 1.1 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 126.139 1.828 . . . . 0.0 113.416 -171.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 163.45 4.18 0.04 OUTLIER Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.344 1.926 . . . . 0.0 113.182 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.65 -63.01 4.06 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 119.846 1.823 . . . . 0.0 110.796 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.41 70.57 0.22 Allowed Glycine 0 CA--C 1.521 0.421 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 163.67 58.02 0.02 OUTLIER Glycine 0 C--N 1.332 0.315 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -171.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -173.09 129.31 0.47 Allowed 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 126.269 1.827 . . . . 0.0 107.62 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -161.49 165.1 29.16 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 125.357 1.661 . . . . 0.0 110.498 171.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 98.2 m -151.84 97.16 2.32 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.399 1.479 . . . . 0.0 107.866 -170.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.6 m -89.08 117.08 27.82 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.023 1.729 . . . . 0.0 109.768 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.93 159.27 26.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.755 1.622 . . . . 0.0 110.744 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.409 ' HA ' ' HG2' ' A' ' 155' ' ' LYS . 25.9 m120 -76.32 111.96 12.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.71 -67.59 1.82 Allowed Glycine 0 C--N 1.334 0.423 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.99 -160.98 34.73 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -171.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 37.5 m -107.05 128.35 54.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.448 1.099 . . . . 0.0 108.504 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 19.6 t -104.5 105.75 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 166.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -78.85 143.49 35.92 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 170.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -122.32 122.88 40.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -128.61 168.78 15.25 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.687 1.195 . . . . 0.0 109.699 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 138.88 -161.78 25.88 Favored Glycine 0 N--CA 1.443 -0.9 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -162.07 170.36 19.34 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.08 129.89 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 168.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.4 m -115.38 147.98 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 C-N-CA 127.166 2.186 . . . . 0.0 107.844 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -75.78 41.9 0.22 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.358 1.463 . . . . 0.0 113.356 -174.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.253 1.276 0 C-N-CA 129.627 3.171 . . . . 0.0 113.605 175.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.92 159.11 43.14 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.102 1.361 . . . . 0.0 107.976 166.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.48 161.64 40.9 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.805 1.242 . . . . 0.0 108.024 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.9 t -151.9 113.16 4.3 Favored 'General case' 0 N--CA 1.457 -0.113 0 O-C-N 120.919 -1.113 . . . . 0.0 109.703 172.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -147.58 154.59 11.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 165.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -64.41 -50.78 66.29 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 122.272 -0.267 . . . . 0.0 110.771 -165.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.81 37.81 3.31 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.115 0.864 . . . . 0.0 111.595 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.13 41.49 0.2 Allowed Glycine 0 C--N 1.338 0.662 0 CA-C-N 118.49 1.145 . . . . 0.0 111.468 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -163.14 13.22 0.06 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.889 1.276 . . . . 0.0 109.173 174.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.438 ' C ' ' H ' ' A' ' 12' ' ' PHE . 35.0 m -71.28 35.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 130.345 3.458 . . . . 0.0 111.696 -169.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.3 m170 31.8 -21.04 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.02 1 C-N-CA 137.484 6.314 . . . . 0.0 117.576 -146.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.438 ' H ' ' C ' ' A' ' 10' ' ' VAL . 41.8 m-85 -103.8 1.14 31.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 128.191 2.597 . . . . 0.0 112.067 -166.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.8 mttt 68.03 -27.92 0.14 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 128.478 2.711 . . . . 0.0 116.101 -172.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.1 -16.76 1.96 Allowed Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.33 1.919 . . . . 0.0 115.774 170.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.505 ' HG3' ' H ' ' A' ' 17' ' ' VAL . 13.3 pt-20 -80.11 -153.28 0.08 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 129.686 3.195 . . . . 0.0 110.928 -173.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.566 HG11 HG12 ' A' ' 170' ' ' VAL . 14.6 p -46.79 -26.54 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 126.717 2.007 . . . . 0.0 113.587 167.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.505 ' H ' ' HG3' ' A' ' 15' ' ' GLU . 27.6 m 41.81 33.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 130.704 3.602 . . . . 0.0 113.802 -174.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -160.5 104.99 1.43 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.935 2.094 . . . . 0.0 106.861 171.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.45 36.55 1.49 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 128.553 2.741 . . . . 0.0 108.438 175.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.56 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . 48.7 -69.02 0.0 OUTLIER 'General case' 0 C--N 1.34 0.182 1 C-N-CA 133.453 4.701 . . . . 0.0 112.099 -171.679 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 29.1 m -83.19 -176.23 6.22 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.972 2.109 . . . . 0.0 111.229 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.31 16.14 10.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.925 2.09 . . . . 0.0 113.27 -171.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t 24.62 102.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 130.164 3.385 . . . . 0.0 113.137 172.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -55.32 157.59 3.59 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.63 1.172 . . . . 0.0 112.221 -171.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.22 -23.08 62.0 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.927 -1.108 . . . . 0.0 111.553 169.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.15 -18.49 73.07 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 117.872 -1.516 . . . . 0.0 113.671 172.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.2 p -118.43 -17.76 9.33 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.254 2.027 . . . . 0.0 111.919 -176.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.01 -27.77 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 O-C-N 120.876 -1.14 . . . . 0.0 112.771 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -167.3 82.3 0.21 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 -167.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.58 129.72 56.27 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -173.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -77.57 142.24 39.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 156.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.5 t -117.66 99.94 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 162.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -82.43 101.24 10.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.18 -17.3 59.6 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.767 0.827 . . . . 0.0 109.747 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.55 -165.21 18.78 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 121.716 0.62 . . . . 0.0 113.041 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -66.92 153.81 42.61 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.306 1.443 . . . . 0.0 111.53 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.5 t -137.13 147.95 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 125.414 1.485 . . . . 0.0 108.628 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.41 127.98 32.97 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 p -59.15 -25.1 63.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.227 0.537 . . . . 0.0 111.806 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.31 -27.87 66.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.497 -0.752 . . . . 0.0 111.204 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.5 t -84.52 0.89 48.15 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.245 1.418 . . . . 0.0 112.802 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.434 HD13 HG21 ' A' ' 99' ' ' VAL . 11.1 mt -143.84 82.69 1.73 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.62 1.568 . . . . 0.0 107.826 -170.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.04 0.05 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.408 -1.433 . . . . 0.0 113.485 -174.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.494 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 4.0 pm0 -148.22 157.25 43.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.472 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 33.0 tt0 -63.37 121.83 14.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.51 -4.57 61.97 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.282 1.42 . . . . 0.0 113.523 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB2' ' NE2' ' A' ' 44' ' ' GLN . . . -61.22 154.24 24.01 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 119.24 1.52 . . . . 0.0 109.499 168.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.5 p -144.06 156.23 44.29 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.251 0.478 . . . . 0.0 110.678 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.7 p -72.55 -174.67 1.43 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.6 m -50.54 -40.18 51.11 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 117.101 -1.428 . . . . 0.0 113.806 171.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 95.18 170.92 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 C-N-CA 131.694 3.998 . . . . 0.0 109.815 -166.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.6 t -145.0 139.1 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 167.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.27 69.48 0.22 Allowed Glycine 0 CA--C 1.51 -0.246 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.52 ' HE1' ' HB2' ' A' ' 135' ' ' ALA . 29.4 p90 -69.0 161.0 29.9 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -133.67 175.84 9.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.739 1.616 . . . . 0.0 109.518 169.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.3 mm -109.81 112.29 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -68.55 112.42 5.34 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.301 0.64 . . . . 0.0 109.861 172.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.92 135.91 49.33 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 125.006 1.323 . . . . 0.0 108.272 168.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -136.95 167.65 21.08 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.378 1.471 . . . . 0.0 110.362 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 46.07 30.74 0.99 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.965 2.106 . . . . 0.0 113.353 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 96.3 m -62.83 162.48 10.97 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 127.031 2.132 . . . . 0.0 111.388 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -151.42 120.24 6.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.797 1.639 . . . . 0.0 106.898 -167.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.9 p -79.4 -18.45 52.26 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 120.898 -1.126 . . . . 0.0 112.22 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -60.35 -46.97 88.06 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.472 0.709 . . . . 0.0 109.725 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 20' ' ' ALA . 6.2 p -73.12 -45.78 52.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.212 1.005 . . . . 0.0 109.637 -175.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -161.82 124.17 2.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.145 1.378 . . . . 0.0 108.099 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 m -66.85 -11.75 56.73 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.893 170.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -149.46 163.1 38.72 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 120.846 1.657 . . . . 0.0 114.116 -169.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.89 126.51 39.89 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.713 2.005 . . . . 0.0 106.836 166.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.55 172.96 8.15 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 142.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.453 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.4 OUTLIER -139.88 151.09 21.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 103.182 -2.896 . . . . 0.0 103.182 -171.247 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.76 149.45 46.44 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.427 ' CD1' HG21 ' A' ' 103' ' ' ILE . 17.6 m-85 -114.24 157.88 22.13 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.856 0.862 . . . . 0.0 110.757 177.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.408 HD22 ' HA3' ' A' ' 115' ' ' GLY . 13.9 tp -150.47 140.93 22.44 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.952 1.301 . . . . 0.0 108.934 -176.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.16 -169.0 34.39 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 123.929 0.776 . . . . 0.0 112.381 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 m -81.5 130.87 35.21 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.205 1.802 . . . . 0.0 109.605 166.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -76.97 140.07 40.32 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 119.553 1.07 . . . . 0.0 111.028 172.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.3 tt -64.04 -44.62 97.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 122.689 0.396 . . . . 0.0 111.503 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.43 164.46 34.91 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.836 1.254 . . . . 0.0 108.636 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.85 -27.22 66.47 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.888 1.275 . . . . 0.0 113.114 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.77 -2.94 88.45 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.798 0.713 . . . . 0.0 112.582 175.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -143.34 47.3 1.5 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.772 1.629 . . . . 0.0 109.133 -169.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.474 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 25.5 p -61.89 -15.61 44.03 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.15 0.98 . . . . 0.0 112.943 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -94.48 -12.76 27.05 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 124.709 1.203 . . . . 0.0 109.762 -173.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.09 130.81 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.857 1.263 . . . . 0.0 107.653 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mt -72.2 150.01 44.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.85 1.26 . . . . 0.0 110.291 -174.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.74 14.05 16.44 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.983 1.713 . . . . 0.0 114.351 -164.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 51.1 mt 48.74 -152.48 0.12 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.216 1.007 . . . . 0.0 110.199 -162.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -148.04 179.34 7.81 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.507 1.523 . . . . 0.0 110.374 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.6 m -51.97 145.78 9.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.911 1.684 . . . . 0.0 112.404 170.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.6 m -164.16 174.05 11.7 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.625 2.77 . . . . 0.0 105.876 172.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.69 -38.81 56.71 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -176.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.87 35.06 4.77 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.561 1.544 . . . . 0.0 109.775 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.64 32.13 83.19 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 166.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 62.6 m 66.02 176.88 0.22 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.715 2.406 . . . . 0.0 112.536 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.78 128.9 39.5 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.036 1.334 . . . . 0.0 109.177 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.5 p -87.5 170.27 11.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.893 0.77 . . . . 0.0 110.03 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 49.6 32.78 5.23 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.938 1.695 . . . . 0.0 111.943 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.434 HG21 HD13 ' A' ' 42' ' ' LEU . 3.1 p -154.68 151.02 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.4 172.77 34.83 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.434 HG11 ' CD2' ' A' ' 177' ' ' PHE . 79.2 t -84.61 133.74 28.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -104.48 153.54 21.01 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 157.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.427 HG21 ' CD1' ' A' ' 73' ' ' PHE . 4.0 mp -116.72 128.91 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 103.747 -2.686 . . . . 0.0 103.747 164.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 mt -125.96 143.11 51.22 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.566 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 5.7 p-10 -66.66 -178.33 0.7 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.475 1.11 . . . . 0.0 112.659 173.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.429 ' HG3' HG23 ' A' ' 107' ' ' THR . 9.4 ptm180 -44.37 -31.67 1.12 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 128.605 2.762 . . . . 0.0 114.856 169.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.429 HG23 ' HG3' ' A' ' 106' ' ' ARG . 28.6 p -95.09 -4.65 45.92 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.884 1.274 . . . . 0.0 112.125 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.48 22.23 78.76 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 121.162 -0.961 . . . . 0.0 112.933 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -82.69 144.31 30.33 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.923 1.861 . . . . 0.0 109.081 168.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.87 129.05 37.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.756 0.822 . . . . 0.0 111.106 -176.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.426 HD12 HG22 ' A' ' 103' ' ' ILE . 51.9 mt -89.45 168.68 12.0 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.001 0.52 . . . . 0.0 110.396 176.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 m -122.32 140.63 52.43 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.995 1.318 . . . . 0.0 107.764 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.7 mt -93.69 52.03 1.64 Allowed 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.513 1.125 . . . . 0.0 109.895 -160.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.33 -29.34 19.22 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.238 1.015 . . . . 0.0 111.495 -174.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.408 ' HA3' HD22 ' A' ' 74' ' ' LEU . . . 83.99 -30.43 3.59 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 124.564 1.078 . . . . 0.0 113.697 -172.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.05 -58.04 3.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 116.989 -1.481 . . . . 0.0 109.383 166.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.2 m -40.66 103.97 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.315 1.446 . . . . 0.0 111.956 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -63.32 160.77 15.24 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.068 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.3 p -118.43 173.08 7.03 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.857 1.263 . . . . 0.0 109.383 168.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 17.2 m -25.2 116.46 0.05 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.051 2.14 . . . . 0.0 113.402 166.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -72.33 167.4 20.54 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 122.318 1.056 . . . . 0.0 109.174 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.1 m -132.57 157.11 45.55 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 160.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.4 m -107.04 133.81 51.11 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 123.517 1.627 . . . . 0.0 107.961 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.99 175.77 6.51 Favored 'General case' 0 N--CA 1.428 -1.561 0 C-N-CA 129.179 2.991 . . . . 0.0 108.904 -164.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.479 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 7.3 p30 -145.68 165.48 28.63 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.411 1.484 . . . . 0.0 107.971 172.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -61.09 122.59 15.37 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 169.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.21 -119.27 6.11 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.263 0.935 . . . . 0.0 111.208 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 m -117.58 125.87 51.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 119.232 1.516 . . . . 0.0 110.436 -167.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.479 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -133.22 176.02 8.88 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 125.051 1.34 . . . . 0.0 109.948 175.734 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.0 m -145.28 137.32 25.64 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.261 -0.899 . . . . 0.0 110.586 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.8 mt -102.63 108.88 59.46 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 169.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -86.59 159.5 9.31 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.607 2.205 . . . . 0.0 110.648 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.453 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 40.9 m-85 -146.43 177.17 9.24 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.1 1.76 . . . . 0.0 109.438 -172.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.09 115.34 8.88 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.393 0.997 . . . . 0.0 111.09 153.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.52 ' HB2' ' HE1' ' A' ' 54' ' ' PHE . . . -84.24 164.88 18.8 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 121.45 -0.781 . . . . 0.0 109.535 167.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -157.24 160.63 38.84 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.011 1.325 . . . . 0.0 107.506 171.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -79.77 132.11 36.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 160.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -116.33 123.02 46.59 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.503 1.921 . . . . 0.0 106.054 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -82.06 143.44 31.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.165 0.586 . . . . 0.0 109.82 176.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.472 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 12.3 p -106.19 11.17 31.54 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.765 0.826 . . . . 0.0 112.173 170.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 160.84 -149.25 18.21 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.06 86.78 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.956 1.303 . . . . 0.0 110.01 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.67 155.96 39.71 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.282 0.633 . . . . 0.0 109.871 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.4 p -118.83 161.52 35.71 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.757 0.708 . . . . 0.0 109.896 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -75.39 176.89 9.36 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.681 1.587 . . . . 0.0 110.629 171.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.43 -97.95 0.17 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 164.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.94 163.19 31.29 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 129.947 3.299 . . . . 0.0 105.456 168.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -150.19 77.22 1.3 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.673 0.67 . . . . 0.0 109.816 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -119.81 150.35 40.57 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -174.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -152.73 164.08 38.45 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.454 1.102 . . . . 0.0 108.193 171.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -134.68 98.28 4.01 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.97 177.81 8.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.39 0.614 . . . . 0.0 110.376 168.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.5 p -122.16 162.44 21.32 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 150.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.428 ' CE1' ' HA3' ' A' ' 172' ' ' GLY . 44.4 p90 -115.98 150.86 36.51 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.912 0.863 . . . . 0.0 109.763 158.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -107.37 167.04 10.2 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.042 1.737 . . . . 0.0 106.659 161.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.88 146.71 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 171.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -128.1 85.12 2.31 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -66.54 147.98 52.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.143 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -161.44 176.91 10.61 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 124.76 1.224 . . . . 0.0 110.752 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 142.96 -32.51 1.9 Allowed Glycine 0 CA--C 1.521 0.407 0 C-N-CA 125.056 1.312 . . . . 0.0 111.339 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.67 84.98 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 118.219 1.01 . . . . 0.0 112.458 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 79.27 -81.66 1.42 Allowed Glycine 0 C--N 1.337 0.606 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 174.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 60.33 -87.38 0.03 OUTLIER Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.88 1.705 . . . . 0.0 111.559 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -145.4 22.6 1.87 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.581 1.562 . . . . 0.0 111.651 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 103.59 80.49 1.44 Allowed Glycine 0 C--N 1.336 0.548 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 -165.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.79 119.92 17.69 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.109 1.764 . . . . 0.0 107.253 -173.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -149.29 172.57 14.66 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 127.219 2.208 . . . . 0.0 109.343 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.4 m -130.91 99.41 4.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.6 131.74 42.85 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 167.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.566 HG12 HG11 ' A' ' 16' ' ' VAL . 3.7 m -148.55 140.65 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 124.405 1.082 . . . . 0.0 109.742 -177.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -66.87 126.27 28.54 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 166.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 154' ' ' PHE . . . -93.41 -75.96 1.32 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -160.29 -175.48 31.33 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 123.72 0.306 . . . . 0.0 113.232 -176.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 25.6 m -103.6 142.82 33.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.401 1.48 . . . . 0.0 109.007 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.4 t -125.57 101.56 8.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -88.35 95.6 10.26 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.434 ' CD2' HG11 ' A' ' 101' ' ' VAL . 71.4 m-85 -75.14 102.21 4.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 175.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -114.24 156.94 23.4 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 -175.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 143.75 -163.37 27.63 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -171.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -161.44 170.15 20.54 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -164.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 48.3 t -126.4 140.51 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 167.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 16.9 m -122.06 150.37 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 127.058 2.143 . . . . 0.0 109.046 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.65 24.59 0.09 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -169.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 1 C-N-CA 132.993 4.517 . . . . 0.0 113.719 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.44 -77.93 0.42 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 171.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 4' ' ' THR . 10.0 m 65.27 172.75 0.21 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.975 1.71 . . . . 0.0 111.285 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.554 ' H ' HG22 ' A' ' 3' ' ' THR . 18.9 p -135.58 127.4 29.32 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.912 2.085 . . . . 0.0 106.37 -170.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 6' ' ' ASN . 11.9 p -146.4 172.02 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.416 ' H ' HG22 ' A' ' 5' ' ' VAL . 10.3 m120 -55.69 103.35 0.09 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.745 1.618 . . . . 0.0 111.422 -167.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.57 -88.55 1.59 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.33 173.76 23.66 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -174.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 t -96.6 14.32 25.19 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.022 0.529 . . . . 0.0 112.196 -164.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 74.01 156.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 127.945 2.498 . . . . 0.0 110.43 -155.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -85.35 36.45 0.64 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.78 1.232 . . . . 0.0 110.723 -165.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -159.02 16.88 0.18 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.912 2.085 . . . . 0.0 110.522 -161.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 69.82 -36.32 0.34 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 127.599 2.36 . . . . 0.0 114.877 -175.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.07 27.61 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.884 0 CA-C-O 117.141 -1.921 . . . . 0.0 114.203 -167.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.347 2.2 pt-20 97.77 -157.79 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 130.141 3.376 . . . . 0.0 112.147 173.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 p -41.53 -39.57 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 126.841 2.056 . . . . 0.0 113.283 -176.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.258 22.1 m 33.26 34.52 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 130.051 3.34 . . . . 0.0 117.83 176.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -116.87 100.29 7.68 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.978 0.894 . . . . 0.0 109.667 169.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -129.01 110.79 12.36 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 -173.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.474 ' HB3' ' CD1' ' A' ' 158' ' ' TYR . . . -53.28 -38.87 63.48 Favored 'General case' 0 C--O 1.225 -0.211 0 O-C-N 123.986 0.803 . . . . 0.0 112.206 -165.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.4 ' SG ' HD13 ' A' ' 124' ' ' LEU . 3.5 m -110.22 159.3 17.51 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.798 1.239 . . . . 0.0 107.779 165.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.81 -9.3 52.26 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -164.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.5 t 44.95 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 129.038 2.935 . . . . 0.0 110.744 -167.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -62.91 160.57 14.49 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.289 -170.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.7 -21.2 39.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.953 1.301 . . . . 0.0 112.15 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.53 -12.9 67.53 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.564 1.078 . . . . 0.0 112.755 173.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 t -127.09 -21.67 3.91 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.834 1.654 . . . . 0.0 110.792 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.9 -26.13 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 125.25 1.42 . . . . 0.0 113.007 -173.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -150.7 94.5 2.1 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -132.61 148.31 52.36 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.343 0.657 . . . . 0.0 109.485 -175.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.2 m -124.32 100.4 6.67 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.634 1.973 . . . . 0.0 108.041 -174.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.5 t -74.53 111.28 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -88.55 101.41 13.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.63 HD23 HG11 ' A' ' 52' ' ' VAL . 1.2 mt -76.46 -16.39 59.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.033 1.733 . . . . 0.0 109.7 170.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.39 -166.55 25.49 Favored Glycine 0 C--N 1.343 0.935 0 C-N-CA 124.796 1.189 . . . . 0.0 112.765 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -68.68 147.63 51.58 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.98 0.912 . . . . 0.0 109.64 173.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 t -135.88 143.41 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 124.353 1.061 . . . . 0.0 108.949 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 3.8 mmt85 -73.29 127.67 33.3 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 182' ' ' VAL . 33.3 p -58.01 -21.94 47.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.211 0.529 . . . . 0.0 111.485 172.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.38 -43.3 75.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.165 -0.96 . . . . 0.0 110.675 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.6 m -72.49 -2.11 18.39 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.4 mt -144.0 66.28 1.29 Allowed 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.488 1.915 . . . . 0.0 109.017 -161.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.97 -9.07 6.0 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -167.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.52 163.09 40.26 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.391 1.476 . . . . 0.0 107.928 -178.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -62.77 129.97 42.84 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.24 -10.68 63.58 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.842 1.211 . . . . 0.0 112.734 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.83 106.2 2.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.35 1.06 . . . . 0.0 111.458 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.415 HG21 ' CZ ' ' A' ' 136' ' ' ARG . 11.8 p -101.18 150.6 22.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.44 -0.788 . . . . 0.0 110.812 -176.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.1 p -67.56 172.45 5.09 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 166.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.7 m -24.64 -98.9 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 130.257 3.423 . . . . 0.0 114.517 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 154.72 118.24 0.0 OUTLIER 'General case' 0 C--O 1.233 0.191 0 C-N-CA 129.746 3.218 . . . . 0.0 105.356 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.63 HG11 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -130.58 130.96 65.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -176.17 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.08 139.5 14.58 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -138.48 158.77 43.62 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 168.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -148.94 130.08 14.51 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 120.347 -1.471 . . . . 0.0 110.396 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.7 mm -83.54 115.61 26.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 125.002 1.321 . . . . 0.0 107.459 -167.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -76.63 108.95 9.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.988 0.915 . . . . 0.0 109.826 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.7 mp -111.71 97.13 6.5 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 125.414 1.485 . . . . 0.0 108.294 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -95.83 160.32 14.53 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.161 1.784 . . . . 0.0 112.227 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.3 t70 40.49 49.7 2.68 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.275 2.63 . . . . 0.0 114.007 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 57.5 m -65.66 122.16 16.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 127.701 2.4 . . . . 0.0 111.05 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.425 ' HB3' HG23 ' A' ' 65' ' ' VAL . 5.9 t0 -111.17 112.6 24.51 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.582 1.153 . . . . 0.0 110.161 -173.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.9 p -70.84 -24.68 62.57 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.146 2.178 . . . . 0.0 113.738 -165.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -61.47 -48.2 82.19 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 128.543 2.737 . . . . 0.0 112.44 168.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 62' ' ' ASP . 40.1 t -64.88 -39.13 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -176.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -168.63 146.06 3.91 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.117 -176.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.25 -11.42 35.34 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 118.795 -0.621 . . . . 0.0 111.67 170.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -134.04 164.8 26.5 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 125.46 1.504 . . . . 0.0 109.942 -173.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.79 144.06 37.18 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 163.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.79 167.88 9.83 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.98 1.712 . . . . 0.0 107.429 158.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.7 t -124.8 150.97 29.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 169.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.25 155.21 37.62 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 161.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.623 ' CE1' HG21 ' A' ' 103' ' ' ILE . 60.0 m-85 -114.04 154.85 26.98 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.406 HD13 ' C ' ' A' ' 114' ' ' ASP . 9.7 tp -142.11 125.97 17.11 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 125.373 1.469 . . . . 0.0 107.365 177.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.679 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -165.85 162.91 36.34 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.3 m -63.08 129.47 40.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.003 0.901 . . . . 0.0 109.107 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.69 141.31 46.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.071 0.462 . . . . 0.0 110.245 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.3 tt -60.77 -37.51 76.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 123.931 0.892 . . . . 0.0 110.382 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -158.24 165.56 34.55 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.45 -35.4 72.06 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.856 1.262 . . . . 0.0 111.254 169.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.79 -3.68 64.29 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 121.276 -0.89 . . . . 0.0 112.381 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -147.78 48.54 1.08 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.959 1.704 . . . . 0.0 108.788 -164.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.3 p -58.75 -18.4 31.4 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.598 1.959 . . . . 0.0 112.414 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.558 ' H ' HD21 ' A' ' 84' ' ' ASN . 0.6 OUTLIER -95.07 -1.79 51.44 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 117.928 -1.034 . . . . 0.0 113.076 175.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.3 t -115.58 130.59 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 120.329 1.422 . . . . 0.0 109.807 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.679 HD21 ' HA3' ' A' ' 75' ' ' GLY . 4.8 mt -72.2 151.47 42.89 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.209 1.004 . . . . 0.0 111.393 -175.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.72 17.41 10.39 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.999 1.719 . . . . 0.0 113.656 -168.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.644 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 63.8 mt 52.34 -154.17 0.2 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.606 1.562 . . . . 0.0 109.406 -168.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -145.09 -172.43 3.85 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.725 0.693 . . . . 0.0 110.158 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.4 m -56.08 154.74 7.27 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.794 0.807 . . . . 0.0 111.75 170.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.509 ' HB2' ' H ' ' A' ' 95' ' ' SER . 1.4 m -162.12 178.8 8.46 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.635 1.974 . . . . 0.0 106.556 167.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -45.15 -58.88 2.93 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.857 0.863 . . . . 0.0 109.271 169.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -101.41 16.41 25.69 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.786 0.834 . . . . 0.0 113.01 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.96 48.22 73.72 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.634 -0.666 . . . . 0.0 111.998 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.509 ' H ' ' HB2' ' A' ' 91' ' ' SER . 45.8 m 62.45 177.78 0.14 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.484 2.314 . . . . 0.0 113.343 175.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.07 139.07 57.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.389 1.476 . . . . 0.0 107.57 164.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 p -90.36 170.4 10.28 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.761 0.709 . . . . 0.0 109.594 173.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 58.73 19.92 7.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 126.536 1.934 . . . . 0.0 112.71 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.7 p -143.49 151.38 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -153.5 177.67 30.92 Favored Glycine 0 C--O 1.225 -0.408 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 m -96.03 142.87 13.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 CA-C-N 120.018 1.909 . . . . 0.0 109.056 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -110.15 156.61 20.37 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 120.257 1.39 . . . . 0.0 109.328 161.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.623 HG21 ' CE1' ' A' ' 73' ' ' PHE . 4.6 mp -114.02 142.97 24.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 126.995 2.118 . . . . 0.0 105.562 159.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 110' ' ' ALA . 8.3 mt -131.77 156.0 46.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.235 1.814 . . . . 0.0 106.674 170.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 106' ' ' ARG . 3.5 t70 -72.34 -105.35 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 165.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.402 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 19.7 ptt180 -151.21 -9.79 0.23 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.744 1.618 . . . . 0.0 112.432 178.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.5 p -83.12 7.54 15.66 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.646 1.578 . . . . 0.0 109.344 172.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.45 8.1 30.1 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.441 1.496 . . . . 0.0 113.484 -166.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.31 114.65 3.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 119.476 1.638 . . . . 0.0 107.377 170.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.499 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -95.08 127.44 41.15 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.43 131.62 51.59 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.826 0.704 . . . . 0.0 110.623 -162.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.8 m -65.18 153.96 39.41 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.616 0.366 . . . . 0.0 110.611 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.81 49.92 0.8 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.393 1.477 . . . . 0.0 110.226 -171.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.406 ' C ' HD13 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -88.59 -28.86 20.42 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.564 -1.335 . . . . 0.0 111.091 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.44 2.03 56.63 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 126.523 2.011 . . . . 0.0 113.641 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.78 -31.69 1.95 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 117.583 -1.198 . . . . 0.0 111.35 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.1 m -54.67 104.35 0.11 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.713 1.142 . . . . 0.0 110.131 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -87.26 149.95 24.22 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.886 -173.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.6 -160.73 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.896 1.278 . . . . 0.0 111.789 -174.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 m -50.76 156.49 0.94 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.519 0.727 . . . . 0.0 111.778 147.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -102.4 152.93 20.53 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.393 1.877 . . . . 0.0 108.313 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.8 m -132.03 118.25 19.44 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.449 1.499 . . . . 0.0 107.851 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.5 m -59.15 123.76 17.71 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 166.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.4 HD13 ' SG ' ' A' ' 21' ' ' CYS . 73.3 mt -91.2 -174.69 4.04 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 128.805 2.842 . . . . 0.0 109.59 176.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -163.04 172.94 14.22 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.522 1.929 . . . . 0.0 108.537 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -59.57 107.38 0.58 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.974 1.709 . . . . 0.0 109.748 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.1 -124.25 3.19 Favored Glycine 0 N--CA 1.474 1.226 0 CA-C-N 120.417 1.462 . . . . 0.0 112.8 169.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 99.2 m -122.75 125.31 45.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 120.535 2.168 . . . . 0.0 109.091 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -133.29 177.72 7.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.474 1.91 . . . . 0.0 109.706 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.57 162.18 40.71 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -166.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 17.6 mt -139.92 112.29 7.5 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.64 153.08 43.46 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.971 1.781 . . . . 0.0 109.431 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -136.41 161.3 36.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.894 1.677 . . . . 0.0 107.605 170.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -127.18 97.27 4.87 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -175.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.12 157.23 25.41 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.406 1.482 . . . . 0.0 110.578 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.415 ' CZ ' HG21 ' A' ' 48' ' ' THR . 24.9 ptt180 -159.14 169.83 23.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.079 1.352 . . . . 0.0 111.306 162.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.433 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 76.0 m-85 -82.78 146.05 29.18 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 152.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -123.83 116.53 23.11 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.97 2.108 . . . . 0.0 106.914 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.54 141.15 36.92 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 171.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.2 p -105.67 17.13 24.28 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.895 0.878 . . . . 0.0 110.375 171.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 161.64 -155.98 27.36 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.06 91.34 0.15 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.995 1.718 . . . . 0.0 110.043 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.12 152.72 32.11 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 55.0 p -104.38 161.06 23.99 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -72.87 170.9 18.56 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 N-CA-C 109.215 -1.11 . . . . 0.0 109.215 160.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.06 -95.46 0.15 Allowed Glycine 0 C--O 1.226 -0.348 0 O-C-N 121.35 -0.844 . . . . 0.0 112.114 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -151.12 161.18 43.21 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.175 1.79 . . . . 0.0 106.743 173.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.433 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -147.11 81.23 1.54 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -118.92 139.53 51.49 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.644 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -151.5 157.24 42.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -130.34 121.88 26.84 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -101.15 163.57 12.22 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 162.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.3 p -103.8 156.15 18.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 151.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -115.84 157.8 23.89 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.49 0.716 . . . . 0.0 109.604 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -126.31 162.7 24.88 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 126.946 2.098 . . . . 0.0 107.768 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.411 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 10.8 t -128.55 123.34 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 -175.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -111.78 85.56 2.16 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 20' ' ' ALA . 85.8 m-85 -64.7 146.84 54.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.283 170.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -164.47 168.21 18.66 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 121.838 0.827 . . . . 0.0 112.44 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 154.28 -86.02 0.14 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 105.894 -2.883 . . . . 0.0 105.894 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -24.71 -59.18 0.06 OUTLIER Glycine 0 CA--C 1.523 0.544 0 C-N-CA 129.891 3.615 . . . . 0.0 116.87 -172.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -71.47 -22.47 78.61 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 119.487 1.644 . . . . 0.0 112.772 -171.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.62 49.53 3.61 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 118.262 1.031 . . . . 0.0 111.604 167.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 86.85 116.47 1.04 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -172.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.34 32.22 9.79 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 123.664 0.65 . . . . 0.0 111.939 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -155.88 124.48 5.94 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -155.8 148.2 23.75 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 123.588 0.555 . . . . 0.0 110.491 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 90.9 m -103.58 91.89 4.22 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.414 1.486 . . . . 0.0 107.939 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.2 m -79.02 101.97 8.1 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 171.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -104.84 169.2 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 126.111 1.765 . . . . 0.0 108.791 170.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.33 173.63 4.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.437 0.637 . . . . 0.0 111.094 169.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -127.16 -72.09 0.18 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 174.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.68 -167.23 39.88 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -167.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.1 m -96.9 137.5 35.89 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.048 0.939 . . . . 0.0 108.745 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.7 t -117.96 105.49 18.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 163.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -78.11 141.74 38.56 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 171.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -123.56 101.15 7.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.27 2.228 . . . . 0.0 105.174 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -115.06 155.99 25.99 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.89 0.876 . . . . 0.0 109.265 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.64 -166.71 27.28 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -167.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -167.09 175.22 7.66 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -169.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 24.3 t -128.86 138.0 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 174.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 39' ' ' THR . 11.0 m -124.69 151.43 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 C-N-CA 127.255 2.222 . . . . 0.0 107.75 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -74.89 30.88 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -171.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.249 1.049 0 C-N-CA 131.074 3.75 . . . . 0.0 114.017 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.925 0 CA-C-O 117.92 -1.038 . . . . 0.0 108.74 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.46 169.43 23.93 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.761 1.619 . . . . 0.0 110.7 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.5 t -114.72 46.97 1.31 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.356 1.074 . . . . 0.0 109.483 178.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -148.53 175.11 11.44 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.681 1.193 . . . . 0.0 108.218 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -49.72 -33.27 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.842 2.057 . . . . 0.0 111.41 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 t30 64.11 -60.22 0.19 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 129.095 2.958 . . . . 0.0 112.769 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.37 106.59 0.23 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 106.013 -2.835 . . . . 0.0 106.013 176.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.61 -65.46 0.01 OUTLIER Glycine 0 CA--C 1.505 -0.574 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -172.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 t -63.94 3.81 0.36 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.839 2.056 . . . . 0.0 115.326 -171.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.9 p 174.97 -24.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 131.427 3.891 . . . . 0.0 111.008 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 77.33 39.49 0.19 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.565 2.346 . . . . 0.0 112.048 178.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -136.78 132.08 34.25 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 169.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -136.79 -102.48 0.2 Allowed 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 167.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.15 -3.35 33.34 Favored Glycine 0 N--CA 1.46 0.292 0 C-N-CA 125.702 1.62 . . . . 0.0 112.623 170.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -166.84 -163.4 0.55 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.947 1.699 . . . . 0.0 106.424 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.597 HG11 HG12 ' A' ' 170' ' ' VAL . 5.9 p -46.07 -31.82 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 127.203 2.201 . . . . 0.0 113.469 167.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m 26.15 56.47 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 127.64 2.376 . . . . 0.0 115.348 -171.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -140.33 97.41 3.22 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -140.24 119.33 12.75 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.554 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -48.4 -40.21 25.1 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.87 1.268 . . . . 0.0 112.377 -175.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -112.79 160.71 17.71 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.755 1.622 . . . . 0.0 109.579 178.404 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.92 -21.62 31.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.334 -167.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 t 56.51 107.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 128.633 2.773 . . . . 0.0 110.272 -165.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -65.7 163.14 17.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.66 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.552 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -53.26 -29.6 33.76 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.242 1.017 . . . . 0.0 111.356 167.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.43 4.61 3.65 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.673 1.13 . . . . 0.0 114.784 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.8 t -147.6 -34.13 0.25 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.188 1.494 . . . . 0.0 110.351 -167.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 25' ' ' ALA . 8.1 p -60.4 -36.84 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 O-C-N 120.738 -1.226 . . . . 0.0 111.371 174.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -151.24 97.38 2.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.96 0.886 . . . . 0.0 109.081 -172.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -131.33 133.83 45.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 123.376 1.56 . . . . 0.0 110.179 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.8 m -108.75 88.96 2.85 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -174.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.56 105.11 7.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -171.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -80.89 115.14 20.23 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.674 HD23 HG11 ' A' ' 52' ' ' VAL . 1.2 mt -79.89 -7.44 58.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.974 0.91 . . . . 0.0 110.732 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.19 -178.47 51.42 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.647 1.117 . . . . 0.0 110.703 -177.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -79.05 146.82 33.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 165.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.58 145.58 35.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 124.395 1.078 . . . . 0.0 108.637 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -77.63 132.44 38.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.3 p -59.04 -22.81 61.31 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 122.489 0.316 . . . . 0.0 110.7 168.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.14 -9.64 41.95 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.91 -1.119 . . . . 0.0 113.274 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.0 m -101.36 -2.38 31.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.456 1.103 . . . . 0.0 113.28 168.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.594 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 17.4 mt -142.56 83.22 1.81 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 126.845 2.058 . . . . 0.0 106.815 -166.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.69 6.98 1.45 Allowed 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.289 -0.882 . . . . 0.0 112.274 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.464 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 6.5 pm0 -154.48 160.15 41.42 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.701 1.2 . . . . 0.0 107.886 -174.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -64.09 136.42 57.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 121.528 -0.732 . . . . 0.0 109.796 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.31 -4.17 56.09 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-O 117.51 -1.717 . . . . 0.0 112.344 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.464 ' HB2' ' NE2' ' A' ' 44' ' ' GLN . . . -58.71 143.78 45.69 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 120.562 2.181 . . . . 0.0 108.113 170.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.8 p -140.75 154.68 46.4 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -176.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.5 p -73.41 -178.49 3.03 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.2 m -28.55 -91.03 0.0 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.622 2.769 . . . . 0.0 114.735 173.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.41 111.02 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 130.495 3.518 . . . . 0.0 104.356 -176.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.674 HG11 HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -107.02 136.08 43.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 173.374 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.33 88.77 0.43 Allowed Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 -173.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -83.22 -179.55 7.44 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -148.53 162.97 38.58 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 120.189 -1.569 . . . . 0.0 109.997 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.1 mm -99.62 103.81 15.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -69.49 124.47 23.99 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 174.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.4 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 6.5 mp -117.5 165.46 13.51 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.729 1.612 . . . . 0.0 108.789 174.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -176.03 153.26 1.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.313 1.445 . . . . 0.0 109.219 -165.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 47.12 37.47 5.4 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.542 2.337 . . . . 0.0 114.501 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.534 ' SG ' HD13 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -67.3 119.42 12.13 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.407 1.483 . . . . 0.0 110.35 177.403 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -90.53 142.57 27.61 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 163.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.3 p -91.19 -14.02 31.8 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.664 1.575 . . . . 0.0 114.308 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -70.64 -43.49 69.1 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.739 0.781 . . . . 0.0 110.222 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 20' ' ' ALA . 2.8 p -60.27 -49.71 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.86 130.37 3.19 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 125.955 1.702 . . . . 0.0 108.081 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -82.29 -8.05 59.63 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.018 0.927 . . . . 0.0 111.695 174.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -131.24 167.04 19.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.921 1.689 . . . . 0.0 110.111 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.56 ' HB2' HD11 ' A' ' 124' ' ' LEU . . . -141.03 129.1 22.01 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 162.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.4 176.91 5.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 145.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.424 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.4 OUTLIER -144.03 160.5 15.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 101.648 -3.464 . . . . 0.0 101.648 -168.418 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.25 167.9 21.71 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 120.354 -1.466 . . . . 0.0 107.458 168.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -126.39 153.51 44.86 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 tp -142.13 142.72 32.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.11 170.07 42.85 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 2.0 m -57.19 125.76 24.18 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.954 1.701 . . . . 0.0 109.374 177.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.43 137.52 46.51 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.687 1.13 . . . . 0.0 109.866 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.1 tt -59.2 -49.21 84.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 124.405 1.082 . . . . 0.0 110.7 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -147.78 166.72 26.67 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.09 -34.41 76.24 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.961 1.304 . . . . 0.0 112.231 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.9 -12.69 84.17 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 119.514 -0.603 . . . . 0.0 112.347 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -125.79 48.86 2.01 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.266 1.427 . . . . 0.0 110.153 -173.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.4 p -63.89 -11.96 32.53 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 126.776 2.03 . . . . 0.0 114.041 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -86.25 -4.05 59.09 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.15 -0.968 . . . . 0.0 111.074 171.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.7 t -124.47 132.7 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 119.832 1.196 . . . . 0.0 109.258 -168.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.34 148.25 35.72 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.47 1.508 . . . . 0.0 110.473 -172.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 76' ' ' THR . . . -91.53 17.33 8.83 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.395 1.478 . . . . 0.0 114.27 -166.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.402 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 26.0 mt 51.27 -153.02 0.19 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.261 0.624 . . . . 0.0 109.811 -166.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -146.94 171.59 15.0 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.073 1.349 . . . . 0.0 109.238 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.9 m -48.57 140.02 8.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.062 1.745 . . . . 0.0 111.01 174.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.61 168.79 25.95 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.985 1.314 . . . . 0.0 108.406 176.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.99 -48.95 78.49 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.002 0.921 . . . . 0.0 111.471 -174.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.53 11.48 7.01 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.411 0.684 . . . . 0.0 112.4 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 54.83 50.61 57.6 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 125.578 1.561 . . . . 0.0 111.344 -166.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.5 t 58.11 -176.64 0.07 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 128.77 2.828 . . . . 0.0 111.901 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.06 156.75 14.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 112.277 -2.238 . . . . 0.0 107.891 151.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.44 163.8 28.55 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.495 1.518 . . . . 0.0 108.471 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 59.03 15.65 4.16 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.298 1.439 . . . . 0.0 111.214 -170.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.14 152.71 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 120.207 1.367 . . . . 0.0 109.025 -176.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.27 176.11 28.16 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 125.396 1.474 . . . . 0.0 110.306 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.406 HG11 ' CG ' ' A' ' 177' ' ' PHE . 92.9 t -86.4 142.51 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 172.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.64 157.87 28.62 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.659 1.184 . . . . 0.0 108.544 163.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.7 mp -134.72 138.68 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 C-N-CA 129.082 2.953 . . . . 0.0 104.783 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.07 147.28 46.01 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -178.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.473 ' CG ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -67.84 -175.26 0.53 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.263 0.938 . . . . 0.0 110.405 175.278 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -52.16 -18.14 1.37 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 171.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 t -81.41 -13.65 58.04 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.51 -0.744 . . . . 0.0 109.363 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.15 13.26 52.98 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.557 2.027 . . . . 0.0 113.501 -167.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.05 127.59 33.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 168.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.04 129.05 39.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.328 1.451 . . . . 0.0 111.482 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.0 mt -100.76 160.44 14.36 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 124.086 0.866 . . . . 0.0 110.54 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.0 m -96.13 153.16 17.94 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.995 0.918 . . . . 0.0 108.567 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.4 mt -107.19 64.26 0.64 Allowed 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 123.593 0.757 . . . . 0.0 109.542 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -111.06 -12.61 14.17 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.616 0.766 . . . . 0.0 111.799 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.82 -27.02 1.38 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 125.179 1.371 . . . . 0.0 112.739 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.02 -69.7 0.57 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 117.862 -1.066 . . . . 0.0 109.266 164.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.7 m -39.6 99.09 0.02 OUTLIER 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.804 2.041 . . . . 0.0 112.128 -169.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -70.16 155.96 39.9 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.207 1.403 . . . . 0.0 109.81 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.8 p -109.98 -138.94 0.38 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.043 0.937 . . . . 0.0 112.181 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' CG ' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -70.51 135.44 48.6 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.177 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -78.53 163.17 25.77 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.737 0.779 . . . . 0.0 108.969 167.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.0 m -145.61 118.75 8.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 174.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.1 m -70.32 113.64 7.68 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 171.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 69' ' ' ALA . 31.2 mt -80.29 177.78 8.73 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.048 2.139 . . . . 0.0 107.868 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -143.36 164.9 29.0 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.62 -0.675 . . . . 0.0 109.846 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -63.72 104.99 0.73 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.919 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 122.99 -109.49 1.38 Allowed Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.586 1.565 . . . . 0.0 111.681 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 94.3 m -126.55 131.25 51.6 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 120.769 -1.43 . . . . 0.0 111.587 -164.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.06 174.41 12.78 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.649 1.979 . . . . 0.0 108.249 -172.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.0 m -151.23 157.45 42.62 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 10.5 mt -118.33 110.7 39.01 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 170.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -67.36 154.25 74.5 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 121.709 1.606 . . . . 0.0 109.996 172.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.424 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 25.8 m-85 -136.12 166.77 22.62 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.595 1.558 . . . . 0.0 108.496 173.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -120.02 152.17 37.9 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 164.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.88 166.84 20.71 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 162.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -164.25 158.29 18.75 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 170.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.451 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 84.3 m-85 -71.32 153.89 42.02 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 159.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -134.01 112.89 11.58 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.226 2.21 . . . . 0.0 105.931 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -80.08 150.68 30.22 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.123 0.963 . . . . 0.0 109.184 170.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 68.1 p -115.61 8.04 14.96 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 125.958 1.703 . . . . 0.0 110.601 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.58 -154.28 24.33 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.05 87.0 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.002 1.321 . . . . 0.0 112.064 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -67.07 137.45 56.41 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.243 1.417 . . . . 0.0 111.495 -170.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 31.1 p -99.97 160.8 26.25 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 118.26 0.482 . . . . 0.0 110.613 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -72.36 178.78 5.71 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.446 1.43 . . . . 0.0 110.743 166.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.01 -93.59 0.14 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.593 1.092 . . . . 0.0 112.213 158.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.24 159.12 42.71 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 127.559 2.343 . . . . 0.0 105.06 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -149.33 71.78 1.13 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 120.015 1.279 . . . . 0.0 110.767 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -115.47 154.79 28.65 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -176.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -157.0 152.63 26.85 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.749 0.82 . . . . 0.0 109.715 175.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -120.74 121.32 37.98 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -120.79 175.69 5.9 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.009 2.124 . . . . 0.0 109.819 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.7 p -127.61 152.11 48.06 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 159.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -105.09 156.1 18.38 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 164.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -113.49 171.98 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.797 1.239 . . . . 0.0 107.943 168.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.461 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 15.6 t -129.34 129.05 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -120.9 89.37 3.12 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.543 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 67.0 m-85 -67.58 146.62 53.71 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 125.115 1.366 . . . . 0.0 110.716 173.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -155.87 171.71 19.6 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 126.702 2.001 . . . . 0.0 110.556 166.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 157.89 -60.29 0.33 Allowed Glycine 0 N--CA 1.45 -0.424 0 O-C-N 120.847 -1.158 . . . . 0.0 111.432 166.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -53.71 -34.67 50.88 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 123.828 0.728 . . . . 0.0 113.289 -173.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -128.23 43.95 1.28 Allowed Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.923 1.249 . . . . 0.0 109.996 171.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -53.02 -16.15 4.02 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 118.47 1.135 . . . . 0.0 115.256 -170.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -61.55 -19.96 58.58 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 118.962 1.381 . . . . 0.0 114.52 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 168.94 53.45 0.03 OUTLIER Glycine 0 CA--C 1.525 0.718 0 CA-C-N 119.547 1.673 . . . . 0.0 111.094 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -154.62 121.84 5.64 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.673 1.189 . . . . 0.0 109.05 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -142.79 -173.94 4.03 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.41 1.484 . . . . 0.0 110.229 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 34.4 m -150.06 100.18 2.9 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 120.399 -1.438 . . . . 0.0 108.235 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.54 109.51 15.12 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.799 2.04 . . . . 0.0 109.763 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.597 HG12 HG11 ' A' ' 16' ' ' VAL . 16.0 m -129.36 157.69 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.018 1.327 . . . . 0.0 109.974 -177.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.0 157.39 36.24 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.339 -0.851 . . . . 0.0 109.949 174.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.59 -59.93 0.46 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 172.52 176.5 41.28 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -168.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.9 m -97.45 128.35 44.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.255 1.422 . . . . 0.0 110.197 177.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.43 115.2 49.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -106.4 90.34 3.32 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -172.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.406 ' CG ' HG11 ' A' ' 101' ' ' VAL . 75.2 m-85 -67.34 118.77 11.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 175.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -123.69 160.45 27.19 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 138.41 -165.21 25.55 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -163.47 168.85 19.66 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -167.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.08 136.76 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 167.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 184' ' ' ALA . 6.1 m -115.8 152.36 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 C-N-CA 126.963 2.105 . . . . 0.0 108.329 177.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -75.11 31.42 0.1 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -172.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 N--CA 1.442 -0.837 1 C-N-CA 131.711 4.004 . . . . 0.0 112.096 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.51 147.6 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.124 1.37 . . . . 0.0 110.473 -145.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.8 t 171.43 -56.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.807 2.443 . . . . 0.0 107.026 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 m 72.32 115.17 0.05 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.276 2.23 . . . . 0.0 110.217 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -164.16 162.42 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.024 1.33 . . . . 0.0 107.587 -174.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -84.19 -1.36 54.97 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.143 0.883 . . . . 0.0 111.846 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.11 -76.16 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -174.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.04 -86.62 0.15 Allowed Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 172.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.3 t -141.66 6.74 1.86 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -160.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 9' ' ' THR . 2.5 p 95.86 -178.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 130.761 3.625 . . . . 0.0 108.307 -155.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.478 ' O ' HG13 ' A' ' 10' ' ' VAL . 7.2 m-70 -125.65 -135.42 0.26 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 162.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.32 41.32 0.72 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 120.509 1.504 . . . . 0.0 110.032 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -81.81 84.51 6.85 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.49 -0.756 . . . . 0.0 110.97 -160.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.52 4.95 0.28 Allowed Glycine 0 CA--C 1.525 0.705 0 C-N-CA 123.156 0.407 . . . . 0.0 113.367 166.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.97 -159.45 0.96 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.818 0.847 . . . . 0.0 111.211 -165.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.2 t -44.73 -43.04 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 127.243 2.217 . . . . 0.0 111.831 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.9 t 37.13 49.62 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 127.438 2.295 . . . . 0.0 110.263 -173.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -148.92 94.44 2.25 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 172.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.485 ' HB2' HG21 ' A' ' 170' ' ' VAL . . . -132.46 132.46 42.76 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 102.471 -3.159 . . . . 0.0 102.471 157.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.72 -13.42 61.72 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.204 -0.998 . . . . 0.0 112.808 -173.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.5 m -130.91 151.06 51.75 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.014 1.726 . . . . 0.0 107.799 -175.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.89 -10.26 59.32 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -173.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 t 55.21 140.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 129.036 2.934 . . . . 0.0 112.121 -160.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.62 163.99 13.33 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.182 -0.949 . . . . 0.0 112.711 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.75 78.3 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.501 1.121 . . . . 0.0 111.392 -173.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.91 28.0 2.22 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.38 0.991 . . . . 0.0 112.006 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.7 t -139.68 -55.6 0.56 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.0 1.32 . . . . 0.0 108.554 -174.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.4 p -50.87 -36.09 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.844 1.258 . . . . 0.0 112.873 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -143.41 101.36 3.78 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 104.87 -2.271 . . . . 0.0 104.87 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -130.9 138.48 49.81 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.055 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 176' ' ' HIS . 93.3 m -106.96 98.66 8.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 172.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.8 t -77.67 115.89 20.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -89.66 127.67 35.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 mt -100.99 -3.63 29.04 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.375 1.87 . . . . 0.0 109.57 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.01 179.77 37.26 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.49 1.043 . . . . 0.0 112.345 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -76.01 116.57 16.84 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.777 1.631 . . . . 0.0 109.889 170.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.5 t -103.0 140.67 20.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 122.776 1.274 . . . . 0.0 109.245 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 7.4 mmt180 -71.76 126.58 30.08 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 125.466 1.506 . . . . 0.0 107.003 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 p -50.92 -31.57 18.0 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.321 1.448 . . . . 0.0 111.073 166.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.29 -16.58 60.76 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 t -92.72 0.28 57.39 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.064 1.346 . . . . 0.0 112.062 172.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.9 mt -145.9 67.65 1.2 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.881 1.672 . . . . 0.0 106.653 -162.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.63 -6.27 4.12 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -163.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.413 ' OE1' ' HB2' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -147.85 157.56 43.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.855 1.662 . . . . 0.0 106.848 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 16.4 tt0 -63.33 134.62 56.1 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 170.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.71 -7.09 77.37 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 118.822 -0.988 . . . . 0.0 112.322 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -65.35 152.42 43.87 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.475 1.138 . . . . 0.0 109.604 172.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.9 p -138.08 158.57 44.05 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.858 0.837 . . . . 0.0 111.237 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.6 p -72.05 -175.86 1.59 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.438 0.695 . . . . 0.0 111.484 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 p -40.38 -47.45 2.56 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 126.635 1.974 . . . . 0.0 113.607 160.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 83.74 162.78 0.12 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 129.047 2.939 . . . . 0.0 108.914 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -144.9 133.23 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.87 104.23 3.14 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 106.111 -2.796 . . . . 0.0 106.111 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -104.69 156.74 17.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 168.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.466 ' HB2' HG22 ' A' ' 130' ' ' THR . 0.1 OUTLIER -135.97 151.87 50.38 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 120.515 -1.366 . . . . 0.0 109.701 -177.255 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.2 mm -99.78 115.01 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.63 136.33 38.16 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -173.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.6 mt -123.52 160.26 27.37 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.444 1.498 . . . . 0.0 107.955 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -149.59 151.35 33.67 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.448 1.499 . . . . 0.0 111.077 -164.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.6 t70 38.74 44.11 0.78 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.453 2.701 . . . . 0.0 113.524 -171.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.8 m -72.53 97.14 2.05 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.781 1.632 . . . . 0.0 113.909 -164.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -71.92 104.93 3.65 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.166 0.986 . . . . 0.0 111.126 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.1 p -68.67 -11.88 60.7 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -175.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -66.49 -48.21 70.57 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.707 0.685 . . . . 0.0 109.159 173.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -58.02 -41.76 81.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 124.204 1.001 . . . . 0.0 109.081 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 159' ' ' GLN . . . -167.04 138.24 3.2 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.767 1.627 . . . . 0.0 108.345 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.1 m -96.46 12.58 30.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.927 1.291 . . . . 0.0 113.059 169.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.56 ' CA ' HD21 ' A' ' 124' ' ' LEU . 28.1 mtmt -148.04 167.1 25.81 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 121.309 1.868 . . . . 0.0 113.326 158.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.21 93.6 2.46 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.189 2.196 . . . . 0.0 112.088 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.34 152.22 24.23 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 119.031 -2.293 . . . . 0.0 108.734 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 t -120.44 123.81 71.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.99 165.49 14.53 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 165.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.547 ' CE1' HG21 ' A' ' 103' ' ' ILE . 27.0 m-85 -127.66 160.34 31.93 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.543 163.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.728 HD22 ' OG1' ' A' ' 153' ' ' THR 0.285 0.0 OUTLIER -139.15 160.25 40.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.228 168.077 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.84 163.78 32.91 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 4.6 m -58.17 125.93 25.31 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 164.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.05 140.49 43.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 119.374 0.988 . . . . 0.0 109.091 174.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.4 tt -60.53 -48.46 88.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 123.35 0.66 . . . . 0.0 110.557 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.73 162.6 35.09 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.98 -24.98 67.92 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.678 0.791 . . . . 0.0 112.306 166.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.77 4.91 83.98 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 119.003 -0.887 . . . . 0.0 112.727 173.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -149.39 57.06 1.0 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.163 1.385 . . . . 0.0 109.126 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.3 p -64.61 -20.09 66.07 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.103 1.361 . . . . 0.0 113.101 -173.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -102.6 3.56 37.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -172.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.1 t -116.18 136.21 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 124.916 1.287 . . . . 0.0 108.366 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.07 151.87 26.85 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 125.229 1.412 . . . . 0.0 110.63 -172.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.427 ' HB3' ' HB ' ' A' ' 76' ' ' THR . . . -95.53 15.38 19.92 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -164.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt 56.3 -167.8 0.11 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.438 1.095 . . . . 0.0 110.589 -163.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -149.65 167.79 25.4 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 120.922 -1.111 . . . . 0.0 110.645 -174.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.1 t 55.72 -154.59 0.3 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.3 p 24.45 68.24 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.257 2.623 . . . . 0.0 115.891 162.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.79 -26.23 5.41 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.874 1.67 . . . . 0.0 114.5 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.33 30.43 1.39 Allowed 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 123.308 0.38 . . . . 0.0 110.169 168.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.66 -19.71 5.24 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.687 1.137 . . . . 0.0 112.451 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.1 m -63.93 173.76 1.73 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.146 0.978 . . . . 0.0 110.42 169.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.81 148.59 38.68 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 163.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.7 p -90.68 165.81 13.5 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 159.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 54.46 31.02 13.9 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 127.274 2.23 . . . . 0.0 113.142 170.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.18 153.39 10.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 O-C-N 121.085 -1.009 . . . . 0.0 109.156 175.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.31 174.16 29.78 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 124.465 1.031 . . . . 0.0 110.66 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.406 HG11 ' CD2' ' A' ' 177' ' ' PHE . 44.2 t -83.92 151.91 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 173.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -128.79 163.43 25.22 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.144 0.884 . . . . 0.0 109.094 153.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.549 HG22 HD23 ' A' ' 111' ' ' LEU . 4.6 mp -121.01 141.81 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 128.19 2.596 . . . . 0.0 104.12 171.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mt -141.26 135.62 30.82 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.792 2.437 . . . . 0.0 105.455 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.64 -174.4 2.1 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.731 1.15 . . . . 0.0 108.376 169.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.1 ptt85 -58.33 -20.11 40.62 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.6 p -68.42 -10.63 56.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 124.298 1.039 . . . . 0.0 112.001 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.48 6.31 34.04 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 119.256 0.935 . . . . 0.0 112.291 -168.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.94 126.19 33.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.965 1.382 . . . . 0.0 107.314 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.83 151.08 42.18 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.865 0.364 . . . . 0.0 110.718 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.549 HD23 HG22 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -105.49 145.69 30.55 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.381 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.451 ' H ' HG21 ' A' ' 117' ' ' THR . 4.1 m -70.32 157.35 37.9 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.5 mt -104.91 63.71 0.71 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.615 1.566 . . . . 0.0 108.548 -172.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.1 -1.41 6.46 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.669 1.188 . . . . 0.0 113.064 -171.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.434 ' N ' ' HB2' ' A' ' 74' ' ' LEU . . . 86.32 -1.77 87.47 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.259 -1.301 . . . . 0.0 112.121 170.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -139.82 -28.01 0.76 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.852 1.326 . . . . 0.0 114.3 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.451 HG21 ' H ' ' A' ' 112' ' ' THR . 51.5 m -53.3 146.89 11.18 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.046 1.738 . . . . 0.0 110.638 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -116.73 141.74 47.82 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.015 -1.053 . . . . 0.0 109.065 -166.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.25 79.0 p -86.74 -124.78 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 123.3 0.64 . . . . 0.0 111.295 -170.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.52 21.7 6.03 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.183 1.393 . . . . 0.0 113.828 -169.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 56.91 171.66 0.04 OUTLIER 'General case' 0 N--CA 1.42 -1.931 1 C-N-CA 131.786 4.034 . . . . 0.0 114.307 173.368 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 m -149.9 134.42 17.48 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 158.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.8 m -88.58 126.28 35.2 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 169.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.788 ' H ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -86.76 179.86 6.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.211 -168.491 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.82 138.93 14.54 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 -171.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -57.48 94.65 0.02 OUTLIER 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.318 1.847 . . . . 0.0 108.567 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.56 -137.86 6.65 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -159.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.5 m -125.2 146.0 49.71 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.854 2.061 . . . . 0.0 107.197 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.44 154.46 22.98 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.553 1.141 . . . . 0.0 108.811 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.466 HG22 ' HB2' ' A' ' 55' ' ' ASN . 29.7 m -144.87 141.41 29.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.179 -165.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.2 mt -104.97 107.48 58.86 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 126.653 1.981 . . . . 0.0 106.149 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -85.65 103.1 0.74 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.502 2.801 . . . . 0.0 112.316 -175.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -81.27 174.66 11.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 122.897 1.332 . . . . 0.0 111.457 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -127.79 126.7 42.23 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 162.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -101.02 138.81 37.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 163.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -150.31 134.96 17.45 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -60.01 143.82 50.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -118.95 115.22 23.9 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -79.94 142.3 35.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.423 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 63.4 p -109.94 23.76 13.94 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.002 1.321 . . . . 0.0 110.095 176.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 148.78 -153.99 25.56 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 107.85 -2.1 . . . . 0.0 107.85 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.38 91.21 0.54 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.704 1.201 . . . . 0.0 109.497 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.43 124.96 21.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.767 0.827 . . . . 0.0 109.306 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.4 p -85.63 154.54 59.02 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -71.95 160.28 48.09 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 120.932 1.088 . . . . 0.0 110.449 169.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.72 -148.72 15.87 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -170.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -91.0 152.49 20.66 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 118.913 1.356 . . . . 0.0 109.036 163.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -136.24 66.14 1.5 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.424 0.69 . . . . 0.0 109.675 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -104.53 151.79 23.17 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 178.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.26 166.48 30.81 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.427 1.091 . . . . 0.0 108.101 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -148.72 140.73 23.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.054 0.93 . . . . 0.0 111.231 174.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.61 156.61 46.6 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.532 2.333 . . . . 0.0 109.283 -171.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.728 ' OG1' HD22 ' A' ' 74' ' ' LEU . 64.5 p -91.33 163.45 14.21 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 117.422 -1.711 . . . . 0.0 108.27 152.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.509 ' CD1' HG23 ' A' ' 175' ' ' VAL . 23.0 p90 -127.9 153.4 46.7 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 158.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -119.54 175.41 5.86 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.817 0.847 . . . . 0.0 110.541 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 4.4 t -138.4 99.62 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -84.25 100.04 10.95 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.595 1.958 . . . . 0.0 107.825 171.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.412 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 87.1 m-85 -73.52 139.46 45.69 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.398 1.094 . . . . 0.0 113.546 167.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.438 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 3.5 mt-30 -133.98 160.31 38.1 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 129.484 3.114 . . . . 0.0 111.041 -168.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 99.26 -44.01 1.75 Allowed Glycine 0 C--N 1.321 -0.254 0 CA-C-O 119.089 -0.84 . . . . 0.0 111.047 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -87.07 66.33 3.56 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 -172.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.71 -45.1 0.43 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -160.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.13 52.63 4.8 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.17 -58.17 5.01 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 124.37 0.986 . . . . 0.0 111.603 170.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.93 4.49 9.96 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.815 1.198 . . . . 0.0 114.458 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -141.73 139.79 32.96 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 127.887 2.475 . . . . 0.0 104.753 171.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -146.45 167.75 22.87 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.53 1.132 . . . . 0.0 109.38 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 19.6 m -138.4 81.65 1.86 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.238 0.615 . . . . 0.0 109.455 -165.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.1 m -83.06 95.3 8.01 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.156 1.382 . . . . 0.0 109.972 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.485 HG21 ' HB2' ' A' ' 19' ' ' ALA . 1.8 m -81.72 167.18 2.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 158.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -72.89 154.99 40.34 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.542 -0.723 . . . . 0.0 109.292 164.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.19 -25.57 2.94 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 124.128 0.87 . . . . 0.0 112.944 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 146.26 -163.51 28.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 117.784 0.792 . . . . 0.0 111.647 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.9 m -116.24 136.48 52.97 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.509 HG23 ' CD1' ' A' ' 154' ' ' PHE . 40.2 t -112.56 115.63 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 166.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 31' ' ' THR . 10.3 m-70 -97.07 113.13 24.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 175.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.406 ' CD2' HG11 ' A' ' 101' ' ' VAL . 81.7 m-85 -87.1 119.48 27.37 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 176.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -116.06 166.66 11.75 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 135.5 -173.13 21.88 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 106.264 -2.735 . . . . 0.0 106.264 -171.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.67 170.51 18.34 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -171.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.3 t -120.82 130.1 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 175.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 15.3 m -115.79 146.62 19.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 126.81 2.044 . . . . 0.0 109.046 -177.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -74.94 27.4 0.09 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -172.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.248 1.024 0 C-N-CA 128.269 2.628 . . . . 0.0 113.793 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.38 56.48 7.41 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.11 0.957 . . . . 0.0 109.0 -156.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.4 p -142.49 151.48 41.73 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.651 1.58 . . . . 0.0 107.078 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -58.57 155.74 11.86 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.223 1.409 . . . . 0.0 110.746 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.51 166.89 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 170.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -151.78 177.69 10.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.685 1.594 . . . . 0.0 107.065 171.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.28 18.94 56.5 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 119.292 -0.727 . . . . 0.0 113.375 170.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.33 178.45 45.17 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 108.841 -1.703 . . . . 0.0 108.841 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -76.98 9.49 2.92 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.236 1.014 . . . . 0.0 111.722 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 95.8 -172.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 131.175 3.79 . . . . 0.0 106.47 -149.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -157.25 113.16 2.89 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 173.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -98.28 -134.35 0.25 Allowed 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 127.453 2.301 . . . . 0.0 106.115 170.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.63 ' HB3' HG21 ' A' ' 17' ' ' VAL . 3.7 ptpt -169.36 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 128.551 2.74 . . . . 0.0 105.984 175.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.455 ' H ' ' HG3' ' A' ' 13' ' ' LYS . . . 137.08 -37.99 1.79 Allowed Glycine 0 C--N 1.319 -0.404 0 C-N-CA 126.747 2.118 . . . . 0.0 109.974 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -130.81 -169.85 2.24 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 125.172 1.389 . . . . 0.0 108.549 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.581 HG11 HG12 ' A' ' 170' ' ' VAL . 6.9 p -50.94 -31.38 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 126.236 1.814 . . . . 0.0 113.286 -172.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.63 HG21 ' HB3' ' A' ' 13' ' ' LYS . 27.2 m 36.11 34.68 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 127.916 2.487 . . . . 0.0 115.886 -177.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -131.96 94.74 3.54 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -175.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.58 108.64 4.76 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.24 -26.93 31.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 118.411 -0.804 . . . . 0.0 113.016 -169.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.402 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -130.41 153.91 48.26 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.794 1.638 . . . . 0.0 110.063 -179.474 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.7 93.96 6.27 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.997 2.519 . . . . 0.0 109.526 166.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.4 p -48.46 106.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 125.39 1.476 . . . . 0.0 109.313 158.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -69.23 166.24 18.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.355 1.462 . . . . 0.0 113.008 -161.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.32 -32.31 66.57 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.253 1.021 . . . . 0.0 112.253 171.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.88 7.97 47.08 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.617 1.103 . . . . 0.0 112.882 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.15 -44.67 1.58 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.993 1.717 . . . . 0.0 109.606 -170.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.38 -28.0 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 127.352 2.261 . . . . 0.0 113.693 -168.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -149.39 61.69 1.03 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.613 1.165 . . . . 0.0 108.007 -169.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -104.97 137.5 42.62 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.272 0.629 . . . . 0.0 109.85 -168.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.9 m -108.32 92.84 4.23 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.08 1.352 . . . . 0.0 108.045 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.2 t -78.7 108.34 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 126.328 1.851 . . . . 0.0 107.125 -171.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -91.61 122.82 34.52 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -98.91 -1.02 41.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 122.844 0.457 . . . . 0.0 110.412 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.6 -177.84 33.02 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 126.423 1.963 . . . . 0.0 111.273 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -70.29 138.1 51.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 122.187 -0.596 . . . . 0.0 109.628 158.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.8 t -128.41 146.41 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 124.372 1.069 . . . . 0.0 109.501 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 9.4 mmt180 -75.82 127.07 32.24 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 125.832 1.653 . . . . 0.0 107.34 -176.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 p -55.57 -29.03 58.3 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.204 0.602 . . . . 0.0 111.008 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.03 -39.86 72.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.453 1.101 . . . . 0.0 111.577 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 62.1 m -74.23 -0.8 18.04 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.0 mt -134.28 31.52 3.48 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 125.226 1.41 . . . . 0.0 111.827 -160.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.49 13.92 13.58 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -150.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -149.61 162.71 39.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 171.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -60.32 121.22 11.47 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 164.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.95 -8.58 57.79 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 118.812 -0.993 . . . . 0.0 113.691 -173.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -67.79 154.52 41.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.835 1.818 . . . . 0.0 110.644 174.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.5 p -147.97 157.25 43.42 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.884 0.766 . . . . 0.0 112.17 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.0 p -72.1 175.17 6.21 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.949 -1.094 . . . . 0.0 111.241 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.0 m -47.63 -27.46 1.89 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.611 1.964 . . . . 0.0 114.591 172.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 81.37 145.93 0.08 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 129.479 3.112 . . . . 0.0 111.06 167.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 m -141.8 130.65 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 C-N-CA 124.113 0.965 . . . . 0.0 109.415 -152.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.25 121.31 6.79 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -174.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 10.1 p90 -130.82 102.56 6.13 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 118.313 1.056 . . . . 0.0 108.279 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.453 ' HB2' HG22 ' A' ' 130' ' ' THR . 27.1 p30 -93.95 150.83 20.02 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.063 -1.023 . . . . 0.0 111.242 -170.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.0 mm -94.66 98.1 7.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -65.84 126.87 29.84 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' A' ' 21' ' ' CYS . 2.2 mp -133.68 123.06 24.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 129.742 3.217 . . . . 0.0 106.589 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -118.04 154.39 32.11 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.509 1.049 . . . . 0.0 113.434 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 t70 65.92 37.41 5.46 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.094 1.758 . . . . 0.0 114.104 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 97.9 m -68.97 104.36 2.07 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.012 1.325 . . . . 0.0 108.798 -174.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -81.87 137.17 35.28 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.174 0.99 . . . . 0.0 109.593 174.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.5 p -83.0 -17.87 41.86 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -65.44 -42.63 92.2 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.319 1.048 . . . . 0.0 110.364 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.411 HG12 ' H ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -68.02 -54.56 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 125.87 1.668 . . . . 0.0 106.705 -176.103 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.21 158.46 43.94 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.9 m -115.2 3.6 14.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.745 0.702 . . . . 0.0 111.804 168.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -128.87 149.39 50.79 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.277 1.431 . . . . 0.0 109.28 171.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 124' ' ' LEU . . . -117.63 153.13 33.82 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.412 1.085 . . . . 0.0 108.457 165.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.89 -178.18 5.14 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.825 1.65 . . . . 0.0 106.779 157.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -153.78 141.02 12.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 -164.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.23 152.65 51.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 119.957 1.253 . . . . 0.0 108.678 175.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -114.55 153.61 29.75 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.438 0.695 . . . . 0.0 110.081 -175.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 tp -148.3 143.07 26.67 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.614 1.166 . . . . 0.0 107.996 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.81 173.35 35.05 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 108.104 -1.998 . . . . 0.0 108.104 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 m -59.88 121.88 12.85 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.513 1.125 . . . . 0.0 110.359 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.8 138.44 52.69 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.425 0.557 . . . . 0.0 110.413 172.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.0 tt -64.35 -31.12 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.576 0.75 . . . . 0.0 110.937 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -160.71 168.64 24.43 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.639 1.576 . . . . 0.0 107.441 165.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.36 -36.24 66.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.629 1.172 . . . . 0.0 111.311 166.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.29 -2.91 64.07 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 120.792 -1.193 . . . . 0.0 112.998 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -149.93 55.47 0.94 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.298 1.439 . . . . 0.0 109.716 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.6 p -69.43 -6.84 32.88 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.44 1.096 . . . . 0.0 111.886 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -85.89 3.54 41.37 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.931 1.293 . . . . 0.0 112.655 170.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.65 143.04 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.934 1.243 . . . . 0.0 111.63 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.02 151.26 28.5 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.954 1.301 . . . . 0.0 111.237 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.12 14.72 10.13 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 127.477 2.311 . . . . 0.0 114.059 -169.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 71.5 mt 55.26 -157.65 0.22 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.167 1.387 . . . . 0.0 111.227 -166.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -165.24 -178.34 5.0 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.732 2.813 . . . . 0.0 107.748 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.6 t 71.73 160.34 0.22 Allowed 'General case' 0 C--O 1.227 -0.096 0 C-N-CA 128.735 2.814 . . . . 0.0 112.017 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.536 ' HB3' ' HA3' ' A' ' 94' ' ' GLY . 0.6 OUTLIER 41.53 35.5 0.47 Allowed 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 127.485 2.314 . . . . 0.0 113.291 -166.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.2 -70.35 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.067 1.747 . . . . 0.0 112.924 -150.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.11 20.91 2.1 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.723 1.609 . . . . 0.0 111.132 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.536 ' HA3' ' HB3' ' A' ' 91' ' ' SER . . . -71.29 -14.23 74.07 Favored Glycine 0 N--CA 1.467 0.703 0 O-C-N 121.226 -0.921 . . . . 0.0 112.567 176.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -31.6 161.31 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.383 1.873 . . . . 0.0 114.158 151.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.98 131.55 45.0 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.484 1.114 . . . . 0.0 109.697 174.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.4 p -85.39 169.42 13.7 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 58.5 14.65 3.11 Favored 'General case' 0 C--N 1.335 -0.04 0 C-N-CA 126.247 1.819 . . . . 0.0 112.712 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.26 156.68 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 119.927 1.24 . . . . 0.0 107.819 -174.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -165.14 168.16 39.12 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -168.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.674 HG11 ' CD2' ' A' ' 177' ' ' PHE . 9.9 t -90.56 112.66 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -82.06 153.84 25.93 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.363 0.983 . . . . 0.0 108.52 160.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 mp -125.54 136.33 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 166.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 110' ' ' ALA . 9.0 mt -136.54 143.93 43.96 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.645 1.178 . . . . 0.0 107.838 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.521 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 24.5 p-10 -54.06 -74.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.278 1.431 . . . . 0.0 113.204 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.0 ptt85 179.61 -47.45 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 127.781 2.432 . . . . 0.0 107.994 -163.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 p -68.04 -29.12 68.02 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.169 0.895 . . . . 0.0 109.784 172.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.76 9.96 27.59 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.815 1.198 . . . . 0.0 111.176 -169.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.69 110.67 0.93 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 163.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.463 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -84.89 125.88 33.01 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.589 ' H ' HD22 ' A' ' 111' ' ' LEU . 0.4 OUTLIER -88.75 150.22 23.06 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -167.237 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -82.31 146.61 29.33 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.344 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.6 mt -88.16 61.87 6.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.844 0.858 . . . . 0.0 108.87 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.26 -15.16 14.55 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.063 1.345 . . . . 0.0 112.27 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.18 -7.38 60.51 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 125.872 1.701 . . . . 0.0 114.476 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.46 -6.36 5.84 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.158 1.479 . . . . 0.0 112.877 172.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.9 m -65.15 94.41 0.15 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.692 1.133 . . . . 0.0 108.623 171.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -67.51 131.65 46.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.786 1.235 . . . . 0.0 109.14 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.8 p -72.19 168.29 18.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.135 0.493 . . . . 0.0 110.906 170.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 14.2 m -26.37 113.85 0.05 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.527 2.331 . . . . 0.0 112.569 155.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -66.45 155.11 38.44 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 122.248 1.023 . . . . 0.0 108.74 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 98.6 m -127.12 112.99 15.81 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 169.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.7 m -58.06 126.25 26.63 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 167.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 69' ' ' ALA . 80.8 mt -98.73 -177.88 3.8 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 124.745 1.218 . . . . 0.0 108.679 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -147.53 169.69 19.03 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.805 1.642 . . . . 0.0 108.327 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -65.22 104.49 0.93 Allowed 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.852 0.72 . . . . 0.0 109.551 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.08 -160.8 26.8 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 124.643 1.116 . . . . 0.0 111.3 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 93.3 m -90.53 134.08 34.62 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.31 -1.112 . . . . 0.0 108.828 -179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -146.2 154.56 41.89 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.152 1.381 . . . . 0.0 110.418 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 55' ' ' ASN . 6.1 m -137.49 144.23 42.12 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.928 0.871 . . . . 0.0 109.987 -174.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.9 mt -104.72 118.35 56.62 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -65.14 157.02 59.65 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.349 1.366 . . . . 0.0 108.646 171.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -136.52 157.14 47.47 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 153.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -119.76 94.67 4.48 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.581 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -79.11 156.2 28.4 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 167.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -161.93 153.76 18.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 166.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.422 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 60.7 m-85 -63.73 130.5 44.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 163.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -103.19 151.52 22.53 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 163.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -115.67 137.79 51.73 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.593 0.757 . . . . 0.0 109.736 173.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 69.5 p -96.86 14.06 26.57 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.976 0.91 . . . . 0.0 111.034 170.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 169.5 -153.89 22.68 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.49 93.08 0.47 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.259 1.024 . . . . 0.0 110.157 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.06 119.07 5.3 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 44.3 p -76.65 163.62 64.67 Favored Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 165.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -74.73 172.71 15.71 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.118 1.212 . . . . 0.0 111.007 168.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.69 179.72 16.29 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 124.756 1.169 . . . . 0.0 111.283 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.9 140.67 58.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.422 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -132.9 73.34 1.52 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -115.5 158.7 22.2 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -157.97 160.48 37.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.69 0.677 . . . . 0.0 109.413 175.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -133.38 116.21 15.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.34 1.067 . . . . 0.0 110.233 -170.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.01 164.69 19.62 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.416 1.486 . . . . 0.0 111.22 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.9 p -119.21 157.08 28.7 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 155.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -115.91 146.68 41.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.522 1.129 . . . . 0.0 109.195 167.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -104.57 171.28 7.42 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.041 1.737 . . . . 0.0 108.316 168.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.4 t -129.2 128.21 66.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -130.52 84.48 2.2 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.478 1.111 . . . . 0.0 109.54 -172.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -70.12 151.98 44.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.562 -1.199 . . . . 0.0 112.242 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -161.64 174.3 13.51 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.42 1.488 . . . . 0.0 111.849 169.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 148.03 -33.81 1.24 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 125.405 1.479 . . . . 0.0 110.136 174.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -94.89 99.16 2.39 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 166.39 165.52 23.9 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 118.223 1.011 . . . . 0.0 111.11 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -73.97 -22.41 78.01 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 124.468 1.032 . . . . 0.0 110.609 171.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 128.5 120.85 2.32 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 168.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 109.2 58.4 0.53 Allowed Glycine 0 CA--C 1.517 0.215 0 N-CA-C 106.815 -2.514 . . . . 0.0 106.815 -173.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -172.42 108.8 0.21 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.59 1.556 . . . . 0.0 107.975 -162.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -153.89 164.91 37.62 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.025 0.93 . . . . 0.0 109.106 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 40.4 m -122.14 90.75 3.36 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -176.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.5 m -82.37 120.53 25.55 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.581 HG12 HG11 ' A' ' 16' ' ' VAL . 31.6 m -130.47 158.32 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.812 1.645 . . . . 0.0 109.415 177.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -79.28 143.02 35.64 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.097 -1.002 . . . . 0.0 108.984 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -105.21 -73.0 0.88 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -175.75 -174.21 42.12 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.884 0.342 . . . . 0.0 113.01 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.4 m -100.87 141.8 33.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.912 2.085 . . . . 0.0 108.635 -177.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.65 104.42 12.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -96.14 96.98 9.19 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 -176.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.674 ' CD2' HG11 ' A' ' 101' ' ' VAL . 79.9 m-85 -73.19 127.09 31.63 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 176.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -128.68 156.57 43.25 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.552 0.741 . . . . 0.0 111.636 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 142.37 -160.07 27.22 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -163.72 169.2 18.76 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.833 0.853 . . . . 0.0 108.97 -175.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 75.3 t -116.79 124.51 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 171.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 6.3 m -103.58 153.33 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 127.026 2.13 . . . . 0.0 108.782 174.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.04 25.67 0.09 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -168.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.25 1.121 1 C-N-CA 132.117 4.167 . . . . 0.0 114.544 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.6 136.33 5.29 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.6 p -145.23 86.25 1.76 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.799 0.84 . . . . 0.0 109.363 -165.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.1 p -135.83 178.68 6.86 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.97 -1.081 . . . . 0.0 110.911 -174.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -53.77 148.73 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 126.272 1.829 . . . . 0.0 112.249 175.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -85.06 158.56 20.41 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.376 -0.828 . . . . 0.0 110.456 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 61.3 77.91 0.18 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 173.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.13 5.0 1.42 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-O 118.691 -1.061 . . . . 0.0 113.534 173.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -172.1 2.76 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 120.871 2.335 . . . . 0.0 111.151 -169.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.9 t -55.78 -32.99 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 C-N-CA 127.921 2.489 . . . . 0.0 109.987 -173.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 17.1 p-80 -163.87 19.49 0.07 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 147.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -85.29 -0.19 53.94 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.823 -1.173 . . . . 0.0 111.651 -156.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 mttm 45.04 49.59 9.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.828 1.651 . . . . 0.0 112.913 -172.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.51 -3.94 50.09 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.411 170.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -172.87 -164.57 0.26 Allowed 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.251 1.42 . . . . 0.0 109.707 -167.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.1 t -49.12 -35.96 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 128.814 2.846 . . . . 0.0 113.187 172.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 t 35.27 54.76 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 127.027 2.131 . . . . 0.0 112.371 -169.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -152.23 96.11 2.14 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 171.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -129.49 118.01 21.41 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 163.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.41 -28.65 30.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.286 1.034 . . . . 0.0 113.745 -170.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.9 m -131.19 151.93 50.98 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.502 1.921 . . . . 0.0 108.071 -171.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.32 -10.56 51.93 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -169.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.323 14.2 p 45.9 97.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 129.36 3.064 . . . . 0.0 112.911 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -50.58 141.08 13.08 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.575 1.95 . . . . 0.0 110.719 -172.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.665 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . . . -59.5 -9.94 2.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.295 1.838 . . . . 0.0 111.945 -176.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.64 -7.41 88.16 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.115 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.8 p -124.13 -33.05 3.15 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.692 1.746 . . . . 0.0 112.18 -164.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.665 ' CG2' ' HA ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -52.48 -78.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 127.84 2.456 . . . . 0.0 109.924 166.138 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.486 ' H ' HG23 ' A' ' 28' ' ' VAL . 10.5 t70 -95.53 83.1 3.73 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -114.15 142.53 46.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.286 1.041 . . . . 0.0 108.92 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.5 m -105.06 88.77 2.95 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.6 t -69.39 98.51 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 174.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -72.42 103.09 3.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.3 mt -70.58 -15.59 62.77 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.899 0.88 . . . . 0.0 109.329 169.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.83 -175.93 49.55 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 124.599 1.095 . . . . 0.0 112.138 170.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.49 143.6 56.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 162.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.8 t -133.59 148.83 30.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 124.96 1.304 . . . . 0.0 107.674 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 28.2 mtm105 -79.14 132.87 36.7 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 182' ' ' VAL . 20.4 p -55.14 -24.25 25.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.609 173.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.25 -48.44 68.23 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.649 0.779 . . . . 0.0 110.141 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.54 3.61 5.96 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.0 mt -146.22 66.18 1.19 Allowed 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.679 1.592 . . . . 0.0 107.446 -166.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.13 -2.25 3.19 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -170.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.467 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 7.0 pm0 -146.92 151.79 37.61 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.998 1.319 . . . . 0.0 107.751 -176.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.441 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 47.5 tt0 -64.38 120.77 12.87 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.2 1.45 61.04 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-O 117.364 -1.798 . . . . 0.0 112.481 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.626 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -66.53 163.54 18.42 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 120.055 1.928 . . . . 0.0 110.122 169.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.1 p -146.74 155.12 42.15 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 122.014 -0.429 . . . . 0.0 110.472 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 84.8 p -68.22 178.64 1.83 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 164.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.0 p -30.89 -92.59 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 129.697 3.199 . . . . 0.0 114.633 173.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 154.11 113.22 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 131.284 3.834 . . . . 0.0 105.46 -172.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.28 105.25 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -173.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.21 154.71 44.87 Favored Glycine 0 C--N 1.311 -0.843 0 CA-C-N 112.45 -2.159 . . . . 0.0 110.721 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -152.58 176.6 11.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.242 1.817 . . . . 0.0 107.172 171.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.431 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 0.5 OUTLIER -143.0 163.18 33.49 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 120.885 -1.134 . . . . 0.0 110.6 177.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.9 mm -117.79 108.06 23.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -81.22 103.72 11.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.806 0.842 . . . . 0.0 109.312 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.9 mp -99.23 93.03 5.73 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -84.48 167.6 16.24 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.202 1.401 . . . . 0.0 109.094 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.32 31.06 17.89 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.162 0.985 . . . . 0.0 110.853 173.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 80.3 m -69.3 148.24 50.01 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.982 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -120.23 152.42 37.76 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 163.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 p -94.58 -20.84 19.26 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.62 -43.62 84.23 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.96 0.886 . . . . 0.0 110.555 -177.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.9 p -56.2 -52.92 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.647 1.579 . . . . 0.0 108.027 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.63 133.61 4.91 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 128.083 2.553 . . . . 0.0 104.773 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.3 m -87.81 -5.13 58.77 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.846 0.748 . . . . 0.0 111.805 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -128.3 164.29 22.93 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.089 1.356 . . . . 0.0 109.853 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.63 160.72 34.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 164.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.65 168.28 20.18 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 158.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.3 t -122.15 142.77 37.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.84 162.26 19.42 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 169.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -134.99 149.11 50.14 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.077 0.951 . . . . 0.0 109.191 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 tp -143.67 151.53 40.21 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.632 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . 174.2 169.69 36.62 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.3 m -66.28 126.84 30.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.246 1.023 . . . . 0.0 109.157 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.14 137.06 50.75 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.996 -0.44 . . . . 0.0 110.637 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.0 tt -59.78 -40.25 82.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 123.354 0.662 . . . . 0.0 110.285 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -152.09 167.9 26.99 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 127.13 2.172 . . . . 0.0 107.765 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.28 -40.08 95.24 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.564 1.546 . . . . 0.0 112.117 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.98 3.9 48.96 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.268 -0.74 . . . . 0.0 112.234 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -142.89 41.1 1.54 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.053 1.426 . . . . 0.0 110.67 -172.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.3 p -67.68 -6.31 20.01 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.875 -1.141 . . . . 0.0 113.317 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.78 -16.39 59.48 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.612 -1.305 . . . . 0.0 111.811 166.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.48 129.61 74.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 120.478 -1.389 . . . . 0.0 108.62 -160.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.632 HD21 ' HA3' ' A' ' 75' ' ' GLY . 3.8 mt -77.15 149.83 35.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.87 0.759 . . . . 0.0 111.504 -172.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.42 22.0 3.12 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.829 1.652 . . . . 0.0 113.494 -173.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.636 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 53.6 mt 49.7 -146.44 0.38 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.827 0.851 . . . . 0.0 109.067 -170.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -153.41 177.79 10.51 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 126.042 1.737 . . . . 0.0 108.067 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.82 160.76 9.0 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.557 1.17 . . . . 0.0 112.561 176.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.7 m -169.06 158.77 8.74 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 128.938 2.895 . . . . 0.0 106.98 176.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.14 91.63 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.871 0.869 . . . . 0.0 111.509 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.53 12.76 4.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.833 1.253 . . . . 0.0 112.972 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 61.59 14.69 43.93 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.681 0.658 . . . . 0.0 114.294 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 59.4 m 52.74 175.04 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.281 2.233 . . . . 0.0 114.504 -171.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.77 113.66 3.16 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 125.281 1.432 . . . . 0.0 107.933 170.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.28 165.61 24.25 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.66 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 55.31 24.15 6.24 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.261 1.425 . . . . 0.0 113.162 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.2 p -145.0 151.6 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.24 175.43 27.54 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 173.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 177' ' ' PHE . 1.2 m -86.71 155.44 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 118.653 1.227 . . . . 0.0 108.384 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -124.52 147.01 48.66 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 170.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.511 HG22 HD23 ' A' ' 111' ' ' LEU . 3.8 mp -117.02 135.82 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 169.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 9.9 mt -126.41 159.48 33.17 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 128.408 2.683 . . . . 0.0 107.109 174.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -73.11 -106.37 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 123.956 0.785 . . . . 0.0 109.437 171.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -149.26 3.81 0.6 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.895 2.078 . . . . 0.0 110.624 -169.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.4 p -123.64 7.31 8.84 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.115 1.366 . . . . 0.0 109.493 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.09 1.89 90.19 Favored Glycine 0 C--N 1.342 0.861 0 C-N-CA 127.22 2.343 . . . . 0.0 114.27 -172.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.13 122.77 20.07 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 119.468 1.634 . . . . 0.0 107.917 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -87.29 147.4 25.54 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.034 0.533 . . . . 0.0 110.419 176.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.511 HD23 HG22 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -110.8 138.85 46.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.707 -173.283 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 m -69.62 147.31 50.85 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.73 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.9 mt -79.86 69.54 6.22 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.612 1.565 . . . . 0.0 108.303 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.51 -13.87 13.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.51 0.724 . . . . 0.0 111.242 174.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.437 ' O ' ' HE3' ' A' ' 155' ' ' LYS . . . 75.09 -9.03 13.27 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 120.626 -1.296 . . . . 0.0 113.278 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.54 -12.91 7.17 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.145 1.378 . . . . 0.0 111.272 174.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 92.3 m -76.77 90.91 3.46 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -72.71 172.84 9.96 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.322 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.3 p -120.7 -176.12 3.18 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.668 1.587 . . . . 0.0 110.036 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -33.46 111.52 0.11 Allowed 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 126.082 1.753 . . . . 0.0 111.328 169.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.99 155.8 38.7 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.5 m -151.72 114.95 4.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.7 m -58.52 133.2 55.6 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.528 1.931 . . . . 0.0 108.344 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.5 mt -86.57 178.54 7.04 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.302 1.441 . . . . 0.0 108.831 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -135.45 170.3 16.16 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.62 1.968 . . . . 0.0 107.067 156.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.73 128.2 35.0 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 166.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 61' ' ' CYS . . . 99.09 -168.24 22.09 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -171.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 90.6 m -83.33 139.91 32.76 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 120.776 -1.426 . . . . 0.0 111.806 -166.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -139.34 168.22 20.32 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 128.678 2.791 . . . . 0.0 109.37 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 85.0 m -155.47 158.9 39.29 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 120.347 -1.47 . . . . 0.0 110.369 176.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.4 mt -131.93 112.79 14.83 Favored Pre-proline 0 C--O 1.24 0.603 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.72 150.0 38.94 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.598 1.532 . . . . 0.0 108.348 170.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -128.4 165.74 20.05 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.534 1.934 . . . . 0.0 108.59 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -133.26 113.28 12.46 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 121.453 -0.78 . . . . 0.0 108.909 172.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -94.83 170.36 9.5 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.819 0.819 . . . . 0.0 109.263 173.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -160.68 179.55 8.46 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.036 1.334 . . . . 0.0 108.909 167.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -91.45 149.41 21.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 153.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -122.5 124.84 44.5 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.835 2.054 . . . . 0.0 106.365 173.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.626 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -88.92 145.73 25.35 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.441 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 54.1 p -108.58 10.36 27.13 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 125.525 1.53 . . . . 0.0 111.168 176.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 161.65 -151.69 21.94 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.38 91.44 0.26 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.548 1.939 . . . . 0.0 109.935 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.19 157.06 20.18 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.022 0.439 . . . . 0.0 110.942 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 77.0 p -112.06 158.16 37.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 170.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -78.65 162.01 27.48 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.025 1.817 . . . . 0.0 110.636 165.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.39 -76.12 0.18 Allowed Glycine 0 N--CA 1.462 0.373 0 O-C-N 121.391 -0.818 . . . . 0.0 113.922 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -158.93 155.42 27.63 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.339 1.856 . . . . 0.0 106.874 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.98 91.04 1.74 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -125.73 135.44 52.07 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -146.19 167.19 24.07 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 165.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.49 111.05 6.78 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 167.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.82 169.87 17.56 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 162.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.8 p -116.2 151.98 34.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 153.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -114.71 132.12 56.53 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.201 0.601 . . . . 0.0 109.502 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.437 ' HE3' ' O ' ' A' ' 115' ' ' GLY . 29.2 mtmt -97.28 171.2 8.58 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.97 0.908 . . . . 0.0 109.199 167.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.1 t -133.1 118.63 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 -172.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -105.55 83.64 1.97 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -62.2 150.78 37.93 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.775 0.83 . . . . 0.0 108.936 168.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -167.94 169.84 11.04 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 123.289 0.636 . . . . 0.0 110.779 -174.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 151.22 -79.74 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -24.43 -75.32 0.01 OUTLIER Glycine 0 CA--C 1.527 0.809 0 C-N-CA 129.515 3.436 . . . . 0.0 115.045 -168.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -68.83 157.43 53.28 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 122.48 1.044 . . . . 0.0 113.041 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -91.6 57.53 3.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 125.563 1.554 . . . . 0.0 110.437 -167.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.45 85.52 1.81 Allowed Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 115.69 58.16 0.34 Allowed Glycine 0 C--N 1.329 0.173 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 167.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -146.54 111.82 5.47 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.863 1.265 . . . . 0.0 108.961 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -154.81 160.05 41.01 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.893 0.877 . . . . 0.0 110.903 -177.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.6 m -133.14 119.47 19.98 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.343 2.257 . . . . 0.0 106.799 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 m -114.52 123.9 50.54 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.469 1.108 . . . . 0.0 109.152 -169.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.2 m -143.49 150.91 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 123.975 0.91 . . . . 0.0 110.988 -168.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.07 132.25 48.1 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.627 1.571 . . . . 0.0 109.274 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -101.36 -78.54 1.34 Allowed Glycine 0 CA--C 1.519 0.344 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -173.95 -170.54 37.44 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.905 0.764 . . . . 0.0 111.772 -170.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 28.3 m -114.15 120.83 41.84 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.736 1.614 . . . . 0.0 110.989 -170.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.5 t -104.94 96.9 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -80.81 94.82 6.51 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.421 ' CD2' HG21 ' A' ' 101' ' ' VAL . 58.9 m-85 -76.91 85.49 3.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -93.86 165.7 12.55 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.623 0.769 . . . . 0.0 109.518 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 147.7 -161.96 28.62 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -170.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -170.25 174.77 5.18 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 75.4 t -123.19 138.28 53.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 171.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 39' ' ' THR . 6.8 m -116.61 149.22 18.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 126.008 1.723 . . . . 0.0 109.08 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -76.77 33.08 0.14 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -171.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 C-N-CA 128.454 2.702 . . . . 0.0 112.019 175.217 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.479 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -49.29 -34.92 16.56 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 126.587 1.955 . . . . 0.0 111.189 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.8 m -125.76 146.51 49.74 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 127.376 2.27 . . . . 0.0 107.649 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.93 1.81 55.31 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -163.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.307 13.7 p 49.54 113.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 129.81 3.244 . . . . 0.0 114.275 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -53.0 141.78 21.41 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.423 1.089 . . . . 0.0 110.736 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.493 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -51.08 -39.12 55.31 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.768 1.227 . . . . 0.0 109.643 171.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.19 13.84 1.84 Allowed Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.799 -1.0 . . . . 0.0 114.522 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 t -144.63 -36.69 0.31 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.665 1.586 . . . . 0.0 111.515 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 25' ' ' ALA . 10.6 p -58.08 -49.87 80.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.424 0 CA-C-N 119.698 1.135 . . . . 0.0 109.095 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -121.94 75.52 1.22 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -171.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -105.68 138.21 42.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.388 -169.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 m -106.87 99.93 9.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.5 t -86.33 101.22 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -92.12 98.42 11.53 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -174.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.5 mt -75.94 -7.28 54.2 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.304 2.242 . . . . 0.0 109.883 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.54 -172.64 27.3 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 124.108 0.861 . . . . 0.0 111.734 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -77.67 142.39 38.85 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.943 0.878 . . . . 0.0 110.915 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.7 t -124.01 150.77 28.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 125.538 1.535 . . . . 0.0 108.095 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.92 137.66 32.98 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.0 p -60.39 -21.79 62.59 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 122.931 0.492 . . . . 0.0 112.253 171.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.47 -48.78 47.48 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-O 122.439 1.114 . . . . 0.0 111.312 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.2 m -79.19 5.87 11.1 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.221 1.008 . . . . 0.0 113.448 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.567 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 13.7 mt -142.65 72.08 1.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.696 1.998 . . . . 0.0 107.114 -170.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.72 -7.19 1.68 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -171.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.889 HE21 ' HB2' ' A' ' 47' ' ' ALA . 2.5 pm0 -145.51 162.82 36.49 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.651 1.18 . . . . 0.0 108.056 174.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -62.65 117.84 6.82 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 173.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.444 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 106.6 -10.33 41.84 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-O 118.305 -1.275 . . . . 0.0 112.471 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.889 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -64.34 147.69 52.0 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.809 1.305 . . . . 0.0 109.432 171.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.1 p -143.72 155.62 44.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.528 0.68 . . . . 0.0 111.736 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.4 p -66.7 -177.69 0.62 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.388 0.675 . . . . 0.0 110.56 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -59.56 -22.32 61.56 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 119.56 -1.962 . . . . 0.0 113.397 171.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 74.07 164.83 0.28 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 127.335 2.254 . . . . 0.0 110.782 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.2 t -149.2 142.63 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.17 125.3 8.3 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -115.6 158.52 22.56 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 170.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.512 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 2.7 m-20 -131.14 173.9 10.57 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.085 0.857 . . . . 0.0 110.808 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.9 mm -121.57 109.84 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.602 1.161 . . . . 0.0 107.935 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.36 109.38 17.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.539 1.936 . . . . 0.0 109.5 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.66 106.61 17.22 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 127.218 2.207 . . . . 0.0 108.507 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -87.05 158.55 19.19 Favored 'General case' 0 CA--C 1.523 -0.085 0 C-N-CA 124.539 1.135 . . . . 0.0 110.667 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 32.98 57.75 0.45 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.269 2.628 . . . . 0.0 113.145 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.9 m -64.36 142.3 58.47 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 125.705 1.602 . . . . 0.0 110.602 168.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -120.32 132.48 55.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 127.305 2.242 . . . . 0.0 108.73 171.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.7 p -92.74 -9.43 40.67 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -67.32 -47.66 69.86 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.036 0.834 . . . . 0.0 109.871 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.479 HG11 ' HA ' ' A' ' 20' ' ' ALA . 3.6 p -65.14 -49.1 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.237 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.67 114.04 2.6 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.44 1.896 . . . . 0.0 108.294 -170.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.8 m -76.75 -2.24 32.09 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.711 169.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -137.6 164.69 28.16 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.986 1.721 . . . . 0.0 112.03 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.96 140.35 26.84 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.64 166.09 13.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.537 1.935 . . . . 0.0 106.292 163.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 t -125.71 157.89 34.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.57 167.64 19.67 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 164.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -130.82 155.86 45.98 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.549 1.54 . . . . 0.0 109.94 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 tp -150.79 134.04 16.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.909 0.484 . . . . 0.0 111.192 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.6 172.67 42.53 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.124 0.869 . . . . 0.0 111.325 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 2.3 m -55.39 125.79 22.35 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.494 1.117 . . . . 0.0 108.347 171.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.55 139.83 44.02 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.424 1.011 . . . . 0.0 108.666 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.1 tt -57.06 -39.39 66.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.032 0.533 . . . . 0.0 111.112 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -160.59 177.75 10.2 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.672 1.589 . . . . 0.0 108.025 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.93 -37.77 79.1 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.396 0.678 . . . . 0.0 111.549 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.06 5.26 55.01 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.622 0.63 . . . . 0.0 111.966 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -146.91 50.47 1.11 Allowed 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.146 -1.208 . . . . 0.0 110.1 -171.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.5 p -67.03 -8.87 33.37 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.355 1.462 . . . . 0.0 111.749 171.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -81.77 -11.92 58.79 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 167.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.8 t -125.83 136.3 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 121.308 1.867 . . . . 0.0 109.964 -161.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.85 156.01 30.66 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 118.923 0.783 . . . . 0.0 111.737 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.435 ' HB3' ' HB ' ' A' ' 76' ' ' THR . . . -94.58 19.3 10.02 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.485 1.514 . . . . 0.0 113.866 -171.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.3 mt 55.19 -156.87 0.23 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.943 0.897 . . . . 0.0 109.902 -165.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.239 0.536 0 C-N-CA 125.733 1.613 . . . . 0.0 108.659 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.447 -0.617 0 CA-C-O 122.501 1.143 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.19 153.97 24.61 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.611 -0.681 . . . . 0.0 109.292 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.0 p -115.85 164.69 14.03 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.906 0.882 . . . . 0.0 109.194 170.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 57.05 20.82 5.76 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.928 1.691 . . . . 0.0 111.889 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -138.4 152.04 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.46 177.94 28.22 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.427 HG21 ' CD2' ' A' ' 177' ' ' PHE . 0.7 OUTLIER -90.48 155.05 3.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -126.45 167.52 15.47 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 120.744 -1.223 . . . . 0.0 110.558 158.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.12 130.59 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 127.428 2.291 . . . . 0.0 105.33 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.0 mt -122.19 140.81 52.14 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -62.68 171.55 2.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 122.216 1.008 . . . . 0.0 110.252 164.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -53.22 -25.82 15.45 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.462 1.505 . . . . 0.0 113.966 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.1 p -75.13 -23.76 57.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 119.677 1.126 . . . . 0.0 108.974 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.72 6.44 40.61 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.504 2.002 . . . . 0.0 112.708 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.52 131.33 34.39 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.247 1.524 . . . . 0.0 109.31 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.88 120.0 14.96 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.903 1.281 . . . . 0.0 111.701 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.0 mt -78.76 157.42 28.49 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.341 0.656 . . . . 0.0 109.756 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 m -100.69 144.97 29.03 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.426 1.09 . . . . 0.0 109.545 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.5 mt -89.22 70.79 8.29 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.454 1.102 . . . . 0.0 108.743 -173.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.55 -9.84 11.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.301 0.64 . . . . 0.0 112.316 174.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.02 -9.56 31.39 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.743 -1.032 . . . . 0.0 112.871 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.33 -8.34 5.82 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.087 1.355 . . . . 0.0 113.083 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.0 m -67.16 91.48 0.23 Allowed 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 168.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -64.89 164.2 12.96 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.795 0.838 . . . . 0.0 109.609 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 57.9 p -133.58 -175.93 3.98 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.662 1.185 . . . . 0.0 110.888 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -32.36 112.89 0.12 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 128.105 2.562 . . . . 0.0 112.431 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -73.26 108.58 6.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 88.4 m -81.95 113.3 19.76 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 167.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 93.8 m -57.95 121.0 9.52 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 160.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 99.0 mt -77.16 -170.06 1.57 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.393 1.477 . . . . 0.0 109.694 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.433 ' H ' HD21 ' A' ' 129' ' ' ASN . 0.6 OUTLIER -151.64 161.46 42.64 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 127.167 2.187 . . . . 0.0 107.593 168.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -64.49 140.19 58.84 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 170.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.25 -111.22 4.12 Favored Glycine 0 N--CA 1.467 0.704 0 CA-C-O 118.148 -1.362 . . . . 0.0 111.54 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 m -125.33 139.88 53.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.322 2.061 . . . . 0.0 110.488 -171.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.433 HD21 ' H ' ' A' ' 125' ' ' ASN . 12.1 m-80 -142.32 151.97 42.48 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 124.313 1.045 . . . . 0.0 109.959 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.512 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 97.1 m -132.72 124.22 27.74 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.017 0.527 . . . . 0.0 109.902 170.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.0 116.02 64.12 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 166.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.98 155.99 34.15 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.895 1.73 . . . . 0.0 110.51 166.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -139.1 172.69 12.47 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 127.743 2.417 . . . . 0.0 108.263 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.99 155.97 34.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 162.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -137.6 149.35 46.57 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.705 1.202 . . . . 0.0 108.014 171.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -161.04 153.68 20.73 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.404 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 77.3 m-85 -70.02 133.32 47.11 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 174.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.444 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 60.8 t80 -113.11 124.82 53.47 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.384 1.474 . . . . 0.0 107.85 176.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.43 141.65 29.81 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 170.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.4 p -105.48 11.19 32.83 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.862 0.465 . . . . 0.0 111.258 172.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.22 -153.8 23.63 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.54 93.65 0.05 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.94 1.696 . . . . 0.0 109.893 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -70.82 170.01 13.43 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 122.976 0.511 . . . . 0.0 111.443 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.8 p -136.49 159.19 71.51 Favored Pre-proline 0 N--CA 1.467 0.386 0 C-N-CA 123.441 0.696 . . . . 0.0 110.528 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -75.12 177.08 9.08 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.63 1.554 . . . . 0.0 110.434 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.01 -95.84 0.17 Allowed Glycine 0 CA--C 1.522 0.494 0 O-C-N 121.606 -0.684 . . . . 0.0 111.695 168.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.03 157.36 45.43 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.884 1.674 . . . . 0.0 107.189 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.404 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -146.51 66.41 1.18 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.592 0.71 . . . . 0.0 110.612 -176.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -108.45 150.95 26.71 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.28 163.03 40.27 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.616 1.566 . . . . 0.0 109.161 170.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -138.95 96.35 3.11 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.27 167.66 20.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.492 166.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.2 p -106.88 164.84 11.78 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 147.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -122.35 157.38 31.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 168.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -117.49 166.66 12.1 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.609 1.564 . . . . 0.0 108.595 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 8.5 t -127.86 106.65 15.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.455 HE21 ' NE2' ' A' ' 159' ' ' GLN . 40.8 tt0 -88.1 92.64 9.22 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 167.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 73.5 m-85 -63.42 153.97 33.57 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 163.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.455 ' NE2' HE21 ' A' ' 157' ' ' GLN . 11.9 pt20 -160.84 170.46 20.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.208 0.603 . . . . 0.0 110.662 168.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.419 0 CA-C-O 118.251 -1.305 . . . . 0.0 111.784 177.672 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.632 0 CA-C-O 120.472 0.177 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 87.2 m -142.61 108.49 5.16 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.59 1.956 . . . . 0.0 107.647 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 15.5 m -97.0 94.04 6.95 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.789 0.836 . . . . 0.0 110.15 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -85.32 168.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 124.121 0.968 . . . . 0.0 110.018 168.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -63.62 174.97 1.18 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.056 0.542 . . . . 0.0 109.688 160.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -144.64 -34.17 0.08 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-O 117.817 -1.546 . . . . 0.0 114.416 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 147.58 -176.8 26.25 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 119.412 1.606 . . . . 0.0 112.67 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.1 m -101.34 140.05 36.16 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.291 1.836 . . . . 0.0 108.908 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.56 96.48 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -83.42 88.49 6.98 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.427 ' CD2' HG21 ' A' ' 101' ' ' VAL . 58.8 m-85 -66.19 113.06 4.26 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 170.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -120.42 161.6 20.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 135.88 -174.19 21.49 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -170.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -161.51 172.14 16.92 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -168.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 39.2 t -124.93 133.45 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.4 m -112.61 148.19 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 C-N-CA 127.113 2.165 . . . . 0.0 108.365 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.77 31.23 0.09 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.686 2.395 . . . . 0.0 112.429 -170.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 127.856 2.463 . . . . 0.0 110.028 -165.488 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.547 ' HB1' ' CE2' ' A' ' 158' ' ' TYR . . . . . . . . 0 C--O 1.234 0.278 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.7 -18.04 61.05 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -172.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.0 m -133.77 160.04 38.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.15 109.45 19.91 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.621 1.568 . . . . 0.0 107.867 161.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -50.15 125.86 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 152.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.68 151.77 40.93 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.713 0.688 . . . . 0.0 109.698 174.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.75 -29.26 53.3 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 120.952 -1.092 . . . . 0.0 112.396 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.38 -50.48 66.36 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 123.91 0.767 . . . . 0.0 111.26 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.0 m -72.03 -27.05 62.45 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.899 0.88 . . . . 0.0 111.286 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.1 t -60.74 -25.87 36.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.368 1.067 . . . . 0.0 113.035 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -145.48 30.63 1.11 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.691 1.196 . . . . 0.0 111.488 -166.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -77.87 133.27 38.17 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 120.828 -1.17 . . . . 0.0 108.663 -162.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 176' ' ' HIS . 4.4 m -100.88 103.05 14.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.3 t -82.8 95.72 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -176.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -77.82 95.51 4.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -71.43 -12.31 61.34 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.983 1.313 . . . . 0.0 111.162 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.18 -177.89 31.37 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.325 0.964 . . . . 0.0 112.431 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -67.84 121.01 15.09 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.206 1.403 . . . . 0.0 109.748 168.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.5 t -99.82 149.26 5.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 126.063 1.745 . . . . 0.0 106.961 171.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -82.93 133.85 35.1 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.9 p -58.77 -19.37 40.14 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.817 0.847 . . . . 0.0 111.048 170.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.91 -50.09 61.77 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 120.746 -1.221 . . . . 0.0 109.336 170.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.437 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 66.4 m -73.12 -2.31 20.95 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.554 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 13.5 mt -141.23 79.19 1.68 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.403 1.481 . . . . 0.0 107.366 -171.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.31 -0.27 1.27 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.668 HE21 ' HB2' ' A' ' 47' ' ' ALA . 2.9 pm0 -148.69 159.42 44.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.439 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 35.6 tt0 -62.21 118.17 7.04 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.11 6.55 66.66 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 126.347 1.927 . . . . 0.0 112.885 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.668 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -57.84 149.02 23.48 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 148.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.37 153.57 42.1 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -178.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.9 p -70.3 171.78 9.34 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.366 -0.834 . . . . 0.0 109.065 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -47.5 -66.78 0.35 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -173.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 154.19 136.71 0.0 OUTLIER 'General case' 0 C--O 1.233 0.224 0 C-N-CA 128.199 2.6 . . . . 0.0 106.74 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.6 t -137.7 138.38 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 173.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.64 127.4 9.21 Favored Glycine 0 CA--C 1.516 0.148 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -132.47 87.95 2.48 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 123.307 1.527 . . . . 0.0 109.263 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.513 ' HB2' HG22 ' A' ' 130' ' ' THR . 6.7 p30 -81.13 160.77 24.33 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 120.626 -1.297 . . . . 0.0 111.487 -173.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 130' ' ' THR . 4.2 mm -112.03 108.71 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 175.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -76.31 110.82 11.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.69 1.996 . . . . 0.0 109.113 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.56 108.6 18.16 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.474 1.51 . . . . 0.0 107.173 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.0 168.46 10.94 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.489 1.116 . . . . 0.0 109.832 171.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t70 51.46 36.26 16.3 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.828 2.451 . . . . 0.0 116.76 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.9 m -69.89 85.62 0.5 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.626 1.97 . . . . 0.0 114.736 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -72.98 111.8 8.42 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.454 -0.778 . . . . 0.0 112.375 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.6 p -62.5 -12.86 24.8 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.374 1.07 . . . . 0.0 112.234 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -66.37 -38.35 87.36 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.359 0.981 . . . . 0.0 110.272 173.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.55 -58.15 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.37 143.83 19.19 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.186 1.394 . . . . 0.0 107.743 -172.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.2 p -88.19 -12.79 42.84 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.66 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -140.82 156.15 46.21 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 127.125 2.17 . . . . 0.0 107.797 -166.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.56 85.94 1.2 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -173.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.11 173.52 11.2 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 123.642 0.777 . . . . 0.0 109.293 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.405 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -148.14 107.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -170.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.71 163.8 13.21 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 124.037 0.935 . . . . 0.0 108.922 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CE2' HG21 ' A' ' 103' ' ' ILE . 6.7 m-85 -135.36 148.61 49.47 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.758 0.823 . . . . 0.0 109.652 -168.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.426 HD13 ' C ' ' A' ' 114' ' ' ASP . 13.2 tp -146.91 132.71 18.97 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.122 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.27 175.53 39.55 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 172.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.5 m -60.2 134.04 56.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.67 1.188 . . . . 0.0 108.79 172.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.81 132.06 35.18 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.207 1.003 . . . . 0.0 109.003 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.7 tt -60.5 -34.26 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 122.83 0.452 . . . . 0.0 110.609 -178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -153.25 164.74 37.55 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 126.382 1.873 . . . . 0.0 109.623 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.72 -31.04 46.62 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.113 2.565 . . . . 0.0 115.061 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.97 -40.18 6.28 Favored Glycine 0 CA--C 1.518 0.274 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 174.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -86.71 43.59 1.09 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.435 1.494 . . . . 0.0 110.51 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.6 p -63.81 -12.88 39.64 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.816 1.646 . . . . 0.0 112.232 173.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -82.13 -9.44 59.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.517 -0.739 . . . . 0.0 112.629 171.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 t -127.98 137.24 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 119.726 1.148 . . . . 0.0 109.855 -165.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.95 149.17 29.48 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.306 1.442 . . . . 0.0 110.743 -168.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.71 14.02 22.54 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -162.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.8 mt 51.54 -169.21 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.509 1.124 . . . . 0.0 110.41 -162.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 . . . . . 0 CA--C 1.514 -0.418 0 C-N-CA 126.364 1.866 . . . . 0.0 108.292 -177.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.443 -0.784 0 CA-C-O 122.35 1.071 . . . . 0.0 108.345 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.42 145.25 33.41 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.008 -1.451 . . . . 0.0 107.562 162.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 p -118.24 160.87 20.84 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 124.628 1.171 . . . . 0.0 109.156 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 59.83 27.04 16.3 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.511 0.725 . . . . 0.0 110.635 -173.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.404 HG21 HD13 ' A' ' 42' ' ' LEU . 2.0 p -143.74 145.45 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 121.215 -0.928 . . . . 0.0 108.667 170.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.88 174.12 23.74 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.411 HG11 ' CG ' ' A' ' 177' ' ' PHE . 99.3 t -86.45 147.2 5.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -129.99 140.81 50.83 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.333 1.053 . . . . 0.0 108.575 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.504 HG22 HD12 ' A' ' 111' ' ' LEU . 5.3 mp -108.3 134.99 48.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 110' ' ' ALA . 9.8 mt -134.11 132.77 40.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.959 1.704 . . . . 0.0 107.673 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.424 ' CB ' ' HB2' ' A' ' 120' ' ' SER . 1.5 t70 -73.11 -170.85 0.81 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.724 1.147 . . . . 0.0 112.046 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -48.63 -37.15 17.47 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.757 1.623 . . . . 0.0 111.854 167.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 p -77.83 -5.84 52.17 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.512 1.925 . . . . 0.0 112.484 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 57.25 25.12 53.8 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.755 1.169 . . . . 0.0 112.975 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.27 138.78 32.74 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.423 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -72.71 154.21 40.81 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.231 0.469 . . . . 0.0 111.704 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.504 HD12 HG22 ' A' ' 103' ' ' ILE . 90.3 mt -127.22 119.92 27.51 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.238 1.015 . . . . 0.0 110.487 -167.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.9 m -74.11 156.93 36.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.822 0.849 . . . . 0.0 111.578 -171.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.7 mt -99.3 71.57 1.8 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.889 1.676 . . . . 0.0 108.151 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.426 ' C ' HD13 ' A' ' 74' ' ' LEU . 79.2 m-20 -120.71 -20.94 6.85 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.317 0.647 . . . . 0.0 111.016 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.35 -22.53 8.49 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.488 1.518 . . . . 0.0 113.092 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.55 -40.78 9.68 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 119.091 1.446 . . . . 0.0 110.638 168.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 38.3 m -55.96 99.74 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.71 2.004 . . . . 0.0 110.595 -174.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -71.11 173.71 7.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.183 1.393 . . . . 0.0 111.396 -173.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 59.7 p -115.51 -160.74 0.76 Allowed 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.593 1.157 . . . . 0.0 111.834 -170.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.424 ' HB2' ' CB ' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -65.7 147.37 53.5 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.596 0.758 . . . . 0.0 109.027 172.103 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -89.71 141.41 28.64 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 120.659 -1.275 . . . . 0.0 107.983 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.1 m -121.29 110.31 15.98 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 128.537 2.735 . . . . 0.0 104.163 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.5 m -68.53 117.05 9.78 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.169 1.387 . . . . 0.0 107.808 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.9 mt -64.69 173.69 2.11 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.999 1.72 . . . . 0.0 111.369 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.617 ' H ' HD21 ' A' ' 129' ' ' ASN . 0.7 OUTLIER -132.39 159.12 40.18 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 127.676 2.39 . . . . 0.0 107.058 156.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -58.31 129.58 42.7 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.02 -140.55 15.67 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -172.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.5 m -107.51 142.7 36.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.886 1.343 . . . . 0.0 109.826 -172.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.617 HD21 ' H ' ' A' ' 125' ' ' ASN . 12.8 m-80 -143.18 173.53 11.5 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 127.923 2.489 . . . . 0.0 108.532 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 55' ' ' ASN . 86.3 m -157.15 141.25 16.27 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.357 -1.465 . . . . 0.0 109.955 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.27 116.04 65.78 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.593 1.557 . . . . 0.0 107.361 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -86.25 78.27 2.18 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 124.121 3.214 . . . . 0.0 112.171 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.405 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 97.5 m-85 -66.22 162.72 19.34 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.393 -0.817 . . . . 0.0 111.216 171.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -115.42 141.26 48.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.345 154.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -101.55 145.32 29.18 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 126.299 1.839 . . . . 0.0 108.462 160.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -149.61 152.56 35.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 159.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.417 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 69.9 m-85 -70.03 151.23 45.78 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 163.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -129.16 116.11 18.71 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.921 2.488 . . . . 0.0 106.626 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.73 146.72 29.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.439 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 29.3 p -114.27 7.0 16.35 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.095 0.958 . . . . 0.0 112.068 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 168.79 -150.41 15.78 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.5 94.59 0.03 OUTLIER 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.621 1.169 . . . . 0.0 108.756 170.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -79.42 128.98 34.03 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.221 1.008 . . . . 0.0 108.734 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.3 p -90.84 171.58 8.04 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.151 1.38 . . . . 0.0 109.855 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -88.13 172.92 5.05 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.172 1.915 . . . . 0.0 110.371 166.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.96 -95.23 0.14 Allowed Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -144.1 155.7 44.06 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 127.718 2.407 . . . . 0.0 107.574 174.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.417 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -143.44 92.14 2.33 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.548 1.166 . . . . 0.0 108.238 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -126.15 145.32 50.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.32 153.18 34.31 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.535 1.534 . . . . 0.0 107.41 169.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.43 98.14 4.6 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.87 1.268 . . . . 0.0 110.521 176.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.81 163.49 23.41 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.665 171.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.2 p -99.8 161.98 13.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 147.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -122.96 153.62 39.5 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 162.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -113.71 168.21 9.97 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.534 1.934 . . . . 0.0 107.954 172.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.494 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 18.4 t -121.67 134.73 64.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.476 HE21 ' NE2' ' A' ' 159' ' ' GLN . 28.0 tt0 -122.09 87.55 2.77 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.547 ' CE2' ' HB1' ' A' ' 19' ' ' ALA . 84.4 m-85 -57.11 149.69 18.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.188 166.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.476 ' NE2' HE21 ' A' ' 157' ' ' GLN . 4.6 pt20 -165.6 164.11 19.24 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.408 1.483 . . . . 0.0 109.59 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.529 0 CA-C-O 117.855 -1.525 . . . . 0.0 113.419 173.853 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.444 0 CA-C-O 121.169 0.509 . . . . 0.0 111.853 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.0 m -134.23 95.58 3.44 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.113 1.765 . . . . 0.0 107.366 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.2 m -76.93 133.59 39.18 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 168.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 13.1 m -149.06 171.44 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 127.013 2.125 . . . . 0.0 109.097 -175.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -68.11 170.67 8.09 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.416 1.007 . . . . 0.0 109.682 172.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -135.89 -52.21 0.07 OUTLIER Glycine 0 CA--C 1.522 0.524 0 C-N-CA 124.341 0.972 . . . . 0.0 111.063 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 161.08 -162.14 33.44 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 118.043 0.922 . . . . 0.0 111.352 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.7 m -127.15 112.95 15.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.988 2.115 . . . . 0.0 107.247 -166.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 7.7 t -105.16 106.72 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . 0.432 ' HB2' HG23 ' A' ' 31' ' ' THR . 28.9 m-70 -96.75 87.76 4.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -169.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.411 ' CG ' HG11 ' A' ' 101' ' ' VAL . 73.5 m-85 -68.37 113.07 5.62 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -120.07 166.33 13.54 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.035 -1.041 . . . . 0.0 108.261 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 143.82 -161.57 27.78 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -170.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -165.82 172.44 11.67 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.59 135.47 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 166.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' A' ' 184' ' ' ALA . 3.3 m -117.84 151.65 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 127.637 2.375 . . . . 0.0 107.677 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -74.03 24.59 0.08 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.781 1.632 . . . . 0.0 113.5 -169.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.246 0.91 0 C-N-CA 131.402 3.881 . . . . 0.0 112.565 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.747 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.48 -20.65 64.78 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -160.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.3 m -123.22 160.57 26.29 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 127.895 2.478 . . . . 0.0 107.792 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.8 -20.27 27.82 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -167.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.261 8.6 t 54.81 124.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 130.143 3.377 . . . . 0.0 111.509 -163.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -77.65 164.63 25.14 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.138 1.775 . . . . 0.0 110.676 -174.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.04 -39.98 60.41 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.623 -1.298 . . . . 0.0 110.598 164.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.38 2.71 36.1 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.962 1.744 . . . . 0.0 113.979 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 63.4 p -141.73 -9.85 0.92 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 119.886 1.843 . . . . 0.0 113.488 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.0 p -72.09 -65.42 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 119.15 0.886 . . . . 0.0 110.612 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -126.32 46.08 2.52 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.202 -0.936 . . . . 0.0 108.499 -160.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -82.91 144.47 30.02 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.543 1.137 . . . . 0.0 109.81 -163.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.71 154.52 27.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 164.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.9 t -131.28 96.97 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 165.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.85 94.87 3.96 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.831 HD23 ' CG1' ' A' ' 52' ' ' VAL . 2.1 mt -68.46 -10.08 53.01 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.555 1.942 . . . . 0.0 110.224 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.5 -177.9 32.55 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 124.945 1.26 . . . . 0.0 111.304 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -69.35 138.68 53.92 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 122.067 -0.666 . . . . 0.0 109.373 167.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -121.01 147.64 24.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 125.582 1.553 . . . . 0.0 106.926 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -83.39 131.93 35.02 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.0 p -59.1 -23.03 61.74 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 118.904 0.775 . . . . 0.0 110.397 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.89 -27.45 66.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.064 1.346 . . . . 0.0 112.134 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.3 m -80.21 -15.4 57.09 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.035 -0.984 . . . . 0.0 113.076 173.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.458 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . 29.1 mt -134.11 75.86 1.62 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.708 2.003 . . . . 0.0 109.336 -164.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.91 -4.05 7.0 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -167.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.874 HE21 ' HB2' ' A' ' 47' ' ' ALA . 2.7 pm0 -152.7 163.38 39.78 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 124.425 1.09 . . . . 0.0 109.284 -175.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -64.83 127.34 31.15 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.39 -1.19 75.97 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-O 118.511 -1.161 . . . . 0.0 111.762 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.874 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -64.59 146.29 54.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 119.807 1.803 . . . . 0.0 109.769 168.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.8 p -138.09 151.29 47.67 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.112 0.414 . . . . 0.0 110.744 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.7 p -75.57 -169.91 1.14 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -45.11 -92.38 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.98 75.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 129.607 3.163 . . . . 0.0 107.259 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.831 ' CG1' HD23 ' A' ' 34' ' ' LEU . 1.6 p -73.66 148.57 8.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 169.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.85 155.72 19.83 Favored Glycine 0 CA--C 1.51 -0.262 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -147.71 1.59 0.69 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -171.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.42 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 2.8 m-20 36.92 -169.95 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 130.963 3.705 . . . . 0.0 114.281 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 mm -133.29 106.36 9.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 159.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -65.99 113.38 4.39 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 171.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.86 149.13 23.23 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -148.69 153.43 38.23 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.1 2.16 . . . . 0.0 108.609 -165.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 30.18 54.25 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 129.263 3.025 . . . . 0.0 114.825 -169.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.8 m -69.64 138.34 52.96 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.328 2.251 . . . . 0.0 111.3 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -113.96 119.76 38.33 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.147 1.379 . . . . 0.0 109.294 166.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.5 p -71.81 -17.66 62.14 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -59.65 -44.89 93.37 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 124.101 0.96 . . . . 0.0 109.939 175.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.4 t -61.42 -61.59 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.04 120.42 4.56 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.395 1.478 . . . . 0.0 109.061 -174.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.9 m -76.24 -6.94 53.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.864 0.865 . . . . 0.0 111.135 169.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -130.72 159.02 38.51 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 120.155 -1.591 . . . . 0.0 110.368 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.75 159.56 41.98 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 160.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.55 167.83 18.72 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.804 2.042 . . . . 0.0 106.258 161.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.0 t -119.95 148.82 22.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.64 159.45 26.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.427 ' CE1' HG21 ' A' ' 103' ' ' ILE . 20.7 m-85 -133.49 155.53 49.4 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.901 1.68 . . . . 0.0 108.548 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.404 HD13 ' C ' ' A' ' 114' ' ' ASP . 7.4 tp -141.46 161.55 37.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.787 0.435 . . . . 0.0 110.095 173.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.424 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -178.16 179.82 48.38 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 173.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 3.3 m -64.9 135.83 56.16 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 164.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.17 141.83 41.74 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.079 0.854 . . . . 0.0 109.322 171.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.6 tt -60.77 -36.12 69.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 122.998 0.519 . . . . 0.0 111.036 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -160.87 171.2 19.18 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.207 1.803 . . . . 0.0 107.343 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.1 -28.14 68.59 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.753 0.821 . . . . 0.0 111.341 165.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.64 -19.13 72.74 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 119.109 -0.829 . . . . 0.0 112.224 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -147.2 57.93 1.15 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.15 1.475 . . . . 0.0 110.619 -164.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.3 p -63.09 -14.74 52.06 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 128.297 2.639 . . . . 0.0 113.313 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -84.96 -3.26 58.68 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 170.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.2 t -123.21 138.37 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 119.897 1.226 . . . . 0.0 109.446 -170.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.424 HD21 ' HA3' ' A' ' 75' ' ' GLY . 0.9 OUTLIER -76.08 150.04 37.34 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.641 1.176 . . . . 0.0 110.787 -178.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB3' ' HB ' ' A' ' 76' ' ' THR . . . -95.19 14.99 20.32 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -167.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.9 mt 54.36 -161.27 0.14 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.482 1.113 . . . . 0.0 111.665 -167.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 . . . . . 0 C--O 1.235 0.303 0 C-N-CA 125.311 1.444 . . . . 0.0 110.869 -178.493 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.44 -0.94 0 CA-C-O 122.622 1.201 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.23 120.57 8.9 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 159.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.4 p -85.26 166.45 16.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 57.58 24.54 10.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.576 1.151 . . . . 0.0 111.499 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.413 HG21 HD13 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -148.36 154.5 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 119.304 0.956 . . . . 0.0 109.655 -178.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.33 -179.06 27.62 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 125.644 1.592 . . . . 0.0 110.322 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.45 HG11 ' CG ' ' A' ' 177' ' ' PHE . 73.5 t -91.89 152.93 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.404 HE22 ' HB1' ' A' ' 110' ' ' ALA . 1.7 mt-30 -132.1 167.97 18.79 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.218 -0.926 . . . . 0.0 110.247 161.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.427 HG21 ' CE1' ' A' ' 73' ' ' PHE . 4.8 mp -128.23 142.67 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 127.506 2.322 . . . . 0.0 105.559 174.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 110' ' ' ALA . 35.1 mt -129.33 146.41 51.22 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 126.282 1.833 . . . . 0.0 107.53 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.96 -72.25 0.14 Allowed 'General case' 0 C--O 1.221 -0.431 0 O-C-N 124.309 1.005 . . . . 0.0 111.873 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 108' ' ' GLY . 15.8 ptt180 -167.84 -35.23 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.044 1.338 . . . . 0.0 111.553 172.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 107' ' ' THR . 1.7 t -66.77 11.1 0.1 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.622 2.369 . . . . 0.0 111.063 167.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.426 ' HA2' HD13 ' A' ' 104' ' ' LEU . . . 61.99 12.31 35.73 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.239 1.4 . . . . 0.0 114.68 -171.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.71 110.76 1.6 Allowed 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.246 1.419 . . . . 0.0 108.781 175.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.54 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -63.03 118.57 8.03 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.902 1.281 . . . . 0.0 109.572 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 mt -79.16 155.93 28.46 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 m -86.67 170.36 11.87 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 169.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.8 85.96 2.41 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 171.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.404 ' C ' HD13 ' A' ' 74' ' ' LEU . 8.2 t70 -111.32 -17.05 13.24 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 165.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.89 -0.06 73.47 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.342 0.972 . . . . 0.0 112.512 -168.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -128.35 -32.84 2.18 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.525 1.53 . . . . 0.0 111.419 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.2 m -57.26 112.07 1.27 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.133 0.973 . . . . 0.0 108.566 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -79.39 146.78 32.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.9 p -74.69 -150.46 0.03 OUTLIER 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.503 1.121 . . . . 0.0 109.869 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.35 156.85 38.65 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 120.995 -1.066 . . . . 0.0 109.107 163.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -76.94 157.42 31.31 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 122.666 1.222 . . . . 0.0 108.274 166.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.9 m -133.57 122.75 23.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 164.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.1 m -65.49 120.92 13.74 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 167.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.3 mt -78.94 -168.24 1.39 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.171 2.188 . . . . 0.0 107.915 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.511 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 5.7 p-10 -153.63 160.06 42.29 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.782 0.833 . . . . 0.0 108.941 164.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -65.56 107.68 1.79 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 127.22 -102.45 0.61 Allowed Glycine 0 C--O 1.225 -0.414 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 -172.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 m -137.36 147.64 45.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.444 1.122 . . . . 0.0 109.204 -167.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.511 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 0.4 OUTLIER -168.45 161.05 11.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.552 1.541 . . . . 0.0 107.117 -175.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.42 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 96.8 m -149.54 151.48 33.95 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -175.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.5 mt -115.53 121.68 34.14 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.28 67.26 7.56 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.232 2.621 . . . . 0.0 113.206 -168.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -65.92 145.07 56.36 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -114.67 148.66 37.9 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.922 168.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -123.39 156.1 36.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 166.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.508 ' NH1' HD21 ' A' ' 104' ' ' LEU . 5.7 ptt-85 -157.37 167.92 28.86 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 169.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.469 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 96.2 m-85 -80.16 147.77 31.19 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 167.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -116.42 117.91 31.23 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 127.053 2.141 . . . . 0.0 106.103 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -87.01 139.74 30.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 53.6 p -102.09 13.68 34.04 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.646 1.179 . . . . 0.0 110.277 172.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.73 -154.21 24.9 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 107.756 -2.138 . . . . 0.0 107.756 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.71 95.66 0.9 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.477 1.111 . . . . 0.0 109.555 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.72 121.4 10.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.624 0.769 . . . . 0.0 109.179 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 63.8 p -74.78 161.82 76.12 Favored Pre-proline 0 C--O 1.235 0.323 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -68.71 173.49 9.93 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 120.861 1.041 . . . . 0.0 110.412 159.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.03 -109.95 0.42 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 173.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -138.94 152.93 48.11 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 128.064 2.546 . . . . 0.0 105.904 174.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.469 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -145.31 75.78 1.45 Allowed 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.934 1.243 . . . . 0.0 111.553 -175.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -118.1 157.47 26.81 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.97 164.96 36.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.488 1.515 . . . . 0.0 108.607 172.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -131.59 113.0 13.1 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -91.12 169.8 10.55 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.416 1.087 . . . . 0.0 109.79 170.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.3 p -115.41 156.22 25.98 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 152.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -120.52 152.41 38.09 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -122.36 169.7 10.68 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.861 1.664 . . . . 0.0 108.37 170.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.562 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 61.1 t -126.09 132.18 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -107.78 89.77 3.1 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 166.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.562 ' CZ ' HG11 ' A' ' 156' ' ' VAL . 85.5 m-85 -62.04 145.35 53.41 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 163.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -164.36 169.77 16.96 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.678 0.791 . . . . 0.0 111.287 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.284 0 N-CA-C 107.696 -2.162 . . . . 0.0 107.696 -173.091 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 120.739 0.304 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 60.6 m -150.29 103.11 3.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.639 1.976 . . . . 0.0 107.141 -173.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.2 m -101.48 109.22 21.0 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 125.595 1.558 . . . . 0.0 109.616 -170.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 19.6 m -137.29 149.52 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.955 1.302 . . . . 0.0 109.708 -160.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.97 163.03 20.67 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.244 0.929 . . . . 0.0 111.906 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -121.94 -80.87 0.57 Allowed Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -174.29 -153.9 10.35 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -165.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.0 m -128.31 105.97 8.7 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.277 1.831 . . . . 0.0 110.327 -161.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.421 HG21 ' CE2' ' A' ' 73' ' ' PHE . 3.8 t -94.08 106.9 18.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -90.17 101.08 13.8 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -175.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.45 ' CG ' HG11 ' A' ' 101' ' ' VAL . 70.5 m-85 -82.55 121.5 26.87 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -126.74 159.4 33.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.6 -163.68 27.87 Favored Glycine 0 CA--C 1.518 0.269 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -166.26 166.24 16.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 81.8 t -113.86 125.46 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 172.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.9 m -106.27 152.32 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 126.265 1.826 . . . . 0.0 108.823 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -75.13 24.78 0.1 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -169.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 C-N-CA 129.103 2.961 . . . . 0.0 111.839 -175.127 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.415 ' HB2' HG11 ' A' ' 170' ' ' VAL . . . . . . . . 0 C--O 1.218 -0.599 0 CA-C-O 119.058 -0.496 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 43.67 -50.63 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.28 1 C-N-CA 134.45 5.1 . . . . 0.0 115.48 -167.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 1.6 m -104.51 174.24 5.96 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.262 2.225 . . . . 0.0 110.977 172.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.6 102.82 12.04 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 127.634 2.374 . . . . 0.0 108.065 172.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.05 130.85 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -67.41 153.75 42.96 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -55.12 -32.31 61.95 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.908 -1.12 . . . . 0.0 110.486 165.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.84 4.65 4.1 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 118.606 -1.108 . . . . 0.0 114.705 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.3 m -143.38 -19.57 0.62 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 120.609 2.204 . . . . 0.0 114.535 175.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 25' ' ' ALA . 8.4 p -60.57 -39.72 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 119.384 0.993 . . . . 0.0 111.292 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -136.23 67.1 1.47 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -167.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.89 140.15 44.18 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.577 -164.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.2 m -109.89 100.19 9.2 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.25 102.22 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -84.77 93.15 8.4 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -69.57 -16.44 63.41 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.903 1.681 . . . . 0.0 109.059 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.84 -168.63 43.56 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.434 1.016 . . . . 0.0 111.15 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -73.63 152.27 40.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.358 1.063 . . . . 0.0 109.798 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.46 147.25 28.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 125.208 1.403 . . . . 0.0 108.109 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -82.68 131.37 35.21 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -57.12 -27.59 61.95 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 122.74 0.416 . . . . 0.0 111.266 170.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.71 -35.3 65.95 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.535 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.2 m -77.14 -1.53 29.75 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.5 mt -143.71 74.08 1.42 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.726 1.61 . . . . 0.0 108.043 -163.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.22 -6.47 4.85 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -170.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.664 HE21 ' HB2' ' A' ' 47' ' ' ALA . 2.6 pm0 -151.94 163.81 38.47 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 126.292 1.837 . . . . 0.0 107.408 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.401 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 16.2 tt0 -61.43 136.21 57.95 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 122.071 0.939 . . . . 0.0 108.735 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.471 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 82.93 -3.58 83.39 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-O 118.095 -1.391 . . . . 0.0 111.27 175.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.664 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -58.17 151.29 19.41 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.478 1.139 . . . . 0.0 109.46 158.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 p -143.37 154.44 43.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.577 0.703 . . . . 0.0 109.702 -174.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.5 t -65.27 175.84 1.55 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 166.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -38.38 -81.52 0.01 OUTLIER 'General case' 0 C--N 1.339 0.12 0 C-N-CA 127.622 2.369 . . . . 0.0 110.375 167.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.57 158.48 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 129.733 3.213 . . . . 0.0 106.146 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.7 t -145.03 152.06 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 168.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.47 144.13 16.6 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 106.339 -2.704 . . . . 0.0 106.339 167.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -141.01 157.72 44.93 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -141.53 168.81 18.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 119.886 1.221 . . . . 0.0 113.241 -172.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 mm -111.41 92.63 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.32 118.68 13.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.884 1.673 . . . . 0.0 108.011 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.4 mt -118.8 132.18 56.12 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.829 1.251 . . . . 0.0 109.947 -175.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -116.49 164.68 14.21 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.365 1.466 . . . . 0.0 108.863 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.3 t0 53.66 31.72 13.23 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.742 2.017 . . . . 0.0 113.384 163.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 2.7 t -75.05 153.58 38.34 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.467 -1.396 . . . . 0.0 113.096 -170.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.639 ' HB3' HG23 ' A' ' 65' ' ' VAL . 14.2 t0 -126.38 125.9 42.99 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.978 1.311 . . . . 0.0 110.742 176.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 p -73.75 -17.1 61.15 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.059 0.543 . . . . 0.0 110.955 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -58.87 -45.75 89.43 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.899 1.28 . . . . 0.0 110.001 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.639 HG23 ' HB3' ' A' ' 62' ' ' ASP . 4.1 t -72.57 -46.11 56.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -175.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -165.85 130.91 2.38 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.162 1.385 . . . . 0.0 109.253 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 m -73.83 -23.19 59.61 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -120.79 166.09 14.23 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 126.154 1.782 . . . . 0.0 110.205 -173.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.83 151.64 51.55 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 157.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.77 170.79 10.68 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 144.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.408 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -134.36 159.74 41.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -172.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.55 167.07 23.04 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -125.33 154.9 41.1 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.642 0.777 . . . . 0.0 109.101 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.2 tp -150.01 124.26 9.51 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.918 0.887 . . . . 0.0 108.998 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.15 -178.98 42.75 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.674 1.131 . . . . 0.0 110.824 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m -70.37 133.68 47.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.399 1.48 . . . . 0.0 110.174 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.84 141.13 47.98 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 121.296 -0.878 . . . . 0.0 111.156 169.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 tt -63.01 -37.58 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 123.554 0.742 . . . . 0.0 110.961 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -159.83 165.78 31.63 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.752 2.021 . . . . 0.0 107.279 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.22 69.5 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 125.536 1.534 . . . . 0.0 112.318 169.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.54 -3.38 90.1 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-O 118.691 -1.061 . . . . 0.0 113.277 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -145.78 50.09 1.2 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.211 1.506 . . . . 0.0 109.614 -172.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.0 p -64.51 -17.41 63.87 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.978 1.311 . . . . 0.0 114.38 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -75.75 -25.78 56.82 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.92 173.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.27 137.84 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.396 1.478 . . . . 0.0 110.23 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.82 146.19 32.39 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.221 1.008 . . . . 0.0 111.79 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.36 18.17 6.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.353 1.861 . . . . 0.0 114.226 -167.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 73.4 mt 51.48 -156.12 0.14 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.797 1.239 . . . . 0.0 110.762 -169.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 . . . . . 0 CA--C 1.537 0.446 0 C-N-CA 128.622 2.769 . . . . 0.0 107.827 177.971 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 121.173 0.511 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.96 142.33 3.56 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.144 1.378 . . . . 0.0 111.079 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.8 p -94.93 163.42 13.33 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 169.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 56.07 23.75 7.16 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.451 1.501 . . . . 0.0 112.425 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -144.23 155.02 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.19 -168.06 14.04 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.483 HG11 ' CG ' ' A' ' 177' ' ' PHE . 95.5 t -101.42 136.94 30.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 169.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -115.12 158.73 21.78 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 164.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.495 HG22 HD12 ' A' ' 111' ' ' LEU . 2.7 mp -133.48 123.57 46.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.512 1.925 . . . . 0.0 106.768 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 110' ' ' ALA . 10.9 mt -114.41 153.47 29.83 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 174.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.419 ' CB ' ' HB2' ' A' ' 120' ' ' SER . 7.9 t70 -85.76 -107.82 0.05 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.438 0.563 . . . . 0.0 110.325 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.79 -45.78 4.69 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 129.618 3.167 . . . . 0.0 109.528 168.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.8 p -78.38 -0.17 28.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.052 0.541 . . . . 0.0 112.078 -166.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.77 14.15 57.68 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.055 1.312 . . . . 0.0 112.684 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.7 142.35 55.05 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 159.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.559 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -95.82 135.64 37.28 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.495 HD12 HG22 ' A' ' 103' ' ' ILE . 74.3 mt -105.82 120.51 41.9 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.653 -0.655 . . . . 0.0 110.702 -157.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.6 m -73.31 160.1 32.37 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.858 0.837 . . . . 0.0 110.725 -173.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.1 mt -109.38 40.64 1.81 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.243 1.417 . . . . 0.0 111.794 -160.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -106.76 0.28 24.03 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.32 -0.863 . . . . 0.0 112.593 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.26 -17.77 31.64 Favored Glycine 0 CA--C 1.519 0.335 0 O-C-N 120.423 -1.423 . . . . 0.0 114.196 166.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -115.1 -6.7 12.49 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.313 1.056 . . . . 0.0 112.899 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.2 m -68.94 99.4 1.06 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 168.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -61.19 130.09 44.53 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.484 171.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.8 m -83.55 -158.31 0.29 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 127.19 2.196 . . . . 0.0 109.962 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.419 ' HB2' ' CB ' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -73.45 129.62 38.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.973 0.892 . . . . 0.0 108.942 -170.262 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -84.57 115.17 22.47 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -166.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m -96.66 110.14 22.64 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.0 m -61.83 130.34 45.26 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 163.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 51.5 mt -96.33 -149.26 0.31 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 126.184 1.794 . . . . 0.0 108.255 -170.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -150.34 173.79 13.6 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.616 1.566 . . . . 0.0 107.974 164.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.57 115.24 12.72 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 159.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 119.0 -150.46 17.94 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.631 1.11 . . . . 0.0 111.631 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.6 m -75.27 135.27 40.95 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.326 1.45 . . . . 0.0 110.766 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.62 168.97 25.76 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.528 1.531 . . . . 0.0 108.514 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 95.0 m -152.24 149.81 29.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.556 0.742 . . . . 0.0 109.291 -176.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.75 106.97 57.06 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.479 1.112 . . . . 0.0 108.356 163.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.65 117.37 3.66 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 124.319 3.346 . . . . 0.0 111.552 171.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.408 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 91.2 m-85 -93.08 170.43 9.66 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.037 1.735 . . . . 0.0 110.849 168.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -134.71 113.83 12.07 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.917 2.087 . . . . 0.0 107.287 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -104.34 133.88 48.5 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 128.553 2.741 . . . . 0.0 109.239 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 136' ' ' ARG . 10.1 ptt-85 -145.15 143.36 30.31 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 170.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.437 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 71.6 m-85 -70.46 116.46 10.81 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 162.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.471 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 3.0 t80 -101.62 130.54 47.97 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.71 144.84 26.92 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.401 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 30.3 p -98.7 7.0 46.6 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.273 1.029 . . . . 0.0 112.158 167.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 160.26 -152.64 23.46 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.89 89.3 0.05 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.892 1.277 . . . . 0.0 111.329 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.04 141.64 49.29 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.934 0.893 . . . . 0.0 110.999 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.5 p -112.36 152.99 44.95 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 119.161 -0.447 . . . . 0.0 110.241 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -76.86 162.4 32.36 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.402 1.401 . . . . 0.0 110.081 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 156.42 -133.08 3.51 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.903 1.239 . . . . 0.0 110.397 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.11 152.13 18.99 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.29 1.045 . . . . 0.0 108.234 169.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.437 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -136.96 82.28 1.93 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.664 0.745 . . . . 0.0 109.133 168.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -121.06 152.12 39.01 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -145.32 175.55 10.22 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -138.78 115.21 10.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 171.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -108.63 156.64 19.31 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 167.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 p -99.4 158.91 15.4 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 149.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -117.91 147.93 42.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 165.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -120.19 167.7 11.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.278 1.431 . . . . 0.0 107.645 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.94 106.38 3.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -169.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -95.14 87.94 5.04 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.148 1.379 . . . . 0.0 108.995 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -68.58 149.11 49.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.655 1.182 . . . . 0.0 110.704 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -172.82 174.9 3.48 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.135 1.774 . . . . 0.0 109.092 -173.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.171 0 N-CA-C 107.835 -2.106 . . . . 0.0 107.835 -177.777 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.818 0 CA-C-O 121.215 0.531 . . . . 0.0 109.972 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 21.2 m -135.78 101.94 4.92 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.1 m -79.11 104.82 10.0 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 162.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -90.14 156.76 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.44 161.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -65.25 129.04 38.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 153.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -85.29 -61.47 1.73 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 166.93 -157.53 30.05 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 89.8 m -116.89 135.75 53.48 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.952 1.701 . . . . 0.0 109.29 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.7 t -114.35 107.67 23.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 122.306 1.05 . . . . 0.0 108.344 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -88.36 91.31 8.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.483 ' CG ' HG11 ' A' ' 101' ' ' VAL . 73.0 m-85 -71.2 115.2 10.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -123.27 159.49 28.64 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 124.369 1.068 . . . . 0.0 109.149 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 145.95 -166.2 27.98 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 106.491 -2.644 . . . . 0.0 106.491 -173.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.56 176.23 10.62 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.3 130.15 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 171.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.405 ' C ' ' H ' ' A' ' 184' ' ' ALA . 4.2 m -105.66 152.29 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 127.393 2.277 . . . . 0.0 108.536 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.21 24.9 0.08 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.837 1.255 . . . . 0.0 114.065 -170.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.257 1.463 1 C-N-CA 133.424 4.689 . . . . 0.0 113.374 -176.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.413 ' HA ' ' HE2' ' A' ' 158' ' ' TYR . . . . . . . . 0 N--CA 1.457 -0.089 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.432 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -39.96 -39.22 0.81 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 128.168 2.587 . . . . 0.0 112.93 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.3 m -111.34 142.42 43.6 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.04 -8.96 13.44 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -168.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.2 t 45.95 102.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.29 0 C-N-CA 130.233 3.413 . . . . 0.0 109.265 -162.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -58.97 154.02 16.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.761 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.26 -31.16 65.28 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.812 0.733 . . . . 0.0 110.823 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.55 -11.9 60.61 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.987 -0.896 . . . . 0.0 114.249 176.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.6 m -105.86 -36.49 6.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.864 1.332 . . . . 0.0 109.921 172.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.3 t -52.02 -39.69 26.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 123.878 0.871 . . . . 0.0 110.127 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.93 77.21 1.59 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.959 0.885 . . . . 0.0 110.909 -173.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.25 138.28 49.17 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.907 -170.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.4 m -115.13 84.56 2.1 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.407 2.283 . . . . 0.0 110.026 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.4 t -67.93 112.43 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -87.37 97.29 10.72 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.44 HD23 HG11 ' A' ' 52' ' ' VAL . 6.2 mt -70.97 -3.18 18.09 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.722 2.009 . . . . 0.0 109.003 172.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.73 -176.63 35.67 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 124.541 1.067 . . . . 0.0 111.979 169.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -68.67 148.98 49.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.471 0.653 . . . . 0.0 109.569 164.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.7 t -136.16 144.97 31.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 125.536 1.534 . . . . 0.0 107.356 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.08 133.69 34.63 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.4 p -57.62 -25.02 59.49 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.004 0.522 . . . . 0.0 110.663 173.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.45 69.92 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.865 1.266 . . . . 0.0 112.65 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.8 m -76.37 -11.0 59.82 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 173.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.46 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . 37.1 mt -139.12 74.37 1.47 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.92 2.088 . . . . 0.0 109.209 -157.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.22 10.65 4.15 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.177 -0.952 . . . . 0.0 112.901 -169.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.466 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 4.8 pm0 -154.91 158.41 39.25 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 124.885 1.274 . . . . 0.0 108.824 -174.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -61.29 132.39 53.44 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 166.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.73 5.68 87.87 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-O 118.194 -1.337 . . . . 0.0 112.464 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -63.65 153.36 36.27 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.652 1.726 . . . . 0.0 109.27 163.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.8 p -141.45 155.43 45.86 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.9 t -68.39 178.05 2.13 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.345 1.058 . . . . 0.0 109.039 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.8 m -44.71 -86.14 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.915 2.486 . . . . 0.0 113.155 171.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 157.69 134.85 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 127.416 2.286 . . . . 0.0 107.239 -171.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.44 HG11 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -146.36 104.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -177.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.92 135.14 30.08 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 112.746 -2.025 . . . . 0.0 109.16 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -143.96 80.64 1.66 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.442 ' HB2' HG22 ' A' ' 130' ' ' THR . 27.7 p30 -77.79 141.56 39.16 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.284 -0.885 . . . . 0.0 110.027 -177.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 130' ' ' THR . 7.0 mm -81.09 102.62 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 -174.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -65.34 101.71 0.6 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.4 mt -91.19 161.0 15.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 161.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.47 ' HA ' HG23 ' A' ' 128' ' ' THR . 86.3 m-20 -131.49 160.37 35.39 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 167.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 t70 45.21 54.51 7.11 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 127.109 2.164 . . . . 0.0 113.418 175.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.7 m -68.62 103.35 1.69 Allowed 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.848 -0.532 . . . . 0.0 110.361 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -66.04 149.46 50.22 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 161.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 p -110.13 -15.84 13.92 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.049 0.94 . . . . 0.0 112.724 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -60.24 -46.65 89.05 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 122.361 1.077 . . . . 0.0 109.297 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 66' ' ' ALA . 5.9 p -60.2 -52.75 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 125.69 1.596 . . . . 0.0 108.55 177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 158' ' ' TYR . . . -167.24 135.73 2.62 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.37 1.468 . . . . 0.0 108.363 171.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.0 m -77.87 -12.49 59.98 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.32 -0.848 . . . . 0.0 113.074 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -117.3 152.38 35.01 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 120.232 1.378 . . . . 0.0 109.841 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.91 138.9 51.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 169.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.66 -176.68 3.52 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 123.266 1.508 . . . . 0.0 107.367 150.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.415 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -153.49 160.3 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 131.678 3.991 . . . . 0.0 103.773 -162.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.85 171.57 13.89 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 165.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.413 ' CD1' HG21 ' A' ' 103' ' ' ILE . 23.0 m-85 -129.72 152.41 49.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.458 HD22 ' HA3' ' A' ' 115' ' ' GLY . 14.4 tp -152.87 126.8 8.99 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -176.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.83 169.8 42.69 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.3 m -60.27 128.11 35.1 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.075 0.95 . . . . 0.0 110.669 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.99 135.99 46.59 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.76 -0.587 . . . . 0.0 110.431 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.2 tt -60.6 -33.66 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.783 0.833 . . . . 0.0 110.333 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -160.0 168.14 26.31 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 164.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.63 -31.85 66.66 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.942 1.297 . . . . 0.0 111.351 166.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.0 -10.92 60.03 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 120.588 -1.32 . . . . 0.0 112.531 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -148.33 50.63 1.02 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.154 1.781 . . . . 0.0 111.206 -165.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.3 p -68.22 -12.6 61.24 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.964 -1.085 . . . . 0.0 112.121 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -80.94 1.49 30.81 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.469 -0.769 . . . . 0.0 111.233 172.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.1 t -136.45 138.91 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 120.939 -1.1 . . . . 0.0 110.893 -169.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -87.75 148.11 24.88 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 125.63 1.572 . . . . 0.0 111.51 -168.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.14 14.26 12.94 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.735 1.614 . . . . 0.0 115.305 -163.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.534 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 58.1 mt 52.08 -164.88 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.3 1.04 . . . . 0.0 110.643 -166.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 125.553 1.541 . . . . 0.0 108.49 177.258 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 120.014 -0.041 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.31 168.31 3.56 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.315 1.446 . . . . 0.0 109.692 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.9 p -116.43 167.57 10.93 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.492 1.117 . . . . 0.0 109.039 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 53.36 27.25 6.06 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.695 1.598 . . . . 0.0 111.881 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.84 151.14 13.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 CA-C-N 120.265 1.393 . . . . 0.0 110.827 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.11 174.45 31.1 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 124.969 1.271 . . . . 0.0 111.317 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.412 HG11 ' CD2' ' A' ' 177' ' ' PHE . 97.7 t -86.48 126.75 40.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 176.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -95.64 153.07 17.91 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 120.121 1.328 . . . . 0.0 108.358 158.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.601 HG22 HD12 ' A' ' 111' ' ' LEU . 2.6 mp -122.59 138.45 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 169.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 110' ' ' ALA . 12.9 mt -133.49 138.99 46.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -65.8 178.45 1.05 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.295 1.045 . . . . 0.0 110.347 170.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -53.88 -13.31 0.71 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.807 1.243 . . . . 0.0 114.287 172.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.7 p -102.36 -11.63 18.51 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.636 1.107 . . . . 0.0 110.902 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.82 11.04 74.67 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.941 1.257 . . . . 0.0 113.467 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.85 60.04 5.69 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.77 1.228 . . . . 0.0 111.513 -174.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.435 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . 23.47 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 128.827 2.851 . . . . 0.0 113.834 153.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.601 HD12 HG22 ' A' ' 103' ' ' ILE . 87.7 mt -78.08 168.0 20.56 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.228 -169.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -109.19 164.21 12.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -172.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.7 mt -113.29 52.59 0.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.325 1.05 . . . . 0.0 108.323 -175.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -104.32 -23.31 13.23 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.588 1.155 . . . . 0.0 111.742 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.458 ' HA3' HD22 ' A' ' 74' ' ' LEU . . . 67.62 21.76 72.99 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 118.634 0.652 . . . . 0.0 113.261 -174.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -161.51 34.52 0.13 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.179 1.792 . . . . 0.0 110.392 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 26.9 m -128.92 91.81 3.28 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.078 -2.194 . . . . 0.0 105.078 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -62.35 152.91 32.64 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.097 0.475 . . . . 0.0 110.632 -170.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.9 m -126.3 104.07 8.0 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.546 0.739 . . . . 0.0 109.63 -163.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 49.98 -177.73 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.588 1.955 . . . . 0.0 112.018 -168.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -117.48 172.99 6.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 119.632 -1.918 . . . . 0.0 108.167 154.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m -151.02 116.06 5.28 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 165.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.1 m -67.62 137.87 55.96 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.9 mt -108.88 -178.85 3.7 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 129.038 2.935 . . . . 0.0 110.085 -170.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.45 156.98 44.8 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.009 1.724 . . . . 0.0 109.121 167.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -60.78 85.8 0.01 OUTLIER 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.943 2.097 . . . . 0.0 110.644 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.57 -169.57 25.1 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.758 0.694 . . . . 0.0 111.804 -161.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 59' ' ' ASN . 28.7 m -96.8 125.48 41.28 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 120.574 -1.545 . . . . 0.0 111.822 -158.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -139.92 157.79 45.13 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 129.097 2.959 . . . . 0.0 109.686 -171.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 56' ' ' ILE . 61.2 m -131.53 150.09 52.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.049 1.339 . . . . 0.0 110.003 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 17.1 mt -106.11 118.47 54.9 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -71.15 148.52 56.31 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.236 1.957 . . . . 0.0 112.039 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.415 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 71.1 m-85 -148.39 165.37 31.3 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 127.459 2.304 . . . . 0.0 109.003 170.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -128.46 140.83 51.62 Favored 'General case' 0 CA--C 1.523 -0.082 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 162.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.12 165.9 10.89 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 161.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -166.34 152.38 8.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 169.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.502 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 86.7 m-85 -69.06 151.48 46.39 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 166.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -126.51 133.79 51.07 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.493 1.917 . . . . 0.0 106.509 172.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -101.2 148.32 25.23 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.49 0.716 . . . . 0.0 110.55 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 66.7 p -109.96 12.34 23.77 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.576 1.15 . . . . 0.0 111.089 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.97 -154.44 24.85 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.88 89.24 0.16 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.356 1.062 . . . . 0.0 110.721 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -61.62 119.95 9.65 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.405 1.882 . . . . 0.0 109.599 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.3 p -83.17 161.78 56.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 123.847 0.859 . . . . 0.0 109.449 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -75.02 173.4 14.58 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 119.777 0.956 . . . . 0.0 109.633 165.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.26 -111.75 0.49 Allowed Glycine 0 C--O 1.229 -0.215 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 172.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.84 168.19 14.19 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.063 1.745 . . . . 0.0 106.828 166.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.502 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -145.14 89.39 1.95 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 173.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -125.29 140.79 52.52 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 178.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.534 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -147.71 170.06 18.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.535 1.061 . . . . 0.0 109.563 171.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -142.08 115.25 8.83 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.175 1.39 . . . . 0.0 108.648 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.633 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -130.25 167.74 17.97 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.677 1.591 . . . . 0.0 110.332 172.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 76.9 p -121.05 145.59 47.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -100.35 135.98 40.94 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 170.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -81.55 169.26 17.3 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 157.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.866 HG13 HG23 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -113.64 152.13 15.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 127.998 2.519 . . . . 0.0 105.342 163.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -143.96 87.68 1.92 Allowed 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.596 1.558 . . . . 0.0 107.493 164.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.802 ' CE2' HG21 ' A' ' 156' ' ' VAL . 83.0 m-85 -60.79 163.22 5.85 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.494 166.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.522 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 2.0 pt20 -161.85 162.76 29.47 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.765 1.226 . . . . 0.0 111.316 172.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.443 0 CA-C-O 117.464 -1.742 . . . . 0.0 116.048 171.021 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.093 0 CA-C-O 121.619 0.723 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 56.6 m -142.1 84.34 1.87 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.1 m -77.11 116.0 17.38 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.009 1.323 . . . . 0.0 108.336 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.866 HG23 HG13 ' A' ' 156' ' ' VAL . 28.2 m -134.84 162.15 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 125.697 1.599 . . . . 0.0 110.166 -175.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -75.68 159.49 31.08 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.91 -1.119 . . . . 0.0 109.332 169.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -129.73 -67.35 0.11 Allowed Glycine 0 CA--C 1.52 0.374 0 CA-C-O 119.475 -0.625 . . . . 0.0 111.655 -163.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 175.85 175.42 43.23 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 117.412 0.606 . . . . 0.0 111.64 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 54.0 m -104.06 138.46 40.55 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.058 1.343 . . . . 0.0 109.214 -174.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.79 92.95 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -73.13 85.01 1.34 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.325 1.85 . . . . 0.0 108.234 174.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.412 ' CD2' HG11 ' A' ' 101' ' ' VAL . 57.6 m-85 -67.45 125.16 25.26 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -131.17 163.38 27.84 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.454 1.102 . . . . 0.0 109.895 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 140.77 -162.71 26.64 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 -172.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -165.06 170.08 15.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.55 125.51 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 167.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.8 m -103.68 151.83 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 126.506 1.923 . . . . 0.0 108.424 173.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.39 25.05 0.08 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.685 1.594 . . . . 0.0 113.567 -169.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 C-N-CA 129.209 3.004 . . . . 0.0 110.756 -168.955 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.765 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.55 -22.2 61.36 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 123.973 0.796 . . . . 0.0 112.982 -167.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.4 m -118.84 156.23 29.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.087 1.355 . . . . 0.0 107.364 171.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.33 171.64 14.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.477 0.656 . . . . 0.0 109.779 156.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.63 150.26 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 168.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -87.22 18.0 3.97 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -171.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 69.99 -34.75 0.3 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 130.177 3.391 . . . . 0.0 110.305 -166.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.61 -18.32 73.73 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-O 119.057 -0.857 . . . . 0.0 113.966 -172.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -108.24 -7.08 16.06 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.35 1.06 . . . . 0.0 111.209 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.93 -32.18 26.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 C-N-CA 125.22 1.408 . . . . 0.0 111.338 -170.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -148.8 73.09 1.21 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 -172.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.1 142.35 38.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -171.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.42 HG23 ' HB2' ' A' ' 176' ' ' HIS . 22.5 m -112.59 100.1 8.47 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 172.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.35 102.15 2.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -79.53 100.54 7.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.768 HD23 HG11 ' A' ' 52' ' ' VAL . 14.6 mt -64.77 -19.01 65.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.635 1.974 . . . . 0.0 110.399 169.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.12 -178.15 41.31 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 125.244 1.402 . . . . 0.0 111.662 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -66.13 154.47 39.59 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.7 t -140.21 143.07 30.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 124.49 1.116 . . . . 0.0 108.514 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -76.19 133.68 40.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 p -58.73 -23.09 59.18 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.167 0.987 . . . . 0.0 110.627 174.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.46 74.57 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.158 -0.964 . . . . 0.0 111.041 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.418 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 67.2 m -69.74 -10.69 59.32 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 172.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.605 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 17.9 mt -140.55 79.44 1.7 Allowed 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 120.071 1.305 . . . . 0.0 107.547 -162.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.01 1.47 0.98 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.438 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -147.22 152.16 37.89 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.03 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 50.9 tt0 -61.33 125.39 23.59 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.419 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 101.46 -10.66 57.94 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 118.014 -1.437 . . . . 0.0 112.976 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -61.05 155.18 20.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.972 1.886 . . . . 0.0 110.227 177.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.8 p -136.44 161.63 35.29 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.425 0.557 . . . . 0.0 110.814 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.2 p -73.58 -163.31 0.16 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.458 0.703 . . . . 0.0 111.356 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.4 m -46.11 -31.68 2.49 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 126.979 2.111 . . . . 0.0 114.655 166.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 63.51 167.05 0.14 Allowed 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 126.359 2.287 . . . . 0.0 110.055 -166.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.768 HG11 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -162.05 143.35 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 C-N-CA 126.119 1.768 . . . . 0.0 106.276 -167.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.57 121.52 5.39 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 107.228 -2.349 . . . . 0.0 107.228 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -121.17 134.58 55.22 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -115.04 131.66 56.85 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -167.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.8 mm -89.89 108.8 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -77.61 118.46 20.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 mt -122.31 121.4 36.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -91.91 162.43 14.42 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.358 1.063 . . . . 0.0 110.068 -172.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.0 t0 47.33 42.52 13.98 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.889 1.675 . . . . 0.0 112.276 167.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.3 m -63.74 136.49 57.5 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.511 0.724 . . . . 0.0 109.292 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -121.47 103.78 9.18 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.837 0.855 . . . . 0.0 110.739 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.9 p -63.98 -19.91 65.5 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.957 0.903 . . . . 0.0 112.037 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -61.89 -37.52 84.89 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.318 1.447 . . . . 0.0 110.577 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.5 t -78.3 -57.91 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.1 125.27 3.96 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -166.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 m -71.4 -14.76 62.27 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 118.566 -0.731 . . . . 0.0 111.93 169.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -132.42 162.8 30.23 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 120.019 1.281 . . . . 0.0 111.689 -173.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.08 136.06 45.66 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 154.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.8 169.14 11.88 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 147.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.0 t -120.59 163.19 18.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 165.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.62 163.11 33.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.872 2.069 . . . . 0.0 107.526 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -133.74 152.18 51.81 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.091 1.756 . . . . 0.0 109.729 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.7 tp -152.31 131.07 12.4 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 122.805 0.442 . . . . 0.0 110.847 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.21 -172.12 34.82 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.15 163.96 1.43 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.061 1.744 . . . . 0.0 110.373 171.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.53 130.47 53.56 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 125.753 1.621 . . . . 0.0 109.143 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.6 tt -60.62 -46.77 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 O-C-N 123.413 0.446 . . . . 0.0 110.526 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.1 164.86 32.59 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.75 -15.84 63.83 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.21 -0.24 74.17 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.888 1.232 . . . . 0.0 112.386 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -143.45 41.21 1.47 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.963 1.705 . . . . 0.0 109.691 -167.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.2 p -61.11 -19.85 61.95 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.199 -0.938 . . . . 0.0 112.324 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -75.51 -7.22 53.61 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.855 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.7 t -124.7 130.43 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.711 1.141 . . . . 0.0 108.702 -168.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mt -74.71 151.33 39.23 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.812 1.245 . . . . 0.0 111.133 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.06 19.91 10.96 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.147 2.179 . . . . 0.0 114.093 -163.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.7 mt 53.44 -163.85 0.1 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.983 1.313 . . . . 0.0 110.872 -164.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 . . . . . 0 CA--C 1.514 -0.414 0 C-N-CA 124.441 1.096 . . . . 0.0 110.485 -178.376 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.446 -0.659 0 CA-C-O 122.109 0.957 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.08 168.77 2.32 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.396 157.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.9 p -126.85 170.38 12.28 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 127.263 2.225 . . . . 0.0 108.645 171.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 53.51 29.54 9.21 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 127.472 2.309 . . . . 0.0 111.329 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.1 p -148.44 151.14 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 124.126 0.971 . . . . 0.0 108.565 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.72 -176.21 21.12 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.413 HG11 ' CG ' ' A' ' 177' ' ' PHE . 46.4 t -102.54 138.8 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -115.58 159.89 20.69 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.524 1.056 . . . . 0.0 110.411 171.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.38 137.38 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 170.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -135.69 151.84 50.59 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.718 -177.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 4.1 p-10 -66.6 179.22 1.08 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.042 0.925 . . . . 0.0 111.975 160.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -44.22 -33.92 1.71 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 129.191 2.996 . . . . 0.0 114.966 168.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.4 p -87.83 -7.14 57.66 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.183 1.356 . . . . 0.0 110.846 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.38 22.34 78.77 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.798 1.666 . . . . 0.0 112.419 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.8 34.13 0.49 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -165.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.437 ' HA ' HD13 ' A' ' 104' ' ' LEU . . . 33.08 94.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 129.051 2.941 . . . . 0.0 114.978 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.73 136.31 56.09 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.82 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 113' ' ' LEU . 16.9 m -68.61 167.7 14.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 166.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.457 ' H ' HG22 ' A' ' 112' ' ' THR . 66.9 mt -119.73 70.58 0.86 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -168.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -113.82 -11.77 12.82 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.862 0.865 . . . . 0.0 111.816 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.65 -12.38 4.81 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.082 -1.011 . . . . 0.0 113.894 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -133.45 -10.67 2.83 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.945 1.298 . . . . 0.0 112.942 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.4 t -61.22 123.52 17.97 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 164.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -84.57 157.88 21.09 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.2 t -104.11 174.37 5.9 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.438 1.495 . . . . 0.0 109.073 173.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.444 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 0.5 OUTLIER -45.31 13.98 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.525 1 C-N-CA 134.708 5.203 . . . . 0.0 120.765 179.756 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 44.69 -179.63 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 130.314 3.445 . . . . 0.0 113.458 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 m -158.43 137.66 11.59 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 157.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.0 m -77.82 110.86 13.07 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 175.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.4 mt -72.44 -174.11 1.28 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.413 2.285 . . . . 0.0 108.221 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -151.45 176.17 11.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.6 1.96 . . . . 0.0 108.723 169.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -68.16 101.32 1.15 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 137.77 -170.36 23.75 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.788 1.185 . . . . 0.0 110.698 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 51.4 m -76.74 129.19 35.97 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.087 -1.243 . . . . 0.0 110.0 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -123.41 166.35 15.5 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.289 1.436 . . . . 0.0 109.333 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.0 m -154.71 147.44 24.34 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.037 0.923 . . . . 0.0 109.666 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.2 mt -130.33 111.31 16.64 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 -171.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.67 100.16 0.86 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.918 3.079 . . . . 0.0 110.367 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.86 166.62 20.74 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 171.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -117.32 155.84 28.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 168.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.53 163.55 34.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.673 1.989 . . . . 0.0 107.835 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -175.41 156.06 1.93 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.467 1.907 . . . . 0.0 107.626 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.413 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 85.5 m-85 -71.83 147.22 47.4 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 156.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.419 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 31.1 t80 -123.55 121.0 34.51 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.423 1.889 . . . . 0.0 106.893 176.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -82.88 141.31 32.32 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 46.4 p -100.41 11.07 40.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.463 0.705 . . . . 0.0 111.599 169.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 158.59 -148.22 17.03 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.82 82.37 0.2 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.15 1.78 . . . . 0.0 110.214 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -65.31 157.51 28.92 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.247 1.019 . . . . 0.0 111.342 -177.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.1 p -123.79 153.95 67.07 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 124.592 1.157 . . . . 0.0 109.964 -176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.86 163.41 26.06 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.434 1.422 . . . . 0.0 111.018 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.23 -116.51 0.72 Allowed Glycine 0 N--CA 1.469 0.877 0 C-N-CA 124.442 1.02 . . . . 0.0 111.045 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -119.89 145.36 46.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.164 0.982 . . . . 0.0 109.668 167.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -134.45 86.16 2.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -120.48 146.72 45.98 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -149.0 175.16 11.54 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -152.48 152.95 32.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 173.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.13 175.34 9.66 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.836 2.455 . . . . 0.0 107.881 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.9 p -116.54 153.52 32.04 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 155.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -112.54 151.54 29.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -131.28 157.62 42.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.429 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 9.3 t -122.85 133.81 67.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -169.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -120.84 85.13 2.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.429 ' CZ ' HG11 ' A' ' 156' ' ' VAL . 94.7 m-85 -67.92 128.85 38.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.983 175.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -153.64 176.67 11.81 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 124.801 1.24 . . . . 0.0 111.452 -174.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.279 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -173.832 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 122.405 1.098 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 10.1 m -79.48 99.48 7.26 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 164.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.9 m -78.16 129.64 35.38 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 165.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.18 151.84 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.713 1.605 . . . . 0.0 109.722 -176.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -61.48 139.59 58.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.7 -56.73 0.56 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 166.42 -171.35 41.38 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -175.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.5 m -103.15 138.4 40.02 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.75 1.22 . . . . 0.0 109.657 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.1 t -119.72 103.07 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . 0.42 ' HB2' HG23 ' A' ' 31' ' ' THR . 20.0 m-70 -82.67 141.99 32.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 171.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.413 ' CG ' HG11 ' A' ' 101' ' ' VAL . 86.3 m-85 -121.16 113.74 20.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -124.75 156.39 37.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 118.582 0.628 . . . . 0.0 110.677 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 148.59 -162.6 28.89 Favored Glycine 0 N--CA 1.437 -1.279 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 -167.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.25 177.22 3.66 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 -173.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.4 t -125.87 135.98 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.8 m -118.86 149.97 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 C-N-CA 127.59 2.356 . . . . 0.0 108.492 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -74.99 34.18 0.1 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 C-N-CA 130.269 3.428 . . . . 0.0 112.765 173.033 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.536 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -51.11 -37.44 46.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 116.671 -1.633 . . . . 0.0 111.913 172.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.1 m -121.48 164.86 16.48 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 125.104 1.503 . . . . 0.0 112.128 -167.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.43 -12.81 25.3 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.974 1.31 . . . . 0.0 113.866 -170.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.453 HG13 ' OG ' ' A' ' 27' ' ' SER . 70.8 t 50.06 109.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 130.191 3.396 . . . . 0.0 112.127 -174.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.06 151.68 39.23 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.001 -1.062 . . . . 0.0 109.525 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.593 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -49.82 -33.72 17.54 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.353 1.461 . . . . 0.0 111.189 166.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.35 -6.03 1.98 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.442 1.496 . . . . 0.0 114.537 171.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.453 ' OG ' HG13 ' A' ' 23' ' ' VAL . 96.5 p -132.69 -34.93 1.13 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.847 1.824 . . . . 0.0 112.342 -177.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 25' ' ' ALA . 8.0 p -62.13 -55.23 25.42 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 123.396 0.679 . . . . 0.0 111.282 -170.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -132.04 67.8 1.51 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -165.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -105.72 140.3 38.98 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.902 -1.499 . . . . 0.0 108.295 -161.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.1 m -110.32 94.59 5.09 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.6 t -77.65 104.32 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -86.68 107.79 18.36 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 mt -85.37 -3.39 58.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.8 1.24 . . . . 0.0 110.029 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.5 -178.34 23.76 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 125.241 1.4 . . . . 0.0 112.298 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -65.74 151.51 46.42 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.088 0.555 . . . . 0.0 109.877 162.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.46 152.95 34.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 C-N-CA 125.919 1.688 . . . . 0.0 107.578 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -83.2 134.92 34.94 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.1 p -59.31 -21.94 60.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.82 0.448 . . . . 0.0 111.735 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.1 -31.44 70.04 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.684 -1.26 . . . . 0.0 112.229 171.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -74.05 -9.58 58.77 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.854 0.861 . . . . 0.0 111.449 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.542 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 18.6 mt -143.35 76.56 1.53 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.176 1.39 . . . . 0.0 107.715 -159.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.93 -1.27 2.21 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -171.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 2.7 pm0 -151.14 161.29 43.0 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 35.6 tt0 -64.08 126.76 28.73 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.27 2.53 79.99 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.995 -0.891 . . . . 0.0 113.166 -174.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.57 ' HB2' ' NE2' ' A' ' 44' ' ' GLN . . . -70.45 159.55 34.01 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.642 1.721 . . . . 0.0 109.779 161.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.0 p -149.67 162.81 39.49 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.301 0.64 . . . . 0.0 110.203 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.5 p -73.85 174.8 7.98 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.646 -0.659 . . . . 0.0 110.339 168.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -55.13 -17.27 3.92 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 83.0 160.62 0.13 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 129.765 3.226 . . . . 0.0 112.121 173.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.1 t -143.26 140.53 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.85 130.0 10.09 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 107.152 -2.379 . . . . 0.0 107.152 169.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -136.49 130.19 32.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.468 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 2.8 m-20 -109.64 165.48 11.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -169.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.9 mm -116.74 99.33 8.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -68.36 95.84 0.63 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.902 1.681 . . . . 0.0 110.281 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.45 158.31 19.62 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 122.473 1.13 . . . . 0.0 109.123 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -163.39 155.59 17.87 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 126.794 2.037 . . . . 0.0 107.547 -169.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 45.55 59.2 3.74 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 127.91 2.484 . . . . 0.0 111.079 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.8 m -108.77 107.81 18.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.389 2.275 . . . . 0.0 111.15 -168.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -79.4 158.45 27.37 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.679 1.127 . . . . 0.0 111.121 172.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.4 p -100.52 -18.04 16.83 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.226 1.41 . . . . 0.0 113.554 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -64.77 -46.85 80.39 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.403 1.081 . . . . 0.0 109.063 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 20' ' ' ALA . 2.4 p -57.96 -53.05 50.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 114.184 -1.371 . . . . 0.0 107.442 -175.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.431 ' HA ' ' HA2' ' A' ' 160' ' ' GLY . . . -153.19 142.26 21.34 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 166.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -93.75 11.39 29.31 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.394 172.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.469 ' HE3' ' OE1' ' A' ' 159' ' ' GLN . 7.7 mtmt -148.48 163.34 37.47 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.036 1.334 . . . . 0.0 108.724 168.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.84 177.08 9.85 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 123.764 0.665 . . . . 0.0 109.486 157.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.54 178.37 8.18 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 128.696 2.798 . . . . 0.0 107.726 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.6 t -143.85 100.96 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.435 1.894 . . . . 0.0 106.929 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.63 152.52 28.46 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 118.341 -0.838 . . . . 0.0 109.267 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -112.75 158.66 19.81 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 118.814 0.733 . . . . 0.0 110.328 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.9 tp -144.5 153.45 41.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.747 1.619 . . . . 0.0 108.002 175.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.0 170.69 33.92 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 m -64.45 131.44 47.14 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.191 1.397 . . . . 0.0 109.334 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.94 135.65 43.25 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.613 1.097 . . . . 0.0 110.366 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.7 tt -63.19 -35.29 71.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.229 0.611 . . . . 0.0 111.076 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -159.57 166.53 30.58 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.392 1.477 . . . . 0.0 108.755 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.44 -19.86 57.82 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 127.654 2.382 . . . . 0.0 114.612 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.2 -20.23 43.01 Favored Glycine 0 CA--C 1.524 0.629 0 O-C-N 120.838 -1.164 . . . . 0.0 112.149 171.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -125.02 53.76 1.48 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.634 1.573 . . . . 0.0 108.18 -170.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.9 p -63.58 -15.56 58.45 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 127.303 2.241 . . . . 0.0 111.99 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -97.04 2.84 51.89 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.717 2.007 . . . . 0.0 113.073 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 t -128.35 141.13 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 120.157 1.344 . . . . 0.0 109.392 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -81.41 146.11 30.45 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.271 -169.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.55 ' H ' HD23 ' A' ' 86' ' ' LEU . . . -88.95 14.52 10.32 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.629 1.572 . . . . 0.0 114.509 -166.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.5 mt 51.51 -154.3 0.17 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.328 1.051 . . . . 0.0 110.556 -167.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 . . . . . 0 N--CA 1.45 -0.435 0 O-C-N 121.504 -0.747 . . . . 0.0 110.729 179.218 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.937 0 CA-C-O 122.224 1.011 . . . . 0.0 112.884 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.79 125.73 14.06 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 148.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.1 p -90.3 172.6 8.66 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 56.6 28.62 14.26 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.993 1.717 . . . . 0.0 111.361 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.28 151.29 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.858 0.863 . . . . 0.0 109.485 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.6 175.18 29.73 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 124.382 0.991 . . . . 0.0 110.815 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.2 t -85.11 126.54 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -98.87 144.61 27.88 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 164.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.6 mp -118.41 146.95 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 169.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 mt -141.52 151.42 43.26 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.201 1.4 . . . . 0.0 107.643 -172.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -59.25 -75.08 0.06 Allowed 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.118 0.485 . . . . 0.0 111.073 170.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.1 ptt-85 -176.0 -24.57 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 128.055 2.542 . . . . 0.0 109.415 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.4 p -80.58 -28.17 37.24 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.107 1.363 . . . . 0.0 108.588 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.6 7.06 9.13 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.016 1.77 . . . . 0.0 112.591 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.88 104.87 2.17 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 120.146 1.973 . . . . 0.0 108.402 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.95 100.78 0.22 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.166 0.986 . . . . 0.0 109.279 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.34 132.48 52.76 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.888 0.875 . . . . 0.0 109.251 -170.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 49.3 m -74.63 148.34 40.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.32 0.581 . . . . 0.0 109.789 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.7 mt -92.35 81.55 4.93 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -127.61 -24.42 3.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.6 1.96 . . . . 0.0 111.324 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.84 7.78 71.1 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.14 1.353 . . . . 0.0 113.548 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -140.17 -29.17 0.71 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.785 1.292 . . . . 0.0 112.482 170.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.4 m -53.81 115.09 1.81 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.633 1.173 . . . . 0.0 108.846 173.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -71.52 179.64 2.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.309 1.052 . . . . 0.0 112.384 -164.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.8 p -134.27 126.22 29.34 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.938 1.695 . . . . 0.0 107.791 167.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.6 m 23.2 85.25 0.01 OUTLIER 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.757 2.023 . . . . 0.0 114.083 147.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -61.61 144.95 53.61 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.128 -162.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.9 m -113.71 114.21 26.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 86.0 m -53.74 110.58 0.6 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 154.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.0 mt -72.84 176.9 5.23 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 170.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.12 162.22 30.38 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 121.621 -0.675 . . . . 0.0 109.993 171.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.37 132.18 47.54 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 94.7 -118.54 5.85 Favored Glycine 0 C--O 1.223 -0.58 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.9 m -118.54 144.47 46.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.455 1.102 . . . . 0.0 109.706 -164.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.63 171.5 18.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.127 1.371 . . . . 0.0 109.309 -173.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.468 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 97.1 m -154.32 163.78 39.62 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 119.527 -1.983 . . . . 0.0 108.637 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -122.05 121.0 28.14 Favored Pre-proline 0 N--CA 1.446 -0.638 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 168.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -70.62 135.64 28.86 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 N-CA-C 108.026 -1.567 . . . . 0.0 108.026 160.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -120.54 170.78 9.08 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.802 0.841 . . . . 0.0 108.75 163.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.77 143.33 50.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 168.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -115.74 164.5 14.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.694 1.197 . . . . 0.0 107.915 162.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -164.77 152.33 11.53 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 167.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.451 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 70.4 m-85 -69.5 142.09 53.79 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 165.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -121.74 122.01 38.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -86.18 141.79 29.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.46 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 65.4 p -101.43 7.35 42.59 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.271 1.028 . . . . 0.0 111.302 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.81 -151.97 21.3 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.17 91.98 0.08 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.069 1.348 . . . . 0.0 109.658 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -79.34 144.46 34.19 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.529 0.732 . . . . 0.0 110.897 -174.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.2 p -110.56 165.58 12.4 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.014 0.925 . . . . 0.0 110.019 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.9 174.48 12.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.166 1.911 . . . . 0.0 111.17 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.96 -85.55 0.14 Allowed Glycine 0 C--N 1.336 0.555 0 O-C-N 121.36 -0.838 . . . . 0.0 113.819 167.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -147.11 162.9 37.91 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.311 2.244 . . . . 0.0 105.771 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -151.74 68.42 0.89 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 119.443 1.02 . . . . 0.0 110.133 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -114.73 150.37 35.4 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.08 169.95 20.58 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 169.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -132.93 120.53 21.57 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 174.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -120.44 159.64 24.72 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.933 1.693 . . . . 0.0 108.95 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.0 p -124.54 141.33 52.17 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 162.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -104.36 155.94 18.34 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 168.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -119.5 131.03 55.49 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 171.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 156' ' ' VAL . 0.2 OUTLIER -66.21 137.98 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 171.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -128.8 90.15 3.0 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 171.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.536 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 84.6 m-85 -62.23 161.52 11.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 166.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.469 ' OE1' ' HE3' ' A' ' 68' ' ' LYS . 8.2 mt-30 -103.35 -142.99 0.36 Allowed 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 125.027 1.331 . . . . 0.0 108.044 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 66' ' ' ALA . . . . . . . . 0 N--CA 1.434 -1.468 1 C-N-CA 113.642 -4.123 . . . . 0.0 118.419 126.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.655 0 CA-C-O 121.083 0.468 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.3 m -137.92 92.8 2.7 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.566 1.546 . . . . 0.0 108.04 -173.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.51 126.15 28.4 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 167.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.38 140.58 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.624 1.17 . . . . 0.0 109.328 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -58.96 143.13 49.07 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -114.68 -87.77 1.51 Allowed Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -144.58 -144.35 4.16 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 126.711 2.101 . . . . 0.0 112.137 -167.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 96.5 m -138.18 149.42 45.83 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.333 2.253 . . . . 0.0 108.2 166.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.7 t -115.73 119.15 61.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 163.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -96.97 94.51 7.23 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -72.35 119.5 16.64 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -124.95 160.27 29.29 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 138.15 -169.91 24.03 Favored Glycine 0 C--N 1.321 -0.292 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -171.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -162.66 177.05 9.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -167.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 41.3 t -126.69 131.06 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 167.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.3 m -101.9 155.9 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 127.354 2.262 . . . . 0.0 108.227 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.13 37.79 0.16 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.421 1.088 . . . . 0.0 113.494 -172.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 C-N-CA 127.844 2.457 . . . . 0.0 110.371 -167.189 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.177 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.414 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -30.78 -52.8 0.18 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 126.58 1.952 . . . . 0.0 111.452 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 1.8 m -103.73 143.3 32.98 Favored 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 124.684 1.24 . . . . 0.0 108.774 166.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.97 172.26 1.83 Allowed 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 124.621 1.201 . . . . 0.0 109.918 164.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.8 137.55 55.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -71.37 158.2 36.74 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.779 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -59.03 -32.56 69.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.176 0.99 . . . . 0.0 111.869 172.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.65 3.36 60.22 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.435 -1.203 . . . . 0.0 113.901 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.8 t -128.39 -40.92 1.58 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.355 1.462 . . . . 0.0 109.087 -169.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 25' ' ' ALA . 9.0 p -56.57 -41.46 73.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 123.992 0.917 . . . . 0.0 111.06 171.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -131.4 69.02 1.48 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.074 0.94 . . . . 0.0 109.503 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -103.02 129.48 49.81 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.545 -171.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.621 HG23 ' HB2' ' A' ' 176' ' ' HIS . 0.3 OUTLIER -97.45 99.34 10.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 172.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.2 t -85.17 115.21 26.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -90.04 108.35 19.67 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.68 -16.52 62.25 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.566 0.747 . . . . 0.0 109.801 173.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.48 -175.53 52.98 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -71.27 156.81 39.09 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.497 0.719 . . . . 0.0 109.484 171.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.3 t -141.63 146.57 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.5 1.92 . . . . 0.0 107.026 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.11 137.54 37.54 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.8 p -59.87 -20.85 59.5 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.254 0.622 . . . . 0.0 111.337 173.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.48 -39.43 87.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.245 1.018 . . . . 0.0 111.883 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.4 m -67.66 -9.27 41.82 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mt -142.05 60.93 1.46 Allowed 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 125.882 1.673 . . . . 0.0 110.412 -162.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.64 -3.8 7.19 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -166.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.874 HE21 ' HB2' ' A' ' 47' ' ' ALA . 2.7 pm0 -153.45 160.26 42.54 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.516 1.526 . . . . 0.0 107.19 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.408 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 36.3 tt0 -61.52 135.09 57.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.98 0.895 . . . . 0.0 109.131 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.91 -7.88 64.87 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-O 117.088 -1.951 . . . . 0.0 112.982 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.874 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -58.8 155.93 12.11 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 120.239 2.019 . . . . 0.0 110.51 165.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.3 p -146.74 150.51 35.49 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.688 0.756 . . . . 0.0 110.382 -171.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.5 t -59.54 164.57 3.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 163.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 m -46.35 -81.17 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.335 1.054 . . . . 0.0 112.772 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 173.32 143.49 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.53 1.932 . . . . 0.0 106.839 -172.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 t -141.29 130.46 24.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 170.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.55 126.53 8.93 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.549 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 8.3 p90 -131.55 78.01 1.8 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 123.707 1.718 . . . . 0.0 109.539 -177.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.443 ' HB2' HG22 ' A' ' 130' ' ' THR . 0.2 OUTLIER -70.16 153.51 43.04 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.362 -173.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.9 mm -94.3 104.08 15.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.39 112.92 2.63 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.886 -1.154 . . . . 0.0 107.886 167.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.87 167.0 11.52 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 161.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -137.92 169.7 17.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.401 1.481 . . . . 0.0 107.485 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 43.47 54.02 5.46 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 128.287 2.635 . . . . 0.0 114.712 164.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 2.0 t -81.12 168.71 18.28 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -137.73 141.62 40.99 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.804 2.442 . . . . 0.0 106.446 172.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.1 p -95.72 -12.63 25.14 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.372 1.069 . . . . 0.0 113.138 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -60.71 -49.36 77.82 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.919 1.288 . . . . 0.0 109.475 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.414 HG11 ' HA ' ' A' ' 20' ' ' ALA . 3.0 p -59.64 -58.92 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 113.692 -1.595 . . . . 0.0 107.378 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.4 132.02 9.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.38 1.872 . . . . 0.0 107.38 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.49 -18.53 61.1 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.838 170.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -129.2 157.4 41.94 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 119.605 1.093 . . . . 0.0 110.856 -164.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.94 145.73 46.47 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 124.974 1.31 . . . . 0.0 107.74 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.5 164.95 23.7 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 124.509 1.124 . . . . 0.0 108.534 157.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.415 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -153.77 92.07 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 -169.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.04 165.77 24.38 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.966 0.907 . . . . 0.0 109.405 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -130.22 163.42 26.75 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.16 1.384 . . . . 0.0 109.136 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 tp -154.42 133.55 12.47 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.122 1.369 . . . . 0.0 109.217 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.31 177.07 42.56 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.7 m -73.77 130.7 40.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.105 0.962 . . . . 0.0 109.946 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.02 136.88 48.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 118.949 0.795 . . . . 0.0 111.3 176.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.5 tt -62.24 -42.04 93.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.758 0.823 . . . . 0.0 110.946 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -152.64 164.83 36.93 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.59 1.556 . . . . 0.0 106.924 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.15 82.6 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 126.22 1.808 . . . . 0.0 110.955 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.87 -4.83 78.12 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 119.541 -0.588 . . . . 0.0 112.476 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -143.02 41.84 1.53 Allowed 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.884 1.342 . . . . 0.0 110.53 -167.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 p -62.99 -13.38 34.34 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.209 2.204 . . . . 0.0 115.023 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -81.37 -13.48 58.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.761 0.315 . . . . 0.0 111.329 171.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.0 t -115.31 133.01 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 O-C-N 120.36 -1.462 . . . . 0.0 108.624 -166.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -76.08 148.11 38.16 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.649 1.18 . . . . 0.0 110.014 -174.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.77 14.89 12.3 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.301 1.84 . . . . 0.0 113.955 -164.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.4 mt 52.76 -155.35 0.19 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.125 0.97 . . . . 0.0 109.565 -163.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 C--O 1.234 0.283 0 C-N-CA 122.707 0.403 . . . . 0.0 110.856 -178.643 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.213 0.53 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.82 144.85 56.98 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.954 2.101 . . . . 0.0 110.044 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.401 ' H ' ' HG1' ' A' ' 144' ' ' THR . 3.8 p -90.96 165.93 13.3 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 56.55 20.85 5.19 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 127.286 2.234 . . . . 0.0 113.517 175.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -142.79 149.76 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 119.209 0.913 . . . . 0.0 108.844 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.94 174.99 24.81 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 124.864 1.221 . . . . 0.0 110.603 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.432 HG11 ' CD2' ' A' ' 177' ' ' PHE . 53.4 t -84.36 149.3 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -136.69 143.97 43.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.56 1.544 . . . . 0.0 106.935 175.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.35 137.29 57.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.9 mt -133.44 129.13 36.85 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.767 1.627 . . . . 0.0 107.061 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 12.0 p30 -55.45 -60.7 3.05 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -175.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -171.62 -45.31 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.294 2.238 . . . . 0.0 108.408 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.293 0.5 OUTLIER -82.05 18.65 1.3 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.427 1.891 . . . . 0.0 109.94 -177.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.8 10.94 48.02 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 120.252 -1.53 . . . . 0.0 112.105 -169.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.79 111.42 8.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.554 1.677 . . . . 0.0 107.484 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.78 138.86 58.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.11 0.564 . . . . 0.0 109.801 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 73.0 mt -108.33 110.25 21.78 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.418 0.687 . . . . 0.0 110.398 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -53.25 139.16 30.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.699 1.6 . . . . 0.0 110.6 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.6 mt -89.41 59.39 4.79 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 127.903 2.481 . . . . 0.0 108.015 -173.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.69 -31.98 10.53 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.314 0.578 . . . . 0.0 111.257 -174.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.74 -36.85 3.95 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-O 117.522 -1.71 . . . . 0.0 114.086 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.55 -16.56 13.63 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.91 1.355 . . . . 0.0 112.222 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.1 m -73.02 95.74 2.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -70.24 173.19 7.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.363 2.265 . . . . 0.0 110.786 -174.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.0 p -112.88 -170.36 1.66 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.302 1.441 . . . . 0.0 111.814 -172.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -44.43 142.59 1.53 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.579 1.552 . . . . 0.0 111.594 164.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -80.67 134.39 35.86 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.623 0.725 . . . . 0.0 109.156 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.9 m -113.93 113.26 24.59 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 167.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.7 m -61.44 143.5 55.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.9 mt -115.41 179.48 3.95 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.301 2.24 . . . . 0.0 109.105 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -134.03 167.87 19.84 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.347 1.459 . . . . 0.0 108.21 172.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -72.28 104.11 3.6 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.07 -149.9 18.26 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -173.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.95 138.36 31.48 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.269 1.028 . . . . 0.0 111.248 -165.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.78 169.0 24.57 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.449 1.9 . . . . 0.0 110.915 -174.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.6 m -151.99 150.39 29.94 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.534 1.134 . . . . 0.0 109.641 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.27 119.31 55.51 Favored Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 124.58 1.152 . . . . 0.0 108.784 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -81.54 83.69 2.09 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 124.011 3.141 . . . . 0.0 112.782 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.415 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 76.3 m-85 -74.52 160.9 30.31 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.269 -0.894 . . . . 0.0 112.572 173.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -116.95 147.65 42.08 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 155.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.549 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -122.82 161.63 23.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.833 1.653 . . . . 0.0 107.121 160.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -157.61 160.16 37.79 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.421 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 97.4 m-85 -76.76 148.83 36.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 163.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -124.19 127.23 47.43 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.254 1.422 . . . . 0.0 107.376 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.77 144.26 25.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.482 0.713 . . . . 0.0 109.639 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.408 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 24.8 p -104.35 8.33 35.87 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 123.617 0.767 . . . . 0.0 111.653 171.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 162.96 -150.35 19.17 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 107.944 -2.062 . . . . 0.0 107.944 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.8 89.74 0.27 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.582 1.153 . . . . 0.0 110.699 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.53 141.7 46.88 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.512 0.725 . . . . 0.0 109.672 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.401 ' HG1' ' H ' ' A' ' 97' ' ' THR . 69.6 p -92.72 160.6 33.95 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -75.96 157.84 38.61 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 121.126 1.218 . . . . 0.0 109.464 160.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.67 176.23 18.49 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.357 1.456 . . . . 0.0 109.685 -168.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.16 157.67 34.85 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.526 -0.984 . . . . 0.0 108.732 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.421 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -144.75 81.63 1.66 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.719 0.771 . . . . 0.0 110.174 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -124.77 152.1 44.27 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -173.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -156.11 175.34 14.1 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.702 1.201 . . . . 0.0 109.523 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -156.47 84.69 0.98 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.936 0.874 . . . . 0.0 110.642 -175.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.448 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -81.31 169.89 16.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.934 173.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.3 p -117.61 163.12 16.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.86 155.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.406 ' CD2' ' HA3' ' A' ' 172' ' ' GLY . 38.9 p90 -120.37 159.55 24.83 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.534 1.134 . . . . 0.0 109.91 173.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -129.1 125.27 36.83 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 167.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.31 143.32 15.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 163.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -137.26 82.24 1.92 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -67.51 154.03 42.35 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.744 -0.646 . . . . 0.0 109.687 176.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -158.32 176.12 12.87 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.498 1.119 . . . . 0.0 112.795 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.483 0 C-N-CA 125.095 1.331 . . . . 0.0 111.644 177.873 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.707 0 CA-C-O 122.051 0.929 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.1 m -145.1 90.69 2.06 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.119 0.967 . . . . 0.0 109.341 -168.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.3 m -92.95 96.58 10.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.1 0.952 . . . . 0.0 110.678 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.53 135.12 51.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 125.767 1.627 . . . . 0.0 110.292 -174.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -55.78 107.67 0.37 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.452 1.101 . . . . 0.0 108.907 168.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.406 ' HA3' ' CD2' ' A' ' 154' ' ' PHE . . . -74.95 -58.05 4.19 Favored Glycine 0 CA--C 1.523 0.578 0 O-C-N 120.587 -1.321 . . . . 0.0 110.931 -168.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 169.33 -161.47 35.0 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -171.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.6 m -122.43 133.93 54.61 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 127.588 2.355 . . . . 0.0 107.008 -176.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.49 109.65 28.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . 0.621 ' HB2' HG23 ' A' ' 31' ' ' THR . 20.2 m-70 -88.07 96.75 10.64 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.432 ' CD2' HG11 ' A' ' 101' ' ' VAL . 77.9 m-85 -76.63 133.03 39.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -137.73 162.1 34.8 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 121.537 -0.727 . . . . 0.0 111.325 175.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 146.92 -155.87 26.75 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -169.97 175.28 5.18 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -168.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 32.0 t -128.22 136.99 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 16.3 m -118.72 147.49 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 C-N-CA 126.495 1.918 . . . . 0.0 109.496 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.35 25.31 0.1 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -167.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 128.54 2.736 . . . . 0.0 111.326 -167.63 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.401 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . . . -70.12 -16.32 63.09 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.795 -177.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.7 m -129.68 157.08 43.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.695 1.198 . . . . 0.0 107.829 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.25 107.14 15.59 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 161.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.12 118.58 2.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 121.104 -0.997 . . . . 0.0 108.859 167.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -70.97 163.88 26.62 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.737 -0.602 . . . . 0.0 111.135 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -72.27 -12.9 61.35 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.99 -1.069 . . . . 0.0 113.209 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.63 -1.65 90.04 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 121.233 -0.917 . . . . 0.0 112.787 167.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.4 t -121.82 -31.1 4.01 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.758 1.279 . . . . 0.0 110.765 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 25' ' ' ALA . 4.1 p -63.75 -24.32 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 O-C-N 121.11 -0.994 . . . . 0.0 113.3 -175.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -157.01 53.67 0.51 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.664 0.786 . . . . 0.0 110.365 -162.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -99.49 143.37 29.81 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 120.543 -1.348 . . . . 0.0 110.404 -169.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 176' ' ' HIS . 4.9 m -113.79 95.32 5.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 t -73.15 136.45 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -114.26 118.78 34.91 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.501 1.143 . . . . 0.0 108.464 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 34' ' ' LEU . 1.3 mm? -85.94 -21.2 28.02 Favored 'General case' 0 N--CA 1.44 -0.974 1 C-N-CA 131.9 4.08 . . . . 0.0 108.422 177.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.45 -172.58 34.79 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 124.658 1.123 . . . . 0.0 111.144 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -67.57 112.77 4.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.806 0.842 . . . . 0.0 108.827 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.19 153.23 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 125.258 1.423 . . . . 0.0 107.691 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 5.8 mmt180 -86.32 136.34 33.18 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.3 p -60.66 -27.25 67.68 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 169.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.08 3.24 2.19 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.975 1.71 . . . . 0.0 113.789 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 m -121.45 7.0 10.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.866 1.267 . . . . 0.0 112.203 164.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.569 HD13 HG21 ' A' ' 99' ' ' VAL . 29.6 mt -142.26 71.79 1.36 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.397 1.879 . . . . 0.0 109.15 -171.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.55 4.46 3.37 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.813 -1.18 . . . . 0.0 113.901 -171.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.533 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 4.1 pm0 -153.69 158.57 41.23 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 19.1 tt0 -61.42 136.42 58.03 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 172.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.417 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 86.42 -5.79 83.67 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 118.371 -1.238 . . . . 0.0 112.965 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -63.12 156.48 24.92 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.376 1.588 . . . . 0.0 109.892 169.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.2 p -146.29 155.44 42.65 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.309 0.959 . . . . 0.0 111.834 -176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 137' ' ' TYR . 60.6 p -69.33 178.62 2.31 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.831 -0.543 . . . . 0.0 110.142 175.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.84 -21.27 4.02 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 81.62 129.57 0.05 OUTLIER 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 128.744 2.817 . . . . 0.0 112.572 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 m -133.56 129.2 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-O 122.932 1.349 . . . . 0.0 109.74 -158.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.19 149.96 39.91 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 171.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 2.2 p90 -154.09 154.57 33.86 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 162.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.545 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 4.6 m-20 -135.44 166.47 23.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.93 0.786 . . . . 0.0 109.854 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.2 mm -108.7 97.24 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 125.52 1.528 . . . . 0.0 107.281 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.65 132.56 51.48 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 170.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.6 mt -137.79 110.76 7.73 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.867 1.667 . . . . 0.0 107.72 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -86.01 150.63 24.34 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.978 1.311 . . . . 0.0 108.85 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 t70 36.96 70.73 0.16 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.231 2.613 . . . . 0.0 114.734 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.552 ' SG ' HD12 ' A' ' 124' ' ' LEU . 58.3 m -84.71 86.57 7.31 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 128.357 2.663 . . . . 0.0 112.267 -175.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.82 103.76 0.96 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.505 1.922 . . . . 0.0 111.147 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -60.24 -19.79 56.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.365 1.066 . . . . 0.0 112.415 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -61.3 -36.63 80.64 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.769 1.228 . . . . 0.0 111.932 175.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 20' ' ' ALA . 14.0 t -70.67 -49.59 50.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 177.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.41 ' HB1' ' H ' ' A' ' 159' ' ' GLN . . . -165.3 127.59 2.11 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -171.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -68.3 -12.27 60.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 117.454 -1.26 . . . . 0.0 111.695 169.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HA ' HD23 ' A' ' 124' ' ' LEU . 30.3 mtmt -136.33 157.61 46.39 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 120.844 1.657 . . . . 0.0 113.94 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.07 123.26 20.48 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.806 2.042 . . . . 0.0 108.329 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.75 -177.61 3.83 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 149.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.422 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -145.33 146.5 19.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 -165.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.23 168.18 13.3 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 120.273 1.397 . . . . 0.0 107.871 166.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -128.89 158.83 37.67 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.114 1.766 . . . . 0.0 108.969 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 22.1 tp -147.17 150.9 35.84 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.462 1.905 . . . . 0.0 107.949 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.467 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -167.29 -162.69 19.63 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 119.138 0.881 . . . . 0.0 112.531 -175.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.7 m -105.88 121.28 43.74 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.101 1.761 . . . . 0.0 106.782 163.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.06 140.14 50.62 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.4 tt -60.27 -35.69 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.257 0.623 . . . . 0.0 110.356 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -165.47 165.86 18.8 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.743 1.617 . . . . 0.0 108.684 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.24 -35.1 62.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 127.576 2.351 . . . . 0.0 113.419 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.37 -8.54 66.4 Favored Glycine 0 CA--C 1.531 1.058 0 O-C-N 120.955 -1.091 . . . . 0.0 112.801 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -147.11 47.7 1.14 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.115 1.366 . . . . 0.0 109.899 -160.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.3 p -67.69 -8.82 38.19 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.554 1.542 . . . . 0.0 112.625 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -98.32 3.3 48.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.865 1.266 . . . . 0.0 112.704 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 t -120.3 131.78 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.763 1.165 . . . . 0.0 108.954 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.68 HD13 ' HB1' ' A' ' 150' ' ' ALA . 8.3 mt -71.76 153.88 41.69 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.392 1.077 . . . . 0.0 111.749 175.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.04 15.0 14.24 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 128.198 2.599 . . . . 0.0 114.08 -171.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 53.9 mt 54.65 -150.54 0.4 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.462 1.105 . . . . 0.0 109.204 -158.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 . . . . . 0 C--O 1.236 0.351 0 C-N-CA 126.035 1.734 . . . . 0.0 107.282 177.303 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.445 -0.699 0 CA-C-O 121.923 0.868 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.56 145.33 5.01 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 160.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.5 p -115.94 142.54 46.65 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.935 1.294 . . . . 0.0 109.796 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 77.3 28.78 0.59 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.908 1.683 . . . . 0.0 113.18 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.569 HG21 HD13 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -143.79 167.15 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 125.009 1.323 . . . . 0.0 109.645 169.027 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -168.78 173.85 43.37 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -171.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.496 HG11 ' CG ' ' A' ' 177' ' ' PHE . 8.6 t -91.82 136.98 23.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 177.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.438 HE22 ' HB1' ' A' ' 110' ' ' ALA . 2.3 mm-40 -118.86 161.26 20.45 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.088 1.755 . . . . 0.0 108.17 169.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.483 HG22 HD12 ' A' ' 111' ' ' LEU . 8.7 mt -144.09 122.52 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 127.78 2.432 . . . . 0.0 105.296 -169.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 110' ' ' ALA . 5.4 mt -124.72 153.26 42.64 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -74.54 -102.99 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.316 1.047 . . . . 0.0 110.919 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -148.32 -26.39 0.33 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 128.566 2.746 . . . . 0.0 110.341 -170.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.258 13.3 t -78.7 -4.71 50.54 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 167.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.57 20.04 79.78 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 118.543 -1.143 . . . . 0.0 110.864 -177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.93 127.41 33.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 170.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.612 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -73.9 132.95 43.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 103' ' ' ILE . 79.7 mt -102.35 108.37 19.69 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.509 0.724 . . . . 0.0 109.176 -166.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.3 m -65.67 152.01 45.19 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.013 0.435 . . . . 0.0 110.957 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.5 mt -109.14 73.1 0.84 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.861 1.664 . . . . 0.0 109.726 -160.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -120.25 0.49 10.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.651 1.18 . . . . 0.0 113.094 171.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.28 13.77 83.25 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.009 -0.884 . . . . 0.0 112.862 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -149.43 -17.43 0.28 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.77 1.285 . . . . 0.0 114.178 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.7 m -70.96 97.64 1.47 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 120.453 1.479 . . . . 0.0 107.629 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -76.5 130.54 38.09 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.17 0.988 . . . . 0.0 109.696 -168.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.4 m -72.64 -171.54 0.84 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.981 2.513 . . . . 0.0 111.367 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.37 148.44 6.71 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.803 -0.56 . . . . 0.0 111.037 167.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -85.65 166.64 16.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 123.662 1.696 . . . . 0.0 110.154 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.7 m -130.06 138.6 50.82 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 153.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.4 m -86.85 135.48 33.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 164.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.552 HD12 ' SG ' ' A' ' 61' ' ' CYS . 2.5 mm? -95.08 172.35 8.18 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 126.102 1.761 . . . . 0.0 109.104 -168.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.548 ' H ' HD21 ' A' ' 129' ' ' ASN . 6.8 p30 -132.33 158.87 40.78 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 158.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -64.45 100.14 0.34 Allowed 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 125.615 1.822 . . . . 0.0 106.265 170.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.26 -167.86 25.32 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 107.802 -2.119 . . . . 0.0 107.802 -160.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 98.2 m -106.65 136.65 46.09 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.402 -1.058 . . . . 0.0 108.85 -166.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.548 HD21 ' H ' ' A' ' 125' ' ' ASN . 27.2 m-80 -135.71 170.46 15.94 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.835 1.654 . . . . 0.0 108.895 -169.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.545 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 3.7 m -146.32 142.84 28.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.972 0.909 . . . . 0.0 108.999 172.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.65 116.44 65.39 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 161.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.5 159.61 28.86 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.54 2.16 . . . . 0.0 110.86 170.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.422 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 62.2 m-85 -141.31 172.62 12.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.326 1.85 . . . . 0.0 109.697 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.44 99.83 4.48 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.596 1.558 . . . . 0.0 107.0 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.505 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -102.64 146.23 28.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.076 -1.015 . . . . 0.0 108.728 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -152.77 160.27 43.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.422 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 7.7 m-30 -69.44 153.02 44.18 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 117.35 -1.74 . . . . 0.0 108.813 166.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.417 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 11.0 t80 -128.05 125.84 40.1 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.584 1.954 . . . . 0.0 108.324 173.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -85.32 145.62 27.42 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.778 0.831 . . . . 0.0 110.356 174.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.488 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 41.3 p -105.62 10.64 32.9 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.372 1.069 . . . . 0.0 112.235 175.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.08 -150.63 19.24 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.26 98.09 0.3 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.71 164.15 1.6 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.444 1.116 . . . . 0.0 109.348 171.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.6 p -120.26 162.14 35.35 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 164.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -74.24 168.38 24.93 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 N-CA-C 109.667 -0.936 . . . . 0.0 109.667 164.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.24 178.96 16.17 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.315 1.436 . . . . 0.0 111.364 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.88 150.61 44.53 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 121.467 -1.019 . . . . 0.0 109.582 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.404 ' HB1' ' CE2' ' A' ' 137' ' ' TYR . . . -145.97 93.64 2.36 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -125.48 150.23 47.54 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 172.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.68 ' HB1' HD13 ' A' ' 86' ' ' LEU . . . -151.31 164.49 36.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 120.484 1.493 . . . . 0.0 108.204 175.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.21 140.52 27.96 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -173.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.08 172.96 11.95 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 128.291 2.637 . . . . 0.0 110.633 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 37.5 p -127.84 159.56 34.48 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 159.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -124.41 154.69 40.03 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.368 1.067 . . . . 0.0 109.453 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -114.75 173.59 6.4 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.091 1.756 . . . . 0.0 109.087 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.467 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 3.0 t -127.95 128.97 69.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 127.443 2.297 . . . . 0.0 105.386 175.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.578 HE21 ' NE2' ' A' ' 159' ' ' GLN . 32.0 tt0 -112.96 86.86 2.46 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 173.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.467 ' CZ ' HG11 ' A' ' 156' ' ' VAL . 90.3 m-85 -68.39 150.83 47.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.652 172.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.578 ' NE2' HE21 ' A' ' 157' ' ' GLN . 6.0 pt20 -168.93 165.5 11.49 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.199 1.4 . . . . 0.0 109.35 -175.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.707 0 CA-C-O 117.751 -1.583 . . . . 0.0 114.795 -179.359 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 98.7 m -135.5 107.19 6.97 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 173.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.6 m -102.76 112.52 25.35 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.775 0.83 . . . . 0.0 108.947 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.16 156.43 40.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 126.144 1.778 . . . . 0.0 109.9 -172.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -66.97 132.48 48.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.17 -40.74 3.19 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 118.646 -1.086 . . . . 0.0 111.727 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 158.29 -176.02 35.34 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 118.882 1.341 . . . . 0.0 112.334 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.9 m -91.06 144.36 25.73 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.779 1.232 . . . . 0.0 108.25 172.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.0 t -123.95 136.76 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 168.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . 0.622 ' HB2' HG23 ' A' ' 31' ' ' THR . 23.8 m-70 -120.52 145.74 47.0 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.496 ' CG ' HG11 ' A' ' 101' ' ' VAL . 97.7 m-85 -131.03 126.53 36.14 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -130.87 159.05 38.53 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.08 0.855 . . . . 0.0 109.93 -172.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 159.98 -160.92 32.02 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -164.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -172.66 173.02 4.05 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 128.556 2.743 . . . . 0.0 104.411 174.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.84 144.0 31.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 165.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.7 m -127.25 150.56 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.936 2.094 . . . . 0.0 107.568 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -74.51 36.08 0.1 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.785 1.634 . . . . 0.0 112.634 -173.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.252 1.227 0 C-N-CA 129.131 2.972 . . . . 0.0 112.726 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 118.001 -1.0 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 41.35 -55.21 0.0 OUTLIER 'General case' 0 C--N 1.34 0.166 1 C-N-CA 135.425 5.49 . . . . 0.0 115.794 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 58' ' ' LEU . 1.6 m -87.81 -166.99 1.74 Allowed 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.952 1.301 . . . . 0.0 109.982 166.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.25 -6.79 11.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.131 1.372 . . . . 0.0 113.922 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.26 3.7 t 50.87 120.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 129.535 3.134 . . . . 0.0 113.06 -165.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.37 153.28 41.54 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.526 1.13 . . . . 0.0 109.343 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -65.28 -25.5 67.67 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.101 -1.0 . . . . 0.0 111.035 173.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.96 5.29 1.3 Allowed Glycine 0 CA--C 1.534 1.261 0 CA-C-O 117.001 -2.0 . . . . 0.0 113.789 167.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.5 t -149.85 7.36 0.63 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 120.279 2.04 . . . . 0.0 113.986 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 25' ' ' ALA . 8.4 p -92.14 -40.48 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 121.269 1.849 . . . . 0.0 112.81 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.7 47.95 1.64 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -170.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -85.87 145.44 27.18 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.824 -159.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 m -117.72 98.95 6.63 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.676 1.19 . . . . 0.0 108.794 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.17 104.57 5.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -77.93 109.67 12.18 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 170.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.762 HD23 HG11 ' A' ' 52' ' ' VAL . 3.7 mt -87.33 -6.75 58.38 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.714 2.006 . . . . 0.0 109.799 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.83 -171.68 37.92 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 121.925 0.736 . . . . 0.0 112.464 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -84.41 134.95 34.45 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.396 1.478 . . . . 0.0 109.448 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 t -125.94 142.0 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 124.231 1.012 . . . . 0.0 109.008 -173.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.37 120.6 21.84 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 125.682 1.593 . . . . 0.0 107.733 -177.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 p -48.52 -29.76 4.52 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.036 1.334 . . . . 0.0 111.471 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.34 -35.01 77.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.823 0.849 . . . . 0.0 111.691 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.1 m -72.26 -7.09 47.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.251 1.02 . . . . 0.0 113.123 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.551 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 21.3 mt -136.88 78.75 1.72 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 128.61 2.764 . . . . 0.0 108.585 -170.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.04 3.91 3.2 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.584 -1.322 . . . . 0.0 112.227 -175.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.429 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 6.8 pm0 -149.66 155.77 40.78 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 124.758 1.223 . . . . 0.0 108.247 -175.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 31.7 tt0 -62.25 129.7 41.96 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 90.14 -4.46 82.92 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.011 -1.438 . . . . 0.0 113.233 -176.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -66.45 157.5 31.87 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 119.371 1.586 . . . . 0.0 110.933 172.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.2 p -148.42 161.09 42.28 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -173.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.3 p -73.08 -171.45 0.9 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.268 0.627 . . . . 0.0 110.706 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 m -54.11 -24.45 17.71 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 170.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.98 150.4 0.07 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.27 1.428 . . . . 0.0 112.399 -170.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.762 HG11 HD23 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.42 153.49 9.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 126.841 2.057 . . . . 0.0 105.716 -165.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.01 162.28 21.04 Favored Glycine 0 CA--C 1.526 0.721 0 O-C-N 121.02 -1.05 . . . . 0.0 110.549 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 1.2 p90 -160.63 63.02 0.31 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 124.562 2.125 . . . . 0.0 109.566 177.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.563 HD22 HG21 ' A' ' 130' ' ' THR . 9.5 p-10 -55.12 139.47 41.58 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 112.424 -2.171 . . . . 0.0 111.467 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 mm -84.28 105.45 13.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -76.85 104.61 7.44 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.538 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 57.5 mt -84.5 -175.09 5.63 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 167.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -173.36 144.35 1.16 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 126.237 1.815 . . . . 0.0 109.914 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.0 t0 48.67 63.62 2.03 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.957 2.103 . . . . 0.0 113.117 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.433 ' HB2' HD21 ' A' ' 129' ' ' ASN . 0.8 OUTLIER -86.32 115.6 23.96 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 121.692 -0.63 . . . . 0.0 111.774 -177.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.564 ' HB3' HG23 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -75.11 108.33 7.77 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 161.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.5 p -62.09 -7.94 4.72 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.427 0.691 . . . . 0.0 112.838 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -79.14 -31.15 43.97 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.207 1.403 . . . . 0.0 112.234 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 62' ' ' ASP . 2.2 t -72.87 -35.0 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -170.39 138.53 1.57 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.88 2.472 . . . . 0.0 105.072 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -78.89 -6.83 57.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 116.774 -1.584 . . . . 0.0 110.774 163.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -141.56 161.51 37.74 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 122.605 2.457 . . . . 0.0 115.624 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.31 115.02 15.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.71 175.9 7.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 152.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.405 HG21 ' CZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -156.38 128.97 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 101.718 -3.438 . . . . 0.0 101.718 -160.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 154' ' ' PHE . . . -114.54 169.98 8.65 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.509 1.524 . . . . 0.0 107.623 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.52 ' CD1' HG21 ' A' ' 103' ' ' ILE . 21.4 m-85 -131.2 154.27 48.59 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.902 0.774 . . . . 0.0 110.496 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.624 ' O ' ' HB1' ' A' ' 152' ' ' ALA 0.347 0.1 OUTLIER -145.51 171.33 14.82 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 168.151 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.84 177.06 30.59 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.405 1.479 . . . . 0.0 110.056 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.2 m -67.0 141.33 57.62 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.288 1.044 . . . . 0.0 109.542 174.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.0 134.2 33.87 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 119.366 0.985 . . . . 0.0 110.874 174.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.3 tt -62.79 -33.93 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 122.898 0.479 . . . . 0.0 111.002 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -153.16 166.55 32.16 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.946 1.298 . . . . 0.0 108.724 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.66 -34.53 78.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.549 167.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.17 5.45 76.65 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.258 0.932 . . . . 0.0 112.874 174.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -148.45 48.44 1.03 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.124 1.962 . . . . 0.0 110.01 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.1 p -71.12 -7.81 49.17 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.68 -1.263 . . . . 0.0 113.809 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -84.91 -6.37 59.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.44 -0.788 . . . . 0.0 111.812 169.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 t -118.97 134.23 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.073 0 CA-C-N 119.665 1.12 . . . . 0.0 108.837 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.883 HD11 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -79.25 148.72 32.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.92 1.288 . . . . 0.0 110.234 -169.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.44 20.06 5.61 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.248 1.419 . . . . 0.0 113.958 -167.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.6 mt 55.16 -157.32 0.23 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.287 1.035 . . . . 0.0 109.969 -168.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 CA--C 1.515 -0.374 0 C-N-CA 125.057 1.343 . . . . 0.0 109.042 176.44 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 122.9 1.333 . . . . 0.0 111.959 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.02 159.98 10.69 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.0 148.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.99 167.2 11.97 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.672 1.189 . . . . 0.0 108.702 168.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 62.26 3.63 1.07 Allowed 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 125.945 1.698 . . . . 0.0 113.105 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.452 HG21 HD13 ' A' ' 42' ' ' LEU . 1.6 p -125.91 150.48 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 121.373 1.897 . . . . 0.0 108.764 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.36 177.7 25.47 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 125.025 1.297 . . . . 0.0 110.736 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.534 HG11 ' CG ' ' A' ' 177' ' ' PHE . 90.8 t -92.14 122.34 43.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -91.17 158.55 16.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.819 1.19 . . . . 0.0 109.521 163.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.581 HG22 HD23 ' A' ' 111' ' ' LEU . 3.1 mp -127.84 136.84 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 165.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.443 ' CD2' ' HB2' ' A' ' 110' ' ' ALA . 5.1 mt -133.04 142.33 48.73 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.109 1.363 . . . . 0.0 108.025 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.3 p30 -68.64 -179.86 1.52 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.93 1.347 . . . . 0.0 111.175 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.8 ptt85 -58.46 -7.08 0.8 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.809 1.644 . . . . 0.0 114.589 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.356 10.9 t -116.03 8.26 14.51 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 120.433 1.469 . . . . 0.0 110.985 177.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.11 7.84 84.7 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 120.598 -1.314 . . . . 0.0 112.53 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.96 126.07 30.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.564 1.182 . . . . 0.0 108.328 172.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.443 ' HB2' ' CD2' ' A' ' 104' ' ' LEU . . . -89.11 130.44 35.55 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.164 0.985 . . . . 0.0 111.349 -172.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.581 HD23 HG22 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -100.62 151.47 21.57 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 123.92 0.763 . . . . 0.0 111.464 -164.1 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.2 m -75.64 154.63 36.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 123.553 0.533 . . . . 0.0 110.688 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.6 mt -97.68 64.03 1.76 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.171 1.388 . . . . 0.0 108.427 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.27 -11.12 9.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.267 0.627 . . . . 0.0 111.644 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.406 ' HA3' HD13 ' A' ' 74' ' ' LEU . . . 79.64 13.2 82.77 Favored Glycine 0 CA--C 1.524 0.594 0 O-C-N 120.577 -1.327 . . . . 0.0 113.858 170.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.68 -40.66 0.26 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.365 1.466 . . . . 0.0 110.034 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.2 m -53.91 96.27 0.01 OUTLIER 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.188 1.795 . . . . 0.0 109.461 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -86.03 138.06 32.24 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.231 0.612 . . . . 0.0 109.431 -164.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.55 -175.99 1.8 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.087 2.155 . . . . 0.0 109.171 174.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 t -52.85 143.2 17.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.37 0.605 . . . . 0.0 110.19 169.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -88.33 176.04 7.38 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 123.198 1.475 . . . . 0.0 108.966 167.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.3 m -144.82 163.29 34.52 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 128.205 2.602 . . . . 0.0 105.103 169.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.9 m -100.23 142.95 31.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 122.416 1.103 . . . . 0.0 110.24 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.91 167.68 9.9 Favored 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 129.571 3.149 . . . . 0.0 108.0 -168.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.434 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 0.8 OUTLIER -152.26 156.2 39.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.796 -173.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -73.98 91.57 2.04 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 125.285 1.616 . . . . 0.0 107.107 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 147.22 -123.58 1.78 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 107.691 -2.164 . . . . 0.0 107.691 -164.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.4 m -143.5 139.24 29.73 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.619 1.167 . . . . 0.0 109.075 -172.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.434 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 1.2 p30 -147.74 162.32 39.44 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 127.594 2.358 . . . . 0.0 108.702 -170.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.563 HG21 HD22 ' A' ' 55' ' ' ASN . 4.1 m -144.73 137.97 26.89 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -170.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.91 122.54 61.82 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.63 145.07 68.67 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.952 1.768 . . . . 0.0 110.564 173.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.405 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 58.4 m-85 -142.32 157.3 44.96 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 124.777 1.231 . . . . 0.0 110.24 166.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -131.81 113.75 13.88 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.57 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -101.29 167.56 10.11 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.752 1.221 . . . . 0.0 109.227 171.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -168.05 153.83 7.16 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 127.225 2.21 . . . . 0.0 106.444 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.458 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 82.1 m-85 -66.76 144.11 56.52 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 160.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.429 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 16.5 t80 -123.35 133.12 54.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 126.074 1.75 . . . . 0.0 106.827 174.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -104.39 143.48 32.95 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.967 1.307 . . . . 0.0 109.89 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 46.9 p -103.08 4.66 37.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.683 1.593 . . . . 0.0 111.529 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.51 -141.45 6.87 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.08 93.61 0.3 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.479 1.112 . . . . 0.0 110.332 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -72.27 147.6 46.26 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.301 -0.874 . . . . 0.0 110.108 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 35.0 p -120.71 153.38 56.79 Favored Pre-proline 0 CA--C 1.537 0.442 0 C-N-CA 125.153 1.381 . . . . 0.0 109.028 -175.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -74.69 166.92 28.28 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.02 1.813 . . . . 0.0 112.663 173.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.77 -85.39 0.11 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.098 166.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -142.62 163.06 33.85 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.66 1.984 . . . . 0.0 106.623 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.458 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -151.46 77.33 1.24 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.075 0.852 . . . . 0.0 109.674 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -117.59 155.97 28.92 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.48 173.44 16.67 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.356 1.063 . . . . 0.0 109.004 171.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -150.31 146.46 26.77 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.775 1.23 . . . . 0.0 108.153 169.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.883 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -161.48 169.79 21.18 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 127.802 2.441 . . . . 0.0 108.771 -165.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.53 141.68 46.77 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 116.996 -1.882 . . . . 0.0 107.57 -172.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 72' ' ' ALA . 14.1 p90 -103.68 152.21 22.07 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -134.2 114.02 12.63 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.44 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 13.1 t -77.4 125.61 37.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -176.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -111.52 90.81 3.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.44 ' CZ ' HG11 ' A' ' 156' ' ' VAL . 70.5 m-85 -62.52 148.51 45.65 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.885 1.274 . . . . 0.0 110.344 173.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -165.93 169.66 14.54 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.697 1.199 . . . . 0.0 110.635 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.412 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -170.419 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 54.7 m -137.32 92.84 2.75 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.869 1.267 . . . . 0.0 109.313 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.1 m -72.05 133.7 45.42 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.68 165.81 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 127.747 2.419 . . . . 0.0 108.554 173.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -59.45 143.78 48.89 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 164.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -101.34 -64.44 0.77 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 169.16 168.76 31.64 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -174.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 89.9 m -90.22 118.89 30.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.772 1.286 . . . . 0.0 107.987 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.1 t -88.09 106.76 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 166.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -79.28 144.38 34.35 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 164.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.534 ' CG ' HG11 ' A' ' 101' ' ' VAL . 96.3 m-85 -126.45 121.1 31.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -127.68 156.01 43.03 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.816 0.734 . . . . 0.0 109.475 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.02 -158.66 27.48 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -163.69 167.34 21.21 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.603 -0.94 . . . . 0.0 108.999 -173.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 73.7 t -113.15 126.01 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 167.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.2 m -106.28 150.27 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 126.705 2.002 . . . . 0.0 108.436 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -74.9 39.56 0.14 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.246 1.418 . . . . 0.0 113.1 -176.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.304 0 C-N-CA 127.634 2.374 . . . . 0.0 111.934 -179.773 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.494 ' HB1' ' HE2' ' A' ' 158' ' ' TYR . . . . . . . . 0 N--CA 1.439 -1.0 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.49 -18.14 6.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.027 1.331 . . . . 0.0 112.753 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -134.35 147.49 50.54 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.132 2.173 . . . . 0.0 107.235 176.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.05 -14.12 44.19 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 118.257 2.688 . . . . 0.0 118.257 -155.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.3 t 49.46 104.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 127.645 2.378 . . . . 0.0 111.342 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.46 159.02 10.97 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.39 -0.819 . . . . 0.0 113.096 -169.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.91 -42.07 88.77 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.541 -0.725 . . . . 0.0 109.94 171.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.39 27.52 2.44 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.737 -1.035 . . . . 0.0 112.682 171.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -138.94 -33.07 0.66 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.286 1.543 . . . . 0.0 111.402 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.34 -35.66 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 119.791 1.178 . . . . 0.0 111.122 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -139.92 69.56 1.36 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -170.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -110.52 146.45 35.99 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.863 0.865 . . . . 0.0 111.414 -169.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -112.18 121.33 44.63 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.309 1.043 . . . . 0.0 109.904 173.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.6 t -87.39 113.41 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 169.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -88.22 96.18 10.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 172.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.782 HD23 HG11 ' A' ' 52' ' ' VAL . 9.4 mt -76.81 -8.16 56.8 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 126.009 1.724 . . . . 0.0 110.221 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.23 -171.26 32.75 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 121.829 0.683 . . . . 0.0 112.231 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -90.99 126.91 36.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.505 1.922 . . . . 0.0 110.491 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.406 HG21 ' HD2' ' A' ' 137' ' ' TYR . 21.0 t -117.64 137.73 50.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 123.4 0.68 . . . . 0.0 109.772 -172.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 4.6 mmt180 -66.56 124.18 22.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.874 2.07 . . . . 0.0 106.53 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.9 p -55.25 -30.02 59.24 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 123.787 0.679 . . . . 0.0 110.37 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.89 -36.06 76.16 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.368 1.467 . . . . 0.0 111.524 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.447 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 70.0 m -80.16 2.37 24.47 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 123.521 0.728 . . . . 0.0 112.797 176.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.4 mt -131.83 32.08 4.13 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.37 1.868 . . . . 0.0 110.922 -170.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.49 5.24 13.37 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -150.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.537 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 4.2 pm0 -154.69 155.96 35.55 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.405 1.882 . . . . 0.0 106.725 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 36.4 tt0 -64.23 116.84 6.39 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.33 -11.51 36.55 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 117.847 -1.529 . . . . 0.0 112.752 -177.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.537 ' HB2' ' NE2' ' A' ' 44' ' ' GLN . . . -66.27 156.88 33.03 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.432 1.616 . . . . 0.0 110.253 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.6 p -144.88 157.34 44.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.41 0.624 . . . . 0.0 112.179 -174.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -73.58 -168.19 0.53 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 122.008 -0.433 . . . . 0.0 110.091 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -43.55 -99.57 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.719 2.007 . . . . 0.0 114.281 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.37 73.57 0.0 OUTLIER 'General case' 0 C--O 1.236 0.393 0 C-N-CA 131.002 3.721 . . . . 0.0 107.427 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.782 HG11 HD23 ' A' ' 34' ' ' LEU . 3.9 p -69.55 148.32 11.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 170.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.03 127.2 7.97 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 107.145 -2.382 . . . . 0.0 107.145 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 135' ' ' ALA . 5.1 p90 -135.41 89.91 2.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 123.215 1.483 . . . . 0.0 109.624 -170.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -84.11 165.86 18.13 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 120.892 -1.13 . . . . 0.0 112.69 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.0 mm -102.3 99.01 7.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -71.8 126.32 29.42 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.435 HD11 HD11 ' A' ' 131' ' ' ILE . 95.9 mt -109.25 171.84 7.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 174.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 11.5 p30 -153.81 175.05 13.77 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.253 0.933 . . . . 0.0 111.504 165.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.6 t70 32.12 48.75 0.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 129.821 3.248 . . . . 0.0 115.974 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 4.6 t -69.69 167.46 16.99 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -171.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.501 ' HB3' HG23 ' A' ' 65' ' ' VAL . 32.1 t0 -133.76 114.49 13.47 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.872 1.669 . . . . 0.0 112.253 168.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.9 p -56.16 -29.68 61.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.698 1.599 . . . . 0.0 113.575 172.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -62.32 -42.47 99.4 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 123.117 0.567 . . . . 0.0 110.323 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.501 HG23 ' HB3' ' A' ' 62' ' ' ASP . 15.2 t -65.24 -52.68 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 175.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.433 ' CB ' ' HB3' ' A' ' 158' ' ' TYR . . . -165.49 127.04 1.98 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.192 0.52 . . . . 0.0 111.674 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.4 m -77.37 -8.58 57.92 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.55 1.54 . . . . 0.0 112.163 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -130.03 152.65 49.25 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 121.377 1.899 . . . . 0.0 110.371 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.02 144.36 49.88 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 165.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.94 172.01 9.27 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 122.076 0.941 . . . . 0.0 109.617 156.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.261 0.5 OUTLIER -143.22 144.23 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 113.633 -1.621 . . . . 0.0 106.693 -174.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.41 162.39 30.28 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.313 2.645 . . . . 0.0 107.045 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -137.15 152.6 50.13 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.711 0.804 . . . . 0.0 110.328 -172.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 74' ' ' LEU . 19.1 tp -151.6 124.68 8.68 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 122.082 -0.386 . . . . 0.0 110.609 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.26 165.87 33.97 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -54.08 128.7 31.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.313 1.445 . . . . 0.0 109.944 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.71 134.97 41.85 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.823 1.192 . . . . 0.0 110.371 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.2 tt -60.38 -37.39 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 122.72 0.408 . . . . 0.0 110.81 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -157.27 168.62 26.86 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.182 1.793 . . . . 0.0 109.046 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.33 -39.95 67.54 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.759 1.624 . . . . 0.0 112.641 171.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.28 7.44 80.69 Favored Glycine 0 CA--C 1.526 0.752 0 O-C-N 121.433 -0.792 . . . . 0.0 112.884 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -142.76 42.4 1.58 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.456 1.102 . . . . 0.0 109.481 -175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.5 p -67.95 -11.68 59.26 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.958 1.303 . . . . 0.0 112.84 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -77.69 -2.08 34.29 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.631 -0.668 . . . . 0.0 112.19 168.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.41 137.09 48.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 O-C-N 120.44 -1.412 . . . . 0.0 110.894 -166.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.77 150.9 29.05 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.469 1.508 . . . . 0.0 111.405 -171.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.73 18.33 11.84 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.675 1.99 . . . . 0.0 114.192 -167.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 79.4 mt 53.71 -159.9 0.14 Allowed 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.587 1.155 . . . . 0.0 110.621 -169.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 C--O 1.237 0.432 0 C-N-CA 124.453 1.101 . . . . 0.0 109.309 176.092 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.644 0.259 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.78 148.74 48.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 168.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.34 164.93 12.09 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.88 0.872 . . . . 0.0 108.762 166.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 69.96 -7.88 0.88 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 128.725 2.81 . . . . 0.0 115.11 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.7 p -126.99 152.19 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 121.417 1.917 . . . . 0.0 107.949 -171.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -146.31 170.64 27.37 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 126.11 1.814 . . . . 0.0 111.82 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.437 HG11 ' CG ' ' A' ' 177' ' ' PHE . 94.2 t -83.56 120.44 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -100.65 154.19 18.8 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.714 1.597 . . . . 0.0 108.3 164.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.09 143.97 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 170.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 110' ' ' ALA . 15.4 mt -139.58 138.98 36.68 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.044 1.738 . . . . 0.0 108.042 -168.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.542 ' HB2' ' HB3' ' A' ' 120' ' ' SER . 29.0 p30 -66.22 173.62 3.06 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 122.219 1.009 . . . . 0.0 111.959 167.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -55.32 -13.18 1.26 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.194 1.398 . . . . 0.0 113.667 175.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 p -105.08 -9.09 18.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.929 1.292 . . . . 0.0 110.874 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.81 10.21 65.21 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.712 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.06 117.13 13.3 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 119.061 1.431 . . . . 0.0 107.938 169.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.456 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -74.68 131.15 40.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.661 0.784 . . . . 0.0 110.122 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.0 mt -103.34 117.27 34.1 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.589 1.156 . . . . 0.0 110.745 -158.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.0 m -67.39 143.23 56.42 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.77 0.795 . . . . 0.0 110.539 -170.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.9 mt -93.6 74.78 4.38 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.196 1.398 . . . . 0.0 107.307 -171.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.46 -18.31 11.01 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.327 1.051 . . . . 0.0 110.683 170.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.67 -28.27 4.96 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-O 118.16 -1.356 . . . . 0.0 112.751 176.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -82.62 -45.08 15.0 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.407 1.604 . . . . 0.0 110.505 166.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.2 m -51.25 97.33 0.01 OUTLIER 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.839 2.055 . . . . 0.0 111.586 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.66 169.38 4.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.81 2.044 . . . . 0.0 111.112 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 75.5 p -135.75 -161.59 1.17 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.611 0.765 . . . . 0.0 111.35 173.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 0.9 OUTLIER -42.82 122.53 2.4 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 129.73 3.212 . . . . 0.0 111.69 -175.016 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -89.01 106.23 18.3 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.942 0.877 . . . . 0.0 108.701 -173.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.7 m -70.34 117.88 12.44 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 162.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.2 m -64.0 141.77 58.65 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 155.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.98 -170.44 2.14 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.052 0.941 . . . . 0.0 109.785 176.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -148.87 167.56 25.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.818 2.047 . . . . 0.0 107.071 178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -64.41 128.36 35.43 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 120.29 -159.57 15.13 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 22.0 m -83.13 136.01 34.61 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.669 1.188 . . . . 0.0 111.648 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.48 177.98 9.76 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.369 1.468 . . . . 0.0 108.325 -176.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.6 m -155.01 144.48 21.27 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.33 -0.856 . . . . 0.0 109.734 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.435 HD11 HD11 ' A' ' 58' ' ' LEU . 2.4 mp -100.05 114.53 65.72 Favored Pre-proline 0 C--O 1.237 0.446 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 162.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.01 151.39 50.08 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.192 1.928 . . . . 0.0 110.475 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -141.17 167.03 23.16 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.716 2.006 . . . . 0.0 108.303 171.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.24 154.29 33.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 122.722 1.248 . . . . 0.0 110.071 161.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.507 ' HB2' ' CD1' ' A' ' 54' ' ' PHE . . . -132.83 147.3 52.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 127.517 2.327 . . . . 0.0 106.398 175.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -163.89 151.95 12.97 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 170.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.473 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 76.0 m-85 -66.18 135.84 55.08 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 170.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -111.28 127.8 55.74 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.978 1.711 . . . . 0.0 108.482 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.26 142.47 27.72 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.424 1.09 . . . . 0.0 111.242 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 17.6 p -110.82 9.21 22.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.273 1.429 . . . . 0.0 112.135 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.5 -152.47 22.2 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.38 95.92 0.22 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.116 1.366 . . . . 0.0 110.891 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -53.82 151.98 5.91 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.621 0.724 . . . . 0.0 110.497 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 73.1 p -105.5 154.02 39.39 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 162.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -71.48 174.73 10.46 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.115 1.21 . . . . 0.0 109.284 166.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.79 -93.67 0.14 Allowed Glycine 0 C--O 1.225 -0.441 0 O-C-N 121.855 -0.528 . . . . 0.0 112.838 171.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -146.65 161.95 39.47 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.38 1.872 . . . . 0.0 106.394 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.473 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -151.35 73.37 1.09 Allowed 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 121.776 -0.577 . . . . 0.0 110.52 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -117.64 151.65 36.78 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -157.9 179.25 9.37 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -156.35 145.94 20.87 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -146.38 169.41 18.92 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.81 2.044 . . . . 0.0 106.992 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.7 p -106.98 163.66 12.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 156.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -117.72 155.87 29.23 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 164.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 38.5 mttm -125.61 137.9 53.91 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 168.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.903 HG13 HG23 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -87.18 150.75 3.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 175.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -142.12 84.16 1.86 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.539 1.536 . . . . 0.0 108.918 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.752 ' CE2' HG21 ' A' ' 156' ' ' VAL . 59.0 m-85 -63.7 156.16 27.82 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.988 1.315 . . . . 0.0 112.805 169.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -174.82 174.83 2.5 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.721 2.009 . . . . 0.0 108.567 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.319 0 O-C-N 120.852 -1.155 . . . . 0.0 111.359 177.405 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.941 0 CA-C-O 121.282 0.563 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 52.9 m -96.81 89.3 4.85 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.65 1.98 . . . . 0.0 106.458 171.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.3 m -82.02 120.4 25.22 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 175.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.903 HG23 HG13 ' A' ' 156' ' ' VAL . 30.2 m -128.14 145.72 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 118.645 0.657 . . . . 0.0 111.209 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -77.88 105.44 9.07 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -79.75 -68.49 1.48 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 124.035 0.826 . . . . 0.0 111.936 -164.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -178.14 -172.62 42.76 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 117.503 0.651 . . . . 0.0 111.847 -173.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.4 HG21 ' CE1' ' A' ' 176' ' ' HIS . 8.3 m -89.22 145.38 25.44 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.782 1.633 . . . . 0.0 108.971 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.6 119.95 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 156.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . 0.4 ' CE1' HG21 ' A' ' 174' ' ' THR . 88.1 m-70 -88.94 134.48 33.95 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 172.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.437 ' CG ' HG11 ' A' ' 101' ' ' VAL . 90.3 m-85 -114.17 113.09 24.2 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -117.31 157.47 26.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 147.29 -165.42 28.64 Favored Glycine 0 C--O 1.239 0.411 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -176.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -161.56 171.73 17.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.9 t -122.15 132.84 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 173.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.2 m -117.91 149.69 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 127.608 2.363 . . . . 0.0 107.972 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -76.23 34.23 0.13 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -170.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 N--CA 1.438 -1.035 0 C-N-CA 131.231 3.812 . . . . 0.0 112.802 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.221 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.507 ' HB3' ' CD1' ' A' ' 158' ' ' TYR . . . -86.97 1.83 51.46 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 117.672 -1.156 . . . . 0.0 113.799 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.25 164.18 30.94 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.554 1.542 . . . . 0.0 107.68 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.67 -24.29 21.65 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.757 0.823 . . . . 0.0 113.002 -168.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t 58.58 131.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 128.07 2.548 . . . . 0.0 112.172 -173.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -78.44 156.13 29.55 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.033 -1.042 . . . . 0.0 111.895 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.48 -31.95 64.52 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.611 -0.681 . . . . 0.0 110.682 166.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.54 -2.12 73.7 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 117.559 -1.69 . . . . 0.0 114.293 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.4 p -125.21 -30.02 3.22 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 121.018 2.409 . . . . 0.0 111.809 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.94 -38.9 78.48 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 124.822 1.249 . . . . 0.0 113.789 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -132.6 46.69 2.6 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.085 0.954 . . . . 0.0 109.726 -168.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -93.13 132.19 37.5 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.283 -0.885 . . . . 0.0 110.478 -159.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.4 HG23 ' HB2' ' A' ' 176' ' ' HIS . 15.3 m -113.98 86.8 2.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.737 1.215 . . . . 0.0 108.652 -175.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.75 99.91 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 127.047 2.139 . . . . 0.0 108.02 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -84.48 102.97 13.23 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -170.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mt -76.79 -7.61 55.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.713 1.205 . . . . 0.0 111.004 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.82 -173.53 26.77 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.529 1.061 . . . . 0.0 112.327 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -68.97 153.88 43.03 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.954 0.902 . . . . 0.0 109.479 170.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.4 t -139.7 148.14 23.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 C-N-CA 125.067 1.347 . . . . 0.0 108.611 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -81.18 134.44 35.63 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 121.508 -0.745 . . . . 0.0 109.053 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.1 p -60.64 -24.06 65.24 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.556 0.742 . . . . 0.0 110.899 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.43 -46.41 66.37 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.35 0.66 . . . . 0.0 110.454 170.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 t -71.9 -2.38 17.76 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.962 177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 17.3 mt -142.93 64.86 1.35 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 120.546 1.521 . . . . 0.0 108.854 -170.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.94 0.22 5.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -167.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.442 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 3.1 pm0 -158.32 159.62 36.11 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.395 1.478 . . . . 0.0 108.404 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 39.1 tt0 -65.33 118.15 8.92 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 106.77 -12.97 42.14 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-O 118.422 -1.21 . . . . 0.0 112.112 -174.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -61.71 142.26 57.34 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.899 1.35 . . . . 0.0 109.44 173.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 p -136.66 159.44 41.81 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.094 0.861 . . . . 0.0 111.052 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.5 p -74.5 -175.07 2.25 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.778 0.799 . . . . 0.0 112.216 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.7 m -56.08 -24.04 37.62 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.803 2.041 . . . . 0.0 114.417 171.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.1 158.95 0.18 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 129.336 3.054 . . . . 0.0 112.582 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.3 t -145.56 140.48 22.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -171.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.67 141.26 15.45 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 170.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 2.8 p90 -136.88 149.55 47.72 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 171.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.448 ' HB2' HG22 ' A' ' 130' ' ' THR . 0.8 OUTLIER -145.37 117.52 8.36 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.056 -1.027 . . . . 0.0 108.619 -167.146 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 mm -77.88 101.11 3.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -163.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -65.36 121.44 14.84 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 mp -125.8 107.17 10.26 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.598 1.959 . . . . 0.0 106.914 -172.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -101.87 157.42 16.86 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -171.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 48.6 t0 50.87 50.58 18.77 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 123.189 1.471 . . . . 0.0 111.847 167.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.7 m -73.29 151.29 41.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.967 1.707 . . . . 0.0 110.365 174.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -136.47 107.53 6.74 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.616 1.166 . . . . 0.0 110.683 -174.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.1 p -60.29 -18.48 49.64 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.434 1.494 . . . . 0.0 112.886 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -60.44 -38.24 83.49 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.35 1.46 . . . . 0.0 111.171 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.03 -55.89 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.35 144.38 18.4 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.689 1.195 . . . . 0.0 108.438 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.21 -15.04 42.16 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.978 -0.534 . . . . 0.0 111.839 169.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -135.44 160.94 36.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.28 0.945 . . . . 0.0 110.584 -167.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.61 153.88 38.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 159.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.528 ' HB1' ' H ' ' A' ' 119' ' ' SER . . . -132.18 173.44 11.24 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.916 1.686 . . . . 0.0 107.301 162.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.446 ' HB ' ' CZ ' ' A' ' 133' ' ' PHE . 61.0 t -135.87 123.55 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 118.804 0.729 . . . . 0.0 109.415 -171.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.55 0.46 26.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -160.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.409 ' CD1' HG21 ' A' ' 103' ' ' ILE . 48.5 m-85 37.29 -177.84 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.702 1 C-N-CA 131.963 4.105 . . . . 0.0 112.504 -166.298 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.526 HD22 ' HA3' ' A' ' 115' ' ' GLY . 7.8 tp -168.07 126.92 1.22 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 164.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.73 173.43 42.72 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -68.74 129.34 39.65 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.258 1.423 . . . . 0.0 109.516 -172.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -86.35 131.53 34.19 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.581 1.152 . . . . 0.0 113.156 -176.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.4 tt -65.54 -32.27 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.132 0.973 . . . . 0.0 112.018 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -152.87 165.27 35.97 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.694 0.797 . . . . 0.0 109.07 166.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.74 -43.5 47.88 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.707 2.003 . . . . 0.0 112.477 165.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.18 0.83 88.37 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.265 0.936 . . . . 0.0 112.524 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -142.03 40.62 1.65 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.207 1.504 . . . . 0.0 109.886 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.429 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 21.8 p -64.26 -15.84 60.89 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 124.825 1.25 . . . . 0.0 113.788 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -73.43 -12.02 60.66 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.433 174.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.9 t -133.15 143.82 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 123.088 1.423 . . . . 0.0 108.394 -164.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.936 HD23 HG22 ' A' ' 101' ' ' VAL . 1.5 mm? -80.55 136.47 36.28 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 112.682 -2.054 . . . . 0.0 110.717 -159.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.9 14.22 0.12 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 124.742 1.217 . . . . 0.0 113.242 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 86' ' ' LEU . 89.0 mt 48.11 -147.91 0.22 Allowed 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.535 1.934 . . . . 0.0 108.484 -171.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 . . . . . 0 N--CA 1.449 -0.487 0 C-N-CA 124.941 1.297 . . . . 0.0 108.518 177.35 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 CA--C 1.533 0.304 0 CA-C-O 122.281 1.038 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.05 144.15 57.15 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.575 -0.703 . . . . 0.0 109.218 164.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.0 p -91.91 168.69 11.24 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.691 1.196 . . . . 0.0 109.003 166.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 55.85 18.78 3.15 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.115 1.766 . . . . 0.0 113.865 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.4 p -146.34 142.92 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 121.132 -0.98 . . . . 0.0 108.508 175.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.32 165.28 27.49 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 175.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.936 HG22 HD23 ' A' ' 86' ' ' LEU . 0.9 OUTLIER -70.81 150.06 9.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -125.55 147.01 49.42 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 129.019 2.928 . . . . 0.0 105.917 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.492 HD11 ' CE2' ' A' ' 177' ' ' PHE . 1.9 mp -118.99 141.83 36.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.41 149.08 46.66 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.72 1.608 . . . . 0.0 107.015 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.07 -172.21 1.03 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.348 1.07 . . . . 0.0 112.342 174.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -47.51 -48.31 27.38 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 127.567 2.347 . . . . 0.0 110.115 170.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.5 p -81.3 -14.37 57.43 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.072 -168.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.91 22.7 44.67 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 126.386 1.946 . . . . 0.0 111.567 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.54 133.46 40.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 162.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.44 151.99 42.76 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.6 mt -117.14 151.64 36.41 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.039 1.336 . . . . 0.0 109.257 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.1 m -78.67 163.97 25.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 167.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.489 HD22 HD13 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -124.69 68.67 1.1 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 101.466 -3.531 . . . . 0.0 101.466 174.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.06 -7.34 19.24 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.983 0.897 . . . . 0.0 111.641 -175.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.526 ' HA3' HD22 ' A' ' 74' ' ' LEU . . . 66.87 31.36 77.96 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -158.91 -64.01 0.08 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.027 1.731 . . . . 0.0 106.879 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.7 m -49.65 99.95 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.205 2.202 . . . . 0.0 112.131 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -72.39 171.79 11.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.588 1.155 . . . . 0.0 111.003 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.528 ' H ' ' HB1' ' A' ' 70' ' ' ALA . 39.6 p -131.81 -146.95 0.3 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.993 1.717 . . . . 0.0 110.776 -169.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.9 t -58.37 124.64 20.23 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.446 1.021 . . . . 0.0 108.938 172.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -85.36 110.5 19.16 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 122.035 0.921 . . . . 0.0 108.559 170.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.7 m -79.35 121.83 25.61 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 161.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.1 m -66.36 111.06 3.33 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 160.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.0 mt -73.66 -179.4 3.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.604 1.962 . . . . 0.0 108.973 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.404 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 0.7 OUTLIER -152.27 165.8 33.76 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.443 1.097 . . . . 0.0 109.538 173.188 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -59.39 138.14 57.75 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 171.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.15 -139.7 15.36 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -172.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.1 m -111.51 146.34 37.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 118.44 1.12 . . . . 0.0 111.37 -164.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.404 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 18.9 m-80 -144.97 174.35 11.1 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 128.423 2.689 . . . . 0.0 108.606 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 55' ' ' ASN . 91.4 m -157.01 148.19 21.99 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 170.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.5 mt -110.05 112.63 57.58 Favored Pre-proline 0 C--O 1.237 0.418 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.8 137.17 19.69 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.276 1.984 . . . . 0.0 110.184 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.446 ' CZ ' ' HB ' ' A' ' 71' ' ' VAL . 76.1 m-85 -127.4 172.59 10.52 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 127.007 2.123 . . . . 0.0 107.74 171.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -128.88 143.72 50.97 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 167.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.579 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -126.85 139.08 53.35 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.92 2.088 . . . . 0.0 108.063 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -160.26 159.91 32.0 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 175.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.426 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 74.4 m-85 -73.61 126.28 29.93 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 171.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.47 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 23.7 t80 -111.55 120.81 43.36 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.948 2.099 . . . . 0.0 106.877 172.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -83.28 137.8 33.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 175.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.496 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 64.1 p -97.18 6.92 47.64 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.15 0.98 . . . . 0.0 111.283 171.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.69 -155.81 27.24 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.05 91.79 0.5 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.204 1.002 . . . . 0.0 111.172 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -56.97 158.52 4.83 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.673 0.789 . . . . 0.0 111.469 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 42.3 p -115.82 158.35 42.36 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 170.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -80.95 164.56 20.04 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.916 1.744 . . . . 0.0 111.681 170.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.6 -84.87 0.11 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.953 0.787 . . . . 0.0 114.277 171.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -153.11 143.56 22.56 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 128.917 2.887 . . . . 0.0 106.365 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.426 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -137.95 84.16 2.02 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.989 0.813 . . . . 0.0 109.931 -177.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -126.84 154.38 44.43 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.45 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -156.27 -178.22 7.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.766 0.712 . . . . 0.0 110.975 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -151.34 110.18 3.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 122.63 1.205 . . . . 0.0 109.672 172.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.14 163.99 12.02 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 169.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.1 p -109.02 152.68 24.65 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 160.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -102.59 117.08 33.9 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 170.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.427 ' HE3' ' HA3' ' A' ' 115' ' ' GLY . 19.7 mttt -92.69 154.68 18.19 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 167.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.446 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 14.8 t -119.13 126.72 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.591 HE21 ' NE2' ' A' ' 159' ' ' GLN . 35.7 tt0 -103.59 89.54 3.38 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 170.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.507 ' CD1' ' HB3' ' A' ' 20' ' ' ALA . 96.5 m-85 -69.79 139.59 53.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.327 169.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.591 ' NE2' HE21 ' A' ' 157' ' ' GLN . 9.6 pt20 -155.0 170.62 21.33 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.686 0.795 . . . . 0.0 111.288 176.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.552 0 C-N-CA 125.966 1.746 . . . . 0.0 110.728 178.268 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.779 0 CA-C-O 123.667 1.699 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 95.5 m -76.2 99.06 4.6 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 113.024 -1.898 . . . . 0.0 107.879 170.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 93.6 m -66.08 138.37 57.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 158.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.05 137.27 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 124.927 1.291 . . . . 0.0 107.859 169.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -57.22 121.55 10.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 161.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -88.77 -86.88 1.23 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -146.78 -177.13 21.12 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.665 1.603 . . . . 0.0 110.449 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 27.4 m -93.88 144.58 25.31 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.152 1.381 . . . . 0.0 110.254 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.3 t -123.39 124.56 70.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 169.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . 0.4 ' HB2' HG23 ' A' ' 31' ' ' THR . 32.7 m-70 -110.97 99.48 8.36 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.002 1.321 . . . . 0.0 107.609 -174.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.492 ' CE2' HD11 ' A' ' 103' ' ' ILE . 53.9 m-85 -79.33 107.13 11.87 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 175.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -112.66 157.78 20.82 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.792 1.637 . . . . 0.0 106.815 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.04 -162.91 27.8 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -174.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -165.67 174.37 9.85 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -166.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 82.3 t -129.73 138.13 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 170.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 17.2 m -119.96 151.13 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 C-N-CA 128.663 2.785 . . . . 0.0 108.777 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.72 26.07 0.09 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -168.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 130.969 3.708 . . . . 0.0 111.279 177.631 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.128 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -49.65 -28.72 6.23 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.671 1.588 . . . . 0.0 114.012 -170.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.1 m -126.64 153.65 45.07 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 171.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.31 6.86 35.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.514 1.526 . . . . 0.0 114.851 -167.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.28 9.8 p 36.17 100.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 130.686 3.595 . . . . 0.0 113.245 -174.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -59.49 162.16 5.18 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.117 0.967 . . . . 0.0 111.922 -162.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.28 -28.69 43.53 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.234 1.413 . . . . 0.0 111.411 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.97 8.49 66.43 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.899 1.237 . . . . 0.0 114.444 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.0 m -142.6 -23.8 0.65 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.683 1.741 . . . . 0.0 113.634 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.0 p -55.01 -33.96 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 120.529 1.513 . . . . 0.0 111.091 165.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -137.89 105.06 5.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -131.22 132.84 44.94 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.345 1.058 . . . . 0.0 108.97 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.4 m -118.64 89.72 3.19 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.2 t -72.78 124.01 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -88.51 101.06 13.56 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.4 mt -69.8 -14.72 62.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 165.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.89 -172.21 46.74 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -92.28 142.37 27.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.8 t -128.98 143.65 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 125.499 1.52 . . . . 0.0 108.406 -172.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 0.8 OUTLIER -75.69 130.58 38.92 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -179.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.3 p -56.22 -24.17 40.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.01 0.924 . . . . 0.0 110.791 172.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.62 -23.99 67.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.34 1.056 . . . . 0.0 112.892 174.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.5 m -89.77 2.96 54.24 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.581 -1.324 . . . . 0.0 113.406 169.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.4 mt -142.17 68.93 1.32 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.959 1.303 . . . . 0.0 108.413 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.84 -5.19 7.5 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -168.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.573 HE21 ' HB2' ' A' ' 47' ' ' ALA . 2.3 pm0 -155.09 164.51 38.76 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 125.158 1.383 . . . . 0.0 108.072 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -62.18 133.62 55.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.67 -10.97 73.41 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-O 118.62 -1.1 . . . . 0.0 111.96 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.573 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -61.45 148.18 42.68 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 119.176 1.488 . . . . 0.0 110.018 168.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.7 p -137.39 153.8 50.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 122.053 0.93 . . . . 0.0 110.251 -178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.2 t -55.35 160.34 2.33 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.59 160.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 m -44.81 -28.58 0.66 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.64 2.376 . . . . 0.0 114.587 169.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 85.03 149.17 0.07 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 129.281 3.033 . . . . 0.0 110.383 174.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.03 156.92 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 C-N-CA 128.634 2.774 . . . . 0.0 106.178 -163.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.3 151.41 17.25 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -158.11 142.2 15.8 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.725 ' HB3' HG22 ' A' ' 130' ' ' THR . 3.7 m-20 -126.62 147.75 49.87 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.511 1.05 . . . . 0.0 109.801 -174.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.4 mm -89.95 108.76 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.466 1.107 . . . . 0.0 108.038 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -69.21 115.03 8.02 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.732 0.813 . . . . 0.0 109.981 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.0 mt -116.86 101.96 8.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.145 1.378 . . . . 0.0 107.681 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -94.3 158.53 15.54 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.918 2.087 . . . . 0.0 110.324 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.4 t70 34.46 63.07 0.46 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 128.107 2.563 . . . . 0.0 114.052 -167.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 49.4 m -76.06 91.93 3.14 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.611 0.764 . . . . 0.0 111.461 177.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -64.35 124.33 21.48 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 167.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 p -81.88 -24.42 35.73 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.905 -1.122 . . . . 0.0 113.499 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -63.0 -40.32 97.4 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.361 0.982 . . . . 0.0 110.356 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.468 HG11 ' HA ' ' A' ' 20' ' ' ALA . 2.4 p -66.51 -45.28 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.094 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -164.07 127.75 2.62 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.107 1.363 . . . . 0.0 107.715 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -81.2 6.78 12.95 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 116.837 -1.554 . . . . 0.0 112.508 169.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.505 ' CA ' HD21 ' A' ' 124' ' ' LEU . 49.1 mtmt -147.36 157.71 43.69 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 121.504 1.956 . . . . 0.0 114.354 172.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.21 133.43 51.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.479 1.911 . . . . 0.0 108.224 168.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.34 173.1 6.47 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 154.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.96 166.27 29.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.28 167.67 21.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -134.97 149.11 50.16 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -173.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 tp -146.44 124.79 12.3 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.89 0.376 . . . . 0.0 110.157 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.54 177.89 39.98 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 2.1 m -63.74 129.6 40.79 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.658 1.983 . . . . 0.0 110.124 -171.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.83 130.52 39.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.885 0.766 . . . . 0.0 110.073 173.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.6 tt -60.24 -40.32 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.839 0.856 . . . . 0.0 110.619 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -151.94 171.44 17.79 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 174.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.33 -35.36 75.84 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.013 0.925 . . . . 0.0 112.639 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.19 -0.07 89.47 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 123.661 0.648 . . . . 0.0 112.162 173.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -129.04 39.99 3.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.097 1.759 . . . . 0.0 109.28 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.9 p -66.66 -8.83 30.29 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.017 1.327 . . . . 0.0 113.018 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -87.93 -0.5 57.07 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.334 1.454 . . . . 0.0 113.024 167.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 36.1 t -129.08 139.54 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 120.739 1.609 . . . . 0.0 108.984 -177.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.454 HD23 ' H ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -89.43 143.05 27.12 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.752 -167.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.454 ' H ' HD23 ' A' ' 86' ' ' LEU . . . -84.31 15.48 3.58 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.334 1.854 . . . . 0.0 114.764 -165.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.0 mt 52.83 -169.17 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.059 0.944 . . . . 0.0 110.016 -168.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 124.905 1.282 . . . . 0.0 108.276 177.728 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.4 m . . . . . 0 C--O 1.236 0.391 0 CA-C-O 121.05 0.452 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.44 164.82 4.08 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.086 1.354 . . . . 0.0 110.058 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.9 p -120.65 166.81 13.16 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.622 1.169 . . . . 0.0 109.508 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.4 m-20 55.22 25.59 7.49 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.072 1.349 . . . . 0.0 111.191 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.83 150.77 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 119.373 0.988 . . . . 0.0 109.122 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.35 174.83 34.14 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -81.71 144.19 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -126.35 155.42 42.08 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.558 1.143 . . . . 0.0 108.95 165.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 mp -131.82 141.6 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.951 2.1 . . . . 0.0 107.011 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.691 HD23 ' HA ' ' A' ' 110' ' ' ALA . 5.1 mt -140.69 146.49 37.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.896 1.278 . . . . 0.0 107.827 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.56 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 4.2 p-10 -70.36 176.23 4.13 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.683 1.23 . . . . 0.0 111.915 166.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -45.71 -30.17 1.5 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.731 2.812 . . . . 0.0 115.271 171.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 50.9 p -88.64 -31.57 18.48 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 120.724 1.602 . . . . 0.0 110.98 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.409 ' O ' HD22 ' A' ' 104' ' ' LEU . . . 115.47 10.39 11.69 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.413 1.482 . . . . 0.0 113.622 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.9 131.18 44.04 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.188 1.494 . . . . 0.0 109.286 174.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.691 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -70.38 116.28 10.53 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.211 1.404 . . . . 0.0 109.778 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.1 mt -83.32 109.85 17.62 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.709 0.803 . . . . 0.0 109.011 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.4 m -57.86 151.94 16.98 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.077 0.465 . . . . 0.0 109.808 171.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.3 mt -102.84 76.06 1.46 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.024 2.129 . . . . 0.0 108.099 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -113.0 -19.58 11.85 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.646 1.178 . . . . 0.0 111.589 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.04 -22.49 0.76 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 126.579 2.038 . . . . 0.0 113.222 -175.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.23 -68.51 0.7 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 117.303 -1.332 . . . . 0.0 108.363 162.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.0 m -37.18 98.38 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.213 2.205 . . . . 0.0 111.745 -167.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -74.87 159.42 31.91 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.963 1.705 . . . . 0.0 110.175 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.9 p -107.85 175.51 5.46 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.423 1.489 . . . . 0.0 112.349 -175.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 5.6 m -39.88 110.95 0.16 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.728 2.011 . . . . 0.0 112.748 167.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -63.38 164.59 8.88 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.663 1.221 . . . . 0.0 110.48 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 86.1 m -140.15 137.23 34.26 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 165.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 100.0 m -82.95 141.24 32.29 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.194 0.998 . . . . 0.0 108.654 173.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.678 HD22 ' H ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -113.37 173.35 6.44 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 127.821 2.448 . . . . 0.0 107.773 -175.562 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.592 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 27.1 p30 -138.05 166.5 23.94 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 127.008 2.123 . . . . 0.0 109.02 176.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.59 115.16 2.85 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 123.967 0.792 . . . . 0.0 109.297 172.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 129.9 -104.37 0.62 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 174.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 86.5 m -146.19 129.25 16.51 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.11 -1.818 . . . . 0.0 110.148 -169.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.592 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 56.0 m-80 -135.07 169.03 18.06 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 126.818 2.047 . . . . 0.0 109.396 -171.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 55' ' ' ASN . 1.9 m -158.22 112.09 2.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -172.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.4 mt -76.74 121.35 84.66 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -75.32 146.91 32.08 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.636 1.557 . . . . 0.0 111.194 169.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -132.04 172.74 11.98 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.473 1.909 . . . . 0.0 107.629 168.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.36 151.75 45.68 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 162.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -130.54 162.73 28.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 165.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -157.2 166.13 34.06 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.411 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 85.2 m-85 -82.63 138.57 34.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 156.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -117.21 128.05 54.71 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.643 1.977 . . . . 0.0 106.156 174.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.42 146.87 24.99 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.671 0.788 . . . . 0.0 109.883 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.5 p -113.24 18.07 18.15 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.682 1.593 . . . . 0.0 111.164 172.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 163.03 -157.55 29.66 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.08 92.29 0.17 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.376 1.088 . . . . 0.0 109.833 174.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.41 128.78 35.89 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.214 1.005 . . . . 0.0 109.267 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.2 p -76.42 159.64 79.31 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 118.924 -1.11 . . . . 0.0 109.0 166.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -69.5 171.88 13.39 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 N-CA-C 110.061 -0.784 . . . . 0.0 110.061 158.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.02 178.99 17.4 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 125.769 1.652 . . . . 0.0 109.574 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.3 146.31 51.39 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.411 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -138.66 74.23 1.47 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -113.88 156.42 23.98 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.47 167.62 28.18 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.812 1.245 . . . . 0.0 108.027 173.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -137.84 136.62 37.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.78 169.37 17.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.436 1.494 . . . . 0.0 108.522 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.42 152.25 41.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 165.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -117.67 158.19 25.12 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -118.98 168.66 10.59 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 169.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.9 t -133.4 123.88 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -120.37 85.21 2.35 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.577 1.18 . . . . 0.0 108.856 -172.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.472 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 92.0 m-85 -72.59 157.42 37.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.894 -1.503 . . . . 0.0 112.847 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.426 ' HG3' ' HE3' ' A' ' 68' ' ' LYS . 3.4 pt20 -174.33 170.02 3.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.243 1.817 . . . . 0.0 110.01 -174.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.69 0 O-C-N 120.895 -1.128 . . . . 0.0 113.214 171.991 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 86.5 m -99.99 104.51 16.12 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.708 1.203 . . . . 0.0 109.206 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.2 m -94.57 93.17 7.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.427 1.891 . . . . 0.0 109.329 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.2 m -94.16 155.01 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 124.036 0.935 . . . . 0.0 110.166 173.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.98 144.88 52.18 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 161.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -103.71 -75.69 1.07 Allowed Glycine 0 C--N 1.332 0.352 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -177.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -175.62 -173.16 41.1 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -167.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.1 m -99.1 128.04 45.16 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.809 1.243 . . . . 0.0 109.53 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 19.9 t -104.98 105.34 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -82.49 143.27 31.23 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 168.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -122.76 126.39 47.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -134.75 152.23 51.6 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 118.185 0.448 . . . . 0.0 111.182 -171.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 139.94 -161.57 26.32 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.88 169.12 16.95 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -166.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 87.3 t -116.51 130.77 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.18 147.22 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 C-N-CA 125.895 1.678 . . . . 0.0 109.804 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.82 30.8 0.09 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -171.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.251 1.155 0 C-N-CA 131.436 3.895 . . . . 0.0 115.959 166.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.311 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.665 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -56.33 -43.6 79.18 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.5 m -108.92 175.19 5.55 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.536 1.535 . . . . 0.0 108.576 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.76 -16.06 15.04 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -167.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 t 54.88 114.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 128.343 2.657 . . . . 0.0 111.836 -173.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.17 154.38 16.21 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.2 1.4 . . . . 0.0 111.678 169.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -60.89 -27.3 68.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.732 1.213 . . . . 0.0 112.397 174.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.1 9.98 50.84 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.406 1.003 . . . . 0.0 112.997 172.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.2 t -129.46 -40.41 1.43 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.356 1.862 . . . . 0.0 108.546 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 25' ' ' ALA . 5.1 p -58.16 -34.13 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 123.696 0.798 . . . . 0.0 111.067 173.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -150.52 75.52 1.22 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.491 0.662 . . . . 0.0 109.565 -167.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.52 145.7 35.86 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.702 -0.624 . . . . 0.0 109.496 -173.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.9 m -112.58 95.3 5.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.94 111.8 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -84.54 103.46 13.69 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.4 HD23 HG21 ' A' ' 52' ' ' VAL . 13.2 mt -83.82 -4.99 59.1 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.045 1.338 . . . . 0.0 109.988 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.79 177.7 36.05 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 122.014 0.785 . . . . 0.0 112.522 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -75.83 139.6 41.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 167.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -125.77 143.42 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.129 0.971 . . . . 0.0 109.509 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.433 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 7.6 mmt180 -74.39 131.19 40.88 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 p -56.49 -23.3 38.46 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 123.304 0.642 . . . . 0.0 111.569 173.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.51 -48.67 71.62 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.488 1.115 . . . . 0.0 110.71 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.416 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 45.0 m -74.36 5.92 4.14 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.4 mt -142.92 59.39 1.42 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.354 1.862 . . . . 0.0 107.72 -168.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.57 6.41 3.5 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -165.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 1.004 HE21 ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -153.35 168.32 26.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.794 1.638 . . . . 0.0 107.161 170.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -63.09 136.56 57.86 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 167.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.42 3.37 86.03 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-O 118.936 -0.924 . . . . 0.0 112.123 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 1.004 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -65.53 145.32 56.24 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.766 1.283 . . . . 0.0 109.045 162.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -142.24 152.44 43.07 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.563 0.697 . . . . 0.0 110.377 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.4 p -69.82 -179.2 1.74 Allowed 'General case' 0 CA--C 1.555 1.141 0 O-C-N 121.518 -0.739 . . . . 0.0 109.097 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.43 -28.93 32.64 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -169.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 95.58 110.75 0.02 OUTLIER 'General case' 0 C--N 1.343 0.301 0 C-N-CA 130.703 3.601 . . . . 0.0 109.522 -168.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.4 HG21 HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -100.77 147.55 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.23 112.73 2.87 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.655 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 7.9 p90 -116.13 179.01 4.11 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.891 0.877 . . . . 0.0 109.142 177.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -158.66 172.44 18.27 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.193 -0.942 . . . . 0.0 110.659 176.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.3 mm -121.76 103.71 13.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -65.96 132.35 48.4 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 172.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 mp -129.24 119.9 24.81 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.245 2.218 . . . . 0.0 107.663 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -120.99 167.73 12.27 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.147 2.179 . . . . 0.0 111.178 -171.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.2 t70 25.31 57.0 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.28 2.632 . . . . 0.0 114.385 -165.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 91.2 m -73.74 121.73 21.26 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.551 2.34 . . . . 0.0 109.425 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -92.52 140.06 29.95 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 167.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.1 p -88.92 -13.79 38.24 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.907 1.685 . . . . 0.0 114.503 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -60.92 -51.33 69.74 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.112 0.958 . . . . 0.0 109.009 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.665 HG11 ' HA ' ' A' ' 20' ' ' ALA . 2.1 p -58.26 -48.72 84.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 124.809 1.244 . . . . 0.0 108.126 -175.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HB1' ' H ' ' A' ' 159' ' ' GLN . . . -167.8 127.17 1.31 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.41 1.884 . . . . 0.0 107.28 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.3 m -88.34 1.67 54.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.599 0.76 . . . . 0.0 110.821 169.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -127.68 160.79 30.57 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 121.107 1.776 . . . . 0.0 110.802 172.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.83 132.58 25.67 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.108 0.963 . . . . 0.0 109.385 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.35 170.38 9.41 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 122.384 1.088 . . . . 0.0 109.266 167.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.9 t -138.81 147.75 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 127.007 2.123 . . . . 0.0 105.453 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.53 159.33 36.65 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -123.61 157.31 34.03 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.613 1.565 . . . . 0.0 109.165 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.7 tp -152.59 142.14 21.77 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.715 0.806 . . . . 0.0 108.897 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.661 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -177.37 171.14 43.87 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -175.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 m -58.04 124.88 20.83 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.758 1.279 . . . . 0.0 110.261 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.56 136.6 44.02 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 119.533 1.061 . . . . 0.0 110.34 173.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.5 tt -61.0 -54.22 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 O-C-N 123.786 0.679 . . . . 0.0 110.686 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -134.12 161.7 34.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 176.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.8 -33.61 74.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.07 -0.394 . . . . 0.0 111.146 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.66 1.72 76.6 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 121.614 -0.679 . . . . 0.0 113.721 175.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -140.37 43.8 1.88 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.902 1.681 . . . . 0.0 109.86 -173.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 p -66.26 -3.89 6.71 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 128.233 2.613 . . . . 0.0 112.503 169.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -93.52 9.16 37.84 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.774 1.23 . . . . 0.0 112.183 167.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.7 t -138.37 143.6 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 120.892 -1.13 . . . . 0.0 110.939 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.683 HD13 ' HB1' ' A' ' 150' ' ' ALA . 6.4 mt -78.62 151.91 32.05 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 119.305 0.957 . . . . 0.0 112.071 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.58 18.73 5.98 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 127.444 2.297 . . . . 0.0 114.017 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.633 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 62.5 mt 51.74 -156.5 0.14 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.045 0.938 . . . . 0.0 110.806 -167.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 . . . . . 0 N--CA 1.447 -0.592 0 C-N-CA 125.417 1.487 . . . . 0.0 108.516 174.605 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 CA--C 1.536 0.43 0 CA-C-O 121.294 0.568 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.86 132.96 46.84 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 164.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.7 p -87.37 166.81 14.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 170.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 59.8 18.73 7.6 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.294 1.838 . . . . 0.0 112.507 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -141.46 156.35 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -165.58 170.16 40.31 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -169.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.21 138.66 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 119.283 1.542 . . . . 0.0 108.671 -175.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -105.32 156.46 18.14 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.317 0.962 . . . . 0.0 109.955 163.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -117.73 141.62 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 158.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 110' ' ' ALA . 50.7 mt -125.29 137.63 54.08 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.15 2.18 . . . . 0.0 105.385 175.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -63.29 166.67 6.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.72 1.248 . . . . 0.0 110.298 166.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.0 ptt85 -59.26 -26.01 64.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.085 1.354 . . . . 0.0 112.806 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.63 -12.93 60.9 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.967 0.803 . . . . 0.0 109.635 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.69 3.59 68.5 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 126.612 2.053 . . . . 0.0 112.738 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.05 159.61 31.52 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.398 1.599 . . . . 0.0 109.202 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.47 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -92.58 158.11 16.16 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.58 0.352 . . . . 0.0 110.207 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.6 mt -114.72 138.25 50.94 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 -172.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -75.22 157.19 34.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 170.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.7 mt -110.32 76.43 0.98 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.86 -14.97 10.07 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.289 0.635 . . . . 0.0 111.588 172.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.28 -2.82 81.66 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 117.055 -1.97 . . . . 0.0 113.946 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -139.66 -15.6 1.04 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.467 1.634 . . . . 0.0 112.851 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 49.6 m -59.54 111.7 1.51 Allowed 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 164.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.4 168.18 9.35 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.96 0.904 . . . . 0.0 110.082 173.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.6 p -120.01 -38.18 2.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -175.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.68 121.28 0.09 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.428 1.891 . . . . 0.0 109.41 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -67.62 140.29 56.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.7 m -130.96 117.39 19.15 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 55.0 m -56.92 137.73 54.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 171.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 45.4 mt -90.96 -163.59 1.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.195 0.998 . . . . 0.0 109.174 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.489 ' H ' HD21 ' A' ' 129' ' ' ASN . 16.0 p30 -154.63 166.58 32.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.878 2.071 . . . . 0.0 108.149 167.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -66.45 91.01 0.16 Allowed 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.274 1.83 . . . . 0.0 109.621 170.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.12 -107.93 0.64 Allowed Glycine 0 C--O 1.224 -0.517 0 CA-C-O 119.04 -0.867 . . . . 0.0 112.424 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.64 136.75 54.74 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 119.219 1.509 . . . . 0.0 110.614 -172.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.489 HD21 ' H ' ' A' ' 125' ' ' ASN . 45.2 m-80 -137.58 168.98 18.57 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 127.159 2.184 . . . . 0.0 108.529 -176.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 97.6 m -149.41 145.12 26.79 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 168.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.41 107.77 59.68 Favored Pre-proline 0 N--CA 1.447 -0.582 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 169.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.35 156.23 65.02 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 N-CA-C 109.117 -1.147 . . . . 0.0 109.117 171.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -139.72 166.29 25.0 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.827 1.651 . . . . 0.0 107.184 170.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -117.48 137.64 52.4 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 167.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.655 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -128.87 149.86 50.58 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.59 -175.4 5.37 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.944 -0.472 . . . . 0.0 110.443 170.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.468 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 72.4 m-85 -89.65 140.81 29.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 161.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -102.85 147.28 27.09 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.134 1.774 . . . . 0.0 106.321 164.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -112.11 144.55 41.31 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 166.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 75.0 p -102.51 12.4 36.51 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.192 0.997 . . . . 0.0 110.974 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 162.99 -145.49 10.65 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 176.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.04 87.11 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.897 1.679 . . . . 0.0 111.591 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.27 130.13 45.45 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.321 -0.862 . . . . 0.0 109.334 173.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 49.1 p -83.39 161.42 56.92 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 168.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -70.28 174.2 10.31 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.653 1.569 . . . . 0.0 110.079 163.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.26 -93.51 0.14 Allowed Glycine 0 C--N 1.333 0.365 0 O-C-N 120.965 -1.084 . . . . 0.0 111.536 172.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -149.53 163.3 38.21 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 175.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -146.02 86.05 1.7 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -125.63 153.43 43.78 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.683 ' HB1' HD13 ' A' ' 86' ' ' LEU . . . -162.93 165.73 24.73 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.682 1.193 . . . . 0.0 107.986 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -137.67 134.93 36.01 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -126.56 165.47 19.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.918 1.687 . . . . 0.0 109.484 174.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 41.4 p -119.67 124.86 47.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -93.8 149.66 21.05 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HG2' ' HA ' ' A' ' 171' ' ' ASN . 3.2 mtmp? -121.35 163.45 18.64 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.256 1.422 . . . . 0.0 107.757 171.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.52 109.13 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.248 -2.131 . . . . 0.0 105.248 -164.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -111.01 80.32 1.29 Allowed 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.316 1.446 . . . . 0.0 108.935 -167.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -71.6 161.72 30.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.802 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.421 ' H ' ' HB1' ' A' ' 66' ' ' ALA . 10.1 pt20 -175.26 171.53 2.91 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.352 1.061 . . . . 0.0 111.251 -174.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.376 0 C-N-CA 124.496 1.046 . . . . 0.0 111.591 176.64 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.776 0 CA-C-O 120.735 0.302 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 98.2 m -151.84 97.16 2.32 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.399 1.479 . . . . 0.0 107.866 -170.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.6 m -89.08 117.08 27.82 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.023 1.729 . . . . 0.0 109.768 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.93 159.27 26.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.755 1.622 . . . . 0.0 110.744 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.409 ' HA ' ' HG2' ' A' ' 155' ' ' LYS . 25.9 m120 -76.32 111.96 12.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.71 -67.59 1.82 Allowed Glycine 0 C--N 1.334 0.423 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.99 -160.98 34.73 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -171.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 37.5 m -107.05 128.35 54.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.448 1.099 . . . . 0.0 108.504 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 19.6 t -104.5 105.75 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 166.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -78.85 143.49 35.92 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 170.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -122.32 122.88 40.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -128.61 168.78 15.25 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.687 1.195 . . . . 0.0 109.699 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 138.88 -161.78 25.88 Favored Glycine 0 N--CA 1.443 -0.9 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -162.07 170.36 19.34 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.08 129.89 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 168.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.4 m -115.38 147.98 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 C-N-CA 127.166 2.186 . . . . 0.0 107.844 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.78 41.9 0.22 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.358 1.463 . . . . 0.0 113.356 -174.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.253 1.276 0 C-N-CA 129.627 3.171 . . . . 0.0 113.605 175.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.56 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . 48.7 -69.02 0.0 OUTLIER 'General case' 0 C--N 1.34 0.182 1 C-N-CA 133.453 4.701 . . . . 0.0 112.099 -171.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 29.1 m -83.19 -176.23 6.22 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.972 2.109 . . . . 0.0 111.229 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.31 16.14 10.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.925 2.09 . . . . 0.0 113.27 -171.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t 24.62 102.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 130.164 3.385 . . . . 0.0 113.137 172.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -55.32 157.59 3.59 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.63 1.172 . . . . 0.0 112.221 -171.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.22 -23.08 62.0 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.927 -1.108 . . . . 0.0 111.553 169.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.15 -18.49 73.07 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 117.872 -1.516 . . . . 0.0 113.671 172.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.2 p -118.43 -17.76 9.33 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.254 2.027 . . . . 0.0 111.919 -176.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.01 -27.77 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 O-C-N 120.876 -1.14 . . . . 0.0 112.771 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -167.3 82.3 0.21 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 -167.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.58 129.72 56.27 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -173.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -77.57 142.24 39.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 156.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.5 t -117.66 99.94 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 162.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -82.43 101.24 10.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.18 -17.3 59.6 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.767 0.827 . . . . 0.0 109.747 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.55 -165.21 18.78 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 121.716 0.62 . . . . 0.0 113.041 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -66.92 153.81 42.61 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.306 1.443 . . . . 0.0 111.53 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.5 t -137.13 147.95 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 125.414 1.485 . . . . 0.0 108.628 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.41 127.98 32.97 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 p -59.15 -25.1 63.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.227 0.537 . . . . 0.0 111.806 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.31 -27.87 66.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.497 -0.752 . . . . 0.0 111.204 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.5 t -84.52 0.89 48.15 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.245 1.418 . . . . 0.0 112.802 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.434 HD13 HG21 ' A' ' 99' ' ' VAL . 11.1 mt -143.84 82.69 1.73 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.62 1.568 . . . . 0.0 107.826 -170.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.04 0.05 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.408 -1.433 . . . . 0.0 113.485 -174.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.494 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 4.0 pm0 -148.22 157.25 43.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.472 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 33.0 tt0 -63.37 121.83 14.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.51 -4.57 61.97 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.282 1.42 . . . . 0.0 113.523 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB2' ' NE2' ' A' ' 44' ' ' GLN . . . -61.22 154.24 24.01 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 119.24 1.52 . . . . 0.0 109.499 168.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.5 p -144.06 156.23 44.29 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.251 0.478 . . . . 0.0 110.678 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.7 p -72.55 -174.67 1.43 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.6 m -50.54 -40.18 51.11 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 117.101 -1.428 . . . . 0.0 113.806 171.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 95.18 170.92 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 C-N-CA 131.694 3.998 . . . . 0.0 109.815 -166.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.6 t -145.0 139.1 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 167.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.27 69.48 0.22 Allowed Glycine 0 CA--C 1.51 -0.246 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.52 ' HE1' ' HB2' ' A' ' 135' ' ' ALA . 29.4 p90 -69.0 161.0 29.9 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -133.67 175.84 9.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.739 1.616 . . . . 0.0 109.518 169.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.3 mm -109.81 112.29 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -68.55 112.42 5.34 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.301 0.64 . . . . 0.0 109.861 172.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.92 135.91 49.33 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 125.006 1.323 . . . . 0.0 108.272 168.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -136.95 167.65 21.08 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.378 1.471 . . . . 0.0 110.362 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 46.07 30.74 0.99 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.965 2.106 . . . . 0.0 113.353 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 96.3 m -62.83 162.48 10.97 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 127.031 2.132 . . . . 0.0 111.388 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -151.42 120.24 6.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.797 1.639 . . . . 0.0 106.898 -167.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.9 p -79.4 -18.45 52.26 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 120.898 -1.126 . . . . 0.0 112.22 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -60.35 -46.97 88.06 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.472 0.709 . . . . 0.0 109.725 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 20' ' ' ALA . 6.2 p -73.12 -45.78 52.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.212 1.005 . . . . 0.0 109.637 -175.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -161.82 124.17 2.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.145 1.378 . . . . 0.0 108.099 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 m -66.85 -11.75 56.73 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.893 170.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -149.46 163.1 38.72 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 120.846 1.657 . . . . 0.0 114.116 -169.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.89 126.51 39.89 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.713 2.005 . . . . 0.0 106.836 166.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.55 172.96 8.15 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 142.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.453 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.4 OUTLIER -139.88 151.09 21.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 103.182 -2.896 . . . . 0.0 103.182 -171.247 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.76 149.45 46.44 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.427 ' CD1' HG21 ' A' ' 103' ' ' ILE . 17.6 m-85 -114.24 157.88 22.13 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.856 0.862 . . . . 0.0 110.757 177.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.408 HD22 ' HA3' ' A' ' 115' ' ' GLY . 13.9 tp -150.47 140.93 22.44 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.952 1.301 . . . . 0.0 108.934 -176.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.16 -169.0 34.39 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 123.929 0.776 . . . . 0.0 112.381 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 m -81.5 130.87 35.21 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.205 1.802 . . . . 0.0 109.605 166.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -76.97 140.07 40.32 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 119.553 1.07 . . . . 0.0 111.028 172.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.3 tt -64.04 -44.62 97.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 122.689 0.396 . . . . 0.0 111.503 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.43 164.46 34.91 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.836 1.254 . . . . 0.0 108.636 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.85 -27.22 66.47 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.888 1.275 . . . . 0.0 113.114 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.77 -2.94 88.45 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.798 0.713 . . . . 0.0 112.582 175.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -143.34 47.3 1.5 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.772 1.629 . . . . 0.0 109.133 -169.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.474 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 25.5 p -61.89 -15.61 44.03 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.15 0.98 . . . . 0.0 112.943 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -94.48 -12.76 27.05 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 124.709 1.203 . . . . 0.0 109.762 -173.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.09 130.81 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.857 1.263 . . . . 0.0 107.653 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mt -72.2 150.01 44.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.85 1.26 . . . . 0.0 110.291 -174.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.74 14.05 16.44 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.983 1.713 . . . . 0.0 114.351 -164.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 51.1 mt 48.74 -152.48 0.12 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.216 1.007 . . . . 0.0 110.199 -162.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--O 1.241 0.623 0 C-N-CA 125.507 1.523 . . . . 0.0 110.374 -178.005 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 CA--C 1.538 0.511 0 CA-C-O 122.513 1.149 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.78 128.9 39.5 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.036 1.334 . . . . 0.0 109.177 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.5 p -87.5 170.27 11.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.893 0.77 . . . . 0.0 110.03 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 49.6 32.78 5.23 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.938 1.695 . . . . 0.0 111.943 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.434 HG21 HD13 ' A' ' 42' ' ' LEU . 3.1 p -154.68 151.02 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.4 172.77 34.83 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.434 HG11 ' CD2' ' A' ' 177' ' ' PHE . 79.2 t -84.61 133.74 28.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -104.48 153.54 21.01 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 157.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.427 HG21 ' CD1' ' A' ' 73' ' ' PHE . 4.0 mp -116.72 128.91 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 103.747 -2.686 . . . . 0.0 103.747 164.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 mt -125.96 143.11 51.22 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.566 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 5.7 p-10 -66.66 -178.33 0.7 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.475 1.11 . . . . 0.0 112.659 173.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.429 ' HG3' HG23 ' A' ' 107' ' ' THR . 9.4 ptm180 -44.37 -31.67 1.12 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 128.605 2.762 . . . . 0.0 114.856 169.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.429 HG23 ' HG3' ' A' ' 106' ' ' ARG . 28.6 p -95.09 -4.65 45.92 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.884 1.274 . . . . 0.0 112.125 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.48 22.23 78.76 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 121.162 -0.961 . . . . 0.0 112.933 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -82.69 144.31 30.33 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.923 1.861 . . . . 0.0 109.081 168.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.87 129.05 37.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.756 0.822 . . . . 0.0 111.106 -176.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.426 HD12 HG22 ' A' ' 103' ' ' ILE . 51.9 mt -89.45 168.68 12.0 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.001 0.52 . . . . 0.0 110.396 176.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 m -122.32 140.63 52.43 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.995 1.318 . . . . 0.0 107.764 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.7 mt -93.69 52.03 1.64 Allowed 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.513 1.125 . . . . 0.0 109.895 -160.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.33 -29.34 19.22 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.238 1.015 . . . . 0.0 111.495 -174.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.408 ' HA3' HD22 ' A' ' 74' ' ' LEU . . . 83.99 -30.43 3.59 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 124.564 1.078 . . . . 0.0 113.697 -172.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.05 -58.04 3.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 116.989 -1.481 . . . . 0.0 109.383 166.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.2 m -40.66 103.97 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.315 1.446 . . . . 0.0 111.956 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -63.32 160.77 15.24 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.068 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.3 p -118.43 173.08 7.03 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.857 1.263 . . . . 0.0 109.383 168.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 17.2 m -25.2 116.46 0.05 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.051 2.14 . . . . 0.0 113.402 166.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -72.33 167.4 20.54 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 122.318 1.056 . . . . 0.0 109.174 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.1 m -132.57 157.11 45.55 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 160.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.4 m -107.04 133.81 51.11 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 123.517 1.627 . . . . 0.0 107.961 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.99 175.77 6.51 Favored 'General case' 0 N--CA 1.428 -1.561 0 C-N-CA 129.179 2.991 . . . . 0.0 108.904 -164.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.479 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 7.3 p30 -145.68 165.48 28.63 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.411 1.484 . . . . 0.0 107.971 172.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -61.09 122.59 15.37 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 169.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.21 -119.27 6.11 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.263 0.935 . . . . 0.0 111.208 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 m -117.58 125.87 51.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 119.232 1.516 . . . . 0.0 110.436 -167.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.479 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -133.22 176.02 8.88 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 125.051 1.34 . . . . 0.0 109.948 175.734 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.0 m -145.28 137.32 25.64 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.261 -0.899 . . . . 0.0 110.586 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.8 mt -102.63 108.88 59.46 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 169.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -86.59 159.5 9.31 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.607 2.205 . . . . 0.0 110.648 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.453 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 40.9 m-85 -146.43 177.17 9.24 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.1 1.76 . . . . 0.0 109.438 -172.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.09 115.34 8.88 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.393 0.997 . . . . 0.0 111.09 153.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.52 ' HB2' ' HE1' ' A' ' 54' ' ' PHE . . . -84.24 164.88 18.8 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 121.45 -0.781 . . . . 0.0 109.535 167.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -157.24 160.63 38.84 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.011 1.325 . . . . 0.0 107.506 171.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -79.77 132.11 36.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 160.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -116.33 123.02 46.59 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.503 1.921 . . . . 0.0 106.054 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -82.06 143.44 31.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.165 0.586 . . . . 0.0 109.82 176.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.472 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 12.3 p -106.19 11.17 31.54 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.765 0.826 . . . . 0.0 112.173 170.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 160.84 -149.25 18.21 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.06 86.78 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.956 1.303 . . . . 0.0 110.01 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.67 155.96 39.71 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.282 0.633 . . . . 0.0 109.871 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.4 p -118.83 161.52 35.71 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.757 0.708 . . . . 0.0 109.896 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -75.39 176.89 9.36 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.681 1.587 . . . . 0.0 110.629 171.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.43 -97.95 0.17 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 164.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.94 163.19 31.29 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 129.947 3.299 . . . . 0.0 105.456 168.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -150.19 77.22 1.3 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.673 0.67 . . . . 0.0 109.816 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -119.81 150.35 40.57 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -174.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -152.73 164.08 38.45 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.454 1.102 . . . . 0.0 108.193 171.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -134.68 98.28 4.01 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.97 177.81 8.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.39 0.614 . . . . 0.0 110.376 168.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.5 p -122.16 162.44 21.32 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 150.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.428 ' CE1' ' HA3' ' A' ' 172' ' ' GLY . 44.4 p90 -115.98 150.86 36.51 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.912 0.863 . . . . 0.0 109.763 158.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -107.37 167.04 10.2 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.042 1.737 . . . . 0.0 106.659 161.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.88 146.71 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 171.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -128.1 85.12 2.31 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -66.54 147.98 52.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.143 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -161.44 176.91 10.61 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 124.76 1.224 . . . . 0.0 110.752 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.407 0 C-N-CA 125.056 1.312 . . . . 0.0 111.339 175.605 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.4 m -130.91 99.41 4.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.6 131.74 42.85 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 167.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.7 m -148.55 140.65 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 124.405 1.082 . . . . 0.0 109.742 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -66.87 126.27 28.54 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 166.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 154' ' ' PHE . . . -93.41 -75.96 1.32 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -160.29 -175.48 31.33 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 123.72 0.306 . . . . 0.0 113.232 -176.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 25.6 m -103.6 142.82 33.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.401 1.48 . . . . 0.0 109.007 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.4 t -125.57 101.56 8.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -88.35 95.6 10.26 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.434 ' CD2' HG11 ' A' ' 101' ' ' VAL . 71.4 m-85 -75.14 102.21 4.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 175.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -114.24 156.94 23.4 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 -175.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 143.75 -163.37 27.63 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -171.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -161.44 170.15 20.54 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -164.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 48.3 t -126.4 140.51 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 167.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 16.9 m -122.06 150.37 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 127.058 2.143 . . . . 0.0 109.046 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.65 24.59 0.09 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -169.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 1 C-N-CA 132.993 4.517 . . . . 0.0 113.719 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.909 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.474 ' HB3' ' CD1' ' A' ' 158' ' ' TYR . . . -53.28 -38.87 63.48 Favored 'General case' 0 C--O 1.225 -0.211 0 O-C-N 123.986 0.803 . . . . 0.0 112.206 -165.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.4 ' SG ' HD13 ' A' ' 124' ' ' LEU . 3.5 m -110.22 159.3 17.51 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.798 1.239 . . . . 0.0 107.779 165.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.81 -9.3 52.26 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -164.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.5 t 44.95 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 129.038 2.935 . . . . 0.0 110.744 -167.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -62.91 160.57 14.49 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.289 -170.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.7 -21.2 39.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.953 1.301 . . . . 0.0 112.15 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.53 -12.9 67.53 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.564 1.078 . . . . 0.0 112.755 173.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 t -127.09 -21.67 3.91 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.834 1.654 . . . . 0.0 110.792 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.9 -26.13 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 125.25 1.42 . . . . 0.0 113.007 -173.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -150.7 94.5 2.1 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -132.61 148.31 52.36 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.343 0.657 . . . . 0.0 109.485 -175.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.2 m -124.32 100.4 6.67 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.634 1.973 . . . . 0.0 108.041 -174.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.5 t -74.53 111.28 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -88.55 101.41 13.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.63 HD23 HG11 ' A' ' 52' ' ' VAL . 1.2 mt -76.46 -16.39 59.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.033 1.733 . . . . 0.0 109.7 170.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.39 -166.55 25.49 Favored Glycine 0 C--N 1.343 0.935 0 C-N-CA 124.796 1.189 . . . . 0.0 112.765 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -68.68 147.63 51.58 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.98 0.912 . . . . 0.0 109.64 173.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 t -135.88 143.41 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 124.353 1.061 . . . . 0.0 108.949 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 3.8 mmt85 -73.29 127.67 33.3 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 182' ' ' VAL . 33.3 p -58.01 -21.94 47.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.211 0.529 . . . . 0.0 111.485 172.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.38 -43.3 75.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.165 -0.96 . . . . 0.0 110.675 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.6 m -72.49 -2.11 18.39 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.4 mt -144.0 66.28 1.29 Allowed 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.488 1.915 . . . . 0.0 109.017 -161.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.97 -9.07 6.0 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -167.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.669 HE21 ' HB2' ' A' ' 47' ' ' ALA . 2.8 pm0 -152.52 163.09 40.26 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.391 1.476 . . . . 0.0 107.928 -178.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -62.77 129.97 42.84 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.24 -10.68 63.58 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.842 1.211 . . . . 0.0 112.734 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.669 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -67.83 106.2 2.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.35 1.06 . . . . 0.0 111.458 169.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.415 HG21 ' CZ ' ' A' ' 136' ' ' ARG . 11.8 p -101.18 150.6 22.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.44 -0.788 . . . . 0.0 110.812 -176.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.1 p -67.56 172.45 5.09 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 166.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.7 m -24.64 -98.9 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 130.257 3.423 . . . . 0.0 114.517 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 154.72 118.24 0.0 OUTLIER 'General case' 0 C--O 1.233 0.191 0 C-N-CA 129.746 3.218 . . . . 0.0 105.356 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.63 HG11 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -130.58 130.96 65.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -176.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.08 139.5 14.58 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -138.48 158.77 43.62 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 168.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -148.94 130.08 14.51 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 120.347 -1.471 . . . . 0.0 110.396 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.7 mm -83.54 115.61 26.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 125.002 1.321 . . . . 0.0 107.459 -167.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -76.63 108.95 9.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.988 0.915 . . . . 0.0 109.826 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.7 mp -111.71 97.13 6.5 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 125.414 1.485 . . . . 0.0 108.294 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -95.83 160.32 14.53 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.161 1.784 . . . . 0.0 112.227 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.3 t70 40.49 49.7 2.68 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.275 2.63 . . . . 0.0 114.007 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 57.5 m -65.66 122.16 16.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 127.701 2.4 . . . . 0.0 111.05 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.425 ' HB3' HG23 ' A' ' 65' ' ' VAL . 5.9 t0 -111.17 112.6 24.51 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.582 1.153 . . . . 0.0 110.161 -173.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.9 p -70.84 -24.68 62.57 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.146 2.178 . . . . 0.0 113.738 -165.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -61.47 -48.2 82.19 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 128.543 2.737 . . . . 0.0 112.44 168.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 62' ' ' ASP . 40.1 t -64.88 -39.13 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -176.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -168.63 146.06 3.91 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.117 -176.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.25 -11.42 35.34 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 118.795 -0.621 . . . . 0.0 111.67 170.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -134.04 164.8 26.5 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 125.46 1.504 . . . . 0.0 109.942 -173.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.79 144.06 37.18 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 163.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.79 167.88 9.83 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.98 1.712 . . . . 0.0 107.429 158.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.7 t -124.8 150.97 29.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 169.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.25 155.21 37.62 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 161.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.623 ' CE1' HG21 ' A' ' 103' ' ' ILE . 60.0 m-85 -114.04 154.85 26.98 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.406 HD13 ' C ' ' A' ' 114' ' ' ASP . 9.7 tp -142.11 125.97 17.11 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 125.373 1.469 . . . . 0.0 107.365 177.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.679 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -165.85 162.91 36.34 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.3 m -63.08 129.47 40.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.003 0.901 . . . . 0.0 109.107 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.69 141.31 46.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.071 0.462 . . . . 0.0 110.245 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.3 tt -60.77 -37.51 76.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 123.931 0.892 . . . . 0.0 110.382 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -158.24 165.56 34.55 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.45 -35.4 72.06 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.856 1.262 . . . . 0.0 111.254 169.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.79 -3.68 64.29 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 121.276 -0.89 . . . . 0.0 112.381 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -147.78 48.54 1.08 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.959 1.704 . . . . 0.0 108.788 -164.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.3 p -58.75 -18.4 31.4 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.598 1.959 . . . . 0.0 112.414 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -95.07 -1.79 51.44 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 117.928 -1.034 . . . . 0.0 113.076 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.3 t -115.58 130.59 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 120.329 1.422 . . . . 0.0 109.807 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.679 HD21 ' HA3' ' A' ' 75' ' ' GLY . 4.8 mt -72.2 151.47 42.89 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.209 1.004 . . . . 0.0 111.393 -175.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.72 17.41 10.39 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.999 1.719 . . . . 0.0 113.656 -168.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.644 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 63.8 mt 52.34 -154.17 0.2 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.606 1.562 . . . . 0.0 109.406 -168.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--O 1.234 0.255 0 CA-C-N 118.725 0.693 . . . . 0.0 110.158 -179.245 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.8 m . . . . . 0 CA--C 1.536 0.417 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.07 139.07 57.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.389 1.476 . . . . 0.0 107.57 164.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 p -90.36 170.4 10.28 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.761 0.709 . . . . 0.0 109.594 173.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 58.73 19.92 7.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 126.536 1.934 . . . . 0.0 112.71 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.7 p -143.49 151.38 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -153.5 177.67 30.92 Favored Glycine 0 C--O 1.225 -0.408 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 m -96.03 142.87 13.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 CA-C-N 120.018 1.909 . . . . 0.0 109.056 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -110.15 156.61 20.37 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 120.257 1.39 . . . . 0.0 109.328 161.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.623 HG21 ' CE1' ' A' ' 73' ' ' PHE . 4.6 mp -114.02 142.97 24.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 126.995 2.118 . . . . 0.0 105.562 159.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 110' ' ' ALA . 8.3 mt -131.77 156.0 46.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.235 1.814 . . . . 0.0 106.674 170.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 106' ' ' ARG . 3.5 t70 -72.34 -105.35 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 165.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.402 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 19.7 ptt180 -151.21 -9.79 0.23 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.744 1.618 . . . . 0.0 112.432 178.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.5 p -83.12 7.54 15.66 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.646 1.578 . . . . 0.0 109.344 172.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.45 8.1 30.1 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.441 1.496 . . . . 0.0 113.484 -166.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.31 114.65 3.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 119.476 1.638 . . . . 0.0 107.377 170.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.499 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -95.08 127.44 41.15 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.43 131.62 51.59 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.826 0.704 . . . . 0.0 110.623 -162.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.8 m -65.18 153.96 39.41 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.616 0.366 . . . . 0.0 110.611 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.81 49.92 0.8 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.393 1.477 . . . . 0.0 110.226 -171.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.406 ' C ' HD13 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -88.59 -28.86 20.42 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.564 -1.335 . . . . 0.0 111.091 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.44 2.03 56.63 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 126.523 2.011 . . . . 0.0 113.641 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.78 -31.69 1.95 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 117.583 -1.198 . . . . 0.0 111.35 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.1 m -54.67 104.35 0.11 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.713 1.142 . . . . 0.0 110.131 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -87.26 149.95 24.22 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.886 -173.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.6 -160.73 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.896 1.278 . . . . 0.0 111.789 -174.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 m -50.76 156.49 0.94 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.519 0.727 . . . . 0.0 111.778 147.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -102.4 152.93 20.53 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.393 1.877 . . . . 0.0 108.313 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.8 m -132.03 118.25 19.44 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.449 1.499 . . . . 0.0 107.851 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.5 m -59.15 123.76 17.71 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 166.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.4 HD13 ' SG ' ' A' ' 21' ' ' CYS . 73.3 mt -91.2 -174.69 4.04 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 128.805 2.842 . . . . 0.0 109.59 176.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -163.04 172.94 14.22 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.522 1.929 . . . . 0.0 108.537 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -59.57 107.38 0.58 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.974 1.709 . . . . 0.0 109.748 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.1 -124.25 3.19 Favored Glycine 0 N--CA 1.474 1.226 0 CA-C-N 120.417 1.462 . . . . 0.0 112.8 169.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 99.2 m -122.75 125.31 45.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 120.535 2.168 . . . . 0.0 109.091 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -133.29 177.72 7.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.474 1.91 . . . . 0.0 109.706 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.57 162.18 40.71 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -166.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 17.6 mt -139.92 112.29 7.5 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.64 153.08 43.46 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.971 1.781 . . . . 0.0 109.431 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -136.41 161.3 36.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.894 1.677 . . . . 0.0 107.605 170.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -127.18 97.27 4.87 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -175.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.12 157.23 25.41 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.406 1.482 . . . . 0.0 110.578 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.415 ' CZ ' HG21 ' A' ' 48' ' ' THR . 24.9 ptt180 -159.14 169.83 23.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.079 1.352 . . . . 0.0 111.306 162.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.433 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 76.0 m-85 -82.78 146.05 29.18 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 152.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -123.83 116.53 23.11 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.97 2.108 . . . . 0.0 106.914 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.54 141.15 36.92 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 171.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.2 p -105.67 17.13 24.28 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.895 0.878 . . . . 0.0 110.375 171.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 161.64 -155.98 27.36 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.06 91.34 0.15 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.995 1.718 . . . . 0.0 110.043 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.12 152.72 32.11 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 55.0 p -104.38 161.06 23.99 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -72.87 170.9 18.56 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 N-CA-C 109.215 -1.11 . . . . 0.0 109.215 160.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.06 -95.46 0.15 Allowed Glycine 0 C--O 1.226 -0.348 0 O-C-N 121.35 -0.844 . . . . 0.0 112.114 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -151.12 161.18 43.21 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.175 1.79 . . . . 0.0 106.743 173.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.433 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -147.11 81.23 1.54 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -118.92 139.53 51.49 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.644 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -151.5 157.24 42.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -130.34 121.88 26.84 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -101.15 163.57 12.22 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 162.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.3 p -103.8 156.15 18.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 151.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -115.84 157.8 23.89 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.49 0.716 . . . . 0.0 109.604 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -126.31 162.7 24.88 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 126.946 2.098 . . . . 0.0 107.768 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.411 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 10.8 t -128.55 123.34 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 -175.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -111.78 85.56 2.16 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 20' ' ' ALA . 85.8 m-85 -64.7 146.84 54.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.283 170.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -164.47 168.21 18.66 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 121.838 0.827 . . . . 0.0 112.44 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 105.894 -2.883 . . . . 0.0 105.894 -176.928 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.682 0 CA-C-O 120.834 0.349 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 90.9 m -103.58 91.89 4.22 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.414 1.486 . . . . 0.0 107.939 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.2 m -79.02 101.97 8.1 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 171.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -104.84 169.2 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 126.111 1.765 . . . . 0.0 108.791 170.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.33 173.63 4.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.437 0.637 . . . . 0.0 111.094 169.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -127.16 -72.09 0.18 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 174.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.68 -167.23 39.88 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -167.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.1 m -96.9 137.5 35.89 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.048 0.939 . . . . 0.0 108.745 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.7 t -117.96 105.49 18.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 163.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -78.11 141.74 38.56 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 171.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -123.56 101.15 7.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.27 2.228 . . . . 0.0 105.174 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -115.06 155.99 25.99 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.89 0.876 . . . . 0.0 109.265 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.64 -166.71 27.28 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -167.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -167.09 175.22 7.66 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -169.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 24.3 t -128.86 138.0 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 174.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 39' ' ' THR . 11.0 m -124.69 151.43 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 C-N-CA 127.255 2.222 . . . . 0.0 107.75 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -74.89 30.88 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -171.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.249 1.049 0 C-N-CA 131.074 3.75 . . . . 0.0 114.017 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.554 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -48.4 -40.21 25.1 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.87 1.268 . . . . 0.0 112.377 -175.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -112.79 160.71 17.71 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.755 1.622 . . . . 0.0 109.579 178.404 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.92 -21.62 31.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.334 -167.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 t 56.51 107.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 128.633 2.773 . . . . 0.0 110.272 -165.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -65.7 163.14 17.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.66 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.552 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -53.26 -29.6 33.76 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.242 1.017 . . . . 0.0 111.356 167.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.43 4.61 3.65 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.673 1.13 . . . . 0.0 114.784 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.8 t -147.6 -34.13 0.25 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.188 1.494 . . . . 0.0 110.351 -167.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 25' ' ' ALA . 8.1 p -60.4 -36.84 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 O-C-N 120.738 -1.226 . . . . 0.0 111.371 174.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -151.24 97.38 2.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.96 0.886 . . . . 0.0 109.081 -172.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -131.33 133.83 45.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 123.376 1.56 . . . . 0.0 110.179 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.8 m -108.75 88.96 2.85 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -174.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.56 105.11 7.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -171.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -80.89 115.14 20.23 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.674 HD23 HG11 ' A' ' 52' ' ' VAL . 1.2 mt -79.89 -7.44 58.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.974 0.91 . . . . 0.0 110.732 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.19 -178.47 51.42 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.647 1.117 . . . . 0.0 110.703 -177.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -79.05 146.82 33.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 165.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.58 145.58 35.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 124.395 1.078 . . . . 0.0 108.637 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -77.63 132.44 38.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.3 p -59.04 -22.81 61.31 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 122.489 0.316 . . . . 0.0 110.7 168.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.14 -9.64 41.95 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.91 -1.119 . . . . 0.0 113.274 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.0 m -101.36 -2.38 31.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.456 1.103 . . . . 0.0 113.28 168.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.594 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 17.4 mt -142.56 83.22 1.81 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 126.845 2.058 . . . . 0.0 106.815 -166.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.69 6.98 1.45 Allowed 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.289 -0.882 . . . . 0.0 112.274 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.464 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 6.5 pm0 -154.48 160.15 41.42 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.701 1.2 . . . . 0.0 107.886 -174.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -64.09 136.42 57.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 121.528 -0.732 . . . . 0.0 109.796 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.31 -4.17 56.09 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-O 117.51 -1.717 . . . . 0.0 112.344 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.464 ' HB2' ' NE2' ' A' ' 44' ' ' GLN . . . -58.71 143.78 45.69 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 120.562 2.181 . . . . 0.0 108.113 170.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.8 p -140.75 154.68 46.4 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -176.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.5 p -73.41 -178.49 3.03 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.2 m -28.55 -91.03 0.0 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.622 2.769 . . . . 0.0 114.735 173.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.41 111.02 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 130.495 3.518 . . . . 0.0 104.356 -176.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.674 HG11 HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -107.02 136.08 43.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 173.374 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.33 88.77 0.43 Allowed Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 -173.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -83.22 -179.55 7.44 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -148.53 162.97 38.58 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 120.189 -1.569 . . . . 0.0 109.997 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.1 mm -99.62 103.81 15.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -69.49 124.47 23.99 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 174.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.4 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 6.5 mp -117.5 165.46 13.51 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.729 1.612 . . . . 0.0 108.789 174.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -176.03 153.26 1.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.313 1.445 . . . . 0.0 109.219 -165.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 47.12 37.47 5.4 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.542 2.337 . . . . 0.0 114.501 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.534 ' SG ' HD13 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -67.3 119.42 12.13 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.407 1.483 . . . . 0.0 110.35 177.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -90.53 142.57 27.61 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 163.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.3 p -91.19 -14.02 31.8 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.664 1.575 . . . . 0.0 114.308 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -70.64 -43.49 69.1 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.739 0.781 . . . . 0.0 110.222 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 20' ' ' ALA . 2.8 p -60.27 -49.71 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.86 130.37 3.19 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 125.955 1.702 . . . . 0.0 108.081 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -82.29 -8.05 59.63 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.018 0.927 . . . . 0.0 111.695 174.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -131.24 167.04 19.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.921 1.689 . . . . 0.0 110.111 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.56 ' HB2' HD11 ' A' ' 124' ' ' LEU . . . -141.03 129.1 22.01 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 162.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.4 176.91 5.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 145.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.424 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.4 OUTLIER -144.03 160.5 15.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 101.648 -3.464 . . . . 0.0 101.648 -168.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.25 167.9 21.71 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 120.354 -1.466 . . . . 0.0 107.458 168.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -126.39 153.51 44.86 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 tp -142.13 142.72 32.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.11 170.07 42.85 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 2.0 m -57.19 125.76 24.18 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.954 1.701 . . . . 0.0 109.374 177.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.43 137.52 46.51 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.687 1.13 . . . . 0.0 109.866 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.1 tt -59.2 -49.21 84.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 124.405 1.082 . . . . 0.0 110.7 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -147.78 166.72 26.67 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.09 -34.41 76.24 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.961 1.304 . . . . 0.0 112.231 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.9 -12.69 84.17 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 119.514 -0.603 . . . . 0.0 112.347 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -125.79 48.86 2.01 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.266 1.427 . . . . 0.0 110.153 -173.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.4 p -63.89 -11.96 32.53 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 126.776 2.03 . . . . 0.0 114.041 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -86.25 -4.05 59.09 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.15 -0.968 . . . . 0.0 111.074 171.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.7 t -124.47 132.7 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 119.832 1.196 . . . . 0.0 109.258 -168.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.34 148.25 35.72 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.47 1.508 . . . . 0.0 110.473 -172.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 76' ' ' THR . . . -91.53 17.33 8.83 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.395 1.478 . . . . 0.0 114.27 -166.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.402 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 26.0 mt 51.27 -153.02 0.19 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.261 0.624 . . . . 0.0 109.811 -166.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 . . . . . 0 N--CA 1.45 -0.462 0 C-N-CA 125.073 1.349 . . . . 0.0 109.238 177.689 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.44 -0.931 0 CA-C-O 124.343 2.021 . . . . 0.0 111.901 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.06 156.75 14.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 112.277 -2.238 . . . . 0.0 107.891 151.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.44 163.8 28.55 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.495 1.518 . . . . 0.0 108.471 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 59.03 15.65 4.16 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.298 1.439 . . . . 0.0 111.214 -170.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.14 152.71 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 120.207 1.367 . . . . 0.0 109.025 -176.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.27 176.11 28.16 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 125.396 1.474 . . . . 0.0 110.306 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.406 HG11 ' CG ' ' A' ' 177' ' ' PHE . 92.9 t -86.4 142.51 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 172.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.708 HE22 ' HB1' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -120.64 157.87 28.62 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.659 1.184 . . . . 0.0 108.544 163.009 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.7 mp -134.72 138.68 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 C-N-CA 129.082 2.953 . . . . 0.0 104.783 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.07 147.28 46.01 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -178.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.473 ' CG ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -67.84 -175.26 0.53 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.263 0.938 . . . . 0.0 110.405 175.278 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -52.16 -18.14 1.37 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 171.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 t -81.41 -13.65 58.04 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.51 -0.744 . . . . 0.0 109.363 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.15 13.26 52.98 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.557 2.027 . . . . 0.0 113.501 -167.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.05 127.59 33.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 168.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.708 ' HB1' HE22 ' A' ' 102' ' ' GLN . . . -62.04 129.05 39.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.328 1.451 . . . . 0.0 111.482 -177.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.0 mt -100.76 160.44 14.36 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 124.086 0.866 . . . . 0.0 110.54 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.0 m -96.13 153.16 17.94 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.995 0.918 . . . . 0.0 108.567 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.4 mt -107.19 64.26 0.64 Allowed 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 123.593 0.757 . . . . 0.0 109.542 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -111.06 -12.61 14.17 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.616 0.766 . . . . 0.0 111.799 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.82 -27.02 1.38 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 125.179 1.371 . . . . 0.0 112.739 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.02 -69.7 0.57 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 117.862 -1.066 . . . . 0.0 109.266 164.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.7 m -39.6 99.09 0.02 OUTLIER 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.804 2.041 . . . . 0.0 112.128 -169.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -70.16 155.96 39.9 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.207 1.403 . . . . 0.0 109.81 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.8 p -109.98 -138.94 0.38 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.043 0.937 . . . . 0.0 112.181 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' CG ' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -70.51 135.44 48.6 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.177 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -78.53 163.17 25.77 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.737 0.779 . . . . 0.0 108.969 167.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.0 m -145.61 118.75 8.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 174.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.1 m -70.32 113.64 7.68 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 171.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 69' ' ' ALA . 31.2 mt -80.29 177.78 8.73 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.048 2.139 . . . . 0.0 107.868 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -143.36 164.9 29.0 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.62 -0.675 . . . . 0.0 109.846 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -63.72 104.99 0.73 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.919 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 122.99 -109.49 1.38 Allowed Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.586 1.565 . . . . 0.0 111.681 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 94.3 m -126.55 131.25 51.6 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 120.769 -1.43 . . . . 0.0 111.587 -164.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.06 174.41 12.78 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.649 1.979 . . . . 0.0 108.249 -172.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.0 m -151.23 157.45 42.62 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 10.5 mt -118.33 110.7 39.01 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 170.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -67.36 154.25 74.5 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 121.709 1.606 . . . . 0.0 109.996 172.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.424 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 25.8 m-85 -136.12 166.77 22.62 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.595 1.558 . . . . 0.0 108.496 173.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -120.02 152.17 37.9 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 164.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.88 166.84 20.71 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 162.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -164.25 158.29 18.75 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 170.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.451 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 84.3 m-85 -71.32 153.89 42.02 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 159.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -134.01 112.89 11.58 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.226 2.21 . . . . 0.0 105.931 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -80.08 150.68 30.22 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.123 0.963 . . . . 0.0 109.184 170.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 68.1 p -115.61 8.04 14.96 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 125.958 1.703 . . . . 0.0 110.601 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.58 -154.28 24.33 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.05 87.0 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.002 1.321 . . . . 0.0 112.064 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -67.07 137.45 56.41 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.243 1.417 . . . . 0.0 111.495 -170.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 31.1 p -99.97 160.8 26.25 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 118.26 0.482 . . . . 0.0 110.613 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -72.36 178.78 5.71 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.446 1.43 . . . . 0.0 110.743 166.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.01 -93.59 0.14 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.593 1.092 . . . . 0.0 112.213 158.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.24 159.12 42.71 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 127.559 2.343 . . . . 0.0 105.06 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -149.33 71.78 1.13 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 120.015 1.279 . . . . 0.0 110.767 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -115.47 154.79 28.65 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -176.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -157.0 152.63 26.85 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.749 0.82 . . . . 0.0 109.715 175.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -120.74 121.32 37.98 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -120.79 175.69 5.9 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.009 2.124 . . . . 0.0 109.819 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.7 p -127.61 152.11 48.06 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 159.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -105.09 156.1 18.38 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 164.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -113.49 171.98 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.797 1.239 . . . . 0.0 107.943 168.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.461 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 15.6 t -129.34 129.05 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -120.9 89.37 3.12 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.543 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 67.0 m-85 -67.58 146.62 53.71 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 125.115 1.366 . . . . 0.0 110.716 173.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -155.87 171.71 19.6 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 126.702 2.001 . . . . 0.0 110.556 166.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.424 0 O-C-N 120.847 -1.158 . . . . 0.0 111.432 166.669 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 34.4 m -150.06 100.18 2.9 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 120.399 -1.438 . . . . 0.0 108.235 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.54 109.51 15.12 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.799 2.04 . . . . 0.0 109.763 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.0 m -129.36 157.69 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.018 1.327 . . . . 0.0 109.974 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.0 157.39 36.24 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.339 -0.851 . . . . 0.0 109.949 174.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.59 -59.93 0.46 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 172.52 176.5 41.28 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -168.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.9 m -97.45 128.35 44.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.255 1.422 . . . . 0.0 110.197 177.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.43 115.2 49.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -106.4 90.34 3.32 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -172.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.406 ' CG ' HG11 ' A' ' 101' ' ' VAL . 75.2 m-85 -67.34 118.77 11.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 175.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -123.69 160.45 27.19 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 138.41 -165.21 25.55 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -163.47 168.85 19.66 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -167.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.08 136.76 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 167.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 184' ' ' ALA . 6.1 m -115.8 152.36 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 C-N-CA 126.963 2.105 . . . . 0.0 108.329 177.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -75.11 31.42 0.1 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -172.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 N--CA 1.442 -0.837 1 C-N-CA 131.711 4.004 . . . . 0.0 112.096 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.485 ' HB2' HG21 ' A' ' 170' ' ' VAL . . . . . . . . 0 N--CA 1.447 -0.581 0 N-CA-C 102.471 -3.159 . . . . 0.0 102.471 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.72 -13.42 61.72 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.204 -0.998 . . . . 0.0 112.808 -173.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.5 m -130.91 151.06 51.75 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.014 1.726 . . . . 0.0 107.799 -175.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.89 -10.26 59.32 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -173.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 t 55.21 140.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 129.036 2.934 . . . . 0.0 112.121 -160.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.62 163.99 13.33 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.182 -0.949 . . . . 0.0 112.711 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.75 78.3 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.501 1.121 . . . . 0.0 111.392 -173.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.91 28.0 2.22 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.38 0.991 . . . . 0.0 112.006 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.7 t -139.68 -55.6 0.56 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.0 1.32 . . . . 0.0 108.554 -174.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.4 p -50.87 -36.09 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.844 1.258 . . . . 0.0 112.873 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -143.41 101.36 3.78 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 104.87 -2.271 . . . . 0.0 104.87 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -130.9 138.48 49.81 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.055 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 176' ' ' HIS . 93.3 m -106.96 98.66 8.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 172.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.8 t -77.67 115.89 20.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -89.66 127.67 35.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 mt -100.99 -3.63 29.04 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.375 1.87 . . . . 0.0 109.57 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.01 179.77 37.26 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.49 1.043 . . . . 0.0 112.345 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -76.01 116.57 16.84 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.777 1.631 . . . . 0.0 109.889 170.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.5 t -103.0 140.67 20.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 122.776 1.274 . . . . 0.0 109.245 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 7.4 mmt180 -71.76 126.58 30.08 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 125.466 1.506 . . . . 0.0 107.003 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 p -50.92 -31.57 18.0 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.321 1.448 . . . . 0.0 111.073 166.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.29 -16.58 60.76 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 t -92.72 0.28 57.39 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.064 1.346 . . . . 0.0 112.062 172.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.9 mt -145.9 67.65 1.2 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.881 1.672 . . . . 0.0 106.653 -162.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.63 -6.27 4.12 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -163.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.67 HE21 ' HB2' ' A' ' 47' ' ' ALA . 3.0 pm0 -147.85 157.56 43.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.855 1.662 . . . . 0.0 106.848 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 16.4 tt0 -63.33 134.62 56.1 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 170.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.71 -7.09 77.37 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 118.822 -0.988 . . . . 0.0 112.322 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.67 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -65.35 152.42 43.87 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.475 1.138 . . . . 0.0 109.604 172.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.9 p -138.08 158.57 44.05 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.858 0.837 . . . . 0.0 111.237 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.6 p -72.05 -175.86 1.59 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.438 0.695 . . . . 0.0 111.484 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 p -40.38 -47.45 2.56 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 126.635 1.974 . . . . 0.0 113.607 160.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 83.74 162.78 0.12 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 129.047 2.939 . . . . 0.0 108.914 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -144.9 133.23 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.87 104.23 3.14 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 106.111 -2.796 . . . . 0.0 106.111 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -104.69 156.74 17.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 168.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.466 ' HB2' HG22 ' A' ' 130' ' ' THR . 0.1 OUTLIER -135.97 151.87 50.38 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 120.515 -1.366 . . . . 0.0 109.701 -177.255 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.2 mm -99.78 115.01 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.63 136.33 38.16 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -173.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.6 mt -123.52 160.26 27.37 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.444 1.498 . . . . 0.0 107.955 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -149.59 151.35 33.67 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.448 1.499 . . . . 0.0 111.077 -164.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.6 t70 38.74 44.11 0.78 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.453 2.701 . . . . 0.0 113.524 -171.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.8 m -72.53 97.14 2.05 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.781 1.632 . . . . 0.0 113.909 -164.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -71.92 104.93 3.65 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.166 0.986 . . . . 0.0 111.126 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.1 p -68.67 -11.88 60.7 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -175.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -66.49 -48.21 70.57 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.707 0.685 . . . . 0.0 109.159 173.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -58.02 -41.76 81.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 124.204 1.001 . . . . 0.0 109.081 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 159' ' ' GLN . . . -167.04 138.24 3.2 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.767 1.627 . . . . 0.0 108.345 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.1 m -96.46 12.58 30.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.927 1.291 . . . . 0.0 113.059 169.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.56 ' CA ' HD21 ' A' ' 124' ' ' LEU . 28.1 mtmt -148.04 167.1 25.81 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 121.309 1.868 . . . . 0.0 113.326 158.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.21 93.6 2.46 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.189 2.196 . . . . 0.0 112.088 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.34 152.22 24.23 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 119.031 -2.293 . . . . 0.0 108.734 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 t -120.44 123.81 71.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.99 165.49 14.53 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 165.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.547 ' CE1' HG21 ' A' ' 103' ' ' ILE . 27.0 m-85 -127.66 160.34 31.93 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.543 163.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.728 HD22 ' OG1' ' A' ' 153' ' ' THR 0.285 0.0 OUTLIER -139.15 160.25 40.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.228 168.077 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.84 163.78 32.91 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 4.6 m -58.17 125.93 25.31 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 164.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.05 140.49 43.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 119.374 0.988 . . . . 0.0 109.091 174.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.4 tt -60.53 -48.46 88.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 123.35 0.66 . . . . 0.0 110.557 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.73 162.6 35.09 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.98 -24.98 67.92 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.678 0.791 . . . . 0.0 112.306 166.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.77 4.91 83.98 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 119.003 -0.887 . . . . 0.0 112.727 173.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -149.39 57.06 1.0 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.163 1.385 . . . . 0.0 109.126 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.3 p -64.61 -20.09 66.07 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.103 1.361 . . . . 0.0 113.101 -173.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -102.6 3.56 37.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -172.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.1 t -116.18 136.21 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 124.916 1.287 . . . . 0.0 108.366 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.07 151.87 26.85 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 125.229 1.412 . . . . 0.0 110.63 -172.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.427 ' HB3' ' HB ' ' A' ' 76' ' ' THR . . . -95.53 15.38 19.92 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -164.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt 56.3 -167.8 0.11 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.438 1.095 . . . . 0.0 110.589 -163.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 . . . . . 0 C--O 1.236 0.348 0 O-C-N 120.922 -1.111 . . . . 0.0 110.645 -174.135 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 120.746 0.308 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.81 148.59 38.68 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 163.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.7 p -90.68 165.81 13.5 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 159.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 54.46 31.02 13.9 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 127.274 2.23 . . . . 0.0 113.142 170.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.18 153.39 10.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 O-C-N 121.085 -1.009 . . . . 0.0 109.156 175.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.31 174.16 29.78 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 124.465 1.031 . . . . 0.0 110.66 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.406 HG11 ' CD2' ' A' ' 177' ' ' PHE . 44.2 t -83.92 151.91 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 173.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -128.79 163.43 25.22 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.144 0.884 . . . . 0.0 109.094 153.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.549 HG22 HD23 ' A' ' 111' ' ' LEU . 4.6 mp -121.01 141.81 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 128.19 2.596 . . . . 0.0 104.12 171.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mt -141.26 135.62 30.82 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.792 2.437 . . . . 0.0 105.455 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.64 -174.4 2.1 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.731 1.15 . . . . 0.0 108.376 169.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.1 ptt85 -58.33 -20.11 40.62 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.6 p -68.42 -10.63 56.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 124.298 1.039 . . . . 0.0 112.001 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.48 6.31 34.04 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 119.256 0.935 . . . . 0.0 112.291 -168.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.94 126.19 33.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.965 1.382 . . . . 0.0 107.314 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.83 151.08 42.18 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.865 0.364 . . . . 0.0 110.718 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.549 HD23 HG22 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -105.49 145.69 30.55 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.381 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.451 ' H ' HG21 ' A' ' 117' ' ' THR . 4.1 m -70.32 157.35 37.9 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.5 mt -104.91 63.71 0.71 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.615 1.566 . . . . 0.0 108.548 -172.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.1 -1.41 6.46 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.669 1.188 . . . . 0.0 113.064 -171.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.434 ' N ' ' HB2' ' A' ' 74' ' ' LEU . . . 86.32 -1.77 87.47 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.259 -1.301 . . . . 0.0 112.121 170.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -139.82 -28.01 0.76 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.852 1.326 . . . . 0.0 114.3 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.451 HG21 ' H ' ' A' ' 112' ' ' THR . 51.5 m -53.3 146.89 11.18 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.046 1.738 . . . . 0.0 110.638 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -116.73 141.74 47.82 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.015 -1.053 . . . . 0.0 109.065 -166.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.25 79.0 p -86.74 -124.78 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 123.3 0.64 . . . . 0.0 111.295 -170.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.52 21.7 6.03 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.183 1.393 . . . . 0.0 113.828 -169.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 56.91 171.66 0.04 OUTLIER 'General case' 0 N--CA 1.42 -1.931 1 C-N-CA 131.786 4.034 . . . . 0.0 114.307 173.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 m -149.9 134.42 17.48 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 158.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.8 m -88.58 126.28 35.2 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 169.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.788 ' H ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -86.76 179.86 6.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.211 -168.491 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.436 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -156.82 138.93 14.54 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 -171.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -57.48 94.65 0.02 OUTLIER 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.318 1.847 . . . . 0.0 108.567 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.56 -137.86 6.65 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -159.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.5 m -125.2 146.0 49.71 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.854 2.061 . . . . 0.0 107.197 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 0.8 OUTLIER -160.44 154.46 22.98 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.553 1.141 . . . . 0.0 108.811 -179.057 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.466 HG22 ' HB2' ' A' ' 55' ' ' ASN . 29.7 m -144.87 141.41 29.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.179 -165.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.2 mt -104.97 107.48 58.86 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 126.653 1.981 . . . . 0.0 106.149 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -85.65 103.1 0.74 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.502 2.801 . . . . 0.0 112.316 -175.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -81.27 174.66 11.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 122.897 1.332 . . . . 0.0 111.457 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -127.79 126.7 42.23 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 162.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -101.02 138.81 37.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 163.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -150.31 134.96 17.45 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -60.01 143.82 50.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -118.95 115.22 23.9 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -79.94 142.3 35.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.423 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 63.4 p -109.94 23.76 13.94 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.002 1.321 . . . . 0.0 110.095 176.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 148.78 -153.99 25.56 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 107.85 -2.1 . . . . 0.0 107.85 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.38 91.21 0.54 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.704 1.201 . . . . 0.0 109.497 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.43 124.96 21.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.767 0.827 . . . . 0.0 109.306 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.4 p -85.63 154.54 59.02 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -71.95 160.28 48.09 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 120.932 1.088 . . . . 0.0 110.449 169.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.72 -148.72 15.87 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -170.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -91.0 152.49 20.66 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 118.913 1.356 . . . . 0.0 109.036 163.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -136.24 66.14 1.5 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.424 0.69 . . . . 0.0 109.675 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -104.53 151.79 23.17 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 178.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.26 166.48 30.81 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.427 1.091 . . . . 0.0 108.101 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -148.72 140.73 23.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.054 0.93 . . . . 0.0 111.231 174.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.61 156.61 46.6 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.532 2.333 . . . . 0.0 109.283 -171.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.728 ' OG1' HD22 ' A' ' 74' ' ' LEU . 64.5 p -91.33 163.45 14.21 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 117.422 -1.711 . . . . 0.0 108.27 152.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.509 ' CD1' HG23 ' A' ' 175' ' ' VAL . 23.0 p90 -127.9 153.4 46.7 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 158.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -119.54 175.41 5.86 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.817 0.847 . . . . 0.0 110.541 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 4.4 t -138.4 99.62 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -84.25 100.04 10.95 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.595 1.958 . . . . 0.0 107.825 171.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.412 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 87.1 m-85 -73.52 139.46 45.69 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.398 1.094 . . . . 0.0 113.546 167.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.438 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 3.5 mt-30 -133.98 160.31 38.1 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 129.484 3.114 . . . . 0.0 111.041 -168.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.254 0 CA-C-O 119.089 -0.84 . . . . 0.0 111.047 -177.683 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.722 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 19.6 m -138.4 81.65 1.86 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.238 0.615 . . . . 0.0 109.455 -165.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.1 m -83.06 95.3 8.01 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.156 1.382 . . . . 0.0 109.972 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.485 HG21 ' HB2' ' A' ' 19' ' ' ALA . 1.8 m -81.72 167.18 2.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 158.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -72.89 154.99 40.34 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.542 -0.723 . . . . 0.0 109.292 164.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.19 -25.57 2.94 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 124.128 0.87 . . . . 0.0 112.944 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 146.26 -163.51 28.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 117.784 0.792 . . . . 0.0 111.647 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.9 m -116.24 136.48 52.97 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.509 HG23 ' CD1' ' A' ' 154' ' ' PHE . 40.2 t -112.56 115.63 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 166.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 31' ' ' THR . 10.3 m-70 -97.07 113.13 24.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 175.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.406 ' CD2' HG11 ' A' ' 101' ' ' VAL . 81.7 m-85 -87.1 119.48 27.37 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 176.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -116.06 166.66 11.75 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 135.5 -173.13 21.88 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 106.264 -2.735 . . . . 0.0 106.264 -171.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.67 170.51 18.34 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -171.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.3 t -120.82 130.1 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 175.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 15.3 m -115.79 146.62 19.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 126.81 2.044 . . . . 0.0 109.046 -177.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.94 27.4 0.09 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -172.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.248 1.024 0 C-N-CA 128.269 2.628 . . . . 0.0 113.793 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.609 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.24 -26.93 31.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 118.411 -0.804 . . . . 0.0 113.016 -169.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.402 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -130.41 153.91 48.26 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.794 1.638 . . . . 0.0 110.063 -179.474 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.7 93.96 6.27 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.997 2.519 . . . . 0.0 109.526 166.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.4 p -48.46 106.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 125.39 1.476 . . . . 0.0 109.313 158.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -69.23 166.24 18.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.355 1.462 . . . . 0.0 113.008 -161.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.32 -32.31 66.57 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.253 1.021 . . . . 0.0 112.253 171.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.88 7.97 47.08 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.617 1.103 . . . . 0.0 112.882 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.15 -44.67 1.58 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.993 1.717 . . . . 0.0 109.606 -170.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.38 -28.0 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 127.352 2.261 . . . . 0.0 113.693 -168.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -149.39 61.69 1.03 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.613 1.165 . . . . 0.0 108.007 -169.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -104.97 137.5 42.62 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.272 0.629 . . . . 0.0 109.85 -168.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.9 m -108.32 92.84 4.23 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.08 1.352 . . . . 0.0 108.045 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.2 t -78.7 108.34 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 126.328 1.851 . . . . 0.0 107.125 -171.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -91.61 122.82 34.52 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -98.91 -1.02 41.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 122.844 0.457 . . . . 0.0 110.412 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.6 -177.84 33.02 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 126.423 1.963 . . . . 0.0 111.273 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -70.29 138.1 51.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 122.187 -0.596 . . . . 0.0 109.628 158.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.8 t -128.41 146.41 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 124.372 1.069 . . . . 0.0 109.501 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 9.4 mmt180 -75.82 127.07 32.24 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 125.832 1.653 . . . . 0.0 107.34 -176.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 p -55.57 -29.03 58.3 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.204 0.602 . . . . 0.0 111.008 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.03 -39.86 72.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.453 1.101 . . . . 0.0 111.577 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 62.1 m -74.23 -0.8 18.04 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.0 mt -134.28 31.52 3.48 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 125.226 1.41 . . . . 0.0 111.827 -160.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.49 13.92 13.58 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -150.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.923 HE21 ' HB2' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -149.61 162.71 39.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 171.011 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -60.32 121.22 11.47 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 164.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.95 -8.58 57.79 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 118.812 -0.993 . . . . 0.0 113.691 -173.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.923 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -67.79 154.52 41.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.835 1.818 . . . . 0.0 110.644 174.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.5 p -147.97 157.25 43.42 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.884 0.766 . . . . 0.0 112.17 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.0 p -72.1 175.17 6.21 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.949 -1.094 . . . . 0.0 111.241 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.0 m -47.63 -27.46 1.89 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.611 1.964 . . . . 0.0 114.591 172.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 81.37 145.93 0.08 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 129.479 3.112 . . . . 0.0 111.06 167.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 m -141.8 130.65 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 C-N-CA 124.113 0.965 . . . . 0.0 109.415 -152.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.25 121.31 6.79 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -174.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 10.1 p90 -130.82 102.56 6.13 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 118.313 1.056 . . . . 0.0 108.279 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.453 ' HB2' HG22 ' A' ' 130' ' ' THR . 0.2 OUTLIER -93.95 150.83 20.02 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.063 -1.023 . . . . 0.0 111.242 -170.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.0 mm -94.66 98.1 7.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -65.84 126.87 29.84 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' A' ' 21' ' ' CYS . 2.2 mp -133.68 123.06 24.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 129.742 3.217 . . . . 0.0 106.589 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -118.04 154.39 32.11 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.509 1.049 . . . . 0.0 113.434 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 t70 65.92 37.41 5.46 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.094 1.758 . . . . 0.0 114.104 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 97.9 m -68.97 104.36 2.07 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.012 1.325 . . . . 0.0 108.798 -174.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -81.87 137.17 35.28 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.174 0.99 . . . . 0.0 109.593 174.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.5 p -83.0 -17.87 41.86 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -65.44 -42.63 92.2 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.319 1.048 . . . . 0.0 110.364 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.411 HG12 ' H ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -68.02 -54.56 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 125.87 1.668 . . . . 0.0 106.705 -176.103 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.21 158.46 43.94 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.9 m -115.2 3.6 14.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.745 0.702 . . . . 0.0 111.804 168.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -128.87 149.39 50.79 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.277 1.431 . . . . 0.0 109.28 171.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 124' ' ' LEU . . . -117.63 153.13 33.82 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.412 1.085 . . . . 0.0 108.457 165.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.89 -178.18 5.14 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.825 1.65 . . . . 0.0 106.779 157.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -153.78 141.02 12.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 -164.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.23 152.65 51.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 119.957 1.253 . . . . 0.0 108.678 175.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -114.55 153.61 29.75 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.438 0.695 . . . . 0.0 110.081 -175.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 tp -148.3 143.07 26.67 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.614 1.166 . . . . 0.0 107.996 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.81 173.35 35.05 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 108.104 -1.998 . . . . 0.0 108.104 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 m -59.88 121.88 12.85 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.513 1.125 . . . . 0.0 110.359 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.8 138.44 52.69 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.425 0.557 . . . . 0.0 110.413 172.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.0 tt -64.35 -31.12 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.576 0.75 . . . . 0.0 110.937 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -160.71 168.64 24.43 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.639 1.576 . . . . 0.0 107.441 165.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.36 -36.24 66.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.629 1.172 . . . . 0.0 111.311 166.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.29 -2.91 64.07 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 120.792 -1.193 . . . . 0.0 112.998 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -149.93 55.47 0.94 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.298 1.439 . . . . 0.0 109.716 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.6 p -69.43 -6.84 32.88 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.44 1.096 . . . . 0.0 111.886 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -85.89 3.54 41.37 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.931 1.293 . . . . 0.0 112.655 170.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.65 143.04 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.934 1.243 . . . . 0.0 111.63 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.02 151.26 28.5 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.954 1.301 . . . . 0.0 111.237 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.12 14.72 10.13 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 127.477 2.311 . . . . 0.0 114.059 -169.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 71.5 mt 55.26 -157.65 0.22 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.167 1.387 . . . . 0.0 111.227 -166.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 . . . . . 0 CA--C 1.539 0.546 0 C-N-CA 128.732 2.813 . . . . 0.0 107.748 178.086 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.831 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.98 131.55 45.0 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.484 1.114 . . . . 0.0 109.697 174.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.4 p -85.39 169.42 13.7 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 58.5 14.65 3.11 Favored 'General case' 0 C--N 1.335 -0.04 0 C-N-CA 126.247 1.819 . . . . 0.0 112.712 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.26 156.68 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 119.927 1.24 . . . . 0.0 107.819 -174.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -165.14 168.16 39.12 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -168.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.674 HG11 ' CD2' ' A' ' 177' ' ' PHE . 9.9 t -90.56 112.66 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -82.06 153.84 25.93 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.363 0.983 . . . . 0.0 108.52 160.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 mp -125.54 136.33 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 166.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 110' ' ' ALA . 9.0 mt -136.54 143.93 43.96 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.645 1.178 . . . . 0.0 107.838 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.521 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 24.5 p-10 -54.06 -74.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.278 1.431 . . . . 0.0 113.204 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.0 ptt85 179.61 -47.45 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 127.781 2.432 . . . . 0.0 107.994 -163.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 p -68.04 -29.12 68.02 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.169 0.895 . . . . 0.0 109.784 172.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.76 9.96 27.59 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.815 1.198 . . . . 0.0 111.176 -169.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.69 110.67 0.93 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 163.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.463 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -84.89 125.88 33.01 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.589 HD22 ' H ' ' A' ' 111' ' ' LEU . 0.4 OUTLIER -88.75 150.22 23.06 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -167.237 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -82.31 146.61 29.33 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.344 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.6 mt -88.16 61.87 6.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.844 0.858 . . . . 0.0 108.87 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.26 -15.16 14.55 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.063 1.345 . . . . 0.0 112.27 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.18 -7.38 60.51 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 125.872 1.701 . . . . 0.0 114.476 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.46 -6.36 5.84 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.158 1.479 . . . . 0.0 112.877 172.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.9 m -65.15 94.41 0.15 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.692 1.133 . . . . 0.0 108.623 171.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -67.51 131.65 46.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.786 1.235 . . . . 0.0 109.14 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.8 p -72.19 168.29 18.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.135 0.493 . . . . 0.0 110.906 170.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 14.2 m -26.37 113.85 0.05 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.527 2.331 . . . . 0.0 112.569 155.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -66.45 155.11 38.44 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 122.248 1.023 . . . . 0.0 108.74 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 98.6 m -127.12 112.99 15.81 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 169.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.7 m -58.06 126.25 26.63 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 167.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 69' ' ' ALA . 80.8 mt -98.73 -177.88 3.8 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 124.745 1.218 . . . . 0.0 108.679 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -147.53 169.69 19.03 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.805 1.642 . . . . 0.0 108.327 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -65.22 104.49 0.93 Allowed 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.852 0.72 . . . . 0.0 109.551 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.08 -160.8 26.8 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 124.643 1.116 . . . . 0.0 111.3 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 93.3 m -90.53 134.08 34.62 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.31 -1.112 . . . . 0.0 108.828 -179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -146.2 154.56 41.89 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.152 1.381 . . . . 0.0 110.418 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 55' ' ' ASN . 6.1 m -137.49 144.23 42.12 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.928 0.871 . . . . 0.0 109.987 -174.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.9 mt -104.72 118.35 56.62 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -65.14 157.02 59.65 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.349 1.366 . . . . 0.0 108.646 171.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -136.52 157.14 47.47 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 153.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -119.76 94.67 4.48 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.581 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -79.11 156.2 28.4 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 167.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -161.93 153.76 18.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 166.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.422 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 60.7 m-85 -63.73 130.5 44.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 163.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -103.19 151.52 22.53 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 163.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -115.67 137.79 51.73 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.593 0.757 . . . . 0.0 109.736 173.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 69.5 p -96.86 14.06 26.57 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.976 0.91 . . . . 0.0 111.034 170.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 169.5 -153.89 22.68 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.49 93.08 0.47 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.259 1.024 . . . . 0.0 110.157 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.06 119.07 5.3 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 44.3 p -76.65 163.62 64.67 Favored Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 165.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -74.73 172.71 15.71 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.118 1.212 . . . . 0.0 111.007 168.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.69 179.72 16.29 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 124.756 1.169 . . . . 0.0 111.283 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.9 140.67 58.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.422 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -132.9 73.34 1.52 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -115.5 158.7 22.2 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -157.97 160.48 37.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.69 0.677 . . . . 0.0 109.413 175.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -133.38 116.21 15.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.34 1.067 . . . . 0.0 110.233 -170.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.01 164.69 19.62 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.416 1.486 . . . . 0.0 111.22 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.9 p -119.21 157.08 28.7 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 155.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -115.91 146.68 41.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.522 1.129 . . . . 0.0 109.195 167.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -104.57 171.28 7.42 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.041 1.737 . . . . 0.0 108.316 168.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.4 t -129.2 128.21 66.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -130.52 84.48 2.2 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.478 1.111 . . . . 0.0 109.54 -172.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -70.12 151.98 44.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.562 -1.199 . . . . 0.0 112.242 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -161.64 174.3 13.51 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.42 1.488 . . . . 0.0 111.849 169.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.271 0 C-N-CA 125.405 1.479 . . . . 0.0 110.136 174.492 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 40.4 m -122.14 90.75 3.36 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -176.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.5 m -82.37 120.53 25.55 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.6 m -130.47 158.32 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.812 1.645 . . . . 0.0 109.415 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -79.28 143.02 35.64 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.097 -1.002 . . . . 0.0 108.984 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -105.21 -73.0 0.88 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -175.75 -174.21 42.12 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.884 0.342 . . . . 0.0 113.01 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.4 m -100.87 141.8 33.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.912 2.085 . . . . 0.0 108.635 -177.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.65 104.42 12.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -96.14 96.98 9.19 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 -176.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.674 ' CD2' HG11 ' A' ' 101' ' ' VAL . 79.9 m-85 -73.19 127.09 31.63 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 176.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -128.68 156.57 43.25 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.552 0.741 . . . . 0.0 111.636 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 142.37 -160.07 27.22 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -163.72 169.2 18.76 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.833 0.853 . . . . 0.0 108.97 -175.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 75.3 t -116.79 124.51 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 171.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 6.3 m -103.58 153.33 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 127.026 2.13 . . . . 0.0 108.782 174.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.04 25.67 0.09 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -168.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.25 1.121 1 C-N-CA 132.117 4.167 . . . . 0.0 114.544 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.41 -28.65 30.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.286 1.034 . . . . 0.0 113.745 -170.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.9 m -131.19 151.93 50.98 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.502 1.921 . . . . 0.0 108.071 -171.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.32 -10.56 51.93 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -169.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.323 14.2 p 45.9 97.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 129.36 3.064 . . . . 0.0 112.911 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -50.58 141.08 13.08 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.575 1.95 . . . . 0.0 110.719 -172.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.665 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . . . -59.5 -9.94 2.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.295 1.838 . . . . 0.0 111.945 -176.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.64 -7.41 88.16 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.115 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.8 p -124.13 -33.05 3.15 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.692 1.746 . . . . 0.0 112.18 -164.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.665 ' CG2' ' HA ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -52.48 -78.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 127.84 2.456 . . . . 0.0 109.924 166.138 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.486 ' H ' HG23 ' A' ' 28' ' ' VAL . 10.5 t70 -95.53 83.1 3.73 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -114.15 142.53 46.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.286 1.041 . . . . 0.0 108.92 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.5 m -105.06 88.77 2.95 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.6 t -69.39 98.51 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 174.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -72.42 103.09 3.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.3 mt -70.58 -15.59 62.77 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.899 0.88 . . . . 0.0 109.329 169.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.83 -175.93 49.55 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 124.599 1.095 . . . . 0.0 112.138 170.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.49 143.6 56.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 162.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.8 t -133.59 148.83 30.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 124.96 1.304 . . . . 0.0 107.674 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 28.2 mtm105 -79.14 132.87 36.7 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 182' ' ' VAL . 20.4 p -55.14 -24.25 25.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.609 173.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.25 -48.44 68.23 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.649 0.779 . . . . 0.0 110.141 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.54 3.61 5.96 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.0 mt -146.22 66.18 1.19 Allowed 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.679 1.592 . . . . 0.0 107.446 -166.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.13 -2.25 3.19 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -170.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.467 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 7.0 pm0 -146.92 151.79 37.61 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.998 1.319 . . . . 0.0 107.751 -176.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.441 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 47.5 tt0 -64.38 120.77 12.87 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.2 1.45 61.04 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-O 117.364 -1.798 . . . . 0.0 112.481 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.626 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -66.53 163.54 18.42 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 120.055 1.928 . . . . 0.0 110.122 169.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.1 p -146.74 155.12 42.15 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 122.014 -0.429 . . . . 0.0 110.472 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 84.8 p -68.22 178.64 1.83 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 164.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.0 p -30.89 -92.59 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 129.697 3.199 . . . . 0.0 114.633 173.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 154.11 113.22 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 131.284 3.834 . . . . 0.0 105.46 -172.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.28 105.25 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -173.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.21 154.71 44.87 Favored Glycine 0 C--N 1.311 -0.843 0 CA-C-N 112.45 -2.159 . . . . 0.0 110.721 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -152.58 176.6 11.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.242 1.817 . . . . 0.0 107.172 171.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.431 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 11.8 p-10 -143.0 163.18 33.49 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 120.885 -1.134 . . . . 0.0 110.6 177.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.9 mm -117.79 108.06 23.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -81.22 103.72 11.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.806 0.842 . . . . 0.0 109.312 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.9 mp -99.23 93.03 5.73 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -84.48 167.6 16.24 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.202 1.401 . . . . 0.0 109.094 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.32 31.06 17.89 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.162 0.985 . . . . 0.0 110.853 173.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 80.3 m -69.3 148.24 50.01 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.982 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -120.23 152.42 37.76 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 163.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 p -94.58 -20.84 19.26 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.62 -43.62 84.23 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.96 0.886 . . . . 0.0 110.555 -177.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.9 p -56.2 -52.92 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.647 1.579 . . . . 0.0 108.027 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.63 133.61 4.91 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 128.083 2.553 . . . . 0.0 104.773 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.3 m -87.81 -5.13 58.77 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.846 0.748 . . . . 0.0 111.805 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -128.3 164.29 22.93 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.089 1.356 . . . . 0.0 109.853 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.63 160.72 34.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 164.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.65 168.28 20.18 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 158.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.3 t -122.15 142.77 37.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.84 162.26 19.42 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 169.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -134.99 149.11 50.14 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.077 0.951 . . . . 0.0 109.191 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 tp -143.67 151.53 40.21 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.632 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . 174.2 169.69 36.62 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.3 m -66.28 126.84 30.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.246 1.023 . . . . 0.0 109.157 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.14 137.06 50.75 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.996 -0.44 . . . . 0.0 110.637 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.0 tt -59.78 -40.25 82.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 123.354 0.662 . . . . 0.0 110.285 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -152.09 167.9 26.99 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 127.13 2.172 . . . . 0.0 107.765 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.28 -40.08 95.24 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.564 1.546 . . . . 0.0 112.117 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.98 3.9 48.96 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.268 -0.74 . . . . 0.0 112.234 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -142.89 41.1 1.54 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.053 1.426 . . . . 0.0 110.67 -172.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.3 p -67.68 -6.31 20.01 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.875 -1.141 . . . . 0.0 113.317 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.78 -16.39 59.48 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.612 -1.305 . . . . 0.0 111.811 166.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.48 129.61 74.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 120.478 -1.389 . . . . 0.0 108.62 -160.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.632 HD21 ' HA3' ' A' ' 75' ' ' GLY . 3.8 mt -77.15 149.83 35.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.87 0.759 . . . . 0.0 111.504 -172.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.42 22.0 3.12 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.829 1.652 . . . . 0.0 113.494 -173.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.636 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 53.6 mt 49.7 -146.44 0.38 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.827 0.851 . . . . 0.0 109.067 -170.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 . . . . . 0 N--CA 1.451 -0.375 0 C-N-CA 126.042 1.737 . . . . 0.0 108.067 176.577 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 59.4 m . . . . . 0 N--CA 1.45 -0.431 0 CA-C-O 123.098 1.428 . . . . 0.0 114.504 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.77 113.66 3.16 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 125.281 1.432 . . . . 0.0 107.933 170.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.28 165.61 24.25 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.66 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 55.31 24.15 6.24 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.261 1.425 . . . . 0.0 113.162 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.2 p -145.0 151.6 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.24 175.43 27.54 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 173.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 177' ' ' PHE . 1.2 m -86.71 155.44 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 118.653 1.227 . . . . 0.0 108.384 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -124.52 147.01 48.66 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 170.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.511 HG22 HD23 ' A' ' 111' ' ' LEU . 3.8 mp -117.02 135.82 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 169.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 9.9 mt -126.41 159.48 33.17 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 128.408 2.683 . . . . 0.0 107.109 174.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -73.11 -106.37 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 123.956 0.785 . . . . 0.0 109.437 171.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -149.26 3.81 0.6 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.895 2.078 . . . . 0.0 110.624 -169.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.4 p -123.64 7.31 8.84 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.115 1.366 . . . . 0.0 109.493 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.09 1.89 90.19 Favored Glycine 0 C--N 1.342 0.861 0 C-N-CA 127.22 2.343 . . . . 0.0 114.27 -172.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.13 122.77 20.07 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 119.468 1.634 . . . . 0.0 107.917 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -87.29 147.4 25.54 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.034 0.533 . . . . 0.0 110.419 176.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.511 HD23 HG22 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -110.8 138.85 46.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.707 -173.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 m -69.62 147.31 50.85 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.73 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.9 mt -79.86 69.54 6.22 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.612 1.565 . . . . 0.0 108.303 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.51 -13.87 13.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.51 0.724 . . . . 0.0 111.242 174.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.437 ' O ' ' HE3' ' A' ' 155' ' ' LYS . . . 75.09 -9.03 13.27 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 120.626 -1.296 . . . . 0.0 113.278 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.54 -12.91 7.17 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.145 1.378 . . . . 0.0 111.272 174.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 92.3 m -76.77 90.91 3.46 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -72.71 172.84 9.96 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.322 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.3 p -120.7 -176.12 3.18 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.668 1.587 . . . . 0.0 110.036 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -33.46 111.52 0.11 Allowed 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 126.082 1.753 . . . . 0.0 111.328 169.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.99 155.8 38.7 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.5 m -151.72 114.95 4.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.7 m -58.52 133.2 55.6 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.528 1.931 . . . . 0.0 108.344 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.5 mt -86.57 178.54 7.04 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.302 1.441 . . . . 0.0 108.831 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.515 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 0.5 OUTLIER -135.45 170.3 16.16 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.62 1.968 . . . . 0.0 107.067 156.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.73 128.2 35.0 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 166.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 61' ' ' CYS . . . 99.09 -168.24 22.09 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -171.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 90.6 m -83.33 139.91 32.76 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 120.776 -1.426 . . . . 0.0 111.806 -166.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.515 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 26.3 m-80 -139.34 168.22 20.32 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 128.678 2.791 . . . . 0.0 109.37 -173.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 85.0 m -155.47 158.9 39.29 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 120.347 -1.47 . . . . 0.0 110.369 176.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.4 mt -131.93 112.79 14.83 Favored Pre-proline 0 C--O 1.24 0.603 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.72 150.0 38.94 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.598 1.532 . . . . 0.0 108.348 170.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -128.4 165.74 20.05 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.534 1.934 . . . . 0.0 108.59 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -133.26 113.28 12.46 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 121.453 -0.78 . . . . 0.0 108.909 172.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -94.83 170.36 9.5 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.819 0.819 . . . . 0.0 109.263 173.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -160.68 179.55 8.46 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.036 1.334 . . . . 0.0 108.909 167.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -91.45 149.41 21.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 153.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -122.5 124.84 44.5 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.835 2.054 . . . . 0.0 106.365 173.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.626 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -88.92 145.73 25.35 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.441 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 54.1 p -108.58 10.36 27.13 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 125.525 1.53 . . . . 0.0 111.168 176.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 161.65 -151.69 21.94 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.38 91.44 0.26 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.548 1.939 . . . . 0.0 109.935 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.19 157.06 20.18 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.022 0.439 . . . . 0.0 110.942 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 77.0 p -112.06 158.16 37.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 170.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -78.65 162.01 27.48 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.025 1.817 . . . . 0.0 110.636 165.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.39 -76.12 0.18 Allowed Glycine 0 N--CA 1.462 0.373 0 O-C-N 121.391 -0.818 . . . . 0.0 113.922 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -158.93 155.42 27.63 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.339 1.856 . . . . 0.0 106.874 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.98 91.04 1.74 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -125.73 135.44 52.07 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -146.19 167.19 24.07 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 165.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.49 111.05 6.78 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 167.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.82 169.87 17.56 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 162.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.8 p -116.2 151.98 34.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 153.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -114.71 132.12 56.53 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.201 0.601 . . . . 0.0 109.502 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.437 ' HE3' ' O ' ' A' ' 115' ' ' GLY . 29.2 mtmt -97.28 171.2 8.58 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.97 0.908 . . . . 0.0 109.199 167.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.1 t -133.1 118.63 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 -172.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -105.55 83.64 1.97 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -62.2 150.78 37.93 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.775 0.83 . . . . 0.0 108.936 168.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -167.94 169.84 11.04 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 123.289 0.636 . . . . 0.0 110.779 -174.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 177.474 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.629 0 CA-C-O 121.067 0.46 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.6 m -133.14 119.47 19.98 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.343 2.257 . . . . 0.0 106.799 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 m -114.52 123.9 50.54 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.469 1.108 . . . . 0.0 109.152 -169.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.2 m -143.49 150.91 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 123.975 0.91 . . . . 0.0 110.988 -168.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.07 132.25 48.1 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.627 1.571 . . . . 0.0 109.274 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -101.36 -78.54 1.34 Allowed Glycine 0 CA--C 1.519 0.344 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -173.95 -170.54 37.44 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.905 0.764 . . . . 0.0 111.772 -170.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 28.3 m -114.15 120.83 41.84 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.736 1.614 . . . . 0.0 110.989 -170.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.5 t -104.94 96.9 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -80.81 94.82 6.51 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.421 ' CD2' HG21 ' A' ' 101' ' ' VAL . 58.9 m-85 -76.91 85.49 3.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -93.86 165.7 12.55 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.623 0.769 . . . . 0.0 109.518 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 147.7 -161.96 28.62 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -170.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -170.25 174.77 5.18 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 75.4 t -123.19 138.28 53.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 171.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 39' ' ' THR . 6.8 m -116.61 149.22 18.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 126.008 1.723 . . . . 0.0 109.08 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.77 33.08 0.14 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -171.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 C-N-CA 128.454 2.702 . . . . 0.0 112.019 175.217 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 118.343 -0.837 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -42.51 -42.78 3.44 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 125.001 1.32 . . . . 0.0 113.17 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.3 m 47.69 65.41 1.29 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.467 1.507 . . . . 0.0 110.538 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.5 t -146.12 168.51 20.78 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.577 0.751 . . . . 0.0 109.09 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.7 t 70.21 147.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 127.423 2.289 . . . . 0.0 111.157 173.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -71.94 -45.09 62.39 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.256 -173.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 143.05 84.84 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 107.219 -2.353 . . . . 0.0 107.219 -175.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.77 165.82 10.42 Favored Glycine 0 N--CA 1.44 -1.079 0 N-CA-C 106.42 -2.672 . . . . 0.0 106.42 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.41 91.83 5.14 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 172.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 t 45.43 71.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.812 1.245 . . . . 0.0 110.426 157.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -85.5 50.97 2.06 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.304 -0.873 . . . . 0.0 109.214 -168.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -156.66 118.05 3.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -135.38 54.73 1.91 Allowed 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.419 1.088 . . . . 0.0 109.911 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.87 -47.23 76.82 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.09 -0.804 . . . . 0.0 111.09 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -129.94 -154.6 0.64 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.832 1.253 . . . . 0.0 109.671 -164.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.59 70.59 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 127.574 2.349 . . . . 0.0 110.706 172.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -76.11 58.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 120.446 -1.409 . . . . 0.0 110.559 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -129.89 95.6 4.0 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 124.848 1.259 . . . . 0.0 109.978 170.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -133.74 114.71 13.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.479 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -49.29 -34.92 16.56 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 126.587 1.955 . . . . 0.0 111.189 -173.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.8 m -125.76 146.51 49.74 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 127.376 2.27 . . . . 0.0 107.649 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.93 1.81 55.31 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -163.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.307 13.7 p 49.54 113.4 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 129.81 3.244 . . . . 0.0 114.275 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -53.0 141.78 21.41 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.423 1.089 . . . . 0.0 110.736 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.493 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -51.08 -39.12 55.31 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.768 1.227 . . . . 0.0 109.643 171.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.19 13.84 1.84 Allowed Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.799 -1.0 . . . . 0.0 114.522 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.4 t -144.63 -36.69 0.31 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.665 1.586 . . . . 0.0 111.515 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 25' ' ' ALA . 10.6 p -58.08 -49.87 80.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.424 0 CA-C-N 119.698 1.135 . . . . 0.0 109.095 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -121.94 75.52 1.22 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -171.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -105.68 138.21 42.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.388 -169.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.8 m -106.87 99.93 9.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 72.5 t -86.33 101.22 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -92.12 98.42 11.53 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -174.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.5 mt -75.94 -7.28 54.2 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.304 2.242 . . . . 0.0 109.883 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.54 -172.64 27.3 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 124.108 0.861 . . . . 0.0 111.734 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -77.67 142.39 38.85 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.943 0.878 . . . . 0.0 110.915 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 37.7 t -124.01 150.77 28.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 125.538 1.535 . . . . 0.0 108.095 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.92 137.66 32.98 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.0 p -60.39 -21.79 62.59 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 122.931 0.492 . . . . 0.0 112.253 171.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.47 -48.78 47.48 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-O 122.439 1.114 . . . . 0.0 111.312 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.2 m -79.19 5.87 11.1 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.221 1.008 . . . . 0.0 113.448 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.567 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 13.7 mt -142.65 72.08 1.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 126.696 1.998 . . . . 0.0 107.114 -170.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.72 -7.19 1.68 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -171.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.889 HE21 ' HB2' ' A' ' 47' ' ' ALA . 2.5 pm0 -145.51 162.82 36.49 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.651 1.18 . . . . 0.0 108.056 174.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -62.65 117.84 6.82 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 173.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.444 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 106.6 -10.33 41.84 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-O 118.305 -1.275 . . . . 0.0 112.471 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.889 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -64.34 147.69 52.0 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.809 1.305 . . . . 0.0 109.432 171.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.1 p -143.72 155.62 44.26 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.528 0.68 . . . . 0.0 111.736 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.4 p -66.7 -177.69 0.62 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.388 0.675 . . . . 0.0 110.56 175.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -59.56 -22.32 61.56 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 119.56 -1.962 . . . . 0.0 113.397 171.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 74.07 164.83 0.28 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 127.335 2.254 . . . . 0.0 110.782 -176.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.2 t -149.2 142.63 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.17 125.3 8.3 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -115.6 158.52 22.56 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 170.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.512 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 2.7 m-20 -131.14 173.9 10.57 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.085 0.857 . . . . 0.0 110.808 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.9 mm -121.57 109.84 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.602 1.161 . . . . 0.0 107.935 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.36 109.38 17.25 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.539 1.936 . . . . 0.0 109.5 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 mp -106.66 106.61 17.22 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 127.218 2.207 . . . . 0.0 108.507 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -87.05 158.55 19.19 Favored 'General case' 0 CA--C 1.523 -0.085 0 C-N-CA 124.539 1.135 . . . . 0.0 110.667 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 32.98 57.75 0.45 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.269 2.628 . . . . 0.0 113.145 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.9 m -64.36 142.3 58.47 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 125.705 1.602 . . . . 0.0 110.602 168.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -120.32 132.48 55.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 127.305 2.242 . . . . 0.0 108.73 171.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.7 p -92.74 -9.43 40.67 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -67.32 -47.66 69.86 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 119.036 0.834 . . . . 0.0 109.871 175.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.479 HG11 ' HA ' ' A' ' 20' ' ' ALA . 3.6 p -65.14 -49.1 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.237 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.67 114.04 2.6 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.44 1.896 . . . . 0.0 108.294 -170.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.8 m -76.75 -2.24 32.09 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.711 169.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.7 mtmt -137.6 164.69 28.16 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.986 1.721 . . . . 0.0 112.03 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.96 140.35 26.84 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.64 166.09 13.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.537 1.935 . . . . 0.0 106.292 163.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 t -125.71 157.89 34.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.57 167.64 19.67 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 164.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -130.82 155.86 45.98 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.549 1.54 . . . . 0.0 109.94 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.2 tp -150.79 134.04 16.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.909 0.484 . . . . 0.0 111.192 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.6 172.67 42.53 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.124 0.869 . . . . 0.0 111.325 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 2.3 m -55.39 125.79 22.35 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 124.494 1.117 . . . . 0.0 108.347 171.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.55 139.83 44.02 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 119.424 1.011 . . . . 0.0 108.666 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.1 tt -57.06 -39.39 66.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.032 0.533 . . . . 0.0 111.112 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -160.59 177.75 10.2 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.672 1.589 . . . . 0.0 108.025 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.93 -37.77 79.1 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.396 0.678 . . . . 0.0 111.549 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -78.06 5.26 55.01 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 123.622 0.63 . . . . 0.0 111.966 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -146.91 50.47 1.11 Allowed 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.146 -1.208 . . . . 0.0 110.1 -171.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.5 p -67.03 -8.87 33.37 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.355 1.462 . . . . 0.0 111.749 171.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -81.77 -11.92 58.79 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 167.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.8 t -125.83 136.3 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 121.308 1.867 . . . . 0.0 109.964 -161.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.85 156.01 30.66 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 118.923 0.783 . . . . 0.0 111.737 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.435 ' HB3' ' HB ' ' A' ' 76' ' ' THR . . . -94.58 19.3 10.02 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.485 1.514 . . . . 0.0 113.866 -171.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.3 mt 55.19 -156.87 0.23 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.943 0.897 . . . . 0.0 109.902 -165.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -152.14 -176.94 5.88 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 125.733 1.613 . . . . 0.0 108.659 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t 67.58 -143.99 0.13 Allowed 'General case' 0 C--N 1.339 0.136 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.7 m -46.15 86.07 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.916 2.086 . . . . 0.0 112.297 169.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.5 7.77 0.21 Allowed 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.258 1.023 . . . . 0.0 112.946 161.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.35 18.1 4.01 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 126.079 1.752 . . . . 0.0 110.516 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -153.95 -26.56 0.04 OUTLIER Glycine 0 CA--C 1.531 1.047 0 CA-C-N 119.444 1.02 . . . . 0.0 113.961 -176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.7 m -60.43 175.06 0.48 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 122.501 1.143 . . . . 0.0 109.536 162.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.19 153.97 24.61 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 121.611 -0.681 . . . . 0.0 109.292 171.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.0 p -115.85 164.69 14.03 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.906 0.882 . . . . 0.0 109.194 170.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 57.05 20.82 5.76 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.928 1.691 . . . . 0.0 111.889 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -138.4 152.04 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.46 177.94 28.22 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.427 HG21 ' CD2' ' A' ' 177' ' ' PHE . 0.7 OUTLIER -90.48 155.05 3.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -126.45 167.52 15.47 Favored 'General case' 0 C--O 1.24 0.6 0 O-C-N 120.744 -1.223 . . . . 0.0 110.558 158.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.12 130.59 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 127.428 2.291 . . . . 0.0 105.33 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.0 mt -122.19 140.81 52.14 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.885 -1.894 . . . . 0.0 105.885 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -62.68 171.55 2.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 122.216 1.008 . . . . 0.0 110.252 164.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.8 ptm180 -53.22 -25.82 15.45 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.462 1.505 . . . . 0.0 113.966 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.1 p -75.13 -23.76 57.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 119.677 1.126 . . . . 0.0 108.974 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.72 6.44 40.61 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 126.504 2.002 . . . . 0.0 112.708 -174.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -85.52 131.33 34.39 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.247 1.524 . . . . 0.0 109.31 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.88 120.0 14.96 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.903 1.281 . . . . 0.0 111.701 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.0 mt -78.76 157.42 28.49 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.341 0.656 . . . . 0.0 109.756 176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 m -100.69 144.97 29.03 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.426 1.09 . . . . 0.0 109.545 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.5 mt -89.22 70.79 8.29 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.454 1.102 . . . . 0.0 108.743 -173.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.55 -9.84 11.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.301 0.64 . . . . 0.0 112.316 174.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.02 -9.56 31.39 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.743 -1.032 . . . . 0.0 112.871 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.33 -8.34 5.82 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.087 1.355 . . . . 0.0 113.083 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.0 m -67.16 91.48 0.23 Allowed 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 168.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -64.89 164.2 12.96 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.795 0.838 . . . . 0.0 109.609 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 57.9 p -133.58 -175.93 3.98 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.662 1.185 . . . . 0.0 110.888 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -32.36 112.89 0.12 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 128.105 2.562 . . . . 0.0 112.431 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -73.26 108.58 6.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 88.4 m -81.95 113.3 19.76 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 167.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 93.8 m -57.95 121.0 9.52 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 160.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 99.0 mt -77.16 -170.06 1.57 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.393 1.477 . . . . 0.0 109.694 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.433 ' H ' HD21 ' A' ' 129' ' ' ASN . 0.6 OUTLIER -151.64 161.46 42.64 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 127.167 2.187 . . . . 0.0 107.593 168.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -64.49 140.19 58.84 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 170.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 100.25 -111.22 4.12 Favored Glycine 0 N--CA 1.467 0.704 0 CA-C-O 118.148 -1.362 . . . . 0.0 111.54 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 m -125.33 139.88 53.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.322 2.061 . . . . 0.0 110.488 -171.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.433 HD21 ' H ' ' A' ' 125' ' ' ASN . 12.1 m-80 -142.32 151.97 42.48 Favored 'General case' 0 CA--C 1.509 -0.622 0 C-N-CA 124.313 1.045 . . . . 0.0 109.959 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.512 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 97.1 m -132.72 124.22 27.74 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 123.017 0.527 . . . . 0.0 109.902 170.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.0 116.02 64.12 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 166.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.98 155.99 34.15 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.895 1.73 . . . . 0.0 110.51 166.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -139.1 172.69 12.47 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 127.743 2.417 . . . . 0.0 108.263 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.99 155.97 34.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 162.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -137.6 149.35 46.57 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.705 1.202 . . . . 0.0 108.014 171.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -161.04 153.68 20.73 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 168.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.404 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 77.3 m-85 -70.02 133.32 47.11 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 174.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.444 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 60.8 t80 -113.11 124.82 53.47 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.384 1.474 . . . . 0.0 107.85 176.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -85.43 141.65 29.81 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 170.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 22.4 p -105.48 11.19 32.83 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.862 0.465 . . . . 0.0 111.258 172.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.22 -153.8 23.63 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.54 93.65 0.05 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.94 1.696 . . . . 0.0 109.893 175.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -70.82 170.01 13.43 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 122.976 0.511 . . . . 0.0 111.443 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 7.8 p -136.49 159.19 71.51 Favored Pre-proline 0 N--CA 1.467 0.386 0 C-N-CA 123.441 0.696 . . . . 0.0 110.528 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -75.12 177.08 9.08 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.63 1.554 . . . . 0.0 110.434 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.01 -95.84 0.17 Allowed Glycine 0 CA--C 1.522 0.494 0 O-C-N 121.606 -0.684 . . . . 0.0 111.695 168.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.03 157.36 45.43 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.884 1.674 . . . . 0.0 107.189 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.404 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -146.51 66.41 1.18 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.592 0.71 . . . . 0.0 110.612 -176.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -108.45 150.95 26.71 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.573 -1.639 . . . . 0.0 106.573 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.28 163.03 40.27 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.616 1.566 . . . . 0.0 109.161 170.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -138.95 96.35 3.11 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.27 167.66 20.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.492 166.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.2 p -106.88 164.84 11.78 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 147.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -122.35 157.38 31.92 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 168.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -117.49 166.66 12.1 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.609 1.564 . . . . 0.0 108.595 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 8.5 t -127.86 106.65 15.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.455 HE21 ' NE2' ' A' ' 159' ' ' GLN . 40.8 tt0 -88.1 92.64 9.22 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 167.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 73.5 m-85 -63.42 153.97 33.57 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 163.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.455 ' NE2' HE21 ' A' ' 157' ' ' GLN . 11.9 pt20 -160.84 170.46 20.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.208 0.603 . . . . 0.0 110.662 168.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 94.59 50.95 2.07 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-O 118.251 -1.305 . . . . 0.0 111.784 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -109.27 -1.57 31.35 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 117.847 0.824 . . . . 0.0 114.232 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.65 171.12 12.84 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 125.776 1.655 . . . . 0.0 110.872 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.79 -51.47 4.04 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 125.517 1.532 . . . . 0.0 112.146 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 151.35 -25.22 0.97 Allowed Glycine 0 C--N 1.334 0.428 0 CA-C-N 118.496 1.148 . . . . 0.0 114.718 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -124.34 -83.16 0.56 Allowed Glycine 0 C--N 1.329 0.174 0 N-CA-C 107.2 -2.36 . . . . 0.0 107.2 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 46.71 98.99 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 129.513 3.125 . . . . 0.0 113.156 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -130.06 153.71 48.18 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.154 1.382 . . . . 0.0 110.946 -170.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 87.2 m -142.61 108.49 5.16 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.59 1.956 . . . . 0.0 107.647 -175.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 15.5 m -97.0 94.04 6.95 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.789 0.836 . . . . 0.0 110.15 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -85.32 168.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 124.121 0.968 . . . . 0.0 110.018 168.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -63.62 174.97 1.18 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.056 0.542 . . . . 0.0 109.688 160.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -144.64 -34.17 0.08 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-O 117.817 -1.546 . . . . 0.0 114.416 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 147.58 -176.8 26.25 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 119.412 1.606 . . . . 0.0 112.67 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.1 m -101.34 140.05 36.16 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.291 1.836 . . . . 0.0 108.908 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.56 96.48 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -83.42 88.49 6.98 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.427 ' CD2' HG21 ' A' ' 101' ' ' VAL . 58.8 m-85 -66.19 113.06 4.26 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 170.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 39.1 mmtt -120.42 161.6 20.94 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 135.88 -174.19 21.49 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -170.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -161.51 172.14 16.92 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -168.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 39.2 t -124.93 133.45 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.4 m -112.61 148.19 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 C-N-CA 127.113 2.165 . . . . 0.0 108.365 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.77 31.23 0.09 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.686 2.395 . . . . 0.0 112.429 -170.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 127.856 2.463 . . . . 0.0 110.028 -165.488 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.77 -37.63 87.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.822 0.737 . . . . 0.0 112.229 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . 0.383 13.5 t 46.95 -157.54 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.428 1.491 . . . . 0.0 109.991 -162.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.1 p 24.24 82.74 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.687 2.395 . . . . 0.0 115.367 159.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.8 p -155.79 121.31 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 119.429 1.013 . . . . 0.0 108.586 170.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 24.52 84.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 130.416 3.487 . . . . 0.0 113.337 173.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.87 -102.46 1.33 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 106.109 -2.796 . . . . 0.0 106.109 -162.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.07 60.99 0.22 Allowed Glycine 0 N--CA 1.446 -0.678 0 CA-C-O 117.185 -1.897 . . . . 0.0 110.173 176.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.256 1.7 t 45.54 100.37 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 128.766 2.826 . . . . 0.0 111.977 -173.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.256 1.3 m 54.56 21.08 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.257 1.423 . . . . 0.0 113.789 166.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.8 p80 40.73 61.99 1.51 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.969 2.108 . . . . 0.0 113.194 -162.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -142.58 87.99 2.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 104.81 -2.292 . . . . 0.0 104.81 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -133.49 98.05 4.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 168.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -166.63 8.07 0.06 OUTLIER Glycine 0 CA--C 1.529 0.912 0 C-N-CA 123.282 0.467 . . . . 0.0 113.651 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -140.62 -153.65 0.47 Allowed 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.498 HG11 HG12 ' A' ' 170' ' ' VAL . 9.8 p -56.13 -39.97 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 119.6 1.091 . . . . 0.0 110.129 159.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m 37.18 49.59 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 126.981 2.112 . . . . 0.0 111.685 -171.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -139.25 144.0 38.23 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 160.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.547 ' HB1' ' CE2' ' A' ' 158' ' ' TYR . . . -173.34 137.77 0.68 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 128.766 2.827 . . . . 0.0 104.375 159.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.7 -18.04 61.05 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -172.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 27.0 m -133.77 160.04 38.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.15 109.45 19.91 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.621 1.568 . . . . 0.0 107.867 161.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.6 t -50.15 125.86 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 152.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.68 151.77 40.93 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.713 0.688 . . . . 0.0 109.698 174.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.75 -29.26 53.3 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 120.952 -1.092 . . . . 0.0 112.396 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.38 -50.48 66.36 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 123.91 0.767 . . . . 0.0 111.26 173.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.0 m -72.03 -27.05 62.45 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.899 0.88 . . . . 0.0 111.286 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.1 t -60.74 -25.87 36.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.368 1.067 . . . . 0.0 113.035 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -145.48 30.63 1.11 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.691 1.196 . . . . 0.0 111.488 -166.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -77.87 133.27 38.17 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 120.828 -1.17 . . . . 0.0 108.663 -162.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 176' ' ' HIS . 4.4 m -100.88 103.05 14.22 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.3 t -82.8 95.72 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -176.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -77.82 95.51 4.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -71.43 -12.31 61.34 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.983 1.313 . . . . 0.0 111.162 175.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.18 -177.89 31.37 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.325 0.964 . . . . 0.0 112.431 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -67.84 121.01 15.09 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.206 1.403 . . . . 0.0 109.748 168.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.5 t -99.82 149.26 5.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 126.063 1.745 . . . . 0.0 106.961 171.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -82.93 133.85 35.1 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.9 p -58.77 -19.37 40.14 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.817 0.847 . . . . 0.0 111.048 170.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.91 -50.09 61.77 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 120.746 -1.221 . . . . 0.0 109.336 170.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.437 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 66.4 m -73.12 -2.31 20.95 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.554 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 13.5 mt -141.23 79.19 1.68 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.403 1.481 . . . . 0.0 107.366 -171.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.31 -0.27 1.27 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.668 HE21 ' HB2' ' A' ' 47' ' ' ALA . 2.9 pm0 -148.69 159.42 44.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.439 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 35.6 tt0 -62.21 118.17 7.04 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.11 6.55 66.66 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 126.347 1.927 . . . . 0.0 112.885 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.668 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -57.84 149.02 23.48 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 148.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.37 153.57 42.1 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -178.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.9 p -70.3 171.78 9.34 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.366 -0.834 . . . . 0.0 109.065 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.8 m -47.5 -66.78 0.35 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 -173.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 154.19 136.71 0.0 OUTLIER 'General case' 0 C--O 1.233 0.224 0 C-N-CA 128.199 2.6 . . . . 0.0 106.74 -177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.6 t -137.7 138.38 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 173.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.64 127.4 9.21 Favored Glycine 0 CA--C 1.516 0.148 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -132.47 87.95 2.48 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 123.307 1.527 . . . . 0.0 109.263 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.513 ' HB2' HG22 ' A' ' 130' ' ' THR . 6.7 p30 -81.13 160.77 24.33 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 120.626 -1.297 . . . . 0.0 111.487 -173.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 130' ' ' THR . 4.2 mm -112.03 108.71 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 175.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -76.31 110.82 11.14 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.69 1.996 . . . . 0.0 109.113 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.56 108.6 18.16 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.474 1.51 . . . . 0.0 107.173 178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.0 168.46 10.94 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.489 1.116 . . . . 0.0 109.832 171.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t70 51.46 36.26 16.3 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.828 2.451 . . . . 0.0 116.76 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.9 m -69.89 85.62 0.5 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.626 1.97 . . . . 0.0 114.736 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -72.98 111.8 8.42 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.454 -0.778 . . . . 0.0 112.375 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.6 p -62.5 -12.86 24.8 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.374 1.07 . . . . 0.0 112.234 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -66.37 -38.35 87.36 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.359 0.981 . . . . 0.0 110.272 173.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.55 -58.15 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.37 143.83 19.19 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.186 1.394 . . . . 0.0 107.743 -172.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.2 p -88.19 -12.79 42.84 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 119.24 -0.41 . . . . 0.0 111.66 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -140.82 156.15 46.21 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 127.125 2.17 . . . . 0.0 107.797 -166.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.56 85.94 1.2 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -173.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.11 173.52 11.2 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 123.642 0.777 . . . . 0.0 109.293 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.405 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -148.14 107.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -170.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -94.71 163.8 13.21 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 124.037 0.935 . . . . 0.0 108.922 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CE2' HG21 ' A' ' 103' ' ' ILE . 6.7 m-85 -135.36 148.61 49.47 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.758 0.823 . . . . 0.0 109.652 -168.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.426 HD13 ' C ' ' A' ' 114' ' ' ASP . 13.2 tp -146.91 132.71 18.97 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.122 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.27 175.53 39.55 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 172.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.5 m -60.2 134.04 56.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.67 1.188 . . . . 0.0 108.79 172.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.81 132.06 35.18 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.207 1.003 . . . . 0.0 109.003 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.7 tt -60.5 -34.26 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 122.83 0.452 . . . . 0.0 110.609 -178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -153.25 164.74 37.55 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 126.382 1.873 . . . . 0.0 109.623 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.72 -31.04 46.62 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.113 2.565 . . . . 0.0 115.061 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.97 -40.18 6.28 Favored Glycine 0 CA--C 1.518 0.274 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 174.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -86.71 43.59 1.09 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.435 1.494 . . . . 0.0 110.51 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.6 p -63.81 -12.88 39.64 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.816 1.646 . . . . 0.0 112.232 173.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -82.13 -9.44 59.52 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 121.517 -0.739 . . . . 0.0 112.629 171.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.0 t -127.98 137.24 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 119.726 1.148 . . . . 0.0 109.855 -165.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.95 149.17 29.48 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.306 1.442 . . . . 0.0 110.743 -168.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.71 14.02 22.54 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -162.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.8 mt 51.54 -169.21 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.509 1.124 . . . . 0.0 110.41 -162.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -140.32 174.8 10.16 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 126.364 1.866 . . . . 0.0 108.292 -177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.2 p 59.66 -170.06 0.14 Allowed 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.747 1.219 . . . . 0.0 110.277 172.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.9 m 24.76 71.48 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.716 2.406 . . . . 0.0 114.853 158.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -45.96 -34.63 4.1 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.486 1.114 . . . . 0.0 113.198 -174.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.43 16.92 4.02 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.923 1.289 . . . . 0.0 111.494 178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -109.91 -27.26 4.66 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.792 1.187 . . . . 0.0 110.894 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.5 m -61.04 162.61 6.9 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.35 1.071 . . . . 0.0 108.345 161.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.42 145.25 33.41 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 114.008 -1.451 . . . . 0.0 107.562 162.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.5 p -118.24 160.87 20.84 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 124.628 1.171 . . . . 0.0 109.156 177.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 59.83 27.04 16.3 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 123.511 0.725 . . . . 0.0 110.635 -173.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.404 HG21 HD13 ' A' ' 42' ' ' LEU . 2.0 p -143.74 145.45 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 121.215 -0.928 . . . . 0.0 108.667 170.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -142.88 174.12 23.74 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.411 HG11 ' CG ' ' A' ' 177' ' ' PHE . 99.3 t -86.45 147.2 5.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 176.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -129.99 140.81 50.83 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.333 1.053 . . . . 0.0 108.575 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.504 HG22 HD12 ' A' ' 111' ' ' LEU . 5.3 mp -108.3 134.99 48.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 110' ' ' ALA . 9.8 mt -134.11 132.77 40.32 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.959 1.704 . . . . 0.0 107.673 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.424 ' CB ' ' HB2' ' A' ' 120' ' ' SER . 1.5 t70 -73.11 -170.85 0.81 Allowed 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.724 1.147 . . . . 0.0 112.046 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -48.63 -37.15 17.47 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.757 1.623 . . . . 0.0 111.854 167.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 p -77.83 -5.84 52.17 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.512 1.925 . . . . 0.0 112.484 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 57.25 25.12 53.8 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.755 1.169 . . . . 0.0 112.975 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.27 138.78 32.74 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 167.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.423 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -72.71 154.21 40.81 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.231 0.469 . . . . 0.0 111.704 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.504 HD12 HG22 ' A' ' 103' ' ' ILE . 90.3 mt -127.22 119.92 27.51 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 124.238 1.015 . . . . 0.0 110.487 -167.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.9 m -74.11 156.93 36.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.822 0.849 . . . . 0.0 111.578 -171.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.7 mt -99.3 71.57 1.8 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.889 1.676 . . . . 0.0 108.151 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.426 ' C ' HD13 ' A' ' 74' ' ' LEU . 79.2 m-20 -120.71 -20.94 6.85 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.317 0.647 . . . . 0.0 111.016 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.35 -22.53 8.49 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.488 1.518 . . . . 0.0 113.092 174.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.55 -40.78 9.68 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 119.091 1.446 . . . . 0.0 110.638 168.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 38.3 m -55.96 99.74 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.71 2.004 . . . . 0.0 110.595 -174.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -71.11 173.71 7.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.183 1.393 . . . . 0.0 111.396 -173.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 59.7 p -115.51 -160.74 0.76 Allowed 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.593 1.157 . . . . 0.0 111.834 -170.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.424 ' HB2' ' CB ' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -65.7 147.37 53.5 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.596 0.758 . . . . 0.0 109.027 172.103 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -89.71 141.41 28.64 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 120.659 -1.275 . . . . 0.0 107.983 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.1 m -121.29 110.31 15.98 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 128.537 2.735 . . . . 0.0 104.163 171.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.5 m -68.53 117.05 9.78 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 125.169 1.387 . . . . 0.0 107.808 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.9 mt -64.69 173.69 2.11 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.999 1.72 . . . . 0.0 111.369 177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.617 ' H ' HD21 ' A' ' 129' ' ' ASN . 0.7 OUTLIER -132.39 159.12 40.18 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 127.676 2.39 . . . . 0.0 107.058 156.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -58.31 129.58 42.7 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 168.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 109.02 -140.55 15.67 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -172.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.5 m -107.51 142.7 36.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.886 1.343 . . . . 0.0 109.826 -172.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.617 HD21 ' H ' ' A' ' 125' ' ' ASN . 12.8 m-80 -143.18 173.53 11.5 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 127.923 2.489 . . . . 0.0 108.532 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 55' ' ' ASN . 86.3 m -157.15 141.25 16.27 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.357 -1.465 . . . . 0.0 109.955 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.27 116.04 65.78 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.593 1.557 . . . . 0.0 107.361 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -86.25 78.27 2.18 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 124.121 3.214 . . . . 0.0 112.171 -176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.405 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 97.5 m-85 -66.22 162.72 19.34 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.393 -0.817 . . . . 0.0 111.216 171.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -115.42 141.26 48.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.345 154.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -101.55 145.32 29.18 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 126.299 1.839 . . . . 0.0 108.462 160.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -149.61 152.56 35.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 159.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.417 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 69.9 m-85 -70.03 151.23 45.78 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 163.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -129.16 116.11 18.71 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.921 2.488 . . . . 0.0 106.626 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.73 146.72 29.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.439 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 29.3 p -114.27 7.0 16.35 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.095 0.958 . . . . 0.0 112.068 175.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 168.79 -150.41 15.78 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.5 94.59 0.03 OUTLIER 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.621 1.169 . . . . 0.0 108.756 170.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -79.42 128.98 34.03 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.221 1.008 . . . . 0.0 108.734 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.3 p -90.84 171.58 8.04 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 125.151 1.38 . . . . 0.0 109.855 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -88.13 172.92 5.05 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.172 1.915 . . . . 0.0 110.371 166.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.96 -95.23 0.14 Allowed Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -144.1 155.7 44.06 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 127.718 2.407 . . . . 0.0 107.574 174.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.417 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -143.44 92.14 2.33 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.548 1.166 . . . . 0.0 108.238 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -126.15 145.32 50.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.32 153.18 34.31 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.535 1.534 . . . . 0.0 107.41 169.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.43 98.14 4.6 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.87 1.268 . . . . 0.0 110.521 176.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.81 163.49 23.41 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.665 171.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.2 p -99.8 161.98 13.28 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 147.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -122.96 153.62 39.5 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 162.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -113.71 168.21 9.97 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.534 1.934 . . . . 0.0 107.954 172.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.494 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 18.4 t -121.67 134.73 64.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.476 HE21 ' NE2' ' A' ' 159' ' ' GLN . 28.0 tt0 -122.09 87.55 2.77 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.547 ' CE2' ' HB1' ' A' ' 19' ' ' ALA . 84.4 m-85 -57.11 149.69 18.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.188 166.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.476 ' NE2' HE21 ' A' ' 157' ' ' GLN . 4.6 pt20 -165.6 164.11 19.24 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.408 1.483 . . . . 0.0 109.59 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 136.66 -8.69 3.97 Favored Glycine 0 CA--C 1.522 0.529 0 CA-C-O 117.855 -1.525 . . . . 0.0 113.419 173.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -64.37 -70.35 1.1 Allowed Glycine 0 C--N 1.335 0.49 0 CA-C-N 119.521 1.661 . . . . 0.0 109.934 175.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -83.45 -9.67 83.13 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-O 118.182 -1.344 . . . . 0.0 113.508 -171.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.01 -74.31 2.2 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-N 118.841 1.321 . . . . 0.0 110.744 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -55.54 -77.35 0.16 Allowed Glycine 0 CA--C 1.521 0.429 0 C-N-CA 125.949 1.738 . . . . 0.0 111.813 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.61 83.94 0.23 Allowed Glycine 0 CA--C 1.519 0.327 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -172.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -156.83 123.04 4.91 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -154.02 168.8 25.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.289 1.036 . . . . 0.0 111.853 -172.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.0 m -134.23 95.58 3.44 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.113 1.765 . . . . 0.0 107.366 175.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.2 m -76.93 133.59 39.18 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 168.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.498 HG12 HG11 ' A' ' 16' ' ' VAL . 13.1 m -149.06 171.44 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 127.013 2.125 . . . . 0.0 109.097 -175.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -68.11 170.67 8.09 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.416 1.007 . . . . 0.0 109.682 172.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -135.89 -52.21 0.07 OUTLIER Glycine 0 CA--C 1.522 0.524 0 C-N-CA 124.341 0.972 . . . . 0.0 111.063 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 161.08 -162.14 33.44 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 118.043 0.922 . . . . 0.0 111.352 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.7 m -127.15 112.95 15.74 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.988 2.115 . . . . 0.0 107.247 -166.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 7.7 t -105.16 106.72 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . 0.432 ' HB2' HG23 ' A' ' 31' ' ' THR . 28.9 m-70 -96.75 87.76 4.42 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -169.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.411 ' CG ' HG11 ' A' ' 101' ' ' VAL . 73.5 m-85 -68.37 113.07 5.62 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 50.2 mmtt -120.07 166.33 13.54 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.035 -1.041 . . . . 0.0 108.261 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 143.82 -161.57 27.78 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -170.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -165.82 172.44 11.67 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.59 135.47 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 166.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' A' ' 184' ' ' ALA . 3.3 m -117.84 151.65 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 127.637 2.375 . . . . 0.0 107.677 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -74.03 24.59 0.08 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.781 1.632 . . . . 0.0 113.5 -169.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.246 0.91 0 C-N-CA 131.402 3.881 . . . . 0.0 112.565 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.886 0 CA-C-O 116.704 -1.617 . . . . 0.0 107.272 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.37 50.12 15.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.37 1.468 . . . . 0.0 110.945 -173.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.7 t -69.46 152.88 44.33 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 169.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.7 t -64.77 165.07 11.07 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 158.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.58 101.2 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -60.3 -49.92 75.7 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.264 0.626 . . . . 0.0 110.216 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.33 171.32 36.53 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 127.357 2.408 . . . . 0.0 107.249 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.08 9.52 31.88 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.383 -0.676 . . . . 0.0 112.296 -175.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.299 0.4 OUTLIER -146.22 70.32 1.22 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 172.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.271 12.9 p 32.92 62.71 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 128.623 2.769 . . . . 0.0 115.752 175.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -66.87 -11.67 56.57 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -169.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 67.36 56.31 0.62 Allowed 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 126.672 1.989 . . . . 0.0 106.771 171.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.9 67.89 9.16 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -170.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.03 36.25 1.77 Allowed Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -167.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER 71.2 163.49 0.26 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.91 1.284 . . . . 0.0 109.21 -163.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.647 HG11 HG12 ' A' ' 170' ' ' VAL 0.371 11.7 p 54.82 -28.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 1 C-N-CA 133.447 4.699 . . . . 0.0 114.965 -175.863 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 15' ' ' GLU 0.259 4.6 m 38.3 33.44 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.288 1 C-N-CA 132.106 4.162 . . . . 0.0 112.708 178.928 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -146.61 94.42 2.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.427 1.891 . . . . 0.0 106.018 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.81 111.61 7.76 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 161.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.48 -20.65 64.78 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -160.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.3 m -123.22 160.57 26.29 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 127.895 2.478 . . . . 0.0 107.792 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.8 -20.27 27.82 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -167.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.261 8.6 t 54.81 124.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 130.143 3.377 . . . . 0.0 111.509 -163.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -77.65 164.63 25.14 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.138 1.775 . . . . 0.0 110.676 -174.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.04 -39.98 60.41 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.623 -1.298 . . . . 0.0 110.598 164.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.38 2.71 36.1 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.962 1.744 . . . . 0.0 113.979 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 63.4 p -141.73 -9.85 0.92 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 119.886 1.843 . . . . 0.0 113.488 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.0 p -72.09 -65.42 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 119.15 0.886 . . . . 0.0 110.612 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -126.32 46.08 2.52 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.202 -0.936 . . . . 0.0 108.499 -160.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -82.91 144.47 30.02 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.543 1.137 . . . . 0.0 109.81 -163.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.71 154.52 27.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 164.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 28.9 t -131.28 96.97 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 165.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.85 94.87 3.96 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 173.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.831 HD23 ' CG1' ' A' ' 52' ' ' VAL . 2.1 mt -68.46 -10.08 53.01 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.555 1.942 . . . . 0.0 110.224 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.5 -177.9 32.55 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 124.945 1.26 . . . . 0.0 111.304 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -69.35 138.68 53.92 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 122.067 -0.666 . . . . 0.0 109.373 167.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.9 t -121.01 147.64 24.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 125.582 1.553 . . . . 0.0 106.926 176.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -83.39 131.93 35.02 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.0 p -59.1 -23.03 61.74 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 118.904 0.775 . . . . 0.0 110.397 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.89 -27.45 66.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.064 1.346 . . . . 0.0 112.134 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 75.3 m -80.21 -15.4 57.09 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.035 -0.984 . . . . 0.0 113.076 173.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.458 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . 29.1 mt -134.11 75.86 1.62 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 126.708 2.003 . . . . 0.0 109.336 -164.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.91 -4.05 7.0 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -167.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.874 HE21 ' HB2' ' A' ' 47' ' ' ALA . 2.7 pm0 -152.7 163.38 39.78 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 124.425 1.09 . . . . 0.0 109.284 -175.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -64.83 127.34 31.15 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.39 -1.19 75.97 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-O 118.511 -1.161 . . . . 0.0 111.762 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.874 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -64.59 146.29 54.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 119.807 1.803 . . . . 0.0 109.769 168.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.8 p -138.09 151.29 47.67 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.112 0.414 . . . . 0.0 110.744 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.7 p -75.57 -169.91 1.14 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -45.11 -92.38 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.98 75.1 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 129.607 3.163 . . . . 0.0 107.259 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.831 ' CG1' HD23 ' A' ' 34' ' ' LEU . 1.6 p -73.66 148.57 8.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 169.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -126.85 155.72 19.83 Favored Glycine 0 CA--C 1.51 -0.262 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -147.71 1.59 0.69 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -171.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.42 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 2.8 m-20 36.92 -169.95 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 130.963 3.705 . . . . 0.0 114.281 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 mm -133.29 106.36 9.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 159.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -65.99 113.38 4.39 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 171.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.7 mp -98.86 149.13 23.23 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -148.69 153.43 38.23 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 127.1 2.16 . . . . 0.0 108.609 -165.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 30.18 54.25 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 129.263 3.025 . . . . 0.0 114.825 -169.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.8 m -69.64 138.34 52.96 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.328 2.251 . . . . 0.0 111.3 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -113.96 119.76 38.33 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.147 1.379 . . . . 0.0 109.294 166.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 79.5 p -71.81 -17.66 62.14 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -59.65 -44.89 93.37 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 124.101 0.96 . . . . 0.0 109.939 175.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.4 t -61.42 -61.59 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 176.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.04 120.42 4.56 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 125.395 1.478 . . . . 0.0 109.061 -174.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.9 m -76.24 -6.94 53.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.864 0.865 . . . . 0.0 111.135 169.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -130.72 159.02 38.51 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 120.155 -1.591 . . . . 0.0 110.368 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.75 159.56 41.98 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 160.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.55 167.83 18.72 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.804 2.042 . . . . 0.0 106.258 161.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 69.0 t -119.95 148.82 22.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -121.64 159.45 26.47 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.427 ' CE1' HG21 ' A' ' 103' ' ' ILE . 20.7 m-85 -133.49 155.53 49.4 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.901 1.68 . . . . 0.0 108.548 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.404 HD13 ' C ' ' A' ' 114' ' ' ASP . 7.4 tp -141.46 161.55 37.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.787 0.435 . . . . 0.0 110.095 173.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.424 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -178.16 179.82 48.38 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 173.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 3.3 m -64.9 135.83 56.16 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 164.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.17 141.83 41.74 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.079 0.854 . . . . 0.0 109.322 171.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.6 tt -60.77 -36.12 69.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 122.998 0.519 . . . . 0.0 111.036 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -160.87 171.2 19.18 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 126.207 1.803 . . . . 0.0 107.343 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.1 -28.14 68.59 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.753 0.821 . . . . 0.0 111.341 165.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.64 -19.13 72.74 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 119.109 -0.829 . . . . 0.0 112.224 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -147.2 57.93 1.15 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.15 1.475 . . . . 0.0 110.619 -164.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.3 p -63.09 -14.74 52.06 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 128.297 2.639 . . . . 0.0 113.313 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -84.96 -3.26 58.68 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 170.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.2 t -123.21 138.37 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 119.897 1.226 . . . . 0.0 109.446 -170.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.424 HD21 ' HA3' ' A' ' 75' ' ' GLY . 0.9 OUTLIER -76.08 150.04 37.34 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.641 1.176 . . . . 0.0 110.787 -178.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.537 ' HB3' ' HB ' ' A' ' 76' ' ' THR . . . -95.19 14.99 20.32 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -167.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 40.9 mt 54.36 -161.27 0.14 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.482 1.113 . . . . 0.0 111.665 -167.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -148.87 162.36 40.0 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.311 1.444 . . . . 0.0 110.869 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.4 p 49.55 -158.78 0.07 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.186 1.795 . . . . 0.0 111.099 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.4 m 24.98 75.5 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 129.172 2.989 . . . . 0.0 111.901 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.35 -30.48 12.26 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.309 1.844 . . . . 0.0 114.088 -169.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.61 17.29 3.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.227 1.411 . . . . 0.0 110.164 174.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -113.99 -16.27 8.01 Favored Glycine 0 C--N 1.34 0.753 0 C-N-CA 125.474 1.511 . . . . 0.0 111.751 -171.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 m -62.13 172.23 1.5 Allowed 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 122.622 1.201 . . . . 0.0 109.205 164.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.23 120.57 8.9 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 159.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.4 p -85.26 166.45 16.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 57.58 24.54 10.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.576 1.151 . . . . 0.0 111.499 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.413 HG21 HD13 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -148.36 154.5 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 119.304 0.956 . . . . 0.0 109.655 -178.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.33 -179.06 27.62 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 125.644 1.592 . . . . 0.0 110.322 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.45 HG11 ' CG ' ' A' ' 177' ' ' PHE . 73.5 t -91.89 152.93 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.404 HE22 ' HB1' ' A' ' 110' ' ' ALA . 1.7 mt-30 -132.1 167.97 18.79 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.218 -0.926 . . . . 0.0 110.247 161.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.427 HG21 ' CE1' ' A' ' 73' ' ' PHE . 4.8 mp -128.23 142.67 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 127.506 2.322 . . . . 0.0 105.559 174.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 110' ' ' ALA . 35.1 mt -129.33 146.41 51.22 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 126.282 1.833 . . . . 0.0 107.53 176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.96 -72.25 0.14 Allowed 'General case' 0 C--O 1.221 -0.431 0 O-C-N 124.309 1.005 . . . . 0.0 111.873 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 108' ' ' GLY . 15.8 ptt180 -167.84 -35.23 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.044 1.338 . . . . 0.0 111.553 172.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 107' ' ' THR . 1.7 t -66.77 11.1 0.1 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.622 2.369 . . . . 0.0 111.063 167.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.426 ' HA2' HD13 ' A' ' 104' ' ' LEU . . . 61.99 12.31 35.73 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.239 1.4 . . . . 0.0 114.68 -171.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.71 110.76 1.6 Allowed 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.246 1.419 . . . . 0.0 108.781 175.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.54 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -63.03 118.57 8.03 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.902 1.281 . . . . 0.0 109.572 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 mt -79.16 155.93 28.46 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.4 m -86.67 170.36 11.87 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 169.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.8 85.96 2.41 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 171.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.404 ' C ' HD13 ' A' ' 74' ' ' LEU . 8.2 t70 -111.32 -17.05 13.24 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 165.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.89 -0.06 73.47 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.342 0.972 . . . . 0.0 112.512 -168.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -128.35 -32.84 2.18 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.525 1.53 . . . . 0.0 111.419 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.2 m -57.26 112.07 1.27 Allowed 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.133 0.973 . . . . 0.0 108.566 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -79.39 146.78 32.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.9 p -74.69 -150.46 0.03 OUTLIER 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.503 1.121 . . . . 0.0 109.869 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.35 156.85 38.65 Favored 'General case' 0 N--CA 1.44 -0.951 0 O-C-N 120.995 -1.066 . . . . 0.0 109.107 163.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -76.94 157.42 31.31 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 122.666 1.222 . . . . 0.0 108.274 166.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.9 m -133.57 122.75 23.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 164.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.1 m -65.49 120.92 13.74 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 167.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.3 mt -78.94 -168.24 1.39 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 127.171 2.188 . . . . 0.0 107.915 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.511 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 5.7 p-10 -153.63 160.06 42.29 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.782 0.833 . . . . 0.0 108.941 164.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -65.56 107.68 1.79 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 127.22 -102.45 0.61 Allowed Glycine 0 C--O 1.225 -0.414 0 N-CA-C 110.584 -1.007 . . . . 0.0 110.584 -172.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 m -137.36 147.64 45.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 118.444 1.122 . . . . 0.0 109.204 -167.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.511 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 0.4 OUTLIER -168.45 161.05 11.59 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.552 1.541 . . . . 0.0 107.117 -175.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.42 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 96.8 m -149.54 151.48 33.95 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -175.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.5 mt -115.53 121.68 34.14 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.28 67.26 7.56 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.232 2.621 . . . . 0.0 113.206 -168.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -65.92 145.07 56.36 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -114.67 148.66 37.9 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.922 168.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -123.39 156.1 36.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 166.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.508 ' NH1' HD21 ' A' ' 104' ' ' LEU . 5.7 ptt-85 -157.37 167.92 28.86 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 169.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.469 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 96.2 m-85 -80.16 147.77 31.19 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 167.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -116.42 117.91 31.23 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 127.053 2.141 . . . . 0.0 106.103 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -87.01 139.74 30.26 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 53.6 p -102.09 13.68 34.04 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.646 1.179 . . . . 0.0 110.277 172.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.73 -154.21 24.9 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 107.756 -2.138 . . . . 0.0 107.756 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.71 95.66 0.9 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.477 1.111 . . . . 0.0 109.555 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.72 121.4 10.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.624 0.769 . . . . 0.0 109.179 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 63.8 p -74.78 161.82 76.12 Favored Pre-proline 0 C--O 1.235 0.323 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 169.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -68.71 173.49 9.93 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 120.861 1.041 . . . . 0.0 110.412 159.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.03 -109.95 0.42 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 173.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -138.94 152.93 48.11 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 128.064 2.546 . . . . 0.0 105.904 174.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.469 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -145.31 75.78 1.45 Allowed 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.934 1.243 . . . . 0.0 111.553 -175.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -118.1 157.47 26.81 Favored 'General case' 0 C--O 1.222 -0.345 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.97 164.96 36.29 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.488 1.515 . . . . 0.0 108.607 172.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -131.59 113.0 13.1 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 172.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -91.12 169.8 10.55 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.416 1.087 . . . . 0.0 109.79 170.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.3 p -115.41 156.22 25.98 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 152.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -120.52 152.41 38.09 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 169.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -122.36 169.7 10.68 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.861 1.664 . . . . 0.0 108.37 170.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.562 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 61.1 t -126.09 132.18 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -107.78 89.77 3.1 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 104.972 -2.232 . . . . 0.0 104.972 166.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.562 ' CZ ' HG11 ' A' ' 156' ' ' VAL . 85.5 m-85 -62.04 145.35 53.41 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 163.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -164.36 169.77 16.96 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.678 0.791 . . . . 0.0 111.287 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 135.44 -89.72 0.23 Allowed Glycine 0 C--O 1.237 0.284 0 N-CA-C 107.696 -2.162 . . . . 0.0 107.696 -173.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 55.54 -108.36 1.02 Allowed Glycine 0 CA--C 1.522 0.482 0 C-N-CA 126.55 2.024 . . . . 0.0 110.057 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -76.74 -110.19 0.14 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -153.23 20.95 0.74 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-O 119.238 -0.757 . . . . 0.0 111.495 -173.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 178.48 105.7 0.19 Allowed Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 119.207 1.503 . . . . 0.0 109.557 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 76.41 73.62 1.0 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 177.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -148.16 120.59 8.47 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 160.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -151.73 160.73 43.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 124.384 1.052 . . . . 0.0 110.511 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 60.6 m -150.29 103.11 3.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.639 1.976 . . . . 0.0 107.141 -173.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.2 m -101.48 109.22 21.0 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 125.595 1.558 . . . . 0.0 109.616 -170.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.647 HG12 HG11 ' A' ' 16' ' ' VAL . 19.6 m -137.29 149.52 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 124.955 1.302 . . . . 0.0 109.708 -160.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.97 163.03 20.67 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.244 0.929 . . . . 0.0 111.906 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -121.94 -80.87 0.57 Allowed Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -174.29 -153.9 10.35 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -165.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.0 m -128.31 105.97 8.7 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.277 1.831 . . . . 0.0 110.327 -161.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.421 HG21 ' CE2' ' A' ' 73' ' ' PHE . 3.8 t -94.08 106.9 18.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -90.17 101.08 13.8 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -175.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.45 ' CG ' HG11 ' A' ' 101' ' ' VAL . 70.5 m-85 -82.55 121.5 26.87 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -126.74 159.4 33.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.6 -163.68 27.87 Favored Glycine 0 CA--C 1.518 0.269 0 N-CA-C 108.194 -1.962 . . . . 0.0 108.194 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -166.26 166.24 16.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 81.8 t -113.86 125.46 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 172.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.9 m -106.27 152.32 7.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 126.265 1.826 . . . . 0.0 108.823 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -75.13 24.78 0.1 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -169.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.162 0 C-N-CA 129.103 2.961 . . . . 0.0 111.839 -175.127 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.88 -178.35 7.0 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.748 1.619 . . . . 0.0 107.673 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.1 t -140.08 152.78 46.43 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.487 -0.758 . . . . 0.0 109.031 166.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -134.31 20.15 3.69 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.364 1.865 . . . . 0.0 107.585 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 p -57.9 144.16 11.0 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 C-N-CA 125.419 1.487 . . . . 0.0 109.347 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -147.22 159.66 43.38 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.34 -143.65 14.57 Favored Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 -172.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -85.2 -89.55 0.87 Allowed Glycine 0 C--N 1.331 0.29 0 N-CA-C 105.04 -3.224 . . . . 0.0 105.04 161.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -136.72 117.22 13.78 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 157.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.3 p 23.36 99.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.284 1.833 . . . . 0.0 111.425 147.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -81.05 -123.89 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -146.61 25.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.113 -0.992 . . . . 0.0 112.409 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 75.6 mttt 32.61 -94.78 0.01 OUTLIER 'General case' 0 C--O 1.238 0.448 0 C-N-CA 127.434 2.294 . . . . 0.0 111.611 -170.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -157.58 50.2 0.43 Allowed Glycine 0 N--CA 1.444 -0.833 0 CA-C-O 117.729 -1.595 . . . . 0.0 110.897 170.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 95.88 167.14 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 129.452 3.101 . . . . 0.0 110.793 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.424 ' C ' ' H ' ' A' ' 18' ' ' ASN . 29.0 t 23.79 71.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.55 0 C-N-CA 130.405 3.482 . . . . 0.0 110.294 -177.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.9 t -76.03 34.95 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 128.451 2.7 . . . . 0.0 110.616 -172.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.424 ' H ' ' C ' ' A' ' 16' ' ' VAL . 68.0 m-80 -146.51 112.05 5.56 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 128.096 2.558 . . . . 0.0 105.213 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' HB2' HG11 ' A' ' 170' ' ' VAL . . . -142.01 29.15 1.68 Allowed 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 122.986 0.514 . . . . 0.0 110.531 177.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 43.67 -50.63 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.28 1 C-N-CA 134.45 5.1 . . . . 0.0 115.48 -167.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 1.6 m -104.51 174.24 5.96 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.262 2.225 . . . . 0.0 110.977 172.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.6 102.82 12.04 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 127.634 2.374 . . . . 0.0 108.065 172.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -58.05 130.85 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 171.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -67.41 153.75 42.96 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -55.12 -32.31 61.95 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 120.908 -1.12 . . . . 0.0 110.486 165.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.84 4.65 4.1 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 118.606 -1.108 . . . . 0.0 114.705 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.3 m -143.38 -19.57 0.62 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 120.609 2.204 . . . . 0.0 114.535 175.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 25' ' ' ALA . 8.4 p -60.57 -39.72 82.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 119.384 0.993 . . . . 0.0 111.292 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -136.23 67.1 1.47 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -167.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.89 140.15 44.18 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.577 -164.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.2 m -109.89 100.19 9.2 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -76.25 102.22 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -84.77 93.15 8.4 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.2 mt -69.57 -16.44 63.41 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.903 1.681 . . . . 0.0 109.059 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.84 -168.63 43.56 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.434 1.016 . . . . 0.0 111.15 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -73.63 152.27 40.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.358 1.063 . . . . 0.0 109.798 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.5 t -135.46 147.25 28.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 125.208 1.403 . . . . 0.0 108.109 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -82.68 131.37 35.21 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -57.12 -27.59 61.95 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 122.74 0.416 . . . . 0.0 111.266 170.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.71 -35.3 65.95 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.535 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.2 m -77.14 -1.53 29.75 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.5 mt -143.71 74.08 1.42 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.726 1.61 . . . . 0.0 108.043 -163.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.22 -6.47 4.85 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -170.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.664 HE21 ' HB2' ' A' ' 47' ' ' ALA . 2.6 pm0 -151.94 163.81 38.47 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 126.292 1.837 . . . . 0.0 107.408 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.401 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 16.2 tt0 -61.43 136.21 57.95 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 122.071 0.939 . . . . 0.0 108.735 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.471 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 82.93 -3.58 83.39 Favored Glycine 0 N--CA 1.434 -1.449 0 CA-C-O 118.095 -1.391 . . . . 0.0 111.27 175.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.664 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -58.17 151.29 19.41 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 118.478 1.139 . . . . 0.0 109.46 158.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.1 p -143.37 154.44 43.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.577 0.703 . . . . 0.0 109.702 -174.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.5 t -65.27 175.84 1.55 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 166.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -38.38 -81.52 0.01 OUTLIER 'General case' 0 C--N 1.339 0.12 0 C-N-CA 127.622 2.369 . . . . 0.0 110.375 167.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.57 158.48 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 129.733 3.213 . . . . 0.0 106.146 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.7 t -145.03 152.06 14.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 168.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.47 144.13 16.6 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 106.339 -2.704 . . . . 0.0 106.339 167.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -141.01 157.72 44.93 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -141.53 168.81 18.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 119.886 1.221 . . . . 0.0 113.241 -172.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 mm -111.41 92.63 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.32 118.68 13.44 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.884 1.673 . . . . 0.0 108.011 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.4 mt -118.8 132.18 56.12 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.829 1.251 . . . . 0.0 109.947 -175.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -116.49 164.68 14.21 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.365 1.466 . . . . 0.0 108.863 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.3 t0 53.66 31.72 13.23 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.742 2.017 . . . . 0.0 113.384 163.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 2.7 t -75.05 153.58 38.34 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.467 -1.396 . . . . 0.0 113.096 -170.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.639 ' HB3' HG23 ' A' ' 65' ' ' VAL . 14.2 t0 -126.38 125.9 42.99 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.978 1.311 . . . . 0.0 110.742 176.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 p -73.75 -17.1 61.15 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.059 0.543 . . . . 0.0 110.955 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -58.87 -45.75 89.43 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.899 1.28 . . . . 0.0 110.001 173.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.639 HG23 ' HB3' ' A' ' 62' ' ' ASP . 4.1 t -72.57 -46.11 56.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -175.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -165.85 130.91 2.38 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.162 1.385 . . . . 0.0 109.253 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 m -73.83 -23.19 59.61 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 171.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -120.79 166.09 14.23 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 126.154 1.782 . . . . 0.0 110.205 -173.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.83 151.64 51.55 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 157.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.77 170.79 10.68 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 144.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.408 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -134.36 159.74 41.88 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -172.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.55 167.07 23.04 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 174.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -125.33 154.9 41.1 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.642 0.777 . . . . 0.0 109.101 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.2 tp -150.01 124.26 9.51 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.918 0.887 . . . . 0.0 108.998 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.15 -178.98 42.75 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.674 1.131 . . . . 0.0 110.824 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.2 m -70.37 133.68 47.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.399 1.48 . . . . 0.0 110.174 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.84 141.13 47.98 Favored 'General case' 0 C--O 1.231 0.131 0 O-C-N 121.296 -0.878 . . . . 0.0 111.156 169.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 tt -63.01 -37.58 79.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 123.554 0.742 . . . . 0.0 110.961 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -159.83 165.78 31.63 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.752 2.021 . . . . 0.0 107.279 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.22 69.5 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 125.536 1.534 . . . . 0.0 112.318 169.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.54 -3.38 90.1 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-O 118.691 -1.061 . . . . 0.0 113.277 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -145.78 50.09 1.2 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.211 1.506 . . . . 0.0 109.614 -172.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.0 p -64.51 -17.41 63.87 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.978 1.311 . . . . 0.0 114.38 -177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -75.75 -25.78 56.82 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.92 173.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.27 137.84 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.396 1.478 . . . . 0.0 110.23 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.82 146.19 32.39 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.221 1.008 . . . . 0.0 111.79 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.36 18.17 6.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.353 1.861 . . . . 0.0 114.226 -167.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 73.4 mt 51.48 -156.12 0.14 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.797 1.239 . . . . 0.0 110.762 -169.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.38 -173.44 4.42 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.622 2.769 . . . . 0.0 107.827 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.8 t 76.26 158.37 0.2 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.553 1.941 . . . . 0.0 112.548 163.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.408 ' HB3' ' HA3' ' A' ' 94' ' ' GLY . 6.1 t 46.46 27.39 0.61 Allowed 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 127.958 2.503 . . . . 0.0 114.429 -175.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 61.78 -50.87 0.14 Allowed 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 128.48 2.712 . . . . 0.0 114.327 -163.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -151.37 11.27 0.61 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.778 1.231 . . . . 0.0 110.675 -170.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.408 ' HA3' ' HB3' ' A' ' 91' ' ' SER . . . -95.57 -12.9 52.85 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 126.264 1.888 . . . . 0.0 114.311 -161.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 p -51.71 162.74 0.37 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 121.768 -0.842 . . . . 0.0 110.784 162.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -46.96 142.33 3.56 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.144 1.378 . . . . 0.0 111.079 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.8 p -94.93 163.42 13.33 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 169.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 56.07 23.75 7.16 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.451 1.501 . . . . 0.0 112.425 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -144.23 155.02 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.19 -168.06 14.04 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.483 HG11 ' CG ' ' A' ' 177' ' ' PHE . 95.5 t -101.42 136.94 30.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 169.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -115.12 158.73 21.78 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 164.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.495 HG22 HD12 ' A' ' 111' ' ' LEU . 2.7 mp -133.48 123.57 46.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.512 1.925 . . . . 0.0 106.768 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 110' ' ' ALA . 10.9 mt -114.41 153.47 29.83 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 174.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.419 ' CB ' ' HB2' ' A' ' 120' ' ' SER . 7.9 t70 -85.76 -107.82 0.05 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 118.438 0.563 . . . . 0.0 110.325 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.79 -45.78 4.69 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 129.618 3.167 . . . . 0.0 109.528 168.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 32.8 p -78.38 -0.17 28.01 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.052 0.541 . . . . 0.0 112.078 -166.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.77 14.15 57.68 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.055 1.312 . . . . 0.0 112.684 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.7 142.35 55.05 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 159.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.559 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -95.82 135.64 37.28 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.495 HD12 HG22 ' A' ' 103' ' ' ILE . 74.3 mt -105.82 120.51 41.9 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.653 -0.655 . . . . 0.0 110.702 -157.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.6 m -73.31 160.1 32.37 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.858 0.837 . . . . 0.0 110.725 -173.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.1 mt -109.38 40.64 1.81 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.243 1.417 . . . . 0.0 111.794 -160.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -106.76 0.28 24.03 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.32 -0.863 . . . . 0.0 112.593 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.26 -17.77 31.64 Favored Glycine 0 CA--C 1.519 0.335 0 O-C-N 120.423 -1.423 . . . . 0.0 114.196 166.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -115.1 -6.7 12.49 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.313 1.056 . . . . 0.0 112.899 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.2 m -68.94 99.4 1.06 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 168.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -61.19 130.09 44.53 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.484 171.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.8 m -83.55 -158.31 0.29 Allowed 'General case' 0 C--O 1.239 0.525 0 C-N-CA 127.19 2.196 . . . . 0.0 109.962 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.419 ' HB2' ' CB ' ' A' ' 105' ' ' ASP . 0.2 OUTLIER -73.45 129.62 38.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.973 0.892 . . . . 0.0 108.942 -170.262 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -84.57 115.17 22.47 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -166.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m -96.66 110.14 22.64 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.0 m -61.83 130.34 45.26 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 163.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 51.5 mt -96.33 -149.26 0.31 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 126.184 1.794 . . . . 0.0 108.255 -170.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -150.34 173.79 13.6 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.616 1.566 . . . . 0.0 107.974 164.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.57 115.24 12.72 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 159.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 119.0 -150.46 17.94 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.631 1.11 . . . . 0.0 111.631 -177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.6 m -75.27 135.27 40.95 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.326 1.45 . . . . 0.0 110.766 -177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.62 168.97 25.76 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.528 1.531 . . . . 0.0 108.514 175.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 95.0 m -152.24 149.81 29.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.556 0.742 . . . . 0.0 109.291 -176.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.75 106.97 57.06 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.479 1.112 . . . . 0.0 108.356 163.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -79.65 117.37 3.66 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 124.319 3.346 . . . . 0.0 111.552 171.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.408 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 91.2 m-85 -93.08 170.43 9.66 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.037 1.735 . . . . 0.0 110.849 168.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -134.71 113.83 12.07 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 126.917 2.087 . . . . 0.0 107.287 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -104.34 133.88 48.5 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 128.553 2.741 . . . . 0.0 109.239 -175.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 136' ' ' ARG . 10.1 ptt-85 -145.15 143.36 30.31 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 170.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.437 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 71.6 m-85 -70.46 116.46 10.81 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 162.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.471 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 3.0 t80 -101.62 130.54 47.97 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -86.71 144.84 26.92 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.401 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 30.3 p -98.7 7.0 46.6 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.273 1.029 . . . . 0.0 112.158 167.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 160.26 -152.64 23.46 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.89 89.3 0.05 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.892 1.277 . . . . 0.0 111.329 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.04 141.64 49.29 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.934 0.893 . . . . 0.0 110.999 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.5 p -112.36 152.99 44.95 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 119.161 -0.447 . . . . 0.0 110.241 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -76.86 162.4 32.36 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.402 1.401 . . . . 0.0 110.081 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 156.42 -133.08 3.51 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 124.903 1.239 . . . . 0.0 110.397 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.11 152.13 18.99 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.29 1.045 . . . . 0.0 108.234 169.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.437 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -136.96 82.28 1.93 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.664 0.745 . . . . 0.0 109.133 168.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -121.06 152.12 39.01 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -145.32 175.55 10.22 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -138.78 115.21 10.48 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 171.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -108.63 156.64 19.31 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 167.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 p -99.4 158.91 15.4 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 149.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -117.91 147.93 42.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 165.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -120.19 167.7 11.99 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.278 1.431 . . . . 0.0 107.645 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.94 106.38 3.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -169.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -95.14 87.94 5.04 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.148 1.379 . . . . 0.0 108.995 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -68.58 149.11 49.57 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.655 1.182 . . . . 0.0 110.704 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -172.82 174.9 3.48 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.135 1.774 . . . . 0.0 109.092 -173.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 145.8 -80.95 0.22 Allowed Glycine 0 CA--C 1.517 0.171 0 N-CA-C 107.835 -2.106 . . . . 0.0 107.835 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -71.06 165.97 52.78 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 123.71 0.671 . . . . 0.0 111.684 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 129.64 162.78 10.96 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 125.996 1.76 . . . . 0.0 110.46 174.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -57.24 -41.16 92.73 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 118.934 -0.926 . . . . 0.0 113.336 -172.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 167.76 25.48 0.02 OUTLIER Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.269 0.937 . . . . 0.0 112.038 -172.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 157.17 96.6 0.12 Allowed Glycine 0 C--N 1.335 0.498 0 N-CA-C 106.483 -2.647 . . . . 0.0 106.483 -166.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -168.17 128.73 1.32 Allowed 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 125.093 1.357 . . . . 0.0 110.1 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -157.72 170.47 22.3 Favored 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 123.746 0.654 . . . . 0.0 109.972 174.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 21.2 m -135.78 101.94 4.92 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.1 m -79.11 104.82 10.0 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 162.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.415 HG11 ' HB2' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -90.14 156.76 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.44 161.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -65.25 129.04 38.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 153.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -85.29 -61.47 1.73 Allowed Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 166.93 -157.53 30.05 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 89.8 m -116.89 135.75 53.48 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.952 1.701 . . . . 0.0 109.29 -175.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.7 t -114.35 107.67 23.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 122.306 1.05 . . . . 0.0 108.344 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -88.36 91.31 8.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.483 ' CG ' HG11 ' A' ' 101' ' ' VAL . 73.0 m-85 -71.2 115.2 10.07 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -123.27 159.49 28.64 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 124.369 1.068 . . . . 0.0 109.149 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 145.95 -166.2 27.98 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 106.491 -2.644 . . . . 0.0 106.491 -173.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.56 176.23 10.62 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 43.6 t -122.3 130.15 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 171.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.405 ' C ' ' H ' ' A' ' 184' ' ' ALA . 4.2 m -105.66 152.29 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 127.393 2.277 . . . . 0.0 108.536 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.21 24.9 0.08 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.837 1.255 . . . . 0.0 114.065 -170.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 C--O 1.257 1.463 1 C-N-CA 133.424 4.689 . . . . 0.0 113.374 -176.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 117.303 -1.332 . . . . 0.0 107.533 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 45.62 73.0 0.18 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.708 1.603 . . . . 0.0 112.433 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.3 p -136.37 -47.99 0.64 Allowed 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.048 0.939 . . . . 0.0 109.192 172.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.6 m 63.35 21.59 12.88 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.612 1.165 . . . . 0.0 110.594 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 p -144.35 160.68 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.504 1.521 . . . . 0.0 107.696 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -52.52 117.17 2.68 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.459 1.904 . . . . 0.0 109.141 174.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 63.54 -103.62 0.71 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -172.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.4 179.45 40.93 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 126.097 1.808 . . . . 0.0 108.808 -175.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.252 0.4 OUTLIER -87.98 85.42 6.98 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 124.014 1.864 . . . . 0.0 106.575 -164.213 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 t 48.49 60.64 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 126.442 1.897 . . . . 0.0 110.968 157.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.415 ' CD2' ' H ' ' A' ' 11' ' ' HIS . 1.8 p80 -82.41 34.72 0.43 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.086 1.354 . . . . 0.0 112.84 -154.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -130.63 56.37 1.78 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.44 1.096 . . . . 0.0 108.656 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -105.27 79.95 1.54 Allowed 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 171.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -145.98 7.33 1.42 Allowed Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 119.136 -0.813 . . . . 0.0 111.98 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -152.81 -171.43 3.93 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 118.913 1.356 . . . . 0.0 108.066 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.0 t -53.18 -37.81 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 126.249 1.82 . . . . 0.0 111.765 -172.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 m 40.91 34.55 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 128.149 2.58 . . . . 0.0 116.202 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.465 ' O ' HG11 ' A' ' 170' ' ' VAL . 2.5 m120 -120.61 103.19 8.95 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 124.24 1.016 . . . . 0.0 109.058 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.413 ' HA ' ' HE2' ' A' ' 158' ' ' TYR . . . -109.92 118.18 35.77 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 167.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.432 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -39.96 -39.22 0.81 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 128.168 2.587 . . . . 0.0 112.93 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.3 m -111.34 142.42 43.6 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.04 -8.96 13.44 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -168.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.2 t 45.95 102.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.29 0 C-N-CA 130.233 3.413 . . . . 0.0 109.265 -162.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -58.97 154.02 16.29 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.761 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.26 -31.16 65.28 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.812 0.733 . . . . 0.0 110.823 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.55 -11.9 60.61 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.987 -0.896 . . . . 0.0 114.249 176.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.6 m -105.86 -36.49 6.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.864 1.332 . . . . 0.0 109.921 172.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.3 t -52.02 -39.69 26.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 123.878 0.871 . . . . 0.0 110.127 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.93 77.21 1.59 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.959 0.885 . . . . 0.0 110.909 -173.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.25 138.28 49.17 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.907 -170.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.4 m -115.13 84.56 2.1 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.407 2.283 . . . . 0.0 110.026 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.4 t -67.93 112.43 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -87.37 97.29 10.72 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.44 HD23 HG11 ' A' ' 52' ' ' VAL . 6.2 mt -70.97 -3.18 18.09 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.722 2.009 . . . . 0.0 109.003 172.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.73 -176.63 35.67 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 124.541 1.067 . . . . 0.0 111.979 169.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -68.67 148.98 49.64 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.471 0.653 . . . . 0.0 109.569 164.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.7 t -136.16 144.97 31.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 125.536 1.534 . . . . 0.0 107.356 176.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.08 133.69 34.63 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.4 p -57.62 -25.02 59.49 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.004 0.522 . . . . 0.0 110.663 173.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.98 -31.45 69.92 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.865 1.266 . . . . 0.0 112.65 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.8 m -76.37 -11.0 59.82 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 173.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.46 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . 37.1 mt -139.12 74.37 1.47 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.92 2.088 . . . . 0.0 109.209 -157.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.22 10.65 4.15 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.177 -0.952 . . . . 0.0 112.901 -169.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.466 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 4.8 pm0 -154.91 158.41 39.25 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 124.885 1.274 . . . . 0.0 108.824 -174.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -61.29 132.39 53.44 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 166.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.73 5.68 87.87 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-O 118.194 -1.337 . . . . 0.0 112.464 -177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -63.65 153.36 36.27 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.652 1.726 . . . . 0.0 109.27 163.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.8 p -141.45 155.43 45.86 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 171.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.9 t -68.39 178.05 2.13 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.345 1.058 . . . . 0.0 109.039 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.8 m -44.71 -86.14 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 127.915 2.486 . . . . 0.0 113.155 171.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 157.69 134.85 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 127.416 2.286 . . . . 0.0 107.239 -171.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.44 HG11 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -146.36 104.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -177.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.92 135.14 30.08 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 112.746 -2.025 . . . . 0.0 109.16 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -143.96 80.64 1.66 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.442 ' HB2' HG22 ' A' ' 130' ' ' THR . 27.7 p30 -77.79 141.56 39.16 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.284 -0.885 . . . . 0.0 110.027 -177.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 130' ' ' THR . 7.0 mm -81.09 102.62 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 -174.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -65.34 101.71 0.6 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 169.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.4 mt -91.19 161.0 15.26 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 161.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.47 ' HA ' HG23 ' A' ' 128' ' ' THR . 86.3 m-20 -131.49 160.37 35.39 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 167.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 t70 45.21 54.51 7.11 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 127.109 2.164 . . . . 0.0 113.418 175.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.7 m -68.62 103.35 1.69 Allowed 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 121.848 -0.532 . . . . 0.0 110.361 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -66.04 149.46 50.22 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 161.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 p -110.13 -15.84 13.92 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.049 0.94 . . . . 0.0 112.724 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -60.24 -46.65 89.05 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 122.361 1.077 . . . . 0.0 109.297 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 66' ' ' ALA . 5.9 p -60.2 -52.75 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 125.69 1.596 . . . . 0.0 108.55 177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 158' ' ' TYR . . . -167.24 135.73 2.62 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.37 1.468 . . . . 0.0 108.363 171.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.0 m -77.87 -12.49 59.98 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.32 -0.848 . . . . 0.0 113.074 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -117.3 152.38 35.01 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 120.232 1.378 . . . . 0.0 109.841 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.91 138.9 51.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 169.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.66 -176.68 3.52 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 123.266 1.508 . . . . 0.0 107.367 150.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.415 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -153.49 160.3 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 131.678 3.991 . . . . 0.0 103.773 -162.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.85 171.57 13.89 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 165.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.413 ' CD1' HG21 ' A' ' 103' ' ' ILE . 23.0 m-85 -129.72 152.41 49.25 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.458 HD22 ' HA3' ' A' ' 115' ' ' GLY . 14.4 tp -152.87 126.8 8.99 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -176.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -170.83 169.8 42.69 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.3 m -60.27 128.11 35.1 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.075 0.95 . . . . 0.0 110.669 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.99 135.99 46.59 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.76 -0.587 . . . . 0.0 110.431 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.2 tt -60.6 -33.66 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.783 0.833 . . . . 0.0 110.333 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -160.0 168.14 26.31 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 164.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.63 -31.85 66.66 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.942 1.297 . . . . 0.0 111.351 166.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.0 -10.92 60.03 Favored Glycine 0 CA--C 1.533 1.215 0 O-C-N 120.588 -1.32 . . . . 0.0 112.531 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -148.33 50.63 1.02 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.154 1.781 . . . . 0.0 111.206 -165.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.3 p -68.22 -12.6 61.24 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 120.964 -1.085 . . . . 0.0 112.121 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -80.94 1.49 30.81 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.469 -0.769 . . . . 0.0 111.233 172.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.1 t -136.45 138.91 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 120.939 -1.1 . . . . 0.0 110.893 -169.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -87.75 148.11 24.88 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 125.63 1.572 . . . . 0.0 111.51 -168.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.14 14.26 12.94 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.735 1.614 . . . . 0.0 115.305 -163.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.534 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 58.1 mt 52.08 -164.88 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.3 1.04 . . . . 0.0 110.643 -166.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -139.87 177.23 8.11 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.553 1.541 . . . . 0.0 108.49 177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.6 m -54.1 142.93 23.81 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.249 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.2 m -177.45 86.52 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.426 2.69 . . . . 0.0 106.832 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 37.44 -74.72 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 129.949 3.3 . . . . 0.0 113.853 -168.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.66 14.3 1.35 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.72 1.208 . . . . 0.0 112.647 172.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 72.63 41.4 50.87 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 121.1 -1.0 . . . . 0.0 111.768 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.2 m 63.07 -170.51 0.18 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.837 1.655 . . . . 0.0 111.078 -169.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.31 168.31 3.56 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.315 1.446 . . . . 0.0 109.692 170.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.9 p -116.43 167.57 10.93 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.492 1.117 . . . . 0.0 109.039 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 53.36 27.25 6.06 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.695 1.598 . . . . 0.0 111.881 -176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.84 151.14 13.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 CA-C-N 120.265 1.393 . . . . 0.0 110.827 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.11 174.45 31.1 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 124.969 1.271 . . . . 0.0 111.317 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.412 HG11 ' CD2' ' A' ' 177' ' ' PHE . 97.7 t -86.48 126.75 40.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 176.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -95.64 153.07 17.91 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 120.121 1.328 . . . . 0.0 108.358 158.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.601 HG22 HD12 ' A' ' 111' ' ' LEU . 2.6 mp -122.59 138.45 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 169.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 110' ' ' ALA . 12.9 mt -133.49 138.99 46.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -65.8 178.45 1.05 Allowed 'General case' 0 C--O 1.236 0.373 0 CA-C-O 122.295 1.045 . . . . 0.0 110.347 170.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -53.88 -13.31 0.71 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.807 1.243 . . . . 0.0 114.287 172.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.7 p -102.36 -11.63 18.51 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.636 1.107 . . . . 0.0 110.902 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.82 11.04 74.67 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.941 1.257 . . . . 0.0 113.467 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.85 60.04 5.69 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.77 1.228 . . . . 0.0 111.513 -174.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.435 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . 23.47 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 128.827 2.851 . . . . 0.0 113.834 153.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.601 HD12 HG22 ' A' ' 103' ' ' ILE . 87.7 mt -78.08 168.0 20.56 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.228 -169.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -109.19 164.21 12.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -172.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.7 mt -113.29 52.59 0.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.325 1.05 . . . . 0.0 108.323 -175.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -104.32 -23.31 13.23 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 124.588 1.155 . . . . 0.0 111.742 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.458 ' HA3' HD22 ' A' ' 74' ' ' LEU . . . 67.62 21.76 72.99 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 118.634 0.652 . . . . 0.0 113.261 -174.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -161.51 34.52 0.13 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.179 1.792 . . . . 0.0 110.392 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 26.9 m -128.92 91.81 3.28 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.078 -2.194 . . . . 0.0 105.078 174.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -62.35 152.91 32.64 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.097 0.475 . . . . 0.0 110.632 -170.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.9 m -126.3 104.07 8.0 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.546 0.739 . . . . 0.0 109.63 -163.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 49.98 -177.73 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.588 1.955 . . . . 0.0 112.018 -168.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -117.48 172.99 6.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 119.632 -1.918 . . . . 0.0 108.167 154.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.8 m -151.02 116.06 5.28 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 165.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.1 m -67.62 137.87 55.96 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 170.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 18.9 mt -108.88 -178.85 3.7 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 129.038 2.935 . . . . 0.0 110.085 -170.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.45 156.98 44.8 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.009 1.724 . . . . 0.0 109.121 167.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -60.78 85.8 0.01 OUTLIER 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.943 2.097 . . . . 0.0 110.644 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.57 -169.57 25.1 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 123.758 0.694 . . . . 0.0 111.804 -161.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 59' ' ' ASN . 28.7 m -96.8 125.48 41.28 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 120.574 -1.545 . . . . 0.0 111.822 -158.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -139.92 157.79 45.13 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 129.097 2.959 . . . . 0.0 109.686 -171.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 56' ' ' ILE . 61.2 m -131.53 150.09 52.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.049 1.339 . . . . 0.0 110.003 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 17.1 mt -106.11 118.47 54.9 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -71.15 148.52 56.31 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.236 1.957 . . . . 0.0 112.039 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.415 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 71.1 m-85 -148.39 165.37 31.3 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 127.459 2.304 . . . . 0.0 109.003 170.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -128.46 140.83 51.62 Favored 'General case' 0 CA--C 1.523 -0.082 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 162.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -106.12 165.9 10.89 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 161.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -166.34 152.38 8.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 169.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.502 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 86.7 m-85 -69.06 151.48 46.39 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 166.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -126.51 133.79 51.07 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.493 1.917 . . . . 0.0 106.509 172.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -101.2 148.32 25.23 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.49 0.716 . . . . 0.0 110.55 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 66.7 p -109.96 12.34 23.77 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.576 1.15 . . . . 0.0 111.089 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.97 -154.44 24.85 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.88 89.24 0.16 Allowed 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.356 1.062 . . . . 0.0 110.721 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -61.62 119.95 9.65 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.405 1.882 . . . . 0.0 109.599 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 21.3 p -83.17 161.78 56.37 Favored Pre-proline 0 C--N 1.33 -0.268 0 C-N-CA 123.847 0.859 . . . . 0.0 109.449 178.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -75.02 173.4 14.58 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 119.777 0.956 . . . . 0.0 109.633 165.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.26 -111.75 0.49 Allowed Glycine 0 C--O 1.229 -0.215 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 172.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.84 168.19 14.19 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 126.063 1.745 . . . . 0.0 106.828 166.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.502 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -145.14 89.39 1.95 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 173.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -125.29 140.79 52.52 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 178.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.534 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -147.71 170.06 18.37 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.535 1.061 . . . . 0.0 109.563 171.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -142.08 115.25 8.83 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.175 1.39 . . . . 0.0 108.648 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.633 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -130.25 167.74 17.97 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.677 1.591 . . . . 0.0 110.332 172.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 76.9 p -121.05 145.59 47.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -100.35 135.98 40.94 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 170.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -81.55 169.26 17.3 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 157.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.866 HG13 HG23 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -113.64 152.13 15.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 127.998 2.519 . . . . 0.0 105.342 163.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -143.96 87.68 1.92 Allowed 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.596 1.558 . . . . 0.0 107.493 164.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.802 ' CE2' HG21 ' A' ' 156' ' ' VAL . 83.0 m-85 -60.79 163.22 5.85 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.494 166.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.522 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 2.0 pt20 -161.85 162.76 29.47 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.765 1.226 . . . . 0.0 111.316 172.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 148.33 -15.95 1.3 Allowed Glycine 0 CA--C 1.521 0.443 0 CA-C-O 117.464 -1.742 . . . . 0.0 116.048 171.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -64.78 -83.17 0.09 OUTLIER Glycine 0 C--N 1.336 0.563 0 CA-C-N 120.31 2.055 . . . . 0.0 110.959 -174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.468 ' H ' ' CB ' ' A' ' 166' ' ' ALA . . . -47.98 -55.73 9.71 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-O 118.502 -1.166 . . . . 0.0 111.563 166.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.97 39.65 5.12 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 118.063 0.932 . . . . 0.0 111.028 -172.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 178.9 -55.5 0.09 OUTLIER Glycine 0 C--N 1.334 0.442 0 O-C-N 121.672 -0.899 . . . . 0.0 111.616 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -121.32 33.88 4.18 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.275 1.417 . . . . 0.0 111.007 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.468 ' CB ' ' H ' ' A' ' 162' ' ' GLY . . . -128.91 100.37 5.65 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 123.99 0.916 . . . . 0.0 110.277 -177.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -148.91 167.76 24.86 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 125.413 1.485 . . . . 0.0 110.522 -174.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 56.6 m -142.1 84.34 1.87 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.1 m -77.11 116.0 17.38 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.009 1.323 . . . . 0.0 108.336 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.866 HG23 HG13 ' A' ' 156' ' ' VAL . 28.2 m -134.84 162.15 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 125.697 1.599 . . . . 0.0 110.166 -175.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -75.68 159.49 31.08 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.91 -1.119 . . . . 0.0 109.332 169.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -129.73 -67.35 0.11 Allowed Glycine 0 CA--C 1.52 0.374 0 CA-C-O 119.475 -0.625 . . . . 0.0 111.655 -163.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 175.85 175.42 43.23 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 117.412 0.606 . . . . 0.0 111.64 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 54.0 m -104.06 138.46 40.55 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.058 1.343 . . . . 0.0 109.214 -174.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.3 t -119.79 92.95 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -73.13 85.01 1.34 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.325 1.85 . . . . 0.0 108.234 174.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.412 ' CD2' HG11 ' A' ' 101' ' ' VAL . 57.6 m-85 -67.45 125.16 25.26 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -131.17 163.38 27.84 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.454 1.102 . . . . 0.0 109.895 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 140.77 -162.71 26.64 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 107.25 -2.34 . . . . 0.0 107.25 -172.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -165.06 170.08 15.5 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.55 125.51 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 167.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.8 m -103.68 151.83 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 126.506 1.923 . . . . 0.0 108.424 173.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.39 25.05 0.08 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.685 1.594 . . . . 0.0 113.567 -169.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 C-N-CA 129.209 3.004 . . . . 0.0 110.756 -168.955 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.725 0 CA-C-O 118.639 -0.696 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.62 127.13 28.73 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 168.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.9 m -165.7 163.19 19.08 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.673 1.989 . . . . 0.0 106.227 -174.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 56.49 -115.22 0.89 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.88 173.5 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.519 1.528 . . . . 0.0 109.537 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -60.11 -35.44 75.24 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.063 1.345 . . . . 0.0 112.582 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.51 -89.93 2.13 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.57 -103.16 2.3 Favored Glycine 0 CA--C 1.503 -0.703 0 N-CA-C 105.859 -2.896 . . . . 0.0 105.859 166.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 t -114.44 83.39 1.88 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 168.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 p 41.14 76.45 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 122.85 1.31 . . . . 0.0 112.035 157.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.604 ' CD2' ' H ' ' A' ' 11' ' ' HIS . 17.4 p80 -74.51 40.39 0.13 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.555 1.142 . . . . 0.0 111.551 -172.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -80.18 -6.8 58.4 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 120.527 -1.358 . . . . 0.0 111.497 -171.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? 58.3 32.64 22.31 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.033 2.533 . . . . 0.0 112.309 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.17 -16.35 80.7 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.404 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.82 -164.39 1.83 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.403 2.281 . . . . 0.0 108.565 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.3 t -57.39 -27.55 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 126.482 1.913 . . . . 0.0 112.199 -175.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 t 44.46 56.9 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 126.69 1.996 . . . . 0.0 112.358 -170.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -144.54 101.77 3.72 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 122.49 1.138 . . . . 0.0 109.688 155.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -138.89 115.42 10.56 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.55 -22.2 61.36 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 123.973 0.796 . . . . 0.0 112.982 -167.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.4 m -118.84 156.23 29.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.087 1.355 . . . . 0.0 107.364 171.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.33 171.64 14.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.477 0.656 . . . . 0.0 109.779 156.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.63 150.26 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 168.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -87.22 18.0 3.97 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -171.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 69.99 -34.75 0.3 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 130.177 3.391 . . . . 0.0 110.305 -166.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.61 -18.32 73.73 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-O 119.057 -0.857 . . . . 0.0 113.966 -172.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -108.24 -7.08 16.06 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.35 1.06 . . . . 0.0 111.209 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.93 -32.18 26.94 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 C-N-CA 125.22 1.408 . . . . 0.0 111.338 -170.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -148.8 73.09 1.21 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 -172.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.1 142.35 38.42 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -171.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.42 HG23 ' HB2' ' A' ' 176' ' ' HIS . 22.5 m -112.59 100.1 8.47 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 172.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.35 102.15 2.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 174.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -79.53 100.54 7.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.768 HD23 HG11 ' A' ' 52' ' ' VAL . 14.6 mt -64.77 -19.01 65.57 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.635 1.974 . . . . 0.0 110.399 169.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.12 -178.15 41.31 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 125.244 1.402 . . . . 0.0 111.662 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -66.13 154.47 39.59 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 170.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.7 t -140.21 143.07 30.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 124.49 1.116 . . . . 0.0 108.514 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -76.19 133.68 40.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 p -58.73 -23.09 59.18 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.167 0.987 . . . . 0.0 110.627 174.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.46 74.57 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.158 -0.964 . . . . 0.0 111.041 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.418 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 67.2 m -69.74 -10.69 59.32 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 172.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.605 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 17.9 mt -140.55 79.44 1.7 Allowed 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 120.071 1.305 . . . . 0.0 107.547 -162.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.01 1.47 0.98 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -174.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.438 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -147.22 152.16 37.89 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.03 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 50.9 tt0 -61.33 125.39 23.59 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.419 ' HA2' ' CZ ' ' A' ' 138' ' ' PHE . . . 101.46 -10.66 57.94 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 118.014 -1.437 . . . . 0.0 112.976 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -61.05 155.18 20.88 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.972 1.886 . . . . 0.0 110.227 177.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.8 p -136.44 161.63 35.29 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 118.425 0.557 . . . . 0.0 110.814 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.2 p -73.58 -163.31 0.16 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.458 0.703 . . . . 0.0 111.356 177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.4 m -46.11 -31.68 2.49 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 126.979 2.111 . . . . 0.0 114.655 166.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 63.51 167.05 0.14 Allowed 'General case' 0 N--CA 1.439 -0.981 0 O-C-N 126.359 2.287 . . . . 0.0 110.055 -166.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.768 HG11 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -162.05 143.35 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 C-N-CA 126.119 1.768 . . . . 0.0 106.276 -167.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.57 121.52 5.39 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 107.228 -2.349 . . . . 0.0 107.228 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -121.17 134.58 55.22 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -115.04 131.66 56.85 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -167.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.8 mm -89.89 108.8 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -77.61 118.46 20.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 23.3 mt -122.31 121.4 36.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 174.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -91.91 162.43 14.42 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.358 1.063 . . . . 0.0 110.068 -172.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 44.0 t0 47.33 42.52 13.98 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 125.889 1.675 . . . . 0.0 112.276 167.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.3 m -63.74 136.49 57.5 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.511 0.724 . . . . 0.0 109.292 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -121.47 103.78 9.18 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.837 0.855 . . . . 0.0 110.739 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.9 p -63.98 -19.91 65.5 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.957 0.903 . . . . 0.0 112.037 -174.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -61.89 -37.52 84.89 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.318 1.447 . . . . 0.0 110.577 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.5 t -78.3 -57.91 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.1 125.27 3.96 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -166.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 m -71.4 -14.76 62.27 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 118.566 -0.731 . . . . 0.0 111.93 169.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -132.42 162.8 30.23 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 120.019 1.281 . . . . 0.0 111.689 -173.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -133.08 136.06 45.66 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 154.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.8 169.14 11.88 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 147.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.0 t -120.59 163.19 18.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 165.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.62 163.11 33.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.872 2.069 . . . . 0.0 107.526 171.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -133.74 152.18 51.81 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.091 1.756 . . . . 0.0 109.729 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.7 tp -152.31 131.07 12.4 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 122.805 0.442 . . . . 0.0 110.847 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.21 -172.12 34.82 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.15 163.96 1.43 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.061 1.744 . . . . 0.0 110.373 171.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.53 130.47 53.56 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 125.753 1.621 . . . . 0.0 109.143 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.6 tt -60.62 -46.77 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 O-C-N 123.413 0.446 . . . . 0.0 110.526 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.1 164.86 32.59 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.75 -15.84 63.83 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.21 -0.24 74.17 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.888 1.232 . . . . 0.0 112.386 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -143.45 41.21 1.47 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.963 1.705 . . . . 0.0 109.691 -167.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.2 p -61.11 -19.85 61.95 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.199 -0.938 . . . . 0.0 112.324 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -75.51 -7.22 53.61 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.855 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.7 t -124.7 130.43 73.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.711 1.141 . . . . 0.0 108.702 -168.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 mt -74.71 151.33 39.23 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.812 1.245 . . . . 0.0 111.133 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -96.06 19.91 10.96 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.147 2.179 . . . . 0.0 114.093 -163.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.7 mt 53.44 -163.85 0.1 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.983 1.313 . . . . 0.0 110.872 -164.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -148.05 164.08 34.93 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.441 1.096 . . . . 0.0 110.485 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.8 m 53.73 -166.96 0.07 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.912 1.285 . . . . 0.0 110.262 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m 24.42 70.3 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 128.546 2.739 . . . . 0.0 114.906 158.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -38.82 -39.4 0.51 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.122 1.769 . . . . 0.0 113.229 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.09 29.58 3.08 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.602 1.161 . . . . 0.0 111.478 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.54 -21.03 6.28 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 166.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.9 m -64.94 173.81 2.18 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.417 -1.049 . . . . 0.0 110.079 162.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.08 168.77 2.32 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.396 157.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.9 p -126.85 170.38 12.28 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 127.263 2.225 . . . . 0.0 108.645 171.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 53.51 29.54 9.21 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 127.472 2.309 . . . . 0.0 111.329 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.1 p -148.44 151.14 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 124.126 0.971 . . . . 0.0 108.565 175.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.72 -176.21 21.12 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.413 HG11 ' CG ' ' A' ' 177' ' ' PHE . 46.4 t -102.54 138.8 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 -177.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -115.58 159.89 20.69 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.524 1.056 . . . . 0.0 110.411 171.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.38 137.38 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 170.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -135.69 151.84 50.59 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.718 -177.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 4.1 p-10 -66.6 179.22 1.08 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.042 0.925 . . . . 0.0 111.975 160.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -44.22 -33.92 1.71 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 129.191 2.996 . . . . 0.0 114.966 168.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 45.4 p -87.83 -7.14 57.66 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.183 1.356 . . . . 0.0 110.846 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.38 22.34 78.77 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.798 1.666 . . . . 0.0 112.419 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -83.8 34.13 0.49 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -165.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.437 ' HA ' HD13 ' A' ' 104' ' ' LEU . . . 33.08 94.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 129.051 2.941 . . . . 0.0 114.978 -177.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.73 136.31 56.09 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.82 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 113' ' ' LEU . 16.9 m -68.61 167.7 14.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 166.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.457 ' H ' HG22 ' A' ' 112' ' ' THR . 66.9 mt -119.73 70.58 0.86 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -168.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -113.82 -11.77 12.82 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.862 0.865 . . . . 0.0 111.816 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.65 -12.38 4.81 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.082 -1.011 . . . . 0.0 113.894 -175.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -133.45 -10.67 2.83 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.945 1.298 . . . . 0.0 112.942 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.4 t -61.22 123.52 17.97 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 164.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -84.57 157.88 21.09 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.2 t -104.11 174.37 5.9 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.438 1.495 . . . . 0.0 109.073 173.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.444 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 0.5 OUTLIER -45.31 13.98 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.525 1 C-N-CA 134.708 5.203 . . . . 0.0 120.765 179.756 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 44.69 -179.63 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 130.314 3.445 . . . . 0.0 113.458 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 m -158.43 137.66 11.59 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 157.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.0 m -77.82 110.86 13.07 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 175.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 31.4 mt -72.44 -174.11 1.28 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.413 2.285 . . . . 0.0 108.221 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -151.45 176.17 11.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.6 1.96 . . . . 0.0 108.723 169.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -68.16 101.32 1.15 Allowed 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 172.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 137.77 -170.36 23.75 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.788 1.185 . . . . 0.0 110.698 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 51.4 m -76.74 129.19 35.97 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.087 -1.243 . . . . 0.0 110.0 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -123.41 166.35 15.5 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 125.289 1.436 . . . . 0.0 109.333 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.0 m -154.71 147.44 24.34 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.037 0.923 . . . . 0.0 109.666 -174.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.2 mt -130.33 111.31 16.64 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 -171.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -83.67 100.16 0.86 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.918 3.079 . . . . 0.0 110.367 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -80.86 166.62 20.74 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 171.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -117.32 155.84 28.85 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 168.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -145.53 163.55 34.4 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.673 1.989 . . . . 0.0 107.835 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -175.41 156.06 1.93 Allowed 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.467 1.907 . . . . 0.0 107.626 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.413 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 85.5 m-85 -71.83 147.22 47.4 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 156.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.419 ' CZ ' ' HA2' ' A' ' 46' ' ' GLY . 31.1 t80 -123.55 121.0 34.51 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.423 1.889 . . . . 0.0 106.893 176.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -82.88 141.31 32.32 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 46.4 p -100.41 11.07 40.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.463 0.705 . . . . 0.0 111.599 169.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 158.59 -148.22 17.03 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.82 82.37 0.2 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.15 1.78 . . . . 0.0 110.214 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -65.31 157.51 28.92 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.247 1.019 . . . . 0.0 111.342 -177.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.1 p -123.79 153.95 67.07 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 124.592 1.157 . . . . 0.0 109.964 -176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.86 163.41 26.06 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.434 1.422 . . . . 0.0 111.018 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.23 -116.51 0.72 Allowed Glycine 0 N--CA 1.469 0.877 0 C-N-CA 124.442 1.02 . . . . 0.0 111.045 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -119.89 145.36 46.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.164 0.982 . . . . 0.0 109.668 167.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -134.45 86.16 2.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -120.48 146.72 45.98 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -149.0 175.16 11.54 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -152.48 152.95 32.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 173.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.13 175.34 9.66 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.836 2.455 . . . . 0.0 107.881 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.9 p -116.54 153.52 32.04 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 155.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -112.54 151.54 29.88 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 169.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt -131.28 157.62 42.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.429 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 9.3 t -122.85 133.81 67.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -169.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -120.84 85.13 2.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.429 ' CZ ' HG11 ' A' ' 156' ' ' VAL . 94.7 m-85 -67.92 128.85 38.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.983 175.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -153.64 176.67 11.81 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 124.801 1.24 . . . . 0.0 111.452 -174.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 129.16 -50.58 0.88 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -173.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -68.77 173.53 34.17 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 173.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.9 169.12 41.4 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 69.54 4.88 47.76 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 119.518 -0.601 . . . . 0.0 112.215 -169.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 149.95 87.62 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -172.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 100.23 74.68 1.12 Allowed Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -123.91 115.0 20.58 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 69.4 75.3 0.23 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 126.756 2.022 . . . . 0.0 112.119 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 10.1 m -79.48 99.48 7.26 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 164.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.9 m -78.16 129.64 35.38 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 165.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.18 151.84 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.713 1.605 . . . . 0.0 109.722 -176.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -61.48 139.59 58.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -108.7 -56.73 0.56 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 166.42 -171.35 41.38 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -175.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.5 m -103.15 138.4 40.02 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.75 1.22 . . . . 0.0 109.657 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.1 t -119.72 103.07 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . 0.42 ' HB2' HG23 ' A' ' 31' ' ' THR . 20.0 m-70 -82.67 141.99 32.04 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 171.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.413 ' CG ' HG11 ' A' ' 101' ' ' VAL . 86.3 m-85 -121.16 113.74 20.42 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -124.75 156.39 37.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 118.582 0.628 . . . . 0.0 110.677 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 148.59 -162.6 28.89 Favored Glycine 0 N--CA 1.437 -1.279 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 -167.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -171.25 177.22 3.66 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 -173.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.4 t -125.87 135.98 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.8 m -118.86 149.97 21.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.441 0 C-N-CA 127.59 2.356 . . . . 0.0 108.492 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -74.99 34.18 0.1 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 C-N-CA 130.269 3.428 . . . . 0.0 112.765 173.033 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 106.687 -1.598 . . . . 0.0 106.687 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.36 142.26 22.09 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 156.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.6 m -132.57 152.77 51.5 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.039 1.336 . . . . 0.0 108.795 -172.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.4 t -143.56 150.81 39.4 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 159.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 p -173.36 160.95 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 128.412 2.685 . . . . 0.0 105.541 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -120.05 158.05 27.63 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.564 1.146 . . . . 0.0 110.712 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.44 -39.98 2.17 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.254 1.883 . . . . 0.0 112.638 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.36 -97.96 0.11 Allowed Glycine 0 C--N 1.334 0.425 0 N-CA-C 105.694 -2.962 . . . . 0.0 105.694 169.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.4 t -145.86 113.54 6.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 160.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.291 4.3 p 22.74 85.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.087 1.355 . . . . 0.0 112.112 145.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -53.93 -78.46 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.676 0.79 . . . . 0.0 111.321 -155.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 176.69 71.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 130.553 3.541 . . . . 0.0 101.678 165.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -85.74 -103.7 0.06 Allowed 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -173.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.13 -13.76 65.4 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 123.614 0.626 . . . . 0.0 113.781 163.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -142.89 -158.46 0.87 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.97 2.108 . . . . 0.0 106.412 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.0 t -55.92 -20.08 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.773 1.229 . . . . 0.0 111.391 167.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 56.4 45.13 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.726 1.211 . . . . 0.0 110.238 -166.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -152.21 99.95 2.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 162.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.13 133.85 52.67 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 165.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.536 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -51.11 -37.44 46.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 116.671 -1.633 . . . . 0.0 111.913 172.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.1 m -121.48 164.86 16.48 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 125.104 1.503 . . . . 0.0 112.128 -167.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.43 -12.81 25.3 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.974 1.31 . . . . 0.0 113.866 -170.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.453 HG13 ' OG ' ' A' ' 27' ' ' SER . 70.8 t 50.06 109.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 130.191 3.396 . . . . 0.0 112.127 -174.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.06 151.68 39.23 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.001 -1.062 . . . . 0.0 109.525 174.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.593 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -49.82 -33.72 17.54 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.353 1.461 . . . . 0.0 111.189 166.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.35 -6.03 1.98 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.442 1.496 . . . . 0.0 114.537 171.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.453 ' OG ' HG13 ' A' ' 23' ' ' VAL . 96.5 p -132.69 -34.93 1.13 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.847 1.824 . . . . 0.0 112.342 -177.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 25' ' ' ALA . 8.0 p -62.13 -55.23 25.42 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 123.396 0.679 . . . . 0.0 111.282 -170.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -132.04 67.8 1.51 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -165.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -105.72 140.3 38.98 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.902 -1.499 . . . . 0.0 108.295 -161.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.1 m -110.32 94.59 5.09 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.6 t -77.65 104.32 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -86.68 107.79 18.36 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 mt -85.37 -3.39 58.82 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.8 1.24 . . . . 0.0 110.029 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.5 -178.34 23.76 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 125.241 1.4 . . . . 0.0 112.298 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -65.74 151.51 46.42 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.088 0.555 . . . . 0.0 109.877 162.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.46 152.95 34.51 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 C-N-CA 125.919 1.688 . . . . 0.0 107.578 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -83.2 134.92 34.94 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.1 p -59.31 -21.94 60.48 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.82 0.448 . . . . 0.0 111.735 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.1 -31.44 70.04 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.684 -1.26 . . . . 0.0 112.229 171.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.1 t -74.05 -9.58 58.77 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.854 0.861 . . . . 0.0 111.449 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.542 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 18.6 mt -143.35 76.56 1.53 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.176 1.39 . . . . 0.0 107.715 -159.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.93 -1.27 2.21 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -171.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.57 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 2.7 pm0 -151.14 161.29 43.0 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 35.6 tt0 -64.08 126.76 28.73 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.27 2.53 79.99 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.995 -0.891 . . . . 0.0 113.166 -174.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.57 ' HB2' ' NE2' ' A' ' 44' ' ' GLN . . . -70.45 159.55 34.01 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.642 1.721 . . . . 0.0 109.779 161.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.0 p -149.67 162.81 39.49 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.301 0.64 . . . . 0.0 110.203 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 87.5 p -73.85 174.8 7.98 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.646 -0.659 . . . . 0.0 110.339 168.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -55.13 -17.27 3.92 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 83.0 160.62 0.13 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 129.765 3.226 . . . . 0.0 112.121 173.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.1 t -143.26 140.53 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.85 130.0 10.09 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 107.152 -2.379 . . . . 0.0 107.152 169.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -136.49 130.19 32.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.468 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 2.8 m-20 -109.64 165.48 11.64 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -169.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.9 mm -116.74 99.33 8.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 172.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -68.36 95.84 0.63 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.902 1.681 . . . . 0.0 110.281 178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mp -86.45 158.31 19.62 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 122.473 1.13 . . . . 0.0 109.123 169.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -163.39 155.59 17.87 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 126.794 2.037 . . . . 0.0 107.547 -169.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 45.55 59.2 3.74 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 127.91 2.484 . . . . 0.0 111.079 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.8 m -108.77 107.81 18.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.389 2.275 . . . . 0.0 111.15 -168.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -79.4 158.45 27.37 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.679 1.127 . . . . 0.0 111.121 172.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.4 p -100.52 -18.04 16.83 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.226 1.41 . . . . 0.0 113.554 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -64.77 -46.85 80.39 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 124.403 1.081 . . . . 0.0 109.063 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 20' ' ' ALA . 2.4 p -57.96 -53.05 50.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 114.184 -1.371 . . . . 0.0 107.442 -175.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.431 ' HA ' ' HA2' ' A' ' 160' ' ' GLY . . . -153.19 142.26 21.34 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 166.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -93.75 11.39 29.31 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.394 172.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.469 ' HE3' ' OE1' ' A' ' 159' ' ' GLN . 7.7 mtmt -148.48 163.34 37.47 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 125.036 1.334 . . . . 0.0 108.724 168.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.84 177.08 9.85 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 123.764 0.665 . . . . 0.0 109.486 157.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.54 178.37 8.18 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 128.696 2.798 . . . . 0.0 107.726 174.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 74.6 t -143.85 100.96 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 126.435 1.894 . . . . 0.0 106.929 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.63 152.52 28.46 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 118.341 -0.838 . . . . 0.0 109.267 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -112.75 158.66 19.81 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 118.814 0.733 . . . . 0.0 110.328 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.9 tp -144.5 153.45 41.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.747 1.619 . . . . 0.0 108.002 175.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.0 170.69 33.92 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.6 m -64.45 131.44 47.14 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.191 1.397 . . . . 0.0 109.334 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.94 135.65 43.25 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.613 1.097 . . . . 0.0 110.366 176.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.7 tt -63.19 -35.29 71.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.229 0.611 . . . . 0.0 111.076 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -159.57 166.53 30.58 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 125.392 1.477 . . . . 0.0 108.755 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.44 -19.86 57.82 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 127.654 2.382 . . . . 0.0 114.612 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.2 -20.23 43.01 Favored Glycine 0 CA--C 1.524 0.629 0 O-C-N 120.838 -1.164 . . . . 0.0 112.149 171.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -125.02 53.76 1.48 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.634 1.573 . . . . 0.0 108.18 -170.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.9 p -63.58 -15.56 58.45 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 127.303 2.241 . . . . 0.0 111.99 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -97.04 2.84 51.89 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.717 2.007 . . . . 0.0 113.073 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 t -128.35 141.13 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 120.157 1.344 . . . . 0.0 109.392 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -81.41 146.11 30.45 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.271 -169.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.55 ' H ' HD23 ' A' ' 86' ' ' LEU . . . -88.95 14.52 10.32 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.629 1.572 . . . . 0.0 114.509 -166.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 41.5 mt 51.51 -154.3 0.17 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.328 1.051 . . . . 0.0 110.556 -167.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -145.34 94.67 2.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.504 -0.747 . . . . 0.0 110.729 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.7 m 51.58 -148.59 0.37 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.084 170.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.7 m 141.43 65.05 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 121.342 1.883 . . . . 0.0 108.844 141.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 53.62 -77.7 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.566 1.947 . . . . 0.0 111.46 -171.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.79 27.16 1.19 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.078 1.751 . . . . 0.0 112.727 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.06 36.93 86.8 Favored Glycine 0 C--N 1.334 0.417 0 O-C-N 121.739 -0.601 . . . . 0.0 113.458 163.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.83 -173.13 0.08 Allowed 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 126.458 1.903 . . . . 0.0 112.884 -171.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.79 125.73 14.06 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 148.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.1 p -90.3 172.6 8.66 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 170.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 56.6 28.62 14.26 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.993 1.717 . . . . 0.0 111.361 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -150.28 151.29 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.858 0.863 . . . . 0.0 109.485 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.6 175.18 29.73 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 124.382 0.991 . . . . 0.0 110.815 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.2 t -85.11 126.54 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -98.87 144.61 27.88 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 164.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.6 mp -118.41 146.95 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 169.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.2 mt -141.52 151.42 43.26 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.201 1.4 . . . . 0.0 107.643 -172.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -59.25 -75.08 0.06 Allowed 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.118 0.485 . . . . 0.0 111.073 170.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.1 ptt-85 -176.0 -24.57 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 128.055 2.542 . . . . 0.0 109.415 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.4 p -80.58 -28.17 37.24 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.107 1.363 . . . . 0.0 108.588 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.6 7.06 9.13 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.016 1.77 . . . . 0.0 112.591 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.88 104.87 2.17 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 120.146 1.973 . . . . 0.0 108.402 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.95 100.78 0.22 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.166 0.986 . . . . 0.0 109.279 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.34 132.48 52.76 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 123.888 0.875 . . . . 0.0 109.251 -170.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 49.3 m -74.63 148.34 40.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.32 0.581 . . . . 0.0 109.789 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.7 mt -92.35 81.55 4.93 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -127.61 -24.42 3.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.6 1.96 . . . . 0.0 111.324 -177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.84 7.78 71.1 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.14 1.353 . . . . 0.0 113.548 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -140.17 -29.17 0.71 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.785 1.292 . . . . 0.0 112.482 170.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.4 m -53.81 115.09 1.81 Allowed 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.633 1.173 . . . . 0.0 108.846 173.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -71.52 179.64 2.92 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.309 1.052 . . . . 0.0 112.384 -164.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.8 p -134.27 126.22 29.34 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.938 1.695 . . . . 0.0 107.791 167.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.6 m 23.2 85.25 0.01 OUTLIER 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.757 2.023 . . . . 0.0 114.083 147.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -61.61 144.95 53.61 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.128 -162.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.9 m -113.71 114.21 26.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 86.0 m -53.74 110.58 0.6 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 154.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.0 mt -72.84 176.9 5.23 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 170.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.12 162.22 30.38 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 121.621 -0.675 . . . . 0.0 109.993 171.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.37 132.18 47.54 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 94.7 -118.54 5.85 Favored Glycine 0 C--O 1.223 -0.58 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.9 m -118.54 144.47 46.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.455 1.102 . . . . 0.0 109.706 -164.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.63 171.5 18.81 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.127 1.371 . . . . 0.0 109.309 -173.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.468 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 97.1 m -154.32 163.78 39.62 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 119.527 -1.983 . . . . 0.0 108.637 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -122.05 121.0 28.14 Favored Pre-proline 0 N--CA 1.446 -0.638 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 168.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -70.62 135.64 28.86 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 N-CA-C 108.026 -1.567 . . . . 0.0 108.026 160.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -120.54 170.78 9.08 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.802 0.841 . . . . 0.0 108.75 163.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.77 143.33 50.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 168.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -115.74 164.5 14.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.694 1.197 . . . . 0.0 107.915 162.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -164.77 152.33 11.53 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 167.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.451 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 70.4 m-85 -69.5 142.09 53.79 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 165.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -121.74 122.01 38.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -86.18 141.79 29.09 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.46 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 65.4 p -101.43 7.35 42.59 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.271 1.028 . . . . 0.0 111.302 173.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.81 -151.97 21.3 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.17 91.98 0.08 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.069 1.348 . . . . 0.0 109.658 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -79.34 144.46 34.19 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 123.529 0.732 . . . . 0.0 110.897 -174.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 46.2 p -110.56 165.58 12.4 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.014 0.925 . . . . 0.0 110.019 -175.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -78.9 174.48 12.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.166 1.911 . . . . 0.0 111.17 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.96 -85.55 0.14 Allowed Glycine 0 C--N 1.336 0.555 0 O-C-N 121.36 -0.838 . . . . 0.0 113.819 167.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -147.11 162.9 37.91 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.311 2.244 . . . . 0.0 105.771 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -151.74 68.42 0.89 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 119.443 1.02 . . . . 0.0 110.133 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -114.73 150.37 35.4 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -175.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.08 169.95 20.58 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 169.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -132.93 120.53 21.57 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 174.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -120.44 159.64 24.72 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.933 1.693 . . . . 0.0 108.95 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.0 p -124.54 141.33 52.17 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 162.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -104.36 155.94 18.34 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 168.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -119.5 131.03 55.49 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 171.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 156' ' ' VAL . 0.2 OUTLIER -66.21 137.98 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 171.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -128.8 90.15 3.0 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 171.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.536 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 84.6 m-85 -62.23 161.52 11.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 166.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.469 ' OE1' ' HE3' ' A' ' 68' ' ' LYS . 8.2 mt-30 -103.35 -142.99 0.36 Allowed 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 125.027 1.331 . . . . 0.0 108.044 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 66' ' ' ALA . . . -131.9 9.85 5.44 Favored Glycine 0 N--CA 1.434 -1.468 1 C-N-CA 113.642 -4.123 . . . . 0.0 118.419 126.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.439 ' HA2' ' HE2' ' A' ' 68' ' ' LYS . . . 86.41 13.03 68.84 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 120.996 2.398 . . . . 0.0 111.852 -176.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -84.04 -168.06 43.28 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 150.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.25 76.46 0.39 Allowed Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 108.497 -1.841 . . . . 0.0 108.497 -177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.36 101.24 0.6 Allowed Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 142.32 9.42 0.57 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 124.525 1.059 . . . . 0.0 113.701 173.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -155.51 123.44 5.73 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.966 0.907 . . . . 0.0 109.544 174.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -164.67 153.85 13.14 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.265 1.826 . . . . 0.0 110.848 173.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 46.3 m -137.92 92.8 2.7 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.566 1.546 . . . . 0.0 108.04 -173.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.51 126.15 28.4 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 167.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.38 140.58 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.624 1.17 . . . . 0.0 109.328 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -58.96 143.13 49.07 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -114.68 -87.77 1.51 Allowed Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -144.58 -144.35 4.16 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 126.711 2.101 . . . . 0.0 112.137 -167.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 96.5 m -138.18 149.42 45.83 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.333 2.253 . . . . 0.0 108.2 166.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 61.7 t -115.73 119.15 61.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 163.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -96.97 94.51 7.23 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -72.35 119.5 16.64 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 176.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 48.9 mmtt -124.95 160.27 29.29 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 138.15 -169.91 24.03 Favored Glycine 0 C--N 1.321 -0.292 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -171.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -162.66 177.05 9.72 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -167.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 41.3 t -126.69 131.06 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 167.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.3 m -101.9 155.9 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 C-N-CA 127.354 2.262 . . . . 0.0 108.227 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.13 37.79 0.16 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.421 1.088 . . . . 0.0 113.494 -172.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 C-N-CA 127.844 2.457 . . . . 0.0 110.371 -167.189 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.263 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.55 151.77 39.41 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.325 1.421 . . . . 0.0 110.357 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.8 p -136.82 -25.57 1.09 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -166.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.254 3.6 t 37.06 -158.71 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 128.876 2.87 . . . . 0.0 116.16 164.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 p -82.96 79.31 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 126.395 1.878 . . . . 0.0 108.324 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -75.92 82.83 2.83 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 121.046 -1.034 . . . . 0.0 109.148 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.71 -98.8 0.13 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.155 -0.803 . . . . 0.0 112.728 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.26 -40.72 1.68 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.412 1.482 . . . . 0.0 110.003 -171.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.55 84.39 1.8 Allowed 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 157.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.25 10.2 p 24.31 68.36 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 128.577 2.751 . . . . 0.0 113.249 164.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -74.65 -38.43 62.49 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.937 -175.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.3 t80 85.3 -2.36 0.85 Allowed 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 128.771 2.828 . . . . 0.0 113.085 165.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt 47.0 104.43 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.125 0 CA-C-O 124.378 2.037 . . . . 0.0 109.355 -140.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -56.84 78.3 0.01 OUTLIER Glycine 0 C--N 1.306 -1.096 0 C-N-CA 126.937 2.208 . . . . 0.0 111.987 166.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.3 0.0 OUTLIER 72.25 168.04 0.31 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.466 2.306 . . . . 0.0 110.222 -177.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . 0.431 2.1 p 53.17 -42.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.511 1 C-N-CA 133.01 4.524 . . . . 0.0 113.336 -164.852 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 t 41.85 31.14 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 128.513 2.725 . . . . 0.0 115.394 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -134.86 107.5 7.41 Favored 'General case' 0 CA--C 1.494 -1.208 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 -176.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -111.3 110.83 21.5 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 103.737 -2.69 . . . . 0.0 103.737 171.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.414 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -30.78 -52.8 0.18 Allowed 'General case' 0 C--N 1.343 0.309 0 C-N-CA 126.58 1.952 . . . . 0.0 111.452 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 1.8 m -103.73 143.3 32.98 Favored 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 124.684 1.24 . . . . 0.0 108.774 166.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.97 172.26 1.83 Allowed 'General case' 0 N--CA 1.443 -0.818 0 O-C-N 124.621 1.201 . . . . 0.0 109.918 164.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.5 t -122.8 137.55 55.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -71.37 158.2 36.74 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.779 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -59.03 -32.56 69.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.176 0.99 . . . . 0.0 111.869 172.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.65 3.36 60.22 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 118.435 -1.203 . . . . 0.0 113.901 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.8 t -128.39 -40.92 1.58 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.355 1.462 . . . . 0.0 109.087 -169.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 25' ' ' ALA . 9.0 p -56.57 -41.46 73.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 123.992 0.917 . . . . 0.0 111.06 171.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -131.4 69.02 1.48 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.074 0.94 . . . . 0.0 109.503 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -103.02 129.48 49.81 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.545 -171.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.621 HG23 ' HB2' ' A' ' 176' ' ' HIS . 0.3 OUTLIER -97.45 99.34 10.75 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 172.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.2 t -85.17 115.21 26.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -90.04 108.35 19.67 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 175.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.2 mt -71.68 -16.52 62.25 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.566 0.747 . . . . 0.0 109.801 173.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.48 -175.53 52.98 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -71.27 156.81 39.09 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.497 0.719 . . . . 0.0 109.484 171.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.3 t -141.63 146.57 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 126.5 1.92 . . . . 0.0 107.026 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.11 137.54 37.54 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.8 p -59.87 -20.85 59.5 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.254 0.622 . . . . 0.0 111.337 173.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.48 -39.43 87.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.245 1.018 . . . . 0.0 111.883 173.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.4 m -67.66 -9.27 41.82 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mt -142.05 60.93 1.46 Allowed 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 125.882 1.673 . . . . 0.0 110.412 -162.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.64 -3.8 7.19 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -166.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.874 HE21 ' HB2' ' A' ' 47' ' ' ALA . 2.7 pm0 -153.45 160.26 42.54 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.516 1.526 . . . . 0.0 107.19 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.408 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 36.3 tt0 -61.52 135.09 57.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.98 0.895 . . . . 0.0 109.131 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.91 -7.88 64.87 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-O 117.088 -1.951 . . . . 0.0 112.982 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.874 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -58.8 155.93 12.11 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 120.239 2.019 . . . . 0.0 110.51 165.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.3 p -146.74 150.51 35.49 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.688 0.756 . . . . 0.0 110.382 -171.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 14.5 t -59.54 164.57 3.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 163.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 m -46.35 -81.17 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.335 1.054 . . . . 0.0 112.772 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 173.32 143.49 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.53 1.932 . . . . 0.0 106.839 -172.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 t -141.29 130.46 24.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 170.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.55 126.53 8.93 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 107.437 -2.265 . . . . 0.0 107.437 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.549 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 8.3 p90 -131.55 78.01 1.8 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 123.707 1.718 . . . . 0.0 109.539 -177.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.443 ' HB2' HG22 ' A' ' 130' ' ' THR . 0.2 OUTLIER -70.16 153.51 43.04 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.362 -173.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.9 mm -94.3 104.08 15.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 175.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -62.39 112.92 2.63 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.886 -1.154 . . . . 0.0 107.886 167.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.87 167.0 11.52 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 161.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -137.92 169.7 17.34 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.401 1.481 . . . . 0.0 107.485 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 43.47 54.02 5.46 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 128.287 2.635 . . . . 0.0 114.712 164.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 2.0 t -81.12 168.71 18.28 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -137.73 141.62 40.99 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.804 2.442 . . . . 0.0 106.446 172.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.1 p -95.72 -12.63 25.14 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.372 1.069 . . . . 0.0 113.138 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 -60.71 -49.36 77.82 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.919 1.288 . . . . 0.0 109.475 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.414 HG11 ' HA ' ' A' ' 20' ' ' ALA . 3.0 p -59.64 -58.92 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 113.692 -1.595 . . . . 0.0 107.378 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.4 132.02 9.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.38 1.872 . . . . 0.0 107.38 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.49 -18.53 61.1 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.838 170.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -129.2 157.4 41.94 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 119.605 1.093 . . . . 0.0 110.856 -164.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.94 145.73 46.47 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 124.974 1.31 . . . . 0.0 107.74 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.5 164.95 23.7 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 124.509 1.124 . . . . 0.0 108.534 157.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.415 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -153.77 92.07 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 -169.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.04 165.77 24.38 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.966 0.907 . . . . 0.0 109.405 169.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -130.22 163.42 26.75 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.16 1.384 . . . . 0.0 109.136 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 14.1 tp -154.42 133.55 12.47 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.122 1.369 . . . . 0.0 109.217 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.31 177.07 42.56 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.7 m -73.77 130.7 40.49 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.105 0.962 . . . . 0.0 109.946 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.02 136.88 48.59 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 118.949 0.795 . . . . 0.0 111.3 176.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.5 tt -62.24 -42.04 93.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.758 0.823 . . . . 0.0 110.946 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -152.64 164.83 36.93 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.59 1.556 . . . . 0.0 106.924 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.15 82.6 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 126.22 1.808 . . . . 0.0 110.955 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.87 -4.83 78.12 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-O 119.541 -0.588 . . . . 0.0 112.476 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -143.02 41.84 1.53 Allowed 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.884 1.342 . . . . 0.0 110.53 -167.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 p -62.99 -13.38 34.34 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.209 2.204 . . . . 0.0 115.023 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -81.37 -13.48 58.29 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 120.761 0.315 . . . . 0.0 111.329 171.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.0 t -115.31 133.01 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 O-C-N 120.36 -1.462 . . . . 0.0 108.624 -166.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -76.08 148.11 38.16 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.649 1.18 . . . . 0.0 110.014 -174.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.77 14.89 12.3 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.301 1.84 . . . . 0.0 113.955 -164.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.4 mt 52.76 -155.35 0.19 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.125 0.97 . . . . 0.0 109.565 -163.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -127.82 -165.58 1.5 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.707 0.403 . . . . 0.0 110.856 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -53.78 -178.14 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.654 1.981 . . . . 0.0 111.778 171.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.513 ' HB3' ' HA3' ' A' ' 94' ' ' GLY . 0.7 OUTLIER 66.77 79.52 0.23 Allowed 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 125.97 1.708 . . . . 0.0 107.23 -149.442 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.85 -44.76 29.49 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.5 2.32 . . . . 0.0 112.011 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.73 -4.13 12.19 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.022 0.929 . . . . 0.0 111.455 175.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 91' ' ' SER . . . -74.31 -50.76 9.49 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.7 m -68.75 150.91 47.34 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.239 173.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.82 144.85 56.98 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 126.954 2.101 . . . . 0.0 110.044 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.401 ' H ' ' HG1' ' A' ' 144' ' ' THR . 3.8 p -90.96 165.93 13.3 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 56.55 20.85 5.19 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 127.286 2.234 . . . . 0.0 113.517 175.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -142.79 149.76 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 119.209 0.913 . . . . 0.0 108.844 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.94 174.99 24.81 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 124.864 1.221 . . . . 0.0 110.603 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.432 HG11 ' CD2' ' A' ' 177' ' ' PHE . 53.4 t -84.36 149.3 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -136.69 143.97 43.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.56 1.544 . . . . 0.0 106.935 175.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.35 137.29 57.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.9 mt -133.44 129.13 36.85 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.767 1.627 . . . . 0.0 107.061 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 12.0 p30 -55.45 -60.7 3.05 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -175.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -171.62 -45.31 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.294 2.238 . . . . 0.0 108.408 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.293 0.5 OUTLIER -82.05 18.65 1.3 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.427 1.891 . . . . 0.0 109.94 -177.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.8 10.94 48.02 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 120.252 -1.53 . . . . 0.0 112.105 -169.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.79 111.42 8.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.554 1.677 . . . . 0.0 107.484 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.78 138.86 58.07 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.11 0.564 . . . . 0.0 109.801 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 73.0 mt -108.33 110.25 21.78 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.418 0.687 . . . . 0.0 110.398 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -53.25 139.16 30.27 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.699 1.6 . . . . 0.0 110.6 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.6 mt -89.41 59.39 4.79 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 127.903 2.481 . . . . 0.0 108.015 -173.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.69 -31.98 10.53 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.314 0.578 . . . . 0.0 111.257 -174.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.74 -36.85 3.95 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-O 117.522 -1.71 . . . . 0.0 114.086 -174.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.55 -16.56 13.63 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.91 1.355 . . . . 0.0 112.222 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.1 m -73.02 95.74 2.06 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -70.24 173.19 7.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.363 2.265 . . . . 0.0 110.786 -174.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.0 p -112.88 -170.36 1.66 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.302 1.441 . . . . 0.0 111.814 -172.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -44.43 142.59 1.53 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.579 1.552 . . . . 0.0 111.594 164.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -80.67 134.39 35.86 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.623 0.725 . . . . 0.0 109.156 170.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.9 m -113.93 113.26 24.59 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 167.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.7 m -61.44 143.5 55.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 169.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.9 mt -115.41 179.48 3.95 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.301 2.24 . . . . 0.0 109.105 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -134.03 167.87 19.84 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.347 1.459 . . . . 0.0 108.21 172.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -72.28 104.11 3.6 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.07 -149.9 18.26 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 -173.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.95 138.36 31.48 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.269 1.028 . . . . 0.0 111.248 -165.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -159.78 169.0 24.57 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.449 1.9 . . . . 0.0 110.915 -174.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 55' ' ' ASN . 1.6 m -151.99 150.39 29.94 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.534 1.134 . . . . 0.0 109.641 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.27 119.31 55.51 Favored Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 124.58 1.152 . . . . 0.0 108.784 168.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -81.54 83.69 2.09 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 124.011 3.141 . . . . 0.0 112.782 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.415 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 76.3 m-85 -74.52 160.9 30.31 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.269 -0.894 . . . . 0.0 112.572 173.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -116.95 147.65 42.08 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 155.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.549 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -122.82 161.63 23.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.833 1.653 . . . . 0.0 107.121 160.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -157.61 160.16 37.79 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.421 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 97.4 m-85 -76.76 148.83 36.43 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 163.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -124.19 127.23 47.43 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.254 1.422 . . . . 0.0 107.376 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -91.77 144.26 25.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.482 0.713 . . . . 0.0 109.639 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.408 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 24.8 p -104.35 8.33 35.87 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 123.617 0.767 . . . . 0.0 111.653 171.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 162.96 -150.35 19.17 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 107.944 -2.062 . . . . 0.0 107.944 -176.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.8 89.74 0.27 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.582 1.153 . . . . 0.0 110.699 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.53 141.7 46.88 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.512 0.725 . . . . 0.0 109.672 173.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.401 ' HG1' ' H ' ' A' ' 97' ' ' THR . 69.6 p -92.72 160.6 33.95 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -75.96 157.84 38.61 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 121.126 1.218 . . . . 0.0 109.464 160.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.67 176.23 18.49 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.357 1.456 . . . . 0.0 109.685 -168.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.16 157.67 34.85 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 121.526 -0.984 . . . . 0.0 108.732 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.421 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -144.75 81.63 1.66 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.719 0.771 . . . . 0.0 110.174 -177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -124.77 152.1 44.27 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -173.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -156.11 175.34 14.1 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.702 1.201 . . . . 0.0 109.523 177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -156.47 84.69 0.98 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.936 0.874 . . . . 0.0 110.642 -175.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.448 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -81.31 169.89 16.72 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.934 173.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.3 p -117.61 163.12 16.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.86 155.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.406 ' CD2' ' HA3' ' A' ' 172' ' ' GLY . 38.9 p90 -120.37 159.55 24.83 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.534 1.134 . . . . 0.0 109.91 173.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -129.1 125.27 36.83 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 167.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.31 143.32 15.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 163.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -137.26 82.24 1.92 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 169.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -67.51 154.03 42.35 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 118.744 -0.646 . . . . 0.0 109.687 176.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -158.32 176.12 12.87 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.498 1.119 . . . . 0.0 112.795 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 141.35 -32.53 2.07 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.095 1.331 . . . . 0.0 111.644 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -90.44 -141.69 9.28 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.439 1.971 . . . . 0.0 110.167 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 151.38 -13.98 0.82 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.963 1.268 . . . . 0.0 111.809 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -80.05 79.43 1.71 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 176.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 149.54 -100.5 0.21 Allowed Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -87.84 -46.28 4.87 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 76.76 119.33 0.05 Allowed 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 127.753 2.421 . . . . 0.0 110.541 -168.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 59.61 175.6 0.08 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.512 2.325 . . . . 0.0 112.538 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.1 m -145.1 90.69 2.06 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.119 0.967 . . . . 0.0 109.341 -168.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.3 m -92.95 96.58 10.19 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.1 0.952 . . . . 0.0 110.678 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.53 135.12 51.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 125.767 1.627 . . . . 0.0 110.292 -174.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -55.78 107.67 0.37 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.452 1.101 . . . . 0.0 108.907 168.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.406 ' HA3' ' CD2' ' A' ' 154' ' ' PHE . . . -74.95 -58.05 4.19 Favored Glycine 0 CA--C 1.523 0.578 0 O-C-N 120.587 -1.321 . . . . 0.0 110.931 -168.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 169.33 -161.47 35.0 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -171.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.6 m -122.43 133.93 54.61 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 127.588 2.355 . . . . 0.0 107.008 -176.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.49 109.65 28.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . 0.621 ' HB2' HG23 ' A' ' 31' ' ' THR . 20.2 m-70 -88.07 96.75 10.64 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.432 ' CD2' HG11 ' A' ' 101' ' ' VAL . 77.9 m-85 -76.63 133.03 39.73 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -137.73 162.1 34.8 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 121.537 -0.727 . . . . 0.0 111.325 175.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 146.92 -155.87 26.75 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 108.021 -2.032 . . . . 0.0 108.021 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -169.97 175.28 5.18 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -168.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 32.0 t -128.22 136.99 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 175.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 16.3 m -118.72 147.49 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 C-N-CA 126.495 1.918 . . . . 0.0 109.496 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.35 25.31 0.1 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -167.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.302 0 C-N-CA 128.54 2.736 . . . . 0.0 111.326 -167.63 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.35 106.06 4.12 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -155.53 121.83 5.19 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -173.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.0 m -153.68 101.67 2.49 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 173.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.6 t -66.06 134.38 29.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 162.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -63.48 92.8 0.07 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.285 1.434 . . . . 0.0 107.965 169.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.4 -87.78 0.71 Allowed Glycine 0 CA--C 1.521 0.461 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.6 -111.48 0.29 Allowed Glycine 0 C--N 1.336 0.541 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -130.55 96.83 4.22 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.263 11.4 p 41.98 48.8 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 127.33 2.252 . . . . 0.0 115.366 160.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.438 ' H ' ' CD2' ' A' ' 11' ' ' HIS . 4.6 p80 -89.85 68.37 7.4 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.164 -1.585 . . . . 0.0 110.663 -164.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -144.98 -2.92 0.79 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -77.27 22.63 0.22 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -164.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -120.79 36.93 3.18 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -150.98 -171.71 4.01 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 171.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 p -55.23 -29.61 23.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.896 1.278 . . . . 0.0 112.478 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.1 t 25.71 63.67 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 126.923 2.089 . . . . 0.0 112.458 -172.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -136.77 105.86 5.98 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 170.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.71 139.11 53.81 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.401 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . . . -70.12 -16.32 63.09 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.795 -177.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.7 m -129.68 157.08 43.14 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.695 1.198 . . . . 0.0 107.829 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.25 107.14 15.59 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 161.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.0 p -58.12 118.58 2.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 121.104 -0.997 . . . . 0.0 108.859 167.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -70.97 163.88 26.62 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.737 -0.602 . . . . 0.0 111.135 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -72.27 -12.9 61.35 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 120.99 -1.069 . . . . 0.0 113.209 -178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.63 -1.65 90.04 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 121.233 -0.917 . . . . 0.0 112.787 167.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.4 t -121.82 -31.1 4.01 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.758 1.279 . . . . 0.0 110.765 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 25' ' ' ALA . 4.1 p -63.75 -24.32 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 O-C-N 121.11 -0.994 . . . . 0.0 113.3 -175.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -157.01 53.67 0.51 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.664 0.786 . . . . 0.0 110.365 -162.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -99.49 143.37 29.81 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 120.543 -1.348 . . . . 0.0 110.404 -169.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 176' ' ' HIS . 4.9 m -113.79 95.32 5.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.1 t -73.15 136.45 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -114.26 118.78 34.91 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.501 1.143 . . . . 0.0 108.464 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.466 HD22 ' N ' ' A' ' 34' ' ' LEU . 1.3 mm? -85.94 -21.2 28.02 Favored 'General case' 0 N--CA 1.44 -0.974 1 C-N-CA 131.9 4.08 . . . . 0.0 108.422 177.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.45 -172.58 34.79 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 124.658 1.123 . . . . 0.0 111.144 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -67.57 112.77 4.91 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.806 0.842 . . . . 0.0 108.827 171.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.19 153.23 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 125.258 1.423 . . . . 0.0 107.691 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 5.8 mmt180 -86.32 136.34 33.18 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.3 p -60.66 -27.25 67.68 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 169.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.08 3.24 2.19 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.975 1.71 . . . . 0.0 113.789 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 m -121.45 7.0 10.08 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.866 1.267 . . . . 0.0 112.203 164.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.569 HD13 HG21 ' A' ' 99' ' ' VAL . 29.6 mt -142.26 71.79 1.36 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.397 1.879 . . . . 0.0 109.15 -171.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.55 4.46 3.37 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 120.813 -1.18 . . . . 0.0 113.901 -171.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.533 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 4.1 pm0 -153.69 158.57 41.23 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 19.1 tt0 -61.42 136.42 58.03 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 172.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.417 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 86.42 -5.79 83.67 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 118.371 -1.238 . . . . 0.0 112.965 -176.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -63.12 156.48 24.92 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 119.376 1.588 . . . . 0.0 109.892 169.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.2 p -146.29 155.44 42.65 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.309 0.959 . . . . 0.0 111.834 -176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.422 ' HB3' ' HB2' ' A' ' 137' ' ' TYR . 60.6 p -69.33 178.62 2.31 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.831 -0.543 . . . . 0.0 110.142 175.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.84 -21.27 4.02 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 81.62 129.57 0.05 OUTLIER 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 128.744 2.817 . . . . 0.0 112.572 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 m -133.56 129.2 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-O 122.932 1.349 . . . . 0.0 109.74 -158.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.19 149.96 39.91 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 171.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 2.2 p90 -154.09 154.57 33.86 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 162.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.545 ' HB3' ' CG2' ' A' ' 130' ' ' THR . 4.6 m-20 -135.44 166.47 23.1 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.93 0.786 . . . . 0.0 109.854 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.2 mm -108.7 97.24 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 125.52 1.528 . . . . 0.0 107.281 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.65 132.56 51.48 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 170.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.6 mt -137.79 110.76 7.73 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.867 1.667 . . . . 0.0 107.72 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -86.01 150.63 24.34 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.978 1.311 . . . . 0.0 108.85 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 t70 36.96 70.73 0.16 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.231 2.613 . . . . 0.0 114.734 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.552 ' SG ' HD12 ' A' ' 124' ' ' LEU . 58.3 m -84.71 86.57 7.31 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 128.357 2.663 . . . . 0.0 112.267 -175.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.82 103.76 0.96 Allowed 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.505 1.922 . . . . 0.0 111.147 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -60.24 -19.79 56.11 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.365 1.066 . . . . 0.0 112.415 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -61.3 -36.63 80.64 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.769 1.228 . . . . 0.0 111.932 175.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 20' ' ' ALA . 14.0 t -70.67 -49.59 50.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 177.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.41 ' HB1' ' H ' ' A' ' 159' ' ' GLN . . . -165.3 127.59 2.11 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -171.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -68.3 -12.27 60.79 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 117.454 -1.26 . . . . 0.0 111.695 169.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.474 ' HA ' HD23 ' A' ' 124' ' ' LEU . 30.3 mtmt -136.33 157.61 46.39 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 120.844 1.657 . . . . 0.0 113.94 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.07 123.26 20.48 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.806 2.042 . . . . 0.0 108.329 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.75 -177.61 3.83 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 149.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.422 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -145.33 146.5 19.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 -165.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -124.23 168.18 13.3 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 120.273 1.397 . . . . 0.0 107.871 166.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -128.89 158.83 37.67 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.114 1.766 . . . . 0.0 108.969 174.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 22.1 tp -147.17 150.9 35.84 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.462 1.905 . . . . 0.0 107.949 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.467 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -167.29 -162.69 19.63 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-N 119.138 0.881 . . . . 0.0 112.531 -175.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 23.7 m -105.88 121.28 43.74 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.101 1.761 . . . . 0.0 106.782 163.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.06 140.14 50.62 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 110.135 -0.321 . . . . 0.0 110.135 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.4 tt -60.27 -35.69 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.257 0.623 . . . . 0.0 110.356 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -165.47 165.86 18.8 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.743 1.617 . . . . 0.0 108.684 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.24 -35.1 62.1 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 127.576 2.351 . . . . 0.0 113.419 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.37 -8.54 66.4 Favored Glycine 0 CA--C 1.531 1.058 0 O-C-N 120.955 -1.091 . . . . 0.0 112.801 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -147.11 47.7 1.14 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.115 1.366 . . . . 0.0 109.899 -160.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.3 p -67.69 -8.82 38.19 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.554 1.542 . . . . 0.0 112.625 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -98.32 3.3 48.65 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.865 1.266 . . . . 0.0 112.704 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 t -120.3 131.78 71.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.763 1.165 . . . . 0.0 108.954 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.68 HD13 ' HB1' ' A' ' 150' ' ' ALA . 8.3 mt -71.76 153.88 41.69 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.392 1.077 . . . . 0.0 111.749 175.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.04 15.0 14.24 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 128.198 2.599 . . . . 0.0 114.08 -171.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 53.9 mt 54.65 -150.54 0.4 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.462 1.105 . . . . 0.0 109.204 -158.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -152.72 158.48 42.39 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.035 1.734 . . . . 0.0 107.282 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.4 m 55.78 -173.84 0.06 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.576 1.15 . . . . 0.0 113.04 171.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.434 ' HB3' ' HA3' ' A' ' 94' ' ' GLY . 15.0 m 25.03 79.25 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 129.805 3.242 . . . . 0.0 112.498 178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.3 -28.31 27.53 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.36 1.464 . . . . 0.0 114.09 -168.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.3 2.06 5.14 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.958 1.303 . . . . 0.0 111.423 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 91' ' ' SER . . . -89.03 -41.68 5.83 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 126.089 1.804 . . . . 0.0 109.798 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.7 m -56.76 158.06 4.99 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 121.923 0.868 . . . . 0.0 109.363 171.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.56 145.33 5.01 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 160.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.5 p -115.94 142.54 46.65 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.935 1.294 . . . . 0.0 109.796 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 77.3 28.78 0.59 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.908 1.683 . . . . 0.0 113.18 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.569 HG21 HD13 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -143.79 167.15 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 125.009 1.323 . . . . 0.0 109.645 169.027 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -168.78 173.85 43.37 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -171.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.496 HG11 ' CG ' ' A' ' 177' ' ' PHE . 8.6 t -91.82 136.98 23.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 177.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.438 HE22 ' HB1' ' A' ' 110' ' ' ALA . 2.3 mm-40 -118.86 161.26 20.45 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.088 1.755 . . . . 0.0 108.17 169.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.483 HG22 HD12 ' A' ' 111' ' ' LEU . 8.7 mt -144.09 122.52 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 127.78 2.432 . . . . 0.0 105.296 -169.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 110' ' ' ALA . 5.4 mt -124.72 153.26 42.64 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -74.54 -102.99 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.316 1.047 . . . . 0.0 110.919 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -148.32 -26.39 0.33 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 128.566 2.746 . . . . 0.0 110.341 -170.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.258 13.3 t -78.7 -4.71 50.54 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 167.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.57 20.04 79.78 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-O 118.543 -1.143 . . . . 0.0 110.864 -177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.93 127.41 33.02 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 170.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.612 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -73.9 132.95 43.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 103' ' ' ILE . 79.7 mt -102.35 108.37 19.69 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.509 0.724 . . . . 0.0 109.176 -166.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.3 m -65.67 152.01 45.19 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.013 0.435 . . . . 0.0 110.957 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.5 mt -109.14 73.1 0.84 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.861 1.664 . . . . 0.0 109.726 -160.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -120.25 0.49 10.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.651 1.18 . . . . 0.0 113.094 171.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.28 13.77 83.25 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.009 -0.884 . . . . 0.0 112.862 175.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -149.43 -17.43 0.28 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.77 1.285 . . . . 0.0 114.178 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.7 m -70.96 97.64 1.47 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 120.453 1.479 . . . . 0.0 107.629 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -76.5 130.54 38.09 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 124.17 0.988 . . . . 0.0 109.696 -168.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.4 m -72.64 -171.54 0.84 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 127.981 2.513 . . . . 0.0 111.367 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -52.37 148.44 6.71 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.803 -0.56 . . . . 0.0 111.037 167.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -85.65 166.64 16.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 123.662 1.696 . . . . 0.0 110.154 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.7 m -130.06 138.6 50.82 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 153.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.4 m -86.85 135.48 33.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 164.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.552 HD12 ' SG ' ' A' ' 61' ' ' CYS . 2.5 mm? -95.08 172.35 8.18 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 126.102 1.761 . . . . 0.0 109.104 -168.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.548 ' H ' HD21 ' A' ' 129' ' ' ASN . 6.8 p30 -132.33 158.87 40.78 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 158.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -64.45 100.14 0.34 Allowed 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 125.615 1.822 . . . . 0.0 106.265 170.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 140.26 -167.86 25.32 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 107.802 -2.119 . . . . 0.0 107.802 -160.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 98.2 m -106.65 136.65 46.09 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.402 -1.058 . . . . 0.0 108.85 -166.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.548 HD21 ' H ' ' A' ' 125' ' ' ASN . 27.2 m-80 -135.71 170.46 15.94 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.835 1.654 . . . . 0.0 108.895 -169.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.545 ' CG2' ' HB3' ' A' ' 55' ' ' ASN . 3.7 m -146.32 142.84 28.68 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.972 0.909 . . . . 0.0 108.999 172.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.65 116.44 65.39 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 161.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.5 159.61 28.86 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.54 2.16 . . . . 0.0 110.86 170.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.422 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 62.2 m-85 -141.31 172.62 12.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.326 1.85 . . . . 0.0 109.697 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -134.44 99.83 4.48 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.596 1.558 . . . . 0.0 107.0 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.505 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -102.64 146.23 28.49 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.076 -1.015 . . . . 0.0 108.728 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -152.77 160.27 43.12 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.422 ' HB2' ' HB3' ' A' ' 49' ' ' SER . 7.7 m-30 -69.44 153.02 44.18 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 117.35 -1.74 . . . . 0.0 108.813 166.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.417 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 11.0 t80 -128.05 125.84 40.1 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.584 1.954 . . . . 0.0 108.324 173.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -85.32 145.62 27.42 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.778 0.831 . . . . 0.0 110.356 174.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.488 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 41.3 p -105.62 10.64 32.9 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.372 1.069 . . . . 0.0 112.235 175.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.08 -150.63 19.24 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.26 98.09 0.3 Allowed 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.71 164.15 1.6 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-O 122.444 1.116 . . . . 0.0 109.348 171.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.6 p -120.26 162.14 35.35 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 164.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -74.24 168.38 24.93 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 N-CA-C 109.667 -0.936 . . . . 0.0 109.667 164.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.24 178.96 16.17 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.315 1.436 . . . . 0.0 111.364 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.88 150.61 44.53 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 121.467 -1.019 . . . . 0.0 109.582 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.404 ' HB1' ' CE2' ' A' ' 137' ' ' TYR . . . -145.97 93.64 2.36 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -125.48 150.23 47.54 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 172.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.68 ' HB1' HD13 ' A' ' 86' ' ' LEU . . . -151.31 164.49 36.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 120.484 1.493 . . . . 0.0 108.204 175.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.21 140.52 27.96 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -173.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.08 172.96 11.95 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 128.291 2.637 . . . . 0.0 110.633 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 37.5 p -127.84 159.56 34.48 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 159.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -124.41 154.69 40.03 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 124.368 1.067 . . . . 0.0 109.453 173.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -114.75 173.59 6.4 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.091 1.756 . . . . 0.0 109.087 170.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.467 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 3.0 t -127.95 128.97 69.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 127.443 2.297 . . . . 0.0 105.386 175.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.578 HE21 ' NE2' ' A' ' 159' ' ' GLN . 32.0 tt0 -112.96 86.86 2.46 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 173.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.467 ' CZ ' HG11 ' A' ' 156' ' ' VAL . 90.3 m-85 -68.39 150.83 47.69 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.652 172.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.578 ' NE2' HE21 ' A' ' 157' ' ' GLN . 6.0 pt20 -168.93 165.5 11.49 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.199 1.4 . . . . 0.0 109.35 -175.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 130.64 1.83 5.01 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 117.751 -1.583 . . . . 0.0 114.795 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -82.99 -81.04 0.97 Allowed Glycine 0 C--N 1.333 0.392 0 CA-C-N 119.687 1.744 . . . . 0.0 109.779 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 148.48 103.08 0.3 Allowed Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -159.36 21.79 0.29 Allowed Glycine 0 CA--C 1.526 0.748 0 CA-C-O 118.936 -0.924 . . . . 0.0 113.437 175.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 56.92 58.19 15.85 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 124.4 1.0 . . . . 0.0 111.186 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 86.08 74.93 1.26 Allowed Glycine 0 C--N 1.333 0.382 0 N-CA-C 107.085 -2.406 . . . . 0.0 107.085 -164.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -146.54 101.83 3.51 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.885 0.874 . . . . 0.0 108.974 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -116.72 -175.94 2.87 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.987 2.115 . . . . 0.0 108.551 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 98.7 m -135.5 107.19 6.97 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 173.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.6 m -102.76 112.52 25.35 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.775 0.83 . . . . 0.0 108.947 -173.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.16 156.43 40.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 126.144 1.778 . . . . 0.0 109.9 -172.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -66.97 132.48 48.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.17 -40.74 3.19 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 118.646 -1.086 . . . . 0.0 111.727 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 158.29 -176.02 35.34 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 118.882 1.341 . . . . 0.0 112.334 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.9 m -91.06 144.36 25.73 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.779 1.232 . . . . 0.0 108.25 172.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.0 t -123.95 136.76 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 168.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . 0.622 ' HB2' HG23 ' A' ' 31' ' ' THR . 23.8 m-70 -120.52 145.74 47.0 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.496 ' CG ' HG11 ' A' ' 101' ' ' VAL . 97.7 m-85 -131.03 126.53 36.14 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -130.87 159.05 38.53 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.08 0.855 . . . . 0.0 109.93 -172.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 159.98 -160.92 32.02 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -164.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -172.66 173.02 4.05 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 128.556 2.743 . . . . 0.0 104.411 174.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.0 t -120.84 144.0 31.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 165.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.7 m -127.25 150.56 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 126.936 2.094 . . . . 0.0 107.568 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -74.51 36.08 0.1 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.785 1.634 . . . . 0.0 112.634 -173.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.252 1.227 0 C-N-CA 129.131 2.972 . . . . 0.0 112.726 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.277 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.24 -74.96 0.59 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.436 ' CG2' ' H ' ' A' ' 25' ' ' ALA . 45.3 m 69.73 101.9 0.06 Allowed 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.659 1.984 . . . . 0.0 110.955 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.3 p -140.95 162.97 34.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.089 1.356 . . . . 0.0 108.331 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.9 t 82.12 91.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 127.509 2.324 . . . . 0.0 107.617 -174.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.28 -170.55 3.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.049 0.539 . . . . 0.0 110.391 172.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.0 -113.12 3.62 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-N 118.6 0.636 . . . . 0.0 112.733 168.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.49 -95.97 1.0 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.741 -1.343 . . . . 0.0 109.741 -164.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 t -125.59 104.59 8.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 104.06 -2.57 . . . . 0.0 104.06 150.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.8 p 28.33 78.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 129.437 3.095 . . . . 0.0 112.525 161.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -75.69 -80.03 0.09 Allowed 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.72 -0.612 . . . . 0.0 110.916 -167.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 153.53 -16.87 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 130.679 3.591 . . . . 0.0 110.725 168.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -149.51 -35.76 0.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.893 1.277 . . . . 0.0 111.47 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.5 34.24 7.54 Favored Glycine 0 CA--C 1.517 0.196 0 CA-C-O 118.145 -1.364 . . . . 0.0 113.734 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 17' ' ' VAL 0.257 0.7 OUTLIER 72.61 159.51 0.22 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.685 1.243 . . . . 0.0 109.87 175.399 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.2 t 54.44 -17.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 130.834 3.654 . . . . 0.0 114.493 -165.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 15' ' ' GLU 0.279 3.9 m 43.36 33.99 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 130.95 3.7 . . . . 0.0 113.325 -177.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -149.79 93.57 2.05 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -146.74 31.73 0.96 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.35 1.06 . . . . 0.0 112.261 -174.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 41.35 -55.21 0.0 OUTLIER 'General case' 0 C--N 1.34 0.166 1 C-N-CA 135.425 5.49 . . . . 0.0 115.794 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 58' ' ' LEU . 1.6 m -87.81 -166.99 1.74 Allowed 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 124.952 1.301 . . . . 0.0 109.982 166.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.25 -6.79 11.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.131 1.372 . . . . 0.0 113.922 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.26 3.7 t 50.87 120.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 129.535 3.134 . . . . 0.0 113.06 -165.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.37 153.28 41.54 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.526 1.13 . . . . 0.0 109.343 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -65.28 -25.5 67.67 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.101 -1.0 . . . . 0.0 111.035 173.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.96 5.29 1.3 Allowed Glycine 0 CA--C 1.534 1.261 0 CA-C-O 117.001 -2.0 . . . . 0.0 113.789 167.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.5 t -149.85 7.36 0.63 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 120.279 2.04 . . . . 0.0 113.986 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 25' ' ' ALA . 8.4 p -92.14 -40.48 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 121.269 1.849 . . . . 0.0 112.81 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.7 47.95 1.64 Allowed 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -170.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -85.87 145.44 27.18 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.824 -159.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.6 m -117.72 98.95 6.63 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.676 1.19 . . . . 0.0 108.794 -173.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.4 t -77.17 104.57 5.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -77.93 109.67 12.18 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 170.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.762 HD23 HG11 ' A' ' 52' ' ' VAL . 3.7 mt -87.33 -6.75 58.38 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 126.714 2.006 . . . . 0.0 109.799 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.83 -171.68 37.92 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 121.925 0.736 . . . . 0.0 112.464 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -84.41 134.95 34.45 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.396 1.478 . . . . 0.0 109.448 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.0 t -125.94 142.0 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 124.231 1.012 . . . . 0.0 109.008 -173.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.37 120.6 21.84 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 125.682 1.593 . . . . 0.0 107.733 -177.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 p -48.52 -29.76 4.52 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.036 1.334 . . . . 0.0 111.471 174.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.34 -35.01 77.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.823 0.849 . . . . 0.0 111.691 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.1 m -72.26 -7.09 47.47 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.251 1.02 . . . . 0.0 113.123 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.551 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 21.3 mt -136.88 78.75 1.72 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 128.61 2.764 . . . . 0.0 108.585 -170.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.04 3.91 3.2 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.584 -1.322 . . . . 0.0 112.227 -175.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.429 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 6.8 pm0 -149.66 155.77 40.78 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 124.758 1.223 . . . . 0.0 108.247 -175.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 31.7 tt0 -62.25 129.7 41.96 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 90.14 -4.46 82.92 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.011 -1.438 . . . . 0.0 113.233 -176.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -66.45 157.5 31.87 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 119.371 1.586 . . . . 0.0 110.933 172.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.2 p -148.42 161.09 42.28 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -173.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.3 p -73.08 -171.45 0.9 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.268 0.627 . . . . 0.0 110.706 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.9 m -54.11 -24.45 17.71 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 170.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.98 150.4 0.07 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.27 1.428 . . . . 0.0 112.399 -170.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.762 HG11 HD23 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -151.42 153.49 9.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 126.841 2.057 . . . . 0.0 105.716 -165.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.01 162.28 21.04 Favored Glycine 0 CA--C 1.526 0.721 0 O-C-N 121.02 -1.05 . . . . 0.0 110.549 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 1.2 p90 -160.63 63.02 0.31 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 124.562 2.125 . . . . 0.0 109.566 177.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.563 HD22 HG21 ' A' ' 130' ' ' THR . 9.5 p-10 -55.12 139.47 41.58 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 112.424 -2.171 . . . . 0.0 111.467 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 mm -84.28 105.45 13.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -76.85 104.61 7.44 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.538 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 57.5 mt -84.5 -175.09 5.63 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 167.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -173.36 144.35 1.16 Allowed 'General case' 0 C--O 1.226 -0.164 0 C-N-CA 126.237 1.815 . . . . 0.0 109.914 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.0 t0 48.67 63.62 2.03 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.957 2.103 . . . . 0.0 113.117 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.433 ' HB2' HD21 ' A' ' 129' ' ' ASN . 0.8 OUTLIER -86.32 115.6 23.96 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 121.692 -0.63 . . . . 0.0 111.774 -177.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.564 ' HB3' HG23 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -75.11 108.33 7.77 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 161.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.5 p -62.09 -7.94 4.72 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.427 0.691 . . . . 0.0 112.838 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -79.14 -31.15 43.97 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.207 1.403 . . . . 0.0 112.234 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 62' ' ' ASP . 2.2 t -72.87 -35.0 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -170.39 138.53 1.57 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 127.88 2.472 . . . . 0.0 105.072 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.5 m -78.89 -6.83 57.13 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 116.774 -1.584 . . . . 0.0 110.774 163.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -141.56 161.51 37.74 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 122.605 2.457 . . . . 0.0 115.624 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.31 115.02 15.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -88.71 175.9 7.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 152.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.405 HG21 ' CZ ' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -156.38 128.97 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 101.718 -3.438 . . . . 0.0 101.718 -160.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 154' ' ' PHE . . . -114.54 169.98 8.65 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.509 1.524 . . . . 0.0 107.623 173.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.52 ' CD1' HG21 ' A' ' 103' ' ' ILE . 21.4 m-85 -131.2 154.27 48.59 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.902 0.774 . . . . 0.0 110.496 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.624 ' O ' ' HB1' ' A' ' 152' ' ' ALA 0.347 0.1 OUTLIER -145.51 171.33 14.82 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 168.151 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.84 177.06 30.59 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.405 1.479 . . . . 0.0 110.056 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.2 m -67.0 141.33 57.62 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.288 1.044 . . . . 0.0 109.542 174.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.0 134.2 33.87 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 119.366 0.985 . . . . 0.0 110.874 174.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.3 tt -62.79 -33.93 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 122.898 0.479 . . . . 0.0 111.002 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -153.16 166.55 32.16 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 124.946 1.298 . . . . 0.0 108.724 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.66 -34.53 78.51 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.549 167.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.17 5.45 76.65 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.258 0.932 . . . . 0.0 112.874 174.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -148.45 48.44 1.03 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.124 1.962 . . . . 0.0 110.01 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.1 p -71.12 -7.81 49.17 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 120.68 -1.263 . . . . 0.0 113.809 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -84.91 -6.37 59.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.44 -0.788 . . . . 0.0 111.812 169.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 t -118.97 134.23 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.073 0 CA-C-N 119.665 1.12 . . . . 0.0 108.837 -175.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.883 HD11 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -79.25 148.72 32.09 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.92 1.288 . . . . 0.0 110.234 -169.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.44 20.06 5.61 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.248 1.419 . . . . 0.0 113.958 -167.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.6 mt 55.16 -157.32 0.23 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.287 1.035 . . . . 0.0 109.969 -168.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -143.21 174.8 10.39 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 125.057 1.343 . . . . 0.0 109.042 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.7 m -51.09 131.29 27.27 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.54 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.4 m -148.58 161.66 41.24 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 128.044 2.538 . . . . 0.0 107.359 164.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.13 -48.31 74.06 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.187 0.595 . . . . 0.0 111.5 -169.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.62 8.81 1.28 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.44 0.696 . . . . 0.0 112.509 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 63.42 35.21 91.75 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 124.141 0.877 . . . . 0.0 111.291 -170.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 73.6 m 57.95 -167.77 0.13 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.155 1.382 . . . . 0.0 111.959 -176.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.02 159.98 10.69 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.871 -1.058 . . . . 0.0 109.0 148.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.99 167.2 11.97 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.672 1.189 . . . . 0.0 108.702 168.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 62.26 3.63 1.07 Allowed 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 125.945 1.698 . . . . 0.0 113.105 -176.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.452 HG21 HD13 ' A' ' 42' ' ' LEU . 1.6 p -125.91 150.48 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 121.373 1.897 . . . . 0.0 108.764 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.36 177.7 25.47 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 125.025 1.297 . . . . 0.0 110.736 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.534 HG11 ' CG ' ' A' ' 177' ' ' PHE . 90.8 t -92.14 122.34 43.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -91.17 158.55 16.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.819 1.19 . . . . 0.0 109.521 163.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.581 HG22 HD23 ' A' ' 111' ' ' LEU . 3.1 mp -127.84 136.84 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 165.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.443 ' CD2' ' HB2' ' A' ' 110' ' ' ALA . 5.1 mt -133.04 142.33 48.73 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.109 1.363 . . . . 0.0 108.025 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 45.3 p30 -68.64 -179.86 1.52 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.93 1.347 . . . . 0.0 111.175 171.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.8 ptt85 -58.46 -7.08 0.8 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.809 1.644 . . . . 0.0 114.589 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.356 10.9 t -116.03 8.26 14.51 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 120.433 1.469 . . . . 0.0 110.985 177.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.11 7.84 84.7 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 120.598 -1.314 . . . . 0.0 112.53 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.96 126.07 30.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.564 1.182 . . . . 0.0 108.328 172.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.443 ' HB2' ' CD2' ' A' ' 104' ' ' LEU . . . -89.11 130.44 35.55 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.164 0.985 . . . . 0.0 111.349 -172.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.581 HD23 HG22 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -100.62 151.47 21.57 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 123.92 0.763 . . . . 0.0 111.464 -164.1 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.2 m -75.64 154.63 36.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 123.553 0.533 . . . . 0.0 110.688 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 75.6 mt -97.68 64.03 1.76 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.171 1.388 . . . . 0.0 108.427 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.27 -11.12 9.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.267 0.627 . . . . 0.0 111.644 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.406 ' HA3' HD13 ' A' ' 74' ' ' LEU . . . 79.64 13.2 82.77 Favored Glycine 0 CA--C 1.524 0.594 0 O-C-N 120.577 -1.327 . . . . 0.0 113.858 170.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.68 -40.66 0.26 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.365 1.466 . . . . 0.0 110.034 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.2 m -53.91 96.27 0.01 OUTLIER 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.188 1.795 . . . . 0.0 109.461 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -86.03 138.06 32.24 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 123.231 0.612 . . . . 0.0 109.431 -164.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.55 -175.99 1.8 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.087 2.155 . . . . 0.0 109.171 174.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 t -52.85 143.2 17.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.37 0.605 . . . . 0.0 110.19 169.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -88.33 176.04 7.38 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 123.198 1.475 . . . . 0.0 108.966 167.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.3 m -144.82 163.29 34.52 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 128.205 2.602 . . . . 0.0 105.103 169.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.9 m -100.23 142.95 31.01 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 122.416 1.103 . . . . 0.0 110.24 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.91 167.68 9.9 Favored 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 129.571 3.149 . . . . 0.0 108.0 -168.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.434 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 0.8 OUTLIER -152.26 156.2 39.21 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.796 -173.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -73.98 91.57 2.04 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 125.285 1.616 . . . . 0.0 107.107 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 147.22 -123.58 1.78 Allowed Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 107.691 -2.164 . . . . 0.0 107.691 -164.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 19.4 m -143.5 139.24 29.73 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.619 1.167 . . . . 0.0 109.075 -172.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.434 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 1.2 p30 -147.74 162.32 39.44 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 127.594 2.358 . . . . 0.0 108.702 -170.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.563 HG21 HD22 ' A' ' 55' ' ' ASN . 4.1 m -144.73 137.97 26.89 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -170.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.91 122.54 61.82 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 172.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.63 145.07 68.67 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.952 1.768 . . . . 0.0 110.564 173.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.405 ' CZ ' HG21 ' A' ' 71' ' ' VAL . 58.4 m-85 -142.32 157.3 44.96 Favored 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 124.777 1.231 . . . . 0.0 110.24 166.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -131.81 113.75 13.88 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.57 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -101.29 167.56 10.11 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.752 1.221 . . . . 0.0 109.227 171.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -168.05 153.83 7.16 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 127.225 2.21 . . . . 0.0 106.444 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.458 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 82.1 m-85 -66.76 144.11 56.52 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 160.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.429 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 16.5 t80 -123.35 133.12 54.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 126.074 1.75 . . . . 0.0 106.827 174.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -104.39 143.48 32.95 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.967 1.307 . . . . 0.0 109.89 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 46.9 p -103.08 4.66 37.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.683 1.593 . . . . 0.0 111.529 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.51 -141.45 6.87 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.08 93.61 0.3 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.479 1.112 . . . . 0.0 110.332 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -72.27 147.6 46.26 Favored 'General case' 0 C--O 1.239 0.522 0 O-C-N 121.301 -0.874 . . . . 0.0 110.108 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 35.0 p -120.71 153.38 56.79 Favored Pre-proline 0 CA--C 1.537 0.442 0 C-N-CA 125.153 1.381 . . . . 0.0 109.028 -175.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -74.69 166.92 28.28 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.02 1.813 . . . . 0.0 112.663 173.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.77 -85.39 0.11 Allowed Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.098 166.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -142.62 163.06 33.85 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.66 1.984 . . . . 0.0 106.623 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.458 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -151.46 77.33 1.24 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 119.075 0.852 . . . . 0.0 109.674 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -117.59 155.97 28.92 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -155.48 173.44 16.67 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.356 1.063 . . . . 0.0 109.004 171.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -150.31 146.46 26.77 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.775 1.23 . . . . 0.0 108.153 169.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.883 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -161.48 169.79 21.18 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 127.802 2.441 . . . . 0.0 108.771 -165.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.53 141.68 46.77 Favored 'General case' 0 CA--C 1.505 -0.761 0 C-N-CA 116.996 -1.882 . . . . 0.0 107.57 -172.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 72' ' ' ALA . 14.1 p90 -103.68 152.21 22.07 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -134.2 114.02 12.63 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.44 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 13.1 t -77.4 125.61 37.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -176.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -111.52 90.81 3.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 172.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.44 ' CZ ' HG11 ' A' ' 156' ' ' VAL . 70.5 m-85 -62.52 148.51 45.65 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.885 1.274 . . . . 0.0 110.344 173.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -165.93 169.66 14.54 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.697 1.199 . . . . 0.0 110.635 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 139.31 -73.16 0.41 Allowed Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -170.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -76.79 87.59 0.95 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 124.782 1.182 . . . . 0.0 110.329 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -162.33 175.59 38.77 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 118.185 0.992 . . . . 0.0 112.149 -176.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -131.24 27.13 3.84 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.777 1.18 . . . . 0.0 111.313 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 107.08 11.52 25.81 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 117.986 -1.452 . . . . 0.0 113.699 173.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -156.57 22.6 0.49 Allowed Glycine 0 CA--C 1.528 0.877 0 CA-C-N 120.486 2.143 . . . . 0.0 112.793 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -129.91 119.77 23.79 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.857 1.263 . . . . 0.0 109.973 -173.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -152.33 175.29 12.83 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 129.359 3.064 . . . . 0.0 108.139 171.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 54.7 m -137.32 92.84 2.75 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.869 1.267 . . . . 0.0 109.313 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.1 m -72.05 133.7 45.42 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.68 165.81 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 127.747 2.419 . . . . 0.0 108.554 173.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -59.45 143.78 48.89 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 164.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -101.34 -64.44 0.77 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 171.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 169.16 168.76 31.64 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -174.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 89.9 m -90.22 118.89 30.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.772 1.286 . . . . 0.0 107.987 172.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.1 t -88.09 106.76 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 166.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -79.28 144.38 34.35 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 164.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.534 ' CG ' HG11 ' A' ' 101' ' ' VAL . 96.3 m-85 -126.45 121.1 31.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -127.68 156.01 43.03 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.816 0.734 . . . . 0.0 109.475 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.02 -158.66 27.48 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -163.69 167.34 21.21 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 121.603 -0.94 . . . . 0.0 108.999 -173.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 73.7 t -113.15 126.01 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 167.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.2 m -106.28 150.27 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 C-N-CA 126.705 2.002 . . . . 0.0 108.436 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -74.9 39.56 0.14 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.246 1.418 . . . . 0.0 113.1 -176.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.304 0 C-N-CA 127.634 2.374 . . . . 0.0 111.934 -179.773 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.12 125.28 20.97 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.458 0.703 . . . . 0.0 109.501 -175.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.6 t -124.52 8.2 8.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.242 1.417 . . . . 0.0 111.023 -171.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 m 92.91 147.09 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 129.146 2.978 . . . . 0.0 109.19 165.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.606 HG13 ' H ' ' A' ' 6' ' ' ASN 0.366 7.3 p 44.04 -86.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 129.539 3.136 . . . . 0.0 113.875 -171.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.606 ' H ' HG13 ' A' ' 5' ' ' VAL . 78.6 m-20 143.57 -88.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 131.178 3.791 . . . . 0.0 107.961 160.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.7 -61.82 3.67 Favored Glycine 0 C--N 1.336 0.543 0 O-C-N 121.907 -0.496 . . . . 0.0 113.177 -165.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.98 -178.27 15.88 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 106.779 -2.528 . . . . 0.0 106.779 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.264 1.3 t -102.39 84.18 2.42 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 -169.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.608 HG22 ' H ' ' A' ' 11' ' ' HIS 0.294 10.1 p 48.32 -139.94 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.055 1.742 . . . . 0.0 108.108 176.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.608 ' H ' HG22 ' A' ' 10' ' ' VAL . 73.5 m-70 -135.99 57.83 1.77 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-N 120.868 1.667 . . . . 0.0 109.423 161.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.38 101.29 3.97 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -128.26 -114.14 0.26 Allowed 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 103.408 -2.812 . . . . 0.0 103.408 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.94 -72.4 0.64 Allowed Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 106.885 -2.486 . . . . 0.0 106.885 167.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -168.86 162.91 11.58 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 166.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.721 HG13 HG12 ' A' ' 170' ' ' VAL 0.356 3.2 p 56.38 -29.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 131.286 3.834 . . . . 0.0 114.415 -178.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t 44.44 37.55 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.866 2.066 . . . . 0.0 111.519 166.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.621 ' O ' HG11 ' A' ' 170' ' ' VAL . 53.9 m-20 -141.38 93.54 2.59 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.072 171.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.494 ' HB1' ' HE2' ' A' ' 158' ' ' TYR . . . -85.5 134.07 34.06 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 150.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.49 -18.14 6.62 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.027 1.331 . . . . 0.0 112.753 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -134.35 147.49 50.54 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.132 2.173 . . . . 0.0 107.235 176.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.05 -14.12 44.19 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 118.257 2.688 . . . . 0.0 118.257 -155.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.3 t 49.46 104.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 127.645 2.378 . . . . 0.0 111.342 -164.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.46 159.02 10.97 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.39 -0.819 . . . . 0.0 113.096 -169.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.91 -42.07 88.77 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.541 -0.725 . . . . 0.0 109.94 171.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.39 27.52 2.44 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.737 -1.035 . . . . 0.0 112.682 171.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -138.94 -33.07 0.66 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.286 1.543 . . . . 0.0 111.402 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.34 -35.66 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 119.791 1.178 . . . . 0.0 111.122 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -139.92 69.56 1.36 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -170.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -110.52 146.45 35.99 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.863 0.865 . . . . 0.0 111.414 -169.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 m -112.18 121.33 44.63 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.309 1.043 . . . . 0.0 109.904 173.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.6 t -87.39 113.41 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 169.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -88.22 96.18 10.45 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 172.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.782 HD23 HG11 ' A' ' 52' ' ' VAL . 9.4 mt -76.81 -8.16 56.8 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 126.009 1.724 . . . . 0.0 110.221 -179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.23 -171.26 32.75 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 121.829 0.683 . . . . 0.0 112.231 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -90.99 126.91 36.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.505 1.922 . . . . 0.0 110.491 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG21 ' HD2' ' A' ' 137' ' ' TYR . 21.0 t -117.64 137.73 50.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 123.4 0.68 . . . . 0.0 109.772 -172.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 4.6 mmt180 -66.56 124.18 22.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.874 2.07 . . . . 0.0 106.53 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.9 p -55.25 -30.02 59.24 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 123.787 0.679 . . . . 0.0 110.37 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.89 -36.06 76.16 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.368 1.467 . . . . 0.0 111.524 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.447 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 70.0 m -80.16 2.37 24.47 Favored 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 123.521 0.728 . . . . 0.0 112.797 176.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 75.4 mt -131.83 32.08 4.13 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.37 1.868 . . . . 0.0 110.922 -170.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.49 5.24 13.37 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -150.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.537 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 4.2 pm0 -154.69 155.96 35.55 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.405 1.882 . . . . 0.0 106.725 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 36.4 tt0 -64.23 116.84 6.39 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.33 -11.51 36.55 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 117.847 -1.529 . . . . 0.0 112.752 -177.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.537 ' HB2' ' NE2' ' A' ' 44' ' ' GLN . . . -66.27 156.88 33.03 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.432 1.616 . . . . 0.0 110.253 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.6 p -144.88 157.34 44.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.41 0.624 . . . . 0.0 112.179 -174.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.6 p -73.58 -168.19 0.53 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 122.008 -0.433 . . . . 0.0 110.091 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.1 m -43.55 -99.57 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.719 2.007 . . . . 0.0 114.281 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.37 73.57 0.0 OUTLIER 'General case' 0 C--O 1.236 0.393 0 C-N-CA 131.002 3.721 . . . . 0.0 107.427 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.782 HG11 HD23 ' A' ' 34' ' ' LEU . 3.9 p -69.55 148.32 11.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 170.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.03 127.2 7.97 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 107.145 -2.382 . . . . 0.0 107.145 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 135' ' ' ALA . 5.1 p90 -135.41 89.91 2.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 123.215 1.483 . . . . 0.0 109.624 -170.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -84.11 165.86 18.13 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 120.892 -1.13 . . . . 0.0 112.69 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.0 mm -102.3 99.01 7.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -71.8 126.32 29.42 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.435 HD11 HD11 ' A' ' 131' ' ' ILE . 95.9 mt -109.25 171.84 7.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 174.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 11.5 p30 -153.81 175.05 13.77 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.253 0.933 . . . . 0.0 111.504 165.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.6 t70 32.12 48.75 0.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 129.821 3.248 . . . . 0.0 115.974 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 4.6 t -69.69 167.46 16.99 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -171.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.501 ' HB3' HG23 ' A' ' 65' ' ' VAL . 32.1 t0 -133.76 114.49 13.47 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.872 1.669 . . . . 0.0 112.253 168.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.9 p -56.16 -29.68 61.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.698 1.599 . . . . 0.0 113.575 172.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -62.32 -42.47 99.4 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 123.117 0.567 . . . . 0.0 110.323 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.501 HG23 ' HB3' ' A' ' 62' ' ' ASP . 15.2 t -65.24 -52.68 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 175.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.433 ' CB ' ' HB3' ' A' ' 158' ' ' TYR . . . -165.49 127.04 1.98 Allowed 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.192 0.52 . . . . 0.0 111.674 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.4 m -77.37 -8.58 57.92 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.55 1.54 . . . . 0.0 112.163 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -130.03 152.65 49.25 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 121.377 1.899 . . . . 0.0 110.371 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -124.02 144.36 49.88 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 165.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.94 172.01 9.27 Favored 'General case' 0 N--CA 1.439 -0.975 0 CA-C-O 122.076 0.941 . . . . 0.0 109.617 156.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.261 0.5 OUTLIER -143.22 144.23 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 113.633 -1.621 . . . . 0.0 106.693 -174.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.41 162.39 30.28 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.313 2.645 . . . . 0.0 107.045 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -137.15 152.6 50.13 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.711 0.804 . . . . 0.0 110.328 -172.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 74' ' ' LEU . 19.1 tp -151.6 124.68 8.68 Favored 'General case' 0 N--CA 1.456 -0.167 0 O-C-N 122.082 -0.386 . . . . 0.0 110.609 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.26 165.87 33.97 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.9 m -54.08 128.7 31.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.313 1.445 . . . . 0.0 109.944 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.71 134.97 41.85 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 119.823 1.192 . . . . 0.0 110.371 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.2 tt -60.38 -37.39 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 122.72 0.408 . . . . 0.0 110.81 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -157.27 168.62 26.86 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.182 1.793 . . . . 0.0 109.046 173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.33 -39.95 67.54 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.759 1.624 . . . . 0.0 112.641 171.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.28 7.44 80.69 Favored Glycine 0 CA--C 1.526 0.752 0 O-C-N 121.433 -0.792 . . . . 0.0 112.884 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -142.76 42.4 1.58 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.456 1.102 . . . . 0.0 109.481 -175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.5 p -67.95 -11.68 59.26 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.958 1.303 . . . . 0.0 112.84 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -77.69 -2.08 34.29 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.631 -0.668 . . . . 0.0 112.19 168.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.41 137.09 48.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 O-C-N 120.44 -1.412 . . . . 0.0 110.894 -166.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.77 150.9 29.05 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.469 1.508 . . . . 0.0 111.405 -171.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -94.73 18.33 11.84 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.675 1.99 . . . . 0.0 114.192 -167.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.495 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 79.4 mt 53.71 -159.9 0.14 Allowed 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.587 1.155 . . . . 0.0 110.621 -169.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -141.82 170.32 15.94 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.453 1.101 . . . . 0.0 109.309 176.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.1 m -45.88 147.94 0.89 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.342 1.457 . . . . 0.0 112.074 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 t -160.79 161.83 32.15 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.156 1.382 . . . . 0.0 107.358 168.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.21 -23.81 65.88 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -176.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -117.19 12.44 14.43 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.37 1.468 . . . . 0.0 110.712 176.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.41 26.48 65.66 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.523 1.059 . . . . 0.0 114.459 173.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 75.7 m 56.87 -170.83 0.09 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.959 0.904 . . . . 0.0 110.682 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.78 148.74 48.75 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 168.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.34 164.93 12.09 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.88 0.872 . . . . 0.0 108.762 166.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 69.96 -7.88 0.88 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 128.725 2.81 . . . . 0.0 115.11 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.7 p -126.99 152.19 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 121.417 1.917 . . . . 0.0 107.949 -171.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -146.31 170.64 27.37 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 126.11 1.814 . . . . 0.0 111.82 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.437 HG11 ' CG ' ' A' ' 177' ' ' PHE . 94.2 t -83.56 120.44 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -100.65 154.19 18.8 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.714 1.597 . . . . 0.0 108.3 164.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.5 mp -121.09 143.97 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 170.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 110' ' ' ALA . 15.4 mt -139.58 138.98 36.68 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.044 1.738 . . . . 0.0 108.042 -168.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.542 ' HB2' ' HB3' ' A' ' 120' ' ' SER . 29.0 p30 -66.22 173.62 3.06 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 122.219 1.009 . . . . 0.0 111.959 167.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -55.32 -13.18 1.26 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.194 1.398 . . . . 0.0 113.667 175.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 p -105.08 -9.09 18.04 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.929 1.292 . . . . 0.0 110.874 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 89.81 10.21 65.21 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.595 -1.114 . . . . 0.0 113.712 -177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.06 117.13 13.3 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 119.061 1.431 . . . . 0.0 107.938 169.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.456 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -74.68 131.15 40.65 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.661 0.784 . . . . 0.0 110.122 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.0 mt -103.34 117.27 34.1 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.589 1.156 . . . . 0.0 110.745 -158.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 17.0 m -67.39 143.23 56.42 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.77 0.795 . . . . 0.0 110.539 -170.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.9 mt -93.6 74.78 4.38 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.196 1.398 . . . . 0.0 107.307 -171.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.46 -18.31 11.01 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.327 1.051 . . . . 0.0 110.683 170.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.67 -28.27 4.96 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-O 118.16 -1.356 . . . . 0.0 112.751 176.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -82.62 -45.08 15.0 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.407 1.604 . . . . 0.0 110.505 166.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.2 m -51.25 97.33 0.01 OUTLIER 'General case' 0 C--O 1.234 0.253 0 C-N-CA 126.839 2.055 . . . . 0.0 111.586 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.66 169.38 4.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.81 2.044 . . . . 0.0 111.112 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 75.5 p -135.75 -161.59 1.17 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.611 0.765 . . . . 0.0 111.35 173.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 105' ' ' ASP . 0.9 OUTLIER -42.82 122.53 2.4 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 129.73 3.212 . . . . 0.0 111.69 -175.016 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -89.01 106.23 18.3 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.942 0.877 . . . . 0.0 108.701 -173.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.7 m -70.34 117.88 12.44 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 162.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.2 m -64.0 141.77 58.65 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 155.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.98 -170.44 2.14 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.052 0.941 . . . . 0.0 109.785 176.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -148.87 167.56 25.36 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.818 2.047 . . . . 0.0 107.071 178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -64.41 128.36 35.43 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 120.29 -159.57 15.13 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 22.0 m -83.13 136.01 34.61 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.669 1.188 . . . . 0.0 111.648 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.48 177.98 9.76 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.369 1.468 . . . . 0.0 108.325 -176.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 26.6 m -155.01 144.48 21.27 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.33 -0.856 . . . . 0.0 109.734 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.435 HD11 HD11 ' A' ' 58' ' ' LEU . 2.4 mp -100.05 114.53 65.72 Favored Pre-proline 0 C--O 1.237 0.446 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 162.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.01 151.39 50.08 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.192 1.928 . . . . 0.0 110.475 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -141.17 167.03 23.16 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.716 2.006 . . . . 0.0 108.303 171.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.24 154.29 33.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 122.722 1.248 . . . . 0.0 110.071 161.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.507 ' HB2' ' CD1' ' A' ' 54' ' ' PHE . . . -132.83 147.3 52.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 127.517 2.327 . . . . 0.0 106.398 175.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -163.89 151.95 12.97 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 170.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.473 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 76.0 m-85 -66.18 135.84 55.08 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 170.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -111.28 127.8 55.74 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.978 1.711 . . . . 0.0 108.482 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.26 142.47 27.72 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.424 1.09 . . . . 0.0 111.242 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 17.6 p -110.82 9.21 22.56 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.273 1.429 . . . . 0.0 112.135 169.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 164.5 -152.47 22.2 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.38 95.92 0.22 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.116 1.366 . . . . 0.0 110.891 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -53.82 151.98 5.91 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.621 0.724 . . . . 0.0 110.497 174.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 73.1 p -105.5 154.02 39.39 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 162.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -71.48 174.73 10.46 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.115 1.21 . . . . 0.0 109.284 166.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.79 -93.67 0.14 Allowed Glycine 0 C--O 1.225 -0.441 0 O-C-N 121.855 -0.528 . . . . 0.0 112.838 171.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -146.65 161.95 39.47 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.38 1.872 . . . . 0.0 106.394 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.473 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -151.35 73.37 1.09 Allowed 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 121.776 -0.577 . . . . 0.0 110.52 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -117.64 151.65 36.78 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -157.9 179.25 9.37 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -156.35 145.94 20.87 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -146.38 169.41 18.92 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.81 2.044 . . . . 0.0 106.992 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.7 p -106.98 163.66 12.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 156.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -117.72 155.87 29.23 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 164.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 38.5 mttm -125.61 137.9 53.91 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 168.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.903 HG13 HG23 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -87.18 150.75 3.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 175.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -142.12 84.16 1.86 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.539 1.536 . . . . 0.0 108.918 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.752 ' CE2' HG21 ' A' ' 156' ' ' VAL . 59.0 m-85 -63.7 156.16 27.82 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.988 1.315 . . . . 0.0 112.805 169.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -174.82 174.83 2.5 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.721 2.009 . . . . 0.0 108.567 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 139.99 -48.01 0.86 Allowed Glycine 0 N--CA 1.461 0.319 0 O-C-N 120.852 -1.155 . . . . 0.0 111.359 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -77.83 -15.04 81.72 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 170.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -73.75 88.07 0.64 Allowed Glycine 0 N--CA 1.438 -1.184 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 166.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -61.07 -4.76 4.9 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.286 -1.285 . . . . 0.0 113.747 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -107.27 -75.54 0.94 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 107.004 -2.439 . . . . 0.0 107.004 159.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -139.74 -61.24 0.04 OUTLIER Glycine 0 C--O 1.228 -0.222 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 24.85 93.65 0.01 OUTLIER 'General case' 0 C--O 1.235 0.301 0 C-N-CA 129.511 3.124 . . . . 0.0 113.39 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -117.47 146.88 43.21 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.237 -161.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 52.9 m -96.81 89.3 4.85 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.65 1.98 . . . . 0.0 106.458 171.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.3 m -82.02 120.4 25.22 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 175.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.903 HG23 HG13 ' A' ' 156' ' ' VAL . 30.2 m -128.14 145.72 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 118.645 0.657 . . . . 0.0 111.209 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -77.88 105.44 9.07 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -79.75 -68.49 1.48 Allowed Glycine 0 C--N 1.335 0.504 0 C-N-CA 124.035 0.826 . . . . 0.0 111.936 -164.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -178.14 -172.62 42.76 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 117.503 0.651 . . . . 0.0 111.847 -173.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.4 HG21 ' CE1' ' A' ' 176' ' ' HIS . 8.3 m -89.22 145.38 25.44 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 125.782 1.633 . . . . 0.0 108.971 174.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.6 119.95 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 156.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . 0.4 ' CE1' HG21 ' A' ' 174' ' ' THR . 88.1 m-70 -88.94 134.48 33.95 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 172.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.437 ' CG ' HG11 ' A' ' 101' ' ' VAL . 90.3 m-85 -114.17 113.09 24.2 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -117.31 157.47 26.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 147.29 -165.42 28.64 Favored Glycine 0 C--O 1.239 0.411 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -176.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -161.56 171.73 17.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.9 t -122.15 132.84 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 173.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.2 m -117.91 149.69 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 C-N-CA 127.608 2.363 . . . . 0.0 107.972 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -76.23 34.23 0.13 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -170.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 N--CA 1.438 -1.035 0 C-N-CA 131.231 3.812 . . . . 0.0 112.802 -179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.38 -53.47 0.89 Allowed 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 123.906 0.754 . . . . 0.0 110.735 -165.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.8 t 50.35 -169.43 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.773 2.029 . . . . 0.0 112.092 -177.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.82 0.88 1.64 Allowed 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.418 -0.801 . . . . 0.0 110.562 163.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.91 114.13 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 120.459 -1.401 . . . . 0.0 108.277 -174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -54.45 -40.79 68.73 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.29 167.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.26 133.87 1.59 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.955 1.264 . . . . 0.0 110.042 162.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.26 -93.19 0.11 Allowed Glycine 0 C--N 1.335 0.497 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 165.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -148.36 107.02 3.79 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 153.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.272 10.5 p 22.68 74.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 126.946 2.098 . . . . 0.0 114.687 153.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -82.51 45.23 0.95 Allowed 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.892 -1.13 . . . . 0.0 112.901 -168.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -159.31 51.34 0.36 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.208 1.003 . . . . 0.0 109.834 -161.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -133.54 87.79 2.42 Favored 'General case' 0 C--N 1.334 -0.086 0 C-N-CA 124.319 1.048 . . . . 0.0 108.695 -176.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.64 5.32 0.23 Allowed Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.602 -0.554 . . . . 0.0 114.093 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -146.56 -157.83 0.85 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 16' ' ' VAL . 1.3 p -58.85 -44.35 90.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.488 1.04 . . . . 0.0 110.752 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 t 44.36 59.11 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 127.151 2.18 . . . . 0.0 111.281 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -149.41 105.95 3.53 Favored 'General case' 0 C--O 1.228 -0.079 0 O-C-N 121.97 -0.456 . . . . 0.0 109.813 169.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -126.44 141.5 51.86 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 166.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.507 ' HB3' ' CD1' ' A' ' 158' ' ' TYR . . . -86.97 1.83 51.46 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 117.672 -1.156 . . . . 0.0 113.799 -173.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.25 164.18 30.94 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.554 1.542 . . . . 0.0 107.68 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.67 -24.29 21.65 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.757 0.823 . . . . 0.0 113.002 -168.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t 58.58 131.19 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 128.07 2.548 . . . . 0.0 112.172 -173.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -78.44 156.13 29.55 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.033 -1.042 . . . . 0.0 111.895 -176.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.48 -31.95 64.52 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.611 -0.681 . . . . 0.0 110.682 166.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.54 -2.12 73.7 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 117.559 -1.69 . . . . 0.0 114.293 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.4 p -125.21 -30.02 3.22 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 121.018 2.409 . . . . 0.0 111.809 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 p -59.94 -38.9 78.48 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 124.822 1.249 . . . . 0.0 113.789 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -132.6 46.69 2.6 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.085 0.954 . . . . 0.0 109.726 -168.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -93.13 132.19 37.5 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 121.283 -0.885 . . . . 0.0 110.478 -159.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.4 HG23 ' HB2' ' A' ' 176' ' ' HIS . 15.3 m -113.98 86.8 2.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.737 1.215 . . . . 0.0 108.652 -175.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.75 99.91 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 127.047 2.139 . . . . 0.0 108.02 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -84.48 102.97 13.23 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -170.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mt -76.79 -7.61 55.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.713 1.205 . . . . 0.0 111.004 -177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.82 -173.53 26.77 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.529 1.061 . . . . 0.0 112.327 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -68.97 153.88 43.03 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.954 0.902 . . . . 0.0 109.479 170.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.4 t -139.7 148.14 23.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.408 0 C-N-CA 125.067 1.347 . . . . 0.0 108.611 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -81.18 134.44 35.63 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 121.508 -0.745 . . . . 0.0 109.053 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.1 p -60.64 -24.06 65.24 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 123.556 0.742 . . . . 0.0 110.899 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.43 -46.41 66.37 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.35 0.66 . . . . 0.0 110.454 170.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 t -71.9 -2.38 17.76 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.962 177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.416 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 17.3 mt -142.93 64.86 1.35 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 120.546 1.521 . . . . 0.0 108.854 -170.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.94 0.22 5.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -167.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.442 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 3.1 pm0 -158.32 159.62 36.11 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.395 1.478 . . . . 0.0 108.404 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.496 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 39.1 tt0 -65.33 118.15 8.92 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 138' ' ' PHE . . . 106.77 -12.97 42.14 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-O 118.422 -1.21 . . . . 0.0 112.112 -174.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -61.71 142.26 57.34 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 118.899 1.35 . . . . 0.0 109.44 173.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 p -136.66 159.44 41.81 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.094 0.861 . . . . 0.0 111.052 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 97.5 p -74.5 -175.07 2.25 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.778 0.799 . . . . 0.0 112.216 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.7 m -56.08 -24.04 37.62 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.803 2.041 . . . . 0.0 114.417 171.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.1 158.95 0.18 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 129.336 3.054 . . . . 0.0 112.582 173.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.3 t -145.56 140.48 22.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 -171.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.67 141.26 15.45 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 170.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 2.8 p90 -136.88 149.55 47.72 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 171.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.448 ' HB2' HG22 ' A' ' 130' ' ' THR . 0.8 OUTLIER -145.37 117.52 8.36 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.056 -1.027 . . . . 0.0 108.619 -167.146 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.3 mm -77.88 101.11 3.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 -163.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -65.36 121.44 14.84 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 mp -125.8 107.17 10.26 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.598 1.959 . . . . 0.0 106.914 -172.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -101.87 157.42 16.86 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -171.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 48.6 t0 50.87 50.58 18.77 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 123.189 1.471 . . . . 0.0 111.847 167.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.7 m -73.29 151.29 41.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.967 1.707 . . . . 0.0 110.365 174.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -136.47 107.53 6.74 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.616 1.166 . . . . 0.0 110.683 -174.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.1 p -60.29 -18.48 49.64 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.434 1.494 . . . . 0.0 112.886 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -60.44 -38.24 83.49 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.35 1.46 . . . . 0.0 111.171 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 t -79.03 -55.89 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.35 144.38 18.4 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.689 1.195 . . . . 0.0 108.438 -171.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.21 -15.04 42.16 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.978 -0.534 . . . . 0.0 111.839 169.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -135.44 160.94 36.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 119.28 0.945 . . . . 0.0 110.584 -167.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.61 153.88 38.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 159.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.528 ' HB1' ' H ' ' A' ' 119' ' ' SER . . . -132.18 173.44 11.24 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.916 1.686 . . . . 0.0 107.301 162.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.446 ' HB ' ' CZ ' ' A' ' 133' ' ' PHE . 61.0 t -135.87 123.55 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 118.804 0.729 . . . . 0.0 109.415 -171.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.55 0.46 26.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -160.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.409 ' CD1' HG21 ' A' ' 103' ' ' ILE . 48.5 m-85 37.29 -177.84 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.702 1 C-N-CA 131.963 4.105 . . . . 0.0 112.504 -166.298 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.526 HD22 ' HA3' ' A' ' 115' ' ' GLY . 7.8 tp -168.07 126.92 1.22 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 164.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.73 173.43 42.72 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.1 m -68.74 129.34 39.65 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.258 1.423 . . . . 0.0 109.516 -172.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -86.35 131.53 34.19 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.581 1.152 . . . . 0.0 113.156 -176.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.4 tt -65.54 -32.27 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.132 0.973 . . . . 0.0 112.018 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -152.87 165.27 35.97 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.694 0.797 . . . . 0.0 109.07 166.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -49.74 -43.5 47.88 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.707 2.003 . . . . 0.0 112.477 165.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.18 0.83 88.37 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.265 0.936 . . . . 0.0 112.524 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -142.03 40.62 1.65 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.207 1.504 . . . . 0.0 109.886 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.429 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 21.8 p -64.26 -15.84 60.89 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 124.825 1.25 . . . . 0.0 113.788 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -73.43 -12.02 60.66 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.433 174.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.9 t -133.15 143.82 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 123.088 1.423 . . . . 0.0 108.394 -164.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.936 HD23 HG22 ' A' ' 101' ' ' VAL . 1.5 mm? -80.55 136.47 36.28 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 112.682 -2.054 . . . . 0.0 110.717 -159.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.9 14.22 0.12 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 124.742 1.217 . . . . 0.0 113.242 168.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 86' ' ' LEU . 89.0 mt 48.11 -147.91 0.22 Allowed 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.535 1.934 . . . . 0.0 108.484 -171.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -143.29 -177.87 5.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.941 1.297 . . . . 0.0 108.518 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.1 m -58.81 148.08 31.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.311 1.444 . . . . 0.0 110.818 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.6 m -164.69 176.2 9.05 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.295 1.838 . . . . 0.0 107.85 169.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.43 -18.31 65.28 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -167.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.56 16.8 12.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.151 0.98 . . . . 0.0 111.344 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.34 29.68 68.01 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.177 0.894 . . . . 0.0 113.072 -173.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.8 m 62.38 -176.73 0.14 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.913 1.285 . . . . 0.0 112.031 -174.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.05 144.15 57.15 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.575 -0.703 . . . . 0.0 109.218 164.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 28.0 p -91.91 168.69 11.24 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.691 1.196 . . . . 0.0 109.003 166.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 55.85 18.78 3.15 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.115 1.766 . . . . 0.0 113.865 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.4 p -146.34 142.92 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 121.132 -0.98 . . . . 0.0 108.508 175.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.32 165.28 27.49 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 175.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.936 HG22 HD23 ' A' ' 86' ' ' LEU . 0.9 OUTLIER -70.81 150.06 9.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -125.55 147.01 49.42 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 129.019 2.928 . . . . 0.0 105.917 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.492 HD11 ' CE2' ' A' ' 177' ' ' PHE . 1.9 mp -118.99 141.83 36.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 172.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.41 149.08 46.66 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.72 1.608 . . . . 0.0 107.015 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -73.07 -172.21 1.03 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.348 1.07 . . . . 0.0 112.342 174.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -47.51 -48.31 27.38 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 127.567 2.347 . . . . 0.0 110.115 170.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.5 p -81.3 -14.37 57.43 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.072 -168.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.91 22.7 44.67 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 126.386 1.946 . . . . 0.0 111.567 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.54 133.46 40.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 162.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.44 151.99 42.76 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.6 mt -117.14 151.64 36.41 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.039 1.336 . . . . 0.0 109.257 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.1 m -78.67 163.97 25.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 167.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.489 HD22 HD13 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -124.69 68.67 1.1 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 101.466 -3.531 . . . . 0.0 101.466 174.448 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.06 -7.34 19.24 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.983 0.897 . . . . 0.0 111.641 -175.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.526 ' HA3' HD22 ' A' ' 74' ' ' LEU . . . 66.87 31.36 77.96 Favored Glycine 0 N--CA 1.439 -1.111 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -158.91 -64.01 0.08 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.027 1.731 . . . . 0.0 106.879 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 27.7 m -49.65 99.95 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.205 2.202 . . . . 0.0 112.131 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -72.39 171.79 11.59 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.588 1.155 . . . . 0.0 111.003 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.528 ' H ' ' HB1' ' A' ' 70' ' ' ALA . 39.6 p -131.81 -146.95 0.3 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.993 1.717 . . . . 0.0 110.776 -169.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.9 t -58.37 124.64 20.23 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 119.446 1.021 . . . . 0.0 108.938 172.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -85.36 110.5 19.16 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 122.035 0.921 . . . . 0.0 108.559 170.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.7 m -79.35 121.83 25.61 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 161.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 53.1 m -66.36 111.06 3.33 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 160.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.0 mt -73.66 -179.4 3.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.604 1.962 . . . . 0.0 108.973 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.404 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 0.7 OUTLIER -152.27 165.8 33.76 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.443 1.097 . . . . 0.0 109.538 173.188 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -59.39 138.14 57.75 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 171.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.15 -139.7 15.36 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 108.443 -1.863 . . . . 0.0 108.443 -172.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.1 m -111.51 146.34 37.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 118.44 1.12 . . . . 0.0 111.37 -164.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.404 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 18.9 m-80 -144.97 174.35 11.1 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 128.423 2.689 . . . . 0.0 108.606 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 55' ' ' ASN . 91.4 m -157.01 148.19 21.99 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 170.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.5 mt -110.05 112.63 57.58 Favored Pre-proline 0 C--O 1.237 0.418 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.8 137.17 19.69 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.276 1.984 . . . . 0.0 110.184 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.446 ' CZ ' ' HB ' ' A' ' 71' ' ' VAL . 76.1 m-85 -127.4 172.59 10.52 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 127.007 2.123 . . . . 0.0 107.74 171.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -128.88 143.72 50.97 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 167.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.579 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -126.85 139.08 53.35 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.92 2.088 . . . . 0.0 108.063 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -160.26 159.91 32.0 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 175.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.426 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 74.4 m-85 -73.61 126.28 29.93 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 171.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.47 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 23.7 t80 -111.55 120.81 43.36 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.948 2.099 . . . . 0.0 106.877 172.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -83.28 137.8 33.84 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 175.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.496 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 64.1 p -97.18 6.92 47.64 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.15 0.98 . . . . 0.0 111.283 171.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.69 -155.81 27.24 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.05 91.79 0.5 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.204 1.002 . . . . 0.0 111.172 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -56.97 158.52 4.83 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.673 0.789 . . . . 0.0 111.469 179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 42.3 p -115.82 158.35 42.36 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 170.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -80.95 164.56 20.04 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.916 1.744 . . . . 0.0 111.681 170.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.6 -84.87 0.11 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.953 0.787 . . . . 0.0 114.277 171.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -153.11 143.56 22.56 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 128.917 2.887 . . . . 0.0 106.365 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.426 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -137.95 84.16 2.02 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.989 0.813 . . . . 0.0 109.931 -177.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -126.84 154.38 44.43 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.45 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -156.27 -178.22 7.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.766 0.712 . . . . 0.0 110.975 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -151.34 110.18 3.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 122.63 1.205 . . . . 0.0 109.672 172.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.14 163.99 12.02 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 169.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.1 p -109.02 152.68 24.65 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 160.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -102.59 117.08 33.9 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 170.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.427 ' HE3' ' HA3' ' A' ' 115' ' ' GLY . 19.7 mttt -92.69 154.68 18.19 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 167.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.446 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 14.8 t -119.13 126.72 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.591 HE21 ' NE2' ' A' ' 159' ' ' GLN . 35.7 tt0 -103.59 89.54 3.38 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 170.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.507 ' CD1' ' HB3' ' A' ' 20' ' ' ALA . 96.5 m-85 -69.79 139.59 53.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.327 169.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.591 ' NE2' HE21 ' A' ' 157' ' ' GLN . 9.6 pt20 -155.0 170.62 21.33 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.686 0.795 . . . . 0.0 111.288 176.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 137.16 -46.6 1.0 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 125.966 1.746 . . . . 0.0 110.728 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -67.35 175.95 24.21 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 124.097 0.856 . . . . 0.0 112.42 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -136.68 -153.35 6.46 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 125.638 1.589 . . . . 0.0 111.14 -173.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 70.5 -100.27 0.8 Allowed Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 107.799 -2.12 . . . . 0.0 107.799 -167.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -137.15 31.42 2.54 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-O 119.09 -0.839 . . . . 0.0 114.764 -148.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -141.1 -92.75 0.2 Allowed Glycine 0 CA--C 1.521 0.456 0 N-CA-C 107.815 -2.114 . . . . 0.0 107.815 166.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 70.49 122.59 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 128.826 2.851 . . . . 0.0 111.235 -171.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 61.4 75.31 0.41 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.408 1.883 . . . . 0.0 111.038 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 95.5 m -76.2 99.06 4.6 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 113.024 -1.898 . . . . 0.0 107.879 170.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 93.6 m -66.08 138.37 57.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 158.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.05 137.27 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 124.927 1.291 . . . . 0.0 107.859 169.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -57.22 121.55 10.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 161.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -88.77 -86.88 1.23 Allowed Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -146.78 -177.13 21.12 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.665 1.603 . . . . 0.0 110.449 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 27.4 m -93.88 144.58 25.31 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.152 1.381 . . . . 0.0 110.254 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.3 t -123.39 124.56 70.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 169.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . 0.4 ' HB2' HG23 ' A' ' 31' ' ' THR . 32.7 m-70 -110.97 99.48 8.36 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 125.002 1.321 . . . . 0.0 107.609 -174.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.492 ' CE2' HD11 ' A' ' 103' ' ' ILE . 53.9 m-85 -79.33 107.13 11.87 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 175.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -112.66 157.78 20.82 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.792 1.637 . . . . 0.0 106.815 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.04 -162.91 27.8 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -174.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -165.67 174.37 9.85 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -166.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 82.3 t -129.73 138.13 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 170.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 17.2 m -119.96 151.13 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 C-N-CA 128.663 2.785 . . . . 0.0 108.777 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.72 26.07 0.09 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -168.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 130.969 3.708 . . . . 0.0 111.279 177.631 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.023 -0.037 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.94 -48.39 30.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.784 0.434 . . . . 0.0 110.521 170.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.8 m 67.41 -66.72 0.19 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.153 1.781 . . . . 0.0 111.613 -172.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 m 60.66 170.7 0.09 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.936 2.094 . . . . 0.0 110.751 -176.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.9 t -78.79 52.07 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 O-C-N 119.949 -1.719 . . . . 0.0 107.739 172.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.46 46.58 0.75 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.705 1.602 . . . . 0.0 110.632 -169.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.49 -7.25 0.23 Allowed Glycine 0 CA--C 1.526 0.729 0 O-C-N 120.854 -1.154 . . . . 0.0 114.143 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.4 -72.78 0.59 Allowed Glycine 0 CA--C 1.503 -0.669 0 N-CA-C 106.111 -2.796 . . . . 0.0 106.111 163.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.6 t -125.01 90.94 3.33 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.0 p 46.9 56.54 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 125.323 1.449 . . . . 0.0 112.404 161.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -34.95 -58.75 0.51 Allowed 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 126.792 2.037 . . . . 0.0 116.148 -166.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 153.87 52.33 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 130.69 3.596 . . . . 0.0 108.693 169.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -129.38 105.08 7.87 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 173.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -128.68 -13.58 2.49 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 118.796 -1.002 . . . . 0.0 112.313 177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -130.58 -156.96 0.79 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-N 118.815 1.307 . . . . 0.0 108.961 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.1 t -49.22 -49.87 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 126.752 2.021 . . . . 0.0 110.278 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m 38.95 40.82 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 127.921 2.489 . . . . 0.0 113.652 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -136.33 98.17 3.77 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 125.39 1.476 . . . . 0.0 107.827 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -131.39 109.67 10.5 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.986 -1.071 . . . . 0.0 108.915 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB3' ' CE1' ' A' ' 158' ' ' TYR . . . -49.65 -28.72 6.23 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.671 1.588 . . . . 0.0 114.012 -170.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.1 m -126.64 153.65 45.07 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 171.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.31 6.86 35.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.514 1.526 . . . . 0.0 114.851 -167.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.28 9.8 p 36.17 100.45 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 130.686 3.595 . . . . 0.0 113.245 -174.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -59.49 162.16 5.18 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.117 0.967 . . . . 0.0 111.922 -162.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.28 -28.69 43.53 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.234 1.413 . . . . 0.0 111.411 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.97 8.49 66.43 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.899 1.237 . . . . 0.0 114.444 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.0 m -142.6 -23.8 0.65 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.683 1.741 . . . . 0.0 113.634 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.0 p -55.01 -33.96 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-N 120.529 1.513 . . . . 0.0 111.091 165.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -137.89 105.06 5.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -131.22 132.84 44.94 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.345 1.058 . . . . 0.0 108.97 -177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.4 m -118.64 89.72 3.19 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 17.2 t -72.78 124.01 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -88.51 101.06 13.56 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.4 mt -69.8 -14.72 62.9 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 165.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.89 -172.21 46.74 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -92.28 142.37 27.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 32.8 t -128.98 143.65 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 125.499 1.52 . . . . 0.0 108.406 -172.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 0.8 OUTLIER -75.69 130.58 38.92 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -179.123 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.3 p -56.22 -24.17 40.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.01 0.924 . . . . 0.0 110.791 172.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.62 -23.99 67.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.34 1.056 . . . . 0.0 112.892 174.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.5 m -89.77 2.96 54.24 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.581 -1.324 . . . . 0.0 113.406 169.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.4 mt -142.17 68.93 1.32 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.959 1.303 . . . . 0.0 108.413 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -124.84 -5.19 7.5 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -168.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.573 HE21 ' HB2' ' A' ' 47' ' ' ALA . 2.3 pm0 -155.09 164.51 38.76 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 125.158 1.383 . . . . 0.0 108.072 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -62.18 133.62 55.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 175.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.67 -10.97 73.41 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-O 118.62 -1.1 . . . . 0.0 111.96 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.573 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -61.45 148.18 42.68 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 119.176 1.488 . . . . 0.0 110.018 168.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.7 p -137.39 153.8 50.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 122.053 0.93 . . . . 0.0 110.251 -178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.2 t -55.35 160.34 2.33 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.59 160.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 m -44.81 -28.58 0.66 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.64 2.376 . . . . 0.0 114.587 169.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 85.03 149.17 0.07 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 129.281 3.033 . . . . 0.0 110.383 174.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.03 156.92 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 C-N-CA 128.634 2.774 . . . . 0.0 106.178 -163.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.3 151.41 17.25 Favored Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 175.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -158.11 142.2 15.8 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.725 ' HB3' HG22 ' A' ' 130' ' ' THR . 3.7 m-20 -126.62 147.75 49.87 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.511 1.05 . . . . 0.0 109.801 -174.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.4 mm -89.95 108.76 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.466 1.107 . . . . 0.0 108.038 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -69.21 115.03 8.02 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.732 0.813 . . . . 0.0 109.981 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.0 mt -116.86 101.96 8.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.145 1.378 . . . . 0.0 107.681 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -94.3 158.53 15.54 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.918 2.087 . . . . 0.0 110.324 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 24.4 t70 34.46 63.07 0.46 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 128.107 2.563 . . . . 0.0 114.052 -167.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 49.4 m -76.06 91.93 3.14 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.611 0.764 . . . . 0.0 111.461 177.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -64.35 124.33 21.48 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 167.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 18.8 p -81.88 -24.42 35.73 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.905 -1.122 . . . . 0.0 113.499 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -63.0 -40.32 97.4 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.361 0.982 . . . . 0.0 110.356 -176.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.468 HG11 ' HA ' ' A' ' 20' ' ' ALA . 2.4 p -66.51 -45.28 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.094 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -164.07 127.75 2.62 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.107 1.363 . . . . 0.0 107.715 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m -81.2 6.78 12.95 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 116.837 -1.554 . . . . 0.0 112.508 169.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.505 ' CA ' HD21 ' A' ' 124' ' ' LEU . 49.1 mtmt -147.36 157.71 43.69 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 121.504 1.956 . . . . 0.0 114.354 172.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.21 133.43 51.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.479 1.911 . . . . 0.0 108.224 168.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.34 173.1 6.47 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 154.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.96 166.27 29.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.28 167.67 21.56 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -134.97 149.11 50.16 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -173.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 tp -146.44 124.79 12.3 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.89 0.376 . . . . 0.0 110.157 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.54 177.89 39.98 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 2.1 m -63.74 129.6 40.79 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.658 1.983 . . . . 0.0 110.124 -171.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.83 130.52 39.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.885 0.766 . . . . 0.0 110.073 173.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.6 tt -60.24 -40.32 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.839 0.856 . . . . 0.0 110.619 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -151.94 171.44 17.79 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 174.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.33 -35.36 75.84 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 124.013 0.925 . . . . 0.0 112.639 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.19 -0.07 89.47 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 123.661 0.648 . . . . 0.0 112.162 173.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -129.04 39.99 3.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.097 1.759 . . . . 0.0 109.28 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.9 p -66.66 -8.83 30.29 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.017 1.327 . . . . 0.0 113.018 174.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -87.93 -0.5 57.07 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.334 1.454 . . . . 0.0 113.024 167.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 36.1 t -129.08 139.54 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 120.739 1.609 . . . . 0.0 108.984 -177.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.454 HD23 ' H ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -89.43 143.05 27.12 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.752 -167.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.454 ' H ' HD23 ' A' ' 86' ' ' LEU . . . -84.31 15.48 3.58 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.334 1.854 . . . . 0.0 114.764 -165.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.0 mt 52.83 -169.17 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.059 0.944 . . . . 0.0 110.016 -168.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -131.39 176.73 8.05 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.905 1.282 . . . . 0.0 108.276 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.6 t -63.68 150.96 43.14 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 123.339 1.542 . . . . 0.0 111.077 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.449 ' HB2' ' H ' ' A' ' 95' ' ' SER . 71.9 m -151.55 177.09 10.68 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 128.42 2.688 . . . . 0.0 106.356 170.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.14 -50.97 63.44 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.036 0.534 . . . . 0.0 111.773 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.44 21.26 13.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.426 0.691 . . . . 0.0 110.755 175.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.98 22.43 71.59 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-O 118.325 -1.264 . . . . 0.0 114.95 171.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.449 ' H ' ' HB2' ' A' ' 91' ' ' SER . 44.4 m 65.46 173.47 0.22 Allowed 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.997 2.119 . . . . 0.0 112.067 -175.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.44 164.82 4.08 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.086 1.354 . . . . 0.0 110.058 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.9 p -120.65 166.81 13.16 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 124.622 1.169 . . . . 0.0 109.508 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 37.4 m-20 55.22 25.59 7.49 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.072 1.349 . . . . 0.0 111.191 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.83 150.77 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 119.373 0.988 . . . . 0.0 109.122 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.35 174.83 34.14 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -81.71 144.19 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -126.35 155.42 42.08 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.558 1.143 . . . . 0.0 108.95 165.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 mp -131.82 141.6 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.951 2.1 . . . . 0.0 107.011 -179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.691 HD23 ' HA ' ' A' ' 110' ' ' ALA . 5.1 mt -140.69 146.49 37.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 124.896 1.278 . . . . 0.0 107.827 -173.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.56 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 4.2 p-10 -70.36 176.23 4.13 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.683 1.23 . . . . 0.0 111.915 166.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -45.71 -30.17 1.5 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.731 2.812 . . . . 0.0 115.271 171.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 50.9 p -88.64 -31.57 18.48 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 120.724 1.602 . . . . 0.0 110.98 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.409 ' O ' HD22 ' A' ' 104' ' ' LEU . . . 115.47 10.39 11.69 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.413 1.482 . . . . 0.0 113.622 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.9 131.18 44.04 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.188 1.494 . . . . 0.0 109.286 174.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.691 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -70.38 116.28 10.53 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.211 1.404 . . . . 0.0 109.778 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.1 mt -83.32 109.85 17.62 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.709 0.803 . . . . 0.0 109.011 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.4 m -57.86 151.94 16.98 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.077 0.465 . . . . 0.0 109.808 171.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.3 mt -102.84 76.06 1.46 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.024 2.129 . . . . 0.0 108.099 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -113.0 -19.58 11.85 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.646 1.178 . . . . 0.0 111.589 -177.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.04 -22.49 0.76 Allowed Glycine 0 CA--C 1.524 0.613 0 C-N-CA 126.579 2.038 . . . . 0.0 113.222 -175.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.23 -68.51 0.7 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 117.303 -1.332 . . . . 0.0 108.363 162.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.0 m -37.18 98.38 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.213 2.205 . . . . 0.0 111.745 -167.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -74.87 159.42 31.91 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.963 1.705 . . . . 0.0 110.175 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.9 p -107.85 175.51 5.46 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.423 1.489 . . . . 0.0 112.349 -175.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 5.6 m -39.88 110.95 0.16 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.728 2.011 . . . . 0.0 112.748 167.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -63.38 164.59 8.88 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.663 1.221 . . . . 0.0 110.48 -175.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 86.1 m -140.15 137.23 34.26 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 165.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 100.0 m -82.95 141.24 32.29 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.194 0.998 . . . . 0.0 108.654 173.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.678 HD22 ' H ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -113.37 173.35 6.44 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 127.821 2.448 . . . . 0.0 107.773 -175.562 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.592 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 27.1 p30 -138.05 166.5 23.94 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 127.008 2.123 . . . . 0.0 109.02 176.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.59 115.16 2.85 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 123.967 0.792 . . . . 0.0 109.297 172.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 129.9 -104.37 0.62 Allowed Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 174.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 86.5 m -146.19 129.25 16.51 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 120.11 -1.818 . . . . 0.0 110.148 -169.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.592 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 56.0 m-80 -135.07 169.03 18.06 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 126.818 2.047 . . . . 0.0 109.396 -171.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 55' ' ' ASN . 1.9 m -158.22 112.09 2.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -172.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.4 mt -76.74 121.35 84.66 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -75.32 146.91 32.08 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.636 1.557 . . . . 0.0 111.194 169.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -132.04 172.74 11.98 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.473 1.909 . . . . 0.0 107.629 168.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.36 151.75 45.68 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 162.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -130.54 162.73 28.63 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 165.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -157.2 166.13 34.06 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.411 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 85.2 m-85 -82.63 138.57 34.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 156.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -117.21 128.05 54.71 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.643 1.977 . . . . 0.0 106.156 174.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.42 146.87 24.99 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.671 0.788 . . . . 0.0 109.883 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 31.5 p -113.24 18.07 18.15 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.682 1.593 . . . . 0.0 111.164 172.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 163.03 -157.55 29.66 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.08 92.29 0.17 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.376 1.088 . . . . 0.0 109.833 174.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.41 128.78 35.89 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.214 1.005 . . . . 0.0 109.267 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.2 p -76.42 159.64 79.31 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 118.924 -1.11 . . . . 0.0 109.0 166.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -69.5 171.88 13.39 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 N-CA-C 110.061 -0.784 . . . . 0.0 110.061 158.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.02 178.99 17.4 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 125.769 1.652 . . . . 0.0 109.574 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -62.3 146.31 51.39 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 174.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.411 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -138.66 74.23 1.47 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -113.88 156.42 23.98 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -152.47 167.62 28.18 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.812 1.245 . . . . 0.0 108.027 173.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -137.84 136.62 37.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.78 169.37 17.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.436 1.494 . . . . 0.0 108.522 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.42 152.25 41.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 165.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -117.67 158.19 25.12 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -118.98 168.66 10.59 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 169.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.9 t -133.4 123.88 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -120.37 85.21 2.35 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 122.577 1.18 . . . . 0.0 108.856 -172.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.472 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 92.0 m-85 -72.59 157.42 37.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 113.894 -1.503 . . . . 0.0 112.847 177.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.426 ' HG3' ' HE3' ' A' ' 68' ' ' LYS . 3.4 pt20 -174.33 170.02 3.71 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.243 1.817 . . . . 0.0 110.01 -174.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 143.02 -23.61 2.26 Favored Glycine 0 N--CA 1.466 0.69 0 O-C-N 120.895 -1.128 . . . . 0.0 113.214 171.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -65.83 -22.78 70.47 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 111.281 -0.727 . . . . 0.0 111.281 175.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 70.48 -108.35 2.45 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 107.975 -2.05 . . . . 0.0 107.975 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.18 -77.29 2.05 Favored Glycine 0 C--N 1.332 0.35 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.91 81.54 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 73.52 81.87 0.38 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 176.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -151.73 128.56 10.93 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.242 1.417 . . . . 0.0 107.639 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -153.24 137.31 16.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.491 1.516 . . . . 0.0 108.512 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 86.5 m -99.99 104.51 16.12 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.708 1.203 . . . . 0.0 109.206 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.2 m -94.57 93.17 7.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.427 1.891 . . . . 0.0 109.329 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.2 m -94.16 155.01 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 124.036 0.935 . . . . 0.0 110.166 173.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.98 144.88 52.18 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 161.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -103.71 -75.69 1.07 Allowed Glycine 0 C--N 1.332 0.352 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -177.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -175.62 -173.16 41.1 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -167.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.1 m -99.1 128.04 45.16 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.809 1.243 . . . . 0.0 109.53 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 19.9 t -104.98 105.34 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -82.49 143.27 31.23 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 168.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -122.76 126.39 47.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -134.75 152.23 51.6 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 118.185 0.448 . . . . 0.0 111.182 -171.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 139.94 -161.57 26.32 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.88 169.12 16.95 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -166.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 87.3 t -116.51 130.77 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 168.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.18 147.22 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 C-N-CA 125.895 1.678 . . . . 0.0 109.804 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.82 30.8 0.09 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -171.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.251 1.155 0 C-N-CA 131.436 3.895 . . . . 0.0 115.959 166.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.49 -79.45 0.13 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.778 1.172 . . . . 0.0 108.269 176.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 74.45 159.15 0.22 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.014 2.126 . . . . 0.0 109.351 -172.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.7 t -154.15 160.32 41.85 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 165.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -171.59 168.79 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.708 2.003 . . . . 0.0 106.608 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -66.93 85.51 0.12 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 122.335 1.064 . . . . 0.0 110.247 174.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.7 -53.35 3.64 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 120.391 -1.443 . . . . 0.0 112.343 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.84 -173.39 44.12 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 172.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t -92.7 95.72 9.74 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 146.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.3 t 56.03 61.28 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 122.195 0.998 . . . . 0.0 113.555 146.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -54.23 -49.46 69.42 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -158.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 153.95 71.07 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.176 1 C-N-CA 132.017 4.127 . . . . 0.0 104.943 176.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -71.16 -97.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.95 7.69 9.01 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.834 1.683 . . . . 0.0 115.957 156.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -176.65 -158.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.305 2.242 . . . . 0.0 105.072 -160.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.8 t -64.68 -11.42 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 O-C-N 120.679 -1.263 . . . . 0.0 112.262 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 t 56.39 40.63 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.353 1.061 . . . . 0.0 111.964 -176.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -154.67 94.56 1.69 Allowed 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 121.23 -0.919 . . . . 0.0 108.971 168.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.35 128.12 47.68 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 159.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.665 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -56.33 -43.6 79.18 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.5 m -108.92 175.19 5.55 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.536 1.535 . . . . 0.0 108.576 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.76 -16.06 15.04 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -167.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 t 54.88 114.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 128.343 2.657 . . . . 0.0 111.836 -173.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.17 154.38 16.21 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.2 1.4 . . . . 0.0 111.678 169.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.436 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -60.89 -27.3 68.05 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.732 1.213 . . . . 0.0 112.397 174.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.1 9.98 50.84 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.406 1.003 . . . . 0.0 112.997 172.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.2 t -129.46 -40.41 1.43 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.356 1.862 . . . . 0.0 108.546 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 25' ' ' ALA . 5.1 p -58.16 -34.13 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 123.696 0.798 . . . . 0.0 111.067 173.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -150.52 75.52 1.22 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.491 0.662 . . . . 0.0 109.565 -167.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.52 145.7 35.86 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 121.702 -0.624 . . . . 0.0 109.496 -173.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.9 m -112.58 95.3 5.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.94 111.8 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -84.54 103.46 13.69 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.4 HD23 HG21 ' A' ' 52' ' ' VAL . 13.2 mt -83.82 -4.99 59.1 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.045 1.338 . . . . 0.0 109.988 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.79 177.7 36.05 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 122.014 0.785 . . . . 0.0 112.522 174.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -75.83 139.6 41.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 167.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -125.77 143.42 39.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.129 0.971 . . . . 0.0 109.509 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.433 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 7.6 mmt180 -74.39 131.19 40.88 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 p -56.49 -23.3 38.46 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 123.304 0.642 . . . . 0.0 111.569 173.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.51 -48.67 71.62 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.488 1.115 . . . . 0.0 110.71 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.416 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 45.0 m -74.36 5.92 4.14 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.4 mt -142.92 59.39 1.42 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.354 1.862 . . . . 0.0 107.72 -168.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.57 6.41 3.5 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -165.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 1.004 HE21 ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -153.35 168.32 26.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.794 1.638 . . . . 0.0 107.161 170.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -63.09 136.56 57.86 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 167.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.42 3.37 86.03 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-O 118.936 -0.924 . . . . 0.0 112.123 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 1.004 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -65.53 145.32 56.24 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.766 1.283 . . . . 0.0 109.045 162.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -142.24 152.44 43.07 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.563 0.697 . . . . 0.0 110.377 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.4 p -69.82 -179.2 1.74 Allowed 'General case' 0 CA--C 1.555 1.141 0 O-C-N 121.518 -0.739 . . . . 0.0 109.097 174.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.43 -28.93 32.64 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 -169.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 95.58 110.75 0.02 OUTLIER 'General case' 0 C--N 1.343 0.301 0 C-N-CA 130.703 3.601 . . . . 0.0 109.522 -168.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.4 HG21 HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -100.77 147.55 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 176.623 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.23 112.73 2.87 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.655 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 7.9 p90 -116.13 179.01 4.11 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.891 0.877 . . . . 0.0 109.142 177.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.1 p30 -158.66 172.44 18.27 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.193 -0.942 . . . . 0.0 110.659 176.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.3 mm -121.76 103.71 13.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 105.18 -2.156 . . . . 0.0 105.18 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -65.96 132.35 48.4 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 172.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 mp -129.24 119.9 24.81 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.245 2.218 . . . . 0.0 107.663 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -120.99 167.73 12.27 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.147 2.179 . . . . 0.0 111.178 -171.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.2 t70 25.31 57.0 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.28 2.632 . . . . 0.0 114.385 -165.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 91.2 m -73.74 121.73 21.26 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 127.551 2.34 . . . . 0.0 109.425 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -92.52 140.06 29.95 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 167.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.1 p -88.92 -13.79 38.24 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.907 1.685 . . . . 0.0 114.503 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -60.92 -51.33 69.74 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.112 0.958 . . . . 0.0 109.009 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.665 HG11 ' HA ' ' A' ' 20' ' ' ALA . 2.1 p -58.26 -48.72 84.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 124.809 1.244 . . . . 0.0 108.126 -175.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HB1' ' H ' ' A' ' 159' ' ' GLN . . . -167.8 127.17 1.31 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.41 1.884 . . . . 0.0 107.28 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 72.3 m -88.34 1.67 54.13 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.599 0.76 . . . . 0.0 110.821 169.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -127.68 160.79 30.57 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 121.107 1.776 . . . . 0.0 110.802 172.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.83 132.58 25.67 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 124.108 0.963 . . . . 0.0 109.385 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -120.35 170.38 9.41 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 122.384 1.088 . . . . 0.0 109.266 167.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.9 t -138.81 147.75 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 127.007 2.123 . . . . 0.0 105.453 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.53 159.33 36.65 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.464 -1.309 . . . . 0.0 107.464 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -123.61 157.31 34.03 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.613 1.565 . . . . 0.0 109.165 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.7 tp -152.59 142.14 21.77 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.715 0.806 . . . . 0.0 108.897 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.661 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -177.37 171.14 43.87 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -175.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 m -58.04 124.88 20.83 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.758 1.279 . . . . 0.0 110.261 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.56 136.6 44.02 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 119.533 1.061 . . . . 0.0 110.34 173.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.5 tt -61.0 -54.22 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 O-C-N 123.786 0.679 . . . . 0.0 110.686 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -134.12 161.7 34.16 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 176.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.8 -33.61 74.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.07 -0.394 . . . . 0.0 111.146 175.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.66 1.72 76.6 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 121.614 -0.679 . . . . 0.0 113.721 175.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -140.37 43.8 1.88 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.902 1.681 . . . . 0.0 109.86 -173.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 p -66.26 -3.89 6.71 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 128.233 2.613 . . . . 0.0 112.503 169.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -93.52 9.16 37.84 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.774 1.23 . . . . 0.0 112.183 167.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.7 t -138.37 143.6 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 120.892 -1.13 . . . . 0.0 110.939 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.683 HD13 ' HB1' ' A' ' 150' ' ' ALA . 6.4 mt -78.62 151.91 32.05 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 119.305 0.957 . . . . 0.0 112.071 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -90.58 18.73 5.98 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 127.444 2.297 . . . . 0.0 114.017 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.633 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 62.5 mt 51.74 -156.5 0.14 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.045 0.938 . . . . 0.0 110.806 -167.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -143.44 -179.47 6.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.417 1.487 . . . . 0.0 108.516 174.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.2 m -60.31 156.82 14.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.27 1.828 . . . . 0.0 113.195 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.418 ' HB2' ' H ' ' A' ' 95' ' ' SER . 51.0 m -158.85 175.11 14.0 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 128.318 2.647 . . . . 0.0 107.494 168.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.78 -54.32 24.51 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.508 0.723 . . . . 0.0 111.741 168.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.5 -0.26 49.44 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.46 37.41 94.41 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 121.102 -0.999 . . . . 0.0 113.015 -167.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.418 ' H ' ' HB2' ' A' ' 91' ' ' SER . 13.9 m 66.16 -168.64 0.2 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.822 1.649 . . . . 0.0 111.758 168.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.86 132.96 46.84 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 164.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.7 p -87.37 166.81 14.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 170.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 59.8 18.73 7.6 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.294 1.838 . . . . 0.0 112.507 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -141.46 156.35 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -165.58 170.16 40.31 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -169.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.21 138.66 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 119.283 1.542 . . . . 0.0 108.671 -175.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -105.32 156.46 18.14 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.317 0.962 . . . . 0.0 109.955 163.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.1 mp -117.73 141.62 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 103.743 -2.688 . . . . 0.0 103.743 158.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 110' ' ' ALA . 50.7 mt -125.29 137.63 54.08 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.15 2.18 . . . . 0.0 105.385 175.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -63.29 166.67 6.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.72 1.248 . . . . 0.0 110.298 166.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.0 ptt85 -59.26 -26.01 64.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.085 1.354 . . . . 0.0 112.806 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.63 -12.93 60.9 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.967 0.803 . . . . 0.0 109.635 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.69 3.59 68.5 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 126.612 2.053 . . . . 0.0 112.738 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.05 159.61 31.52 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.398 1.599 . . . . 0.0 109.202 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.47 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -92.58 158.11 16.16 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.58 0.352 . . . . 0.0 110.207 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.6 mt -114.72 138.25 50.94 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 -172.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -75.22 157.19 34.89 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 170.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.7 mt -110.32 76.43 0.98 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.86 -14.97 10.07 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.289 0.635 . . . . 0.0 111.588 172.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.28 -2.82 81.66 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-O 117.055 -1.97 . . . . 0.0 113.946 175.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -139.66 -15.6 1.04 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.467 1.634 . . . . 0.0 112.851 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 49.6 m -59.54 111.7 1.51 Allowed 'General case' 0 C--O 1.236 0.392 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 164.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.4 168.18 9.35 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.96 0.904 . . . . 0.0 110.082 173.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.6 p -120.01 -38.18 2.98 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -175.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.68 121.28 0.09 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.428 1.891 . . . . 0.0 109.41 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -67.62 140.29 56.87 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 171.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.7 m -130.96 117.39 19.15 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 55.0 m -56.92 137.73 54.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 171.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 45.4 mt -90.96 -163.59 1.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.195 0.998 . . . . 0.0 109.174 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.489 ' H ' HD21 ' A' ' 129' ' ' ASN . 16.0 p30 -154.63 166.58 32.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.878 2.071 . . . . 0.0 108.149 167.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -66.45 91.01 0.16 Allowed 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.274 1.83 . . . . 0.0 109.621 170.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.12 -107.93 0.64 Allowed Glycine 0 C--O 1.224 -0.517 0 CA-C-O 119.04 -0.867 . . . . 0.0 112.424 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.64 136.75 54.74 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 119.219 1.509 . . . . 0.0 110.614 -172.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.489 HD21 ' H ' ' A' ' 125' ' ' ASN . 45.2 m-80 -137.58 168.98 18.57 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 127.159 2.184 . . . . 0.0 108.529 -176.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 97.6 m -149.41 145.12 26.79 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 168.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 10.6 mt -109.41 107.77 59.68 Favored Pre-proline 0 N--CA 1.447 -0.582 0 N-CA-C 103.482 -2.784 . . . . 0.0 103.482 169.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -69.35 156.23 65.02 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 N-CA-C 109.117 -1.147 . . . . 0.0 109.117 171.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -139.72 166.29 25.0 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.827 1.651 . . . . 0.0 107.184 170.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -117.48 137.64 52.4 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 167.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.655 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -128.87 149.86 50.58 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.59 -175.4 5.37 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.944 -0.472 . . . . 0.0 110.443 170.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.468 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 72.4 m-85 -89.65 140.81 29.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 161.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -102.85 147.28 27.09 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.134 1.774 . . . . 0.0 106.321 164.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -112.11 144.55 41.31 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 166.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 75.0 p -102.51 12.4 36.51 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.192 0.997 . . . . 0.0 110.974 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 162.99 -145.49 10.65 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 176.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.04 87.11 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.897 1.679 . . . . 0.0 111.591 176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.27 130.13 45.45 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.321 -0.862 . . . . 0.0 109.334 173.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 49.1 p -83.39 161.42 56.92 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 168.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -70.28 174.2 10.31 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.653 1.569 . . . . 0.0 110.079 163.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.26 -93.51 0.14 Allowed Glycine 0 C--N 1.333 0.365 0 O-C-N 120.965 -1.084 . . . . 0.0 111.536 172.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -149.53 163.3 38.21 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 175.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -146.02 86.05 1.7 Allowed 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -125.63 153.43 43.78 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.683 ' HB1' HD13 ' A' ' 86' ' ' LEU . . . -162.93 165.73 24.73 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.682 1.193 . . . . 0.0 107.986 174.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -137.67 134.93 36.01 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -126.56 165.47 19.09 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.918 1.687 . . . . 0.0 109.484 174.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 41.4 p -119.67 124.86 47.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -93.8 149.66 21.05 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.409 ' HG2' ' HA ' ' A' ' 171' ' ' ASN . 3.2 mtmp? -121.35 163.45 18.64 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.256 1.422 . . . . 0.0 107.757 171.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.52 109.13 15.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.248 -2.131 . . . . 0.0 105.248 -164.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -111.01 80.32 1.29 Allowed 'General case' 0 C--O 1.239 0.529 0 C-N-CA 125.316 1.446 . . . . 0.0 108.935 -167.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -71.6 161.72 30.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.802 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.421 ' H ' ' HB1' ' A' ' 66' ' ' ALA . 10.1 pt20 -175.26 171.53 2.91 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.352 1.061 . . . . 0.0 111.251 -174.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 141.61 -46.65 0.88 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 124.496 1.046 . . . . 0.0 111.591 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -72.45 70.16 1.1 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 126.139 1.828 . . . . 0.0 113.416 -171.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 163.45 4.18 0.04 OUTLIER Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.344 1.926 . . . . 0.0 113.182 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.65 -63.01 4.06 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 119.846 1.823 . . . . 0.0 110.796 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.41 70.57 0.22 Allowed Glycine 0 CA--C 1.521 0.421 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 163.67 58.02 0.02 OUTLIER Glycine 0 C--N 1.332 0.315 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -171.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -173.09 129.31 0.47 Allowed 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 126.269 1.827 . . . . 0.0 107.62 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -161.49 165.1 29.16 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 125.357 1.661 . . . . 0.0 110.498 171.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 98.2 m -151.84 97.16 2.32 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.399 1.479 . . . . 0.0 107.866 -170.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.6 m -89.08 117.08 27.82 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.023 1.729 . . . . 0.0 109.768 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.93 159.27 26.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.755 1.622 . . . . 0.0 110.744 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.409 ' HA ' ' HG2' ' A' ' 155' ' ' LYS . 25.9 m120 -76.32 111.96 12.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -71.71 -67.59 1.82 Allowed Glycine 0 C--N 1.334 0.423 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.99 -160.98 34.73 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 -171.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 37.5 m -107.05 128.35 54.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.448 1.099 . . . . 0.0 108.504 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 19.6 t -104.5 105.75 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 166.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -78.85 143.49 35.92 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 170.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -122.32 122.88 40.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -128.61 168.78 15.25 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.687 1.195 . . . . 0.0 109.699 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 138.88 -161.78 25.88 Favored Glycine 0 N--CA 1.443 -0.9 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 -174.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -162.07 170.36 19.34 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.08 129.89 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 104.991 -2.225 . . . . 0.0 104.991 168.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.4 m -115.38 147.98 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 C-N-CA 127.166 2.186 . . . . 0.0 107.844 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.78 41.9 0.22 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.358 1.463 . . . . 0.0 113.356 -174.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.253 1.276 0 C-N-CA 129.627 3.171 . . . . 0.0 113.605 175.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.92 159.11 43.14 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.102 1.361 . . . . 0.0 107.976 166.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.48 161.64 40.9 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.805 1.242 . . . . 0.0 108.024 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.9 t -151.9 113.16 4.3 Favored 'General case' 0 N--CA 1.457 -0.113 0 O-C-N 120.919 -1.113 . . . . 0.0 109.703 172.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -147.58 154.59 11.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 165.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -64.41 -50.78 66.29 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 122.272 -0.267 . . . . 0.0 110.771 -165.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.81 37.81 3.31 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.115 0.864 . . . . 0.0 111.595 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.13 41.49 0.2 Allowed Glycine 0 C--N 1.338 0.662 0 CA-C-N 118.49 1.145 . . . . 0.0 111.468 -175.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -163.14 13.22 0.06 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.889 1.276 . . . . 0.0 109.173 174.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.438 ' C ' ' H ' ' A' ' 12' ' ' PHE . 35.0 m -71.28 35.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 130.345 3.458 . . . . 0.0 111.696 -169.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 5.3 m170 31.8 -21.04 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.02 1 C-N-CA 137.484 6.314 . . . . 0.0 117.576 -146.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.438 ' H ' ' C ' ' A' ' 10' ' ' VAL . 41.8 m-85 -103.8 1.14 31.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 128.191 2.597 . . . . 0.0 112.067 -166.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.8 mttt 68.03 -27.92 0.14 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 128.478 2.711 . . . . 0.0 116.101 -172.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.1 -16.76 1.96 Allowed Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.33 1.919 . . . . 0.0 115.774 170.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.505 ' HG3' ' H ' ' A' ' 17' ' ' VAL . 13.3 pt-20 -80.11 -153.28 0.08 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 129.686 3.195 . . . . 0.0 110.928 -173.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.566 HG11 HG12 ' A' ' 170' ' ' VAL . 14.6 p -46.79 -26.54 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 126.717 2.007 . . . . 0.0 113.587 167.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.505 ' H ' ' HG3' ' A' ' 15' ' ' GLU . 27.6 m 41.81 33.57 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 130.704 3.602 . . . . 0.0 113.802 -174.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -160.5 104.99 1.43 Allowed 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.935 2.094 . . . . 0.0 106.861 171.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -142.45 36.55 1.49 Allowed 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 128.553 2.741 . . . . 0.0 108.438 175.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.56 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . 48.7 -69.02 0.0 OUTLIER 'General case' 0 C--N 1.34 0.182 1 C-N-CA 133.453 4.701 . . . . 0.0 112.099 -171.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 29.1 m -83.19 -176.23 6.22 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 126.972 2.109 . . . . 0.0 111.229 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.31 16.14 10.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.925 2.09 . . . . 0.0 113.27 -171.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t 24.62 102.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 130.164 3.385 . . . . 0.0 113.137 172.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -55.32 157.59 3.59 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.63 1.172 . . . . 0.0 112.221 -171.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.22 -23.08 62.0 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 120.927 -1.108 . . . . 0.0 111.553 169.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.15 -18.49 73.07 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 117.872 -1.516 . . . . 0.0 113.671 172.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.2 p -118.43 -17.76 9.33 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 120.254 2.027 . . . . 0.0 111.919 -176.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.01 -27.77 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 O-C-N 120.876 -1.14 . . . . 0.0 112.771 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -167.3 82.3 0.21 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 -167.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.58 129.72 56.27 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -173.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 m -77.57 142.24 39.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 156.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.5 t -117.66 99.94 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 162.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -82.43 101.24 10.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.18 -17.3 59.6 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.767 0.827 . . . . 0.0 109.747 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.55 -165.21 18.78 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 121.716 0.62 . . . . 0.0 113.041 -174.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -66.92 153.81 42.61 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.306 1.443 . . . . 0.0 111.53 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 91.5 t -137.13 147.95 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 125.414 1.485 . . . . 0.0 108.628 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.41 127.98 32.97 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 p -59.15 -25.1 63.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.227 0.537 . . . . 0.0 111.806 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.31 -27.87 66.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.497 -0.752 . . . . 0.0 111.204 175.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.5 t -84.52 0.89 48.15 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.245 1.418 . . . . 0.0 112.802 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.434 HD13 HG21 ' A' ' 99' ' ' VAL . 11.1 mt -143.84 82.69 1.73 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.62 1.568 . . . . 0.0 107.826 -170.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.04 0.05 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 O-C-N 120.408 -1.433 . . . . 0.0 113.485 -174.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.494 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 4.0 pm0 -148.22 157.25 43.38 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.472 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 33.0 tt0 -63.37 121.83 14.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.51 -4.57 61.97 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.282 1.42 . . . . 0.0 113.523 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.494 ' HB2' ' NE2' ' A' ' 44' ' ' GLN . . . -61.22 154.24 24.01 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 119.24 1.52 . . . . 0.0 109.499 168.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.5 p -144.06 156.23 44.29 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 118.251 0.478 . . . . 0.0 110.678 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.7 p -72.55 -174.67 1.43 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.6 m -50.54 -40.18 51.11 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 117.101 -1.428 . . . . 0.0 113.806 171.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 95.18 170.92 0.02 OUTLIER 'General case' 0 C--O 1.238 0.478 0 C-N-CA 131.694 3.998 . . . . 0.0 109.815 -166.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.6 t -145.0 139.1 22.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 167.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.27 69.48 0.22 Allowed Glycine 0 CA--C 1.51 -0.246 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -173.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.52 ' HE1' ' HB2' ' A' ' 135' ' ' ALA . 29.4 p90 -69.0 161.0 29.9 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 169.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -133.67 175.84 9.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.739 1.616 . . . . 0.0 109.518 169.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.3 mm -109.81 112.29 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -68.55 112.42 5.34 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.301 0.64 . . . . 0.0 109.861 172.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.3 mp -108.92 135.91 49.33 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 125.006 1.323 . . . . 0.0 108.272 168.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -136.95 167.65 21.08 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.378 1.471 . . . . 0.0 110.362 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 46.07 30.74 0.99 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.965 2.106 . . . . 0.0 113.353 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 96.3 m -62.83 162.48 10.97 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 127.031 2.132 . . . . 0.0 111.388 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -151.42 120.24 6.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.797 1.639 . . . . 0.0 106.898 -167.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.9 p -79.4 -18.45 52.26 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 120.898 -1.126 . . . . 0.0 112.22 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -60.35 -46.97 88.06 Favored 'General case' 0 C--N 1.342 0.274 0 C-N-CA 123.472 0.709 . . . . 0.0 109.725 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 20' ' ' ALA . 6.2 p -73.12 -45.78 52.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.212 1.005 . . . . 0.0 109.637 -175.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -161.82 124.17 2.94 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.145 1.378 . . . . 0.0 108.099 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 m -66.85 -11.75 56.73 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.301 -0.857 . . . . 0.0 112.893 170.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -149.46 163.1 38.72 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 120.846 1.657 . . . . 0.0 114.116 -169.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.89 126.51 39.89 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.713 2.005 . . . . 0.0 106.836 166.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.55 172.96 8.15 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 142.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.453 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.4 OUTLIER -139.88 151.09 21.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 103.182 -2.896 . . . . 0.0 103.182 -171.247 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -137.76 149.45 46.44 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.427 ' CD1' HG21 ' A' ' 103' ' ' ILE . 17.6 m-85 -114.24 157.88 22.13 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.856 0.862 . . . . 0.0 110.757 177.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.408 HD22 ' HA3' ' A' ' 115' ' ' GLY . 13.9 tp -150.47 140.93 22.44 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.952 1.301 . . . . 0.0 108.934 -176.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.16 -169.0 34.39 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 123.929 0.776 . . . . 0.0 112.381 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 m -81.5 130.87 35.21 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.205 1.802 . . . . 0.0 109.605 166.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -76.97 140.07 40.32 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 119.553 1.07 . . . . 0.0 111.028 172.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.3 tt -64.04 -44.62 97.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 122.689 0.396 . . . . 0.0 111.503 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.43 164.46 34.91 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.836 1.254 . . . . 0.0 108.636 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.85 -27.22 66.47 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.888 1.275 . . . . 0.0 113.114 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.77 -2.94 88.45 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.798 0.713 . . . . 0.0 112.582 175.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -143.34 47.3 1.5 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.772 1.629 . . . . 0.0 109.133 -169.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.474 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 25.5 p -61.89 -15.61 44.03 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.15 0.98 . . . . 0.0 112.943 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -94.48 -12.76 27.05 Favored 'General case' 0 N--CA 1.432 -1.353 0 C-N-CA 124.709 1.203 . . . . 0.0 109.762 -173.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.09 130.81 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.857 1.263 . . . . 0.0 107.653 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mt -72.2 150.01 44.12 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.85 1.26 . . . . 0.0 110.291 -174.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.74 14.05 16.44 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.983 1.713 . . . . 0.0 114.351 -164.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 51.1 mt 48.74 -152.48 0.12 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.216 1.007 . . . . 0.0 110.199 -162.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -148.04 179.34 7.81 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.507 1.523 . . . . 0.0 110.374 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.6 m -51.97 145.78 9.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.911 1.684 . . . . 0.0 112.404 170.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.6 m -164.16 174.05 11.7 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.625 2.77 . . . . 0.0 105.876 172.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.69 -38.81 56.71 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -176.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.87 35.06 4.77 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.561 1.544 . . . . 0.0 109.775 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.64 32.13 83.19 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 166.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 62.6 m 66.02 176.88 0.22 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.715 2.406 . . . . 0.0 112.536 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.78 128.9 39.5 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.036 1.334 . . . . 0.0 109.177 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.5 p -87.5 170.27 11.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 118.893 0.77 . . . . 0.0 110.03 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 49.6 32.78 5.23 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.938 1.695 . . . . 0.0 111.943 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.434 HG21 HD13 ' A' ' 42' ' ' LEU . 3.1 p -154.68 151.02 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.4 172.77 34.83 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.434 HG11 ' CD2' ' A' ' 177' ' ' PHE . 79.2 t -84.61 133.74 28.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -104.48 153.54 21.01 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 157.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.427 HG21 ' CD1' ' A' ' 73' ' ' PHE . 4.0 mp -116.72 128.91 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 103.747 -2.686 . . . . 0.0 103.747 164.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 mt -125.96 143.11 51.22 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.566 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 5.7 p-10 -66.66 -178.33 0.7 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.475 1.11 . . . . 0.0 112.659 173.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.429 ' HG3' HG23 ' A' ' 107' ' ' THR . 9.4 ptm180 -44.37 -31.67 1.12 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 128.605 2.762 . . . . 0.0 114.856 169.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.429 HG23 ' HG3' ' A' ' 106' ' ' ARG . 28.6 p -95.09 -4.65 45.92 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.884 1.274 . . . . 0.0 112.125 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.48 22.23 78.76 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 121.162 -0.961 . . . . 0.0 112.933 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -82.69 144.31 30.33 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.923 1.861 . . . . 0.0 109.081 168.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.87 129.05 37.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.756 0.822 . . . . 0.0 111.106 -176.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.426 HD12 HG22 ' A' ' 103' ' ' ILE . 51.9 mt -89.45 168.68 12.0 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.001 0.52 . . . . 0.0 110.396 176.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 m -122.32 140.63 52.43 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.995 1.318 . . . . 0.0 107.764 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 94.7 mt -93.69 52.03 1.64 Allowed 'General case' 0 C--O 1.226 -0.172 0 C-N-CA 124.513 1.125 . . . . 0.0 109.895 -160.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.33 -29.34 19.22 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.238 1.015 . . . . 0.0 111.495 -174.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.408 ' HA3' HD22 ' A' ' 74' ' ' LEU . . . 83.99 -30.43 3.59 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 124.564 1.078 . . . . 0.0 113.697 -172.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.05 -58.04 3.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 116.989 -1.481 . . . . 0.0 109.383 166.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 59.2 m -40.66 103.97 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.315 1.446 . . . . 0.0 111.956 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -63.32 160.77 15.24 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.068 177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 47.3 p -118.43 173.08 7.03 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.857 1.263 . . . . 0.0 109.383 168.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 17.2 m -25.2 116.46 0.05 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.051 2.14 . . . . 0.0 113.402 166.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -72.33 167.4 20.54 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 122.318 1.056 . . . . 0.0 109.174 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.1 m -132.57 157.11 45.55 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 160.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.4 m -107.04 133.81 51.11 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 123.517 1.627 . . . . 0.0 107.961 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.99 175.77 6.51 Favored 'General case' 0 N--CA 1.428 -1.561 0 C-N-CA 129.179 2.991 . . . . 0.0 108.904 -164.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.479 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 7.3 p30 -145.68 165.48 28.63 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.411 1.484 . . . . 0.0 107.971 172.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -61.09 122.59 15.37 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 169.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 105.21 -119.27 6.11 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.263 0.935 . . . . 0.0 111.208 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 m -117.58 125.87 51.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 119.232 1.516 . . . . 0.0 110.436 -167.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.479 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -133.22 176.02 8.88 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 125.051 1.34 . . . . 0.0 109.948 175.734 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.0 m -145.28 137.32 25.64 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.261 -0.899 . . . . 0.0 110.586 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.8 mt -102.63 108.88 59.46 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 169.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -86.59 159.5 9.31 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.607 2.205 . . . . 0.0 110.648 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.453 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 40.9 m-85 -146.43 177.17 9.24 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.1 1.76 . . . . 0.0 109.438 -172.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.09 115.34 8.88 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.393 0.997 . . . . 0.0 111.09 153.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.52 ' HB2' ' HE1' ' A' ' 54' ' ' PHE . . . -84.24 164.88 18.8 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 121.45 -0.781 . . . . 0.0 109.535 167.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -157.24 160.63 38.84 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.011 1.325 . . . . 0.0 107.506 171.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -79.77 132.11 36.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 160.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -116.33 123.02 46.59 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.503 1.921 . . . . 0.0 106.054 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -82.06 143.44 31.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.165 0.586 . . . . 0.0 109.82 176.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.472 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 12.3 p -106.19 11.17 31.54 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.765 0.826 . . . . 0.0 112.173 170.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 160.84 -149.25 18.21 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.06 86.78 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.956 1.303 . . . . 0.0 110.01 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.67 155.96 39.71 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.282 0.633 . . . . 0.0 109.871 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 69.4 p -118.83 161.52 35.71 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.757 0.708 . . . . 0.0 109.896 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -75.39 176.89 9.36 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.681 1.587 . . . . 0.0 110.629 171.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.43 -97.95 0.17 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 164.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.94 163.19 31.29 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 129.947 3.299 . . . . 0.0 105.456 168.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -150.19 77.22 1.3 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 118.673 0.67 . . . . 0.0 109.816 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -119.81 150.35 40.57 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -174.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -152.73 164.08 38.45 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 124.454 1.102 . . . . 0.0 108.193 171.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -134.68 98.28 4.01 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.97 177.81 8.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.39 0.614 . . . . 0.0 110.376 168.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.5 p -122.16 162.44 21.32 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 150.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.428 ' CE1' ' HA3' ' A' ' 172' ' ' GLY . 44.4 p90 -115.98 150.86 36.51 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.912 0.863 . . . . 0.0 109.763 158.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -107.37 167.04 10.2 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.042 1.737 . . . . 0.0 106.659 161.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.88 146.71 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 171.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -128.1 85.12 2.31 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -66.54 147.98 52.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.143 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -161.44 176.91 10.61 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 124.76 1.224 . . . . 0.0 110.752 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 142.96 -32.51 1.9 Allowed Glycine 0 CA--C 1.521 0.407 0 C-N-CA 125.056 1.312 . . . . 0.0 111.339 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -64.65 -32.67 84.98 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 118.219 1.01 . . . . 0.0 112.458 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 79.27 -81.66 1.42 Allowed Glycine 0 C--N 1.337 0.606 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 174.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 60.33 -87.38 0.03 OUTLIER Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.88 1.705 . . . . 0.0 111.559 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -145.4 22.6 1.87 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.581 1.562 . . . . 0.0 111.651 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 103.59 80.49 1.44 Allowed Glycine 0 C--N 1.336 0.548 0 N-CA-C 107.284 -2.326 . . . . 0.0 107.284 -165.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.79 119.92 17.69 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.109 1.764 . . . . 0.0 107.253 -173.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -149.29 172.57 14.66 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 127.219 2.208 . . . . 0.0 109.343 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.4 m -130.91 99.41 4.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.6 131.74 42.85 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 167.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.566 HG12 HG11 ' A' ' 16' ' ' VAL . 3.7 m -148.55 140.65 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 124.405 1.082 . . . . 0.0 109.742 -177.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -66.87 126.27 28.54 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 166.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 154' ' ' PHE . . . -93.41 -75.96 1.32 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -160.29 -175.48 31.33 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 123.72 0.306 . . . . 0.0 113.232 -176.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 25.6 m -103.6 142.82 33.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.401 1.48 . . . . 0.0 109.007 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 3.4 t -125.57 101.56 8.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -88.35 95.6 10.26 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.434 ' CD2' HG11 ' A' ' 101' ' ' VAL . 71.4 m-85 -75.14 102.21 4.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 175.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -114.24 156.94 23.4 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 -175.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 143.75 -163.37 27.63 Favored Glycine 0 CA--C 1.521 0.431 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -171.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -161.44 170.15 20.54 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -164.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 48.3 t -126.4 140.51 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 167.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 16.9 m -122.06 150.37 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 127.058 2.143 . . . . 0.0 109.046 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.65 24.59 0.09 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -169.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 1 C-N-CA 132.993 4.517 . . . . 0.0 113.719 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.44 -77.93 0.42 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 171.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 4' ' ' THR . 10.0 m 65.27 172.75 0.21 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.975 1.71 . . . . 0.0 111.285 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.554 ' H ' HG22 ' A' ' 3' ' ' THR . 18.9 p -135.58 127.4 29.32 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.912 2.085 . . . . 0.0 106.37 -170.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 6' ' ' ASN . 11.9 p -146.4 172.02 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.416 ' H ' HG22 ' A' ' 5' ' ' VAL . 10.3 m120 -55.69 103.35 0.09 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.745 1.618 . . . . 0.0 111.422 -167.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.57 -88.55 1.59 Allowed Glycine 0 CA--C 1.522 0.514 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.33 173.76 23.66 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -174.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 t -96.6 14.32 25.19 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.022 0.529 . . . . 0.0 112.196 -164.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 74.01 156.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 127.945 2.498 . . . . 0.0 110.43 -155.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -85.35 36.45 0.64 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.78 1.232 . . . . 0.0 110.723 -165.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -159.02 16.88 0.18 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.912 2.085 . . . . 0.0 110.522 -161.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 69.82 -36.32 0.34 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 127.599 2.36 . . . . 0.0 114.877 -175.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.07 27.61 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.884 0 CA-C-O 117.141 -1.921 . . . . 0.0 114.203 -167.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.347 2.2 pt-20 97.77 -157.79 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 130.141 3.376 . . . . 0.0 112.147 173.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 p -41.53 -39.57 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 126.841 2.056 . . . . 0.0 113.283 -176.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.258 22.1 m 33.26 34.52 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 130.051 3.34 . . . . 0.0 117.83 176.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -116.87 100.29 7.68 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.978 0.894 . . . . 0.0 109.667 169.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -129.01 110.79 12.36 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 -173.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.474 ' HB3' ' CD1' ' A' ' 158' ' ' TYR . . . -53.28 -38.87 63.48 Favored 'General case' 0 C--O 1.225 -0.211 0 O-C-N 123.986 0.803 . . . . 0.0 112.206 -165.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.4 ' SG ' HD13 ' A' ' 124' ' ' LEU . 3.5 m -110.22 159.3 17.51 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.798 1.239 . . . . 0.0 107.779 165.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.81 -9.3 52.26 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -164.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.5 t 44.95 96.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 129.038 2.935 . . . . 0.0 110.744 -167.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -62.91 160.57 14.49 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.289 -170.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.7 -21.2 39.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.953 1.301 . . . . 0.0 112.15 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.53 -12.9 67.53 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.564 1.078 . . . . 0.0 112.755 173.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.4 t -127.09 -21.67 3.91 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.834 1.654 . . . . 0.0 110.792 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.9 -26.13 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 125.25 1.42 . . . . 0.0 113.007 -173.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -150.7 94.5 2.1 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -132.61 148.31 52.36 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.343 0.657 . . . . 0.0 109.485 -175.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.2 m -124.32 100.4 6.67 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.634 1.973 . . . . 0.0 108.041 -174.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 8.5 t -74.53 111.28 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -88.55 101.41 13.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.63 HD23 HG11 ' A' ' 52' ' ' VAL . 1.2 mt -76.46 -16.39 59.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.033 1.733 . . . . 0.0 109.7 170.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.39 -166.55 25.49 Favored Glycine 0 C--N 1.343 0.935 0 C-N-CA 124.796 1.189 . . . . 0.0 112.765 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -68.68 147.63 51.58 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.98 0.912 . . . . 0.0 109.64 173.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.8 t -135.88 143.41 36.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 124.353 1.061 . . . . 0.0 108.949 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 3.8 mmt85 -73.29 127.67 33.3 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 182' ' ' VAL . 33.3 p -58.01 -21.94 47.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.211 0.529 . . . . 0.0 111.485 172.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.38 -43.3 75.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.165 -0.96 . . . . 0.0 110.675 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.6 m -72.49 -2.11 18.39 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.4 mt -144.0 66.28 1.29 Allowed 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 126.488 1.915 . . . . 0.0 109.017 -161.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.97 -9.07 6.0 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -167.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.669 HE21 ' HB2' ' A' ' 47' ' ' ALA . 2.8 pm0 -152.52 163.09 40.26 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.391 1.476 . . . . 0.0 107.928 -178.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -62.77 129.97 42.84 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.24 -10.68 63.58 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.842 1.211 . . . . 0.0 112.734 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.669 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -67.83 106.2 2.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.35 1.06 . . . . 0.0 111.458 169.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.415 HG21 ' CZ ' ' A' ' 136' ' ' ARG . 11.8 p -101.18 150.6 22.79 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.44 -0.788 . . . . 0.0 110.812 -176.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 86.1 p -67.56 172.45 5.09 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 166.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.7 m -24.64 -98.9 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 130.257 3.423 . . . . 0.0 114.517 177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 154.72 118.24 0.0 OUTLIER 'General case' 0 C--O 1.233 0.191 0 C-N-CA 129.746 3.218 . . . . 0.0 105.356 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.63 HG11 HD23 ' A' ' 34' ' ' LEU . 0.2 OUTLIER -130.58 130.96 65.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -176.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.08 139.5 14.58 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -138.48 158.77 43.62 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 168.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -148.94 130.08 14.51 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 120.347 -1.471 . . . . 0.0 110.396 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 17.7 mm -83.54 115.61 26.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 C-N-CA 125.002 1.321 . . . . 0.0 107.459 -167.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -76.63 108.95 9.98 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.988 0.915 . . . . 0.0 109.826 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.7 mp -111.71 97.13 6.5 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 125.414 1.485 . . . . 0.0 108.294 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -95.83 160.32 14.53 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.161 1.784 . . . . 0.0 112.227 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.3 t70 40.49 49.7 2.68 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.275 2.63 . . . . 0.0 114.007 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 57.5 m -65.66 122.16 16.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 127.701 2.4 . . . . 0.0 111.05 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.425 ' HB3' HG23 ' A' ' 65' ' ' VAL . 5.9 t0 -111.17 112.6 24.51 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.582 1.153 . . . . 0.0 110.161 -173.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.9 p -70.84 -24.68 62.57 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.146 2.178 . . . . 0.0 113.738 -165.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -61.47 -48.2 82.19 Favored 'General case' 0 CA--C 1.503 -0.856 0 C-N-CA 128.543 2.737 . . . . 0.0 112.44 168.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 62' ' ' ASP . 40.1 t -64.88 -39.13 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -176.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -168.63 146.06 3.91 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.117 -176.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.25 -11.42 35.34 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 118.795 -0.621 . . . . 0.0 111.67 170.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -134.04 164.8 26.5 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 125.46 1.504 . . . . 0.0 109.942 -173.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.79 144.06 37.18 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 163.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -109.79 167.88 9.83 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 125.98 1.712 . . . . 0.0 107.429 158.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 49.7 t -124.8 150.97 29.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 169.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -123.25 155.21 37.62 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 161.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.623 ' CE1' HG21 ' A' ' 103' ' ' ILE . 60.0 m-85 -114.04 154.85 26.98 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 169.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.406 HD13 ' C ' ' A' ' 114' ' ' ASP . 9.7 tp -142.11 125.97 17.11 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 125.373 1.469 . . . . 0.0 107.365 177.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.679 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . -165.85 162.91 36.34 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 107.583 -2.207 . . . . 0.0 107.583 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.3 m -63.08 129.47 40.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 118.003 0.901 . . . . 0.0 109.107 176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.69 141.31 46.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.071 0.462 . . . . 0.0 110.245 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.3 tt -60.77 -37.51 76.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 123.931 0.892 . . . . 0.0 110.382 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -158.24 165.56 34.55 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.45 -35.4 72.06 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 124.856 1.262 . . . . 0.0 111.254 169.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.79 -3.68 64.29 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 121.276 -0.89 . . . . 0.0 112.381 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -147.78 48.54 1.08 Allowed 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.959 1.704 . . . . 0.0 108.788 -164.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.3 p -58.75 -18.4 31.4 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.598 1.959 . . . . 0.0 112.414 175.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -95.07 -1.79 51.44 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 117.928 -1.034 . . . . 0.0 113.076 175.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.3 t -115.58 130.59 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 120.329 1.422 . . . . 0.0 109.807 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.679 HD21 ' HA3' ' A' ' 75' ' ' GLY . 4.8 mt -72.2 151.47 42.89 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 124.209 1.004 . . . . 0.0 111.393 -175.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.72 17.41 10.39 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.999 1.719 . . . . 0.0 113.656 -168.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.644 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 63.8 mt 52.34 -154.17 0.2 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.606 1.562 . . . . 0.0 109.406 -168.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -145.09 -172.43 3.85 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.725 0.693 . . . . 0.0 110.158 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.4 m -56.08 154.74 7.27 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 121.794 0.807 . . . . 0.0 111.75 170.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.509 ' HB2' ' H ' ' A' ' 95' ' ' SER . 1.4 m -162.12 178.8 8.46 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.635 1.974 . . . . 0.0 106.556 167.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -45.15 -58.88 2.93 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 123.857 0.863 . . . . 0.0 109.271 169.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -101.41 16.41 25.69 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.786 0.834 . . . . 0.0 113.01 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 64.96 48.22 73.72 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.634 -0.666 . . . . 0.0 111.998 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.509 ' H ' ' HB2' ' A' ' 91' ' ' SER . 45.8 m 62.45 177.78 0.14 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.484 2.314 . . . . 0.0 113.343 175.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.07 139.07 57.71 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.389 1.476 . . . . 0.0 107.57 164.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 p -90.36 170.4 10.28 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 118.761 0.709 . . . . 0.0 109.594 173.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 58.73 19.92 7.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 126.536 1.934 . . . . 0.0 112.71 175.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.7 p -143.49 151.38 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -153.5 177.67 30.92 Favored Glycine 0 C--O 1.225 -0.408 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 m -96.03 142.87 13.14 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 CA-C-N 120.018 1.909 . . . . 0.0 109.056 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -110.15 156.61 20.37 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 120.257 1.39 . . . . 0.0 109.328 161.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.623 HG21 ' CE1' ' A' ' 73' ' ' PHE . 4.6 mp -114.02 142.97 24.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 126.995 2.118 . . . . 0.0 105.562 159.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 110' ' ' ALA . 8.3 mt -131.77 156.0 46.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.235 1.814 . . . . 0.0 106.674 170.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 106' ' ' ARG . 3.5 t70 -72.34 -105.35 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 165.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.402 ' H ' ' CG ' ' A' ' 105' ' ' ASP . 19.7 ptt180 -151.21 -9.79 0.23 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.744 1.618 . . . . 0.0 112.432 178.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 69.5 p -83.12 7.54 15.66 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.646 1.578 . . . . 0.0 109.344 172.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.45 8.1 30.1 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.441 1.496 . . . . 0.0 113.484 -166.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.31 114.65 3.02 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 119.476 1.638 . . . . 0.0 107.377 170.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.499 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -95.08 127.44 41.15 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 176.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.43 131.62 51.59 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.826 0.704 . . . . 0.0 110.623 -162.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.8 m -65.18 153.96 39.41 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.616 0.366 . . . . 0.0 110.611 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.81 49.92 0.8 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.393 1.477 . . . . 0.0 110.226 -171.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.406 ' C ' HD13 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -88.59 -28.86 20.42 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 120.564 -1.335 . . . . 0.0 111.091 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.44 2.03 56.63 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 126.523 2.011 . . . . 0.0 113.641 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -129.78 -31.69 1.95 Allowed 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 117.583 -1.198 . . . . 0.0 111.35 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.1 m -54.67 104.35 0.11 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.713 1.142 . . . . 0.0 110.131 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -87.26 149.95 24.22 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.886 -173.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.6 -160.73 0.19 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.896 1.278 . . . . 0.0 111.789 -174.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 m -50.76 156.49 0.94 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.519 0.727 . . . . 0.0 111.778 147.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -102.4 152.93 20.53 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.393 1.877 . . . . 0.0 108.313 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.8 m -132.03 118.25 19.44 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.449 1.499 . . . . 0.0 107.851 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 73.5 m -59.15 123.76 17.71 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 166.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.4 HD13 ' SG ' ' A' ' 21' ' ' CYS . 73.3 mt -91.2 -174.69 4.04 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 128.805 2.842 . . . . 0.0 109.59 176.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -163.04 172.94 14.22 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.522 1.929 . . . . 0.0 108.537 175.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -59.57 107.38 0.58 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.974 1.709 . . . . 0.0 109.748 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.1 -124.25 3.19 Favored Glycine 0 N--CA 1.474 1.226 0 CA-C-N 120.417 1.462 . . . . 0.0 112.8 169.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 99.2 m -122.75 125.31 45.26 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 120.535 2.168 . . . . 0.0 109.091 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -133.29 177.72 7.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.474 1.91 . . . . 0.0 109.706 -177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.57 162.18 40.71 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -166.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 17.6 mt -139.92 112.29 7.5 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.64 153.08 43.46 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.971 1.781 . . . . 0.0 109.431 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -136.41 161.3 36.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.894 1.677 . . . . 0.0 107.605 170.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -127.18 97.27 4.87 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -175.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.12 157.23 25.41 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.406 1.482 . . . . 0.0 110.578 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.415 ' CZ ' HG21 ' A' ' 48' ' ' THR . 24.9 ptt180 -159.14 169.83 23.31 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.079 1.352 . . . . 0.0 111.306 162.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.433 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 76.0 m-85 -82.78 146.05 29.18 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 152.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -123.83 116.53 23.11 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.97 2.108 . . . . 0.0 106.914 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -79.54 141.15 36.92 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 171.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.2 p -105.67 17.13 24.28 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.895 0.878 . . . . 0.0 110.375 171.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 161.64 -155.98 27.36 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.06 91.34 0.15 Allowed 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.995 1.718 . . . . 0.0 110.043 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.12 152.72 32.11 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 55.0 p -104.38 161.06 23.99 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 171.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -72.87 170.9 18.56 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 N-CA-C 109.215 -1.11 . . . . 0.0 109.215 160.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.06 -95.46 0.15 Allowed Glycine 0 C--O 1.226 -0.348 0 O-C-N 121.35 -0.844 . . . . 0.0 112.114 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -151.12 161.18 43.21 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.175 1.79 . . . . 0.0 106.743 173.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.433 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -147.11 81.23 1.54 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -118.92 139.53 51.49 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.644 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -151.5 157.24 42.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 171.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -130.34 121.88 26.84 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -101.15 163.57 12.22 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 162.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 17.3 p -103.8 156.15 18.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 151.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -115.84 157.8 23.89 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.49 0.716 . . . . 0.0 109.604 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -126.31 162.7 24.88 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 126.946 2.098 . . . . 0.0 107.768 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.411 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 10.8 t -128.55 123.34 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 -175.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -111.78 85.56 2.16 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 20' ' ' ALA . 85.8 m-85 -64.7 146.84 54.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.283 170.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -164.47 168.21 18.66 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 121.838 0.827 . . . . 0.0 112.44 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 154.28 -86.02 0.14 Allowed Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 105.894 -2.883 . . . . 0.0 105.894 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -24.71 -59.18 0.06 OUTLIER Glycine 0 CA--C 1.523 0.544 0 C-N-CA 129.891 3.615 . . . . 0.0 116.87 -172.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -71.47 -22.47 78.61 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 119.487 1.644 . . . . 0.0 112.772 -171.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.62 49.53 3.61 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 118.262 1.031 . . . . 0.0 111.604 167.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 86.85 116.47 1.04 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -172.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.34 32.22 9.79 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 123.664 0.65 . . . . 0.0 111.939 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -155.88 124.48 5.94 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 170.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -155.8 148.2 23.75 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 123.588 0.555 . . . . 0.0 110.491 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 90.9 m -103.58 91.89 4.22 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.414 1.486 . . . . 0.0 107.939 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.2 m -79.02 101.97 8.1 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 171.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -104.84 169.2 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 126.111 1.765 . . . . 0.0 108.791 170.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.33 173.63 4.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.437 0.637 . . . . 0.0 111.094 169.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -127.16 -72.09 0.18 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 174.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 167.68 -167.23 39.88 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -167.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.1 m -96.9 137.5 35.89 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.048 0.939 . . . . 0.0 108.745 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.7 t -117.96 105.49 18.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 163.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 50.8 m-70 -78.11 141.74 38.56 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 171.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -123.56 101.15 7.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.27 2.228 . . . . 0.0 105.174 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -115.06 155.99 25.99 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.89 0.876 . . . . 0.0 109.265 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 144.64 -166.71 27.28 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -167.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -167.09 175.22 7.66 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -169.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 24.3 t -128.86 138.0 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 174.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 39' ' ' THR . 11.0 m -124.69 151.43 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 C-N-CA 127.255 2.222 . . . . 0.0 107.75 -178.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -74.89 30.88 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -171.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.249 1.049 0 C-N-CA 131.074 3.75 . . . . 0.0 114.017 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.925 0 CA-C-O 117.92 -1.038 . . . . 0.0 108.74 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.46 169.43 23.93 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 120.761 1.619 . . . . 0.0 110.7 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.5 t -114.72 46.97 1.31 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 122.356 1.074 . . . . 0.0 109.483 178.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -148.53 175.11 11.44 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.681 1.193 . . . . 0.0 108.218 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.1 t -49.72 -33.27 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.842 2.057 . . . . 0.0 111.41 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 t30 64.11 -60.22 0.19 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 129.095 2.958 . . . . 0.0 112.769 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.37 106.59 0.23 Allowed Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 106.013 -2.835 . . . . 0.0 106.013 176.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.61 -65.46 0.01 OUTLIER Glycine 0 CA--C 1.505 -0.574 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -172.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 t -63.94 3.81 0.36 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.839 2.056 . . . . 0.0 115.326 -171.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.9 p 174.97 -24.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 131.427 3.891 . . . . 0.0 111.008 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 77.33 39.49 0.19 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.565 2.346 . . . . 0.0 112.048 178.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -136.78 132.08 34.25 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 169.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -136.79 -102.48 0.2 Allowed 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 167.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.15 -3.35 33.34 Favored Glycine 0 N--CA 1.46 0.292 0 C-N-CA 125.702 1.62 . . . . 0.0 112.623 170.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -166.84 -163.4 0.55 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.947 1.699 . . . . 0.0 106.424 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.597 HG11 HG12 ' A' ' 170' ' ' VAL . 5.9 p -46.07 -31.82 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 127.203 2.201 . . . . 0.0 113.469 167.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m 26.15 56.47 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 127.64 2.376 . . . . 0.0 115.348 -171.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -140.33 97.41 3.22 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -140.24 119.33 12.75 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 173.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.554 ' HA ' HG11 ' A' ' 65' ' ' VAL . . . -48.4 -40.21 25.1 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.87 1.268 . . . . 0.0 112.377 -175.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -112.79 160.71 17.71 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.755 1.622 . . . . 0.0 109.579 178.404 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.92 -21.62 31.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.334 -167.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.2 t 56.51 107.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 128.633 2.773 . . . . 0.0 110.272 -165.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -65.7 163.14 17.07 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.66 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.552 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -53.26 -29.6 33.76 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.242 1.017 . . . . 0.0 111.356 167.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.43 4.61 3.65 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.673 1.13 . . . . 0.0 114.784 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.8 t -147.6 -34.13 0.25 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.188 1.494 . . . . 0.0 110.351 -167.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 25' ' ' ALA . 8.1 p -60.4 -36.84 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 O-C-N 120.738 -1.226 . . . . 0.0 111.371 174.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -151.24 97.38 2.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.96 0.886 . . . . 0.0 109.081 -172.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -131.33 133.83 45.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 123.376 1.56 . . . . 0.0 110.179 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.8 m -108.75 88.96 2.85 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -174.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.56 105.11 7.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -171.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -80.89 115.14 20.23 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.674 HD23 HG11 ' A' ' 52' ' ' VAL . 1.2 mt -79.89 -7.44 58.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.974 0.91 . . . . 0.0 110.732 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.19 -178.47 51.42 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.647 1.117 . . . . 0.0 110.703 -177.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -79.05 146.82 33.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 165.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.58 145.58 35.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 124.395 1.078 . . . . 0.0 108.637 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -77.63 132.44 38.25 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.3 p -59.04 -22.81 61.31 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 122.489 0.316 . . . . 0.0 110.7 168.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.14 -9.64 41.95 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.91 -1.119 . . . . 0.0 113.274 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.0 m -101.36 -2.38 31.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.456 1.103 . . . . 0.0 113.28 168.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.594 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 17.4 mt -142.56 83.22 1.81 Allowed 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 126.845 2.058 . . . . 0.0 106.815 -166.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.69 6.98 1.45 Allowed 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.289 -0.882 . . . . 0.0 112.274 -175.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.464 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 6.5 pm0 -154.48 160.15 41.42 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.701 1.2 . . . . 0.0 107.886 -174.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -64.09 136.42 57.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 121.528 -0.732 . . . . 0.0 109.796 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.31 -4.17 56.09 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-O 117.51 -1.717 . . . . 0.0 112.344 -174.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.464 ' HB2' ' NE2' ' A' ' 44' ' ' GLN . . . -58.71 143.78 45.69 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 120.562 2.181 . . . . 0.0 108.113 170.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.8 p -140.75 154.68 46.4 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -176.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.5 p -73.41 -178.49 3.03 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.2 m -28.55 -91.03 0.0 OUTLIER 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.622 2.769 . . . . 0.0 114.735 173.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 153.41 111.02 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 130.495 3.518 . . . . 0.0 104.356 -176.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.674 HG11 HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -107.02 136.08 43.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 173.374 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.33 88.77 0.43 Allowed Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 -173.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -83.22 -179.55 7.44 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -148.53 162.97 38.58 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 120.189 -1.569 . . . . 0.0 109.997 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.1 mm -99.62 103.81 15.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -69.49 124.47 23.99 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 174.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.4 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 6.5 mp -117.5 165.46 13.51 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.729 1.612 . . . . 0.0 108.789 174.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -176.03 153.26 1.29 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.313 1.445 . . . . 0.0 109.219 -165.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 47.12 37.47 5.4 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.542 2.337 . . . . 0.0 114.501 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.534 ' SG ' HD13 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -67.3 119.42 12.13 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.407 1.483 . . . . 0.0 110.35 177.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -90.53 142.57 27.61 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 163.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.3 p -91.19 -14.02 31.8 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 120.664 1.575 . . . . 0.0 114.308 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -70.64 -43.49 69.1 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.739 0.781 . . . . 0.0 110.222 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 20' ' ' ALA . 2.8 p -60.27 -49.71 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.86 130.37 3.19 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 125.955 1.702 . . . . 0.0 108.081 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -82.29 -8.05 59.63 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.018 0.927 . . . . 0.0 111.695 174.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -131.24 167.04 19.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.921 1.689 . . . . 0.0 110.111 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.56 ' HB2' HD11 ' A' ' 124' ' ' LEU . . . -141.03 129.1 22.01 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 162.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.4 176.91 5.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 145.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.424 ' CG1' ' HZ ' ' A' ' 133' ' ' PHE . 0.4 OUTLIER -144.03 160.5 15.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 101.648 -3.464 . . . . 0.0 101.648 -168.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.25 167.9 21.71 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 120.354 -1.466 . . . . 0.0 107.458 168.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -126.39 153.51 44.86 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 tp -142.13 142.72 32.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.11 170.07 42.85 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 2.0 m -57.19 125.76 24.18 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.954 1.701 . . . . 0.0 109.374 177.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.43 137.52 46.51 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.687 1.13 . . . . 0.0 109.866 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 18.1 tt -59.2 -49.21 84.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 124.405 1.082 . . . . 0.0 110.7 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -147.78 166.72 26.67 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 173.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.09 -34.41 76.24 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 124.961 1.304 . . . . 0.0 112.231 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.9 -12.69 84.17 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 119.514 -0.603 . . . . 0.0 112.347 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -125.79 48.86 2.01 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.266 1.427 . . . . 0.0 110.153 -173.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.4 p -63.89 -11.96 32.53 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 126.776 2.03 . . . . 0.0 114.041 177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -86.25 -4.05 59.09 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.15 -0.968 . . . . 0.0 111.074 171.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.7 t -124.47 132.7 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 119.832 1.196 . . . . 0.0 109.258 -168.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.34 148.25 35.72 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.47 1.508 . . . . 0.0 110.473 -172.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 76' ' ' THR . . . -91.53 17.33 8.83 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.395 1.478 . . . . 0.0 114.27 -166.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.402 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 26.0 mt 51.27 -153.02 0.19 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.261 0.624 . . . . 0.0 109.811 -166.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -146.94 171.59 15.0 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.073 1.349 . . . . 0.0 109.238 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.9 m -48.57 140.02 8.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.062 1.745 . . . . 0.0 111.01 174.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.61 168.79 25.95 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.985 1.314 . . . . 0.0 108.406 176.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.99 -48.95 78.49 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.002 0.921 . . . . 0.0 111.471 -174.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.53 11.48 7.01 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.411 0.684 . . . . 0.0 112.4 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 54.83 50.61 57.6 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 125.578 1.561 . . . . 0.0 111.344 -166.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.5 t 58.11 -176.64 0.07 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 128.77 2.828 . . . . 0.0 111.901 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.06 156.75 14.25 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 112.277 -2.238 . . . . 0.0 107.891 151.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.44 163.8 28.55 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.495 1.518 . . . . 0.0 108.471 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 59.03 15.65 4.16 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.298 1.439 . . . . 0.0 111.214 -170.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.14 152.71 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 120.207 1.367 . . . . 0.0 109.025 -176.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.27 176.11 28.16 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 125.396 1.474 . . . . 0.0 110.306 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.406 HG11 ' CG ' ' A' ' 177' ' ' PHE . 92.9 t -86.4 142.51 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 172.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.708 HE22 ' HB1' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -120.64 157.87 28.62 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.659 1.184 . . . . 0.0 108.544 163.009 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.7 mp -134.72 138.68 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 C-N-CA 129.082 2.953 . . . . 0.0 104.783 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.07 147.28 46.01 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -178.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.473 ' CG ' ' HB2' ' A' ' 120' ' ' SER . 0.8 OUTLIER -67.84 -175.26 0.53 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.263 0.938 . . . . 0.0 110.405 175.278 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -52.16 -18.14 1.37 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 171.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 t -81.41 -13.65 58.04 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.51 -0.744 . . . . 0.0 109.363 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.15 13.26 52.98 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.557 2.027 . . . . 0.0 113.501 -167.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.05 127.59 33.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 168.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.708 ' HB1' HE22 ' A' ' 102' ' ' GLN . . . -62.04 129.05 39.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.328 1.451 . . . . 0.0 111.482 -177.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.0 mt -100.76 160.44 14.36 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 124.086 0.866 . . . . 0.0 110.54 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.0 m -96.13 153.16 17.94 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.995 0.918 . . . . 0.0 108.567 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.4 mt -107.19 64.26 0.64 Allowed 'General case' 0 N--CA 1.461 0.097 0 C-N-CA 123.593 0.757 . . . . 0.0 109.542 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -111.06 -12.61 14.17 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.616 0.766 . . . . 0.0 111.799 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.82 -27.02 1.38 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 125.179 1.371 . . . . 0.0 112.739 178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.02 -69.7 0.57 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 117.862 -1.066 . . . . 0.0 109.266 164.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 51.7 m -39.6 99.09 0.02 OUTLIER 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.804 2.041 . . . . 0.0 112.128 -169.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -70.16 155.96 39.9 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.207 1.403 . . . . 0.0 109.81 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.8 p -109.98 -138.94 0.38 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.043 0.937 . . . . 0.0 112.181 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.473 ' HB2' ' CG ' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -70.51 135.44 48.6 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.177 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -78.53 163.17 25.77 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.737 0.779 . . . . 0.0 108.969 167.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 50.0 m -145.61 118.75 8.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.202 -2.518 . . . . 0.0 104.202 174.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 67.1 m -70.32 113.64 7.68 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 171.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 69' ' ' ALA . 31.2 mt -80.29 177.78 8.73 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.048 2.139 . . . . 0.0 107.868 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -143.36 164.9 29.0 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.62 -0.675 . . . . 0.0 109.846 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -63.72 104.99 0.73 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.919 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 122.99 -109.49 1.38 Allowed Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.586 1.565 . . . . 0.0 111.681 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 94.3 m -126.55 131.25 51.6 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 120.769 -1.43 . . . . 0.0 111.587 -164.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.06 174.41 12.78 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.649 1.979 . . . . 0.0 108.249 -172.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 25.0 m -151.23 157.45 42.62 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 10.5 mt -118.33 110.7 39.01 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 170.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -67.36 154.25 74.5 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 121.709 1.606 . . . . 0.0 109.996 172.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.424 ' HZ ' ' CG1' ' A' ' 71' ' ' VAL . 25.8 m-85 -136.12 166.77 22.62 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.595 1.558 . . . . 0.0 108.496 173.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -120.02 152.17 37.9 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 164.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -131.88 166.84 20.71 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 162.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -164.25 158.29 18.75 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 170.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.451 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 84.3 m-85 -71.32 153.89 42.02 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 159.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -134.01 112.89 11.58 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.226 2.21 . . . . 0.0 105.931 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -80.08 150.68 30.22 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.123 0.963 . . . . 0.0 109.184 170.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 68.1 p -115.61 8.04 14.96 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 125.958 1.703 . . . . 0.0 110.601 175.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 167.58 -154.28 24.33 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.05 87.0 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.002 1.321 . . . . 0.0 112.064 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -67.07 137.45 56.41 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.243 1.417 . . . . 0.0 111.495 -170.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 31.1 p -99.97 160.8 26.25 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 118.26 0.482 . . . . 0.0 110.613 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -72.36 178.78 5.71 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 121.446 1.43 . . . . 0.0 110.743 166.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.01 -93.59 0.14 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.593 1.092 . . . . 0.0 112.213 158.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.24 159.12 42.71 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 127.559 2.343 . . . . 0.0 105.06 171.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -149.33 71.78 1.13 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 120.015 1.279 . . . . 0.0 110.767 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -115.47 154.79 28.65 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -176.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -157.0 152.63 26.85 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.749 0.82 . . . . 0.0 109.715 175.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -120.74 121.32 37.98 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -120.79 175.69 5.9 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.009 2.124 . . . . 0.0 109.819 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.7 p -127.61 152.11 48.06 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 159.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -105.09 156.1 18.38 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 164.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -113.49 171.98 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.797 1.239 . . . . 0.0 107.943 168.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.461 HG11 ' CZ ' ' A' ' 158' ' ' TYR . 15.6 t -129.34 129.05 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -120.9 89.37 3.12 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 173.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.543 ' CE1' ' HB3' ' A' ' 20' ' ' ALA . 67.0 m-85 -67.58 146.62 53.71 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 125.115 1.366 . . . . 0.0 110.716 173.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -155.87 171.71 19.6 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 126.702 2.001 . . . . 0.0 110.556 166.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 157.89 -60.29 0.33 Allowed Glycine 0 N--CA 1.45 -0.424 0 O-C-N 120.847 -1.158 . . . . 0.0 111.432 166.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -53.71 -34.67 50.88 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 123.828 0.728 . . . . 0.0 113.289 -173.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -128.23 43.95 1.28 Allowed Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.923 1.249 . . . . 0.0 109.996 171.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -53.02 -16.15 4.02 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 118.47 1.135 . . . . 0.0 115.256 -170.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -61.55 -19.96 58.58 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 118.962 1.381 . . . . 0.0 114.52 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 168.94 53.45 0.03 OUTLIER Glycine 0 CA--C 1.525 0.718 0 CA-C-N 119.547 1.673 . . . . 0.0 111.094 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -154.62 121.84 5.64 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.673 1.189 . . . . 0.0 109.05 178.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -142.79 -173.94 4.03 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.41 1.484 . . . . 0.0 110.229 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 34.4 m -150.06 100.18 2.9 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 120.399 -1.438 . . . . 0.0 108.235 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.54 109.51 15.12 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.799 2.04 . . . . 0.0 109.763 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.597 HG12 HG11 ' A' ' 16' ' ' VAL . 16.0 m -129.36 157.69 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 125.018 1.327 . . . . 0.0 109.974 -177.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.0 157.39 36.24 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.339 -0.851 . . . . 0.0 109.949 174.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -111.59 -59.93 0.46 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 172.52 176.5 41.28 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -168.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.9 m -97.45 128.35 44.16 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.255 1.422 . . . . 0.0 110.197 177.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.43 115.2 49.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -106.4 90.34 3.32 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -172.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.406 ' CG ' HG11 ' A' ' 101' ' ' VAL . 75.2 m-85 -67.34 118.77 11.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 175.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -123.69 160.45 27.19 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 138.41 -165.21 25.55 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -163.47 168.85 19.66 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -167.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.08 136.76 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 167.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 184' ' ' ALA . 6.1 m -115.8 152.36 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 C-N-CA 126.963 2.105 . . . . 0.0 108.329 177.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -75.11 31.42 0.1 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -172.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 182' ' ' VAL . . . . . . . . 0 N--CA 1.442 -0.837 1 C-N-CA 131.711 4.004 . . . . 0.0 112.096 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 118.71 -0.662 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.51 147.6 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.124 1.37 . . . . 0.0 110.473 -145.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.8 t 171.43 -56.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.807 2.443 . . . . 0.0 107.026 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 m 72.32 115.17 0.05 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.276 2.23 . . . . 0.0 110.217 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -164.16 162.42 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.024 1.33 . . . . 0.0 107.587 -174.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -84.19 -1.36 54.97 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.143 0.883 . . . . 0.0 111.846 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.11 -76.16 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -174.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.04 -86.62 0.15 Allowed Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 172.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.511 ' O ' HG12 ' A' ' 10' ' ' VAL . 1.3 t -141.66 6.74 1.86 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -160.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 9' ' ' THR . 2.5 p 95.86 -178.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 130.761 3.625 . . . . 0.0 108.307 -155.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.478 ' O ' HG13 ' A' ' 10' ' ' VAL . 7.2 m-70 -125.65 -135.42 0.26 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 162.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -151.32 41.32 0.72 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 120.509 1.504 . . . . 0.0 110.032 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -81.81 84.51 6.85 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.49 -0.756 . . . . 0.0 110.97 -160.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.52 4.95 0.28 Allowed Glycine 0 CA--C 1.525 0.705 0 C-N-CA 123.156 0.407 . . . . 0.0 113.367 166.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -136.97 -159.45 0.96 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.818 0.847 . . . . 0.0 111.211 -165.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.2 t -44.73 -43.04 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 127.243 2.217 . . . . 0.0 111.831 174.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.9 t 37.13 49.62 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 127.438 2.295 . . . . 0.0 110.263 -173.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -148.92 94.44 2.25 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 172.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.485 ' HB2' HG21 ' A' ' 170' ' ' VAL . . . -132.46 132.46 42.76 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 102.471 -3.159 . . . . 0.0 102.471 157.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.72 -13.42 61.72 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.204 -0.998 . . . . 0.0 112.808 -173.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.5 m -130.91 151.06 51.75 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.014 1.726 . . . . 0.0 107.799 -175.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.89 -10.26 59.32 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -173.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.4 t 55.21 140.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 129.036 2.934 . . . . 0.0 112.121 -160.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.62 163.99 13.33 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.182 -0.949 . . . . 0.0 112.711 -178.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.34 -38.75 78.3 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.501 1.121 . . . . 0.0 111.392 -173.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.91 28.0 2.22 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.38 0.991 . . . . 0.0 112.006 175.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.7 t -139.68 -55.6 0.56 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.0 1.32 . . . . 0.0 108.554 -174.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.4 p -50.87 -36.09 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.844 1.258 . . . . 0.0 112.873 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -143.41 101.36 3.78 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 104.87 -2.271 . . . . 0.0 104.87 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -130.9 138.48 49.81 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.055 174.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 176' ' ' HIS . 93.3 m -106.96 98.66 8.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 172.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 38.8 t -77.67 115.89 20.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -89.66 127.67 35.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.7 mt -100.99 -3.63 29.04 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.375 1.87 . . . . 0.0 109.57 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.01 179.77 37.26 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.49 1.043 . . . . 0.0 112.345 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -76.01 116.57 16.84 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.777 1.631 . . . . 0.0 109.889 170.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.5 t -103.0 140.67 20.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 122.776 1.274 . . . . 0.0 109.245 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 7.4 mmt180 -71.76 126.58 30.08 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 125.466 1.506 . . . . 0.0 107.003 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 p -50.92 -31.57 18.0 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 125.321 1.448 . . . . 0.0 111.073 166.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.29 -16.58 60.76 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 t -92.72 0.28 57.39 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.064 1.346 . . . . 0.0 112.062 172.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.9 mt -145.9 67.65 1.2 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.881 1.672 . . . . 0.0 106.653 -162.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.63 -6.27 4.12 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -163.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.67 HE21 ' HB2' ' A' ' 47' ' ' ALA . 3.0 pm0 -147.85 157.56 43.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.855 1.662 . . . . 0.0 106.848 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 16.4 tt0 -63.33 134.62 56.1 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 170.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.71 -7.09 77.37 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 118.822 -0.988 . . . . 0.0 112.322 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.67 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -65.35 152.42 43.87 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.475 1.138 . . . . 0.0 109.604 172.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.9 p -138.08 158.57 44.05 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.858 0.837 . . . . 0.0 111.237 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.6 p -72.05 -175.86 1.59 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.438 0.695 . . . . 0.0 111.484 177.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 p -40.38 -47.45 2.56 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 126.635 1.974 . . . . 0.0 113.607 160.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 83.74 162.78 0.12 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 129.047 2.939 . . . . 0.0 108.914 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.0 t -144.9 133.23 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.87 104.23 3.14 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 106.111 -2.796 . . . . 0.0 106.111 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -104.69 156.74 17.72 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 168.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.466 ' HB2' HG22 ' A' ' 130' ' ' THR . 0.1 OUTLIER -135.97 151.87 50.38 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 120.515 -1.366 . . . . 0.0 109.701 -177.255 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.2 mm -99.78 115.01 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.63 136.33 38.16 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -173.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.6 mt -123.52 160.26 27.37 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.444 1.498 . . . . 0.0 107.955 176.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -149.59 151.35 33.67 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.448 1.499 . . . . 0.0 111.077 -164.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.6 t70 38.74 44.11 0.78 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.453 2.701 . . . . 0.0 113.524 -171.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.8 m -72.53 97.14 2.05 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.781 1.632 . . . . 0.0 113.909 -164.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -71.92 104.93 3.65 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.166 0.986 . . . . 0.0 111.126 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.1 p -68.67 -11.88 60.7 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -175.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -66.49 -48.21 70.57 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.707 0.685 . . . . 0.0 109.159 173.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -58.02 -41.76 81.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 124.204 1.001 . . . . 0.0 109.081 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 159' ' ' GLN . . . -167.04 138.24 3.2 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.767 1.627 . . . . 0.0 108.345 178.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.1 m -96.46 12.58 30.89 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.927 1.291 . . . . 0.0 113.059 169.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.56 ' CA ' HD21 ' A' ' 124' ' ' LEU . 28.1 mtmt -148.04 167.1 25.81 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 121.309 1.868 . . . . 0.0 113.326 158.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.21 93.6 2.46 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 127.189 2.196 . . . . 0.0 112.088 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.34 152.22 24.23 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 119.031 -2.293 . . . . 0.0 108.734 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.5 t -120.44 123.81 71.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.99 165.49 14.53 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 165.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.547 ' CE1' HG21 ' A' ' 103' ' ' ILE . 27.0 m-85 -127.66 160.34 31.93 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.543 163.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.728 HD22 ' OG1' ' A' ' 153' ' ' THR 0.285 0.0 OUTLIER -139.15 160.25 40.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.228 168.077 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.84 163.78 32.91 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 4.6 m -58.17 125.93 25.31 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 164.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.05 140.49 43.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 119.374 0.988 . . . . 0.0 109.091 174.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.4 tt -60.53 -48.46 88.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 123.35 0.66 . . . . 0.0 110.557 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.73 162.6 35.09 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.98 -24.98 67.92 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 123.678 0.791 . . . . 0.0 112.306 166.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.77 4.91 83.98 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 119.003 -0.887 . . . . 0.0 112.727 173.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -149.39 57.06 1.0 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.163 1.385 . . . . 0.0 109.126 -175.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.3 p -64.61 -20.09 66.07 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.103 1.361 . . . . 0.0 113.101 -173.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -102.6 3.56 37.43 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -172.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 62.1 t -116.18 136.21 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 124.916 1.287 . . . . 0.0 108.366 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.07 151.87 26.85 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 125.229 1.412 . . . . 0.0 110.63 -172.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.427 ' HB3' ' HB ' ' A' ' 76' ' ' THR . . . -95.53 15.38 19.92 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -164.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt 56.3 -167.8 0.11 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.438 1.095 . . . . 0.0 110.589 -163.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -149.65 167.79 25.4 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 120.922 -1.111 . . . . 0.0 110.645 -174.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.1 t 55.72 -154.59 0.3 Allowed 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.3 p 24.45 68.24 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 128.257 2.623 . . . . 0.0 115.891 162.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -50.79 -26.23 5.41 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.874 1.67 . . . . 0.0 114.5 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.33 30.43 1.39 Allowed 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 123.308 0.38 . . . . 0.0 110.169 168.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -116.66 -19.71 5.24 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.687 1.137 . . . . 0.0 112.451 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.1 m -63.93 173.76 1.73 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.146 0.978 . . . . 0.0 110.42 169.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.81 148.59 38.68 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 163.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.7 p -90.68 165.81 13.5 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 159.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 54.46 31.02 13.9 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 127.274 2.23 . . . . 0.0 113.142 170.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.18 153.39 10.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 O-C-N 121.085 -1.009 . . . . 0.0 109.156 175.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.31 174.16 29.78 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 124.465 1.031 . . . . 0.0 110.66 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.406 HG11 ' CD2' ' A' ' 177' ' ' PHE . 44.2 t -83.92 151.91 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 173.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -128.79 163.43 25.22 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.144 0.884 . . . . 0.0 109.094 153.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.549 HG22 HD23 ' A' ' 111' ' ' LEU . 4.6 mp -121.01 141.81 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 128.19 2.596 . . . . 0.0 104.12 171.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.5 mt -141.26 135.62 30.82 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.792 2.437 . . . . 0.0 105.455 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.64 -174.4 2.1 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.731 1.15 . . . . 0.0 108.376 169.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 33.1 ptt85 -58.33 -20.11 40.62 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.6 p -68.42 -10.63 56.55 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 124.298 1.039 . . . . 0.0 112.001 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.48 6.31 34.04 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 119.256 0.935 . . . . 0.0 112.291 -168.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.94 126.19 33.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.965 1.382 . . . . 0.0 107.314 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.83 151.08 42.18 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 120.865 0.364 . . . . 0.0 110.718 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.549 HD23 HG22 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -105.49 145.69 30.55 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -179.381 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.451 ' H ' HG21 ' A' ' 117' ' ' THR . 4.1 m -70.32 157.35 37.9 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 81.5 mt -104.91 63.71 0.71 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.615 1.566 . . . . 0.0 108.548 -172.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.1 -1.41 6.46 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.669 1.188 . . . . 0.0 113.064 -171.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.434 ' N ' ' HB2' ' A' ' 74' ' ' LEU . . . 86.32 -1.77 87.47 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.259 -1.301 . . . . 0.0 112.121 170.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -139.82 -28.01 0.76 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.852 1.326 . . . . 0.0 114.3 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.451 HG21 ' H ' ' A' ' 112' ' ' THR . 51.5 m -53.3 146.89 11.18 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.046 1.738 . . . . 0.0 110.638 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -116.73 141.74 47.82 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.015 -1.053 . . . . 0.0 109.065 -166.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.25 79.0 p -86.74 -124.78 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 123.3 0.64 . . . . 0.0 111.295 -170.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.52 21.7 6.03 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.183 1.393 . . . . 0.0 113.828 -169.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 56.91 171.66 0.04 OUTLIER 'General case' 0 N--CA 1.42 -1.931 1 C-N-CA 131.786 4.034 . . . . 0.0 114.307 173.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.2 m -149.9 134.42 17.48 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 158.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.8 m -88.58 126.28 35.2 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 169.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.788 ' H ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -86.76 179.86 6.68 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.211 -168.491 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.436 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 0.0 OUTLIER -156.82 138.93 14.54 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 -171.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -57.48 94.65 0.02 OUTLIER 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.318 1.847 . . . . 0.0 108.567 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.56 -137.86 6.65 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 -159.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.5 m -125.2 146.0 49.71 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.854 2.061 . . . . 0.0 107.197 -175.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 0.8 OUTLIER -160.44 154.46 22.98 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.553 1.141 . . . . 0.0 108.811 -179.057 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.466 HG22 ' HB2' ' A' ' 55' ' ' ASN . 29.7 m -144.87 141.41 29.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.179 -165.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.2 mt -104.97 107.48 58.86 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 126.653 1.981 . . . . 0.0 106.149 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -85.65 103.1 0.74 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.502 2.801 . . . . 0.0 112.316 -175.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -81.27 174.66 11.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 122.897 1.332 . . . . 0.0 111.457 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -127.79 126.7 42.23 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 162.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -101.02 138.81 37.56 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 163.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.5 ptt180 -150.31 134.96 17.45 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 170.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -60.01 143.82 50.88 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -118.95 115.22 23.9 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -79.94 142.3 35.24 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 172.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.423 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 63.4 p -109.94 23.76 13.94 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.002 1.321 . . . . 0.0 110.095 176.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 148.78 -153.99 25.56 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 107.85 -2.1 . . . . 0.0 107.85 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.38 91.21 0.54 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.704 1.201 . . . . 0.0 109.497 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.43 124.96 21.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.767 0.827 . . . . 0.0 109.306 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.4 p -85.63 154.54 59.02 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -71.95 160.28 48.09 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 120.932 1.088 . . . . 0.0 110.449 169.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.72 -148.72 15.87 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -170.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -91.0 152.49 20.66 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 118.913 1.356 . . . . 0.0 109.036 163.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -136.24 66.14 1.5 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.424 0.69 . . . . 0.0 109.675 174.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -104.53 151.79 23.17 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 178.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -151.26 166.48 30.81 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.427 1.091 . . . . 0.0 108.101 171.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -148.72 140.73 23.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.054 0.93 . . . . 0.0 111.231 174.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.61 156.61 46.6 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.532 2.333 . . . . 0.0 109.283 -171.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.728 ' OG1' HD22 ' A' ' 74' ' ' LEU . 64.5 p -91.33 163.45 14.21 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 117.422 -1.711 . . . . 0.0 108.27 152.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.509 ' CD1' HG23 ' A' ' 175' ' ' VAL . 23.0 p90 -127.9 153.4 46.7 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 158.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -119.54 175.41 5.86 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.817 0.847 . . . . 0.0 110.541 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 4.4 t -138.4 99.62 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -84.25 100.04 10.95 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.595 1.958 . . . . 0.0 107.825 171.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.412 ' HB3' ' CB ' ' A' ' 66' ' ' ALA . 87.1 m-85 -73.52 139.46 45.69 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.398 1.094 . . . . 0.0 113.546 167.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.438 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 3.5 mt-30 -133.98 160.31 38.1 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 129.484 3.114 . . . . 0.0 111.041 -168.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 99.26 -44.01 1.75 Allowed Glycine 0 C--N 1.321 -0.254 0 CA-C-O 119.089 -0.84 . . . . 0.0 111.047 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -87.07 66.33 3.56 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 -172.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.71 -45.1 0.43 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -160.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 79.13 52.63 4.8 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.17 -58.17 5.01 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 124.37 0.986 . . . . 0.0 111.603 170.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.93 4.49 9.96 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.815 1.198 . . . . 0.0 114.458 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -141.73 139.79 32.96 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 127.887 2.475 . . . . 0.0 104.753 171.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -146.45 167.75 22.87 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.53 1.132 . . . . 0.0 109.38 177.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 19.6 m -138.4 81.65 1.86 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.238 0.615 . . . . 0.0 109.455 -165.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 41.1 m -83.06 95.3 8.01 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.156 1.382 . . . . 0.0 109.972 177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.485 HG21 ' HB2' ' A' ' 19' ' ' ALA . 1.8 m -81.72 167.18 2.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 158.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -72.89 154.99 40.34 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.542 -0.723 . . . . 0.0 109.292 164.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -118.19 -25.57 2.94 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 124.128 0.87 . . . . 0.0 112.944 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 146.26 -163.51 28.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 117.784 0.792 . . . . 0.0 111.647 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.9 m -116.24 136.48 52.97 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.509 HG23 ' CD1' ' A' ' 154' ' ' PHE . 40.2 t -112.56 115.63 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 166.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . 0.423 ' O ' ' HA ' ' A' ' 31' ' ' THR . 10.3 m-70 -97.07 113.13 24.66 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 175.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.406 ' CD2' HG11 ' A' ' 101' ' ' VAL . 81.7 m-85 -87.1 119.48 27.37 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 176.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 34.9 mmtt -116.06 166.66 11.75 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 135.5 -173.13 21.88 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 106.264 -2.735 . . . . 0.0 106.264 -171.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.67 170.51 18.34 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -171.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.3 t -120.82 130.1 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 175.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 15.3 m -115.79 146.62 19.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 126.81 2.044 . . . . 0.0 109.046 -177.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.94 27.4 0.09 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -172.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.248 1.024 0 C-N-CA 128.269 2.628 . . . . 0.0 113.793 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.38 56.48 7.41 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 122.11 0.957 . . . . 0.0 109.0 -156.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.4 p -142.49 151.48 41.73 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.651 1.58 . . . . 0.0 107.078 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.3 m -58.57 155.74 11.86 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.223 1.409 . . . . 0.0 110.746 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.51 166.89 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 170.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -151.78 177.69 10.15 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.685 1.594 . . . . 0.0 107.065 171.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.28 18.94 56.5 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 119.292 -0.727 . . . . 0.0 113.375 170.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 175.33 178.45 45.17 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 108.841 -1.703 . . . . 0.0 108.841 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -76.98 9.49 2.92 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.236 1.014 . . . . 0.0 111.722 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER 95.8 -172.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 131.175 3.79 . . . . 0.0 106.47 -149.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -157.25 113.16 2.89 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 173.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -98.28 -134.35 0.25 Allowed 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 127.453 2.301 . . . . 0.0 106.115 170.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.63 ' HB3' HG21 ' A' ' 17' ' ' VAL . 3.7 ptpt -169.36 -101.2 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.336 0 C-N-CA 128.551 2.74 . . . . 0.0 105.984 175.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.455 ' H ' ' HG3' ' A' ' 13' ' ' LYS . . . 137.08 -37.99 1.79 Allowed Glycine 0 C--N 1.319 -0.404 0 C-N-CA 126.747 2.118 . . . . 0.0 109.974 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -130.81 -169.85 2.24 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 125.172 1.389 . . . . 0.0 108.549 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.581 HG11 HG12 ' A' ' 170' ' ' VAL . 6.9 p -50.94 -31.38 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 126.236 1.814 . . . . 0.0 113.286 -172.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.63 HG21 ' HB3' ' A' ' 13' ' ' LYS . 27.2 m 36.11 34.68 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 127.916 2.487 . . . . 0.0 115.886 -177.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -131.96 94.74 3.54 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -175.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.58 108.64 4.76 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.24 -26.93 31.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 118.411 -0.804 . . . . 0.0 113.016 -169.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.402 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -130.41 153.91 48.26 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.794 1.638 . . . . 0.0 110.063 -179.474 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.7 93.96 6.27 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.997 2.519 . . . . 0.0 109.526 166.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.4 p -48.46 106.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 125.39 1.476 . . . . 0.0 109.313 158.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -69.23 166.24 18.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.355 1.462 . . . . 0.0 113.008 -161.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.32 -32.31 66.57 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.253 1.021 . . . . 0.0 112.253 171.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.88 7.97 47.08 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.617 1.103 . . . . 0.0 112.882 175.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.15 -44.67 1.58 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.993 1.717 . . . . 0.0 109.606 -170.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.38 -28.0 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 127.352 2.261 . . . . 0.0 113.693 -168.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -149.39 61.69 1.03 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.613 1.165 . . . . 0.0 108.007 -169.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -104.97 137.5 42.62 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.272 0.629 . . . . 0.0 109.85 -168.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.9 m -108.32 92.84 4.23 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.08 1.352 . . . . 0.0 108.045 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.2 t -78.7 108.34 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 126.328 1.851 . . . . 0.0 107.125 -171.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -91.61 122.82 34.52 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -98.91 -1.02 41.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 122.844 0.457 . . . . 0.0 110.412 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.6 -177.84 33.02 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 126.423 1.963 . . . . 0.0 111.273 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -70.29 138.1 51.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 122.187 -0.596 . . . . 0.0 109.628 158.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.8 t -128.41 146.41 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 124.372 1.069 . . . . 0.0 109.501 -178.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 184' ' ' ALA . 9.4 mmt180 -75.82 127.07 32.24 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 125.832 1.653 . . . . 0.0 107.34 -176.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 p -55.57 -29.03 58.3 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.204 0.602 . . . . 0.0 111.008 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.03 -39.86 72.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.453 1.101 . . . . 0.0 111.577 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 62.1 m -74.23 -0.8 18.04 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 55.0 mt -134.28 31.52 3.48 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 125.226 1.41 . . . . 0.0 111.827 -160.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.49 13.92 13.58 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -150.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.923 HE21 ' HB2' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -149.61 162.71 39.65 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 171.011 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -60.32 121.22 11.47 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 164.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.95 -8.58 57.79 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-O 118.812 -0.993 . . . . 0.0 113.691 -173.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.923 ' HB2' HE21 ' A' ' 44' ' ' GLN . . . -67.79 154.52 41.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.835 1.818 . . . . 0.0 110.644 174.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.5 p -147.97 157.25 43.42 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.884 0.766 . . . . 0.0 112.17 -176.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.0 p -72.1 175.17 6.21 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.949 -1.094 . . . . 0.0 111.241 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.0 m -47.63 -27.46 1.89 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.611 1.964 . . . . 0.0 114.591 172.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 81.37 145.93 0.08 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 129.479 3.112 . . . . 0.0 111.06 167.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 m -141.8 130.65 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 C-N-CA 124.113 0.965 . . . . 0.0 109.415 -152.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.25 121.31 6.79 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -174.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 135' ' ' ALA . 10.1 p90 -130.82 102.56 6.13 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 118.313 1.056 . . . . 0.0 108.279 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.453 ' HB2' HG22 ' A' ' 130' ' ' THR . 0.2 OUTLIER -93.95 150.83 20.02 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.063 -1.023 . . . . 0.0 111.242 -170.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.0 mm -94.66 98.1 7.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -65.84 126.87 29.84 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 171.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' A' ' 21' ' ' CYS . 2.2 mp -133.68 123.06 24.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 129.742 3.217 . . . . 0.0 106.589 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -118.04 154.39 32.11 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.509 1.049 . . . . 0.0 113.434 178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.3 t70 65.92 37.41 5.46 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.094 1.758 . . . . 0.0 114.104 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 97.9 m -68.97 104.36 2.07 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.012 1.325 . . . . 0.0 108.798 -174.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -81.87 137.17 35.28 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.174 0.99 . . . . 0.0 109.593 174.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.5 p -83.0 -17.87 41.86 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 177.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -65.44 -42.63 92.2 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.319 1.048 . . . . 0.0 110.364 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.411 HG12 ' H ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -68.02 -54.56 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 125.87 1.668 . . . . 0.0 106.705 -176.103 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.21 158.46 43.94 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.9 m -115.2 3.6 14.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 118.745 0.702 . . . . 0.0 111.804 168.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -128.87 149.39 50.79 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.277 1.431 . . . . 0.0 109.28 171.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 124' ' ' LEU . . . -117.63 153.13 33.82 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 124.412 1.085 . . . . 0.0 108.457 165.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -137.89 -178.18 5.14 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.825 1.65 . . . . 0.0 106.779 157.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -153.78 141.02 12.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 103.972 -2.603 . . . . 0.0 103.972 -164.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.23 152.65 51.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 119.957 1.253 . . . . 0.0 108.678 175.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -114.55 153.61 29.75 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 123.438 0.695 . . . . 0.0 110.081 -175.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 tp -148.3 143.07 26.67 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.614 1.166 . . . . 0.0 107.996 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.81 173.35 35.05 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 108.104 -1.998 . . . . 0.0 108.104 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 m -59.88 121.88 12.85 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.513 1.125 . . . . 0.0 110.359 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.8 138.44 52.69 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.425 0.557 . . . . 0.0 110.413 172.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.0 tt -64.35 -31.12 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.576 0.75 . . . . 0.0 110.937 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -160.71 168.64 24.43 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.639 1.576 . . . . 0.0 107.441 165.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -55.36 -36.24 66.12 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.629 1.172 . . . . 0.0 111.311 166.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.29 -2.91 64.07 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 120.792 -1.193 . . . . 0.0 112.998 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -149.93 55.47 0.94 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.298 1.439 . . . . 0.0 109.716 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.6 p -69.43 -6.84 32.88 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.44 1.096 . . . . 0.0 111.886 172.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -85.89 3.54 41.37 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.931 1.293 . . . . 0.0 112.655 170.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.65 143.04 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 119.934 1.243 . . . . 0.0 111.63 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.02 151.26 28.5 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.954 1.301 . . . . 0.0 111.237 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.12 14.72 10.13 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 127.477 2.311 . . . . 0.0 114.059 -169.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 71.5 mt 55.26 -157.65 0.22 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.167 1.387 . . . . 0.0 111.227 -166.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -165.24 -178.34 5.0 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 128.732 2.813 . . . . 0.0 107.748 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.6 t 71.73 160.34 0.22 Allowed 'General case' 0 C--O 1.227 -0.096 0 C-N-CA 128.735 2.814 . . . . 0.0 112.017 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.536 ' HB3' ' HA3' ' A' ' 94' ' ' GLY . 0.6 OUTLIER 41.53 35.5 0.47 Allowed 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 127.485 2.314 . . . . 0.0 113.291 -166.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 52.2 -70.35 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.067 1.747 . . . . 0.0 112.924 -150.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -142.11 20.91 2.1 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.723 1.609 . . . . 0.0 111.132 174.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.536 ' HA3' ' HB3' ' A' ' 91' ' ' SER . . . -71.29 -14.23 74.07 Favored Glycine 0 N--CA 1.467 0.703 0 O-C-N 121.226 -0.921 . . . . 0.0 112.567 176.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -31.6 161.31 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.383 1.873 . . . . 0.0 114.158 151.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.98 131.55 45.0 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.484 1.114 . . . . 0.0 109.697 174.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.4 p -85.39 169.42 13.7 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 58.5 14.65 3.11 Favored 'General case' 0 C--N 1.335 -0.04 0 C-N-CA 126.247 1.819 . . . . 0.0 112.712 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.26 156.68 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 119.927 1.24 . . . . 0.0 107.819 -174.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -165.14 168.16 39.12 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -168.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.674 HG11 ' CD2' ' A' ' 177' ' ' PHE . 9.9 t -90.56 112.66 25.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -82.06 153.84 25.93 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.363 0.983 . . . . 0.0 108.52 160.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.8 mp -125.54 136.33 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 166.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 110' ' ' ALA . 9.0 mt -136.54 143.93 43.96 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.645 1.178 . . . . 0.0 107.838 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.521 ' HB2' ' HB2' ' A' ' 120' ' ' SER . 24.5 p-10 -54.06 -74.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.278 1.431 . . . . 0.0 113.204 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.0 ptt85 179.61 -47.45 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 127.781 2.432 . . . . 0.0 107.994 -163.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.4 p -68.04 -29.12 68.02 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.169 0.895 . . . . 0.0 109.784 172.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.76 9.96 27.59 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.815 1.198 . . . . 0.0 111.176 -169.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.69 110.67 0.93 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 163.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.463 ' HA ' HD23 ' A' ' 104' ' ' LEU . . . -84.89 125.88 33.01 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.589 ' H ' HD22 ' A' ' 111' ' ' LEU . 0.4 OUTLIER -88.75 150.22 23.06 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -167.237 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.3 m -82.31 146.61 29.33 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 119.264 -0.974 . . . . 0.0 109.344 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.6 mt -88.16 61.87 6.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.844 0.858 . . . . 0.0 108.87 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.26 -15.16 14.55 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.063 1.345 . . . . 0.0 112.27 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.18 -7.38 60.51 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 125.872 1.701 . . . . 0.0 114.476 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -127.46 -6.36 5.84 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.158 1.479 . . . . 0.0 112.877 172.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.9 m -65.15 94.41 0.15 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.692 1.133 . . . . 0.0 108.623 171.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -67.51 131.65 46.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.786 1.235 . . . . 0.0 109.14 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.8 p -72.19 168.29 18.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.135 0.493 . . . . 0.0 110.906 170.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 14.2 m -26.37 113.85 0.05 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.527 2.331 . . . . 0.0 112.569 155.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -66.45 155.11 38.44 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 122.248 1.023 . . . . 0.0 108.74 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 98.6 m -127.12 112.99 15.81 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 169.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 27.7 m -58.06 126.25 26.63 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 167.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.7 HD11 ' HB2' ' A' ' 69' ' ' ALA . 80.8 mt -98.73 -177.88 3.8 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 124.745 1.218 . . . . 0.0 108.679 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -147.53 169.69 19.03 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.805 1.642 . . . . 0.0 108.327 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -65.22 104.49 0.93 Allowed 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.852 0.72 . . . . 0.0 109.551 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.08 -160.8 26.8 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 124.643 1.116 . . . . 0.0 111.3 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 93.3 m -90.53 134.08 34.62 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.31 -1.112 . . . . 0.0 108.828 -179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -146.2 154.56 41.89 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.152 1.381 . . . . 0.0 110.418 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 55' ' ' ASN . 6.1 m -137.49 144.23 42.12 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.928 0.871 . . . . 0.0 109.987 -174.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.9 mt -104.72 118.35 56.62 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -65.14 157.02 59.65 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.349 1.366 . . . . 0.0 108.646 171.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -136.52 157.14 47.47 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 153.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -119.76 94.67 4.48 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.581 ' HB2' ' CE1' ' A' ' 54' ' ' PHE . . . -79.11 156.2 28.4 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 167.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -161.93 153.76 18.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 166.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.422 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 60.7 m-85 -63.73 130.5 44.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 163.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -103.19 151.52 22.53 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 163.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -115.67 137.79 51.73 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.593 0.757 . . . . 0.0 109.736 173.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 69.5 p -96.86 14.06 26.57 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.976 0.91 . . . . 0.0 111.034 170.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 169.5 -153.89 22.68 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -68.49 93.08 0.47 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.259 1.024 . . . . 0.0 110.157 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.06 119.07 5.3 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 44.3 p -76.65 163.62 64.67 Favored Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 165.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -74.73 172.71 15.71 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.118 1.212 . . . . 0.0 111.007 168.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 130.69 179.72 16.29 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 124.756 1.169 . . . . 0.0 111.283 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -61.9 140.67 58.27 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.422 ' HB1' ' CE1' ' A' ' 137' ' ' TYR . . . -132.9 73.34 1.52 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -178.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -115.5 158.7 22.2 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -157.97 160.48 37.58 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.69 0.677 . . . . 0.0 109.413 175.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -133.38 116.21 15.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.34 1.067 . . . . 0.0 110.233 -170.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.01 164.69 19.62 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.416 1.486 . . . . 0.0 111.22 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.9 p -119.21 157.08 28.7 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 155.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -115.91 146.68 41.86 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.522 1.129 . . . . 0.0 109.195 167.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -104.57 171.28 7.42 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 126.041 1.737 . . . . 0.0 108.316 168.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.4 t -129.2 128.21 66.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -130.52 84.48 2.2 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.478 1.111 . . . . 0.0 109.54 -172.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -70.12 151.98 44.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.562 -1.199 . . . . 0.0 112.242 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -161.64 174.3 13.51 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.42 1.488 . . . . 0.0 111.849 169.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 148.03 -33.81 1.24 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 125.405 1.479 . . . . 0.0 110.136 174.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -94.89 99.16 2.39 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 166.39 165.52 23.9 Favored Glycine 0 CA--C 1.522 0.495 0 CA-C-N 118.223 1.011 . . . . 0.0 111.11 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -73.97 -22.41 78.01 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 124.468 1.032 . . . . 0.0 110.609 171.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 128.5 120.85 2.32 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 168.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 109.2 58.4 0.53 Allowed Glycine 0 CA--C 1.517 0.215 0 N-CA-C 106.815 -2.514 . . . . 0.0 106.815 -173.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -172.42 108.8 0.21 Allowed 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.59 1.556 . . . . 0.0 107.975 -162.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -153.89 164.91 37.62 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.025 0.93 . . . . 0.0 109.106 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 40.4 m -122.14 90.75 3.36 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -176.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.5 m -82.37 120.53 25.55 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.581 HG12 HG11 ' A' ' 16' ' ' VAL . 31.6 m -130.47 158.32 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.812 1.645 . . . . 0.0 109.415 177.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -79.28 143.02 35.64 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.097 -1.002 . . . . 0.0 108.984 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -105.21 -73.0 0.88 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -173.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -175.75 -174.21 42.12 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 116.884 0.342 . . . . 0.0 113.01 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 9.4 m -100.87 141.8 33.24 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.912 2.085 . . . . 0.0 108.635 -177.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.65 104.42 12.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 177.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -96.14 96.98 9.19 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 -176.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.674 ' CD2' HG11 ' A' ' 101' ' ' VAL . 79.9 m-85 -73.19 127.09 31.63 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 176.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -128.68 156.57 43.25 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.552 0.741 . . . . 0.0 111.636 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 142.37 -160.07 27.22 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -163.72 169.2 18.76 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.833 0.853 . . . . 0.0 108.97 -175.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 75.3 t -116.79 124.51 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 171.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 6.3 m -103.58 153.33 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 C-N-CA 127.026 2.13 . . . . 0.0 108.782 174.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.04 25.67 0.09 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -168.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 38' ' ' ARG . . . . . . . . 0 C--O 1.25 1.121 1 C-N-CA 132.117 4.167 . . . . 0.0 114.544 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.6 136.33 5.29 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.6 p -145.23 86.25 1.76 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.799 0.84 . . . . 0.0 109.363 -165.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.1 p -135.83 178.68 6.86 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.97 -1.081 . . . . 0.0 110.911 -174.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -53.77 148.73 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 126.272 1.829 . . . . 0.0 112.249 175.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -85.06 158.56 20.41 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.376 -0.828 . . . . 0.0 110.456 170.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 61.3 77.91 0.18 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 173.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 139.13 5.0 1.42 Allowed Glycine 0 CA--C 1.526 0.726 0 CA-C-O 118.691 -1.061 . . . . 0.0 113.534 173.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -172.1 2.76 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 120.871 2.335 . . . . 0.0 111.151 -169.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.9 t -55.78 -32.99 33.16 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 C-N-CA 127.921 2.489 . . . . 0.0 109.987 -173.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -163.87 19.49 0.07 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 147.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -85.29 -0.19 53.94 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 120.823 -1.173 . . . . 0.0 111.651 -156.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.3 mttm 45.04 49.59 9.44 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.828 1.651 . . . . 0.0 112.913 -172.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.51 -3.94 50.09 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.411 170.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -172.87 -164.57 0.26 Allowed 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.251 1.42 . . . . 0.0 109.707 -167.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.1 t -49.12 -35.96 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 128.814 2.846 . . . . 0.0 113.187 172.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.4 t 35.27 54.76 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 127.027 2.131 . . . . 0.0 112.371 -169.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -152.23 96.11 2.14 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 171.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -129.49 118.01 21.41 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 163.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.41 -28.65 30.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.286 1.034 . . . . 0.0 113.745 -170.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.9 m -131.19 151.93 50.98 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.502 1.921 . . . . 0.0 108.071 -171.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.32 -10.56 51.93 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -169.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.323 14.2 p 45.9 97.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 129.36 3.064 . . . . 0.0 112.911 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -50.58 141.08 13.08 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.575 1.95 . . . . 0.0 110.719 -172.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.665 ' HA ' ' CG2' ' A' ' 28' ' ' VAL . . . -59.5 -9.94 2.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.295 1.838 . . . . 0.0 111.945 -176.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.64 -7.41 88.16 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.115 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.8 p -124.13 -33.05 3.15 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.692 1.746 . . . . 0.0 112.18 -164.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.665 ' CG2' ' HA ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -52.48 -78.82 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 127.84 2.456 . . . . 0.0 109.924 166.138 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.486 ' H ' HG23 ' A' ' 28' ' ' VAL . 10.5 t70 -95.53 83.1 3.73 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -114.15 142.53 46.11 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.286 1.041 . . . . 0.0 108.92 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.5 m -105.06 88.77 2.95 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.6 t -69.39 98.51 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 174.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -72.42 103.09 3.36 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.3 mt -70.58 -15.59 62.77 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.899 0.88 . . . . 0.0 109.329 169.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.83 -175.93 49.55 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 124.599 1.095 . . . . 0.0 112.138 170.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.49 143.6 56.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 162.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.8 t -133.59 148.83 30.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 124.96 1.304 . . . . 0.0 107.674 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 28.2 mtm105 -79.14 132.87 36.7 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 182' ' ' VAL . 20.4 p -55.14 -24.25 25.4 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.609 173.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.25 -48.44 68.23 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.649 0.779 . . . . 0.0 110.141 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.54 3.61 5.96 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.0 mt -146.22 66.18 1.19 Allowed 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 125.679 1.592 . . . . 0.0 107.446 -166.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -133.13 -2.25 3.19 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -170.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.467 ' NE2' ' HB2' ' A' ' 47' ' ' ALA . 7.0 pm0 -146.92 151.79 37.61 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.998 1.319 . . . . 0.0 107.751 -176.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.441 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 47.5 tt0 -64.38 120.77 12.87 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 175.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.2 1.45 61.04 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-O 117.364 -1.798 . . . . 0.0 112.481 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.626 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -66.53 163.54 18.42 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 120.055 1.928 . . . . 0.0 110.122 169.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.1 p -146.74 155.12 42.15 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 122.014 -0.429 . . . . 0.0 110.472 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 84.8 p -68.22 178.64 1.83 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 164.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.0 p -30.89 -92.59 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 129.697 3.199 . . . . 0.0 114.633 173.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 154.11 113.22 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 131.284 3.834 . . . . 0.0 105.46 -172.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.28 105.25 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -173.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.21 154.71 44.87 Favored Glycine 0 C--N 1.311 -0.843 0 CA-C-N 112.45 -2.159 . . . . 0.0 110.721 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -152.58 176.6 11.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.242 1.817 . . . . 0.0 107.172 171.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.431 ' HB2' ' CG2' ' A' ' 130' ' ' THR . 11.8 p-10 -143.0 163.18 33.49 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 120.885 -1.134 . . . . 0.0 110.6 177.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.9 mm -117.79 108.06 23.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 174.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -81.22 103.72 11.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.806 0.842 . . . . 0.0 109.312 -177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.9 mp -99.23 93.03 5.73 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -84.48 167.6 16.24 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.202 1.401 . . . . 0.0 109.094 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.32 31.06 17.89 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.162 0.985 . . . . 0.0 110.853 173.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 127' ' ' GLY . 80.3 m -69.3 148.24 50.01 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.982 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -120.23 152.42 37.76 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 163.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 p -94.58 -20.84 19.26 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.62 -43.62 84.23 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.96 0.886 . . . . 0.0 110.555 -177.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.9 p -56.2 -52.92 45.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.647 1.579 . . . . 0.0 108.027 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.63 133.61 4.91 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 128.083 2.553 . . . . 0.0 104.773 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.3 m -87.81 -5.13 58.77 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 118.846 0.748 . . . . 0.0 111.805 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -128.3 164.29 22.93 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.089 1.356 . . . . 0.0 109.853 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.63 160.72 34.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 164.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.65 168.28 20.18 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 158.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.3 t -122.15 142.77 37.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -119.84 162.26 19.42 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 169.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -134.99 149.11 50.14 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.077 0.951 . . . . 0.0 109.191 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 tp -143.67 151.53 40.21 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.632 ' HA3' HD21 ' A' ' 86' ' ' LEU . . . 174.2 169.69 36.62 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.3 m -66.28 126.84 30.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.246 1.023 . . . . 0.0 109.157 173.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.14 137.06 50.75 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.996 -0.44 . . . . 0.0 110.637 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.0 tt -59.78 -40.25 82.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 123.354 0.662 . . . . 0.0 110.285 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -152.09 167.9 26.99 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 127.13 2.172 . . . . 0.0 107.765 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.28 -40.08 95.24 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.564 1.546 . . . . 0.0 112.117 173.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.98 3.9 48.96 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.268 -0.74 . . . . 0.0 112.234 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -142.89 41.1 1.54 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.053 1.426 . . . . 0.0 110.67 -172.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.3 p -67.68 -6.31 20.01 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.875 -1.141 . . . . 0.0 113.317 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.78 -16.39 59.48 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.612 -1.305 . . . . 0.0 111.811 166.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 61.8 t -118.48 129.61 74.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 120.478 -1.389 . . . . 0.0 108.62 -160.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.632 HD21 ' HA3' ' A' ' 75' ' ' GLY . 3.8 mt -77.15 149.83 35.59 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.87 0.759 . . . . 0.0 111.504 -172.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.42 22.0 3.12 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.829 1.652 . . . . 0.0 113.494 -173.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.636 ' HA ' ' HB2' ' A' ' 150' ' ' ALA . 53.6 mt 49.7 -146.44 0.38 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.827 0.851 . . . . 0.0 109.067 -170.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -153.41 177.79 10.51 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 126.042 1.737 . . . . 0.0 108.067 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -60.82 160.76 9.0 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.557 1.17 . . . . 0.0 112.561 176.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.7 m -169.06 158.77 8.74 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 128.938 2.895 . . . . 0.0 106.98 176.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.14 91.63 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.871 0.869 . . . . 0.0 111.509 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.53 12.76 4.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.833 1.253 . . . . 0.0 112.972 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 61.59 14.69 43.93 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 123.681 0.658 . . . . 0.0 114.294 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 59.4 m 52.74 175.04 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.281 2.233 . . . . 0.0 114.504 -171.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.77 113.66 3.16 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 125.281 1.432 . . . . 0.0 107.933 170.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.28 165.61 24.25 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.66 173.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 55.31 24.15 6.24 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.261 1.425 . . . . 0.0 113.162 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.2 p -145.0 151.6 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.24 175.43 27.54 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 173.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 177' ' ' PHE . 1.2 m -86.71 155.44 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 118.653 1.227 . . . . 0.0 108.384 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -124.52 147.01 48.66 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 170.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.511 HG22 HD23 ' A' ' 111' ' ' LEU . 3.8 mp -117.02 135.82 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 169.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 9.9 mt -126.41 159.48 33.17 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 128.408 2.683 . . . . 0.0 107.109 174.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -73.11 -106.37 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 123.956 0.785 . . . . 0.0 109.437 171.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -149.26 3.81 0.6 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 126.895 2.078 . . . . 0.0 110.624 -169.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.4 p -123.64 7.31 8.84 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.115 1.366 . . . . 0.0 109.493 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.09 1.89 90.19 Favored Glycine 0 C--N 1.342 0.861 0 C-N-CA 127.22 2.343 . . . . 0.0 114.27 -172.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.13 122.77 20.07 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 119.468 1.634 . . . . 0.0 107.917 174.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -87.29 147.4 25.54 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.034 0.533 . . . . 0.0 110.419 176.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.511 HD23 HG22 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -110.8 138.85 46.67 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.707 -173.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 m -69.62 147.31 50.85 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.73 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.9 mt -79.86 69.54 6.22 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.612 1.565 . . . . 0.0 108.303 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -111.51 -13.87 13.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.51 0.724 . . . . 0.0 111.242 174.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.437 ' O ' ' HE3' ' A' ' 155' ' ' LYS . . . 75.09 -9.03 13.27 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 120.626 -1.296 . . . . 0.0 113.278 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -124.54 -12.91 7.17 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.145 1.378 . . . . 0.0 111.272 174.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 92.3 m -76.77 90.91 3.46 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -72.71 172.84 9.96 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.322 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.3 p -120.7 -176.12 3.18 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 125.668 1.587 . . . . 0.0 110.036 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -33.46 111.52 0.11 Allowed 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 126.082 1.753 . . . . 0.0 111.328 169.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.99 155.8 38.7 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.5 m -151.72 114.95 4.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.426 -2.064 . . . . 0.0 105.426 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.7 m -58.52 133.2 55.6 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.528 1.931 . . . . 0.0 108.344 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.5 mt -86.57 178.54 7.04 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.302 1.441 . . . . 0.0 108.831 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.515 ' H ' ' ND2' ' A' ' 129' ' ' ASN . 0.5 OUTLIER -135.45 170.3 16.16 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.62 1.968 . . . . 0.0 107.067 156.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -65.73 128.2 35.0 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 166.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 61' ' ' CYS . . . 99.09 -168.24 22.09 Favored Glycine 0 C--O 1.222 -0.656 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -171.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 90.6 m -83.33 139.91 32.76 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 120.776 -1.426 . . . . 0.0 111.806 -166.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.515 ' ND2' ' H ' ' A' ' 125' ' ' ASN . 26.3 m-80 -139.34 168.22 20.32 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 128.678 2.791 . . . . 0.0 109.37 -173.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.431 ' CG2' ' HB2' ' A' ' 55' ' ' ASN . 85.0 m -155.47 158.9 39.29 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 120.347 -1.47 . . . . 0.0 110.369 176.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.4 mt -131.93 112.79 14.83 Favored Pre-proline 0 C--O 1.24 0.603 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.72 150.0 38.94 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 121.598 1.532 . . . . 0.0 108.348 170.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -128.4 165.74 20.05 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.534 1.934 . . . . 0.0 108.59 176.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -133.26 113.28 12.46 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 121.453 -0.78 . . . . 0.0 108.909 172.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -94.83 170.36 9.5 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.819 0.819 . . . . 0.0 109.263 173.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -160.68 179.55 8.46 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.036 1.334 . . . . 0.0 108.909 167.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -91.45 149.41 21.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 153.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -122.5 124.84 44.5 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.835 2.054 . . . . 0.0 106.365 173.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.626 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -88.92 145.73 25.35 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 176.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.441 ' HA ' ' HG3' ' A' ' 45' ' ' GLU . 54.1 p -108.58 10.36 27.13 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 125.525 1.53 . . . . 0.0 111.168 176.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 161.65 -151.69 21.94 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.38 91.44 0.26 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.548 1.939 . . . . 0.0 109.935 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.19 157.06 20.18 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.022 0.439 . . . . 0.0 110.942 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 77.0 p -112.06 158.16 37.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 170.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -78.65 162.01 27.48 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.025 1.817 . . . . 0.0 110.636 165.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.39 -76.12 0.18 Allowed Glycine 0 N--CA 1.462 0.373 0 O-C-N 121.391 -0.818 . . . . 0.0 113.922 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -158.93 155.42 27.63 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.339 1.856 . . . . 0.0 106.874 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -149.98 91.04 1.74 Allowed 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -125.73 135.44 52.07 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.636 ' HB2' ' HA ' ' A' ' 88' ' ' LEU . . . -146.19 167.19 24.07 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 165.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.49 111.05 6.78 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 167.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.82 169.87 17.56 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 162.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.8 p -116.2 151.98 34.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 153.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -114.71 132.12 56.53 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.201 0.601 . . . . 0.0 109.502 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.437 ' HE3' ' O ' ' A' ' 115' ' ' GLY . 29.2 mtmt -97.28 171.2 8.58 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.97 0.908 . . . . 0.0 109.199 167.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.1 t -133.1 118.63 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 -172.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -105.55 83.64 1.97 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -62.2 150.78 37.93 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.775 0.83 . . . . 0.0 108.936 168.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -167.94 169.84 11.04 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 123.289 0.636 . . . . 0.0 110.779 -174.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 151.22 -79.74 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 177.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -24.43 -75.32 0.01 OUTLIER Glycine 0 CA--C 1.527 0.809 0 C-N-CA 129.515 3.436 . . . . 0.0 115.045 -168.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -68.83 157.43 53.28 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 122.48 1.044 . . . . 0.0 113.041 -174.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -91.6 57.53 3.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 125.563 1.554 . . . . 0.0 110.437 -167.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 106.45 85.52 1.81 Allowed Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 115.69 58.16 0.34 Allowed Glycine 0 C--N 1.329 0.173 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 167.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -146.54 111.82 5.47 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.863 1.265 . . . . 0.0 108.961 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -154.81 160.05 41.01 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.893 0.877 . . . . 0.0 110.903 -177.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.6 m -133.14 119.47 19.98 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.343 2.257 . . . . 0.0 106.799 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.9 m -114.52 123.9 50.54 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.469 1.108 . . . . 0.0 109.152 -169.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 1.2 m -143.49 150.91 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 123.975 0.91 . . . . 0.0 110.988 -168.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.07 132.25 48.1 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.627 1.571 . . . . 0.0 109.274 176.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -101.36 -78.54 1.34 Allowed Glycine 0 CA--C 1.519 0.344 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -173.95 -170.54 37.44 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.905 0.764 . . . . 0.0 111.772 -170.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 28.3 m -114.15 120.83 41.84 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.736 1.614 . . . . 0.0 110.989 -170.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 2.5 t -104.94 96.9 4.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -80.81 94.82 6.51 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.421 ' CD2' HG21 ' A' ' 101' ' ' VAL . 58.9 m-85 -76.91 85.49 3.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -93.86 165.7 12.55 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.623 0.769 . . . . 0.0 109.518 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 147.7 -161.96 28.62 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -170.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -170.25 174.77 5.18 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 75.4 t -123.19 138.28 53.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 171.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 39' ' ' THR . 6.8 m -116.61 149.22 18.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 126.008 1.723 . . . . 0.0 109.08 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -76.77 33.08 0.14 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -171.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 C-N-CA 128.454 2.702 . . . . 0.0 112.019 175.217 . . . . . . . . 0 0 . 1 stop_ save_